PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Turner-Stokes, L; Ashford, S; Jacinto, J; Maisonobe, P; Balcaitiene, J; Fheodoroff, K				Turner-Stokes, Lynne; Ashford, Stephen; Jacinto, Jorge; Maisonobe, Pascal; Balcaitiene, Jovita; Fheodoroff, Klemens			Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)	BMJ OPEN			English	Article						botulinum toxin A; goal attainment scaling (GAS); spasticity; rehabilitation; REHABILITATION MEDICINE	TRAUMATIC BRAIN-INJURY; POSTSTROKE SPASTICITY; MUSCLE SPASTICITY; ASHWORTH SCALE; RELIABILITY; STROKE; REHABILITATION; TRIAL; PATHOPHYSIOLOGY; INTERRATER	Objectives Describe the rationale and protocol for the Upper Limb International Spasticity (ULIS)-III study, which aims to evaluate the impact of integrated spasticity management, involving multiple botulinum toxin A (BoNT-A) injection cycles and concomitant therapies, on patient-centred goal attainment. Outline novel outcome assessment methods for ULIS-III and report initial evaluation data from goal setting in early stages of the study. Design Large international longitudinal cohort study of integrated upper limb spasticity management, including BoNT-A. Participants and setting ULIS-III is a 2-year study expected to enrol >1000 participants at 58 study centres across 14 countries. Interventions The study design is non-interventional and intended to reflect real-life clinical practice. It will describe injection practices and additional treatment strategies, and record clinical decision-making in a serial approach to long-term spasticity management. Outcome measures ULIS-III will use a goal-directed approach to selection of targeted standardised measures to capture the diversity of presentation, goals and outcomes. ULIS-III will implement the Upper Limb Spasticity Index, a battery of assessments including a structured approach to goal attainment scaling (Goal Attainment ScalingEvaluation of Outcomes for Upper Limb Spasticity tool), alongside a limited set of standardised measures, chosen according to patients' selected goal areas. Concomitant therapy inputs, patient satisfaction with engagement in goal setting, health economic end points and health-related quality of life data will also be captured. Results of initial evaluation of goal quality Recruitment started in January 2015. By June 2015, 58 sites had been identified and initial data collected for 79 patients across 13 sites in 3 countries. Goal setting data were quality-checked and centres rated on the basis of function-related and Specific, Measurable, Achievable, Realistic, Timed (SMART) characteristics of goal statements. Overall, 11/13 centres achieved the highest rating (A++). Conclusions ULIS-III will provide valuable information regarding treatment of and outcomes from real-life upper limb spasticity management worldwide. Trial registration number NCT02454803; Pre-results.	[Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Dept Palliat Care Policy & Rehabil, Sch Med, Northwick Pk Hosp, London, England; [Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Reg Rehabil Unit, Sch Med, Northwick Pk Hosp, London, England; [Jacinto, Jorge] Ctr Med Reabilitacaode Alcoitao, Serv Reabilitacao Adultos, Estoril, Portugal; [Maisonobe, Pascal; Balcaitiene, Jovita] Ipsen Pharma, Med Affairs, Boulogne, France; [Fheodoroff, Klemens] Gailtal Klin, Dept Neurorehabil, Hermagor, Austria	Turner-Stokes, L (corresponding author), Kings Coll London, Dept Palliat Care Policy & Rehabil, Sch Med, Northwick Pk Hosp, London, England.; Turner-Stokes, L (corresponding author), Kings Coll London, Reg Rehabil Unit, Sch Med, Northwick Pk Hosp, London, England.	lynne.turner-stokes@doctors.org.uk	Turner-Stokes, Lynne/F-4418-2012; Ashford, Stephen/D-6653-2013; Fheodoroff, Klemens/H-6406-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Ashford, Stephen/0000-0001-5541-7063; Fheodoroff, Klemens/0000-0002-6508-5055; Jacinto, Jorge/0000-0002-3428-2312	Ipsen PharmaIpsen; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CAT-CL-03-2012-010] Funding Source: researchfish	Ipsen Pharma.	Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Ashford S, 2016, CLIN REHABIL, V30, P617, DOI 10.1177/0269215515593391; Ashford S, 2013, CLIN REHABIL, V27, P728, DOI 10.1177/0269215512474942; Ashford S, 2009, DISABIL REHABIL, V31, P220, DOI 10.1080/09638280801906388; Bakheit AM, 2010, INT J REHABIL RES, V33, P199, DOI 10.1097/MRR.0b013e328332f5e0; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Council for International Organizations of Medical Sciences (CIOMS), 2009, INT EITH GUID EP STU; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Holliday RC, 2007, J NEUROL NEUROSUR PS, V78, P576, DOI 10.1136/jnnp.2006.102509; International Society for Pharmocoepidemiology, 2007, GUID GOOD PHARM PRAC; Ipsen, ATT PERS CTR GOALS B; Jackson D, 2006, CLIN MED, V6, P580, DOI 10.7861/clinmedicine.6-6-580; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Macfarlane A, 2002, CLIN REHABIL, V16, P726, DOI 10.1191/0269215502cr546oa; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Oemar M, 2013, EQ 5D 5L US GUID BAS; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy Association of Chartered Physiotherapists Interested in Neurology, 2009, SPAST AD MAN US BOT; Scottish intercollegiate Guidelines network, 2010, MAN PAT STROK REH PR; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Tennant A, 2007, DISABIL REHABIL, V29, P1583, DOI 10.1080/09638280701618828; Turner-Stokes L, 2012, PHYS MED REHABILITAT, V2, pS190; Turner-Stokes L, 2012, NEUROREHAB NEURAL RE, V26, P695; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Turner-Stokes L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002771; Turner-Stokes L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002230; Turner-Stokes L, 2014, DISABIL REHABIL, V36, P23, DOI 10.3109/09638288.2013.775360; Turner-Stokes L, 2010, J REHABIL MED, V42, P81, DOI 10.2340/16501977-0474; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Ward AB, 2014, J REHABIL MED, V46, P504, DOI 10.2340/16501977-1817; World Health Organization, 2002, INT CLASS FUNCT DIS	38	13	13	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	6							e011157	10.1136/bmjopen-2016-011157			12	Medicine, General & Internal	General & Internal Medicine	DR9ST	WOS:000380237100106	27315835	DOAJ Gold, Green Published			2021-06-18	
J	Naro, A; Russo, M; Leo, A; Rifici, C; Pollicino, P; Bramanti, P; Calabro, RS				Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore			Cortical Responsiveness to Nociceptive Stimuli in Patients with Chronic Disorders of Consciousness: Do C-Fiber Laser Evoked Potentials Have a Role?	PLOS ONE			English	Article							COMA RECOVERY SCALE; BRAIN POTENTIALS; A-DELTA; SURFACE-AREAS; PAIN; HYPERALGESIA; GUIDELINES; RESPONSES; PATHWAYS; NOVELTY	It has been shown that the presence of Ad-fiber laser evoked potentials (Ad-LEP) in patients suffering from chronic disorders of consciousness (DOC), such as vegetative state (VS) and minimally conscious state (MCS), may be the expression of a residual cortical pain arousal. Interestingly, the study of C-fiber LEP (C-LEP) could be useful in the assessment of cortical pain arousal in the DOC individuals who lack of A delta-LEP. To this end, we enrolled 38 DOC patients following post-anoxic or post-traumatic brain injury, who met the international criteria for VS and MCS diagnosis. Each subject was clinically evaluated, through the coma recovery scale-revised (CRS-R) and the nociceptive coma scale-revised (NCS-R), and electrophysiologically tested by means of a solid-state laser for A delta-LEP and C-LEP. VS individuals showed increased latencies and reduced amplitudes of both the A delta-LEP and C-LEP components in comparison to MCS patients. Although nearly all of the patients had both the LEP components, some VS individuals showed only the C-LEP ones. Notably, such patients had a similar NCS-R score to those having both the LEP components. Hence, we could hypothesize that C-LEP generators may be rearranged or partially spared in order to still guarantee cortical pain arousal when A delta-LEP generators are damaged. Therefore, the residual presence of C-LEP should be assessed when A delta-LEP are missing, since a potential pain experience should be still present in some patients, so to properly initiate, or adapt, the most appropriate pain treatment.	[Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	salbro77@tiscali.it	calabro, rocco salvatore/L-9570-2019; Leo, Antonino/K-7529-2016; Rifici, Carmela/ABH-4398-2020; Leo, Antonino/ABI-7198-2020; Calabro, Rocco S/K-7520-2016; Bramanti, Placido/K-5117-2016	calabro, rocco salvatore/0000-0002-8566-3166; Leo, Antonino/0000-0003-4163-5830; Leo, Antonino/0000-0003-4163-5830; 			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BENNETT GJ, 1994, TXB PAIN; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Bragard D, 1996, NEUROSCI LETT, V209, P81, DOI 10.1016/0304-3940(96)12604-5; BROMM B, 1983, PFLUG ARCH EUR J PHY, V399, P155, DOI 10.1007/BF00663913; CAMPBELL JN, 1983, J NEUROPHYSIOL, V49, P98; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; de Tommaso M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00017; de Tommaso M, 2013, BRAIN INJURY, V27, P962, DOI 10.3109/02699052.2013.775507; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 2002, BRAIN, V125, P2766, DOI 10.1093/brain/awf275; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hu L, 2014, J NEUROSCI, V34, P11439, DOI 10.1523/JNEUROSCI.1355-14.2014; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Iannetti GD, 2003, J NEUROPHYSIOL, V89, P562, DOI 10.1152/jn.00393.2002; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; LAMOTTE RH, 1983, J NEUROPHYSIOL, V50, P1; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Lenz FA, 1991, PAIN CENTRAL NERVOU; Letham B, 2011, J NEUROSCI METH, V194, P374, DOI 10.1016/j.jneumeth.2010.10.016; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; Montagna W, 1959, P BROWN U S BIOL SKI; Mouraux A, 2006, Suppl Clin Neurophysiol, V59, P197; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Opsommer E, 2001, CLIN NEUROPHYSIOL, V112, P1868, DOI 10.1016/S1388-2457(01)00622-8; Opsommer E, 1999, NEUROPHYSIOL CLIN, V29, P411, DOI 10.1016/S0987-7053(00)87265-2; Perchet C, 2008, CLIN NEUROPHYSIOL, V119, P2615, DOI 10.1016/j.clinph.2008.06.021; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; Spiegel J, 2000, CLIN NEUROPHYSIOL, V111, P725, DOI 10.1016/S1388-2457(99)00297-7; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Treede RD, 1998, PAIN FORUM, V7, P191, DOI 10.1016/S1082-3174(98)80005-6; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; Valeriani M, 2002, NEUROSCI LETT, V329, P329, DOI 10.1016/S0304-3940(02)00671-7; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wang AL, 2010, J NEUROPHYSIOL, V104, P2116, DOI 10.1152/jn.01088.2009; Weng HR, 2000, NEUROSCIENCE, V101, P393, DOI 10.1016/S0306-4522(00)00368-7; Wu Q, 1999, PAIN, V80, P209, DOI 10.1016/S0304-3959(98)00206-1; Zanatta P, 2012, MINERVA ANESTESIOL, V78, P749	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144713	10.1371/journal.pone.0144713			12	Multidisciplinary Sciences	Science & Technology - Other Topics	CY9JH	WOS:000366722700055	26674634	DOAJ Gold, Green Published			2021-06-18	
J	Bonds, BW; Hu, P; Li, Y; Yang, SM; Colton, K; Gonchigar, A; Cheriyan, J; Grissom, T; Fang, R; Stein, DM				Bonds, Brandon W.; Hu, Peter; Li, Yao; Yang, Shiming; Colton, Katharine; Gonchigar, Anish; Cheriyan, Jerry; Grissom, Thomas; Fang, Raymond; Stein, Deborah M.			Predictive value of hyperthermia and intracranial hypertension on neurological outcomes in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						Hyperthermia; intracranial hypertension; traumatic brain injury	INTENSIVE-CARE-UNIT; THERAPEUTIC HYPOTHERMIA; NEUROCRITICAL CARE; FEVER; MANAGEMENT; PRESSURE; MODERATE; BURDEN; TRIAL	Background: Intracranial hypertension (ICH) and hyperthermia are common after traumatic brain injury (TBI) and associated with worse neurological outcomes. This study sets out to determine the combined power of temperature and intracranial pressure (ICP) for predicting neurologic outcomes and prolonged length of stay (LOS) following severe TBI.Methods: High resolution (every 6 seconds) temperature and ICP data were collected in adults with severe TBI from 2008-2010. Temperatures were plotted against concurrent ICP and divided based on breakpoints (Temperature: <36, 36-38.5 or >38.5 degrees C, ICP: <20, 20-30 or >30mmHg). The percentage of time spent in each section, as well as several pooled unfavourable conditions (hyperthermiaICH), were then evaluated for predictive value for ICU-LOS>7 days and short-term (<6 months) vs. long-term (>6 months) dichotomized neurologic outcomes.Results: Fifty patients were included for analysis with severe TBI. Evaluation of the area under the operating receiver curve (AUC) showed significant periods of fever and high ICP (<30mmHg) had a strong association with poor long-term neurological outcomes (Day 3, AUC=0.71, p=0.04) and were higher than either condition alone. ICU-LOS>7 days was increased when hyperthermia and/or ICH remained uncontrolled by Day 5 (AUC=0.82, p=0.02).Summary: Hyperthermia combined with ICH were shown to be significant prognostic indicators of future poor neurologic outcomes in patients with severe traumatic brain injury.	[Bonds, Brandon W.; Hu, Peter; Li, Yao; Yang, Shiming; Colton, Katharine; Gonchigar, Anish; Grissom, Thomas; Fang, Raymond; Stein, Deborah M.] Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD 21201 USA; [Bonds, Brandon W.; Hu, Peter; Li, Yao; Yang, Shiming; Colton, Katharine; Gonchigar, Anish; Grissom, Thomas; Fang, Raymond; Stein, Deborah M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Colton, Katharine] Duke Univ, Sch Med, Durham, NC USA; [Cheriyan, Jerry] Marshfield Clin Fdn Med Res & Educ, Dept Surg, Marshfield, WI USA	Bonds, BW (corresponding author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	bbonds@stapa.umm.edu	Grissom, Thomas E./AAH-5749-2019; Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963; Cheriyan, Jerry/0000-0002-4624-0291	USAF	This work was funded in part through a grant provided by the USAF. The views expressed in this article are those of the authors and do not necessarily represent the official position or policy of the US Air Force, the Department of Defense or the US Government.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brinnel H., 1987, P CSIRO DIV AN PROD, P209; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Circiumaru B, 1999, INTENS CARE MED, V25, P668, DOI 10.1007/s001340050928; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gozzoli V, 2001, ARCH INTERN MED, V161, P121, DOI 10.1001/archinte.161.1.121; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holtzclaw BJ, 2002, ONLINE J CLIN INNOVA, V5, P1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Plaisance KI, 2000, ARCH INTERN MED, V160, P449, DOI 10.1001/archinte.160.4.449; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; Rupich K, 2009, J NEUROSCI NURS, V41, P159, DOI 10.1097/JNN.0b013e3181a23ec1; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Segatore M, 1992, J Neurosci Nurs, V24, P104; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720	41	13	14	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1642	1647		10.3109/02699052.2015.1075157			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800015	26479461				2021-06-18	
J	Hamilton, M; Williams, G; Bryant, A; Clark, R; Spelman, T				Hamilton, Megan; Williams, Gavin; Bryant, Adam; Clark, Ross; Spelman, Tim			Which factors influence the activity levels of individuals with traumatic brain injury when they are first discharged home from hospital?	BRAIN INJURY			English	Article							ASSESSMENT-TOOL HIMAT; OF-SPORTS-MEDICINE; PHYSICAL-ACTIVITY; POSTURAL STABILITY; PUBLIC-HEALTH; EXERCISE QUESTIONNAIRE; INTERRATER RELIABILITY; BEHAVIORAL-REGULATION; MULTIPLE-SCLEROSIS; OBJECTIVE MEASURES		[Hamilton, Megan; Williams, Gavin] Epworth Healthcare, Physiotherapy Dept, Epworth Rehabil, Melbourne, Vic, Australia; [Hamilton, Megan; Williams, Gavin; Bryant, Adam; Clark, Ross] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Spelman, Tim] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia	Hamilton, M (corresponding author), Epworth Rehabil, Community Integrat Team, 29 Erin St, Richmond, Vic 3121, Australia.	megan.hamilton@epworth.org.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Williams, Gavin/0000-0003-2758-7473	Epworth Healthcare Scholarship	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This research was partially funded by an Epworth Healthcare Scholarship.	Alzahrani MA, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/470648; Australian Food Statistics, 2012, AUSTR PHYS ACT SED B, P8; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Booth FW, 2000, J APPL PHYSIOL, V88, P774; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Buchman AS, 2011, AM J GERIAT PSYCHIAT, V19, P571, DOI 10.1097/JGP.0b013e3181ef7a2e; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cerin E, 2008, MEAS PHYS EDUC EXERC, V12, P31, DOI 10.1080/10913670701715190; Chiu CY, 2012, REHABIL COUNS BULL, V56, P23, DOI 10.1177/0034355212439898; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cink R E, 1981, Br J Sports Med, V15, P182; Committee on Physical Activity Guidelines Advisory, 2008, PHYS ACT GUID ADV CO; de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035; Department of Health, 2004, LEAST 5 WEEK EV IMP; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Fidell L, 2007, USING MULTIVARIATE S; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; IBM, 2013, IBM SPSS STAT WIND 2; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Keegan JP, 2012, REHABIL COUNS BULL, V56, P34, DOI 10.1177/0034355212440732; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191; Mayo NE, 1999, DISABIL REHABIL, V21, P258; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; Moylan S, 2013, NEUROSCI BIOBEHAV R, V37, P573, DOI 10.1016/j.neubiorev.2013.02.003; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P296, DOI 10.1016/j.apmr.2008.07.025; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Murtezani Ardiana, 2009, Med Arh, V63, P216; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Neven A, 2013, DISABIL REHABIL, V35, P1718, DOI 10.3109/09638288.2012.751137; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robinson CA, 2011, PHYS THER, V91, P1865, DOI 10.2522/ptj.20100216; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Santiago MC, 2004, DISABIL REHABIL, V26, P485, DOI 10.1080/09638280410001663139; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sohlberg MM, 2005, BRAIN INJURY, V19, P1249, DOI 10.1080/02699050500309510; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Teixeira CM, 2013, SOC INDIC RES, V113, P307, DOI 10.1007/s11205-012-0094-9; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Thurman DJ, 1999, TRAUMATIC BRAIN INJU; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; van Heuvelen MJG, 2006, GERONTOLOGY, V52, P366, DOI 10.1159/000094986; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson PM, 2012, PSYCHOL SPORT EXERC, V13, P614, DOI 10.1016/j.psychsport.2012.03.009; Wise EK, 2012, BENEFITS EXERCISE MA; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	83	13	13	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1572	1580		10.3109/02699052.2015.1075145			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800007	26399973				2021-06-18	
J	Almeida, OP; Hankey, GJ; Yeap, BB; Golledge, J; Flicker, L				Almeida, Osvaldo P.; Hankey, Graeme J.; Yeap, Bu B.; Golledge, Jonathan; Flicker, Leon			Prevalence, associated factors, mood and cognitive outcomes of traumatic brain injury in later life: the health in men study (HIMS)	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						traumatic brain injury; depression; cognitive impairment; dementia; epidemiology; prevalence	ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; OLDER-ADULTS; DEPRESSION; EPIDEMIOLOGY; FALLS; PREVENTION; DISORDERS; HISTORY	BackgroundThe incidence of traumatic brain injury (TBI) is rising, as are its neuropsychiatric complications. This study aims to determine (1) the prevalence of TBI, (2) the association between history of past TBI and sociodemographic, lifestyle and clinical factors, and (3) the risk of depression and cognitive impairment in later life associated with exposure to TBI. MethodsCross-sectional study of a community-derived sample of 5486 Australian men aged 70-89 years. Information on TBI was retrieved from the Western Australian Data Linkage System (WADLS) and via self-report. We used the WADLS and self-report to ascertain history of past depression, and the Geriatric Depression Scale 15-items to assess current clinically significant symptoms of depression, defined by score 7. We defined cognitive impairment by a mini-mental state examination score <24 or a WADLS diagnosis of dementia. ResultsNine hundred fifty-three men had history of TBI (17.4%). Factors associated with TBI included coronary heart disease, stroke, poor self-perceived physical health and falls. TBI increased the odds ratio of past (odds ratio (OR)=1.55, 95% confidence interval (CI)=1.21, 1.99) and current depression (OR=1.77, 95% CI=1.36, 2.32), as well as of cognitive impairment (OR=1.23, 95% CI=1.00, 1.51). The population fractions of depression and cognitive impairment attributable to TBI were 6.9% (95% CI=3.3%, 10.3%) and 3.4% (95% CI=0.0%, 6.9%). ConclusionsHistory of TBI is common in older men, and is associated with increased risk of depression and cognitive impairment. If this association is truly causal, then the effective reduction of events leading to TBI (e.g., motor vehicle accidents and falls) may also decrease the prevalence of depression and cognitive impairment in later life. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Periral Vasc Dis, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia	Almeida, OP (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	golledge, jonathan/I-2371-2013; Almeida, Osvaldo P./A-4925-2008; Hankey, Graeme J/H-4968-2014	Almeida, Osvaldo P./0000-0002-8689-6199; Hankey, Graeme J/0000-0002-6044-7328; golledge, jonathan/0000-0002-5779-8848; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710, 1060557]	This work was funded through competitive project grants from the National Health and Medical Research Council of Australia (NHMRC), numbers 279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710 and 1060557. The sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review, or approval of the manuscript.	Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111882; Almeida OP, 2013, PREV MED, V57, P878, DOI 10.1016/j.ypmed.2013.09.021; Australian Bureau of Statistics (ABS), 2010, 3201 0 POP AG SEX AU; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CORKIN S, 1989, J NEUROSCI, V9, P3876; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strakowski SM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0386-z; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; USDHHS, 2012, ADM AG AOA ADM COMM; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X	38	13	13	0	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	DEC	2015	30	12					1215	1223		10.1002/gps.4276			9	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CW1XB	WOS:000364784100009	25703581				2021-06-18	
J	Woods, DL; Wyma, JM; Yund, EW; Herron, TJ				Woods, David L.; Wyma, John M.; Yund, E. W.; Herron, Timothy J.			The Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury on Visual Choice Reaction Time	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						aging; concussion; head injury; reliability; response selection; feigning; effort; timing precision	TEST-RETEST RELIABILITY; MEASURING PROCESSING SPEED; COGNITIVE TEST-PERFORMANCE; VALIDITY TEST-PERFORMANCE; CLOSED-HEAD-INJURY; MULTIPLE-SCLEROSIS; VERBAL MEMORY; NIH TOOLBOX; CONCUSSION; ATTENTION	Choice reaction time (CRT), the time required to discriminate and respond appropriately to different stimuli, is a basic measure of attention and processing speed. Here, we describe the reliability and clinical sensitivity of a new CRT test that presents lateralized visual stimuli and adaptively adjusts stimulus onset asynchronies using a staircase procedure. Experiment 1 investigated the test-retest reliability in three test sessions performed at weekly intervals. Performance in the first test session was accurately predicted from age and computer-use regression functions obtained in a previously studied normative cohort. Central processing time (CentPT), the difference between the CRTs and simple reaction time latencies measured in a separate experiment, accounted for 55% of CRT latency and more than 85% of CRT latency variance. Performance improved significantly across the three test sessions. High intraclass correlation coefficients were seen for CRTs (0.90), CentPTs (0.87), and an omnibus performance measure (0.81) that combined CRT and minimal SOA z-scores. Experiment 2 investigated performance in the same participants when instructed to feign symptoms of traumatic brain injury (TBI): 87% produced abnormal omnibus z-scores. Simulated malingerers showed greater elevations in simple reaction times than CRTs, and hence reduced CentPTs. Latency-consistency z-scores, based on the difference between the CRTs obtained and those predicted based on CentPT latencies, discriminated malingering participants from controls with high sensitivity and specificity. Experiment 3 investigated CRT test performance in military veterans who had suffered combat-related TBI and symptoms of post-traumatic stress disorder, and revealed small but significant deficits in performance in the TBI population. The results indicate that the new CRT test shows high test-retest reliability, can assist in detecting participants performing with suboptimal effort, and is sensitive to the effects of TBI on the speed and accuracy of visual processing.	[Woods, David L.; Wyma, John M.; Yund, E. W.; Herron, Timothy J.] Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.] UC Davis Dept Neurol, Sacramento, CA USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA USA	Woods, DL (corresponding author), Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.	dlwoods@ucdavis.edu		Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X; Yund, E./0000-0002-6833-0052	VA Merit Grants [CX000583, CX001000]; Veterans AffairsUS Department of Veterans Affairs [I01CX001000, I01CX000583] Funding Source: NIH RePORTER	This research was supported by VA Merit Grants CX000583 and CX001000 to DW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. We would also like to thank Ben Edwards, Oren Poliva, Masood Younus, Nabeel Rahman, Kerry Hubel, Nerene Lynskey, Kataraina George, and John McKeogh who helped to gather the data used in this report, and to Robert Hink who developed the MySQL database.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Klein RM, 2011, ACTA PSYCHOL, V136, P225, DOI 10.1016/j.actpsy.2010.08.003; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lapshin H, 2013, MULT SCLER J, V19, P1905, DOI 10.1177/1352458513488841; Lee KS, 2012, NEUROTOXICOLOGY, V33, P1362, DOI 10.1016/j.neuro.2012.08.013; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; McNally RJ, 2012, J TRAUMA STRESS, V25, P454, DOI 10.1002/jts.21713; Papapetropoulos S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/760196; Pellizzer G, 2007, EXP BRAIN RES, V180, P705, DOI 10.1007/s00221-007-0892-5; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Snyder PJ, 2001, NEUROPSYCHOLOGY, V15, P617, DOI 10.1037//0894-4105.15.4.617; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Versavel M, 1997, ARZNEIMITTEL-FORSCH, V47, P781; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149	56	13	14	0	17	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 24	2015	9								595	10.3389/fnhum.2015.00595			13	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CY7DB	WOS:000366567300001	26635569	DOAJ Gold, Green Published			2021-06-18	
J	Krishnamoorthy, V; Vavilala, MS; Mills, B; Rowhani-Rahbar, A				Krishnamoorthy, Vijay; Vavilala, Monica S.; Mills, Brianna; Rowhani-Rahbar, Ali			Demographic and clinical risk factors associated with hospital mortality after isolated severe traumatic brain injury: a cohort study	JOURNAL OF INTENSIVE CARE			English	Article						Trauma; Brain injury; Outcomes	GLASGOW COMA SCALE; EXTRACRANIAL COMPLICATIONS; OUTCOMES; PREVENTION; PNEUMONIA; INFECTIONS	Background: Traumatic brain injury (TBI) is a major public health problem and a leading cause of death worldwide. A paucity of literature exists on risk factors for mortality in isolated severe TBI, a condition that is distinct from severe TBI in the setting of multisystem trauma. We determined risk factors for in-hospital mortality in this patient population. Methods: We conducted a retrospective cohort study using data from the National Trauma Databank from 2008-2012 to study all patients admitted with a diagnosis of severe TBI, excluding children, patients with non-isolated TBI, transfers, and hospitalization < 48 h. We used multivariable Poisson regression to analyze the association between demographic, clinical, and facility-level characteristics and in-hospital mortality. Results: A total of 41,590 patients were included in our analysis. The cumulative incidence of in-hospital mortality was 10.2 %. In multivariable analysis, older age (RR 3.92, 95 % CI 3.54-4.34), male gender (RR 1.17, 95 % CI 1.09-1.25), admission hypotension (RR 1.83, 95 % CI 1.61-2.09), the need for mechanical ventilation (RR 4.18, 95 % CI 3.64-4.80), higher injury severity score (RR 1.86, 95 % CI 1.41-2.45), and poor initial neurologic grade (RR 3.06, 95 % CI 2.74-3.43) were associated with a higher risk for mortality. Conclusions: Admission hypotension and the need for mechanical ventilation were possible modifiable risk factors associated with increased in-hospital mortality following isolated severe TBI. Although risk factors for mortality are similar in isolated and non-isolated TBI, the underlying etiologies for hypotension and respiratory failure are likely different in both conditions and require further exploration.	[Krishnamoorthy, Vijay; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB 1469, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Mills, Brianna; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Vavilala, Monica S.; Mills, Brianna; Rowhani-Rahbar, Ali] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA	Krishnamoorthy, V (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB 1469, Seattle, WA 98195 USA.	vkrish@u.washington.edu		Mills, Brianna/0000-0002-6632-9592	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM086270]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD042828, T32HD007543] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health (National Research Service Award T32 GM086270)	Allareddy V, 2015, AM J SURG; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Brown JR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000714; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Kramer AH, 2013, CAN J ANESTH, V60, P966, DOI 10.1007/s12630-013-0001-0; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mills B, 2015, J NEUROTRAUM, V32, P841, DOI 10.1089/neu.2014.3733; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Terre R, 2012, NEUROGASTROENT MOTIL, V24, P414, DOI 10.1111/j.1365-2982.2011.01869.x; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	27	13	13	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-0492			J INTENSIVE CARE	J. Intensive Care	NOV 10	2015	3								46	10.1186/s40560-015-0113-4			8	Critical Care Medicine	General & Internal Medicine	CW1KC	WOS:000364747600001	26561524	DOAJ Gold, Green Published			2021-06-18	
J	Bulloch, AGM; Fiest, KM; Williams, JVA; Lavorato, DH; Berzins, SA; Jette, N; Pringsheim, TM; Patten, SB				Bulloch, Andrew G. M.; Fiest, Kirsten M.; Williams, Jeanne V. A.; Lavorato, Dina H.; Berzins, Sandra A.; Jette, Nathalie; Pringsheim, Tamara M.; Patten, Scott B.			Depression - a common disorder across a broad spectrum of neurological conditions: a cross-sectional nationally representative survey	GENERAL HOSPITAL PSYCHIATRY			English	Article						Neurological conditions; Depressive disorder; Depression rating scales; Prevalence; Community-based study	QUALITY-OF-LIFE; HEALTH QUESTIONNAIRE PHQ-9; SELF-REPORTED EPILEPSY; MAJOR DEPRESSION; BRAIN-TUMOR; MULTIPLE-SCLEROSIS; SUICIDAL IDEATION; RISK-FACTORS; PREVALENCE; DISEASE	Objective: To estimate the prevalence of depression across a range of neurological conditions in a nationally representative sample. Methods: The data source was the Survey of Living with Neurological Conditions in Canada (SLNCC), which accrued its sample by selecting participants from the Canadian Community Health Survey. The point prevalence of depression was estimated by assessment of depressive symptoms with the Patient Health Questionnaire, Brief (Patient Health Questionnaire, 9-item). Results: A total of n=4408 participated in the SLNCC. The highest point prevalence of depression (>30%) was seen in those with traumatic brain injury and brain/spinal cord tumors. Depression was also highly prevalent (18-28%) in those with (listed from highest to lowest) Alzheimer's disease/dementia, dystonia, multiple sclerosis, Parkinson's disease, stroke, migraine, epilepsy and spina bifida. The odds ratios for depression, with the referent group being the general population, were significant (from highest to lowest) for migraine, traumatic brain injury, stroke, dystonia and epilepsy. Conclusions: All neurological conditions included in this study are associated with an elevated prevalence of depression in community populations. The conditions with the highest prevalence are traumatic brain injury and brain/spinal cord tumors. (c) 2015 Elsevier Inc. All rights reserved.	[Bulloch, Andrew G. M.; Fiest, Kirsten M.; Williams, Jeanne V. A.; Lavorato, Dina H.; Berzins, Sandra A.; Jette, Nathalie; Patten, Scott B.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Bulloch, Andrew G. M.; Patten, Scott B.] Univ Calgary, Dept Psychiat, Calgary, AB T2N 1N4, Canada; [Jette, Nathalie; Pringsheim, Tamara M.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Jette, Nathalie; Pringsheim, Tamara M.] Univ Calgary, Inst Publ Hlth, Calgary, AB T2N 1N4, Canada; [Bulloch, Andrew G. M.; Fiest, Kirsten M.; Berzins, Sandra A.; Pringsheim, Tamara M.; Patten, Scott B.] Univ Calgary, Hotchkiss Brain Inst, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB T2N 1N4, Canada	Bulloch, AGM (corresponding author), Dept Community Hlth Sci, TRW 4D67,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	bulloch@ucalgary.ca	Fiest, Kirsten/AAV-5052-2020; Pringsheim, Tamara/L-5955-2019; Patten, Scott/B-4434-2011	Fiest, Kirsten/0000-0002-7299-6594; Pringsheim, Tamara/0000-0002-8229-8431; Patten, Scott/0000-0001-9871-4041	Hotchkiss Brain Institute at the University of Calgary; Alberta Innovates - Health Solutions; Alberta Addiction and Mental Health Research Partnership Program; endMS Studentship	This project was supported by a grant from the Hotchkiss Brain Institute at the University of Calgary. This Institute had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report or in the decision to submit the article for publication. Scott Patten, Nathalie Jette and Kirsten Fiest were supported by salary awards by Alberta Innovates - Health Solutions. Nathalie Jette also holds a Canada Research Chair Tier 2 in Neuroscience Health Services Research. Sandy Berzins was supported by an operating grant from the Alberta Addiction and Mental Health Research Partnership Program and by an endMS Studentship.	Ben-Shlomo Y, 2002, J NEUROL NEUROSUR PS, V72, P608, DOI 10.1136/jnnp.72.5.608; Boylan LS, 2004, NEUROLOGY, V62, P258, DOI 10.1212/01.WNL.0000103282.62353.85; Bronnum-Hansen H, 2005, J NEUROL NEUROSUR PS, V76, P1457, DOI 10.1136/jnnp.2004.056747; Brooks DR, 2012, EPILEPSY BEHAV, V23, P57, DOI 10.1016/j.yebeh.2011.11.002; Bruce Travis O, 2008, Curr Psychiatry Rep, V10, P258, DOI 10.1007/s11920-008-0042-1; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; FARRER LA, 1986, AM J MED GENET, V24, P305, DOI 10.1002/ajmg.1320240211; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fiest KM, 2014, EPILEPSIA, V55, P1642, DOI 10.1111/epi.12754; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hermida AP, 2012, EXPERT REV NEUROTHER, V12, P1339, DOI [10.1586/ern.12.127, 10.1586/ERN.12.127]; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kessler R. C., 1998, INT J METH PSYCH RES, V7, P171, DOI 10.1002/mpr.47.; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lewis L, 2008, J NEUROL, V255, P1750, DOI 10.1007/s00415-008-0020-x; Lou JS, 2003, NEUROLOGY, V60, P122, DOI 10.1212/01.WNL.0000042781.22278.0A; Mainio A, 2011, CLIN NEUROL NEUROSUR, V113, P649, DOI 10.1016/j.clineuro.2011.05.006; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Miller KM, 2007, MOVEMENT DISORD, V22, P666, DOI 10.1002/mds.21376; Moller-Leimkuhler AM, 2010, WORLD J BIOL PSYCHIA, V11, P922, DOI 10.3109/15622975.2010.523481; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Oladeji BD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0390-3; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Pascoe MC, 2011, INT J STROKE, V6, P128, DOI 10.1111/j.1747-4949.2010.00565.x; Patten SB, 2015, MULT SCLER IN PRESS; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Payne JL, 2002, INT J GERIATR PSYCH, V17, P247, DOI 10.1002/gps.589; Pelletier G, 2002, J NEURO-ONCOL, V57, P41, DOI 10.1023/A:1015728825642; Poole L, 2011, J PSYCHOSOM RES, V71, P61, DOI 10.1016/j.jpsychores.2010.12.009; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; Sjonnesen K, 2012, POSTGRAD MED, V124, P69, DOI 10.3810/pgm.2012.09.2595; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; STARKSTEIN S, 2002, PSYCHIAT COGNITIVE D; Starkstein SE, 2008, MOVEMENT DISORD, V23, P546; Statistics Canada, SURV LIV NEUR COND C; Statistics Canada, TABL 105 1300 NEUR C; SULLIVAN M, 1993, ARCH INTERN MED, V153, P2251, DOI 10.1001/archinte.153.19.2251; Tellez-Zenteno JF, 2004, EPILEPSIA, V45, P1623, DOI 10.1111/j.0013-9580.2004.24904.x; Thompson AW, 2011, PARKINSONISM RELAT D, V17, P40, DOI 10.1016/j.parkreldis.2010.10.007; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Viner R, 2014, J PSYCHOSOM RES, V76, P312, DOI 10.1016/j.jpsychores.2013.12.010; Walker AK, 2014, PHARMACOL REV, V66, P80, DOI 10.1124/pr.113.008144; Wang JL, 2000, INT J PSYCHIAT MED, V30, P309; Wellisch DK, 2002, PSYCHO-ONCOLOGY, V11, P230, DOI 10.1002/pon.562; Williams LS, 2005, SEMIN NEUROL, V25, P396, DOI 10.1055/s-2005-923534; Zunszain Patricia A, 2013, Curr Top Behav Neurosci, V14, P135, DOI 10.1007/7854_2012_211	51	13	13	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2015	37	6					507	512		10.1016/j.genhosppsych.2015.06.007			6	Psychiatry	Psychiatry	CV8AK	WOS:000364498700002	26153456				2021-06-18	
J	Chang, J; Phelan, M; Cummings, BJ				Chang, Janessa; Phelan, Michael; Cummings, Brian J.			A meta-analysis of efficacy in pre-clinical human stem cell therapies for traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Cell therapy; Cell transplantation; Stem cell therapy; Traumatic brain injury; Neurotrauma; Meta-analysis; Scientific rigor; Review	SPINAL-CORD-INJURY; UNITED-STATES; TRANSPLANTATION; ENGRAFTMENT; RECOVERY; STROKE; NEUROPROTECTION; FUTURE; SAFETY; MICE	Objectives: Evaluate the preclinical evidence for human cell therapies for the treatment of traumatic brain injury (TBI), determine behavioral effect sizes for modified and non-modified cells, and identify variables that correlate with greater effect sizes. Methods: A literature search identified 58 animal studies of TBI using human stem cells. Each study received a Quality Index (QI) score based on existing guidelines. Effect sizes for cell therapies were determined for the most common behavioral endpoints: Morris Water Maze (MWM) latency/correct quadrant, and modified Neurological Severity Score (mNSS). Results: 50 studies reported significant behavioral and/or histological improvement. The mean effect size for MWM latency was -1.08 for non-modified cells and -335 for modified cells. The mean effect size for MWM percent time in the correct quadrant was 1.66 for non-modified cells and 4.36 for modified cells. The mean effect size on the mNSS was -1.56 for non-modified cells and -4.46 for modified cells. No significant associations were found between methodological variables and effect sizes other than route of administration, where intra-lesional delivery resulted in larger effect sizes than i.v. or ventricular delivery. Studies with higher QI had smaller effect sizes; studies with larger effect sizes had greater standard errors. QI was not associated with journal impact factor. Conclusions: Although human cell therapy studies report improved behavioral outcomes in the majority of preclinical literature, the methods are too heterogeneous to facilitate direct comparisons and bias was detected. Replication and standardization are needed to identify procedural variables to yield the best results. We encourage the use of quality criteria and rigor for future studies of human cell therapy in animal models of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Chang, Janessa; Cummings, Brian J.] Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Dept Phys Med, Irvine, CA 92697 USA; [Chang, Janessa; Cummings, Brian J.] Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Dept Rehabil, Irvine, CA 92697 USA; [Phelan, Michael] Univ Calif Irvine, Dept Stat, Ctr Stat Consulting, Irvine, CA 92697 USA; [Cummings, Brian J.] Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Neurol Surg, Irvine, CA 92697 USA	Cummings, BJ (corresponding author), Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Dept Phys Med, Room 2026 Gross Hall,845 Hlth Sci Rd, Irvine, CA 92697 USA.	ChangJan@uphs.upenn.edu; phelanm@uci.edu; Cummings@uci.edu	Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290	California Institute for Regenerative MedicineCalifornia Institute for Regenerative Medicine [TR2-01767]	We wish to thank Dr. Steven Cramer for discussion of meta-analysis in stoke, Benita Lin for assistance with data entry, and Drs. Mitra Hooshmand and Aileen Anderson for critical review and comments. This work was supported, in part, by a grant from the California Institute for Regenerative Medicine (TR2-01767 to BJC).	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; CDC, INJ PREV CONTR TRAUM; Cook D, 2014, J BIOMECH, V47, P1241, DOI 10.1016/j.jbiomech.2014.01.040; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cummings BJ, 2006, NEUROL RES, V28, P474, DOI 10.1179/016164106X115116; FDA, 2013, GUID IND PRECL ASS I; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; NINDS, STROKE; OLKIN I, 1995, J CLIN EPIDEMIOL, V48, P133, DOI 10.1016/0895-4356(94)00136-E; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P961, DOI 10.5966/sctm.2013-0064; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P204, DOI 10.5966/sctm.2012-0110; Roet KCD, 2011, EXP NEUROL, V229, P10, DOI 10.1016/j.expneurol.2011.03.001; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Sontag CJ, 2013, STEM CELL TRANSL MED, V2, P731, DOI 10.5966/sctm.2012-0175; Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116; Team R. C., 2014, LANG ENV STAT COMP; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vu Q, 2014, NEUROLOGY, V82, P1277, DOI 10.1212/WNL.0000000000000278; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863	40	13	13	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						225	233		10.1016/j.expneurol.2015.08.020			9	Neurosciences	Neurosciences & Neurology	CW7BB	WOS:000365151800021	26342754				2021-06-18	
J	Hughes, AJ; Hartoonian, N; Parmenter, B; Haselkorn, JK; Lovera, JF; Bourdette, D; Turner, AP				Hughes, Abbey J.; Hartoonian, Narineh; Parmenter, Brett; Haselkorn, Jodie K.; Lovera, Jesus F.; Bourdette, Dennis; Turner, Aaron P.			Cognitive Impairment and Community Integration Outcomes in Individuals Living With Multiple Sclerosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Community integration; Multiple sclerosis; Neurobehavioral manifestations; Rehabilitation	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; INFORMATION-PROCESSING SPEED; BECK DEPRESSION INVENTORY; FATIGUE SEVERITY SCALE; MEMORY IMPAIRMENT; GINKGO-BILOBA; QUESTIONNAIRE; DISABILITY; VALIDITY	Objectives: To determine the association between unique domains of cognitive impairment and community integration in individuals with multiple sclerosis (MS), and to determine the contributions of cognitive impairment to community integration beyond the influence of demographic and clinical variables. Design: Cross-sectional analysis of objective neuropsychological assessment and self-report data. Data were collected during baseline assessment of a randomized, multisite controlled trial of ginkgo biloba for cognitive impairment in MS. Hierarchical regression analyses examined the association between subjective and objective measures of cognitive impairment and 3 domains of community integration, adjusting for relevant covariates. Setting: Two Veterans Affairs medical center MS clinics. Participants: Adults (N = 121; ages 24-65y) with a confirmed MS diagnosis. Interventions: Not applicable. Main Outcome Measures: Primary outcomes were scores on the Home Integration (CIQ-H), Social Integration (CIQ-S), and Productivity (CIQ-P) domains of the Community Integration Questionnaire (CIQ). Results: Cognitive impairment was associated with lower scores on the CIQ-H and CIQ-S, but not the CIQ-P. Greater levels of subjective cognitive impairment were associated with lower scores on the CIQ-H and CIQ-S. Greater levels of objective cognitive impairment, specifically slower processing speed and poorer inhibitory control, were related to lower CIQ-S scores. Subjective and objective measures of cognitive impairment were significantly and independently associated with CIQ-S. Conclusions: Objective cognitive impairment may interfere with participation in social activities. Subjective cognitive impairment is also important to assess, because individuals who perceive themselves to be cognitively impaired may be less likely to participate in both home and social activities. Clinical interventions to enhance community integration in individuals with MS may benefit from addressing objective and subjective cognitive impairment by integrating cognitive rehabilitation approaches with self-efficacy enhancing strategies. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hughes, Abbey J.; Hartoonian, Narineh; Haselkorn, Jodie K.; Turner, Aaron P.] Vet Affairs Puget Sound Hlth Care Syst, Seattle Div, Multiple Sclerosis Ctr Excellence West, Seattle, WA USA; [Hughes, Abbey J.; Haselkorn, Jodie K.; Turner, Aaron P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Parmenter, Brett] Vet Affairs Puget Sound Hlth Care Syst, Amer Lake Div, Tacoma, WA USA; [Haselkorn, Jodie K.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Lovera, Jesus F.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA USA; [Bourdette, Dennis] Vet Affairs Portland Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Portland, OR USA; [Bourdette, Dennis] Oregon Hlth & Sci Univ, Dept Neurol, Sch Med, Portland, OR 97201 USA	Hughes, AJ (corresponding author), Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA.	ajhughes@uw.edu	Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003; Hughes, Abbey/0000-0002-7612-6887	Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development [B4368R]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [MB 0026]	Supported by the Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development (grant no. B4368R), and by a mentor-based fellowship grant from the National Multiple Sclerosis Society (grant no. MB 0026). The contents of this paper do not represent the view of the Department of Veterans Affairs of the U.S. Government.	Archibald CJ, 2000, J CLIN EXP NEUROPSYC, V22, P686, DOI 10.1076/1380-3395(200010)22:5;1-9;FT686; Armutlu K, 2007, INT J REHABIL RES, V30, P81, DOI 10.1097/MRR.0b013e3280146ec4; Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; Beck A., 1996, MANUAL BDI 2; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belsky DA, 2005, REGRESSION DIAGNOSTI, V571; Benton AL, 1983, MULTILINGUAL APHASIA; Busche KD, 2003, CAN J NEUROL SCI, V30, P137, DOI 10.1017/S0317167100053403; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CARROLL M, 1984, NEUROPSYCHOLOGIA, V22, P297, DOI 10.1016/0028-3932(84)90076-9; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cutajar R, 2000, J NEUROVIROL, V6, pS186; Delis DC, 2000, CALIFORNIA VERBAL LE; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Diamond BJ, 2000, ARCH PHYS MED REHAB, V81, P668, DOI 10.1016/S0003-9993(00)90052-2; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Drew MA, 2009, ARCH CLIN NEUROPSYCH, V24, P47, DOI 10.1093/arclin/acp007; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Fischer JS, 1999, MULT SCLER J, V5, P251, DOI 10.1177/135245859900500410; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hughes AJ, 2011, J INT NEUROPSYCH SOC, V17, P1113, DOI 10.1017/S1355617711001135; HUGHES C, 1995, AM J MENT RETARD, V99, P623; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kurtzke J, 1983, NEUROLOGY, V33, P1444; LAROCCA N, 1985, J CHRON DIS, V38, P203, DOI 10.1016/0021-9681(85)90093-1; Lovera J, 2006, J REHABIL RES DEV, V43, P73, DOI 10.1682/JRRD.2004.09.0118; Lovera JF, 2012, NEUROLOGY, V79, P1278, DOI 10.1212/WNL.0b013e31826aac60; Manic RA, 2003, MULT SCLER, V9, P621; Marini I, 2012, PSYCHOSOCIAL ASPECTS OF DISABILITY: INSIDER PERSPECTIVES AND COUNSELING STRATEGIES, P1; Minden SL, 2006, MULT SCLER J, V12, P24, DOI 10.1191/135248506ms1262oa; MINDEN SL, 1990, J CLIN EXP NEUROPSYC, V12, P566, DOI 10.1080/01688639008401002; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; Potter K, 2014, PHYS THER, V94, P593, DOI 10.2522/ptj.20130149; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Rosti Otajiirvi EM, 2011, COCHRANE DB SYST REV; Schiavolin S, 2013, INT J REHABIL RES, V36, P105, DOI 10.1097/MRR.0b013e32835c79ea; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steyerberg EW., 2009, CLIN PREDICTION MODE; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; van de Ven L, 2005, DISABIL SOC, V20, P311, DOI 10.1080/09687590500060778; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 2001, INT CLASS FUNCT DIS; Yorkston KM, 2008, DISABIL REHABIL, V30, P88, DOI 10.1080/09638280701191891	52	13	13	1	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2015	96	11					1973	1979		10.1016/j.apmr.2015.07.003			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DB1YX	WOS:000368306600005	26189203				2021-06-18	
J	Lin, Y; Wan, JQ; Gao, GY; Pan, YH; Ding, SH; Fan, YL; Wang, Y; Jiang, JY				Lin, Yong; Wan, Jie-qing; Gao, Guo-yi; Pan, Yao-hua; Ding, Sheng-hao; Fan, Yi-ling; Wang, Yong; Jiang, Ji-yao			Direct hippocampal injection of pseudo lentivirus-delivered nerve growth factor gene rescues the damaged cognitive function after traumatic brain injury in the rat	BIOMATERIALS			English	Article						Traumatic brain injury; Nerve growth factor; Gene; Pseudo lentivirus; Hippocampus	PC12 CELL-DIFFERENTIATION; CORTICAL IMPACT MODEL; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; IN-VIVO; EXPRESSION; ACTIVATION; VECTORS; NEURONS; REPAIR	Traumatic brain injury (TBI) treatment is a long-term process and requires repeated medicine administration, which, however, can cause high expense, infection, and hemorrhage to patients. To investigate how a long-term expression of nerve growth factor (Ngf) gene affects the injured hippocampus function post-TBI, in this study, a pseudo lentivirus carrying the beta-Ngf fusion gene, with green fluorescence protein (GFP) gene, was constructed to show the gene expression and its ability of protecting cells from oxidative damage in vitro. Then, the pseudo lentivirus-carried beta-Ngf fusion gene was directly injected into the injured brain to evaluate its influence on the injured hippocampus function post-TBI in vivo. We found that the expression of the pseudo lentivirus-delivered beta-Ngf fusion gene lasted more than four-week after the cell transduction and the encoded beta-NGF fusion protein could induce the neuron-like PC12 cell differentiation. Moreover, the hippocampal injection of the pseudo lentivirus-carried beta-Ngf fusion gene sped the injured cognitive function recovery of the rat subjected to TBI. Together, our findings indicate that the long-term expression of the beta-Ngf fusion gene, delivered by the pseudo lentivirus, can promote the neurite outgrowth of the neuron-like cells and protect the cells from the oxidative damage in vitro, and that the direct and single dose hippocampal injection of the pseudo lentivirus-carried beta-Ngf fusion gene is able to rescue the hippocampus function after the TBI in the rat. (C) 2015 Elsevier Ltd. All rights reserved.	[Lin, Yong; Wan, Jie-qing; Gao, Guo-yi; Pan, Yao-hua; Ding, Sheng-hao; Fan, Yi-ling; Wang, Yong; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Dept Neurol Surg, Sch Med, Ren Ji Hosp, Shanghai 200127, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol Surg, Sch Med, Ren Ji Hosp, 160 Pujian Rd, Shanghai 200127, Peoples R China.	jiyaojiang@126.com			National Science and Nature Committee of China [81271381, 81471856, 81471244]; National Key project [2012CB518100]; Shanghai Science and Technology CommitteeShanghai Science & Technology Committee [11JC1408602]; Natural Science Foundation of Shanghai Jiao Tong University School of Medicine [14XJ10021]	This work was supported by the Grants from the National Science and Nature Committee of China (No. 81271381, 81471856, 81471244), National Key project (No. 2012CB518100), Shanghai Science and Technology Committee (No. 11JC1408602), and Natural Science Foundation of Shanghai Jiao Tong University School of Medicine (No. 14XJ10021).	Ahmed BY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-4; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aurelie D, 2013, CURR DRUG TARGETS, V14, P1336; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Benraiss A, 2001, J NEUROSCI, V21, P6718; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Flowers BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114535; Hohsfield LA, 2013, J IMMUNOL METHODS, V391, P112, DOI 10.1016/j.jim.2013.02.016; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kirkland RA, 2007, J NEUROSCI, V27, P11315, DOI 10.1523/JNEUROSCI.3590-07.2007; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/0897715042664876; Migdal C, 2011, M S-MED SCI, V27, P405, DOI 10.1051/medsci/2011274017; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Onyango IG, 2010, J NEUROCHEM, V114, P1605, DOI 10.1111/j.1471-4159.2010.06871.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Parr-Brownlie LC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00014; Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Terada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093223; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Utley DS, 1996, ARCH OTOLARYNGOL, V122, P407; Valdovinos-Flores C, 2013, FREE RADICAL RES, V47, P404, DOI 10.3109/10715762.2013.783210; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Virk MS, 2008, BONE, V42, P921, DOI 10.1016/j.bone.2007.12.216; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003; Zou LL, 1999, GENE THER, V6, P994, DOI 10.1038/sj.gt.3300936	43	13	14	0	30	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	NOV	2015	69						148	157		10.1016/j.biomaterials.2015.08.010			10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CR5UI	WOS:000361409500015	26285082				2021-06-18	
J	Liu, ZH; Tu, PH; Chen, NY; Yip, PK; Bowes, AL; Lee, CC; Chan, SH; Kung, CC; Wang, AYC; Wu, CT; Lee, ST				Liu, Zhuo-Hao; Tu, Po-Hsun; Chen, Nan-Yu; Yip, Ping K.; Bowes, Amy L.; Lee, Cheng-Chi; Chan, She-Hung; Kung, Chua-Chi; Wang, Alvin Yi-Chou; Wu, Chieh-Tsai; Lee, Shih-Tseng			Raised Proinflammatory Cytokine Production Within Cerebrospinal Fluid Precedes Fever Onset in Patients With Neurosurgery-Associated Bacterial Meningitis	CRITICAL CARE MEDICINE			English	Article						cerebrospinal fluid; cytokines; fever; meningitis; neurosurgery; proinflammatory markers	NECROSIS-FACTOR-ALPHA; POSTOPERATIVE ASEPTIC-MENINGITIS; SERUM PROCALCITONIN LEVELS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; SUBARACHNOID HEMORRHAGE; DIFFERENTIAL-DIAGNOSIS; MENINGEAL INFLAMMATION; INTERLEUKIN-6 LEVELS	Objective: The objective of the present study was to determine whether selective inflammatory cytokine concentrations within cerebrospinal fluid are useful markers for the differential diagnosis of aseptic and bacterial meningitis within neurosurgical patients. Design: Prospective, open-label, observational, cohort study. Setting: Neurosurgical ICU, Chang Gung Memorial Hospital. Patients: Thirty-two consecutive neurosurgical patients who had postoperative fever following external ventricular drain insertion for the treatment of brain injury underwent serial cerebrospinal fluid cytokine analysis pre and post fever to determine the value of such markers in ascertaining the differential diagnosis of meningitis. Intervention: Cerebrospinal fluid samples were collected on the day of fever onset, as well as on day 2 and 4 pre and post fever development. Tumor necrosis factor-, interleukin-1, interleukin-6, interleukin-8, transforming growth factor-, and procalcitonin were subsequently analyzed using enzyme-linked immunosorbent assay analysis techniques. Measurement and Main Results: Inflammatory marker levels were compared among febrile aseptic, bacterial, and nonmeningitis patients to determine cerebrospinal fluid inflammatory changes over time. Significant increases in cerebrospinal fluid tumor necrosis factor -, interleukin-1, interleukin-6, and interleukin-8 levels were observed within patients with bacterial meningitis at fever onset, which was not evident in aseptic or nonmeningitis patients. Furthermore, significant increases in cerebrospinal fluid tumor necrosis factor-, interleukin-1, interleukin-6, and interleukin-8 levels were detected as early as 4 days prior to fever onset within patients with bacterial meningitis when compared with both aseptic and nonmeningitis groups. Interestingly, procalcitonin was only significantly increased in patients with bacterial meningitis on the fourth day post fever. Conclusion: The present study suggests that raised cerebrospinal fluid tumor necrosis factor -, interleukin-1, and interleukin-8 in a temporal manner may indicate early bacterial meningitis development in neurosurgical patients, enabling earlier diagnostic certainty and improved patient outcomes.	[Liu, Zhuo-Hao; Tu, Po-Hsun; Lee, Cheng-Chi; Chan, She-Hung; Kung, Chua-Chi; Wang, Alvin Yi-Chou; Wu, Chieh-Tsai; Lee, Shih-Tseng] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Liu, Zhuo-Hao; Yip, Ping K.; Bowes, Amy L.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, London, England; [Chen, Nan-Yu] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Internal Med, Linkou, Taiwan	Chen, NY (corresponding author), Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan.	yun0710@cgmh.org.tw	Liu, Zhuo-Hao/C-6758-2011	Liu, Zhuo-Hao/0000-0003-4079-8697; Chen, Nan-Yu/0000-0001-8922-397X; Wu, Chieh-Tsai/0000-0002-8419-3764	Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRP982171B]; Barts and the London Charity	We acknowledge the generous support of Chang Gung Memorial Hospital, Taiwan (CMRP982171B) (Dr. Liu) and Barts and the London Charity (Dr. Yip).	Vazquez JA, 2012, J EMERG MED, V43, P322, DOI 10.1016/j.jemermed.2011.07.029; Alkholi UM, 2011, J GLOB INFECT DIS, V3, P14, DOI 10.4103/0974-777X.77290; ALOISI F, 1992, J IMMUNOL, V149, P2358; Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Aschner M, 1998, TOXICOL LETT, V103, P283, DOI 10.1016/S0378-4274(98)00324-5; Bhimraj A, 2012, CLEV CLIN J MED, V79, P393, DOI 10.3949/ccjm.79gr.12003; Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; BLOMSTEDT GC, 1987, ACTA NEUROCHIR, V89, P112, DOI 10.1007/BF01560375; Bociaga-Jasik M, 2012, ADV MED SCI-POLAND, V57, P142, DOI 10.2478/v10039-012-0013-y; BOHR V, 1984, ARCH NEUROL-CHICAGO, V41, P1045, DOI 10.1001/archneur.1984.04050210043012; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; CARMEL PW, 1993, PEDIATR NEUROSURG, V19, P276, DOI 10.1159/000120744; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101961; Choi SH, 2013, INFECT CHEMOTHER, V45, P308, DOI 10.3947/ic.2013.45.3.308; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Desai A, 2009, J NEUROS-PEDIATR, V4, P184, DOI 10.3171/2009.4.PEDS08279; Dubos F, 2006, J PEDIATR-US, V149, P72, DOI 10.1016/j.jpeds.2006.02.034; Fernandes D, 2014, J CRIT CARE, V29, P347, DOI 10.1016/j.jcrc.2013.12.001; Forgacs P, 2001, CLIN INFECT DIS, V32, P179, DOI 10.1086/318471; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HATTORI A, 1993, J BIOL CHEM, V268, P2577; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Howitz MF, 2014, EPIDEMIOL INFECT, V142, P1300, DOI 10.1017/S0950268813001878; Huang CC, 1997, J NEUROL, V244, P634, DOI 10.1007/s004150050159; Imai K, 2000, INFECT IMMUN, V68, P2418, DOI 10.1128/IAI.68.5.2418-2423.2000; Jereb M, 2001, INFECTION, V29, P209, DOI 10.1007/s15010-001-1165-z; Junior P, 2011, BRAZ J INFECT DIS, V15, P156, DOI DOI 10.1016/S1413-8670(11)70162-3; Konstantinidis T, 2015, J CLIN LAB ANAL, V29, P169, DOI 10.1002/jcla.21746; Kulik DM, 2013, J EMERG MED, V45, P508, DOI 10.1016/j.jemermed.2013.03.042; Kwon KY, 2001, J KOREAN MED SCI, V16, P774, DOI 10.3346/jkms.2001.16.6.774; Laifer G, 2005, CLIN MICROBIOL INFEC, V11, P679, DOI 10.1111/j.1469-0691.2005.01205.x; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; LOPEZCORTES LF, 1995, J INFECT DIS, V172, P581, DOI 10.1093/infdis/172.2.581; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lv S, 2014, EUR J NEUROL, V21, P1115, DOI 10.1111/ene.12441; Matera G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-68; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Mukai AO, 2006, PEDIATR NEUROL, V34, P25, DOI 10.1016/j.pediatrneurol.2005.06.003; MUSTAFA MM, 1989, J PEDIATR-US, V115, P208, DOI 10.1016/S0022-3476(89)80067-8; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; OHGA S, 1994, ARCH DIS CHILD, V70, P123, DOI 10.1136/adc.70.2.123; Ostergaard C, 1996, EUR J CLIN MICROBIOL, V15, P166, DOI 10.1007/BF01591492; Prasad R, 2014, PEDIATR NEUROL, V50, P60, DOI 10.1016/j.pediatrneurol.2013.08.016; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; REDDY ST, 1994, J LEUKOCYTE BIOL, V55, P192; Richard GC, 2013, CLIN PEDIATR EMERG M, V14, P146; ROSS D, 1988, J NEUROSURG, V69, P669, DOI 10.3171/jns.1988.69.5.0669; SAUKKONEN K, 1990, J EXP MED, V171, P439, DOI 10.1084/jem.171.2.439; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Schoch B, 2008, ZBL NEUROCHIR, V69, P80, DOI 10.1055/s-2007-1022559; Schwarz S, 2000, CRIT CARE MED, V28, P1828, DOI 10.1097/00003246-200006000-00024; SEKI T, 1993, IMMUNOLOGY, V80, P333; Takahashi W, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.02.020; Tang RB, 2001, CHILD NERV SYST, V17, P453, DOI 10.1007/s003810000422; Tauber MG, 1999, CLIN INFECT DIS, V28, P1, DOI 10.1086/515079; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; VAN MEIR E, 1992, CANCER RES, V52, P4297; Viallon A, 1999, CLIN INFECT DIS, V28, P1313, DOI 10.1086/514793; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Walti LN, 2013, J INFECTION, V66, P424, DOI 10.1016/j.jinf.2012.12.010; Wandschneider W, 2003, J THORAC CARDIOV SUR, V126, P872, DOI 10.1016/S0022-5223(03)00692-5; Yo CH, 2012, ANN EMERG MED, V60, P591, DOI 10.1016/j.annemergmed.2012.05.027; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169	73	13	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2015	43	11					2416	2428		10.1097/CCM.0000000000001188			13	Critical Care Medicine	General & Internal Medicine	CT5CX	WOS:000362826200019	26196350				2021-06-18	
J	Ozyurt, E; Goksu, E; Cengiz, M; Yilmaz, M; Ramazanoglu, A				Ozyurt, Erhan; Goksu, Ethem; Cengiz, Melike; Yilmaz, Murat; Ramazanoglu, Atilla			Retrospective Analysis of Prognostic Factors of Severe Traumatic Brain Injury in a University Hospital in Turkey	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Prognostic factors; Outcome	IMPACT; COMA	AIM: To examine the use of prognostic factors such as age, Glasgow Coma Scale (GCS) score, pupil reactivity and computerized tomography (CT) findings for predicting the prognosis of severe traumatic brain injury (TBI) patients in Turkey. MATERIAL and METHODS: We retrospectively evaluated TBI patients who were accepted to Akdeniz University Intensive Care Unit between 1 January 2007 and 31 December 2009. Patient data were collected from the hospital information system. Marshall CT classification was performed and CT findings were noted. The Glasgow outcome scale (GOS) score of patients was calculated according to their 6-months follow up. RESULTS: A total of 101 patients with severe TBI were studied. The mean age of the patients was 34.7 +/- 14.1 years. Of these, male patients (81.2%) were dominant and road accidents (83.2%) were the most common mechanism of TBI development. In addition, poor neurological outcome was detected in 58.4% of the patients and 29 patients (28.7%) died. The mechanism of injury (p = 0.34), gender (p = 0.64) or age (p = 0.34) did not lead to a difference in neurologic outcomes while the GCS score (p = 0.01), pupillary reactivity (p = 0.000), Marshall CT classification (p = 0.01) and the presence of traumatic subarachnoid haemorrhage (p = 0.04) affected the GOS scores. CONCLUSION: In our study, GCS score, CT findings and pupil reactivity were prominent as prognostic factors, but a relationship between age and prognosis was not observed.	[Ozyurt, Erhan; Cengiz, Melike; Yilmaz, Murat; Ramazanoglu, Atilla] Akdeniz Univ, Sch Med, Dept Anaesthesiol & Reanimat, TR-07058 Antalya, Turkey; [Goksu, Ethem] Akdeniz Univ, Sch Med, Dept Neurosurg, TR-07058 Antalya, Turkey	Ozyurt, E (corresponding author), Akdeniz Univ, Sch Med, Dept Anaesthesiol & Reanimat, TR-07058 Antalya, Turkey.	eozyurt@hotmail.com	Yilmaz, Murat/I-6629-2017				Akyel S, 2012, ULUS TRAVMA ACIL CER, V18, P125, DOI 10.5505/tjtes.2012.37928; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sut N, 2010, ULUS TRAVMA ACIL CER, V16, P149; TEASDALE G, 1974, LANCET, V2, P81	19	13	16	1	6	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2015	25	6					877	882		10.5137/1019-5149.JTN.9181-13.0			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY1FV	WOS:000366153000007	26617136				2021-06-18	
J	Roumeliotis, N; Pettersen, G; Crevier, L; Emeriaud, G				Roumeliotis, Nadia; Pettersen, Geraldine; Crevier, Louis; Emeriaud, Guillaume			ICP monitoring in children: why are we not adhering to guidelines?	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatric; Intracranial pressure monitoring; Practice guidelines; Glasgow coma score	BRAIN-INJURY; EPIDEMIOLOGY	Despite pediatric guidelines, variability exists in the management of severe traumatic brain injury (TBI), as somewhere between 7 and 60 % of children undergo intracranial pressure (ICP) monitoring. Reasons for this low adherence to TBI management guidelines remain unclear. The objective of this study was to evaluate the current practices at CHU Sainte-Justine with regards to ICP monitoring in severe TBI and explore the reasons why ICP monitoring is not undertaken. A retrospective review was conducted of all patients age 1 month to 18 years, with severe TBI (Glasgow Coma Scale (GCS) a parts per thousand currency sign8) from 2007 to 2014. Presence of ICP monitoring, head imaging reports, and reasons for lack of monitoring were recorded. Sixty-four patients with severe TBI were admitted. Twenty (31 %) patients had invasive ICP monitoring in the first 6 h and 5 in the following 24 h. Improvement of the GCS on arrival to tertiary care center (20 %, n = 13) and moribund status (20 %, n = 13) were the two main reasons ICP monitoring was not undertaken. Fourteen patients (21 %) with reassuring cerebral tomography (Rotterdam scores 1-3) and median GCS 7 (IQR 6-8) were initially followed with clinical surveillance, five of which ended up with an ICP monitor (> 6 h). Our study confirms that many children with severe TBI do not undergo ICP monitoring, mainly due to rapid improvement or moribund status. A subgroup of patients, with reassuring cerebral CT scan, was not monitored. Further research is necessary to assess if imaging should be considered in ICP indication, as in adult guidelines.	[Roumeliotis, Nadia; Pettersen, Geraldine; Emeriaud, Guillaume] Univ Montreal, Hop St Justine, Dept Crit Care, Montreal, PQ H3T 1C5, Canada; [Crevier, Louis] Univ Montreal, Hop St Justine, Dept Neurosurg, Montreal, PQ H3T 1C5, Canada	Roumeliotis, N (corresponding author), Univ Montreal, Hop St Justine, Dept Crit Care, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nadia.roumeliotis@gmail.com		Roumeliotis, Nadia/0000-0001-7463-1233			Bratton S.L., 2007, J NEUROTRAUMA S1, V24; Centers for Disease Control and Prevention, 2012, 10 LEAD CAUS DEATH A; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049	7	13	13	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2015	31	11					2011	2014		10.1007/s00381-015-2837-9			4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CU4FT	WOS:000363483300007	26216060				2021-06-18	
J	Wang, D; Zheng, SQ; Chen, XC; Jiang, SW; Chen, HB				Wang, Dong; Zheng, Shao-Qin; Chen, Xian-Cai; Jiang, Shi-Wen; Chen, Hai-Bin			Comparisons between small intestinal and gastric feeding in severe traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials	JOURNAL OF NEUROSURGERY			English	Article						enteral nutrition; traumatic brain injury; small bowel feeding; gastric feeding; meta-analysis	CRITICALLY-ILL PATIENTS; IMMUNE-ENHANCING DIET; SEVERE HEAD-INJURIES; ENTERAL NUTRITION; RISK; VENTILATION; GUIDELINES; PNEUMONIA; SUPPORT; PATIENT	OBJECT Nutritional support is highly recommended for reducing the risk of nosocomial infections, such as pneumonitis, in patients with severe traumatic brain injury (TBI). Currently, there is no consensus for the preferred route of feeding. The authors compared the risks of pneumonitis and other important outcomes associated with small intestinal and gastric feeding in patients with severe TBI. METHODS This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Relevant randomized controlled trials (up to December 16, 2013) that compared small bowel to gastric feeding in patients with severe TBI were identified from searches in the PubMed and Embase databases. The primary outcome was risk of pneumonia. Secondary outcomes included ventilator-associated pneumonia, mortality, length of intensive care unit stay, length of hospital stay, duration of mechanical ventilation, total number of complications, aspiration, diarrhea, distention, Glasgow Coma Scale score, Injury Severity Score, and Acute Physiology and Chronic Health Evaluation II score. RESULTS Five randomized controlled trials with 325 participants in total were included in the meta-analysis. Compared with gastric feeding, small bowel feeding was associated with a significant reduction in the incidence of pneumonitis (risk ratio [RR] 0.67; 95% CI 0.52-0.87; p = 0.002; I-2 = 0.0%) and ventilator-associated pneumonia (RR 0.52; 95% CI 0.34-0.81; p = 0.003; I-2 = 0.0%). Small intestinal feeding was also associated with a decrease in the total number of complications (RR 0.43; 95% CI 0.20-0.93; p = 0.03; I-2 = 68%). However, small intestinal feeding did not seem to significantly convert any of the other end points in the meta-analysis. CONCLUSIONS The limited evidence suggests that small bowel feeding in patients with severe TBI is associated with a risk of pneumonia that is lower than that with gastric feeding. From this result, the authors recommend the use of small intestinal feeding to reduce the incidence of pneumonitis in patients with severe TBI.	[Wang, Dong; Zheng, Shao-Qin; Chen, Hai-Bin] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Neurosurg, Shantou, Guangdong, Peoples R China; [Wang, Dong; Chen, Xian-Cai; Chen, Hai-Bin] Shantou Univ, Coll Med, Dept Histol & Embryol, Shantou 515041, Guangdong, Peoples R China; [Jiang, Shi-Wen] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA	Chen, HB (corresponding author), Shantou Univ, Coll Med, Dept Histol & Embryol, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	chenhb@stu.edu.cn					Escribano JA, 2011, NUTR HOSP, V26, P72, DOI 10.1590/S0212-16112011000800016; Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Alhazzani W, 2013, CRIT CARE, V17, DOI 10.1186/cc12806; APELGREN KN, 1982, CRIT CARE MED, V10, P305, DOI 10.1097/00003246-198205000-00003; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; DEMPSEY DT, 1988, AM J CLIN NUTR, V47, P352, DOI 10.1093/ajcn/47.2.352; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fernandez-Vivas M, 2003, INTENS CARE MED, V29, P1126, DOI 10.1007/s00134-003-1768-1; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jing JY, 2013, CLIN NUTR, V32, P8, DOI [10.1016/j.clnu.2012.07.002, 10.1016/j.clnu.2012.7.002]; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kortbeek JB, 1999, J TRAUMA, V46, P992, DOI 10.1097/00005373-199906000-00002; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Kudsk KA, 1996, ANN SURG, V224, P531, DOI 10.1097/00000658-199610000-00011; Marino LV, 2005, J CLIN NEUROSCI, V12, P435, DOI 10.1016/j.jocn.2004.04.009; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Montejo JC, 2010, INTENS CARE MED, V36, P1386, DOI 10.1007/s00134-010-1856-y; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838	28	13	21	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2015	123	5					1194	1201		10.3171/2014.11.JNS141109			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CU3QL	WOS:000363439800013	26024007	Bronze			2021-06-18	
J	Krasny-Pacini, A; Limond, J; Evans, J; Hiebel, J; Bendjelida, K; Chevignard, M				Krasny-Pacini, Agata; Limond, Jennifer; Evans, Jonathan; Hiebel, Jean; Bendjelida, Karim; Chevignard, Mathilde			Self-awareness assessment during cognitive rehabilitation in children with acquired brain injury: a feasibility study and proposed model of child anosognosia	DISABILITY AND REHABILITATION			English	Article						Brain injury; children; cognitive rehabilitation; executive functions; model; self-awareness	EXECUTIVE DYSFUNCTION; AUTOBIOGRAPHICAL MEMORY; CONTROLLED-TRIAL; DEFICITS; METACOGNITION; MIND; TBI; COMMUNICATION; QUESTIONNAIRE; STRATEGIES	Purpose: To compare three ways of assessing self-awareness in children with traumatic brain injury (TBI) and to propose a model of child anosognosia. Method: Five single cases of children with severe TBI, aged 8-14, undergoing metacognitive training. Awareness was assessed using three different measures: two measures of metacognitive knowledge/intellectual awareness (a questionnaire and illustrated stories where child characters have everyday problems related to their executive dysfunction) and one measure of on-line/emergent awareness (post-task appraisal of task difficulty). Results: All three measures showed good feasibility. Analysis of awareness deficit scores indicated large variability (1-100%). Three children showed dissociated scores. Conclusions: Based on these results, we propose a model of child self-awareness and anosognosia and a framework for awareness assessment for rehabilitation purposes. The model emphasizes (1) the role of on-line error detection in the construction of autobiographical memories that allow a child to build a self-knowledge of his/her strengths and difficulties; (2) the multiple components of awareness that need to be assessed separately; (3) the implications for rehabilitation: errorless versus error-based learning, rehabilitation approaches based on metacognition, rationale for rehabilitation intervention based on child's age and impaired awareness component, ethical and developmental consideration of confrontational methods. Implications for RehabilitationSelf-awareness has multiple components that need to be assessed separately, to better adapt cognitive rehabilitation.Using questionnaires and discrepancy scores are not sufficient to assess awareness, because it does not include on-line error detection, which can be massively impaired in children, especially those with impaired executive functions.On-line error detection is important to promote and error-based learning is useful to allow a child to build a self-knowledge of his/her strengths and difficulties, in the absence of severe episodic memory problems.Metacognitive trainings may not be appropriate for younger children who have age appropriate developmentally immature self-awareness, nor for patients with brain injury if they suffer anosognosia because of their brain injury.	[Krasny-Pacini, Agata; Hiebel, Jean] Inst Univ Readaptat Clemenceau Strasbourg, 45 Bd Clemenceau, F-67082 Strasbourg, France; [Krasny-Pacini, Agata; Hiebel, Jean] Hautepierre Strasbourg Univ Hosp, Dept Paediat Surg, Strasbourg, France; [Krasny-Pacini, Agata; Chevignard, Mathilde] Univ Paris 06, Sorbonne Univ, UMR 7371, CNRS,LIB, F-75006 Paris, France; [Limond, Jennifer; Evans, Jonathan] Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, Deaprtment Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Bendjelida, Karim] Hop Hasenrain, EMOI TC 68, Mulhouse, France; [Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France	Krasny-Pacini, A (corresponding author), Inst Univ Readaptat Clemenceau Strasbourg, 45 Bd Clemenceau, F-67082 Strasbourg, France.	agata.krasny@ugecam-alsace.fr			"SOFMER" (French Society of Physical and Rehabilitation Medicine); "SFERHE" (French Research Society against Children's handicap); Fondation Gueules Cassees	This study was supported by scholarships, from the "SOFMER" (French Society of Physical and Rehabilitation Medicine), the "SFERHE" (French Research Society against Children's handicap) and the "Fondation Gueules Cassees". Results of this work were presented at the joined 29th SOFMER - 19th ESPRM congress in Marseille in May 2014.	Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bertens D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-64; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Bjorklund DF., 2012, CHILDRENS THINKING C; BORKOWSKI JG, 1989, LEARN DISABILITY Q, V12, P57, DOI 10.2307/1510252; Burden V., 2003, BEHAV ASSESSMENT DYS; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN MJ, 2001, ECHELLE MEMOIRE ENFA; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Crowther JE, 2011, J HEAD TRAUMA REHAB, V26, P192, DOI 10.1097/HTR.0b013e318218dd22; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dermitzaki I, 2005, PSYCHOL REP, V97, P759, DOI 10.2466/PR0.97.7.759-768; Desoete A, 2001, J LEARN DISABIL-US, V34, P435, DOI 10.1177/002221940103400505; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Garrett Adia J, 2006, Learn Disabil Res Pract, V21, P77, DOI 10.1111/j.1540-5826.2006.00208.x; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2014, ADAPTATION FRANCAISE; Hacker DJ, 1998, EDUC PSYCHO, P1; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hoffmann-Biencourt A, 2010, BRIT J DEV PSYCHOL, V28, P767, DOI 10.1348/026151009X479042; JACOBS JE, 1987, EDUC PSYCHOL, V22, P255, DOI 10.1207/s15326985ep2203&4_4; JACOBS MP, 1993, NEUROPSYCHOL REHABIL, V3, P341, DOI 10.1080/09602019308401446; Josman N, 2000, OCCUP THER J RES, V20, P241, DOI 10.1177/153944920002000402; Josman Naomi, 2000, Physical and Occupational Therapy in Pediatrics, V19, P39, DOI 10.1300/J006v19n03_04; Koriat A, 2008, MEM COGNITION, V36, P416, DOI 10.3758/MC.36.2.416; Koriat A, 2010, CONSCIOUS COGN, V19, P251, DOI 10.1016/j.concog.2009.12.010; Koriat A, 2009, J EXP CHILD PSYCHOL, V102, P265, DOI 10.1016/j.jecp.2008.10.005; Krasny-Pacini A., 2013, GOAL MANAGEMENT TRAI; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P61, DOI 10.1016/j.ijpsycho.2011.02.001; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lyons KE, 2011, ADV CHILD DEV BEHAV, V40, P379; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; NELSON TO, 1990, PSYCHOL LEARN MOTIV, P1; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Perner J, 2003, CONSCIOUS COGN, V12, P63, DOI 10.1016/S1053-8100(02)00010-7; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; Robertson IH, GOAL MANAGEMENT TRAI; Roebers CM, 2007, J EXP CHILD PSYCHOL, V97, P117, DOI 10.1016/j.jecp.2006.12.006; Roebers CM, 2009, BRIT J EDUC PSYCHOL, V79, P749, DOI 10.1348/978185409X429842; Rosenzweig C, 2011, J LEARN DISABIL-US, V44, P508, DOI 10.1177/0022219410378445; Roy A, FONCTIONS EXEC UNPUB; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Stuss DT., 1991, AWARENESS DEFICIT BR, P63; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Viguier D, 2001, BRAIN INJURY, V15, P263; Wales L, 2013, BRIT J OCCUP THER, V76, P325, DOI 10.4276/030802213X13729279115013; Wechsler D, 2005, WISC 6 ECHELLE INTEL; Williams D, 2010, AUTISM, V14, P474, DOI 10.1177/1362361310366314; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, Vxiv, P246; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669	77	13	14	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2015	37	22					2092	2106		10.3109/09638288.2014.998783			15	Rehabilitation	Rehabilitation	DD2JM	WOS:000369748600008	25673145				2021-06-18	
J	Farrell-Carnahan, L; Barnett, S; Lamberty, G; Hammond, FM; Kretzmer, TS; Franke, LM; Geiss, M; Howe, L; Nakase-Richardson, R				Farrell-Carnahan, Leah; Barnett, Scott; Lamberty, Gregory; Hammond, Flora M.; Kretzmer, Tracy S.; Franke, Laura M.; Geiss, Meghan; Howe, Laura; Nakase-Richardson, Risa			Insomnia symptoms and behavioural health symptoms in veterans 1 year after traumatic brain injury	BRAIN INJURY			English	Article						Anxiety; depression; headache; insomnia; substance use; TBI; traumatic brain injury	DEPLOYED MILITARY PERSONNEL; POSTTRAUMATIC-STRESS-DISORDER; AFFAIRS POLYTRAUMA SYSTEM; SLEEP DISTURBANCE; HEAD-INJURY; ASSESSING DEPRESSION; SUICIDE RISK; REHABILITATION; SEVERITY; AMNESIA	Objective: Insomnia and behavioural health symptoms 1 year after traumatic brain injury (TBI) were examined in a clinical sample representative of veterans who received inpatient treatment for TBI-related issues within the Veterans Health Administration.Methods: This was a cross-sectional sub-study (n=112) of the Polytrauma Rehabilitation Centres' traumatic brain injury model system programme. Prevalence estimates of insomnia, depression, general anxiety, nightmares, headache and substance use, stratified by injury severity, were derived. Univariate logistic regression was used to examine unadjusted effects for each behavioural health problem and insomnia by injury severity.Results: Participants were primarily male, < 30 years old and high school educated. Twenty-nine per cent met study criteria for insomnia; those with mild TBI were significantly more likely to meet criteria (43%) than those with moderate/severe TBI (22%), (2)(1, n=112)=5.088, p0.05. Univariable logistic regression analyses revealeddepressive symptoms and general anxiety were significantly associated with insomnia symptoms after TBI of any severity. Headache and binge drinking were significantly inversely related to insomnia symptoms after moderate/severe TBI, but not MTBI.Conclusions: Veterans with history of TBI, of any severity, and current insomnia symptoms may be at increased risk for depression and anxiety 1 year after TBI.	[Farrell-Carnahan, Leah; Franke, Laura M.; Geiss, Meghan] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Farrell-Carnahan, Leah; Franke, Laura M.] Virginia Commonwealth Univ, Richmond, VA USA; [Barnett, Scott; Kretzmer, Tracy S.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Lamberty, Gregory] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Lamberty, Gregory] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Franke, Laura M.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Howe, Laura] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	Farrell-Carnahan, L (corresponding author), 1201 Broad Rock Blvd Mailcode 116B, Richmond, VA 23249 USA.	leah.farrell-carnahan@va.gov		Howe, Laura/0000-0003-3357-2796	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability and Rehabilitation Research	This study was carried out by researchers affiliated with the Polytrauma Rehabilitation Centre Traumatic Brain Injury Model System Collaboration, the National Institute for Disability and Rehabilitation Research Traumatic Brain Injury Model Systems (H133A120035) and the Federal Government Centre of Innovation on Disability and Rehabilitation VA Health Services Research and Development (HSRD) (1 I50 HX001233-01 & VA HSRD; SDR 13-228). The Polytrauma Rehabilitation Centre Traumatic Brain Injury Model System Collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability and Rehabilitation Research. The contents do not necessarily represent the policy of the Department of Education or the Department of Veterans Affairs and endorsement by the USA federal government should not be assumed.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Cappelleri JC, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-54; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COUCH JR, 1995, J NEUROL REHABIL, V9, P83; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; de Man-van Ginkel JM, 2012, NURS RES, V61, P333, DOI 10.1097/NNR.0b013e31825d9e9e; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hatoum HT, 1998, PHARMACOECONOMICS, V14, P629, DOI 10.2165/00019053-199814060-00004; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Leger D, 2006, SLEEP, V29, P171; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parsons E, 2013, THEM SESS MAY 20 8 1; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tanielian T, 2008, INVISIBLE WOUNDS WAR; The Management of Major Depressive Disorder Working Group, 2010, VA DOD CLIN PRACT GU; The Management of Post-Traumatic Stress Working Group, 2009, MAN MAJ DEPR DIS; United States Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism, 2013, MOD BING DRINK; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Weathers F. W., 1993, M INT SOC TRAUM STRE; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	61	13	14	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1400	1408		10.3109/02699052.2015.1063161			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200002	26287761				2021-06-18	
J	Hanell, A; Greer, JE; Jacobs, KM				Hanell, Anders; Greer, John E.; Jacobs, Kimberle M.			Increased Network Excitability Due to Altered Synaptic Inputs to Neocortical Layer V Intact and Axotomized Pyramidal Neurons after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axotomy; field potential; neocortex; patch clamp; synaptic excitation	CONTROLLED CORTICAL IMPACT; TENSOR IMAGING FINDINGS; POSTTRAUMATIC EPILEPSY; DENTATE GYRUS; UNITED-STATES; AXONAL INJURY; IN-VITRO; CONNECTIVITY; CORTEX; MODEL	Mild traumatic brain injury (mTBI) can produce long lasting cognitive dysfunction. There is typically no cell death and only diffuse structural injury after mTBI. Thus, functional changes in intact neurons may contribute to symptoms. We have previously shown altered intrinsic properties of axotomized and intact neurons within 2 d after a central fluid percussion injury in mice expressing yellow fluorescent protein (YFP) that allow identification of axonal state prior to recording. Here, whole-cell patch clamp recordings were used to examine synaptic properties of YFP+ layer V pyramidal neurons. An increased frequency of spontaneous and miniature excitatory postsynaptic currents (EPSCs) was recorded from axotomized neurons at 1 d and intact neurons at 2 d after injury, likely reflecting an increased number of afferents. This also was reflected in the increased amplitude of the EPSC evoked by local extracellular stimulation for all neurons from injured cortex and increased likelihood of producing an action potential for intact cells. Field potentials recorded in superficial layers after online deep layer stimulation contained a single negative peak in controls but multiple negative peaks in injured tissue. The amplitude of this evoked negativity was significantly larger than controls over a series of stimulus intensities at both the 1 d and 2 d survival times. Interictal-like spikes never occurred in the field potential recordings from controls but were observed in 20-80% of stimulus presentations in injured cortex. Together, these results suggest an overall increase in network excitability and the production of particularly powerful (intact) neurons that have both increased intrinsic and synaptic excitability.	[Hanell, Anders; Jacobs, Kimberle M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Greer, John E.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA	Jacobs, KM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	kmjacobs@vcu.edu	Jacobs, Kimberle/AAW-7526-2020; Hanell, Anders/E-4776-2011	Hanell, Anders/0000-0001-9369-3886	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077675] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS077675.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P549; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; George AL, 2011, BRAIN RES, V1374, P116, DOI 10.1016/j.brainres.2010.12.020; Gerberding J, 2003, REPORT C MILD TRAUMA, P1; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hall EC, 2014, J TRAUMA ACUTE CARE, V76, P859, DOI 10.1097/TA.0000000000000148; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Makwana M, 2010, J COMP NEUROL, V518, P699, DOI 10.1002/cne.22240; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Mascaro ALA, 2013, P NATL ACAD SCI USA, V110, P10824, DOI 10.1073/pnas.1219256110; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Neil M.E., 2013, COMPLICATIONS MILD T; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004	57	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1590	1598		10.1089/neu.2014.3592			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500007	25789412	Green Published			2021-06-18	
J	Zhan, J; Gao, L; Zhou, FQ; Kuang, HM; Zhao, J; Wang, SY; He, LC; Zeng, XJ; Gong, HH				Zhan, Jie; Gao, Lei; Zhou, Fuqing; Kuang, Hongmei; Zhao, Jing; Wang, Siyong; He, Laichang; Zeng, Xianjun; Gong, Honghan			Decreased Regional Homogeneity in Patients With Acute Mild Traumatic Brain Injury A Resting-State fMRI Study	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Acute brain injuries; mTBI; functional MRI; resting-state; regional homogeneity	DEFAULT-MODE NETWORK; MINI-MENTAL-STATE; WORKING-MEMORY; SALIENCE NETWORK; FUNCTIONAL CONNECTIVITY; MOTOR CORTEX; DISEASE; ABNORMALITIES; CONCUSSION; DISRUPTION	Mild traumatic brain injury (mTBI) is characterized by structural disconnection and large-scale neural network dysfunction in the resting state. However, little is known concerning the intrinsic changes in local spontaneous brain activity in patients with mTBI. The aim of the current study was to assess regional synchronization in acute mTBI patients. Fifteen acute mTBI patients and 15 sex-, age-, and education-matched healthy controls (HCs) were studied. We used the regional homogeneity (ReHo) method to map local connectivity across the whole brain and performed a two-sample t-test between the two groups. Compared with HCs, patients with acute mTBI showed significantly decreased ReHo in the left insula, left precentral/postcentral gyrus, and left supramarginal gyrus (p < 0.05, AlphaSim corrected). The ReHo index of the left insula showed a positive correlation with the Mini-Mental State Examination (MMSE) scores across all acute mTBI patients (p < 0.05, uncorrected). The ReHo method may provide an objective biomarker for evaluating the functional abnormity of mTBI in the acute setting.	[Zhan, Jie; Gao, Lei; Zhou, Fuqing; Kuang, Hongmei; Zhao, Jing; Wang, Siyong; He, Laichang; Zeng, Xianjun; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang City 330006, Jiangxi, Peoples R China	Gong, HH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, 17 Yongwai Zheng St, Nanchang City 330006, Jiangxi, Peoples R China.	ncumd.cn@gmail.com		Gao, Lei/0000-0002-0081-0172	National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81460263]	This study was supported by grants from the National Natural Science Foundations of China (grant no. 81260217, 81460263).	Agcaoglu O, 2015, NEUROIMAGE, V104, P310, DOI 10.1016/j.neuroimage.2014.09.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chiong W, 2013, BRAIN, V136, P1929, DOI 10.1093/brain/awt066; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Crowe DA, 2004, EXP BRAIN RES, V158, P28, DOI 10.1007/s00221-004-1876-3; de Guise E, 2011, APPL NEUROPSYCHOL, V18, P179, DOI 10.1080/09084282.2011.595444; Deschamps I, 2014, NEUROPSYCHOLOGIA, V53, P39, DOI 10.1016/j.neuropsychologia.2013.10.015; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Ghiso Jorge A, 2013, J Glaucoma, V22 Suppl 5, pS36, DOI 10.1097/IJG.0b013e3182934af6; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hummer TA, 2013, BIOL PSYCHIAT, V73, P136, DOI 10.1016/j.biopsych.2012.06.036; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Rajab AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00625; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060191; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhou FQ, 2014, NEUROSCI LETT, V558, P192, DOI 10.1016/j.neulet.2013.11.022; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	58	13	15	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	OCT	2015	203	10					786	791		10.1097/NMD.0000000000000368			6	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CT3LU	WOS:000362709000009	26348589				2021-06-18	
J	Gonzalez, OC; Krishnan, GP; Chauvette, S; Timofeev, I; Sejnowski, T; Bazhenov, M				Gonzalez, Oscar C.; Krishnan, Giri P.; Chauvette, Sylvain; Timofeev, Igor; Sejnowski, Terrence; Bazhenov, Maxim			Modeling of Age-Dependent Epileptogenesis by Differential Homeostatic Synaptic Scaling	JOURNAL OF NEUROSCIENCE			English	Article						epileptic seizures; homeostatic plasticity; ion concentration dynamics; network models; synaptic plasticity	PARTIAL CORTICAL DEAFFERENTATION; TRAUMATIC BRAIN-INJURY; V PYRAMIDAL NEURONS; IN-VIVO; POSTTRAUMATIC EPILEPSY; EXCITATORY SYNAPSES; QUANTAL AMPLITUDE; SEIZURES; PLASTICITY; CORTEX	Homeostatic synaptic plasticity (HSP) has been implicated in the development of hyperexcitability and epileptic seizures following traumatic brain injury (TBI). Our in vivo experimental studies in cats revealed that the severity of TBI-mediated epileptogenesis depends on the age of the animal. To characterize mechanisms of these differences, we studied the properties of the TBI-induced epileptogenesis in a biophysically realistic cortical network model with dynamic ion concentrations. After deafferentation, which was induced by dissection of the afferent inputs, there was a reduction of the network activity and upregulation of excitatory connections leading to spontaneous spike-and-wave type seizures. When axonal sprouting was implemented, the seizure threshold increased in the model of young but not the older animals, which had slower or unidirectional homeostatic processes. Our study suggests that age-related changes in the HSP mechanisms are sufficient to explain the difference in the likelihood of seizure onset in young versus older animals.	[Gonzalez, Oscar C.; Bazhenov, Maxim] Univ Calif Riverside, Grad Program Neurosci, Riverside, CA 92521 USA; [Gonzalez, Oscar C.; Krishnan, Giri P.; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Chauvette, Sylvain; Timofeev, Igor] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; [Timofeev, Igor] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ G1V 0A6, Canada; [Sejnowski, Terrence] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Sejnowski, Terrence] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 900 Univ Ave, Riverside, CA 92521 USA.	maksim.bazhenov@ucr.edu	Timofeev, Igor/AAP-7529-2021; Timofeev, Igor/E-8828-2012	Timofeev, Igor/0000-0002-1389-5857; Gonzalez, Oscar/0000-0003-1302-1911	National Institutes of Health GrantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EB009282, R01NS081243]; Office of Naval Research Multidisciplinary University Research Initiative Grant [N000141310672]; Canadian Institutes of Health Research GrantsCanadian Institutes of Health Research (CIHR) [201403MOP-325213, 201403MOP-324941]; National Science Foundation Graduate Research Fellowship Grant [DGE-1326120]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081243] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants R01EB009282 and R01NS081243, Office of Naval Research Multidisciplinary University Research Initiative Grant N000141310672, and Canadian Institutes of Health Research Grants 201403MOP-325213 and 201403MOP-324941. O.C.G. was supported by the National Science Foundation Graduate Research Fellowship Grant DGE-1326120.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dinner Dudley S., 1993, P654; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Frohlich F, 2008, NEUROSCIENTIST, V14, P422, DOI 10.1177/1073858408317955; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Frohlich F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031922; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Frohlich Flavio, 2005, Thalamus & Related Systems, V3, P147, DOI 10.1017/S1472928807000155; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Grand L, 2013, J NEUROSCI METH, V212, P237, DOI 10.1016/j.jneumeth.2012.10.008; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Jaerve A, 2011, EXP NEUROL, V231, P284, DOI 10.1016/j.expneurol.2011.07.002; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jyoti A, 2009, NEUROSCI LETT, V453, P86, DOI 10.1016/j.neulet.2009.01.082; Kager H, 2000, J NEUROPHYSIOL, V84, P495; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Kusmierczak M, 2015, NEUROSCIENCE, V284, P153, DOI 10.1016/j.neuroscience.2014.09.079; Lee KFH, 2014, NEUROPHARMACOLOGY, V78, P31, DOI 10.1016/j.neuropharm.2013.03.016; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; Leslie KR, 2001, J NEUROSCI, V21, part. no.; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Remme MWH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002494; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Salin P, 1995, J NEUROSCI, V15, P8234; SCHAUWECKER PE, 1995, J NEUROSCI, V15, P2462; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Temkin N R, 1995, New Horiz, V3, P518; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00154; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Volman V, 2011, J NEUROPHYSIOL, V106, P1933, DOI 10.1152/jn.00458.2011; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Xiong W, 2011, J VIS EXP, V55	63	13	13	0	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 30	2015	35	39					13448	13462		10.1523/JNEUROSCI.5038-14.2015			15	Neurosciences	Neurosciences & Neurology	CV2RN	WOS:000364104700016	26424890	Green Accepted, Green Published, Bronze			2021-06-18	
J	Elliott, MR; Margulies, SS; Maltese, MR; Arbogast, KB				Elliott, Michael R.; Margulies, Susan S.; Maltese, Matthew R.; Arbogast, Kristy B.			Accounting for sampling variability, injury under-reporting, and sensor error in concussion injury risk curves	JOURNAL OF BIOMECHANICS			English	Article						Sensor error; Injury risk; Traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; HEAD IMPACTS; SIMULATION-EXTRAPOLATION; SYSTEM; BIOMECHANICS; VALIDATION; KINEMATICS	There has been recent dramatic increase in the use of sensors affixed to the heads or helmets of athletes to measure the biomechanics of head impacts that lead to concussion. The relationship between injury and linear or rotational head acceleration measured by such sensors can be quantified with an injury risk curve. The utility of the injury risk curve relies on the accuracy of both the clinical diagnosis and the biomechanical measure. The focus of our analysis was to demonstrate the influence of three sources of error on the shape and interpretation of concussion injury risk curves: sampling variability associated with a rare event, concussion under-reporting, and sensor measurement error. We utilized Bayesian statistical methods to generate synthetic data from previously published concussion injury risk curves developed using data from helmet-based sensors on collegiate football players and assessed the effect of the three sources of error on the risk relationship. Accounting for sampling variability adds uncertainty or width to the injury risk curve. Assuming a variety of rates of unreported concussions in the non-concussed group, we found that accounting for under-reporting lowers the rotational acceleration required for a given concussion risk. Lastly, after accounting for sensor error, we find strengthened relationships between rotational acceleration and injury risk, further lowering the magnitude of rotational acceleration needed for a given risk of concussion. As more accurate sensors are designed and more sensitive and specific clinical diagnostic tools are introduced, our analysis provides guidance for the future development of comprehensive concussion risk curves. (C) 2015 Elsevier Ltd. All rights reserved.	[Elliott, Michael R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Elliott, Michael R.] Univ Michigan, Inst Social Res, Survey Methodol Program, Ann Arbor, MI 48109 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Maltese, Matthew R.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.] Univ Penn, Dept Pediat, Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA	Arbogast, KB (corresponding author), Univ Penn, Dept Pediat, Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 34th & Civ,Ctr Blvd,Suite 1150, Philadelphia, PA 19104 USA.	Arbogast@email.chop.edu		Arbogast, Kristy/0000-0002-1694-4562			Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; CARROL RJ, 1995, MEASUREMENT ERROR NO; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gelman A., 2014, BAYESIAN DATA ANAL; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Little R, 2002, STAT ANAL MISSING DA, V2nd; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; RICE SO, 1945, AT&T TECH J, V24, P46, DOI 10.1002/j.1538-7305.1945.tb00453.x; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Stefanski LA, 1995, J AM STAT ASSOC, V90, P1247, DOI 10.2307/2291515; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005	24	13	13	0	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 18	2015	48	12					3059	3065		10.1016/j.jbiomech.2015.07.026			7	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CT8ME	WOS:000363069900018	26296855				2021-06-18	
J	Armstrong, E; Hersh, D; Katzenellenbogen, JM; Coffin, J; Thompson, SC; Ciccone, N; Hayward, C; Flicker, L; Woods, D; McAllister, M				Armstrong, Elizabeth; Hersh, Deborah; Katzenellenbogen, Judith M.; Coffin, Juli; Thompson, Sandra C.; Ciccone, Natalie; Hayward, Colleen; Flicker, Leon; Woods, Deborah; McAllister, Meaghan			Study Protocol: Missing Voices - Communication Difficulties after Stroke and Traumatic Brain Injury in Aboriginal Australians	BRAIN IMPAIRMENT			English	Article						Aboriginal; stroke; traumatic brain injury; acquired communication disorder; rehabilitation; speech pathology; health worker; Australia; aphasia; dysarthria	CHRONIC DISEASE; INDIGENOUS AUSTRALIANS; COGNITIVE ASSESSMENT; APHASIA; PEOPLE; CARE; EXPERIENCES; SERVICES; IMPACT	Background: Aboriginal and Torres Strait Islander Australians experience stroke and traumatic brain injury (TBI) with much greater frequency than non-Aboriginal Australians. Acquired communication disorders (ACD) can result from these conditions and can significantly impact everyday life. Yet few Aboriginal people access rehabilitation services and little is known about Aboriginal peoples' experiences of ACD. This paper describes the protocol surrounding a study that aims to explore the extent and impact of ACD in Western Australian Aboriginal populations following stroke or TBI and develop a culturally appropriate screening tool for ACD and accessible and culturally appropriate service delivery models. Method/Design: The 3-year, mixed methods study is being conducted in metropolitan Perth and five regional centres in Western Australia. Situated within an Aboriginal research framework, methods include an analysis of linked routine hospital admission data and retrospective file audits, development of a screening tool for ACD, interviews with people with ACD, their families, and health professionals, and drafting of alternative service delivery models. Discussion: This study will address the extent of ACD in Aboriginal populations and document challenges for Aboriginal people in accessing speech pathology services. Documenting the burden and impact of ACD within a culturally secure framework is a forerunner to developing better ways to address the problems faced by Aboriginal people with ACD and their families. This will in turn increase the likelihood that Aboriginal people with ACD will be diagnosed and referred to professional support to improve their communication, quality of life and functioning within the family and community context. Keywords: Aboriginal, stroke, traumatic brain injury, acquired	[Armstrong, Elizabeth; Hersh, Deborah; Ciccone, Natalie; McAllister, Meaghan] Edith Cowan Univ, Sch Psychol & Social Sci, Joondalup, WA 6025, Australia; [Katzenellenbogen, Judith M.; Thompson, Sandra C.] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, WA, Australia; [Coffin, Juli] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Coffin, Juli; Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, WA, Australia; [Hayward, Colleen] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Perth, WA, Australia; [Flicker, Leon] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia	Armstrong, E (corresponding author), Edith Cowan Univ, Sch Psychol & Social Sci, 270 Joondalup Dr, Joondalup, WA 6025, Australia.	b.armstrong@ecu.edu.au	; Thompson, Sandra/H-5955-2014	Flicker, Leon/0000-0002-3650-0475; Hersh, Deborah/0000-0003-2466-0225; Armstrong, Elizabeth/0000-0003-4469-1117; Ciccone, Natalie/0000-0002-1822-7217; Thompson, Sandra/0000-0003-0327-7155; Katzenellenbogen, Judith/0000-0001-5287-5819	National Health and Medical Research Council ProjectNational Health and Medical Research Council of Australia [1046228]	The study is funded by National Health and Medical Research Council Project Grant #1046228.	[Anonymous], 2004, HEART STROK VASC DIS; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Armstrong E, 2012, INT J SPEECH-LANG PA, V14, P271, DOI 10.3109/17549507.2011.663790; Australian Health Ministers' Advisory Council, 2011, AB TORR STRAIT ISL H; Australian Institute of Health and Welfare, 2008, IND TORR STRAIT ISL; Bessarab D., 2010, INT J CRIT INDIG STU, V3, P37, DOI [10.5204/ijcis.v3i1.57, DOI 10.5204/IJCIS.V3I1.57, DOI 10.5204/ijcis.v3i1.57]; Brameld K, 1999, AM J KIDNEY DIS, V34, P1033, DOI 10.1016/S0272-6386(99)70008-9; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Cass A, 2002, MED J AUSTRALIA, V176, P466, DOI 10.5694/j.1326-5377.2002.tb04517.x; Coffin J., 2007, ISI HLTH WORKER J, V31, P22; Cruice M, 2011, DISABIL REHABIL, V33, P219, DOI 10.3109/09638288.2010.503835; Dalemans R, 2009, CLIN REHABIL, V23, P948, DOI 10.1177/0269215509337197; Davidson P., 2010, RES METHODS HLTH FDN, P61; Dept. of Health of Western Australia, 2011, EP INJ W AUSTR 2000; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Durey A, 2012, INTERN MED J, V42, P17, DOI 10.1111/j.1445-5994.2011.02628.x; Enderby P, 1996, DISABIL REHABIL, V18, P238, DOI 10.3109/09638289609166307; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; Faux S, 2009, TOP STROKE REHABIL, V16, P1, DOI [10.1310/tsr1601-1, 10.1310/tsr1601-01]; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Helander E., 2007, ASIA PAC DISAB REHAB, V18, P3; Hersh D, 2015, INT J SPEECH-LANG PA, V17, P74, DOI 10.3109/17549507.2014.923510; Hersh D, 2015, DISABIL REHABIL, V37, P33, DOI 10.3109/09638288.2014.890675; Hilari K, 2011, DISABIL REHABIL, V33, P211, DOI 10.3109/09638288.2010.508829; Hilari K, 2009, INT J LANG COMM DIS, V44, P193, DOI 10.1080/13682820802008820; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; Kilkenny MF, 2013, INT J STROKE, V8, P164, DOI 10.1111/j.1747-4949.2011.00717.x; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI DOI 10.1037/1091-7527.26.1.69; Laycock AF., 2011, RES INDIGENOUS HLTH; Liamputtong P., 2009, QUALITATIVE RES METH; Liaw ST, 2011, AUST NZ J PUBL HEAL, V35, P238, DOI 10.1111/j.1753-6405.2011.00701.x; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Lowell A, 2012, INT J SPEECH-LANG PA, V14, P200, DOI 10.3109/17549507.2012.663791; Luck AM, 2007, APHASIOLOGY, V21, P208, DOI 10.1080/02687030601065470; MCLELLAN K, 2011, NZ MED J, V124, P1; McLellan KM, 2014, APHASIOLOGY, V28, P453, DOI 10.1080/02687038.2013.845740; National Health & Medical Research Council, 2003, NH MRC VAL ETH GUID; National Stroke Foundation, 2004, NAT STROK UN PROGR I; Purdy N, 2010, WORKING TOGETHER ABO; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Queensland Health, 2010, JOURN AFT STROK; Shahid S, 2011, AUST HEALTH REV, V35, P235, DOI 10.1071/AH09835; Shahid S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-60; Shahid S, 2009, AUST NZ J PUBL HEAL, V33, P109, DOI 10.1111/j.1753-6405.2009.00355.x; Speech Pathology Australia, 2014, SUBM INQ PREV DIFF T; Tate R.L., 1998, J AUSTR NZ PUBLIC HL, V22, P11; Taylor KP, 2009, AUST HEALTH REV, V33, P549, DOI 10.1071/AH090549; Taylor S. J., 1994, CHALLENGES SERVICE S, P43; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thrift AG, 2011, STROKE, V42, P1501, DOI 10.1161/STROKEAHA.111.617746; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Zabiela C., 2007, ACQUIRING KNOWLEDGE, V9, P39	56	13	13	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2015	16	2					145	156		10.1017/BrImp.2015.15			12	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CV0MJ	WOS:000363944500007					2021-06-18	
J	Chen, Y; Bao, Y; Zhang, JP; Woehrle, T; Sumi, Y; Ledderose, S; Li, XO; Ledderose, C; Junger, WG				Chen, Yu; Bao, Yi; Zhang, Jingping; Woehrle, Tobias; Sumi, Yuka; Ledderose, Stephan; Li, Xiaoou; Ledderose, Carola; Junger, Wolfgang G.			Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases	SHOCK			English	Article							TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE P38; HEMORRHAGIC-SHOCK; ATP RELEASE; OXIDATIVE BURST; CELL-ACTIVATION; RESUSCITATION; RECEPTORS; HEMICHANNELS; HYPOTENSION	Hypertonic saline (HS) resuscitation has been studied as a possible strategy to reduce polymorphonuclear neutrophil (PMN) activation and tissue damage in trauma patients. Hypertonic saline blocks PMNs by adenosine triphosphate (ATP) release and stimulation of A2a adenosine receptors. Here, we studied the underlying mechanisms in search of possible reasons for the inconsistent results of recent clinical trials with HS resuscitation. Purified human PMNs or PMNs in whole blood were treated with HS to simulate hypertonicity levels found after HS resuscitation (40 mmol/L beyond isotonic levels). Adenosine triphosphate release was measured with a luciferase assay. Polymorphonuclear neutrophil activation was assessed by measuring oxidative burst. The pannexin-1 (panx1) inhibitor (10)panx1 and the gap junction inhibitor carbenoxolone (CBX) blocked ATP release from PMNs in purified and whole blood preparations, indicating that HS releases ATP via panx1 and gap junction channels. Hypertonic saline blocked N-formyl-Met-Leu-Phe-induced PMN activation by 40% in purified PMN preparations and by 60% in whole blood. These inhibitory effects were abolished by (10)panx1 but only partially reduced by CBX, which indicates that panx1 has a central role in the immunomodulatory effects of HS. Inhibition of the ectonucleotidases CD39 and CD73 abolished the suppressive effect of HS on purified PMN cultures but only partially reduced the effect of HS in whole blood. These findings suggest redundant mechanisms in whole blood that may strengthen the immunomodulatory effect of HS in vivo. We conclude that HS resuscitation exerts anti-inflammatory effects that involve panx1, CD39, CD73, and other ectonucleotidases, which produce the adenosine that blocks PMNs by stimulating their A2a receptors. Our findings shed new light on the immunomodulatory mechanisms of HS and suggest possible new strategies to improve the clinical efficacy of hypertonic resuscitation.	[Chen, Yu; Bao, Yi; Zhang, Jingping; Woehrle, Tobias; Sumi, Yuka; Ledderose, Stephan; Li, Xiaoou; Ledderose, Carola; Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, Vienna, Austria	Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617; Bao, Yi/0000-0003-0748-1575	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM-51477, GM-60475, AI-072287, AI-080582, T32 GM-103702]; CDMRPUnited States Department of Defense [PR043034]; Shock Society/Nova Nordisk research grant for Early Career Investigators; German Research FoundationGerman Research Foundation (DFG) [LE-3209/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI072287, R01AI080582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060475, T32GM103702, R01GM116162, R01GM051477, R29GM051477] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462830] Funding Source: KAKEN	This work received financial support through the National Institute of Health grants GM-51477, GM-60475, AI-072287, AI-080582, and T32 GM-103702, a grant from CDMRP (PR043034; W.G.J.), a Shock Society/Nova Nordisk research grant for Early Career Investigators (Y.C.), and a grant from the German Research Foundation (LE-3209/1-1; C.L.).	Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Bao Y, 2014, J BIOL CHEM, V289, P26794, DOI 10.1074/jbc.M114.572495; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Bulger Eileen M, 2012, Adv Surg, V46, P73; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Dubick MA, 2013, CLINICS, V68, P883, DOI 10.6061/clinics/2013(06)25; HAMPTON MB, 1994, J INFECT DIS, V169, P839, DOI 10.1093/infdis/169.4.839; Hashiguchi N, 2007, J TRAUMA, V62, P299, DOI 10.1097/01.ta.0000222956.88760.33; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Junger WG, 2013, SHOCK, V40, P366, DOI 10.1097/SHK.0000000000000038; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Murao Y, 2000, SHOCK, V14, P18, DOI 10.1097/00024382-200014010-00004; Murao Y, 2003, SHOCK, V20, P29, DOI 10.1097/01.shk.0000071060.78689.f1; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	35	13	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2015	44	3					221	227		10.1097/SHK.0000000000000402			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CP6FU	WOS:000359981300005	26009814	Green Accepted			2021-06-18	
J	Kelly, ML; Roach, MJ; Banerjee, A; Steinmetz, MP; Claridge, JA				Kelly, Michael L.; Roach, Mary Jo; Banerjee, Aman; Steinmetz, Michael P.; Claridge, Jeffrey A.			Functional and long-term outcomes in severe traumatic brain injury following regionalization of a trauma system	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery28th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	SEP 09-13, 2014JAN 13-17, 2015	Philadelphia, PALake Buena Vista, FL	Amer Assoc Surg TraumaEastern Assoc Surg Trauma		Traumatic brain injury; regionalization; health systems; outcomes; mortality	HOSPITAL SYSTEMS; UNITED-STATES; LEVEL I; CARE; MORTALITY	BACKGROUND: We previously demonstrated that regionalization of trauma (RT) significantly reduced in-hospital mortality from 19% to 14% in patients with severe traumatic brain injury (sTBI). However, functional and long-term outcomes had not been assessed. We hypothesized that RT would be associated with improved functional and long-term outcomes in sTBI patients. METHODS: All TBI patients older than 14 years with a head Abbreviated Injury Scale (AIS) score of 3 or greater were identified from the RT database and matched to the state death index and the regional TBI rehabilitation (TBIr) database. Data from 2008 through 2012 were analyzed before and after RT in 2010. For patients discharged to the TBIr unit, overall Functional Independence Measure (FIM) scores and FIM score gains were compared before and after RT. RESULTS: A total of 3,496 patients with sTBI were identified in the RT database, 1,359 in the pre-RT and 2,137 in the post-RT period. The mortality rate after discharge decreased significantly after RT from 21% to 16% (p < 0.0001) at 30 days and from 24% to 20% (p = 0.004) at 6 months. Multivariable logistic regression demonstrated RT to be an independent predictor against mortality at 30 days (odds ratio, 0.74; 95% confidence interval, 0.60-0.91; C statistic, 0.84) and 6 months (odds ratio, 0.82; 95% confidence interval, 0.67-0.99; C statistic, 0.82). Discharges to the TBIr unit increased from 117 (9%) in the pre-RT to 297 (14%) in the post-RT period (p < 0.0001), while discharges to home and non-TBIr units remained similar. Injury Severity Score (ISS) and Glasgow Coma Scale (GCS) score for all discharged patients remained similar. FIM admission scores were similar in the pre-RT (median, 54; interquartile range [IQR], 30-65) and post-RT period (median, 48; IQR, 31-61) (p = 0.2) and remained similar at discharge in the pre-RT (median, 92; IQR, 75-102) and post-RT period (median, 89; IQR, 73-100) (p = 0.1). TBIr patients showed similar FIM score gains in the pre-RT (median, 37; IQR, 26-46) and post-RT period (median, 36; IQR, 24-49) (p = 0.6). CONCLUSION: RT was associated with reduced long-term mortality, increased TBIr admissions, and similar FIM score improvements for patients with sTBI. (J Trauma Acute Care Surg. 2015;79: 372-377. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Kelly, Michael L.] Cleveland Clin, Dept Neurosurg, Neurol Inst, Cleveland, OH 44106 USA; [Roach, Mary Jo; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Ctr Healthcare Res & Policy, Cleveland, OH 44109 USA; [Banerjee, Aman; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Northern Ohio Trauma Syst, Cleveland, OH 44109 USA; [Steinmetz, Michael P.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Surg, Cleveland, OH 44109 USA; [Steinmetz, Michael P.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Neurosurg, Cleveland, OH 44109 USA	Claridge, JA (corresponding author), Case Western Reserve Univ, Div Trauma Crit Care Burns & Acute Care Surg, MetroHlth Med Ctr, Northern Ohio Trauma Syst,Dept Surg,Sch Med, Cleveland, OH 44109 USA.	jclaridge@metrohealth.org					Bailey J, 2012, SURG CLIN N AM, V92, P1009, DOI 10.1016/j.suc.2012.04.008; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Claridge JA, 2013, SURGERY, V154, P875, DOI 10.1016/j.surg.2013.07.013; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Kelly ML, 2015, J TRAUMA ACUTE CARE, V78, P715, DOI 10.1097/TA.0000000000000590; NICE, HEAD INJ TRIAG ASS I; Ohio trauma registry, 2010, OH TRAUM REG ANN DAT; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; Sanchez AI, 2012, J HEAD TRAUMA REHAB, V27, P159, DOI 10.1097/HTR.0b013e3182074c41; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; The Uniform Data System for Medical Rehabilitation, FIM INSTR ITS BACKGR; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2	17	13	13	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2015	79	3					372	377		10.1097/TA.0000000000000762			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CQ4JV	WOS:000360571900009	26307868				2021-06-18	
J	Loosemore, M; Lightfoot, J; Palmer-Green, D; Gatt, I; Bilzon, J; Beardsley, C				Loosemore, Michael; Lightfoot, Joseph; Palmer-Green, Deborah; Gatt, Ian; Bilzon, James; Beardsley, Chris			Boxing injury epidemiology in the Great Britain team: a 5-year surveillance study of medically diagnosed injury incidence and outcome	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							AMATEUR; FOOTBALL; BOXERS; LEAGUE; RISK	Objectives There has been no comprehensive injury report of elite-level amateur boxers in competition and training. We reviewed injuries in training and competition in the Great Britain (GB) amateur boxing squad between 2005 and 2009. Methods Longitudinal, prospective injury surveillance over 5 years of the GB boxing squad from 2005 to 2009. 66 boxers passed through the squad. The location, region affected, description, and the duration of each injury were recorded by the team doctor and team physiotherapist. We recorded whether the injury occurred during competition or training, and also whether it was a new or a recurrent injury. The injury rate during competition was calculated as the number of injuries per 1000 h. Results More injuries affected the hand than any other body location. This was the case overall, in training and competition individually, and for both new and recurrent injuries. More injuries occurred during training than during competition, and most injuries were new rather than recurrent. Total injury rate during competition was 828 per 1000 h and hand injury rate in competition was 302 injuries per 1000 h. Hand injury rate in competition was significantly higher than at the other locations. The incidence of concussion is comparatively low. Conclusions Injury prevention should aim to protect the hands and wrists of elite amateur boxers.	[Loosemore, Michael; Lightfoot, Joseph] UCL, Inst Sport Exercise & Hlth, London W1T 7HA, England; [Palmer-Green, Deborah] Univ Nottingham, Div Orthopaed & Accid Surg, Nottingham NG7 2RD, England; [Gatt, Ian] English Inst Sport, Physiotherapy Dept, Sheffield, S Yorkshire, England; [Bilzon, James] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Beardsley, Chris] Strength & Conditioning Res Ltd, London, England	Loosemore, M (corresponding author), UCL, Inst Sport Exercise & Hlth, First Floor,170 Tottenham Court Rd, London W1T 7HA, England.	mike.loosemore@eis2win.co.uk		Bilzon, James/0000-0002-6701-7603			Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Hagglund M, 2005, SCAND J MED SCI SPOR, V15, P21, DOI 10.1111/j.1600-0838.2004.00395.x; Joch W, 1981, BIOMECHANICS A, P343; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Massimiliano B, 2011, BRIT J SPORT MED, V45, P563, DOI 10.1136/bjsm.2009.061135; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; R Core Team, 2014, LANG ENV STAT COMP; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Smith MS, 2006, J SPORT SCI MED, V5, P74; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Timm Kent E., 1993, Journal of Athletic Training, V28, P330; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	22	13	14	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2015	49	17					1100	1107		10.1136/bjsports-2015-094755			8	Sport Sciences	Sport Sciences	CP3AW	WOS:000359750200004	26192194	Green Accepted			2021-06-18	
J	Neselius, S; Brisby, H; Granholm, F; Zetterberg, H; Blennow, K				Neselius, Sanna; Brisby, Helena; Granholm, Fredrik; Zetterberg, Henrik; Blennow, Kaj			Monitoring concussion in a knocked-out boxer by CSF biomarker analysis	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Concussion; Traumatic brain injury (TBI); Mild traumatic brain injury; Boxing	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; PROTEIN; TAU; DISEASE; ELISA	Concussion is common in many sports, and the incidence is increasing. The medical consequences after a sport-related concussion have received increased attention in recent years since it is known that concussions cause axonal and glial damage, which disturbs the cerebral physiology and makes the brain more vulnerable for additional concussions. This study reports on a knocked-out amateur boxer in whom cerebrospinal fluid (CSF) neurofilament light (NFL) protein, reflecting axonal damage, was used to identify and monitor brain damage. CSF NFL was markedly increased during 36 weeks, suggesting that neuronal injury persists longer than expected after a concussion. CSF biomarker analysis may be valuable in the medical counselling of concussed athletes and in return-to-play considerations. Level of evidence IV.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, S-41345 Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Granholm, Fredrik] Sundsvall Cty Hosp, Dept Emergency Med, Sundsvall, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Clin Neurochem Lab, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London WC1N 3BG, England	Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, S-41345 Gothenburg, Sweden.	sanna.neselius@vgregion.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Swedish State Support for Clinical Research	This study has been funded by Swedish Research Council, the Knut and Alice Wallenberg Foundation and Swedish State Support for Clinical Research.	Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; BLENNOW K, 1993, EUR NEUROL, V33, P129, DOI 10.1159/000116919; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Petzold Axel, 2008, J Stroke Cerebrovasc Dis, V17, P196, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.002; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; ROSENGREN LE, 1992, J NEUROSCI METH, V44, P113, DOI 10.1016/0165-0270(92)90004-W; Shahani N, 2002, CELL MOL LIFE SCI, V59, P1668, DOI 10.1007/PL00012495; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	18	13	13	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	SEP	2015	23	9					2536	2539		10.1007/s00167-014-3066-6			4	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CP6ND	WOS:000360003300011	24819180				2021-06-18	
J	Painter, TJ; Rickerds, J; Alban, RF				Painter, Thomas J.; Rickerds, Jennifer; Alban, Rodrigo F.			Immune enhancing nutrition in traumatic brain injury - A preliminary study	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Immune-enhancing nutrition; Infection rates; Pre-albumin; Traumatic brain injury	CRITICALLY-ILL PATIENTS; CLOSED-HEAD INJURY; ENTERAL NUTRITION; SEVERE SEPSIS; IMMUNONUTRITION; SUPPORT; GUIDELINES; MANAGEMENT; METABOLISM; GLUTAMINE	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Certain patients appear to benefit when they receive immune enhancing additives, such as glutamine, arginine, and omega-3 fatty acids. We hypothesized that TBI patients given enteral feedings containing these supplements may have improved nutrition measures and infection rates when compared to standard tube feedings. This is a retrospective review of patients from a Level-One trauma center from July 2009 to July 2013. A total of 240 TBI patients received either an immune enhancing nutrition (LEN) formula (n = 126), or a standard formula (SF) (n = 114) based on the attending surgeon's preference. Data collected included demographic information, infection information and outcome measures. Patients were similar in terms of age, ISS, head AIS, and initial prealbumin level. Patients receiving LEN were found to have lower rates of blood stream infections (10.3% vs 19.3%, p <0.05), whereas pneumonia and UTI rates were similar between groups. In addition, both groups had similar rates of all-cause mortality and hospital length of stay, however LEN patients spent longer in the ICU and on ventilators. In TBI patients receiving LEN, prealbumin levels were higher at the second, third, and fourth week of admission (week 2 - 22.2 vs 17.4, p = 0.006; week 3 - 24.6 vs 20.1, p = 0.04; week 4 26.3 vs 22.1, p = 0.19; week 5 - 25.8 vs 20.3, p = 0.21). This study suggests that patients with traumatic brain injury who receive LEN are more likely to have increased prealbumin levels perhaps reflecting improved nutrition throughout their hospital stay and may show some benefit in rates of infections, particularly in bacteremia. (C) 2015 US Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Alban, Rodrigo F.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Painter, Thomas J.] Orlando Hlth, Dept Surg Educ, Orlando, FL 32806 USA	Alban, RF (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8635 W 3rd St,Suite 650-W, Los Angeles, CA 90048 USA.	tjpainter11@gmail.com; jrickerds@gmail.com; Rodrigo.alban@cshs.org					Balk RA, 2000, CRIT CARE CLIN, V16, P337, DOI 10.1016/S0749-0704(05)70113-5; Bertolini G, 2003, INTENS CARE MED, V29, P834, DOI 10.1007/s00134-003-1711-5; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; CERRA FB, 1987, SURGERY, V101, P1; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; DALY JM, 1992, SURGERY, V112, P56; Darbar A, 2001, NUTRITION, V17, P71, DOI 10.1016/S0899-9007(00)00476-7; DEUTSCHMAN CS, 1987, J NEUROSURG, V66, P388, DOI 10.3171/jns.1987.66.3.0388; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Griffiths RD, 1997, NUTRITION, V13, P752, DOI 10.1016/S0899-9007(97)83039-0; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 2003, INTENS CARE MED, V29, P669, DOI 10.1007/s00134-003-1710-6; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Jones C, 1999, NUTRITION, V15, P108, DOI 10.1016/S0899-9007(98)00172-5; Kazamias P, 1998, WORLD J SURG, V22, P6, DOI 10.1007/s002689900341; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kudsk K, 1996, ANN SURG, V224, P540; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Wilson RF, 2001, NEUROL RES, V23, P121, DOI 10.1179/016164101101198451	21	13	19	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	SEP	2015	21						70	74		10.1016/j.ijsu.2015.07.008			5	Surgery	Surgery	CR0FL	WOS:000360993700014	26209585	Bronze			2021-06-18	
J	Sirianni, AC; Jiang, JY; Zeng, J; Mao, LL; Zhou, SH; Sugarbaker, P; Zhang, XM; Li, W; Friedlander, RM; Wang, X				Sirianni, Ana C.; Jiang, Jiying; Zeng, Jiang; Mao, Lilly L.; Zhou, Shuanhu; Sugarbaker, Peter; Zhang, Xinmu; Li, Wei; Friedlander, Robert M.; Wang, Xin			N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis	JOURNAL OF NEUROCHEMISTRY			English	Article						amyotrophic lateral sclerosis; mitochondrial death pathway; N-acetyl-l-tryptophan; neuroprotection; structure-bioactivity relationship; substance P	TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; CYTOCHROME-C RELEASE; SUBSTANCE-P IMMUNOREACTIVITY; DELAYS DISEASE ONSET; SPINAL-CORD-INJURY; NEURODEGENERATIVE DISEASES; RECEPTOR ANTAGONISTS; NK1 RECEPTOR; IN-VITRO	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron loss. Evidence suggests that mitochondrial dysfunction, apoptosis, oxidative stress, inflammation, glutamate excitotoxicity, and proteasomal dysfunction are all responsible for ALS pathogenesis. N-acetyl-tryptophan has been identified as an inhibitor of mitochondrial cytochrome c release and therefore is a potential neuroprotective agent. By quantifying cell death, we demonstrate that N-acetyl-l-tryptophan (L-NAT) and N-acetyl-DL-tryptophan are neuroprotective in NSC-34 motor neuron-like cells and/or primary motor neurons, while their isomer N-acetyl-d-tryptophan has no protective effect. These findings are consistent with energy minimization and molecular modeling analysis, confirming that L-NAT generates the most stable complex with the neurokinin-1 receptor (NK-1R). L-NAT inhibits the secretion of Substance P and IL-1 (Enzyme-Linked Immunosorbent Assay and/or dot blots) and mitochondrial dysfunction by effectively inhibiting the release of cytochrome c/Smac/AIF from mitochondria into the cytoplasm and activation of apoptotic pathways, including the activation of caspase-1, -9, and -3, as well as proteasomal dysfunction through restoring chymotrypsin-like, trypsin-like, and caspase-like proteasome activity. These data provide insight into the molecular mechanisms by which L-NAT offers neuroprotection in models of ALS and suggest its potential as a novel therapeutic strategy for ALS.	[Sirianni, Ana C.; Jiang, Jiying; Sugarbaker, Peter; Zhang, Xinmu; Li, Wei; Wang, Xin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Jiang, Jiying] Weifang Med Univ, Dept Anat, Weifang, Shandong, Peoples R China; [Zeng, Jiang] Nantong Univ, Inst Analyt Chem Life Sci, Sch Publ Hlth, Nantong, Jiangsu, Peoples R China; [Mao, Lilly L.] Aimcan Pharma Res & Technol, Guelph, ON, Canada; [Zhou, Shuanhu] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; [Friedlander, Robert M.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA	Wang, X (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, 221 Longwood Ave, Boston, MA 02115 USA.	friedlanderr@upmc.edu; xwang@rics.bwh.harvard.edu	Friedlander, Robert M/A-2845-2016; Zhou, Shuanhu/Q-7137-2019; Zhang, Xinmu/G-8128-2018	Friedlander, Robert M/0000-0003-4423-9219; Zhou, Shuanhu/0000-0003-4745-5347	Muscular Dystrophy AssociationMuscular Dystrophy Association; ALS Therapy Alliance; Bill & Melinda Gates FoundationBill & Melinda Gates Foundation; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	We thank Dr Gerhard Klebe (Philipps-University Marburg, Germany) for providing the 3D model of NK-1R. We thank Drs. Lei Lv and Akiko Maekawa for experimental discussion. This work was supported by grants from the Muscular Dystrophy Association (to X. W.), the ALS Therapy Alliance (to X. W.), Bill & Melinda Gates Foundation (To X. W.), and the National Institutes of Health/National Institute of Neurological Disorders and Stroke (X. W., R.M.F.).	Bang R, 2004, J PHARMACOL EXP THER, V308, P1174, DOI 10.1124/jpet.103.059329; Bishop A, 1999, FREE RADICAL BIO MED, V26, P978, DOI 10.1016/S0891-5849(98)00284-6; Caioli S, 2011, NEUROBIOL DIS, V44, P92, DOI 10.1016/j.nbd.2011.06.008; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; Czeh B, 2006, EXPERT OPIN INV DRUG, V15, P479, DOI 10.1517/13543784.15.5.479; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Duan QH, 2006, J PINEAL RES, V41, P351, DOI 10.1111/j.1600-079X.2006.00374.x; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUJITA Y, 1980, J NUTR SCI VITAMINOL, V26, P381, DOI 10.3177/jnsv.26.381; Gao YQ, 2010, STROKE, V41, P166, DOI 10.1161/STROKEAHA.109.561852; Goswami A, 2006, BIOCHEM BIOPH RES CO, V342, P184, DOI 10.1016/j.bbrc.2006.01.136; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guegn C, 2001, J NEUROSCI, V21, P6569; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Herpter I, 2003, WORLD J BIOL PSYCHIA, V4, P56, DOI 10.3109/15622970309167952; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Kabashi E, 2008, J NEUROCHEM, V105, P2353, DOI 10.1111/j.1471-4159.2008.05317.x; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kang MH, 2009, WOUND REPAIR REGEN, V17, P216, DOI 10.1111/j.1524-475X.2009.00456.x; Kenkyu I., 1980, STUDY MED S, V11, P635; KOWALL NW, 1993, REGUL PEPTIDES, V46, P174, DOI 10.1016/0167-0115(93)90028-7; Leonard AV, 2013, J NEUROTRAUM, V30, P1812, DOI 10.1089/neu.2013.2993; Leonard Anna V, 2013, Acta Neurochir Suppl, V118, P303, DOI 10.1007/978-3-7091-1434-6_59; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li W, 2015, NEUROBIOL DIS, V80, P93, DOI 10.1016/j.nbd.2015.05.002; Liu RG, 2002, J NEUROCHEM, V80, P488, DOI 10.1046/j.0022-3042.2001.00720.x; Lv L, 2012, EXP NEUROL, V233, P783, DOI 10.1016/j.expneurol.2011.11.042; Ma J, 2010, AM J PHYSIOL-GASTR L, V299, pG791, DOI 10.1152/ajpgi.00160.2010; Macdonald R L, 1981, Adv Biochem Psychopharmacol, V28, P159; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Matsuishi T, 1999, J NEURAL TRANSM, V106, P943, DOI 10.1007/s007020050214; Monk PN, 2006, NAT MED, V12, P885, DOI 10.1038/nm0806-885; Pandya Rachna S., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P15; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Peters EMJ, 2005, BRAIN BEHAV IMMUN, V19, P252, DOI 10.1016/j.bbi.2004.08.005; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Pinter E, 2002, NEUROSCI LETT, V318, P13, DOI 10.1016/S0304-3940(01)02468-5; Puttaparthi K, 2007, EXP NEUROL, V206, P53, DOI 10.1016/j.expneurol.2007.03.024; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Saria A, 1999, EUR J PHARMACOL, V375, P51, DOI 10.1016/S0014-2999(99)00259-9; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Sterner-Kock A, 1999, J LEUKOCYTE BIOL, V65, P834; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thornton E, 2014, PARKINSONISM RELAT D, V20, P508, DOI 10.1016/j.parkreldis.2014.02.008; Thornton E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034138; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner R. J., 2005, J CEREB BLOOD FLOW M, V25, pS32; Turner R, 2007, DRUG NEWS PERSPECT, V20, P221, DOI 10.1358/dnp.2007.20.4.1103527; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wang HY, 2007, EUR J NEUROSCI, V26, P633, DOI 10.1111/j.1460-9568.2007.05663.x; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wang X, 2008, J NEUROSCI, V28, P9473, DOI 10.1523/JNEUROSCI.1867-08.2008; Wang X, 2006, BBA-MOL BASIS DIS, V1762, P742, DOI 10.1016/j.bbadis.2006.06.015; Wang X, 2011, J NEUROSCI, V31, P14496, DOI 10.1523/JNEUROSCI.3059-11.2011; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; WEGMANN H, 1979, HELV PAEDIATR ACTA, V34, P497; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39; Zhang GL, 2004, BRAIN RES, V1028, P225, DOI 10.1016/j.brainres.2004.09.017; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhang X, 2008, NEUROPHARMACOLOGY, V54, P1143, DOI 10.1016/j.neuropharm.2008.03.005; Zhang Y, 2013, NEUROBIOL DIS, V55, P26, DOI 10.1016/j.nbd.2013.03.008; Zhang Y, 2011, NEUROSURGERY, V69, P942, DOI 10.1227/NEU.0b013e318222afb2; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zhu YJ, 2015, DRUG DISCOV TODAY, V20, P65, DOI 10.1016/j.drudis.2014.08.016	81	13	13	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	SEP	2015	134	5					956	968		10.1111/jnc.13190			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CO7ZO	WOS:000359383500015	26031348				2021-06-18	
J	Sours, C; Chen, HX; Roys, S; Zhuo, JC; Varshney, A; Gullapalli, RP				Sours, Chandler; Chen, Haoxing; Roys, Steven; Zhuo, Jiachen; Varshney, Amitabh; Gullapalli, Rao P.			Investigation of Multiple Frequency Ranges Using Discrete Wavelet Decomposition of Resting-State Functional Connectivity in Mild Traumatic Brain Injury Patients	BRAIN CONNECTIVITY			English	Article						discrete wavelet; mild traumatic brain injury; postconcussive syndrome; resting state fMRI	DEFAULT-MODE NETWORK; MRI; RELIABILITY; DISRUPTION; IMPACT	The aim of this study was to investigate if discrete wavelet decomposition provides additional insight into resting-state processes through the analysis of functional connectivity within specific frequency ranges within the default mode network (DMN) that may be affected by mild traumatic brain injury (mTBI). Participants included 32 mTBI patients (15 with postconcussive syndrome [PCS +] and 17 without [PCS-]). mTBI patients received resting-state functional magnetic resonance imaging (rs-fMRI) at acute (within 10 days of injury) and chronic (6 months postinjury) time points and were compared with 31 controls (healthy control [HC]). The wavelet decomposition divides the time series into multiple frequency ranges based on four scaling factors (SF1: 0.125-0.250 Hz, SF2: 0.060-0.125 Hz, SF3: 0.030-0.060 Hz, SF4: 0.015-0.030 Hz). Within each SF, wavelet connectivity matrices for nodes of the DMN were created for each group (HC, PCS +, PCS-), and bivariate measures of strength and diversity were calculated. The results demonstrate reduced strength of connectivity in PCS + patients compared with PCS- patients within SF1 during both the acute and chronic stages of injury, as well as recovery of connectivity within SF1 across the two time points. Furthermore, the PCS- group demonstrated greater network strength compared with controls at both time points, suggesting a potential compensatory or protective mechanism in these patients. These findings stress the importance of investigating resting-state connectivity within multiple frequency ranges; however, many of our findings are within SF1, which may overlap with frequencies associated with cardiac and respiratory activities.	[Sours, Chandler; Roys, Steven; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA; [Sours, Chandler; Roys, Steven; Zhuo, Jiachen; Gullapalli, Rao P.] MRRC, Baltimore, MD USA; [Chen, Haoxing] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Varshney, Amitabh] Univ Maryland, Dept Comp Sci, Inst Adv Comp Studies, College Pk, MD 20742 USA	Sours, C (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.	csour001@umaryland.edu			Department of DefenseUnited States Department of Defense [W81XWH08-1-0725, W81XWH-12-1-0098]; NRSA grant from the National Institute of Neurological Disorders and Stroke [1F31NS081984]; University of Maryland/Mpowering the State through the Center for Health-related Informatics and Bioimaging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS081984] Funding Source: NIH RePORTER	The authors would like to thank Joshua Betz, Jacqueline Janowich, Teodora Stoica, and Joseph Rosenberg for their help with patient recruitment and George Makris for his help with acquiring the data. Support for this work was, in part, provided by the Department of Defense (W81XWH08-1-0725 and W81XWH-12-1-0098 to R.P.G). C.S. was supported by an NRSA grant from the National Institute of Neurological Disorders and Stroke (1F31NS081984). The authors also acknowledge support provided by The University of Maryland/Mpowering the State through the Center for Health-related Informatics and Bioimaging.	Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; CDC, 2003, REP C MILD TRAUM BRA; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cheng H, 2013, CHINESE MED J-PEKING, V126, P2459, DOI 10.3760/cma.j.issn.0366-6999.20122681; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Franco AR, 2013, BRAIN CONNECT, V3, P363, DOI 10.1089/brain.2012.0134; Gohel SR, 2015, BRAIN CONNECT, V5, P23, DOI 10.1089/brain.2013.0210; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Percival D.B., 2000, CA ST PR MA; Poggi J-M, 1996, WAVELET TOOLBOX; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reich S, 2005, VALIDATION ANAM TEST; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2014, BRAIN IMAGING BEHAV; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; World Health Organization, 2010, INT CLASS DIS; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wu JT, 2011, NEUROSCI LETT, V504, P62, DOI 10.1016/j.neulet.2011.08.059; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	37	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	SEP	2015	5	7			SI		442	450		10.1089/brain.2014.0333			9	Neurosciences	Neurosciences & Neurology	VG7GK	WOS:000448203700005	25808612	Green Published			2021-06-18	
J	Al-Burdeni, S; Abuodeh, Y; Ibrahim, T; Ahmed, G				Al-Burdeni, Salah; Abuodeh, Yousef; Ibrahim, Talal; Ahmed, Ghalib			Open reduction and internal fixation versus radial head arthroplasty in the treatment of adult closed comminuted radial head fractures (modified Mason type III and IV)	INTERNATIONAL ORTHOPAEDICS			English	Article						Radial head fracture; Radial head fixation; Radial head arthroplasty	FOLLOW-UP; EXCISION; ELBOW; REPLACEMENT; PROSTHESIS; KINEMATICS; RESECTION	Background The purpose of our study was to compare the outcome of radial head fractures (modified Mason type III and IV) treated by open reduction and internal fixation (ORIF) versus radial head arthroplasty (RHA). Patients and methods A retrospective review of 36 patients with closed comminuted radial head fractures treated either by ORIF or RHA with an average of 15-months' follow-up was undertaken. The primary outcome was the QuickDASH, the shortened version of the Dissabilities of the Arm, Shouler and Hand score. Other outcomes included regain of functional range of motion (ROM) of the elbow and duration of surgery. Surgical complications were noted. Results Thirty-six patients with a mean age of 36 years were evaluated. Nineteen patients underwent ORIF and 17 RHA. The two treatment groups were comparable with regards to gender, side of injury, Mason type and mechanism of injury. Patients who underwent RHA were slightly older (p < 0.001). At follow-up, the QuickDASH score was similar between groups (p = 0.58). Regain of functional ROM of the elbow (p = 0.13) and complication rate (p = 0.57) were similar. Conclusion The treatment of closed comminuted radial head fracture (modified Mason type III and IV) with ORIF and RHA demonstrates similar findings despite less surgical time for performing RHA.	[Al-Burdeni, Salah; Abuodeh, Yousef; Ibrahim, Talal; Ahmed, Ghalib] Hamad Gen Hosp, Doha, Qatar	Ahmed, G (corresponding author), Hamad Gen Hosp, POB 3050, Doha, Qatar.	ghaliboudah@gmail.com	Ibrahim, Talal/AAK-6433-2020	Ibrahim, Talal/0000-0001-9192-1435; ALHANEEDI, GHALIB/0000-0003-4326-7250; Abuodeh, Yousef/0000-0002-9008-5487			Bain G I, 2005, J Bone Joint Surg Am, V87 Suppl 1, P136, DOI 10.2106/JBJS.D.02710; Beingessner DM, 2004, J BONE JOINT SURG AM, V86A, P1730, DOI 10.2106/00004623-200408000-00018; Chen X, 2011, INT ORTHOP, V35, P1071, DOI 10.1007/s00264-010-1107-4; COLEMAN DA, 1987, J BONE JOINT SURG AM, V69A, P385; ESSER RD, 1995, J ORTHOP TRAUMA, V9, P318, DOI 10.1097/00005131-199509040-00008; GOLDBERG I, 1986, J BONE JOINT SURG AM, V68A, P675, DOI 10.2106/00004623-198668050-00006; Holmenschlager F, 2002, REV CHIR ORTHOP, V88, P387; Ikeda A, 2003, J BONE JOINT SURG BR, V85B, P1040, DOI 10.1302/0301-620X.85B7.13823; Janssen RPA, 1998, J BONE JOINT SURG BR, V80B, P231, DOI 10.1302/0301-620X.80B2.8255; Johnson JA, 2005, J SHOULDER ELB SURG, V14, p195S, DOI 10.1016/j.jse.2004.09.034; King G J, 1991, J Orthop Trauma, V5, P21, DOI 10.1097/00005131-199103000-00004; KNIGHT DJ, 1993, J BONE JOINT SURG BR, V75, P572; Leppilahti J, 2000, INT ORTHOP, V24, P160, DOI 10.1007/s002640000134; MANCINI G B, 1989, Italian Journal of Orthopaedics and Traumatology, V15, P295; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; MCARTHUR RA, 1987, CLIN ORTHOP RELAT R, P79; MIKIC ZD, 1983, CLIN ORTHOP RELAT R, P220; Moro JK, 2001, J BONE JOINT SURG AM, V83A, P1201, DOI 10.2106/00004623-200108000-00010; MORREY BF, 1979, J BONE JOINT SURG AM, V61, P63, DOI 10.2106/00004623-197961010-00012; Morrey BF, 2000, ELBOW ITS DISORDERS, P341; Postacchini F, 1992, Ital J Orthop Traumatol, V18, P323; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Ruan HJ, 2009, INT ORTHOP, V33, P249, DOI 10.1007/s00264-007-0453-3; RYMASZEWSKI LA, 1984, J BONE JOINT SURG BR, V66, P109; Schnetzke M, 2014, INT ORTHOP, V38, P2295, DOI 10.1007/s00264-014-2478-8	25	13	15	0	11	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	AUG	2015	39	8					1659	1664		10.1007/s00264-015-2755-1			6	Orthopedics	Orthopedics	CN4FE	WOS:000358385000029	25823518				2021-06-18	
J	Hammond, FM; Horn, SD; Smout, RJ; Beaulieu, CL; Barrett, RS; Ryser, DK; Sommerfeld, T				Hammond, Flora M.; Horn, Susan D.; Smout, Randall J.; Beaulieu, Cynthia L.; Barrett, Ryan S.; Ryser, David K.; Sommerfeld, Teri			Readmission to an Acute Care Hospital During Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Hospitalization; Patient readmission; Rehabilitation	LENGTH-OF-STAY; MEDICAL REHABILITATION; RESOURCE USE; COMPLICATIONS; COMPLEXITY; MORTALITY; QUALITY; SYSTEM	Objective: To assess the incidence of, causes for, and factors associated with readmission to an acute care hospital (RTAC) during inpatient rehabilitation for traumatic brain injury (TBI). Design: Prospective observational cohort. Setting: Inpatient rehabilitation. Participants: Individuals with TBI admitted consecutively for inpatient rehabilitation (N=2130). Interventions: Not applicable. Main Outcome Measures: RTAC incidence, RTAC causes, rehabilitation length of stay (RLOS), and rehabilitation discharge location. Results: A total of 183 participants (9%) experienced RTAC for a total of 210 episodes. Of 183 participants, 161 patients experienced 1 RTAC episode, 17 had 2, and 5 had 3. The mean time from rehabilitation admission to first RTAC was 22 +/- 22 days. The mean duration in acute care during RTAC was 7 +/- 8 days. Eighty-four participants (46%) had >= 1 RTAC episodes for medical reasons, 102 (56%) had >= 1 RTAC episodes for surgical reasons, and 6 (3%) participants had RTAC episodes for unknown reasons. Most common surgical RTAC reasons were neurosurgical (65%), pulmonary (9%), infection (5%), and orthopedic (5%); most common medical reasons were infection (26%), neurological (23%), and cardiac (12%). Any RTAC was predicted as more likely for patients with older age, history of coronary artery disease, history of congestive heart failure, acute care diagnosis of depression, craniotomy or craniectomy during acute care, and presence of dysphagia at rehabilitation admission. RTAC was less likely for patients with higher admission FIM motor scores and education less than high school diploma. RTAC occurrence during rehabilitation was significantly associated with longer RLOS and smaller likelihood of discharge home. Conclusions: Approximately 9% of patients with TBI experienced RTAC episodes during inpatient rehabilitation for various medical and surgical reasons. This information may help inform interventions aimed at reducing interruptions in rehabilitation for RTAC. RTACs were associated with longer RLOS and discharge to an institutional setting. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Ryser, David K.] Intermt Med Ctr, Salt Lake City, UT USA; [Sommerfeld, Teri] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Hammond, FM (corresponding author), Indiana Univ Sch Med, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Apisarnthanarak A, 2008, INFECT CONT HOSP EP, V29, P1094, DOI 10.1086/591743; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Centers for Medicare & Medicaid Services, SPEC ALL CAUS UNPL R; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corral L, 2012, CRITICAL CARE, V16, P2; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DOLCE G, 2008, J NEUROTRAUMA; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; Faulk CE, 2013, PM&R, V5, P757, DOI 10.1016/j.pmrj.2013.06.002; Gerhardt G, MED READMISSION RATE; Giaquinto S, 2003, EUR J NEUROL, V10, P235, DOI 10.1046/j.1468-1331.2003.00563.x; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Heinemann AW, 1994, TOP STROKE REHABIL, V1, P1; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Loeb M, 2008, J GEN INTERN MED, V23, P816, DOI 10.1007/s11606-008-0620-2; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; SIEGLER EL, 1994, ARCH INTERN MED, V154, P2185, DOI 10.1001/archinte.154.19.2185; Stineman MG, 2000, ARCH PHYS MED REHAB, V81, P549, DOI 10.1053/mr.2000.5977; Tan WS, 2009, ARCH PHYS MED REHAB, V90, P1202, DOI 10.1016/j.apmr.2009.01.027; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; The Moran Company, 2011, UT TRENDS INP REH UP, P1; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	33	13	13	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S293	S303		10.1016/j.apmr.2014.08.026			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100011	26212405	Bronze, Green Accepted			2021-06-18	
J	Tanrikulu, L; Oez-Tanrikulu, A; Weiss, C; Scholz, T; Schiefer, J; Clusmann, H; Schubert, GA				Tanrikulu, L.; Oez-Tanrikulu, A.; Weiss, C.; Scholz, T.; Schiefer, J.; Clusmann, H.; Schubert, G. A.			The bigger, the better? About the size of decompressive hemicraniectomies	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Decompressive hemicraniectomy; Craniectomy size; Traumatic brain injury; Subarachnoid hemorrhage; Malignapt stroke	MIDDLE-CEREBRAL-ARTERY; INTRACEREBRAL HEMORRHAGE; MALIGNANT INFARCTION; ISCHEMIC-STROKE; COMPLICATIONS; CRANIECTOMY; SURGERY; INJURY	Introduction: Decompressive hemicraniectomy (DHC) is a treatment option in refractory ICP elevation and malignant infarction. A minimum diameter of 12 cm has been widely accepted as mandatory for effective decompression for ICP control. Complete hemispheric exposure is frequently advocated to further reduce the risk of parenchymal shear stress, hemorrhage and swelling. At the same time, superior efficacy and comparable risk profile of a more extensive decompression have yet to be established. Material and methods: We reviewed 74 patients with comprehensive clinical data sets undergoing DHC from 2008 to 2013 at our institution. With a minimum threshold of 12 cm in AP diameter being observed in all cases, patients were grouped according to the absolute size of maximum AP diameter (<18 cm, >= 18 cm) and surface estimate (<180 cm(2), >= 180 cm(2)). Surgical technique, efficacy of ICP control, surgical complications and early clinical course were recorded. Results: Baseline demographics were comparable in both groups. Surgery was effective in relieving or preventing intracranial hypertension in all patients, irrespective of craniectomy size. With smaller craniectomies, immediate surgical and secondary complications such as parenchymal herniation, hemorrhage, or swelling did not occur more frequently. Conclusion: Due to the heterogeneity of underlying disease, a conclusion as to effect of craniectomy size on long-term outcome cannot be made based on this study. However, if the obligatory lower threshold of 12 cm for DHC size and decompression to the temporal base are observed, a smaller craniectomy is equally effective in relieving intracranial hypertension. While not inadvertently associated with a more favorable surgical risk profile, it does not increase the risk for early secondary complications such as parenchymal shear stress, hemorrhage and swelling. (C) 2015 Published by Elsevier B.V.	[Tanrikulu, L.; Scholz, T.; Clusmann, H.; Schubert, G. A.] Rhein Westfal TH Aachen, Dept Neurosurg, D-52074 Aachen, Germany; [Oez-Tanrikulu, A.] St Martinus Hosp Dusseldorf, Dept Ophthalmol, Dusseldorf, Germany; [Weiss, C.] Heidelberg Univ, Inst Biomed Stat, Univ Med Mannheim, Heidelberg, Germany; [Schiefer, J.] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany	Schubert, GA (corresponding author), Rhein Westfal TH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	gerrit.schubert@me.com	Schubert, Gerrit Alexander/Q-9192-2017	Schubert, Gerrit Alexander/0000-0001-9135-6042			Agarwalla PK, 2014, NEUROSURGERY, V74, pS151, DOI 10.1227/NEU.0000000000000226; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Heuts SG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1326; Inamasu J, 2013, J STROKE CEREBROVASC, V22, P1350, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.008; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Neugebauer H, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-115; Park Jaechan, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P61, DOI 10.7461/jcen.2013.15.2.61; Rahme R, 2012, STROKE, V43, P550, DOI 10.1161/STROKEAHA.111.635185; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Suyama K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.07.015; Takeuchi S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12424; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	17	13	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2015	135						15	21		10.1016/j.clineuro.2015.04.019			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL8LS	WOS:000357226800004	26005165				2021-06-18	
J	Lorente, L; Martin, MM; Almeida, T; Abreu-Gonzalez, P; Ramos, L; Argueso, M; Riano-Ruiz, M; Sole-Violan, J; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Almeida, Teresa; Abreu-Gonzalez, Pedro; Ramos, Luis; Argueso, Monica; Riano-Ruiz, Marta; Sole-Violan, Jordi; Jimenez, Alejandro			Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury	BMC NEUROLOGY			English	Article						Total antioxidant capacity; Brain trauma; Patients; Mortality; Injury	OXIDATIVE STRESS; HEAD-INJURY; DAMAGE; MELATONIN	Background: Previously, circulating total antioxidant capacity (TAC) in traumatic brain injury (TBI) patients has been scarcely studied and only in studies of small sample size (lower than 55 TBI patients). In one study were found higher serum TAC in non-survivor than in survivor TBI patients; however, an association between circulating TAC and mortality in patients with TBI has not been previously reported. Thus, the objective of this study was to determine whether there is an association between circulating TAC, peroxidation state and mortality in patients with severe TBI. Methods: This was a multicenter, observational and prospective study was carried out in six Spanish Intensive Care Units. We included patients with severe TBI defined as Glasgow Coma Scale (GCS) lower than 9. We excluded patients with Injury Severity Score (ISS) in non-cranial aspects higher than 9. We measured serum TAC on day 1 of TBI. The 30-day mortality was established as endpoint. Results: Non-surviving TBI patients (N = 27) showed higher serum TAC (P < 0.001) than survivor ones (N = 73). Logistic regression analyses showed that serum TAC higher than 2.59 nmol/mL were associated with 30-day mortality controlling for APACHE-II and CT classification (OR = 4.40; 95 % CI = 1.14-16.98; P = 0.03), controlling for GCS and age (OR = 5.88; 95 % CI = 1.57-22.06; P = 0.009), and controlling for CT classification and admission abnormal pupils (OR = 3.89; 95 % CI = 1.30-11.61; P = 0.02). There was an association between serum TAC and malondialdehyde (a biomarker of lipid peroxidation) levels (rho = 0.25; p = 0.01), APACHE-II score (rho = 0.23; p = 0.03) and GCS (rho = -0.21; p = 0.04). Conclusions: To our knowledge, our series is the largest reporting data on circulating TAC in patients with severe TBI. The most relevant and new findings of our study were that there is an association between circulating TAC and peroxidation state and mortality in patients with severe TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife 38320, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife 38320, Spain; [Almeida, Teresa] Univ La Laguna, Inst Enfermedades Trop & Salud Publ Canarias, Unidad Genet, San Cristobal la Laguna 38071, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Phisiol, Santa Cruz De Tenerife 38320, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta 38713, La Palma, Spain; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia 46004, Spain; [Riano-Ruiz, Marta] Complejo Hosp Univ Insular Materno Infantil, Serv Bioquim Clin, Las Palmas Gran Canaria 35016, Canaria, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria 35010, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz DeTe, Spain	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain.	lorentemartin@msn.com	Abreu-Gonzalez, Pedro/AAC-7790-2020; Almeida, Teresa/S-1166-2018	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Argueso, Monica/0000-0001-5917-1056; Almeida, Teresa/0000-0002-7644-3436	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	We would like to thank Andreina Leon Carmenatis and Henoc del Rosario Garcia for their technical assistance. This study was supported by fundings from Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain). The fundings have not affected in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chuang CC, 2006, CRIT CARE, V10, DOI 10.1186/cc4826; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kavakli HS, 2010, SCI RES ESSAYS, V5, P2832; Kaya H, 2013, HONG KONG J EMERG ME, V20, P225; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lorente L, 2015, J CRIT CARE, V30; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; MacKinnon KL, 1999, CLIN BIOCHEM, V32, P263, DOI 10.1016/S0009-9120(98)00109-X; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Sogut O, 2012, TURK J MED SCI, V42, P1010, DOI 10.3906/sag-1109-35; TEASDALE G, 1974, LANCET, V2, P81; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	34	13	13	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 25	2015	15								115	10.1186/s12883-015-0378-1			7	Clinical Neurology	Neurosciences & Neurology	CN5QD	WOS:000358483100001	26205136	DOAJ Gold, Green Published			2021-06-18	
J	Baldwin, VN; Powell, T				Baldwin, Victoria N.; Powell, Theresa			Google Calendar: A single case experimental design study of a man with severe memory problems	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Prospective memory; Single case experimental design; Acquired brain injury; Google Calendar	TRAUMATIC BRAIN-INJURY; DRIVEN TRAINING-PROGRAM; PAGING SYSTEM; POCKET-COMPUTER; EVERYDAY MEMORY; REHABILITATION; PEOPLE; AID; DEFICITS; SCALE	A single case experimental design across behaviours was utilised to explore the effectiveness of Google Calendar text alerts delivered to a mobile phone as a memory aid. The participant was a 43-year-old man (JA) with severe memory problems and executive difficulties caused by a traumatic brain injury (TBI). JA was initially very unwilling to use any memory aid and so a detailed assessment of his beliefs about memory aids, his cognitive difficulties and his social context was performed and a set of specifications for an aid was produced collaboratively. Six weeks of baseline data and six weeks of intervention data were collected for three target memory behaviours and three control memory behaviours. Results were analysed using nonoverlap of all pairs (NAP) analysis which showed a reduction in forgetting in the three target behaviours and no change in two of the three control behaviours. A subjective measure (the revised Everyday Memory Questionnaire) also suggested improvement. This study illustrates that Google Calendar is a highly effective memory aid and emphasises the importance of choosing a memory aid to suit the person's lifestyle and beliefs.	[Baldwin, Victoria N.; Powell, Theresa] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Powell, T (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	t.powell@bham.ac.uk		Powell, Theresa/0000-0002-3351-9453			BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Baldwin V. N., 2012, THESIS U BIRMINGHAM; Baldwin VN, 2011, NEUROPSYCHOL REHABIL, V21, P484, DOI 10.1080/09602011.2011.582378; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Electronics Take Back Coalition, 2010, FACTS FIG E WAST REC; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gartland D, 2004, NEUROPSYCHOL REHABIL, V14, P61, DOI 10.1080/09602010343000165; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Hodges S, 2006, LECT NOTES COMPUT SC, V4206, P177; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Manolov R, 2011, BEHAV THER, V42, P533, DOI 10.1016/j.beth.2010.12.003; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; Morris K., 2010, SPECIAL INTEREST SEC, V20, P1; Ofcom, 2013, MARK CONT UK CMR 201; Pape TLB, 2002, DISABIL REHABIL, V24, P5, DOI 10.1080/09638280110066235; Parker RI, 2009, BEHAV THER, V40, P357, DOI 10.1016/j.beth.2008.10.006; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Scherer M., 2010, EPARENT; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; THONEOTTO AIT, 2003, INT J PSYCHOL, V38, P1, DOI DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Waldron B., 2012, IRISH J PSYCHOL, V33, DOI [https://doi.org/10.1080/03033910.2012.659044, DOI 10.1080/03033910.2012.659044]; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	13	13	1	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 4	2015	25	4					617	636		10.1080/09602011.2014.956764			20	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CK6QJ	WOS:000356352400006	25263266	Green Published			2021-06-18	
J	das Nair, R; Martin, KJ; Sinclair, EJ				das Nair, Roshan; Martin, Kristy-Jane; Sinclair, Emma J.			A meta-synthesis of qualitative research on perceptions of people with long-term neurological conditions about group-based memory rehabilitation	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Cognitive rehabilitation; Meta-synthesis; Memory; Qualitative analysis; Neurological conditions	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; MULTIPLE-SCLEROSIS; IMPROVING MEMORY; ISSUES; DISABILITIES; PERFORMANCE; DEMENTIA; THERAPY; STROKE	The effectiveness of memory rehabilitation based on randomised controlled trials and meta-analyses has been inconclusive, but patient reports based on qualitative studies have been largely positive. We conducted a meta-synthesis of qualitative studies of group-based memory rehabilitation programmes for people with neurological conditions. Based on systematic searches of electronic databases and reference lists, five papers (87 participants) were selected. Quality appraisal of papers was conducted by two independent reviewers using the Critical Appraisal Skills Programme tool. Data synthesis was guided by the meta-ethnography approach. Five higher order themes were elicited. These suggested that memory rehabilitation was associated with insight and acceptance of participants' neurological condition and resultant cognitive deficits. The therapeutic effects of the groups, with social support and leisure activities, helped with participants' confidence. There were improvements in memory related to better self-awareness and learning to use new skills and strategies to compensate for memory deficits. These improvements also related to other psychological effects, in terms of positively affected mood, confidence and fatigue. Ultimately, these changes had a positive impact on daily life, with changes seen in the personal, inter-personal and professional spheres. Therefore, this synthesis of qualitative studies suggests that memory rehabilitation offers positive outcomes for people with long-term neurological conditions.	[das Nair, Roshan; Martin, Kristy-Jane] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2UH, England; [das Nair, Roshan; Sinclair, Emma J.] Nottingham Univ Hosp NHS Trust, Dept Clin Psychol & Neuropsychol, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Trent Doctorate Clin Psychol, Nottingham NG7 2UH, England	das Nair, R (corresponding author), Univ Nottingham, Div Rehabil & Ageing, Sch Med, Queens Med Ctr, B98,B Floor, Nottingham NG7 2UH, England.	Roshan.Nair@nottingham.ac.uk		das Nair, Roshan/0000-0001-8143-7893			Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Banningh LWAJW, 2013, DEMENTIA-LONDON, V12, P81, DOI 10.1177/1471301211420332; Bhaskar R., 2013, CRITICAL REALISM ESS; Brissart H, 2011, REV NEUROL-FRANCE, V167, P280, DOI 10.1016/j.neurol.2010.07.039; Cappa SF, 2005, EUR J NEUROL, V12, P665; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; CASP, 2010, CRIT APPR SKILLS PRO; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; das Nair R. D., 2007, COCHRANE DATABASE SY; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; Dixon-Woods M., 2007, QUAL RES, V7, P375, DOI [DOI 10.1177/1468794107078517, 10.1177/1468794107078517]; Ferguson H., 2012, COCHRANE DATABASE SY, V3; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Gilbert T, 2004, HEALTH SOC CARE COMM, V12, P298, DOI 10.1111/j.1365-2524.2004.00499.x; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; HAMMELL KRW, 1994, INT J REHABIL RES, V17, P319; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; Hoon C, 2013, ORGAN RES METHODS, V16, P522, DOI 10.1177/1094428113484969; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Mitchell A.J., 2007, ADV PSYCHIAT TREATME, V13, P423, DOI [10.1192/apt.bp.106.003202, DOI 10.1192/APT.BP.106.003202]; Montenegro M, 2013, REV NEUROLOGIA, V57, P396, DOI 10.33588/rn.5709.2013047; Moore TF, 2003, NURS SCI QUART, V16, P163, DOI 10.1177/0894318403251793251793; Motl RW, 2009, PSYCHOL HEALTH MED, V14, P111, DOI 10.1080/13548500802241902; National Audit Office, 2005, NAT SERV FRAM LONG T; National Audit Office, 2011, SERV PEOPL NEUR COND; Neurological Alliance, 2003, BRIEF REV NUMB PEOP; Neurological Commissioning Support, 2010, HALFW AR WE HALFW TH; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Noblit G., 1988, META ETHNOGRAPHY SYN; Noyes J., 2008, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9780470712184.CH20, 10.1002/9780470712184.ch20]; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Rao S.M., 1993, NEUROPSYCHOLOGY, V7, P364, DOI [10.1037/0894-4105.7.3.364, DOI 10.1037/0894-4105.7.3.364]; Rapport F, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-54; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Seale C., 2002, QUALITATIVE SOCIAL W, V1, P97, DOI [10.1177/147332500200100107, DOI 10.1177/147332500200100107]; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Spector A, 2011, AGING MENT HEALTH, V15, P945, DOI 10.1080/13607863.2011.586622; Stuifbergen AK, 2012, CLIN REHABIL, V26, P882, DOI 10.1177/0269215511434997; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Thorne S, 2004, QUAL HEALTH RES, V14, P1342, DOI 10.1177/1049732304269888; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilkinson H., 2013, BRIT J NEUROSCIENCE, V9, P172, DOI DOI 10.12968/BJNN.2013.9.4.172; Wilson B., 2002, ESSENTIAL HDB MEMORY; Wilson Barbara A., 2009, MEMORY REHABILITATIO	56	13	13	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 4	2015	25	4					479	502		10.1080/09602011.2014.971820			24	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CK6QJ	WOS:000356352400001	25366270	Green Accepted			2021-06-18	
J	Schober, K; Ondruschka, B; Dressler, J; Abend, M				Schober, K.; Ondruschka, B.; Dressler, J.; Abend, M.			Detection of hypoxia markers in the cerebellum after a traumatic frontal cortex injury: a human postmortem gene expression analysis	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Traumatic brain injury; Human; Post mortem; Gene expression; Biomarker; mRNA; miRNA; IL-6; FOSB; HSPA12B; HSD11B1; miR-138; miR-744; miR-195; miR-324-5p	BRAIN-INJURY; MICRORNA EXPRESSION; RATS; APOPTOSIS; MICROARRAY; MIRBASE; TARGETS; TISSUE; CELLS	The response to traumatic brain injury (TBI) is complex and induces various biological pathways in all brain regions that contribute to bad outcomes. The cerebellar hypoxia after a frontal cortex injury may potentiate the pathophysiological impacts of TBI. Therefore, a gene expression analysis was conducted to determine the influence of hypoxia on TBIs. Total RNA, including microRNAs, was isolated from the cerebellum of individuals who had died from severe frontal cortex injuries or due to natural causes of death (reference group). From a total of 19,596 genes, an average of 59.56 % messenger RNAs (mRNAs) appeared expressed with 42 of them showing significant > 2-fold differences of upregulated (n = 18) and downregulated (n = 24) genes. The validity of 14 candidate genes (with low p values and high fold differences or based on cited literature) was confirmed using qRT-PCR (Spearman correlation r (2) = 0.93). Only four genes appeared to be either upregulated (FOSB and IL6) or downregulated (HSD11B1 and HSPA12B). From a total of 667 microRNAs, altogether, 248 microRNAs appeared expressed with 13 of them showing significant differences in the mean gene expression. The combination of two mRNAs (HSPA12B/FOSB or IL6/HSD11B1) or two microRNAs (either miR-138/miR-744 or miR-195/miR-324-5p) completely discriminated both groups, a finding unaltered by potential confounders such as age at biosampling, survival time, and the postmortem interval. Cerebellar hypoxia markers are important to understand the pathophysiology of TBIs and could be used for therapeutic strategies or forensic purposes, e.g., to assess the severity of a brain injury.	[Schober, K.] German Air Force Ctr Aerosp Med, D-82242 Furstenfeldbruck, Germany; [Ondruschka, B.; Dressler, J.] Univ Leipzig, Inst Legal Med, Fac Med, D-04103 Leipzig, Germany; [Abend, M.] Bundeswehr Inst Radiobiol, D-80937 Munich, Germany	Schober, K (corresponding author), German Air Force Ctr Aerosp Med, Postfach 1264-KFL, D-82242 Furstenfeldbruck, Germany.	kristinschober@bundeswehr.org; Benjamin.Ondruschka@medizin.uni-leipzig.de; Jan.Dressler@medizin.uni-leipzig.de; michaelabend@bundeswehr.org			German Ministry of Defense	We would like to thank Sven Senf for his skillful technical assistance and his very sophisticated introduction into all methodological aspects of the qRT-PCR employed in this study. The German Ministry of Defense supported this work.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Chesnut R M, 1995, New Horiz, V3, P366; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Dressler Jan, 2009, Leg Med (Tokyo), V11 Suppl 1, pS54, DOI 10.1016/j.legalmed.2009.02.024; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hausmann R, 2007, INT J LEGAL MED, V121, P175, DOI 10.1007/s00414-006-0122-x; HEISS WD, 1994, CURR OPIN NEUROL, V7, P11, DOI 10.1097/00019052-199402000-00004; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lidwell K, 2000, J NEUROSCI RES, V62, P427, DOI 10.1002/1097-4547(20001101)62:3<427::AID-JNR13>3.0.CO;2-O; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; PULSINELLI W, 1992, LANCET, V339, P533, DOI 10.1016/0140-6736(92)90347-6; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Wang YX, 2010, J SURG RES, V161, P119, DOI 10.1016/j.jss.2008.10.030; Yau JLW, 2001, P NATL ACAD SCI USA, V98, P4716, DOI 10.1073/pnas.071562698	40	13	14	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2015	129	4					701	707		10.1007/s00414-014-1129-3			7	Medicine, Legal	Legal Medicine	CK8ZW	WOS:000356530000004	25432860	Green Published, Other Gold			2021-06-18	
J	Shen, X; Dutcher, SK; Palmer, J; Liu, XG; Kiptanui, Z; Khokhar, B; Al-Jawadi, MH; Zhu, Y; Zuckerman, IH				Shen, Xian; Dutcher, Sarah K.; Palmer, Jacqueline; Liu, Xinggang; Kiptanui, Zippora; Khokhar, Bilal; Al-Jawadi, Mohammad H.; Zhu, Yue; Zuckerman, Ilene H.			A Systematic Review of the Benefits and Risks of Anticoagulation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							DEEP VENOUS THROMBOSIS; BLUNT CEREBROVASCULAR INJURIES; MOLECULAR-WEIGHT HEPARIN; THROMBOEMBOLISM PROPHYLAXIS; VEIN THROMBOSIS; ENOXAPARIN PROPHYLAXIS; INTRACRANIAL HEMORRHAGE; COMPRESSION DEVICES; SAFETY; HEAD	Objective: To synthesize the existing literature on benefits and risks of anticoagulant use after traumatic brain injury (TBI). Design: Systematic review. A literature search was performed in MEDLINE, International Pharmaceutical Abstracts, Health Star, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) on October 11, 2012, and updated on September 2, 2013, using terms related to TBI and anticoagulants. Main Measures: Human studies evaluating the effects of post-TBI anticoagulation on venous thromboembolism, hemorrhage, mortality, or coagulation parameters with original analyses were eligible for the review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline was followed throughout the conduct of the review. Results: Thirty-nine eligible studies were identified from the literature, of which 23 studies with complete information on post-TBI anticoagulant use and patient outcomes were summarized in this review. Meta-analysis was unwarranted because of varying methodological design and quality of the studies. Twenty-one studies focused on the effects of pharmacological thromboprophylaxis (PTP) post-TBI on venous thromboembolism and/or progression of intracranial hemorrhage, whereas 2 randomized controlled trials analyzed coagulation parameters as the result of anticoagulation. Conclusion: Pharmacological thromboprophylaxis appears to be safe among TBI patients with stabilized hemorrhagic patterns. More evidence is needed regarding effectiveness of PTP in preventing venous thromboembolism as well as preferred agent, dose, and timing for PTP.	[Shen, Xian; Dutcher, Sarah K.; Palmer, Jacqueline; Liu, Xinggang; Kiptanui, Zippora; Khokhar, Bilal; Al-Jawadi, Mohammad H.; Zuckerman, Ilene H.] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Zhu, Yue] Univ Maryland, Dept Surg, Baltimore, MD 21201 USA; [Zuckerman, Ilene H.] IMPAQ Int, Columbia, MD 21044 USA	Zuckerman, IH (corresponding author), IMPAQ Int, 10420 Little Patuxent Pkwy,Suite 300, Columbia, MD 21044 USA.	izuckerman@impaqint.com	Aljawadi, Mohammad H/R-7589-2017	Aljawadi, Mohammad H/0000-0002-5114-1343	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R21 AG042768-01]; NIA Epidemiology of Aging Training Program [2T32AG000262-16]; Ruth L. Kirschstein NRSA predoctoral fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 AG044091]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F31AG044091, T32AG000262, R21AG042768] Funding Source: NIH RePORTER	The project was supported by National Institutes of Health 1 R21 AG042768-01. Bilal R. Khokhar is supported by NIA Epidemiology of Aging Training Program (2T32AG000262-16). Sarah K. Dutcher is supported by a Ruth L. Kirschstein NRSA predoctoral fellowship (F31 AG044091).	Arnold JD, 2010, AM SURGEON, V76, P563; Brandt MM, 2007, AM J SURG, V193, P383; BRATHWAITE CEM, 1993, CHEST, V104, P718, DOI 10.1378/chest.104.3.718; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS32, DOI DOI 10.1089/NEU.2007.9991; Carlile M, 2010, J TRAUMA, V68, P916, DOI 10.1097/TA.0b013e3181b16d2d; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; David M, 2009, INT J SURG, V8, P336; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Depew AJ, 2008, AM SURGEON, V74, P906; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Faul M.D., 2010, TRAUMATIC BRAIN INJU; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Kim KS, 2009, NEUROCRIT CARE, V11, P28, DOI 10.1007/s12028-009-9201-4; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Maxwell RA, 2002, J TRAUMA, V52, P902, DOI 10.1097/00005373-200205000-00013; MEYER CS, 1995, ANN VASC SURG, V9, P109, DOI 10.1007/BF02015324; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Nickele CM, 2013, NEUROCRIT CARE, V18, P184, DOI 10.1007/s12028-012-9786-x; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; O'Brien Sarah H, 2012, J Trauma Nurs, V19, P117, DOI 10.1097/JTN.0b013e31825629c4; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; RADECKI RT, 1994, ARCH PHYS MED REHAB, V75, P248, DOI 10.1016/0003-9993(94)90023-X; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Schweizer M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2743; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Shackford SR, 2004, ANN SURG, V240, P496; Sharma S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-385; Spain DA, 1998, AM SURGEON, V64, P522; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Wahl WL, 2011, J TRAUMA, V71, P399; Zhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058821	56	13	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					E29	E37		10.1097/HTR.0000000000000077			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CM8JB	WOS:000357944800004	24992639	Green Accepted			2021-06-18	
J	Wahab, RA; Neuberger, EJ; Lyeth, BG; Santhakumar, V; Pfister, BJ				Wahab, Radia Abdul; Neuberger, Eric J.; Lyeth, Bruce G.; Santhakumar, Vijayalakshmi; Pfister, Bryan J.			Fluid percussion injury device for the precise control of injury parameters	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain injury; Fluid percussion injury; Injury rate; Injury biomechanics	TRAUMATIC BRAIN-INJURY; ACUTE NEURONAL DEGENERATION; ELASTIC BEHAVIOR; CORTICAL INJURY; AXONAL INJURY; HEAD TRAUMA; WATER MAZE; RAT; MODEL; TISSUE	Background: Injury to the brain can occur from a variety of physical insults and the degree of disability can greatly vary from person to person. It is likely that injury outcome is related to the biomechanical parameters of the traumatic event such as magnitude, direction and speed of the forces acting on the head. New method: To model variations in the biomechanical injury parameters, a voice coil driven fluid percussion injury (FPI) system was designed and built to generate fluid percussion waveforms with adjustable rise times, peak pressures, and durations. Using this system, pathophysiological outcomes in the rat were investigated and compared to animals injured with the same biomechanical parameters using the pendulum based FPI system. Results in comparison with existing methods: Immediate post-injury behavior shows similar rates of seizures and mortality in adolescent rats and similar righting times, toe pinch responses and mortality rates in adult rats. Interestingly, post injury mortality in adult rats was sensitive to changes in injury rate. Fluoro-Jade labeling of degenerating neurons in the hilus and CA2-3 hippocampus were consistent between injuries produced with the voice coil and pendulum operated systems. Granule cell population spike amplitude to afferent activation, a measure of dentate network excitability, also showed consistent enhancement 1 week after injury using either system. Conclusions: Overall our results suggest that this new FPI device produces injury outcomes consistent with the commonly used pendulum FPI system and has the added capability to investigate pathophysiology associated with varying rates and durations of injury. (C) 2015 Elsevier B.V. All rights reserved.	[Wahab, Radia Abdul; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Neuberger, Eric J.; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA	Pfister, BJ (corresponding author), Univ Hts, New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	pfister@njit.edu	Santhakumar, Viji/K-4856-2019; mcDonald, Eric/G-8414-2015	Santhakumar, Viji/0000-0001-6278-4187; Lyeth, Bruce/0000-0003-4811-1474	New Jersey Commission on Brain Injury Research [CBIR11PJT003]	This research was funded by the New Jersey Commission on Brain Injury Research, CBIR11PJT003.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Cater HL, 2005, J BIOMECH; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Faul F., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; King A. I., 2003, IRCOBI C; KINGLIU Y, 1975, J BIOMECH, V8, P285; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; PAMIDI MR, 1978, J BIOMECH ENG-T ASME, V100, P44, DOI 10.1115/1.3426188; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SCHETTINI A, 1988, AM J PHYSIOL, V255, pR799; SCHETTINI A, 1991, AM J PHYSIOL, V260, pR172; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Shulyakov AV, 2011, J MECH BEHAV BIOMED, V4, P484, DOI 10.1016/j.jmbbm.2010.12.012; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; WALSH EK, 1976, AM J PHYSIOL, V230, P1058; WALSH EK, 1977, AM J PHYSIOL, V232, pR27; WANG HC, 1972, J BIOMECH, V5, P431, DOI 10.1016/0021-9290(72)90002-4; Yu JD, 2013, J NEUROPHYSIOL, V109, P1746, DOI 10.1152/jn.00891.2012; Zhang Jiangyue, 2009, Ann Adv Automot Med, V53, P249; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	57	13	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUN 15	2015	248						16	26		10.1016/j.jneumeth.2015.03.010			11	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CI8VA	WOS:000355048600003	25800515	Green Published			2021-06-18	
J	Baker, A; Unsworth, CA; Lannin, NA				Baker, Anne; Unsworth, Carolyn A.; Lannin, Natasha A.			Fitness-to-drive after mild traumatic brain injury: Mapping the time trajectory of recovery in the acute stages post injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Acute care; Fitness-to-drive; Mild traumatic brain injury	HOME MAZE TEST; VALIDITY	Introduction: Little is known about the trajectory of recovery in fitness-to-drive after mild traumatic brain injury (mTBI). This means that health-care professionals have limited evidence on which to base recommendations to this cohort about driving. Objective: To determine fitness-to-drive status of patients with a mTBI at 24 h and two weeks post injury, and to summarise issues reported by this cohort about return to driving. Method: Quasi-experimental case-control design. Two groups of participants were recruited: patients with a mTBI (n = 60) and a control group with orthopaedic injuries (n = 60). Both groups were assessed at 24 h post injury on assessments of fitness-to-drive. Follow-up occurred at two weeks post injury to establish driver status. Main Measures: Mini mental state examination, occupational therapy-drive home maze test (OT-DHMT), Road Law Road Craft Test, University of Queensland-Hazard Perception Test, and demographic/interview form collected at 24 h and at two weeks. Results: At the 24 h assessment, only the OT-DHMT showed a difference in scores between the two groups, with mTBI participants being significantly slower to complete the test (p = 0.01). At the two week follow-up, only 26 of the 60 mTBI participants had returned to driving. Injury severity combined with scores from the 24 h assessment predicted 31% of the variance in time taken to return to driving. Delayed return to driving was reported due to: "not feeling 100% right" (n = 14, 23%), headaches and pain (n = 12, 20%), and dizziness (n=5, 8%). Conclusion: This research supports existing guidelines which suggest that patients with a mTBI should not to drive for 24h; however, further research is required to map factors which facilitate timely return to driving. (C) 2015 Elsevier Ltd. All rights reserved.	[Baker, Anne] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Unsworth, Carolyn A.; Lannin, Natasha A.] La Trobe Univ, Fac Hlth Sci, Bundoora, Vic 3086, Australia; [Unsworth, Carolyn A.] Cent Queensland Univ, Dept Occupat Therapy, Melbourne, Vic, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Sch Hlth Sci, Dept Rehabil, Jonkoping, Sweden; [Unsworth, Carolyn A.] Curtin Univ, Dept Occupat Therapy, Perth, WA 6845, Australia; [Lannin, Natasha A.] Alfred Hlth, Dept Occupat Therapy, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia	Baker, A (corresponding author), Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia.	anne.baker@monash.edu	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345; Unsworth, Carolyn/0000-0001-6430-2823; Baker, Anne/0000-0002-3779-5463	La Trobe University Physical Activity and Rehabilitation Group; La Trobe University Postgraduate Research Scholarship	This study was supported by a grant from the La Trobe University Physical Activity and Rehabilitation Group. Anne Baker was supported by a La Trobe University Postgraduate Research Scholarship.	Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Australian Bureau of Statistics, 2010, TRANSP ROAD SAF; Austroads, 2012, ASS FITN DRIV COMM P; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Baker A, 2015, AUST OCCUP THER J, V62, P50, DOI 10.1111/1440-1630.12172; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Department of Motor Vehicles, 2013, DRIV SAF INF LAPS CO; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Horswill MS, 2008, J GERONTOL B-PSYCHOL, V63, pP212, DOI 10.1093/geronb/63.4.P212; Krishnasamy C, 2012, ACCIDENT ANAL PREV, V49, P274, DOI 10.1016/j.aap.2012.02.019; Krishnasamy C, 2011, CLIN REHABIL, V25, P88, DOI 10.1177/0269215510382846; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore C, 2004, NZ MED J, V117, P1; PORTARE, 2009, HDB DIS DRIV ASS; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Reid M.W., 2014, J NEUROTRAU IN PRESS; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; The Alfred Hospital, 2012, ALFR TRAUM REG; Unsworth C.A., 2005, AUST OCCUP THER J, V52, P57, DOI [10.1111/j.1440, DOI 10.1111/J.1440-1630.2005.00456.X]; Unsworth CA, 2011, OT DORA BATTERY OCCU; Vrkljan BH, 2011, CAN J OCCUP THER, V78, P80, DOI 10.2182/cjot.2011.78.2.3; Wetton MA, 2010, ACCIDENT ANAL PREV, V42, P1232, DOI 10.1016/j.aap.2010.01.017	31	13	13	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUN	2015	79						50	55		10.1016/j.aap.2015.03.014			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CJ2ZF	WOS:000355352500005	25797386				2021-06-18	
J	Douglas, J				Douglas, Jacinta			Elizabeth Usher Memorial Lecture: Placing therapy in the context of the self and social connection	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Speech Pathology Australia National Conference	MAY 18-21, 2014	Melbourne, AUSTRALIA			Brain injury; therapy; social interaction	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INCOG RECOMMENDATIONS; COMMUNICATIVE ABILITY; COMMUNITY INTEGRATION; HEAD-INJURY; FOLLOW-UP; PEOPLE; REHABILITATION; IDENTITY	Background: The concept of self influences the choice of goals and helps to make sense of lives. Essentially, self-concept is a dynamic internal representation of the individual. This representation shapes behaviour and how information about oneself is processed. The self-story is developed and validated through social interactions and shaped continuously through life experiences. Method: The focus of this paper is the client's perspective of self and how one can actively use that perspective to plan therapy, particularly in the case of individuals with acquired brain injury (ABI). The paper draws upon the results of a number of research projects constructed around two primary aims: (1) to represent the perspectives of clients and their close others and (2) to maximize social connection through the delivery of effective communication intervention. Result: A model of self, derived from in-depth qualitative exploration of the experiences of people with ABI, is presented as a framework to guide collaborative therapy. The model depicts the multidimensional and cyclical nature of self-conceptualization supported by factors that facilitate social connection. Conclusion: Communication is crucial to maintaining social ties and communication breakdown is a significant predictor of participation. A new intervention that effectively improves coping with communication breakdown is presented.	[Douglas, Jacinta] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia; [Douglas, Jacinta] Summer Fdn, Blackburn, Vic, Australia	Douglas, J (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia.	j.douglas@latrobe.edu.au		Douglas, Jacinta/0000-0003-0940-6624			Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Campbell JD, 1996, J PERS SOC PSYCHOL, V70, P141, DOI 10.1037/0022-3514.70.1.141; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charmaz K, 2006, CONSTRUCTING GROUNDE; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; *CRAIG HOSP RES DE, 1999, CRAIG HAND ASS REP T; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douglas J., 2014, J INT NEUROPSYCHO S1, V20, P239; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Douglas J., 2010, BRAIN INJURY, V24, P153; Douglas J., 2012, BRAIN IMPAIR, V13, P170; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Douglas JM, 2006, BRAIN IMPAIR, V7, P107, DOI DOI 10.1375/BRIM.7.2.107; Durkheim Emile, 1951, SUICIDE; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Friedman A., 2005, BRAIN INJURY S, V19, P50; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gardner W. L., 2005, SOCIAL OUTCAST OSTRA, P227; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; Jetten J., 2012, SOCIAL CURE IDENTITY; Klein SB, 2010, WIRES COGN SCI, V1, P172, DOI 10.1002/wcs.25; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lin N., 1986, SOCIAL SUPPORT LIFE; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Mackey J., 2007, BRAIN IMPAIR, V8, P207; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Morf C, 2005, SELF IDENTITY, V4, P97; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Muir A., 2007, BRAIN IMPAIR, V8, P83; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ownsworth T., 2014, SELF IDENTITY BRAIN; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Putnam R.D., 2000, BOWLING ALONE COLLAP; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rutledge T, 2008, PSYCHOSOM MED, V70, P282, DOI 10.1097/PSY.0b013e3181656e09; Sabat Ayesha, 2006, S Afr J Commun Disord, V53, P17; Shaddon B., 2008, LIFE STORIES NARRATI; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein KF, 1996, J PSYCHOTHER INTEGR, V6, P349, DOI 10.1037/h0101118; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tate R., 2005, BRAIN IMPAIR, V6, P81; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P235; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	82	13	13	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	JUN	2015	17	3			SI		199	210		10.3109/17549507.2015.1016113			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	CI5LC	WOS:000354796600002	25833073				2021-06-18	
J	Kang, WH; Morrison, B				Kang, Woo Hyeun; Morrison, Barclay, III			Functional tolerance to mechanical deformation developed from organotypic hippocampal slice cultures	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Hippocampus; Tolerance criteria; Electrophysiology; Paired-pulse; In vitro	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; PAIRED-PULSE FACILITATION; DENTATE GYRUS; PROFESSIONAL FOOTBALL; RAT HIPPOCAMPUS; HEAD-INJURY; AREA CA1; IN-VIVO; CONCUSSION	In this study, we measured changes in electrophysiological activity after mechanical deformation of living organotypic hippocampal brain slice cultures at tissue strains and strain rates relevant to traumatic brain injury (TBI). Electrophysiological activity was measured throughout the hippocampus with a 60-electrode microelectrode array. Electrophysiological parameters associated with unstimulated spontaneous activity (neural event firing rate, duration, and magnitude), stimulated evoked responses (the maximum response , the stimulus current necessary for a half-maximal response , and the electrophysiological parameter m that is representative of firing uniformity), and paired-pulse responses (paired-pulse ratio at varying interstimulus intervals) were quantified for each hippocampal region (CA1, CA3, and DG). We present functional tolerance criteria for the hippocampus in the form of mathematical relationships between the input tissue-level injury parameters (strain and strain rate) and altered neuronal network function. Most changes in electrophysiology were dependent on strain and strain rate in a complex fashion, independent of hippocampal anatomy, with the notable exception of . Until it becomes possible to directly measure brain tissue deformation in vivo, finite element (FE) models will be necessary to simulate and predict the in vivo consequences of TBI. One application of our study is to provide functional relationships that can be incorporated into these FE models to enhance their biofidelity of accident and collision reconstructions by predicting biological outcomes in addition to mechanical responses.	[Kang, Woo Hyeun; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Highway Traffic Safety Administration [DTNH22-08-C-00088]; Multidisciplinary University Research Initiative from the Army Research Office [W911MF-10-1-0526]	The authors would like to thank Shruthi Nammalwar for assisting in preparing and maintaining slice cultures and Chaitanya Rastogi for help with statistical analysis and fitting the raw data. Funding for this research was provided by the National Highway Traffic Safety Administration (DTNH22-08-C-00088) and by a Multidisciplinary University Research Initiative from the Army Research Office (W911MF-10-1-0526).	Akaike H, 1973, P 2 INTERNTERNATIONA, P267, DOI 10.1007/978-1-4612-1694-0; Allen M.P., 1997, UNDERSTANDING REGRES; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Burnham K. P., 2002, MODEL SELECTION INFE; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Commins S, 1998, NEUROREPORT, V9, P4109, DOI 10.1097/00001756-199812210-00019; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; DISCENNA PG, 1994, HIPPOCAMPUS, V4, P569, DOI 10.1002/hipo.450040506; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Egert U, 2005, PRACTICAL METHODS IN CARDIOVASCULAR RESEARCH, P432, DOI 10.1007/3-540-26574-0_22; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Exo J, 2009, Ped Health, V3, P533, DOI 10.2217/phe.09.54; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fueta Y, 1998, BRAIN RES, V779, P324, DOI 10.1016/S0006-8993(97)01214-6; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Guo Y, 2008, HUM BRAIN MAPP, V29, P1092, DOI 10.1002/hbm.20450; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Ji K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/627325; JOY RM, 1993, BRAIN RES, V604, P273, DOI 10.1016/0006-8993(93)90379-2; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; KETTENMANN H, 1993, GLIA, V7, P93, DOI 10.1002/glia.440070115; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lea PM, 2002, PHARMACOL BIOCHEM BE, V73, P287, DOI 10.1016/S0091-3057(02)00825-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Maugineanu DG, 2000, BRAIN RES BULL, V51, P69, DOI 10.1016/S0361-9230(99)00209-9; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Moss WC, 2014, COMPUT METHOD BIOMEC, V17, P1173, DOI 10.1080/10255842.2012.739162; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Navarrete M, 2013, CEREB CORTEX, V23, P1240, DOI 10.1093/cercor/bhs122; Nirula R, 2004, J TRAUMA, V57, P779, DOI 10.1097/01.TA.0000106506.34691.B6; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Ommaya AK., 1967, SAE TECHNICAL PAPERS; Ounpraseuth Songthip, 2012, BMC Res Notes, V5, P656, DOI 10.1186/1756-0500-5-656; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Savanthrapadian S, 2013, HIPPOCAMPUS, V23, P1395, DOI 10.1002/hipo.22193; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Sloviter R S, 1991, Hippocampus, V1, P31, DOI 10.1002/hipo.450010105; STANFORD IM, 1995, EUR J PHARMACOL, V277, P229, DOI 10.1016/0014-2999(95)00083-W; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viskontas IV, 2006, J COGNITIVE NEUROSCI, V18, P1654, DOI 10.1162/jocn.2006.18.10.1654; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	92	13	13	0	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2015	14	3					561	575		10.1007/s10237-014-0622-4			15	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CI0ED	WOS:000354408100009	25236799				2021-06-18	
J	Knutson, KM; Dal Monte, O; Schintu, S; Wassermann, EM; Raymont, V; Grafman, J; Krueger, F				Knutson, Kristine M.; Dal Monte, Olga; Schintu, Selene; Wassermann, Eric M.; Raymont, Vanessa; Grafman, Jordan; Krueger, Frank			Areas of Brain Damage Underlying Increased Reports of Behavioral Disinhibition	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							FRONTAL-LOBE DAMAGE; VOXEL-BASED LESION; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; INHIBITION; CORTEX; APATHY; SELF; DEGENERATION; INTELLIGENCE	Disinhibition, the inability to inhibit inappropriate behavior, is seen in frontal-temporal degeneration, Alzheimer's disease, and stroke. Behavioral disinhibition leads to social and emotional impairments, including impulsive behavior and disregard for social conventions. The authors investigated the effects of lesions on behavioral disinhibition measured by the Neuropsychiatric Inventory in 177 veterans with traumatic brain injuries. The authors performed voxel-based lesion-symptom mapping using MEDx. Damage in the frontal and temporal lobes, gyrus rectus, and insula was associated with greater behavioral disinhibition, providing further evidence of the frontal lobe's involvement in behavioral inhibition and suggesting that these regions are necessary to inhibit improper behavior.	[Knutson, Kristine M.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bethesda, MD 20892 USA; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy; [Schintu, Selene] INSERM, CNRS, Lyon Neurosci Res Ctr, ImpAct Team,U1028,UMR5292, F-69008 Lyon, France; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Sch Med, Dept Phys Med & Rehabil Psychiat & Behav Sci & Co, Chicago, IL USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Krueger, F (corresponding author), George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA.	jgrafman@northwestern.edu; fkrueger@gmu.edu	Dal Monte, Olga/P-3759-2018; Schintu, Selene/ABF-7032-2020; Wassermann, Eric M./AAC-9064-2020	Dal Monte, Olga/0000-0002-7823-4769; Schintu, Selene/0000-0002-6362-3905; Wassermann, Eric M./0000-0003-0628-0210	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]; National Naval Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER	This work was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program, and a project grant from the U.S. Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Grant DAMD17-01-1-0675). The authors thank the Vietnam War veterans who participated in this study; the National Naval Medical Center for support and provision of their facilities; and S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for invaluable help with the testing of participants and organization of this study.	Anderson ND, 2011, J COGNITIVE NEUROSCI, V23, P3804, DOI 10.1162/jocn_a_00050; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cohen J. R., 2010, SELF CONTROL SOC MIN, V9, P141, DOI DOI 10.1093/ACPROF:OSO/9780195391381.003.0008; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Dillon DG, 2007, APPL PREV PSYCHOL, V12, P99, DOI 10.1016/j.appsy.2007.09.004; Dimitrov M, 2003, BRAIN COGNITION, V52, P258, DOI 10.1016/S0278-2626(03)00080-0; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; First MB., 2002, STRUCTURED CLIN INTE; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Harnishfeger KK, 1995, DEV COGNITIVE INHIBI, P175; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Heflin LH, 2011, NEUROPSYCHOLOGY, V25, P655, DOI 10.1037/a0023863; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Jurado MA, 1998, J CLIN EXP NEUROPSYC, V20, P353, DOI 10.1076/jcen.20.3.353.816; Krueger CE, 2011, NEUROPSYCHOLOGY, V25, P249, DOI 10.1037/a0021681; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Litvan I, 1998, J NEUROL NEUROSUR PS, V65, P717, DOI 10.1136/jnnp.65.5.717; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; Mayer JD., 2002, MAYER SALOVEY CARUSO; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; Mehrabian A., 1996, MANUAL BALANCED EMOT; Muraven M, 2006, J PERS SOC PSYCHOL, V91, P524, DOI 10.1037/0022-3514.91.3.524; Perri R, 2014, J ALZHEIMERS DIS, V39, P669, DOI 10.3233/JAD-131337; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Schintu S, 2014, CORTEX, V57, P244, DOI 10.1016/j.cortex.2014.04.009; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Szatkowska I, 2007, EXP BRAIN RES, V181, P109, DOI 10.1007/s00221-007-0906-3; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95; 1997, WECHSLER ADULT INTEL	48	13	13	0	11	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2015	27	3					193	198		10.1176/appi.neuropsych.14060126			6	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CR7LK	WOS:000361531000013	25959040	Green Accepted, Bronze			2021-06-18	
J	Park, HY; Maitra, K; Martinez, KM				Park, Hae Yean; Maitra, Kinsuk; Martinez, Kristina Marie			The Effect of Occupation-based Cognitive Rehabilitation for Traumatic Brain Injury: A Meta-analysis of Randomized Controlled Trials	OCCUPATIONAL THERAPY INTERNATIONAL			English	Article						occupation-based cognitive rehabilitation; meta-analysis; RCT; traumatic brain injury	LOW-BIRTH-WEIGHT; QUALITY-OF-LIFE; SELF-AWARENESS; IMPROVE; LONG; NEUROMUSCULOSKELETAL; INTERVENTION; IMPAIRMENT; MANAGEMENT; DIFFICULTY	Traumatic brain injury (TBI) is the leading cause of death and disability among people younger than 35 years in the United States. Cognitive difficulty is a common consequence of TBI. To address cognitive deficits of patients with TBI, various cognitive rehabilitation approaches have been used for the clinical setting. The purpose of this study was to investigate the overall effect of occupation-based cognitive rehabilitation on patients' improvement in cognitive performance components, activity of daily living (ADL) performance, and values, beliefs and spirituality functions of patients with TBI. The papers used in this study were retrieved from the Cochrane Database, EBSCO (CINAHL), PsycINFO, PubMed and Web of Science published between 1997 and 2014. The keywords for searching were cognitive, rehabilitation, occupation, memory, attention, problem-solving, executive function, ADL, values, beliefs, spirituality, randomized controlled trials and TBI. For the meta-analysis, we examined 60 effect sizes from nine studies that are related to the occupation-based cognitive rehabilitation on persons with TBI. In persons with TBI, overall mental functions, ADL, and values, beliefs and spirituality were significantly improved in the groups that received occupation-based cognitive rehabilitation compared with comparison groups (mean d=0.19, p<.05). Evidence from the present meta-analytic study suggests that occupation-based cognitive rehabilitation would be beneficial for individuals with TBI for improving daily functioning and positively be able to affect their psychosocial functions. Collecting many outcome measures in studies with relatively few participants and the final data are less reliable than the whole instrument itself. Future research should evaluate the effectiveness of specific occupation-based cognitive rehabilitations programmes in order to improve consistency among rehabilitation providers. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Park, Hae Yean; Maitra, Kinsuk] Florida Int Univ, Occupat Therapy, Miami, FL 33199 USA; [Park, Hae Yean] Yonsei Univ, Occupat Therapy, Wonju 220710, Gangwon Do, South Korea; [Martinez, Kristina Marie] James A Haley Vet Hosp, DVBIC, Tampa, FL 33637 USA	Maitra, K (corresponding author), Florida Int Univ, Occupat Therapy, 11200 SW 8th St,AHC 3,443, Miami, FL 33199 USA.	kmaitra@fiu.edu	Maitra, Kinsuk/AAE-4630-2021				AMERICAN OCCUPATIONAL THERAPY ASSOCIATION-AOTA, 2008, AM J OCCUPATIONAL S1, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.2014.682006]; Baum C. M., 2010, NEUROPSYCHOLOGY EVER, P63; Baum M.C., 2005, OCCUPATIONAL THERAPY, V3rd ed., P242, DOI [10.1080/07380570802555117, DOI 10.1080/07380570802555117]; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Borenstein M, 2011, INTRO META ANAL; Bovend'Eerdt TJ, 2010, ARCH PHYS MED REHAB, V91, P939, DOI 10.1016/j.apmr.2010.03.008; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chochinov H.M., 2005, J PALLIAT MED, V8, DOI [https://doi.org/10.1089/jpm.2005.8.s-103, DOI 10.1089/JPM.2005.8.S-103]; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Finset A, 2000, BRAIN INJURY, V14, P887; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hall JR, 2011, INT J ALZHEIMERS DIS, V2011, P189; Hemayattalab R, 2010, RES DEV DISABIL, V31, P81, DOI 10.1016/j.ridd.2009.07.022; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; KALIVAS PW, 1993, LIMBIC MOTOR CIRCUIT; Kaye P, 2006, NOTES SYMPTOM CONTRO; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Lieberman D, 2002, AM J OCCUP THER, V56, P344, DOI 10.5014/ajot.56.3.344; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Maitra K, 2014, AM J OCCUP THER, V68, P140, DOI 10.5014/ajot.2014.009985; Marin R.S., 1996, SEMIN CLIN NEUROPSYC, V1, P304, DOI [10.1053/SCNP00100304, DOI 10.1053/SCNP00100304]; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Page SJ, 2012, APHASIOLOGY, V26, P127, DOI 10.1080/02687038.2011.636027; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Park HY, 2014, AM J OCCUP THER, V68, P268, DOI 10.5014/ajot.2014.010371; Perneczky R, 2006, AGE AGEING, V35, P240, DOI 10.1093/ageing/afj054; Prince-Paul M, 2008, J PALLIAT MED, V11, P20, DOI 10.1089/jpm.2007.0119; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; REBEIRO KL, 1998, CANADIAN J OCCUPATIO, V65, P12, DOI DOI 10.1177/000841749806500102.; Rechetinikov RP, 2009, AM J OCCUP THER, V63, P255, DOI 10.5014/ajot.63.3.255; ROSENTHAL R, 1982, PSYCHOL BULL, V92, P500, DOI 10.1037/0033-2909.92.2.500; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Schaefer A, 2007, REV NEUROSCIENCE, V18, P355; SIMES RJ, 1987, STAT MED, V6, P11, DOI 10.1002/sim.4780060104; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stein F., 2002, PSYCHOSOCIAL OCCUPAT; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson PH, 1998, J CHILD PSYCHOL PSYC, V39, P829, DOI 10.1111/1469-7610.00384; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	65	13	14	0	35	WILEY-HINDAWI	LONDON	ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND	0966-7903	1557-0703		OCCUP THER INT	Occup. Ther. Int.	JUN	2015	22	2					104	116		10.1002/oti.1389			13	Rehabilitation	Rehabilitation	CP7TB	WOS:000360089900006	25808426				2021-06-18	
J	Ramesh, D; Keyser-Marcus, LA; Ma, L; Schmitz, JM; Lane, SD; Marwitz, JH; Kreutzer, JS; Moeller, FG				Ramesh, Divya; Keyser-Marcus, Lori A.; Ma, Liangsuo; Schmitz, Joy M.; Lane, Scott D.; Marwitz, Jennifer H.; Kreutzer, Jeffrey S.; Moeller, Frederick Gerard			Prevalence of Traumatic Brain Injury in Cocaine-Dependent Research Volunteers	AMERICAN JOURNAL ON ADDICTIONS			English	Article							SUBSTANCE-ABUSE; DECISION-MAKING; HEAD-INJURY; IMPULSIVITY; DISORDER; PREDICTION; HISTORY; UPDATE; RISK	BackgroundThere is a high prevalence of traumatic brain injury (TBI) among those with substance dependence. However, TBI often remains undiagnosed in these individuals, due to lack of routine screening in substance use treatment settings or due to overlap in some of the cognitive sequelae (eg impulsivity, disinhibition) of TBI and cocaine dependence. MethodsThe prevalence of self-reported mild to moderate TBI in a group of cocaine-dependent (n=95) and a group of healthy volunteers (n=75) enrolled at the same facility was assessed. Additionally, the relationship between TBI and clinically relevant correlates, including impulsivity, cocaine use history, and treatment outcome in the cocaine-dependent group was also examined. ResultsA higher proportion of individuals with cocaine dependence (29.5%) reported having suffered a TBI in their lifetime compared to controls (8%) on a Closed Head Injury scale. Among cocaine users, the average age of sustaining TBI was significantly lower than the age of initiating cocaine use. Presence of TBI was not associated with higher impulsivity on the Barratt Impulsiveness Scale-11 or self-reported years of cocaine use. No differences were noted on treatment outcome for cocaine dependence as measured by treatment effectiveness scores (TES) between cocaine users with TBI and their non-TBI counterparts. ConclusionsThese results are the first to highlight the high prevalence of TBI among individuals with cocaine dependence. This study underscores the possible role of TBI history as a risk factor for onset of cocaine use, however, more research is needed to determine the impact of co-morbid TBI as a complicating factor in the substance abuse treatment setting. (Am J Addict 2015;XX:XX-XX)	[Ramesh, Divya; Moeller, Frederick Gerard] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA 23219 USA; [Keyser-Marcus, Lori A.; Moeller, Frederick Gerard] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23219 USA; [Ramesh, Divya; Keyser-Marcus, Lori A.; Ma, Liangsuo; Moeller, Frederick Gerard] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23219 USA; [Schmitz, Joy M.; Lane, Scott D.] Univ Texas Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Marwitz, Jennifer H.; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23219 USA	Ramesh, D (corresponding author), Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Dept Pharmacol & Toxicol, 203 East Cary St,Suite 202, Richmond, VA 23219 USA.	rameshd@vcu.edu		Schmitz, Joy/0000-0002-3561-4614	NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P50DA009262]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA009262, R01DA034131, U54DA038999] Funding Source: NIH RePORTER	This research was supported by NIDA grant P50DA009262 (PI. Moeller, Schmitz). The authors would like to acknowledge the technical assistance of Edward A. Zuniga, Nuvan Rathnayaka, and Zarha Kamdar.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI 10.1089/neu.2008-0849; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; First M., 2002, STRUCTURED CLIN INTE; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Levin FR, 1998, DRUG ALCOHOL DEPEN, V52, P15, DOI 10.1016/S0376-8716(98)00049-0; Lindsay JA, 2009, AM J DRUG ALCOHOL AB, V35, P193, DOI 10.1080/00952990902933860; Ling W, 1997, NIDA Res Monogr, V175, P208; Ling W, 1994, NIDA RES MONOGR, V153, P495; Liu SJ, 2011, AM J DRUG ALCOHOL AB, V37, P117, DOI 10.3109/00952990.2010.543204; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Moeller FG, 2002, DRUG ALCOHOL DEPEN, V68, P105; Moeller FG, 2004, NEUROPSYCHOBIOLOGY, V50, P167, DOI 10.1159/000079110; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Report to Congress on Mild Traumatic Brain Injury in the United States, 2003, REP C MILD TRAUM BRA; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Sofuoglu M, 2003, AM J DRUG ALCOHOL AB, V29, P713, DOI 10.1081/ADA-120026256; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Winhusen T, 2013, J SUBST ABUSE TREAT, V44, P541, DOI 10.1016/j.jsat.2012.12.005; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X	37	13	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1055-0496	1521-0391		AM J ADDICTION	Am. J. Addict.	JUN	2015	24	4					341	347		10.1111/ajad.12192			7	Substance Abuse	Substance Abuse	CH6YT	WOS:000354183200010	25662909	Green Accepted			2021-06-18	
J	Schmidt, AT; Li, XQ; Hanten, GR; McCauley, SR; Faber, J; Levin, HS				Schmidt, Adam T.; Li, Xiaoqi; Hanten, Gerri R.; McCauley, Stephen R.; Faber, Jessica; Levin, Harvey S.			A Longitudinal Investigation of Sleep Quality in Adolescents and Young Adults After Mild Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						mild traumatic brain injury; sleep; Pittsburgh Sleep Quality Index; adolescents; young adults	RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS-DISORDER; IDENTIFICATION TEST AUDIT; ABUSE SCREENING-TEST; PRACTICAL SCALE; RISK-FACTORS; INSOMNIA; DISTURBANCE; INDEX; SYMPTOMS	Objective and Background:We examined sleep-related problems in adolescents and young adults after a mild traumatic brain injury (MTBI) or orthopedic injury. We extended the analysis of data from a study of early emotional and neuropsychological sequelae in these populations (McCauley et al. 2014. J Neurotrauma. 31:914).Methods:We gave the Pittsburgh Sleep Quality Index to 77 participants with MTBI, 71 with orthopedic injury, and 43 non-injured controls. The age range was 12 to 30 years. We tested sleep quality within 96 hours of injury and at 1- and 3-month follow-up. Participants also completed measures of pain and fatigue, drug and alcohol use, and post-traumatic stress symptoms.Results:Older participants (mean age=25 years) in the MTBI group exhibited a sharp increase in sleep-related symptoms between the baseline assessment and 1 month, and still had difficulties at 3 months. Younger participants with MTBI (mean age=15 years) and older participants with an orthopedic injury had modest increases in sleep difficulties between baseline and 1 month. The participants with MTBI also had more clinically significant sleep difficulties at all 3 assessments. At 3 months, Pittsburgh Sleep Quality Index scores in younger participants with MTBI and all participants with orthopedic injury did not differ significantly from the non-injured controls'. The controls had no significant change in their sleep symptoms during the 3 months.Conclusions:Sleep difficulties in young adults may persist for 3 months after MTBI and exceed those after orthopedic injury. Clinicians should seek and treat sleep-related problems after MTBI.	[Schmidt, Adam T.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77340 USA; [Li, Xiaoqi; Hanten, Gerri R.; McCauley, Stephen R.; Faber, Jessica; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Hanten, Gerri R.] Rice Univ, Dept Psychol, Houston, TX 77251 USA	Schmidt, AT (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, Campus Box 2447, Huntsville, TX 77340 USA.	ats1978@gmail.com			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 P01 NS056202]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202] Funding Source: NIH RePORTER	Supported in part by National Institute of Neurological Disorders and Stroke Grant 5 P01 NS056202 (H.S.L.).	Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dewald-Kaufmann JF, 2014, J CHILD PSYCHOL PSYC, V55, P273, DOI 10.1111/jcpp.12157; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fichtenberg NL, 2012, BRAIN INJURY, V16, P197; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Geng FL, 2013, J CLIN PSYCHIAT, V74, P69, DOI 10.4088/JCP.12m07872; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lallukka T, 2012, SLEEP MED, V13, P680, DOI 10.1016/j.sleep.2011.10.036; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lunsford-Avery JR, 2013, SCHIZOPHR RES, V151, P148, DOI 10.1016/j.schres.2013.09.015; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Megdal SP, 2007, SLEEP MED, V9, P60, DOI 10.1016/j.sleep.2007.01.012; Moos RH, 1994, LISRES A LIFE STRESS; Morgan K, 2003, BRIT J GEN PRACT, V53, P923; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Petersen H, 2013, J SLEEP RES, V22, P50, DOI 10.1111/j.1365-2869.2012.01034.x; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; Martinez MP, 2014, J BEHAV MED, V37, P683, DOI 10.1007/s10865-013-9520-y; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Tan E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-189; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	51	13	13	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	JUN	2015	28	2					53	62		10.1097/WNN.0000000000000056			10	Behavioral Sciences; Clinical Neurology	Behavioral Sciences; Neurosciences & Neurology	CL9RQ	WOS:000357316200003	26102995	Green Accepted			2021-06-18	
J	Shrivats, AR; Hsu, E; Averick, S; Klimak, M; Watt, ACS; DeMaio, M; Matyjaszewski, K; Hollinger, JO				Shrivats, Arun R.; Hsu, Eric; Averick, Saadyah; Klimak, Molly; Watt, April C. S.; DeMaio, Marlene; Matyjaszewski, Krzysztof; Hollinger, Jeffrey O.			Cationic Nanogel-mediated Runx2 and Osterix siRNA Delivery Decreases Mineralization in MC3T3 Cells	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							TRANSFER RADICAL POLYMERIZATION; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; HETEROTOPIC OSSIFICATION; TRANSCRIPTIONAL REGULATION; RISK-FACTORS; RADIATION PROPHYLAXIS; EARLY EXCISION; BONE-FORMATION	Heterotopic ossification (HO) may occur after musculoskeletal trauma, traumatic brain injury, and total joint arthroplasty. As such, HO is a compelling clinical concern in both military and civilian medicine. A possible etiology of HO involves dysregulated signals in the bone morphogenetic protein osteogenic cascade. Contemporary treatment options for HO (ie, nonsteroidal antiinflammatory drugs and radiation therapy) have adverse effects associated with their use and are not biologically engineered to abrogate the molecular mechanisms that govern osteogenic differentiation. We hypothesized that (1) nanogel-mediated short interfering RNA (siRNA) delivery against Runt-related transcription factor 2 (Runx2) and osterix (Osx) genes will decrease messenger RNA expression; (2) inhibit activity of the osteogenic marker alkaline phosphatase (ALP); and (3) inhibit hydroxyapatite (HA) deposition in osteoblast cell cultures. Nanogel nanostructured polymers delivered siRNA in 48-hour treatment cycles against master osteogenic regulators, Runx2 and Osx, in murine calvarial preosteoblasts (MC3T3-E1.4) stimulated for osteogenic differentiation by recombinant human bone morphogenetic protein (rhBMP-2). The efficacy of RNA interference (RNAi) therapeutics was determined by quantitation of messenger RNA knockdown (by quantitative reverse transcription-polymerase chain reaction), downstream protein knockdown (determined ALP enzymatic activity assay), and HA deposition (determined by OsteoImage (TM) assay). Gene expression assays demonstrated that nanogel-based RNAi treatments at 1:1 and 5:1 nanogel:short interfering RNA weight ratios reduced Runx2 expression by 48.59% +/- A 19.53% (p < 0.001) and 43.22% +/- A 18.01% (both p < 0.001). The same 1:1 and 5:1 treatments against both Runx2 and Osx reduced expression of Osx by 51.65% +/- A 10.85% and 47.65% +/- A 9.80% (both p < 0.001). Moreover, repeated 48-hour RNAi treatment cycles against Runx2 and Osx rhBMP-2 administration reduced ALP activity after 4 and 7 days. ALP reductions after 4 days in culture by nanogel 5:1 and 10:1 RNAi treatments were 32.4% +/- A 12.0% and 33.6% +/- A 13.8% (both p < 0.001). After 7 days in culture, nanogel 1:1 and 5:1 RNAi treatments produced 35.9% +/- A 14.0% and 47.7% +/- A 3.2% reductions in ALP activity. Osteoblast mineralization data after 21 days suggested that nanogel 1:1, 5:1, and 10:1 RNAi treatments decreased mineralization (ie, HA deposition) from cultures treated only with rhBMP-2 (p < 0.001). However, despite RNAi attack on Runx2 and Osx, HA deposition levels remained greater than non-rhBMP-2-treated cell cultures. Although mRNA and protein knockdown were confirmed as a result of RNAi treatments against Runx2 and Osx, complete elimination of mineralization processes was not achieved. RNAi targeting mid- and late-stage osteoblast differentiation markers such as ALP, osteocalcin, osteopontin, and bone sialoprotein) may produce the desired RNAi-nanogel nanostructured polymer HO prophylaxis. Successful HO prophylaxis should target and silence osteogenic markers critical for heterotopic bone formation processes. The identification of such markers, beyond RUNX2 and OSX, may enhance the effectiveness of RNAi prophylaxes for HO.	[Shrivats, Arun R.; Hsu, Eric; Klimak, Molly; Watt, April C. S.; Hollinger, Jeffrey O.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15219 USA; [Averick, Saadyah; Matyjaszewski, Krzysztof] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [DeMaio, Marlene] Naval Med Ctr Portsmouth, Dept Orthopaed Surg, Portsmouth, VA 23708 USA	Hollinger, JO (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, 700 Technol Dr, Pittsburgh, PA 15219 USA.	hollinge@cs.cmu.edu	Averick, Saadyah/A-9999-2015; Matyjaszewski, Krzysztof/A-2508-2008	Averick, Saadyah/0000-0003-4775-2317; Matyjaszewski, Krzysztof/0000-0003-1960-3402	DoD - Defense Medical Research and Development Program [W81XWH1120073, DMR09-69301]	Two of the authors (ARS, EH) contributed equally. All institutions in this study, during the study period, received funding from DoD Grant W81XWH1120073, which was awarded by the Defense Medical Research and Development Program, and DMR09-69301.	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Arikawa T, 2004, J CELL PHYSIOL, V200, P400, DOI 10.1002/jcp.20031; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Averick S, 2012, ACS MACRO LETT, V1, P6, DOI 10.1021/mz200020c; Averick SE, 2012, BIOMACROMOLECULES, V13, P3445, DOI 10.1021/bm301166s; Bal BS, 2010, J ARTHROPLASTY, V25, P538, DOI 10.1016/j.arth.2009.04.019; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BROOKE MM, 1991, ARCH PHYS MED REHAB, V72, P425; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351; Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703; Farris MK, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-140; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Gersbach CA, 2004, EXP CELL RES, V300, P406, DOI 10.1016/j.yexcr.2004.07.031; Gurkan UA, 2010, TISSUE ENG PT A, V16, P2295, DOI [10.1089/ten.tea.2009.0565, 10.1089/ten.TEA.2009.0565]; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Haversath M, 2012, CAN J PHYSIOL PHARM, V90, P1434, DOI 10.1139/y2012-123; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hsu EW, 2014, J BIOMED NANOTECHNOL, V10, P1130, DOI 10.1166/jbn.2014.1823; Huang WB, 2004, BONE, V34, P799, DOI 10.1016/j.bone.2003.11.027; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Kan LX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/309287; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Lin L, 2006, BIOCHEM BIOPH RES CO, V349, P564, DOI 10.1016/j.bbrc.2006.08.089; Matyjaszewski K, 2014, J AM CHEM SOC, V136, P6513, DOI 10.1021/ja408069v; Matyjaszewski K, 2012, MACROMOLECULES, V45, P4015, DOI 10.1021/ma3001719; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; McCarthy TL, 2003, J BIOL CHEM, V278, P43121, DOI 10.1074/jbc.M306531200; Medina A, 2014, J BURN CARE RES, V35, P251, DOI 10.1097/BCR.0b013e3182957768; Melcer T, 2011, J REHABIL RES DEV, V48, P1, DOI 10.1682/JRRD.2010.03.0033; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Mishra S, 2012, INTEGR BIOL-UK, V4, P1498, DOI 10.1039/c2ib20200j; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Oh JK, 2006, J AM CHEM SOC, V128, P5578, DOI 10.1021/ja060586a; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Oh JK, 2007, BIOMACROMOLECULES, V8, P3326, DOI 10.1021/bm070381+; Oh JK, 2007, J AM CHEM SOC, V129, P5939, DOI 10.1021/ja069150l; Oh JK, 2009, POLYMER, V50, P4407, DOI 10.1016/j.polymer.2009.06.045; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS191; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217; Seegenschmiedt MH, 2001, INT J RADIAT ONCOL, V51, P756, DOI 10.1016/S0360-3016(01)01640-6; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550; Shehab D, 2002, J NUCL MED, V43, P346; Shrivats A. R., 2013, BIOMIMETICS STEM CEL; Shrivats AR, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1201, DOI 10.1016/B978-0-12-398358-9.00055-0; Simakova A, 2012, MACROMOLECULES, V45, P6371, DOI 10.1021/ma301303b; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhu B, 2011, J TISSUE ENG REGEN M	70	13	15	0	32	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUN	2015	473	6					2139	2149		10.1007/s11999-014-4073-0			11	Orthopedics; Surgery	Orthopedics; Surgery	CH6FX	WOS:000354133000043	25448327	Green Published, Bronze			2021-06-18	
J	Shumway-Cook, A; Matsuda, PN; Taylor, C				Shumway-Cook, Anne; Matsuda, Patricia Noritake; Taylor, Catherine			Investigating the Validity of the Environmental Framework Underlying the Original and Modified Dynamic Gait Index	PHYSICAL THERAPY			English	Article								Background. The modified Dynamic Gait Index (mDGD, developed from a person-environment model of mobility disability, measures mobility function relative to specific environmental demands. The framework for interpreting mDGI scores relative to specific environmental dimensions has not been investigated. Objective. The aim of this study was to examine the person-environmental model underlying the development and interpretation of mDGI scores. Design. This was a cross-sectional, descriptive study. Methods. There were 794 participants in the study, Including 140 controls. Out of the total study population, 239 had sustained a stroke, 140 had vestibular dysfunction, 100 had sustained a traumatic brain injury, 91 had gait abnormality, and 84 had Parkinson disease. Exploratory factor analysis was used to investigate whether mDGI scores supported the 4 environmental dimensions. Results. Factor analysis showed that, with some exceptions, tasks loaded on 4 underlying factors, partially supporting the underlying environmental model. Limitations. Limitations of this study included the uneven sample sizes in the 6 groups. Conclusions. Support for the environmental framework underlying the mDGI extends its usefulness as a clinical measure of functional mobility by providing a rationale for interpretation of scores that can be used to direct treatment and infer change in mobility function.	[Shumway-Cook, Anne; Matsuda, Patricia Noritake] Univ Washington, Dept Rehabil Med, Div Phys Therapy, Seattle, WA 98195 USA; [Taylor, Catherine] Univ Washington, Coll Educ, Seattle, WA 98195 USA	Shumway-Cook, A (corresponding author), Univ Washington, Dept Rehabil Med, Div Phys Therapy, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA.	ashumway@uw.edu	Matsuda, Patricia/T-3606-2019		Walter C. and Anita Stolov Research Fund, Department of Rehabilitation Medicine, University of Washington	This study was supported by a grant from the Walter C. and Anita Stolov Research Fund, Department of Rehabilitation Medicine, University of Washington.	Dye DC, 2013, PHYS THER, V93, P809, DOI 10.2522/ptj.20120163; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; Matsuda PN, 2014, PHYS THER, V94, P996, DOI 10.2522/ptj.20130294; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; Pett M., 2003, MAKING SENSE FACTOR; Portney L. G., 2008, FDN CLIN RES APPL PR, V3rd; Shumway-Cook A, 2002, PHYS THER, V82, P670, DOI 10.1093/ptj/82.7.670; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL; Shumway-Cook A, 2013, PHYS THER, V93, P1493, DOI 10.2522/ptj.20130035; World Health Organization, 2014, INT CLASS DIS ICD 10; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0	11	13	13	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUN	2015	95	6					864	870		10.2522/ptj.20140047			7	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	CJ3MQ	WOS:000355388500005	25524870				2021-06-18	
J	Vasterling, JJ; Proctor, SP; Aslan, M; Ko, J; Jakupcak, M; Harte, CB; Marx, BP; Concato, J				Vasterling, Jennifer J.; Proctor, Susan P.; Aslan, Mihaela; Ko, John; Jakupcak, Matthew; Harte, Christopher B.; Marx, Brian P.; Concato, John			Military, Demographic, and Psychosocial Predictors of Military Retention in Enlisted Army Soldiers 12 Months After Deployment to Iraq	MILITARY MEDICINE			English	Article							NATIONAL-GUARD SOLDIERS; HEALTH-CARE UTILIZATION; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; US MILITARY; PTSD SYMPTOMS; UNIT COHESION; ATTRITION; AFGHANISTAN; VETERANS	Objective: To examine military, demographic, and psychosocial predictors of military retention following operational deployment. Methods: Military status 12 months following return from Iraq deployment was assessed via service records in 740 regular active duty Army Soldiers. Potential predictors of military retention were derived from prospectively administered in-person interviews and questionnaires conducted within 3 months following return from Iraq. Results: At 12 months following return from deployment, 18.1% (n = 134) of the sample had separated from military service. Cox proportional hazards analyses, adjusting for demographic, military, and psychosocial predictors, identified several factors that were independently associated with military attrition: less than (vs. equal to or more than) 6 years military experience (hazards ratio [HR], 3.98; 95% CI, 2.12-7.45); unmarried (vs. married) status (HR, 1.51; 95% CI, 1.06-2.16); and lower (vs. higher) levels of self-reported unit support during deployment (HR, 2.22; 95% CI, 1.42-3.47). Conclusions: Service members early in their career may be especially prone to military attrition. With regard to military retention, our findings suggest that it may be particularly important to develop initiatives that target organizational cohesion and support.	[Vasterling, Jennifer J.; Harte, Christopher B.; Marx, Brian P.] VA Boston Healthcare Syst, Natl Ctr PTSD & Psychol, Boston, MA 02130 USA; [Vasterling, Jennifer J.; Harte, Christopher B.; Marx, Brian P.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Proctor, Susan P.] US Army Res Inst Environm Med, Natick, MA 01760 USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Aslan, Mihaela; Ko, John; Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Aslan, Mihaela] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Jakupcak, Matthew] VA Puget Sound Healthcare Syst, Seattle, WA 98108 USA; [Jakupcak, Matthew] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD & Psychol, 150 South Huntington Ave, Boston, MA 02130 USA.		Marx, Brian/AAK-5072-2020		U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD 17-03-0020]; Department of Veterans Affairs Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs; Clinical Epidemiology Research Center, VA Cooperative Studies Program	We appreciate the support of the Defense Manpower Data Center in obtaining military service status data. We are also grateful to the Soldiers who comprise the Neurocognition Deployment Health Study cohort for volunteering their time to participate in the study and for their military service more generally. Funding for the collection of primary assessment data was provided by the U.S. Army Medical Research and Materiel Command (DAMD 17-03-0020) and the Department of Veterans Affairs Clinical Sciences Research and Development. Data analyses and collection of secondary data from military administrative records were supported by the Clinical Epidemiology Research Center, VA Cooperative Studies Program. The primary funding organizations had no role in the scientific aspects of the study or the preparation of the manuscript. The manuscript underwent scientific and administrative review within the U.S. Army Research Institute for Environmental Medicine.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Booth-Kewley S, 2002, MIL MED, V167, P760; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Du Preez J, 2012, OCCUP MED-OXFORD, V62, P47, DOI 10.1093/occmed/kqr151; Han SC, 2014, J ANXIETY DISORD, V28, P446, DOI 10.1016/j.janxdis.2014.04.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; Horton JL, 2013, OCCUP ENVIRON MED, V70, P408, DOI 10.1136/oemed-2012-101073; Institute of Medicine, 2014, PREV PSYCH DIS SERV; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lancaster SL, 2013, MIL MED, V178, P267, DOI 10.7205/MILMED-D-12-00147; Merrill LL, 2004, MIL MED, V169, P465, DOI 10.7205/MILMED.169.6.465; Patrick V, 2011, MIL MED, V176, P182, DOI 10.7205/MILMED-D-09-00276; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Reis JP, 2007, MIL MED, V172, P936, DOI 10.7205/MILMED.172.9.936; Rhoades L, 2002, J APPL PSYCHOL, V87, P698, DOI 10.1037//0021-9010.87.4.698; Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233; Selim AJ, 2011, QUAL LIFE RES, V20, P1337, DOI 10.1007/s11136-011-9866-y; Stewart AL, 1992, MEASURING FUNCTIONIN, P102, DOI [10.7249/cb361, DOI 10.7249/CB361]; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2006, MIL MED, V171, P253, DOI 10.7205/MILMED.171.3.253; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wilson ALG, 2009, SOC PSYCH PSYCH EPID, V44, P473, DOI 10.1007/s00127-008-0461-7; Wolfe J, 2005, MIL MED, V170, P1037, DOI 10.7205/MILMED.170.12.1037; Wright PJ, 2012, MIL MED, V177, P773, DOI 10.7205/MILMED-D-11-00403	29	13	13	0	10	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2015	180	5					524	532		10.7205/MILMED-D-14-00468			9	Medicine, General & Internal	General & Internal Medicine	CJ5WF	WOS:000355562600016	25939106	Bronze			2021-06-18	
J	Cui, X; Baker, JM; Liu, N; Reiss, AL				Cui, Xu; Baker, Joseph M.; Liu, Ning; Reiss, Allan L.			Sensitivity of fNIRS measurement to head motion: An applied use of smartphones in the lab	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Near-infrared spectroscopy; fNIRS; Smartphone; Technology; Neuroimaging; Accelerometer	IPHONE; ACCELEROMETER; ENVIRONMENT; VALIDATION; CONCUSSION; VALIDITY; SYSTEM	Background: Powerful computing capabilities in small, easy to use hand-held devices have made smart technologies such as smartphones and tablets ubiquitous in today's society. The capabilities of these devices provide scientists with many tools that can be used to improve the scientific method. Method: Here, we demonstrate how smartphones may be used to quantify the sensitivity of functional near-infrared spectroscopy (fNIRS) signal to head motion. By attaching a smartphone to participants' heads during the fNIRS scan, we were able to capture data describing the degree of head motion. Results: Our results demonstrate that data recorded from an off-the-shelf smartphone accelerometer may be used to identify correlations between head-movement and fNIRS signal change. Furthermore, our results identify correlations between the magnitudes of head-movement and signal artifact, as well as a relationship between the direction of head movement and the location of the resulting signal noise. Conclusions: These data provide a valuable proof-of-concept for the use of off-the-shelf smart technologies in neuroimaging applications. (C) 2015 Elsevier B.V. All rights reserved.	[Cui, Xu; Baker, Joseph M.; Liu, Ning; Reiss, Allan L.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; [Reiss, Allan L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Cui, X (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA.	cuixu@stanford.edu			Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN) fellowship;  [S10 RR024657]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR024657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019908] Funding Source: NIH RePORTER	We would like to thank Manish Saggar for helpful discussion. Furthermore, we would like to thank Kristen Sheau for her support in collecting accelerometer data. This work is supported by S10 RR024657 (A.L.R., P.I.) and the Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN) fellowship (X.C. and A.L.R.). The funders had no role in the study design, data	Amick RZ, 2013, INT J APPL SCI TECHN, V3, P97, DOI DOI 10.13140/2.1.1568.8324; Aslin RN, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854672; Balg F, 2014, SCOLIOSIS, V11, P12; Curaudeau GA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11186; Demaerschalk BM, 2012, STROKE, V43, P3098, DOI 10.1161/STROKEAHA.112.669325; Dunton GF, 2011, OBESITY, V19, P1205, DOI 10.1038/oby.2010.302; Ege T, 2013, SKELETAL RADIOL, V42, P269, DOI 10.1007/s00256-012-1455-9; Fakhar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058665; Friston K., 2011, MAGN RESON MED, V35, P346; International Data Corporation (IDC) IDC Media Center, 2013, TABL SHIPM FOR TOP T; Isik AH, 2013, TELEMED E-HEALTH, V19, P24, DOI 10.1089/tmj.2012.0056; Izatt MT, 2012, SCOLIOSIS, V7, P1; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Kwon S, 2011, IEEE ENG MED BIO, P5260, DOI 10.1109/IEMBS.2011.6091301; Lee J, 2001, ROBOTICA, V19, P601, DOI 10.1017/S0263574701003319; Lee MH, 2011, HEALTHC INFORM RES, V17, P76, DOI 10.4258/hir.2011.17.1.76; LeMoyne R, 2010, IEEE ENG MED BIO, P3847, DOI 10.1109/IEMBS.2010.5627699; Maki H, 2011, IEEE ENG MED BIO, P5608, DOI 10.1109/IEMBS.2011.6091357; McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Mellone S, 2012, GAIT POSTURE, V36, P163, DOI 10.1016/j.gaitpost.2012.02.006; Mitchell JR, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1732; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Ockendon M, 2012, J KNEE SURG, V25, P341, DOI 10.1055/s-0031-1299669; Shaw M, 2012, EUR SPINE J, V21, P1062, DOI 10.1007/s00586-011-2059-0; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Stopczynski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086733; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Wieringen M, 2008, IEEE ENG MED BIO, P2397, DOI 10.1109/IEMBS.2008.4649682; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111	31	13	13	0	24	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 30	2015	245						37	43		10.1016/j.jneumeth.2015.02.006			7	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CG8XN	WOS:000353599100004	25687634	Green Accepted			2021-06-18	
J	Li, M; Lin, YP; Chen, JL; Li, H; Jiang, RC; Zhang, JN				Li, Min; Lin, Yun-Peng; Chen, Jie-Li; Li, Hong; Jiang, Rong-Cai; Zhang, Jian-Ning			Role of Regulatory T cell in Clinical Outcome of Traumatic Brain Injury	CHINESE MEDICAL JOURNAL			English	Article						Clinical Outcome; Dynamic Change; Prognostic Marker; Regulatory T cell; Traumatic Brain Injury	CENTRAL-NERVOUS-SYSTEM; AUTOIMMUNE ENCEPHALOMYELITIS; TOLERANCE	Background: Traumatic brain injury (TBI) is a life-threatening disease worldwide. Regulatory T cells (Treg cells) were involved in the immunological system in central nervous system. It is defined as a subpopulation of CD4(+) cells that express CD25 and transcription factor forkhead box P3. The level of circulating Treg cells increases in a variety of pathologic conditions. The purpose of this study was to uncover the role of circulating Treg cells in TBI. Methods: A clinical study was conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Second Hospital of Tianjin Medical University (Tianjin, China). Forty patients and 30 healthy controls were recruited from August 2013 to November 2013. Circulating Treg cells was detected on the follow-up period of 1, 4, 7, 14, and 21 days after TBI. Blood sample (1 ml) was withdrawn in the morning and processed within 2 h. Results: There was no significant difference in the level of circulating Treg cells between TBI patients and normal controls during follow-up. TBI patients exhibited higher circulating Treg level than normal controls on the 1st day after TBI. Treg level was decreased on the 4th day, climbed up on the 7th day and peaked on 14th day after TBI. Treg cells declined to the normal level on 21th day after TBI. The level of circulating Treg cells was significantly higher in survival TBI patients when compared to nonsurvival TBI patients. TBI patients with improved conditions exhibited significantly higher circulating Treg level when compared to those with deteriorated conditions. The circulating Treg level was correlated with neurologic recovery after TBI. A better neural recovery and lower hospital mortality were found in TBI patients with circulating Treg cells more than 4.91% in total CD4(+) mononuclear cells as compared to those with circulating Treg cells less than 4.91% in total CD4(+) mononuclear cells in the first 14 days. Conclusions: The level of circulating Treg cells is positively correlated with clinical outcome of TBI. The level of Treg cells predicts the progress for TBI patients and may be a target in TBI treatment.	[Li, Min; Lin, Yun-Peng; Jiang, Rong-Cai; Zhang, Jian-Ning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Jie-Li] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Li, Hong] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin 300211, Peoples R China	Zhang, JN (corresponding author), Tianjin Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com					Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Cabbage SE, 2007, J IMMUNOL, V178, P887, DOI 10.4049/jimmunol.178.2.887; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Huang XY, 2009, J NEUROIMMUNOL, V211, P3, DOI 10.1016/j.jneuroim.2009.04.006; Jia WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064397; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628	17	13	16	0	5	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	APR 20	2015	128	8					1072	1078		10.4103/0366-6999.155094			7	Medicine, General & Internal	General & Internal Medicine	CG8MX	WOS:000353563300014	25881602	DOAJ Gold, Green Published			2021-06-18	
J	Graber, DJ; Costine, BA; Hickey, WF				Graber, David J.; Costine, Beth A.; Hickey, William F.			Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets	JOURNAL OF NEUROINFLAMMATION			English	Article						Cytokines; Cerebral cortex; Chemokines; Injury; Mouse; Pig; Prostaglandin-endoperoxide synthase-2; Slice	CLOSED-HEAD INJURY	Background: The immunological response during the first 24 hours after traumatic brain injury (TBI) may be a critical therapeutic interval for limiting the secondary neuronal damage that is influenced by enhanced inflammatory mediator expression. Methods: To gain further insight of the early injury response, we examined the expression of several inflammatory genes by real-time qPCR as a function of time or distance from injury in two distinct mammalian models: an ex vivo mouse cortical slice injury system and an in vivo piglet model of brain injury. Results: Interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), chemokine ligands 2 (CCL2), 3 (CCL3), 4 (CCL4), and prostaglandin-endoperoxide synthase 2 (PTGS2) mRNAs increased within 5 h after injury in mouse cortical slices. Chemokine and PTGS2 mRNAs remained elevated in slices at 24 h, whereas IL-1 beta and TNF-alpha expressions decreased from earlier peak levels. At 24 h after cortical injury in 1-month-old piglets, the expression of CCL2 mRNA was significantly increased in the lesion core and in the penumbra region. The expression of PTGS2, IL-1 beta, and TNF-alpha was variable among the piglets. Conclusions: These in vitro and large animal models of cortical injury expand our understanding of the early timing and spread of the immunological response and can serve as preclinical systems to facilitate the discovery of therapeutic agents for TBI aimed at regulating inflammatory mediator expression.	[Graber, David J.; Hickey, William F.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH 03756 USA; [Costine, Beth A.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Costine, Beth A.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Graber, DJ (corresponding author), Geisel Sch Med Dartmouth, Dept Pathol, One Med Ctr Dr, Lebanon, NH 03756 USA.	David.J.Graber@Dartmouth.Edu			Hitchcock Foundation (Geisel School of Medicine at Dartmouth); Nicholas T. Zervas Chair Fund (Harvard Medical School); Hitchcock Foundation (Dartmouth-Hitchcock Medical Center)	This research was supported in part by a grant from the Hitchcock Foundation (Geisel School of Medicine at Dartmouth and the Dartmouth-Hitchcock Medical Center) and Nicholas T. Zervas Chair Fund (Harvard Medical School).	Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Costine B, 2015, DEV NEUROSCI, V37; Costine BA, 2012, J NEUROTRAUM, V29, P2689, DOI 10.1089/neu.2012.2428; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Graber DJ, 2012, J NEUROIMMUNE PHARM, V7, P266, DOI 10.1007/s11481-011-9338-8; Graber DJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-122; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rice T, 2007, J NEUROPATH EXP NEUR, V66, P184, DOI 10.1097/01.jnen.0000248552.07338.7f; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229	30	13	13	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 18	2015	12								76	10.1186/s12974-015-0298-4			8	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CG4PQ	WOS:000353269000002	25895671	DOAJ Gold, Green Published			2021-06-18	
J	Baschera, D; Hasler, RM; Taugwalder, D; Exadaktylos, A; Raabe, A				Baschera, Dominik; Hasler, Rebecca M.; Taugwalder, David; Exadaktylos, Aristomenis; Raabe, Andreas			Association between Head Injury and Helmet Use in Alpine Skiers: Cohort Study from a Swiss Level I Trauma Center	JOURNAL OF NEUROTRAUMA			English	Article						skiing; helmet; TBI; head trauma	SNOWBOARDING INJURIES; PRACTICAL SCALE; SLOPES; RISK	The association between helmet use during alpine skiing and incidence and severity of head injuries was analyzed. All patients admitted to a level 1 trauma center for traumatic brain injuries (TBIs) sustained from skiing accidents during the seasons 2000-2001 and 2010-2011 were eligible. Primary outcome was the association between helmet use and severity of TBI measured by Glasgow Coma Scale (GCS), computed tomography (CT) results, and necessity of neurosurgical intervention. Of 1362 patients injured during alpine skiing, 245 (18%) sustained TBI and were included. TBI was fatal in 3%. Head injury was in 76% minor (Glasgow Coma Scale, 13-15), 6% moderate, and 14% severe. Number and percentage of TBI patients showed no significant trend over the investigated seasons. Forty-five percent of the 245 patients had pathological CT findings and 26% of these required neurosurgical intervention. Helmet use increased from 0% in 2000-2001 to 71% in 2010-2011 (p<0.001). The main analysis, comparing TBI in patients with or without a helmet, showed an adjusted odds ratio (OR) of 1.44 (p=0.430) for suffering moderate-to-severe head injury in helmet users. Analyses comparing off-piste to on-slope skiers revealed a significantly increased OR among off-piste skiers of 7.62 (p=0.004) for sustaining a TBI requiring surgical intervention. Despite increases in helmet use, we found no decrease in severe TBI among alpine skiers. Logistic regression analysis showed no significant difference in TBI with regard to helmet use, but increased risk for off-piste skiers. The limited protection of helmets and dangers of skiing off-piste should be targeted by prevention programs.	[Baschera, Dominik; Raabe, Andreas] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; [Hasler, Rebecca M.; Taugwalder, David; Exadaktylos, Aristomenis] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland	Baschera, D (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurosurg, Freiburgstr 10, CH-3010 Bern, Switzerland.	dominik.baschera@insel.ch	Dominik, Baschera/AAI-1953-2021	Dominik, Baschera/0000-0002-9634-9922			American Society for Testing and Materials (ASTM), 2011, F204011 ASTM; [Anonymous], 2007, 1077 CSN EN; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; JENNETT B, 1975, LANCET, V1, P480; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Montagne M. D., 2012, STUDY ACCIDENT WINTE; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Sommer H., 2007, VOLKSWIRTSCHFTLICHE, VAvailable at; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; TEASDALE G, 1974, LANCET, V2, P81; Unfallverhutung B-Bf, 2013, ENTW ANT KOPFV SCHN; Unfallverhutung B-Bf. bfu-Erhebung, 2013, TRAGG SCHUTZ BEIM SK; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; Vanat L., 2013, SAISONBILANZ SCHWEIZ; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Wick MC, 2013, ARCH ORTHOP TRAUM SU, V133, P1367, DOI 10.1007/s00402-013-1822-6; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	28	13	13	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					557	562		10.1089/neu.2014.3604			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900005	25244343				2021-06-18	
J	Ohye, BY; Brendel, RW; Fredman, SJ; Bui, E; Rauch, PK; Allard, MD; Pentel, KZ; Simon, NM				Ohye, Bonnie Y.; Brendel, Rebecca W.; Fredman, Steffany J.; Bui, Eric; Rauch, Paula K.; Allard, Michael D.; Pentel, Kimberly Z.; Simon, Naomi M.			Three-Generation Model: A Family Systems Framework for the Assessment and Treatment of Veterans With Posttraumatic Stress Disorder and Related Conditions	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						PTSD; veteran; family-centered health care; family systems; traumatic brain injury	PSYCHOLOGICAL DISTRESS; HEALTH-CARE; SYMPTOMS; IRAQ; DEPLOYMENT; PTSD; AFGHANISTAN; CHILDREN; ADJUSTMENT; COUPLES	This article describes the three-generation family systems health care model developed at the Veteran and Family Clinic of the Home Base Program, a partnership between the Red Sox Foundation and Massachusetts General Hospital designed to improve treatment engagement of veterans with posttraumatic stress disorder (PTSD) and related conditions, and to provide care to the entire military-connected family. This clinical model was designed to address 3 interdependent facets of the PTSD-affected family system: (a) the multiple attachment relationships that are often strained; (b) the veteran's family roles, which may be impaired; and (c) the multiple pathways for treatment engagement and amelioration of the veteran's PTSD-related distress and behaviors within the family system. In addition, we describe the assessment system, designed to probe the interrelationships of individual veteran, couple, parenting, child, and family levels of functioning. Three cases illustrative of the three-generation model's clinical application, how it can address unmet needs, and its ability to overcome barriers to health care for military families are also discussed.	[Ohye, Bonnie Y.; Brendel, Rebecca W.; Bui, Eric; Rauch, Paula K.; Allard, Michael D.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Fredman, Steffany J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Complicated Grief Program, Boston, MA 02114 USA; [Ohye, Bonnie Y.] Harvard Univ, Sch Med, Psychol, Cambridge, MA 02138 USA; [Brendel, Rebecca W.; Simon, Naomi M.] Harvard Univ, Sch Med, Psychiat, Cambridge, MA 02138 USA; [Fredman, Steffany J.; Bui, Eric; Rauch, Paula K.; Allard, Michael D.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Pentel, Kimberly Z.] Univ N Carolina, Chapel Hill, NC USA	Ohye, BY (corresponding author), Massachusetts Gen Hosp, Red Sox Fdn, Home Base Clin, 101 Merrimac St,Suite 250, Boston, MA 02114 USA.	bohye@mgh.harvard.edu	Bui, Eric/J-8347-2015	Bui, Eric/0000-0002-1413-6473; FREDMAN, STEFFANY/0000-0002-2053-8700	Red Sox Foundation; Massachusetts General Hospital Home Base Program	WE THANK THE PHILANTHROPIC SUPPORTERS of the Red Sox Foundation and Massachusetts General Hospital Home Base Program, who have supported this work. We would also like to thank all of the staff and clinicians of the Home Base Program (HBP) who have contributed to the development and implementation of this model. Finally, we thank Yang (Karen) Chen for her assistance with the revised manuscript.	Allen ES, 2010, J FAM PSYCHOL, V24, P280, DOI 10.1037/a0019405; Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Department of Defense, 2011, 2011 DEM PROF MIL CO; Department of Defense, 2010, REP IMP DEPL MEMB AR; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Erbes CR, 2011, J FAM PSYCHOL, V25, P479, DOI 10.1037/a0024007; Foa EB, 2007, PROLONGED EXPOSURE T; Fontana A, 2008, J NERV MENT DIS, V196, P513, DOI 10.1097/NMD.0b013e31817cf6e6; Fredman SJ, 2014, J ANXIETY DISORD, V28, P372, DOI 10.1016/j.janxdis.2014.04.001; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Gibaud-Wallston J., 1978, ANN M AM PSYCH ASS T; Grubaugh AL, 2008, J NERV MENT DIS, V196, P166, DOI 10.1097/NMD.0b013e318162aa2d; Herman D., 1993, ANN CONV INT SOC TRA; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; JACKSON D D, 1957, Psychiatr Q Suppl, V31, P79; JELLINEK MS, 1988, J PEDIATR-US, V112, P201, DOI 10.1016/S0022-3476(88)80056-8; Johnson SM, 1999, CLIN PSYCHOL-SCI PR, V6, P67, DOI 10.1093/clipsy/6.1.67; Khaylis A, 2011, MIL MED, V176, P126, DOI 10.7205/MILMED-D-10-00094; Lambert JE, 2012, J FAM PSYCHOL, V26, P729, DOI 10.1037/a0029341; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Lyle A., 2012, DISABILITY ADVOCATE; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI DOI 10.1177/088626087002002003; Mansfield AJ, 2011, ARCH PEDIAT ADOL MED, V165, P999, DOI 10.1001/archpediatrics.2011.123; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Meis LA, 2013, PSYCHOL TRAUMA-US, V5, P334, DOI 10.1037/a0028366; Meis LA, 2010, J FAM PSYCHOL, V24, P560, DOI 10.1037/a0020925; Miller IW, 2005, AM J PSYCHIAT, V162, P2131, DOI 10.1176/appi.ajp.162.11.2131; Monson C. M., 2012, COGNITIVE BEHAV CONJ; Monson CM, 2012, JAMA-J AM MED ASSOC, V308, P700, DOI 10.1001/jama.2012.9307; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; National Council for Behavioral Health, 2012, M BEH HLTH NEEDS VET; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Renshaw KD, 2011, J FAM PSYCHOL, V25, P461, DOI 10.1037/a0023994; Resick PA, 2008, COGNITIVE PROCESSING; Sautter FJ, 2011, PROF PSYCHOL-RES PR, V42, P63, DOI 10.1037/a0022323; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Sherman MD, 2012, PSYCHOL SERV, V9, P349, DOI 10.1037/a0028963; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tanielian TL, 2008, INVISIBLE WOUNDS WAR, V720; Zerach G, 2012, J FAM PSYCHOL, V26, P274, DOI 10.1037/a0027159	48	13	13	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	APR	2015	46	2					97	106		10.1037/a0037735			10	Psychology, Multidisciplinary	Psychology	CH3DL	WOS:000353906700004					2021-06-18	
J	Rockett, H; Thompson, HJ; Blissitt, PA				Rockett, Hannah; Thompson, Hilaire J.; Blissitt, Patricia A.			Fever Management Practices of Neuroscience Nurses: What Has Changed?	JOURNAL OF NEUROSCIENCE NURSING			English	Article						clinical decision making; fever; hyperthermia; nursing intervention	ELEVATED BODY-TEMPERATURE; BRAIN TEMPERATURE; SUBARACHNOID HEMORRHAGE; RISK-FACTORS; ACUTE STROKE; CARE; HYPERTHERMIA; IMPACT; INJURY; ACETAMINOPHEN	Current evidence shows that fever and hyperthermia are especially detrimental to patients with neurologic injury, leading to higher rates of mortality, greater disability, and longer lengths of stay. Although clinical practice guidelines exist for ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury, they lack specificity in their recommendations for fever management, making it difficult to formulate appropriate protocols for care. Using survey methods, the aims of this study were to (a) describe how nursing practices for fever management in this population have changed over the last several years, (b) assess if institutional protocols and nursing judgment follow published national guidelines for fever management in neuroscience patients, and (c) explore whether nurse or institutional characteristics influence decision making. Compared with the previous survey administered in 2007, there was a small increase (8%) in respondents reporting having an institutional fever protocol specific to neurologic patients. Temperatures to initiate treatment either based on protocols or nurse determination did not change from the previous survey. However, nurses with specialty certification and/or working in settings with institutional awards (e.g., Magnet status or Stroke Center Designation) initiated therapy at a lower temperature. Oral acetaminophen continues to be the primary choice for fever management, followed by ice packs and fans. This study encourages the development of a stepwise approach to neuro-specific protocols for fever management. Furthermore, it shows the continuing need to promote further education and specialty training among nurses and encourage collaboration with physicians to establish best practices.	[Rockett, Hannah] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; [Blissitt, Patricia A.] Univ Washington, Sch Nursing, Biobehav Nursing Hlth Syst, Seattle, WA 98195 USA; [Blissitt, Patricia A.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Blissitt, Patricia A.] Swedish Med Ctr, Seattle, WA USA	Thompson, HJ (corresponding author), Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA.	hilairet@uw.edu	Viani, Rafael/V-1196-2018				Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Alexander S. E., 2007, CARE PATIENT ANEURYS; Balas MC, 2012, CRIT CARE NURSE, V32, P35, DOI 10.4037/ccn2012229; Blegen Mary A, 2012, Evid Based Nurs, V15, P54, DOI 10.1136/ebnurs.2011.100228; Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, pS21; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs C, 2010, FRONT NEUROL, V146, P1; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; CLASEN RA, 1974, J NEUROSURG, V41, P576, DOI 10.3171/jns.1974.41.5.0576; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Grau AJ, 1999, J NEUROL SCI, V171, P115, DOI 10.1016/S0022-510X(99)00261-0; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Jaunch E. C., 2013, STROKE, V44, P870, DOI DOI 10.1161/STR.0B013E318284056A; Karaszewski B, 2013, J CEREBR BLOOD F MET, V33, P1083, DOI 10.1038/jcbfm.2013.52; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kendall-Gallagher D, 2011, J NURS SCHOLARSHIP, V43, P188, DOI 10.1111/j.1547-5069.2011.01391.x; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Laws C., 2010, JEFFERSON HOSP NEURO, V5, P22; Mackowiak PA, 2000, CLIN INFECT DIS, V31, pS185, DOI 10.1086/317511; Mcilvoy L., 2008, NURSING MANAGEMENT A; Mcilvoy L, 2012, AACN ADV CRIT CARE, V23, P204, DOI 10.1097/NCI.0b013e31824db1c6; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Morimoto T, 1997, BRAIN RES, V746, P43, DOI 10.1016/S0006-8993(96)01154-7; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; National Association of Clinical Nurse Specialists, 2013, CNS FAQS; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Pugh S., 2008, GUIDE CARE HOSP PATI; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Schulman Carl I, 2005, Surg Infect (Larchmt), V6, P369; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sulter G, 2004, CEREBROVASC DIS, V17, P118, DOI 10.1159/000075779; Summers D, 2009, STROKE, V40, P2911, DOI 10.1161/STROKEAHA.109.192362; Takagi K., 1994, AM J PHYSIOL, V267, pH170; The Joint Commission, 2012, FACTS PRIM STROK CTR; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P151; Thompson HJ, 2011, J ADV NURS, V67, P359, DOI 10.1111/j.1365-2648.2010.05506.x; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	51	13	14	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2015	47	2					66	75		10.1097/JNN.0000000000000118			10	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	CC7VU	WOS:000350577300003	25634653				2021-06-18	
J	Xu, GT; Hu, B; Chen, GQ; Yu, XJ; Luo, JM; Lv, JY; Gu, J				Xu, Guangtao; Hu, Bo; Chen, Guiqian; Yu, Xiaojun; Luo, Jianming; Lv, Junyao; Gu, Jiang			Analysis of Blood Trace Elements and Biochemical Indexes Levels in Severe Craniocerebral Trauma Adults with Glasgow Coma Scale and Injury Severity Score	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Trace element; Trauma; Craniocerebral injury; Injury severity score	UREA NITROGEN/CREATININE RATIO; IRON; COPPER; ZINC; DYSFUNCTION; CREATININE; MAGNESIUM; NITROGEN; PLASMA; ZN	We aimed to investigate the correlation between the Glasgow Coma Scale (GCS), the injury severity score (ISS) and serum levels of trace elements (TE) in severe trauma patients to analyze alteration of the levels of trace elements and serum biochemical indexes in the period of admission from 126 adult cases of severe brain trauma with traffic accidents. Multi-trace elements for patients in the trauma-TE groups were used. The results indicated that all patients presented an acute trace elements deficiency syndrome (ATEDs) after severe trauma, and the correlation between ISS and serum levels of Fe, Zn, and Mg was significant. Compared to the normal control group, levels of the trace elements in serum were significantly decreased after trauma, suggesting that enhancement of immunity to infection and multiple organ failure (MOF) via the monitoring and supplement of trace elements will be a good strategy to severe traumatic patients in clinics.	[Xu, Guangtao; Yu, Xiaojun; Luo, Jianming; Lv, Junyao; Gu, Jiang] Shantou Univ, Coll Med, Dept Forens & Pathol, Natl Key Disciplines, Shantou 515041, Guangdong, Peoples R China; [Xu, Guangtao; Chen, Guiqian] Jiaxing Univ, Dept Forens & Pathol, Coll Med, Jiaxing 314001, Zhejiang, Peoples R China; [Hu, Bo] Jiaxing Hosp Tradit Chinese Med, Dept Pathol, Jiaxing 314001, Zhejiang, Peoples R China	Yu, XJ (corresponding author), Shantou Univ, Coll Med, Dept Forens & Pathol, Natl Key Disciplines, Shantou 515041, Guangdong, Peoples R China.	2523381625@qq.com; xjyu@stu.edu.cn	Hu, Bo/I-2889-2019; Xu, Guangtao/L-8929-2017	Hu, Bo/0000-0001-8601-8284; Xu, Guangtao/0000-0001-5846-9280; Gu, Jiang/0000-0002-0706-8329	Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LQ14H230001]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201330031]; National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458, 81400489, 81400654]	We are grateful to Miss Xingxing Wang and Mr. Bo Li for the data analysis. We appreciate the support from the Zhejiang Provincial Natural Science Foundation (LQ14H230001), Scientific Research Fund of Zhejiang Provincial Education Department (Y201330031), and the National Natural Science Foundation Council of China (30772458, 81400489, and 81400654).	Agay D, 2005, BURNS, V31, P366, DOI 10.1016/j.burns.2004.11.010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blass SC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-157; Bonham M, 2002, BRIT J NUTR, V87, P393, DOI 10.1079/BJN2002558; Brisco MA, 2013, CIRC-HEART FAIL, V6, P233, DOI 10.1161/CIRCHEARTFAILURE.112.968230; Cortese-Krott MM, 2014, REDOX BIOL, V2, P945, DOI 10.1016/j.redox.2014.06.011; Decker H, 2000, J EXP BIOL, V203, P1777; Dlouhy AC, 2013, METAL IONS LIFE SCI, V12, P241, DOI 10.1007/978-94-007-5561-1_8; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Ge KY, 2000, J AM DIET ASSOC, V100, P885, DOI 10.1016/S0002-8223(00)00256-X; Geiger H, 2012, CLIN KIDNEY J, V5, P25, DOI 10.1093/ndtplus/sfr165; Georgetti Flávia Carolina Davini, 2006, Rev. bras. ter. intensiva, V18, P418, DOI 10.1590/S0103-507X2006000400017; Ghasemi A, 2010, BIOL TRACE ELEM RES, V136, P18, DOI 10.1007/s12011-009-8522-7; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; Hoppe M, 2006, EUR J NUTR, V45, P37, DOI 10.1007/s00394-005-0560-0; Huang XL, 2014, CLIN LAB, V60, P1123, DOI 10.7754/Clin.Lab.2013.130530; Iankova Andriana, 2006, Emerg Nurse, V14, P30; Jang JY, 2014, J CRIT CARE, V29, pe5; Kehoe A, 2014, EMERG MED J; Kennedy AB, 2014, NUCLEIC ACIDS RES, V42, P12306, DOI 10.1093/nar/gku875; Liu Q, 2014, GENET MOL RES, V13, P7666, DOI 10.4238/2014.September.26.4; Liu XD, 2013, HEPATO-GASTROENTEROL, V60, P343, DOI 10.5754/hge11216; MORGAN DB, 1977, BMJ-BRIT MED J, V2, P929, DOI 10.1136/bmj.2.6092.929; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Palmer CS, 2013, INJURY, V44, P1437, DOI 10.1016/j.injury.2012.08.033; Panhwar AH, 2014, CLIN LAB, V60, P463, DOI 10.7754/Clin.Lab.2013.130122; Pineda O, 2001, NUTRITION, V17, P381, DOI 10.1016/S0899-9007(01)00519-6; Riccardi A, 2013, EUR REV MED PHARMACO, V17, P1800; Romani AMP, 2013, METAL IONS LIFE SCI, V12, P69, DOI 10.1007/978-94-007-5561-1_4; Saaka Mahama, 2009, East Afr J Public Health, V6, P55; Schrock JW, 2012, CLIN NEUROL NEUROSUR, V114, P881, DOI 10.1016/j.clineuro.2012.01.031; Smith ZA, 2014, J NEUROSURG-SPINE, V21, P495, DOI 10.3171/2014.3.SPINE14301; Strachan S, 2010, CURR ANAESTH CRIT CA, V21, P44, DOI DOI 10.1016/j.cacc.2009.08.004; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; TraumaRegister DGU, 2014, INJURY, V45, pS14, DOI 10.1016/j.injury.2014.08.012; Ucar SK, 2010, J TRACE ELEM MED BIO, V24, P42, DOI 10.1016/j.jtemb.2009.10.004; Wang BH, 2007, J TRACE ELEM MED BIO, V21, P102, DOI 10.1016/j.jtemb.2007.03.006; WANG BH, 2005, J FORENSIC MED, V21, P42; Wang D, 2006, J SURG CONCEPTS PRAC, V11, P239; Wang GH, 2013, BIOL TRACE ELEM RES, V152, P300, DOI 10.1007/s12011-013-9623-x; Wang GH, 2012, BIOL TRACE ELEM RES, V147, P28, DOI 10.1007/s12011-011-9281-9; Yuan WA, 2010, J TRACE ELEM MED BIO, V24, P36, DOI 10.1016/j.jtemb.2009.08.002	42	13	19	1	15	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	APR	2015	164	2					192	197		10.1007/s12011-014-0225-z			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CD9SX	WOS:000351439700005	25575666				2021-06-18	
J	Holzinger, U; Brunner, R; Losert, H; Fuhrmann, V; Herkner, H; Madl, C; Sterz, F; Schneeweiss, B				Holzinger, Ulrike; Brunner, Richard; Losert, Heidrun; Fuhrmann, Valentin; Herkner, Harald; Madl, Christian; Sterz, Fritz; Schneeweiss, Bruno			Resting energy expenditure and substrate oxidation rates correlate to temperature and outcome after cardiac arrest - a prospective observational cohort study	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; CHRONIC-RENAL-FAILURE; OXYGEN-CONSUMPTION; INDIRECT CALORIMETRY; COMATOSE SURVIVORS; METABOLISM; HYPOTHERMIA; INSULIN; MECHANISMS	Introduction: Targeted temperature management improves outcome after cardiopulmonary resuscitation. Reduction of resting energy expenditure might be one mode of action. The aim of this study was to correlate resting energy expenditure and substrate oxidation rates with targeted temperature management at 33 degrees C and outcome in patients after cardiac arrest. Methods: This prospective, observational cohort study was performed at the department of emergency medicine and a medical intensive care unit of a university hospital. Patients after successful cardiopulmonary resuscitation undergoing targeted temperature management at 33 degrees C for 24 hours with subsequent rewarming to 36 degrees C and standardized sedation, analgesic and paralytic medication were included. Indirect calorimetry was performed five times within 48 h after cardiac arrest. Measurements were correlated to outcome with repeated measures ANOVA, linear and logistic regression analysis. Results: In 25 patients resting energy expenditure decreased 20 (18 to 27) % at 33 degrees C compared to 36 degrees C without differences between outcome groups (favourable vs. unfavourable: 25 (21 to 26) vs. 21 (16 to 26); P = 0.5). In contrast to protein oxidation rate (favourable vs. unfavourable: 35 (11 to 68) g/day vs. 39 (7 to 75) g/day, P = 0.8) patients with favourable outcome had a significantly higher fat oxidation rate (139 (104 to 171) g/day vs. 117 (70 to 139) g/day, P < 0.05) and a significantly lower glucose oxidation rate (30 (-34 to 88) g/day vs. 77 (19 to 138) g/day; P < 0.05) as compared to patients with unfavourable neurological outcome. Conclusions: Targeted temperature management at 33 degrees C after cardiac arrest reduces resting energy expenditure by 20% compared to 36 degrees C. Glucose and fat oxidation rates differ significantly between patients with favourable and unfavourable neurological outcome.	[Holzinger, Ulrike; Brunner, Richard; Madl, Christian; Schneeweiss, Bruno] Med Univ Vienna, ICU 13H1, Dept Med 3, Div Gastroenterol & Hepatol, A-1090 Vienna, Austria; [Losert, Heidrun; Herkner, Harald; Sterz, Fritz] Med Univ Vienna, Dept Emergency Med, A-1090 Vienna, Austria; [Fuhrmann, Valentin] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care, D-20246 Hamburg, Germany	Holzinger, U (corresponding author), Med Univ Vienna, ICU 13H1, Dept Med 3, Div Gastroenterol & Hepatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	ulrike.holzinger@meduniwien.ac.at					Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BURSZTEIN S, 1977, J APPL PHYSIOL, V42, P117; CHAMBERLAIN D, 1991, RESUSCITATION, V22, P1, DOI 10.1016/0300-9572(91)90061-3; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; HAMER J, 1978, ACTA NEUROCHIR, V44, P151, DOI 10.1007/BF01402057; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2010, NEW ENGL J MED, V363, P1256, DOI 10.1056/NEJMct1002402; HOOPARIS R, 1988, AM J PHYSIOL, V255, pR1035; KURPAD AV, 1994, AM J PHYSIOL, V266, pE877; LIVESEY G, 1988, AM J CLIN NUTR, V47, P608; Magistretti Pierre J., 1995, P657; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P210, DOI 10.1164/ajrccm.151.1.7812556; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P10, DOI 10.1164/ajrccm.151.1.7812538; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; MARSH WH, 1965, CLIN CHEM, V11, P624; NATALI A, 1990, DIABETES, V39, P490, DOI 10.2337/diabetes.39.4.490; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Poblete B, 1997, BRIT J ANAESTH, V78, P123; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; SCHNEEWEISS B, 1993, GASTROENTEROLOGY, V105, P1515, DOI 10.1016/0016-5085(93)90159-A; SCHNEEWEISS B, 1990, HEPATOLOGY, V11, P387, DOI 10.1002/hep.1840110309; SCHNEEWEISS B, 1992, METABOLISM, V41, P125, DOI 10.1016/0026-0495(92)90138-Z; SCHNEEWEISS B, 1990, AM J CLIN NUTR, V52, P596; Sessler DI, 2009, CRIT CARE MED, V37, pS203, DOI 10.1097/CCM.0b013e3181aa5568; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399; Terao Y, 2003, CRIT CARE MED, V31, P830, DOI 10.1097/01.CCM.0000054868.93459.E1; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Urabe T, 1996, J NEUROCHEM, V67, P265; Vallerand AL, 1999, AVIAT SPACE ENVIR MD, V70, P42; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; WELLE S, 1988, J CLIN ENDOCR METAB, V66, P593, DOI 10.1210/jcem-66-3-593	39	13	13	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	MAR 29	2015	19								128	10.1186/s13054-015-0856-2			9	Critical Care Medicine	General & Internal Medicine	CG3SD	WOS:000353199000002	25888299	DOAJ Gold, Green Published			2021-06-18	
J	Afari, N; Pittman, J; Floto, E; Owen, L; Buttner, M; Hossain, N; Baker, DG; Lindamer, L; Lohr, JB				Afari, Niloofar; Pittman, James; Floto, Elizabeth; Owen, Laura; Buttner, Melissa; Hossain, Nazia; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.			Differential Impact of Combat on Postdeployment Symptoms in Female and Male Veterans of Iraq and Afghanistan	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILITARY SEXUAL TRAUMA; MENTAL-HEALTH PROBLEMS; GENDER-DIFFERENCES; WOMEN VETERANS; WAR VETERANS; US MILITARY; DEPRESSION; DEPLOYMENT; VALIDITY	Objectives: We aimed to describe differences in combat experience for male and female veterans and characterize differential effects on postdeployment physical and mental health symptoms, including aggression. Methods: Retrospective cross-sectional health screening data from 554 Operation Enduring Freedom and Operation Iraqi Freedom veterans who enrolled for Veterans Affairs health care in San Diego were examined including measures of combat experience, pain intensity, traumatic brain injury symptoms, military sexual trauma, post-traumatic stress disorder, depression, alcohol use, and aggression. Results: Although male veterans (n = 458) experienced significantly higher rates of combat than female veterans (n = 96), both experienced similar levels of postdeployment post-traumatic stress disorder and depression symptoms as well self-reported aggressive behavior compared to male veterans. Female veterans had higher rates of military sexual trauma and lower alcohol consumption than male veterans. Conclusions: All Operation Enduring Freedom and Operation Iraqi Freedom veterans returning from deployment may benefit from broad-based screening of physical and mental health symptoms, beyond those currently mandated by Veterans Affairs, including anger and aggression.	[Afari, Niloofar; Pittman, James; Floto, Elizabeth; Owen, Laura; Buttner, Melissa; Hossain, Nazia; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.] VA Ctr Excellence Stress & Mental Hlth, La Jolla, CA 92161 USA; [Afari, Niloofar; Pittman, James; Floto, Elizabeth; Owen, Laura; Buttner, Melissa; Hossain, Nazia; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Afari, Niloofar; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA	Afari, N (corresponding author), VA Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,MC116A, La Jolla, CA 92161 USA.		Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838; Floto, Elizabeth/0000-0002-8238-0793	Department of Veterans Affairs Center of Excellence for Stress and Mental Health; VA San Diego Healthcare SystemUS Department of Veterans Affairs	This material is based on work supported by the Department of Veterans Affairs Center of Excellence for Stress and Mental Health. This material is also the result of work supported with resources of the VA San Diego Healthcare System.	Angkaw AC, 2013, MIL MED, V178, P1044, DOI 10.7205/MILMED-D-13-00061; Aviram RB, 2006, HARVARD REV PSYCHIAT, V14, P249, DOI 10.1080/10673220600975121; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Butterfield MI, 2000, J TRAUMA STRESS, V13, P735, DOI 10.1023/A:1007874620024; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Department of Veterans Affairs, 2008, VHA HDB; Dixon-Gordon KL, 2014, J AFFECT DISORDERS, V166, P359, DOI 10.1016/j.jad.2014.05.033; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Dutra L, 2011, J TRAUMA DISSOCIATIO, V12, P25, DOI 10.1080/15299732.2010.496141; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Favaro A, 2007, J CLIN PSYCHIAT, V68, P122, DOI 10.4088/JCP.v68n0117; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; Fontana A, 2008, J NERV MENT DIS, V196, P513, DOI 10.1097/NMD.0b013e31817cf6e6; Freedy JR, 2010, MIL MED, V175, P750, DOI 10.7205/MILMED-D-10-00123; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gerlock A A, 1994, Issues Ment Health Nurs, V15, P393, DOI 10.3109/01612849409006916; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heaton P., 2012, UNEMPLOYMENT POST 9; Hoge CW, 2007, INT J EPIDEMIOL, V36, P327, DOI 10.1093/ije/dym013; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehavot K, 2014, J COUNS PSYCHOL, V61, P392, DOI 10.1037/cou0000019; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Murdoch M, 2006, J GEN INTERN MED, V21, pS5, DOI 10.1111/j.1525-1497.2006.00368.x; Novaco RW, 2012, PSYCHOL ASSESSMENT, V24, P661, DOI 10.1037/a0026636; Owen GP., 2009, TRAUMATOLOGY, V15, P31, DOI [10.1177/1534765609336361, DOI 10.1177/1534765609336361]; Pallant J., 2013, SPSS SURVIVAL MANUAL; Pierce PF, 2011, WOMEN HEALTH ISS, V21, pS152, DOI 10.1016/j.whi.2011.04.017; Prudential Financial Inc, 2012, 02240610000101 PRUD; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Sanborn JK, 2013, MARINE CORPS TI 1118; Scott JC, 2014, J CLIN PSYCHIAT, V75, P637, DOI 10.4088/JCP.13m08808; Sorgi P, 1991, J Neuropsychiatry Clin Neurosci, V3, pS52; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wright KM, 2012, J CLIN PSYCHOL, V68, P782, DOI 10.1002/jclp.21864; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319	48	13	13	0	16	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3					296	303		10.7205/MILMED-D-14-00255			8	Medicine, General & Internal	General & Internal Medicine	CD3OI	WOS:000350987700015	25735020	Bronze			2021-06-18	
J	Brown, J; Thiessen, A; Beukelman, D; Hux, K				Brown, Jessica; Thiessen, Amber; Beukelman, David; Hux, Karen			Noun Representation in AAC Grid Displays: Visual Attention Patterns of People with Traumatic Brain Injury	AUGMENTATIVE AND ALTERNATIVE COMMUNICATION			English	Article						Augmentative and alternative communication; Traumatic brain injury; Message representation; Grid-based displays; Eye tracking; Visual search	EYE TRACKING RESEARCH; POTENTIAL CONTRIBUTIONS; SCENE DISPLAYS; GUIDED SEARCH; INFORMATION; CATEGORIZATION; INTERVENTION; PERFORMANCE; MOVEMENTS; SURVIVORS	Clinicians supporting the communication of people with traumatic brain injury (TBI) must determine an efficient message representation method for augmentative and alternative communication (AAC) systems. Due to the frequency with which visual deficits occur following brain injury, some adults with TBI may have difficulty locating items on AAC displays. The purpose of this study was to identify aspects of graphic supports that increase efficiency of target-specific visual searches. Nine adults with severe TBI and nine individuals without neurological conditions located targets on static grids displaying one of three message representation methods. Data collected through eye tracking technology revealed significantly more efficient target location for icon-only grids than for text-only or icon-plus-text grids for both participant groups; no significant differences emerged between participant groups.	[Brown, Jessica; Beukelman, David; Hux, Karen] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA; [Thiessen, Amber] Univ Houston, Dept Special Educ & Commun Disorders, Houston, TX USA	Brown, J (corresponding author), Univ Nebraska, Barkley Mem Ctr 350, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA.	jessica.anne.brown@gmail.com	Hux, Karen/AAQ-2078-2020		Rehabilitation Engineering Research Center on Communication Enhancement (AAC-RERC) from the NIDRR in the U.S. Department of Education's OSERS [H133E080011]; Tobii Technologies	This project was supported in part by the Rehabilitation Engineering Research Center on Communication Enhancement (AAC-RERC) under grant H133E080011 from the National Institute on Disability and Rehabilitation Research (NIDRR) in the U.S. Department of Education's Office of Special Education and Rehabilitative Services (OSERS) and in part by Tobii Technologies.	ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beck A. R., 1998, AUGMENTATIVE ALTERNA, V14, P184; Beharelle A. R., 2011, FRONT HUM NEUROSCI, V5, P1; Berryman A, 2010, NEUROREHABILITATION, V27, P261, DOI 10.3233/NRE-2010-0607; Beukelman D., 2013, AUGMENTATIVE ALTERNA, V4th ed; Beukelman DR, 2007, AUGMENT ALTERN COMM, V23, P230, DOI 10.1080/07434610701553668; Blair MR, 2009, J EXP PSYCHOL LEARN, V35, P1196, DOI 10.1037/a0016272; Brown JA, 2015, DISABIL REHABIL-ASSI, V10, P378, DOI 10.3109/17483107.2014.921250; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cilo M, 2010, NEUROREHABILITATION, V27, P237, DOI 10.3233/NRE-2010-0603; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Dietz A., 2006, PERSPECTIVES AUGMENT, V15, P13, DOI [10.1044/aac15.1.13, DOI 10.1044/AAC15.1.13]; Drager KDR, 2003, J SPEECH LANG HEAR R, V46, P298, DOI 10.1044/1092-4388(2003/024); Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Fried-Oken M, 1992, J HEAD TRAUMA REHAB, V7, P59, DOI DOI 10.1097/00001199-199209000-00008; Gastwirth JL, 2009, STAT SCI, V24, P343, DOI 10.1214/09-STS301; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hays W., 1981, STATISTICS; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Higginbotham DJ, 2007, AUGMENT ALTERN COMM, V23, P243, DOI 10.1080/07434610701571058; Holmqvist K, 2011, EYE TRACKING COMPREH; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; Hulse P, 2010, NEUROREHABILITATION, V27, P269, DOI 10.3233/NRE-2010-0608; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; JAGAROO V, 2002, SMART ENG SYSTEM DES, V12, P81; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kertesz A., 2006, W APHASIA BATTERY RE; Kozleski E., 1991, EXCEPTIONALITY, V2, P173, DOI DOI 10.1080/09362839109524782; Light J, 2014, AUGMENT ALTERN COMM, V30, P99, DOI 10.3109/07434618.2014.906498; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAuliffe MJ, 2010, BRAIN INJURY, V24, P1408, DOI 10.3109/02699052.2010.511590; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); Politzer T, 2010, NEUROREHABILITATION, V27, P247, DOI 10.3233/NRE-2010-0605; Poole A., 2006, ENCY HUMAN COMPUTER, P211, DOI DOI 10.4018/978-1-59140-562-7.CH034; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Ripley DL, 2010, NEUROREHABILITATION, V27, P231, DOI 10.3233/NRE-2010-0602; Ripley DL, 2010, NEUROREHABILITATION, V27, P215, DOI 10.3233/NRE-2010-0599; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; Sigafoos J., 2002, AUGMENTATIVE ALTERNA, V18, DOI [DOI 10.1080/07434610212331281201, 10.1080/07434610212331281201]; Simone Raffaele, 1995, ICONICITY LANGUAGE; Snyder C, 2000, J MED SPEECH-LANG PA, V8, P187; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace SE, 2010, PERSPECT AUGMENT ALT, V19, P79; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Wilkinson K.M., 2004, AUGMENTATIVE ALTERNA, V20, DOI [10.1080/07434610410001699717, DOI 10.1080/07434610410001699717]; Wilkinson KM, 2014, AUGMENT ALTERN COMM, V30, P106, DOI 10.3109/07434618.2014.904435; Wilkinson KM, 2012, AUGMENT ALTERN COMM, V28, P137, DOI 10.3109/07434618.2012.704522; Wilkinson KM, 2011, J SPEECH LANG HEAR R, V54, P1644, DOI 10.1044/1092-4388(2011/10-0098); WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411	59	13	13	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0743-4618	1477-3848		AUGMENT ALTERN COMM	Augment. Altern. Commun.	MAR	2015	31	1					15	26		10.3109/07434618.2014.995224			12	Audiology & Speech-Language Pathology; Rehabilitation	Audiology & Speech-Language Pathology; Rehabilitation	CB7WH	WOS:000349838800002	25685881				2021-06-18	
J	Hassett, L; Moseley, A; Harmer, A; van der Ploeg, HP				Hassett, Leanne; Moseley, Anne; Harmer, Alison; van der Ploeg, Hidde P.			The Reliability, Validity, and Feasibility of Physical Activity Measurement in Adults With Traumatic Brain Injury: An Observational Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; motor activity; physiotherapy specialty; questionnaires; reproducibility of results	ACTIVITY SCALE; INDIVIDUALS; PEOPLE; CALIBRATION; RECOMMENDATIONS; INACTIVITY; CHILDREN; MODERATE; FITNESS	Objective: To determine the reliability and validity of the Physical Activity Scale for Individuals with a Physical Disability (PASIPD) in adults with severe traumatic brain injury (TBI) and estimate the proportion of the sample participants who fail to meet the World Health Organization guidelines for physical activity. Design and Participants: A single-center observational study recruited a convenience sample of 30 community-based ambulant adults with severe TBI. Protocol: Participants completed the PASIPD on 2 occasions, 1 week apart, and wore an accelerometer (ActiGraph GT3X; ActiGraph LLC, Pensacola, Florida) for the 7 days between these 2 assessments. Results: The PASIPD test-retest reliability was substantial (intraclass correlation coefficient = 0.85; 95% confidence interval, 0.70-0.92), and the correlation with the accelerometer ranged from too low to be meaningful (R = 0.09) to moderate (R = 0.57). From device-based measurement of physical activity, 56% of participants failed to meet the World Health Organization physical activity guidelines. Conclusion: The PASIPD is a reliable measure of the type of physical activity people with severe TBI participate in, but it is not a valid measure of the amount of moderate to vigorous physical activity in which they engage. Accelerometers should be used to quantify moderate to vigorous physical activity in people with TBI.	[Hassett, Leanne; Harmer, Alison] Univ Sydney, Fac Hlth Sci, Clin & Rehabil Sci Res Grp, Sydney, NSW 2141, Australia; [Hassett, Leanne; Moseley, Anne] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2141, Australia; [van der Ploeg, Hidde P.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2141, Australia; [van der Ploeg, Hidde P.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Hassett, L (corresponding author), Univ Sydney, Discipline Physiotherapy, Fac Hlth Sci, 75 East St, Sydney, NSW 2141, Australia.	Leanne.hassett@sydney.edu.au	van der Ploeg, Hidde P/B-2599-2013	van der Ploeg, Hidde P/0000-0002-3719-5249; Hassett, Leanne/0000-0002-3546-1822	Menzies Foundation	This study was funding by the Menzies Foundation. The authors thank clients and physiotherapy staff of the Liverpool Brain Injury Rehabilitation Unit, and Christy Bruce and Anna Wong, from the Liverpool Hospital Physiotherapy Department.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Ainsworth BE, 2012, J PHYS ACT HEALTH, V9, pS76, DOI 10.1123/jpah.9.s1.s76; American College of Sports Medicine, 2000, GUID EX TEST PRESCR; [Anonymous], 2009, EC COST SPINAL CORD, P1; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Blair SN, 2009, BRIT J SPORT MED, V43, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Dusick DM, 2012, INTRO INFERENTIAL ST; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Pfaff A, 2004, MANUAL MODIFIED OXFO; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Raymond J, 2010, SPINAL CORD, V48, P591, DOI 10.1038/sc.2009.180; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2012, LANCET, V380, P193, DOI 10.1016/S0140-6736(12)61028-9; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2012, J PHYS ACT HEALTH, V9, pS68, DOI 10.1123/jpah.9.s1.s68; Tweedy SM, 2005, MED SCI SPORT EXER, V37, P1474, DOI 10.1249/01.mss.0000177584.43330.ae; van den Berg-Emons RJ, 2011, ARCH PHYS MED REHAB, V92, P923, DOI 10.1016/j.apmr.2010.12.006; van der Ploeg Hidde P, 2007, J Phys Act Health, V4, P96; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Washburn RA, 2002, ARCH PHYS MED REHAB, V83, P193, DOI 10.1053/apmr.2002.27467; WHO, PHYS IN GLOB PUBL HL; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; World Health Organization, 2010, GLOB REC PHYS ACT HL	42	13	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E55	E61		10.1097/HTR.0000000000000047			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300006	24721810				2021-06-18	
J	Hou, PF; Liu, ZH; Li, N; Cheng, WJ; Guo, SW				Hou, Peng-Fei; Liu, Zhan-Hui; Li, Nan; Cheng, Wen-Jia; Guo, Shi-Wen			Knockdown of STIM1 Improves Neuronal Survival After Traumatic Neuronal Injury Through Regulating mGluR1-Dependent Ca2+ Signaling in Mouse Cortical Neurons	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; STIM1; mGluR1; Endoplasmic reticulum	METABOTROPIC GLUTAMATE RECEPTORS; CELL-DEATH MECHANISMS; DIFFUSE BRAIN-INJURY; IN-VITRO; CALCIUM-CHANNELS; ER STRESS; EXCITOTOXICITY; ACTIVATION; EXPRESSION; PATHWAY	Activation of glutamate receptors and followed increase of intracellular calcium concentration is a key pathological mechanism involved in secondary neuronal injury after traumatic brain injury (TBI). Stromal interaction molecule (STIM) proteins are considered to be important players in regulating neuronal Ca2+ homeostasis under normal aging and pathological conditions. Here, we investigated the role of STIM1 in regulating metabotropic glutamate receptor 1 (mGluR1)-related Ca2+ signaling and neuronal survival by using an in vitro traumatic neuronal injury (TNI) model. The expression of STIM1 was significantly increased at both mRNA and protein levels after TNI. Down-regulation of STIM1 by specific small interfere RNA significantly preserved neuronal viability, decreased lactate dehydrogenase release, and inhibited apoptotic cell death after traumatic injury. Moreover, knockdown of STIM1 significantly alleviated the mGluR1-related increase of cytoplasmic Ca2+ levels after TNI. By analyzing Ca2+ imaging in Ca2+-free conditions, we demonstrated that the mGluR1-dependent inositol trisphosphate receptor and/or ryanodine receptor-mediated Ca2+ release from the endoplasmic reticulum after TNI is strongly attenuated in the absence of STIM1. Together, our results demonstrate that in the mammalian nervous system, STIM1 is a key regulator of mGluR1-dependent Ca2+ signaling and knockdown of STIM1 might be an effective intervention target in TBI.	[Hou, Peng-Fei; Li, Nan; Guo, Shi-Wen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China; [Hou, Peng-Fei; Liu, Zhan-Hui] Ninth Hosp Xian, Dept Neurosurg, Xian 710054, Shaanxi, Peoples R China; [Li, Nan] Xian Chidrens Hosp, Dept Neurosurg, Xian 710043, Shaanxi, Peoples R China; [Cheng, Wen-Jia] Ninth Hosp Xian, Dept Pathol, Xian 710054, Shaanxi, Peoples R China	Guo, SW (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	guoshiwen_xjtu@163.com					Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Belousov AB, 2012, BRAIN RES, V1487, P123, DOI 10.1016/j.brainres.2012.05.063; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cucchiaroni ML, 2010, J NEUROSCI, V30, P5176, DOI 10.1523/JNEUROSCI.5351-09.2010; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Goudet C, 2009, BRAIN RES REV, V60, P43, DOI 10.1016/j.brainresrev.2008.12.007; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Harraz OF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00043; Hartmann J, 2014, NEURON, V82, P635, DOI 10.1016/j.neuron.2014.03.027; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huang WD, 2005, NEUROSCI LETT, V389, P46, DOI 10.1016/j.neulet.2005.07.014; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Li B, 2014, FREE RADICAL RES, V48, P758, DOI 10.3109/10715762.2014.905687; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Ng AN, 2011, J NEUROSCI RES, V89, P1235, DOI 10.1002/jnr.22648; O'Shea RD, 2002, CLIN EXP PHARMACOL P, V29, P1018, DOI 10.1046/j.1440-1681.2002.03770.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004	44	13	13	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2015	35	2					283	292		10.1007/s10571-014-0123-0			10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CC3HG	WOS:000350236800014	25304289				2021-06-18	
J	Kim, DY; Kobayashi, L; Chang, D; Fortlage, D; Coimbra, R				Kim, Dennis Yong; Kobayashi, Leslie; Chang, David; Fortlage, Dale; Coimbra, Raul			Early Pharmacological Venous Thromboembolism Prophylaxis Is Safe After Operative Fixation of Traumatic Spine Fractures	SPINE			English	Article						venous thromboembolism; spine fractures; pharmacological prophylaxis; trauma; epidural hematoma; complications; outcomes	MOLECULAR-WEIGHT HEPARIN; MAJOR TRAUMA; BRAIN-INJURY; DATA-BANK; 1602 EPISODES; RISK-FACTORS; SURGERY; THROMBOPROPHYLAXIS; ENOXAPARIN; PATIENT	Study Design. Retrospective cohort study. Objective. To examine the impact of early (<48 hr) versus late (>= 48 hr) initiation of pharmacological venous thromboembolism (VTE) prophylaxis on outcomes and complications among trauma patients undergoing operative fixation of spine fractures. Summary of Background Data. VTE complications are associated with poor outcomes after trauma. Although pharmacological prophylaxis decreases the risk of VTE after trauma, concerns regarding bleeding-related complications among certain patient subgroups persist. At present, there are limited data regarding the safety of early VTE prophylaxis in trauma patients undergoing operative fixation of spine fractures. Methods. We performed a 5-year retrospective analysis of our level 1 trauma center registry to identify consecutive patients undergoing operative fixation of spine fractures. Demographics, injury patterns and severity, details of operative procedures, timing of administration of VTE prophylaxis, and outcomes were analyzed. Patients receiving early VTE prophylaxis were compared with patients receiving late VTE prophylaxis. Multivariate analysis was performed to identify independent predictors of VTE. Results. Of 1432 patients with spine fractures, 206 patients (14.4%) underwent operative fixation. Forty-eight (23.3%) received early VTE prophylaxis and 158 (76.7%) received late VTE prophylaxis. No patient developed an epidural hematoma or postoperative bleeding necessitating intervention in either group. Thirteen patients (6.2%) developed VTE, of which 12 occurred in the late VTE prophylaxis group. Age 45 years or more (odds ratio = 5.12, 95% confidence interval = 1.01-25.94, P = 0.048) and traumatic brain injury (odds ratio = 6.94, 95% confidence interval = 1.19-40.35, P = 0.031) were independently associated with an increased risk for VTE. Conclusion. Pharmacological VTE prophylaxis initiated within 48 hours of operative fixation of traumatic spine fractures seems to be safe and is not associated with an increased risk of bleeding or neurological complications. Large, multicenter prospective studies are required to further define the efficacy and safety of an early pharmacological VTE prophylaxis strategy in this at-risk patient population.	[Kim, Dennis Yong; Kobayashi, Leslie; Chang, David; Fortlage, Dale; Coimbra, Raul] Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA	Coimbra, R (corresponding author), Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, 200 W Arbor Dr,8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Bono CM, 2009, SPINE J, V9, P1046, DOI 10.1016/j.spinee.2009.09.005; Bryson DJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-14; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Glotzbecker MP, 2010, SPINE, V35, pE413, DOI 10.1097/BRS.0b013e3181d9bb77; Glotzbecker MP, 2008, SPINE, V33, P2915, DOI 10.1097/BRS.0b013e318190702a; Glotzbecker MP, 2009, SPINE, V34, P291, DOI 10.1097/BRS.0b013e318195601d; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Jawa RS, 2011, J SURG RES, V167, P24, DOI 10.1016/j.jss.2010.09.046; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Kim DY, 2012, J TRAUMA ACUTE CARE, V72, P1286, DOI 10.1097/TA.0b013e31824ef9ec; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; Platzer P, 2006, ACTA ORTHOP, V77, P755, DOI 10.1080/17453670610012944; Ploumis A, 2010, SPINE, V35, P323, DOI 10.1097/BRS.0b013e3181ca652e; Ploumis A, 2009, SPINE J, V9, P530, DOI 10.1016/j.spinee.2009.01.008; Rogers SO, 2007, J TRAUMA, V62, P562; Shackford SR, 2004, ANN SURG, V240, P496; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021	27	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAR 1	2015	40	5					299	304		10.1097/BRS.0000000000000754			6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CD0HO	WOS:000350751600015	25901977				2021-06-18	
J	Levan, A; Baxter, L; Kirwan, CB; Black, G; Gale, SD				Levan, Ashley; Baxter, Leslie; Kirwan, C. Brock; Black, Garrett; Gale, Shawn D.			Right Frontal Pole Cortical Thickness and Social Competence in Children With Chronic Traumatic Brain Injury: Cognitive Proficiency as a Mediator	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive proficiency; cortical thickness; pediatric; social competence; traumatic brain injury	WORKING-MEMORY; EXECUTIVE FUNCTIONS; FLUID INTELLIGENCE; PERSONALITY-CHANGE; PREFRONTAL CORTEX; PROCESSING SPEED; YOUNG-CHILDREN; OUTCOMES; TBI; RECOMMENDATIONS	Objective: To examine the association between right frontal pole cortical thickness, social competence, and cognitive proficiency in children participants with a history of chronic traumatic brain injury (TBI). Participants: Twenty-three children (65% male; M age = 12.8 years, SD = 2.3 years) at least 1 year post-injury (M = 3.3 years, SD = 1.7 years) were evaluated with the Cognitive Proficiency Index (CPI) from the Wechsler Intelligence Scale for Children, 4th Edition, and their caregiver completed the Child Behavior Checklist. Social competence was evaluated with the Social Competence and Social Problems subscales from the Child Behavior Checklist. Right frontal pole cortical thickness was calculated via FreeSurfer from high-resolution 3-dimensional T1 magnetic resonance imaging scans. Results: Direct effect of right frontal pole cortical thickness on social competence was significant (beta = 14.09, SE = 4.6, P < .01). Right frontal pole cortical thickness significantly predicted CPI (beta = 18.44, SE = 4.9, P < .05), and CPI significantly predicted social competence (beta = 0.503, SE = 0.17, P < .01). Findings were consistent with the hypothesized mediation model. Conclusions: The association between right frontal lobe cortical integrity and social competence in pediatric participants with chronic TBI may be mediated through cognitive proficiency.	[Levan, Ashley; Kirwan, C. Brock; Black, Garrett; Gale, Shawn D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Kirwan, C. Brock; Gale, Shawn D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Baxter, Leslie] St Josephs Hosp, Barrow Neurol Inst, Dept Neuroimaging, Phoenix, AZ USA	Gale, SD (corresponding author), Brigham Young Univ, Dept Psychol, 1060 SWKT, Provo, UT 84602 USA.	shawn_gale@byu.edu	Gale, Shawn/M-3144-2013; Kirwan, Brock/B-1520-2014	Gale, Shawn/0000-0002-8989-0964; Kirwan, Brock/0000-0003-0768-1446			Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; [Anonymous], 2006, AMOS COMP PROGR; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gottlieb L, 2012, EPILEPSY BEHAV, V23, P146, DOI 10.1016/j.yebeh.2011.10.024; Kail R, 2000, J SCHOOL PSYCHOL, V38, P51, DOI 10.1016/S0022-4405(99)00036-9; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P123, DOI 10.1080/09084281003709009; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PERRIN EC, 1991, J PEDIATR PSYCHOL, V16, P411, DOI 10.1093/jpepsy/16.4.411; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Prifitera A, 2008, WISC 4 CLIN ASSESSME; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Rackley C, 2012, CHILD NEUROPSYCHOL, V18, P512, DOI 10.1080/09297049.2011.628308; Salpekar JA, 2010, EPILEPSY BEHAV, V17, P50, DOI 10.1016/j.yebeh.2009.10.002; Sattler J. M., 2008, ASSESSMENT CHILDREN; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Swanson HL, 2003, MEMORY DIFFICULTIES; Wechsler D., 2003, WECHSLER INTELLIGENC; Weiss LG, 2010, THEORETICAL EMPIRICA; Weiss LG, 2006, WISC 4 ADV CLIN INTE, P139; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zbikowski SM, 1998, J APPL DEV PSYCHOL, V19, P249, DOI 10.1016/S0193-3973(99)80039-2	51	13	13	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E24	E31		10.1097/HTR.0000000000000040			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300003	24714213				2021-06-18	
J	Samadani, U; Farooq, S; Ritlop, R; Warren, F; Reyes, M; Lamm, E; Alex, A; Nehrbass, E; Kolecki, R; Jureller, M; Schneider, J; Chen, A; Shi, C; Mendhiratta, N; Huang, JH; Qian, M; Kwak, R; Mikheev, A; Rusinek, H; George, A; Fergus, R; Kondziolka, D; Huang, PP; Smith, RT				Samadani, Uzma; Farooq, Sameer; Ritlop, Robert; Warren, Floyd; Reyes, Marleen; Lamm, Elizabeth; Alex, Anastasia; Nehrbass, Elena; Kolecki, Radek; Jureller, Michael; Schneider, Julia; Chen, Agnes; Shi, Chen; Mendhiratta, Neil; Huang, Jason H.; Qian, Meng; Kwak, Roy; Mikheev, Artem; Rusinek, Henry; George, Ajax; Fergus, Robert; Kondziolka, Douglas; Huang, Paul P.; Smith, R. Theodore			Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip	JOURNAL OF NEUROSURGERY			English	Article						abducent nerve; diplopia; eye movement tracking; hydrocephalus; oculomotor nerve; prepontine cistern; diagnostic and operative techniques	TRAUMATIC BRAIN-INJURY; OCULOMOTOR DEFICITS; MOVEMENT-DISORDERS; OCULAR MOTILITY; CHILDREN; DYSFUNCTION; DISEASE; HYDROCEPHALUS; DEMENTIA	OBJECT Automated eye movement tracking may provide clues to nervous system function at many levels. Spatial calibration of the eye tracking device requires the subject to have relatively intact ocular motility that implies function of cranial nerves (CNs) III (oculomotor), IV (trochlear), and VI (abducent) and their associated nuclei, along with the multiple regions of the brain imparting cognition and volition. The authors have developed a technique for eye tracking that uses temporal rather than spatial calibration, enabling detection of impaired ability to move the pupil relative to normal (neurologically healthy) control volunteers. This work was performed to demonstrate that this technique may detect CN palsies related to brain compression and to provide insight into how the technique may be of value for evaluating neuropathological conditions associated with CN palsy, such as hydrocephalus or acute mass effect. METHODS The authors recorded subjects' eye movements by using an Eye link 1000 eye tracker sampling at 500 Hz over 200 seconds while the subject viewed a music video playing inside an aperture on a computer monitor. The aperture moved in a rectangular pattern over a fixed time period. This technique was used to assess ocular motility in 157 neurologically healthy control subjects and 12 patients with either clinical CN III or VI palsy confirmed by neuro-ophthalmological examination, or surgically treatable pathological conditions potentially impacting these nerves. The authors compared the ratio of vertical to horizontal eye movement (height/width defined as aspect ratio) in normal and test subjects. RESULTS In 157 normal controls, the aspect ratio (height/width) for the left eye had a mean value +/- SD of 1.0117 +/- 0.0706. For the right eye, the aspect ratio had a mean of 1.0077 +/- 0.0679 in these 157 subjects. There was no difference between sexes or ages. A patient with known CN VI palsy had a significantly increased aspect ratio (1.39), whereas 2 patients with known CN III palsy had significantly decreased ratios of 0.19 and 0.06, respectively. Three patients with surgically treatable pathological conditions impacting CN VI, such as infratentorial mass effect or hydrocephalus, had significantly increased ratios (1.84, 1.44, and 1.34, respectively) relative to normal controls, and 6 patients with supratentorial mass effect had significantly decreased ratios (0.27, 0.53, 0.62, 0.45, 0.49, and 0.41, respectively). These alterations in eye tracking all reverted to normal ranges after surgical treatment of underlying pathological conditions in these 9 neurosurgical cases. CONCLUSIONS This proof of concept series of cases suggests that the use of eye tracking to detect CN palsy while the patient watches television or its equivalent represents a new capacity for this technology. It may provide a new tool for the assessment of multiple CNS functions that can potentially be useful in the assessment of awake patients with elevated intracranial pressure from hydrocephalus or trauma.	[Samadani, Uzma; Warren, Floyd; Reyes, Marleen; Nehrbass, Elena; Shi, Chen; Mendhiratta, Neil; Kwak, Roy] NYU, Sch Med, Manhattan Vet Adm, New York Harbor Hlth Care Syst, New York, NY USA; [Samadani, Uzma; Farooq, Sameer; Ritlop, Robert; Reyes, Marleen; Lamm, Elizabeth; Nehrbass, Elena; Kolecki, Radek; Jureller, Michael; Schneider, Julia; Chen, Agnes; Shi, Chen; Mendhiratta, Neil; Kondziolka, Douglas; Huang, Paul P.] NYU, Sch Med, Dept Neurosurg, New York, NY USA; [Warren, Floyd; Alex, Anastasia; Smith, R. Theodore] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Qian, Meng] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Mikheev, Artem; Rusinek, Henry; George, Ajax] NYU, Sch Med, Dept Radiol, New York, NY USA; [Lamm, Elizabeth; Fergus, Robert] NYU, Courant Inst, Dept Comp Sci, New York, NY USA; [Huang, Jason H.] Scott & White Hlth Care, Dept Neurosurg, Temple, TX USA	Samadani, U (corresponding author), 423 E 23rd St,MC 112, New York, NY 10010 USA.	uzma.samadani@nyumc.org	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168; Warren, Floyd/0000-0001-7326-7142; Huang, Paul/0000-0003-0563-921X; george, ajax/0000-0001-6355-2951; smith, theodore/0000-0002-1693-943X	Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service via a VA Merit Award [1I01RX000319-01]; American College of Surgeons/Neurosurgery Research Education Foundation of the AANS; Steven and Alexandra Cohen Center for Veteran Post-Traumatic Stress and Traumatic Brain Injury; Thrasher Research Fund; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000319] Funding Source: NIH RePORTER	Dr. Samadani's work is supported in part by the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service, via a VA Merit Award (1I01RX000319-01), and she was supported by a Career Development Award from the American College of Surgeons/Neurosurgery Research Education Foundation of the AANS. She is also supported by the Steven and Alexandra Cohen Center for Veteran Post-Traumatic Stress and Traumatic Brain Injury; by the Thrasher Research Fund; and by Research to Prevent Blindness.	Adler DE, 2002, J NEUROSURG, V96, P1103, DOI 10.3171/jns.2002.96.6.1103; Alemdar M, 2006, J NEURO-OPHTHALMOL, V26, P173, DOI 10.1097/01.wno.0000235588.18169.de; Altintas O, 2005, GRAEF ARCH CLIN EXP, V243, P1213, DOI 10.1007/s00417-005-0001-z; Archibald NK, 2013, BRAIN, V136, P739, DOI 10.1093/brain/awt005; Beaufils E, 2012, AMYOTROPH LATERAL SC, V13, P84, DOI 10.3109/17482968.2011.580848; Brodsky MC, 2003, BRIT J OPHTHALMOL, V87, P1440, DOI 10.1136/bjo.87.12.1440; Brodsky Michael C, 2011, Am Orthopt J, V61, P28; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cavezian C, 2010, RES DEV DISABIL, V31, P1102, DOI 10.1016/j.ridd.2010.03.006; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Clark D, 2012, CURR OPIN OPHTHALMOL, V23, P491, DOI 10.1097/ICU.0b013e328358ba14; Matta APD, 2008, DEV NEUROREHABIL, V11, P159, DOI 10.1080/17518420701783622; Dagi LR, 2011, OPHTHAL PLAST RECONS, V27, P102, DOI 10.1097/IOP.0b013e3181e9a063; DELEU D, 1989, ARCH NEUROL-CHICAGO, V46, P1361, DOI 10.1001/archneur.1989.00520480105028; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; Friedman DI, 2010, SEMIN NEUROL, V30, P54, DOI 10.1055/s-0029-1244995; FRIEDMAN DI, 1992, J CLIN NEURO-OPHTHAL, V12, P104; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hanson RA, 2004, NEUROLOGY, V62, P33, DOI 10.1212/WNL.62.1.33; Hicks SL, 2008, PROG BRAIN RES, V171, P555, DOI 10.1016/S0079-6123(08)00678-X; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Kerrison J B, 1997, Curr Opin Ophthalmol, V8, P35, DOI 10.1097/00055735-199712000-00006; Levy DL, 2010, CURR TOP BEHAV NEURO, V4, P311, DOI 10.1007/7854_2010_60; Marx S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00088; Mikheev A, 2008, J MAGN RESON IMAGING, V27, P1235, DOI 10.1002/jmri.21372; NATHAN H, 1974, J NEUROSURG, V41, P561, DOI 10.3171/jns.1974.41.5.0561; Pelak VS, 2010, CURR NEUROL NEUROSCI, V10, P440, DOI 10.1007/s11910-010-0137-z; Pierrot-Deseilligny Charles, 2011, Handb Clin Neurol, V102, P319, DOI 10.1016/B978-0-444-52903-9.00018-2; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rogers GL, 2013, PEDIATR REV, V34, P126, DOI 10.1542/pir.34-3-126; Rudolph G, 2009, EUR J OPHTHALMOL, V19, P667; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Tamhankar MA, 2011, EYE, V25, P91, DOI 10.1038/eye.2010.160; Vaphiades MS, 2012, CURR OPIN OPHTHALMOL, V23, P537, DOI 10.1097/ICU.0b013e328358b94a; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364; ZEINER HK, 1985, CHILD NERV SYST, V1, P115, DOI 10.1007/BF00706692	37	13	15	1	18	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					707	720		10.3171/2014.10.JNS14762			14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600030	25495739	Green Accepted, Bronze			2021-06-18	
J	Sivertsen, M; Normann, B				Sivertsen, Marianne; Normann, Britt			Embodiment and self in reorientation to everyday life following severe traumatic brain injury	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Embodiment; phenomenology; physiotherapy; self; traumatic brain injury	QUALITY-OF-LIFE; PEOPLE; PARTICIPATION; REHABILITATION; SATISFACTION; REFLECTIONS; EXPERIENCE; NARRATIVES; MODERATE; ISSUES	People with severe traumatic brain injury (sTBI) are often young and need long-term follow-up as many suffer complex motor, sensory, perceptual and cognitive impairments. This paper aims to introduce phenomenological notions of embodiment and self as a framework to help understand how people with sTBI experience reorientation to everyday life, and to inform clinical practice in neurological physiotherapy. The impairments caused by the sTBI may lead to a sense of alienation of one's own body and changes in operative intentionality and in turn disrupt the reorganization of self, identity, everyday life and integration/co-construction of meaning with others. Applying a first-person conception of the body may extend insights into the importance of an adapted and individualized approach to strengthen the sensory, perceptual and motor body functions, which underpin the pre-reflective and reflective aspects of the self. It seems important to integrate these aspects, while also paying attention to optimizing co-construction of meaning for the person with sTBI in the treatment context. This requires understanding the patient as an experiencing and expressive body, a lived body (body-as-subject) and not just the body-as-object as is favored in more traditional frameworks of physiotherapy.	[Sivertsen, Marianne; Normann, Britt] Nordland Hosp Trust, Dept Physiotherapy, N-8092 Bodo, Norway; [Normann, Britt] UiT Arctic Univ Tromso, Dept Hlth & Care Sci, Tromso, Norway	Sivertsen, M (corresponding author), Nordland Hosp Trust, Dept Physiotherapy, N-8092 Bodo, Norway.	marianne.sivertsen2@nordlandssykehuset.no		Sivertsen, Marianne/0000-0003-0895-1081			Antetius E, 2007, MED ANTHROPOL Q, V21, P324, DOI 10.1525/MAQ.2007.21.3.324; Bischofberger W, 2004, MOVEMENT ACTION LEAR, P213; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Brodal P., 2010, CENTRAL NERVOUS SYST, V4th ed; Brough JB, 2001, HDB PHENOMENOLOGY ME; Carr JH., 2010, NEUROLOGICAL REHABIL, V2nd ed.; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Fuchs T, 2009, PHENOMENOL COGN SCI, V8, P465, DOI 10.1007/s11097-009-9136-4; Gallagher S, 2000, J CONSCIOUSNESS STUD, V7, P45; Gallagher S., 2012, PHENOMENOLOGY; Gallagher S., 2008, PHENOMENOLOGICAL MIN; Gallagher S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00443; Gallagher Shaun, 2005, BODY SHAPES MIND; Gibson BE, 2010, PHYSIOTHER CAN, V62, P98, DOI 10.3138/physio.62.2.98; Gibson J., 1979, ECOLOGICAL APPROACH; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jaegher Hanne De, 2007, PHENOMENOL COGN SCI, V6, P485, DOI [https://doi.org/10.1007/s11097-007-9076-9, DOI 10.1007/S11097-007-9076-9, 10.1007/s11097-007-9076-9]; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Leder D., 1990, ABSENT BODY; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Lund LB, 2013, J NOVEL PHYSIOTHERAP, V4, P1; Meadows L, 2009, BOBATH CONCEPT THEOR; Merleau-Ponty M., 2008, PHENOMENOLOGY PERCEP; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nicholls David A., 2010, Physiotherapy Theory and Practice, V26, P497, DOI 10.3109/09593981003710316; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Normann B, 2013, PHYSIOTHER THEOR PR, V29, P19, DOI 10.3109/09593985.2012.698717; Normann Britt, 2012, Physiotherapy Theory and Practice, V28, P108, DOI 10.3109/09593985.2011.574782; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Roth C, 2013, NEUROCRIT CARE, V18, P33, DOI 10.1007/s12028-012-9799-5; Rowland LP, 2010, MERRITS NEUROLOGY; Schutz Alfred, 2005, HVERDAGSLIVETS SOCIO; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shumway-Cook A., 2012, MOTOR CONTROL TRANSL; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432	51	13	13	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	MAR	2015	31	3					153	159		10.3109/09593985.2014.986350			7	Rehabilitation	Rehabilitation	CF9CD	WOS:000352858300001	25431992				2021-06-18	
J	Suehiro, E; Koizumi, H; Fujisawa, H; Fujita, M; Kaneko, T; Oda, Y; Yamashita, S; Tsuruta, R; Maekawa, T; Suzuki, M				Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Fujita, Motoki; Kaneko, Tadashi; Oda, Yasutaka; Yamashita, Susumu; Tsuruta, Ryosuke; Maekawa, Tsuyoshi; Suzuki, Michiyasu			Diverse Effects of Hypothermia Therapy in Patients with Severe Traumatic Brain Injury Based on the Computed Tomography Classification of the Traumatic Coma Data Bank	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; hypothermia; Traumatic Coma Data Bank; multicenter randomized controlled trial; heterogeneous pathophysiology; CT classification	POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; AXONAL INJURY; HEAD-INJURY; INDUCTION; GLUTAMATE; DAMAGE; RAT	A multicenter randomized controlled trial of patients with severe traumatic brain injury who received therapeutic hypothermia or fever control was performed from 2002 to 2008 in Japan (BHYPO). There was no difference in the therapeutic effect on traumatic brain injury between the two groups. The efficacy of hypothermia treatment and the objective of the treatment were reexamined based on a secondary analysis of the BHYPO trial in 135 patients (88 treated with therapeutic hypothermia and 47 with fever control). This analysis was performed to examine clinical outcomes according to the CT classification of the Traumatic Coma Data Bank on admission. Clinical outcomes were evaluated with the Glasgow Outcome Scale and mortality at 6 months after injury. Good recovery and moderate disability were defined as favorable outcomes. Favorable outcomes in young patients (<= 50 years old) with evacuated mass lesions significantly increased from 33.3% with fever control to 77.8% with therapeutic hypothermia. Patients with diffuse injury III who were treated with therapeutic hypothermia, however, had significantly higher mortality than patients treated with fever control. It was difficult to control intracranial pressure with hypothermia for patients with diffuse injury III, but hypothermia was effective for young patients with an evacuated mass lesion.	[Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi; Fujita, Motoki; Kaneko, Tadashi; Oda, Yasutaka; Yamashita, Susumu; Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan; [Maekawa, Tsuyoshi] Yamaguchi Grand Med Ctr, Hofu, Yamaguchi, Japan	Suehiro, E (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019		Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462219] Funding Source: KAKEN	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare, H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001, and by the Japanese Human Science Association, 2002-2004.	Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Delbarre B, 1992, EXS, V62, P199; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Holzer M, 2002, NEW ENGL J MED, V346, P549; *JAP SOC NEUR, 2001, GUID MAN SEV HEAD IN, P1; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KURODA Y, 1992, NEUROSURGERY, V30, P687; Maekawa T., 2014, J NEUROTRAU IN PRESS; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906	25	13	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					353	358		10.1089/neu.2014.3584			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700007	25233298	Green Published			2021-06-18	
J	Williams, G; Lai, D; Schache, A; Morris, ME				Williams, Gavin; Lai, Daniel; Schache, Anthony; Morris, Meg E.			Classification of Gait Disorders Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain trauma; classification; gait disorders; rehabilitation	SPASTIC HEMIPLEGIA; CHILDREN; PATTERNS; IMPAIRMENT; MANAGEMENT; ASYMMETRY; OUTCOMES; PROFILE	Objective: To determine the extent to which gait disorders associated with traumatic brain injury (TBI) are able to be classified into clinically relevant and distinct subgroups. Design: Cross-sectional cohort study comprising people with TBI receiving physiotherapy for mobility limitations. Participants: One hundred two people with TBI. Outcome Measures: The taxonomic framework for gait disorders following TBI was devised on the basis of a framework previously developed for people with cerebral palsy. Participants with TBI who were receiving therapy for mobility problems were assessed using 3-dimensional gait analysis. Pelvis and bilateral lower limb kinematic data were recorded using a VICON motion analysis system while each participant walked at a self-selected speed. Five trials of data were collected for each participant. Multiclass support vector machine models were developed to systematically and automatically ascertain the clinical classification. Results: The statistical features derived from the major joint angles from unaffected limbs contributed to the best classification accuracy of 82.35% (84 of the 102 subjects). Features from the affected limb resulted in a classification accuracy of 76.47% (78 of 102 subjects). Conclusions: Despite considerable variability in gait disorders following TBI, we were able to generate a clinical classification system on the basis of 6 distinct subgroups of gait deviations. Statistical features related to the motion of the pelvis, hip, knee, and ankle on the less affected leg were able to accurately classify 82% of people with TBI-related gait disorders using a multiclass support vector machine framework.	[Williams, Gavin] Epworth Healthcare, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Melbourne, Vic, Australia; [Lai, Daniel] Victoria Univ, Melbourne, Vic 8001, Australia; [Schache, Anthony] Univ Melbourne, Sch Mech Engn, Melbourne, Vic 3010, Australia; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia	Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Williams, Gavin/0000-0003-2758-7473; Morris, Meg/0000-0002-0114-4175; Lai, Daniel/0000-0003-3459-7709			Balasubramanian CK, 2007, ARCH PHYS MED REHAB, V88, P43, DOI 10.1016/j.apmr.2006.10.004; Begg RK, 2005, IEEE T BIO-MED ENG, V52, P828, DOI 10.1109/TBME.2005.845241; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Davids JR, 1999, J PEDIATR ORTHOPED, V19, P211, DOI 10.1097/00004694-199903000-00015; Deuschl G, 2000, BRAIN, V123, P1568, DOI 10.1093/brain/123.8.1568; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Gradenigo B, 2002, EURA MEDICOPHYS, V38, P215; Graham HK, 2004, J PEDIATR ORTHOPED, V24, P514, DOI 10.1097/01241398-200409000-00011; Hallett M, 2001, ADV NEUROL, V87, P155; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Herbrich R, 2002, LEARNING KERNEL CLAS; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hudson CC, 2000, EXP BRAIN RES, V132, P103, DOI 10.1007/s002219900291; Kaczmarczyk K, 2009, GAIT POSTURE, V30, P207, DOI 10.1016/j.gaitpost.2009.04.010; KNUTSSON E, 1979, BRAIN, V102, P405, DOI 10.1093/brain/102.2.405; Lai DTH, 2009, IEEE T INF TECHNOL B, V13, P687, DOI 10.1109/TITB.2009.2022913; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; Oken O, 2008, EUR J PHYS REHAB MED, V44, P127; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Olver J, 2013, REHABILITATION IN MOVEMENT DISORDERS, P131; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Patikas D, 2005, EUR J NEUROL, V12, P691, DOI 10.1111/j.1468-1331.2005.01047.x; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Shilton A, 2012, IEEE IJCNN; Steinwart Ingo, 2008, SUPPORT VECTOR MACHI; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; SUTHERLAND DH, 1993, CLIN ORTHOP RELAT R, P139; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Thurman DJ, 1999, TRAUMATIC BRAIN INJU; Vapnik V.N., 2000, NATURE STAT LEARNING; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; Wong AM, 2004, ARCH PHYS MED REHAB, V85, P1625, DOI 10.1016/j.apmr.2003.11.039	48	13	13	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E13	E23		10.1097/HTR.0000000000000038			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300002	24695264				2021-06-18	
J	Chan, V; Thurairajah, P; Colantonio, A				Chan, Vincy; Thurairajah, Pravheen; Colantonio, Angela			Defining pediatric traumatic brain injury using International Classification of Diseases Version 10 Codes: A systematic review	BMC NEUROLOGY			English	Article						Coding; International Classification of Diseases; Pediatric brain injury	SHAKEN BABY SYNDROME; ABUSIVE HEAD TRAUMA; FACIAL FRACTURES; CONCOMITANT INJURIES; RETINAL HEMORRHAGE; YOUNG-CHILDREN; POST-TBI; EPIDEMIOLOGY; CONCUSSION; PATTERNS	Background: Although healthcare administrative data are commonly used for traumatic brain injury (TBI) research, there is currently no consensus or consistency on the International Classification of Diseases Version 10 (ICD-10) codes used to define TBI among children and youth internationally. This study systematically reviewed the literature to explore the range of ICD-10 codes that are used to define TBI in this population. The identification of the range of ICD-10 codes to define this population in administrative data is crucial, as it has implications for policy, resource allocation, planning of healthcare services, and prevention strategies. Methods: The databases MEDLINE, MEDLINE In-Process, Embase, PsychINFO, CINAHL, SPORTDiscus, and Cochrane Database of Systematic Reviews were systematically searched. Grey literature was searched using Grey Matters and Google. Reference lists of included articles were also searched for relevant studies. Two reviewers independently screened all titles and abstracts using pre-defined inclusion and exclusion criteria. A full text screen was conducted on articles that met the first screen inclusion criteria. All full text articles that met the pre-defined inclusion criteria were included for analysis in this systematic review. Results: A total of 1,326 publications were identified through the predetermined search strategy and 32 articles/reports met all eligibility criteria for inclusion in this review. Five articles specifically examined children and youth aged 19 years or under with TBI. ICD-10 case definitions ranged from the broad injuries to the head codes (ICD-10 S00 to S09) to concussion only (S06.0). There was overwhelming consensus on the inclusion of ICD-10 code S06, intracranial injury, while codes S00 (superficial injury of the head), S03 (dislocation, sprain, and strain of joints and ligaments of head), and S05 (injury of eye and orbit) were only used by articles that examined head injury, none of which specifically examined children and youth. Conclusion: This review provides evidence for discussion on how best to use ICD codes for different goals. This is an important first step in reaching an appropriate definition and can inform future work on reaching consensus on the ICD-10 codes to define TBI for this vulnerable population.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Chan, Vincy; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada; [Chan, Vincy; Thurairajah, Pravheen; Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON M5G 1V7, Canada	Colantonio, A (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	angela.colantonio@utoronto.ca	Chan, Vincy/AAA-7813-2020; Meijer, Anna/K-5118-2016	Colantonio, Angela/0000-0003-2094-4765; Chan, Vincy/0000-0002-6884-044X	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Pediatric Oncology Group of Ontario for a Doctoral Research Award; Brain Canada; Ontario Neurotrauma Foundation for the Jane Gillett Pediatric ABI Studentship; CIHR Research Chair in Gender, Work and Health [CGW-126580]; Toronto Rehabilitation Institute-University Health Network (TRI-UHN); CIBC	This study had no external funding source. VC received support from the Canadian Institutes of Health Research (CIHR) and Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada and CIBC for a Brain Cancer Training Award, and the Ontario Neurotrauma Foundation for the Jane Gillett Pediatric ABI Studentship. AC received support through a CIHR Research Chair in Gender, Work and Health (# CGW-126580). We recognize support from the Toronto Rehabilitation Institute-University Health Network (TRI-UHN). We would like to thank Ms. Jessica Babineau, information specialist from TRI-UHN, for her assistance with the search strategies and Ms. Sabrina Curatolo for assistance in formatting and editing this paper.	Afrooz PN, 2012, J CRANIOFAC SURG, V23, P1270, DOI 10.1097/SCS.0b013e31824e6447; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; [Anonymous], BIG DAT KNOWL; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barker-Collo SL, TRENDS HEAD INJURY I; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Bhatoe CHS, 2007, INDIAN J NEUROTRAUM, V4, P89, DOI 10.1016/S0973-0508(07)80022-0; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Blumenthal I, 2002, POSTGRAD MED J, V78, P732, DOI 10.1136/pmj.78.926.732; Canadian Agency for Drugs and Technologies in Health, GREY MATT PRACT SEAR; Canadian Institute for Health Information, CAN COD STAND VERS 2; Canadian Institute for Health Information, ICD 10 CA CCI IMPL S; Canadian Institute for Health Information, HEAD INJ CAN DEC CHA; Canadian Institute for Health Information Canadian Neurological Sciences Federation & Canadian Brain and Nerve Health Coalition, BURD NEUR DIS DIS IN; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Centers for Disease Control and Prevention, HEADS PREV SHAK BAB; Centers for Disease Control and Prevention, MANY PEOPL HAV TBI; Chan V, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-102; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Child Safety Link & Atlantic Collaborative on Injury Prevention, CHILD YOUTH UN INJ A; Colantonio A, ONTARIO ACQUIRED BRA; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Coronado VG, 1997, SURVEILLANCE TRAUMAT; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Deisch J, 2011, J FORENSIC SCI, V56, P1049, DOI 10.1111/j.1556-4029.2011.01765.x; Department of Health and Human Resources USA, ICD 10 CM PCS ENXT G; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Faul M, 2002, TRAUMATIC BRAIN INJR; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Harrison JE, 2012, BRAIN INJURY, V26, P996, DOI 10.3109/02699052.2012.660515; Hoyt CS, 2007, EYE, V21, P1285, DOI 10.1038/sj.eye.6702849; Hubbard G, 2012, TRAUMATIC BRAIN INJR; Hyder AA, IMPOACT TRUAMATIC BR; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Juurlink D, CANADIAN I HLTH INFO; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kivlin J D, 1999, Trans Am Ophthalmol Soc, V97, P545; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Martin RCG, 2002, AM SURGEON, V68, P477; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Morad Y, 2004, J AAPOS, V8, P521, DOI 10.1016/j.jaapos.2004.07.009; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Mungan NK, 2007, CURR OPIN OPHTHALMOL, V18, P392, DOI 10.1097/ICU.0b013e3282a167f0; Nestman P, CHILD YOUTH INJRIES; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; O'Rance L, DISABILITY AUSTR ACQ; Ontario Injury Prevention Resource Centre, ONT INJ DAT REP; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Parks SE, PEDIATRIC ABUSE HEAD; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Prasad MR, 1999, J CHILD NEUROL, V14, P496, DOI 10.1177/088307389901400803; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Roberts RF, 1998, MED J AUSTRALIA, V169, pS32, DOI 10.5694/j.1326-5377.1998.tb123473.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ropper AH, CONCUSSION OTHER HEA; Russell HV, 2013, PEDIATRICS, V131, pE273, DOI 10.1542/peds.2012-0912; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; Socie E, SPORTS RECREATION RE; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takeshi M, 2006, J TRAUMA, V60, P1245, DOI 10.1097/01.ta.0000196932.11384.ac; Tang Johnny, 2008, Int Ophthalmol Clin, V48, P237, DOI 10.1097/IIO.0b013e3181693236; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; The Victorian Neurotrauma Initiative, EC COST SPIN CORD IN; Thoren H, 2012, J ORAL MAXIL SURG, V70, P92, DOI 10.1016/j.joms.2011.06.227; Thurman DJ, STANDARDS SURVEILLAN; WellFlorida Council Inc, TRAUM BRAIN INJ FLOR; WHO, INT CLASS DIS; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037; World Health Organization, NEUR DIS PUBL HLTH C; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023; Xia X, 2012, INT J ENV RES PUB HE, V9, P4187, DOI 10.3390/ijerph9114187; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zimmermann CE, 2006, INT J ORAL MAX SURG, V35, P1, DOI 10.1016/j.ijom.2005.06.015	105	13	13	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	FEB 4	2015	15								7	10.1186/s12883-015-0259-7			26	Clinical Neurology	Neurosciences & Neurology	CD0UR	WOS:000350789900001	25648197	DOAJ Gold, Green Published			2021-06-18	
J	Belanger, HG; Barwick, F; Silva, MA; Kretzmer, T; Kip, KE; Vanderploeg, RD				Belanger, Heather G.; Barwick, Fiona; Silva, Marc A.; Kretzmer, Tracy; Kip, Kevin E.; Vanderploeg, Rodney D.			Web-Based Psychoeducational Intervention for Postconcussion Symptoms: A Randomized Trial	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIOR THERAPY; PSYCHOLOGICAL TREATMENTS; HEAD-INJURY; METAANALYSIS; CONCUSSION; COMPLAINTS; VETERANS; PILOT; DEPRESSION	The objective of this study was to investigate the effectiveness of a web-based educational intervention for reducing postconcussion symptoms. 158 participants with self-reported symptomatic mild traumatic brain injury were randomized to intervention versus control. There was no effect of intervention on symptom severity or attributions. Subgroup analyses suggested benefit of the web-based intervention in those receiving concurrent mental health treatment and in those participants with the greatest time since injury (>1 year after mild traumatic brain injury). Web-based educational intervention was not effective overall in this sample. However, there is some suggestion of promise in those receiving concurrent mental health treatment and with more chronic symptoms. Findings also suggest potential benefit of interventions targeting self-efficacy.	[Belanger, Heather G.; Silva, Marc A.; Kretzmer, Tracy; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Barwick, Fiona] VA Greater Los Angeles Healthcare Syst, Dept Mental Behav Hlth, Los Angeles, CA 90073 USA; [Kip, Kevin E.] Univ S Florida, Coll Nursing, Tampa, FL USA	Belanger, HG (corresponding author), James A Haley VA, Dept Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.		Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Department of DefenseUnited States Department of Defense [W81XWH-10-1-0719]; Department of Veterans AffairsUS Department of Veterans Affairs; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs	The research reported here was supported by the Department of Defense (W81XWH-10-1-0719), Department of Veterans Affairs, Veterans Health Administration (VHA), and the Defense and Veterans Brain Injury Center (DVBIC). Further support was provided by the James A. Haley Veterans' Hospital.	Ackerman R, 2011, J EXP PSYCHOL-APPL, V17, P18, DOI 10.1037/a0022086; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Derogatis LR, 2000, BSI 18 ADM SCORING P; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Eagly A.H, 1995, ATTITUDE STRENGTH AN, V1, P413; Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4, DOI 10.5694/j.1326-5377.2010.tb03685.x; Hailey D, 2008, CAN J PSYCHIAT, V53, P769, DOI 10.1177/070674370805301109; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ern.12.63, 10.1586/ERN.12.63]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; Knutson MB, 2013, J PSYCHIATR MENT HLT, V20, P874, DOI 10.1111/jpm.12043; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Noyes JM, 2008, ERGONOMICS, V51, P1352, DOI 10.1080/00140130802170387; Noyes JM, 2003, INT J IND ERGONOM, V31, P411, DOI 10.1016/S0169-8141(03)00027-1; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Stepnowsky C, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/239382; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turvey CL, 2013, ELSEV INSIGHT, P3, DOI 10.1016/B978-0-12-416048-4.00001-4; Vanderploeg RD, 2013, J HEAD TRAU IN PRESS; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Wastlund E, 2005, COMPUT HUM BEHAV, V21, P377, DOI 10.1016/j.chb.2004.02.007; Weathers F. W., 1991, PCL C FOR DSM IV; World Health Organization, 2012, HLTH ED THEOR CONC E; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241	53	13	13	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					192	200		10.7205/MILMED-D-14-00388			9	Medicine, General & Internal	General & Internal Medicine	CA7MR	WOS:000349101900012	25643387	Bronze			2021-06-18	
J	de Lanerolle, NC; Kim, JH; Bandak, FA				de Lanerolle, Nihal C.; Kim, Jung H.; Bandak, Faris A.			Neuropathology of Traumatic Brain Injury: Comparison of Penetrating, Nonpenetrating Direct Impact and Explosive Blast Etiologies	SEMINARS IN NEUROLOGY			English	Article						traumatic brain Injury; neuropathology; penetrating injury; closed head injury; explosive blast; concussion; microglia; astrocytes; diffuse axonal injury	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; MILD HEAD-INJURY; WAR VETERANS; ALZHEIMERS-DISEASE; GUNSHOT WOUNDS; BETA-APP; DAMAGE; RISK; ENCEPHALOPATHY	The neuropathology of traumatic brain injury (TBI) from various causes in humans is not as yet fully understood. The authors review and compare the known neuropathology in humans with severe, moderate, and mild TBI (mTBI) from nonpenetrating closed head injury (CHI) from blunt impacts and explosive blasts, as well as penetrating head injury (PHI). Penetrating head injury and CHI that are moderate to severe are more likely than mTBI to cause gross disruption of the cerebral vasculature. Axonal injury is classically exhibited as diffuse axonal injury (DAI) in severe to moderate CHI. Diffuse axonal injury is also prevalent in PHI. It is less so in mTBI. There may be a unique pattern of periventricular axonal injury in explosive blast mTBI. Neuronal injury is more prevalent in PHI and moderate to severe CHI than mTBI. Astrocyte and microglial activation and proliferation are found in all forms of animal TBI models and in severe to moderate TBI in humans. Their activation in mTBI in the human brain has not yet been studied.	[de Lanerolle, Nihal C.] Yale Univ, Sch Med, Dept Neurosurg & Neurobiol, New Haven, CT 06520 USA; [Kim, Jung H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bandak, Faris A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA	de Lanerolle, NC (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, FMB414,333 Cedar St, New Haven, CT 06520 USA.	Nihal.delanerolle@yale.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blissitt Patricia A, 2006, Crit Care Nurs Clin North Am, V18, P321, DOI 10.1016/j.ccell.2006.05.006; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; Campbell GA, 1999, MISSILE WOUNDS HEAD, P73; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hetherington HP, 2015, HDB CLIN NE IN PRESS; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; HOF PR, 1992, ACTA NEUROPATHOL, V84, P45, DOI 10.1007/BF00427214; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Koszyca B, 1998, J NEUROTRAUM, V15, P675, DOI 10.1089/neu.1998.15.675; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Ling G, 2015, HDB CLIN NEUROLOGY; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mott F. W., 1917, J ROY ARMY MED CORPS, V29, P662; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Oehmichen M, 2004, FORENSIC SCI INT, V146, P111, DOI 10.1016/j.forsciint.2004.06.023; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Oehmichen M, 2001, FORENSIC SCI INT, V115, P189, DOI 10.1016/S0379-0738(00)00335-2; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; TEASDALE G, 1974, LANCET, V2, P81; Tsao JW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004595; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	63	13	14	0	10	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					12	19		10.1055/s-0035-1544240			8	Clinical Neurology	Neurosciences & Neurology	CC4AP	WOS:000350293300004	25714863				2021-06-18	
J	Yuan, Q; Wu, X; Du, ZY; Sun, YR; Yu, J; Li, ZQ; Wu, XH; Mao, Y; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Du, Zhuo-Ying; Sun, Yi-Rui; Yu, Jian; Li, Zhi-Qi; Wu, Xue-Hai; Mao, Ying; Zhou, Liang-Fu; Hu, Jin			Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Coagulopathy; Recombinant factor VIIa	ACTIVATED FACTOR-VII; FRESH-FROZEN PLASMA; COAGULATION DISORDERS; TRANSFUSION; HEMORRHAGE	Purpose: The purpose of this study was to investigate the role of low-dose recombinant factor VIIa (rFVIIa) (20 mu g/kg) in reversing coagulopathy in patients with isolated traumatic brain injury (TBI). Materials and methods: Patients with isolated TBI and coagulopathy at admission were enrolled prospectively from January 2010 to December 2011. The patients were divided into 2 groups: the rFVIIa and the no-rFVIIa groups. In the rFVIIa group, patients received a single dose of 20 mu g/kg rFVIIa intravenously to reverse their coagulopathy in addition to blood products. Patients in the no-rFVIIa group received only blood products to correct the coagulopathy. The clinical outcome variables evaluated included changes in coagulation parameters after administration for reversing coagulopathy, the occurrence of progressive hemorrhagic injury (PHI), intensive care unit length of stay, the incidence of thromboembolic complications, inhospital mortality, and 90-day Glasgow Outcome Scale. Results: Eighty-seven patients were ultimately included in this study. Of them, 49 patients were treated with blood products alone, whereas 38 patients also received rFVIIa to reverse their coagulopathy. The improvement in international normalized ratio was greater in the rFVIIa group (0.26 [0.18-0.39]) than in the no-rFVIIa group (0.06 [-0.11 to 0.30]) (P = .001). In addition, the improvement in lactate was also greater in the rFVIIa group (0.33 [-0.18 to 0.54]) than in the no-rFVIIa group (0.04 [-0.25 to 0.20]) (P = .029). During the period after we began to correct the coagulopathy, PHI occurred in 19 patients (38.8%) in the no-rFVIIa group, which was significantly higher than that in the rFVIIa group (7, 18.4%; P = .040). The rate of cerebral infarction was similar in both groups (10.2% vs 5.3%). There was a trend indicating that low-dose rFVIIa therapy was associated with a lower mortality, but the association was not statistically significant (P = .266). Conclusions: The use of low-dose rFVIIa (20 mu g/kg) is effective for correcting coagulopathy in patients with TBI without an increase in thromboembolic events. Moreover, it is more effective for preventing the occurrence of PHI. (C) 2014 Elsevier Inc. All right reserved.	[Yuan, Qiang; Wu, Xing; Du, Zhuo-Ying; Sun, Yi-Rui; Yu, Jian; Li, Zhi-Qi; Wu, Xue-Hai; Mao, Ying; Zhou, Liang-Fu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China	Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	yq123abc011@163.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, 08dj1400503]; National Basic Research ProgramNational Basic Research Program of China [2009CB941100, 2010CB945500, 2012CB966300]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This work is supported, in part, by funds from the National Natural Science Foundation of China (NSFC grants 30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, and 08dj1400503), the National Basic Research Program (2009CB941100, 2010CB945500, 2012CB966300), the Science and Technology Commission of Shanghai Municipality Project (10JC1402300), and the Shanghai Nature Science Foundation (08411952000).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Andersen ND, 2012, ANN THORAC SURG, V93, P1921, DOI 10.1016/j.athoracsur.2012.02.037; Bochicchio GV, 2008, WORLD J SURG, V32, P2185, DOI 10.1007/s00268-008-9655-0; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS55; Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI [10.1097/01.CCM.0000186745.53059.F0, 10.1097/01.CCM.0000151062.00501.60]; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; Eikelboom JW, 2003, BLOOD COAGUL FIBRIN, V14, P713, DOI 10.1097/00001721-200312000-00004; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; FARINGER PD, 1993, J TRAUMA, V34, P481, DOI 10.1097/00005373-199304000-00002; Geeraedts LMG, 2005, INJURY, V36, P495, DOI 10.1016/j.injury.2004.08.001; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hawryluk GWJ, 2006, J NEUROSURG, V105, P859, DOI 10.3171/jns.2006.105.6.859; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Howes Jeremy L, 2009, Am J Surg, V198, P895, DOI 10.1016/j.amjsurg.2009.05.026; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Khan AZ, 2005, AM J SURG, V189, P331, DOI 10.1016/j.amjsurg.2004.11.021; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Morey Allen F, 2005, J Urol, V174, P968, DOI 10.1097/01.ju.0000168117.11396.89; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; O'Connell NM, 2003, TRANSFUSION, V43, P1711, DOI 10.1046/j.0041-1132.2003.00577.x; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Schurr MJ, 2004, J TRAUMA, V57, P718; Simpson E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005011.pub4; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	41	13	19	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2015	30	1					116	120		10.1016/j.jcrc.2014.07.009			5	Critical Care Medicine	General & Internal Medicine	AW4GJ	WOS:000346238900020	25092615				2021-06-18	
J	Ma, BQ; Zhang, M; Ba, L				Ma, Bu-Qing; Zhang, Mao; Ba, Li			Plasma pituitary adenylate cyclase-activating polypeptide concentrations and mortality after acute spontaneous basal ganglia hemorrhage	CLINICA CHIMICA ACTA			English	Article						Pituitary adenylate cyclase activating polypeptide; Intracerebral hemorrhage; Mortality; Severity; Biomarker	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; VASOACTIVE-INTESTINAL-PEPTIDE; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; PACAP; APOPTOSIS; LOCALIZATION; MACROPHAGES; NEURONS; GROWTH	Background: Plasma pituitary adenylate cyclase activating polypeptide (PACAP) concentrations are elevated after traumatic brain injury. We assessed the prognostic value of PACAP for short-term and long-term mortality of acute intracerebral hemorrhage (ICH) patients. Methods: A total of 150 patients and 150 age- and gender- matched healthy controls were recruited. The plasma PACAP concentrations were measured using sandwich immunoassays. ICH severity was assessed using hematoma volume and National Institutes of Health Stroke Scale (NIHSS) score. The end points included 1-week mortality and 6-month mortality. The relationships between plasma PACAP concentrations and ICH severity and the end points were analyzed statistically. Results: Plasma PACAP concentrations were statistically significantly higher in the ICH patients than in the healthy controls and were correlated positively with hematoma volumes and NIHSS scores using a multivariate linear regression. Multivariate analysis results indicated that plasma PACAP concentration was an independent predictor of 1-week mortality, 6-month mortality and 6-month overall survival. It also had high predictive value based on receiver operating characteristic curve. Conclusions: Plasma PACAP concentrations are increased and are highly associated with the severity of ICH; PACAP may be a good predictor of short-term and long-term mortality of ICH. (C) 2014 Elsevier B.V. All rights reserved.	[Ma, Bu-Qing; Zhang, Mao; Ba, Li] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency, Hangzhou 310000, Zhejiang, Peoples R China; [Ma, Bu-Qing] Third Peoples Hosp Hangzhou, Dept Emergency, Hangzhou 310000, Zhejiang, Peoples R China	Ba, L (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	hijiang123@163.com					Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; ARIMURA A, 1994, ANN NY ACAD SCI, V739, P228, DOI 10.1111/j.1749-6632.1994.tb19825.x; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brunswick AS, 2012, J NEUROL SCI, V321, P1, DOI 10.1016/j.jns.2012.06.008; Bukovics P, 2014, PEPTIDES, V60, P18, DOI 10.1016/j.peptides.2014.07.001; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; Cheung C. M., 2008, Hong Kong Medical Journal, V14, P367; Delgado M, 1999, J IMMUNOL, V162, P2358; Delgado M, 2002, GLIA, V39, P148, DOI 10.1002/glia.10098; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Du Q, 2014, CLIN CHIM ACTA, V437, P141, DOI 10.1016/j.cca.2014.07.014; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee EH, 2014, BMB REP, V47, P369, DOI 10.5483/BMBRep.2014.47.7.086; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591; Mester L, 2011, J MOL NEUROSCI, V43, P35, DOI 10.1007/s12031-010-9427-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Naval NS, 2008, NEUROL CLIN, V26, P373, DOI 10.1016/j.ncl.2008.03.002; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Racz B, 2010, REGUL PEPTIDES, V160, P91, DOI 10.1016/j.regpep.2009.12.003; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Szabadfi K, 2012, NEUROTOX RES, V21, P41, DOI 10.1007/s12640-011-9254-y; Szakaly P, 2010, TRANSPL P, V42, P2283, DOI 10.1016/j.transproceed.2010.05.012; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tsuchikawa D, 2012, J MOL NEUROSCI, V48, P508, DOI 10.1007/s12031-012-9817-2; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029	37	13	13	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 15	2015	439						102	106		10.1016/j.cca.2014.10.010			5	Medical Laboratory Technology	Medical Laboratory Technology	AY3RG	WOS:000347499700018	25314937				2021-06-18	
J	Lengenfelder, J; Arjunan, A; Chiaravalloti, N; Smith, A; DeLuca, J				Lengenfelder, Jeannie; Arjunan, Aparna; Chiaravalloti, Nancy; Smith, Angela; DeLuca, John			Assessing Frontal Behavioral Syndromes and Cognitive Functions in Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						traumatic brain injury; frontal behaviors; executive functions	POSITRON-EMISSION-TOMOGRAPHY; EXECUTIVE DYSFUNCTION; SELF-AWARENESS; SCALE FRSBE; DRUG-USE; DIFFERENTIAL IMPACT; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; VISUAL MEMORY; HEAD-INJURY	This study examined the relationship between individual and family ratings on a measure of frontal behaviors using the Frontal Systems Behavior Scale (FrSBe). Additionally, this study investigated whether self-reported symptoms of frontal-lobe dysfunction correspond to neuropsychological performance, particularly those tests measuring executive functions. Thirty-three individuals with moderate-to-severe traumatic brain injury (TBI) and 19 healthy individuals completed the FrSBe and neuropsychological measures. Results indicated that the self-ratings of individuals' apathy, disinhibition, and executive dysfunction significantly increased from before to after injury, as did the family members' ratings, with no significant difference between the patients' and family members' reports for any of the three FrSBe subscales. Although individuals with TBI demonstrated impairments in neuropsychological measures, including measures of executive functioning, few significant correlations were found between the patients' FrSBe ratings and measures of cognitive functioning. This suggests that information from the FrSBe may differ from information gathered during a cognitive evaluation and may enhance our understanding of the behavioral sequelae following TBI that may not be captured by neuropsychological assessment alone.	[Lengenfelder, Jeannie; Arjunan, Aparna; Chiaravalloti, Nancy; Smith, Angela; DeLuca, John] Kessler Fdn Res Ctr, W Orange, NJ 07052 USA; [Lengenfelder, Jeannie; Chiaravalloti, Nancy; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA	Lengenfelder, J (corresponding author), Kessler Fdn Res Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jlengenfelder@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K23HD042128-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD042128] Funding Source: NIH RePORTER	This research was supported in part by the National Institute of Health Grant #5K23HD042128-05 awarded to Dr. Lengenfelder.	Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Cahn-Weiner DA, 2002, NEUROPSY NEUROPSY BE, V15, P79, DOI 10.1097/01.WNN.0000012908.05122.F4; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grace J, 2001, FRONTAL SYSTEM BEHAV; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim E, 2002, NEUROREHABILITATION, V17, P297; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1016/S0003-9993(00)90227-2; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Marsh L, 2009, MOVEMENT DISORD, V24, P277, DOI 10.1002/mds.22307; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McKinlay W, 1999, COGNITIVE BEHAV EFFE; Mendez MF, 2008, INT J GERIATR PSYCH, V23, P1203, DOI 10.1002/gps.2019; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41; Pachalska M., 2002, MED SCI MONITOR, V8, P1; Perecman E., 1987, FRONTAL LOBES REVISI; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; RICKER JH, 1994, NEUROPSYCHOLOGIA, V32, P1287, DOI 10.1016/0028-3932(94)90110-4; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Spinella M, 2007, J GEN PSYCHOL, V134, P101, DOI 10.3200/GENP.134.1.101-111; Stout JC, 2003, AM J GERIAT PSYCHIAT, V11, P683; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Verdejo-Garcia A, 2008, PSYCHIAT RES, V158, P172, DOI 10.1016/j.psychres.2006.08.001; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Yoshizumi M, 2008, PSYCHIAT CLIN NEUROS, V62, P669, DOI 10.1111/j.1440-1819.2008.01866.x	55	13	14	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2015	22	1					7	15		10.1080/23279095.2013.816703			9	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	CC5ZA	WOS:000350442800001	25529586				2021-06-18	
J	Alsalaheen, BA; Haines, J; Yorke, A; Stockdale, K; Broglio, SP				Alsalaheen, Bara A.; Haines, Jamie; Yorke, Amy; Stockdale, Kayla; Broglio, Steven P.			Reliability and concurrent validity of instrumented balance error scoring system using a portable force plate system	PHYSICIAN AND SPORTSMEDICINE			English	Article						Postural control; static balance; measurements; concussion	POSTURAL STABILITY; ANKLE INSTABILITY; CONCUSSION; SCHOOL; SPORT; REPRODUCIBILITY; ASSESSMENTS; PERFORMANCE; STATEMENT; SYMPTOMS	Objectives: The Balance Error Scoring System (BESS) is a commonly used test in adolescents and young adults. Affordability and portability of newer force plates has led to instrumentation of many clinical balance tests including the BESS. Despite the higher precision of force plate measures compared with clinical scoring, it is unclear if the instrumented BESS demonstrate concurrent validity and reliability when compared with the original BESS. The purpose of this study was to examine the reliability and concurrent validity of instrumented BESS testing using a commercially available force plate system. Methods: Thirty-six participants participated in the initial testing day (17 male/19 female, M = 15.9 years, SD = 1.5 years). The test-retest sample consisted of 26 participants who completed the same testing procedure after 1 week. For all testing sessions, participants performed the BESS while standing on a portable force plate system. Number of errors and sway velocity were obtained. Concurrent validity was established through correlation analysis examining the relationship between the original and the instrumented BESS scores. Reliability was established using Intraclass Correlation Coefficient (ICC3,1) computed for the instrumented and the original BESS. Results: A significant moderate relationship exists between the total scores of the original and the instrumented BESS (rs = 0.54, p = 0.001). Despite a range of reliability scores for the different conditions in the instrumented BESS (ICC3,1 = 0.19-0.61) and the clinically scored BESS (ICC3,1 = 0.13-0.71), the reliability score for the total test score was the same for the instrumented and the clinical test (ICC3,1 = 0.74). Conclusion: Although the instrumented BESS may appear to demonstrate concurrent validity against the original BESS, instrumentation did not improve its reliability. Future research should examine if the instrumented BESS demonstrates validity against laboratory level force plates and if it is able to overcome the ceiling effect reported for the clinical BESS test.	[Alsalaheen, Bara A.; Haines, Jamie; Yorke, Amy; Stockdale, Kayla] Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA; [Broglio, Steven P.] Univ Michigan, NeuroSport Res Lab, Ann Arbor, MI 48109 USA	Alsalaheen, BA (corresponding author), Univ Michigan, Phys Therapy Dept, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313	Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity (RCA) Award	This project was funded by Ben F. Bryer Foundation Medical Research Fund, and by the University of Michigan-Flint's Research and Creative Activity (RCA) Award. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Abujaber S, 2015, GAIT POSTURE, V41, P676, DOI 10.1016/j.gaitpost.2015.01.023; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Arnold BL, 2009, MED SCI SPORT EXER, V41, P1048, DOI 10.1249/MSS.0b013e318192d044; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davisson C, 2014, TEST RETEST RELIABIL; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Portney LG, 2009, FDN CLIN RES APPL PR, P595; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Walsh MS, 2006, J STRENGTH COND RES, V20, P730; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E	40	13	13	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2015	43	3					221	226		10.1080/00913847.2015.1040717			6	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	CR4TF	WOS:000361331100004	26109242				2021-06-18	
J	Ao, BT; Tobias, M; Ameratunga, S; McPherson, K; Theadom, A; Dowell, A; Starkey, N; Jones, K; Barker-Collo, S; Brown, P; Feigin, V				Ao, Braden Te; Tobias, Martin; Ameratunga, Shanthi; McPherson, Kathryn; Theadom, Alice; Dowell, Anthony; Starkey, Nicola; Jones, Kelly; Barker-Collo, Suzanne; Brown, Paul; Feigin, Valery		BIONIC Study Grp	Burden of Traumatic Brain Injury in New Zealand: Incidence, Prevalence and Disability-Adjusted Life Years	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Incidence; Prevalence; Disability-adjusted life years and DISMOD	GLOBAL BURDEN; SPECTRUM; OUTCOMES; DISEASE; REHABILITATION; EPIDEMIOLOGY; HEALTH; COSTS	Objective: The study aimed to estimate the incidence, prevalence and disability-adjusted life years (DALY) for traumatic brain injury (TBI) in New Zealand (NZ) in 2010. Methods: A multi-state life table model was constructed using inputs from the Brain Injury Outcomes New Zealand in the Community study for the first-ever incidence of TBI in a lifetime and its severity distribution, from the NZ Ministry of Health's Mortality Collection for the data on TBI mortality and from Statistics of NZ for the population data. The modeled estimate of prevalence was combined with the disability weights for TBI (by stage and severity level) from the Global Burden of Disease 2010 study to obtain estimates of health loss (DALYs) for TBI. Results: Approximately, 11,300 first-ever incident TBIs occurred in NZ during 2010, with 527,000 New Zealanders estimated to have ever experienced a TBI (prevalent cases). The estimated 20,300 DALYs attributable to TBI accounted for 27% of total injury-related health loss and 2.4% of DALYs from all causes. Of the total DALYs attributable to TBI, 71% resulted from fatal injuries. However, nonfatal outcomes accounted for a substantial share of the burden (29%) with mild TBI making the greater contribution of non-fatal outcomes (56%). Conclusions: The burden of TBI in NZ is substantial, and mild TBI contributes to a major part of non-fatal outcomes. (C) 2015 S. Karger AG, Basel	[Ao, Braden Te; Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Auckland 1142, New Zealand; [Ao, Braden Te] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Publ Hlth & Psychosocial Studies, Dept Biostat & Epidemiol, Auckland 1142, New Zealand; [McPherson, Kathryn] Auckland Univ Technol, Fac Hlth & Environm Sci, Hlth & Rehabil Res Inst, Auckland 1142, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Tobias, Martin] Minist Hlth, Hlth & Disabil Intelligence, Wellington, New Zealand; [Dowell, Anthony] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Starkey, Nicola] Univ Waikato, Fac Arts & Social Sci, Sch Psychol, Hamilton, New Zealand; [Brown, Paul] Univ Calif, Sch Social Sci Humanities & Arts, Merced, CA USA	Ao, BT (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Private Bag 92006, Auckland 1142, New Zealand.	braden.teao@aut.ac.nz	Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Te Ao, Braden/0000-0002-1050-200X; Feigin, Valery L./0000-0002-6372-1740; Ameratunga, Shanthi/0000-0001-8042-2251; McPherson, Kathryn/0000-0003-1240-8882; Theadom, Alice/0000-0003-0351-6216; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand; Waikato-Tainui doctoral grant	We would like to acknowledge our collaborators on the Brain Injury Outcomes New Zealand in the Community (BIONIC) study for providing data for our analyses. We wish to thank the research assistants, members of the BIONIC Steering Committee, BIONIC study participants, their families and friends and the Health Research Council of NZ for Raiding the research program. Braden Te Ao was supported by a PhD fellowship from the Health Research Council of New Zealand and a Waikato-Tainui doctoral grant. We acknowledge with gratitude the intellectual leadership and disability weights provided by Christopher Murray and colleagues at the GBD project, Institute for Health Metrics and Evaluation, University of Washington.	Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Barendregt JJ, 2005, EUR J EPIDEMIOL, V20, P827, DOI 10.1007/s10654-005-2227-9; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Che G, 2000, AGE STANDARDIZATION; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; JENNETT B, 1975, LANCET, V1, P480; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Ministry of Health and Accident Compensation Corporation, 2013, REP NZ BURD DIS INJ; Ministry of Health (New Zealand) Ways and Means, 2012, REP METH NZ BURD DIS; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Roberts MG, 2001, IMA J MATH APPL MED, V18, P119; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746	24	13	13	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2015	44	4					255	261		10.1159/000431043			7	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	CO0CJ	WOS:000358817400007	26088707				2021-06-18	
J	Bailie, JM; Cole, WR; Ivins, B; Boyd, C; Lewis, S; Neff, J; Schwab, K				Bailie, Jason M.; Cole, Wesley R.; Ivins, Brian; Boyd, Cynthia; Lewis, Steven; Neff, John; Schwab, Karen			The Experience, Expression, and Control of Anger Following Traumatic Brain Injury in a Military Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger; explosive blast injury; military injury; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; AFGHANISTAN WAR VETERANS; HEAD-INJURY; MANAGEMENT THERAPY; AGGRESSION; MILD; IRAQ; IRRITABILITY; HOSTILITY; SYMPTOMS	Objective: To investigate the impact of traumatic brain injury (TBI) on the experience and expression of anger in a military sample. Participants: A total of 661 military personnel with a history of TBI and 1204 military personnel with no history of TBI. Design: Cross-sectional, between-group design, using multivariate analysis of variance. Main Measure: State-Trait Anger Expression Inventory-2 (STAXI-2). Results: Participants with a history of TBI had higher scores on the STAXI-2 than controls and were 2 to 3 times more likely than the participants in the control group to have at least 1 clinically significant elevation on the STAXI-2. Results suggested that greater time since injury (ie, months between TBI and assessment) was associated with lower scores on the STAXI-2 State Anger scale. Conclusion: Although the results do not take into account confounding psychiatric conditions and cannot address causality, they suggest that a history of TBI increases the risk of problems with the experience, expression, and control of anger. This bolsters the need for proper assessment of anger when evaluating TBI in a military cohort.	[Bailie, Jason M.; Boyd, Cynthia; Neff, John] Naval Med Ctr San Diego, Def & Vet Brain Injury Ctr, San Diego, CA 92134 USA; [Bailie, Jason M.; Cole, Wesley R.; Boyd, Cynthia] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA; [Ivins, Brian] Adv Mil Med Inc, Henry M Jackson Fdn, Washington, DC USA; [Ivins, Brian] Def & Vet Brain Injury Ctr, Washington, DC USA; [Cole, Wesley R.; Lewis, Steven] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Lewis, Steven] Womack Army Med Ctr, Dept Traumat Brain Injury, Ft Bragg, NC USA; [Neff, John] US Navy, Rehabil Med, San Diego, CA 92152 USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Epidemiol & Res Support Serv, Washington, DC USA	Bailie, JM (corresponding author), Naval Med Ctr San Diego, Def & Vet Brain Injury Ctr, 34730 Bob Wilson Dr,Ste 201, San Diego, CA 92134 USA.	jason.bailie.ctr@med.navy.mil			 [W91YTZ-12-C-0132]	Research on this article was done under contract # W91YTZ-12-C-0132.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; [Anonymous], 2005, GAO05952; [Anonymous], 2008, REP SURG GEN TRAUM B; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cornell DG, 1999, J CONSULT CLIN PSYCH, V67, P108, DOI 10.1037/0022-006X.67.1.108; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Department of the Army, 2012, ARM 2020 GEN HLTH DI; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Elbogen EB, 2008, J TRAUMA STRESS, V21, P113, DOI 10.1002/jts.20283; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; LAMBERT SJ, 1990, HUM RELAT, V43, P239, DOI 10.1177/001872679004300303; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Murphy CM, 2007, J COUNS PSYCHOL, V54, P189, DOI 10.1037/0022-0167.54.2.189; O'Leary CA, 2000, BEHAV INTERVENT, V15, P205, DOI 10.1002/1099-078X(200007/09)15:3<205::AID-BIN56>3.3.CO;2-B; Paniak C, 2000, BRAIN INJURY, V14, P219; Potegal M, 2010, INTERNATIONAL HANDBOOK OF ANGER, P3, DOI 10.1007/978-0-387-89676-2_1; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Spielberger C., 1999, STAXI 2 STATE TRAIT; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Waller M, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-7; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	40	13	13	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					12	20		10.1097/HTR.0000000000000024			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400010	24590149				2021-06-18	
J	Deng-Bryant, Y; Readnower, RD; Leung, LY; Cunningham, TL; Shear, DA; Tortella, FC				Deng-Bryant, Ying; Readnower, Ryan D.; Leung, Lai Yee; Cunningham, Tracy L.; Shear, Deborah A.; Tortella, Frank C.			Treatment with amnion-derived cellular cytokine solution (ACCS) induces persistent motor improvement and ameliorates neuroinflammation in a rat model of penetrating ballistic-like brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Amnion-derived cellular cytokine solution; penetrating ballistic-like brain injury; rotarod; morris water maze; neuroinflammation; microglia; neutrophil; neurodegeneration	WHITE-MATTER INJURY; CLOSED-HEAD INJURY; BARRIER PERMEABILITY; GROWTH-FACTOR; NEONATAL-RAT; FUNCTIONAL RECOVERY; MICROGLIAL CELLS; IMMUNE-RESPONSE; EDEMA FORMATION; SMALL MOLECULES	Purpose: The present work compared the behavioral outcomes of ACCS therapy delivered either intravenously (i.v.) or intracerebroventricularly (i.c.v.) after penetrating ballistic-like brain injury (PBBI). Histological markers for neuroinflammation and neurodegeneration were employed to investigate the potential therapeutic mechanism of ACCS. Methods: Experiment-1, ACCS was administered either i.v. or i.c.v. for 1 week post-PBBI. Outcome metrics included behavioral (rotarod and Morris water maze) and gross morphological assessments. Experiment-2, rats received ACCS i.c.v for either 1 or 2 weeks post-PBBI. The inflammatory response was determined by immunohistochemistry for neutrophils and microglia reactivity. Neurodegeneration was visualized using silver staining. Results: Both i.v. and i.c.v. delivery of ACCS improved motor outcome but failed to improve cognitive outcome or tissue sparing. Importantly, only i.c.v. ACCS treatment produced persistent motor improvements at a later endpoint. The i.c.v. ACCS treatment significantly reduced PBBI-induced increase in myeloperoxidase (MPO) and ionized calcium binding adaptor molecule 1 (Iba1) expression. Concomitant reduction of both Iba1 and silver staining were detected in corpus callosum with i.c.v. ACCS treatment. Conclusions: ACCS, as a treatment for TBI, showed promise with regard to functional (motor) recovery and demonstrated strong capability to modulate neuroinflammatory responses that may underline functional recovery. However, the majority of beneficial effects appear restricted to the i.c.v. route of ACCS delivery, which warrants future studies examining delivery routes (e.g. intranasal delivery) which are more clinically viable for the treatment of TBI.	[Deng-Bryant, Ying; Readnower, Ryan D.; Leung, Lai Yee; Cunningham, Tracy L.; Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	Deng-Bryant, Y (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave Room 2W12, Silver Spring, MD 20910 USA.	ying.d.bryant.civ@mail.mil			CDMRPUnited States Department of Defense [W81XWH-08-2-0127]	The authors are grateful for the excellent technical assistance provided by Christopher van der Merwe and Francis P. Bustos. This work was funded by CDMRP W81XWH-08-2-0127.	Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Cunningham T.L., 2013, J NEUROTRAUMA; Deng-Bryant Y, 2012, J TRAUMA ACUTE CARE, V73, pS156, DOI 10.1097/TA.0b013e3182625f5f; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Fan LW, 2005, J NEUROSCI RES, V82, P71, DOI 10.1002/jnr.20623; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Franz Michael G, 2008, Eplasty, V8, pe21; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Iihara K, 1997, J CEREBR BLOOD F MET, V17, P1097, DOI 10.1097/00004647-199710000-00012; Kawabe T, 1997, NEUROSCI RES, V29, P335, DOI 10.1016/S0168-0102(97)00105-3; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Payne WG, 2010, WORLD J SURG, V34, P1663, DOI 10.1007/s00268-010-0420-9; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Proescholdt MG, 2002, NEUROSCIENCE, V112, P731, DOI 10.1016/S0306-4522(02)00048-9; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Steed David L, 2008, Eplasty, V8, pe18; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Uberti M Georgina, 2009, Eplasty, V9, pe12; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014	53	13	13	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	2					189	203		10.3233/RNN-140455			15	Neurosciences	Neurosciences & Neurology	CB7UX	WOS:000349835000009	25588460				2021-06-18	
J	Dutta, D; Fauer, C; Mulleneux, HL; Stabenfeldt, SE				Dutta, D.; Fauer, C.; Mulleneux, H. L.; Stabenfeldt, S. E.			Tunable controlled release of bioactive SDF-1 alpha via specific protein interactions within fibrin/nanoparticle composites	JOURNAL OF MATERIALS CHEMISTRY B			English	Article							FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; DRUG-DELIVERY SYSTEMS; NEURAL STEM-CELLS; PLGA NANOPARTICLES; TISSUE-REPAIR; FIBRIN; MIGRATION; HYDROGELS; FACTOR-1-ALPHA	The chemokine, stromal cell-derived factor 1 alpha (SDF-1 alpha), is a key regulator of the endogenous neural progenitor/stem cell-mediated regenerative response after neural injury. Increased and sustained bioavailability of SDF-1 alpha in the peri-injury region is hypothesized to modulate this endogenous repair response. Here, we describe poly(lactic-co-glycolic) acid (PLGA) nanoparticles capable of releasing bioactive SDF-1 alpha in a sustained manner over 60 days after a burst of 23%. Moreover, we report a biphasic cellular response to SDF-1 alpha concentrations thus the large initial burst release in an in vivo setting may result in supratherapeutic concentrations of SDF-1 alpha. Specific protein-protein interactions between SDF-1 alpha and fibrin (as well as its monomer, fibrinogen) were exploited to control the magnitude of the burst release. Nanoparticles embedded in fibrin significantly reduced the amount of SDF-1 alpha released after 72 h as a function of fibrin density. Therefore, the nanoparticle/fibrin composites represented a means to independently tune the magnitude of the burst phase release from the nanoparticles while perserving a bioactive depot of SDF-1 alpha for release over 60 days.	[Dutta, D.; Fauer, C.; Mulleneux, H. L.; Stabenfeldt, S. E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA	Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	sarah.stabenfeldt@asu.edu		Dutta, Dipankar/0000-0001-9864-1452	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2HD084067]; NSFNational Science Foundation (NSF) [1454282]; ASU Start-up Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER	The authors acknowledge Dr Rachael Sirianni of Barrow Neurological Institute for technical training and support with the PLGA NP synthesis, Dr Vikram Kodibagkar of ASU for his assistance with the ultrasonicator, Caroline Addington as well as Christine Pauken for cell culture expertise and the John M. Cowley Center for High Resolution Electron Microscopy (CHREM) for assistance with the SEM. The following funding sources are acknowledged: NIH (1DP2HD084067; SES), NSF (1454282; SES), and ASU Start-up Funds (SES).	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMIMI.S20062, 10.4137/BMI.S20062]; Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Aprili D, 2009, ANESTHESIOLOGY, V111, P1346, DOI 10.1097/ALN.0b013e3181bfab9a; Asghar W, 2012, IEEE T NANOTECHNOL, V11, P546, DOI 10.1109/TNANO.2012.2183004; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049; Bhakta S, 2006, CARDIOVASC REVASCULA, V7, P19, DOI 10.1016/j.carrev.2005.10.008; Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]; Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215; Catelas I, 2008, TISSUE ENG PART C-ME, V14, P119, DOI 10.1089/ten.tec.2007.0262; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cross DP, 2011, PHARM RES-DORDR, V28, P2477, DOI 10.1007/s11095-011-0474-x; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Edith N. S. P., 1997, INT J PHARMACEUT, V153, P235; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Giteau A, 2008, INT J PHARMACEUT, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012; Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x; Hines DJ, 2013, CRIT REV THER DRUG, V30, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.2013006475; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030; Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kucia M, 2004, J MOL HISTOL, V35, P233; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; McCall RL, 2013, JOVE-J VIS EXP, DOI 10.3791/51015; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Overstreet DJ, 2012, J POLYM SCI POL PHYS, V50, P881, DOI 10.1002/polb.23081; Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Riedel T, 2009, J BIOMED MATER RES A, V88A, P437, DOI 10.1002/jbm.a.31755; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Sirianni RW, 2014, BIOCONJUGATE CHEM, V25, P2157, DOI 10.1021/bc500315j; Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025; Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079; Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Vulic K, 2014, BIOMACROMOLECULES, V15, P3867, DOI 10.1021/bm501084u; Wedgwood J, 2013, MACROMOL SYMP, V334, P117, DOI 10.1002/masy.201300111; Wong C, 2003, THROMB HAEMOSTASIS, V89, P573; Wood MD, 2009, J BIOMED MATER RES A, V89A, P909, DOI 10.1002/jbm.a.32043; Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037; Zamani M, 2015, J COLLOID INTERF SCI, V451, P144, DOI 10.1016/j.jcis.2015.04.005; Zhang JW, 2013, CHEM ENG PROG, V109, P25; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088	61	13	14	0	14	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-750X	2050-7518		J MATER CHEM B	J. Mat. Chem. B		2015	3	40					7963	7973		10.1039/c5tb00935a			11	Materials Science, Biomaterials	Materials Science	CT2VO	WOS:000362663000015	26660666	Green Accepted, Other Gold			2021-06-18	
J	Fayaz, SM; Raj, YV; Krishnamurthy, RG				Fayaz, Shaik M.; Raj, Yanamala V.; Krishnamurthy, Rajanikant G.			CypD: The Key to the Death Door	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Apoptosis; calcium homeostasis; cyclosporin A; cyclophilin D; mitochondrial permeability transition pore; necroptosis; neurological disorders	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; ADENINE-NUCLEOTIDE TRANSLOCASE; HEPATITIS-C-VIRUS; INTERMEMBRANE JUNCTIONAL COMPLEXES; ALZHEIMERS-DISEASE IMPLICATIONS; CYCLOSPORINE DERIVATIVE NIM811; CULTURED HIPPOCAMPAL-NEURONS; TRANSIENT FOREBRAIN ISCHEMIA; ABNORMAL CALCIUM HOMEOSTASIS	Numerous studies have deciphered the importance of Cyclophilin D (CypD/peptidyl prolyl cis-trans isomerase F) in the formation and regulation of mitochondrial permeability transition pore (MPTP), implicated in the cell death mechanisms in various neurological diseases. Decrease in the ATP and increase in the calcium levels are the most common aftermath consequences that are observed in these diseases. Increased calcium level leads to the persistent opening of MPTP and cell death, which is mediated by CypD. However, the underlying mechanisms that contribute to the abnormal calcium homeostasis in different diseases remain elusive. In this review, we attempted to connect the disruption of mitochondrial bioenergetics with abnormal calcium levels and MPTP. Further, various proteins that interact with the CypD and the subsequent consequences have been described. All the cell death pathways in various neurological disorders merge at CypD, which acts as a key regulatory protein in cellular demise. Agents inhibiting CypD may have a therapeutic potential for treating neurological disorders such as Alzheimer's disease, Parkinson's disease and cerebral ischemia. Further, the knowledge regarding the pathophysiological processes involved in CypD-regulated MPTP and cell death would assist in battling with these diseases.	[Fayaz, Shaik M.; Raj, Yanamala V.; Krishnamurthy, Rajanikant G.] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India	Krishnamurthy, RG (corresponding author), Natl Inst Technol Calicut, DBT Ctr Bioinformat, Sch Biotechnol, Calicut 673601, Kerala, India.	rajanikant@nitc.ac.in	G.K, Rajanikant/H-3275-2019; S.M., Fayaz/P-6103-2015	S.M., Fayaz/0000-0002-1212-7952; , Rajanikant/0000-0001-9754-997X			Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Baines CP, 2007, AM J PHYSIOL-HEART C, V293, pH903, DOI 10.1152/ajpheart.00575.2007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Bambrick LL, 1997, GLIA, V19, P352, DOI 10.1002/(SICI)1098-1136(199704)19:4<352::AID-GLIA8>3.0.CO;2-Z; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Barsukova AG, 2011, EUR J NEUROSCI, V34, P437, DOI 10.1111/j.1460-9568.2011.07760.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Damiano M, 2013, HUM MOL GENET, V22, P3869, DOI 10.1093/hmg/ddt242; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DENTON RM, 1975, MOL CELL BIOCHEM, V9, P27, DOI 10.1007/BF01731731; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Favreau DJ, 2012, J VIROL, V86, P81, DOI 10.1128/JVI.06062-11; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; Guo HX, 2005, ACTA PHARMACOL SIN, V26, P1201, DOI 10.1111/j.1745-7254.2005.00189.x; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hazelton JL, 2009, J NEUROSCI RES, V87, P1250, DOI 10.1002/jnr.21921; Hokari M, 2010, J PHARM PHARMACOL, V62, P485, DOI 10.1211/jpp.62.04.0011; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kim HJ, 2012, BRAIN, V135, P2865, DOI 10.1093/brain/aws208; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Komuro H, 2005, CELL CALCIUM, V37, P387, DOI 10.1016/j.ceca.2005.01.006; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kubota M, 2010, INT J NEUROPSYCHOPH, V13, P1355, DOI 10.1017/S1461145710000362; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2011, TOXICOL PATHOL, V39, P220, DOI 10.1177/0192623310389475; Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015; Mathy JE, 2008, ANTIMICROB AGENTS CH, V52, P3267, DOI 10.1128/AAC.00498-08; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Muirhead KEA, 2010, BIOCHEM J, V426, P255, DOI 10.1042/BJ20091941; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Naziroglu M, 2012, NEUROCHEM RES, V37, P2065, DOI 10.1007/s11064-012-0850-x; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; SCHAPIRA AHV, 1993, ADV NEUROL, V60, P288; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shinde S, 2006, NEUROL INDIA, V54, P390, DOI 10.4103/0028-3886.28112; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tavecchio M, 2013, J BIOL CHEM, V288, P5553, DOI 10.1074/jbc.M112.433045; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Valasani KR, 2014, J CHEM INF MODEL, V54, P902, DOI 10.1021/ci5000196; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Vyssokikh M, 2004, BBA-MOL CELL RES, V1644, P27, DOI 10.1016/j.bbamcr.2003.10.007; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	115	13	15	0	20	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	5					654	663		10.2174/1871527314666150429113239			10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CI8DM	WOS:000354999100011	25921742				2021-06-18	
J	Hart, T; Brockway, JA; Fann, JR; Maiuro, RD; Vaccaro, MJ				Hart, Tessa; Brockway, Jo Ann; Fann, Jesse R.; Maiuro, Roland D.; Vaccaro, Monica J.			Anger self-management in chronic traumatic brain injury: protocol for a psycho-educational treatment with a structurally equivalent control and an evaluation of treatment enactment	CONTEMPORARY CLINICAL TRIALS			English	Article						Brain injuries; Anger management; Psychological treatment; Problem solving	TREATMENT FIDELITY; CONTROLLED-TRIALS; BEHAVIOR-CHANGE; IRRITABILITY; RECOMMENDATIONS; INTERVENTIONS; AGGRESSION; PROGRAM; PSYCHOTHERAPY; AWARENESS	Anger and irritability are important and persistent clinical problems following traumatic brain injury (TBI). Treatment options include medications, behavioral modification, and psychotherapies, but some are impractical and none have proven efficacy with this population. We describe a randomized multi-center clinical trial testing a novel, one-on-one, 8-session psychoeducational treatment program, Anger Self-Manageinent Training (ASMT), designed specifically for people with TBI who have significant cognitive impairment. The trial is notable for its use of a structurally equivalent comparison treatment, called Personal Readjustment and Education (PRE), which was created for the study and is intended to maximize equipoise for both participants and treaters. Fidelity assessment is conducted in real time and used in therapist supervision sessions. The primary outcome is change in self-reported anger on validated measures from pre-treatment to 1 week after the final session. Secondary outcomes include participant anger as reported by a significant other; emotional distress in domains other than anger/irritability; behavioral functioning; and quality of life. An interim assessment after the 4th session will allow examination of the trajectory of any observed treatment effects, and a follow-up assessment 2 months after the end of intervention will allow examination of persistence of effects. A treatment enactment phase, in which participants are interviewed several months after the last therapy session, is designed to provide qualitative data on whether and to what extent the principles and techniques learned in treatment are still carried out in daily life. (C) 2014 Elsevier Inc. All rights reserved.	[Hart, Tessa; Vaccaro, Monica J.] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Hart, Tessa] Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Brockway, Jo Ann] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Maiuro, Roland D.] Seattle Anger Management Program, Seattle, WA USA; [Maiuro, Roland D.] Seattle Domest Violence Program, Seattle, WA USA	Hart, T (corresponding author), Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA.	thart@einstein.edu			National Institutes of Health (NICHD/NCMRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1HD061400]; Moss Rehabilitation Research Institute Peer Review Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061400] Funding Source: NIH RePORTER	This research is supported by the National Institutes of Health (NICHD/NCMRR) grant #1RO1HD061400 and by a grant from the Moss Rehabilitation Research Institute Peer Review Committee. We thank Sureyya Dikmen, PhD, Nancy Temkin, PhD, and Thomas Novack, PhD for their assistance in developing the trial protocol. Cindy Harrison-Felix, PhD, David Mellick, and Christopher Cusick contributed substantially to the plans for data quality assurance.	Aboulafia-Brakha T, 2013, NEUROPSYCHOL REHABIL, V23, P216, DOI 10.1080/09602011.2012.747443; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Babor TF., 2001, AUDIT ALCOHOL USE DI, V2nd; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Burkhardt F, 2009, IEEE INT C AC SPEECH; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deffenbacher JL, 2002, COUNS PSYCHOL, V30, P262, DOI 10.1177/0011000002302004; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Derogatis L, 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DiGiuseppe R, 2003, CLIN PSYCHOL-SCI PR, V10, P70, DOI 10.1093/clipsy/10.1.70; Eames P., 1990, NEUROBEHAVIORAL SEQU, P410; Eckhardt C, 2004, AGGRESS VIOLENT BEH, V9, P17, DOI 10.1016/S1359-1789(02)00116-7; Fleminger S, 2006, COCHRANE DATABASE SY, V3; GALSKI T, 1994, ARCH PHYS MED REHAB, V75, P380, DOI 10.1016/0003-9993(94)90158-9; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; LaBrie JW, 2005, PSYCHOL ADDICT BEHAV, V19, P112, DOI 10.1037/0893-164X.19.1.112; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI DOI 10.1177/088626087002002003; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1964, EXAMEN CLIN PSYCHOL; Robb SL, 2011, PSYCHO-ONCOLOGY, V20, P1193, DOI 10.1002/pon.1845; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; Schnurr PR, 2007, J TRAUMA STRESS, V20, P779, DOI 10.1002/jts.20292; Shallice, 1997, HAYLING BRIXTON TEST; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Silver J, 2007, BRAIN INJURY MED PRI, P963; Spielberger C. D., 2000, STATE TRAIT ANGER EX; Taft CT, 2012, J REHABIL RES DEV, V49, P777, DOI 10.1682/JRRD.2011.09.0156; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Wechsler D., 2011, WECHLSER ABBREVIATED; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; WHO ASSIST Working Group, 2002, ALC SMOK SUBST INV S; Whyte J, 2010, DELISAS PHYS MED REH, P575; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374	61	13	13	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2015	40						180	192		10.1016/j.cct.2014.12.005			13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CB6IZ	WOS:000349732000021	25530306	Green Accepted			2021-06-18	
J	Hussmann, B; Heuer, M; Lefering, R; Touma, A; Schoeneberg, C; Keitel, J; Lendemans, S				Hussmann, Bjoern; Heuer, Matthias; Lefering, Rolf; Touma, Alexander; Schoeneberg, Carsten; Keitel, Judith; Lendemans, Sven			Prehospital Volume Therapy as an Independent Risk Factor after Trauma	BIOMED RESEARCH INTERNATIONAL			English	Article							FLUID RESUSCITATION; CLINICAL-COURSE; MANAGEMENT; MORTALITY; EPIDEMIOLOGY; REPLACEMENT; TRANSPORT; PATTERNS; SURVIVAL; DEATHS	Background. Prehospital volume therapy remains widely used after trauma, while evidence regarding its disadvantages is growing. The primary objective of this study was to investigate the volume administered in a prehospital setting as an independent risk factor for mortality. Material and Methods. Patients who met the following criteria were analyzed retrospectively: Injury Severity Score = 16, primary admission (between 2002 and 2010), and age = 16 years. The following data had to be available: volume administered (including packed red cells), blood pressure, Glasgow Coma Scale, therapeutic measures, and laboratory results. Following a univariate analysis, independent risk factors for mortality after trauma were investigated using a multivariate regression analysis. Results. A collective of 7,641 patients met the inclusion criteria, showing that increasing volumes administered in a prehospital setting were an independent risk factor for mortality (odds ratio: 1.34). This tendency was even more pronounced in patients without severe traumatic brain injury (TBI) (odds ratio: 2.71), while the opposite tendency was observed in patients with TBI. Conclusions. Prehospital volume therapy in patients without severe TBI represents an independent risk factor for mortality. In such cases, respiratory and circulatory conditions should be stabilized during permissive hypotension, and patient transfer should not be delayed.	[Hussmann, Bjoern; Schoeneberg, Carsten; Keitel, Judith; Lendemans, Sven] Alfried Krupp Hosp Essen, Trauma Surg Dept, D-45131 Essen, Germany; [Heuer, Matthias] Philippusstift Essen, Surg Dept, D-45355 Essen, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Touma, Alexander] Univ Hosp Essen, Trauma Surg Dept, D-45147 Essen, Germany	Hussmann, B (corresponding author), Alfried Krupp Hosp Essen, Trauma Surg Dept, Alfried Krupp Str 21, D-45131 Essen, Germany.	bjoern.hussmann@krupp-krankenhaus.de		Schoeneberg, Carsten/0000-0001-5633-1616			American College of Surgeons Committee on Trauma, 2008, ATLS STUD COURS MAN; Bickell W H, 1998, Curr Opin Anaesthesiol, V11, P177, DOI 10.1097/00001503-199804000-00010; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1993, ANN EMERG MED, V22, P225, DOI 10.1016/S0196-0644(05)80208-2; BICKELL WH, 1994, AM J EMERG MED, V12, P36, DOI 10.1016/0735-6757(94)90194-5; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; BRANAS CC, 1995, ACAD EMERG MED, V2, P486, DOI 10.1111/j.1553-2712.1995.tb03245.x; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Cornwell EE, 2000, ARCH SURG-CHICAGO, V135, P315, DOI 10.1001/archsurg.135.3.315; DALTON AM, 1995, J ROY SOC MED, V88, pP213; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; Demetriades D, 1996, ARCH SURG-CHICAGO, V131, P133; Dula David J, 2002, Prehosp Emerg Care, V6, P417, DOI 10.1080/10903120290938058; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Hubetamann Bjorn, 2011, J Emerg Trauma Shock, V4, P465, DOI 10.4103/0974-2700.86630; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; Hussmann B, 2012, CRIT CARE, V16, DOI 10.1186/cc11809; Hussmann B, 2013, INJURY, V44, P611, DOI 10.1016/j.injury.2012.02.004; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Lendemans S, 2004, UNFALLCHIRURG, V107, P203, DOI 10.1007/s00113-004-0729-7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; OGORMAN M, 1989, J TRAUMA, V29, P84, DOI 10.1097/00005373-198901000-00017; Pepe Paul E, 2002, Prehosp Emerg Care, V6, P81, DOI 10.1080/10903120290938887; Riddez L, 1998, J TRAUMA, V44, P433, DOI 10.1097/00005373-199803000-00001; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sloan EP, 2015, PREHOSP DISASTER MED, V30, P54, DOI 10.1017/S1049023X14001174; SLOVIS CM, 1990, AM J EMERG MED, V8, P305, DOI 10.1016/0735-6757(90)90080-J; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Soudry E, 2004, ISR MED ASSOC J, V6, P485; Talving P, 2005, PREHOSP DISASTER MED, V20, P228, DOI 10.1017/S1049023X00002582; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Turner J., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [DOI 10.3310/hta4310, 10.3310/hta4310, DOI 10.3310/HTA4310]; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	38	13	13	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								354367	10.1155/2015/354367			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CG3NU	WOS:000353187700001	25949995	DOAJ Gold, Green Published			2021-06-18	
J	Maddy, KM; Howell, DM; Capilouto, GJ				Maddy, Katherine McComas; Howell, Dana M.; Capilouto, Gilson J.			Current practices regarding discourse analysis and treatment following non-aphasic brain injury: A qualitative study	JOURNAL OF INTERACTIONAL RESEARCH IN COMMUNICATION DISORDERS			English	Article						DISCOURSE IMPAIRMENTS; SPEECH LANGUAGE PATHOLOGISTS; STROKE; TRAUMATIC BRAIN INJURY	OF-LIFE; ATTENTION; COHESION; LANGUAGE; STORY; REHABILITATION; COHERENCE; DEFICITS; STROKE	Discourse production deficits are a common feature of non-aphasic brain injury (NABI). However, little is known about current practices of speech-language pathologists in the assessment and treatment of discourse production deficits following NABI. A phenomenological approach of inquiry was used to examine the experiences of speech-language pathologists in the assessment and treatment of individuals with NABI, with a particular focus on discourse production deficits. Nine speech-language pathologists participated in semi-structured individual interviews. Participants identified common discourse production deficits and hypothesized about the impact on a person's quality of life. However, external influences negatively impacted participants' practice regarding discourse assessment and treatment. External influences included time constraints, lack of standardized data, and the lack of formalized education regarding discourse assessment and treatment. These findings suggest that there is a discrepancy between speech-language pathologists' values and their actual clinical practice related to the analysis and implementation of treatment for discourse production deficits.	[Maddy, Katherine McComas] Univ Kentucky, Rehabil Sci Interdisciplinary PhD Program, Lexington, KY 40506 USA; [Howell, Dana M.] Univ Kentucky, Lexington, KY 40506 USA; [Capilouto, Gilson J.] Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40506 USA	Maddy, KM (corresponding author), Univ Kentucky, Rehabil Sci Interdisciplinary PhD Program, Lexington, KY 40506 USA.	klmc227@uky.edu					Ahern KJ, 1999, QUAL HEALTH RES, V9, P407, DOI 10.1177/104973299129121947; American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Brady M, 2005, APHASIOLOGY, V19, P731, DOI 10.1080/02687030500141430; Brookshire R. H., 2003, INTRO NEUROGENIC COM; Brown J., 2013, ASHA LEADER, V18, P30; BRYAN KL, 1988, BRIT J DISORD COMMUN, V23, P111; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Cherney L., 1993, CLIN APHASIOLOGY, V21, P123; Christensen SC, 2009, APHASIOLOGY, V23, P898, DOI 10.1080/02687030802642010; Clarke P, 2002, STROKE, V33, P1016, DOI 10.1161/01.STR.0000013066.24300.F9; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Creswell J., 2011, DESIGNING CONDUCTING; Creswell J.W., 2007, QUAL INQ; Davis GA, 1997, BRAIN LANG, V56, P183; Doody Owen, 2013, Nurse Res, V20, P28; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Fischler I, 2000, SCI PRACT NEUROPSYCH, P348; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gibbs Graham., 2007, ANAL QUALITATIVE DAT; Glaser B. G., 1967, DISCOVERY GROUNDED T; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Groenewald T., 2008, SAGE ENCY QUALITATIV, V2, P505; Halliday Michael A. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hillis Trupe E., 1985, CLIN APHASIOLOGY, V15, P83; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Houghton Catherine, 2013, Nurse Res, V20, P12; Kaplan E., 2001, BOSTON NAMING TEST 2; Mackenzie AE, 2002, DISABIL REHABIL, V24, P259, DOI 10.1080/09638380110081805; MALIA K, 2004, RECOMMENDATIONS BEST; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Miles M.B., 1994, QUALITATIVE DATA ANA; Miller J.F., 2012, SALT SYSTEMATIC ANAL; Murray L. L., 2001, LANGUAGE INTERVENTIO, P55; Myers P.S., 1999, RIGHT HEMISPHERE DAM; MYERS PS, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P279; O'Brien SR, 2013, PHYS THER, V93, P1592, DOI 10.2522/ptj.20120484; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Olness G, 2005, CLIN APH C SAN FL; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; REHAK A, 1992, BRAIN LANG, V42, P320, DOI 10.1016/0093-934X(92)90104-M; Reistetter TA, 2014, ARCH PHYS MED REHAB, V95, P29, DOI 10.1016/j.apmr.2013.07.018; Rossman G.B., 1998, LEARNING FIELD INTRO; ROWLES G, 2002, QUALITATIVE GERONTOL; Ska B., 2004, ENCY COMMUNICATION D, P302; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Srivastava P., 2009, INT J QUALITATIVE ME, V8, P76, DOI DOI 10.1177/160940690900800107; Tesch R., 1990, QUALITATIVE RES ANAL; Tuckett Anthony G, 2004, Nurse Res, V12, P47; Turkstra L., 2005, SEMINARS SPEECH LANG, V26, P214; Ulatowska H. K., 2004, MIT ENCY COMMUNICATI, P300; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Van Manen M., 1990, RES LIVED EXPERIENCE; Youse KM, 2009, NEUROREHABILITATION, V24, P355, DOI 10.3233/NRE-2009-0490	61	13	13	0	9	EQUINOX PUBLISHING LTD	SHEFFIELD	415, THE WORKSTATION, 15 PATERNOSTER ROW, SHEFFIELD, S1 2BX, ENGLAND	2040-5111	2040-512X		J INTERACT RES COM D	J. Interact. Res. Commun. Disord.		2015	6	2					211	236		10.1558/jircd.v7i1.25519			26	Linguistics	Linguistics	DK5MZ	WOS:000374965300005					2021-06-18	
J	Max, JE; Lopez, A; Wilde, EA; Bigler, ED; Schachar, RJ; Saunders, A; Ewing-Cobbs, L; Chapman, SB; Yang, TT; Levin, HS				Max, Jeffrey E.; Lopez, Aholibama; Wilde, Elisabeth A.; Bigler, Erin D.; Schachar, Russell J.; Saunders, Ann; Ewing-Cobbs, Linda; Chapman, Sandra B.; Yang, Tony T.; Levin, Harvey S.			Anxiety disorders in children and adolescents in the second six months after traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Anxiety; traumatic brain injury; child and adolescent psychiatric disorders		The objective of this prospective longitudinal study was to assess the nature, rate, predictive variables, and neuroimaging characteristics of novel (new-onset) anxiety disorders (compared with no novel anxiety disorders) 6-12 months after pediatric traumatic brain injury (TBI). Psychiatric and psychosocial interviews were administered to children who sustained mild to severe TBI at baseline (soon after injury) and at the 12-month follow-up post-injury (n = 125). The psychiatric outcome of children 12-months post-injury revealed that novel anxiety disorders present in the second six months after TBI were heterogeneous and occurred in 13 (10.4%) participants. Novel anxiety disorder was significantly associated with concurrent novel depressive disorder and with novel personality change due to TBI. Novel anxiety disorder was marginally associated with younger age at injury and with pre-injury anxiety disorder in univariate analyses. Age at injury, pre-injury anxiety disorder, and personality change due to TBI were each significantly and independently related to novel anxiety disorder in a logistic regression analysis. There were no significant neuroimaging group differences. These findings suggest that the emergence of novel anxiety disorder after TBI might be related to a broader problem of affective dysregulation especially in younger children and those with a vulnerability even to pre-injury anxiety disorder.	[Max, Jeffrey E.; Lopez, Aholibama] Univ Calif San Diego, La Jolla, CA 92093 USA; [Max, Jeffrey E.] Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Provo, UT 84602 USA; [Schachar, Russell J.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Saunders, Ann; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Dallas, TX USA; [Yang, Tony T.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Max, JE (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu			National institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085734, K08MH001800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by National institute of Mental Health (NIMH) Grant K-08 MH01800 (Dr. Max) and National Institute of Neurological Disorders and Stroke (NINDS) Grant NS-21889 (Dr. Levin). Drs. Max and Bigler independently provide expert testimony in cases of traumatic brain injury on an ad hoc basis for plaintiffs and defendants on a more or less equal ratio. This activity constitutes approximately 5% of each of Dr. Max's and Dr. Bigler's professional activity. Dr. Schachar is a consultant for Eli Lily Corporation and Purdue Pharma (Canada). Other authors have no conflict of interest to declare.	American Psychiatric Association, 2000, DIAGNC STAT MAN MENT; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Last CG, 1996, J AM ACAD CHILD PSY, V35, P1502, DOI 10.1097/00004583-199611000-00019; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Sciberras E, 2014, PEDIATRICS, V133, P801, DOI 10.1542/peds.2013-3686; Sparrow S., 1984, VINELAND ADAPTIVE BE; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x	42	13	13	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					345	355		10.3233/PRM-150352			11	Pediatrics	Pediatrics	VG7LK	WOS:000448290900008	26684074				2021-06-18	
J	Michalets, E; Creger, J; Shillinglaw, WR				Michalets, Elizabeth; Creger, Julie; Shillinglaw, William R.			Outcomes of expanded use of clinical pharmacist practitioners in addition to team-based care in a community health system intensive care unit	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article							ADVERSE DRUG EVENTS; CRITICALLY-ILL PATIENTS; ECONOMIC OUTCOMES; INTERVENTIONS; IMPACT; PARTICIPATION; GUIDELINES; ERRORS; PROPHYLAXIS; SERVICES	Purpose. Clinical and cost benefits achieved through expanded use of state-licensed clinical pharmacist practitioners (CPPs) with prescribing authority on a critical care team are reported. Methods. A retrospective pre-post analysis was conducted to evaluate patient care outcomes and cost savings during one-year periods before and after the number of CPPs on a North Carolina community health system's neurotrauma intensive care unit (NTICU) team was increased from one to three. Outcomes assessed included the number and types of medication management encounters, estimated cost savings, and the rate of preventable adverse drug events (ADEs) with expanded use of CPPs. Results. During the two-year study period, CPPs conducted 13,386 documented medication encounters involving 2,198 patients; associated cost savings totaled an estimated $2,118,426. During the 12 months after CPP involvement on the NTICU team was increased, there was a 182% increase in encounters for therapeutic optimization (p = 0.01), with an associated 29% increase in cost savings and an improved return on investment. The CPP service expansion was also associated with a reduction in preventable ADEs, including a 75% reduction in prescribing-related ADEs (risk ratio [RR], 0.25; 95% confidence interval [CI], 0.05-1.2; p = 0.09) and a 37% reduction in higher-severity ADEs (RR, 0.63; 95% CI, 0.25-1.57; p = 0.36). Conclusion. With expanded CPP involvement on the NTICU team, there was a substantial increase in therapeutic optimization interventions and a clinically notable reduction in preventable ADEs, as well as an estimated 30% increase in associated cost savings.	[Michalets, Elizabeth; Creger, Julie] Univ N Carolina, Eshelman Sch Pharm, Mission Hlth Syst Dept Pharm, Neurotrauma Intens Care Unit, Asheville, NC 28804 USA; [Shillinglaw, William R.] Mission Hlth Syst Dept Trauma Surg & Crit Care, Asheville, NC USA	Michalets, E (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Mission Hlth Syst Dept Pharm, Neurotrauma Intens Care Unit, Asheville, NC 28804 USA.	elizabeth.michalets@msj.org					Bond CA, 2008, PHARMACOTHERAPY, V28, P1, DOI 10.1592/phco.28.1.1; Bourne RS, 2011, INT J CLIN PHARM-NET, V33, P755, DOI 10.1007/s11096-011-9538-6; Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026; Brophy GM, 2002, PHARMACOTHERAPY, V22, P251, DOI 10.1592/phco.22.3.251.33547; Bureau of Labor Statistics, 2010, OCC EMPL WAG, P29; Calabrese AD, 2001, INTENS CARE MED, V27, P1592, DOI 10.1007/s001340101065; Cullen DJ, 1997, CRIT CARE MED, V25, P1289, DOI 10.1097/00003246-199708000-00014; Dennis B, OVERVIEW CLIN PHARM; Devlin JW, 1997, ANN PHARMACOTHER, V31, P689, DOI 10.1177/106002809703100604; Devlin JW, 2001, PHARMACOTHERAPY, V21, P740, DOI 10.1592/phco.21.7.740.34578; Hamblin S, 2012, J TRAUMA ACUTE CARE, V73, P1484, DOI 10.1097/TA.0b013e318267cd80; Haupt MT, 2003, CRIT CARE MED, V31, P2677, DOI 10.1097/01.CCM.0000094227.89800.93; Kane-Gill SL, 2012, CRIT CARE MED, V40, P823, DOI 10.1097/CCM.0b013e318236f473; Kaushal R, 2007, CRIT CARE MED, V35, P2479, DOI 10.1097/01.CCM.0000284510.04248.66; Klopotowska JE, 2010, CRIT CARE, V14, DOI 10.1186/cc9278; Kopp BJ, 2007, AM J HEALTH-SYST PH, V64, P2483, DOI 10.2146/ajhp060674; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; LEE AJ, 2007, HOSP PHARM, V42, P337; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; MacLaren R, 2009, PHARMACOTHERAPY, V29, P761, DOI 10.1592/phco.29.7.761; Marshall J, 2008, CRIT CARE MED, V36, P427, DOI 10.1097/01.CCM.0000300275.63811.B3; Mitchell P, 2012, CORE PRINCIPLES VALU; MONTAZERI M, 1994, CRIT CARE MED, V22, P1044, DOI 10.1097/00003246-199406000-00027; Murawski M, 2011, AM J HEALTH-SYST PH, V68, P2341, DOI 10.2146/ajhp110351; Ng TM, 2008, ANN PHARMACOTHER, V42, P475, DOI 10.1345/aph.1K458; Patel NP, 2006, J BURN CARE RES, V27, P310, DOI 10.1097/01.BCR.0000216287.98801.96; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Rudis MI, 2000, PHARMACOTHERAPY, V20, P1400; Rudis MI, 2000, CRIT CARE MED, V28, P3746, DOI 10.1097/00003246-200011000-00037; Task Force on Guidelines Society of Critical Care Medicine, 1988, CRIT CARE MED, V16, P809; Weant KA, 2009, NEUROSURGERY, V65, P946, DOI 10.1227/01.NEU.0000347090.22818.35	31	13	14	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	JAN 1	2015	72	1					47	53		10.2146/ajhp140105			7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY0HJ	WOS:000347277700013	25511838				2021-06-18	
J	Raggi, A; Leonardi, M; Covelli, V; Sattin, D; Scaratti, C; Schiavolin, S; Willems, M; Meucci, P				Raggi, A.; Leonardi, M.; Covelli, V.; Sattin, D.; Scaratti, C.; Schiavolin, S.; Willems, M.; Meucci, P.			The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions	NEUROREHABILITATION			English	Article						Disability; ICF classification; mental functions; mobility; barriers	DISEASE; BRAIN	INTRODUCTION: Neurological conditions are associated with high levels of disability. OBJECTIVES: The aim of this study was to describe, using the International Classification of Functioning, Disability and Health (ICF), the most relevant aspects of disability in patients with neurological conditions. We collated data from previous studies on myasthenia gravis, migraine, Parkinson's disease, multiple sclerosis, traumatic brain injury, stroke, epilepsy, vegetative state and minimally conscious state, and identified as relevant those ICF categories reported by at least 50% of patients in each condition. CONCLUSIONS: Records from 1310 patients were available. A total of 97 ICF categories were reported, and 21 were commonly addressed in more than five conditions. Approximately half of the categories in body functions were related to mental and movement-related functions and more than 25% of the activities-related categories involved activities that require the support from a caregiver. Environmental factors were mostly reported as facilitators. Our data indicate a residual mind-body dichotomy, the relevance of disability not only for the patients but also for their caregivers, and the difficulties in addressing barriers in the environment.	[Raggi, A.; Leonardi, M.; Covelli, V.; Sattin, D.; Scaratti, C.; Schiavolin, S.; Willems, M.; Meucci, P.] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, I-20133 Milan, Italy	Raggi, A (corresponding author), Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Via Celoria 11, I-20133 Milan, Italy.	araggi@istituto-besta.it	Raggi, Alberto/K-5787-2016; COVELLI, VENUSIA/AAG-9232-2020; Sattin, Davide/K-5963-2016; Sattin, Davide/AAX-4083-2020; leonardi, matilde/J-9997-2018; Schiavolin, Silvia/K-6595-2016; Scaratti, Chiara/K-5196-2018	Raggi, Alberto/0000-0002-7433-7779; COVELLI, VENUSIA/0000-0002-5965-2658; Sattin, Davide/0000-0001-7736-4337; Sattin, Davide/0000-0001-7736-4337; leonardi, matilde/0000-0003-0552-8923; Schiavolin, Silvia/0000-0002-5391-7539; Scaratti, Chiara/0000-0002-6664-4787			Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS22, DOI 10.1097/PHM.0b013e31823d4d6f; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Goljar N, 2010, DISABIL REHABIL, V32, pS50, DOI 10.3109/09638288.2010.517598; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Leonardi M, 2012, SCI WORLD J, P1, DOI 10.1100/2012/189097; Leonardi M, 2010, DISABIL REHABIL, V32, pS23, DOI 10.3109/09638288.2010.511687; Leonardi M, 2010, DISABIL REHABIL, V32, pS139, DOI 10.3109/09638288.2010.520807; Leonardi M, 2009, DISABIL REHABIL, V31, P2041, DOI 10.3109/09638280902893634; Raggi A, 2010, DISABIL REHABIL, V32, pS33, DOI 10.3109/09638288.2010.511688; Sattin D, 2014, EUR J PHYS REHAB MED, V50, P309; Svestkova O, 2010, DISABIL REHABIL, V32, pS59, DOI 10.3109/09638288.2010.511689; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2001, INT CLASS FUNCT DIS	15	13	13	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	1					17	22		10.3233/NRE-141186			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CB0OT	WOS:000349326700004	25547761				2021-06-18	
J	Roscigno, CI; Fleig, DK; Knafl, KA				Roscigno, Cecelia I.; Fleig, Denise K.; Knafl, Kathleen A.			Parent management of the school reintegration needs of children and youth following moderate or severe traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Children; parents; traumatic brain injury; young adults	SECONDARY ANALYSIS; STUDENTS; SUPPORT; CARE; TBI; REHABILITATION; PERCEPTIONS; ADOLESCENTS; RETURN	Purpose: School reintegration following children's traumatic brain injury (TBI) is still poorly understood from families' perspectives. We aimed to understand how both unique and common experiences during children's school reintegration were explained by parents to influence the family. Methods: Data came from an investigation using descriptive phenomenology (2005-2007) to understand parents' experiences in the first five years following children's moderate to severe TBI. Parents (N = 42 from 37 families in the United States) participated in two 90-min interviews (first M = 15 months; second M = 27 months). Two investigators independently coded parents' discussions of school reintegration using content analysis to understand the unique and common factors that parents perceived affected the family. Results: Parents' school negotiation themes included the following: (1) legal versus moral basis for helping the child; (2) inappropriate state and local services that did not consider needs specific to TBI; and (3) involvement in planning, implementing and evaluating the child's education plan. Parents perceived that coordinated and collaboration leadership with school personnel lessened families' workload. Families who home-schooled had unique challenges. Conclusions: School reintegration can add to family workload by changing roles and relationships and by adding to parents' perceived stress in managing of the child's condition.	[Roscigno, Cecelia I.; Knafl, Kathleen A.] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA; [Fleig, Denise K.] Advocate Lutheran Gen Hosp, Park Ridge, IL USA	Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Family Hlth Div, Carrington Hall,CB 7460, Chapel Hill, NC 27599 USA.	croscign@email.unc.edu			Irving B. Harris Foundation Faculty Scholars Initiative at the University of Illinois at Chicago College of Nursing; National Institutes of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599, T32NR007091] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, training or authorship of this article: The first author was supported by a post-doctoral fellowship (Irving B. Harris Foundation Faculty Scholars Initiative at the University of Illinois at Chicago College of Nursing, Dr, White-Traut, PI) during the conceptualization and analysis phases of the study. The authorship of the manuscript was supported by a National Institutes of Nursing Research post-doctoral training fellowship, Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17).; The original research study was funded by a NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG # 6 T73 MC 00041-11-03); a University of Washington Gatzert Child Welfare Fellowship; and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Barnard-Brak L, 2010, QUAL REP, V15, P411; Bronfenbrenner U., 1977, ECOLOGY HUMAN DEV; Bronfenbrenner U., 2005, MAKING HUMAN BEINGS; Bronfenbrenner U., 1989, ANN CHILD DEV, P185; Carney J, 2009, DEV DISABIL RES REV, V15, P152, DOI 10.1002/ddrr.57; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Copeland SR, 2004, REM SPEC EDUC, V25, P342, DOI 10.1177/07419325040250060201; Crothers IR, 2007, BRAIN INJURY, V21, P47, DOI 10.1080/02699050601149054; Farmer TW, 2011, J APPL DEV PSYCHOL, V32, P247, DOI 10.1016/j.appdev.2011.04.006; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gordon W. A., 2013, STATE STATES M ED NE; Government Accountability Office, 2009, GAO1033; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Health Resources and Services Administration, FED TRAUM BRAIN INJ; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI DOI 10.1207/s15327035ex1403_5; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Husserl E, 1965, PHENOMENOLOGY CRISIS; Juster F. H., 2004, CHANGING TIMES AM YO; Kennedy CH, 1997, EXCEPT CHILDREN, V64, P31, DOI 10.1177/001440299706400103; Knafl KA, 2012, J FAM NURS, V18, P11, DOI 10.1177/1074840711427294; Koro-Ljungberg M, 2008, QUAL HEALTH RES, V18, P983, DOI 10.1177/1049732308318039; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Morina A, 2010, DISABIL SOC, V25, P163, DOI 10.1080/09687590903534346; Patton M.Q., 2002, QUALITATIVE RES EVAL; Perie M, 2005, 2006459 NCES USDA; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Roscigno CI, 2011, BRAIN INJURY, V25, P882, DOI 10.3109/02699052.2011.581638; Ryan-Nicholls Kimberley D, 2009, Nurse Res, V16, P70; Savage RC, 2001, NEUROREHABILITATION, V16, P49; SEMIN GR, 1988, J PERS SOC PSYCHOL, V54, P558, DOI 10.1037/0022-3514.54.4.558; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Simeonsson RJ, 2001, DISABIL REHABIL, V23, P49; Szabo V, 1997, ADV NURS SCI, V20, P66, DOI 10.1097/00012272-199712000-00008; U. S. Department of Education National Center for Education Statistics, 2010, HOM US 2003 PAR SURV; Ularntinon S, 2010, CURR PSYCHIATRY REV, V6, P261, DOI 10.2174/157340010793499422; Wigboldus D, 2007, FRONT SOC PSYCHOL, P79; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	46	13	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	6					523	533		10.3109/09638288.2014.933896			11	Rehabilitation	Rehabilitation	CD3UK	WOS:000351007500007	24969697	Green Accepted			2021-06-18	
J	Shang, HB; Cui, DR; Yang, DH; Liang, S; Zhang, WF; Zhao, WG				Shang, Hanbing; Cui, Derong; Yang, Dehua; Liang, Sheng; Zhang, Weifeng; Zhao, Weiguo			The Radical Scavenger Edaravone Improves Neurologic Function and Perihematomal Glucose Metabolism after Acute Intracerebral Hemorrhage	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Intracerebral hemorrhage; edaravonecerebral metabolism; apoptosis; positron emission tomography/computed; tomography	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ACUTE CEREBRAL INFARCTION; CELL-DEATH; WHOLE-BLOOD; RAT MODEL; ISCHEMIA; MICRODIALYSIS; EDEMA; PLASMA	Oxidative injury caused by reactive oxygen species plays an important role in the progression of intracerebral hemorrhage (ICH)-induced secondary brain injury. Previous studies have demonstrated that the free radical scavenger edaravone may prevent neuronal injury and brain edema after ICH. However, the influence of edaravone on cerebral metabolism in the early stages after ICH and the underlying mechanism have not been fully investigated. In the present study, we investigated the effect of edaravone on perihematomal glucose metabolism using F-18-fluorordeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). Additionally, the neurologic deficits, brain edemas, and cell death that followed ICH were quantitatively analyzed. After blood infusion, the rats treated with edaravone showed significant improvement in both forelimb placing and corner turn tests compared with those treated with vehicle. Moreover, the brain water content of the edaravone-treated group was significantly decreased compared with that of the vehicle group on day 3 after ICH. PET/CT images of ICH rats exhibited obvious decreases in FDG standardized uptake values in perihematomal region on day 3, and the lesion-to-normal ratio of the edaravone-treated ICH rats was significantly increased compared with that of the control rats. Calculation of the brain injury volumes from the PET/CT images revealed that the volumes of the blood-induced injuries were significantly smaller in the edaravone group compared with the vehicle group. Terminal Deoxynucleotidyl Transferasemediated dUTP Nick End Labeling assays performed 3 days after ICH revealed that the numbers of apoptotic cells in perihematomal region of edaravone-treated ICH rats were decreased relative to the vehicle group. Thus, the present study demonstrates that edaravone has scavenging properties that attenuate neurologic behavioral deficits and brain edema in the early period of ICH. Additionally, edaravone may improve cerebral metabolism around the hematoma by attenuating apoptotic cell death after ICH.	[Shang, Hanbing; Zhang, Weifeng; Zhao, Weiguo] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China; [Cui, Derong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Dept Anesthesiol, Shanghai 200025, Peoples R China; [Yang, Dehua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Yang, Dehua] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200025, Peoples R China; [Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Micro PET CT Res Ctr, Shanghai 200025, Peoples R China	Zhao, WG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	rjneurosurgery@gmail.com	Yang, Dehua/M-5789-2019; Yang, Dehua/S-6156-2017				ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Frykholm P, 2004, ACTA NEUROL SCAND, V109, P25, DOI 10.1034/j.1600-0404.2003.00174.x; Gaetani P, 1992, J Neurosurg Sci, V36, P1; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Hickenbottom SL, 1999, STROKE, V30, P2472, DOI 10.1161/01.STR.30.11.2472; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; HUTCHINS GD, 1984, J CEREBR BLOOD F MET, V4, P35, DOI 10.1038/jcbfm.1984.5; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kaynar MY, 2005, NEUROL RES, V27, P562, DOI 10.1179/016164105X17288; Krengli M, 2009, RADIAT ONCOL, V4, DOI [10.1186/1748-717X-5-10, 10.1186/1748-717X-4-9]; Lin XT, 2010, ACTA RADIOL, V51, P549, DOI 10.3109/02841851003660065; Liu H, 2004, BRAIN RES, V1025, P43, DOI 10.1016/j.brainres.2004.07.071; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Mizuno A, 1998, GEN PHARMACOL-VASC S, V30, P575, DOI 10.1016/S0306-3623(97)00311-X; Nakagomi Tadayoshi, 2003, J Stroke Cerebrovasc Dis, V12, P17, DOI 10.1053/jscd.2003.2; Nakamura T, 2005, BRAIN RES, V1039, P30, DOI 10.1016/j.brainres.2005.01.036; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Peeling J, 1998, BRAIN RES, V795, P63, DOI 10.1016/S0006-8993(98)00253-4; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Sorokin J, 2014, CLIN NUCL MED, V39, pE35, DOI 10.1097/RLU.0b013e318292aa81; Strong AJ, 2008, INTENS CARE MED, V34, P1169, DOI 10.1007/s00134-008-1045-4; Uno M, 2005, FREE RADICAL BIO MED, V39, P1109, DOI 10.1016/j.freeradbiomed.2005.06.001; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wagner KR, 2002, DEV NEUROSCI-BASEL, V24, P154, DOI 10.1159/000065703; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06; Zhou F, 2009, BRAIN INJURY, V23, P353, DOI 10.1080/02699050902788527	54	13	14	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					215	222		10.1016/j.jstrokecerebrovasdis.2014.08.021			8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700045	25440340				2021-06-18	
J	Songarj, P; Luh, C; Staib-Lasarzik, I; Engelhard, K; Moosmann, B; Thal, SC				Songarj, Phuriphong; Luh, Clara; Staib-Lasarzik, Irina; Engelhard, Kristin; Moosmann, Bernd; Thal, Serge C.			The antioxidative, non-psychoactive tricyclic phenothiazine reduces brain damage after experimental traumatic brain injury in mice	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Oxidative stress; Phenothiazine; Controlled cortical impact; Mice	NITRIC-OXIDE SYNTHASE; PARKINSONS-DISEASE; PATHOPHYSIOLOGY; INHIBITION; EXPRESSION; INDUCTION; THERAPIES; BINDING; MODELS; CELLS	Oxidative stress due to free radical formation is an important mechanism of secondary brain damage following traumatic brain injury (TBI). Phenothiazine has been found to be a strong antioxidant in eukaryotic cells in vitro and in invertebrates in vivo. The present study was designed to determine the neuroprotective potency of unsubstituted phenothiazine in a paradigm of acute brain injury. Thirty minutes after pneumatic, controlled cortical impact (CCI) injury, C57BI6 mice were randomly assigned to "low dose" (3 mg/kg, LD) or "high dose" (30 mg/kg, HD) s.c. phenothiazine or vehicle treatment. Brain lesion, neurofunctional impairment, body weight, and markers of cerebral inflammation were determined 24 h after the insult. Phenothiazine treatment dose-dependently reduced brain lesion volume (LD: -19.8%; HD: -26.1%) and posttraumatic body weight loss. There were no significant differences in the neurological function score and in markers of cerebral inflammation (Iba-1 positive cells, TNF alpha expression), whereas iNOS expression was significantly lower compared to vehicle-treated animals. Phenothiazine appears to modify in a post-treatment protocol certain aspects of secondary brain damage in vivo at unusually low concentrations, in particular the cortical contusion volume after TBI. The potential role of the reduced iNOS expression is unclear at present. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Songarj, Phuriphong; Luh, Clara; Staib-Lasarzik, Irina; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Moosmann, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55131 Mainz, Germany; [Songarj, Phuriphong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok 10700, Thailand	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Department of Anesthesiology, Johannes Gutenberg-University, Mainz, Germany	The authors thank Frida Kornes (Department of Anesthesiology) for her excellent technical assistance. This work was financially supported by institutional funding of the Department of Anesthesiology, Johannes Gutenberg-University, Mainz, Germany.	ANDERSEN PH, 1985, LIFE SCI, V37, P1971, DOI 10.1016/0024-3205(85)90028-1; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bulic B, 2013, J MED CHEM, V56, P4135, DOI 10.1021/jm3017317; Corcoran TB, 2011, ANTIOXID REDOX SIGN, V15, P2663, DOI 10.1089/ars.2011.4125; ECM, 2000, EUR CHEM BUR IUCLID; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hattori Y, 2001, ARTERIOSCL THROM VAS, V21, P1179, DOI 10.1161/hq0701.092135; Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906, DOI 10.1093/jnen/60.9.906; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Koppula S, 2012, INT J MOL SCI, V13, P10608, DOI 10.3390/ijms130810608; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Mocko JB, 2010, NEUROBIOL DIS, V40, P120, DOI 10.1016/j.nbd.2010.03.019; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Moosmann B, 2001, BIOL CHEM, V382, P1601, DOI 10.1515/BC.2001.195; MURPHY CM, 1950, IND ENG CHEM, V42, P2479, DOI 10.1021/ie50492a027; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Rojas JC, 2009, NEUROSCIENCE, V163, P877, DOI 10.1016/j.neuroscience.2009.07.012; TADROS FW, 1962, J MENT SCI, V108, P816; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tapias P. G. V. M., 2012, NEUR M NEW ORL, V856, P811; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; YU MJ, 1992, J MED CHEM, V35, P716, DOI 10.1021/jm00082a012	35	13	14	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 1	2015	584						253	258		10.1016/j.neulet.2014.10.037			6	Neurosciences	Neurosciences & Neurology	AY4XS	WOS:000347579000048	25449871				2021-06-18	
J	Stenberg, M; Godbolt, AK; De Boussard, CN; Levi, R; Stalnacke, BM				Stenberg, Maud; Godbolt, Alison K.; De Boussard, Catharina Nygren; Levi, Richard; Stalnacke, Britt-Marie			Cognitive Impairment after Severe Traumatic Brain Injury, Clinical Course and Impact on Outcome: A Swedish-Icelandic Study	BEHAVIOURAL NEUROLOGY			English	Article							HIGHER CEREBRAL FUNCTIONS; NEUROLOGICAL-INSTITUTE SCREEN; DEPRESSION SCALE; HOSPITAL ANXIETY; SELF-AWARENESS; CARE PATHWAYS; HEAD-INJURY; BNI SCREEN; VALIDITY; POPULATION	Objective. To assess the clinical course of cognitive and emotional impairments in patients with severe TBI (sTBI) from 3 weeks to 1 year after trauma and to study associations with outcomes at 1 year. Methods. Prospective, multicenter, observational study of sTBI in Sweden and Iceland. Patients aged 18-65 years with acute Glasgow Coma Scale 3-8 were assessed with the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS) and the Hospital Anxiety and Depression Scale (HADS). Outcome measures were Glasgow Outcome Scale Extended (GOSE) and Rancho Los Amigos Cognitive Scale-Revised (RLAS-R). Results. Cognition was assessed with the BNIS assessed for 42 patients out of 100 at 3 weeks, 75 patients at 3 months, and 78 patients at 1 year. Cognition improved over time, especially from 3 weeks to 3 months. The BNIS subscales "orientation" and "visuospatial and visual problem solving" were associated with the GOSE and RLAS-R at 1 year. Conclusion. Cognition seemed to improve over time after sTBI and appeared to be rather stable from 3 months to 1 year. Since cognitive function was associated with outcomes, these results indicate that early screening of cognitive function could be of importance for rehabilitation planning in a clinical setting.	[Stenberg, Maud; Levi, Richard; Stalnacke, Britt-Marie] Umea Univ, Rehabil Med, Dept Community Med & Rehabil, S-90185 Umea, Sweden; [Godbolt, Alison K.; De Boussard, Catharina Nygren] Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden; [Godbolt, Alison K.; De Boussard, Catharina Nygren] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, S-18288 Stockholm, Sweden	Stenberg, M (corresponding author), Umea Univ, Rehabil Med, Dept Community Med & Rehabil, S-90185 Umea, Sweden.	maud.stenberg@rehabmed.umu.se			AFA Insurance [060833, 130095]; Uppsala University Hospital; Danderyd Hospital; Umea University Hospital	The authors thank the patients and their relatives, the PRO-BRAIN collaborators, the clinical staff of their units, and their neurosurgical colleagues who allowed recruitment of their patients. They also thank Dr. Anna Tolli, Danderyd Hospital and Karolinska Institute; Dr. Kristina Lindgren, Karlstad Hospital; Dr. Bjorn Johansson, University Hospital Uppsala; and Dr. Christer Tengvar, University Hospital Uppsala, who assisted in assessment of patients. Paramedical staff contributing to the study included Stina Gunnarsson and Marina Bystrom Odhe (Linkoping), Anna-Lisa Nilsson (Umea), Marie Sandgren (Stockholm), Staffan Stenson (Uppsala), and Siv Svensson (Gothenburg). Seija Lund was nurse coordinator in Stockholmand Ingrid Morberg in Gothenburg. PRO-BRAIN collaborators are AKG, CND, Professor Jorgen Borg, Department of Clinical Sciences, Karolinska Institute, and University Department of Rehabilitation Medicine Stockholm, Danderyd Hospital, Stockholm, Sweden; Dr. Marie Lindgren, Department of Clinical Rehabilitation Medicine, County Council, Linkoping, Sweden; Dr. Gudrun Karlsdottir, Department of Rehabilitation Medicine, Landspitalinn, University Hospital, Reykjavik, Iceland; Dr. Trandur Ulfarsson, MD, Department of Rehabilitation Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden; and Dr. Marianne Lannsjo, Department of Neuroscience, Uppsala University and Department of Rehabilitation Medicine, Gavle and Sandviken Hospital, Sweden. This study was supported by Grants 060833 and 130095 from AFA Insurance and from ALF-grants from Uppsala University Hospital, Danderyd Hospital, and Umea University Hospital.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Borgaro SR, 2003, J HEAD TRAUMA REHAB, V18, P284, DOI 10.1097/00001199-200305000-00006; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Denvall V, 2008, BNI SCREEN HIGHER CE; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Hagen C, 1987, REHABILITATION HEAD; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Hung CI, 2012, INT J PSYCHIAT CLIN, V16, P33, DOI 10.3109/13651501.2011.617456; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Knottnerus AM, 2007, CLIN REHABIL, V21, P805, DOI 10.1177/0269215507079129; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Prigatano G., 1991, BNI Q, V7, P2; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TEASDALE G, 1974, LANCET, V2, P81; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	13	13	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								680308	10.1155/2015/680308			12	Clinical Neurology	Neurosciences & Neurology	CZ1FA	WOS:000366850100001	26783381	DOAJ Gold, Green Published			2021-06-18	
J	Wares, JR; Hoke, KW; Walker, W; Franke, LM; Cifu, DX; Carne, W; Ford-Smith, C				Wares, Joanna R.; Hoke, Kathy W.; Walker, William; Franke, Laura Manning; Cifu, David X.; Carne, William; Ford-Smith, Cheryl			Characterizing effects of mild traumatic brain injury and posttraumatic stress disorder on balance impairments in blast-exposed servicemembers and Veterans using computerized posturography	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						balance; balance impairment; blast exposure; computerized posturography; impairment; mild traumatic brain injury; posttraumatic amnesia; posttraumatic stress disorder; servicemembers; Veterans	CONCUSSION; STABILITY; DIZZINESS; DEFICITS; INSTABILITY; RECOVERY; SPACE; HEAD; PTSD	The high rate of blast exposures experienced by U.S. servicemembers (SMs) during the recent conflicts in Iraq and Afghanistan has resulted in frequent combat-related mild traumatic brain injuries (mTBIs). Dizziness and postural instability can persist after mTBI as a component of postconcussion syndrome, but also occur among the somatic complaints of posttraumatic stress disorder (PTSD). The goals of this study were to examine the use of computerized posturography testing (CPT) to objectively characterize chronic balance deficits after mTBI and to explore the utility of CPT in distinguishing between combat and blast-exposed participants with and without mTBI and PTSD. Data were analyzed from a subject pool of 166 combat-exposed SMs and Veterans who had a blast experience within the past 2 yr while deployed. Using nonparametric tests and measures of impairment, we found that balance was deficient in participants diagnosed with mTBI with posttraumatic amnesia (PTA) or PTSD versus those with neither and that deficits were amplified for participants with both diagnoses. In addition, unique deficiencies were found using CPT for individuals having isolated mTBI with PTA and isolated PTSD. Computerized balance assessment offers an objective technique to examine the physiologic effects and provide differentiation between participants with combat-associated mTBI and PTSD.	[Wares, Joanna R.; Hoke, Kathy W.] Univ Richmond, Dept Math & Comp Sci, Richmond, VA 23173 USA; [Walker, William; Franke, Laura Manning; Cifu, David X.; Carne, William] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Walker, William; Franke, Laura Manning] US Dept Vet Affairs, Def & Vet Brain Injury Ctr, Richmond, VA USA; [Ford-Smith, Cheryl] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA	Wares, JR (corresponding author), Univ Richmond, Dept Math & Comp Sci, 28 Westhampton Way, Richmond, VA 23173 USA.	jwares@richmond.edu		Cifu, David/0000-0003-1600-9387	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0095]; Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Materiel Command	This material was based upon work supported by the U.S. Army Medical Research and Materiel Command (award no. W81XWH-13-2-0095). The U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland, is the awarding and administering acquisition office. This material was also based upon work supported with resources and the use of facilities at the Hunter Holmes McGuire VAMC in Richmond, Virginia, and work supported in part by the Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Materiel Command.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; [Anonymous], 2008, DOD VA COD PROP FIN; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; CEVETTE MJ, 1995, OTOLARYNG HEAD NECK, V112, P676, DOI 10.1016/S0194-5998(95)70175-3; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chaudhry H, 2004, J REHABIL RES DEV, V41, P713, DOI 10.1682/JRRD.2003.09.0140; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; RUBIN AM, 1995, AM J OTOL, V16, P216; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Yardley L, 2000, OTOLARYNG CLIN N AM, V33, P603, DOI 10.1016/S0030-6665(05)70229-2; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679	48	13	13	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	5					591	603		10.1682/JRRD.2014.08.0197			13	Rehabilitation	Rehabilitation	CT2HQ	WOS:000362623000008	26437003	Bronze			2021-06-18	
J	Webb, TS; Whitehead, CR; Wells, TS; Gore, RK; Otte, CN				Webb, Timothy S.; Whitehead, Casserly R.; Wells, Timothy S.; Gore, Russell K.; Otte, Clifford N.			Neurologically-related sequelae associated with mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; mild brain injury; neurological; post-concussional syndrome	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POST-CONCUSSION SYNDROME; MINOR HEAD-INJURY; UNITED-STATES; WAR VETERANS; CHRONIC PAIN; IRAQ; EPILEPSY; SLEEP	Objective: Mild traumatic brain injury (mTBI) accounts for more than 75% of traumatic brain injuries every year. This study examines the temporal association between non-blast mTBI and the onset of neurologic sequelae to illuminate risks of post-concussive syndrome, epilepsy and chronic pain. Methods: A large historical prospective study was conducted utilizing electronically-recorded demographic, medical and military-specific data for over half a million active duty US Air Force Airmen. This study utilized diagnostic codes to identify mTBI exposures, two control groups and three post-mTBI time periods. Adjusted hazard ratios (HRs) were calculated using Cox proportional hazards modelling. Results: HRs were higher when mTBI exposed Airmen were compared with the full cohort and lower when compared with the other injured group. When compared to the other injured group, mTBI was positively associated with epilepsy/recurrent seizure outcomes, post-concussive syndrome and pain disorders. HRs tended to be highest within the first 30 days and decreased over time. Conclusions: Findings support that mTBI may have a prolonged neurological impact. Findings are also likely generalizable to young adult populations with exposure to non-blast related mTBI, including civilians, as those included in this study were young adults with a high prevalence of recreational/sports and motor vehicle injuries.	[Webb, Timothy S.; Wells, Timothy S.] Air Force Res Lab, Vulnerabil Anal Branch, Wright Patterson AFB, OH USA; [Whitehead, Casserly R.] Infoscitex Corp, Dayton, OH 45431 USA; [Gore, Russell K.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Otte, Clifford N.] Def Hlth Program Res Management Div, Plans & Programs Off, Wright Patterson AFB, OH USA	Whitehead, CR (corresponding author), Infoscitex Corp, 4027 Colonel Glenn Highway,Suite 210, Dayton, OH 45431 USA.	casserly.whitehead.ctr@wpafb.af.mil	Gore, Russell/N-8988-2016	Gore, Russell/0000-0002-8012-1579	Defense Center of Excellence for Psychological Health and Traumatic Brain Injury	This study was conducted in accordance with all applicable federal regulations governing the protection of human subjects in research as approved by Air Force Research Laboratory/Wright Site Institutional Review Board (Protocol F-WR-2009-0066-H). This study was funded by the Defense Center of Excellence for Psychological Health and Traumatic Brain Injury. The statements herein do not necessarily reflect the opinions of the institutions represented by the authors. All authors made significant contributions to this study. The authors report no conflicts of interest.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jabbari B, 2002, BRAIN INJURY, V16, P463, DOI 10.1080/02699050110102086; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U. S. Department of Health and Human Services, 2003, GEN ICD 9 CM HOSP VE, V1; U. S. Department of Health and Human Services, 2003, GEN ICD 9 CM HOSP VE, V3.; U. S. Department of Health and Human Services, 2003, GEN ICD 9 CM HOSP VE, V2; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	57	13	13	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					430	437		10.3109/02699052.2014.989904			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300003	25541640				2021-06-18	
J	Yengo-Kahn, AM; Solomon, G				Yengo-Kahn, Aaron Michael; Solomon, Gary			Are psychotropic medications associated with differences in baseline neurocognitive assessment scores for young athletes? A pilot study	PHYSICIAN AND SPORTSMEDICINE			English	Article						Brain concussion; neuropsychological test; immediate post-concussion assessment and cognitive test; psychotropic drugs; depression	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; NEUROPSYCHOLOGICAL MEASURES; ONLINE VERSION; UNITED-STATES; IMPACT; SENSITIVITY; PERFORMANCE; DEPRESSION	Objectives. Baseline and post-concussive neurocognitive testing is useful in managing concussed athletes. The Concussion in Sport Group has postulated that the use of psychotropic medications is a modifying factor in the management of sport-related concussion. About 7% of US adolescents are prescribed psychotropics in a given year. Our aim was to investigate whether psychotropic medication use or psychiatric illness is associated with differences in baseline neurocognitive test scores. Methods. From 2007 to 2012, over 7000 athletes underwent pre-participation baseline neurocognitive testing using the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery. Following application of inclusion and exclusion criteria, athletes' self-reported medication lists were reviewed and: 1) classified as psychotropic or not and 2) subclassified. Group subclassification yielded: 1) use of any psychotropic medication, 2) psychostimulant use, 3) antidepressant use and 4) self-reported history of depression and/or anxiety without psychotropic use. Each group was matched, by sex, age, body mass index, education level and concussion history with athletes who were not reportedly prescribed psychotropic medications or did not report a depression/anxiety history, respectively. Each group's baseline ImPACT scores were compared to matched controls. Results. The use of prescribed psychotropic medications without regard to subclass had no effect on baseline ImPACT composite scores among athletes ages 13-25. However, athletes reportedly prescribed psychostimulants displayed significantly lower visual motor speed scores (32.8 vs 37.1, p = 0.030) and slower reaction times (0.65 vs 0.60, p = 0.044) than non-users. In contrast, antidepressant users displayed significantly faster reaction times (0.58 vs 0.61, p = 0.029). Those reporting a history of depression/anxiety, not treated with psychotropics, displayed significantly lower visual memory (70.4 vs 75.2, p = 0.010) and higher symptom scores (8.83 vs 4.72, p = 0.005). Conclusions. This pilot study suggests that self-reported psychotropic medications are associated with differences in baseline ImPACT test scores, which appear dependent on medication subclass. Our preliminary results support the inclusion of psychotropic medications, specifically psychostimulants and antidepressants, as well as history of depression/anxiety as potential concussion modifiers.	[Yengo-Kahn, Aaron Michael; Solomon, Gary] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Solomon, Gary] Vanderbilt Univ, Neurol Surg, Nashville, TN 37235 USA	Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 1500 21st Ave S Suite 1506, Nashville, TN 37212 USA.	aaron.m.yengo-kahn@vanderbilt.edu	Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020; Meijer, Anna/K-5118-2016	Yengo-Kahn, Aaron/0000-0002-5989-3064; 	Nashville Predators; Tennessee Titans; ImPACTEuropean Commission	GS Solomon receives royalties from book sales. He receives consulting fees from the Nashville Predators, Tennessee Titans, ImPACT, and several university athletic programs. However, no funding was received for this study, and none of these institutions with which he is affiliated had any input into the design, execution, analysis, or decision to pursue or publish this study. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; AMADOBOCCARA I, 1995, NEUROSCI BIOBEHAV R, V19, P479, DOI 10.1016/0149-7634(94)00068-C; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Baune BT, 2014, PSYCHIAT RES, V219, P25, DOI 10.1016/j.psychres.2014.05.013; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Comer JS, 2010, J AM ACAD CHILD PSY, V49, P1001, DOI 10.1016/j.jaac.2010.07.007; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; GADDIS GM, 1990, ANN EMERG MED, V19, P1054, DOI 10.1016/S0196-0644(05)82571-5; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gevins A, 2011, J PSYCHOPHARMACOL, V25, P1062, DOI 10.1177/0269881110388334; Gevins A, 2011, CLIN NEUROPHYSIOL, V122, P114, DOI 10.1016/j.clinph.2010.06.010; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ilieva I, 2013, NEUROPHARMACOLOGY, V64, P496, DOI 10.1016/j.neuropharm.2012.07.021; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P1; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Merikangas KR, 2013, JAMA PEDIATR, V167, P141, DOI 10.1001/jamapediatrics.2013.431; Olfson M, 2013, J AM ACAD CHILD PSY, V52, P378, DOI 10.1016/j.jaac.2012.12.006; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	37	13	13	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2015	43	3					227	235		10.1080/00913847.2015.1071638			9	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	CR4TF	WOS:000361331100005	26200262				2021-06-18	
J	McBride, DW; Szu, JI; Hale, C; Hsu, MS; Rodgers, VGJ; Binder, DK				McBride, Devin W.; Szu, Jenny I.; Hale, Chris; Hsu, Mike S.; Rodgers, Victor G. J.; Binder, Devin K.			Reduction of Cerebral Edema after Traumatic Brain Injury Using an Osmotic Transport Device	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; direct osmotherapy; osmotic transport device; cerebral edema; hollow fiber-hydrogel device	INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; PRESSURE; SERUM; MANNITOL; SALINE	Traumatic brain injury (TBI) is significant, from a public health standpoint, because it is a major cause of the morbidity and mortality of young people. Cerebral edema after a TBI, if untreated, can lead to devastating damage of the remaining tissue. The current therapies of severe TBI (sTBI), as outlined by the Brain Trauma Foundation, are often ineffective, thus a new method for the treatment of sTBI is necessary. Herein, the reduction of cerebral edema, after TBI, using an osmotic transport device (OTD) was evaluated. Controlled cortical impact (CCI) was performed on adult female CD-1 mice, and cerebral edema was allowed to form for 3 h, followed by 2 h of treatment. The treatment groups were craniectomy only, craniectomy with a hydrogel, OTD without bovine serum albumin (BSA), and OTD. After CCI, brain water content was significantly higher for animals treated with a craniectomy only, craniectomy with a hydrogel, and OTD without BSA, compared to that of control animals. However, when TBI animals were treated with an OTD, brain water content was not significantly higher than that of controls. Further, brain water content of TBI animals treated with an OTD was significantly reduced, compared to that of untreated TBI animals, TBI animals treated with a craniectomy and a hydrogel, and TBI animals treated with an OTD without BSA. Here, we demonstrate the successful reduction of cerebral edema, as determined by brain water content, after TBI using an OTD. These results demonstrate proof of principle for direct water extraction from edematous brain tissue by direct osmotherapy using an OTD.	[McBride, Devin W.; Hale, Chris; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Grp Biotransport & Bioreact Kinet Grp B2K, Riverside, CA 92521 USA; [McBride, Devin W.; Hale, Chris; Rodgers, Victor G. J.] Univ Calif Riverside, Ctr Bioengn Res, Riverside, CA 92521 USA; [Szu, Jenny I.; Hsu, Mike S.; Binder, Devin K.] Univ Calif Riverside, Sch Med, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Szu, Jenny I.; Hsu, Mike S.; Binder, Devin K.] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA	Binder, DK (corresponding author), Univ Calif Riverside, Div Biomed Sci, 1247 Webber Hall, Riverside, CA 92521 USA.	dbinder@ucr.edu	Rodgers, Victor G/G-3652-2016; Rodgers, Victor G. J./AAF-3838-2021	Rodgers, Victor G/0000-0002-1857-8025; Rodgers, Victor G. J./0000-0002-1857-8025	National Institutes of Health (NIH K08 grant)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-059674]; NSF IGERT Video Bioinformatics FellowshipNational Science Foundation (NSF) [DGE 0903667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS059674] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (NIH K08 grant NS-059674; to D.K.B.). D.W.M. was supported by an NSF IGERT Video Bioinformatics Fellowship (grant no.: DGE 0903667). All ongoing studies are being carried out on protocols approved by the institutional animal care and use committee of the University of California Riverside. Portions of this work were presented in abstract form and poster/oral form at UC Neurotrauma, September 9, 2012; Neurotrauma 2012, July 25, 2012; and The 13th Annual UC Systemwide Bioengineering Symposium at University of California Berkeley, June 22, 2012.	BINGAMAN WE, 1995, NEUROL CLIN, V13, P479, DOI 10.1016/S0733-8619(18)30031-8; Buccola J. R., 2010, SIGNIFICANCE CHOICE; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castillo LB, 2009, CRIT CARE RESUSC, V11, P151; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CSENKER E, 1982, ARCH PSYCHIAT NERVEN, V231, P251, DOI 10.1007/BF00343295; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gill AS, 2011, J NEUROSURG, V114, P470, DOI 10.3171/2010.2.JNS091017; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Kettenmann H, 2005, NEUROGLIA; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; Marmarou A, 2003, ACT NEUR S, V86, P7; McBride D. W., 2013, THESIS U CALIFORNIA; McBride DW, 2012, J NEUROSURG, V116, P1389, DOI 10.3171/2012.2.JNS111540; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Truskey G. A., 2004, TRANSPORT PHENOMENA; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Yousef MA, 1998, J COLLOID INTERF SCI, V207, P273, DOI 10.1006/jcis.1998.5789; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	25	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2014	31	23					1948	1954		10.1089/neu.2014.3439			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AT6US	WOS:000345075500008	24959845	Green Published			2021-06-18	
J	Thongrong, C; Kong, N; Govindarajan, B; Allen, D; Mendel, E; Bergese, SD				Thongrong, Cattleya; Kong, Nicolas; Govindarajan, Barani; Allen, Duane; Mendel, Ehud; Bergese, Sergio D.			Current Purpose and Practice of Hypertonic Saline in Neurosurgery: A Review of the Literature	WORLD NEUROSURGERY			English	Article						Anesthesia; Hyperosmolar agent; Hypertonic saline; Intracranial pressure; Mannitol; Neurosurgery	TRAUMATIC BRAIN-INJURY; ELEVATED INTRACRANIAL-PRESSURE; SPINAL-CORD-INJURY; SMALL-VOLUME RESUSCITATION; RANDOMIZED CLINICAL-TRIAL; HEMORRHAGIC-SHOCK; SODIUM-CHLORIDE; HEAD-INJURY; BLOOD-FLOW; 20-PERCENT MANNITOL	OBJECTIVE: To review and summarize controversies and current concepts regarding the use of hypertonic saline during the perioperative period in neurosurgery. METHODS: Relevant literature was searched on PubMed and Scopus electronic databases to identify all studies that have investigated the use of hypertonic saline in neurosurgery. RESULTS: Fluid management during the course of neurosurgical practice has been debated at length, especially strategies to control intracranial pressure and small volume resuscitation. The goal of fluid therapy includes minimizing cerebral edema, preserving intravascular volume, and maintaining cerebral perfusion pressure. Mannitol is widely recognized as the gold standard for treating intracranial hypertension but can result in systemic hypotension. Thus, hypertonic saline provides volume expansion and may improve cerebral and systemic hemodynamics. Recently published prospective data, however, regarding the use of osmotic agents fails to establish clear guidelines in neurosurgical patients. CONCLUSIONS: We suggest that hypertonic saline will emerge as an alternative to mannitol, especially for a long-term use or multiple doses are needed and lead to a great opportunity for collaborative research.	[Thongrong, Cattleya; Kong, Nicolas; Govindarajan, Barani; Allen, Duane; Bergese, Sergio D.] Ohio State Univ, Wexner Med Ctr, Dept Anesthesiol, Columbus, OH 43210 USA; [Mendel, Ehud; Bergese, Sergio D.] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA; Arthur G James Canc Hosp, Columbus, OH USA; Richard J Solove Res Inst, Columbus, OH USA; [Thongrong, Cattleya] Khon Kaen Univ, Fac Med, Srinagarind Hosp, Dept Anesthesiol, Khon Kaen, Thailand	Thongrong, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Anesthesiol, Columbus, OH 43210 USA.	jupiters66@gmail.com		Bergese, Sergio/0000-0001-5641-5908			ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BEDFORD RF, 1982, ANESTH ANALG, V61, P430; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Charalambous MP, 2008, SURG INFECT, V9, P67, DOI 10.1089/sur.2005.069; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Ciesla DJ, 2001, J TRAUMA, V50, P206, DOI 10.1097/00005373-200102000-00004; Ciesla DJ, 2001, SHOCK, V16, P285, DOI 10.1097/00024382-200116040-00009; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; De Vivo P, 2001, Minerva Anestesiol, V67, P603; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Fields JD, 2009, CRIT CARE MED, V37, P2306, DOI 10.1097/CCM.0b013e3181a9f18f; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Gemma M, 1997, J NEUROSURG ANESTH, V9, P329, DOI 10.1097/00008506-199710000-00007; HARIRI RJ, 1989, J TRAUMA, V29, P1203, DOI 10.1097/00005373-198909000-00003; Hartl R, 1997, ACT NEUR S, V70, P126; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; JOHNSON AL, 2004, CRIT CARE NURSE, V24, P40; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kolsen-Petersen JA, 2005, SCAND J CLIN LAB INV, V65, P13, DOI 10.1080/00365510410003138; Koura SS, 1998, ACT NEUR S, V71, P244; KRAUS GE, 1991, SURG NEUROL, V35, P20, DOI 10.1016/0090-3019(91)90197-H; KREIMEIER U, 1990, CIRC SHOCK, V32, P83; Kumar B, 2011, ANESTH ANALG, V112, P485, DOI 10.1213/ANE.0b013e318200cca4; Levene HB, 2011, J NEUROSURG-SPINE, V14, P131, DOI 10.3171/2010.9.SPINE08314; Luostarinen T, 2011, NEUROCRIT CARE, V14, P238, DOI 10.1007/s12028-010-9475-6; MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009; McDornagh DL, 2007, ANESTHESIOLOGY, V107, P689, DOI 10.1097/01.anes.0000286923.77106.63; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Nout YS, 2009, CRIT CARE MED, V37, P2160, DOI 10.1097/CCM.0b013e3181a05d41; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAMIRES JAF, 1992, CIRC SHOCK, V37, P220; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sapsford W, 2003, J R Army Med Corps, V149, P110; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schimetta W, 2002, WIEN KLIN WOCHENSCHR, V114, P89; Schroder ML, 1998, ACT NEUR S, V71, P127; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Spera PA, 2000, ACTA NEUROCHIR, V142, P811, DOI 10.1007/s007010070097; SPIERS JP, 1993, CIRC SHOCK, V40, P29; STEENBERGEN JM, 1993, AM J PHYSIOL, V265, pH323; STERNS RH, 1986, NEW ENGL J MED, V314, P1535, DOI 10.1056/NEJM198606123142402; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Sumas ME, 2001, NEUROSURGERY, V48, P167; Thompson R, 2006, J R Army Med Corps, V152, P6; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; Tommasino C, 2007, BEST PRACT RES-CLIN, V21, P497, DOI 10.1016/j.bpa.2007.07.002; TRACHTMAN H, 1993, J AM SOC NEPHROL, V3, P1913; TRAVERSO LW, 1987, J TRAUMA, V27, P32, DOI 10.1097/00005373-198701000-00006; Tseng MY, 2007, J NEUROSURG, V107, P274, DOI 10.3171/JNS-07/08/0274; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Victorino GP, 2003, J SURG RES, V112, P79, DOI 10.1016/S0022-4804(03)00132-X; Boas WWV, 2011, REV BRAS ANESTESIOL, V61, P456, DOI 10.1016/S0034-7094(11)70053-8; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; WADE CE, 1989, CIRC SHOCK, V29, P193; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531; Wu CT, 2010, ANESTH ANALG, V110, P903, DOI 10.1213/ANE.0b013e3181cb3f8b; YOUNG WF, 1994, J NEUROSURG ANESTH, V6, P122; Zhao L, 2009, RESUSCITATION, V80, P253, DOI 10.1016/j.resuscitation.2008.10.014	87	13	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2014	82	6								10.1016/j.wneu.2013.02.027			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AY5TZ	WOS:000347635900119	23402866				2021-06-18	
J	Glushakov, AV; Fazal, JA; Narumiya, S; Dore, S				Glushakov, Alexander V.; Fazal, Jawad A.; Narumiya, Shuh; Dore, Sylvain			Role of the Prostaglandin E-2 EP1 Receptor in Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MODEL; CYCLOOXYGENASE-2; RAT; CONTRIBUTES; INHIBITION; ISCHEMIA; SEIZURES; EPILEPSY; DAMAGE	Brain injuries promote upregulation of so-called proinflammatory prostaglandins, notably prostaglandin E-2 (PGE(2)), leading to overactivation of a class of its cognate G-protein-coupled receptors, including EP1, which is considered a promising target for treatment of ischemic stroke. However, the role of the EP1 receptor is complex and depends on the type of brain injury. This study is focused on the investigation of the role of the EP1 receptor in a controlled cortical impact (CCI) model, a preclinical model of traumatic brain injury (TBI). The therapeutic effects of post-treatments with a widely studied EP1 receptor antagonist, SC-51089, were examined in wildtype and EP1 receptor knockout C57BL/6 mice. Neurological deficit scores (NDS) were assessed 24 and 48 h following CCI or sham surgery, and brain immunohistochemical pathology was assessed 48 h after surgery. In wildtype mice, CCI resulted in an obvious cortical lesion and localized hippocampal edema with an associated significant increase in NDS compared to sham-operated animals. Post-treatments with the selective EP1 receptor antagonist SC-51089 or genetic knockout of EP1 receptor had no significant effects on cortical lesions and hippocampal swelling or on the NDS 24 and 48 h after CCI. Immunohistochemistry studies revealed CCI-induced gliosis and microglial activation in selected ipsilateral brain regions that were not affected by SC-51089 or in the EP1 receptor-deleted mice. This study provides further clarification on the respective contribution of the EP1 receptor in TBI and suggests that, under this experimental paradigm, the EP1 receptor would have limited effects in modulating acute neurological and anatomical pathologies following contusive brain trauma. Findings from this protocol, in combination with previous studies demonstrating differential roles of EP1 receptor in ischemic, neurotoxic, and hemorrhagic conditions, provide scientific background and further clarification of potential therapeutic application of prospective prostaglandin G-protein-coupled receptor drugs in the clinic for treatment of TBI and other acute brain injuries.	[Glushakov, Alexander V.; Fazal, Jawad A.; Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	Glushakov, AV (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA.	glushav@ufl.edu; sdore@ufl.edu	Glushakov, Alexander V/B-5452-2008; Dore, Sylvain/AAG-1470-2020	Glushakov, Alexander V/0000-0003-2872-8960; Dore, Sylvain/0000-0003-3771-5109	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS046400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046400] Funding Source: NIH RePORTER	This work was supported by a grant from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Fund (http://mbi.ufl.edu/2011/06/13/brain-and-spinal-cord-injury-research-trust-fund-bscirtf-awards/) (AVG, SD) and a grant from the National Institutes of Health NS046400 (http://www.nih.gov/) (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad Muzamil, 2010, Exp Transl Stroke Med, V2, P12, DOI 10.1186/2040-7378-2-12; Anglada-Huguet M, 2014, MOL NEUROBIOL, V49, P784, DOI 10.1007/s12035-013-8556-x; Audoly LP, 1999, AM J PHYSIOL-HEART C, V277, pH924; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doi T, 2001, MOL BRAIN RES, V92, P107, DOI 10.1016/S0169-328X(01)00159-0; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Fischborn SV, 2010, EPILEPSY RES, V91, P57, DOI 10.1016/j.eplepsyres.2010.06.012; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Homayoun P, 1997, J NEUROCHEM, V69, P199; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kang YJ, 2008, KOREAN J PHYSIOL PHA, V12, P275, DOI 10.4196/kjpp.2008.12.5.275; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P277, DOI 10.1007/978-3-7091-0693-8_46; Kim YT, 2012, NEUROBIOL DIS, V48, P58, DOI 10.1016/j.nbd.2012.06.003; Kinirons P, 2006, SEIZURE-EUR J EPILEP, V15, P387, DOI 10.1016/j.seizure.2006.05.001; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McIntosh TK, 1996, LAB INVEST, V74, P315; Michelucci R, 2006, NEUROLOGY, V67, pS14, DOI 10.1212/WNL.67.12_suppl_4.S14; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; Mohan Shekher, 2012, Front Neurol, V3, P145, DOI 10.3389/fneur.2012.00145; Oliveira MS, 2008, NEUROSCIENCE, V152, P1110, DOI 10.1016/j.neuroscience.2008.01.005; Pagni CA, 2005, ACT NEUR S, V93, P27; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saleem S, 2007, J NEUROSCI RES, V85, P2433, DOI 10.1002/jnr.21399; Saleem S, 2009, NEUROTOX RES, V15, P62, DOI 10.1007/s12640-009-9007-3; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1207, DOI 10.1038/jcbfm.2013.69; Singh N, 2013, NEUROTOX RES, V24, P549, DOI 10.1007/s12640-013-9410-7; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; WILLMORE LJ, 1991, INT J DEV NEUROSCI, V9, P175, DOI 10.1016/0736-5748(91)90009-B; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	65	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113689	10.1371/journal.pone.0113689			19	Multidisciplinary Sciences	Science & Technology - Other Topics	CA8CZ	WOS:000349145400078	25426930	DOAJ Gold, Green Published			2021-06-18	
J	Westerhof-Evers, HJ; Visser-Keizer, AC; McDonald, S; Spikman, JM				Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.; McDonald, Skye; Spikman, Jacoba M.			Performance of healthy subjects on an ecologically valid test for social cognition: The short, Dutch Version of The Awareness of Social Inference Test (TASIT)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Brain injury; Social inferences; Assessment; Emotion recognition; Social cognition	TRAUMATIC BRAIN-INJURY; EMOTION RECOGNITION; FACIAL EXPRESSION; NEUROPSYCHOLOGICAL ASSESSMENT; HEAD-INJURY; FOLLOW-UP; PERCEPTION; MIND; DEFICITS; ABILITY	The present paper addresses the psychometric quality of the shortened Dutch version of The Awareness of Social Inference Test (TASIT), a social cognition task comprising dynamic social interactions. Because the original TASIT required a rather long administration time, two shortened parallel forms were developed. Results showed that TASIT-short was feasible and that the two alternate forms were reasonably comparable in a group of neurologically healthy individuals (N = 98). Also, the results confirmed the ecological validity of TASIT-short in this healthy group. The test appeared sensitive to brain injury as it differentiated between the healthy subjects and a group of patients with acquired brain injury (N = 16). On the basis of the present study we conclude that TASIT-short has added value to the assessment of social cognition in patients with acquired brain injury.	[Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands; [Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Haren, Netherlands; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9712 TS Groningen, Netherlands	Westerhof-Evers, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	h.j.evers@rug.nl	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [F2008-1-18]	This work was supported by the Dutch Brain Foundation [grant number F2008-1-18]	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Allain P, 2011, NEUROPSYCHOLOGY, V25, P741, DOI 10.1037/a0024408; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; Bate S, 2010, PERS INDIV DIFFER, V48, P239, DOI 10.1016/j.paid.2009.10.005; Beer JS, 2006, BRAIN RES, V1079, P1, DOI 10.1016/j.brainres.2006.02.001; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Brothers L., 1990, CONCEPT NEUROSCI, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; CUSTRINI RJ, 1989, J CLIN CHILD PSYCHOL, V18, P336, DOI 10.1207/s15374424jccp1804_7; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; EDWARDS R, 1984, EUR J SOC PSYCHOL, V14, P235, DOI 10.1002/ejsp.2420140212; Ekman P., 1976, PICTURES FACIAL AFFE; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Henderson HA, 2009, J CHILD PSYCHOL PSYC, V50, P853, DOI 10.1111/j.1469-7610.2008.02059.x; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mill A, 2009, EMOTION, V9, P619, DOI 10.1037/a0016562; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Nelson H., 1991, REVISED NATL ADULT R; PHILIPPOT P, 1990, BRIT J SOC PSYCHOL, V29, P43, DOI 10.1111/j.2044-8309.1990.tb00885.x; Pijnenborg GHM, 2009, J INT NEUROPSYCH SOC, V15, P239, DOI 10.1017/S1355617709090341; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Schmand B., 1992, NEDERLANDSE LEESTEST; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; van der Naalt J, 1994, Ned Tijdschr Geneeskd, V138, P2279; Verhage F, 1964, INTELLIGENTIE LEEFTI; VOSK BN, 1983, J BEHAV ASSESS, V5, P151, DOI 10.1007/BF01321447; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Young A., 2002, FACIAL EXPRESSIONS E	48	13	13	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 26	2014	36	10					1031	1041		10.1080/13803395.2014.966661			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AX3MB	WOS:000346842300003	25380130				2021-06-18	
J	Poole, D; Chieregato, A; Langer, M; Viaggi, B; Cingolani, E; Malacarne, P; Mengoli, F; Nardi, G; Nascimben, E; Riccioni, L; Turriziani, I; Volpi, A; Coniglio, C; Gordini, G				Poole, Daniele; Chieregato, Arturo; Langer, Martin; Viaggi, Bruno; Cingolani, Emiliano; Malacarne, Paolo; Mengoli, Francesca; Nardi, Giuseppe; Nascimben, Ennio; Riccioni, Luigi; Turriziani, Ilaria; Volpi, Annalisa; Coniglio, Carlo; Gordini, Giovanni		Trauma Update Working Grp	Systematic Review of the Literature and Evidence-Based Recommendations for Antibiotic Prophylaxis in Trauma: Results from an Italian Consensus of Experts	PLOS ONE			English	Article							PENETRATING ABDOMINAL-TRAUMA; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS MRSA; BASILAR SKULL FRACTURES; EARLY-ONSET PNEUMONIA; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-AEROGENES; COMATOSE PATIENTS; GUIDELINES; GRADE	Background: Antibiotic prophylaxis is frequently administered in severe trauma. However, the risk of selecting resistant bacteria, a major issue especially in critical care environments, has not been sufficiently investigated. The aim of the present study was to provide guidelines for antibiotic prophylaxis for four different trauma-related clinical conditions, taking into account the risks of antibiotic-resistant bacteria selection, thus innovating previous guidelines in the field. Methods: The MEDLINE database was searched for studies comparing antibiotic prophylaxis to controls (placebo or no antibiotic administration) in four clinical traumatic conditions that were selected on the basis of the traumatic event frequency and/or infection severity. The selected studies focused on the prevention of early ventilator associated pneumonia (VAP) in comatose patients with traumatic brain injury, of meningitis in severe basilar skull fractures, of wound infections in long-bone open fractures. Since no placebo-controlled study was available for deep surgical site-infections prevention in abdominal trauma with enteric contamination, we compared 24-hour and 5-day antibiotic prophylaxis policies. A separate specific research focused on the question of antibiotic-resistant bacteria selection caused by antibiotic prophylaxis, an issue not adequately investigated by the selected studies. Randomised trials, reviews, meta-analyses, observational studies were included. Data extraction was carried out by one author according to a predefined protocol, using an electronic form. The strength of evidence was stratified and recommendations were given according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Results: Uncertain evidence deserving further studies was found for two-dose antibiotic prophylaxis for early VAP prevention in comatose patients. In the other cases the risk of resistant-bacteria selection caused by antibiotic administration for 48 hours or more, outweighed potential benefits. Conclusions: When accounting for antibiotic-resistant bacteria selection we found no evidence in favour of antibiotic prophylaxis lasting two or more days in the studied clinical conditions.	[Poole, Daniele] Osped San Martino Genova, UO Anestesia & Rianimaz, Belluno, Italy; [Chieregato, Arturo; Viaggi, Bruno] AOU Careggi, SOD Anestesia & Area Intens CTO, Florence, Italy; [Langer, Martin] Fdn IRCCS Ist Nazl Tumori, Dipartimento Anestesia & Rianimaz, Milan, Italy; [Langer, Martin] Univ Milan, Milan, Italy; [Cingolani, Emiliano; Nardi, Giuseppe; Riccioni, Luigi] AO San Camillo Forlanini, UOC Shock & Trauma, Rome, Italy; [Malacarne, Paolo] Azienda Osped Univ Pisana, UO Anestesia & Rianimaz PS, Pisa, Italy; [Mengoli, Francesca; Turriziani, Ilaria; Coniglio, Carlo; Gordini, Giovanni] Osped Maggiore Bologna, UO Rianimaz 118, Bologna, Italy; [Nascimben, Ennio] Neurorianimaz Osped S Maria Ca Foncello, Treviso, Italy; [Volpi, Annalisa] Azienda Osped Univ Parma, I-43100 Parma, Italy	Poole, D (corresponding author), Osped San Martino Genova, UO Anestesia & Rianimaz, Belluno, Italy.	daniele.poole@alice.it	Poole, Daniele/X-7210-2019; Viaggi, Bruno/X-5074-2018	Poole, Daniele/0000-0001-5279-9844; Viaggi, Bruno/0000-0001-5710-2479			Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BERGMAN BR, 1982, ACTA ORTHOP SCAND, V53, P57, DOI 10.3109/17453678208992179; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; Bozorgzadeh A, 1999, AM J SURG, V177, P125, DOI 10.1016/S0002-9610(98)00317-1; Brand M, 2013, COCHRANE DB SYST REV, V11; Brand M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007370.pub2; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Braun R, 1987, J Orthop Trauma, V1, P12, DOI 10.1097/00005131-198701010-00002; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Cornwell EE, 1999, J GASTROINTEST SURG, V3, P648, DOI 10.1016/S1091-255X(99)80088-2; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; de Kraker MEA, 2011, J ANTIMICROB CHEMOTH, V66, P398, DOI 10.1093/jac/dkq412; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; DEMETRIADES D, 1992, INJURY, V23, P377, DOI 10.1016/0020-1383(92)90011-G; Dickey R L, 1989, J Orthop Trauma, V3, P6, DOI 10.1097/00005131-198903010-00002; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; FABIAN TC, 1992, SURGERY, V112, P788; FEINSTEIN AR, 1995, J CLIN EPIDEMIOL, V48, P71, DOI 10.1016/0895-4356(94)00110-C; Filius PMG, 2005, ANTIMICROB AGENTS CH, V49, P2879, DOI 10.1128/AAC.49.7.2879-2886.2005; FRAZEE RC, 1988, POSTGRAD MED, V83, P267, DOI 10.1080/00325481.1988.11700238; Gosselin RA, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003764.PUB2; Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Hauser Carl J, 2006, Surg Infect (Larchmt), V7, P379; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFF JT, 1976, J NEUROSURG, V44, P649; Hoff WS, 2011, J TRAUMA, V70, P751, DOI 10.1097/TA.0b013e31820930e5; Hospenthal DR, 2011, J TRAUMA, V71, pS210, DOI 10.1097/TA.0b013e318227ac4b; Hurwitz B, 1999, BRIT MED J, V318, P661, DOI 10.1136/bmj.318.7184.661; IGNELZI RJ, 1975, J NEUROSURG, V43, P721, DOI 10.3171/jns.1975.43.6.0721; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; KERNODLE DS, 1988, ANTIMICROB AGENTS CH, V32, P202, DOI 10.1128/AAC.32.2.202; Kirton OC, 2000, J TRAUMA, V49, P822, DOI 10.1097/00005373-200011000-00006; Klastersky J, 1976, Surg Neurol, V6, P111; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Luchette FA, 2000, E PRACT MAN GUID WOR; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; PATZAKIS MJ, 1983, CLIN ORTHOP RELAT R, P31; PATZAKIS MJ, 1974, J BONE JOINT SURG AM, VA 56, P532, DOI 10.2106/00004623-197456030-00010; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PRICE D, 1970, J CLIN PATHOL, V23, P378, DOI 10.1136/jcp.23.4.378-c; PRICE DJE, 1972, J NEUROL NEUROSUR PS, V35, P903, DOI 10.1136/jnnp.35.6.903; PRICE DJE, 1970, LANCET, V2, P1213; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Rojczyk M, 1983, Hefte Unfallheilkd, V162, P33; Schentag JJ, 1998, CLIN INFECT DIS, V26, P1204, DOI 10.1086/520287; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Tacconelli E, 2009, ANTIMICROB AGENTS CH, V53, P4264, DOI 10.1128/AAC.00431-09; Tacconelli E, 2009, CURR OPIN INFECT DIS, V22, P352, DOI 10.1097/QCO.0b013e32832d52e0; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Zrebeet H A, 1986, Del Med J, V58, P741	72	13	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113676	10.1371/journal.pone.0113676			13	Multidisciplinary Sciences	Science & Technology - Other Topics	AT9ND	WOS:000345253000071	25412442	DOAJ Gold, Green Published			2021-06-18	
J	Bolos, M; Hu, YL; Young, KM; Foa, L; Small, DH				Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.			Neurogenin 2 Mediates Amyloid-beta Precursor Protein-stimulated Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; INTRACELLULAR DOMAIN; PYRAMIDAL NEURONS; BHLH GENES; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Amyloid-beta precursor protein (APP) is well studied for its role in Alzheimer disease, although its normal function remains uncertain. It has been reported that APP stimulates the proliferation and neuronal differentiation of neural stem/progenitor cells (NSPCs). In this study we examined the role of APP in NSPC differentiation. To identify proteins that may mediate the effect of APP on NSPC differentiation, we used a gene array approach to find genes whose expression correlated with APP-induced neurogenesis. We found that the expression of neurogenin 2 (Ngn2), a basic helix-loop-helix transcription factor, was significantly down-regulated in NSPCs from APP knock-out mice (APPKO) and increased in APP transgenic (Tg2576) mice. Ngn2 overexpression in APPKO NSPCs promoted neuronal differentiation, whereas siRNA knockdown of Ngn2 expression in wild-type NSPCs decreased neuronal differentiation. The results demonstrate that APP-stimulated neuronal differentiation of NSPCs is mediated by Ngn2.	[Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Foa, Lisa] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia	Small, DH (corresponding author), Private Bag 23, Hobart, Tas 7001, Australia.	d.h.small@menzies.utas.edu.au	Foa, Lisa/J-7781-2014; Bolos, Marta/J-7620-2014	Foa, Lisa/0000-0003-4131-8341; Bolos, Marta/0000-0003-2652-8607; Young, Kaylene/0000-0002-1686-3463	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); BUPA/Alzheimer's Society UK; Multiple Sclerosis Research Australia	This work was supported by project grants from the National Health and Medical Research Council of Australia, BUPA/Alzheimer's Society UK and Multiple Sclerosis Research Australia.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; COCHRAN E, 1991, AM J PATHOL, V139, P485; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hu YL, 2013, J BIOL CHEM, V288, P18853, DOI 10.1074/jbc.M112.443671; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; Lee JA, 2007, ZEBRAFISH, V4, P277, DOI 10.1089/zeb.2007.0516; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Megason SG, 2002, DEVELOPMENT, V129, P2087; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Octave JN, 2013, J NEUROCHEM, V126, P183, DOI 10.1111/jnc.12239; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Small D H, 1999, J Alzheimers Dis, V1, P275; Small DH, 2014, NEURODEGENER DIS, V13, P96, DOI 10.1159/000353686; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TABATON M, 1992, BRAIN RES, V593, P299, DOI 10.1016/0006-8993(92)91323-7; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	64	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31253	31261		10.1074/jbc.M114.581918			9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS9GA	WOS:000344549900030	25217641	Green Published, Other Gold			2021-06-18	
J	Couchman, G; McMahon, G; Kelly, A; Ponsford, J				Couchman, Grace; McMahon, Genevieve; Kelly, Amber; Ponsford, Jennie			A new kind of normal: Qualitative accounts of Multifamily Group Therapy for acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Caregiver; Traumatic brain injury; Family psychoeducation; Family; Experience; Multi-family group; Qualitative	FAMILY GROUP TREATMENT; SELF; PSYCHOEDUCATION; INDIVIDUALS; PEOPLE; RIGOUR	Acquired brain injuries (ABI) can have a major impact on social participation, causing increased social isolation and emotional distress for people with the injury and their family members. Multifamily Group Therapy (MFGT) provides information, resources, problem-solving strategies and opportunities for social networking for families where one member has an illness. By qualitatively examining the experience of group participation from the perspectives of both individuals with ABI and their family members, the present study aimed to elucidate the processes underlying and factors influencing success of facilitated MFG programmes with families impacted by ABI. Following participation in the 12-week MFGT, 29 individuals with brain injury and 30 caregivers participated in 90-minute, semi-structured focus groups. The overarching theme emerging from the transcripts was that of "Finding One's Place", with sub-themes of Connectedness, Identity, and Knowledge and Understanding. The MFGT experience made a contribution to participants' efforts to find their place in the world after an ABI. This was enhanced by connection with others within the group, sharing experiences, the development of self and family identity, and the gaining of knowledge and understanding. These findings consolidate a growing literature, which points to the importance of "Reconstruction of a place in the world" and "Reconstruction of personhood" in ABI recovery.	[Couchman, Grace; McMahon, Genevieve; Kelly, Amber; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Couchman, Grace] Cairnmillar Inst, Sch Psychol Counseling & Psychotherapy, Camberwell, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia	Couchman, G (corresponding author), 184 Weston St East, Melbourne, Vic 3057, Australia.	g.couchman@me.com			Victorian Traffic Accident Commission (TAC), Victorian Neurotrauma Initiative [DP145]	The authors received funding from the Victorian Traffic Accident Commission (TAC), Victorian Neurotrauma Initiative to conduct the described research (project DP145). They believe this has in no way influenced their conduct of the research nor the interpretation of the research findings. The researchers received no direct personal benefit of a financial or other kind.	Arenth PM, 2006, BRAIN INJURY, V20, P253, DOI 10.1080/02699050500487662; Becker B. D., 2006, MULTI FAMILY GROUP T; Bradley GM, 2006, PSYCHIAT SERV, V57, P521, DOI 10.1176/appi.ps.57.4.521; Braun V, 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charles N, 2007, NEUROREHABILITATION, V22, P61; Couchman G., 2008, PSYCHOTHERAPIES PSYC, P240; Davey T. T. L., 2004, J HUMAN BEHAV SOCIAL, V9, P129, DOI DOI 10.1300/J137V09N01_09; Dyck DG, 2000, PSYCHIAT SERV, V51, P513, DOI 10.1176/appi.ps.51.4.513; Fristad MA, 2002, BIPOLAR DISORD, V4, P254, DOI 10.1034/j.1399-5618.2002.09073.x; Geertz C., 1973, INTERPRETATION CULTU; Geist R, 2000, CAN J PSYCHIAT, V45, P173, DOI 10.1177/070674370004500208; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Good Byron J., 1994, MED RATIONALITY EXPE; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Guba EG, 1981, EFFECTIVE EVALUATION; Kersten P, 2010, DISABIL REHABIL, V32, P1028, DOI 10.3109/09638281003775568; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Lemmens GM, 2003, J FAM THER, V25, P41, DOI 10.1111/1467-6427.00234; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McFarlane W., 2002, MULTIFAMILY GROUPS T, V29; McFarlane W., 2002, FAMILY PCYCHOEDUCATI; MCFARLANE WR, 1995, FAM PROCESS, V34, P127, DOI 10.1111/j.1545-5300.1995.00127.x; McPherson KM, 2010, DISABIL REHABIL, V32, P961, DOI 10.3109/09638281003672393; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Meezan W, 1998, RES SOCIAL WORK PRAC, V8, P330, DOI 10.1177/104973159800800306; Mihalopoulos C, 2004, AUST NZ J PSYCHIAT, V38, P511, DOI 10.1080/j.1440-1614.2004.01404.x; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Ryan GW, 2003, FIELD METHOD, V15, P85, DOI [DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; Seale C, 1997, EUR J PUBLIC HEALTH, V7, P379, DOI 10.1093/eurpub/7.4.379; Strauss A., 1990, BASICS QUALITATIVE R; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; White M., 1990, NARRATIVE MEANS THER	37	13	13	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 2	2014	24	6					809	832		10.1080/09602011.2014.912957			24	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	AS4MK	WOS:000344250200001	24824512				2021-06-18	
J	Du, Q; Yu, WH; Dong, XQ; Yang, DB; Shen, YF; Wang, H; Jiang, L; Du, YF; Zhang, ZY; Zhu, Q; Che, ZH; Liu, QJ				Du, Quan; Yu, Wen-Hua; Dong, Xiao-Qiao; Yang, Ding-Bo; Shen, Yong-Feng; Wang, Hao; Jiang, Li; Du, Yuan-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie			Plasma 8-iso-Prostaglandin F2 alpha concentrations and outcomes after acute intracerebral hemorrhage	CLINICA CHIMICA ACTA			English	Article						8-Iso-Prostaglandin F2 alpha; Intracerebral hemorrhage; Functional outcome; Mortality; Severity; Oxidative stress	OXIDATIVE STRESS; FREE-RADICALS; BRAIN-INJURY; BIOMARKERS; STROKE; RAT; ANTIOXIDANTS; ACTIVATION; PATHOLOGY; ISCHEMIA	Background: Higher plasma 8-iso-Prostaglandin F2 alpha concentrations have been associated with poor outcome of severe traumatic brain injury. We further investigated the relationships between plasma 8-iso-Prostaglandin F2 alpha concentrations and clinical outcomes in patients with acute intracerebral hemorrhage. Methods: Plasma 8-iso-Prostaglandin F2 alpha concentrations of 128 consecutive patients and 128 sex- and gender-matched healthy subjects were measured by enzyme-linked immunosorbent assay. We assessed their relationships with disease severity and clinical outcomes including 1-week mortality, 6-month mortality and unfavorable outcome (modified Rankin Scale score > 2). Results: Plasma 8-iso-Prostaglandin F2 alpha concentrations were substantially higher in patients than in healthy controls. Plasma 8-iso-Prostaglandin F2 alpha concentrations were positively associated with National Institutes of Health Stroke Scale (NIHSS) scores and hematoma volume using a multivariate linear regression. It emerged as an independent predictor for clinical outcomes of patients using a forward stepwise logistic regression. ROC curves identified the predictive values of plasma 8-iso-Prostaglandin F2 alpha concentrations, and found its predictive value was similar to NIHSS scores and hematoma volumes. However, it just numerically added the predictive values of NIHSS score and hematoma volume. Conclusions: Increased plasma 8-iso-Prostaglandin F2 alpha concentrations are associated with disease severity and clinical outcome after acute intracerebral hemorrhage. (C) 2014 Elsevier B.V. All rights reserved.	[Du, Quan; Yu, Wen-Hua; Dong, Xiao-Qiao; Yang, Ding-Bo; Shen, Yong-Feng; Wang, Hao; Jiang, Li; Du, Yuan-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, Affiliated Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China	Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, Affiliated Hangzhou Hosp, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Hangzhou Medical Research Fund Scheme A Class Project [2011A014]	The authors thank all staffs in the Department of Neurosurgery, the Hangzhou First People's Hospital for their technical support. This work was financially supported by a grant from the Hangzhou Medical Research Fund Scheme A Class Project (no. 2011A014).	Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; Alexandrova ML, 2011, J CLIN NEUROSCI, V18, P247, DOI 10.1016/j.jocn.2010.07.125; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Basu S, 2001, FEBS LETT, V508, P36, DOI 10.1016/S0014-5793(01)02998-2; Bhatia R, 2013, NEUROL INDIA, V61, P244, DOI 10.4103/0028-3886.115062; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brunetti L, 2002, LIFE SCI, V71, P2447, DOI 10.1016/S0024-3205(02)02037-4; Chen YC, 2011, J NEUROSURG, V115, P1184, DOI 10.3171/2011.7.JNS11718; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Elesber AA, 2006, FREE RADICAL RES, V40, P385, DOI 10.1080/10715760500539154; Elijovich L, 2008, SEMIN NEUROL, V28, P657, DOI 10.1055/s-0028-1105974; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Ji Li Li, 2009, Infectious Disorders - Drug Targets, V9, P428; Keep RF, 2008, ACT NEUR S, V105, P73; Kitagawa Y, 2014, CIRC J, V78, P315, DOI 10.1253/circj.CJ-13-1553; Kohler AC, 2014, J MOL CELL CARDIOL, V73, P92, DOI 10.1016/j.yjmcc.2014.03.001; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x; Owczarek D, 2010, INFLAMM BOWEL DIS, V16, P52, DOI 10.1002/ibd.20994; Peeling J, 1998, BRAIN RES, V795, P63, DOI 10.1016/S0006-8993(98)00253-4; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Szuldrzynski K, 2010, POL ARCH MED WEWN, V120, P19; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wagner KR, 2007, STROKE, V38, P753, DOI 10.1161/01.STR.0000255033.02904.db; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Wiswedel I, 2009, METHODS MOL BIOL, V580, P3, DOI 10.1007/978-1-60761-325-1_1; Woolley JF, 2013, TRENDS BIOCHEM SCI, V38, P556, DOI 10.1016/j.tibs.2013.08.009; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yu GF, 2013, CLIN CHIM ACTA, V421, P7, DOI 10.1016/j.cca.2013.02.030; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014	42	13	13	0	86	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 1	2014	437						141	146		10.1016/j.cca.2014.07.014			6	Medical Laboratory Technology	Medical Laboratory Technology	AP7GX	WOS:000342246900025	25079083				2021-06-18	
J	Kuhn, AW; Solomon, GS				Kuhn, Andrew Warren; Solomon, Gary S.			Supervision and Computerized Neurocognitive Baseline Test Performance in High School Athletes: An Initial Investigation	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; sports; neurocognitive testing; ImPACT	SPORTS-RELATED CONCUSSION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSITION STATEMENT; NATIONAL ACADEMY; ONLINE VERSION; IMPACT; RELIABILITY; MANAGEMENT; SYMPTOMS; OBSERVER	Context: Computerized neuropsychological testing batteries have provided a time-efficient and cost-efficient way to assess and manage the neurocognitive aspects of patients with sport-related concussion. These tests are straightforward and mostly self-guided, reducing the degree of clinician involvement required by traditional clinical neuropsychological paper-and- pencil tests. Objective: To determine if self-reported supervision status affected computerized neurocognitive baseline test performance in high school athletes. Design: Retrospective cohort study. Settings: Supervised testing took place in high school computer libraries or sports medicine clinics. Unsupervised testing took place at the participant's home or another location with computer access. Patients or Other Participants: From 2007 to 2012, high school athletes across middle Tennessee (n = 3771) completed computerized neurocognitive baseline testing (Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT]). They reported taking the test either supervised by a sports medicine professional or unsupervised. These athletes (n = 2140) were subjected to inclusion and exclusion criteria and then matched based on age, sex, and number of prior concussions. Main Outcome Measure(s): We extracted demographic and performance-based data from each de-identified baseline testing record. Paired t tests were performed between the self-reported supervised and unsupervised groups, comparing the following ImPACT baseline composite scores: verbal memory, visual memory, visual motor (processing) speed, reaction time, impulse control, and total symptom score. For differences that reached P < .05, the Cohen d was calculated to measure the effect size. Lastly, a chi(2) analysis was conducted to compare the rate of invalid baseline testing between the groups. All statistical tests were performed at the 95% confidence interval level. Results: Self-reported supervised athletes demonstrated better visual motor (processing) speed (P = .004; 95% confidence interval [0.28, 1.52]; d = 0.12) and faster reaction time (P < .001; 95% confidence interval [-0.026, -0.014]; d = 0.21) composite scores than self-reported unsupervised athletes. Conclusions: Speed-based tasks were most affected by self-reported supervision status, although the effect sizes were relatively small. These data lend credence to the hypothesis that supervision status may be a factor in the evaluation of ImPACT baseline test scores.	[Kuhn, Andrew Warren] Boston Univ, Boston, MA 02215 USA; [Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA	Solomon, GS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, T-4224 Med Ctr North, Nashville, TN 37232 USA.	gary.s.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019; Kuhn, Andrew W/AAM-4820-2020	Kuhn, Andrew W/0000-0003-1836-7575			ALVES WM, 1987, CLIN SPORT MED, V6, P211; Axelrod B, 2000, ARCH CLIN NEUROPSYCH, V15, P379, DOI 10.1093/arclin/15.5.379; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Cohen J., 1969, STAT POWER ANAL BEHA; Cohen J., 1992, CURRENT DIRECTIONS P, V1, P98, DOI [DOI 10.1111/1467-8721.EP10768783, 10.1111/1467-8721.ep10768783]; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Eastvold AD, 2012, CLIN NEUROPSYCHOL, V26, P520, DOI 10.1080/13854046.2012.663000; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; ImPACT, 2007, CLIN INT MAN; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jones NS, 2011, CLIN J SPORT MED, V21, P153; Kehrer CA, 2000, CLIN NEUROPSYCHOL, V14, P67, DOI 10.1076/1385-4046(200002)14:1;1-8;FT067; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008	34	13	13	0	14	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2014	49	6					800	805		10.4085/1062-6050-49.3.66			6	Sport Sciences	Sport Sciences	AY4NW	WOS:000347556500011	25299577	Green Published, Bronze			2021-06-18	
J	Porter, KK; Constantinidou, F; Marron, KH				Porter, Kelly Knollman; Constantinidou, Fofi; Marron, Kathleen Hutchinson			Speech-Language Pathology and Concussion Management in Intercollegiate Athletics: The Miami University Concussion Management Program	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; COLLEGIATE; IMPACT; SYMPTOMS; RECOVERY; STATEMENT; HISTORY	Purpose: The Miami University Concussion Management Program was established in 1999 to assess, manage, and monitor athletes who sustain concussions and experience neurobehavioral and neurocognitive symptoms secondary to their injury. The purpose of this article is to describe the established procedures of one of the oldest universitybased interdisciplinary concussion management programs that is coordinated by speech-language pathologists (SLP). Method: The theoretical and clinical underpinnings of baseline and postconcussion neurocognitive assessment and management procedures are discussed. Additionally, 2 illustrative case studies are presented to demonstrate the evolution and implementation of the interdisciplinary concussion management protocol and to present different patterns of concussion symptoms and recovery. Paper and computer-based neurocognitive assessment protocols are discussed and integrated in the case studies. Results/Conclusions: Successful management of sport-related concussion requires an interdisciplinary team that understands the unique neurobehavioral and neurocognitive symptoms associated with sports concussions. SLPs can play a valuable role on the interdisciplinary team in the prompt and appropriate management of postconcussion symptoms so that athletes can successfully return to their athletic, academic, and social activities.	[Porter, Kelly Knollman; Constantinidou, Fofi; Marron, Kathleen Hutchinson] Miami Univ, Oxford, OH 45056 USA; [Constantinidou, Fofi] Univ Cyprus, Nicosia, Cyprus	Porter, KK (corresponding author), Miami Univ, Oxford, OH 45056 USA.	knollmkk@miamioh.edu		Constantinidou, Fofi/0000-0002-7928-8363			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benton AL, 1978, MULTILINGUAL APHASIA; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2004, STUD NEUROPSYCHOL DE, P111; Constantinidou F., 2005, ARCHIVES OF PHYSICAL, V86, pe13; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Devick S., 2010, KING DEVICK TEST; Duff M. C., 2009, ASHA LEADER; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Geffen L., 1998, OXFORD HDB SPORTS ME, P152; Granito J, 2001, J SPORT BEHAV, V24, P63; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heyanka DJ, 2013, INT J NEUROSCI, V123, P526, DOI 10.3109/00207454.2013.771261; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; Klove H., 1963, LAFAYETTE INSTRUMENT; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nideffer R. M., 2001, APPLIED SPORT PSYCHO, P321; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith A., 1980, SYMBOL DIGITS MODALI; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1	57	13	13	0	29	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2014	23	4					507	519		10.1044/2014_AJSLP-13-0126			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AU5ZR	WOS:000345682400002	25089035				2021-06-18	
J	Kahveci, R; Gokce, EC; Gurer, B; Gokce, A; Kisa, U; Cemil, DB; Sargon, MF; Kahveci, FO; Aksoy, N; Erdogan, B				Kahveci, Ramazan; Gokce, Emre Cemal; Gurer, Bora; Gokce, Aysun; Kisa, Ucler; Cemil, Duran Berker; Sargon, Mustafa Fevzi; Kahveci, Fatih Ozan; Aksoy, Nurkan; Erdogan, Bulent			Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Methylprednisolone; Neuroprotection; Rat; Rosuvastatin; Spinal cord injury; Trauma	A REDUCTASE INHIBITOR; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; LIPID-PEROXIDATION; FUNCTIONAL RECOVERY; SUPEROXIDE-DISMUTASE; CEREBRAL-ISCHEMIA; GLIAL APOPTOSIS; BRAIN-INJURY; CELL-DEATH	Rosuvastatin, which is a potent stain, has never been studied in traumatic spinal cord injury. The aim of this study was to investigate whether rosuvastatin treatment could protect the spinal cord after experimental spinal cord injury. Rats were randomized into the following five groups of eight animals each: control, sham, trauma, rosuvastatin, and methylprednisolone. In the control group, no surgical intervention was performed. In the sham group, only laminectomy was performed. In all the other groups, the spinal cord trauma model was created by the occlusion of the spinal cord with an aneurysm clip. In the spinal cord tissue, caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, nitric oxide levels, and superoxide dismutase levels were analyzed. Histopathological and ultrastructural evaluations were also performed. Neurological evaluation was performed using the Basso, Beattie, and Bresnahan locomotor scale and the inclined plane test After traumatic spinal cord injury, increases in caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels were detected. In contrast, the superoxide dismutase levels were decreased. After the administration of rosuvastatin, decreases were observed in the tissue caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels. In contrast, tissue superoxide dismutase levels were increased. Furthermore, rosuvastatin treatment showed improved results concerning the histopathological scores, the ultrastructural score and the functional tests. Biochemical, histopathological, ultrastructural analysis and functional tests revealed that rosuvastatin exhibits meaningful neuroprotective effects against spinal cord injury. (C) 2014 Elsevier B.V. All rights reserved.	[Kahveci, Ramazan] Kirikkale Yuksek Ihtisas Hosp, Dept Neurosurg, Minist Hlth, Kirikkale, Turkey; [Gokce, Emre Cemal; Cemil, Duran Berker; Erdogan, Bulent] Turgut Ozal Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Gurer, Bora] Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Beyin Cerrahi Serv, Minist Hlth, TR-34752 Istanbul, Turkey; [Gokce, Aysun] Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Pathol, Minist Hlth, Ankara, Turkey; [Kisa, Ucler; Aksoy, Nurkan] Kirikkale Univ, Fac Med, Dept Biochem, Kirikkale, Turkey; [Sargon, Mustafa Fevzi] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey; [Kahveci, Fatih Ozan] Bulent Ecevit Univ, Fac Med, Dept Emergency Med, Zonguldak, Turkey	Gurer, B (corresponding author), Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Beyin Cerrahi Serv, Minist Hlth, TR-34752 Istanbul, Turkey.	boragurer@gmail.com	KISA, Ucler/V-5443-2017; Gurer, Bora/K-1177-2012	KISA, Ucler/0000-0002-8131-6810; Sargon, Mustafa Fevzi/0000-0001-6360-6008; Gurer, Bora/0000-0003-1500-6184			BALENTINE JD, 1978, LAB INVEST, V39, P236; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BORGENS RB, 1986, J COMP NEUROL, V250, P157, DOI 10.1002/cne.902500203; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DAWSON TM, 1994, ANN NY ACAD SCI, V738, P76; Dery MA, 2009, NEUROSCI LETT, V453, P73, DOI 10.1016/j.neulet.2009.01.062; Die J, 2010, BRAIN RES, V1346, P251, DOI 10.1016/j.brainres.2010.05.068; Dinc C, 2013, SPINE, V38, pE1649, DOI 10.1097/BRS.0000000000000055; Domoki F, 2010, NEUROCHEM INT, V56, P404, DOI 10.1016/j.neuint.2009.11.013; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-81; Fletcher B, 2005, CIRCULATION, V112, P3184, DOI 10.1161/CIRCULATIONAHA.105.169180; Han XG, 2012, NEUROSCI LETT, V521, P136, DOI 10.1016/j.neulet.2012.05.071; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jungner M, 2013, MICROVASC RES, V88, P48, DOI 10.1016/j.mvr.2013.03.004; KALTSCHMIDT B, 1993, MOL ASPECTS MED, V14, P171, DOI 10.1016/0098-2997(93)90004-W; Kaptanoglu E, 2002, J NEUROSURG, V97, P49, DOI 10.3171/spi.2002.97.1.0049; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kertmen H, 2013, EUR J PHARMACOL, V714, P148, DOI 10.1016/j.ejphar.2013.05.012; Kilic U, 2005, NEUROSCIENCE, V134, P901, DOI 10.1016/j.neuroscience.2005.04.063; Kurt G, 2009, SURG NEUROL, V71, P332, DOI 10.1016/j.surneu.2008.01.038; Laufs U, 2002, BRAIN RES, V942, P23, DOI 10.1016/S0006-8993(02)02649-5; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Liu XZ, 1997, J NEUROSCI, V17, P5395; Mann CM, 2010, EXP NEUROL, V221, P285, DOI 10.1016/j.expneurol.2009.11.006; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McKenney JM, 2003, CURR MED RES OPIN, V19, P689, DOI 10.1185/030079903125002405; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Prinz V, 2008, STROKE, V39, P433, DOI 10.1161/STROKEAHA.107.492470; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Savoia Claudia, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P57; Schroter A, 2009, NEUROSCIENCE, V161, P753, DOI 10.1016/j.neuroscience.2009.04.016; Sheehy N, 2001, EXPERT OPIN INV DRUG, V10, P1847, DOI 10.1517/13543784.10.10.1847; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sonmez E, 2013, SPINE, V38, P1253, DOI 10.1097/BRS.0b013e3182895587; Stepien K, 2005, PHARMACOL REP, V57, P561; SUN Y, 1988, CLIN CHEM, V34, P497; Tapia-Perez JH, 2010, NEUROSURG REV, V33, P259, DOI 10.1007/s10143-010-0259-4; Torres S, 2010, NEUROPATHOLOGY, V30, P36, DOI 10.1111/j.1440-1789.2009.01037.x; Ucak A, 2011, ANN VASC SURG, V25, P686, DOI 10.1016/j.avsg.2011.02.024; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Yavuz C, 2013, CNS NEUROL DISORD-DR, V12, P1011, DOI 10.2174/18715273113129990085; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yin Y, 2013, NEUROCHEM INT, V62, P903, DOI 10.1016/j.neuint.2013.03.005; Zacco A, 2003, J NEUROSCI, V23, P11104	67	13	15	1	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 15	2014	741						45	54		10.1016/j.ejphar.2014.07.042			10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AQ9CW	WOS:000343140600006	25084223				2021-06-18	
J	Bukovics, P; Czeiter, E; Amrein, K; Kovacs, N; Pal, J; Tamas, A; Bagoly, T; Helyes, Z; Buki, A; Reglodi, D				Bukovics, Peter; Czeiter, Endre; Amrein, Krisztina; Kovacs, Noemi; Pal, Jozsef; Tamas, Andrea; Bagoly, Terez; Helyes, Zsuzsanna; Buki, Andras; Reglodi, Dora			Changes of PACAP level in cerebrospinal fluid and plasma of patients with severe traumatic brain injury	PEPTIDES			English	Article						Endogenous PACAP; Plasma; Cerebrospinal fluid; Traumatic brain injury; Neuroprotective; Blood-brain barrier	CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; INDUCED RETINAL LESION; ADENYLATE-CYCLASE; SPINAL-CORD; CEREBRAL-ISCHEMIA; SUBSTANTIA-NIGRA; CELL-DEATH; BLOOD; RATS	PACAP has well-known neuroprotective potential including traumatic brain injury (TBI). Its level is up-regulated following various insults of the CNS in animal models. A few studies have documented alterations of PACAP levels in human serum. The time course of post-ictal PACAP levels, for example, show correlation with migraine severity. Very little is known about the course of PACAP levels following CNS injury in humans and the presence of PACAP has not yet been detected in cerebrospinal fluid (CSF) of subjects with severe TBI (sTBI). The aim of the present study was to determine whether PACAP occurs in the CSF and plasma (PI) of patients that suffered sTBI and to establish a time course of PACAP levels in the CSF and Pl. Thirty eight subjects with sTBI were enrolled with a Glasgow Coma Scale <= 8 on admission. Samples were taken daily, until the time of death or for maximum 10 days. Our results demonstrated that PACAP was detectable in the CSF, with higher concentrations in patients with TBI. PACAP concentrations markedly increased in both PI and CSF in the majority of patients 24-48 h after the injury stayed high thereafter. In cases of surviving patients, Pl and CSF levels displayed parallel patterns, which may imply the damage of the blood-brain barrier. However, in patients, who died within the first week, Pl levels were markedly higher than CSF levels, possibly indicating the prognostic value of high Pl PACAP levels. (C) 2014 Elsevier Inc. All rights reserved.	[Bukovics, Peter; Amrein, Krisztina; Kovacs, Noemi; Pal, Jozsef; Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Bukovics, Peter; Czeiter, Endre; Buki, Andras] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Czeiter, Endre; Helyes, Zsuzsanna; Buki, Andras] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Czeiter, Endre; Tamas, Andrea; Reglodi, Dora] MTA PTE Lendulet PACAP Res Grp, Pecs, Hungary; [Czeiter, Endre; Tamas, Andrea; Reglodi, Dora] Univ Pecs, Dept Anat, Pecs, Hungary; [Bagoly, Terez; Helyes, Zsuzsanna] Univ Pecs, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary	Czeiter, E (corresponding author), MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary.	endre.czeiter@gmail.com	Bukovics, Peter/A-6019-2009; Czeiter, Endre/B-1404-2009	Pal, Jozsef/0000-0001-6468-6409	National Science Research Found [OTKA PD72240, OTKA K104984]; European UnionEuropean Commission; State of Hungary; European Social FundEuropean Social Fund (ESF) [SROP 4.2.4.A/2-11-1-2012-0001, SROP-4.2.2.A-11/1/KONV-2012-0017, SROP-4.2.2.A-11/1/KONV-2012-0024]; National Excellence Program; Magyary Zoltan Scholarship; Arimura Foundation; MTA-PTE "Lendulet" Program; Hungarian Brain Research Program [KTIA_13_NAP-A-III/5, KTIA_13_NAP-A-II/8]	This study was supported by National Science Research Found OTKA PD72240, OTKA K104984, the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of SROP 4.2.4.A/2-11-1-2012-0001, SROP-4.2.2.A-11/1/KONV-2012-0017, SROP-4.2.2.A-11/1/KONV-2012-0024; 'National Excellence Program'; Magyary Zoltan Scholarship; Arimura Foundation; MTA-PTE "Lendulet" Program and Hungarian Brain Research Program Grant No. KTIA_13_NAP-A-III/5 as well as Hungarian Brain Research Program Grant No. KTIA_13_NAP-A-II/8.	Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Atlasz T, 2007, GEN COMP ENDOCR, V153, P108, DOI 10.1016/j.ygcen.2006.12.022; Babai N, 2005, NEUROTOX RES, V8, P227, DOI 10.1007/BF03033976; BANKS WA, 1993, J PHARMACOL EXP THER, V267, P690; Beal MF, 2000, NEUROTOX RES, V2, P71, DOI 10.1007/BF03033786; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Delgado M, 2003, ANN NY ACAD SCI, V992, P141, DOI 10.1111/j.1749-6632.2003.tb03145.x; Delgado M, 1999, J IMMUNOL, V162, P1200; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; DOW RC, 1994, J ENDOCRINOL, V142, pR1, DOI 10.1677/joe.0.142R001; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Feng SQ, 2005, NEUROTOX RES, V7, P169, DOI 10.1007/BF03033785; de Yebenes JG, 2000, NEUROTOX RES, V2, P115, DOI 10.1007/BF03033789; Gerlach M, 2000, NEUROTOX RES, V2, P99, DOI 10.1007/BF03033788; Helyes Z, 2007, PEPTIDES, V28, P1847, DOI 10.1016/j.peptides.2007.07.001; Katahira M., 2003, Regulatory Peptides, V115, P49; Kim WK, 2000, J NEUROSCI, V20, P3622; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Martinez C, 2006, ANN NY ACAD SCI, V1070, P405, DOI 10.1196/annals.1317.053; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nemeth J, 2006, NEUROSCIENCE, V143, P223, DOI 10.1016/j.neuroscience.2006.07.028; RACZ B, 2006, INT J NEUROPROT NEUR, V2, P80; Racz B, 2006, REGUL PEPTIDES, V137, P20, DOI 10.1016/j.regpep.2006.02.009; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Reglodi D, 2005, NEUROTOX RES, V8, P317; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Segura-Aguilar J, 2006, NEUROTOX RES, V10, P263, DOI 10.1007/BF03033362; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Tamas A, 2006, ANN NY ACAD SCI, V1070, P570, DOI 10.1196/annals.1317.083; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tams JW, 1999, BIOCHEM J, V341, P271, DOI 10.1042/0264-6021:3410271; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	49	13	13	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	OCT	2014	60						18	22		10.1016/j.peptides.2014.07.001			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AP8YI	WOS:000342364900004	25017241				2021-06-18	
J	Haldipur, P; Dupuis, N; Degos, V; Moniaux, N; Chhor, V; Rasika, S; Schwendimann, L; le Charpentier, T; Rougier, E; Amouyal, P; Amouyal, G; Dournaud, P; Brechot, C; El Ghouzzi, V; Faivre, J; Fleiss, B; Mani, S; Gressens, P				Haldipur, Parthiv; Dupuis, Nina; Degos, Vincent; Moniaux, Nicolas; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Amouyal, Paul; Amouyal, Gilles; Dournaud, Pascal; Brechot, Christian; El Ghouzzi, Vincent; Faivre, Jamila; Fleiss, Bobbi; Mani, Shyamala; Gressens, Pierre			HIP/PAP prevents excitotoxic neuronal death and promotes plasticity	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article								Objectives: Excitotoxicity plays a significant role in the pathogenesis of perinatal brain injuries. Among the consequences of excessive activation of the N-methyl-D-aspartate (NMDA)-type glutamate are oxidative stress caused by free radical release from damaged mitochondria, neuronal death and subsequent loss of connectivity. Drugs that could protect nervous tissue and support regeneration are attractive therapeutic options. The hepatocarcinoma intestine pancreas protein/pancreatitis-associated protein I (HIP/PAP) or Reg3 alpha, which is approved for clinical testing for the protection and regeneration of the liver, is upregulated in the central nervous system following injury or disease. Here, we examined the neuroprotective/neuroregenerative potential of HIP/PAP following excitotoxic brain injury. Methods: We studied the expression of HIP/PAP and two of its putative effectors, cAMP-regulated phosphoprotein 19 (ARPP19) and growth-associated protein 43 (GAP-43), in the neonatal brain, and the protective/regenerative properties of HIP/PAP in three paradigms of perinatal excitotoxicity: intracerebral injection of the NMDA agonist ibotenate in newborn pups, a pediatric model of traumatic brain injury, and cultured primary cortical neurons. Results: HIP/PAP, ARPP19, and GAP-43 were expressed in the neonatal mouse brain. HIP/PAP prevented the formation of cortical and white matter lesions and reduced neuronal death and glial activation following excitotoxic insults in vivo. In vitro, HIP/PAP promoted neuronal survival, preserved neurite complexity and fasciculation, and protected cell contents from reactive oxygen species (ROS)-induced damage. Interpretation: HIP/PAP has strong neuroprotective/neuroregenerative potential following excitotoxic injury to the developing brain, and could represent an interesting therapeutic strategy in perinatal brain injury.	[Haldipur, Parthiv; Mani, Shyamala] Natl Brain Res Ctr, Manesar, India; [Haldipur, Parthiv; Mani, Shyamala] IISC, Ctr Neurosci, Bangalore, Karnataka, India; [Dupuis, Nina; Degos, Vincent; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Dournaud, Pascal; El Ghouzzi, Vincent; Fleiss, Bobbi; Gressens, Pierre] INSERM, U1141, Paris, France; [Dupuis, Nina; Degos, Vincent; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Dournaud, Pascal; El Ghouzzi, Vincent; Fleiss, Bobbi; Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, UMRS 1141, Paris, France; [Dupuis, Nina; Degos, Vincent; Chhor, Vibol; Rasika, Sowmyalakshmi; Schwendimann, Leslie; le Charpentier, Tifenn; Rougier, Elodie; Dournaud, Pascal; El Ghouzzi, Vincent; Fleiss, Bobbi; Gressens, Pierre] PremUP, Paris, France; [Moniaux, Nicolas; Brechot, Christian; Faivre, Jamila] INSERM, U785, Ctr Hepatobiliaire, Villejuif, France; [Moniaux, Nicolas; Brechot, Christian; Faivre, Jamila] Univ Paris Sud, Fac Med, Villejuif, France; [Chhor, Vibol; Fleiss, Bobbi; Gressens, Pierre] Kings Coll London, St Thomas Hosp, Ctr Dev Brain, Div Imaging Sci & Biomed Engn,Kings Hlth Partners, London, England; [Amouyal, Paul; Amouyal, Gilles] Alfact Innovat, Paris, France	Gressens, P (corresponding author), Hop Robert Debre, INSERM, U1141, 48 Blvd Serurier, F-75019 Paris, France.	pierre.gressens@inserm.fr	gressens, pierre/M-7557-2017; Fleiss, Bobbi/F-9899-2011; Moniaux, Nicolas/Y-3243-2018; Haldipur, Parthiv/ABH-8875-2020	gressens, pierre/0000-0002-0909-4221; Fleiss, Bobbi/0000-0001-7828-673X; Moniaux, Nicolas/0000-0001-9718-1386; El Ghouzzi, Vincent/0000-0001-5894-8978			Ampo KI, 2009, J NEUROTRAUM, V26, P1683, DOI [10.1089/neu.2008.0847, 10.1089/neu.2008-0847]; Averill S, 2002, J NEUROSCI, V22, P7493; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Carlsson Y, ANN NEUROL; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Guo Q, 1999, P NATL ACAD SCI USA, V96, P4125, DOI 10.1073/pnas.96.7.4125; Gupta SK, 2010, J NEUROSCI, V30, P2755, DOI 10.1523/JNEUROSCI.4218-09.2010; Gupta SK, CELL DEATH DIFFER; Haldipur P, 2012, STEM CELLS DEV, V21, P1059, DOI 10.1089/scd.2011.0206; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Irwin N, P NATL ACAD SCI US; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kaindl AM, 2007, PROTEOM CLIN APPL, V1, P640, DOI 10.1002/prca.200600696; Keller M, 2008, EUR J NEUROSCI, V27, P874, DOI 10.1111/j.1460-9568.2008.06062.x; Klementiev B, EUR J NEUROSCI; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lieu HT, 2006, J HEPATOL, V44, pS136, DOI 10.1016/S0168-8278(06)80356-9; Lieu HT, 2006, HEPATOLOGY, V44, P1452, DOI 10.1002/hep.21434; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Lv YF, 2012, INFLAMM BOWEL DIS, V18, P1950, DOI 10.1002/ibd.22887; Marz-Weiss P, 2011, CELL MOL NEUROBIOL, V31, P1141, DOI 10.1007/s10571-011-9715-0; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; Mattson MP, 1997, PHYSIOL REV, V77, P1081; Medja F, 2006, BRAIN, V129, P3209, DOI 10.1093/brain/awl239; Mesples B, 2005, ACTA PAEDIATR, V94, P185, DOI 10.1080/08035250410022378; Moniaux N, HUMAN HEPATOCARCINOM; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Nishimune H, 2000, NAT CELL BIOL, V2, P906; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Palmer AM, J NEUROCHEM; Redecker C, 1998, DEV BRAIN RES, V109, P109, DOI 10.1016/S0165-3806(98)00065-0; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Viterbo D, 2008, J IMMUNOL, V181, P1948, DOI 10.4049/jimmunol.181.3.1948; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029155	46	13	15	1	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	OCT	2014	1	10					739	754		10.1002/acn3.127			16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V45KN	WOS:000209815600001	25493266	DOAJ Gold, Green Published			2021-06-18	
J	Turner, RJ; Vink, R				Turner, Renee J.; Vink, Robert			NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke	NEUROPEPTIDES			English	Article						Neurogenic inflammation; Neuropeptides; Ischemic stroke; Capsaicin; NK1 tachykinin receptor antagonist	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; NF-KAPPA-B; CEREBRAL-ARTERY OCCLUSION; SUBSTANCE-P; NEUROGENIC INFLAMMATION; REPERFUSION INJURY; EDEMA FORMATION; HUMAN-MONOCYTES; CELL-DEATH	Previous results from our laboratory have shown that blockade of the substance P (SP) pathway with an NK1 tachykinin receptor antagonist significantly reduces blood brain barrier breakdown, cerebral edema and functional deficits following ischemic stroke. However, it is unclear whether removal of all neuropeptides is more efficacious than blocking SP alone. As such, the aim of the present study was to determine the effect of neuropeptide depletion with capsaicin pre-treatment on functional outcome following acute ischemic stroke in rats. Animals received 125 mg/kg of capsaicin or equal volume of saline vehicle, administered subcutaneously over a 3-day period. At 14 days following treatment animals were subject to 2 h of middle cerebral artery occlusion followed by reperfusion. A subset of animals was treated with an NK1 tachykinin receptor antagonist (NAT) or vehicle at 4 h after the onset of stroke only. The functional outcome of animals was assessed for a 7-day period following stroke using a rotarod device, the bilateral asymmetry test, modified neurological severity score, open field and angleboard. Although capsaicin pre-treatment improved outcome, treatment with an NK1 tachykinin receptor antagonist was superior in improving post-stroke functional outcome. This data suggests that some neuropeptides may play a beneficial role following stroke, whilst others such as SP are deleterious. (C) 2014 Elsevier Ltd. All rights reserved.	[Turner, Renee J.; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia; [Vink, Robert] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia	Turner, RJ (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia.	renee.turner@adelaide.edu.au	Vink, Robert/J-7351-2012; AM, Robert Vink/S-5616-2019	Vink, Robert/0000-0002-4885-0667; AM, Robert Vink/0000-0002-4885-0667	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia	This work was supported, in part, by the National Health and Medical Research Council (NHMRC) of Australia.	Bardelli C, 2005, BRIT J PHARMACOL, V145, P385, DOI 10.1038/sj.bjp.0706198; BARSHAVIT Z, 1980, BIOCHEM BIOPH RES CO, V94, P1445, DOI 10.1016/0006-291X(80)90581-1; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Braun JS, 1996, ACTA NEUROPATHOL, V92, P255, DOI 10.1007/s004010050516; Bucinskaite V, 1998, NEUROPEPTIDES, V32, P179, DOI 10.1016/S0143-4179(98)90035-X; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Dembinski A., 2003, MED SCI MONITOR, V9, pBR418; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Guo CJ, 2004, GLIA, V48, P259, DOI 10.1002/glia.20079; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Holzer P, 1998, GEN PHARMACOL, V30, P5, DOI 10.1016/S0306-3623(97)00078-5; Huang RP, 2008, AM J PHYSIOL-HEART C, V294, pH1291, DOI 10.1152/ajpheart.00749.2007; Kashiba H, 1997, NEUROSCIENCE, V76, P299; KJARTANSSON J, 1987, EUR J PHARMACOL, V142, P355, DOI 10.1016/0014-2999(87)90073-2; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lieberman DN, 1998, J NEUROPHYSIOL, V80, P113; Liu Z, 2011, REGUL PEPTIDES, V171, P19, DOI 10.1016/j.regpep.2011.05.014; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; Mak IT, 2003, MAGNESIUM RES, V16, P91; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Pegorini S, 2005, BRIT J PHARMACOL, V144, P727, DOI 10.1038/sj.bjp.0706115; Ramos C, 2007, EXP LUNG RES, V33, P151, DOI 10.1080/01902140701364409; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Rittner HL, 2007, ANESTHESIOLOGY, V107, P1009, DOI 10.1097/01.anes.0000291454.90754.de; RUFF MR, 1985, PEPTIDES, V6, P107, DOI 10.1016/0196-9781(85)90142-1; Souza DG, 2002, BRIT J PHARMACOL, V135, P303, DOI 10.1038/sj.bjp.0704464; Stacey AE, 2002, EUR J NEUROSCI, V16, P1896, DOI 10.1046/j.1460-9568.2002.02266.x; Stumm RK, 2001, J NEUROSCI, V21, P798; Turchanyi B, 2005, PHYSIOL RES, V54, P25; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2012, NEUROSCIENCE, V220, P1, DOI 10.1016/j.neuroscience.2012.06.047; Turner R, 2007, DRUG NEWS PERSPECT, V20, P221, DOI 10.1358/dnp.2007.20.4.1103527; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Wimalawansa SJ, 1996, ENDOCR REV, V17, P533, DOI 10.1210/edrv-17-5-533; Xu J, 2007, EXP LUNG RES, V33, P197, DOI 10.1080/01902140701459514; Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z; Zhang JY, 2011, EUR J PHARMACOL, V671, P61, DOI 10.1016/j.ejphar.2011.09.170	46	13	13	1	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	OCT	2014	48	5					267	272		10.1016/j.npep.2014.07.002			6	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	AQ5XB	WOS:000342880800002	25151181				2021-06-18	
J	Munyon, C; Eakin, KC; Sweet, JA; Miller, JP				Munyon, Charles; Eakin, Katharine C.; Sweet, Jennifer A.; Miller, Jonathan P.			Decreased bursting and novel object-specific cell firing in the hippocampus after mild traumatic brain injury	BRAIN RESEARCH			English	Article						Hippocampus; Bursting; Novel object recognition; Traumatic brain injury	SYNAPTIC PLASTICITY; ENTORHINAL CORTEX; TEMPORAL-LOBE; MEMORY; RAT; NEURONS; CANNABINOIDS; RECOGNITION; PROPAGATION; DEFICITS	Objective: mild traumatic brain injury (mTBI) can produce lasting memory deficits even in the absence of cell loss. We investigated changes in hippocampal firing patterns during exploration and during a novel object recognition (NOR) task. Methods: six male Sprague-Dawley rats were subjected to mTBI via fluid percussion injury and were compared with sham-operated rats. Microelectrodes were implanted into CA1 and CA3 and multiple units were recorded from the pyramidal cell layer. Spontaneous "burst" characteristics were analyzed and temporal firing patterns were correlated with object encounters to establish object-specific firing patterns. Results: mTBI was associated with significantly less hippocampal bursting (p < 0.05) with a trend toward longer bursts and lower interburst spike frequency. mTBI was also associated with no preference for a novel object at 12 h (p < 0.05). During the NOR task, a subset of pyramidal cells were identified which consistently demonstrated a transiently increased firing rate upon encounter of a specific object ("object-specific" cell). Across both groups, there was a significant (p < 0.05) correlation between preference for object novelty and the difference between the total number of novel object-specific cells and familiar object-specific cells. The proportion of object-specific cells that responded to the unexpected (novel) object compared to those responding to the familiar object was significantly smaller in rats that had been exposed to mTBI (p < 0.05). Conclusion: memory deficits after mTBI are associated with decreased intrinsic burst activity and impaired context-specific firing patterns in the hippocampus during object exploration. (C) 2014 Elsevier B.V. All rights reserved.	[Munyon, Charles; Eakin, Katharine C.; Sweet, Jennifer A.; Miller, Jonathan P.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA	Miller, JP (corresponding author), Case Western Reserve Univ, Dept Neurol Surg, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Jonathan.Miller@UHHospitals.org		Munyon, Charles/0000-0002-0093-5442; Miller, Jonathan/0000-0001-5441-1751			Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K.C., 2012, J NEUROTRAUM, V29, P1; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Funahashi M, 2000, BRAIN RES, V884, P104, DOI 10.1016/S0006-8993(00)02854-7; Goonawardena AV, 2011, HIPPOCAMPUS, V21, P520, DOI 10.1002/hipo.20769; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hampson RE, 2003, HIPPOCAMPUS, V13, P543, DOI 10.1002/hipo.10081; Hampson RE, 2000, J NEUROSCI, V20, P8932; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Stewart M, 1999, BRAIN RES, V830, P274, DOI 10.1016/S0006-8993(99)01404-3; Viskontas IV, 2007, HIPPOCAMPUS, V17, P49, DOI 10.1002/hipo.20241; Watson HC, 2012, J NEUROSCI, V32, P4473, DOI 10.1523/JNEUROSCI.5751-11.2012; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	26	13	13	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 25	2014	1582						220	226		10.1016/j.brainres.2014.07.036			7	Neurosciences	Neurosciences & Neurology	AR1PM	WOS:000343357100021	25086204				2021-06-18	
J	Luo, H; Pace, E; Zhang, XG; Zhang, JS				Luo, Hao; Pace, Edward; Zhang, Xueguo; Zhang, Jinsheng			Blast-induced tinnitus and spontaneous activity changes in the rat inferior colliculus	NEUROSCIENCE LETTERS			English	Article						Blast exposure; Tinnitus; Traumatic brain injury (TBI); Inferior colliculus; Spontaneous activity	DORSAL COCHLEAR NUCLEUS; TRAUMATIC BRAIN-INJURY; ACOUSTIC TRAUMA; HEARING-LOSS; HYPERACTIVITY; CHINCHILLAS; PLASTICITY; EXPOSURE; SOUND	High-pressure blast shockwaves are known to cause tinnitus. Imaging studies have shown that blast-induced tinnitus may result from damage to the inner ear structures and/or direct brain impact that trigger a cascade of neuroplastic changes in both auditory and non-auditory centers. Nevertheless, information is still lacking on the neurophysiological mechanisms underlying blast-induced tinnitus. In this study, we used a rat model and investigated the effect of blast-induced tinnitus on spontaneous activity in the inferior colliculus (IC) at one day, one month, and three months following blast. Our results showed that rats with behavioral evidence of tinnitus exhibited hyperactivity in all frequency regions at one day post-blast. Although the induced hyperactivity persisted throughout a three-month recording period, it was more robust in middle frequency loci at one month after blast exposure and in middle-to-high-frequency loci at three months after blast. Our results also showed increased bursting rate in the low and middle frequency regions at one day after blast, in the middle frequency region at one month after blast, and in all frequency regions at three months after blast. The findings suggest that neuroplasticity as reflected by shifted tonotopic representations of hyperactivity and bursting activity subserves blast-induced tinnitus and hearing impairment. (C) 2014 Published by Elsevier Ireland Ltd.	[Luo, Hao; Pace, Edward; Zhang, Xueguo; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48201 USA	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, 5E UHC,4201 St Antoine, Detroit, MI 48201 USA.	Jinzhang@med.wayne.edu			US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the US Department of Defense (grant award #W81XWH-11-2-0031). The authors wish to thank Drs. Pamela VandeVord and Srini Kallakuri for their assistance during blast exposure using a shock tube in the Department of,Biomedical Engineering, Wayne State University.	Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Cho SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067618; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Geckle L., 2004, FORC HLTH PROT C ALB; Izquierdo MA, 2008, NEUROSCIENCE, V154, P355, DOI 10.1016/j.neuroscience.2008.01.057; KALTENBACH JA, 2010, HEAR RES; Knipper M., 2013, PROG NEUROBIOL; Langers DRM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00002; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Luo H., 2014, J NEUROSCI RES; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; MERZENICH MM, 1974, BRAIN RES, V77, P397, DOI 10.1016/0006-8993(74)90630-1; Moller AR, 2006, PROG BRAIN RES, V157, P365, DOI 10.1016/S0079-6123(06)57022-0; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Zhang JS, 2006, J NEUROSCI RES, V84, P819, DOI 10.1002/jnr.20985; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0	29	13	14	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 19	2014	580						47	51		10.1016/j.neulet.2014.07.041			5	Neurosciences	Neurosciences & Neurology	AQ0NC	WOS:000342479000010	25092609				2021-06-18	
J	Jazi, MS; Rezaei, A; Karami, G; Azarmi, F; Ziejewski, M				Jazi, Mehdi Salimi; Rezaei, Asghar; Karami, Ghodrat; Azarmi, Fardad; Ziejewski, Mariusz			A computational study of influence of helmet padding materials on the human brain under ballistic impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						ballistic impact; helmet; finite elements; TBI; pad	FINITE-ELEMENT-ANALYSIS; MECHANICAL-PROPERTIES; HEAD IMPACT; PART I; FOAMS	The results of a computational study of a helmeted human head are presented in this paper. The focus of the work is to study the effects of helmet pad materials on the level of acceleration, inflicted pressure and shear stress in a human brain model subjected to a ballistic impact. Four different closed cell foam materials, made of expanded polystyrene and expanded polypropylene, are examined for the padding material. It is assumed that bullets cannot penetrate the helmet shell. Finite element modelling of the helmet, padding system, head and head components is used for this dynamic nonlinear analysis. Appropriate contacts and conditions are applied between the different components of the head, as well as between the head and the pads, and the pads and the helmet. Based on the results of simulations in this work, it is concluded that the stiffness of the foam has a prominent role in reducing the level of the transferred load to the brain. A pad that is less stiff is more efficient in absorbing the impact energy and reducing the sudden acceleration of the head and consequently lowers the brain injury level. Using the pad with the least stiffness, the influence of the angle of impacts as well as the locations of the ballistic strike is studied.	[Jazi, Mehdi Salimi; Rezaei, Asghar; Karami, Ghodrat; Azarmi, Fardad; Ziejewski, Mariusz] N Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA	Karami, G (corresponding author), N Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA.	g.karami@ndsu.edu			Army Research Office	The authors would like to acknowledge the Army Research Office for the financial support of this research.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Altair Hyperworks, 2011, HYPERMESH US GUID VE; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Avalle M, 2001, INT J IMPACT ENG, V25, P455, DOI 10.1016/S0734-743X(00)00060-9; Baumgartner D., 2003, P RTO SPEC M NATO KO; CARROLL AW, 1978, ANN SURG, V188, P753, DOI 10.1097/00000658-197812000-00007; Chafi M. S., 2009, P I MECH ENG H, V18, P21; Digges KH, 1998, RTO HFM SPEC M MOD A; Dirisala V, 2012, INT J NUMER METH BIO, V28, P472, DOI 10.1002/cnm.1480; Gibson LJ., 1997, CELLULAR SOLIDS STRU, V2nd; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kostopoulos V, 2002, COMPOS PART B-ENG, V33, P99, DOI 10.1016/S1359-8368(01)00066-X; Kurtaran H, 2003, THEOR APPL FRACT MEC, V40, P113, DOI 10.1016/S0167-8442(03)00039-9; Lee YS, 2010, J CELL PLAST, V46, P43, DOI 10.1177/0021955X09346363; LIDEN E, 1988, J TRAUMA, V28, pS145, DOI 10.1097/00005373-198801001-00029; LS-DYNA, 2007, LS DYNA US MAN VERS; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; MILTZ J, 1990, POLYM ENG SCI, V30, P129, DOI 10.1002/pen.760300210; Nahum A. M., 1977, P 21 STAPP CAR CRASH; Othman RB, 2009, THESIS U SAINS MALAY; Pinnoji PK, 2007, SADHANA-ACAD P ENG S, V32, P445, DOI 10.1007/s12046-007-0034-6; Qiu Z., 2007, THESIS NATL U SINGAP; RAMON O, 1990, POLYM ENG SCI, V30, P197, DOI 10.1002/pen.760300402; RUAN JS, 1993, P 37 STAPP CAR CRASH; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Taylor PA, 2006, REPORT DOCUMENTS COM; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; Turquier F, 1996, 962431 SAE; van Hoof J, 2001, 2006160 DREV CR; Van Hoof J, 1999, 18 INT S BALL SAN AN; Viot P, 2011, BEHAV POLYM MULTISCA; Ward C. C., 1980, P 24 STAPP CAR CRASH, P347; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang J., 2010, COMPUTER AIDED APPL, V7, P59, DOI DOI 10.3722/cadaps.2010.59-73; Zhang J, 1998, INT J IMPACT ENG, V21, P369, DOI 10.1016/S0734-743X(97)00087-0; Zhou C., 1995, 95271421 SAE	41	13	14	1	58	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	SEP 10	2014	17	12					1368	1382		10.1080/10255842.2012.748755			15	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Computer Science; Engineering	AF1QH	WOS:000334487900008	23281845				2021-06-18	
J	Classen, S; Cormack, NL; Winter, SM; Monahan, M; Yarney, A; Lutz, AL; Platek, K				Classen, Sherrilene; Cormack, Nicole Leigh; Winter, Sandra M.; Monahan, Miriam; Yarney, Abraham; Lutz, Amanda Link; Platek, Kyle			Efficacy of an Occupational Therapy Driving Intervention for Returning Combat Veterans	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						automobile driving; intervention study; polytrauma	BRAIN-INJURY; PERFORMANCE; FREEDOM; UTILITY	Polytrauma, including mild traumatic brain injury, posttraumatic stress disorder, and orthopedic conditions, is common among combat veterans (CVs) from Operations Enduring Freedom and Iraqi Freedom. Medical conditions, coupled with deployment-related training, may affect CVs' fitness to drive and contribute to post-deployment crash and injury risks. However, empirical interventions are lacking. Therefore, the study purpose was to examine the efficacy of an occupational therapy driving intervention (OT-DI) with pre and post testing of CVs. Using a DriveSafety 250 simulator, Occupational Therapy-Driver Rehabilitation Specialists recorded driving errors. Eight CVs (mean age = 39.83, SD = 7.80) received three OT-DI sessions, which incorporated strategies to address driving errors and visual search retraining. We determined baseline driving errors (mean = 31.63, SD = 8.96) were double the number of posttest errors (mean = 15.38, SD = 9.71). At posttesting, a significant (p < 0.05) decrease was noted for total errors and lane maintenance. Despite study constraints, preliminary data support the efficacy of the OT-DI.	[Classen, Sherrilene] Western Univ, Sch Occupat Therapy, London, ON N6G 1H1, Canada; [Classen, Sherrilene; Winter, Sandra M.; Monahan, Miriam] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Occupat Therapy, Gainesville, FL USA; [Classen, Sherrilene; Winter, Sandra M.; Monahan, Miriam; Yarney, Abraham] Univ Florida, Coll Publ Hlth & Hlth Profess, Inst Mobil Act & Participat, Gainesville, FL USA; [Cormack, Nicole Leigh] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Winter, Sandra M.] North Florida South Georgia Vet Hlth Syst, Vet Affairs Ctr Innovat Disabil & Rehabil Res CIN, Gainesvillesite, Gainesville, FL USA; [Lutz, Amanda Link; Platek, Kyle] Univ Florida, Hlth Rehabil Ctr Magnolia Parke, Gainesville, FL USA	Classen, S (corresponding author), Western Univ, Elborn Coll, Sch Occupat Therapy, 1201 Western Rd, London, ON N6G 1H1, Canada.	sclassen@uwo.ca		Monahan, Miriam/0000-0003-1636-7969			American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Amick MM, 2013, J REHABIL RES DEV, V50, P463, DOI 10.1682/JRRD.2012.06.0108; Carlson K., 2009, THE ASSESSMENT AND T; Classen S., 2010, ADV TRANSPORTATION S, P45; Classen S, 2014, AM J OCCUP THER, V68, P405, DOI 10.5014/ajot.2014.010041; Classen S, 2012, AM J OCCUP THER, V66, P233, DOI 10.5014/ajot.2012.001834; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Congressional Research Service, 2014, U S MILITARY CASUALT; Defense and Veterans Brain Injury Center, 2014, DOD NUMBERS FOR TRAU; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Kennedy R. S., 1993, Int'l. J. Aviat. Psychol., V3, P203, DOI [DOI 10.1207/S15327108IJAP0303_3, 10.1207/s15327108ijap0303_3]; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Monahan M., 2009, VISUAL SEARCH SKILLS; National Institute of Neurological Disorders and Stroke, 2014, NINDS TRAUMATIC BRAI; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; The American Occupational Therapy Association, 2010, AM J OCCUPATIONAL S, V64, P112, DOI DOI 10.5014/AJOT.2010.64S112; Zamorski M.A., 2012, NATO REPORT TR HFM 1	20	13	13	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	FAL	2014	34	4					176	182		10.3928/15394492-20141006-01			7	Rehabilitation	Rehabilitation	AR1PO	WOS:000343357300002	25347755				2021-06-18	
J	Curtis, L; Epstein, P				Curtis, L.; Epstein, P.			Nutritional treatment for acute and chronic traumatic brain injury patients	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Brain concussion; Enteral nutrition; Probiotics; Fatty Acids, Omega-3	CHAIN AMINO-ACIDS; NEUROLOGIC RECOVERY; FUNCTIONAL RECOVERY; LIPOIC ACID; CITICOLINE; OUTCOMES; MODEL; SUPPLEMENTATION; PROBIOTICS; MAGNESIUM	Proper nutrition is critical for recovery from traumatic brain injury (TBI). Prompt enteral feeding of moderate to severe TBI patients has been associated with significantly lower mortality and rates of infection. Probiotic supplementation has been associated with significantly lower rates of infection in TBI and other trauma patients. Human studies have suggested that supplementation with omega 3 fats, vitamin D, N-Acetylcysteine branched chain aminoacids, and zinc may be helpful for recovery from TBI. Animal TBI models have suggested that alpha-lipoic acid, magnesium, taunine, coenzyme Q(10), and many phytonutrients (such as resveratrol) are also helpful. Unfortunately, recent human clinical trials with citicoline in TBI and stroke patients have produced disappointing results. Much more research is needed on multifaceted nutritional strategies to treat TBI patients in both the immediate post-injury phase and throughout the patients lifespan.	[Epstein, P.] Adv Neurodiagnost, Wheeling, IL USA	Curtis, L (corresponding author), 108-49 63rd Ave 6K, Forest Hills, NY 11375 USA.	luketcurtis@aol.com					Adibhatla RM, 2012, NATURE REV NEUROLOGY, P166; Agrawal R, 2010, NEUR M PLANN SOC NEU; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Barraud D, 2013, CHEST, V143, P646, DOI 10.1378/chest.12-1745; Barringer Nick, 2012, J Spec Oper Med, V12, P5; Bayir A, 2008, ACTA NEUROL BELG, V108, P149; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bica D, 2013, HIGH DOSE OMEGA 3 FA; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Blasco G, 2013, EFFICIENCY SMALL PEP; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Cahill LM, 2004, J HEAD TRAUMA REHAB, V19, P241, DOI 10.1097/00001199-200405000-00005; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; Desai A, PLOS ONE, V9; Dhandapani M, 2013, J CLIN NURS IN PRESS; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Duraski SA, 2014, REHABILITAT IN PRESS; Elovic EP, 2001, J HEAD TRAUMA REHAB, V16, P603, DOI 10.1097/00001199-200112000-00008; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Festa M, 1995, PHARM RES, V12, P1769; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Gomez-Pinilla F, 2011, PREV MED, V52, P575; Grieb P, 2014, CNS DRUGS, V28, P185, DOI 10.1007/s40263-014-0144-8; Gu WJ, 2013, JPEN-PARENTER ENTER, V37, P310, DOI 10.1177/0148607112463245; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hoane MR, 2008, MAGNESIUM RES, V21, P29; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Itoh T, 2013, J NEURAL TRANSM, V120, P767, DOI 10.1007/s00702-012-0918-4; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Kalayci M, 2011, BMC NEUROSCI, V29, P12; Leonardo CC, 2011, NUTR NEUROSCI, V14, P226, DOI 10.1179/1476830511Y.0000000013; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Li SY, 2012, NEUROBIOL DIS, V45, P624, DOI 10.1016/j.nbd.2011.10.008; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Matthews LR, 2013, INT J CASE REPORTS I, V4, P143, DOI DOI 10.5348/ijcri-2013-03-281-CS-2; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Pandya JD, 2014, EXPT NEUROL IN PRESS; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Ramos-Cabrer P, 2011, INT J PHARMACEUT, V405, P228, DOI 10.1016/j.ijpharm.2010.12.014; Roberts L, 2008, J AM COLL SURGEONS, V207, P276, DOI 10.1016/j.jamcollsurg.2008.02.015; Rocamonde B, 2012, NEUROSCIENCE, V224, P102, DOI 10.1016/j.neuroscience.2012.08.028; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Scrimgeour AG, 2014, J NEUROTRAU IN PRESS; Senol N, 2014, NEUROCHEM RES; Sheffield-Moore M, 2014, AMINO ACID SUPPLEMEN; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Stein DG, 2011, PHYS MED REHABIL, V3, P100; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun M, 2014, J NEUROTRAUMA; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tarozzi A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/415078; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Twyman D, 1997, CRIT CARE CLIN, V13, P39, DOI 10.1016/S0749-0704(05)70295-5; Wahls T, 2013, NUTR NEUROS IN PRESS; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; Wang Y, 2012, CHIN J INTEGR MED, V18, P690, DOI 10.1007/s11655-012-1053-7; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Yurgelun-Todd D, CITICOLINE OMEGA 3 F; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zorman G, 2013, MILD HYPOTHERMIA SUP	96	13	15	1	56	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2014	58	3					151	160					10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR1XH	WOS:000343377400003	24844176				2021-06-18	
J	Grant, M; Radford, K; Sinclair, E; Walker, M				Grant, Mary; Radford, Kathryn; Sinclair, Emma; Walker, Marion			Return to work after stroke: recording, measuring, and describing occupational therapy intervention	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Stroke; vocational rehabilitation; research	TRAUMATIC BRAIN-INJURY; VOCATIONAL-REHABILITATION; BLACK-BOX; BARRIERS; IMPACT	Introduction: Existing research on vocational rehabilitation following stroke has been criticised for not describing intervention in sufficient detail for replication or clinical implementation. The purpose of this study was to test the feasibility of recording and measuring the content of an early stroke-specific vocational rehabilitation intervention delivered to participants in a feasibility randomized controlled trial, using a proforma previously developed for a study of vocational rehabilitation following traumatic brain injury. Method: The proforma was adapted for use in stroke with input from an expert panel and was used to record intervention content, in 10-minute units, following each intervention session. Findings: Twenty-five people, working or in education at the time of stroke, participated in the study. Two thirds of the therapists' time was spent in face-to-face contact (43%) and liaison with the patient and others (20%). Intervention mainly focused on work preparation (21%) and the return to work process (24%). The remaining time was consumed by administration (19%) and travel (18%). Conclusion: The proforma was quick and easy to use and captured the main focus of intervention. This study suggests that it can be used to record stroke-specific vocational rehabilitation intervention content and has potential for wider use in research and clinical practice.	[Grant, Mary; Radford, Kathryn; Sinclair, Emma; Walker, Marion] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2UH, England	Grant, M (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Div Rehabil & Ageing, B114 B Floor, Nottingham NG7 2UH, England.	mcxmig@nottingham.ac.uk	Radford, Kate A/F-8571-2013	Radford, Kate A/0000-0001-6246-3180; Walker, Marion/0000-0002-3534-591X	National Institute of Health Research - Collaborative Leadership in Health Research and Care - Nottinghamshire, Derbyshire and Lincolnshire; Elizabeth Casson Trust through the United Kingdom Occupational Therapy Research Foundation; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10092] Funding Source: researchfish	The study was funded by National Institute of Health Research - Collaborative Leadership in Health Research and Care - Nottinghamshire, Derbyshire and Lincolnshire. It is also part of the first author's PhD study, funded by the Elizabeth Casson Trust through the United Kingdom Occupational Therapy Research Foundation. The funders had no other part in the direction of the study.	Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; [Anonymous], 2005, CLIN REHABIL, V19, P811, DOI 10.1191/0269215505cr923ed; Baldwin C, 2011, TOP STROKE REHABIL, V18, P562, DOI 10.1310/tsr1805-562; Black C, 2008, WORKING HLTH TOMORRO; Black C.D., 2011, HLTH WORK INDEPENDEN; Care Quality Commission, 2011, SUPP LIF STROK REV S; CLAHRC-NDL, 2013, STROK REH RES; Coole C, 2013, J OCCUP REHABIL, V23, P406, DOI 10.1007/s10926-012-9401-1; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; *DEP WORK PENS, 2004, BUILD CAP WORK UK FR; *DEP WORK PENS, 2005, HLTH WORK WELLB CAR; Department for Work and Pensions, 2012, DIS EMPL SUPP FULF P; Department of Health, 2005, NAT SERV FRAM LONG T; Department of Health, 2010, NHS OUTC FRAM 2011 1; Deshpande P, 2004, VOCATIONAL ASSESSMEN; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Grant MI, 2012, INT J STROKE, V7, P20; Hart T, 2009, NEUROPSYCHOL REHABIL, V19; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Lock S, 2005, DISABIL SOC, V20, P33, DOI 10.1080/0968759042000283629; Medical Research Council, 2008, DEV EVALUATING COMPL; *OFF NAT STAT, 2000, STAND OCC CLASS 2000; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; Playford E., 2011, MAPPING VOCATIONAL R; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Radford KA, 2008, BRAIN IMPAIR, V9, P161, DOI 10.1375/brim.9.2.161; Saeki S, 2010, J REHABIL MED, V42, P254, DOI 10.2340/16501977-0503; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Stroke Association, 2012, WHAT IS STROK; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Tyerman A, 2004, VOCATIONAL ASSESSMEN; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Wade DT, 2003, CLIN REHABIL, V17, P1, DOI 10.1191/0269215503cr578ed; Wade DT, 2001, CLIN REHABIL, V15, P1, DOI 10.1191/026921501675961253; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D	36	13	13	0	25	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	SEP	2014	77	9					457	465		10.4276/030802214X14098207541072			9	Rehabilitation	Rehabilitation	AP0HJ	WOS:000341741800006		Green Accepted			2021-06-18	
J	Li, J; Shi, W; Li, M; Wang, Z; He, H; Xian, J; Lv, B; Yan, F				Li, J.; Shi, W.; Li, M.; Wang, Z.; He, H.; Xian, J.; Lv, B.; Yan, F.			Time-dependent diffusion tensor changes of optic nerve in patients with indirect traumatic optic neuropathy	ACTA RADIOLOGICA			English	Article						Trauma; optic neuropathy (ITON); MRI; diffusion tensor imaging (DTI)	AXONAL INJURY; BRAIN-INJURY; NEURITIS; COEFFICIENTS; TRANSPLANTS; CORRELATE; RECOVERY; DETECTS; CORTEX; RATS	Background: Indirect traumatic optic neuropathy (ITON) is a devastating cause of permanent visual loss. Axonal degeneration, the characteristic pathological change of ITON, cannot be assessed by conventional imaging. Diffusion tensor imaging (DTI) has been widely used as a sensitive non-invasive imaging technique to obtain information on axonal integrity. Purpose: To study time-dependent changes in ITON patients with DTI and to provide imaging evidence for clinical diagnosis and therapy. Material and Methods: We enrolled 28 subjects with unilateral ITON who underwent detailed ocular examinations and magnetic resonance imaging (MRI) examinations. The differences between injured optic nerve (ON) and contralateral ON were tested. The patients were divided into three groups based on time (from injury to examination). Groups 1, 2, and 3 corresponded to the time taken from injury to examination: <7 days, 7-30 days, and >30 days, respectively. DT magnetic resonance imaging (MRI) differences among the groups were compared, including the relationship between diffusion parameters and mean thicknesses of the peripapillary retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) in the macular area. Results: Compared with contralateral ON, we observed reduced fractional anisotropy (FA) of injured nerves in group 2. Reduced FA and decreased axial diffusivity (lambda//) and increased radial diffusivity (lambda perpendicular to) and mean diffusivity (MD) of injured nerves were observed in group 3. The mean FA value of injured nerves showed a progressive decreasing trend, and mean lambda perpendicular to value exhibited a progressive increasing trend. For injured eyes, the MD and lambda perpendicular to increases strongly correlated with the decreased mean thicknesses of RNFL and GCC. Conversely, FA was significantly associated with mean RNFL thickness. Conclusion: DT-MRI parameters could be useful biomarkers in detecting ON changes in ITON patients.	[Li, J.; Wang, Z.; Xian, J.; Yan, F.] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Li, M.; He, H.; Lv, B.] Chinese Acad Sci, Inst Automat, Key Lab Complex Syst & Intelligence Sci, Beijing 100864, Peoples R China; [Shi, W.] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China	Wang, Z (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.wzhch@vip.163.com	He, Huiguang/AAD-7643-2020	He, Huiguang/0000-0002-0684-1711; Li, Jing/0000-0001-9392-6600	Beijing Keji Xinxing project [2004B36]	This work was supported by the Beijing Keji Xinxing project (2004B36).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Awan AH, 2007, PAK J OPHTHALMOL, V23, P100; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Greenfield DS, 2003, ARCH OPHTHALMOL-CHIC, V121, P41; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Kovacic M, 2001, COLLEGIUM ANTROPOL, V25, P57; Lee KF, 2010, INT J OPHTHALMOL-CHI, V3, P175, DOI 10.3980/j.issn.2222-3959.2010.02.20; Li M, 2011, BRIT J RADIOL, V84, P304, DOI 10.1259/bjr/93494520; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mavrakanas NA, 2009, SURV OPHTHALMOL, V54, P412, DOI 10.1016/j.survophthal.2009.02.006; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Sadeghi-Tari A, 2005, ACTA MED IRANICA, V43, P110; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Schwartz ED, 2005, AM J NEURORADIOL, V26, P7; Schwartz ED, 2003, EXP NEUROL, V182, P49, DOI 10.1016/S0014-4886(03)00036-0; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Takagi ST, 2011, J OPHTHALMOL, V2011, P1, DOI DOI 10.1155/2011/914250; TAKAHASHI M, 1993, MAGNET RESON MED, V30, P485, DOI 10.1002/mrm.1910300411; Trip SA, 2006, NEUROIMAGE, V30, P498, DOI 10.1016/j.neuroimage.2005.09.024; Vorisek I, 2002, MAGNET RESON MED, V48, P994, DOI 10.1002/mrm.10305; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wheeler-Kingshott CAM, 2006, MAGN RESON MED, V56, P446, DOI 10.1002/mrm.20964; Yang WG, 2004, ANN PLAS SURG, V52, P36, DOI 10.1097/01.sap.0000096442.82059.6d	31	13	14	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	SEP	2014	55	7					855	863		10.1177/0284185113506900			9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AQ1WS	WOS:000342575300012	24097827				2021-06-18	
J	Ma, Y; Xia, X; Cheng, JM; Kuang, YQ; Yang, T; Yang, LB; Fan, K; Gu, JW				Ma, Yuan; Xia, Xun; Cheng, Jing-min; Kuang, Yong-qin; Yang, Tao; Yang, Li-bin; Fan, Kexia; Gu, Jian-wen			Emodin Inhibits Inducible Nitric Oxide Synthase in a Rat Model of Craniocerebral Explosive Injury	NEUROCHEMICAL RESEARCH			English	Article						Emodin; Nitric oxide; iNOS; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLAST; NEUROINFLAMMATION; MACROPHAGES; AGENTS	To investigate the effects of emodin on blast-induced traumatic brain injury (bTBI) in a rat model. Eighty rats were randomly divided into 2 groups (the control group and the emodin-treated group; N = 40 per group) and were used to establish the model of blast-induced traumatic brain injury. Ten minutes after the explosion, an isotonic saline solution (10 mg/kg) or emodin (10 mg/kg) were administered via an intraperitoneal injection to the control group and the emodin-treated group, respectively. At each time point (pre-explosion, 2, 6, 12, 24 h after explosion), 2 rats were used for the pathological assessment and 6 rats were used for the biochemical assessment. The concentration of nitric oxide (NO) and the expression and activity of inducible nitric oxide synthase (iNOS) were measured at each time point by spectrophotometry and western blot analysis. Light and electron microscopy showed that the brain damage in the emodin-treated group was less serious than that observed in the control group. The concentration of NO in the emodin-treated group was lower compared with the control group (p < 0.05). Western blot analysis showed that protein expression in the emodin-treated group was lower than the control group (p < 0.05). Emodin can alleviate brain damage after bTBI by inhibiting iNOS. These findings suggest that emodin has a protective effect against bTBI. One possible mechanism may occur by inhibiting the expression and activity of iNOS and consequently decreasing the concentration of NO.	[Ma, Yuan; Xia, Xun; Cheng, Jing-min; Kuang, Yong-qin; Yang, Tao; Yang, Li-bin; Fan, Kexia; Gu, Jian-wen] Peoples Liberat Army, Dept Neurosurg, Chengdu Mil Gen Hosp, Chengdu, Peoples R China; [Ma, Yuan; Xia, Xun; Cheng, Jing-min] Third Mil Med Univ, Grad Management Team, Chongqing, Peoples R China; [Gu, Jian-wen] PLA, Air Force Geneal Hosp, Beijing, Peoples R China	Gu, JW (corresponding author), PLA, Air Force Geneal Hosp, 30 Fucheng Rd, Beijing, Peoples R China.	676392000@qq.com					Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Basu S, 2005, PHYTOTHER RES, V19, P888, DOI 10.1002/ptr.1752; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; HUANG HC, 1991, EUR J PHARMACOL, V205, P289; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kuo YC, 2001, LIFE SCI, V68, P1271, DOI 10.1016/S0024-3205(00)01033-X; Li HL, 2005, INT J MOL MED, V16, P41; Lu Jian-Sheng, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1939; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Park MY, 2009, BIOSCI BIOTECH BIOCH, V73, P828, DOI 10.1271/bbb.80714; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Shuangsuo D, 2006, MED SCI MONITOR, V12, pR302; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	19	13	14	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2014	39	9					1809	1816		10.1007/s11064-014-1395-y			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AO9WV	WOS:000341711800021	25064046				2021-06-18	
J	Maller, JJ; Thomson, RHS; Pannek, K; Bailey, N; Lewis, PM; Fitzgerald, PB				Maller, Jerome J.; Thomson, Richard H. S.; Pannek, Kerstin; Bailey, Neil; Lewis, Philip M.; Fitzgerald, Paul B.			Volumetrics relate to the development of depression after traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Brain injury; Major depression; Volume; Neuroimaging	SURFACE-BASED ANALYSIS; MAJOR DEPRESSION; CEREBRAL-CORTEX; WHOLE-BRAIN; MRI; DISORDER; ABNORMALITIES; METAANALYSIS; 1ST-EPISODE; HIPPOCAMPUS	Previous research suggests that many people who sustain a traumatic brain injury (TBI), even of the mild form, will develop major depression (MD). We previously reported white matter integrity differences between those who did and did not develop MD after mild TBI. In this current paper, we aimed to investigate whether there were also volumetric differences between these groups, as suggested by previous volumetric studies in mild TBI populations. A sample of TBI-with-MD subjects (N = 14), TBI-without-MD subjects (N = 12), MD-without-TBI (N = 26) and control subjects (no TBI or MD, N = 23), received structural MRI brain scans. T1-weighted data were analysed using the Freesurfer software package which produces automated volumetric results. The findings of this study indicate that (1) TBI patients who develop MD have reduced volume in temporal, parietal and lingual regions compared to TBI patients who do not develop MD, and (2) MD patients with a history of TBI have decreased volume in the temporal region compared to those who had MD but without a history of TBI. We also found that more severe MD in those with TBI-with-MD significantly correlated with reduced volume in anterior cingulate, temporal lobe and insula. These findings suggest that volumetric reduction to specific regions, including parietal, temporal and occipital lobes, after a mild TBI may underlie the susceptibility of these patients developing major depression, in addition to altered white matter integrity. (C) 2014 Elsevier B.V. All rights reserved.	[Maller, Jerome J.; Thomson, Richard H. S.; Bailey, Neil; Fitzgerald, Paul B.] Alfred & Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Pannek, Kerstin] CSIRO Ctr Computat Informat, Australian EHlth Res Ctr, Brisbane, Qld, Australia; [Pannek, Kerstin] Sch Med, Brisbane, Qld, Australia; [Lewis, Philip M.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia	Maller, JJ (corresponding author), Alfred & Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia.	jerome.maller@monash.edu	Bailey, Neil/AAB-2741-2021; Pannek, Kerstin/C-8059-2011; Fitzgerald, Paul B/A-1225-2008; Maller, Jerome J/H-4963-2014	Pannek, Kerstin/0000-0002-6512-7630; Fitzgerald, Paul B/0000-0003-4217-8096; Maller, Jerome J/0000-0003-4685-1508; Bailey, Neil/0000-0002-8483-1068	NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Cervel Neurotech; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia	PBF is supported by a NHMRC Practitioner Fellowship. He has received equipment for research from Magventure A/S, Brainsway, and Cervel Neurotech and research funding from Cervel Neurotech. JJM is supported by a NHMRC Early Career Fellowship. The funding source had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Finset A, 2000, BRAIN INJURY, V14, P887; First MB, 2001, STRUCTURED CLIN INTE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Foster JK, 1999, MEMORY, V7, P715, DOI 10.1080/096582199387823; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Korgaonkar MS, 2012, NEUROREPORT, V23, P566, DOI 10.1097/WNR.0b013e3283546264; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nugent AC, 2013, PSYCHIAT RES-NEUROIM, V213, P179, DOI 10.1016/j.pscychresns.2013.05.004; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Yuan YG, 2007, NEUROREPORT, V18, P1845, DOI 10.1097/WNR.0b013e3282f1939f	54	13	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 1	2014	271						147	153		10.1016/j.bbr.2014.05.047			7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AN1DN	WOS:000340323000021	24886777				2021-06-18	
J	Pi, XR; Zhou, L; Cui, L; Liu, AZ; Zhang, J; Ma, Y; Liu, BF; Cai, CQ; Zhu, CY; Zhou, TB; Chen, J; Zhou, Z; Wang, CM; Li, LQ; Li, SC; Wu, JZ; Xiao, B				Pi, Xiaorong; Zhou, Luo; Cui, Lei; Liu, Aizhong; Zhang, Jie; Ma, Yan; Liu, Bofu; Cai, Chaoqun; Zhu, Caiyun; Zhou, Tianbin; Chen, Jia; Zhou, Zhen; Wang, Chunmei; Li, Luoqing; Li, Shichuo; Wu, Jianzhong; Xiao, Bo			Prevalence and clinical characteristics of active epilepsy in southern Han Chinese	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Active epilepsy; Prevalence; Clinical characteristics; Treatment gap	TREATMENT GAP; RURAL CHINA; EPIDEMIOLOGY; POPULATION; SEIZURES; PROJECT	Purpose: To investigate the prevalence and clinical characteristics of active epilepsy in southern Han Chinese. Method: A door-to-door survey about epilepsy was conducted in communities identified by random cluster sampling among 20 villages and 3 communities of Yueyang city. A questionnaire for epilepsy based on the World Health Organization screening questionnaire was used. A final diagnosis of epilepsy was made by neurology specialists with the support of head magnetic resonance imaging (MRI), computed tomography (CT), and electroencephalography (EEG) if available. The prevalence, clinical characteristics, and treatment gap were analyzed in patients with active epilepsy within the past year and the past 5 years. Results: Active epilepsy was identified in 91 patients within the past year and 117 patients within the past 5 years. The one-year prevalence was 2.8 parts per thousand, and the five-year prevalence was 3.7 parts per thousand. The prevalence for epilepsy active within the last year and the last five years was significantly higher in rural areas than in urban areas (P < 0.05). Secondary generalized tonic-clonic seizures (53.8%) were the most common seizure type in patients whose epilepsy had been active in the last year. 34.1% of patients were diagnosed with structural or metabolic epilepsy. The most common cause for epilepsy was cerebrovascular disease (32.3%), followed by traumatic brain injury (29.0%). The treatment gap was 93.4%. Conclusion: The prevalence of epilepsy active within the last one and five years was higher in rural areas than in urban areas of Yueyang city. A large treatment gap exists in this area and a rational intervention strategy is needed. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Pi, Xiaorong; Ma, Yan; Liu, Bofu; Zhu, Caiyun; Zhou, Tianbin; Chen, Jia; Zhou, Zhen; Li, Luoqing] Yueyang 1 Peoples Hosp, Dept Neurol, Yueyang 414005, Hunan, Peoples R China; [Zhou, Luo; Cui, Lei; Xiao, Bo] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Liu, Aizhong; Wang, Chunmei] Cent S Univ, Sch Publ Hlth, Changsha 410008, Hunan, Peoples R China; [Zhang, Jie] Hunan Children Hosp, Dept Neurol, Changsha 410007, Hunan, Peoples R China; [Cai, Chaoqun] Yuehua Hosp, Dept Neurol, Yueyang 414014, Hunan, Peoples R China; [Li, Shichuo; Wu, Jianzhong] Inst Neurol Surg, Beijing 100037, Peoples R China	Xiao, B (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	lazroy@live.cn; xiaobo62_xy@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071048]; explore program of Health Bureau of Hunan, China [B2010-110]	This study was supported by National Natural Science Foundation of China (No: 81071048), and the explore program of Health Bureau of Hunan, China (B2010-110).	[Anonymous], 2001, CHIN J NEUROL, V34, P187; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Fong GCY, 2008, SEIZURE-EUR J EPILEP, V17, P457, DOI 10.1016/j.seizure.2007.12.005; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Hunter E, 2012, SEIZURE-EUR J EPILEP, V21, P691, DOI 10.1016/j.seizure.2012.07.009; LI SC, 1985, EPILEPSIA, V26, P391, DOI 10.1111/j.1528-1157.1985.tb05669.x; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x; Meyer ACL, 2012, EPILEPSIA, V53, P2178, DOI 10.1111/epi.12002; Mung'ala-Odera V, 2008, SEIZURE-EUR J EPILEP, V17, P396, DOI 10.1016/j.seizure.2007.11.028; PLACENCIA M, 1992, BRAIN, V115, P783, DOI 10.1093/brain/115.3.783; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Tellez-Zenteno JF, 2004, EPILEPSIA, V45, P1623, DOI 10.1111/j.0013-9580.2004.24904.x; Tuan NA, 2008, EPILEPSIA, V49, P1634, DOI 10.1111/j.1528-1167.2008.01663.x; Wang WZ, 2008, B WORLD HEALTH ORGAN, V86, P964, DOI 10.2471/BLT.07.047050; Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4; Wang WZ, 2002, J CHIN MED, V82, P449; Xun Wu, 2006, CHINESE J INTERN MED, V45, P789; Zeng Jun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P116	22	13	13	0	8	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	SEP	2014	23	8					636	640		10.1016/j.seizure.2014.05.002			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AO7UR	WOS:000341558600009	24895053				2021-06-18	
J	Ray, B; Sapp, D; Kincaid, A				Ray, Bradley; Sapp, Dona; Kincaid, Ashley			Traumatic Brain Injury among Indiana State Prisoners	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; traumatic brain injury; prevalence; prisoners; prior incarceration; psychiatric disorder	EPIDEMIOLOGIC CATCHMENT-AREA; TBI IDENTIFICATION METHOD; HEAD-INJURY; PSYCHIATRIC-DISORDERS; CRIMINAL BEHAVIOR; SEXUAL OFFENSES; PREVALENCE; POPULATION; RELIABILITY; VALIDITY	Research on traumatic brain injury among inmates has focused on comparing the rate of traumatic brain injury among offenders to the general population, but also how best to screen for traumatic brain injury among this population. This study administered the short version of the Ohio State University Traumatic Brain Injury Identification Method to all male inmates admitted into Indiana state prisons were screened for a month (N=831). Results indicate that 35.7% of the inmates reported experiencing a traumatic brain injury during their lifetime and that these inmates were more likely to have a psychiatric disorder and a prior period of incarceration than those without. Logistic regression analysis finds that a traumatic brain injury predicts the likelihood of prior incarceration net of age, race, education, and psychiatric disorder. This study suggests that brief instruments can be successfully implemented into prison screenings to help divert inmates into needed treatment.	[Ray, Bradley; Kincaid, Ashley] Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Indianapolis, IN 46202 USA; [Sapp, Dona] Indiana Univ Purdue Univ, Indiana Univ Publ Policy Inst, Indianapolis, IN 46204 USA	Ray, B (corresponding author), Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Business SPEA Bldg,801 West Michigan St, Indianapolis, IN 46202 USA.	bradray@iupui.edu	Ray, Bradley/C-1843-2017	Ray, Bradley/0000-0003-3643-775X	Indiana Criminal Justice Institute	Funded by a research grant from the Indiana Criminal Justice Institute to the Indiana University Public Policy Institute.	Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Centers for Disease Control, TRAUM BRAIN INJ PRIS; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; Langevin R, 2006, BRAIN COGNITION, V60, P206; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Lewis DO, 1986, AM J PSYCHIAT, V26, P744; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Morrell RF, 1998, J OFFENDER REHABIL, V27, P1, DOI DOI 10.1300/J076V27N03_01; Morris SM, 1997, CRIM JUSTICE BEHAV, V24, P3, DOI 10.1177/0093854897024001001; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; TEPLIN LA, 1990, AM J PUBLIC HEALTH, V80, P663, DOI 10.2105/AJPH.80.6.663; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1080/09602010244000444, 10.1016/S0960-9822(02)01374-X]	41	13	13	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2014	59	5					1248	1253		10.1111/1556-4029.12466			6	Medicine, Legal	Legal Medicine	AQ3GO	WOS:000342679300009	24588316				2021-06-18	
J	Schreiber, S; Lin, R; Haim, L; Baratz-Goldstien, R; Rubovitch, V; Vaisman, N; Pick, CG				Schreiber, S.; Lin, R.; Haim, L.; Baratz-Goldstien, R.; Rubovitch, V.; Vaisman, N.; Pick, C. G.			Enriched environment improves the cognitive effects from traumatic brain injury in mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Enriched environment (EE); (minimal) traumatic brain injury (mTBI); Mice; Novel Object Recognition task; Y maze; Elevated Plus maze	DEFICITS; PATTERNS; PROTECTS; BEHAVIOR; ANXIETY; STRESS; SYSTEM; CORTEX; MTBI	To date, there is yet no established effective treatment (medication or cognitive intervention) for post-traumatic brain injury (TBI) patients with chronic sequelae. Enriched environment (EE) has been recognized of importance in brain regulation, behaviour and physiology. Rodents reared in, or pre-exposed to EE, recovered better from brain insults. Using the concussive head trauma model of minimal TBI in mice, we evaluated the effect of transition to EE following a weight-drop (30g or 50g) induced mTBI on behavioural and cognitive parameters in mice in the Novel Object Recognition task, the Y- and the Elevated Plus mazes. In all assays, both mTBI groups (30 g, 50 g) housed in normal conditions were equally and significantly impaired 6 weeks post injury in comparison with the no-mTBI (p < 0.001 and p < 0.03, respectively) and the mTBI + EE groups (p < 0.001 for the 30 g, and p < 0.017 for the 50 g). No differences were found between the control and the EE mice. Two separate finding emerge: (1) the significantly positive effects of the placement in EE following mTBI, on the rehabilitative process of the tested behaviours in the affected mice; (2) the lack of difference between the groups of mice affected by 30g or by 50g. Further studies are needed in order to characterize the exact pathways involved in the positive effects of the EE on mice recovery from mTBI. Possible clinical implications indicate the importance of adapting correlates of EE to humans, i.e., prolonged and intensive physical activity - possibly combined with juggling training and intensive cognitive stimulation. (C) 2014 Elsevier B.V. All rights reserved.	[Schreiber, S.] Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-6423906 Tel Aviv, Israel; [Schreiber, S.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lin, R.; Haim, L.; Baratz-Goldstien, R.; Rubovitch, V.; Pick, C. G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Vaisman, N.] Tel Aviv Sourasky Med Ctr, Unit Clin Nutr, IL-6423906 Tel Aviv, Israel; [Pick, C. G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Schreiber, S (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-6423906 Tel Aviv, Israel.	shaulsch@tlvmc.gov.il	Schreiber, Shaul/E-5821-2010; Pick, Chaim/D-4789-2009	Schreiber, Shaul/0000-0002-2189-0693; 	Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Tel Aviv, Israel	This research was supported in part by the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Tel Aviv, Israel.	Adhikari A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00112; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bondi CO, 2014, J NEUROTRAUM, V31, P1; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gariepy JL, 2002, PHARMACOL BIOCHEM BE, V73, P7, DOI 10.1016/S0091-3057(02)00789-X; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Independent Review Group on Rehabilitative Care and Administrative Processes at Walter Reed Army Medical Center and National Naval Medical Center, 2007, REB TRUST REP REH CA; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Pryce C, 2002, PHARMACOL BIOCHEM BE, V73, P1, DOI 10.1016/S0091-3057(02)00861-4; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TEASDALE G, 1974, LANCET, V2, P81; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	32	13	14	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 1	2014	271						59	64		10.1016/j.bbr.2014.05.060			6	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AN1DN	WOS:000340323000009	24906196				2021-06-18	
J	Arien-Zakay, H; Gincberg, G; Nagler, A; Cohen, G; Liraz-Zaltsman, S; Trembovler, V; Alexandrovich, AG; Matok, I; Galski, H; Elchalal, U; Lelkes, PI; Lazarovici, P; Shohami, E				Arien-Zakay, Hadar; Gincberg, Galit; Nagler, Arnon; Cohen, Gadi; Liraz-Zaltsman, Sigal; Trembovler, Victoria; Alexandrovich, Alexander G.; Matok, Ilan; Galski, Hanan; Elchalal, Uriel; Lelkes, Peter I.; Lazarovici, Philip; Shohami, Esther			Neurotherapeutic Effect of Cord Blood Derived CD45(+) Hematopoietic Cells in Mice after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; CD45(+) hematopoietic cells; cell transplantation; cord blood; neurotherapy	MESENCHYMAL STEM-CELLS; CLOSED-HEAD INJURY; UMBILICAL-CORD; CEREBRAL-ISCHEMIA; CLINICAL-TRIALS; BONE-MARROW; IN-VITRO; RAT; TRANSPLANTATION; PROGENITORS	Treatment of traumatic brain injury (TBI) is still an unmet need. Cell therapy by human umbilical cord blood (HUCB) has shown promising results in animal models of TBI and is under evaluation in clinical trials. HUCB contains different cell populations but to date, only mesenchymal stem cells have been evaluated for therapy of TBI. Here we present the neurotherapeutic effect, as evaluated by neurological score, using a single dose of HUCB-derived mononuclear cells (MNCs) upon intravenous (IV) administration one day post-trauma in a mouse model of closed head injury (CHI). Delayed (eight days post-trauma) intracerebroventricular administration of MNCs showed improved neurobehavioral deficits thereby extending the therapeutic window for treating TBI. Further, we demonstrated for the first time that HUCB-derived pan-hematopoietic CD45 positive (CD45(+)) cells, isolated by magnetic sorting and characterized by expression of CD45 and CD11b markers (96-99%), improved the neurobehavioral deficits upon IV administration, which persisted for 35 days. The therapeutic effect was in a direct correlation to a reduction in the lesion volume and decreased by pre-treatment of the cells with anti-human-CD45 antibody. At the site of brain injury, 1.5-2 h after transplantation, HUCB-derived cells were identified by near infrared scanning and immunohistochemistry using anti-human-CD45 and anti-human-nuclei antibodies. Nerve growth factor and vascular endothelial growth factor levels were differentially expressed in both ipsilateral and contralateral brain hemispheres, thirty-five days after CHI, measured by enzyme-linked immunosorbent assay. These findings indicate the neurotherapeutic potential of HUCB-derived CD45(+) cell population in a mouse model of TBI and propose their use in the clinical setting of human TBI.	[Arien-Zakay, Hadar; Gincberg, Galit; Cohen, Gadi; Liraz-Zaltsman, Sigal; Trembovler, Victoria; Alexandrovich, Alexander G.; Matok, Ilan; Lazarovici, Philip; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel; [Nagler, Arnon; Galski, Hanan] Chaim Sheba Med Ctr, Bone Marrow Transplantat & Cord Blood Bank, IL-52621 Tel Hashomer, Israel; [Elchalal, Uriel] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; [Lelkes, Peter I.] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA; [Lelkes, Peter I.] Temple Univ, Temple Inst Regenerat Med & Engn, Philadelphia, PA 19122 USA	Lazarovici, P (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, IL-91120 Jerusalem, Israel.	philipl@ekmd.huji.ac.il	Matok, Ilan/H-1562-2016; Lelkes, Peter I/S-1751-2019; Lazarovici, Philip/S-5261-2018	Matok, Ilan/0000-0003-1559-9258; Lazarovici, Philip/0000-0003-3650-4721	Israel Ministry of Science, Technology and Space; David R. Bloom Center for Pharmacy; Dr. Adolf and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel; Israeli Council for Higher Education; Israeli Ministry of Science, Technology and Space	This study was supported by the Israel Ministry of Science, Technology and Space. PL holds the Jacob Gitlin Chair in Physiology and is affiliated with and supported by the David R. Bloom Center for Pharmacy and the Dr. Adolf and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel. HAZ was supported by "VATAT" fellowship from the Israeli Council for Higher Education. GC is supported by "Eshkol fellowship" from the Israeli Ministry of Science, Technology and Space. PIL is the Laura H. Carnell Professor in the Department of Bioengineering, Temple University.	Andres RH, 2011, STROKE, V42, P2923, DOI 10.1161/STROKEAHA.110.606368; Arien-Zakay H, 2007, J MOL NEUROSCI, V32, P179, DOI 10.1007/s12031-007-0027-2; Arien-Zakay H, 2010, BEST PRACT RES CL HA, V23, P291, DOI 10.1016/j.beha.2010.04.001; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; Augello A, 2010, EUR CELLS MATER, V20, P121; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chen Chun-Ta, 2008, Pediatrics and Neonatology, V49, P77, DOI 10.1016/S1875-9572(08)60017-0; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048803; CRAIG W, 1994, BRIT J HAEMATOL, V88, P24, DOI 10.1111/j.1365-2141.1994.tb04972.x; Dahlke MH, 2004, LEUKEMIA LYMPHOMA, V45, P229, DOI 10.1080/1042819031000151932; Davis SM, 2009, STROKE, V40, P2266, DOI 10.1161/STROKEAHA.108.544171; Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2; Gincberg G, 2012, BRIT MED BULL, V104, P7, DOI 10.1093/bmb/lds024; Gorczyca W, 2011, METHOD CELL BIOL, V103, P221, DOI 10.1016/B978-0-12-385493-3.00010-3; Harris David T, 2007, Curr Stem Cell Res Ther, V2, P301, DOI 10.2174/157488807782793790; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liraz-Zaltsman S, 2011, SYNAPSE, V65, P634, DOI 10.1002/syn.20889; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Maurya Dharmendra Kumar, 2011, World J Stem Cells, V3, P34, DOI 10.4252/wjsc.v3.i4.34; McGuckin CP, 2008, CELL PROLIFERAT, V41, P31, DOI 10.1111/j.1365-2184.2008.00490.x; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Meregalli M, 2010, EXPERT OPIN BIOL TH, V10, P1521, DOI 10.1517/14712598.2010.528386; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Sanchez-Pernaute R, 2005, STEM CELLS, V23, P914, DOI 10.1634/stemcells.2004-0172; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Shivtiel S, 2011, EXP HEMATOL, V39, P1161, DOI 10.1016/j.exphem.2011.08.012; Shohami E., 2011, TRAUMATIC BRAIN SPIN; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Stanevsky A, 2011, STEM CELL REV REP, V7, P425, DOI 10.1007/s12015-010-9183-9; Stanevsky A, 2010, LEUKEMIA LYMPHOMA, V51, P975, DOI 10.3109/10428191003699886; Sugiyama T, 2011, NEUROSURGERY, V68, P1036, DOI 10.1227/NEU.0b013e318208f891; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoon JK, 2010, NUCL MED BIOL, V37, P381, DOI 10.1016/j.nucmedbio.2009.12.001; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	52	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1405	1416		10.1089/neu.2013.3270			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700004	24640955	Green Published			2021-06-18	
J	Li, XW; Liu, XY; Zhang, N; Wen, XJ				Li, Xiaowei; Liu, Xiaoyan; Zhang, Ning; Wen, Xuejun			Engineering In Situ Cross-Linkable and Neurocompatible Hydrogels	JOURNAL OF NEUROTRAUMA			English	Article						differentiation; hydrogel; morphology; neural stem cell; proliferation	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR-MATRIX; CELL THERAPY; SPINAL-CORD; STEM-CELLS; TISSUE; DIFFERENTIATION; GROWTH; VITRO; TRANSPLANTATION	Physical injuries of the central nervous system (CNS) are prevalent and very severe because the CNS has limited capacity to replace neuronal loss from the injury. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote CNS regeneration. Direct injection of neural stem cells (NSCs) to the lesion site, however, may not be an optimal therapeutic strategy because of poor viability and functionality of transplanted cells resulting from the local hostile tissue environment. The overall objective of this study is to engineer an injectable and biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted NSCs to survive, functionally differentiate, and integrate with host tissues for CNS regeneration. A highly biocompatible hydrogel, based on thiol functionalized hyaluronic acid and thiol functionalized gelatin (Gtn-SH), which can be cross-linked by poly(ethylene glycol) diacrylate (PEGDA), was used. By controlling the cross-linking density via varying the amount of cross-linker (PEGDA) and the concentration of the adhesive component gelatin, an optimal microenvironment for the survival, proliferation, and neuronal differentiation of NSCs was created in vitro. The soft hydrogel of less than 10 Pa with Gtn-SH content (50%) is one of the optimal conditions to support NSCs growth and neuronal differentiation in vitro. The optimized hydrogel holds great potential as a carrier of stem cells to treat CNS injuries and diseases in which cell therapies may be essential.	[Li, Xiaowei] Johns Hopkins Univ, Whitaker Biomed Engn Inst, Translat Tissue Engn Ctr, Baltimore, MD USA; [Liu, Xiaoyan; Zhang, Ning; Wen, Xuejun] Virginia Commonwealth Univ, Inst Engn & Med, Richmond, VA 23284 USA; [Wen, Xuejun] Tongji Univ, Tongji Med Sch, Inst Biomed Engn & Nano Sci iNANO, Shanghai 200092, Peoples R China	Zhang, N (corresponding author), Virginia Commonwealth Univ, 601 West Main St, Richmond, VA 23284 USA.	nzhang2@vcu.edu; xwen@vcu.edu	Li, Xiaowei/E-4973-2014		NSF CAREERNational Science Foundation (NSF)NSF - Office of the Director (OD) [1055922]; Department of Defense (CDMRP TBI Program); Center for Innovative Technology (Virginia) [MF13-004-LS]; American Heart AssociationAmerican Heart Association [10PRE4280017]; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1346387] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp SysNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1312970] Funding Source: National Science Foundation	This work was made possible by the NSF CAREER (1055922), Department of Defense (CDMRP TBI Program), Center for Innovative Technology (Virginia, MF13-004-LS), and American Heart Association (10PRE4280017).	Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049; Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lim TC, 2012, BIOMATERIALS, V33, P3446, DOI 10.1016/j.biomaterials.2012.01.037; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036; Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70; Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116; Pollok JM, 2001, TRANSPLANT P, V33, P1713, DOI 10.1016/S0041-1345(00)02654-3; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310141; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141; Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002	49	13	13	3	50	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1431	1438		10.1089/neu.2013.3215			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700006	24447305				2021-06-18	
J	Heuss, ND; Pierson, MJ; Montaniel, KRC; McPherson, SW; Lehmann, U; Hussong, SA; Ferrington, DA; Low, WC; Gregerson, DS				Heuss, Neal D.; Pierson, Mark J.; Montaniel, Kim Ramil C.; McPherson, Scott W.; Lehmann, Ute; Hussong, Stacy A.; Ferrington, Deborah A.; Low, Walter C.; Gregerson, Dale S.			Retinal dendritic cell recruitment, but not function, was inhibited in MyD88 and TRIF deficient mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Dendritic cells; Injury; Microglia; Retinal ganglion cells; NF kappa B	REGULATORY T-CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ALZHEIMERS-DISEASE; NEUROPROTECTIVE AUTOIMMUNITY; NEURODEGENERATIVE DISEASES; ENDOTHELIAL-CELLS; GANGLION-CELLS	Background: Immune system cells are known to affect loss of neurons due to injury or disease. Recruitment of immune cells following retinal/CNS injury has been shown to affect the health and survival of neurons in several models. We detected close, physical contact between dendritic cells and retinal ganglion cells following an optic nerve crush, and sought to understand the underlying mechanisms. Methods: CD11c-DTR/GFP mice producing a chimeric protein of diphtheria toxin receptor (DTR) and GFP from a transgenic CD11c promoter were used in conjunction with mice deficient in MyD88 and/or TRIF. Retinal ganglion cell injury was induced by an optic nerve crush, and the resulting interactions of the GFP(hi) cells and retinal ganglion cells were examined. Results: Recruitment of GFP(hi) dendritic cells to the retina was significantly compromised in MyD88 and TRIF knockout mice. GFP(hi) dendritic cells played a significant role in clearing fluorescent-labeled retinal ganglion cells post-injury in the CD11c-DTR/GFP mice. In the TRIF and MyD88 deficient mice, the resting level of GFP(hi) dendritic cells was lower, and their influx was reduced following the optic nerve crush injury. The reduction in GFP(hi) dendritic cell numbers led to their replacement in the uptake of fluorescent-labeled debris by GFP(lo) microglia/macrophages. Depletion of GFP(hi) dendritic cells by treatment with diphtheria toxin also led to their displacement by GFP(lo) microglia/macrophages, which then assumed close contact with the injured neurons. Conclusions: The contribution of recruited cells to the injury response was substantial, and regulated by MyD88 and TRIF. However, the presence of these adaptor proteins was not required for interaction with neurons, or the phagocytosis of debris. The data suggested a two-niche model in which resident microglia were maintained at a constant level post-optic nerve crush, while the injury-stimulated recruitment of dendritic cells and macrophages led to their transient appearance in numbers equivalent to or greater than the resident microglia.	[Heuss, Neal D.; Pierson, Mark J.; Montaniel, Kim Ramil C.; McPherson, Scott W.; Lehmann, Ute; Hussong, Stacy A.; Ferrington, Deborah A.; Gregerson, Dale S.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA	Gregerson, DS (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Lions Res Bldg Rm 314,2001 6th St SE, Minneapolis, MN 55455 USA.	grege001@umn.edu		Gregerson, Dale/0000-0001-5769-796X; Ferrington, Deborah/0000-0003-2561-7464	Wallin Neuroscience Discovery Fund (DSG); Minnesota Lions Clubs; Research to Prevent Blindness, Inc.Research to Prevent Blindness (RPB);  [R01-EY021003];  [T32-EY07133];  [T32-AG029796];  [P30-EY011374]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T32EY007133, P30EY011374, R01EY021003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG029796] Funding Source: NIH RePORTER	Supported by R01-EY021003 (DSG); the Wallin Neuroscience Discovery Fund (DSG); T32-EY07133 (UL); T32-AG029796 (SH); P30-EY011374; the Minnesota Lions Clubs; and Research to Prevent Blindness, Inc. The authors thank Heidi Roehrich and Thien Sam for technical assistance. We also thank Dr. J Douglas Cameron for a helpful critique of the results.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Barton GHM, 2003, NAT IMMUNOL, V4, P432, DOI 10.1038/ni0503-432; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P2913, DOI 10.1167/iovs.11-8564; Chou CF, 2013, AM J PREV MED, V45, P29, DOI 10.1016/j.amepre.2013.02.018; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Downes CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057948; Drouin-Ouellet J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-137; Esen N, 2006, J IMMUNOL, V176, P6802, DOI 10.4049/jimmunol.176.11.6802; Famakin BM, 2011, BRAIN RES, V1388, P148, DOI 10.1016/j.brainres.2011.02.074; Garcia GE, 2000, J LEUKOCYTE BIOL, V67, P577; Garcia JA, 2013, J IMMUNOL, V191, P1063, DOI 10.4049/jimmunol.1300040; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Heuss ND, 2012, J IMMUNOL, V188, P1191, DOI 10.4049/jimmunol.1101621; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kezic J, 2008, INVEST OPHTH VIS SCI, V49, P1599, DOI 10.1167/iovs.07-0953; Kezic J, 2010, INVEST OPHTH VIS SCI, V51, P5121, DOI 10.1167/iovs.10-5325; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Lehmann U, 2010, NEUROBIOL DIS, V40, P177, DOI 10.1016/j.nbd.2010.05.022; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Lim JE, 2011, AM J PATHOL, V179, P1095, DOI 10.1016/j.ajpath.2011.05.045; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-39; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Luhmann UFO, 2013, EXP EYE RES, V107, P80, DOI 10.1016/j.exer.2012.11.015; Mao XRR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-16; Mao XR, 2002, J BIOL CHEM, V277, P44911, DOI 10.1074/jbc.M204292200; McPherson SW, 2013, J IMMUNOL, V190, P4971, DOI 10.4049/jimmunol.1202625; Michaud JP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-5; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Mizrahi T, 2002, J IMMUNOL, V169, P5971, DOI 10.4049/jimmunol.169.10.5971; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Pang JJ, 2011, INVEST OPHTH VIS SCI, V52, P4886, DOI 10.1167/iovs.10-5921; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Payne Andrew J, 2013, Mo Med, V110, P429; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Pimentel-Coelho PM, 2013, J NEUROSCI, V33, P11556, DOI 10.1523/JNEUROSCI.0535-13.2013; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Popovic M, 2008, J LEUKOCYTE BIOL, V84, P215, DOI 10.1189/jlb.0907652; Qiu JH, 2002, J NEUROSCI, V22, P3504; Sanders VM, 2006, J NEUROIMMUNE PHARM, V1, P11, DOI 10.1007/s11481-005-9004-0; Schlamp CL, 2013, MOL VIS, V19, P1387; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Thumann G, 2012, CURR GENOMICS, V13, P350, DOI 10.2174/138920212801619214; Torres M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-19; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Voleti VB, 2013, MATURITAS, V75, P29, DOI 10.1016/j.maturitas.2013.01.018; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhao L, 2009, EXP EYE RES, V88, P1004, DOI 10.1016/j.exer.2008.12.013	71	13	14	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	AUG 13	2014	11								143	10.1186/s12974-014-0143-1			16	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	AN5UD	WOS:000340655900001	25116321	DOAJ Gold, Green Published			2021-06-18	
J	Hasegawa, K; Takeda, T; Nakajima, K; Ozawa, T; Ishigami, K; Narimatsu, K; Noh, K				Hasegawa, Ken; Takeda, Tomotaka; Nakajima, Kazunori; Ozawa, Takamitsu; Ishigami, Keiichi; Narimatsu, Keishiro; Noh, Kwantae			Does clenching reduce indirect head acceleration during rugby contact?	DENTAL TRAUMATOLOGY			English	Article						mouthguard; neck muscle; masseter muscle; concussion; clenching	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; PROTECTIVE EQUIPMENT; CONCUSSION; IMPACTS; RISK; BIOMECHANICS; PREVENTION; SPORT	Background: Concussions are common among athletes, with the potential to cause memory-related, physical, cognitive, emotional, and behavioral damage. A concussion is an acceleration/deceleration injury resulting from direct and indirect biomechanical forces transmitted to the cerebral tissues. From a sports dentistry viewpoint, increased mastication muscle activity or clenching due to the presence of a mouthguard may enhance cervical muscle activity, thereby reducing damage following impact. This relationship has not been previously investigated in the context of rugby. The purpose of this study was to investigate the effect of voluntary clenching on indirect head acceleration during attack-and defense-related drills. Materials and methods: A total of 12 high school rugby players participated in the study. Linear acceleration of the head was measured using an accelerometer that took measurements in three axes. Masseter and sternocleidomastoid muscle activities were measured using wireless electromyography. These data were synchronized using digital video imaging software for analysis. The study protocol was approved by the Tokyo Dental College Ethics Committee. Results and Conclusions: Within the limitations of this study, the following results were obtained: the activities performed during rugby practice involved relatively small indirect head acceleration and masseter and sternocleidomastoid muscle activities. After the young male rugby players were instructed to clench their masseter muscles, a marked decrease in head acceleration was observed.	[Hasegawa, Ken; Takeda, Tomotaka; Nakajima, Kazunori; Ozawa, Takamitsu; Ishigami, Keiichi; Narimatsu, Keishiro] Tokyo Dent Coll, Dept Sports Dent, Mihama Ku, Chiba 2618502, Japan; [Noh, Kwantae] Kyung Hee Univ, Dept Prosthodont, Sch Dent, Seoul, South Korea	Takeda, T (corresponding author), Tokyo Dent Coll, Dept Sports Dent, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	ttakeda@tdc.ac.jp	Meijer, Anna/K-5118-2016; Noh, Kwantae/AAK-3492-2020	Noh, Kwantae/0000-0003-3480-7737			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barth JT, 2001, J ATHL TRAINING, V36, P253; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cusimano MD., 2011, OPEN MED-WARSAW, V5, P57; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Ichii Y, 1999, J CLIN SPORT MED, V16, P234; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maeda Y, 1997, J JPN PROSTHODONT SO, V41, P489; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Miyahara T, 1996, J NEUROPHYSIOL, V76, P2033; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Neal Matthew T, 2012, Surg Neurol Int, V3, P16, DOI 10.4103/2152-7806.92930; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Satoh T, 1990, J JPN SOC BIOMECHANI, V14, P68; Sekimoto T, 1999, J JPN PROSTHODONT SO, V43, P568; SUMIYOSHI S, 1996, NIHON KOUKUU GEKA GA, V42, P1192; Taguchi Y, 2002, J JAPN SOC CLIN SPOR, V19, P609; Takada Y, 1998, Kokubyo Gakkai Zasshi, V65, P64; Takeda T, 2008, J KOREAN SPORTS DENT, V4, P20; Tsukimura Y, 2008, CLIN J SPORT MED, V16, P172; URBANOWICZ M, 1991, CRANIO, V9, P174, DOI 10.1080/08869634.1991.11678365; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Yokoyama Y, 1998, J JPN PROSTHODONT SO, V42, P90	39	13	14	0	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2014	30	4					259	264		10.1111/edt.12082			6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AM2YB	WOS:000339716400002	24138128				2021-06-18	
J	Heverly-Fitt, S; Wimsatt, MA; Menzer, MM; Rubin, KH; Dennis, M; Taylor, HG; Stancin, T; Gerhardt, CA; Vannatta, K; Bigler, ED; Yeates, KO				Heverly-Fitt, Sara; Wimsatt, Maureen A.; Menzer, Melissa M.; Rubin, Kenneth H.; Dennis, Maureen; Taylor, H. Gerry; Stancin, Terry; Gerhardt, Cynthia A.; Vannatta, Kathryn; Bigler, Erin D.; Yeates, Keith Owen			Friendship Quality and Psychosocial Outcomes among Children with Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Pediatric; Behavior; Rejection; Head; Trauma; Social competence	1ST 6 MONTHS; PROBLEM BEHAVIORS; PEER REJECTION; ADOLESCENTS; CHILDHOOD; ADJUSTMENT; PREDICTION; WITHDRAWN; DISORDERS; SKILLS	This study examined differences in friendship quality between children with traumatic brain injury (TBI) and orthopedic injury (OI) and behavioral outcomes for children from both groups. Participants were 41 children with TBI and 43 children with OI (M age = 10.4). Data were collected using peer- and teacher-reported measures of participants' social adjustment and parent-reported measures of children's post-injury behaviors. Participants and their mutually nominated best friends also completed a measure of the quality of their friendships. Children with TBI reported significantly more support and satisfaction in their friendships than children with OI. Children with TBI and their mutual best friend were more similar in their reports of friendship quality compared to children with OI and their mutual best friends. Additionally, for children with TBI who were rejected by peers, friendship support buffered against maladaptive psychosocial outcomes, and predicted skills related to social competence. Friendship satisfaction was related to higher teacher ratings of social skills for the TBI group only. Positive and supportive friendships play an important role for children with TBI, especially for those not accepted by peers. Such friendships may protect children with TBI who are rejected against maladaptive psychosocial outcomes, and promote skills related to social competence.	[Heverly-Fitt, Sara; Wimsatt, Maureen A.; Menzer, Melissa M.; Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43210 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Dept Psychol, Provo, UT 84602 USA	Heverly-Fitt, S (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, 3304 Benjamin Bldg, College Pk, MD 20742 USA.	sfitt@umd.edu	Yeates, Keith/AAJ-4223-2020; Rubin, Kenneth H/M-5276-2018; Stancin, Terry/L-7993-2019	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007542] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058116] Funding Source: NIH RePORTER	This research was supported by grant R01HD048946 from the National Institute of Child Health and Human Development to Keith Owen Yeates. The authors have no conflicts of interest to declare.	Aiken L.S., 1991, MULTIPLE REGRESSION; Anderson V., 2012, DEV SOCIAL NEUROSCIE; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Demir M, 2004, J EXP CHILD PSYCHOL, V88, P68, DOI 10.1016/j.jecp.2004.02.006; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Denton K, 1996, CHILD DEV, V67, P1360, DOI 10.2307/1131705; FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037/0012-1649.21.6.1016; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; HIGHTOWER AD, 1986, SCHOOL PSYCHOL REV, V15, P393; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kendrick K, 2012, J ADOLESCENCE, V35, P1069, DOI 10.1016/j.adolescence.2012.02.014; Kerr DCR, 2007, J CHILD PSYCHOL PSYC, V48, P967, DOI 10.1111/j.1469-7610.2007.01776.x; Kingery JN, 2011, MERRILL PALMER QUART, V57, P215; Ladd GW, 2006, CHILD DEV, V77, P822, DOI 10.1111/j.1467-8624.2006.00905.x; Malcolm KT, 2006, J SOC PERS RELAT, V23, P721, DOI 10.1177/0265407506068260; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McDonald KL, 2013, J EARLY ADOLESCENCE, V33, P897, DOI 10.1177/0272431612472259; McDonald KL, 2010, J YOUTH ADOLESCENCE, V39, P563, DOI 10.1007/s10964-010-9519-4; Menzer M.M., 2012, INT J DEV SCI, V6, P191, DOI [10.3233/dev-1211079, DOI 10.3233/DEV-1211079]; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Nangle DW, 2003, J CLIN CHILD ADOLESC, V32, P546, DOI 10.1207/S15374424JCCP3204_7; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; Peters E, 2011, CHILD DEV, V82, P1906, DOI 10.1111/j.1467-8624.2011.01647.x; Reynolds C.R., 1992, BEHAV ASSESSMENT SYS; Rubin K. H., 2006, SOCIAL EMOTIONAL PER, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Rubin K.H., 2004, INT SOC STUDY BEHAV, V46, P5; Rubin K, 2008, SOC DEV, V17, P1085, DOI 10.1111/j.1467-9507.2007.00445.x; RUBIN KH, 1993, MERRILL PALMER QUART, V39, P518; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Rubin KH., 2009, HDB PEER INTERACTION; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Teasdale G., 1974, BRAIN INJURY, V19, P511; Waldrip AM, 2008, SOC DEV, V17, P832, DOI 10.1111/j.1467-9507.2008.00476.x; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	41	13	13	0	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2014	20	7					684	693		10.1017/S1355617714000393			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AN9QW	WOS:000340943800002	24840021	Green Accepted			2021-06-18	
J	Leung, LY; Larimore, Z; Holmes, L; Cartagena, C; Mountney, A; Deng-Bryant, Y; Schmid, K; Shear, D; Tortella, F				Leung, Lai Yee; Larimore, Zachary; Holmes, Larry; Cartagena, Casandra; Mountney, Andrea; Deng-Bryant, Ying; Schmid, Kara; Shear, Deborah; Tortella, Frank			The WRAIR Projectile Concussive Impact Model of Mild Traumatic Brain Injury: Re-design, Testing and Preclinical Validation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Mild TBI; Projectile; Helmet; Impact energy; Head kinematics; Gait	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; SOMATOSENSORY CORTEX; ANIMAL-MODELS; HEAD-INJURY; RAT; LOCOMOTION; BETA; MICE; GAIT	The WRAIR projectile concussive impact (PCI) model was developed for preclinical study of concussion. It represents a truly non-invasive closed-head injury caused by a blunt impact. The original design, however, has several drawbacks that limit the manipulation of injury parameters. The present study describes engineering advancements made to the PCI injury model including helmet material testing, projectile impact energy/head kinematics and impact location. Material testing indicated that among the tested materials, 'fiber-glass/carbon' had the lowest elastic modulus and yield stress for providing an relative high percentage of load transfer from the projectile impact, resulting in significant hippocampal astrocyte activation. Impact energy testing of small projectiles, ranging in shape and size, showed the steel sphere produced the highest impact energy and the most consistent impact characteristics. Additional tests confirmed the steel sphere produced linear and rotational motions on the rat's head while remaining within a range that meets the criteria for mTBI. Finally, impact location testing results showed that PCI targeted at the temporoparietal surface of the rat head produced the most prominent gait abnormalities. Using the parameters defined above, pilot studies were conducted to provide initial validation of the PCI model demonstrating quantifiable and significant increases in righting reflex recovery time, axonal damage and astrocyte activation following single and multiple concussions.	[Leung, Lai Yee; Cartagena, Casandra; Mountney, Andrea; Deng-Bryant, Ying; Schmid, Kara; Shear, Deborah; Tortella, Frank] WRAIR, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA; [Larimore, Zachary; Holmes, Larry] United States Army Res Labs, Composites & Hybrid Mat Branch, Aberdeen, MD USA	Leung, LY (corresponding author), WRAIR, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	laiyee.leung@us.army.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-12-2-0134]	The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 4-3, AR 360-5). The authors declare that there are no conflicts of interest in this study. This research is funded by Combat Casualty Care Research Program and Congressionally Directed Medical Research Program (Contract #: W81XWH-12-2-0134). The authors would like to thank Weihong Yang, Francis Bustos, Megan Winter, David Miles and SGT Shawn McLoughlin for technical supports.	BLASZCZYK JW, 1995, ACTA NEUROBIOL EXP, V55, P133; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Defense and Veterans Brain Injury Center (DVBIC), 2013, DOD WORLDW NUMB TBI; Deliagina TG, 2006, PHYSIOLOGY, V21, P216, DOI 10.1152/physiol.00001.2006; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Godde B, 2002, NEUROSCI BIOBEHAV R, V26, P743, DOI 10.1016/S0149-7634(02)00061-1; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grant RA, 2012, DEV PSYCHOBIOL, V54, P151, DOI 10.1002/dev.20591; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hodgson V, 1983, 27 STAPP CAR CRASH C; Hong Y., 2010, ROUTLEDGE HDB BIOMEC; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nahum A. M., 2002, ACCIDENTAL INJURY BI; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Paxinos G., 2006, RAT BRAIN STEREOTAXI; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Viano DC, 2012, ANN BIOMED ENG, V40, P213, DOI 10.1007/s10439-011-0386-2	30	13	13	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2014	42	8					1618	1630		10.1007/s10439-014-1014-8			13	Engineering, Biomedical	Engineering	AL8OP	WOS:000339399000004	24756867				2021-06-18	
J	Pesek, M; Kibler, K; Easley, RB; Mytar, J; Rhee, C; Andropoulos, D; Brady, K				Pesek, Matthew; Kibler, Kathleen; Easley, R. Blaine; Mytar, Jennifer; Rhee, Christopher; Andropoulos, Dean; Brady, Ken			The Upper Limit of Cerebral Blood Flow Autoregulation Is Decreased With Elevations in Intracranial Pressure	NEUROSURGERY			English	Article						Autoregulation; Hypertension; Hydrocephalus; Pediatric; Traumatic brain injury	PEDIATRIC HEAD-INJURY; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; ARTERIAL-HYPERTENSION; PERFUSION-PRESSURE; CHILDREN; HYPOXIA	BACKGROUND: The upper limit of cerebrovascular pressure autoregulation (ULA) is inadequately characterized. OBJECTIVE: To delineate the ULA in an infant swine model. METHODS: Neonatal piglets with sham surgery (n = 9), interventricular fluid infusion (INF) (n = 10), controlled cortical impact (CCI) (n = 10), or CCI+INF (n = 11) had intracranial pressure monitoring and bilateral cortical laser-Doppler flowmetry recordings during arterial hypertension to lethality using an aortic balloon catheter. An increase of red cell flux as a function of cerebral perfusion pressure was determined by piecewise linear regression, and static rates of autoregulation were determined above and below this inflection. The ULA was rendered as the first instance of an upward deflection of Doppler flux causing a static rate of autoregulation decrease greater than 0.5. RESULTS: ULA was identified in 55% of piglets after sham surgery, 70% after INF, 70% after CCI, and 91% after CCI with INF (P = .36). When identified, the median (interquartile range) ULA was as follows: sham group, 102 mm Hg (97-109 mm Hg); INF group, 75 mm Hg (52-84 mm Hg); CCI group, 81 mm Hg (69-101 mm Hg); and CCI+INF group, 61 mm Hg (52-57 mm Hg) (P = .01). In post hoc analysis, both groups with interventricular INF had significantly lower ULA than that observed in the sham group. CONCLUSION: Neonatal piglets without intracranial pathology tolerated acute hypertension with minimal perturbation of cerebral blood flow. Piglets with acutely increased intracranial pressure with or without trauma demonstrated loss of autoregulation when subjected to arterial hypertension.	[Pesek, Matthew; Easley, R. Blaine; Brady, Ken] Touro Univ, Div Pediat Crit Care, Dept Pediat, Vallejo, CA USA; [Kibler, Kathleen; Easley, R. Blaine; Andropoulos, Dean; Brady, Ken] Touro Univ, Div Pediat Anesthesiol, Dept Anesthesiol, Vallejo, CA USA; [Mytar, Jennifer] Touro Univ, Coll Osteopath Med, Vallejo, CA USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Rhee, Christopher] Texas Childrens Hosp, Baylor Coll Med, Div Neonatol, Dept Pediat, Houston, TX 77030 USA	Brady, K (corresponding author), Texas Childrens Hosp, 6621 Fannin,WT 17-417B, Houston, TX 77030 USA.	kbrady@texaschildrens.org					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Hauerberg J, 1998, J NEUROSURG ANESTH, V10, P106, DOI 10.1097/00008506-199804000-00007; KANTER RK, 1985, CLIN PEDIATR, V24, P320, DOI 10.1177/000992288502400603; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LASSEN NA, 1959, PHYSIOL REV, V39, P183; LASSEN NA, 1972, SCAND J CLIN LAB INV, V30, P113, DOI 10.3109/00365517209081099; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; STRANDGAARD S, 1974, CIRC RES, V34, P435, DOI 10.1161/01.RES.34.4.435; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	23	13	14	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2014	75	2					163	169		10.1227/NEU.0000000000000367			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AM8PE	WOS:000340138400032	24739364				2021-06-18	
J	Coqueugniot, H; Dutour, O; Arensburg, B; Duday, H; Vandermeersch, B; Tillier, AM				Coqueugniot, Helene; Dutour, Olivier; Arensburg, Baruch; Duday, Henri; Vandermeersch, Bernard; Tillier, Anne-marie			Earliest Cranio-Encephalic Trauma from the Levantine Middle Palaeolithic: 3D Reappraisal of the Qafzeh 11 Skull, Consequences of Pediatric Brain Damage on Individual Life Condition and Social Care	PLOS ONE			English	Article							CEREBRAL ASYMMETRIES; COMPUTED-TOMOGRAPHY; ENAMEL; INJURY; ISRAEL; PATHOLOGY; REMAINS; STRESS	The Qafzeh site (Lower Galilee, Israel) has yielded the largest Levantine hominin collection from Middle Palaeolithic layers which were dated to circa 90-100 kyrs BP or to marine isotope stage 5b-c. Within the hominin sample, Qafzeh 11, circa 1213 yrs old at death, presents a skull lesion previously attributed to a healed trauma. Three dimensional imaging methods allowed us to better explore this lesion which appeared as being a frontal bone depressed fracture, associated with brain damage. Furthermore the endocranial volume, smaller than expected for dental age, supports the hypothesis of a growth delay due to traumatic brain injury. This trauma did not affect the typical human brain morphology pattern of the right frontal and left occipital petalia. It is highly probable that this young individual suffered from personality and neurological troubles directly related to focal cerebral damage. Interestingly this young individual benefited of a unique funerary practice among the south-western Asian burials dated to Middle Palaeolithic.	[Coqueugniot, Helene; Dutour, Olivier; Duday, Henri; Vandermeersch, Bernard; Tillier, Anne-marie] Univ Bordeaux, CNRS, Unite Mixte Rech Prehist Actuel Culture Environm, Pessac, France; [Coqueugniot, Helene] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Dutour, Olivier; Duday, Henri] Ecole Prat Hautes Etud, Lab Anthropol Biol Paul Broca, Paris, France; [Dutour, Olivier] Univ Western Ontario, Dept Anthropol, London, ON, Canada; [Arensburg, Baruch] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Ramat Aviv, Israel; [Tillier, Anne-marie] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA	Coqueugniot, H (corresponding author), Univ Bordeaux, CNRS, Unite Mixte Rech Prehist Actuel Culture Environm, Pessac, France.	helene.coqueugniot@u-bordeaux.fr	Dutour, Olivier/AAG-2237-2020	DUTOUR, Olivier/0000-0001-8134-788X	Irene Levi Sala Care Archaeological Foundation	This research has been financially supported by the Irene Levi Sala Care Archaeological Foundation (http://prehistory.org.il/?page_id=894). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Balzeau A., 2013, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V25, P1, DOI 10.1007/s13219-012-0069-z; Berti PR, 1992, CHIETI ITALY J PALEO, V2, P19; Boutie P, 1989, BRIT ARCHAEOLOGICAL, V497, P213; Brodmann K., 1909, VERGLEICHENDE LOKALI; CHUI HC, 1980, J NEUROL NEUROSUR PS, V43, P873, DOI 10.1136/jnnp.43.10.873; Churchill SE, 2009, J HUM EVOL, V57, P163, DOI 10.1016/j.jhevol.2009.05.010; Coqueugniot H, 1994, ANTHROPOLOGIE BRNO, VXXXII, P243; Coqueugniot H, 2013, French patent, Patent No. 1151284; Coqueugniot H., 2010, ACT C VIRT RETR 2009, V4, P177; Coqueugniot H, 2012, 19 EUR M PAL ASS LIL, V41; Coqueugniot H, 2012, AM J PHYS ANTHROPOL, V147, P312, DOI 10.1002/ajpa.21655; Cowgill LW, 2007, J HUM EVOL, V53, P213, DOI 10.1016/j.jhevol.2007.04.003; DASTUGUE J, 1981, PALEORIENT, V7, P135, DOI DOI 10.3406/PALE0.1981.4292; DeGusta D, 2002, J ARCHAEOL SCI, V29, P1435, DOI 10.1006/jasc.2001.0808; Dutailly B, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P2505, DOI 10.1109/ICIP.2009.5413911; Dutour O, 2012, 39 ANN M PAL ASS POR, V13-14; Etgen AM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1121; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; Grimaud-Herve D., 1997, EVOLUTION ENCEPHALE; Guyomarc'h P, 2013, FORENSIC SCI INT, V231, DOI 10.1016/j.forsciint.2013.04.007; Guyomarc'h P, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2012.01.008; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Hovers E., 2009, LITHIC ASSEMBLAGES Q; Hovers E, 1997, THESIS HEBRE U JERUS; Howell F. Clark, 1958, HUNDERT JAHRE NEANDE, P185; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P6429, DOI 10.1073/pnas.0902614106; Kondo O, 2014, DYNAMICS LEARNING NE, V2, P183; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lloyd D, 2007, WHAT DO BRODMANN ARE; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Mann A, 2008, NEW INSIGHTS KRAPINA, P261; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McCown T.D., 1939, STONE AGE MOUNT CARM, V2; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; NEIBURGER EJ, 1990, AM J PHYS ANTHROPOL, V82, P231, DOI 10.1002/ajpa.1330820211; Rampont M, 1994, THESIS U L PASTEUR S; Schultz M, 1998, DENTAL ANTHROPOLOGY, P293; SCHWARCZ HP, 1988, J HUM EVOL, V17, P733, DOI 10.1016/0047-2484(88)90063-2; Skinner M, 1996, J ARCHAEOL SCI, V23, P833, DOI 10.1006/jasc.1996.0078; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Tillier A. - m, 2004, HUMAN PALEOECOLOGY L, P135; Tillier AM, 2001, AM J PHYS ANTHROPOL, V114, P166, DOI 10.1002/1096-8644(200102)114:2<166::AID-AJPA1017>3.0.CO;2-3; Tillier AM, 1984, PALEORIENT, V10, P7; TILLIER AM, 1999, ENFANTS MOUSTERIENS; Tillier AM, PALEORIENT IN PRESS; Tillier AM, 1995, PALEORIENT, V21, P63; Tillier Anne-Marie, 2009, HOMME MORT EMERGENCE; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; TRINKAUS E, 1985, AM J PHYS ANTHROPOL, V67, P19, DOI 10.1002/ajpa.1330670105; Trinkaus E., 1983, SHANIDAR NEANDERTALS; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; VANDERME.B, 1970, CR ACAD SCI D NAT, V270, P298; VANDERMEERSCH B, 1969, CR ACAD SCI D NAT, V268, P2562; Vandermeersch B, 1981, HOMMES FOSSILES QAFZ; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899	62	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2014	9	7							e102822	10.1371/journal.pone.0102822			10	Multidisciplinary Sciences	Science & Technology - Other Topics	AM1NT	WOS:000339614100060	25054798	DOAJ Gold, Green Published			2021-06-18	
J	Hwang, V; Trickey, AW; Lormel, C; Bradford, AN; Griffen, MM; Lawrence, CP; Sturek, C; Stacey, E; Howell, JM				Hwang, Vivian; Trickey, Amber W.; Lormel, Christy; Bradford, Anna N.; Griffen, Margaret M.; Lawrence, Cheryl P.; Sturek, Charles; Stacey, Elizabeth; Howell, John M.			Are pediatric concussion patients compliant with discharge instructions?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Pediatrics; concussion; emergency department; discharge instructions; compliance	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PLAY GUIDELINES; RUGBY PLAYERS; SPORT HELD; RETURN; ZURICH	BACKGROUND: Concussions are commonly diagnosed in pediatric patients presenting to the emergency department (ED). The primary objective of this study was to evaluate compliance with ED discharge instructions for concussion management. METHODS: A prospective cohort study was conducted from November 2011 to November 2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 pediatric patients per year. Subjects were aged 8 yetis to 17 years and were discharged from the ED with a diagnosis of concussion. Exclusion criteria included recent (past 3 months) diagnosis of head injury, hospital admission, intracranial injury, skull fracture, suspected nonaccidental trauma, or preexisting neurologic condition. Subjects were administered a baseline survey in the ED and were given standardized discharge instructions for concussion by the treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 weeks after ED visit. RESULTS: A total of 150 patients were enrolled. The majority (67%) of concussions were sports related. Among sports-related concussions, soccer (30%), football (11%), lacrosse (8%), and basketball (8%) injuries were most common. More than one third (39%) reported return to play (RTP) on the day of the injury. Physician follow-up was equivalent for sport and nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 0.06; 4 weeks, 29% vs. 8%, p < 0.01). Of the patients who did RTP or normal activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most (58%) did not receive medical clearance. Of the patients who had returned to activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, andmost (54%) received medical clearance. CONCLUSION: Pediatric patients discharged from the ED are mostly compliant with concussion instructions. However, a significant number of patients RTP on the day of injury, while experiencing symptoms or without medical clearance. (J Trauma Acute Care Surg. 2014;77: 117-122. Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Hwang, Vivian; Trickey, Amber W.; Lormel, Christy; Bradford, Anna N.; Griffen, Margaret M.; Lawrence, Cheryl P.; Sturek, Charles; Stacey, Elizabeth; Howell, John M.] Inova Fairfax Hosp, Dept Emergency Med, Falls Church, VA 22042 USA	Hwang, V (corresponding author), Inova Fairfax Hosp, Dept Emergency Med, 3300 Gallows Rd, Falls Church, VA 22042 USA.	vivhwang1@gmail.com					[Anonymous], 2014, FAIRF COUNT SPORTS O; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Centers for Disease Control (CDC), 2013, INJ PREV CONTR TRAUM; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; FCPS, 2013, MILD HEAD INJ CONC A; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, J HEAD TRAUMA REHAB, V24, P355, DOI 10.1097/HTR.0b013e3181b97a4e; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	26	13	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2014	77	1					117	122		10.1097/TA.0000000000000275			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AK4IY	WOS:000338389600031	24977765				2021-06-18	
J	Matsuda, PN; Taylor, CS; Shumway-Cook, A				Matsuda, Patricia Noritake; Taylor, Catherine S.; Shumway-Cook, Anne			Evidence for the Validity of the Modified Dynamic Gait Index Across Diagnostic Groups	PHYSICAL THERAPY			English	Article							MULTIPLE-SCLEROSIS; VESTIBULAR DISORDERS; DETECTABLE CHANGE; OLDER-ADULTS; BALANCE; PEOPLE; RELIABILITY; STROKE; AMBULATION	Background. The modified Dynamic Gait Index (mDGI) measures the capacity to adapt gait to complex tasks utilizing 8 tasks and 3 facets of performance. The measurement stability of the mDGI in specific diagnostic groups is unknown. Objective. This study examined the psychometric properties of the mDGI in 5 diagnostic groups. Design. This was a cross-sectional, descriptive study. Methods. A total of 794 participants were included in the study: 140 controls, 239 with stroke, 140 with vestibular dysfunction, 100 with traumatic brain injury, 91 with gait abnormality, and 84 with Parkinson disease. Differential item functioning analysis was used to examine the comparability of scores across diagnoses. Internal consistency was computed using Cronbach alpha. Factor analysis was used to examine the factor loadings for the 3 performance facet scores. Minimal detectable change at the 95% confidence level (MDC95%) was calculated for each of the groups. Results. Less than 5% of comparisons demonstrated moderate to large differential item functioning, suggesting that item scores had the same order of difficulty for individuals in all 5 diagnostic groups. For all 5 patient groups, 3 factors had eigen-values >1.0 and explained 80% of the variability in scores, supporting the importance of characterizing mobility performance with respect to time, level of assistance, and gait pattern. Limitations. There were uneven sample sizes in the 6 groups. Conclusions. The strength of the psychometric properties of the mDGI across the 5 diagnostic groups further supports the validity and usefulness of scores for clinical and research purposes. In addition, the meaning of a score from the mDGI, regardless of whether at the task, performance facet, or total score level, was comparable across the 5 diagnostic groups, suggesting that the mDGI measured mobility function independent of medical diagnosis.	[Matsuda, Patricia Noritake; Shumway-Cook, Anne] Univ Washington, Dept Rehabil Med, Div Phys Therapy, Seattle, WA 98195 USA; [Taylor, Catherine S.] Univ Washington, Coll Educ, Seattle, WA 98195 USA	Matsuda, PN (corresponding author), Univ Washington, Dept Rehabil Med, Div Phys Therapy, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA.	pmatsuda@u.washington.edu	Matsuda, Patricia/T-3606-2019		Department of Rehabilitation Medicine, University of Washington; Walter C. and Anita C. Stolov Research Fund	This study was supported by a grant from the Walter C. and Anita C. Stolov Research Fund, Department of Rehabilitation Medicine, University of Washington. The authors thank the testing sites, physical therapists, and all of the participants for their contributions to this study.	Cattaneo D, 2006, DISABIL REHABIL, V28, P789, DOI 10.1080/09638280500404289; Chiu YP, 2006, PHYS THER, V86, P778, DOI 10.1093/ptj/86.6.778; Dye DC, 2013, PHYS THER, V93, P809, DOI 10.2522/ptj.20120163; Fidalgo AM, 2004, EDUC PSYCHOL MEAS, V64, P925, DOI 10.1177/0013164404267288; Forsberg A, 2013, PHYS THER, V93, P1369, DOI 10.2522/ptj.20120284; Hall Courtney D, 2006, J Neurol Phys Ther, V30, P74; Huang SL, 2011, PHYS THER, V91, P114, DOI 10.2522/ptj.20090126; Jonsdottir J, 2007, ARCH PHYS MED REHAB, V88, P1410, DOI 10.1016/j.apmr.2007.08.109; Kerlinger FN, 1973, MULTIPLE REGRESSION; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; Linacre JM, 1989, RASCH MEAS T, V3, P52; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Marchetti GF, 2008, PHYS THER, V88, P640, DOI 10.2522/ptj.20070130; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; MAZOR KM, 1992, EDUC PSYCHOL MEAS, V52, P443, DOI 10.1177/0013164492052002020; McConvey J, 2005, ARCH PHYS MED REHAB, V86, P130, DOI 10.1016/j.apmr.2003.11.033; Messick S., 1989, ED MEASUREMENT, V3, P13, DOI DOI 10.7203/RELIEVE.22.1.8248; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; Pett M., 2003, MAKING SENSE FACTOR; Portney L. G., 2008, FDN CLIN RES APPL PR, V3rd; Romero S, 2011, J GERIATR PHYS THER, V34, P131, DOI 10.1519/JPT.0b013e3182048006; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL; Shumway-Cook A, 2013, PHYS THER, V93, P1493, DOI 10.2522/ptj.20130035; Tristan A, 2006, RASCH MEASUREMENT T, V20, P1070; Wert DM, 2013, ARCH GERONTOL GERIAT, V57, P198, DOI 10.1016/j.archger.2013.04.007; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0	27	13	13	0	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2014	94	7					996	1004		10.2522/ptj.20130294			9	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	AK1IZ	WOS:000338170100010	24557650	Bronze			2021-06-18	
J	Piccolino, AL; Solberg, KB				Piccolino, Adam L.; Solberg, Kenneth B.			The Impact of Traumatic Brain Injury on Prison Health Services and Offender Management	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						traumatic brain injury; offenders; correctional health services; prison; recidivism	HEAD-INJURY	A large percentage of incarcerated offenders report a history of traumatic brain injury (TBI) with concomitant neuropsychiatric and social sequelae. However, research looking at the relationship between TBI and delivery of correctional health services and offender management is limited. In this study, the relationships between TBI and use of correctional medical/psychological services, chemical dependency (CD) treatment completion rates, in-prison rule infractions, and recidivism were investigated. Findings indicated that TBI history has a statistically significant association with increased usage of correctional medical/psychological services, including crisis interventions services, and with higher recidivism rates. Results also showed a trend toward offenders with TBI incurring higher rates of in-prison rule infractions and lower rates of CD treatment completion. Implications and future directions for correctional systems are discussed.	[Piccolino, Adam L.] Minnesota Dept Correct, Shakopee, MN 55379 USA; [Solberg, Kenneth B.] St Marys Univ Minnesota, Doctoral Program Counseling Psychol, Minneapolis, MN USA	Piccolino, AL (corresponding author), Minnesota Dept Correct, 1010 West 6th Ave, Shakopee, MN 55379 USA.	adam.piccolino@state.mn.us					Bennett T. L., 2008, NEUROPSYCHOLOGY HDB, P535; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Centers for Disease Control and Prevention, 2011, TRAUM BRAIN INJ PRIS; Centers for Disease Control and Prevention, 2012, WHAT POT EFF TBI; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Glaze L. E., 2011, 236319 NCJ BUR JUST; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCrea M, 2008, MILD TRAUMATIC BRAIN; Merbitz C., 1995, J OFFENDER REHABILIT, V22, P11, DOI DOI 10.1300/J076V22N03_02; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Wald M. M., 2008, BRAIN INJURY PROFESS, V5, P22; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	23	13	13	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	JUL	2014	20	3					203	212		10.1177/1078345814530871			10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AK3RR	WOS:000338342900004	24934838				2021-06-18	
J	Qian, K; Gu, Y; Zhao, YM; Li, ZZ; Sun, M				Qian, Ke; Gu, Yi; Zhao, Yumei; Li, Zhenzong; Sun, Ming			Citicoline Protects Brain Against Closed Head Injury in Rats Through Suppressing Oxidative Stress and Calpain Over-Activation	NEUROCHEMICAL RESEARCH			English	Article						Citicoline; Closed head injury; Oxidative stress; Calpain; Corpus callosum; Hippocampus	TRANSIENT CEREBRAL-ISCHEMIA; CDP-CHOLINE; LIPID-PEROXIDATION; WHITE-MATTER; CORTICAL CONTUSION; STROKE; PATHOPHYSIOLOGY; REPERFUSION; METABOLISM; DISORDERS	Citicoline, a natural compound that functions as an intermediate in the biosynthesis of cell membrane phospholipids, is essential for membrane integrity and repair. It has been reported to protect brain against trauma. This study was designed to investigate the protective effects of citicoline on closed head injury (CHI) in rats. Citicoline (250 mg/kg i.v. 30 min and 4 h after CHI) lessened body weight loss, and improved neurological functions significantly at 7 days after CHI. It markedly lowered brain edema and blood-brain barrier permeability, enhanced the activities of superoxide dismutase and the levels of glutathione, reduced the levels of malondialdehyde and lactic acid. Moreover, citicoline suppressed the activities of calpain, and enhanced the levels of calpastatin, myelin basic protein and alpha II-spectrin in traumatic tissue 24 h after CHI. Also, it attenuated the axonal and myelin sheath damage in corpus callosum and the neuronal cell death in hippocampal CA1 and CA3 subfields 7 days after CHI. These data demonstrate the protection of citicoline against white matter and grey matter damage due to CHI through suppressing oxidative stress and calpain over-activation, providing additional support to the application of citicoline for the treatment of traumatic brain injury.	[Qian, Ke] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Gu, Yi; Zhao, Yumei; Sun, Ming] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropharmacol, Beijing 100050, Peoples R China; [Li, Zhenzong] Capital Med Univ, Beijing Neurosurg Inst, Dept Expt Zool, Beijing 100050, Peoples R China	Sun, M (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropharmacol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	sunming999@yahoo.com					Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Adibhatla Rao Muralikrishna, 2013, Nat Rev Neurol, V9, P173, DOI 10.1038/nrneurol.2012.166-c1; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Adibhatla RM, 2005, BRAIN RES, V1058, P193, DOI 10.1016/j.brainres.2005.07.067; Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Adibhatla RM, 2003, J NEUROSCI RES, V73, P308, DOI 10.1002/jnr.10672; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; AGUILAR J, 1983, ARZNEIMITTELFORSCH, V33-2, P1051; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Alvarez-Sabin J, 2011, STROKE, V42, pS40, DOI 10.1161/STROKEAHA.110.606509; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; ARRIGONI E, 1987, BIOCHEM PHARMACOL, V36, P3697, DOI 10.1016/0006-2952(87)90022-0; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRALET J, 1991, BRAIN RES, V539, P175, DOI 10.1016/0006-8993(91)90703-X; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng CM, 1998, J NEUROSCI, V18, P5673; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fresta M, 1999, PHARMACEUT RES, V16, P1843, DOI 10.1023/A:1018999225435; FRESTA M, 1994, J PHARM PHARMACOL, V46, P974, DOI 10.1111/j.2042-7158.1994.tb03252.x; GALLETTI P, 1985, BIOCHEM PHARMACOL, V34, P4121, DOI 10.1016/0006-2952(85)90204-7; Ghosh S, 2010, NEUROSCIENCE, V171, P1287, DOI 10.1016/j.neuroscience.2010.09.049; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; KAKIHANA M, 1988, STROKE, V19, P217, DOI 10.1161/01.STR.19.2.217; Knapp S, 1999, BRAIN RES, V822, P52, DOI 10.1016/S0006-8993(99)01072-0; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lopez Gonzalez-Coviella I, 1987, NEUROCHEM INT, V11, P293, DOI [10.1016/0197-0186(87)90049-0, DOI 10.1016/0197-0186(87)90049-0]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASSARO AR, 1990, ITAL J NEUROL SCI, V11, P537, DOI 10.1007/BF02337436; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Miura S, 2009, BRAIN DEV-JPN, V31, P307, DOI 10.1016/j.braindev.2008.06.010; MOSS DE, 1991, PHARMACOL BIOCHEM BE, V39, P495, DOI 10.1016/0091-3057(91)90214-M; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Palace J, 2003, J NEUROL SCI, V206, P131, DOI 10.1016/S0022-510X(02)00419-7; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P253, DOI 10.1038/jcbfm.1985.32; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOSHIDA K, 1993, BIOCHIM BIOPHYS ACTA, V1182, P215, DOI 10.1016/0925-4439(93)90143-O; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	68	13	13	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2014	39	7					1206	1218		10.1007/s11064-014-1299-x			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AM3BU	WOS:000339727300005	24691765				2021-06-18	
J	Sabour, H; Javidan, AN; Latifi, S; Larijani, B; Shidfar, F; Vafa, MR; Heshmat, R; Razavi, HE				Sabour, Hadis; Javidan, Abbas Norouzi; Latifi, Sahar; Larijani, Bagher; Shidfar, Farzad; Vafa, Mohammad Reza; Heshmat, Ramin; Razavi, Hassan Emami			Bone biomarkers in patients with chronic traumatic spinal cord injury	SPINE JOURNAL			English	Article						Bone biomarkers; Bone mineral density; Spinal cord injury; Bone alkaline phosphatase	MINERAL DENSITY; SERUM CONCENTRATIONS; OSTEOPOROSIS; METABOLISM; CALCITONIN; AGE; TURNOVER; TISSUE; LEVEL	BACKGROUND CONTEXT: Bone loss after spinal cord injury (SCI) occurs because of pathologic changes in osteoblastic and osteoclastic activities due to mechanical unloading. Some biochemical changes in bone metabolism after SCI are described before that were related to bone mineral loss. PURPOSE: Our purpose was to determine bone markers' changes and related effective factors in patients with chronic traumatic SCI. STUDY DESIGN: This investigation was designed as an observational cross-sectional study. PATIENT SAMPLE: All patients with chronic SCI who were referred to Brain and Spinal Injury Research Center and did not meet our exclusion criteria entered the study. OUTCOME MEASURES: Self-reporting measures including patient's demographic features and date of accident were obtained using a questionnaire and physiologic measures including spinal magnetic resonance imaging to determine the level of injury accompanied with physical examination along with dual-energy X-ray absorptiometry were performed. Blood samples were analyzed in the laboratory. METHODS: Dual-energy X-ray was used to determine bone mineral density in femoral and spinal vertebrae bone sites. Serum level of C-telopeptide cross-linked Type 1 collagen (CTX), parathyroid hormone, calcitonin, osteocalcin, and bone alkaline phosphatase (BALP) were measured. RESULTS: We detected a negative association between CTX level and bone mineral density in femoral and spinal bone sites that confirms that CTX is a bone resorption marker. C-telopeptide cross-linked Type 1 collagen and BALP levels did not show any significant correlation with postduration injury. Patients with spinal injury at lumbar level had the highest calcitonin level (p < .04). C-telopeptide cross-linked Type 1 collagen was positively related with osteocalcin and BALP (p < .0001, r = 0.51), and osteocalcin was positively related with BALP (p < .0001, r = 0.44). Osteocalcin was related negatively only to femoral intertrochanteric zone bone mineral density. CONCLUSIONS: Some bone biomarkers undergo noticeable changes after SCI. C-telopeptide cross-linked Type 1 collagen was positively correlated with BALP and osteocalcin that shows the coincidental occurrence of osteoblastic and osteoclastic activities. Our data also support this fact that although bone reduction after 2 years is slower than acute phase after SCI, bone resorption rate is higher than bone formation. These bone markers also revealed different site of action as osteocalcin level only affected femoral intertrochanteric bone mineral density. Generally, it seems that the coincidental consideration of these factors that influence bone mineral density can lead to a better understanding of bone changes after SCI. (C) 2014 Elsevier Inc. All rights reserved.	[Sabour, Hadis; Javidan, Abbas Norouzi; Latifi, Sahar; Razavi, Hassan Emami] Univ Tehran Med Sci, Imam Khomeini Hosp, Brain & Spinal Injury Res BASIR Ctr, Tehran, Iran; [Larijani, Bagher; Heshmat, Ramin] Univ Tehran Med Sci, Dept Endocrinol, Endocrinol & Metab Res Inst EMRI, Tehran, Iran; [Shidfar, Farzad; Vafa, Mohammad Reza] Iran Univ Med Sci, Dept Nutr, Tehran, Iran	Javidan, AN (corresponding author), Univ Tehran Med Sci, Imam Khomeini Hosp, Brain & Spinal Injury Res BASIR Ctr, Keshavarz Avenu, Tehran, Iran.	noroozia@tums.ac.ir	Vafa, Mohammadreza/AAC-3827-2019; Shidfar, Farzad/H-6651-2018; larijani, Bagher/ABE-3315-2020	Shidfar, Farzad/0000-0002-6531-9253; larijani, Bagher/0000-0001-5386-7597; norouzi javidan, abbas/0000-0002-6611-3919; Vafa, Mohammadreza/0000-0001-7052-8810; Latifi, Sahar/0000-0002-3512-0657	Tehran University of Medical SciencesTehran University of Medical Sciences	Funding of this study was provided by Tehran University of Medical Sciences and up to our knowledge no conflict of interest exists.	Ali AT, 2006, AM J CLIN PATHOL, V126, P437, DOI 10.1309/9N346GXX67B6PX5W; Aloia John F, 2006, Endocr Pract, V12, P137; ARNSTEIN AR, 1973, CLIN ASPECTS METABOL, P253; Ashe Maureen C, 2007, Top Spinal Cord Inj Rehabil, V13, P123, DOI 10.1310/sci1301-123; Bagis S, 2002, TURKISH J RHEUMATOL, V17, P168; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; BIERINGSORENSEN F, 1990, EUR J CLIN INVEST, V20, P330, DOI 10.1111/j.1365-2362.1990.tb01865.x; Bubbear JS, 2011, OSTEOPOROSIS INT, V22, P271, DOI 10.1007/s00198-010-1221-6; CAREY DE, 1985, ARCH PHYS MED REHAB, V66, P640; CHANTRAINE A, 1986, CALCIFIED TISSUE INT, V38, P323, DOI 10.1007/BF02555744; Demirel G, 1998, SPINAL CORD, V36, P822, DOI 10.1038/sj.sc.3100704; Edwards LA, 2008, AM J CLIN NUTR, V87, P600; Eser P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P197; Eser P, 2004, BONE, V34, P869, DOI 10.1016/j.bone.2004.01.001; Fattal C, 2011, ARCH PHYS MED REHAB, V92, P59, DOI 10.1016/j.apmr.2010.09.019; FREEHAFER AA, 1995, ARCH PHYS MED REHAB, V76, P823, DOI 10.1016/S0003-9993(95)80546-X; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Groah SL, 2010, PM&R, V2, P1080, DOI 10.1016/j.pmrj.2010.08.003; Health III H, 1973, CLIN ASPECTS METABOL, P257; Humble SR, 2011, ANAESTH INTENS CARE, V39, P682, DOI 10.1177/0310057X1103900425; Hummel K, 2012, SPINAL CORD, V50, P812, DOI 10.1038/sc.2012.67; Kudlacek S, 2003, BONE, V32, P681, DOI 10.1016/S8756-3282(03)00090-5; LIAN JB, 1988, CLIN ORTHOP RELAT R, P267; Maimoun L, 2006, SPINAL CORD, V44, P203, DOI 10.1038/sj.sc.3101832; Mechanick JI, 1997, ARCH PHYS MED REHAB, V78, P692, DOI 10.1016/S0003-9993(97)90075-7; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; Morse L. R., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P50; NAND S, 1976, ARCH PHYS MED REHAB, V57, P553; Nordin BEC, 1973, METABOLIC BONE STONE, P43; Paker N, 2007, NEUROSCIENCES, V12, P232; PIETSCHMANN P, 1992, PARAPLEGIA, V30, P204, DOI 10.1038/sc.1992.56; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; Roberts D, 1998, J CLIN ENDOCR METAB, V83, P415, DOI 10.1210/jc.83.2.415; Sinaki M, 2001, PHYS MED REHABILITAT, P895; Steinschneider M, 2003, BMC MUSCULOSKEL DIS, V16, P4; Szollar SM, 1998, AM J PHYS MED REHAB, V77, P28, DOI 10.1097/00002060-199801000-00005; Szollar SM, 1997, ARCH PHYS MED REHAB, V78, P455, DOI 10.1016/S0003-9993(97)90155-6; Szulc P, 2001, J CLIN ENDOCR METAB, V86, P3162, DOI 10.1210/jc.86.7.3162; UEBELHART D, 1994, SCAND J REHABIL MED, V26, P197; VAZIRI ND, 1994, ARCH PHYS MED REHAB, V75, P766; von Muhlen DG, 2005, OSTEOPOROSIS INT, V16, P1721, DOI 10.1007/s00198-005-1910-8; WILMET E, 1995, PARAPLEGIA, V33, P674, DOI 10.1038/sc.1995.141; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6	45	13	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUL	2014	14	7					1132	1138		10.1016/j.spinee.2013.07.475			7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AK5LV	WOS:000338467000009	24139865				2021-06-18	
J	Seifi, A; Asadi-Pooya, AA; Carr, K; Maltenfort, M; Emami, M; Bell, R; Moussouttas, M; Yazbeck, M; Rincon, F				Seifi, Ali; Asadi-Pooya, Ali Akbar; Carr, Kevin; Maltenfort, Mitchell; Emami, Mehrdad; Bell, Rodney; Moussouttas, Michael; Yazbeck, Moussa; Rincon, Fred			The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States	SPRINGERPLUS			English	Article						Subdural hematoma; Status epilepticus; Risk factors; Mortality	TRAUMATIC BRAIN-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; SUBARACHNOID HEMORRHAGE; POSTTRAUMATIC EPILEPSY; BURR-HOLE; SEIZURES; POPULATION; EVACUATION; PREVALENCE; DISCHARGES	Introduction: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE), however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE, the prevalence of risk factors, and impact on hospital mortality using a large administrative dataset. Methods: Data was derived from the Nationwide Inpatient Sample from 1988 through 2011. We queried the NIS database for patients older than 18 years, with a diagnosis of SDH and SE. Diagnoses were defined by ICD 9 CM codes 432.1, 852.2, 852.3 and 345.3 for SE. Adjusted incidence rates of admission and prevalence proportions were calculated. Multivariate logistic models were then fitted to assess for the impact of status epilepticus on hospital mortality. Results: Over the 23-year period, we identified more than 1,583,255 admissions with a diagnosis of SDH. The prevalence of SE in this cohort was 0.5% (7,421 admissions). The population adjusted incidence rate of admissions of SDH increased from 13/100,000 in 1988 to 38/100,000 in 2011. The prevalence of SE in SDH, increased from 0.5% in 1988 to 0.7% in 2011. In hospital mortality of patients with SDH and without SE decreased from 17.9% to 10.3% while in hospital mortality of patients with SDH and SE did not statistically change. Mortality increased over the same period (2.3/100,000 in 1988 to 3.9/100.000 in 2011) and the diagnosis of SE increased mortality in this cohort (OR 2.17, p < 0.0001). The risk of SE remained stable throughout the study period, but was higher among older patients, blacks, and in those with respiratory, metabolic, hematological, and renal system dysfunction. Conclusion: Our study demonstrates that the incidence of admissions of SDH is increasing in the United States. Despite a decline in the overall SDH related mortality, SE increased the risk of in-hospital death in patients with a primary diagnosis of SDH.	[Seifi, Ali; Carr, Kevin] Univ Texas Hlth Sci Ctr San Antonio, Div Neurocrit Care, Dept Neurosurg, San Antonio, TX 78229 USA; [Asadi-Pooya, Ali Akbar; Emami, Mehrdad] Shiraz Univ Med Sci, Neurosci Res Ctr, Shiraz, Iran; [Asadi-Pooya, Ali Akbar] Thomas Jefferson Univ, Dept Neurol, Jefferson Comprehens Epilepsy Ctr, Philadelphia, PA 19107 USA; [Maltenfort, Mitchell; Bell, Rodney] Rothman Inst, Philadelphia, PA USA; [Rincon, Fred] Thomas Jefferson Univ, Dept Neurol & Neurosurg, Philadelphia, PA 19107 USA; [Moussouttas, Michael] Capital Inst Neurosci, Div Neuro Crit Care, Trenton, NJ USA; [Yazbeck, Moussa] John Muir Med Ctr, Dept Neurosurg, Walnut Creek, CA USA	Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Neurocrit Care, Dept Neurosurg, Mail Code 7843,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020; Asadi-Pooya, Ali/AAD-4353-2019	Rincon, Fred/0000-0002-8510-118X; Asadi-Pooya, Ali/0000-0002-2598-7601			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Balser D, 2013, NEUROL RES, V35, P233, DOI 10.1179/1743132813Y.0000000166; Becker DP, 1986, ADV NEUROTRAUMATOLOG, V1, P51; Bleck Thomas P, 2012, Continuum (Minneap Minn), V18, P560, DOI 10.1212/01.CON.0000415428.61277.90; BRODERSEN P, 1975, ACTA NEUROL SCAND, V51, P233, DOI 10.1111/j.1600-0404.1975.tb07604.x; CAMERON MM, 1978, J NEUROL NEUROSUR PS, V41, P834, DOI 10.1136/jnnp.41.9.834; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2007, NEUROSURGERY, V61, P4; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; COLE M, 1961, NEW ENGL J MED, V265, P628, DOI 10.1056/NEJM196109282651304; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gupta Y K, 2006, Indian J Physiol Pharmacol, V50, P7; HAERER AF, 1986, EPILEPSIA, V27, P66, DOI 10.1111/j.1528-1157.1986.tb03503.x; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; Huang YH, 2011, NEUROCRIT CARE, V14, P253, DOI 10.1007/s12028-011-9509-8; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; JONES SC, 1989, BMJ-BRIT MED J, V299, P439, DOI 10.1136/bmj.299.6696.439; Ko BS, 2008, J KOREAN NEUROSURG S, V43, P11, DOI 10.3340/jkns.2008.43.1.11; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; KRUPP WF, 1995, BRIT J NEUROSURG, V9, P619, DOI 10.1080/02688699550040909; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; MPAC (U.S.), 2007, REP C PROM GREAT EFF; OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231; Pahatouridis D, 2013, NEUROSURG REV, V36, P151, DOI 10.1007/s10143-012-0412-3; PAYAN H, 1970, EPILEPSIA, V11, P81, DOI 10.1111/j.1528-1157.1970.tb03869.x; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; RUBIN G, 1993, ACTA NEUROCHIR, V123, P39, DOI 10.1007/BF01476283; RUBIN JJ, 1980, EXP NEUROL, V67, P472, DOI 10.1016/0014-4886(80)90119-3; Rudzinski LA, 2011, J CLIN NEUROPHYSIOL, V28, P633, DOI 10.1097/WNP.0b013e31823cc494; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schulte S, 2008, CARDIOVASC INTER RAD, V31, P870, DOI 10.1007/s00270-008-9311-y; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Steg R E, 1993, Nebr Med J, V78, P27; Storti SF, 2012, MAGN RESON MATER PHY, V25, P345, DOI 10.1007/s10334-012-0316-9; SUNG CY, 1989, ACTA NEUROL SCAND, V80, P51, DOI 10.1111/j.1600-0404.1989.tb03842.x; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Urtecho J, 2013, CRIT CARE MED, V41, P1853, DOI 10.1097/CCM.0b013e31828a3994; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Westmoreland BF, 2001, J CLIN NEUROPHYSIOL, V18, P20, DOI 10.1097/00004691-200101000-00005; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	60	13	13	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JUL 1	2014	3								332	10.1186/2193-1801-3-332			10	Multidisciplinary Sciences	Science & Technology - Other Topics	CO3JH	WOS:000359052700003	25077058	Green Published, Other Gold			2021-06-18	
J	Sobuwa, S; Hartzenberg, HB; Geduld, H; Uys, C				Sobuwa, S.; Hartzenberg, H. B.; Geduld, H.; Uys, C.			Predicting outcome in severe traumatic brain injury using a simple prognostic model	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							SURVIVAL	Background. Several studies have made it possible to predict outcome in severe traumatic brain injury (TBI) making it beneficial as an aid for clinical decision-making in the emergency setting. However, reliable predictive models are lacking for resource-limited prehospital settings such as those in developing countries like South Africa. Objective. To develop a simple predictive model for severe TBI using clinical variables in a South African prehospital setting. Methods. All consecutive patients admitted at two level-one centres in Cape Town, South Africa, for severe TBI were included. A binary logistic regression model was used, which included three predictor variables: oxygen saturation (SpO(2)), Glasgow Coma Scale (GCS) and pupil reactivity. The Glasgow Outcome Scale was used to assess outcome on hospital discharge. Results. A total of 74.4% of the outcomes were correctly predicted by the logistic regression model. The model demonstrated SpO(2) (p=0.019), GCS (p=0.001) and pupil reactivity (p=0.002) as independently significant predictors of outcome in severe TBI. Odds ratios of a good outcome were 3.148 (SpO(2) >= 90%), 5.108 (GCS 6 - 8) and 4.405 (pupils bilaterally reactive). Conclusion. This model is potentially useful for effective predictions of outcome in severe TBI.	[Sobuwa, S.] Cape Peninsula Univ Technol, Dept Emergency Med Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa; [Hartzenberg, H. B.] Univ Stellenbosch, Div Neurosurg, Parow, South Africa; [Geduld, H.] Univ Cape Town, Div Emergency Med, ZA-7700 Rondebosch, South Africa; [Uys, C.] Cape Peninsula Univ Technol, Ctr Postgrad Studies, Cape Town, South Africa	Sobuwa, S (corresponding author), Cape Peninsula Univ Technol, Dept Emergency Med Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa.	simpiwesobuwa@gmail.com		Uys, Corrie/0000-0002-0313-3875; Geduld, Heike/0000-0001-6512-1274			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sobuwa Simpiwe, 2013, S Afr Med J, V103, P644, DOI 10.7196/samj.7035	12	13	14	0	5	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	JUL	2014	104	7					492	494		10.7196/SAMJ.7720			3	Medicine, General & Internal	General & Internal Medicine	AP3OA	WOS:000341984400019	25214051	DOAJ Gold			2021-06-18	
J	Wu, CC; Tsai, TH; Chang, C; Lee, TT; Lin, C; Cheng, IHJ; Sun, MC; Chuang, YJ; Chen, BS				Wu, Chia-Chou; Tsai, Tsung-Han; Chang, Chieh; Lee, Tian-Thai; Lin, Che; Cheng, Irene Han-Juo; Sun, Mu-Chien; Chuang, Yung-Jen; Chen, Bor-Sen			On the Crucial Cerebellar Wound Healing-Related Pathways and Their Cross-Talks after Traumatic Brain Injury in Danio rerio	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZEBRAFISH MODEL; CELL-MIGRATION; IMMUNE-SYSTEM; REGENERATION; NEUROTRANSMITTERS; NEUROGENESIS; CANNABINOIDS; PATHOGENESIS; MECHANISMS	Upon injury, the direct damage and the subsequent secondary injury in the brain often result in chronic neurological disorders. Due to multifactorial nature of secondary injury and subsequent complex cellular responses, much of the underlying mechanisms are unclear. This study used an adult zebrafish cerebellum injury model to investigate the phenotypes and the secondary injury responses for recovery mechanisms of injured brain. Using the time course microarray analysis, a candidate protein-protein interaction (PPI) network was refined as cerebellar wound healing PPI network by dynamic modeling and big data mining. Pathway enrichment and ontological analysis were incorporated into the refined network to highlight the main molecular scheme of cerebellar wound healing. Several significant pathways, including chemokine, Phosphatidylinositide 3-kinases, and axon guidance signaling pathway and their cross-talks through PI3K, PAK2, and PLXNA3 were identified to coordinate for neurogenesis and angiogenesis, which are essential for the restoration of the injured brain. Our finding provides an insight into the molecular restoration mechanisms after traumatic brain injury, and open up new opportunity to devise the treatment for traumatic brain injury in human.	[Wu, Chia-Chou; Tsai, Tsung-Han; Lin, Che; Chen, Bor-Sen] Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Deptartment Med Sci, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Irene Han-Juo] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Deptartment Neurol, Changhua, Taiwan	Chen, BS (corresponding author), Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013	Wu, Chia-Chou/0000-0002-4009-6858	National Science Council of Taiwan, R.O.C.Ministry of Science and Technology, Taiwan [NSC 102-2745-E-007-001-ASP]	The work was supported by the National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; BLALOCK JE, 1992, CHEM IMMUNOL, V52, P1; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cameron DA, 2005, MOL VIS, V11, P775; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levin ED, 2009, FRONT NEUROSCI, P293; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Qiu YH, 1996, ADV NEUROIMMUNOL, V6, P223, DOI 10.1016/S0960-5428(96)00018-6; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Wang YC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-20; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19	49	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97902	10.1371/journal.pone.0097902			13	Multidisciplinary Sciences	Science & Technology - Other Topics	AK2VQ	WOS:000338278100009	24926785	DOAJ Gold, Green Published			2021-06-18	
J	Saunders, NR; Noor, NM; Dziegielewska, KM; Wheaton, BJ; Liddelow, SA; Steer, DL; Ek, CJ; Habgood, MD; Wakefield, MJ; Lindsay, H; Truettner, J; Miller, RD; Smith, AI; Dietrich, WD				Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Steer, David L.; Ek, C. Joakim; Habgood, Mark D.; Wakefield, Matthew J.; Lindsay, Helen; Truettner, Jessie; Miller, Robert D.; Smith, A. Ian; Dietrich, W. Dalton			Age-Dependent Transcriptome and Proteome Following Transection of Neonatal Spinal Cord of Monodelphis domestica (South American Grey Short-Tailed Opossum)	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; AXONAL REGENERATION; UBIQUITIN LIGASE; DIFFERENTIAL EXPRESSION; INFLAMMATORY RESPONSE; THERAPEUTIC HYPOTHERMIA; GALECTIN-1 EXPRESSION	This study describes a combined transcriptome and proteome analysis of Monodelphis domestica response to spinal cord injury at two different postnatal ages. Previously we showed that complete transection at postnatal day 7 (P7) is followed by profuse axon growth across the lesion with near-normal locomotion and swimming when adult. In contrast, at P28 there is no axon growth across the lesion, the animals exhibit weight-bearing locomotion, but cannot use hind limbs when swimming. Here we examined changes in gene and protein expression in the segment of spinal cord rostral to the lesion at 24 h after transection at P7 and at P28. Following injury at P7 only forty genes changed (all increased expression); most were immune/inflammatory genes. Following injury at P28 many more genes changed their expression and the magnitude of change for some genes was strikingly greater. Again many were associated with the immune/inflammation response. In functional groups known to be inhibitory to regeneration in adult cords the expression changes were generally muted, in some cases opposite to that required to account for neurite inhibition. For example myelin basic protein expression was reduced following injury at P28 both at the gene and protein levels. Only four genes from families with extracellular matrix functions thought to influence neurite outgrowth in adult injured cords showed substantial changes in expression following injury at P28: Olfactomedin 4 (Olfm4, 480 fold compared to controls), matrix metallopeptidase (Mmp1, 104 fold), papilin (Papln, 152 fold) and integrin alpha 4 (Itga4, 57 fold). These data provide a resource for investigation of a priori hypotheses in future studies of mechanisms of spinal cord regeneration in immature animals compared to lack of regeneration at more mature stages.	[Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Habgood, Mark D.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Steer, David L.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Ek, C. Joakim] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden; [Wakefield, Matthew J.; Lindsay, Helen] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wakefield, Matthew J.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Lindsay, Helen] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Truettner, Jessie; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Miller, Robert D.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia.	n.saunders@unimelb.edu.au	Liddelow, Shane/ABE-6456-2020; Wakefield, Matthew/X-7593-2019; Wakefield, Matthew J/A-7795-2008; Wheaton, Ben/AAC-7037-2021	Liddelow, Shane/0000-0002-0840-1437; Wakefield, Matthew/0000-0001-6624-4698; Wakefield, Matthew J/0000-0001-6624-4698; Saunders, Norman/0000-0001-6660-7639; Lindsay, Helen/0000-0001-8614-1661; Miller, Robert/0000-0002-8479-8819	Victoria Neurotrauma Initiative	This project was supported by the Victoria Neurotrauma Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akbik F, 2011, EXPT NEUROLOGY; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Anders A, 2011, HTSEQ ANAL HIGH THRO; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Biancheri R, 2013, EUR J HUM GENET, V21, P34, DOI 10.1038/ejhg.2012.93; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Chen KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072567; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dealy MJ, 1999, NAT GENET, V23, P245; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Dulhunty A, 2009, J PHYSIOL-LONDON, V587, P3135, DOI 10.1113/jphysiol.2009.171959; Dziegielewska KM, 2000, J COMP NEUROL, V423, P373, DOI 10.1002/1096-9861(20000731)423:3<373::AID-CNE2>3.0.CO;2-D; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Eva R, 2012, INT REV NEUROBIOL, V106, P75, DOI 10.1016/B978-0-12-407178-0.00004-1; Farlow DN, 2000, J CELL BIOCHEM, V80, P171; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gris P, 2003, MOL CELL NEUROSCI, V24, P555, DOI 10.1016/S1044-7431(03)00211-2; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hollis ER, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00005; Hu WH, 2002, J NEUROCHEM, V81, P36, DOI 10.1046/j.1471-4159.2002.00788.x; Hurtado A, 2012, EXP NEUROL, V233, P606, DOI 10.1016/j.expneurol.2010.11.015; Iketani M, 2013, DEV NEUROBIOL, V73, P230, DOI 10.1002/dneu.22058; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; Kubota F, 2008, INT J DEV BIOL, V52, P397, DOI 10.1387/ijdb.072424fk; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Kurihara D, 2010, NEUROSCI RES, V66, P265, DOI 10.1016/j.neures.2009.11.008; Lane MA, 2007, EUR J NEUROSCI, V25, P1725, DOI 10.1111/j.1460-9568.2007.05439.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li C, 2011, NEUROSCIENCE, V197, P121, DOI 10.1016/j.neuroscience.2011.08.031; Lin AW, 2003, J NEUROBIOL, V56, P328, DOI 10.1002/neu.10239; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGraw J, 2005, EXP NEUROL, V195, P103, DOI 10.1016/j.expneurol.2005.04.004; McGraw J, 2004, NEUROSCIENCE, V128, P713, DOI 10.1016/j.neuroscience.2004.06.075; McKerracher L, 2012, INT REV NEUROBIOL, V105, P117, DOI 10.1016/B978-0-12-398309-1.00007-X; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller RD, 2010, SEMIN IMMUNOL, V22, P3, DOI 10.1016/j.smim.2009.11.005; Mladinic M, 2005, CELL MOL NEUROBIOL, V25, P407, DOI 10.1007/s10571-005-3150-z; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Noor NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027465; Parra ZE, 2009, J IMMUNOL, V182, P154, DOI 10.4049/jimmunol.182.1.154; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Ponyeam W, 2012, CELL SIGNAL, V24, P290, DOI 10.1016/j.cellsig.2011.08.020; Ramon, 1928, DEGENERATION REGENER; Reddy SJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E4; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; Seale SM, 2012, PHARMACOL BIOCHEM BE, V101, P77, DOI 10.1016/j.pbb.2011.12.006; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Sharp KG, 2012, EXP NEUROL, V233, P625, DOI 10.1016/j.expneurol.2010.12.020; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tello JF, 1911, TRAB LAB INVEST BIOL, V9, P123; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; van den Berg R, 2012, ADV EXP MED BIOL, V970, P173, DOI 10.1007/978-3-7091-0932-8_8; Veeravalli KK, 2012, J NEUROTRAUM, V29, P2251, DOI 10.1089/neu.2012.2460; Veeravalli KK, 2009, NEUROBIOL DIS, V36, P200, DOI 10.1016/j.nbd.2009.07.012; Verhaagen Joost, 2012, Handb Clin Neurol, V109, P595, DOI 10.1016/B978-0-444-52137-8.00037-1; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045931; Wang XM, 1998, J COMP NEUROL, V398, P83; Wheaton BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071181; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; Xiao Lin, 2005, Shengli Xuebao, V57, P705; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yau TO, 2002, DEV BIOL, V252, P287, DOI 10.1006/dbio.2002.0849; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zhu H, 2012, EXP BIOL MED, V237, P143, DOI 10.1258/ebm.2011.011152	121	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99080	10.1371/journal.pone.0099080			24	Multidisciplinary Sciences	Science & Technology - Other Topics	AN9SD	WOS:000340947700059	24914927	DOAJ Gold, Green Published			2021-06-18	
J	Fares, Y; Fares, J; Gebeily, S				Fares, Youssef; Fares, Jawad; Gebeily, Souheil			Head and facial injuries due to cluster munitions	NEUROLOGICAL SCIENCES			English	Article						Cluster munitions; Cluster bombs; Head injuries; Face injuries; Psychological effects; Lebanon	PENETRATING CRANIOCEREBRAL INJURIES; GUNSHOT WOUNDS; BLAST	Cluster munitions are weapons that scatter smaller sub-munitions intended to kill or mutilate on impact. They have been used by the Israeli army in the south of Lebanon and are now scattered over wide rural areas affecting its inhabitants. Because of their easily "pickable" nature, sub-munitions can inflict injuries to the head and face regions. In this study, we aimed to explore the head and face injuries along with their clinical features in a group of Lebanese patients who suffered from such injuries due to a sub-munition's detonation. The study included all the cases reported between 14 August 2006 and 15 February 2013, with head and face injuries related to cluster bombs. Injuries were classified into brain, eye, otologic and auditory impairments, oral and maxillofacial, and skin and soft-tissue injuries. Psychological effects of these patients were also examined as for post-traumatic stress disorder, major depressive disorder, generalized anxiety disorder and acute stress syndrome. During the study period, there were 417 casualties as a result of cluster munitions' blasts. Out of the total number of victims, 29 (7 %) were injured in the head and the face region. The convention on cluster munitions of 2008 should be adhered to, as these inhumane weapons indiscriminately and disproportionately harm innocent civilians, thereby violating the well-established international principles governing conflict and war today.	[Fares, Youssef; Fares, Jawad] Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon; [Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Gebeily, Souheil] Lebanese Univ, Fac Med Sci, Div Neurol, Beirut, Lebanon	Fares, Y (corresponding author), Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon.	yfares@ul.edu.lb; jyf04@mail.aub.edu	Fares, Jawad/X-4341-2018	Fares, Jawad/0000-0002-5368-8764			American Psychiatric Association, 2013, DIAGN STAT MAN MENT, P271; Bandak FA, 1996, TRAUMATIC BRAIN INJU, P167; Beehner L., 2006, BACKGROUNDER; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Bryant K, 2009, B WORLD HEALTH ORGAN, V87, P8; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; Corbman GR, 1997, ANXIETY DISORDERS CU; Fares Y, 2013, NEUROL SCI, V34, P2095, DOI 10.1007/s10072-013-1343-7; Fares Y, 2013, J INFECT PUBLIC HEAL, V6, P482, DOI 10.1016/j.jiph.2013.05.006; Fares Y, 2013, NEUROL SCI, V34, P1971, DOI 10.1007/s10072-013-1427-4; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Muzaffar W, 2000, BRIT J OPHTHALMOL, V84, P626, DOI 10.1136/bjo.84.6.626; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Torpy Janet M, 2011, JAMA, V305, P522, DOI 10.1001/jama.305.5.522	19	13	13	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2014	35	6					905	910		10.1007/s10072-013-1623-2			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AI4BM	WOS:000336810500013	24389857				2021-06-18	
J	Ozawa, T; Takeda, T; Ishigami, K; Narimatsu, K; Hasegawa, K; Nakajima, K; Noh, K				Ozawa, Takamitsu; Takeda, Tomotaka; Ishigami, Keiichi; Narimatsu, Keishiro; Hasegawa, Ken; Nakajima, Kazunori; Noh, Kwantae			Shock absorption ability of mouthguard against forceful, traumatic mandibular closure	DENTAL TRAUMATOLOGY			English	Article						mouthguard; shock absorption ability; traumatic mandibular closure; tooth; mandibular; strain	HIGH-SCHOOL FOOTBALL; OF-THE-LITERATURE; PROFESSIONAL FOOTBALL; DENTAL INJURIES; CONCUSSIONS; FRACTURES; PREVENTION; IMPACT; SAFE	BackgroundThe positive effects of wearing a mouthguard on shock absorption have been indicated in various papers. The ability of a mouthguard to protect against indirect injury, however, is not clear, and the thickness that a mouthguard would require to provide such protection remains to be determined. The primary aim of this study was to clarify the shock absorption potential of a mouthguard against forced, traumatic occlusion. The secondary objective was to compare the shock absorption ability of different thicknesses of mouthguard against this type of trauma. Materials and methodsAn artificial skull (ZA20; 3B Scientific International, Co. Ltd, Niigata, Japan) with two-axis strain gages applied to the right buccal aspect of the mandible and the mandibular and maxillary teeth was used to measure shock absorption ability. Three different thicknesses of EVA mouthguard (1, 2, and 3mm at the first molar) were tested. Results and conclusionsWithin the limitations of this laboratory study, the following results were obtained: the results showed that increasing the thickness of the mouthguard improved its shock absorption ability.	[Ozawa, Takamitsu; Takeda, Tomotaka; Ishigami, Keiichi; Narimatsu, Keishiro; Hasegawa, Ken; Nakajima, Kazunori] Kyung Hee Univ, Dept Sports Dent, Tokyo Dent Coll, Chiba 2618502, Japan; [Noh, Kwantae] Kyung Hee Univ, Dept Prosthodont, Sch Dent, Chiba 2618502, Japan	Takeda, T (corresponding author), Kyung Hee Univ, Dept Sports Dent, Tokyo Dent Coll, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	ttakeda@tdc.ac.jp	Noh, Kwantae/AAK-3492-2020	Noh, Kwantae/0000-0003-3480-7737			ADA, 2006, J AM DENT ASSOC, V137, P1712; Andreasen JO, 2007, TXB COLOR ATLAS TRAU; Andreasen JO AF, 1994, TXB COLOR ATLAS TRAU; Araki A, 2004, J SPORTS DENT, V7, P1; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Del Rossi G, 2007, DENT TRAUMATOL, V23, P149, DOI 10.1111/j.1600-9657.2006.00436.x; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hayakawa Masaya, 2006, Shikwa Gakuho, V106, P81; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Holan G, 1998, Int J Paediatr Dent, V8, P143; Iinuma M, 2003, J SPORTS DENT, V6, P16; Kawarai C, 2004, J SPORTS DENT, V7, P36; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Ou Meiqi, 1996, Bulletin of Tokyo Medical and Dental University, V43, P13; Padilla R, 1996, J Calif Dent Assoc, V24, P30; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ranalli DN, 2002, DENT TRAUMATOL, V18, P231, DOI 10.1034/j.1600-9657.2002.00122.x; Rayes MA, 2009, INT J SPORTS DENT, V2; Satoh T, 1990, J JPN SOC BIOMECHANI, V14, P68; Saura-Ingles A, 2005, BRIT DENT J, V199, P27, DOI 10.1038/sj.bdj.4812536; Shomura M., 2007, J MATSUMOTO DENT U S, V33, P255; Tajima T, 2003, J SPORTS DENT, V6, P1; Takahashi Mutsumi, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P465; Takamata T, 2008, J SPORTS DENT, V12, P38; Takeda T, 2006, DENT TRAUMATOL, V22, P77, DOI 10.1111/j.1600-9657.2006.00361.x; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Takeda T, 2004, DENT TRAUMATOL, V20, P150, DOI 10.1111/j.1600-4469.2004.00247.x; Takeda T, 2008, DENT TRAUMATOL, V24, P360, DOI 10.1111/j.1600-9657.2008.00576.x; Tejani Z, 2008, DENT TRAUMATOL, V24, P253, DOI 10.1111/j.1600-9657.2007.00537.x; Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Yamada J, 2003, J SPORTS DENT, V6, P42	41	13	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2014	30	3					204	210		10.1111/edt.12063			7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AG5OT	WOS:000335469000007	23998278				2021-06-18	
J	Poropatich, RK; Pavliscsak, HH; Tong, JC; Little, JR; McVeigh, FL				Poropatich, Ronald K.; Pavliscsak, Holly H.; Tong, James C.; Little, Jeanette R.; McVeigh, Francis L.			mCare: Using Secure Mobile Technology to Support Soldier Reintegration and Rehabilitation	TELEMEDICINE AND E-HEALTH			English	Article						health; military medicine; information management; rehabilitation; telecommunications	TRAUMATIC BRAIN-INJURY	Background: The U. S. Army Medical Department conducted a pilot mobile health project to determine the requirements for coordination of care for "Wounded Warriors'' using mobile messaging. The primary objective was to determine if a secure mobile health (mhealth) intervention provided to geographically dispersed patients would improve contact rates and positively impact the military healthcare system. Methods and Materials: Over 21 months, volunteers enrolled in a Health Insurance Portability and Accountability Act-compliant, secure mobile messaging initiative called mCare. The study included males and females, 18-61 years old, with a minimum of 60 days of outpatient recovery. Volunteers were required to have a compatible phone. The mhealth intervention included appointment reminders, health and wellness tips, announcements, and other relevant information to this population exchanged between care teams and patients. Results: Provider respondents reported that 85% would refer patients to mCare, and 56% noted improvement in appointment attendance (n = 90). Patient responses also revealed high acceptability of mCare and refined the frequency and delivery times (n = 114). The pilot project resulted in over 84,000 outbound messages and improved contact rates by 176%. Conclusions: The mCare pilot project demonstrated the feasibility and administrative effectiveness of a scalable mhealth application using secure mobile messaging and information exchanges, including personalized patient education.	[Poropatich, Ronald K.] Univ Pittsburgh, Ctr Mil Med Res, Pittsburgh, PA USA; [Pavliscsak, Holly H.; Little, Jeanette R.] US Army Med Res & Mat Command USAMRMC, Telemed & Adv Technol Res Ctr TATRC, Ft Gordon, GA 30905 USA; [Tong, James C.] PricewaterhouseCoopers LLP, Herndon, VA USA; [McVeigh, Francis L.] US Army Med Res & Mat Command, Telemed & Adv Technol Ctr, Ft Detrick, MD USA	Pavliscsak, HH (corresponding author), US Army Med Res & Mat Command USAMRMC, Mobile Hlth Innovat Ctr MHIC, Telemed & Adv Technol Res Ctr TATRC, mCare Project, Bldg 38711, Ft Gordon, GA 30905 USA.	holly.h.pavliscsak.ctr@mail.mil					[Anonymous], 2011, 26 MOBILE APPL USERS; Blumberg SJ, 2011, NATL HLTH STAT REPOR, P28; Blumberg Stephen J, 2011, Natl Health Stat Report, P1; Canalys, 2012, SMART PHON OV CLIENT; CTIA The Wireless Association, 2012, WIR QUICK FACTS; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Health Resources and Services Administration, 2010, WHAT IS MHEALTH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Luxton DD, 2012, TELEMED E-HEALTH, V18, P409, DOI 10.1089/tmj.2011.0219; Obama B., 2012, PRESIDENTIAL MEMORAN; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ruby D., 2012, APP RETENTION INCREA; Smith A., 2012, CELL INTERNET USE 20; Tanielian T, 2008, PUBLICATION RAND COR; U.S. Department of Defense, 2012, CAS STAT	15	13	13	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	JUN	2014	20	6					563	569		10.1089/tmj.2013.0226			7	Health Care Sciences & Services	Health Care Sciences & Services	AJ8IA	WOS:000337945500010	24666038				2021-06-18	
J	Solbakk, AK; Lovstad, M				Solbakk, Anne-Kristin; Lovstad, Marianne			Effects of focal prefrontal cortex lesions on electrophysiological indices ofexecutive attention and action control	SCANDINAVIAN JOURNAL OF PSYCHOLOGY			English	Article						Neuropsychology; cognitive electrophysiology; event-related potentials; executive function; attention	CONTINGENT NEGATIVE-VARIATION; EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; ANTERIOR CINGULATE CORTEX; STOP-SIGNAL PARADIGM; HUMAN FRONTAL-CORTEX; EXECUTIVE FUNCTIONS; ORBITOFRONTAL CORTEX; RESPONSE-INHIBITION; INTEGRATIVE THEORY	The human capacity to maintain an overarching control over mental states and behavior relies on multiple, distributed and dynamically interacting brain networks, in which prefrontal cortex (PFC) plays a critical role. PFC exerts top-down executive control over subcortical and posterior cortical areas via extensive reciprocal connections. The orbital, lateral, and medial PFC subdivisions are associated with distinct executive functions, but their precise roles in large-scale neural networks remain to be determined. The main objective of our research program is to specify cognitive and neural mechanisms that govern executive control functions. We study effects of focal PFC lesions on behavioral and electrophysiological correlates of attention and action control utilizing experiments that relate to real-life requirements for executive control. We provide a selective review of studies on the impact of lesions to PFC subregions on novelty processing, anticipatory attention, and action preparation and motor inhibition. The studies provide evidence for the contribution of both lateral, dorsomedial and orbital PFC in novelty processing and dynamic contextual updating. We also report evidence for a role of lateral PFC in motor preparation and anticipatory attention. In contrast to the common view that orbitofrontal cortex plays a general role in inhibitory control, we report findings indicating an involvement in action outcome monitoring rather than in behavioral inhibition as such. We argue that improved understanding of how basic aspects of attentional control and inhibition is regulated in the brain, will shed light on the complex behavioral, cognitive and emotional problems experienced by patients with executive dysfunction.	[Solbakk, Anne-Kristin] Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, N-0424 Oslo, Norway; [Solbakk, Anne-Kristin] Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Psychosomat Med, N-0424 Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Res Dept, Nesodden, Norway; [Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway	Solbakk, AK (corresponding author), Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway.	annesolbakk@gmail.com					Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barcelo F, 2007, CEREB CORTEX, V17, pI51, DOI 10.1093/cercor/bhm111; Barch D. M., 2002, PRINCIPLES FRONTAL L, P427; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Brown GG, 2006, ANNU REV CLIN PSYCHO, V2, P51, DOI 10.1146/annurev.clinpsy.2.022305.095241; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Chong H, 2008, J COGNITIVE NEUROSCI, V20, P120, DOI 10.1162/jocn.2008.20.1.120; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; Daffner KR, 2003, J COGNITIVE NEUROSCI, V15, P294, DOI 10.1162/089892903321208213; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Funderud I, 2013, BRAIN RES, V1527, P174, DOI 10.1016/j.brainres.2013.06.017; Fuster JM, 2013, PRINCIPLES FRONTAL L, P11; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hooker C. I., 2002, ORBITOFRONTAL CORTEX, P307; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jung JL, 2011, INT J PSYCHOPHYSIOL, V79, P64, DOI 10.1016/j.ijpsycho.2010.09.014; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Karayanidis F, 2000, PSYCHOPHYSIOLOGY, V37, P319, DOI 10.1111/1469-8986.3730319; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kok A, 2006, BRAIN RES, V1105, P1, DOI 10.1016/j.brainres.2006.03.027; Kotchoubey B, 2006, NEUROSCI BIOBEHAV R, V30, P42, DOI 10.1016/j.neubiorev.2005.04.002; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kramer UM, 2013, CORTEX, V49, P837, DOI 10.1016/j.cortex.2012.05.003; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, BRAIN COGNITION, V80, P237, DOI 10.1016/j.bandc.2012.07.008; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nachev P, 2006, CURR OPIN NEUROL, V19, P586, DOI 10.1097/01.wco.0000247609.36482.ae; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Petrides M, 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramautar JR, 2006, BIOL PSYCHOL, V72, P96, DOI 10.1016/j.biopsycho.2005.08.001; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; ROTH WT, 1978, PSYCHOPHYSIOLOGY, V15, P17, DOI 10.1111/j.1469-8986.1978.tb01328.x; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; RUCHKIN DS, 1995, PSYCHOPHYSIOLOGY, V32, P399, DOI 10.1111/j.1469-8986.1995.tb01223.x; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; Solbakk A. K., 2012, NEUROPSYCHIATRY METH, P101; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Solbakk AK, 2014, J COGNITIVE NEUROSCI, V26, P1528, DOI 10.1162/jocn_a_00561; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; SQUIRES NK, 1975, CLIN NEUROPHYSIOL, V38, P387, DOI DOI 10.1016/0013-4694(75)90263-1; Stuss D.T., 2013, PRINCIPLES FRONTAL L; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; Turken A. U., 2008, BMC NEUROSCI, V9, P1655; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; Zappoli R, 2000, INT J PSYCHOPHYSIOL, V38, P109; Zappoli R, 2002, INT J PSYCHOPHYSIOL, V44, P117, DOI 10.1016/S0167-8760(01)00197-0	85	13	15	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0036-5564	1467-9450		SCAND J PSYCHOL	Scand. J. Psychol.	JUN	2014	55	3			SI		233	243		10.1111/sjop.12106			11	Psychology, Multidisciplinary	Psychology	AJ2UD	WOS:000337518200008	24602177				2021-06-18	
J	Karver, CL; Wade, SL; Cassedy, A; Taylor, HG; Brown, TM; Kirkwood, MW; Stancin, T				Karver, Christine L.; Wade, Shari L.; Cassedy, Amy; Taylor, H. Gerry; Brown, Tanya M.; Kirkwood, Michael W.; Stancin, Terry			Cognitive reserve as a moderator of responsiveness to an online problem-solving intervention for adolescents with complicated mild-to-severe traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Problem solving; Telehealth; Cognitive reserve; Adolescents	TERM BEHAVIOR PROBLEMS; VERBAL-LEARNING-TEST; FAMILY INTERVENTION; PRELIMINARY EFFICACY; EXECUTIVE FUNCTION; ALZHEIMER-DISEASE; SELF-REGULATION; YOUNG-CHILDREN; CHILDHOOD; OUTCOMES	Children and adolescents with traumatic brain injury (TBI) often experience behavior difficulties that may arise from problem-solving deficits and impaired self-regulation. However, little is known about the relationship of neurocognitive ability to post-TBI behavioral recovery. To address this question, we examined whether verbal intelligence, as estimated by Vocabulary scores from the Wechsler Abbreviated Scale of Intelligence, predicted improvements in behavior and executive functioning following a problem-solving intervention for adolescents with TBI. One hundred and thirty-two adolescents with complicated mild-to-severe TBI were randomly assigned to a six-month Web-based problem-solving intervention (CAPS; n = 65) or to an Internet resource comparison (IRC; n = 67) group. Vocabulary moderated the association between treatment group and improvements in metacognitive abilities. Examination of the mean estimates indicated that for those with lower Vocabulary scores, pre-intervention Metacognition Index scores from the Behavior Rating Inventory of Executive Function (BRIEF) did not differ between the groups, but post-intervention scores were significantly lower (more improved) for those in the CAPS group. These findings suggest that low verbal intelligence was associated with greater improvements in executive functioning following the CAPS intervention and that verbal intelligence may have an important role in response to intervention for TBI. Understanding predictors of responsiveness to interventions allows clinicians to tailor treatments to individuals, thus improving efficacy.	[Karver, Christine L.; Wade, Shari L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Karver, Christine L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MI USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA	Karver, CL (corresponding author), Univ Cincinnati, Dept Psychol, 1 Edwards Ctr,ML 0376, Cincinnati, OH 45221 USA.	karvercl@mail.uc.edu	Stancin, Terry/L-7993-2019		National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; University of Cincinnati, University Research Counsel; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (a) grant R01-MH073764 from the National Institute of Mental Health, (b) a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program, and (c) the University of Cincinnati, University Research Counsel. The authors wish to acknowledge the contributions of Kendra McMullen, Robert Blaha, Elizabeth Hagesfeld, Michelle Jacobs, Daniel Maier, and Nina Fox in data collection and entry and John Stullenberger in Web site support. We would also like to acknowledge the contributions of the therapists JoAnne Carey, PsyD, Britt Nielsen, PsyD, and Brad Jackson, PhD.	Achenbach T., 2001, CHILD BEHAV CHECKLIS; Achenbach T. M., 2000, CHILD BEHAV CHECKLIS; Allison P., 1999, LOGISTIC REGRESSION; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Baum KT, 2010, EPILEPSY BEHAV, V17, P467, DOI 10.1016/j.yebeh.2010.01.010; Bierman KL, 2008, CHILD DEV, V79, P1802, DOI 10.1111/j.1467-8624.2008.01227.x; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gioia G.A., 2000, BEHAV RATING INVENTO; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hinshaw SP, 2007, AMBUL PEDIATR, V7, P91, DOI 10.1016/j.ambp.2006.04.012; Hodges K, 1999, USE PSYCHOL TESTING; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McLaughlin K., J HEAD TRAU IN PRESS; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Staff RT, 2004, BRAIN, V127, P1191, DOI 10.1093/brain/awh144; Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Tabachnick BG, 2007, USING MULTIVARIATE S; Taylor H. G., J HEAD TRAU IN PRESS; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Verger K, 2001, BRAIN INJURY, V15, P211; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wechsler D., 2011, WECHLSER ABBREVIATED; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	58	13	13	0	22	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAY 4	2014	20	3					343	357		10.1080/09297049.2013.796918			15	Clinical Neurology	Neurosciences & Neurology	AF8VJ	WOS:000334993400006	23710617	Green Accepted			2021-06-18	
J	Bailey, NW; Segrave, RA; Hoy, KE; Maller, JJ; Fitzgerald, PB				Bailey, Neil W.; Segrave, Rebecca A.; Hoy, Kate E.; Maller, Jerome J.; Fitzgerald, Paul B.			Impaired upper alpha synchronisation during working memory retention in depression and depression following traumatic brain injury	BIOLOGICAL PSYCHOLOGY			English	Article						Traumatic brain injury; Major depression; Working memory; EEG; Alpha	MAJOR DEPRESSION; EEG; INHIBITION	Rates of major depressive disorder (MDD) following traumatic brain injury (TBI) are higher than in the general population. Individuals with depression following traumatic brain injury (TBI-MDD) exhibit working memory (WM) impairments. Electrophysiological evidence has suggested that parieto-occipital upper alpha synchronisation may enhance WM retention by inhibiting irrelevant processes. The current research assessed whether retention period WM parieto-occipital upper alpha activity is disrupted in groups with TBI-only (N = 20), MDD (N = 17), and TBI-MDD (N = 15) compared to healthy controls (N = 31). Behavioural data indicated poorer performance in MDD and TBI-MDD. Parietal-occipital upper alpha was reduced in the MDD and TBI-MDD groups, but was unaffected in TBI-only. These results suggest inhibitory deficits may account for WM impairments in MDD and TBI-MDD, and that for individuals with TBI-MDD it may be the depression rather than the TBI that impairs WM. (C) 2014 Elsevier B.V. All rights reserved.	Alfred Hosp, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia	Bailey, NW (corresponding author), Monash Alfred Psychiat Res Ctr, Level 4,607 St Kilda Rd, Melbourne, Vic 3004, Australia.	neilwbailey@gmail.com	Fitzgerald, Paul B/A-1225-2008; Segrave, Rebecca/H-4554-2014; Maller, Jerome J/H-4963-2014; Bailey, Neil/AAB-2741-2021	Fitzgerald, Paul B/0000-0003-4217-8096; Segrave, Rebecca/0000-0002-1839-0794; Maller, Jerome J/0000-0003-4685-1508; Hoy, Kate/0000-0003-0694-9674; Bailey, Neil/0000-0002-8483-1068	Monash UniversityMonash University; Victorian Neurotrauma Initiative; Neurosciences Victoria Clinical Neurobiology of Psychiatry Platform; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia; NHMRC CDF FellowshipNational Health and Medical Research Council of Australia	Funding for this study was provided by Monash University and the Victorian Neurotrauma Initiative. Equipment funding was provided in part by the Neurosciences Victoria Clinical Neurobiology of Psychiatry Platform. PBF is supported by a Practitioner Fellowship grant from the National Health and Medical Research Council (NHMRC). RAS and KEH are supported by Post Doctoral Training Fellowships from NHMRC. JJM is supported by an NHMRC CDF Fellowship.	ANDREW C, 1999, HANDB EL CL, V6, P119; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; CORSICABRERA M, 1993, INT J NEUROSCI, V72, P257, DOI 10.3109/00207459309024114; Croft RJ, 2000, CLIN NEUROPHYSIOL, V111, P444, DOI 10.1016/S1388-2457(99)00296-5; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lau MA, 2007, PSYCHOL MED, V37, P1249, DOI 10.1017/S0033291707000530; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Segrave RA, 2011, CLIN EEG NEUROSCI, V42, P45, DOI 10.1177/155005941104200110; Segrave RA, 2010, J AFFECT DISORDERS, V127, P191, DOI 10.1016/j.jad.2010.05.022; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Wechsler D., 2001, WECHSLER TEST ADULT; World Health Organization, 2001, WORLD HLTH REP 2001	36	13	13	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	MAY	2014	99						115	124		10.1016/j.biopsycho.2014.03.008			10	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Psychology; Behavioral Sciences	AH2CQ	WOS:000335928700013	24686072				2021-06-18	
J	Crutcher, CL; Ugiliweneza, B; Hodes, JE; Kong, MY; Boakye, M				Crutcher, Clifford L., II; Ugiliweneza, Beatrice; Hodes, Jonathan E.; Kong, Maiying; Boakye, Maxwell			Alcohol Intoxication and Its Effects on Traumatic Spinal Cord Injury Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						intoxication; alcohol; traumatic spinal cord injury; outcomes; acute	DEEP VENOUS THROMBOSIS; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; RISK; EPIDEMIOLOGY; PREDICTORS	There are sparse data regarding the impact of alcohol on in-hospital complications associated with traumatic spinal cord injuries (TSCIs). We set out to quantify the impact of alcohol on TSCI outcomes and its influence on health care cost and utilization. The National Trauma Data Bank (NTDB) Research Data Set version 7.2 (2000-2006) was utilized to gather data between 2007 and 2009. We extracted cases of TSCI (International Classification of Diseases, Ninth Revision, Clinical Modification codes 806.xx) without concurrent traumatic brain injury. Outcomes of interest were mortality, length of stay (LOS), intensive care unit (ICU) days, ventilator days, and complications. Continuous outcomes such as LOS, ICU days, and ventilator days were analyzed using linear regression. Risk-adjusted analysis of risk factors for mortality and complication rates were performed using multiple logistic regression. Of the 10,611 persons identified in the NTDB, alcohol was present in approximately one fifth of all cases (20.76%). A majority of TSCI patients were young (mean age, 39 years) Caucasian (65.07%) males (75.93%). Blunt injury was the most common mechanism of injury. The presence of alcohol did not significantly affect mortality or neurological complications. Alcohol in the blood was associated with extended LOS, longer ICU stays, more days spent ventilated, and increased risk of all-type complications. Further, there was a statistically significant association with the presence alcohol and increased risk for pulmonary, pneumonia, deep vein thrombosis and pulmonary embolism, urinary tract infection, and ulcer/skin complications. Alcohol intoxication is associated with increased in-hospital morbidity. The significant association with in-hospital complications increases health resource utilization after spinal cord injury.	[Crutcher, Clifford L., II] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr New Orleans, New Orleans, LA USA; [Ugiliweneza, Beatrice; Boakye, Maxwell] Univ Louisville, Dept Neurosurg, Louisville, KY 40202 USA; [Hodes, Jonathan E.] Baptist Hlth Ctr Adv Neurosurg, Louisville, KY USA; [Kong, Maiying] Univ Louisville, Dept Biostat & Bioinformat, Sch Publ Hlth & Informat Sci, Louisville, KY 40202 USA; [Boakye, Maxwell] Robley Rex Vet Affairs Med Ctr, Louisville, KY USA; [Boakye, Maxwell] Univ Louisville Phys, Louisville, KY USA	Boakye, M (corresponding author), Univ Louisville, Ctr Adv Neurosurg, Frazier Rehabil Inst, 220 Abraham Flexner Way,Suite 1105, Louisville, KY 40202 USA.	max.boakye@louisville.edu					Aito S, 2002, SPINAL CORD, V40, P300, DOI 10.1038/sj.sc.3101298; [Anonymous], 2007, NAT TRAUM DAT BANK V; Berlly M, 2007, J SPINAL CORD MED, V30, P309, DOI 10.1080/10790268.2007.11753946; Berry C, 2010, AM SURGEON, V76, P1067; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Burke DA, 2001, SPINAL CORD, V39, P274, DOI 10.1038/sj.sc.3101158; Clarke K, 2013, INT J QUAL HEALTH C, V25, P43, DOI 10.1093/intqhc/mzs077; Claxton AR, 1998, CAN J ANAESTH, V45, P144, DOI 10.1007/BF03013253; Curry K, 1992, J Neurosci Nurs, V24, P185; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Fayssoux RS, 2008, SPINE J, V8, P522, DOI 10.1016/j.spinee.2006.11.005; Frankel H, 2007, AM SURGEON, V73, P1215; Furlan JC, 2013, EUR J NEUROL, V20, P1101, DOI 10.1111/ene.12145; Gorman PH, 2009, J TRAUMA, V66, P707, DOI 10.1097/TA.0b013e318188beba; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Maxwell RA, 2002, J TRAUMA, V52, P902, DOI 10.1097/00005373-200205000-00013; NSCISC, 2012, SPIN CORD INJ FACTS; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Teasell RW, 2009, ARCH PHYS MED REHAB, V90, P232, DOI 10.1016/j.apmr.2008.09.557; Titsworth WL, 2012, J NEUROSURG, V116, P911, DOI 10.3171/2011.11.JNS11974; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P11, DOI 10.3171/2012.4.AOSPINE1245; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004	23	13	13	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2014	31	9					798	802		10.1089/neu.2014.3329			5	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AF6TQ	WOS:000334847900002	24617326				2021-06-18	
J	Guo, JD; Li, L; Shi, YM; Wang, HD; Yuan, YL; Shi, XX; Hou, SX				Guo, Ji-Dong; Li, Li; Shi, Ya-min; Wang, Hua-Dong; Yuan, Yan-Li; Shi, Xiu-Xiu; Hou, Shu-Xun			Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Spinal cord injury; Receptor for advanced glycation end products; Apoptosis; Inflammation; Oxidative stress; Nitrosative stress	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; NITRIC-OXIDE; APOPTOSIS; EXPRESSION; RATS; PEROXYNITRITE; INFILTRATION; CONTUSION	Spinal cord injury (SCI) results in a loss of normal motor and sensory function, leading to severe disability and reduced quality of life. The aim of this work was to investigate the effect of receptor for advanced glycation end products (RAGE) deficiency on the function recovery in a mouse model of SCI. Mice received a mid-thoracic spinal contusion injury. Upregulation of RAGE protein expression in spinal cord tissue was evident at 12 h after SCI and continued at 2 and 5 days. Furthermore, we showed that locomotor recovery was improved and lesion pathology was reduced after SCI in RAGE-deficient mice. RAGE deficiency in mice attenuated apoptosis after SCI through inhibiting p53/Bax/caspase-3 pathway. RAGE deficiency in mice inhibited inflammation after SCI, marked by reduced myeloperoxidase activity, NF kappa B nuclear translocation, and TNF-alpha, IL-1 beta, and IL-6 mRNA and protein levels. RAGE deficiency in mice exposed to SCI suppressed the upregulation of inducible nitric oxide synthase (iNOS) and gp91-phox and attenuated oxidative and nitrosative stresses, marked by reduced formation of malondialdehyde, reactive oxygen species, peroxynitrite (OONO-), and 3-nitrotyrosine. RAGE deficiency in mice exposed to SCI attenuated glial scar at the injury site, marked by decreased expression of glial fibrillary acidic protein. These data indicate that the RAGE plays an important role in the development of SCI and might provide a therapeutic target to promote recovery from SCI.	[Guo, Ji-Dong; Li, Li; Shi, Ya-min; Wang, Hua-Dong; Yuan, Yan-Li; Shi, Xiu-Xiu; Hou, Shu-Xun] Peoples Liberat Army, Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100048, Peoples R China	Hou, SX (corresponding author), Peoples Liberat Army, Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100048, Peoples R China.	houshuxun2012@hotmail.com					ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bracchi-Ricard V, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-92; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Carnevale D, 2012, HYPERTENSION, V60, P188, DOI 10.1161/HYPERTENSIONAHA.112.195511; Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001; Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Han X, 2012, NEUROSCI LETT, V511, P28, DOI 10.1016/j.neulet.2012.01.030; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kamide T, 2012, NEUROCHEM INT, V60, P220, DOI 10.1016/j.neuint.2011.12.008; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Leal-Filho Manoel Baldoino, 2011, Surg Neurol Int, V2, P112, DOI 10.4103/2152-7806.83732; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; Tang SC, 2013, ARTERIOSCL THROM VAS, V33, P585, DOI 10.1161/ATVBAHA.112.300523; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Zhou LL, 2012, KIDNEY INT, V82, P759, DOI 10.1038/ki.2012.184	42	13	14	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAY	2014	390	1-2					215	223		10.1007/s11010-014-1972-z			9	Cell Biology	Cell Biology	AE8RA	WOS:000334267800023	24526523				2021-06-18	
J	Manasse-Cohick, NJ; Shapley, KL				Manasse-Cohick, Nancy J.; Shapley, Kathy L.			Concussion Education for High School Football Players: A Pilot Study	COMMUNICATION DISORDERS QUARTERLY			English	Article						high school; cognitive impairments; exceptionalities; family/parent issues; survey; research; speech-language pathologists (SLPs)	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; HEAD-INJURY; EPIDEMIOLOGY; KNOWLEDGE	This survey study compared high school football players' knowledge and attitudes about concussion before and after receiving concussion education. There were no significant changes in the Concussion Attitude Index. Results revealed a statistically significant difference in the athletes' scores for the Concussion Knowledge Index, t(244) = 8.49, p = .000, and Cohen's d = 1.05. Concussion education can help football players learn signs, symptoms, and negative effects of mild brain injuries.	[Manasse-Cohick, Nancy J.] Calif State Univ Los Angeles, Los Angeles, CA 90032 USA; [Shapley, Kathy L.] Univ Arkansas, Little Rock, AR 72204 USA	Manasse-Cohick, NJ (corresponding author), Calif State Univ Los Angeles, Dept Commun Disorders, 5151 State Univ Dr, Los Angeles, CA 90032 USA.	ncohick@calstatela.edu					Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Center for Disease Control and Prevention, 2013, GET HEADS CONC SPORT; Center for Disease Control and Prevention, 2012, HEADS CONC; Centers for Disease Control and Prevention, 2011, NONF TRAUM BRAIN INJ; Clinic Mayo, 2011, POST CONCUSSION SYND; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LIVINGSTON SC, 2004, J ATHL TRAINING, V39, pS17; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2008, MILD TRAUMATIC BRAIN; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	16	13	13	1	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1525-7401	1538-4837		COMMUN DISORD Q	Comm. Disord. Q.	MAY	2014	35	3					182	185		10.1177/1525740113506605			4	Linguistics; Rehabilitation	Linguistics; Rehabilitation	AL7SP	WOS:000339335800006					2021-06-18	
J	McKinlay, A; Ligteringen, V; Than, M				McKinlay, Audrey; Ligteringen, Veronica; Than, Martin			A Comparison of Concussive Symptoms Reported by Parents for Preschool Versus School-Aged Children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						school age; preschool; mild traumatic brain injury; concussive symptoms	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; BIRTH COHORT; IDENTIFICATION; IMPAIRMENT; CHILDHOOD; AGREEMENT; COUNTY; SELF	Objective: To compare parental report of symptoms of concussion for children with superficial head injury versus children with a diagnosis of a mild traumatic brain injury (mTBI). Setting: Urban hospital emergency department. Participants: Parents of 159 children aged 2 to 12 years who presented with an injury to the head. Procedure: Parents were contacted within 1 week of injury and assigned into 3 groups according to their child's age and medical diagnosis (group 1, parents of 2- to 5-year-olds with mTBI (n = 39); group 2, parents of 6- to 12-year-olds with mTBI (n = 41); and group 3, parents of 2- to 12-year-olds with superficial injury to the head (n = 35). Results: Symptoms of concussion were reported in all groups; however, significantly fewer symptoms were reported for children with superficial injuries to the head than for children with mTBI (M = 2.51 vs M = 6.91; P < .001). For mTBI, parents of younger children reported significantly fewer symptoms than parents of older children (M = 5.23 vs M = 8.51; P < .001). Conclusions: A careful approach needs to be taken when evaluating the severity of mTBI for preschool children. Failure to do so may result in misidentification and subsequent lack of management.	[McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [McKinlay, Audrey] Univ Canterbury, Christchurch 1, New Zealand; [Ligteringen, Veronica] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Than, Martin] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand	McKinlay, A (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus, Melbourne, Vic 3800, Australia.	audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council/Accident Compensation Corporation of New Zealand	Dr McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand.	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; HOLM S, 1979, SCAND J STAT, V6, P65; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klassen AF, 2006, CHILD CARE HLTH DEV, V32, P397, DOI 10.1111/j.1365-2214.2006.00609.x; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Lagattuta KH, 2012, J EXP CHILD PSYCHOL, V113, P211, DOI 10.1016/j.jecp.2012.04.001; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Sciberras E, 2011, J ATTEN DISORD, V15, P321, DOI 10.1177/1087054710361671; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Wiebe DJ, 2012, PEDIATR EMERG CARE, V28, P498, DOI 10.1097/PEC.0b013e3182586f76; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	24	13	13	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					233	238		10.1097/HTR.0b013e3182a2dd7f			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100011	23982792				2021-06-18	
J	Olson-Madden, JH; Homaifar, BY; Hostetter, TA; Matarazzo, BB; Huggins, J; Forster, JE; Schneider, AL; Nagamoto, HT; Corrigan, JD; Brenner, LA				Olson-Madden, Jennifer H.; Homaifar, Beeta Y.; Hostetter, Trisha A.; Matarazzo, Bridget B.; Huggins, Joe; Forster, Jeri E.; Schneider, Alexandra L.; Nagamoto, Herbert T.; Corrigan, John D.; Brenner, Lisa A.			Validating the Traumatic Brain Injury-4 Screening Measure for Veterans Seeking Mental Health Treatment With Psychiatric Inpatient and Outpatient Service Utilization Data	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Hospitalization; Mental health; Rehabilitation; Utilization [subheading]	IDENTIFICATION; PREDICTORS; TBI	Objective: To determine whether a positive screen on the Traumatic Brain Injury-4 (TBI-4) can be used to identify veterans who use more inpatient and outpatient mental health services. Design: Validation cohort. Setting: Medical center. Participants: Individuals seeking Veterans Health Administration mental health services (N=1493). Interventions: Not applicable. Main Outcome Measures: One year of inpatient and outpatient mental health utilization data after the TBI-4 screen date. Results: In the year postmental health intake, those who answered positively to any of the 4 TBI-4 screening questions (criterion 1) or question 2 (criterion 2; ever having been knocked out) had significantly more psychiatric hospitalizations than those who met neither criterion. Those who were positive by criterion 2 also had significantly fewer outpatient mental health contacts. Conclusions: Veterans screening positive for history of traumatic brain injury on the TBI-4 had more hospital stays in the year postmental health intake. Those who reported having been knocked out also had fewer outpatient mental health visits. These findings may suggest an overall relation in this population between greater needs for mental health care and likelihood of prior injury. For those with a history of loss of consciousness, the reduced use of outpatient care may reflect greater problems engaging in treatment or with preventive aspects of the health care system during non-crisis periods. Using a screener (eg, the TBI-4) could facilitate identification of veterans who might benefit from targeted and intensive outpatient interventions to avoid frequent inpatient psychiatric hospitalization. (C) 2014 by the American Congress of Rehabilitation Medicine	[Olson-Madden, Jennifer H.; Homaifar, Beeta Y.; Hostetter, Trisha A.; Matarazzo, Bridget B.; Huggins, Joe; Forster, Jeri E.; Schneider, Alexandra L.; Brenner, Lisa A.] Vet Affairs Eastern Colorado Hlth Care Syst, Educ & Clin Ctr, VISN Mental Illness Res 19, Denver, CO 80220 USA; [Olson-Madden, Jennifer H.; Homaifar, Beeta Y.; Matarazzo, Bridget B.; Nagamoto, Herbert T.; Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Aurora, CO USA; [Forster, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Nagamoto, Herbert T.] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Rehabil & Neurol, Aurora, CO USA	Olson-Madden, JH (corresponding author), Vet Affairs Eastern Colorado Hlth Care Syst, Educ & Clin Ctr, VISN Mental Illness Res 19, 1055 Clermont St, Denver, CO 80220 USA.	Jennifer.Olson-Madden@va.gov	Brenner, Lisa A./AAG-2442-2019	Huggins, Joe/0000-0001-8151-5062	Colorado Traumatic Brain Injury Trust Fund Program; VISN 19 Mental Illness Research, Education and Clinical Center	Supported by the Colorado Traumatic Brain Injury Trust Fund Program and the VISN 19 Mental Illness Research, Education and Clinical Center.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Centers for Disease Control and Prevention, FASTSTATS; Corrigan JD, 2007, OHIO STATE U TBI IDE; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Fasoli DR, 2010, MED CARE, V48, P288, DOI 10.1097/MLR.0b013e3181cafbe3; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Klinkenberg WD, 1998, ADM POLICY MENT HLTH, V25, P403, DOI 10.1023/A:1022292407868; Lien L, 2002, NORD J PSYCHIAT, V56, P23, DOI 10.1080/08039480252803873; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002	14	13	13	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2014	95	5					925	929		10.1016/j.apmr.2014.01.008			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AG3CW	WOS:000335294400018	24480334				2021-06-18	
J	Schaefer, JH; Leung, WD; Wu, LM; Van Cott, EM; Lok, J; Whalen, M; van Leyen, K; Lauer, A; van Ryn, J; Lo, EH; Foerch, C				Schaefer, Jan Hendrik; Leung, Wendy; Wu, Limin; Van Cott, Elizabeth M.; Lok, Josephine; Whalen, Michael; van Leyen, Klaus; Lauer, Arne; van Ryn, Joanne; Lo, Eng H.; Foerch, Christian			Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						anticoagulation; dabigatran; intracerebral hemorrhage; novel oral anticoagulants; traumatic brain injury; warfarin	THROMBIN INHIBITOR DABIGATRAN; RE-LY TRIAL; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; FACTOR-XA INHIBITORS; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; ORAL THROMBIN; MICE; COMPLICATIONS; MANAGEMENT	To date, only limited data are available on the effects of pretreatment with novel oral anticoagulants in the event of traumatic brain injury (TBI). We determined intracerebral hemorrhage volume and functional outcome in a standardized TBI model in mice treated with warfarin or dabigatran. Additionally, we investigated whether excess concentrations of dabigatran could increase bleeding and whether this was preventable by using prothrombin complex concentrate (PCC). C57 mice were treated orally with warfarin or dabigatran; sham-treated mice served as controls. Effective anticoagulation was verified by measurement of international normalized ratio and diluted thrombin time, and TBI was induced by controlled cortical impact (CCI). Twenty-four hours after CCI, intracerebral hemorrhage volume was larger in warfarin-pretreated mice than in controls (10.1 +/- 4.9 vs 4.1 +/- 1.7 mu L; analysis of variance post hoc P=0.001), but no difference was found between controls and dabigatran-pretreated mice (5.3 +/- 1.5 mu L). PCC applied 30 minutes after CCI did not reliably reduce intracerebral hemorrhage induced by excess dabigatran concentration compared with saline (10.4 +/- 11.2 vs 8.7 +/- 7.1 mu L). Our data suggest pathophysiological differences in TBI occurring during warfarin and dabigatran anticoagulation. The reduced hemorrhage formation under dabigatran therapy could present a safety advantage compared with warfarin. An excess dabigatran concentration, however, can increase hemorrhage.	[Schaefer, Jan Hendrik; Lauer, Arne; Foerch, Christian] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; [Schaefer, Jan Hendrik; Leung, Wendy; Wu, Limin; Lok, Josephine; van Leyen, Klaus; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA USA; [Wu, Limin] Jilin Univ, Bethune Hosp 1, Dept Neurol, Changchun 130023, Peoples R China; [Van Cott, Elizabeth M.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lok, Josephine; Whalen, Michael] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Whalen, Michael] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci, Boston, MA USA; [van Ryn, Joanne] Boehringer Ingelheim GmbH & Co KG, CardioMetab Dis Res, Biberach, Germany	Schaefer, JH (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	jhs@stud.uni-frankfurt.de	van Leyen, Klaus/C-9126-2013	van Leyen, Klaus/0000-0003-1032-3754; /0000-0002-9465-3533	Boehringer IngelheimBoehringer Ingelheim; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS057339, R01NS076694, R37NS037074, P01NS055104, R01NS049430] Funding Source: NIH RePORTER	This study was supported by Boehringer Ingelheim with a restricted grant.	Awad AJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1323; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; Chen BC, 2012, CLIN TOXICOL, V50, P854, DOI 10.3109/15563650.2012.721888; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Foerch C, 2012, J NEUROTRAUM, V29, P1150, DOI 10.1089/neu.2011.2104; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Lauer A, 2013, LANCET NEUROL, V12, P394, DOI 10.1016/S1474-4422(13)70049-8; Lauer A, 2011, CIRCULATION, V124, P1654, DOI 10.1161/CIRCULATIONAHA.111.035972; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Love JE, 2007, THROMB HAEMOSTASIS, V98, P234, DOI 10.1160/TH06-10-0607; PARRA MW, 2013, J NEUROSURG, P1; Pernod G, 2013, ARCH CARDIOVASC DIS, V106, P382, DOI 10.1016/j.acvd.2013.04.009; Pfeilschifter W, 2011, STROKE, V42, P1116, DOI 10.1161/STROKEAHA.110.604652; Pragst I, 2012, J THROMB HAEMOST, V10, P1841, DOI 10.1111/j.1538-7836.2012.04859.x; Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f; Weitz JI, 2012, CIRCULATION, V126, P2428, DOI 10.1161/CIRCULATIONAHA.112.123224; Zhou W, 2011, STROKE, V42, P3594, DOI 10.1161/STROKEAHA.111.624650	25	13	13	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2014	34	5					870	875		10.1038/jcbfm.2014.31			6	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AG5AE	WOS:000335430700018	24549187	Green Published, Bronze			2021-06-18	
J	Wessel, L; Balakrishnan-Renuka, A; Henkel, C; Meyer, HE; Meller, K; Brand-Saberi, B; Theiss, C				Wessel, Lisa; Balakrishnan-Renuka, Ajeesh; Henkel, Corinna; Meyer, Helmut E.; Meller, Karl; Brand-Saberi, Beate; Theiss, Carsten			Long-term incubation with mifepristone (MLTI) increases the spine density in developing Purkinje cells: new insights into progesterone receptor mechanisms	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Confocal laser scanning microscopy; Electron microscopy; Neuronal development; Microinjection; MALDI IMS; Organotypic slice cultures; PGRMC1; AG 205; Trilostane	TRAUMATIC BRAIN-INJURY; BINDING-PROTEIN 25-DX; SYNTHESIZED DE-NOVO; DENDRITIC GROWTH; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; POSTNATAL-DEVELOPMENT; REGULATED KINASE; RAT; EXPRESSION; BIOSYNTHESIS	Cerebellar Purkinje cells (PC) physiologically reveal an age-dependent expression of progesterone with high endogenous concentrations during the neonatal period. Even if progesterone has been previously shown to induce spinogenesis, dendritogenesis and synaptogenesis in immature PC, data about the effects of progesterone on mature PC are missing, even though they could be of significant therapeutic interest. The current study demonstrates for the first time a progesterone effect, depending on the developmental age of PC. Comparable with the physiological course of the progesterone concentration, experimental treatment with progesterone for 24 h achieves the highest effects on the dendritic tree during the early neonate, inducing an highly significant increase in dendritic length, spine number and spine area, while spine density in mature PC could not be further stimulated by progesterone incubation. Observed progesterone effects are certainly mediated by classical progesterone receptors, as spine area and number were comparable to controls when progesterone incubation was combined with mifepristone (incubation for 24 h), an antagonist of progesterone receptors A and B (PR-A/PR-B). In contrast, an increase in the spine number and area of both immature and mature PC was detected when slice cultures were incubated with mifepristone for more than 72 h (mifepristone long-time incubation, MLTI). By including time-lapse microscopy, electron microscopic techniques, PCR, western blot, and MALDI IMS receptor analysis, as well as specific antagonists like trilostane and AG 205, we were able to detect the underlying mechanism of this diverging mifepristone effect. Thus, our results provide new insights into the function and signaling mechanisms of the recently described progesterone receptor membrane component 1 (PGRMC1) in PC. It is highly suitable that progesterone does not just induce effects by the well-known genomic mechanisms of the classical progesterone receptors but also acts through PGRMC1 mediated non-genomic mechanisms. Thus, our results provide first proofs for a previously discussed progesterone-dependent induction of neurosteroidogenesis in PC by interaction with PGRMC1. But while genomic progesterone effects mediated through classical PR-A and PR-B seem to be restricted to the neonatal period of PC, PGRMC1 also transmits signals by non-genomic mechanisms like regulation of the neurosteroidogenesis in mature PC. Thus, PGRMC1 might be an interesting target for future clinical studies and therapeutic interventions.	[Wessel, Lisa; Balakrishnan-Renuka, Ajeesh; Brand-Saberi, Beate; Theiss, Carsten] Ruhr Univ Bochum, Inst Anat & Mol Embryol, D-44780 Bochum, Germany; [Henkel, Corinna; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; [Meller, Karl; Theiss, Carsten] Ruhr Univ Bochum, Inst Anat, Fac Med, Dept Cytol, D-44780 Bochum, Germany	Theiss, C (corresponding author), Ruhr Univ Bochum, Inst Anat, Fac Med, Dept Cytol, Univ Str 150, D-44780 Bochum, Germany.	carsten.theiss@rub.de			PURE (Protein-research Unit Ruhr within Europe)	The authors gratefully thank C. Grzelak, A. Lodwig, H.- T. Nguyen and J. Elm for excellent technical assistance, as well as A. Lenz for secretarial work. C. Henkel was supported by PURE (Protein-research Unit Ruhr within Europe).	AHIMA RS, 1992, P SOC EXP BIOL MED, V201, P244; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BERRY M, 1976, BRAIN RES, V112, P1, DOI 10.1016/0006-8993(76)90331-0; BERTAGNA X, 1984, J CLIN ENDOCR METAB, V59, P25, DOI 10.1210/jcem-59-1-25; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cadepond F, 1997, ANNU REV MED, V48, P129; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; COMPAGNONE NA, 1995, ENDOCRINOLOGY, V136, P5212, DOI 10.1210/en.136.11.5212; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Furukawa A, 1998, J NEUROCHEM, V71, P2231; GAILLARD RC, 1984, P NATL ACAD SCI-BIOL, V81, P3879, DOI 10.1073/pnas.81.12.3879; Ghoumari AM, 2003, P NATL ACAD SCI USA, V100, P7953, DOI 10.1073/pnas.1332667100; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Kimura I, 2008, J BIOL CHEM, V283, P4323, DOI 10.1074/jbc.M706679200; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; LAIRD SM, 1988, ACTA ENDOCRINOL-COP, V119, P420, DOI 10.1530/acta.0.1190420; LAWSON A, 1992, NEUROENDOCRINOLOGY, V55, P695, DOI 10.1159/000126189; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Maloney SE, 2011, BEHAV SCI-BASEL, V1, P4, DOI 10.3390/behavsci1010004; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meller K, 2005, DEV BRAIN RES, V160, P101, DOI 10.1016/j.devbrainres.2005.08.007; MELLER K, 1989, CELL TISSUE RES, V256, P283; MELLON SH, 1993, BRAIN RES, V629, P283, DOI 10.1016/0006-8993(93)91332-M; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; ROBEL P, 1985, NEUROCHEM INT, V7, P953, DOI 10.1016/0197-0186(85)90143-3; Runko E, 2002, J COMP NEUROL, V451, P289, DOI 10.1002/cne.10356; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Sakamoto H, 2003, NEUROSCI LETT, V343, P163, DOI 10.1016/S0304-9340(03)000362-8; Sakamoto H, 2002, NEUROSCI LETT, V322, P111, DOI 10.1016/S0304-3940(02)00077-0; Sakamoto H, 2001, J NEUROSCI, V21, P6221; Sakamoto H, 2008, CEREBELLUM, V7, P18, DOI 10.1007/s12311-008-0007-2; Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Theiss C, 2005, EUR J CELL BIOL, V84, P29, DOI 10.1016/j.ejcb.2004.09.001; Theiss C, 2010, MICROSCOPY SCI TECHN, P1091; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Tsutsui K, 2000, NEUROSCI RES, V36, P261, DOI 10.1016/S0168-0102(99)00132-7; Tsutsui K, 2006, CEREBELLUM, V5, P89, DOI 10.1080/14734220600697211; Ukena K, 1998, ENDOCRINOLOGY, V139, P137, DOI 10.1210/en.139.1.137; Ukena K, 1999, ENDOCRINOLOGY, V140, P805, DOI 10.1210/en.140.2.805; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	57	13	15	0	6	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	MAY	2014	71	9					1723	1740		10.1007/s00018-013-1448-4			18	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AF0RM	WOS:000334421700010	23982753				2021-06-18	
J	Erenberk, U; Dundaroz, R; Gok, O; Uysal, O; Agus, S; Yuksel, A; Yilmaz, B; Kilic, U				Erenberk, Ufuk; Dundaroz, Rusen; Gok, Ozlem; Uysal, Omer; Agus, Sami; Yuksel, Adnan; Yilmaz, Bayram; Kilic, Ulkan			Melatonin attenuates phenytoin sodium-induced DNA damage	DRUG AND CHEMICAL TOXICOLOGY			English	Article						Antioxidants; DNA damage; melatonin; oxidative stress; phenytoin sodium; rat	CISPLATIN-INDUCED NEPHROTOXICITY; FOCAL CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; REACTIVE OXYGEN; IN-VITRO; PROTECTS; METABOLITE; CATALASE; REPAIR	Phenytoin sodium (PHT Na+) is a potent antiepileptic drug against epileptic seizures and is used as a prophylactic treatment in traumatic brain injury. PHT Na+ leads to the formation of reactive oxygen species (ROS), and DNA is a crucial molecular target of ROS-initiated toxicity. Melatonin and its metabolites possess free-radical-scavenging activity. We therefore designed this study to investigate the potential protective effect of melatonin against PHT Na+-induced DNA damage by using the comet assay in a rat model in vivo. Thirty-three 3-month-old male Wistar rats were divided into five groups of control treated with isotonic sodium chloride (a single injection of isotonic sodium chloride and 100 mL in drinking water for 10 days), ethanol treated (in drinking water for 10 days containing 100 mL of ethanol in each 300-mL drinking bottle), melatonin treated (4 mg/kg body weight [b.w.] intraperitoneally [i.p.] at the start, in drinking water for 10 days), PHT Na+ treated (a single i.p. injection of 50 mg/kg) and PHT Na+ (50 mg/kg b.w., single i.p.) and melatonin (4 mg/kg b.w. i.p. at the start and 4 mg/kg in drinking water for 10 days) cotreated. To determine the protective effects of melatonin, the comet assay was performed using lymphocytes isolated in different time intervals (0, 15, 30, 45 and 60 minutes) from each group of animals. On days 1, 3, 7 and 10, blood samples were taken and the comet assay technique was performed. Our present data suggest that melatonin reversed PHT Na+-induced DNA damage.	[Erenberk, Ufuk; Dundaroz, Rusen] Bezmialem Vakif Univ, Dept Pediat, Istanbul, Turkey; [Gok, Ozlem; Agus, Sami; Kilic, Ulkan] Bezmialem Vakif Univ, Dept Med Biol, Istanbul, Turkey; [Uysal, Omer] Bezmialem Vakif Univ, Fac Med, Dept Biostat, Istanbul, Turkey; [Yuksel, Adnan] Istanbul Univ, Fac Med, Dept Med Genet, Istanbul, Turkey; [Yilmaz, Bayram] Yeditepe Univ, Fac Med, Dept Physiol, Istanbul, Turkey	Kilic, U (corresponding author), Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Adnan Menderes Bulvari Vatan Caddesi, TR-34093 Fatih Istanbul, Turkey.	uckilic@yahoo.com	Uysal, Omer/AAR-4220-2020	Uysal, Omer/0000-0002-8833-697X; Yuksel, Adnan/0000-0002-7275-8254	Scientific and Technological Research Council of TurkeyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [TUBITAK/SBAG 11S418]	This work was supported partially by The Scientific and Technological Research Council of Turkey (TUBITAK/SBAG 11S418).	AMES BN, 1993, ENVIRON HEALTH PERSP, V101, P35, DOI 10.2307/3431840; Bhuller Y, 2006, TOXICOL SCI, V93, P156, DOI 10.1093/toxsci/kfl045; Bhuller Y, 2006, TOXICOL SCI, V93, P146, DOI 10.1093/toxsci/kfl022; Bittigau P, 2003, ANN NY ACAD SCI, V993, P103, DOI 10.1111/j.1749-6632.2003.tb07517.x; Cheung RTF, 2006, J PINEAL RES, V41, P337, DOI 10.1111/j.1600-079X.2006.00372.x; Collins A, 1997, ENVIRON MOL MUTAGEN, V30, P139, DOI 10.1002/(SICI)1098-2280(1997)30:2<139::AID-EM6>3.0.CO;2-I; Dziegiel P, 2002, J PINEAL RES, V33, P95, DOI 10.1034/j.1600-079X.2002.02902.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gitto E, 2001, PEDIATR RES, V50, P756, DOI 10.1203/00006450-200112000-00021; Gitto E, 2001, J PHARM PHARMACOL, V53, P1393, DOI 10.1211/0022357011777747; Hamed SA, 2004, J PHARMACOL SCI, V96, P465, DOI 10.1254/jphs.FPJ04032X; Hara M, 2001, J PINEAL RES, V30, P129, DOI 10.1034/j.1600-079X.2001.300301.x; Hardeland R, 2007, J PINEAL RES, V43, P382, DOI 10.1111/j.1600-079X.2007.00489.x; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Katz I, 2007, J PHARMACOL EXP THER, V322, P494, DOI 10.1124/jpet.107.123133; Kaul A, 2001, TERATOGEN CARCIN MUT, V21, P151, DOI 10.1002/1520-6866(2001)21:2<151::AID-TCM4>3.3.CO;2-5; Kilic E, 2004, J PINEAL RES, V37, P247, DOI 10.1111/j.1600-079X.2004.00162.x; Kilic U, 2005, J PINEAL RES, V38, P67, DOI 10.1111/j.1600-079X.2004.00178.x; Kilic U, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-7; Kilic U, 2012, J PINEAL RES, V52, P228, DOI 10.1111/j.1600-079X.2011.00932.x; Kim PM, 1997, J PHARMACOL EXP THER, V280, P200; Kopjar Nevenka, 2006, Arhiv za Higijenu Rada i Toksikologiju, V57, P155; Lialiaris T, 2008, MUTAGENESIS, V23, P347, DOI 10.1093/mutage/gen020; Lovell DP, 2008, MUTAGENESIS, V23, P171, DOI 10.1093/mutage/gen015; Lowenstein DH, 1998, HARRISONS PRINCIPLES, P2315; Mahle C, 1997, LIFE SCI, V61, P437, DOI 10.1016/S0024-3205(97)00401-3; Manda K, 2007, J PINEAL RES, V42, P386, DOI 10.1111/j.1600-079X.2007.00432.x; Mayo JC, 2003, FREE RADICAL RES, V37, P543, DOI 10.1080/1071576031000083206; Murray JC, 1996, J PEDIAT HEMATOL ONC, V18, P241, DOI 10.1097/00043426-199605000-00033; Nava M, 2000, AM J PHYSIOL-RENAL, V279, pF910; Ortiz GG, 2008, CURR NEUROPHARMACOL, V6, P203, DOI 10.2174/157015908785777201; Pei Z, 2002, J PINEAL RES, V32, P168, DOI 10.1034/j.1600-079x.2002.1o847.x; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Reiter RJ, 2002, J PHARM PHARMACOL, V54, P1299, DOI 10.1211/002235702760345374; Reiter RJ, 2005, EXP BIOL MED, V230, P104; Reiter RJ, 2003, ADV EXP MED BIOL, V527, P539; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Reiter RJ, 2009, CRIT REV BIOCHEM MOL, V44, P175, DOI 10.1080/10409230903044914; Sandal S, 2008, MUTAT RES-GEN TOX EN, V654, P88, DOI 10.1016/j.mrgentox.2008.05.005; Sener G, 2002, J PINEAL RES, V32, P231, DOI 10.1034/j.1600-079X.2002.01858.x; Singh G, 2005, BRAIN, V128, P7, DOI 10.1093/brain/awh363; Sun FY, 2002, J PINEAL RES, V33, P48, DOI 10.1034/j.1600-079X.2002.01891.x; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Ustundag A, 2007, BIOL TRACE ELEM RES, V117, P53, DOI 10.1007/BF02698083; Urata Y, 1999, FREE RADICAL BIO MED, V27, P838, DOI 10.1016/S0891-5849(99)00131-8; Wells PG, 2010, BIRTH DEFECTS RES C, V90, P103, DOI 10.1002/bdrc.20177; Wells PG, 1997, COMPREHENSIVE TOXICO, P479; Winn LM, 2003, J PHARMACOL EXP THER, V306, P523, DOI 10.1124/jpet.103.052639; Winn LM, 1999, FREE RADICAL BIO MED, V26, P266, DOI 10.1016/S0891-5849(98)00193-2; WINN LM, 1995, MOL PHARMACOL, V48, P112	50	13	13	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0148-0545	1525-6014		DRUG CHEM TOXICOL	Drug Chem. Toxicol.	APR	2014	37	2					233	239		10.3109/01480545.2013.838777			7	Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology	Chemistry; Pharmacology & Pharmacy; Toxicology	AB8IZ	WOS:000332034900016	24171672				2021-06-18	
J	Narotam, PK; Morrison, JF; Schmidt, MD; Nathoo, N				Narotam, Pradeep K.; Morrison, John F.; Schmidt, Michael D.; Nathoo, Narendra			Physiological Complexity of Acute Traumatic Brain Injury in Patients Treated with a Brain Oxygen Protocol: Utility of Symbolic Regression in Predictive Modeling of a Dynamical System	JOURNAL OF NEUROTRAUMA			English	Article						intracranial pressure, symbolic regression in biologic systems; brain oxygen; complexity science; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; MAXIMUM-ENTROPY PRODUCTION; TISSUE OXYGEN; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; LUNG INJURY; REGIONAL OXYGENATION; CLINICAL ARTICLE; INSPIRED OXYGEN	Predictive modeling of emergent behavior, inherent to complex physiological systems, requires the analysis of large complex clinical data streams currently being generated in the intensive care unit. Brain tissue oxygen protocols have yielded outcome benefits in traumatic brain injury (TBI), but the critical physiological thresholds for low brain oxygen have not been established for a dynamical patho-physiological system. High frequency, multi-modal clinical data sets from 29 patients with severe TBI who underwent multi-modality neuro-clinical care monitoring and treatment with a brain oxygen protocol were analyzed. The inter-relationship between acute physiological parameters was determined using symbolic regression (SR) as the computational framework. The mean patient age was 44.4 +/- 15 with a mean admission GCS of 6.6 +/- 3.9. Sixty-three percent sustained motor vehicle accidents and the most common pathology was intra-cerebral hemorrhage (50%). Hospital discharge mortality was 21%, poor outcome occurred in 24% of patients, and good outcome occurred in 56% of patients. Criticality for low brain oxygen was intracranial pressure (ICP) >= 22.8 mm Hg, for mortality at ICP >= 37.1 mm Hg. The upper therapeutic threshold for cerebral perfusion pressure (CPP) was 75 mm Hg. Eubaric hyperoxia significantly impacted partial pressure of oxygen in brain tissue (PbtO(2)) at all ICP levels. Optimal brain temperature (T-br) was 34-35 degrees C, with an adverse effect when T-br >= 38 degrees C. Survivors clustered at \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm PbtO}_2\, \cong\, 25 { \rm mm}$$\end{document} Hg vs. non-survivors \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$$\cong $$\end{document} 18 mm Hg. There were two mortality clusters for ICP: High ICP/low PbtO(2) and low ICP/low PbtO(2). Survivors maintained PbtO(2) at all ranges of mean arterial pressure in contrast to non-survivors. The final SR equation for cerebral oxygenation is: \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$$PbtO_ {2} = 6.32774 + \cos ( - 12.9753*CPP ) + \frac {23.2796} {FiO_ {2}} - 1.32622*ICP$$\end{document}. The SR-model of acute TBI advances new physiological thresholds or boundary conditions for acute TBI management: PbtO(2)>= 25 mmHg; ICP <= 22 mmHg; CPP approximate to 60-75 mmHg; and T-br approximate to 34-37 degrees C. SR is congruous with the emerging field of complexity science in the modeling of dynamical physiological systems, especially during pathophysiological states. The SR model of TBI is generalizable to known physical laws. This increase in entropy reduces uncertainty and improves predictive capacity. SR is an appropriate computational framework to enable future smart monitoring devices.	[Narotam, Pradeep K.] Union Hosp Neurosci, Terre Haute, IN 47807 USA; [Morrison, John F.] Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Schmidt, Michael D.] Nutonian Inc, Cambridge, MA USA; [Schmidt, Michael D.] Cornell Univ, Fac Engn & Comp Sci, Ithaca, NY USA; [Nathoo, Narendra] Med Ctr, Bowling Green, KY USA; [Narotam, Pradeep K.; Morrison, John F.; Nathoo, Narendra] Creighton Univ, Med Ctr, Div Neurosurg, Omaha, NE USA	Narotam, PK (corresponding author), Union Hosp Neurosci, 1530 N 7th St,500, Terre Haute, IN 47807 USA.	narotam@mac.com	Viani, Rafael/V-1196-2018				Al-Rawi PG, 2000, ZBL NEUROCHIR, V61, P74, DOI 10.1055/s-2000-8263; Aldrich HE, 2008, J EVOL ECON, V18, P577, DOI 10.1007/s00191-008-0110-z; Anderson J.R., 1983, ARCHITECTURE COGNITI; Andrews P, 2003, BRIT J ANAESTH, V90, P251, DOI 10.1093/bja/aeg517; Andrews PJD, 2005, CRIT CARE, V9, P638, DOI 10.1186/cc3922; Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; Antoniewicz MR, 2006, METABOLOMICS, V2, P41, DOI 10.1007/s11306-006-0018-2; Bardt TF, 1998, ACT NEUR S, V71, P153; Bardt TF, 1998, ACTA NEUROCHIR, V140, P357, DOI 10.1007/s007010050109; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; Bruzzone P, 1998, ACT NEUR S, V71, P111; Bullock MR, 2003, J NEUROSURG, V98, P943, DOI 10.3171/jns.2003.98.5.0943; Burggren WW, 2005, J EXP BIOL, V208, P3221, DOI 10.1242/jeb.01762; Carvalho C R, 1998, Curr Opin Pulm Med, V4, P300, DOI 10.1097/00063198-199809000-00010; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; CRUZ J, 1993, CRIT CARE MED, V21, P1242, DOI 10.1097/00003246-199308000-00027; DELOSSANTOS R, 1987, AM REV RESPIR DIS, V136, P657, DOI 10.1164/ajrccm/136.3.657; Dewar R, 2003, J PHYS A-MATH GEN, V36, P631, DOI 10.1088/0305-4470/36/3/303; DEWAR RC, 2005, NONEQUILIBRIUM THERM; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Duffy J., 2002, EVOLUTIONARY COMPUTA, P461; Dyke J, 2010, ENTROPY-SWITZ, V12, P613, DOI 10.3390/e12030613; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Garat C, 1997, CHEST, V111, P1381, DOI 10.1378/chest.111.5.1381; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hii C., 2011, INT J MACH LEARN COM, V1, P30, DOI DOI 10.7763/IJMLC.2011.V1.5; Hodgson Geoffrey M., 2008, Journal of Bioeconomics, V10, P51, DOI 10.1007/s10818-008-9030-0; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Jenkinson S G, 1993, New Horiz, V1, P504; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 2003, BRIT J NEUROSURG, V17, P311, DOI 10.1080/02688690310001601199; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Koza JR., 1992, GENETIC PROGRAMMING; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Longhi L, 2002, ACT NEUR S, V81, P315; Longhi Luca, 2004, Curr Opin Crit Care, V10, P105, DOI 10.1097/00075198-200404000-00005; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Manson SM, 2001, GEOFORUM, V32, P405, DOI 10.1016/S0016-7185(00)00035-X; MARSHALL LF, 1987, J NEUROSURG, V67, P952; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McKinley BA, 2002, J TRAUMA, V53, P825, DOI 10.1097/00005373-200211000-00004; McKinley Bruce A, 2003, Curr Opin Crit Care, V9, P292, DOI 10.1097/00075198-200308000-00007; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; NaderDjalal N, 1997, CHEST, V112, P1607, DOI 10.1378/chest.112.6.1607; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Narotam PK, 2008, J NEUROSURG, V109, P1065, DOI 10.3171/JNS.2008.109.12.1065; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; POPPER KR, 1963, CONJECTURE REFUTATIO; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Rebitzer JB, 2008, ADV HEALTH ECON HEAL, V19, P43, DOI 10.1016/S0731-2199(08)19003-3; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; SMITH RA, 1990, CRIT CARE MED, V18, P198, DOI 10.1097/00003246-199002000-00014; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 1998, ACT NEUR S, V71, P162; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; van den Brink WA, 1998, ACT NEUR S, V71, P190; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vanga S. R., 2013, AM J THER IN PRESS; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vath A, 2001, NEUROL RES, V23, P315, DOI 10.1179/016164101101198677; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Waite Gabi N, 2012, Biomed Sci Instrum, V48, P462; Zhi DS, 1999, SURG NEUROL, V52, P393, DOI 10.1016/S0090-3019(99)00101-9	90	13	13	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					630	641		10.1089/neu.2013.3104			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000004	24195645				2021-06-18	
J	Sivaswamy, L				Sivaswamy, Lalitha			Approach to Acute Ataxia in Childhood: Diagnosis and Evaluation	PEDIATRIC ANNALS			English	Article							BENIGN PAROXYSMAL VERTIGO; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE CEREBELLAR-ATAXIA; ACUTE OTITIS-MEDIA; CHILDREN; COMPLICATIONS; FEATURES	Ataxia refers to motor incoordination that is usually most prominent during movement or when a child is attempting to maintain a sitting posture. The first part of the review focuses on the anatomic localization of ataxia - both within the nervous system and without - using a combination of historical features and physical findings. The remainder of the review discusses etiological considerations that vary depending on the age group under consideration. In infancy, certain specific diseases, such as opsoclonus myoclonus ataxia syndrome, must receive special mention because the underlying disease process may be amenable to surgical intervention. In the toddler- and school-age groups, certain conditions (such as stroke and acute cerebellitis) require immediate recognition and imaging, whereas others (such as post-infectious ataxia and concussion) require close follow-up. Finally, mention must be made of diseases outside of the central nervous system that can present with ataxia, such as Guillain-Barre syndrome.	[Sivaswamy, Lalitha] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Sivaswamy, Lalitha] Childrens Hosp Michigan, Headache Clin, Detroit, MI USA	Sivaswamy, L (corresponding author), Wayne State Univ, Sch Med, Childrens Hosp Michigan, Dept Neurol, 3901 Beaubien, Detroit, MI 48201 USA.	lsivaswamy@med.wayne.edu					Adams C, 2000, CAN J NEUROL SCI, V27, P316, DOI 10.1017/S0317167100001074; Banwell B, 2007, LANCET NEUROL, V6, P887, DOI 10.1016/S1474-4422(07)70242-9; BASSER LS, 1964, BRAIN, V87, P141, DOI 10.1093/brain/87.1.141; Bigi S, 2012, J CHILD NEUROL, V27, P1378, DOI 10.1177/0883073812452784; BRADSHAW DY, 1992, MUSCLE NERVE, V15, P500, DOI 10.1002/mus.880150415; Brazis PW, 2001, LOCALIZATION CLIN NE, P309; Cuvellier JC, 2010, PEDIATR NEUROL, V42, P1, DOI 10.1016/j.pediatrneurol.2009.07.001; Desai J, 2012, J CHILD NEUROL, V27, P1482, DOI 10.1177/0883073812450318; Edlow JA, 2008, LANCET NEUROL, V7, P951, DOI 10.1016/S1474-4422(08)70216-3; Fumeya Hiroshi, 1994, Neurologia Medico-Chirurgica, V34, P612, DOI 10.2176/nmc.34.612; Gayatri N, 2009, BRAIN DEV-JPN, V31, P618, DOI 10.1016/j.braindev.2008.09.011; GIERONKORTHALS MA, 1994, J CHILD NEUROL, V9, P381, DOI 10.1177/088307389400900408; Gohil JR, 2006, INDIAN PEDIATR, V43, P829; Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f; Hacohen Y, 2011, CLIN NEUROL NEUROSUR, V113, P928, DOI 10.1016/j.clineuro.2011.06.014; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; HEROS RC, 1992, STROKE, V23, P937, DOI 10.1161/01.STR.23.7.937; Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308; Kamate M, 2009, PEDIATR NEUROL, V41, P220, DOI 10.1016/j.pediatrneurol.2009.03.018; KING MD, 1982, HUM TOXICOL, V1, P281, DOI 10.1177/096032718200100311; Kitsko DJ, 2007, CURR ALLERGY ASTHM R, V7, P444, DOI 10.1007/s11882-007-0068-1; LANZI G, 1986, HEADACHE, V26, P494, DOI 10.1111/j.1526-4610.1986.hed2610494.x; Mackay MT, 2010, STROKE, V41, P2201, DOI 10.1161/STROKEAHA.110.583831; Manto Mario, 2012, Handb Clin Neurol, V103, P201, DOI 10.1016/B978-0-444-51892-7.00012-7; Marcelli V, 2006, BRAIN DEV-JPN, V28, P80, DOI 10.1016/j.braindev.2005.05.003; Nussinovitch M, 2003, CLIN PEDIATR, V42, P581, DOI 10.1177/000992280304200702; Pellegrini S, 2012, ACTA OTORRINOLAR ESP, V63, P21, DOI 10.1016/j.otorri.2011.06.007; Ryan MM, 2003, J CHILD NEUROL, V18, P309, DOI 10.1177/08830738030180050901; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; Winchester S, 2013, HAND CLINIC, V112, P1213, DOI 10.1016/B978-0-444-52910-7.00043-X; Yeoh HK, 2006, CHILD NERV SYST, V22, P310, DOI 10.1007/s00381-005-1154-0	31	13	15	0	6	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	APR	2014	43	4					153	159		10.3928/00904481-20140325-13			7	Pediatrics	Pediatrics	AF2XE	WOS:000334575000013	24716559				2021-06-18	
J	Tado, M; Mori, T; Fukushima, M; Oshima, H; Maeda, T; Yoshino, A; Aizawa, S; Katayama, Y				Tado, Masahiro; Mori, Tatsuro; Fukushima, Masamichi; Oshima, Hideki; Maeda, Takeshi; Yoshino, Atsuo; Aizawa, Shin; Katayama, Yoichi			Increased Expression of Vascular Endothelial Growth Factor Attenuates Contusion Necrosis without Influencing Contusion Edema after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular permeability; cerebral contusion; bevacizumab; vascular endothelial growth factor (VEGF)	MIDDLE CEREBRAL-ARTERY; CORTICAL CONTUSION; TRANSIENT ISCHEMIA; VEGF; ANGIOGENESIS; BARRIER; PERMEABILITY; DEGENERATION; BEVACIZUMAB; RECEPTORS	To clarify the role of vascular endothelial growth factor (VEGF) in the formation of contusion edema and necrosis after traumatic brain injury, we examined the time course of changes in the VEGF expression (enzyme-linked immunosorbent assay), cerebrovascular permeability (extravasation of Evans blue), and water content (dry-wet weight method) of the contused brain tissue in a cortical impact injury model using rats. In addition, we tested the effects of administration of bevacizumab (VEGF monoclonal antibody) on changes in the cerebrovascular permeability and water content of the contused brain tissue, as well as the neurological deficits (rota rod test) and volume of contusion necrosis. Increased VEGF expression was maximal at 72 h after injury (p<0.003). Increases in cerebrovascular permeability and water content, however, became maximal within 24 h (p<0.001) after injury (p<0.01), respectively. Administration of bevacizumab did not influence these changes in cerebrovascular permeability and water content, but led to a significant rise in the neurological deficits at 72 h-14 days (p<0.05 or 0.01) and the volume of contusion necrosis at 21 days (p<0.001) after injury. These findings suggest that increased expression of VEGF after injury does not contribute to the formation of contusion edema, but attenuates the formation of contusion necrosis. This is probably because of an increased angiogenesis and improved microcirculation in the areas surrounding the core of contusion.	[Tado, Masahiro; Mori, Tatsuro; Fukushima, Masamichi; Oshima, Hideki; Maeda, Takeshi; Yoshino, Atsuo; Katayama, Yoichi] Nihon Univ, Sch Med, Dept Neurol Surg, Div Neurosurg, Kamimachi, Tokyo 1738610, Japan; [Aizawa, Shin] Nihon Univ, Sch Med, Dept Funct Morphol, Div Anat Sci, Kamimachi, Tokyo 1738610, Japan	Tado, M (corresponding author), Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, 30-1 Oyaguchi, Kamimachi, Tokyo 1738610, Japan.	tadochin1978@yahoo.co.jp					Acevedo LM, 2008, NAT MED, V14, P372, DOI 10.1038/nm0408-372; Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; Bauerle T, 2008, NEOPLASIA, V10, P511, DOI 10.1593/neo.08220; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hai J, 2003, NEUROSURGERY, V53, P963, DOI 10.1227/01.NEU.0000083594.10117.7A; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kawamata T, 1997, ACT NEUR S, V70, P191; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; MADSEN FF, 1990, ACTA NEUROCHIR, V105, P150, DOI 10.1007/BF01670000; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Moreira T, 2006, BEHAV BRAIN RES, V167, P9, DOI 10.1016/j.bbr.2005.06.048; ORTEGA N, 1999, FRONT BIOSCI, V4, P141; Salgaller ML, 2003, CURR OPIN MOL THER, V5, P657; SENGER DR, 1986, CANCER RES, V46, P5629; Shen FX, 2011, J CEREBR BLOOD F MET, V31, P2343, DOI 10.1038/jcbfm.2011.97; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; TODD NV, 1990, ACT NEUR S, V51, P296; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Wang T, 2004, INT J IMPOT RES, V16, P403, DOI 10.1038/sj.ijir.3901186; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	38	13	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					691	698		10.1089/neu.2013.2940			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000011	24294928				2021-06-18	
J	Clark, RA; Weragoda, N; Paterson, K; Telianidis, S; Williams, G				Clark, Ross A.; Weragoda, Natasha; Paterson, Kade; Telianidis, Stacey; Williams, Gavin			A pilot investigation using global positioning systems into the outdoor activity of people with severe traumatic brain injury	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Physical activity; Activity monitor; GPS; Community mobility; HiMAT	PHYSICAL-ACTIVITY; MOBILITY; TRACKING; HEALTH	Background: Little is known about the post-discharge outdoor activities of people who have incurred severe traumatic brain injury (TBI). This study used a body-worn global positioning system (GPS) device to determine the outdoor activity per day performed by this population. Additionally, this study examined the association that mobility, time since injury and injury severity had with levels of outdoor physical activity. Findings: Seventeen people with TBI and 15 control subjects wore a GPS device for between 3-7 days to monitor their outdoor activity. Based on the individual's location and speed of movement the outdoor physical activity in minutes per day was derived. Assessments of duration of outdoor activity between groups, and the relationship that duration of outdoor activity had with results on the high-level mobility assessment tool, length of post-traumatic amnesia, and time since injury were performed. No significant (p = 0.153, effect size = 0.26) difference in time spent in outdoor physical activity was observed between the TBI (median[IQR] = 19[3-43] mins) and control (median[IQR] = 50 [18-65] mins) group. Interestingly, 35% of TBI subjects performed < 10 mins of outdoor activity per day compared to 13% of the control group. The TBI group also recorded three of the four highest values for outdoor physical activity. Higher levels of mobility were associated with more outdoor activity (Spearman's rho = 0.443, p = 0.038). No other significant associations were observed. Conclusions: While preliminary, our results indicate that a sub-group of people with TBI exists who restrict their outdoor activities. GPS has potential as an activity tracking tool, with implications for rehabilitation and exercise prescription.	[Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic 3065, Australia; [Paterson, Kade; Telianidis, Stacey; Williams, Gavin] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia	Clark, RA (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic 3065, Australia.	ross.clark@acu.edu.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019; Paterson, Kade L/G-4715-2012	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Paterson, Kade L/0000-0002-0323-6129; Williams, Gavin/0000-0003-2758-7473			Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Isaacs K, 2013, J EXPO SCI ENV EPID, V23, P328, DOI 10.1038/jes.2012.94; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; McCluskey A, 2012, ISRN REHABIL, V2012; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCurdy LE, 2010, CURR PROB PEDIATR AD, V40, P102, DOI 10.1016/j.cppeds.2010.02.003; McLennan W., 1997, AUSTR STANDARD CLASS; Miskelly F, 2005, AGE AGEING, V34, P497, DOI 10.1093/ageing/afi145; Neven A, 2013, DISABIL REHABIL, V35, P1718, DOI 10.3109/09638288.2012.751137; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Pett MA, 1997, NONPARAMETRIC STAT H; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; Schreuer N, 2014, RES DEV DISABIL, V35, P223, DOI 10.1016/j.ridd.2013.10.001; Shoval N, 2011, AGEING SOC, V31, P849, DOI 10.1017/S0144686X10001455; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395	19	13	13	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	MAR 19	2014	11								37	10.1186/1743-0003-11-37			5	Engineering, Biomedical; Neurosciences; Rehabilitation	Engineering; Neurosciences & Neurology; Rehabilitation	AF4TM	WOS:000334707000001	24645752	DOAJ Gold, Green Published			2021-06-18	
J	Green, CM; Kirk, JW; Connery, AK; Baker, DA; Kirkwood, MW				Green, Cassie M.; Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			The use of the Rey 15-Item Test and recognition trial to evaluate noncredible effort after pediatric mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Postconcussion; Response bias; Recognition trial; Performance validity; Noncredible effort; Rey 15-Item Test	TEST-PERFORMANCE; MEMORY TEST; TEST-SCORES; VALIDITY; CHILDREN; TOMM; INDIVIDUALS; ADOLESCENTS; CAPACITY	The Rey 15-Item Test (FIT) is a performance validity test commonly used in adult neuropsychological assessment. FIT classification statistics across studies have been variable, so a recognition trial was created to enhance the measure (Boone, K. B., Salazar, X., Lu, P., Warner-Chacon, K., & Razani, J. (2002). The Rey 15-Item recognition trial: A technique to enhance sensitivity of the Rey 15-Item Memorization Test. Journal of Clinical and Experimental Neuropsychology, 24(5), 561-573.). The current study assessed the utility of the FIT and recognition trial in a pediatric mild traumatic brain injury sample (N=319, M=14.57 years). All participants were administered the FIT and recognition trial as part of an abbreviated clinical neuropsychological evaluation. Failure on the Medical Symptom Validity Test was used as the criterion for noncredible effort. Fifteen percent of the sample met the criterion. The traditional adult cutoff score of<9 on the FIT recall trial yielded excellent specificity (98%), but very poor sensitivity (12%). When the recognition trial was utilized, a total score of<26 resulted in the best combined cutoff score (sensitivity=55%, specificity=91%). Results indicate that the FIT with recognition trial may be useful in the assessment of noncredible effort with children and adolescents, at least among relatively high-functioning populations.	[Green, Cassie M.; Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; [Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA	Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	michael.kirkwood@childrenscolorado.org					BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MANUAL MED SYMPTOM V; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lee G.P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI [10.1037/1040-3590.4.1.43, DOI 10.1037/1040-3590.4.1.43]; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Stimmel M, 2012, INT J FORENSIC MENT, V11, P51, DOI 10.1080/14999013.2012.676148	33	13	13	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 16	2014	36	3					261	267		10.1080/13803395.2013.879096			7	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AE5MG	WOS:000334032600004	24479707				2021-06-18	
J	Allen, AR; Eilertson, K; Chakraborti, A; Sharma, S; Baure, J; Habdank-Kolaczkowski, J; Allen, B; Rosi, S; Raber, J; Fike, JR				Allen, Antino R.; Eilertson, Kirsten; Chakraborti, Ayanabha; Sharma, Sourabh; Baure, Jennifer; Habdank-Kolaczkowski, Julian; Allen, Barrett; Rosi, Susanna; Raber, Jacob; Fike, John R.			Radiation exposure prior to traumatic brain injury induces responses that differ as a function of animal age	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Radiation; age; hippocampus; neurogenesis; inflammation	HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; IRRADIATION; MICROGLIA	Purpose: Uncontrolled radiation exposure due to radiological terrorism, industrial accidents or military circumstances is a continuing threat for the civilian population. Age plays a major role in the susceptibility to radiation; younger children are at higher risk of developing cognitive deterioration when compared to adults. Our objective was to determine if an exposure to radiation affected the vulnerability of the juvenile hippocampus to a subsequent moderate traumatic injury. Materials and methods: Three-week-old (juvenile) and eight-week-old young adult C57BL/J6 male mice received whole body cesium-137 (Cs-137) irradiation with 4 gray (Gy). One month later, unilateral traumatic brain injury was induced using a controlled cortical impact system. Two months post-irradiation, animals were tested for hippocampus-dependent cognitive performance in the Morris water-maze. After cognitive testing, animals were euthanized and their brains frozen for immunohistochemical assessment of activated microglia and neurogenesis in the hippocampal dentate gyrus. Results: All animals were able to learn the water maze task; however, treatment effects were seen when spatial memory retention was assessed. Animals that received irradiation as juveniles followed by a moderate traumatic brain injury one month later did not show spatial memory retention, i.e., were cognitively impaired. In contrast, all groups of animals that were treated as adults showed spatial memory retention in the probe trials. Conclusion: Although the mechanisms involved are not clear, our results suggest that irradiation enhanced a young animal's vulnerability to develop cognitive injury following a subsequent traumatic injury.	[Allen, Antino R.; Chakraborti, Ayanabha; Sharma, Sourabh; Baure, Jennifer; Habdank-Kolaczkowski, Julian; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Allen, Antino R.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Eilertson, Kirsten] Gladstone Inst, Bioinformat Core, San Francisco, CA USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Div Neurosci, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA	Allen, AR (corresponding author), Univ Arkansas Med Sci, 4301 West Markham,Suite 441B-2, Little Rock, AR 72205 USA.	AAllen@uams.edu	Chakraborti, Ayanabha/N-1898-2019	Eilertson, Kirsten/0000-0003-4850-1210; Chakraborti, Ayanabha/0000-0003-2060-8200	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI08053]; National Institute of General Medical Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266] Funding Source: NIH RePORTER	The research described was supported by National Institutes of Health (NIH) grant R33 AI08053 and Award Number K12GM081266 from the National Institute of General Medical Sciences/National Institutes of Health.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Balk SJ, 2003, PEDIATRICS, V111, P1455; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Joo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025936; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Pandey BN, 2010, INT J RADIAT BIOL, V86, P613, DOI 10.3109/09553001003746059; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2010, TOXICOL PATHOL, V38, P198, DOI 10.1177/0192623309352003; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	29	13	15	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	MAR	2014	90	3					214	223		10.3109/09553002.2014.859761			10	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AC8QA	WOS:000332797500002	24164494	Green Published, Bronze			2021-06-18	
J	Fridgeirsdottir, GA; Hillered, L; Clausen, F				Fridgeirsdottir, Gudrun Andrea; Hillered, Lars; Clausen, Fredrik			Escalated handling of young C57BL/6 mice results in altered Morris water maze performance	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						Handling; mice; Morris water maze	TRAUMATIC BRAIN-INJURY; INBRED STRAINS; STRESS; BEHAVIOR; MEMORY; RAT; NEUTRALIZATION; ANXIETY; TESTS; TASKS	Background. The handling of experimental animals prior to experimental interventions is often poorly described, even though it may affect the final functional outcome. This study explores how the use of repeated handling of C57BL/6 mice prior to Morris water maze (MWM) tests can affect the performance. Methods and materials. The handled animals were subjected to the escalating handling protocol, with the investigator spending 5 min per day per cage for 8 days prior to the MWM test. On the last days of handling, the mice were introduced to water and the concept of a hidden platform. The MWM test consisted of four daily trials for 90 s per day for 4 days with a hidden platform. A probe test was performed 4 days after the last learning trial. Control animals were not handled prior to MWM. Results. Handling reduced the latency to find the platform on the first 2 days of the MWM tests and reduced thigmotaxis. The mice increased their swim speed and elicited more explorative behavior in the learning trials and to some lesser extent in the probe trials. Conclusions. The improvement in MWM navigation was most likely due to reduced stress and anxiety regarding the investigator and the test. Handled mice displayed less variability than non-handled mice, suggesting that by using a controlled handling protocol prior to the experiments fewer C57BL/6 mice would be needed to achieve statistically significant differences in studies of learning and spatial memory using MWM.	[Fridgeirsdottir, Gudrun Andrea; Hillered, Lars; Clausen, Fredrik] Uppsala Univ, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden	Clausen, F (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, Entrance 85,2nd Floor, S-75185 Uppsala, Sweden.	fredrik.clausen@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292; Clausen, Fredrik/0000-0003-3592-4417	Swedish Brain Foundation; Uppsala University Hospital; Ahlen's Foundation; Uppsala University	The work was supported by grants from the Swedish Brain Foundation, Uppsala University Hospital, Ahlen's Foundation, and funds from Uppsala University.	Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; Beeler JA, 2006, PHYSIOL BEHAV, V87, P870, DOI 10.1016/j.physbeh.2006.01.037; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bisaz R, 2011, HIPPOCAMPUS, V21, P56, DOI 10.1002/hipo.20723; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Cuadrado-Tejedor M, 2011, BEHAV BRAIN RES, V220, P338, DOI 10.1016/j.bbr.2011.01.005; Dalm S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039033; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hu M, 2009, EUR J PHARMACOL, V622, P37, DOI 10.1016/j.ejphar.2009.09.031; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/NMETH.1500, 10.1038/nmeth.1500]; Leenaars M, 2009, ATLA-ALTERN LAB ANIM, V37, P297, DOI 10.1177/026119290903700312; Longordo F, 2011, SLEEP, V34, P679, DOI 10.1093/sleep/34.5.679; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Tremml P, 2002, GENES BRAIN BEHAV, V1, P230, DOI 10.1034/j.1601-183X.2002.10405.x; UPCHURCH M, 1987, PHARMACOL BIOCHEM BE, V27, P143, DOI 10.1016/0091-3057(87)90488-6; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Vecsey CG, 2013, SLEEP, V36, P601, DOI 10.5665/sleep.2556; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Wolff M, 2002, BEHAV BRAIN RES, V136, P463, DOI 10.1016/S0166-4328(02)00192-4; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130	34	13	13	0	17	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.	MAR	2014	119	1					1	9		10.3109/03009734.2013.847511			9	Medicine, General & Internal	General & Internal Medicine	AB5KX	WOS:000331828500001	24172203	DOAJ Gold, Green Published			2021-06-18	
J	Gulin, SL; Perrin, PB; Stevens, LF; Villasenor-Cabrera, TJ; Jimenez-Maldonado, M; Martinez-Cortes, ML; Arango-Lasprilla, JC				Gulin, Shaina L.; Perrin, Paul B.; Stevens, Lillian F.; Villasenor-Cabrera, Teresita J.; Jimenez-Maldonado, Miriam; Martinez-Cortes, Ma. Luisa; Arango-Lasprilla, Juan Carlos			Health-Related Quality of Life and Mental Health Outcomes in Mexican TBI Caregivers	FAMILIES SYSTEMS & HEALTH			English	Article						TBI caregivers; Latin America	TRAUMATIC BRAIN-INJURY; FAMILY CAREGIVERS; SURVEY SF-36; BURDEN; SCALE; SATISFACTION; INDIVIDUALS; DEPRESSION; REHABILITATION; PERSPECTIVE	Research has documented the deleterious effects on caregivers of providing care for an individual with traumatic brain injury (TBI). TBI caregivers in Mexico specifically have reduced health-related quality of life (HRQOL) across both physical and mental health domains. The purpose of the current study was to uncover the system of connections between Mexican TBI caregivers' HRQOL and their mental health. A cross-sectional survey was conducted at a public medical facility in Guadalajara, Mexico. Ninety family caregivers of individuals with TBI completed measures of HRQOL, satisfaction with life, depression, and burden. A canonical correlation analysis revealed that the better the caregivers' HRQOL, the better their mental health was, with the effect reaching a largesized effect. A distinct pattern emerged linking caregivers' higher energy levels and better social functioning to lower depression and greater satisfaction with life. A series of multiple regressions similarly uncovered that the most robust independent HRQOL predictors of caregiver mental health were vitality and social functioning. Especially for TBI caregivers with poor health, behavioral health interventions in Latin America that target the HRQOL domains of social functioning and vitality may significantly improve caregiver mental health, and as a result, informal care for TBI.	[Gulin, Shaina L.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian F.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Villasenor-Cabrera, Teresita J.; Jimenez-Maldonado, Miriam; Martinez-Cortes, Ma. Luisa] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Arango-Lasprilla, Juan Carlos] Univ Deusto, Dept Psychol, Bilbao 48007, Spain; [Arango-Lasprilla, Juan Carlos] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Atienza FL, 2000, PSICOTHEMA, V12, P314; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Grant JS, 2000, BRAIN INJURY, V14, P1089; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hanson SL, 2007, REHABIL PSYCHOL, V52, P409, DOI 10.1037/0090-5550.52.4.409; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karlikaya G., 2005, INTERNET J NEUROLOGY, V4, DOI [10.5580/2587, DOI 10.5580/2587]; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Marin G, 1991, RES HISPANIC POPULAT; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin-Carrasco M., 1996, REV GERONTOLOGIA, V6, P338; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Nanda U, 1998, EVAL HEALTH PROF, V21, P179, DOI 10.1177/016327879802100204; Pavot L, 1993, PSYCHOL ASSESSMENTS, V5, P164; Perrin P. B., 2012, MODELING CONNE UNPUB; Perrin P. B., NEUROREHABI IN PRESS; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sanchez-Ayendez M, 1998, J GERONTOL SOC WORK, V30, P75, DOI 10.1300/J083v30n01_06; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; SPSS Inc, 2010, SPSS BAS 19 0 WIND C; Stewart AL, 1992, MEASURING FUNCTIONIN; Stull D, 1996, J CLIN GEROPSYCHOL, V2, P175; TEASDALE G, 1974, LANCET, V2, P81; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE., 1993, SF 36 HLTH SURVEY MA; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	51	13	13	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1091-7527	1939-0602		FAM SYST HEALTH	Fam. Syst. Health	MAR	2014	32	1					53	66		10.1037/a0032623			14	Health Care Sciences & Services; Family Studies; Public, Environmental & Occupational Health	Health Care Sciences & Services; Family Studies; Public, Environmental & Occupational Health	AD9OO	WOS:000333594600013	24417652				2021-06-18	
J	Qiu, B; Li, XG; Sun, XY; Wang, Y; Jing, ZT; Zhang, X; Wang, YJ				Qiu, Bo; Li, Xinguo; Sun, Xiyang; Wang, Yong; Jing, Zhitao; Zhang, Xu; Wang, Yunjie			Overexpression of aquaporin-1 aggravates hippocampal damage in mouse traumatic brain injury models	MOLECULAR MEDICINE REPORTS			English	Article						secondary injury; vasogenic edema; cytotoxic edema; delayed cell death; BALB; c mice	CLOSED-HEAD-INJURY; SELECTIVE VULNERABILITY; CHOROID-PLEXUS; GLIAL-CELLS; IN-VITRO; EDEMA; RAT; PATHOPHYSIOLOGY; ASTROCYTES; EXPRESSION	Secondary insult' following primary traumatic brain injury (TBI), including ischemia and edema, may aggravate brain impairments and affect the outcomes. The hippocampus is particularly sensitive to ischemia or edema due to its selective vulnerability, as neural cells of the hippocampus may be more prone to abnormal function or cell death in response to ischemia and edema. Aquaporin-1 (AQP-1) was reported to be associated with cerebral edema; however, the expression and role of AQP-1 in hippocampal edema following TBI have seldom been investigated. In the current study, BALB/c mouse closed craniocerebral injury models were established and the changes of AQP-1 expression in hippocampi of mouse models following TBI were investigated. Neurological function and edema formation of the models were evaluated and the apoptotic hippocampal cells were then stained in situ and detected, followed by determination of AQP-1 expression in the hippocampus using immunohistochemistry and western blot analysis. As a result, the majority of mice in the TBI group were severely injured and hippocampal edema was confirmed. The apoptotic cells increased significantly in the hippocampi of mice in the TBI group compared with those in the sham group (P<0.01) and the apoptotic rate increased gradually in a time-dependent manner. The expression levels of AQP-1 in the hippocampi of mice were markedly higher in the TBI group than in the sham group (P<0.05) at various time points and AQP-1 expression levels peaked one day following TBI. These results indicate that upregulation of AQP-1 may participate in edema formation and delayed cell death of the hippocampus following TBI and may also be a novel therapeutic target to protect the hippocampus from secondary injury following TBI.	[Qiu, Bo; Li, Xinguo; Wang, Yong; Jing, Zhitao; Wang, Yunjie] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Liaoning, Peoples R China; [Sun, Xiyang] Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China; [Zhang, Xu] Liaoning Ctr Dis Control & Prevent, Shenyang 110005, Liaoning, Peoples R China	Qiu, B (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	bo_qiu@msn.com	Wang, Yonghuai/AAJ-6778-2021	Qiu, Bo/0000-0003-2109-140X	Chinese National Natural Science Foundation of Youth Science Foundation [81000565, 81101917]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2012M520831]; Liaoning Provincial Natural Science Foundation [201102095, 2013021075]	This study was supported by grants from the Chinese National Natural Science Foundation of Youth Science Foundation (grant nos. 81000565 and 81101917), the China Postdoctoral Science Foundation (grant no. 2012M520831) and the Liaoning Provincial Natural Science Foundation (grant nos. 201102095 and 2013021075).	Adeva MM, 2012, NEUROCHEM INT, V61, P166, DOI 10.1016/j.neuint.2012.05.007; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Ameli PA, 2012, ACTA NEUROCHIR SUPPL, V113, P59, DOI 10.1007/978-3-7091-0923-6_13; Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Deng P, 2011, J NEUROTRAUM, V28, P1173, DOI 10.1089/neu.2010.1683; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Kawamata T, 2003, ACTA NEUROCHIR SUPPL, V86, P545; Kim JE, 2009, NEUROSCIENCE, V163, P781, DOI 10.1016/j.neuroscience.2009.07.028; Kim J, 2012, J NEUROSCI RES, V90, P1437, DOI 10.1002/jnr.23017; Kim J, 2011, ANAT CELL BIOL, V44, P295, DOI 10.5115/acb.2011.44.4.295; Kobayashi H, 2001, NEUROSCI LETT, V297, P163, DOI 10.1016/S0304-3940(00)01705-5; Marmarou A, 2007, NEUROSURG FOCUS, V22, pE1, DOI DOI 10.3171/F0C.2007.22.5.2; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Padayachy LC, 2012, CHILD NERV SYST, V28, P1911, DOI 10.1007/s00381-012-1837-2; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Qiu B, 2012, INT J MOL SCI, V13, P9142, DOI 10.3390/ijms13079142; Ringel F, 1997, ACT NEUR S, V70, P144; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Staub F, 1996, ACT NEUR S, V66, P56; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang Q, 2012, INT J LEGAL MED, V126, P875, DOI 10.1007/s00414-012-0758-7; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022	45	13	13	0	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAR	2014	9	3					916	922		10.3892/mmr.2014.1899			7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AC7HO	WOS:000332699000023	24430824	Bronze			2021-06-18	
J	Reddy, S; Eckner, JT; Kutcher, JS				Reddy, Shailesh; Eckner, James T.; Kutcher, Jeffrey S.			Effect of Acute Exercise on Clinically Measured Reaction Time in Collegiate Athletes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						BRAIN CONCUSSION; SIMPLE REACTION TIME; PHYSICAL EXERTION; FATIGUE	CHOICE-REACTION TIME; PHYSICAL-EXERCISE; COGNITIVE PERFORMANCE; HIGH-SCHOOL; SPORTS CONCUSSION; RECOVERY; RELIABILITY; SYMPTOMS; EXERTION; PLAYERS	Purpose We have developed a reliable and valid clinical test of reaction time (RTclin) that is sensitive to the acute effects of concussion. If RTclin is to be used as a sideline concussion assessment tool then the acute effects of exercise on RTclin may need to be controlled for. The purpose of this study was therefore to determine the effect of exercise on RTclin. Methods A gender-balanced group of 42 collegiate athletes were assigned to an exercise (n = 28) and a control (n = 14) group using 2:1 block randomization. The exercise group completed a graded four-stage exercise protocol on a stationary bicycle (100 W x 5 min; 150 W x 5 min; 200 W x 5 min; sprint x 2 min), whereas the control group was tested at identical periods without exercising. Mean RTclin was calculated for eight trials as the fall time of a vertically suspended rigid shaft after its release by the examiner before being caught by the athlete. RTclin was measured at baseline and after each of the four stages. Results As both HR and RPE significantly increased for the four stages in the exercise group (P < 0.001), mean RTclin showed a significant overall decline during repeated test administration (P < 0.008). However, there were no significant group (exercise vs control, P = 0.822) or group-by-stage interaction (P = 0.169) effects on RTclin as assessed by repeated-measures analysis of variance. Conclusions Exercise did not appear to affect RTclin performance in this study. This suggests that RTclin measured during a sideline concussion assessment does not need to be adjusted to account for the acute effects of exercise.	[Reddy, Shailesh] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Eckner, James T.; Kutcher, Jeffrey S.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48108 USA; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48108 USA	Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [2K12HD001097-16, L30 HD070467, K12 HD001097] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER		Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brisswalter J, 1997, PERCEPT MOTOR SKILL, V85, P1019, DOI 10.2466/pms.1997.85.3.1019; BRISSWALTER J, 1995, J HUM MOVEMENT STUD, V29, P15; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brown AM, 2008, MED SCI SPORT EXER, V40, P1142, DOI 10.1249/MSS.0b013e31816770e1; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Dane S, 2003, INT J NEUROSCI, V113, P923, DOI 10.1080/00207450390220367; Davranche K, 2006, J SPORT SCI, V24, P323, DOI 10.1080/02640410500132165; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Hogervorst E, 1996, PERCEPT MOTOR SKILL, V83, P479, DOI 10.2466/pms.1996.83.2.479; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kashihara K, 2005, PERCEPT MOTOR SKILL, V100, P275; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell M., 2001, BRIT J SPORT MED, V35, P373; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McMorris T, 2000, INT J SPORT PSYCHOL, V31, P66; MCMORRIS T, 1994, PERCEPT MOTOR SKILL, V78, P123, DOI 10.2466/pms.1994.78.1.123; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Tsorbatzoudis H, 1998, PERCEPT MOTOR SKILL, V86, P571, DOI 10.2466/pms.1998.86.2.571; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Welford A., 1980, REACTION TIMES, P73	38	13	13	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAR	2014	46	3					429	434		10.1249/MSS.0000000000000140			6	Sport Sciences	Sport Sciences	AH0WG	WOS:000335840900001	24002343	Green Accepted			2021-06-18	
J	Wang, HE; Brown, SP; MacDonald, RD; Dowling, SK; Lin, S; Davis, D; Schreiber, MA; Powell, J; van Heest, R; Daya, M				Wang, Henry E.; Brown, Siobhan P.; MacDonald, Russell D.; Dowling, Shawn K.; Lin, Steve; Davis, Daniel; Schreiber, Martin A.; Powell, Judy; van Heest, Rardi; Daya, Mohamud			Association of out-of-hospital advanced airway management with outcomes after traumatic brain injury and hemorrhagic shock in the ROC hypertonic saline trial	EMERGENCY MEDICINE JOURNAL			English	Article							RAPID-SEQUENCE INTUBATION; SEVERE HEAD-INJURY; RANDOMIZED-CONTROLLED-TRIAL; ENDOTRACHEAL INTUBATION; RESUSCITATION; HYPERVENTILATION; HYPOXIA; IMPACT	Objective Prior studies suggest adverse associations between out-of-hospital advanced airway management (AAM) and patient outcomes after major trauma. This secondary analysis of data from the Resuscitation Outcomes Consortium Hypertonic Saline Trial evaluated associations between out-of-hospital AAM and outcomes in patients suffering isolated severe traumatic brain injury (TBI) or haemorrhagic shock. Methods This multicentre study included adults with severe TBI (GCS <= 8) or haemorrhagic shock (SBP <= 70 mm Hg, or (SBP 71-90 mm Hg and heart rate >= 108 bpm)). We compared patients receiving out-ofhospital AAM with those receiving emergency department AAM. We evaluated the associations between airway strategy and patient outcomes (28-day mortality, and 6-month poor neurologic or functional outcome) and airway strategy, adjusting for confounders. Analysis was stratified by (1) patients with isolated severe TBI and (2) patients with haemorrhagic shock with or without severe TBI. Results Of 2135 patients, we studied 1116 TBI and 528 shock; excluding 491 who died in the field, did not receive AAM or had missing data. In the shock cohort, out-of-hospital AAM was associated with increased 28-day mortality (adjusted OR 5.14; 95% CI 2.42 to 10.90). In TBI, out-of-hospital AAM showed a tendency towards increased 28-day mortality (adjusted OR 1.57; 95% CI 0.93 to 2.64) and 6-month poor functional outcome (1.63; 1.00 to 2.68), but these differences were not statistically significant. Out-of-hospital AAM was associated with poorer 6-month TBI neurologic outcome (1.80; 1.09 to 2.96). Conclusions Out-of-hospital AAM was associated with increased mortality after haemorrhagic shock. The adverse association between out-of-hospital AAM and injury outcome is most pronounced in patients with haemorrhagic shock.	[Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35249 USA; [Brown, Siobhan P.; Powell, Judy] Univ Washington, Dept Biostat, Clin Trials Ctr, Seattle, WA 98195 USA; [MacDonald, Russell D.] Ornge Transport Med, Mississauga, ON, Canada; [MacDonald, Russell D.; Lin, Steve] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [MacDonald, Russell D.; Lin, Steve] St Michaels Hosp, Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dowling, Shawn K.] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada; [Davis, Daniel] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [van Heest, Rardi] Royal Columbian Hosp, Trauma Serv, Vancouver, BC, Canada; [Daya, Mohamud] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA	Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, 619 19th St South,OHB 251, Birmingham, AL 35249 USA.	hwang@uabmc.edu	Daya, Mohamud R/A-9322-2012; Lin, Steve/H-3723-2013	Lin, Steve/0000-0002-8644-9719; Dowling, Shawn/0000-0002-6378-7299; Brown, Siobhan/0000-0002-4774-3122	National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U01 HL077863, HL077866, HL077867, HL077871, HL077872, HL077873, HL077881, HL077885, HL077887, HL077908]; US Army Medical Research & Material Command, The Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada; Heart, Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; American Heart AssociationAmerican Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077866, U01HL077873, U01HL077908, U01HL077885, U01HL077881, U01HL077871, U01HL077867, U01HL077887, U01HL077872, U01HL077863] Funding Source: NIH RePORTER	The Resuscitation Outcomes Consortium (ROC) is supported by a series of cooperative agreements to nine regional clinical centres and one Data Coordinating Center (5U01 HL077863-University of Washington Data Coordinating Center, HL077866-Medical College of Wisconsin, HL077867-University of Washington, HL077871-University of Pittsburgh, HL077872-St. Michael's Hospital, HL077873-Oregon Health and Science University, HL077881-University of Alabama at Birmingham, HL077885-Ottawa Hospital Research Institute, HL077887-University of Texas SW Medical Center/Dallas, HL077908-University of California San Diego) from the National Heart, Lung and Blood Institute in partnership with the US Army Medical Research & Material Command, The Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, and the Heart, Stroke Foundation of Canada and the American Heart Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung and Blood Institute or the National Institutes of Health.	Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Brasel KJ, J AM COLL SURG; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Guyette F, 2011, J TRAUMA, V70, P782, DOI 10.1097/TA.0b013e318210f5c9; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Newgard CD, 2008, RESUSCITATION, V78, P170, DOI 10.1016/j.resuscitation.2008.01.029; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Rubin DB., 2004, MULTIPLE IMPUTATION; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2009, ANN EMERG MED, V54, P645, DOI 10.1016/j.annemergmed.2009.05.024; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	25	13	17	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	MAR	2014	31	3					186	U110		10.1136/emermed-2012-202101			6	Emergency Medicine	Emergency Medicine	AD8RG	WOS:000333532700004	23353663	Green Accepted			2021-06-18	
J	Whitaker-Azmitia, PM; Lobel, M; Moyer, A				Whitaker-Azmitia, Patricia M.; Lobel, Marci; Moyer, Anne			Low maternal progesterone may contribute to both obstetrical complications and autism	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; PERINATAL RISK-FACTORS; SPECTRUM DISORDERS; INFANTILE-AUTISM; NEONATAL FACTORS; GENE-EXPRESSION; NEURODEVELOPMENTAL DISORDERS; SOCIOECONOMIC-STATUS; SYNAPTIC PLASTICITY; RECEPTOR EXPRESSION	Studies show increased autism risk among children born to mothers experiencing obstetrical complications. Although this is usually interpreted as suggesting that the obstetrical complications could be causing autism, it is possible that a single factor could be responsible for both complications and autism. We hypothesized that low levels of the hormone progesterone is responsible since it is supplied to the fetus maternally and does not only support pregnancy but also promotes brain development. Following a review of the literature, we report findings from a survey of mothers of autistic children (n = 86) compared to mothers of typically-developing children (n = 88) regarding obstetrical histories, including five obstetrical risk factors indicative of low progesterone. Using this analysis, the ASD group had significantly more risk factors than controls (1.21 +/- 0.09 vs. 0.76 +/- 0.08, p <.0001), suggesting low progesterone. Thus, results suggest that low progesterone may be responsible for both obstetrical complications and brain changes associated with autism and that progesterone levels should be routinely monitored in at-risk pregnancies. Our hypothesis also suggests that ensuring adequate levels of progesterone may decrease the likelihood of autism. (C) 2014 Elsevier Ltd. All rights reserved.	[Whitaker-Azmitia, Patricia M.; Lobel, Marci; Moyer, Anne] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA	Whitaker-Azmitia, PM (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	patricia.whitaker@stonybrook.edu			Center for Survey Research at Stony Brook University	This research was supported through a seed Grant from the Center for Survey Research at Stony Brook University. The authors are grateful for the assistance of the Center's Director, Dr. Leonie Huddy.	Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Azmitia EC, 2011, NEUROPHARMACOLOGY, V60, P1347, DOI 10.1016/j.neuropharm.2011.02.002; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Bauman MD, 2013, BIOL PSYCHIAT; Bethea CL, 2011, NEUROSCIENCE, V192, P675, DOI 10.1016/j.neuroscience.2011.06.003; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Bilder D, 2009, PEDIATRICS, V123, P1293, DOI 10.1542/peds.2008-0927; Bohm H.V., 2013, MED HYPOTHESES; Bolton PF, 1997, J AM ACAD CHILD PSY, V36, P272, DOI 10.1097/00004583-199702000-00018; Breton AB, 2012, REPROD FERT DEVELOP, V24, P916, DOI 10.1071/RD12006; Brimacombe M, 2007, MATERN CHILD HLTH J, V11, P73, DOI 10.1007/s10995-006-0142-7; Brun CC, 2009, HUM BRAIN MAPP, V30, P3887, DOI 10.1002/hbm.20814; Brunton PJ, 2010, BRAIN RES, V1364, P198, DOI 10.1016/j.brainres.2010.09.062; Burd L, 1999, J PERINAT MED, V27, P441, DOI 10.1515/JPM.1999.059; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Cardwell MS, 2013, OBSTET GYNECOL SURV, V68, P119, DOI 10.1097/OGX.0b013e31827f2481; Carmichael SL, 2005, ARCH PEDIAT ADOL MED, V159, P957, DOI 10.1001/archpedi.159.10.957; Carmody DP, 2010, DEV PSYCHOBIOL, V52, P755, DOI 10.1002/dev.20471; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Chamak B, 2010, M S-MED SCI, V26, P659, DOI 10.1051/medsci/2010266-7659; Chugani DC, 2004, MENT RETARD DEV D R, V10, P112, DOI 10.1002/mrdd.20021; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; DeSoto MC, 2010, ACTA NEUROBIOL EXP, V70, P165; DEYKIN EY, 1980, AM J DIS CHILD, V134, P860, DOI 10.1001/archpedi.1980.02130210044012; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; ELLISON PT, 1990, AM ANTHROPOL, V92, P933, DOI 10.1525/aa.1990.92.4.02a00050; Essa MM, 2013, NEUROTOX RES, V23, P393, DOI 10.1007/s12640-012-9354-3; FINEGAN JA, 1979, J CHILD PSYCHOL PSYC, V20, P119, DOI 10.1111/j.1469-7610.1979.tb00492.x; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; Gil M, 2013, PSYCHONEUROENDOCRINO, V38, P1688, DOI 10.1016/j.psyneuen.2013.02.002; GILLBERG C, 1983, J AUTISM DEV DISORD, V13, P153, DOI 10.1007/BF01531816; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gronborg TK, 2013, JAMA PEDIATR, V167, P947, DOI 10.1001/jamapediatrics.2013.2259; Haas DM, 2008, COCHRANE DB SYST REV, V2; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Hall NR, 2011, OBSTET GYN CLIN N AM, V38, P235, DOI 10.1016/j.ogc.2011.02.014; Halpert J, 2012, ENVIRON HEALTH PERSP, V120, pA390, DOI 10.1289/ehp.120-a390; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hill M, 2011, PHYSIOL RES, V60, P225, DOI 10.33549/physiolres.932077; Hill M, 2010, PHYSIOL RES, V59, P211, DOI 10.33549/physiolres.931807; Hughes GC, 2013, J LEUKOCYTE BIOL, V93, P369, DOI 10.1189/jlb.1012491; Hvidtjorn D, 2009, ARCH PEDIAT ADOL MED, V163, P72, DOI 10.1001/archpediatrics.2008.507; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jahagirdar V, 2010, CEREB CORTEX, V20, P1046, DOI 10.1093/cercor/bhp165; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Juul-Dam N, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e63; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Konno T, 2010, ENDOCRINOLOGY, V151, P4537, DOI 10.1210/en.2010-0440; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lagiou P, 2006, EUR J CANCER PREV, V15, P20, DOI 10.1097/01.cej.0000186639.12249.c7; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; LAUDER JM, 1990, ANN NY ACAD SCI, V600, P297, DOI 10.1111/j.1749-6632.1990.tb16891.x; Lee JH, 2011, J IMMUNOL, V187, P1778, DOI 10.4049/jimmunol.1003919; Lima FB, 2010, MOL PSYCHIATR, V15, P657, DOI 10.1038/mp.2009.97; Lockwood CJ, 2010, J CLIN ENDOCR METAB, V95, P2271, DOI 10.1210/jc.2009-2136; Maimburg RD, 2006, ACTA PSYCHIAT SCAND, V114, P257, DOI 10.1111/j.1600-0447.2006.00805.x; MASONBROTHERS A, 1987, J AM ACAD CHILD PSY, V26, P39, DOI 10.1097/00004583-198701000-00008; Matsunaga H, 2010, J NEUROCHEM, V114, P1333, DOI 10.1111/j.1471-4159.2010.06847.x; Mazer C, 1997, BRAIN RES, V760, P68, DOI 10.1016/S0006-8993(97)00297-7; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Rivera HM, 2013, SYNAPSE, V67, P897, DOI 10.1002/syn.21702; Rivera R, 1999, AM J OBSTET GYNECOL, V181, P1263, DOI 10.1016/S0002-9378(99)70120-1; Romeo RD, 2004, NEURON GLIA BIOL, V1, P219, DOI 10.1017/S1740925X05000086; Sa SI, 2009, NEUROSCIENCE, V162, P307, DOI 10.1016/j.neuroscience.2009.04.066; Sakamoto H, 2001, J NEUROSCI, V21, P6221; Sanchez AM, 2011, J NEUROENDOCRINOL, V24, P195; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Steinman G, 2013, MED HYPOTHESES, V81, P21, DOI 10.1016/j.mehy.2013.03.034; Su MT, 2011, J ASSIST REPROD GEN, V28, P239, DOI 10.1007/s10815-010-9510-8; Szekeres-Bartho J, 2008, HUM REPROD UPDATE, V14, P27, DOI 10.1093/humupd/dmm035; SZEKERESBARTHO J, 1989, J REPROD IMMUNOL, V16, P239, DOI 10.1016/0165-0378(89)90053-3; Theoharides TC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-168; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wagner CK, 2008, ENDOCRINOLOGY, V149, P2743, DOI 10.1210/en.2008-0049; Wagner CK, 1998, ENDOCRINOLOGY, V139, P3658, DOI 10.1210/en.139.8.3658; Walker CK, 2013, BIOL PSYCHIAT; Wang JP, 2011, MOL MED REP, V4, P319, DOI 10.3892/mmr.2011.418; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wiebe ER, 2009, CONTRACEPTION, V79, P178, DOI 10.1016/j.contraception.2008.10.004; Wilkerson DS, 2002, INT J NEUROSCI, V112, P1085, DOI 10.1080/00207450290026076; Willing J, 2013, DEV NEUROBIOL; Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yawno T, 2009, NEUROSCIENCE, V163, P838, DOI 10.1016/j.neuroscience.2009.07.009; Young SL, 2010, SEMIN REPROD MED, V28, P5, DOI 10.1055/s-0029-1242988; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	102	13	16	0	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAR	2014	82	3					313	318		10.1016/j.mehy.2013.12.018			6	Medicine, Research & Experimental	Research & Experimental Medicine	AD8CM	WOS:000333494100014	24485701				2021-06-18	
J	Wilson, DA; Selassie, AW				Wilson, Dulaney A.; Selassie, Anbesaw W.			Risk of severe and repetitive traumatic brain injury in persons with epilepsy: A population-based case-control study	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizure; Traumatic brain injury; Case-control; Population-based; Comorbidities	POSTTRAUMATIC EPILEPSY; HEAD-INJURY; ALZHEIMER-DISEASE; UNITED-STATES; SEIZURES; COMORBIDITY; HOSPITALIZATION; EPIDEMIOLOGY; PREVALENCE; CONCUSSION	Background: While traumatic brain injury (TBI) can lead to epilepsy, individuals with preexisting epilepsy or seizure disorder (ESD), depending on the type of epilepsy and the degree of seizure control, may have a greater risk of TBI from seizure activity or medication side effects. The joint occurrence of ESD and TBI can complicate recovery as signs and symptoms of TBI may be mistaken for postictal effects. Those with ESD are predicted to experience more deleterious outcomes either because of having a more severe TBI or because of the cumulative effects of repetitive TBI. Methods: We conducted a case-control study of all emergency department visits and hospital discharges for TBI from 1998 through 2011 in a statewide population. The severity of TBI, repetitive TBI, and other demographic and clinical characteristics were compared between persons with TBI with preexisting ESD (cases) and those without (controls). Significant differences in proportions were evaluated with confidence intervals. Logistic regression was used to examine the association of the independent variables with ESD. Results: During the study period, 236,164 individuals sustained TBI, 5646 (2.4%) of which had preexisting ESD. After adjustment for demographic and clinical characteristics, cases were more likely to have sustained a severe TBI (OR = 1.49; 95% CI = 1.38-1.60) and have had repetitive TBI (OR = 1.54; 95% CI = 1.41-1.69). Conclusion: The consequences of TBI may be greater in individuals with ESD owing to the potential for a more severe or repetitive TBI. Seizure control is paramount, and aggressive management of comorbid conditions among persons with ESD and increased awareness of the hazard of repetitive TBI is warranted. Furthermore, future studies are needed to examine the long-term outcomes of cases in comparison with controls to determine if the higher risk of severe or repetitive TBI translates into permanent deficits. (C) 2014 Elsevier Inc. All rights reserved.	[Wilson, Dulaney A.; Selassie, Anbesaw W.] Med Univ SC, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Wilson, DA (corresponding author), 135 Cannon St,Suite 303,MSC 835, Charleston, SC 29425 USA.	wilsonda@musc.edu		Wilson, Dulaney/0000-0003-4726-7848	National Center for Chronic Disease Prevention and Health Promotion, the Centers for Disease Control and Prevention [DP003251]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01DP003251] Funding Source: NIH RePORTER	This study was funded by cooperative agreement DP003251 from the National Center for Chronic Disease Prevention and Health Promotion, the Centers for Disease Control and Prevention (PI: Anbesaw Selassie).	Ahmad BS, 2012, NEUROLOGY, V79, P145, DOI 10.1212/WNL.0b013e31825f0466; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Beghi E, 2009, EXPERT REV NEUROTHER, V9, P291, DOI 10.1586/14737175.9.2.291; Berg AT, 2011, EPILEPSY BEHAV, V20, P550, DOI 10.1016/j.yebeh.2010.12.038; Bowman SM, 2010, EPILEPSIA, V51, P862, DOI 10.1111/j.1528-1167.2009.02492.x; Butler JA, 2000, CENTRAL NERVOUS SYST; Center for Injury Research and Policy of The Johns Hopkins University School of Public Health, 1997, ICDMAP 90 SOFTW; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; *COMM INJ SCAL, 1990, ABBR INJ SCAL 1990 R; COWAN LD, 1989, EPILEPSIA, V30, P94, DOI 10.1111/j.1528-1157.1989.tb05289.x; Darlington GA, 1998, ENCY BIOSTATISTICS, P788; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAERER AF, 1986, EPILEPSIA, V27, P66, DOI 10.1111/j.1528-1157.1986.tb03503.x; Hillbom M, 2003, CNS DRUGS, V17, P1013, DOI 10.2165/00023210-200317140-00002; Hosmer DW, 2000, MULTINOMINAL LOGISTI; JENSEN FE, 2009, EPILEPSIA S2, V50, P1, DOI DOI 10.1111/J.1528-1167.2008.02003.X; Krumholz A, 2008, NEUROLOGY, V70, P1874, DOI 10.1212/01.wnl.0000312285.73631.ff; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Mackin P, 2008, HUM PSYCHOPHARM CLIN, V23, P3, DOI 10.1002/hup.915; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NAKKEN KO, 1993, EPILEPSIA, V34, P836, DOI 10.1111/j.1528-1157.1993.tb02099.x; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; National Center for Health Statistics, 2012, INT CLASS DIS; Nei M, 2007, CURR NEUROL NEUROSCI, V7, P335, DOI 10.1007/s11910-007-0051-1; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Office, 2013, REV DEL METR STAT AR; Office of Management and Budget, 2010, FED REGISTER, V2010, P75; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pellock JM, 2004, EPILEPSY BEHAV, V5, pS3, DOI 10.1016/j.yebeh.2004.06.010; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; RUSSELLJONES DL, 1989, J NEUROL NEUROSUR PS, V52, P659, DOI 10.1136/jnnp.52.5.659; Sapna CS, 2008, EPILEPTIC DISORD, V10, P276, DOI 10.1684/epd.2008.0222; SAS Institute Inc, 2008, SAS WIND 9 2; Saunders LL, 2009, ARCH PHYS MED REHAB, V90, P1853, DOI 10.1016/j.apmr.2009.05.020; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Si Y, 2012, SEIZURE-EUR J EPILEP, V21, P40, DOI 10.1016/j.seizure.2011.09.008; Spitz MC, 1998, EPILEPSIA, V39, P904, DOI 10.1111/j.1528-1157.1998.tb01189.x; Sztramko R, 2011, CAN GERIATR J, V14, P79, DOI 10.5770/cgj.v14i4.19; Tassinari CA, 1997, EPILEPSY COMPREHENSI, P601; Thurman DJ., 1995, GUIDELINES SURVEILLA; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	60	13	13	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2014	32						42	48		10.1016/j.yebeh.2013.12.035			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	AC3EU	WOS:000332398600009	24469016				2021-06-18	
J	Turnley, AM; Basrai, HS; Christie, KJ				Turnley, Ann M.; Basrai, Harleen S.; Christie, Kimberly J.			Is integration and survival of newborn neurons the bottleneck for effective neural repair by endogenous neural precursor cells?	FRONTIERS IN NEUROSCIENCE			English	Article						adult neurogenesis; neural stem cells; neural repair; SVZ; SGZ; hippocampus; olfactory bulb; neurite outgrowth	ADULT HIPPOCAMPAL NEUROGENESIS; TRAUMATIC BRAIN-INJURY; ERYTHROPOIETIN ENHANCES NEUROGENESIS; IMPROVES FUNCTIONAL RECOVERY; NEWLY GENERATED NEURONS; SPINAL-CORD-INJURY; OLFACTORY-BULB; DENTATE GYRUS; BORN NEURONS; STEM-CELLS	After two decades of research the existence of adult neural precursor cells and the phenomenon of adult neurogenesis is well established. However, there has been little or no effective harnessing of these endogenous cells to promote functional neuronal replacement following neural injury or disease. Neural precursor cells can respond to neural damage by proliferating, migrating to the site of injury, and differentiating into neuronal or glial lineages. However, after a month or so, very few or no newborn neurons can be detected, suggesting that even though neuroblasts are generated, they generally fail to survive as mature neurons and contribute to the local circuitry. Is this lack of survival and integration one of the major bottlenecks that inhibits effective neuronal replacement and subsequent repair of the nervous system following injury or disease? In this perspective article the possibility that this bottleneck can be targeted to enhance the integration and subsequent survival of newborn neurons will be explored and will suggest some possible mechanisms that may need to be modulated for this to occur.	[Turnley, Ann M.; Basrai, Harleen S.; Christie, Kimberly J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia	Turnley, AM (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Dept Anat & Neurosci, 30 Royal Parade, Parkville, Vic 3010, Australia.	turnley@unimelb.edu.au			NHMRC of AustraliaNational Health and Medical Research Council of Australia [1045125, 628344]	This work is supported by an NHMRC of Australia grant (#1045125) and Fellowship (#628344) to Ann M. Turnley. We apologize to the authors of many papers we could not cite due to word limits.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Basrai H. S., 2013, TRENDS CELL SIGNALIN; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bergami M, 2013, J NEUROSCI, V33, P11464, DOI 10.1523/JNEUROSCI.4812-12.2013; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Cancino GI, 2013, J NEUROSCI, V33, P12569, DOI 10.1523/JNEUROSCI.1251-13.2013; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Chancey JH, 2013, J NEUROSCI, V33, P6614, DOI 10.1523/JNEUROSCI.0781-13.2013; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Christie KJ, 2013, ADV EXP MED BIOL, V786, P129, DOI 10.1007/978-94-007-6621-1_8; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doeppner TR, 2011, ACTA NEUROPATHOL, V122, P429, DOI 10.1007/s00401-011-0856-5; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI 10.1089/neu.2008-0744; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gascon E, 2006, J NEUROSCI, V26, P12956, DOI 10.1523/JNEUROSCI.4508-06.2006; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Lemmens R, 2013, HUM MOL GENET, V22, P2214, DOI 10.1093/hmg/ddt073; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miwa N, 2005, J NEUROSCI, V25, P5404, DOI 10.1523/JNEUROSCI.1039-05.2005; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Murai K, 2010, STEM CELLS, V28, P1581, DOI 10.1002/stem.474; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; Petreanu L, 2002, J NEUROSCI, V22, P6106; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rodriguez-Perez AI, 2013, NEUROBIOL DIS, V58, P209, DOI 10.1016/j.nbd.2013.06.004; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Spanevello MD, 2013, J NEUROTRAUM, V30, P1023, DOI 10.1089/neu.2012.2729; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Vadodaria Krishna C, 2013, Front Synaptic Neurosci, V5, P4, DOI 10.3389/fnsyn.2013.00004; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang SZ, 2012, P NATL ACAD SCI USA, V109, P18589, DOI 10.1073/pnas.1210479109; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015	74	13	15	0	4	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 20	2014	8								29	10.3389/fnins.2014.00029			7	Neurosciences	Neurosciences & Neurology	AW7DT	WOS:000346425500001	24600341	DOAJ Gold, Green Published			2021-06-18	
J	Valk-Kleibeuker, L; Heijenbrok-Kal, MH; Ribbers, GM				Valk-Kleibeuker, Linda; Heijenbrok-Kal, Majanka H.; Ribbers, Gerard M.			Mood after Moderate and Severe Traumatic Brain Injury: A Prospective Cohort Study	PLOS ONE			English	Article							FUNCTIONAL ASSESSMENT MEASURE; DEPRESSION; REHABILITATION; RELIABILITY; DISORDERS; OUTCOMES; PEOPLE	Objective: To evaluate the course of mood and identify its determinants up to 3 years after moderate to severe traumatic brain injury (TBI). Design: Prospective cohort study. Patients: Patients hospitalised with moderate to severe TBI, who survived until hospital discharge. Methods: At 3, 6, 12, 18, 24, and 36 months post-injury, mood was assessed with the Wimbledon Self-Report Scale (WSRS) in the home environment. Motor and cognitive outcome were assessed with the Functional Independence Measure (FIM), and the Functional Assessment Measure (FAM), respectively. Repeated measurements analysis was performed to determine the course of mood over time and its determinants. Results: A total of 98 patients (72% men), aged 33 (SD 12.9) years, 78% with severe TBI, was included. Mood did not change until 18 months post TBI, after which it significantly improved (p = 0.016). The FIM score significantly improved up to 18 months post-TBI (p = 0.012) and the FAM score up to 12 months post-TBI (p = 0.000), after which both remained stable. In univariable analyses, time post TBI (beta = -0.04, p = 0.008), initial discharge destination (beta = 2.13, p = 0.010), FIM (beta = -0.22, p < 0.001) and FAM (beta = -0.29, p < 0.001) were significant predictors of mood. In a multivariable mixed model, time post TBI, FAM score, and discharge destination were the strongest predictors of mood. Higher FAM scores were related to better mood scores (beta = -0.28, p < 0.001). Patients initially discharged home tended to have better mood scores over time than patients first treated in inpatient rehabilitation centers or nursing homes (beta = 1.27; p = 0.071). Conclusion: Mood starts to improve 18 months after TBI when motor and cognitive outcome have stabilized. Time post TBI, cognitive outcome and initial discharge destination are the strongest predictors of mood up to 3 years after TBI. These data suggest that mood scores of patients with moderate and severe TBI should be frequently monitored, especially in rehabilitation centers and nursing homes.	[Valk-Kleibeuker, Linda] Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med & Phys Therapy, Rotterdam, Netherlands; Rijndam Rehabil Ctr, Rotterdam, Netherlands	Valk-Kleibeuker, L (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med & Phys Therapy, Rotterdam, Netherlands.	gribbers@rijndam.nl	Ribbers, Gerard M/C-1454-2014; Ribbers, Gerard/N-3623-2019	Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development [1435.0020]	This study was financially supported by the Netherlands Organisation for Health Research and Development (project no.: 1435.0020; http://www.zonmw.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawkins ML, 2005, AM SURGEON, V71, P920; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schonberger M, 2001, J INT NEUROPSYCH SOC, V17, P781; Stilwell P, 1998, CLIN REHABIL, V12, P521, DOI 10.1191/026921598673761855; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van Balen HG, 1992, MENSEN TRAUMATISCH H; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87414	10.1371/journal.pone.0087414			7	Multidisciplinary Sciences	Science & Technology - Other Topics	302VA	WOS:000330631800032	24503864	DOAJ Gold, Green Published			2021-06-18	
J	Ali, ZS; Lang, SS; Sutton, LN				Ali, Zarina S.; Lang, Shih-Shan; Sutton, Leslie N.			Conservative Management of Presumed Low-Grade Gliomas in the Asymptomatic Pediatric Population	WORLD NEUROSURGERY			English	Article						Conservative; Incidentaloma; Low-grade gliomas; Nonsurgical; Pediatric brain tumors	PROGNOSTIC-FACTORS; HEMISPHERIC GLIOMAS; ADULT PATIENTS; RESECTION; EXTENT	OBJECTIVE: The optimal management of asymptomatic children with small, nonenhancing intracranial lesions presumed to be low-grade gliomas (LGGs) is not entirely clear in the literature. However, surgical intervention via resection or biopsy is not without risk and is of questionable long-term benefit in children with stable lesions. We present a series of 12 patients with incidentally detected, small, nonenhancing, intracranial lesions that were managed with watchful waiting and serial magnetic resonance imaging (MRI) scans. METHODS: We retrospectively reviewed a series of 12 children (eight boys, four girls) with T1 hypointense and T2 hyperintense intracranial lesions < 2 cm without enhancement or surrounding edema. RESULTS: Most patients (n = 5, 41.7%) received MRI studies after suffering a traumatic injury with evidence of an abnormality seen on computed tomography scan. Others received MRI scan as part of headache work-up (n = 4, 33.3%). The majority of lesions were located infratentorially (n = 8, 66.7%), whereas other locations included the frontal lobe and thalamus. The median age of the patients upon identification of the intracranial abnormality was 10 years (range, 1-19 years of age). Patients were followed for a median of 16.7 months (range, 2.7-59.5 months). The most common diagnosis based on clinical and radiographic features of these lesions consisted of LGG. No patient underwent surgery, radiation therapy, or chemotherapy except one patient, in whom the lesion grew in size. Surgical pathologic diagnosis in this case confirmed World Health Organization grade II astrocytoma. CONCLUSIONS: Our case series suggests that conservative management and close follow-up of incidental radiographic lesions consistent with LGGs is a safe and effective initial strategy in the pediatric population. In cases in which lesion size or quality changes, surgical resection may be necessary to confirm diagnosis. Further studies that include a larger number of patients and longer follow-up period are required to compare outcomes between this approach and initial surgical, radiation, or chemotherapy management strategies.	[Ali, Zarina S.; Lang, Shih-Shan; Sutton, Leslie N.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Ali, Zarina S.; Lang, Shih-Shan; Sutton, Leslie N.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA	Ali, ZS (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	zarina.ali@uphs.upenn.edu					BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D; Brown PD, 2003, RADIOGRAPHICS, V23, P1591, DOI 10.1148/rg.236035109; CAIRNCROSS JG, 1989, ARCH NEUROL-CHICAGO, V46, P1238, DOI 10.1001/archneur.1989.00520470106035; Driever PH, 2010, J NEURO-ONCOL, V100, P199, DOI 10.1007/s11060-010-0159-z; Duffau H, 2012, ACTA NEUROCHIR, V154, P569, DOI 10.1007/s00701-012-1275-7; Guillevin R, 2008, J NEURO-ONCOL, V87, P181, DOI 10.1007/s11060-007-9508-y; JANNY P, 1994, CANCER, V73, P1937, DOI 10.1002/1097-0142(19940401)73:7<1937::AID-CNCR2820730727>3.0.CO;2-G; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Perret C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11121; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Prabhu VC, 2010, NEUROL CLIN, V28, P1037, DOI 10.1016/j.ncl.2010.03.022; Rees J, 2009, EUR J RADIOL, V72, P54, DOI 10.1016/j.ejrad.2008.06.013; Reijneveld JC, 2005, NEURORADIOLOGY, V47, P887, DOI 10.1007/s00234-005-1435-z; Shastri-Hurst N, 2006, BRIT J NEUROSURG, V20, P222, DOI 10.1080/02688690600875507; Smith ATT, 2011, NEW ETHNOGRAPHIES, P1, DOI 10.1227/NEU.0b013e31820c3419; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Thom M, 2012, BRAIN PATHOL, V22, P350, DOI 10.1111/j.1750-3639.2012.00582.x; van Veelen MLC, 1998, J NEUROL NEUROSUR PS, V64, P581, DOI 10.1136/jnnp.64.5.581; VECHT CJ, 1993, J NEUROL NEUROSUR PS, V56, P1259, DOI 10.1136/jnnp.56.12.1259; You G, 2012, NEURO-ONCOLOGY, V14, P230, DOI 10.1093/neuonc/nor205	20	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2014	81	2					368	373		10.1016/j.wneu.2013.01.038			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AE6IU	WOS:000334094900052	23321383				2021-06-18	
J	Howe, J; Fitzpatrick, CM; Lakam, DR; Gleisner, A; Vane, DW				Howe, Jarett; Fitzpatrick, Colleen M.; Lakam, Dana Rachel; Gleisner, Ana; Vane, Dennis W.			Routine repeat brain computed tomography in all children with mild traumatic brain injury may result in unnecessary radiation exposure	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Repeat CT scan; pediatric; traumatic brain injury; radiation exposure	BLUNT HEAD TRAUMA; PEDIATRIC-PATIENTS; MODERATE; CT	BACKGROUND: Computed tomography (CT) for pediatric traumatic brain injury (TBI) is common. Evidence suggests that 1 in 1,200 children undergoing CT will die of malignancy from radiation exposure. Presently, there is no protocol for surveying children with mild TBI; repeat CT (rCT) is often performed. We hypothesized that rCT could be avoided. Outcomes of similar patients who underwent rCT were compared with those of patients followed by clinical examination alone. METHODS: An 8-year retrospective review was performed of patients admitted to a Level I pediatric trauma center with TBI, CT evidence of TBI, and Glasgow Coma Scale (GCS) score of 14 to 15. There were two groups, those who underwent rCT (rCT+) and those who did not (rCT(-)). Data included age, Injury Severity Score (ISS), mechanism of injury, type of TBI, and outcome. Patients with coagulopathies, ventriculoperitoneal shunts, developmental disabilities, nonaccidental trauma, concomitant injuries, or medical problems resulting in intubation or sedation not attributed to TBI were excluded. RESULTS: Of 391 patients admitted with TBI, 120 were included in the study. A total of 106 patientswere rCT+, and 14 were rCT-.rCT+ children were older (mean, 98.7 +/- 7.3 vs. 35.3 +/- 11.5 months; p = 0.0025) and more likely to have epidural hematoma (EDH) (100% rCT with EDH vs. 76% rCT all other TBI, p = 0.044). Mechanism of injury and mean ISS (15.2 +/- 0.6 vs. 13.0 +/- 1.1, p = 0.195) were not different between the groups. There were no worsening neurologic symptoms or need for surgery in rCT- children. rCT identified seven patients (6.6%) with CT progression of their injury. Five had an EDH, and two had a subarachnoid hemorrhage. Two children with EDH underwent operation. CONCLUSION: Our study indicates that routine rCT without evidence of clinical deterioration is not indicated in children with admission GCS score of 14 to 15 and TBI on CT scan. Children with EDH seem to have a higher potential for progression, and rCT seems to be indicated in this subgroup. Copyright (C) 2014 by Lippincott Williams& Wilkins	[Howe, Jarett; Lakam, Dana Rachel; Gleisner, Ana; Vane, Dennis W.] Cardinal Glennon Childrens Med Ctr, St Louis, MO 63104 USA; [Fitzpatrick, Colleen M.] St Louis Univ, St Louis CSTARS, St Louis, MO 63103 USA	Vane, DW (corresponding author), Cardinal Glennon Childrens Med Ctr, 1465 S Grand Blvd, St Louis, MO 63104 USA.	dvane@slu.edu					Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Carlos VR, 2004, J TRAUMA, V57, P939; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Langlois JA, 2006, TRAUMATIC BRAIN INJU; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; VANE DW, 1995, J TRAUMA, V38, P867, DOI 10.1097/00005373-199506000-00006; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	13	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2014	76	2					292	296		10.1097/TA.0000000000000119			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AH8KG	WOS:000336386100006	24458036				2021-06-18	
J	Salibi, PN; Agarwal, V; Panczykowski, DM; Puccio, AM; Sheetz, MA; Okonkwo, DO				Salibi, Patrick N.; Agarwal, Vikas; Panczykowski, David M.; Puccio, Ava M.; Sheetz, Michael A.; Okonkwo, David O.			Lifetime Attributable Risk of Cancer From CT Among Patients Surviving Severe Traumatic Brain Injury	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						cancer; CT; radiation; traumatic brain injury	LONG-TERM SURVIVAL; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE	OBJECTIVE. The purpose of this study was to determine the lifetime attributable risk of cancer from CT among patients surviving severe traumatic brain injury. MATERIALS AND METHODS. A retrospective cross-sectional study was conducted with prospectively collected data on patients 16 years old and older admitted with a Glasgow coma scale score of 8 or less to a single level 1 trauma center from 2007 to 2010. The effective dose of each CT examination the patients underwent was predicted with literature-accepted effective dose values of standard helical CT protocols. The lifetime attributable risk of cancer and related mortality incurred as a result of CT were estimated with the cumulative effective dose incurred from the time of injury to a 1-year follow-up evaluation and with the approach established by the Biologic Effects of Ionizing Radiation VII report. RESULTS. The average patient was a 34-year-old man. The median number of CT examinations received during the first 12 months after injury was 20, and the average cumulative effective dose was 87 +/- 45 mSv. This resulted in increases in the lifetime incidence of all cancer types from 45.5% to 46.3% and in the lifetime incidence of cancer-related mortality from 22.1% to 22.5%. CONCLUSION. Radiation exposure from the use of CT in the evaluation and management of severe traumatic brain injury causes negligible increases in lifetime attributable risk of cancer and cancer-related mortality. Treating physicians should not allow the concern for future risk of radiation-induced cancer to influence decisions regarding radiographic evaluation in the acute treatment of traumatic brain injury.	[Salibi, Patrick N.; Panczykowski, David M.; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Agarwal, Vikas; Sheetz, Michael A.] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA	Agarwal, V (corresponding author), Univ Pittsburgh, Med Ctr, Dept Radiol, 200 Lothrop St,Presby South Tower,8N, Pittsburgh, PA 15213 USA.	agarwalv@upmc.edu					Brown AW, 2004, NEUROREHABILITATION, V19, P37; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Laack TA, 2011, J TRAUMA, V70, P1362, DOI 10.1097/TA.0b013e3181e1707f; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Mnyusiwalla A, 2009, NEURORADIOLOGY, V51, P635, DOI 10.1007/s00234-009-0543-6; Monson RR, 2006, HEALTH RISKS FROM EX; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yamauchi-Kawara C, 2010, BRIT J RADIOL, V83, P1029, DOI 10.1259/bjr/52267127	16	13	13	0	4	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	FEB	2014	202	2					397	400		10.2214/AJR.12.10294			4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	299ZN	WOS:000330434300034	24370078				2021-06-18	
J	Tobin, JM; Dutton, RP; Pittet, JF; Sharma, D				Tobin, Joshua M.; Dutton, Richard P.; Pittet, Jean-Francois; Sharma, Deepak			Hypotensive resuscitation in a head-injured multi-trauma patient	JOURNAL OF CRITICAL CARE			English	Article						Resuscitation; Trauma Care; Traumatic Brain Injury; Hypotension	DAMAGE CONTROL RESUSCITATION; BRAIN-INJURY; RISK-FACTORS; INTRAOPERATIVE HYPOTENSION; BLOOD-PRESSURE; FLUID RESUSCITATION; INTRAVENOUS FLUID; HEMORRHAGIC-SHOCK; MORTALITY; CRANIOTOMY	The concept of permissive hypotension is a controversial topic in trauma care. While driving blood pressure to "normal" levels with large volume crystalloid infusions is not appropriate, definitive data on the target blood pressure for hypotensive resuscitation are lacking. Indeed, the concept of systolic blood pressure as a marker for resuscitation is arguable. In this case presentation, a panel of experts in trauma resuscitation discusses the merits and limitations of hypotensive resuscitation in the context of a patient who has sustained multiple injuries, including a head injury. The controversies highlighted herein call attention to the role of the intensivist in managing a continuing resuscitation while coordinating the care of other physicians whose therapies can run at cross-purposes to one another. The challenges of the practice of critical care in the 21st century are no more apparent than in the care of a complex trauma patient. (C) 2014 Elsevier Inc. All rights reserved.	[Tobin, Joshua M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Crit Care, Los Angeles, CA 90095 USA; [Dutton, Richard P.] Univ Chicago, Dept Anesthesia & Crit Care, Amer Soc Anesthesiologists, Anesthesia Qual Inst, Chicago, IL 60637 USA; [Pittet, Jean-Francois] Univ Alabama Birmingham, Div Crit Care Anesthesiol, Birmingham, AL USA; [Sharma, Deepak] Univ Washington, Div Neuroanesthesiol & Perioperat Neurosci, Seattle, WA 98195 USA	Tobin, JM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Crit Care, Los Angeles, CA 90095 USA.	jmtobin@mednet.ucla.edu; r.dutton@asahq.org; pittetj@uab.edu; dsharma@uw.edu					BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brown JB, 2013, J TRAUMA ACUTE CARE, V74, P1207, DOI 10.1097/TA.0b013e31828c44fd; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; de Biasi AR, 2011, TRANSFUSION, V51, P1925, DOI 10.1111/j.1537-2995.2010.03050.x; Duke MD, 2012, J TRAUMA ACUTE CARE, V73, P674, DOI 10.1097/TA.0b013e318265ce1f; Dutton RP, 2012, BRIT J ANAESTH, V109, pI39, DOI 10.1093/bja/aes389; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Hampton DA, 2013, J TRAUMA ACUTE CARE, V75, pS9, DOI 10.1097/TA.0b013e318290cd52; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Hodgetts T J, 2007, J R Army Med Corps, V153, P299; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Kopelman TR, 2010, J TRAUMA, V68, P1294; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Novak L, 1999, J TRAUMA, V47, P834, DOI 10.1097/00005373-199911000-00003; Pecha T, 2011, ANESTH ANALG, V113, P336, DOI 10.1213/ANE.0b013e31821d3dde; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Seamon MJ, 2010, J TRAUMA, V68, P1289, DOI 10.1097/TA.0b013e3181db05dc; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SHAFTAN GW, 1965, SURGERY, V58, P851; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SHATNEY CH, 1995, AM J SURG, V170, P676, DOI 10.1016/S0002-9610(99)80040-3; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Stephens CT, 2009, ANESTH ANALG, V109, P866, DOI 10.1213/ane.0b013e3181ad87b0; Trunkey DD, 1974, J AM COLL EMERG PHYS, P368; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	35	13	14	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	2							313.e1	10.1016/j.jcrc.2013.11.017			5	Critical Care Medicine	General & Internal Medicine	AC3IB	WOS:000332409400031	24388660				2021-06-18	
J	Wolf, H; Machold, W; Frantal, S; Kecht, M; Pajenda, G; Leitgeb, J; Widhalm, H; Hajdu, S; Sarahrudi, K				Wolf, Harald; Machold, Wolfgang; Frantal, Sophie; Kecht, Mathias; Pajenda, Gholam; Leitgeb, Johannes; Widhalm, Harald; Hajdu, Stefan; Sarahrudi, Kambiz			Risk factors indicating the need for cranial CT scans in elderly patients with head trauma: an Austrian trial and comparison with the Canadian CT Head Rule Clinical article	JOURNAL OF NEUROSURGERY			English	Article						head rule; cranial CT; minor head injury; skull radiography; traumatic brain injury	NEW-ORLEANS CRITERIA; NEURON-SPECIFIC ENOLASE; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MILD; ANTICOAGULATION; CONCUSSION; PREDICTION; RADIATION; PROTEIN	Object. This study presents newly defined risk factors for detecting clinically important brain injury requiring neurosurgical intervention and intensive care, and compares it with the Canadian CT Head Rule (CCHR). Methods. This prospective cohort study was conducted in a single Austrian Level-I trauma center and enrolled a consecutive sample of mildly head-injured adults who presented to the emergency department with witnessed loss of consciousness, disorientation, or amnesia, and a Glasgow Coma Scale (GCS) score of 13-15. The studied population consisted of a large number of elderly patients living in Vienna. The aim of the study was to investigate risk factors that help to predict the need for immediate cranial CT in patients with mild head trauma. Results. Among the 12,786 enrolled patients, 1307 received a cranial CT scan. Four hundred eighty-nine patients (37.4%) with a mean age of 63.9 +/- 22.8 years had evidence of an acute traumatic intracranial lesion on CT. Three patients (< 0.1%) were admitted to the intensive care unit for neurological observation and received oropharyngeal intubation. Seventeen patients (0.1%) underwent neurosurgical intervention. In 818 patients (62.6%), no evidence of an acute trauma-related lesion was found on CT. Data analysis showed that the presence of at least 1 of the following factors can predict the necessity of cranial CT: amnesia, GCS score, age > 65 years, loss of consciousness, nausea or vomiting, hypocoagulation, dementia or a history of ischemic stroke, anisocoria, skull fracture, and development of a focal neurological deficit. Patients requiring neurosurgical intervention were detected with a sensitivity of 90% and a specificity of 67% by using the authors' analysis. In contrast, the use of the CCHR in these patients detected the need for neurosurgical intervention with a sensitivity of only 80% and a specificity of 72%. Conclusions. The use of the suggested parameters proved to be superior in the detection of high-risk patients who sustained a mild head trauma compared with the CCHR rules. Further validation of these results in a multicenter setting is needed. Clinical trial registration no.: NCT00451789 (ClinicalTrials.gov.)	[Wolf, Harald; Machold, Wolfgang; Kecht, Mathias; Pajenda, Gholam; Leitgeb, Johannes; Widhalm, Harald; Hajdu, Stefan; Sarahrudi, Kambiz] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Frantal, Sophie] Med Univ Vienna, Dept Med Stat, Vienna, Austria	Wolf, H (corresponding author), Vienna Gen Hosp, Dept Trauma Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	harald.wolf@meduniwien.ac.at	Widhalm, Harald/ABE-8863-2020	Widhalm, Harald/0000-0001-9739-6176			Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Karni A, 2001, AM SURGEON, V67, P1098; Ledic D, 2012, MED HYPOTHESES, V78, P23, DOI 10.1016/j.mehy.2011.09.032; Leidel BA, 2012, UNFALLCHIRURG, V115, P903, DOI 10.1007/s00113-010-1946-x; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Martin DR, 2006, LANCET, V367, P1712, DOI 10.1016/S0140-6736(06)68748-5; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Saadat S, 2009, J NEUROSURG, V111, P688, DOI 10.3171/2009.2.JNS08909; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vogel T, 2008, UNFALLCHIRURG, V111, P898, DOI 10.1007/s00113-008-1502-0; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	29	13	13	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2014	120	2					447	452		10.3171/2013.10.JNS13726			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	301UA	WOS:000330556400028	24313609				2021-06-18	
J	Yu, HR; Watt, H; Mohan, S				Yu, Hongrun; Watt, Heather; Mohan, Subburaman			The negative impact of traumatic brain injury (TBI) on bone in a mouse model	BRAIN INJURY			English	Article						Bone density; bone formation; mice; traumatic brain injury; weight drop model	HYPOTHALAMIC-PITUITARY DYSFUNCTION; HETEROTOPIC OSSIFICATION; CALCIUM-METABOLISM; MINERAL DENSITY; HEAD-INJURY; LONG-TERM; MICE; GROWTH; SERUM; ADOLESCENTS	Introduction: While it is well established that the brain produces hypothalamic hormones and neuropeptides that influence skeletal metabolism, the impact of traumatic brain injury (TBI) on bone is unknown. Based on the recognition from clinical studies that there is an association between TBI and long-term hypothalamic pituitary dysfunction, it was hypothesized that TBI exerts a negative impact on skeletal growth and maintenance. Methods: To test the hypothesis, this study employed a repetitive weight drop model for TBI. Four impacts were applied for four consecutive days on 5-week old female C57BL/6 J mice. Bone measurements were taken 2 weeks after the first impact. Results: Bone mineral content (BMC), bone area (B area) and bone mineral density (BMD) in the total body were reduced by 14.5%, 9.8% and 5.2%, respectively, in the impacted vs. control mice. There was a 17.1% reduction in total volumetric BMD (vBMD) and a 4.0% reduction in material vBMD in cortical bone. In trabecular bone, there was a 44.0% reduction in BV/TV. Although there was no change in the cross-sectional bone size, the tibial growth plate and the tibia itself were shortened. Conclusion: The repetitive animal TBI model produced an immediate, strong negative impact on bone mass acquisition in young mice.	[Yu, Hongrun; Watt, Heather; Mohan, Subburaman] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Yu, Hongrun; Mohan, Subburaman] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA	Mohan, S (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, 11201 Benton St 151, Loma Linda, CA 92357 USA.	subburaman.mohan@va.gov			Rehabilitation Research and Development Merit Review Program of the Department of Veterans AffairsUS Department of Veterans Affairs	This work was funded through the Rehabilitation Research and Development Merit Review Program of the Department of Veterans Affairs, and was performed at research facilities provided by the VA Loma Linda HealthCare System. The authors thank Catrina Alarcon, Sheila Pourteymoor and Joe Rung-Aroon for their technical assistance. They also thank James DeKeyser for making the apparatus used in the study, and Charles Rundle for assistance in taking photographs of the mouse brains.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Affairs DoV, 2011, UND TRAUM BRAIN INJ; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Bruno-Petrina A, POSTTRAUMATIC HETERO; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Injury Prevention and Control, INJ PREV CONTR TRAUM; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kesavan C, 2010, J MUSCULOSKEL NEURON, V10, P274; Kesikburun S, 2011, BRAIN INJURY, V25, P127, DOI 10.3109/02699052.2010.536198; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Linares GR, 2011, AM J PHYSIOL-ENDOC M, V301, pE40, DOI 10.1152/ajpendo.00065.2011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Mohan S, 2005, J ENDOCRINOL, V185, P415, DOI 10.1677/joe.1.06141; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; MYSIW WJ, 1993, AM J PHYS MED REHAB, V72, P184, DOI 10.1097/00002060-199308000-00002; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Sato Y, 2000, ARCH PHYS MED REHAB, V81, P117, DOI 10.1016/S0003-9993(00)90231-4; Sato Y, 2000, J NEUROL SCI, V175, P135, DOI 10.1016/S0022-510X(00)00298-7; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Wergedal JE, 2002, BONE, V31, P670, DOI 10.1016/S8756-3282(02)00908-0; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908; Yu HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042684; Yu HR, 2012, CALCIFIED TISSUE INT, V91, P81, DOI 10.1007/s00223-012-9613-6; Zaben M, 2013, DISABIL REHABIL, V35, P522, DOI 10.3109/09638288.2012.697252	49	13	14	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					244	251		10.3109/02699052.2013.859735			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900014	24295038				2021-06-18	
J	Danila, O; Hirdes, JP; Maxwell, CJ; Marrie, RA; Patten, S; Pringsheim, T; Jette, N				Danila, Oana; Hirdes, John P.; Maxwell, Colleen J.; Marrie, Ruth Ann; Patten, Scott; Pringsheim, Tamara; Jette, Nathalie			Prevalence of neurological conditions across the continuum of care based on interRAI assessments	BMC HEALTH SERVICES RESEARCH			English	Article						Nursing homes; Home care; Psychiatry; Epidemiology; interRAI	MULTIPLE-SCLEROSIS; HUNTINGTONS-DISEASE; ELDERLY-PEOPLE; NURSING-HOMES; INFORMATION; POPULATION; EPILEPSY; RELIABILITY; DEPRESSION; DISORDERS	Background: Although multiple studies have estimated the prevalence of neurological conditions in the general Canadian population, limited research exists regarding the proportion affected with these conditions in non-acute health care settings in Canada. Data from standardized clinical assessments based on the interRAI suite of instruments were used to estimate the prevalence of eight neurological conditions across the continuum of care including Alzheimer's disease, Parkinson's disease, epilepsy, traumatic brain injury, multiple sclerosis, cerebral palsy, Huntington's disease, and amyotrophic lateral sclerosis. Methods: Cohorts of individuals receiving care in nursing homes (N = 103, 820), home care (N = 91, 021), complex continuing care (N = 10,581), and psychiatric hospitals (N = 23,119) in Canada were drawn based on their most recent interRAI assessment within each sector for a six-month period in 2010. These data were linked to the Discharge Abstract Database and National Ambulatory Care Reporting System data sets to develop five different case definition scenarios for estimating prevalence. Results: The conditions with the highest estimated prevalences in these care settings in Canada were Alzheimer's disease and related dementias, Parkinson's disease, epilepsy, and traumatic brain injury. However, there were notable cross-sector differences in the prevalence of each condition, and regional variations. Prevalence estimates based on acute hospital administrative data alone were substantially lower for all conditions evaluated. Conclusions: The proportion of persons with neurological conditions in non-acute health care settings in Canada is substantially higher than is generally reported for the general population. It is essential for these care settings to have the expertise and resources to respond effectively to the strengths, preferences, and needs of the growing population of persons with neurological conditions. The use of hospital or emergency department records alone is likely to substantially underestimate the true prevalence of neurological conditions across the continuum of care. However, interRAI assessment records provide a helpful source of information for obtaining these estimates in nursing home, home care, and mental health settings.	[Danila, Oana; Hirdes, John P.; Maxwell, Colleen J.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Maxwell, Colleen J.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada; [Marrie, Ruth Ann] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Marrie, Ruth Ann] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Patten, Scott; Pringsheim, Tamara] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Patten, Scott; Pringsheim, Tamara; Jette, Nathalie] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Patten, Scott] Univ Calgary, Mathison Ctr Res & Educ Mental Hlth, Calgary, AB, Canada; [Pringsheim, Tamara; Jette, Nathalie] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Pringsheim, Tamara] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Jette, Nathalie] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jette, Nathalie] Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada	Danila, O (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada.	omdanila@uwaterloo.ca	Pringsheim, Tamara/L-5955-2019; Patten, Scott/B-4434-2011	Pringsheim, Tamara/0000-0002-8229-8431; Patten, Scott/0000-0001-9871-4041; Marrie, Ruth Ann/0000-0002-1855-5595	Public Health Agency of Canada [6271-15-2010/3970773]; Alberta Innovates Health Solutions; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	This study is part of the National Population Health Study of Neurological Conditions. We wish to acknowledge the membership of the Neurological Health Charities of Canada and the Public Health Agency of Canada for their contribution to the success of this initiative. Funding for the study was provided by the Public Health Agency of Canada, Project #6271-15-2010/3970773. The opinions expressed in this publication are those of the authors/researchers, and do not necessarily reflect the official views of the Public Health Agency of Canada.; N Jette is the holder of a Canada Research Chair in Neuroscience Health Services Research and a Population Health Investigator Award from Alberta Innovates Health Solutions.; JP Hirdes holds the Ontario Home Care Research and Knowledge Exchange Chair funded by the Ontario Ministry of Health and Long Term Care.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Bernabei R, 2009, INT GERONTOLOGY HAZZ, P69; Bronskill Susan E, 2011, Healthc Q, V14, P21; Canadian Institute for Health Information, 2010, DATA QUALITY DOCUMEN; Canadian Institute for Health Information, 2010, ANALYSIS IN BRIEF CA; Canadian Institute for Health Information, 2001, THE CANADIAN ENHANCE; Canadian Institute for Health Information, 2007, THE BURDEN OF NEUROL; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Costa Andrew P, 2010, Healthc Policy, V6, P32; Evans C, 2013, NEUROEPIDEMIOLOGY, V40, P195, DOI 10.1159/000342779; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Finlayson M., 2002, INT J MS CARE, V4, P139, DOI DOI 10.7224/1537-2073-4.3.139; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Gambassi G, 1998, MED CARE, V36, P167, DOI 10.1097/00005650-199802000-00006; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Health Council of Canada, 2012, SENIORS IN NEED CARE; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-27; Hirdes JP, 2011, CAN J AGING, V30, P371, DOI 10.1017/S0714980811000304; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hirdes JP, 2002, J BEHAV HEALTH SER R, V29, P419, DOI 10.1007/BF02287348; Juurlink D, 2006, TECHNICAL REPORT; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16; Marrie RA, 2013, NEUROEPIDEMIOLOGY, V40, P85, DOI 10.1159/000343188; Martens PJ, 2007, CAN J PSYCHIAT, V52, P581, DOI 10.1177/070674370705200906; Matthews KL, 2002, BIOL PSYCHIAT, V51, P407, DOI 10.1016/S0006-3223(01)01235-5; Minden SL, 2004, NEUROREHABILITATION, V19, P55; MOGHAL S, 1995, NEUROEPIDEMIOLOGY, V14, P297, DOI 10.1159/000109805; Novak MJU, 2011, INT REV NEUROBIOL, V98, P297, DOI 10.1016/B978-0-12-381328-2.00013-4; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Perlman CM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-15; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Reid AY, 2012, EPILEPSY RES, V102, P173, DOI 10.1016/j.eplepsyres.2012.05.009; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Steeves TD, 2012, MOVEMENT DISORD, V27, P1789, DOI 10.1002/mds.25244; Stolp-Smith KA, 1998, NEUROLOGY, V50, P1594, DOI 10.1212/WNL.50.6.1594; Tellez-Zenteno JF, 2004, EPILEPSIA, V45, P1623, DOI 10.1111/j.0013-9580.2004.24904.x; Wodchis WP, 2008, MED CARE, V46, P882, DOI 10.1097/MLR.0b013e3181789471; Wolfson C, 2009, NEUROEPIDEMIOLOGY, V33, P79, DOI 10.1159/000222089; World Health Organization, 2006, NEUROLOGICAL DISORDE	43	13	13	0	20	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	JAN 22	2014	14								29	10.1186/1472-6963-14-29			14	Health Care Sciences & Services	Health Care Sciences & Services	AA5ZN	WOS:000331178600001	24447344	DOAJ Gold, Green Published			2021-06-18	
J	Lange, RT; Shewchuk, JR; Heran, MKS; Rauscher, A; Jarrett, M; Brubacher, JR; Iverson, GL				Lange, Rael T.; Shewchuk, Jason R.; Heran, Manraj K. S.; Rauscher, Alexander; Jarrett, Michael; Brubacher, Jeffrey R.; Iverson, Grant L.			To Exclude or Not To Exclude: Further Examination of the Influence of White Matter Hyperintensities in Diffusion Tensor Imaging Research	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; magnetic resonance imaging; neuroimaging; neurotrauma; traumatic brain injury; white matter hyperintensities	TRAUMATIC BRAIN-INJURY; LOW SCORES; MILD; PREVALENCE; ROBUST; REGISTRATION; ABNORMALITIES; OPTIMIZATION; DYSFUNCTION; ANISOTROPY	White matter hyperintensities (WMHIs) visible on magnetic resonance imaging (MRI) are common in both healthy adults and in those with medical or psychiatric problems. A practical methodological issue for diffusion tensor imaging (DTI) researchers is whether to include, or exclude, participants from a control group who have WMHIs. The aim of this study was to compare the influence of WMHIs on whole-brain DTI in trauma control subjects. Participants were 48 patients (no-WMHIs, n=36; 2+WMHIs, n=12) prospectively recruited from the Emergency Department of Vancouver General Hospital (British Columbia, Canada). Participants completed an MRI brain scan at 6-8 weeks postinjury (mean, 47.3 days; standard deviation [SD], 6.2; range, 39-66). DTI was used to examine the integrity of white matter (WM) in 50 regions of the brain using measures of fractional anisotropy (FA), and mean (MD), radial (RD), and axial (AD) diffusivity. FA values that were >2 SDs below the mean, and MD, RD, and AD values that were >2 SDs above the mean, were classified as abnormal scores indicative of reduced WM integrity. In the entire sample, the 2+WMHI group had a greater number of abnormal FA, MD, and RD scores, compared to the no-WMHI group (p<0.015 and Cohen's d >0.82, indicating large to very large effect sizes, for all comparisons). When controlling for the effects of age using a matched-groups design, the 2+WMHI group still had a significantly greater number of abnormal FA, MD, and RD scores, compared to the no-WMHI group (all p<0.012, all d >0.89, large to very large effect sizes). Researchers should be aware that the inclusion or exclusion of subjects with incidental WMHIs will influence the results of DTI studies.	[Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD 20889 USA; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Shewchuk, Jason R.; Heran, Manraj K. S.; Rauscher, Alexander; Jarrett, Michael] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Rauscher, Alexander; Jarrett, Michael] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Rauscher, Alexander] Univ British Columbia, UBC Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Brubacher, Jeffrey R.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Vancouver Gen Hosp, Dept Emergency Med, Vancouver, BC, Canada	Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	rlange@dvbic.org		Jarrett, Michael/0000-0002-3702-2014; Iverson, Grant/0000-0001-7348-9570; Brubacher, Jeffrey/0000-0002-4866-4231; Rauscher, Alexander/0000-0002-1961-8252	Alcohol Beverage Medical Research Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; CIHR New Investigator Award ProgramCanadian Institutes of Health Research (CIHR); National Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)	This study was partly supported by competitive research funding from the Alcohol Beverage Medical Research Foundation and the Canadian Institutes of Health Research (CIHR).; J.B.'s research program is supported by a scholar award from the Michael Smith Foundation for Health Research. A.R.'s research is supported by the CIHR New Investigator Award Program and by the National Sciences and Engineering Research Council of Canada.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R., 2007, NONLINEAR REGISTRATI; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ayling E, 2012, CURR PSYCHIAT REP, V14, P197, DOI 10.1007/s11920-012-0273-z; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Dimou S, 2013, NEUROSURG REV, V36, P205, DOI 10.1007/s10143-012-0436-8; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jang SH, 2010, NEUROREHABILITATION, V27, P367, DOI 10.3233/NRE-2010-0621; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; National Institute on Alcoholism and Alcohol Abuse, 2005, HELP PAT WHO DRINK T; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soderlund H, 2003, CORTEX, V39, P1093, DOI 10.1016/S0010-9452(08)70879-7; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Van Zijl PCM, 2004, MRI ATLAS HUMAN WHIT; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	60	13	13	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2014	31	2					198	205		10.1089/neu.2013.2866			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	291ZE	WOS:000329870600006	23952763				2021-06-18	
S	Bailes, JE; Dashnaw, ML; Petraglia, AL; Turner, RC		Niranjan, A; Lunsford, LD		Bailes, Julian E.; Dashnaw, Matthew L.; Petraglia, Anthony L.; Turner, Ryan C.			Cumulative Effects of Repetitive Mild Traumatic Brain Injury	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							COLLEGIATE FOOTBALL PLAYERS; MAGNETIC-RESONANCE-SPECTROSCOPY; DEPLOYED MILITARY PERSONNEL; HIGH-SCHOOL FOOTBALL; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; SPORTS CONCUSSIONS; LEAGUE PLAYERS; AXONAL INJURY; HEAD-INJURY	The majority of traumatic brain injuries (TBI) in the USA are mild in severity. Sports, particularly American football, and military experience are especially associated with repetitive, mild TBI (mTBI). The consequences of repetitive brain injury have garnered increasing scientific and public attention following reports of altered mood and behavior, as well as progressive neurological dysfunction many years after injury. This report provides an up-to-date review of the clinical, pathological, and pathophysiological changes associated with repetitive mTBI, and their potential for cumulative effects in certain individuals. (C) 2014 S. Karger AG, Basel	[Bailes, Julian E.] Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA; [Dashnaw, Matthew L.; Petraglia, Anthony L.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Turner, Ryan C.] W Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA; [Turner, Ryan C.] W Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA	Bailes, JE (corresponding author), Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, Dept Neurosurg, 2650 Ridge Ave,Kellogg 3rd Floor, Evanston, IL 60201 USA.	jbailes@northshore.org		Turner, Ryan/0000-0001-5523-0645			Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Lakhan SE, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-2; Lin A, 2010, RADIOLOGICAL SOC N A; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pardini J, 2011, YOUMANS NEUROLOGICAL, P3380; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schieder R, 1973, HEAD NECK INJURIES F; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2013, J NEUROTRAUMA; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003	55	13	13	0	8	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						50	62		10.1159/000358765	10.1159/isbn.978-3-318-02649-8		13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000006	24923392				2021-06-18	
J	Baker, JM; Good, DE				Baker, Julie M.; Good, Dawn E.			Physiological emotional under-arousal in individuals with mild head injury	BRAIN INJURY			English	Article						arousal; electrodermal activity; mild head injury; stress	TRAUMATIC BRAIN-INJURY; ACUTE STRESS DISORDER; DECISION-MAKING; POSTCONCUSSION SYMPTOMS; COGNITIVE NEUROSCIENCE; ORBITOFRONTAL CORTEX; UNIVERSITY-STUDENTS; AFFECTIVE SEQUELAE; FACIAL EXPRESSION; DIAGNOSIS THREAT	Primary objectives: This study examined the potential emotional sequelae following self-reported mild head injury (MHI; e. g. 'altered state of consciousness' [ASC]) in university students with a particular focus on arousal status and responsivity to experimental manipulation of arousal. Research design: A quasi-experimental design (n = 91) was used to examine arousal status (self-reported and physiological indices) and response to manipulated arousal (i.e. induced psychosocial stress/activation; reduced activation/relaxation) between persons who acknowledged prior MHI and persons with no-MHI. Main outcome and results: University students who self-reported MHI were physiologically under-aroused and less responsive to stressors (both laboratory and environmental) compared to their no-MHI cohort. Those with reported loss of consciousness demonstrated the most attenuated emotional arousal responses (i.e. flattened electrodermal responsivity) relative to those with only a reported ASC, followed by those with no-MHI. Conclusions: The under-arousal in traumatic brain injury has been hypothesized to be associated with ventromedial prefrontal cortex disruption. This under-arousal may be mirrored in persons who self-report experiencing subtle head trauma. Students who reported MHI may be less able to physiologically respond and/or cognitively appraise stressful experiences as compared to their no-MHI cohort; and experience subtle persistent consequences despite the subtle nature of the reported head trauma.	[Baker, Julie M.; Good, Dawn E.] Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, St Catharines, ON L2S 3A1, Canada; [Good, Dawn E.] Brock Univ, Ctr Neurosci, St Catharines, ON L2S 3A1, Canada	Baker, JM (corresponding author), Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	js01cb@brocku.ca			Social Sciences and Humanities Research Council of Canada (SSHRC) Joseph Bombardier Canada Graduate Scholarship; Ontario Graduate Scholarship (OGS)Ontario Graduate Scholarship; American Psychological Foundation (APF)/Council of Graduate Departments of Psychology (COGDOP) Graduate Research Scholarship; Ontario Neurotrauma Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. JB held funding from the Social Sciences and Humanities Research Council of Canada (SSHRC) Joseph Bombardier Canada Graduate Scholarship, Ontario Graduate Scholarship (OGS) and American Psychological Foundation (APF)/Council of Graduate Departments of Psychology (COGDOP) Graduate Research Scholarship during the collection and preparation of this research. DG holds funding from the Ontario Neurotrauma Foundation and is affiliated with the Ontario Brain Injury Association. The authors acknowledge that portions of this research have been presented at national and international conferences and abstracts related to this work have been published from conference proceedings [120-122].	AMARAL D G, 1992, P1; Andreassi J. L., 2007, PSYCHOPHYSIOLOGY HUM, P259; Baker J, 2010, FRONT HUM NEUROSCI, DOI [10.3389/conf.fnins.2010.14.00124, DOI 10.3389/C0NF.FNINS.2010.14.00124]; Baker J, 2008, EVERYDAY LIVING QUES; Baker J, 2010, BRAIN INJURY, V24, P106; Baker J, 2009, J HEAD TRAUMA REHAB, V24, P398; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOHNEN N, 1992, NEUROSURGERY, V30, P692; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Canadian Institutes of Health Research, 2006, HEAD INJ CAN DEC CHA; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Carr J, 2007, TRAUMA, V9, P21, DOI 10.1177/1460408607082845; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Damasio A. R., 1998, HUMAN EMOTIONS READE, P122; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DeBono A, 2008, C P 69 ANN CAN PSYCH; Delis DC, 2002, DELIS KAPLAN EXECUTI; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dzyundzyak A, 2008, C P 69 ANN CAN PSYCH; Epstein Richard S., 1994, P285; Gallagher R, 2000, NATL SURVEY COUNSELL; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P22; Iverson G. L., 2009, BLACK BOOK NEUROPSYC; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Jung YH, 2007, C P 68 ANN CAN PSYCH; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kitzrow M.A., 2003, NASPA J, V41, P165, DOI DOI 10.2202/0027-6014.1310; Kraus J. F., 2005, TXB TRAUMATIC BRAIN, P3; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Mateer CA, 2000, NEUROPSYCHOLOGICAL M, P3; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P347; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCormick CM, 2007, CONSCIOUS COGN, P205; McCrea M, 2008, MILD TRAUMATIC BRAIN, P129; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMaster University, 2004, GUID REL COMP DISC G; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales D., 2007, BRAIN CONTUSION; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Polygraph Professional, 2008, POL PROF POL PROF SU; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Reimann M, 2010, J ECON PSYCHOL, V31, P767, DOI 10.1016/j.joep.2010.03.002; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Sharan T, 2012, BRAIN INJURY, V26, P729; SHOSTAK BB, 1990, BEHAV RES THER, V28, P513, DOI 10.1016/0005-7967(90)90138-9; Soet J, 2006, J STUD AFF RES PRACT, V43, P410; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spielberger CD, 1983, STATE TRAIT ANXIETY; SPSS Inc, 2007, STAT PACK SOC SCI SP; St Cyr J, 2007, C P 17 ANN ROTM RES; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; TRANEL D, 2000, SER AFFECTIVE SCI, P192; van Noordt S, 2009, C P 70 ANN CAN PSYCH; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	119	13	14	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					51	65		10.3109/02699052.2013.857787			15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700007	24328800				2021-06-18	
S	Bormann, JE; Weinrich, S; Allard, CB; Beck, D; Johnson, BD; Holt, LC		Kelley, PW		Bormann, Jill E.; Weinrich, Sally; Allard, Carolyn B.; Beck, Danielle; Johnson, Brian D.; Holt, Lindsay Cosco			Mantram Repetition An Evidence-Based Complementary Practice for Military Personnel and Veterans in the 21st Century	ANNUAL REVIEW OF NURSING RESEARCH, VOL 32: MILITARY AND VETERAN INNOVATIONS OF CARE	Annual Review of Nursing Research-Series		English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; CRITICAL INCIDENT; FOCUSED ATTENTION; INTERVENTION; MEDITATION; HIV; MINDFULNESS; RESPONSES; PTSD; SPIRITUALITY	Today in the digital age, with our advances in modern technology and communication, there are additional stressors for our military personnel and Veterans. Constant dangers exist both on and off the battlefield, unlike prior wars that had clearly-defined war zones. In addition, medical advances have assisted in saving the lives of many more gravely injured troops than ever previously possible. As the wars in Iraq and Afghanistan come to an end, large numbers of service men and women are returning home with multiple injuries. This group of Veterans has significantly higher rates of posttraumatic stress disorder (PTSD) and traumatic brain injury than ever before reported. Although existing PTSD therapies have been found to be highly effective for many Veterans, there is a substantial minority unsatisfactorily treated. Mantram repetition, an innovative, complementary, evidence-based treatment, is proving to be successful for these new Veterans. When used regularly it helps with "road rage, impatience, anger, frustration, and being out of control." A mantram is a brief, sacred word or phrase that embodies divine power or the greatest positive energy one can imagine (Easwaran, 2008a). Mantram repetition is a simple, quick, personal, portable, and private complementary practice that may be used as an adjunct to current treatments for PTSD. Growing research evidence supports mantram repetition's value for dissemination and adoption in the 21st century. This chapter summarizes Mantram Program research conducted from 2003 to 2014. It describes the health-related benefits of the Mantram Program in various populations. The current research focuses on benefits for managing psychological distress and promoting quality of life in Veterans. Future areas for research are suggested.	[Bormann, Jill E.; Allard, Carolyn B.; Beck, Danielle] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; [Weinrich, Sally; Johnson, Brian D.; Holt, Lindsay Cosco] Univ San Diego, San Diego, CA 92110 USA	Bormann, JE (corresponding author), Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA.		Allard, Carolyn B./B-3521-2013	Allard, Carolyn B./0000-0002-7803-2243	NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R21 AT01159] Funding Source: Medline		Balshem H., 2011, 05225 VAESP DEP VET; Beck C.T, 2012, NURSING RES GENERATI; Benson H, 1993, MIND BODY MED USE YO, P233; Benson H, 1996, TIMELESS HEALING; Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Blake DD, 1990, CLINICIAN ADM PTSD S; Bormann J. E., MED CARE SP IN PRESS; Bormann JE, 2006, J ADV NURS, V53, P502, DOI 10.1111/j.1365-2648.2006.03752.x; Bormann JE, 2010, CONTEMPLATIVE PRACTI, P78; Bormann J, 2009, FAM COMMUNITY HEALTH, V32, P345, DOI 10.1097/FCH.0b013e3181b91fd6; Bormann JE, 2006, J BEHAV MED, V29, P359, DOI 10.1007/s10865-006-9063-6; Bormann JE, 2005, J HOLIST NURS, V23, P395, DOI 10.1177/0898010105278929; Bormann JE, 2013, J REHABIL RES DEV, V50, P769, DOI 10.1682/JRRD.2012.06.0118; Bormann JE, 2012, INT J BEHAV MED, V19, P496, DOI 10.1007/s12529-011-9186-1; Bormann JE, 2013, PSYCHOL TRAUMA-US, V5, P259, DOI 10.1037/a0027522; Bormann Jill E, 2007, J Healthc Qual, V29, P45; Bormann JE, 2008, J HOLIST NURS, V26, P109, DOI 10.1177/0898010107311276; Bormann JE, 2009, INT J BEHAV MED, V16, P74, DOI 10.1007/s12529-008-9007-3; Bormann Jill E, 2006, J Contin Educ Nurs, V37, P218; Bormann JE, 2009, J PSYCHOSOM RES, V66, P161, DOI 10.1016/j.jpsychores.2008.09.017; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Cahn BR, 2013, SOC COGN AFFECT NEUR, V8, P100, DOI 10.1093/scan/nss060; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chan Roxane Raffin, 2014, Medsurg Nurs, V23, P84; Derogatis L., 2000, BRIEF SYMPTOM INVENT; Easwaran E., 2008, PASSAGE MEDITATION B; Easwaran E, 2008, MANTRAM HDB PRACTICA; Easwaran E., 2005, STRENGTH STORM TRANS; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; Foa E.B., 2010, EFFECTIVE TREATMENTS; Fontana A, 2004, J NERV MENT DIS, V192, P579, DOI 10.1097/01.nmd.0000138224.17375.55; Frost ND, 2014, J TRAUMA STRESS, V27, P1, DOI 10.1002/jts.21881; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hunter L, 2011, APPL NURS RES, V24, P138, DOI 10.1016/j.apnr.2009.06.002; Kemeny ME, 2012, EMOTION, V12, P338, DOI 10.1037/a0026118; Kemppainen J., 2012, SIGM THET TAU INT NU; Kemppainen J, 2012, J ALTERN COMPLEM MED, V18, P76, DOI 10.1089/acm.2009.0489; Khusid M, 2013, PSYCHIAT ANN, V43, P340, DOI 10.3928/00485713-20130703-11; Koenig H., 2012, HDB RELIG HLTH; Lang AJ, 2012, BEHAV MODIF, V36, P759, DOI 10.1177/0145445512441200; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Leary S., 2013, W I NURS 46 ANN COMM; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Oman D., 2013, 34 ANN M SOC BEH MED; Oman D., 2003, J PSYCHOL CHRISTIANI, V22, P5; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Plumb DN, 2014, INT RES C INT MED HL; Richards TA, 2006, NURS SCI QUART, V19, P231, DOI 10.1177/0894318406289490; Schaefer FC, 2008, INT J PSYCHIAT MED, V38, P507, DOI 10.2190/PM.38.4.i; Shaw A, 2005, MENT HEALTH RELIG CU, V8, P1, DOI 10.1080/1367467032000157981; Thorp S, 2009, 2009 ANX DIS ASS AM; Travis F, 2010, CONSCIOUS COGN, V19, P1110, DOI 10.1016/j.concog.2010.01.007; Tsai J, 2012, MIL MED, V177, P27, DOI 10.7205/MILMED-D-11-00128; VA Office of Inspector General, 2012, 1100334115 VA OFF IN, P1; Vujanovic AA, 2011, PROF PSYCHOL-RES PR, V42, P24, DOI 10.1037/a0022272; Wachholtz A. B., 2013, APA HDB PSYCHOL RELI, V1, P311, DOI DOI 10.1037/14045-017; Ware JE, 2002, USERS MANUAL SF 12V2; Weathers FW, 1993, P 9 ANN C INT SOC TR; Weinrich S P, 1998, J Cancer Educ, V13, P213; WEINRICH SP, 1993, GERONTOLOGIST, V33, P491, DOI 10.1093/geront/33.4.491; Wolf DB, 2003, RES SOCIAL WORK PRAC, V13, P27, DOI 10.1177/104973102237471; Yong J, 2011, J CONTIN EDUC NURS, V42, P280, DOI 10.3928/00220124-20101201-04	65	13	13	0	10	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2809-6; 978-0-8261-2807-2	ANNU REV NURS RES-SE			2014	32						79	108		10.1891/0739-6686.32.79			30	Nursing	Nursing	BI5YJ	WOS:000412974700006	25222539				2021-06-18	
J	George, DR; Whitehouse, PJ				George, Daniel R.; Whitehouse, Peter J.			The War (on Terror) on Alzheimer's	DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE			English	Article						Alzheimer's disease; metaphor; traumatic brain injury; public health	TRAUMATIC BRAIN-INJURY; COGNITIVE DECLINE; DISEASE; DEMENTIA; SELF	In the decade following the tragedies of 9/11, a US-led "War on Terror'' has coincided with a US-led "War on Alzheimer's disease''. Not only has the rhetoric from these two wars overlapped and produced similar practical and conceptual problems, the campaigns have also become interwoven through the emerging public health issue of war-related head injuries, as well as a shared neglect for environmental contributions to human suffering. This article first explores similarities in the framing and prosecution of both wars, and then considers the long-term consequences of traumatic brain injuries (TBI) and traumatic environmental injuries (TEI) in the context of a society facing the increased prevalence of dementia. Ultimately, it is argued that addressing the challenges of cognitive aging and preventing violent social conflict both require a vernacular of higher ideals and values - as well as new language patterns rising out of the ecological movement - to trump the more expedient war rhetoric that has disproportionately marked public discourse around terrorism and Alzheimer's disease during the past decade.	[George, Daniel R.] Penn State Hershey Coll Med, Dept Humanities, Hershey, PA 17033 USA; [Whitehouse, Peter J.] Case Western Reserve Univ, Cleveland, OH 44106 USA	George, DR (corresponding author), Penn State Hershey Coll Med, Dept Humanities, 500 Univ Dr, Hershey, PA 17033 USA.	drg21@psu.edu					Alzheimer's Association, 2011, GEN ALZH DEF DIS BAB; Alzheimer's Disease International, 2010, WORLD ALZHEIMER REPO; ANNAS GJ, 1995, NEW ENGL J MED, V332, P744; Ballenger JF., 2006, SELF SENILITY ALZHEI; Behuniak SM, 2011, AGEING SOC, V31, P70, DOI 10.1017/S0144686X10000693; Brayne C., 2010, BRIT MED J, V341, P865; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Bush G. W., 2001, ADDR JOINT SESS C FO; Butler Robert Neil, 2008, LONGEVITY REVOLUTION; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; CNN.com, 2005, CNN             0620; CORKIN S, 1989, J NEUROSCI, V9, P3876; D'Alton S, 2011, J ALZHEIMERS DIS, V25, P571, DOI 10.3233/JAD-2011-110089; Dimond PF, 2010, GENET ENG BIOTECHN N, V30, P51; Ehrenreich B., 2001, HARPERS MAGAZINE NOV, P43; Ehrenreich B, 2009, BRIGHTSIDED RELENTLE; FOX P, 1989, MILBANK Q, V67, P58, DOI 10.2307/3350070; GAINES AD, 1992, SOC SCI MED, V35, P3, DOI 10.1016/0277-9536(92)90115-7; George DR, 2010, LANCET, V376, P586, DOI 10.1016/S0140-6736(10)61286-X; Gingrich N., 2009, MINNEAPOLIS STA 0921; Gubrium J.F, 1986, OLDTIMERS ALZHEIMERS; Hachinski V, 2008, JAMA-J AM MED ASSOC, V300, P2172, DOI 10.1001/jama.2008.525; HERSKOVITS E, 1995, MED ANTHROPOL Q, V9, P146, DOI 10.1525/maq.1995.9.2.02a00030; Holstein M, 1997, J AGING STUD, V11, P1, DOI 10.1016/S0890-4065(97)90008-6; Jobst K. A., 2000, J ALTERN COMPLEM MED, V6, P125, DOI DOI 10.1089/ACM.2000.6.125; Kennedy J. F., 1963, ADDRESS 18 GEN ASSEM; Kleinman Arthur, 1988, ILLNESS NARRATIVES; Korcyzn A. D., 2012, J ALZHEIMERS DIS, V30, P1; Lakoff G., 1980, METAPHORS WE LIVE; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martin E, 2007, BIPOLAR EXPEDITION: MANIA AND DEPRESSION IN AMERICAN CULTURE, P1; Martin E., 1994, FLEXIBLE BODIES ROLE; Martin E., 1987, WOMAN BODY CULTURAL; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Nietzsche F., DAWN DAY, P379; O'Connor S. D., 2010, AGE ALZHEIMERS; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pagel M., 2012, WIRED CULTURE ORIGIN; Pascrell Bill, 2007, FUNDING SIGNATURE IN; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sontag S., 1978, ILLNESS METAPHOR; Sontag S., 1989, AIDS ITS METAPHORS, V1st edn.; STEIN J, 2008, GREATER BOSTON PHYS; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Turner Victor, 1969, RITUAL PROCESS STRUC; Whitehouse PJ, 2011, J ALZHEIMERS DIS, V24, P11, DOI 10.3233/JAD-2010-101639; Whitehouse PJ, 2008, MYTH ALZHEIMERS WHAT; Yaffe K., 2011, INT C ALZH DIS	55	13	14	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1471-3012	1741-2684		DEMENTIA-LONDON	Dement.-Int. J. soc. Res. Pract.	JAN	2014	13	1					120	130		10.1177/1471301212451382			11	Gerontology	Geriatrics & Gerontology	AR7MF	WOS:000343763100009	24381043				2021-06-18	
J	Karol, RL				Karol, Robert L.			Team models in neurorehabilitation: Structure, function, and culture change	NEUROREHABILITATION			English	Article						Team models; rehabilitation teams; multidisciplinary; interdisciplinary; transdisciplinary; role release; scope of practice; culture change	TRAUMATIC BRAIN-INJURY; REHABILITATION TEAM; INTERDISCIPLINARY TEAM; COLLABORATION; HOSPITALS	INTRODUCTION: Neurorehabilitation requires a team effort. Over time the nature of teams has evolved from single discipline work through multi-disciplinary and inter-disciplinary teams to trans-disciplinary teams. However, there are inconsistencies in the literature and clinical practice as to the structure and function of these team models. Each model engenders advantages over its predecessor and unless the models are well understood clinicians may labor in a model that is less efficacious than the most transcendent model. OBJECTIVES: To define and examine the models of single discipline care, multi-disciplinary teams, inter-disciplinary teams, and trans-disciplinary teams and to review in depth trans-disciplinary teams as the most advanced team model. This paper will also consider professional roles and integration across disciplines as well as the crucial topics of staff selection, attendance in rounds and the nature of rounds, staff physical plant assignments, and leadership responsibilities. Leadership responsibilities that will be addressed include scope of practice and role release, peer pressure, and culture change issues. CONCLUSIONS: The trans-disciplinary model is the gold standard for teams in neurorehabilitation because they entail more integrated service delivery than do other teams. Trans-disciplinary teams also represent a more persons-centered approach. To initiate a trans-disciplinary model, team members must have excellent communication and shared decision making including persons with brain injury. Leadership must address staff selection, scope of practice and role-release. Otherwise, the model will fail due to peer pressure and institutional or program cultural variables.	[Karol, Robert L.] Welcov Healthcare, Minneapolis, MN USA; [Karol, Robert L.] Karol Neuropsychol Serv & Consulting, Minneapolis, MN USA	Karol, RL (corresponding author), 9637 Anderson Lakes Pkwy 162, Minneapolis, MN 55344 USA.	karolneuropsych@aol.com					American Board of Professional Psychology, 2013, REHABILITATION PSYCH; American Board of Professional Psychology/American Board of Rehabilitation Psychology, 2012, CERT GUID PROC CAND; American Physical Therapy Association Section on Pediatrics, 2010, FACT SHEET; American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Association of Rehabilitation Nurses, 2014, STRIV EXC ACH CERT R; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bergquist TF, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P38; Butt L., 2010, HDB REHABILITATION P, P451; Cheak-Zamora N, 2012, OXFORD HDB REHABILIT, P511; Commission on Accreditation of Rehabilitation Facilities, 2013, MED REH STAND MAN; Goonan M, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P406; Gordon R. M., PAIN MANAGE IN PRESS; Ivanhoe CB, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P385; Karol R.L., 2004, BRAIN INJ ASS MINN C; Karol R.L., 2011, 5 ANN NAT BRAIN INJ; Karol R. L., 1986, M MINN SPEECH LANG H; Karol RL., 2003, NEUROPSYCHOSOCIAL IN; Katz DI, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P2; King G, 2009, INFANT YOUNG CHILD, V22, P211, DOI 10.1097/IYC.0b013e3181abe1c3; Kneafsey R., 2002, BRIT J THERAPY REHAB, V9, P24; Law B. M., 2013, MONITOR PSYCHOL, V44, P40; Lyon S., 1980, J ASS SEVERELY HANDI, V5, P250; Malec JF, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1288; MCEWEN I, 2000, PROVIDING PHYS THERA; Niemeier J., 2011, OVERCOMING GRIEF LOS; Novack T. A, 2010, HDB REHABILITATION P, P165; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P299; Ravesloot C., 2012, OXFORD HDB REHABILIT, P143; Sander AM, 2008, J HEAD TRAUMA REHAB, V23, P271, DOI 10.1097/01.HTR.0000336839.68585.0f; Savage TA, 2009, PM&R, V1, P1091, DOI 10.1016/j.pmrj.2009.09.017; Sinclair LB, 2009, ARCH PHYS MED REHAB, V90, P1196, DOI 10.1016/j.apmr.2009.01.021; Smithson E. F., 2012, OXFORD HDB REHABILIT, P128; Smits SJ, 2003, ARCH PHYS MED REHAB, V84, P1332, DOI 10.1016/S0003-9993(03)00197-7; Stevenson J. E., 2014, PROFESSIONAL FUNCTIO; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P179, DOI 10.1016/j.apmr.2007.06.774; STRASSER DC, 1994, ARCH PHYS MED REHAB, V75, P177; Strasser DC, 2002, J REHABIL RES DEV, V39, P115; Tate R., 2012, OXFORD HDB REHABILIT, P248; Turner-Stokes L., 2011, MULTIDISCIPLINARY RE; Umphred D., 2001, NEUROLOGICAL REHABIL, P56; Umphred D. A., 2001, NEUROLOGICAL REHABIL, P3; Vash C. L, 2004, PSYCHOL DISABILITY; Warren A. M., 2014, PROFESSIONAL FUNCTIO; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Winkler P. A., 2001, NEUROLOGICAL REHABIL, P416; World Confederation for Physical Therapy, 2011, POL STAT; Wright BA., 1972, REHABIL PSYCHOL, V19, P38, DOI DOI 10.1037/H0090869	47	13	13	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					655	669		10.3233/NRE-141080			15	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100007	24796442				2021-06-18	
J	Lee, HD; Jang, SH				Lee, Han Do; Jang, Sung Ho			Changes of an injured fornix in a patient with mild traumatic brain injury: Diffusion tensor tractography follow-up study	BRAIN INJURY			English	Article						Brain plasticity; diffusion tensor imaging; fornix; memory; traumatic brain injury	FIBER TRACTOGRAPHY; AXONAL INJURY	Background: This study investigated the changes of an injured fornix from early stage to chronic stage in a patient with mild traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Methods: A 25-year-old female suffered from head trauma resulting from a pedestrian car accident. The patient showed a total score of 86 for memory impairment on the Memory Assessment Scale at 2 weeks after onset; however, her memory has been recovered to within normal range, with a score of 105 at 9 months after onset. Results: The middle portion of the right fornical crus showed narrowing and the discontinued left fornical crus was shortened on 9-month DTT compared with 2-week DTT. Two branches from the right fornical column and body were observed on 9-month DTT; in contrast, the two branches from the left fornical column and the left fornical body were elongated and shortened, respectively, on 9-month DTT compared with 2-week DTT. Conclusions: The narrowed lesion in the middle of the right fornical crus and the shortening of the discontinued left fornical crus appear to indicate degeneration following traumatic axonal injury. In contrast, the neural branches from both fornices appear to be related to the functional recovery mechanisms of the injured fornix.	[Lee, Han Do; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Thomas AG, 2011, RADIOGRAPHICS, V31, P1107, DOI 10.1148/rg.314105729; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D., 1981, WAIS R MANUAL WECHSL; Williams JM, 1991, MEMORY ASSESSMENT SC; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, J REHABIL MED, V45, P1078, DOI 10.2340/16501977-1232; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2013, YONSEI MED J, V54, P315, DOI 10.3349/ymj.2013.54.2.315; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469	20	13	13	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1485	1488		10.3109/02699052.2014.930178			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200018	24960471				2021-06-18	
J	Lequerica, A; Chiaravalloti, N; Cantor, J; Dijkers, M; Wright, J; Kolakowsky-Hayner, SA; Bushnick, T; Hammond, F; Bell, K				Lequerica, Anthony; Chiaravalloti, Nancy; Cantor, Joshua; Dijkers, Marcel; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.; Bushnick, Tamara; Hammond, Flora; Bell, Kathleen			The factor structure of the Pittsburgh Sleep Quality Index in persons with traumatic brain injury. A NIDRR TBI model systems module study	NEUROREHABILITATION			English	Article						Brain injury; sleep; measurement	PSYCHOMETRIC EVALUATION; DAYTIME SLEEPINESS; HEAD-INJURY; OF-LIFE; DISTURBANCES; REHABILITATION; PREVALENCE; ADULTS; WAKE; ORIENTATION	BACKGROUND: Sleep disturbances are common following traumatic brain injury (TBI). The Pittsburgh Sleep Quality Index (PSQI) is a widely used measure of sleep quality that has been used in numerous populations. Although this measure has been used in TBI research, there are few studies examining the psychometric properties in this population. OBJECTIVE: The current study examined the factor structure of the PSQI in a sample of persons with TBI and tested the one, two, and three factor models derived from previous studies in other populations. METHODS: A telephone interview was conducted with 243 individuals who had sustained a TBI. All participants were approximately one year post-injury. Factor analyses were conducted (exploratory and confirmatory) to examine the factor structure of the PSQI. RESULTS: Results confirm the fit of models previously tested in the literature but also reveal an alternative conceptualization of sleep containing both qualitative and quantitative factors. CONCLUSIONS: While the 3-factor model best fits the data in this TBI sample, the use of a 2-factor model is acceptable and may be more clinically relevant due to the grouping of time-related variables that could provide important information with regard to circadian rhythm disorders.	[Lequerica, Anthony; Chiaravalloti, Nancy] Kessler Fdn Res Ctr, W Orange, NJ 07052 USA; [Lequerica, Anthony; Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, W Orange, NJ 07052 USA; [Cantor, Joshua; Dijkers, Marcel] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Wright, Jerry; Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Resarch Ctr, San Jose, CA 95128 USA; [Bushnick, Tamara] NYU Sch Med, New York, NY USA; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Bell, Kathleen] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	Lequerica, A (corresponding author), Kessler Fdn Res Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	alequerica@kesslerfoundation.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Chiaravalloti, Nancy/0000-0003-2943-7567; Bell, Kathleen/0000-0002-0928-2046			Afonso P, 2011, INT J PSYCHIAT CLIN, V15, P311, DOI 10.3109/13651501.2011.605954; Afsar B, 2013, GEN HOSP PSYCHIAT, V35, P625, DOI 10.1016/j.genhosppsych.2013.05.001; Afsar B, 2013, HIGH BLOOD PRESS CAR, V20, P19, DOI 10.1007/s40292-013-0002-7; Cavalcanti PRA, 2013, NEUROREHABILITATION, V32, P337, DOI 10.3233/NRE-130853; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Beck SL, 2004, J PAIN SYMPTOM MANAG, V27, P140, DOI 10.1016/j.jpainsymman.2003.12.002; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Burkhalter H, 2011, PROG TRANSPLANT, V21, P27, DOI 10.7182/prtr.21.1.d15486415621357w; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Cole JC, 2006, SLEEP, V29, P112, DOI 10.1093/sleep/29.1.112; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Engstrom M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-12; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gentili A, 1997, AGING-CLIN EXP RES, V9, P207, DOI 10.1007/BF03340151; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; GUILLEMINAULT C, 1983, NEUROLOGY, V33, P1584, DOI 10.1212/WNL.33.12.1584; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Karkare K, 2013, ACTA NEUROL SCAND, V127, P116, DOI 10.1111/j.1600-0404.2012.01688.x; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Knutson KL, 2006, SLEEP, V29, P1503, DOI 10.1093/sleep/29.11.1503; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Magee CA, 2008, SLEEP BIOL RHYTHMS, V6, P222, DOI 10.1111/j.1479-8425.2008.00371.x; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mariman A, 2012, ACTA CLIN BELG, V67, P19, DOI 10.2143/ACB.67.1.2062621; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Soler X, 2013, COPD, V10, P156, DOI 10.3109/15412555.2012.729622; Tabachnick BG, 2013, USING MULTIVARIATE S	36	13	13	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	3					485	492		10.3233/NRE-141141			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AS8UO	WOS:000344523600015	25260230				2021-06-18	
J	Loher, S; Fatzer, ST; Roebers, CM				Loher, Sarah; Fatzer, Simone T.; Roebers, Claudia M.			Executive Functions After Pediatric Mild Traumatic Brain Injury: A Prospective Short-Term Longitudinal Study	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						children; executive functions; inhibition; mild traumatic brain injury; prospective longitudinal study; switching; working memory	WORKING-MEMORY; POSTCONCUSSIVE SYMPTOMS; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; HEAD-INJURY; CHILDREN; INHIBITION; IDENTIFICATION; ADOLESCENTS; PERFORMANCE	Traumatic brain injuries (TBIs) occur frequently in childhood and entail broad cognitive deficits, particularly in the domain of executive functions (EF). Concerning mild TBI (mTBI), only little empirical evidence is available on acute and postacute performance in EF. Given that EF are linked to school adaptation and achievement, even subtle deficits in performance may affect children's academic careers. The present study assessed performance in the EF components of inhibition, working memory (WM), and switching in children after mTBI. Regarding both acute and postacute consequences, performance trajectories were measured in 13 patients aged between 5 and 10 years and 13 controls who were closely matched in terms of sex, age, and education. Performance in the EF components of inhibition, switching, and WM was assessed in a short-term longitudinal design at 2, 6, and 12 weeks after the mTBI. Results indicate subtle deficits after mTBI, which became apparent in the longitudinal trajectory in the EF components of switching and WM. Compared with controls, children who sustained mTBI displayed an inferior performance enhancement across testing sessions in the first 6 weeks after the injury in switching and WM, resulting in a delayed deficit in the EF component of WM 12 weeks after the injury. Results are interpreted as mTBI-related deficits that become evident in terms of an inability to profit from previous learning opportunities, a finding that is potentially important for children's mastery of their daily lives.	[Loher, Sarah; Fatzer, Simone T.; Roebers, Claudia M.] Univ Bern, Dept Dev Psychobiol, CH-3000 Bern 9, Switzerland	Loher, S (corresponding author), Univ Bern, Dept Dev Psychobiol, Muesmattstr 45, CH-3000 Bern 9, Switzerland.	sarah.loher@psy.unibe.ch					Altermatt S., 2002, PAEDIATRICA, V13, P41; Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2000, BRAIN INJURY, V14, P679; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cragg L, 2012, Q J EXP PSYCHOL, V65, P209, DOI 10.1080/17470210903204618; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; Diamond A., 2006, LIFESPAN COGNITION M, P70, DOI DOI 10.1093/ACPROF:OSO/9780195169539.003.0006; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fatzer ST, 2012, J COGN DEV, V13, P454, DOI 10.1080/15248372.2011.608322; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; KAIL R, 1991, DEV PSYCHOL, V27, P259, DOI 10.1037/0012-1649.27.2.259; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; Menascu S., 2007, HEAD INJURY CHILDREN, P41; Michel E, 2008, SWISS J PSYCHOL, V67, P249, DOI 10.1024/1421-0185.67.4.249; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Roebers CM, 2011, EUR J DEV PSYCHOL, V8, P526, DOI 10.1080/17405629.2011.571841; Roebers CM, 2010, J GENET PSYCHOL, V171, P1, DOI 10.1080/00221320903300361; Roebers CM, 2009, DEVELOPMENTAL SCI, V12, P175, DOI 10.1111/j.1467-7687.2008.00755.x; Rose SA, 2011, DEVELOPMENTAL SCI, V14, P1161, DOI 10.1111/j.1467-7687.2011.01068.x; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Schmid C, 2008, Z ENTWICKL PADAGOGIS, V40, P2, DOI 10.1026/0049-8637.40.1.2; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zelazo P.D., 2008, HDB DEV COGNITIVE NE, V2nd ed., P553; Zelazo P. D., 2002, BLACKWELL HDB CHILDH, P445, DOI DOI 10.1002/9780470996652.CH20; Zelazo P. D., NATL I HLTH IN PRESS; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x	55	13	13	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2014	3	2					103	114		10.1080/21622965.2012.716752			12	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	AF8DR	WOS:000334946200003	24716869				2021-06-18	
J	Loughan, AR; Perna, R				Loughan, Ashlee R.; Perna, Robert			Performance and Specificity Rates in the Test of Memory Malingering: An Investigation Into Pediatric Clinical Populations	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						clinical diagnosis; neuropsychology; pediatrics; Test of Memory Malingering; TOMM	COGNITIVELY INTACT; NORMATIVE DATA; TOMM; INDIVIDUALS; DEPRESSION	Symptom validity tests are becoming standard as an effort measure during pediatric neuropsychological assessment. An important component of symptom validity test use is understanding limitations of these measures and how select clinical groups may have difficulty with them. Research has begun to clarify the limits of the Test of Memory Malingering (TOMM) with diverse childhood diagnoses. This study compared TOMM scores of children (N = 86) classified with common childhood disorders. Findings suggest that a substantial proportion of children performed below the recommended cutoff score of 45 on Trial 2 and attained varied specificity rates. This included children with conduct disorders (85%), affective disorders (92%), traumatic brain injury (83%), attention-deficit hyperactivity disorder (93%), learning disabilities (100%), and pervasive developmental disorder (88%). The group with the most children scoring below the cutoff was children with intellectual disabilities (76%). This finding is consistent with some of the adult research suggesting that very limited cognitive ability may compromise TOMM performance. Caution may be necessary when drawing conclusions about test-taking effort based on the recommended TOMM cutoff scores when evaluating children with disabilities.	[Loughan, Ashlee R.] Westside NeuroRehabil Serv, Dept Neuropsychol, Goodwill Ind, Lewiston, ME 04240 USA; [Perna, Robert] Walton Rehabil Hosp, Behav Med Dept, Augusta, GA USA	Loughan, AR (corresponding author), Westside NeuroRehabil Serv, Dept Neuropsychol, 618 Main St, Lewiston, ME 04240 USA.	aspicer88@yahoo.com	Perna, Robert/AAA-3871-2020; Perna, Robert/AAQ-7719-2021				Achenbach T. M., 1991, MANUAL CHILD BEHAV C; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Gilliam J.E., 1995, GILLIAM AUTISM RATIN; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Kovacs M., 1992, CHILD DEPRESSION INV; Langsford S., 2001, PSYCHIATRY, V22, P1; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Simon MJ, 2007, J CLIN PSYCHOL, V63, P339, DOI 10.1002/jclp.20351; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D, 1997, WAIS 3 ADM SCORING M	18	13	13	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2014	3	1					26	30		10.1080/21622965.2012.670584			5	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	AD0TI	WOS:000332946600003	24236938				2021-06-18	
S	Rispoli, M; Machalicek, W; Lang, R		Lancioni, GE; Singh, NN		Rispoli, Mandy; Machalicek, Wendy; Lang, Russell			Assistive Technology for People with Acquired Brain Injury	ASSISTIVE TECHNOLOGIES FOR PEOPLE WITH DIVERSE ABILITIES	Autism and Child Psychopathology Series		English	Article; Book Chapter							POST-COMA PERSONS; MINIMALLY CONSCIOUS STATE; PROFOUND MULTIPLE DISABILITIES; PORTABLE ELECTRONIC DEVICES; CLOSED HEAD-INJURY; VIRTUAL-REALITY; COGNITIVE REHABILITATION; ENVIRONMENTAL STIMULI; MEMORY AID; COMMUNICATION OPPORTUNITIES		[Rispoli, Mandy] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Machalicek, Wendy] Univ Oregon, Dept Special Educ & Clin Sci, Eugene, OR 97403 USA; [Lang, Russell] SW Texas State Univ, Dept Curriculum & Instruct, San Marcos, TX 78666 USA	Rispoli, M (corresponding author), Texas A&M Univ, Dept Educ Psychol, MS 4225 TAMU, College Stn, TX 77843 USA.	mrispoli@tamu.edu					[Anonymous], 1998, ASSIST TECHNOL; [Anonymous], 2004, ASSIST TECHNOL; Anschutz JR, 2010, TOP STROKE REHABIL, V17, P337, DOI 10.1310/tsr1705-337; Beck A. R., 1998, AUGMENTATIVE ALTERNA, V14, P184; Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Beukelman D. R., 1991, SURVEY AAC AUGMENTAT, V7, P100; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Broeren J, 2008, CEREBROVASC DIS, V26, P289, DOI 10.1159/000149576; Canedo A, 2002, BRAIN INJURY, V16, P453, DOI 10.1080/02699050110119853; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Crosbie JH, 2007, DISABIL REHABIL, V29, P1139, DOI 10.1080/09638280600960909; de Joode E, 2012, DISABIL REHABIL-ASSI, V7, P389, DOI 10.3109/17483107.2011.644623; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Doherty EP, 2002, INTERACT COMPUT, V14, P341, DOI 10.1016/S0953-5438(02)00022-X; Dry A, 2006, ASSIST TECHNOL, V18, P170, DOI 10.1080/10400435.2006.10131916; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fong K. N., 2010, J NEUROENG REHABIL, V30, P7; Fox LE, 2000, AUG ALTER COMMUN SER, P3; Fox LE, 2001, APHASIOLOGY, V15, P171, DOI 10.1080/02687040042000133; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Gamble D., 2002, J APPL REHABILITATIO, V33, P41, DOI DOI 10.1891/0047-2220.33.3.41; Garrett K. L., 1989, AUGMENTATIVE ALTERNA, V5, P55, DOI DOI 10.1080/07434618912331274976; Gartland D, 2004, NEUROPSYCHOL REHABIL, V14, P61, DOI 10.1080/09602010343000165; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Gorman P, 2003, NEUROREHABILITATION, V18, P57; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hartmann KD, 2010, WORK, V36, P399, DOI 10.3233/WOR-2010-1048; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Holburn S, 2004, BEHAV INTERVENT, V19, P25, DOI 10.1002/bin.147; Hutchinson J, 1997, TOP LANG DISORD, V18, P45, DOI 10.1097/00011363-199711000-00006; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Inge KJ, 2000, NEUROREHABILITATION, V15, P175; JOHANNSENHORBACH H, 1985, BRAIN LANG, V24, P74, DOI 10.1016/0093-934X(85)90098-7; Johnson RK, 2008, AUGMENT ALTERN COMM, V24, P269, DOI 10.1080/07434610802463957; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; KAPUR N, 2002, HDB MEMORY DISORDERS, P757; Kimberly MHA, 2005, AUGMENT ALTERN COMM, V21, P218, DOI 10.1080/07434610400016694; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; Klarborg B, 2012, ACCIDENT ANAL PREV, V48, P57, DOI 10.1016/j.aap.2011.05.004; Lancioni GE, 2008, RES DEV DISABIL, V29, P21, DOI 10.1016/j.ridd.2006.10.001; Lancioni GE, 2007, RES DEV DISABIL, V28, P50, DOI 10.1016/j.ridd.2005.12.001; Lancioni GE, 2006, RES DEV DISABIL, V27, P290, DOI 10.1016/j.ridd.2005.02.003; Lancioni GE, 2013, RES DEV DISABIL, V34, P809, DOI 10.1016/j.ridd.2012.10.008; Lancioni GE, 2012, RES DEV DISABIL, V33, P1964, DOI 10.1016/j.ridd.2012.05.027; Lancioni GE, 2012, RES DEV DISABIL, V33, P670, DOI 10.1016/j.ridd.2011.11.007; Lancioni GE, 2011, RES DEV DISABIL, V32, P1703, DOI 10.1016/j.ridd.2011.02.025; Lancioni GE, 2011, RES DEV DISABIL, V32, P1638, DOI 10.1016/j.ridd.2011.02.016; Lancioni GE, 2011, DISABIL REHABIL-ASSI, V6, P412, DOI 10.3109/17483107.2011.580899; Lancioni GE, 2011, J DEV PHYS DISABIL, V23, P173, DOI 10.1007/s10882-010-9212-2; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Lancioni GE, 2010, PERCEPT MOTOR SKILL, V110, P488, DOI 10.2466/PMS.110.2.488-492; Lancioni GE, 2009, DISABIL REHABIL-ASSI, V4, P367, DOI 10.1080/17483100903038584; Lancioni GE, 2010, J DEV PHYS DISABIL, V22, P119, DOI 10.1007/s10882-009-9163-7; Lancioni GE, 2009, RES DEV DISABIL, V30, P1084, DOI 10.1016/j.ridd.2009.03.004; Lancioni GE, 2009, RES DEV DISABIL, V30, P689, DOI 10.1016/j.ridd.2008.09.002; Lane AK, 2011, NEUROREHABILITATION, V28, P221, DOI 10.3233/NRE-2011-0651; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Lemoncello R, 2010, BRAIN INJURY, V24, P550, DOI 10.3109/02699050903446807; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Linden A, 2011, DISABIL REHABIL-ASSI, V6, P214, DOI 10.3109/17483107.2010.528142; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McKelvey ML, 2007, J MED SPEECH-LANG PA, V15, P305; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; National Association of State Head Injury Administrators, 2006, TRAUMATIC BRAIN INJU; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; Renton L. B. M., 1997, BRIT J OCCUPATIONAL, V60, P199; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; SANDLER AB, 1992, AM J OCCUP THER, V46, P163, DOI 10.5014/ajot.46.2.163; Scherer MJ, 2005, CRIT REV PHYS REHABI, V17, P195, DOI [DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.30, DOI 10.1615/CritRevPhysRehabilMed.v17.i3.30]; Schultheis MT, 2007, ASSIST TECHNOL, V19, P1, DOI 10.1080/10400435.2007.10131860; Singh S, 2000, APHASIOLOGY, V14, P157, DOI 10.1080/026870300401531; Sohlberg MM, 2007, BRAIN INJURY, V21, P531, DOI 10.1080/02699050701311000; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; U. S. Department of Health and Human Services Center for Disease Control, 2010, INJ PREV CONTR TRAUM; U. S. Department of Health and Human Services Center for Disease Control., 2012, STROK RISK FACT; U. S. Department of Health and Human Services National Institutes of Health, 1999, NIH CONS DEV C STAT; U. S. Department of Health and Human Services National Institutes of Health, 2013, NINDS TRAUM BRAIN IN; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Van Hulle A, 2006, BRAIN INJURY, V20, P101, DOI 10.1080/02699050500309684; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wald J, 2001, ST HEAL T, V81, P564; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace T, 2011, NEUROREHABILITATION, V28, P199, DOI 10.3233/NRE-2011-0649; Watson M., 1999, BRIT J THERAPY REHAB, V6, P436; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	116	13	13	0	7	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	2192-922X		978-1-4899-8029-8; 978-1-4899-8028-1	AUT CHILD PSYCHO			2014							21	52		10.1007/978-1-4899-8029-8_2	10.1007/978-1-4899-8029-8		32	Psychology, Developmental; Rehabilitation	Psychology; Rehabilitation	BB6LI	WOS:000344864800003					2021-06-18	
J	Stratton, KJ; Hawn, SE; Amstadter, AB; Cifu, DX; Walker, WC				Stratton, Kelcey J.; Hawn, Sage E.; Amstadter, Ananda B.; Cifu, David X.; Walker, William C.			Correlates of pain symptoms among Iraq and Afghanistan military personnel following combat-related blast exposure	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast exposure; combat; depression; military; OIF/OEF/OND; pain; polytrauma; posttraumatic stress disorder; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; HEALTH-CARE UTILIZATION; VETERANS; PREVALENCE; COMORBIDITY; DEPRESSION; PTSD; WAR; PERSPECTIVE	Pain complaints are highly prevalent among military servicemembers and Veterans of the recent combat operations in Iraq and Afghanistan. The high comorbidity of pain with conditions such as posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) underscores the importance of a greater understanding of factors associated with complex polytraumatic injuries among military personnel. The present study aimed to identify correlates of current pain among 201 U.S. military personnel who reported at least one blast experience during combat deployment (age [mean +/- standard deviation]: 27.20 +/- 7.58 yr). Theoretically derived subsets of variables were analyzed in successive hierarchical regression models to determine correlates of self-reported pain symptoms. Preliminary models evaluated demographic features, medical and injury characteristics (e.g., TBI classification), psychosocial history (e.g., trauma exposure), and psychiatric variables. A final model was then derived, in which older age, possible or probable mild TBI, depression symptoms, and PTSD re-experiencing symptoms emerged as significant correlates of pain. The findings further the understanding of polytrauma symptoms among military personnel by identifying specific patient characteristics and comorbidity patterns related to pain complaints. Increased awareness of demographic, psychiatric, or medical factors implicated in pain will enhance comprehensive clinical assessment and intervention efforts.	[Stratton, Kelcey J.; Cifu, David X.; Walker, William C.] Hunter Holmes McGuire Dept Vet Affairs Med Ctr, Richmond, VA USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stratton, Kelcey J.; Hawn, Sage E.; Amstadter, Ananda B.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Cifu, David X.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA	Stratton, KJ (corresponding author), Hunter Holmes McGuire VA Med Ctr, 1201 Broad Rock Blvd 116-B, Richmond, VA 23249 USA.	Kelcey.Stratton@va.gov		Cifu, David/0000-0003-1600-9387	VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Program [W191ZSQ8118N6200001]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02AA023239] Funding Source: NIH RePORTER	This material was based on work supported by the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment (K. J. Stratton) and is based upon work supported in part by the Defense and Veterans Brain Injury Center and the U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Program (grant W191ZSQ8118N6200001, W. C. Walker).	ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; Asmundson GJG, 2004, EUR J PAIN, V8, P345, DOI 10.1016/j.ejpain.2003.10.008; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Burris JL, 2009, J OROFAC PAIN, V23, P243; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Department of Veterans Affairs Veterans Health Administration Office of Public Health, 2013, AN VA HLTH CAR UT OP; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Gatchel RJ, 2004, AM PSYCHOL, V59, P795, DOI 10.1037/0003-066X.59.8.795; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Jakupcak M, 2006, J TRAUMA STRESS, V19, P471, DOI 10.1002/jts.20145; Keogh E, 2006, EUR J PAIN, V10, P413, DOI 10.1016/j.ejpain.2005.05.007; Kubany ES., 2004, TRAUMATIC LIFE EVENT; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Masten AS, 2012, ANNU REV PSYCHOL, V63, P227, DOI 10.1146/annurev-psych-120710-100356; MCFARLANE AC, 1994, J PSYCHOSOM RES, V38, P715, DOI 10.1016/0022-3999(94)90024-8; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moeller-Bertram T, 2014, PSYCHOSOMATICS, V55, P172, DOI 10.1016/j.psym.2013.01.011; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Outcalt SD, 2014, PAIN MED, V15, P1872, DOI 10.1111/pme.12045; Palyo SA, 2005, PAIN, V117, P121, DOI 10.1016/j.pain.2005.05.028; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Sherman JJ, 2000, CLIN J PAIN, V16, P127, DOI 10.1097/00002508-200006000-00006; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Sledjeski EM, 2008, J BEHAV MED, V31, P341, DOI 10.1007/s10865-008-9158-3; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Ullrich PM, 2013, REHABIL PSYCHOL, V58, P158, DOI 10.1037/a0032047; Villano CL, 2007, J REHABIL RES DEV, V44, P167, DOI 10.1682/JRRD.2006.05.0052; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Weathers F.W., 1993, P 9 ANN M INT SOC TR	42	13	13	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	8					1189	1202		10.1682/JRRD.2014.04.0111			14	Rehabilitation	Rehabilitation	CA2ZZ	WOS:000348776400003	25789376	Bronze			2021-06-18	
J	Tsai, MC; Tsai, KJ; Wang, HK; Sung, PS; Wu, MH; Hung, KW; Lin, SH				Tsai, Meng-Che; Tsai, Kuen-Jer; Wang, Hao-Kuang; Sung, Pi-Shan; Wu, Ming-Hsiu; Hung, Kuo-Wei; Lin, Sheng-Hsiang			Mood Disorders after Traumatic Brain Injury in Adolescents and Young Adults: A Nationwide Population-Based Cohort Study	JOURNAL OF PEDIATRICS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; PSYCHIATRIC-DISORDERS; DEPRESSIVE SYMPTOMS; CHILDREN; TAIWAN; PREVALENCE; PREDICTORS; SEVERITY; PATTERNS	Objective To delineate the relationship between traumatic brain injury (TBI) and mood disorders from population-based data in Taiwan. Study design This prospectively followed cohort study involved a subset of the National Health Insurance Research Database containing complete inpatient and outpatient data of 1 million randomly drawn beneficiaries. We included 10- to 24-year-old patients (n = 15 203) receiving the diagnosis of TBI in ambulatory visits or hospitalization from 2000-2004 and their age-and sex-matched comparison insureds using health service in the same year (n = 76 015). Diagnosis of mood disorders was recorded within 5 years after the traumatic event or index use of health service. Baseline demographics, clinical characteristics, and premorbid psychiatric conditions were compared using chi(2) analysis. Increased risk during the 5-year follow-up period was represented by crude and adjusted hazard ratios with 95% CI using a Cox proportional hazard regression. Results A total of 451/15 203 patients with TBI (2.97%) received a diagnosis of mood disorders in the 5-year follow-up period compared with 1153/97 445 individuals (1.52%) without antecedent TBI. After adjusting for select premorbid comorbidities, TBI remained a significant predisposing factor with a 1.96-fold (95% CI 1.74-2.22) increase in risk of mood disorders. Conclusions Our findings show a higher likelihood of manifesting mood disorders in adolescents and young adults who sustained a prior TBI. Health professionals should carefully monitor both the physical and psychological impacts of head trauma.	[Tsai, Meng-Che; Tsai, Kuen-Jer; Wang, Hao-Kuang; Sung, Pi-Shan; Wu, Ming-Hsiu; Hung, Kuo-Wei; Lin, Sheng-Hsiang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Meng-Che] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70101, Taiwan; [Wang, Hao-Kuang] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Sung, Pi-Shan] Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan, Taiwan; [Wu, Ming-Hsiu] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Hung, Kuo-Wei] Yuans Gen Hosp, Dept Neurol, Kaohsiung, Taiwan	Lin, SH (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, 138 Shengli Rd, Tainan 70101, Taiwan.	shlin922@mail.ncku.edu.tw	Tsai, Kuen-Jer/B-9393-2009; Tsai, Meng-Che/AAE-6715-2021	Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Meng-Che/0000-0003-1057-3315	National Cheng Kung University Hospital [NCKUH-10001022]	Supported by the National Cheng Kung University Hospital (NCKUH-10001022). The authors declare no conflicts of interest.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Capizzano AA, 2010, J NEUROPSYCH CLIN N, V22, P370, DOI 10.1176/appi.neuropsych.22.4.370; Chang RE, 2002, J FORMOS MED ASSOC, V101, P52; Chen CF, 2009, ACCIDENT ANAL PREV, V41, P963, DOI 10.1016/j.aap.2009.05.013; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chen M-S, 2005, TW J PUBLIC HLTH, V24, P15; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Goldstein BI, 2012, ARCH PEDIAT ADOL MED, V166, P362, DOI 10.1001/archpediatrics.2011.832; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Lau JYF, 2008, J CHILD PSYCHOL PSYC, V49, P142, DOI 10.1111/j.1469-7610.2007.01803.x; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Lundy CT, 2010, EMERG MED J, V27, P659, DOI 10.1136/emj.2009.079020; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Max JE, 1998, BRAIN INJURY, V12, P31; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Tsai MC, 2013, ARCH DIS CHILD, V98, P9, DOI 10.1136/archdischild-2012-301629; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wang JY, 2012, INT J SOC PSYCHIATR, V58, P425, DOI 10.1177/0020764011408000; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	37	13	13	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JAN	2014	164	1					136	+		10.1016/j.jpeds.2013.08.042			7	Pediatrics	Pediatrics	276FU	WOS:000328734700031	24112864				2021-06-18	
J	Umerani, MS; Abbas, A; Sharif, S				Umerani, Muhammad Sohail; Abbas, Asad; Sharif, Salman			Traumatic Brain Injuries: Experience from a Tertiary Care Center in Pakistan	TURKISH NEUROSURGERY			English	Article						Accident; Contusion; CT scan brain; Head trauma; Traumatic brain injury (TBI)	MINOR HEAD-INJURY; NEW-ORLEANS CRITERIA; MOTOR-VEHICLE; CT; MILD; HEMORRHAGE; RULE; ASSOCIATION; TOMOGRAPHY; MANAGEMENT	AIM: Traumatic Brain Injury (TBI) is one of the leading causes for morbidity, mortality and economic loss. The impact is much worse in developing countries like Pakistan. The objective of our study was to highlight the etiological pattern and distribution of TBI in Pakistan. MATERIAL and METHODS: From July 2009 to June 2011, 1378 patients presenting to our Accident and Emergency Department with head injury were included in the study. Patients underwent detailed clinical and radiological evaluation as per trauma protocol. RESULTS: The most commonly affected age group was 21 to 30 years (34.1%) with male to female ratio of 3.3:1. Injuries were predominantly caused by road traffic accident (62.6%), followed by fall (31.7%) and assault (5.5%). Amongst those with RTA less than 1% of the patients were wearing proper safety equipment. The most common CT scan finding was brain contusion (14.1%); others included traumatic sub-arachnoid hemorrhage (7.1%), subdural hematoma (7.6%), extra-dural hematoma (5.8%) and depressed skull fracture (4.6%). CONCLUSION: Motorbike accidents are a major cause of severe traumatic brain injury. Although this can be minimized by wearing proper helmets, its use is limited. Moreover, there is an imperative need to implement proper referral system amongst hospitals citywide in order to minimize the consequences of secondary brain injury.	[Umerani, Muhammad Sohail; Abbas, Asad; Sharif, Salman] Liaquat Natl Hosp, Dept Neurosurg, Karachi, Pakistan; [Abbas, Asad] Ziauddin Univ Hosp, Karachi, Pakistan	Umerani, MS (corresponding author), Liaquat Natl Hosp, Dept Neurosurg, Karachi, Pakistan.	drumerani@yahoo.com	Umerani, Muhammad Sohail/Y-9707-2019	Umerani, Muhammad Sohail/0000-0001-7598-6650			[Anonymous], 2001, J TRAUMA, V51, P516; Bainbridge J, 2012, BRIT J RADIOL, V85, P183, DOI 10.1259/bjr/56169980; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bakshi R, 2000, NEUROLOGY, V55, P1595, DOI 10.1212/WNL.55.10.1595; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Faul M, 2010, TRAUMATIC BRAIN UNJU; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Glauser J, 2004, CLEV CLIN J MED, V71, P353, DOI 10.3949/ccjm.71.4.353; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; Harr ME, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-25; Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038; Hyder A A, 2000, Inj Prev, V6, P199, DOI 10.1136/ip.6.3.199; Jinnah Postgraduate Medical Centre, 2011, HALF YEARL REP JAN J; Jooma R, 2005, J PAK MED ASSOC, V55, P630; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee Bruce, 2005, NeuroRx, V2, P372; Lee YB, 2009, J KOREAN NEUROSURG S, V46, P451, DOI 10.3340/jkns.2009.46.5.451; Leong LB, 2012, EUR J EMERG MED; Marion DW, 2006, NEUROSURGERY, V58, P655; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Medscape, 2011, TRAUM BRAIN INJ TBI; Nasir S, 2011, CHIN J TRAUMATOL, V14, P297, DOI 10.3760/cma.j.issn.1008-1275.2011.05.008; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; O'Neill B, 2002, BRIT MED J, V324, P1142, DOI 10.1136/bmj.324.7346.1142; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Puder DR, 1999, AM J PUBLIC HEALTH, V89, P1736, DOI 10.2105/AJPH.89.11.1736; Raja IA, 2001, WORLD J SURG, V25, P1230; Rivara F P, 1999, Inj Prev, V5, P194; Samandouras G., 2010, NEUROSURGEONS HDB, P207; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Siddiqui FM, 2011, NEUROTHERAPEUTICS, V8, P28, DOI 10.1007/s13311-010-0009-x; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Stevens JA, 2002, INJ PREV, V8, P272, DOI 10.1136/ip.8.4.272; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Swanson JO, 2012, PEDIATR RADIOL, V42, P974, DOI 10.1007/s00247-012-2372-8; Thurman DJ, 2001, HEAD TRAUMA, P327; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60	51	13	14	0	6	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JAN	2014	24	1					19	24		10.5137/1019-5149.JTN.7080-12.1			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AB3AI	WOS:000331663300006	24535786				2021-06-18	
J	Rognas, L; Hansen, TM; Kirkegaard, H; Tonnesen, E				Rognas, Leif; Hansen, Troels Martin; Kirkegaard, Hans; Tonnesen, Else			Standard operating procedure changed pre-hospital critical care anaesthesiologists' behaviour: a quality control study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Pre hospital; Out of hospital; Prehospital emergency care (MeSH); Emergency medical services (MeSH); Helicopter emergency medical service; Critical care (MeSH); Controlled ventilation; Standard operating procedure; Airway management (MeSH); Endotracheal intubation (MeSH); Patient safety	ADVANCED AIRWAY MANAGEMENT; TRAUMATIC BRAIN-INJURY; TIDAL VOLUME; VENTILATION; GUIDELINES; RESUSCITATION; INTUBATION; COUNCIL; DISEASE	Introduction: The ability of standard operating procedures to improve pre-hospital critical care by changing pre-hospital physician behaviour is uncertain. We report data from a prospective quality control study of the effect on pre-hospital critical care anaesthesiologists' behaviour of implementing a standard operating procedure for pre-hospital controlled ventilation. Materials and methods: Anaesthesiologists from eight pre-hospital critical care teams in the Central Denmark Region prospectively registered pre-hospital advanced airway-management data according to the Utstein-style template. We collected pre-intervention data from February 1st 2011 to January 31st 2012, implemented the standard operating procedure on February 1st 2012 and collected post intervention data from February 1st 2012 until October 31st 2012. We included transported patients of all ages in need of controlled ventilation treated with pre-hospital endotracheal intubation or the insertion of a supraglottic airways device. The objective was to evaluate whether the development and implementation of a standard operating procedure for controlled ventilation during transport could change pre-hospital critical care anaesthesiologists' behaviour and thereby increase the use of automated ventilators in these patients. Results: The implementation of a standard operating procedure increased the overall prevalence of automated ventilator use in transported patients in need of controlled ventilation from 0.40 (0.34-0.47) to 0.74 (0.69-0.80) with a prevalence ratio of 1.85 (1.57-2.19) (p = 0.00). The prevalence of automated ventilator use in transported traumatic brain injury patients in need of controlled ventilation increased from 0.44 (0.26-0.62) to 0.85 (0.62-0.97) with a prevalence ratio of 1.94 (1.26-3.0) (p = 0.0039). The prevalence of automated ventilator use in patients transported after return of spontaneous circulation following pre-hospital cardiac arrest increased from 0.39 (0.26-0.48) to 0.69 (0.58-0.78) with a prevalence ratio of 1.79 (1.36-2.35) (p = 0.00). Conclusion: We have shown that the implementation of a standard operating procedure for pre-hospital controlled ventilation can significantly change pre-hospital critical care anaesthesiologists' behaviour.	[Rognas, Leif] Norwegian Air Ambulance Fdn, Dept Res & Dev, N-1441 Drobak, Norway; [Rognas, Leif] Viborg Reg Hosp, Dept Anaesthesiol, Prehosp Crit Care Team, DK-8800 Viborg, Denmark; [Rognas, Leif; Hansen, Troels Martin] Aarhus Univ Hosp, Prehosp Crit Care Team, DK-8200 Aarhus N, Denmark; [Rognas, Leif; Hansen, Troels Martin] Dept Prehosp Med Serv, DK-8200 Aarhus N, Denmark; [Kirkegaard, Hans] Aarhus Univ Hosp, Ctr Emergency Med Res, DK-8200 Aarhus N, Denmark; [Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol, DK-8000 Aarhus, Denmark	Rognas, L (corresponding author), Norwegian Air Ambulance Fdn, Dept Res & Dev, POB 94, N-1441 Drobak, Norway.	leifrogn@rm.dk	Rognas, Leif/AAI-9373-2020; Rognas, Leif/AAF-6182-2020	Rognas, Leif/0000-0002-2542-565X; 	Norwegian Air Ambulance Foundation; Laerdal Foundation for Acute Medicine; Central Denmark Region	A special thanks to EMT Tinna Hojmose Ostergaard for her invaluable assistance in all the practicalities of the implementation and data collection. The Norwegian Air Ambulance Foundation, The Laerdal Foundation for Acute Medicine and The Central Denmark Region founded the study by sponsoring the salary of LR. TMH, HK and ET were funded by their departments. The sponsors have had no influence on study design, data collection, data analysis and-interpretation, the writing of the manuscript or the decision to submit the paper for publication.	[Anonymous], 2000, NEW ENGL J MED, V342, P1301; Bosse G, 2011, J INT MED RES, V39, P267, DOI 10.1177/147323001103900129; Bosse G, 2006, BEST PRACT RES-CLIN, V20, P379, DOI 10.1016/j.bpa.2006.02.005; CHESTERS A, 2013, EMERGENCY MED J EMJ, V2013, P2013, DOI DOI 10.1136/EMERMED-2012-201846; Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; de Oliveira RP, 2010, CRIT CARE, V14, DOI 10.1186/cc8919; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Forsetlund Louise, 2002, J Health Serv Res Policy, V7, P10, DOI 10.1258/1355819021927629; Francis RC, 2013, EUR J EMERG MED; Francis RCE, 2010, EMERG MED J, V27, P350, DOI 10.1136/emj.2008.070284; Haines A, 2001, EVIDENCE BASED PRACT, P157; Harris T, 2011, EMERG MED J, V28, P225, DOI 10.1136/emj.2009.088302; Hejselbaek J, 2012, DAN MED J, V59; Lee HM, 2008, EMERG MED J, V25, P632, DOI 10.1136/emj.2007.053678; Martinon C, 2011, PEDIATR CRIT CARE ME, V12, P65, DOI 10.1097/PCC.0b013e3181e2a244; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; OXMAN AD, 2001, EVIDENCE BASED PRACT, P101; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-75; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Rognas LK, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-10; Sollid SJM, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-58; von Vopelius-Feldt J, 2013, EUR J EMERG MED, V20, P382, DOI 10.1097/MEJ.0b013e32835b08b7; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25	28	13	13	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 5	2013	21								84	10.1186/1757-7241-21-84			7	Emergency Medicine	Emergency Medicine	282OB	WOS:000329180200001	24308781	DOAJ Gold, Green Published			2021-06-18	
J	Forcelli, PA; Kalikhman, D; Gale, K				Forcelli, Patrick A.; Kalikhman, David; Gale, Karen			Delayed Effect of Craniotomy on Experimental Seizures in Rats	PLOS ONE			English	Article							EMBRYONIC DOPAMINE NEURONS; SEVERE PARKINSONS-DISEASE; SHAM NEUROSURGICAL PROCEDURES; INTRACTABLE PARTIAL EPILEPSY; TRAUMATIC BRAIN-INJURY; ELECTRICAL-STIMULATION; DEPTH ELECTRODES; ANTERIOR NUCLEUS; GENE-EXPRESSION; CLINICAL-TRIALS	Neurosurgical therapeutic interventions include components that are presumed to be therapeutically inert, such as craniotomy and electrode implantation. Because these procedures may themselves exert neuroactive actions, with anecdotal evidence suggesting that craniotomy and electrode placement may have a particularly significant impact on epileptic seizures, the importance of their inclusion in sham control groups has become more compelling. Here we set out to test the hypothesis that craniotomy alone is sufficient to alter experimental seizures in rats. We tested adult male rats for seizures evoked by pentylenetetrazole (70 mg/kg) between 3 and 20 days following placement of bilateral craniotomies (either 2.5 or 3.5 mm in diameter) in the parietal bone of the skull, without penetrating the dura. Control (sham-operated) animals underwent anesthesia and surgery without craniotomy. We found that craniotomy significantly decreased the severity of experimental seizures on postoperative days 3, 6, and 10; this effect was dependent on the size of craniotomy. Animals with craniotomies returned to control seizure severity by 20 days post-craniotomy. These data support the hypothesis that damage to the skull is sufficient to cause a significant alteration in seizure susceptibility over an extended postoperative period, and indicate that this damage should not be considered neurologically inert.	[Forcelli, Patrick A.; Kalikhman, David; Gale, Karen] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA	Forcelli, PA (corresponding author), Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA.	paf22@georgetown.edu		Forcelli, Patrick/0000-0003-1763-060X	National Institutes of Health/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD046388]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD046388] Funding Source: NIH RePORTER	PAF was supported by grant number T32HD046388 from the National Institutes of Health/National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 1997, NATURE, V387, P360, DOI 10.1038/387360a0; Andrushko VA, 2008, AM J PHYS ANTHROPOL, V137, P4, DOI 10.1002/ajpa.20836; Brim RL, 2013, J MED ETHICS, V39, P703, DOI 10.1136/medethics-2012-101045; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Cohen PD, 2012, LANCET NEUROL, V11, P1022, DOI 10.1016/S1474-4422(12)70277-6; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Finger S, 2001, NEUROSURGERY, V48, P911, DOI 10.1097/00006123-200104000-00045; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Forcelli PA, 2011, EPILEPSIA, V52, pE20, DOI 10.1111/j.1528-1167.2010.02971.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freed CR, 2011, NEUROTHERAPEUTICS, V8, P549, DOI 10.1007/s13311-011-0082-9; Galpern WR, 2012, LANCET NEUROL, V11, P643, DOI 10.1016/S1474-4422(12)70064-9; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; JORGENSEN JB, 1988, ACTA NEUROCHIR, V93, P3, DOI 10.1007/BF01409893; Katariwala NM, 2001, NEUROLOGY, V57, P1505, DOI 10.1212/WNL.57.8.1505; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; LOSCHER W, 1993, NEUROCHEM RES, V18, P775, DOI 10.1007/BF00966772; LOSCHER W, 1995, BRAIN RES, V697, P197, DOI 10.1016/0006-8993(95)00843-F; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Lv XL, 2013, WORLD NEUROSURG, V80, P897, DOI 10.1016/j.wneu.2012.08.009; Mann JM, 2009, J NEUROL NEUROSUR PS, V80, P794, DOI 10.1136/jnnp.2008.159558; Missios Symeon, 2007, Neurosurg Focus, V23, pE11; Morishita T, 2010, J NEUROSURG, V112, P491, DOI 10.3171/2009.7.JNS09150; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ng MSM, 2006, EPILEPSY RES, V72, P97, DOI 10.1016/j.eplepsyres.2006.06.007; Olanow CW, 2001, NEW ENGL J MED, V345, P146; Panourias IG, 2005, NEUROSURGERY, V57, P181, DOI 10.1227/01.NEU.0000163416.66374.48; Papagrigorakis MJ, 2014, WORLD NEUROSURG, V81, P431, DOI 10.1016/j.wneu.2013.01.044; Redmond DE, 2001, NEW ENGL J MED, V345, P146; Schulze-Bonhage A, 2010, J NEUROL NEUROSUR PS, V81, P352, DOI 10.1136/jnnp.2009.180075; Tykocki T, 2013, STEREOT FUNCT NEUROS, V91, P12, DOI 10.1159/000342161; Verano JW, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P223; Vonck K, 2003, ACTA NEUROL BELG, V103, P212; Wan DC, 2008, J CRANIOFAC SURG, V19, P1292, DOI 10.1097/SCS.0b013e3181843609; Wellmer J, 2012, EPILEPSIA, V53, P1322, DOI 10.1111/j.1528-1167.2012.03545.x; Wobbrock J.O., 2011, P ACM C HUM FACTORS, P143; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81401	10.1371/journal.pone.0081401			6	Multidisciplinary Sciences	Science & Technology - Other Topics	265KD	WOS:000327949300091	24324691	DOAJ Gold, Green Published			2021-06-18	
J	Binenbaum, G; Christian, CW; Ichord, RN; Ying, GS; Simon, MA; Romero, K; Pollock, AN; Forbes, BJ				Binenbaum, Gil; Christian, Cindy W.; Ichord, Rebecca N.; Ying, Gui-shaung; Simon, Melissa A.; Romero, Kathleen; Pollock, Avrum N.; Forbes, Brian J.			Retinal hemorrhage and brain injury patterns on diffusion-weighted magnetic resonance imaging in children with head trauma	JOURNAL OF AAPOS			English	Article							SHAKEN-BABY SYNDROME; HYPOXIC-ISCHEMIC INJURY; MENTAL-RETARDATION; YOUNG-CHILDREN; SHAKING; DAMAGE; INFANTS	PURPOSE To evaluate associations between retinal hemorrhage severity and hypoxic-ischemic brain injury (HIT) patterns by diffusion-weighted magnetic resonance imaging (DIV-MRI) in young children with head trauma. METHODS DW-MRI images of a consecutive cohort study of children under age 3 years with inflicted or accidental head trauma who had eye examinations were analyzed by two independent masked examiners for type, severity, and location of primary lesions attributable to trauma, HIT secondary to trauma, and mixed injury patterns. Retinal hemorrhage was graded retrospectively on a scale from 1 (none) to 5 (severe). RESULTS Retinal hemorrhage score was 3-5 in 6 of 7 patients with predominantly post-traumatic HII pattern and 4 of 32 who had traumatic injury without HIT (P < 0.001) on DW-MRI imaging. Severe retinal hemorrhage was observed in absence of HIT but only in inflicted injury. Retinal hemorrhage severity was correlated with HIT severity (rho = 0.53, P < 0.001) but not traumatic injury severity (rho = -0.10, P = 0.50). HII severity was associated with retinal hemorrhage score 3-5 (P = 0.01), but traumatic injury severity was not (P = 0.37). CONCLUSIONS During inflicted head injury, a distinct type of trauma occurs causing more global brain injury with HIT and more severe retinal hemorrhages. HIT is not a necessary factor for severe retinal hemorrhage to develop from inflicted trauma.	[Binenbaum, Gil; Forbes, Brian J.] Childrens Hosp Philadelphia, Div Ophthalmol, Philadelphia, PA 19104 USA; [Christian, Cindy W.; Ichord, Rebecca N.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Binenbaum, Gil; Ying, Gui-shaung; Forbes, Brian J.] Childrens Hosp Philadelphia, Dept Neuroradiol, Philadelphia, PA 19104 USA; [Binenbaum, Gil; Ying, Gui-shaung; Forbes, Brian J.] Perelman Sch Med, Dept Ophthalmol, Philadelphia, PA USA; [Christian, Cindy W.] Perelman Sch Med, Dept Pediat, Philadelphia, PA USA; [Ichord, Rebecca N.] Perelman Sch Med, Dept Neurol, Philadelphia, PA USA; [Pollock, Avrum N.] Perelman Sch Med, Dept Radiol, Philadelphia, PA USA; [Pollock, Avrum N.] Univ Penn, Philadelphia, PA 19104 USA; [Simon, Melissa A.] Univ Med & Dent New Jersey, Dept Ophthalmol, Newark, NJ 07103 USA; [Romero, Kathleen] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA	Binenbaum, G (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd,9 MAIN, Philadelphia, PA 19104 USA.	binenbaum@email.chop.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 EY015398, P30 EY01583-26, R01NS39679]; Loan Repayment ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY001583, K12EY015398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER	Supported by the National Institutes of Health grants K12 EY015398, P30 EY01583-26, R01NS39679, and Loan Repayment Program.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Agrawal S, 2012, PEDIATRICS, V129, pE1388, DOI 10.1542/peds.2011-2772; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J ROENTGENOL, V114, P217; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; Phillips MD, 1999, NEUROIMAG CLIN N AM, V9, P41	17	13	13	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1091-8531	1528-3933		J AAPOS	J. AAPOS	DEC	2013	17	6					603	608		10.1016/j.jaapos.2013.09.002			6	Ophthalmology; Pediatrics	Ophthalmology; Pediatrics	277DU	WOS:000328799900009	24215807	Green Accepted			2021-06-18	
J	Covassin, T; Crutcher, B; Wallace, J				Covassin, Tracey; Crutcher, Bryan; Wallace, Jessica			Does a 20 minute cognitive task increase concussion symptoms in concussed athletes?	BRAIN INJURY			English	Article						Cognitive rest; concussion; neurocognitive testing; post-concussion symptoms scale	HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; AGREEMENT STATEMENT; FOOTBALL PLAYERS; IMPACT; SPORT; RECOVERY; SENSITIVITY; MANAGEMENT; VALIDITY	Objective: The purpose of the present study was to examine if concussion symptoms worsened immediately (i.e. 20 minutes) following performance on a scomputerized neurocognitive test. Research design: Cross-sectional study; Level of evidence, 2. Methods and procedures: A total of 165 athletes with a concussion participated in the study. Participants completed the Immediate Post-concussion Assessment and Cognitive Test (ImPACT) and Post-concussion Symptom Scale (PCSS) at baseline, 3 and 10 days post-concussion. Participants completed a second PCSS following the ImPACT test at 3 and 10 days post-injury. Main outcomes and results: Athletes with a concussion exhibited greater symptoms post-neurocognitive test 3 days post-concussion on headache (p = 0.01), nausea (p = 0.03), dizziness (p = 0.03), sadness (p = 0.005), mentally foggy (p = 0.002) and visual problems (p = 0.007). Athletes with a concussion demonstrated increased symptoms on sadness (p = 0.00) and difficulty remembering (p = 0.03) at 10 days post-injury. Athletes also demonstrated neurocognitive impairments in verbal memory (p = 0.009) and slower reaction time (p = 0.01) 10 days post-concussion and visual memory (p = 0.000) and motor processing speed (p = 0.000) impairments at 3 days post-injury. Conclusion: The current study suggests that there may be an increase in concussion symptoms following a 20-minute cognitive task. Thus, it illustrates the need for clinicians to make sure they are symptom free with both physical and cognitive testing.	[Covassin, Tracey; Crutcher, Bryan; Wallace, Jessica] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA	Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 105 IM Sport Circle, E Lansing, MI 48824 USA.	covassin@msu.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P287; Lovell MR, 2001, IMMEDIATE POSTCONCUS; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Valentine V, 2012, AM FAM PHYSICIAN, V85, P100; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213	31	13	13	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1589	1594		10.3109/02699052.2013.823656			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400013	24143995				2021-06-18	
J	Gautschi, OP; Huser, MC; Smoll, NR; Maedler, S; Bednarz, S; von Hessling, A; Lussmann, R; Hildebrandt, G; Seule, MA				Gautschi, Oliver P.; Huser, Melanie C.; Smoll, Nicolas R.; Maedler, Sven; Bednarz, Stephan; von Hessling, Alexander; Lussmann, Roger; Hildebrandt, Gerhard; Seule, Martin A.			Long-term neurological and neuropsychological outcome in patients with severe traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; ICP-targeted therapy; Neuropsychological outcome; Glasgow Outcome Scale; Long-term outcome	SEVERE HEAD-INJURY; PROGNOSTIC MODELS; SCALE; MODERATE; THERAPY; VALIDATION; PRINCIPLES; PREDICTION; GUIDELINES; RETURN	Background: Severe traumatic brain injury (TBI) remains a major cause of death and disability worldwide, The aim of the study was to evaluate predictors for neurological and neuropsychological long-term outcome in patients with severe TBI treated according to an intracranial pressure (ICP-) targeted therapy. Methods: From 08/2005 to 12/2008, 46 patients with severe TBI and more than 12 h of intensive care treatment were included in this study. Neurological outcome was assessed with the Glasgow Outcome Scale (GOS). Neuropsychological performance assessing 9 different domains was evaluated at long-term follow-up (median 20.5 months; range 10-46). Logistic regression was used to identify favourable outcomes according to the GOS and Fisher's exact tests were used to identify predictors of severe neuropsychological impairments at follow-up. Results: Twenty-nine patients were available for neuropsychological assessment at long-term follow-up. Only 2 out of 29 patients presented normal or average neuropsychological findings throughout all 9 neuropsychological domains at long-term follow-up. The percentage of a favourable outcome (GOS 4-5) increased from 13.8% at hospital discharge to 75.8% at rehabilitation discharge to 79.3% at long-term follow-up, respectively. Age <= 40 was found to be a strong predictor of favourable outcome at follow-up (OR 5.95, 95% CI 1.41 25.00, p = 0.015). The GOS at hospital discharge was not a predictor for severe impairments in any of the 9 different neuropsychological domains (all p-values were p >0.268). In contrast, the GOS at rehabilitation discharge was found to be a predictor of severe impairments at follow-up in all but one domain assessed (all p-values less than p <0.038). Conclusions: The GOS at rehabilitation discharge should be regarded as a better predictor for neuropsychological impairments at long-term follow-up than the GOS at hospital discharge. Even in patients with favourable GOS after finishing a course of rehabilitation, three quarters of these patients may have at least one severe neuropsychological deficit. Therefore, it remains of paramount importance to provide long-term neuropsychological support to further improve outcome after TBI. (C) 2013 Elsevier B.V. All rights reserved.	[Gautschi, Oliver P.; Huser, Melanie C.; Hildebrandt, Gerhard; Seule, Martin A.] Kantonsspital, Dept Neurosurg, St Gallen, Switzerland; [Gautschi, Oliver P.; Smoll, Nicolas R.] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; [Gautschi, Oliver P.; Smoll, Nicolas R.] Univ Hosp Geneva, Fac Med, Geneva, Switzerland; [Maedler, Sven; Bednarz, Stephan; Lussmann, Roger] Kantonsspital, Surg Intens Care Unit, St Gallen, Switzerland; [von Hessling, Alexander] Kantonsspital, Dept Neuroradiol, St Gallen, Switzerland	Gautschi, OP (corresponding author), Hop Cantonal Univ Geneva, Dept Clin Neurosci, Serv Neurochirurg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	oliver.gautschi@hcuge.ch	Smoll, Nicolas/D-3322-2013	Smoll, Nicolas/0000-0002-6923-9701			ANNONI JM, 1991, SCHWEIZ MED WSCHR, V121, P207; Aschenbrenner S, 2000, REGENSBURGER WORTFLU; Aster M., 2006, WECHSLER INTELLIGENZ; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Clifton GL, 1993, NEUROSURGERY, V33, P8; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Harting C., 2000, WECHSLER GEDACHTNIST; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petermann F., 2012, WECHSLER MEMORY SCAL, V4 German Edition; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R. M., 1992, TRAIL MAKING TEST MA; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Ruff RM, 1993, PERCEPTUAL MOTOR S 2, V76, P1219; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wechsler D., 1987, WMS R WECHSLER MEMOR; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	49	13	13	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2013	115	12					2482	2488		10.1016/j.clineuro.2013.09.038			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	299TB	WOS:000330417500013	24184064				2021-06-18	
J	Harris, MA; Shen, H; Marion, SA; Tsui, JKC; Teschke, K				Harris, M. Anne; Shen, Hui; Marion, Stephen A.; Tsui, Joseph K. C.; Teschke, Kay			Head injuries and Parkinson's disease in a case-control study	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							OCCUPATIONAL-EXPOSURE; RISK; RECALL; EPIDEMIOLOGY; TRAUMA	Background Head injury is a hypothesised risk factor for Parkinson's disease, but there is a knowledge gap concerning the potential effect of injury circumstances (eg, work-related injuries) on risk. The objective of this study is to address this gap while addressing issues of recall bias and potential for reverse causation by prediagnosis symptoms. Methods We conducted a population based case-control study of Parkinson's disease in British Columbia, Canada (403 cases, 405 controls). Interviews queried injury history; whether injuries occurred at work, in a motor vehicle accident or during sports. Participants were also asked to report their suspicions about the causes of Parkinson's disease to provide an indicator of potential recall bias. Associations were estimated with logistic regression, adjusted for age, sex and smoking history. Results Associations were strongest for injuries involving concussion (OR: 2.08, 95% CI 1.30 to 3.33) and unconsciousness (OR: 2.64, 95% CI 1.39 to 5.03). Effects remained for injuries that occurred long before diagnosis and after adjustment for suspicion of head injury as a cause of Parkinson's disease. Injuries that occurred at work were consistently associated with stronger ORs, although small numbers meant that estimates were not statistically significant. Conclusions This study adds to the body of literature suggesting a link between head injury and Parkinson's disease and indicates further scrutiny of workplace incurred head injuries is warranted.	[Harris, M. Anne] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON M5B 2K3, Canada; [Shen, Hui; Marion, Stephen A.; Teschke, Kay] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Tsui, Joseph K. C.] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada	Harris, MA (corresponding author), Ryerson Univ, Sch Occupat & Publ Hlth, 350 Victoria St,Podium Bldg, Toronto, ON M5B 2K3, Canada.	anne.harris@ryerson.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); WorkSafeBC [RS2000/01-010, RS2007-OG05]	Financial support for this study came from the operating grants from Medical Research Council of Canada (now the Canadian Institutes of Health Research) and WorkSafeBC (Operating grants RS2000/01-010 and and RS2007-OG05) and direct and in-kind support from the Pacific Parkinson's Research Centre. The funders were not involved in study conduct or publication of findings.	Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; DREWS CD, 1990, INT J EPIDEMIOL, V19, P1107, DOI 10.1093/ije/19.4.1107; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Fayerman P, 2008, VANCOUVER SUN   0109; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hachiya NS, 2008, MED HYPOTHESES, V70, P1034, DOI 10.1016/j.mehy.2007.06.043; Harris MA, 2008, CAN J PUBLIC HEALTH, V99, P293, DOI 10.1007/BF03403758; Harris MA, 2012, AM J EPIDEMIOL, V176, P299, DOI 10.1093/aje/kws017; Harris MA, 2012, MOVEMENT DISORD, V27, P1111, DOI 10.1002/mds.25077; Harris MA, 2011, PARKINSONISM RELAT D, V17, P464, DOI 10.1016/j.parkreldis.2011.04.007; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rugbjerg K, 2008, BMJ-BRIT MED J, V337, pa2494, DOI [10.1136/bmj.a2494, DOI 10.1136/BMJ.A2494]; Rugbjerg K, 2011, SCAND J WORK ENV HEA, V37, p: 10; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; Silva M, 1996, BRIT MED J, V312, P703; Tan EK, 2005, INT J CLIN PRACT, V59, P511, DOI 10.1111/j.1368-5031.2005.00426.x; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Teschke K, 2000, AM J IND MED, V38, P385, DOI 10.1002/1097-0274(200010)38:4<385::AID-AJIM3>3.0.CO;2-Q	24	13	13	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	DEC	2013	70	12					839	844		10.1136/oemed-2013-101444			6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	251GT	WOS:000326916500005	24142978				2021-06-18	
J	Kumban, W; Amatachaya, S; Emasithi, A; Siritaratiwat, W				Kumban, Wannisa; Amatachaya, Sugalya; Emasithi, Alongkot; Siritaratiwat, Wantana			Effects of task-specific training on functional ability in children with mild to moderate cerebral palsy	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Cerebral palsy; five times sit-to-stand test; functional reach test; motor assessment scale; pediatric balance scale; task-specific training	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; STAND PERFORMANCE; 5-TIMES-SIT-TO-STAND TEST; CONCURRENT VALIDITY; OLDER-PEOPLE; SIT; BALANCE; RELIABILITY; STRENGTH	Objective: To examine the relationship between Five times sit-to-stand Test (FTSST) and functional tests and investigate the effects of task-specific training on functional ability in children with mild to moderate cerebral palsy (CP). Methods: Twenty-one subjects were randomly assigned to experimental and control groups. Motor Assessment Scale (MAS: sit-to-stand), Pediatric Balance Scale (PBS), Functional Reach Test and FTSST were tested before training, after training and at follow-up at 6 weeks post training. Results: FTSST correlated significantly with MAS (rho = -0.733) and with PBS (rho = -0.813) in all children with CP. There were no significant differences in all outcomes between groups. However, FTSST and MAS in children with Gross Motor Function Classification System-Expanded and Revised levels I-II were significantly different between pre and post training within the experimental group (p = 0.03). Conclusions: FTSST is a reliable and valid functional outcome measure after the task-specific training in children with mild to moderate CP.	[Kumban, Wannisa; Amatachaya, Sugalya; Siritaratiwat, Wantana] Khon Kaen Univ, Improvement Phys Performance & Qual Life IPQ Res, Back Neck & Other Joint Pain Res Grp, Fac Associated Med Sci,Sch Phys Therapy, Khon Kaen 40002, Thailand; [Emasithi, Alongkot] Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen 40002, Thailand	Siritaratiwat, W (corresponding author), Khon Kaen Univ, Improvement Phys Performance & Qual Life IPQ Res, Back Neck & Other Joint Pain Res Grp, Fac Associated Med Sci,Sch Phys Therapy, Khon Kaen 40002, Thailand.	wantana@kku.ac.th		Amatachaya, Sugalya/0000-0002-8125-5982	Postgraduate School, Faculty of Associated Medical Sciences, the Improvement of Physical Performance and Quality of Life (IPQ) research groups and Back, Neck and Other Joint Pain Research group, Khon Kaen University, Thailand	This study was partially supported by the Postgraduate School, Faculty of Associated Medical Sciences, the Improvement of Physical Performance and Quality of Life (IPQ) research groups and Back, Neck and Other Joint Pain Research group, Khon Kaen University, Thailand.	Bartlett Doreen, 2003, Pediatr Phys Ther, V15, P84, DOI 10.1097/01.PEP.0000067885.63909.5C; Blundell SW, 2003, CLIN REHABIL, V17, P48, DOI 10.1191/0269215503cr584oa; Canning CG, 2003, CLIN REHABIL, V17, P355, DOI 10.1191/0269215503cr620oa; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Dodd KJ, 2003, DEV MED CHILD NEUROL, V45, P652, DOI 10.1017/S0012162203001221; Donahoe B, 1994, PEDIAT PHYSICAL THER, V6, P189, DOI DOI 10.1097/00001577-199400640-00004; dos Santos AN, 2011, RES DEV DISABIL, V32, P2243, DOI 10.1016/j.ridd.2011.05.001; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Gan SM, 2008, NEUROREHAB NEURAL RE, V22, P745, DOI 10.1177/1545968308316474; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Kumban W, 2013, NEUROREHABILITATION, V32, P9, DOI 10.3233/NRE-130818; Liao HF, 2007, ARCH PHYS MED REHAB, V88, P25, DOI 10.1016/j.apmr.2006.10.006; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Lowes LP, 1996, PEDIAT PHYS THERAPY, V8, P176; Meretta BM, 2006, J VESTIBUL RES-EQUIL, V16, P233; Mong YQ, 2010, ARCH PHYS MED REHAB, V91, P407, DOI 10.1016/j.apmr.2009.10.030; Munro BH, 2005, STAT METHODS HLTH CA; Palisano R., 2007, GMFCS E R GROSS MOTO; Park ES, 2003, GAIT POSTURE, V17, P43, DOI 10.1016/S0966-6362(02)00055-3; Ricken AXC, 2005, MOTOR CONTROL, V9, P357, DOI 10.1123/mcj.9.4.357; Salem Y, 2009, NEUROREHABILITATION, V24, P307, DOI 10.3233/NRE-2009-0483; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4, 89-122; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Wang TH, 2012, CLIN REHABIL, V26, P664, DOI 10.1177/0269215511426889; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034	25	13	13	0	18	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	DEC	2013	16	6					410	417		10.3109/17518423.2013.772672			8	Clinical Neurology; Pediatrics; Rehabilitation	Neurosciences & Neurology; Pediatrics; Rehabilitation	256OG	WOS:000327322600006	23477366				2021-06-18	
J	Lukersmith, S; Radbron, L; Hopman, K				Lukersmith, Sue; Radbron, Lesley; Hopman, Katherine			Development of clinical guidelines for the prescription of a seated wheelchair or mobility scooter for people with traumatic brain injury or spinal cord injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						functioning; guidelines; occupational therapist; scooter; wheelchair	COMPLEX INTERVENTIONS; USER	Background/aimProviding a wheelchair or scooter is a complex therapy intervention aimed at enhancing the person's functioning. The research and experience has shown that a wheelchair which is poorly matched to the individual, adversely affects potential activities and participation, lifestyle goals, health status and can be costly. The development of an evidence-based clinical guideline will provide a synthesis of the evidence and recommendations for best practice. MethodsThe guidelines were developed using a rigorous methodology of systematic search for primary studies, critical appraisal and synthesis of the evidence using an adaptation of the National Health and Medical Research Council recommendation grades in conjunction with a multidisciplinary working party. ResultsSeventy-six recommendations were developed from 44 clinical questions related to goals, assessment and review, capacity and performance, upper limb capacity and injury risk, wheelchair features, propulsion, training, transport and maintenance. Resources were developed to support the use of the guidelines. Only examples of recommendations are provided here. The complete guidelines and technical report should be downloaded from http://www.lifetimecare.nsw.gov.au/Brain_Injury.aspx. ConclusionThe guidelines provide appraisal and synthesis of the literature and recommendations for best practice on the prescription of a wheelchair or scooter for adults with spinal cord injury and/or traumatic brain injury. The guidelines are intended to reduce the potential for poor wheelchair prescription, inform and guide practice to enhance outcomes. Through judicious application of the available research, these guidelines provide best practice recommendations for prescribing the most appropriate wheelchair for a person with a traumatic brain injury/spinal cord injury.	[Lukersmith, Sue; Radbron, Lesley] Lifetime Care & Support Author, Serv Dev & Review, Sydney, NSW 2000, Australia; [Lukersmith, Sue] Lukersmith & Associates, Woodford, NSW, Australia; [Hopman, Katherine] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia	Lukersmith, S (corresponding author), Lifetime Care & Support Author, Serv Dev & Review, Level 24,580 George St, Sydney, NSW 2000, Australia.	sue@lukersmith.com.au		Lukersmith, Sue/0000-0001-8202-3828	Lifetime Care & Support Authority (LTCSA); EnableNSW	The Lifetime Care & Support Authority (LTCSA) and EnableNSW initiated and provided funding for the development of the guidelines. The guidelines were written by S. Lukersmith and revised following feedback from the reviewers and stakeholders.	Bennett S, 2003, AUST OCCUP THER J, V50, P13, DOI DOI 10.1046/J.1440-1630.2003.00341.X; Brubaker C E, 1986, J Rehabil Res Dev, V23, P19; Consortium for Spinal Cord Medicine, 2000, PRESS ULC PREV TREAT; ConsortiumforSpinalCordMedicine, 2005, PRES UPP LIMB FUNCT; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Di Marco A., 2005, THESIS U S AUSTR ADE; Di Marco A, 2003, AUST OCCUP THER J, V50, P30, DOI DOI 10.1046/J.1440-1630.2003.00316.X; Edwards K, 2010, DISABIL REHABIL-ASSI, V5, P411, DOI 10.3109/17483101003793412; EnableNSW and Lifetime Care & Support Authority, 2011, GUID PRESCR SEAT WHE; Fayed N, 2011, DISABIL REHABIL, V33, P1941, DOI 10.3109/09638288.2011.553704; Hoffman T., 2010, EVIDENCE BASED PRACT; Kittel A, 2002, DISABIL REHABIL, V24, P106, DOI 10.1080/09638280110066785; Letts L., 2007, CRITICAL REV FORM QU; Mortenson W Ben, 2008, Can J Occup Ther, V75, P167; MRC (Med. Res. Counc.), 2000, FRAM DEV EV RCTS COM; National Health and Medical Research Council(NHMRC) in Australia, 2009, ADD LEV EV GRAD REC; NHMRC, 1999, REV EV SYST ID REV S; Papadimitriou C, 2008, DISABIL SOC, V23, P691, DOI 10.1080/09687590802469420; Petticrew M, 2011, EUR J PUBLIC HEALTH, V21, P397, DOI 10.1093/eurpub/ckr084; Physiotherapy Evidence Database, 1999, PEDRO SCAL; Samuelsson K, 2008, DISABIL REHABIL, V30, P551, DOI 10.1080/09638280701355777; SCIRE, 2010, SPIN CORD INJ REH EV; Straus SE., 2005, EVIDENCE BASED MED P, V3rd; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; The AGREE Research Trust, 2009, APPR GUID RES EV 2; Transport Accident Commission & Victorian WorkCover Authority, 2009, CLIN FRAM DEL HLTH S; United Nations Office of the High Commissioner for Human Rights, 2006, CONV RIGHTS PERS DIS; Walach H., 2006, BMC MED RES METHODOL, V6, P9; World Health Organization, 2001, INT CLASS FUNCT DIS	29	13	13	0	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	DEC	2013	60	6					378	386		10.1111/1440-1630.12077			9	Rehabilitation	Rehabilitation	260GZ	WOS:000327584300002	24299477				2021-06-18	
J	Norman, RS; Jaramillo, CA; Amuan, M; Wells, MA; Eapen, BC; Pugh, MJ				Norman, Rocio S.; Jaramillo, Carlos A.; Amuan, Megan; Wells, Margaret Ann; Eapen, Blessen C.; Pugh, Mary Jo			Traumatic brain injury in veterans of the wars in Iraq and Afghanistan: Communication disorders stratified by severity of brain injury	BRAIN INJURY			English	Article						aphasia; epidemiology; fluency disorder; TBI severity; Veterans Health Administration; voice disorder	POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; VOICE DISORDERS; MILD; LANGUAGE; SYMPTOMS; REHABILITATION; IMPAIRMENT; MANAGEMENT; ABILITIES	Objective: To describe the prevalence of communication disorders in veterans of the wars in Iraq and Afghanistan with traumatic brain injury (TBI). Design: Retrospective study of the prevalence of aphasia, fluency and voice disorders among veterans with different severity levels of TBI. Data was obtained from the VA National repository for OEF/OIF/OND veterans who received VA care in Fiscal Years 2010 and 2011. Results: Among the 303 716 veterans in this study, 1848 were diagnosed with a communication disorder; 40% of these were also diagnosed with a TBI. Voice disorders were the most prevalent diagnosis (3.5 per 1000) followed by aphasia (1.9 per 1000) and fluency disorder (0.7 per 1000). Individuals with a TBI diagnosis were more likely to have a diagnosis of aphasia, followed by fluency and then voice disorder. The odds ratio (OR) of aphasia with TBI was 11.09-252.75 (95% CI = 8.78-441.52, p < 0.01). OR for fluency disorders with TBI was 3.58-10.41 (95% CI = 2.56-42.40, p < 0.01) and association of voice disorders with TBI was significant for all levels of TBI severity (OR = 1.5-6.61, 95% CI = 1.24-14.05, p < 0.01). Conclusions: Veterans who sustained a TBI were more likely to have a diagnosis of a communication disorder, regardless of TBI severity. Those with TBI, including mild TBI, should be screened and evaluated for communication disorders.	[Norman, Rocio S.; Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Amuan, Megan] Edith Nourse Rogers Mem VA Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Wells, Margaret Ann] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Transit Rehabil Program, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	Norman, RS (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	rnorman2@wisc.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763	South Texas Veterans Healthcare System/Audie L. Murphy Division; Edith Nourse Rogers VA Memorial Hospital; Veterans AffairsUS Department of Veterans Affairs [I01HX000329] Funding Source: NIH RePORTER	The authors acknowledge and appreciate support from the South Texas Veterans Healthcare System/Audie L. Murphy Division and the Edith Nourse Rogers VA Memorial Hospital. We also acknowledge assistance with manuscript preparation by Barbara Elizondo and Kathleen Franklin as well as valuable input by Dr Juan Cabrera at the initial stages of the manuscript process. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cherney LR, 2010, J HEAD TRAUMA REHAB, V25, P219, DOI 10.1097/HTR.0b013e3181dc82c1; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Department of Defense, 2010, DEP DEF ICD 9 COD GU; Dion GR, 2013, J VOICE, V27, P57, DOI 10.1016/j.jvoice.2012.08.001; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ezrati-Vinacour R, 2004, J FLUENCY DISORD, V29, P135, DOI 10.1016/j.jfludis.2004.02.003; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fischer H., 2013, US MILITARY CASUALTY; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Isaki E, 2000, BRAIN INJURY, V14, P441; Iverach L, 2009, J ANXIETY DISORD, V23, P928, DOI 10.1016/j.janxdis.2009.06.003; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Ludlow CL, 2003, J FLUENCY DISORD, V28, P273, DOI 10.1016/j.jfludis.2003.07.001; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; LURIA AR, 1970, SCI AM, V222, P66, DOI 10.1038/scientificamerican0370-66; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Management of Concussion/mTBI Working Group, 2009, J REHABILITATION RES, V46; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; Messenger M, 2004, J FLUENCY DISORD, V29, P201, DOI 10.1016/j.jfludis.2004.06.002; MOHR JP, 1980, NEUROLOGY, V30, P1273, DOI 10.1212/WNL.30.12.1273; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; O'Mara W, 2000, J La State Med Soc, V152, P218; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; REILLY S, 2004, EVIDENCE BASED PRACT; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Roy N, 2000, J SPEECH LANG HEAR R, V43, P737, DOI 10.1044/jslhr.4303.737; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; Saunders GH, 2012, J REHABIL RES DEV, V49, P1043, DOI 10.1682/JRRD.2010.08.0157; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Togher L., 2010, ISL PALMS SC CLIN AP; Togher L, 1999, CODE C COMMUNICATION; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Verschueren DS, 2006, J ORAL MAXIL SURG, V64, P203, DOI 10.1016/j.joms.2005.10.034; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yairi E, 2004, ASHA LEADER, V9, p[4, 14]	50	13	13	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1623	1630		10.3109/02699052.2013.834380			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400018	24131337				2021-06-18	
J	Schmidt, AT; Hanten, G; Li, XQ; Wilde, EA; Ibarra, AP; Chu, ZD; Helbling, AR; Shah, S; Levin, HS				Schmidt, Adam T.; Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Ibarra, Alyssa P.; Chu, Zili D.; Helbling, Antonia R.; Shah, Sanjeev; Levin, Harvey S.			Emotional prosody and diffusion tensor imaging in children after traumatic brain injury	BRAIN INJURY			English	Article						Brain imaging; DTI; emotional prosody; paediatric; traumatic brain injury	PERCEPTION DEFICITS; SOCIAL OUTCOMES; RECOGNITION; LANGUAGE; DISCONNECTION; MODERATE; AMYGDALA	Primary objective: Brain structures and their white matter connections that may contribute to emotion processing and may be vulnerable to disruption by a traumatic brain injury (TBI) occurring in childhood have not been thoroughly explored. Research design and methods: The current investigation examines the relationship between diffusion tensor imaging (DTI) metrics, including fractional anisotropy (FA) and apparent diffusion coefficient (ADC), and 3-month post-injury performance on a task of emotion prosody recognition and a control task of phonological discrimination in a group of 91 children who sustained either a moderate-to-severe TBI (n = 45) or orthopaedic injury (OI) (n = 46). Main outcomes and results: Brain-behaviour findings within OI participants confirmed relationships between several significant white matter tracts in emotional prosody performance (i.e. the cingulum bundle, genu of the corpus callosum, inferior longitudinal fasciculus (ILF) and the inferior fronto-occipital fasciculus (IFOF). The cingulum and genu were also related to phonological discrimination performance. The TBI group demonstrated few strong brain behaviour relationships, with significant findings emerging only in the cingulum bundle for Emotional Prosody and the genu for Phonological Processing. Conclusion: The lack of clear relationships in the TBI group is discussed in terms of the likely disruption to cortical networks secondary to significant brain injuries.	[Schmidt, Adam T.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77340 USA; [Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Ibarra, Alyssa P.; Helbling, Antonia R.; Shah, Sanjeev; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA	Schmidt, AT (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ats013@shsu.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This research was supported by Grant Number R01NS021889 from the National Institute of Neurological Disorders and Stroke to H.S. Levin.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Gaffan D, 2008, CORTEX, V44, P928, DOI 10.1016/j.cortex.2008.03.005; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hoekert M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-93; Koch K, 2010, NEUROSCIENCE, V168, P190, DOI 10.1016/j.neuroscience.2010.03.026; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Leitman DI, 2010, FRONT HUM NEUROSCI, V4, P4; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Moos RH, 1994, LISRES A LIFE STRESS; Mori S, 1999, ANAT REC, V257, P102; Netsch T, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P718, DOI 10.1109/ICCV.2001.937595; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Rota G, 2011, BRAIN LANG, V117, P123, DOI 10.1016/j.bandl.2010.07.008; Schmidt AT, 2010, BRAIN INJURY, V24, P1550, DOI 10.3109/02699052.2010.523047; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; TEASDALE G, 1974, LANCET, V2, P81; Wiethoff S, 2009, NEUROREPORT, V20, P1356, DOI 10.1097/WNR.0b013e328330eb83; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	39	13	14	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1528	1535		10.3109/02699052.2013.828851			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400006	24266795				2021-06-18	
J	Chen, B; Mutschler, M; Yuan, YJ; Neugebauer, E; Huang, QB; Maegele, M				Chen, Bo; Mutschler, Manuel; Yuan, Yongjun; Neugebauer, Edmund; Huang, Qiaobing; Maegele, Marc			Superimposed traumatic brain injury modulates vasomotor responses in third-order vessels after hemorrhagic shock	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Hemorrhagic shock; Lateral fluid percussion; Brain injury; Spinotrapezius muscle; Third order vessels; Vasomotor response; Microcirculation	TUMOR-NECROSIS-FACTOR; SKELETAL-MUSCLE; EXPERIMENTAL-MODELS; FACTOR-ALPHA; PENTOBARBITAL-ANESTHESIA; CARDIAC-OUTPUT; RAT; MICROCIRCULATION; ISCHEMIA; VASODILATATION	Background: Traumatic brain injury (TBI) and hemorrhagic shock (HS) are the leading causes of death in trauma. Recent studies suggest that TBI may influence physiological responses to acute blood loss. This study was designed to assess to what extent superimposed TBI may modulate physiologic vasomotor responses in third-order blood vessels in the context of HS. Methods: We have combined two established experimental models of pressure-controlled hemorrhagic shock (HS; MAP 50 mmHg/60 min) and TBI (lateral fluid percussion (LFP)) to assess vasomotor responses and microcirculatory changes in third-order vessels by intravital microscopy in a spinotrapezius muscle preparation. 23 male Sprague-Dawley rats (260-320 g) were randomly assigned to experimental groups: i) Sham, ii) HS, iii) TBI + HS, subjected to impact or sham operation, and assessed. Results: HS led to a significant decrease in arteriolar diameters by 20% to baseline (p < 0.01). In TBI + HS this vasoconstriction was less pronounced (5%, non-significant). At completed and at 60 minutes of resuscitation arteriolar diameters had recovered to pre-injury baseline values. Assessment of venular diameters revealed similar results. Arteriolar and venular RBC velocity and blood flow decreased sharply to < 20% of baseline in HS and TBI + HS (p < 0.01). Immediately after and at 60 minutes of resuscitation, an overshoot in arterial RBC velocity (140% of baseline) and blood flow (134.2%) was observed in TBI + HS. Conclusion: Superimposed TBI modulated arteriolar and venular responses to HS in third-order vessels in a spinotrapezius muscle preparation. Further research is necessary to precisely define the role of TBI on the microcirculation in tissues vulnerable to HS.	[Chen, Bo; Yuan, Yongjun; Huang, Qiaobing] SMU, Key Lab Shock & Microcirculat Res, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China; [Mutschler, Manuel; Neugebauer, Edmund; Maegele, Marc] Private Univ Witten Herdecke, CMMC, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Mutschler, Manuel; Maegele, Marc] Private Univ Witten Herdecke, CMMC, Dept Traumatol Orthoped Surg & Sportsmed, D-51109 Cologne, Germany	Huang, QB (corresponding author), SMU, Key Lab Shock & Microcirculat Res, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China.	bing@smu.edu.cn; Marc.Maegele@t-online.de			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30971201, 81170297]; International Bureau of the BMBF/GermanyFederal Ministry of Education & Research (BMBF) [01DO12025]	This study was supported by the General Program from the Natural Science Foundation of China (30971201, 81170297) and the International Bureau of the BMBF/Germany (01DO12025). The authors have no other financial interest to disclose.	Adanali G, 2001, ANN PLAS SURG, V47, P652, DOI 10.1097/00000637-200112000-00013; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; Backstrom T, 2004, SHOCK, V21, P572, DOI 10.1097/01.shk.0000127069.65490.65; BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; Boerma EC, 2009, CURR OPIN CRIT CARE, V15, P261, DOI 10.1097/MCC.0b013e32832b0ff4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; den Uil CA, 2008, PROG CARDIOVASC DIS, V51, P161, DOI 10.1016/j.pcad.2008.07.002; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Douzinas EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032968; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Gao C, 2009, AUTON NEUROSCI-BASIC, V147, P70, DOI 10.1016/j.autneu.2009.01.010; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; GRAY SD, 1973, MICROVASC RES, V5, P395, DOI 10.1016/0026-2862(73)90055-1; Guo J, 2008, SHOCK, V29, P205, DOI 10.1097/SHK.0b013e318070c61a; Han JY, 2001, AM J PHYSIOL-GASTR L, V280, pG939; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Joyner MJ, 2003, ACTA PHYSIOL SCAND, V177, P329, DOI 10.1046/j.1365-201X.2003.01090.x; KAWAUE Y, 1984, JPN J PHYSIOL, V34, P283, DOI 10.2170/jjphysiol.34.283; Kerger H, 1999, AM J PHYSIOL-HEART C, V276, pH2035; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609010-00010; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359; LUNDVALL J, 1978, ACTA PHYSIOL SCAND, V102, P450, DOI 10.1111/j.1748-1716.1978.tb06093.x; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; MANDERS WT, 1976, CIRC RES, V39, P512, DOI 10.1161/01.RES.39.4.512; MARSHALL JM, 1982, J PHYSIOL-LONDON, V332, P169, DOI 10.1113/jphysiol.1982.sp014408; Matsukawa K, 1997, J PHYSIOL-LONDON, V500, P213, DOI 10.1113/jphysiol.1997.sp022011; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntyre A, EVIDENCE BASED REV M; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Minghini A, 1998, SHOCK, V9, P210, DOI 10.1097/00024382-199803000-00009; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NAGAI M, 1981, J AUTONOM NERV SYST, V4, P365, DOI 10.1016/0165-1838(81)90039-4; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Russell J, 2003, AM J PHYSIOL-GASTR L, V284, pG123, DOI 10.1152/ajpgi.00303.2002; Sakai H, 1999, AM J PHYSIOL-HEART C, V276, pH563, DOI 10.1152/ajpheart.1999.276.2.H563; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VATNER SF, 1978, ENVIRON HEALTH PERSP, V26, P193, DOI 10.2307/3428842; Venkatesh B, 1999, CRIT CARE MED, V27, P1175, DOI 10.1097/00003246-199906000-00047; VICAUT E, 1991, J CLIN INVEST, V87, P1537, DOI 10.1172/JCI115165; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141; Yuan XQ, 1991, J NEUROTRAUM, V8, P219, DOI 10.1089/neu.1991.8.219; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; ZHAO KS, 1985, MICROVASC RES, V30, P143, DOI 10.1016/0026-2862(85)90046-9; Zhao KS, 2000, CLIN HEMORHEOL MICRO, V23, P259; Zhao O, 2007, SHOCK, V28, P717, DOI 10.1097/shk.0b013e318050c914	63	13	13	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 21	2013	21								77	10.1186/1757-7241-21-77			12	Emergency Medicine	Emergency Medicine	266SB	WOS:000328042900001	24257108	DOAJ Gold, Green Published			2021-06-18	
J	Lu, H; Lei, XY; Hu, H; He, ZP				Lu Hong; Lei Xiao-yan; Hu Hui; He Zhan-ping			Relationship between AQP4 expression and structural damage to the blood-brain barrier at early stages of traumatic brain injury in rats	CHINESE MEDICAL JOURNAL			English	Article						brain injury; edema; blood-brain barrier; aquaporins; animal experiment	AQUAPORIN-4 EXPRESSION; EDEMA; TISSUE; MICE	Background Although some studies have reported that aquaporin-4 (AQP4) plays an important role in the brain edema after traumatic brain injury (TBI), little is known about the AQP4 expression in the early stage of TBI, or about the correlation between the structural damage to the blood-brain barrier (BBB) and angioedema. The aim of this project was to investigate the relationship between AQP4 expression and damage to the BBB at early stages of TBI. Methods One hundred and twenty healthy adult Wistar rats were randomly divided into two groups: sham operation group (SO) and TBI group. The TBI group was divided into five sub-groups according to the different time intervals: 1, 3, 6, 12, and 24 hours. The brains of the animals were taken out at different time points after TBI to measure brain water content. The cerebral edema and BBB changes in structure were examined with an optical microscopy (OM) and transmission electron microscopy (TEM), and the IgG content and AQP4 protein expression in traumatic brain tissue were determined by means of immunohistochemistry and Western blotting. The data were analyzed with SPSS 13.0 statistical software. Results In the SO group, tissue was negative for IgG, and there were no abnormalities in brain water content or AQP4 expression. In the TBI group, brain water content significantly increased at 6 hours and peaked at 24 hours following injury. IgG expression significantly increased from 1 to 6 hours following injury, and remained at a high level at 24 hours. Pathological observation revealed BBB damage at 1 hour following injury. Angioedenna appeared at 1 hour, was gradually aggravated, and became obvious at 6 hours. Intracellular edema occurred at 3 hours, with the presence of large glial cell bodies and mitochondrial swelling. These phenomena were aggravated with time and became obvious at 12 hours. In addition, microglial proliferation was visible at 24 hours. AQP4 protein expression were reduced at 1 hour, lowest at 6 hours, and began to increase at 12 hours, showing a V-shaped curve. Conclusions The angioedenna characterized by BBB damage was the primary type of early traumatic brain edema. It was followed by mixed cerebral edema that consisted of angioedema and cellular edema and was aggravated with time. AQP4 expression was down-regulated during the angioedema attack, but AQP4 expression was upregulated during intracellular edema.	[Lu Hong; Lei Xiao-yan; He Zhan-ping] Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Radiol, Haikou 570208, Hainan, Peoples R China; [Hu Hui] Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Nursing, Haikou 570208, Hainan, Peoples R China	Lu, H (corresponding author), Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Radiol, Haikou 570208, Hainan, Peoples R China.	471739847@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]; International Cooperation Project of Hainan Province [Qiongke (2012) 65]	This project was supported by the National Natural Science Foundation of China (No. 81160181) and the International Cooperation Project of Hainan Province (No. Qiongke (2012) 65).	Akiguchi I, 1998, ACTA NEUROPATHOL, V95, P78, DOI 10.1007/s004010050768; Cui Y, 2006, CHIN J REHABIL THEOR, V12, P649; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Easton AS, 2013, ADV EXP MED BIOL, V763, P1; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Hu H, 2012, NEURAL REGEN RES, V7, P1659, DOI 10.3969/j.issn.1673-5374.2012.21.009; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li M, 2011, PROGR ANATOM SCI, V17, P12; [刘辉 Liu Hui], 2009, [解剖学杂志, Chinese Journal of Anatomy], V32, P68; Lo Pizzo M, 2012, NEUROL SCI; Lu H, 2011, CHINESE J ANATOMY, V34, P47; [鲁宏 Lu Hong], 2012, [解剖学杂志, Chinese Journal of Anatomy], V35, P4; Lu H, 2011, CHINESE MED J-PEKING, V124, P3148, DOI 10.3760/cma.j.issn.0366-6999.2011.19.034; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Ren Z, 2013, J CEREB BLOOD F 0227, DOI [10.1038/jcbfm.2013.30, DOI 10.1038/JCBFM.2013.30.EPUB]; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Sabre L, 2013, SPINAL CORD, DOI [10.1038/sc.2013.41, DOI 10.1038/SC.2013.41.EPUB]; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Yeung CM, 2010, J NEUROSCI RES, V88, P2026, DOI 10.1002/jnr.22349; Zhang L, 2008, SHOUDU YIKE DAXUE XU, V29, P732; [张曙光 Zhang Shuguang], 2010, [中华创伤杂志, Chinese Journal of Trauma], V26, P589; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	29	13	15	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	NOV 20	2013	126	22					4316	4321		10.3760/cma.j.issn.0366-6999.20131139			6	Medicine, General & Internal	General & Internal Medicine	264YJ	WOS:000327916600025	24238521	DOAJ Gold			2021-06-18	
J	Machamer, J; Temkin, N; Dikmen, S				Machamer, Joan; Temkin, Nancy; Dikmen, Sureyya			Health-Related Quality of Life in Traumatic Brain Injury: Is a Proxy Report Necessary?	JOURNAL OF NEUROTRAUMA			English	Article						awareness; brain injuries; quality of life	IMPAIRED SELF-AWARENESS; HEAD-INJURY; RANDOMIZED-TRIAL; PRACTICAL SCALE; FOLLOW-UP; SATISFACTION; MODERATE; REHABILITATION; INDIVIDUALS; EMPLOYMENT	Despite its importance to care, clinicians and researchers often discount patient-reported outcomes in favor of proxy reports, in persons with traumatic brain injury (TBI). The rationale relates to concerns about lack of awareness of patients regarding their functioning. However, although lack of awareness occurs in some patients with severe TBI, or in TBI involving certain lesion locations, or very soon after injury, this conclusion has been overgeneralized. The objective of this study is to determine the validity of patient-reported health-related quality of life by evaluating its relationship to injury severity and more objective indices of outcome, in a representative series of adults with TBI. A consecutive sample of 374 persons with TBI at least 14 years old, and having a post-resuscitation Glasgow Coma Scale score 12, an acute seizure, or a CT scan showing TBI- related findings. Seventy-six percent (374/491) of the eligible survivors were assessed at 6 months post-injury on the Life Satisfaction Survey. The greatest decrease in satisfaction was in the ability to think and remember, work, receive adequate income, and participate in leisure and recreational activities. Dissatisfaction significantly related to the functional limitation in that area as judged by the patients themselves (p<0.001) or by someone who knew them well (p0.001). The most severely injured group reported the most dissatisfaction for 13 out of 17 areas assessed. Patients with TBI, in general, do not need a proxy to report on their behalf regarding their functional limitations or health-related quality of life.	[Machamer, Joan; Temkin, Nancy; Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Temkin, Nancy; Dikmen, Sureyya] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA	Machamer, J (corresponding author), Univ Washington, Dept Rehabil Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	machamer@u.washington.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS19643]; Department of Defense (DoD)United States Department of Defense [W81XWH-08-2-159]; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A070032]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER	This study was supported by grants R01NS19643 from National Institute of Neurological Disorders and Stroke (NINDS), W81XWH-08-2-159 from Department of Defense (DoD), and H133A070032 from National Institute on Disability and Rehabilitation Research (NIDRR). No funding organization or sponsor was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Emery Marie-Pierre, 2005, Health Qual Life Outcomes, V3, P12, DOI 10.1186/1477-7525-3-12; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; JENNETT B, 1975, LANCET, V1, P480; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	41	13	13	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2013	30	22					1845	1851		10.1089/neu.2013.2920			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	243PH	WOS:000326328400002	23731370	Green Published			2021-06-18	
J	Dias, MS; Sussman, JS; Durham, S; Iantosca, MR				Dias, Mark S.; Sussman, Jeffrey S.; Durham, Susan; Iantosca, Mark R.			Perceived benefits and barriers to a career in pediatric neurosurgery: a survey of neurosurgical residents Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric neurosurgery; medical education; residency; postgraduate training; workforce; career choice	UNITED-STATES; BRAIN-TUMORS; WORKFORCE; STUDENTS; SURGERY; CHOICE	Object. Research suggests that there may be a growing disparity between the supply of and demand for both pediatric specialists and neurosurgeons. Whether pediatric neurosurgeons are facing such a disparity is disputable, but interest in pediatric neurosurgery (PNS) has waxed and waned as evidenced by the number of applicants for PNS fellowships. The authors undertook a survey to analyze current neurosurgical residents' perceptions of both benefits and deterrents to a pediatric neurosurgical career. Methods. All residents and PNS fellows in the United States and Canada during the academic year 2008-2009 were invited to complete a Web-based survey that assessed 1) demographic and educational information about residents and their residency training, particularly as it related to training in PNS; 2) residents' exposure to mentoring opportunities from pediatric neurosurgical faculty and their plans for the future; and 3) residents' perceptions about how likely 40 various factors were to influence their decision about whether to pursue a PNS career. Results. Four hundred ninety-six responses were obtained: 89% of the respondents were male, 63% were married, 75% were in at least their 3rd year of postgraduate training, 61% trained in a children's hospital and 29% in a children's "hospital within a hospital," and 72% were in programs having one or more dedicated PNS faculty members. The residencies of 56% of respondents offered 6-11 months of PNS training and nearly three-quarters of respondents had completed 2 months of PNS training. During medical school, 92% had been exposed to neurosurgery and 45% to PNS during a clinical rotation, but only 7% identified a PNS mentor. Nearly half (43%) are considering a PNS career, and of these, 61% are definitely or probably considering post-residency fellowship. On the other hand, 68% would prefer an enfolded fellowship during residency. Perceived strengths of PNS included working with children, developing lasting relationships, wider variety of operations, fast healing and lack of comorbidities, and altruism. Perceived significant deterrents included shunts, lower reimbursement, cross-coverage issues, higher malpractice premiums and greater legal exposure, and working with parents and pediatric health professionals. The intrinsic nature of PNS was listed as the most significant deterrent (46%) followed by financial concerns (25%), additional training (12%), longer work hours (12%), and medicolegal issues (4%). The majority felt that fellowship training and PNS certification should be recommended for surgeons treating of all but traumatic brain injuries and Chiari I malformations and performing simple shunt-related procedures, although they felt that these credentials should be required only for treating complex craniosynostosis. Conclusions. The nature of PNS is the most significant bather to attracting residents, although reimbursement, cross-coverage, and legal issues are also important to residents. The authors provide several recommendations that might enhance resident perceptions of PNS and attract trainees to the specialty.	[Dias, Mark S.; Iantosca, Mark R.] Penn State Univ, Coll Med, Dept Neurosurg, Hershey, PA USA; [Dias, Mark S.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Sussman, Jeffrey S.] Brandeis Univ, Heller Sch Publ Policy & Management, Waltham, MA USA; [Durham, Susan] Dartmouth Coll, Sch Med, Lebanon, NH USA	Dias, MS (corresponding author), Penn State Hershey Med Ctr, Dept Surg, EC 2750,30 Hope Dr, Hershey, PA 17033 USA.	mdias@hmc.psu.edu			Joint Section on Pediatric Neurological Surgery of the American Association of Neurological Surgeons; Congress of Neurological Surgeons	This study was funded in part by the Joint Section on Pediatric Neurological Surgery of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.	Albright AL, 2000, NEUROSURGERY, V47, P879, DOI 10.1097/00006123-200010000-00018; Althouse LA, 1999, ADV HEALTH SCI EDUC, V4, P111, DOI 10.1023/A:1009768526142; Benzil DL, 2006, AANS B, V15, P7; Boop FA, 2007, AANS B, V16, P7; Chen H, 2001, J SURG RES, V97, P172, DOI 10.1006/jsre.2001.6135; Dohn H, 1996, MED EDUC, V30, P157; Durham SR, 2008, J NEUROSURG-PEDIATR, V1, P429, DOI 10.3171/PED/2008/1/6/429; Durham SR, 2009, J NEUROSURG-PEDIATR, V3, P1, DOI 10.3171/2008.10.PEDS08255; ELAM C, 1994, J CAREER DEV, V21, P37, DOI 10.1177/089484539402100104; Ernst R L, 1984, Med Care Rev, V41, P1, DOI 10.1177/107755878404100101; Flannery AM, 1998, PEDIATR NEUROSURG, V29, P114, DOI 10.1159/000028703; Gottfried ON, 2005, J NEUROSURG, V102, P202, DOI 10.3171/jns.2005.102.2.0202; KAUFMAN BA, 1994, PEDIATR NEUROSURG, V21, P36, DOI 10.1159/000120812; Kozar RA, 2003, J SURG RES, V111, P166, DOI 10.1016/S0022-4804(03)00104-5; Mayer ML, 2006, PEDIATRICS, V118, P2313, DOI 10.1542/peds.2006-1570; MITCHELL WD, 1975, SOC SCI MED, V9, P641, DOI 10.1016/0037-7856(75)90178-X; Musunuru S, 2007, J AM COLL SURGEONS, V204, P164, DOI 10.1016/j.jamcollsurg.2006.08.029; O'Herrin JK, 2004, J SURG RES, V119, P124, DOI 10.1016/j.jss.2004.03.009; O'Herrin JK, 2003, AM J SURG, V186, P125, DOI 10.1016/S0002-9610(03)00188-0; O'Neill J A Jr, 1996, Bull Am Coll Surg, V81, P34; O'Neill JA, 2000, ANN SURG, V232, P442, DOI 10.1097/00000658-200009000-00016; Osipow SH., 1996, THEORIES CAREER DEV, V4th Edition; Smith ER, 2004, NEUROSURGERY, V54, P553, DOI 10.1227/01.NEU.0000108421.69822.67; Stoddard JJ, 2000, PEDIATRICS, V106, P1325, DOI 10.1542/peds.106.6.1325	24	13	13	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2013	12	5					422	433		10.3171/2013.7.PEDS12597			12	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	238OD	WOS:000325956400003	23992238				2021-06-18	
J	Doyle, ST; Perrin, PB; Sosa, DMD; Jove, IGE; Lee, GK; Arango-Lasprilla, JC				Doyle, Sarah T.; Perrin, Paul B.; Diaz Sosa, Dulce Maria; Espinosa Jove, Irma Guadalupe; Lee, Gloria K.; Carlos Arango-Lasprilla, Juan			Connecting family needs and TBI caregiver mental health in Mexico City, Mexico	BRAIN INJURY			English	Article						Caregiver and cultural; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PUERTO-RICAN; DEPRESSION; QUESTIONNAIRE; INTEGRATION; ADJUSTMENT; ATTENTION; AMERICAN; BURDEN; IMPACT	Purpose: This study examined relationships between caregiver mental health and the extent to which needs were met in families of individuals with traumatic brain injury (TBI) in Mexico City, Mexico. Method: Sixty-eight TBI caregivers completed Spanish versions of instruments assessing their own mental health and whether specific family needs were met. Results: Twenty-seven per cent of caregivers reported clinically significant depression levels, 40% reported below-average life satisfaction and 49% reported mild-to-severe burden. Several of the most frequently met family needs were in the emotional support domain, whereas the majority of unmet needs were in the health information domain. Family needs and caregiver mental health were significantly and highly related. When family needs were met, caregiver mental health was better. The strongest pattern of connections in multivariate analyses was between family instrumental support (assistance in the completion of daily life tasks) and caregiver burden, such that caregivers with less instrumental support had greater burden. Additional results suggested that instrumental support uniquely predicted caregiver satisfaction with life, burden and depression. Conclusions: Interventions for TBI caregivers, especially in Latin America, should help family members determine how best to meet their health information and instrumental needs, with the former being likely to improve caregiver mental health.	[Doyle, Sarah T.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Diaz Sosa, Dulce Maria] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Espinosa Jove, Irma Guadalupe] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Lee, Gloria K.] SUNY Buffalo, Buffalo, NY 14260 USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbao 48007, Spain	Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, IKERBASQUE, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Chapman D. W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI DOI 10.3102/01623737001003071; Cohen J, 1998, STAT POWER ANAL BEHA, P567; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fischer L, 1994, FAMILY CAREGIVING LI, P287; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Gulin S, FAMILIES SY IN PRESS; Hinojosa MS, 2009, ETHNIC HEALTH, V14, P591, DOI 10.1080/13557850903165403; Kim Y, 2006, PSYCHO-ONCOLOGY, V15, P795, DOI 10.1002/pon.1013; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J, 1989, FAMILY NEEDS QUESTIO; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Marin G, 1991, RES HISPANIC POPULAT, P130; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Martin-Carrasco M., 1996, REV GERONTOLOGIA, V6, P338; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Moules S, 1999, BRAIN INJURY, V13, P983; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Triandis HC, 1995, INDIVIDUALISM COLLEC, P280; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	51	13	13	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1441	1449		10.3109/02699052.2013.826505			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500016	23957747				2021-06-18	
J	Resch, JE; Macciocchi, S; Ferrara, MS				Resch, Jacob E.; Macciocchi, Stephen; Ferrara, Michael S.			Preliminary Evidence of Equivalence of Alternate Forms of the ImPACT	CLINICAL NEUROPSYCHOLOGIST			English	Article						Equivalence; Alternate forms; Concussion; Computerized neuropsychological tests; Psychometric; Cognitive	INTERNATIONAL-CONFERENCE; CONCUSSION; STATEMENT; SPORT; RELIABILITY; CAPACITY; MEMORY	The ImPACT (Immediate Postconcussion Assessment and Cognitive Testing) is a computerized neurocognitive test used to assist in the management of sport concussion management. A number of studies have documented the reliability and sensitivity of the ImPACT, but no studies have examined the equivalence of the ImPACT's alternate forms. The objective of our study was to determine the equivalence of the ImPACT's five alternate forms. Participants were administered alternate forms of ImPACT based on clinically relevant time frame derived from an extensive sports concussion database. Participants completed a baseline assessment followed by various combinations of the remaining alternate forms at 45 and 50 days. Inferential Confidence Intervals were calculated for each composite score for all alternate forms. We found non-equivalence between ImPACT form 1 and forms 2, 3, and 4 on the Verbal Memory and between forms 2 and 4. ImPACT forms 1 and 3 were not equivalent on the Visual Memory Composite. Finally, ImPACT forms 3 and 4 were not equivalent on the Visual Motor Speed and Reaction Time Composites. Alternate form equivalence is necessary to minimize measurement error and optimize clinical decision making. Clinicians using the ImPACT should consider non-equivalence of some forms on certain Composites when interpreting ImPACT following sports concussion.	[Resch, Jacob E.] Univ Texas Arlington, Dept Kinesiol, Brain Injury Lab, Arlington, TX USA; [Macciocchi, Stephen] Shepherd Ctr, Atlanta, GA USA; [Ferrara, Michael S.] Univ New Hampshire, Durham, NH 03824 USA	Resch, JE (corresponding author), ATC, Maverick Act Ctr 113, Box 19259, Arlington, TX 76019 USA.	resch@uta.edu		Resch, Jacob/0000-0001-6031-3197			BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CONNINE CM, 1990, J EXP PSYCHOL LEARN, V16, P1084, DOI 10.1037/0278-7393.16.6.1084; Crocker L., 2008, INTRO CLASSICAL MODE; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Green P., 2005, GREENS WORD MEMORY T; Green P, 2003, WORD MEMORY TEST WIN; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Tryon WW, 2008, PSYCHOL METHODS, V13, P272, DOI 10.1037/a0013158; Tryon WW, 2001, PSYCHOL METHODS, V6, P371, DOI 10.1037//1082-989X.6.4.371	21	13	13	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 1	2013	27	8					1265	1280		10.1080/13854046.2013.845247			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	273KW	WOS:000328534700005	24099175				2021-06-18	
J	Stevens, LF; Perrin, PB; Gulin, S; Rogers, HL; Cabrera, TV; Jimenez-Maldonado, M; Arango-Lasprilla, JC				Stevens, Lillian Flores; Perrin, Paul B.; Gulin, Shaina; Rogers, Heather L.; Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Carlos Arango-Lasprilla, Juan			Examining the Influence of Three Types of Social Support on the Mental Health of Mexican Caregivers of Individuals with Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						TBI; Caregivers; Social Support; Mental Health Outcomes	TRAIT ANXIETY INVENTORY; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; FAMILY; BURDEN; REHABILITATION; PREDICTORS; DISTRESS; CARERS; STRESS	Objective: The aim of this study was to examine the influence of three types of social support (appraisal, belonging, and tangible) on caregiver mental health (anxiety, burden, depression, and satisfaction with life) among Mexican caregivers of individuals with traumatic brain injury. Design: This is a cross-sectional study of 90 family caregivers from Hospital Civil Fray Antonio Alcade in Guadalajara, Mexico. Results: More months spent caregiving was associated with decreases in all three types of social support. Older age and fewer years of education were associated with lower appraisal social support. More hours per week spent caregiving was associated with lower caregiver state anxiety and greater satisfaction with life. Appraisal, belonging, and tangible social support were all significantly correlated with more salubrious caregiver mental health outcomes, except satisfaction with life. Appraisal social support independently predicted lower caregiver depression. Conclusions: Particularly in Latin America, strong social support networks and family connections seem closely tied to key mental health outcomes such as depression. Rehabilitation interventions aimed at strengthening perceptions of social support of caregivers of individuals with traumatic brain injury that specifically target availability of advice may improve mental health and contribute to more optimal informal care for individuals with traumatic brain injury.	[Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Perrin, Paul B.; Gulin, Shaina] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Rogers, Heather L.; Carlos Arango-Lasprilla, Juan] Univ Deusto, Bilbao 48007, Spain; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Arango-Lasprilla, JC (corresponding author), Univ Deusto, Basque Fdn Sci, Dept Psychol, Avda Univ 24, Bilbao 48007, Spain.		Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X; Rogers, Heather L./0000-0002-7562-4542			Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Atienza FL, 2000, PSICOTHEMA, V12, P314; Campos B, 2008, CULT DIVERS ETHN MIN, V14, P155, DOI 10.1037/1099-9809.14.2.155; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; COHEN R, 1979, CULTURE DIS STRESS L; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; GREBLER L, 1970, MEXICAN AM PEOPLE; Gurung R., 2006, HLTH PSYCHOL CULTURA; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KARLIKAYA G, 2005, INTERNET J NEUROL, V4; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasprilla JCA, 2009, AM J ALZHEIMERS DIS, V24, P384, DOI 10.1177/1533317509341465; Lazarus R.S., 1984, STRESS APPRAISAL COP; Marin G, 1991, RES HISPANIC POPULAT; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin-Carrasco M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; NOVY DM, 1995, HISPANIC J BEHAV SCI, V17, P209, DOI 10.1177/07399863950172005; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; SANCHEZAYENDEZ M, 1998, LATINO ELDERS 21 CEN, V30, P75; Sarason, 1985, SOCIAL SUPPORT THEOR, P73, DOI DOI 10.1007/978-94-009-5115-0_5; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Spielberger C.D., 1975, IDARE INVENTARIO ANS; Spielberger C. D., 2010, CORSINI ENCY PSYCHOL, V1, P1698, DOI [10.1002/9780470479216.corpsy0943, DOI 10.1002/9780470479216.CORPSY0943, 10.1002/9780470479216, DOI 10.1002/9780470479216.CORPSY0942]; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; SPSS Inc, 2010, SPSS BAS 19 0 WIND U; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	54	13	13	2	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV	2013	92	11					959	967		10.1097/PHM.0b013e31828cd549			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	299DK	WOS:000330375100002	23552337				2021-06-18	
J	Wagner, AK; Brayer, SW; Hurwitz, M; Niyonkuru, C; Zou, HC; Failla, M; Arenth, P; Manole, MD; Skidmore, E; Thiels, E				Wagner, Amy K.; Brayer, Samuel W.; Hurwitz, Max; Niyonkuru, Christian; Zou, Huichao; Failla, Michelle; Arenth, Patricia; Manole, Mioara D.; Skidmore, Elizabeth; Thiels, Edda			Non-spatial pre-training in the water maze as a clinically relevant model for evaluating learning and memory in experimental TBI	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Traumatic brain injury; Controlled cortical impact; Implicit memory; Water maze; Spatial memory; Thigmotaxis	TRAUMATIC BRAIN-INJURY; COGNITIVE DEFICITS; EXPLICIT MEMORY; SPATIAL NAVIGATION; HIDDEN PLATFORM; SEX-DIFFERENCES; IMPLICIT; LESIONS; PLACE; RATS	Explicit and implicit learning and memory networks exist where each network can facilitate or inhibit cognition. Clinical evidence suggests that implicit networks are relatively preserved after traumatic brain injury (TBI). Non-spatial pre-training (NSPT) in the Morris Water Maze (MWM) provides the necessary behavioral components to complete the task, while limiting the formation of spatial maps. Our study utilized NSPT in the MWM to assess implicit and explicit learning and memory system deficits in the controlled cortical impact (CCI) model of TBI. 76 adult male Sprague-Dawley rats were divided: CCI vs. sham surgery, NSPT vs. No-NSPT, and cued vs. non-cued groups. NSPT occurred for 4d prior to surgery (dynamic hidden platform location, extra-maze cues covered, static pool entry point). Acquisition (d14-18), Probe/Visible Platform (d19), and Reversal (d20-21) trials were conducted with or without extra-maze cues. Novel time allocation and search strategy selection metrics were utilized. Results indicated implicit and explicit learning/memory networks are distinguishable in the MWM. In the cued condition, NSPT reduced thigmotaxis, improved place learning, and largely eliminated the apparent injury-induced deficits typically observed between untrained CCI and sham rats. However, among NSPT groups, incorporation of cues into search strategy selection for CCI rats was relatively impaired compared to shams. Noncued condition performance showed sham/NSPT and CCl/NSPT rats perform similarly, suggesting implicit memory networks are largely intact 2 weeks after CCI. Place learning differences between CCl/NSPT and sham/NSPT rats more accurately reflect spatial deficits in our CCI model compared to untrained controls. These data suggest NSPT as a clinically relevant construct for evaluating potential neurorestorative and neuroprotective therapies. These findings also support development of non-spatial cognitive training paradigms for evaluating rehabilitation relevant combination therapies. (C) 2013 Elsevier Inc. All rights reserved.	[Wagner, Amy K.; Brayer, Samuel W.; Hurwitz, Max; Niyonkuru, Christian; Zou, Huichao; Failla, Michelle; Arenth, Patricia] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, Amy K.; Brayer, Samuel W.; Zou, Huichao; Manole, Mioara D.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Manole, Mioara D.] Childrens Hosp Pittsburgh UPMC, Div Pediat Emergency Med, Pittsburgh, PA 15224 USA; [Skidmore, Elizabeth] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA 15260 USA; [Thiels, Edda] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD071728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD071728] Funding Source: NIH RePORTER	Work associated with this study was supported, in part, by the National Institutes of Health (1R21HD071728). The authors would like to acknowledge Christopher Henderson, Jay Fuletra, Krishma Kumar and Scott Ketchman for their assistance in data collection.	BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Brooks SP, 2007, BRAIN RES, V1185, P179, DOI 10.1016/j.brainres.2007.09.017; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Carrasco C, 2006, BEHAV PHARMACOL, V17, P441, DOI 10.1097/00008877-200609000-00010; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen SHA, 1997, BRAIN INJURY, V11, P197; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Da Cunha C, 2007, NEUROBIOL LEARN MEM, V87, P451, DOI 10.1016/j.nlm.2006.12.004; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Dobkin BH, 2007, DEV NEUROBIOL, V67, P1133, DOI 10.1002/dneu.20514; Dyer K, 2007, BEHAV BRAIN RES, V181, P85, DOI 10.1016/j.bbr.2007.03.029; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0; Hamilton DA, 2008, J EXP PSYCHOL ANIM B, V34, P31, DOI 10.1037/0097-7403.34.1.31; Hamilton DA, 2007, J EXP PSYCHOL-ANIM B, V33, P100, DOI 10.1037/0097-7403.33.2.100; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hoh TE, 1997, BEHAV NEUROSCI, V111, P1285, DOI 10.1037/0735-7044.111.6.1285; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Lukoyanov NV, 2005, BEHAV BRAIN RES, V158, P175, DOI 10.1016/j.bbr.2004.08.023; Mair RG, 2003, BEHAV NEUROSCI, V117, P596, DOI 10.1037/0735-7044.117.3.596; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MOSER E, 1993, J NEUROSCI, V13, P3916; Mouton PR, 2011, UNBIASED STEREOLOGY; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; PerrotSinal TS, 1996, BEHAV NEUROSCI, V110, P1309, DOI 10.1037/0735-7044.110.6.1309; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ramos JMJ, 2010, NEUROBIOL LEARN MEM, V93, P506, DOI 10.1016/j.nlm.2010.01.008; Rothi LJG, 2009, J INT NEUROPSYCH SOC, V15, P311, DOI 10.1017/S1355617709090201; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Steenbergen B, 2010, DISABIL REHABIL, V32, P1509, DOI 10.3109/09638288.2010.497035; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wolff M, 2008, NEUROBIOL LEARN MEM, V90, P71, DOI 10.1016/j.nlm.2008.01.007; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618	63	13	13	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	NOV	2013	106						71	86		10.1016/j.nlm.2013.07.006			16	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	273FO	WOS:000328520800010	23871745	Green Accepted			2021-06-18	
J	Yeo, SS; Jang, SH				Yeo, Sang Seok; Jang, Sung Ho			RECOVERY OF AN INJURED FORNIX IN A STROKE PATIENT	JOURNAL OF REHABILITATION MEDICINE			English	Article						fornix; memory; diffusion tensor imaging; brain plasticity; stroke	TRAUMATIC BRAIN-INJURY; TENSOR TRACTOGRAPHY; HEMORRHAGE	Objective: Knowledge about recovery of an injured fornix following brain injury is limited. We describe here a patient who showed recovery of an injured fornix following stroke. Case report: A 57-year-old female patient underwent coiling for a ruptured anterior communicating cerebral artery aneurysm, and conservative management for subarachnoid and intraventricular haemorrhage. The patient showed severe cognitive impairment 6 weeks after onset. However, her cognition showed continuous improvement with time; based on the Mini-Mental State Examination and the Memory Assessment Scale, her cognition was within the normal range 7 months after onset. Results: Findings from diffusion tensor tractography at 6 weeks and 7 months showed discontinuations in both columns of the fornix. The proximal portion of both crus also showed discontinuation on diffusion tensor tractography at 6 weeks and 7 months; however, on 7-month diffusion tensor tractography, the end of the fornical body was shown to be connected to the splenium of the corpus callosum and then branched to the right medial temporal lobe and right thalamus. Conclusion: The unusual neural connection between the injured fornix and the thalamus appears to be a recovery phenomenon, which allows the injured fornix and the medial temporal lobe to obtain cholinergic innervation from cholinergic nuclei in the brainstem rather than from cholinergic nuclei in the basal forebrain.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Concha L, 2005, AM J NEURORADIOL, V26, P2267; GAFFAN EA, 1991, BRAIN, V114, P1297, DOI 10.1093/brain/114.3.1297; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; MESULAM MM, 1990, PROG BRAIN RES, V84, P231; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wechsler D., 1981, WAIS R MANUAL WECHSL; Williams JM, 1991, MAS MEMORY ASSESSMEN; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469; Yeo SS, 2011, EUR NEUROL, V66, P235, DOI 10.1159/000330942	16	13	14	0	4	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2013	45	10					1078	1080		10.2340/16501977-1232			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	251TE	WOS:000326952800014	24145830	DOAJ Gold			2021-06-18	
J	Nonterah, CW; Jensen, BJ; Perrin, PB; Stevens, LF; Cabrera, TV; Jimenez-Maldonado, M; Arango-Lasprilla, JC				Nonterah, Camilla W.; Jensen, Bryan J.; Perrin, Paul B.; Stevens, Lillian Flores; Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Carlos Arango-Lasprilla, Juan			The influence of TBI impairments on family caregiver mental health in Mexico	BRAIN INJURY			English	Article						Caregiver; cultural; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION; DISTRESS; BURDEN; DEPRESSION; RELATIVES	Purpose: This study examined the influence of five types of impairments in individuals with traumatic brain injury (TBI)-and caregiver stress due to these impairments-on the mental health of family caregivers in Guadalajara, Mexico. Method: Ninety caregivers completed measures of TBI impairments and of their own mental health. The majority were female (92.20%) with a mean age of 47.12 years (SD = 12.67). Caregivers dedicated a median of 50 hours weekly to caregiving and had spent a median of 11 months providing care. Results: Two canonical correlation analyses suggested that these two sets of variables were broadly related, such that more severe impairments in individuals with TBI and more caregiver stress due to those impairments were associated with lower caregiver mental health. Across both analyses, social impairments were most associated with increased caregiver burden. Follow-up analyses also uncovered that caregiver stress due to cognitive impairments was uniquely associated with caregiver burden and anxiety. Conclusions: These results are the first to provide evidence that social and cognitive impairments in individuals with TBI from Latin America are the impairments most associated with caregiver mental health and highlight the need for interventions that target social and cognitive functioning.	[Nonterah, Camilla W.; Jensen, Bryan J.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, IKERBASQUE, Bilbao 48007, Spain	Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, IKERBASQUE, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Belgrave F. Z., 2010, AFRICAN AM PSYCHOL A; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Coy AE, 2013, ARCH PHYS MED REHAB, V94, P362, DOI 10.1016/j.apmr.2012.08.210; Cuellar I, 1995, J COMMUNITY PSYCHOL, V23, P339, DOI 10.1002/1520-6629(199510)23:4<339::AID-JCOP2290230406>3.0.CO;2-7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Diaz-Guerrero R, 1976, CROSS CULTURAL ANXIE; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Lozano JC., 2008, VIGILANCIA EPIDEMIOL, V26, P1; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin-Carrasco M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; NOVY DM, 1995, HISPANIC J BEHAV SCI, V17, P209, DOI 10.1177/07399863950172005; Ownsworth T, 2009, BRAIN IMPAIR, V10, P149, DOI 10.1375/brim.10.2.149; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1126/science.148.3671.804; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183, DOI 10.1590/S0104-11692006000200006; Spielberger C.D., 2010, STATE TRAIT ANXIETY; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; SPSS Inc, 2010, SPSS BAS 19 0 WIND C; TEASDALE G, 1974, LANCET, V2, P81; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	48	13	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1287	1293		10.3109/02699052.2013.812243			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800008	24020441				2021-06-18	
J	Perrin, PB; Stevens, LF; Sutter, M; Hubbard, R; Sosa, DMD; Jove, IGE; Arango-Lasprilla, JC				Perrin, Paul B.; Stevens, Lillian F.; Sutter, Megan; Hubbard, Rebecca; Diaz Sosa, Dulce Maria; Espinosa Jove, Irma Guadalupe; Carlos Arango-Lasprilla, Juan			Exploring the Connections Between Traumatic Brain Injury Caregiver Mental Health and Family Dynamics in Mexico City, Mexico	PM&R			English	Article							PSYCHOLOGICAL DISTRESS; LIFE SATISFACTION; FACES IV; PREDICTORS; REHABILITATION; DEPRESSION; TBI; QUESTIONNAIRE; INDIVIDUALS; ADAPTATION	Objective: To examine the patterns of family dynamics that are most associated with the mental health of traumatic brain injury (TBI) caregivers from Mexico. It was hypothesized that healthier family dynamics would be associated with better caregiver mental health. Design: A cross-sectional study of self-reported data collected from TBI caregivers through the Mexican National Institute of Rehabilitation in Mexico City, Mexico, the premier public medical facility in Mexico that provides rehabilitation services to patients with various disabilities. Setting: One public outpatient medical and rehabilitation facility. Participants: Sixty-eight caregivers of individuals with moderate-to-severe TBI from Mexico City, Mexico, were related to an individual with TBI who was >= 3 months after injury, a primary caregiver for >= 3 months, familiar with the patient's history, and without neurologic or psychiatric conditions. The average (standard deviation) age of caregivers was 50.94 +/- 12.85 years), and 82% were women. Methods: The caregivers completed Spanish versions of instruments that assessed their own mental health and family dynamics. Main Outcome Measurements: Outcomes assessed included family dynamics (Family Adaptability and Cohesion Evaluation Scale Fourth Edition; Family Communication Scale; Family Satisfaction Scale; Family Assessment Device General Functioning; and Relationship-Focused Coping Scale), and caregiver mental health (Patient Health Questionnaire-9, Zarit Burden Interview, and Satisfaction with Life Scale). Results: Results of canonical correlation analyses suggested that caregiver mental health and family dynamics were positively related, with a large effect size. Caregivers with high family satisfaction and cohesion tended to have a low burden and high satisfaction with life. In addition, caregiver depression and burden were positively related to each other and were both inversely related to caregiver satisfaction with life. Conclusions: TBI caregiver interventions in Latino populations would likely benefit from including programming or techniques to improve family dynamics, especially family cohesion, given the strong potentially reciprocal influence of these dynamics on caregiver mental health.	[Perrin, Paul B.; Sutter, Megan; Hubbard, Rebecca] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian F.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Diaz Sosa, Dulce Maria] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Espinosa Jove, Irma Guadalupe] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Dept Methodol & Expt Psychol, IKERBASQUE, Basque Fdn Sci, Bilbao 48007, Spain	Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Methodol & Expt Psychol, IKERBASQUE, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Sutter, Megan/L-9770-2019; Perrin, Paul/L-5373-2015	Sutter, Megan/0000-0001-9816-9549; Perrin, Paul/0000-0003-2070-215X			Anderson M. I., 2006, STRESS ITS IMPACT SO, P23; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chapman D. W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI DOI 10.3102/01623737001003071; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hora Edilene Curvelo, 2005, Rev. Latino-Am. Enfermagem, V13, P93, DOI 10.1590/S0104-11692005000100015; Kabacoff R.I., 1990, J FAMILY PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; KARLIKAYA G, 2005, INTERNET J NEUROL, V4; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Martin-Carrasco M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; OBrien TB, 1996, J PERS, V64, P775, DOI 10.1111/j.1467-6494.1996.tb00944.x; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Olson DH, 2010, FACES 4 MANUAL; Pavot L, 1995, PSYCHOL ASSESSMENT, V5, P164; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivero N, 2010, FAM J, V18, P288, DOI 10.1177/1066480710372084; Sanchez-Ayendez M, 1998, J GERONTOL SOC WORK, V30, P75, DOI 10.1300/J083v30n01_06; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Scharlach A, 2006, FAM RELAT, V55, P625, DOI 10.1111/j.1741-3729.2006.00431.x; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183, DOI 10.1590/S0104-11692006000200006; Steinglass P., 1987, APPL CLIN PSYCHOL FA, P25; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Thomas V, 1999, J FAM THER, V21, P78, DOI 10.1111/1467-6427.00105; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Villarreal R, HISP J BEHAV SCI, V35, P409; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	56	13	13	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2013	5	10					839	849		10.1016/j.pmrj.2013.05.018			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	250LY	WOS:000326855500005	23735587				2021-06-18	
J	Renganathan, K; Gu, JY; Rayborn, ME; Crabb, JS; Salomon, RG; Collier, RJ; Kapin, MA; Romano, C; Hollyfield, JG; Crabb, JW				Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Salomon, Robert G.; Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Hollyfield, Joe G.; Crabb, John W.			CEP Biomarkers as Potential Tools for Monitoring Therapeutics	PLOS ONE			English	Article							5-HT1A RECEPTOR AGONIST; TRAUMATIC BRAIN-INJURY; FACTOR-H POLYMORPHISM; FACTOR-KAPPA-B; MACULAR DEGENERATION; BRUCHS MEMBRANE; SUPEROXIDE-DISMUTASE; DONOR EYES; DAMAGE; RAT	Background: Carboxyethylpyrrole (CEP) adducts are oxidative modifications derived from docosahexaenoate-containing lipids that are elevated in ocular tissues and plasma in age-related macular degeneration (AMD) and in rodents exposed to intense light. The goal of this study was to determine whether light-induced CEP adducts and autoantibodies are modulated by pretreatment with AL-8309A under conditions that prevent photo-oxidative damage of rat retina. AL-8309A is a serotonin 5-HT1A receptor agonist. Methods: Albino rats were dark adapted prior to blue light exposure. Control rats were maintained in normal cyclic light. Rats were injected subcutaneously 3x with 10 mg/kg AL-8309A (2 days, 1 day and 0 hours) before light exposure for 6 h (3.1 mW/cm(2), lambda=450 nm). Animals were sacrificed immediately following light exposure and eyes, retinas and plasma were collected. CEP adducts and autoantibodies were quantified by Western analysis or ELISA. Results: ANOVA supported significant differences in mean amounts of CEP adducts and autoantibodies among the light + vehicle, light + drug and dark control groups from both retina and plasma. Light-induced CEP adducts in retina were reduced similar to 20% following pretreatment with AL-8309A (n = 62 rats, p = 0.006) and retinal CEP immunoreactivity was less intense by immunohistochemistry. Plasma levels of light-induced CEP adducts were reduced at least 30% (n = 15 rats, p = 0.004) by drug pretreatment. Following drug treatment, average CEP autoantibody titer in light exposed rats (n = 22) was unchanged from dark control levels, and similar to 20% (p = 0.046) lower than in vehicle-treated rats. Conclusions: Light-induced CEP adducts in rat retina and plasma were significantly decreased by pretreatment with AL-8309A. These results are consistent with and extend previous studies showing AL-8309A reduces light-induced retinal lesions in rats and support CEP biomarkers as possible tools for monitoring the efficacy of select therapeutics.	[Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Crabb, John W.] Novartis Inst Biomed Res, Ft Worth, TX USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Crabb, JW (corresponding author), Cleveland Clin Fdn, Cole Eye Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	crabbj@ccf.org		Salomon, Robert/0000-0001-9456-3557	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM21249, EY14239, EY14240, EY15638]; Ohio Biomedical Research Technology Transfer grant [05-29]; Research Center grant from The Foundation Fighting Blindness; Llura and Gordon Gund Foundation; Research to Prevent Blindness (RPB)Research to Prevent Blindness (RPB); Macular Vision Research Foundation award; RPB Senior Investigator Award; Steinbach Award; Alcon Research LtdNovartis; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R24EY015638, R56EY014240, R01EY014240, R21EY022134, R01EY016813, R01EY014239, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM021249] Funding Source: NIH RePORTER	This study was supported in part by National Institutes of Health (NIH) grants GM21249, EY14239, EY14240, EY15638, Ohio Biomedical Research Technology Transfer grant 05-29, a Research Center grant from The Foundation Fighting Blindness, the Llura and Gordon Gund Foundation, an unrestricted grant from Research to Prevent Blindness (RPB), a Macular Vision Research Foundation award to JGH, an RPB Senior Investigator Award to JWC, a Steinbach Award to JWC, Alcon Research Ltd, and The Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2003, BBA-MOL CELL RES, V1640, P85, DOI 10.1016/S0167-4889(03)00023-5; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ALVAREZ RA, 1994, INVEST OPHTH VIS SCI, V35, P402; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bando H, 2007, EXP EYE RES, V84, P135, DOI 10.1016/j.exer.2006.09.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradford MM, 1976, CNS DRUGS, V72, P248, DOI 10.1016/0003-2697(76) 90527-3; Collier RJ, 2010, INVEST OPHTH VIS SCI, V52, P2118; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Cosi C, 2005, BRAIN RES, V1043, P32, DOI 10.1016/j.brainres.2005.02.072; Cowen DS, 1997, MOL PHARMACOL, V52, P221; Crabb JW, 2012, OXID STRESS APPL BAS, P65, DOI 10.1007/978-1-61779-606-7_3; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DELMELLE M, 1975, EXP EYE RES, V21, P369, DOI 10.1016/0014-4835(75)90047-0; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fulton B, 1997, CNS DRUGS, V7, P68, DOI 10.2165/00023210-199707010-00007; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Marc RE, 2008, MOL VIS, V14, P782; Mauler F, 2005, J CEREBR BLOOD F MET, V25, P451, DOI 10.1038/sj.jcbfm.9600038; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Oosterink BJ, 2003, NEUROREPORT, V14, P57, DOI 10.1097/00001756-200301200-00011; Organisciak D, 2012, PHOTOCHEM PHOTOBIOL, V88, P1396, DOI 10.1111/j.1751-1097.2012.01134.x; R Development Team, 2008, R LANG ENV STAT COMP; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; RORABACHER DB, 1991, J ANAL CHEM+, V83, P139, DOI DOI 10.1021/AC00003A730; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; WANG N, 1992, CURR EYE RES, V11, P783, DOI 10.3109/02713689209000751; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200	56	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76325	10.1371/journal.pone.0076325			10	Multidisciplinary Sciences	Science & Technology - Other Topics	231OR	WOS:000325427100059	24098476	DOAJ Gold, Green Published			2021-06-18	
J	Tham, SW; Palermo, TM; Wang, J; Jaffe, KM; Temkin, N; Durbin, D; Rivara, FP				Tham, See Wan; Palermo, Tonya M.; Wang, Jin; Jaffe, Kenneth M.; Temkin, Nancy; Durbin, Dennis; Rivara, Frederick P.			Persistent Pain in Adolescents Following Traumatic Brain Injury	JOURNAL OF PAIN			English	Article						Traumatic brain injury; adolescents; pain; longitudinal study; health-related quality of life	QUALITY-OF-LIFE; PATIENT HEALTH QUESTIONNAIRE-9; GLASGOW COMA SCALE; FUNCTIONAL DISABILITY; SEVERITY SCORE; HEAD-INJURY; CHILDREN; DEPRESSION; VALIDITY; PREDICTORS	Traumatic brain injury (TBI) is a leading cause of pediatric disability. Although persistent pain has been recognized as a significant postinjury complication, there is a paucity of data concerning the postinjury pain experience of youth. This study aimed to examine the prevalence of persistent pain in adolescents after TBI, identify risk factors for pain, and evaluate the impact of pain on adolescent health-related quality of life. Participants included 144 adolescents with mild to severe TBI who were followed over 36 months after injury. At 3-, 12-, 24-, and 36-Month assessments, measures of pain intensity, depression, posttraumatic stress disorder, and health-related quality of life were completed by adolescents. Findings demonstrated that 24.3% of adolescents reported persistent pain (defined as usual pain intensity -3/10) at all assessment points after TBI. Female sex (odds ratio = 2.73, 95% confidence interval = 1.12-6.63) and higher levels of depressive symptoms at 3 months after injury (odds ratio = 1.26, 95% confidence interval = 1.12-1.43) were predictors of persistent pain at 36 months. Furthermore, mixed linear models indicated that early pain experience at 3 months following TBI was associated with a significantly poorer long-term health-related quality of life. Perspective: This is the first study to examine the prevalence of persistent pain over long-term follow-up in adolescents after TIM and its impact on health-related quality of life. These findings indicate that adolescents with TBl may benefit from timely evaluation and intervention to minimize the development and impact of pain. (C) 2013 by the American Pain Society	[Tham, See Wan; Palermo, Tonya M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Palermo, Tonya M.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Wang, Jin; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Dept Emergency Med, Philadelphia, PA 19104 USA	Tham, SW (corresponding author), Seattle Childrens Res Inst, M-S-CW8-6,POB 5371, Seattle, WA 98145 USA.	see.tham@seattlechildrens.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM086270-03, K24HD060068]; National Center for Injury Prevention and Control, Centers for Diseases Control and Prevention [R49 CE 001021]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD060068] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086270] Funding Source: NIH RePORTER	Support for this project was provided by the National Institutes of Health grants 5T32GM086270-03 (S.W.T.) and K24HD060068 (T.M.P.) and National Center for Injury Prevention and Control, Centers for Diseases Control and Prevention, grant R49 CE 001021 (ERR.).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Demyttenaere S, 2001, CLIN J PAIN, V17, P173, DOI 10.1097/00002508-200106000-00010; Eccleston C, 2004, PAIN, V108, P221, DOI 10.1016/j.pain.2003.11.008; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gauntlett-Gilbert J, 2007, PAIN, V131, P132, DOI 10.1016/j.pain.2006.12.021; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hunfeld JAM, 2001, J PEDIATR PSYCHOL, V26, P145, DOI 10.1093/jpepsy/26.3.145; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Kashikar-Zuck S, 2001, CLIN J PAIN, V17, P341, DOI 10.1097/00002508-200112000-00009; Keogh E, 2006, PAIN, V123, P275, DOI 10.1016/j.pain.2006.03.004; King S, 2011, PAIN, V152, P2729, DOI 10.1016/j.pain.2011.07.016; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LANSER JBK, 1988, HEADACHE, V28, P176, DOI 10.1111/j.1526-4610.1988.hed2803176.x; Logan DE, 2008, J PAIN, V9, P407, DOI 10.1016/j.jpain.2007.12.003; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marr AL., 2004, CENTRAL NERVOUS SYST; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ruperto N, 2010, ARTHRIT CARE RES, V62, P1542, DOI 10.1002/acr.20283; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stanford EA, 2008, PAIN, V138, P11, DOI 10.1016/j.pain.2007.10.032; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Voepel-Lewis T, 2011, ANESTH ANALG, V112, P415, DOI 10.1213/ANE.0b013e318203f495; von Baeyer CL, 2009, PAIN, V143, P223, DOI 10.1016/j.pain.2009.03.002	53	13	13	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	OCT	2013	14	10					1242	1249		10.1016/j.jpain.2013.05.007			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	236GB	WOS:000325782400024	23911979	Green Accepted			2021-06-18	
J	Andruszkow, H; Probst, C; Grun, O; Krettek, C; Hildebrand, F				Andruszkow, Hagen; Probst, Christian; Gruen, Orna; Krettek, Christian; Hildebrand, Frank			Does Additional Head Trauma Affect the Long-term Outcome After Upper Extremity Trauma in Multiple Traumatized Patients: Is There an Additional Effect of Traumatic Brain Injury?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							QUALITY-OF-LIFE; FOLLOW-UP; POLYTRAUMATIZED PATIENTS; SEVERITY SCORE; HEALTH SURVEY; MAJOR TRAUMA; FRACTURES; MODERATE; GENDER; COHORT	Musculoskeletal injuries are common in patients with multiple trauma resulting in pain, functional deficits, and disability. Traumatic brain injuries (TBIs) are common in severely injured patients potentially resulting in neurological impairment and permanent disability that would add to that from the musculoskeletal injuries. However, it is unclear to what degree the combination affects impairment. We therefore asked whether added upper extremity injuries or TBI worsened the functional, psychological, and vocational status in multiple trauma patients. We retrospectively reviewed 281 patients with multiple trauma: 229 with upper extremity injuries but without TBI (Group I), 32 with concomitant upper extremity injuries and TBI (Group II), and 20 with TBI but no upper extremity injuries (Group III). We assessed patients with the Glasgow Outcome Score (GOS), Hannover Score for Polytrauma Outcome, SF-12 (Physical Component Summary Score and Mental Component Summary Score), medical aid requirements, need of psychological support, and vocational living circumstances. The minimum followup was 10 years (median, 17.5 years; range, 10-28 years). Additional TBI in multiple trauma patients led to reduced function (GOS: Group I: 4.9 +/- 0.2, Group II: 4.5 +/- 0.7, Group III: 4.5 +/- 0.8) resulting in vocational restrictions (job change: Group I: 74%, Group II: 91%, Group III: 90%). The combination of upper extremity and TBIs did not result in worse long-term scores compared with TBI alone. Rehabilitation and social reintegration in multiple trauma patients with TBI requires particular emphasis to minimize disability and vocational isolation. Musculoskeletal injuries should not be neglected to ensure the maximum extremity function given the impaired cognitive functions after TBI. Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.	[Andruszkow, Hagen; Hildebrand, Frank] Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, D-52074 Aachen, Germany; [Probst, Christian] Univ Witten Herdecke, Dept Trauma & Orthopaed Surg, Cologne Merheim Med Ctr, Fac Hlth,Sch Med, Cologne, Germany; [Gruen, Orna] Hannover Re Insurance, Hannover, Germany; [Krettek, Christian] Hannover Med Sch, Trauma Dept, Hannover, Germany	Andruszkow, H (corresponding author), Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, Pauwelsstr 30, D-52074 Aachen, Germany.	handruszkow@ukaachen.de	Hildebrand, Frank/J-3176-2017	Krettek, Christian/0000-0001-9807-0020	Hannover Life Re-Insurance, Hannover, Germany	The institution of one or more of the authors (CP, CK, FH) has received, during the study period, funding from the Hannover Life Re-Insurance, Hannover, Germany.	Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dowrick AS, 2005, J TRAUMA, V58, P1175, DOI 10.1097/01.TA.0000169930.79684.4E; Dowrick AS, 2005, INJURY, V36, P468, DOI 10.1016/j.injury.2004.06.014; Ekholm R, 2006, J ORTHOP TRAUMA, V20, P591, DOI 10.1097/01.bot.0000246466.01287.04; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Helfet DL, 2003, J BONE JOINT SURG AM, V85A, P33, DOI 10.2106/00004623-200301000-00006; JENNETT B, 1975, LANCET, V1, P480; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Mkandawire NC, 2002, INJURY, V33, P111, DOI 10.1016/S0020-1383(01)00047-X; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pfeifer R, 2012, J TRAUMA ACUTE CARE, V72, P467, DOI 10.1097/TA.0b013e318219fbfa; Probst C, 2010, J TRAUMA, V68, P706, DOI 10.1097/TA.0b013e3181a8b21c; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Stalp M, 2001, CHIRURG, V72, P312, DOI 10.1007/s001040051312; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Zeckey C, 2011, BRAIN INJURY, V25, P551, DOI 10.3109/02699052.2011.568036; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670; Zunzunegui MV, 2001, J CLIN EPIDEMIOL, V54, P501, DOI 10.1016/S0895-4356(00)00325-5	36	13	13	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2013	471	9					2899	2905		10.1007/s11999-013-3031-6			7	Orthopedics; Surgery	Orthopedics; Surgery	197VK	WOS:000322879800026	23657878	Green Published			2021-06-18	
J	Esbjornsson, E; Skoglund, T; Sunnerhagen, KS				Esbjornsson, Eva; Skoglund, Thomas; Sunnerhagen, Katharina S.			FATIGUE, PSYCHOSOCIAL ADAPTATION AND QUALITY OF LIFE ONE YEAR AFTER TRAUMATIC BRAIN INJURY AND SUSPECTED TRAUMATIC AXONAL INJURY; EVALUATIONS OF PATIENTS AND RELATIVES: A PILOT STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						head trauma; diffuse axonal injury; fatigue; cognition; quality of life; employment	SELF-AWARENESS; IMPACT; VALIDATION; MODERATE; IMPAIRMENT; DEPRESSION; SEQUELAE; RETURN; DAMAGE; SCALE	Objective: To describe fatigue and its relationship to cognition, psychosocial adjustment, quality of life (QoL), work status and relative's experiences 12 months after suspected traumatic axonal injury. Methods: Eighteen patients were assessed with the Daily Fatigue Impact Scale (D-FIS), the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS), the European Questionnaire 5 Dimensions health-related quality of life, the Glasgow Coma Outcome Scale Extended, and the European Brain Injury Questionnaire (EBIQ) (patient and relative). Return to work was registered. Results: At 1 year, fatigue still caused great problems in daily life. Although fatigue and cognition (BNIS) did not correlate, the more fatigued patients subjectively experienced significantly more cognitive dysfunction. Although D-FIS and QoL did not correlate, most patients reported that feelings of tiredness and dullness related to having lower QoL. However, lower QoL was associated with cognitive and attention disability (BNIS), subjective perception of executive dysfunction, lack of motivation, and mood disturbances (EBIQ). Neither fatigue nor cognition associated with return to work. The general consequences of traumatic axonal injury showed good agreement between patients' and relatives' experiences. Conclusion: The patient's subjective experience of the impact of traumatic axonal injury seems to be most essential, as it is the objective reality that the patient responds to, and this should therefore be assessed and treated.	[Esbjornsson, Eva; Skoglund, Thomas] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Sunnerhagen, Katharina S.] Univ Oslo, Sunnaas Rehabil Hosp, Fac Med, Oslo, Norway	Esbjornsson, E (corresponding author), Sahlgrens Univ Hosp, Dubbsgatan 14,3rd Floor, SE-41345 Gothenburg, Sweden.	esbjornsson@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400	Health and Medical Care Committee of Vastra Gotaland	The study was supported in part by a grant from the Health and Medical Care Committee of Vastra Gotaland. Cathrine Ritzen-Eriksson, Caisa Hofgren and Jerry Larsson have all been involved in logistics and assessments of patients. Without their input this work would not have been possible.	Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fisk JD, 2002, QUAL LIFE RES, V11, P263, DOI 10.1023/A:1015295106602; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; JENNETT B, 1975, LANCET, V1, P480; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Prigatano GP, 2005, ACT NEUR S, V93, P39; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1995, ADM SCORING MANUAL B; Prigatano GP, 2008, BNI SCREEN HIGHER CE; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Szende Agota WA, 2004, MEASURING SELF REPOR; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	38	13	14	0	20	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					771	777		10.2340/16501977-1170			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500012	24002313	DOAJ Gold			2021-06-18	
J	Nobs, L; Nestel, S; Kulik, A; Nitsch, C; Atanasoski, S				Nobs, Lionel; Nestel, Sigrun; Kulik, Akos; Nitsch, Cordula; Atanasoski, Suzana			Cyclin D1 is required for proliferation of olig2-expressing progenitor cells in the injured cerebral cortex	GLIA			English	Article						glial progenitor cells; cell cycle; proliferation; brain injuries	TRAUMATIC BRAIN-INJURY; ADULT NEUROGENESIS; SCHWANN-CELLS; IBOTENIC ACID; SPINAL-CORD; CNS INJURY; EXPRESSION; ACTIVATION; NEURONS; MICE	Little is known about the molecular mechanisms driving proliferation of glial cells after an insult to the central nervous system (CNS). To test the hypothesis that the G1 regulator cyclin D1 is critical for injury-induced cell division of glial cells, we applied an injury model that causes brain damage within a well-defined region. For this, we injected the neurotoxin ibotenic acid into the prefrontal cortex of adult mice, which leads to a local nerve cell loss but does not affect the survival of glial cells. Here, we show that cyclin D1 immunoreativity increases drastically after neurotoxin injection. We find that the cyclin D1-immunopositive (cyclin D1+) cell population within the lesioned area consists to a large extent of Olig2+ oligodendrocyte progenitor cells. Analysis of cyclin D1-deficient mice demonstrates that the proliferation rate of Olig2+ cells diminishes upon loss of cyclin D1. Further, we show that cyclin-dependent kinase (cdk) 4, but not cdk6 or cdk2, is essential for driving cell division of Olig2-expressing cells in our injury model. These data suggest that distinct cell cycle proteins regulate proliferation of Olig2+ progenitor cells following a CNS insult.	[Nobs, Lionel; Atanasoski, Suzana] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland; [Nestel, Sigrun; Atanasoski, Suzana] Univ Freiburg, Inst Anat & Cell Biol, D-79106 Freiburg, Germany; [Kulik, Akos] Univ Freiburg, Inst Physiol, Freiburg, Germany; [Kulik, Akos] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Nitsch, Cordula] Univ Basel, Inst Anat, Dept Biomed, CH-4056 Basel, Switzerland	Atanasoski, S (corresponding author), Univ Basel, Inst Physiol, Dept Biomed, Pestalozzistr 20, CH-4056 Basel, Switzerland.	suzana.atanasoski@unibas.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Swiss Life; Botnar Foundation; Freiwillige Akademische Gesellschaft (FAG), Basel	Grant sponsors: the Swiss National Science Foundation; Swiss Life; the Botnar Foundation; Freiwillige Akademische Gesellschaft (FAG), Basel.	Atanasoski S, 2006, GLIA, V53, P147, DOI 10.1002/glia.20263; Atanasoski S, 2002, J NEUROSCI RES, V67, P443, DOI 10.1002/jnr.10133; Atanasoski S, 2001, MOL CELL NEUROSCI, V18, P581, DOI 10.1006/mcne.2001.1055; Atanasoski S, 2008, MOL CELL NEUROSCI, V37, P519, DOI 10.1016/j.mcn.2007.11.005; Beukelaers P, 2011, STEM CELLS, V29, P713, DOI 10.1002/stem.616; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen Z, 2005, J NEUROCHEM, V92, P1281, DOI 10.1111/j.1471-4159.2004.02934.x; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Glickstein SB, 2007, CEREB CORTEX, V17, P632, DOI 10.1093/cercor/bhk008; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Inglis WL, 1997, BRAIN RES, V755, P17, DOI 10.1016/S0006-8993(97)00101-7; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Koeller HB, 2008, NEUROBIOL DIS, V31, P230, DOI 10.1016/j.nbd.2008.04.010; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Rane SG, 1999, NAT GENET, V22, P44; Sakurai M, 2000, STROKE, V31, P200, DOI 10.1161/01.STR.31.1.200; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Small DL, 2001, BRAIN RES, V900, P26, DOI 10.1016/S0006-8993(01)02102-3; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004	36	13	13	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491			GLIA	Glia	SEP	2013	61	9					1443	1455		10.1002/glia.22533			13	Neurosciences	Neurosciences & Neurology	190ID	WOS:000322331700005	23839966				2021-06-18	
J	Rubiano, AM; Sanchez, AI; Estebanez, G; Peitzman, A; Sperry, J; Puyana, JC				Rubiano, Andres M.; Sanchez, Alvaro I.; Estebanez, Glyn; Peitzman, Andrew; Sperry, Jason; Puyana, Juan Carlos			The effect of admission spontaneous hypothermia on patients with severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Outcome; Severe head injury; Hypothermia; Traumatic brain injury; Mortality	MODERATE HYPOTHERMIA; INTRACRANIAL-PRESSURE; ENZYME-ACTIVITY; THERAPY; TEMPERATURE; COAGULATION; MANAGEMENT	Introduction: Recent information has emerged regarding the harmful effects of spontaneous hypothermia at time of admission in trauma patients. However the volume of evidence regarding the role of spontaneous hypothermia in TBI patients is inadequate. Methods: We performed secondary data analysis of 10 years of the Pennsylvania trauma outcome study (PTOS) database. Unadjusted comparisons of the association of admission spontaneous hypothermia with mortality were performed. In addition, full assessment of the association of hypothermia with mortality was conducted using multivariable logistic regressions reporting the odds ratios (OR) with the 95% confidence intervals (CI) and P-values. Results: There were 11,033 patients identified from the PTOS with severe TBI. There were 4839 deaths (43.9%). The proportion of deaths in hypothermic patients was higher than the proportion of deaths in normothermic patients (53.9% vs. 37.4% respectively; P value < 0.001). In a multivariable logistic regression model adjusted for demographics, injury characteristics, and information at admission to the trauma centre, the odds of death among patients with hypothermia were 1.70 times the odds of death among patients with normothermia (OR 1.70, 95% CI 1.50-1.93), indicating that the probability of death was significantly higher when patients arrived hypothermic at the trauma centre. Conclusion: The presence of spontaneous hypothermia at hospital admission is associated with a significant increase in the risk of mortality in patients with severe TBI. The benefit of maintaining normothermia in severe TBI patients, the impact of prolonged re-warming in patients with established hypothermia and the introduction of prophylactic measures to complications of hypothermia are key points that require further investigation. (C) 2012 Elsevier Ltd. All rights reserved.	[Rubiano, Andres M.] South Colombian Univ, Neiva Univ Hosp, Neiva, Colombia; [Sanchez, Alvaro I.] Univ Pittsburgh, Med Ctr, Div Trauma, Pittsburgh, PA USA; [Estebanez, Glyn] Whiston Hosp, Dept Surg, Warrington, Cheshire, England; [Peitzman, Andrew; Sperry, Jason; Puyana, Juan Carlos] Univ Pittsburgh, Med Ctr, Dept Gen Surg, Div Trauma, Pittsburgh, PA USA	Rubiano, AM (corresponding author), South Colombian Univ, Neiva Univ Hosp, Neiva, Colombia.	andresrubiano@aol.com; sanchezortiza@upmc.edu; glynestebanez@hotmail.com; peitzmanab@upmc.edu; sperryjl@upmc.edu; puyanajc@upmc.edu	RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254	FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007560] Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43 TW007560] Funding Source: Medline		Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Clark DE, 2009, ICDPIC STATA MODULE, VS457028; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; De Deyne CS, 2010, CURR OPIN ANESTHESIO, V23, P258, DOI 10.1097/ACO.0b013e328336ea44; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Jurkovich GJ, 2007, SURG CLIN N AM, V87, P247, DOI 10.1016/j.suc.2006.10.003; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Krause KR, 2000, AM SURGEON, V66, P348; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; REED RL, 1990, CIRC SHOCK, V32, P141; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; World Health Organization, 1977, INT CLASS DIS	37	13	13	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1219	1225		10.1016/j.injury.2012.11.026			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600015	23273319	Green Accepted			2021-06-18	
J	Zhang, MY; Shan, HY; Wang, YQ; Wang, T; Liu, WL; Wang, L; Zhang, L; Chang, P; Dong, WW; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Wang, Yaoqi; Wang, Tao; Liu, Weili; Wang, Long; Zhang, Lu; Chang, Pan; Dong, Wenwen; Chen, Xiping; Tao, Luyang			The Expression Changes of Cystathionine-beta-synthase in Brain Cortex After Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Cystathionine-beta-synthase; Traumatic brain injury; Apoptosis; Mice	INDUCED CELL-DEATH; HYDROGEN-SULFIDE; HUMAN-LIVER; RAT LIVER; MICE; ENZYME; MOUSE; HISTOPATHOLOGY; PROLIFERATION; PURIFICATION	Cystathionine-beta-synthase (CBS) catalyzes the condensation of serine with homocysteine to form cystathionine and occupies a crucial regulatory position between the methionine cycle and the biosynthesis of cysteine by transsulfuration. It was reported that CBS was a novel marker of both differentiation and proliferation for certain cell types, suggesting that CBS represents a survival-promoting protein. However, its expression and function in the central nervous system lesion are not well understood. To investigate changes of CBS after traumatic brain injury (TBI) and its possible role, mice TBI model was established by controlled cortical impact system, and the expression and cellular localization of CBS after TBI was investigated in the present study. Western blot analysis revealed that CBS was present in normal mice brain cortex. It gradually decreased, reached a valley at the third day after TBI, and then restored to basal level. Importantly, more CBS was colocalized with neuron. In addition, Western blot detection showed that the third day postinjury was also the apoptosis peak indicated by the elevated expression of caspase-3. Importantly, immunohistochemistry analysis revealed that injury-induced expression of CBS was colabeled by Bcl-2 and had no co-localization with caspase-3. These data suggested that CBS may be implicated in the apoptosis of neuron and involved in the pathophysiology of brain after TBI.	[Zhang, Mingyang; Wang, Yaoqi; Wang, Tao; Liu, Weili; Wang, Long; Zhang, Lu; Chang, Pan; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Jiangsu, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou 215008, Jiangsu, Peoples R China	Chen, XP (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911, 81271379]; Natural Science Foundation of Medical College of Nantong University [Y201003]; The Priority Academic Program Development of Jiangsu Higher Education Institutions; The Colleges and Universities in Jiangsu Province Plans to Graduate Research and Innovation [CXLX12_0824]	This work was supported by the National Natural Science Foundation of China (No. 30872666, 81172911, and No. 81271379), Natural Science Foundation of Medical College of Nantong University (No. Y201003), The Priority Academic Program Development of Jiangsu Higher Education Institutions, and The Colleges and Universities in Jiangsu Province Plans to Graduate Research and Innovation (CXLX12_0824).	Abe K, 1996, J NEUROSCI, V16, P1066; Abekhoukh S, 2012, MOL NEUROBIOL, DOI [10.1007/s12035-12012-18326-12031, DOI 10.1007/S12035-12012-18326-12031]; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Dutta S, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-25; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Ganapathy PS, 2009, INVEST OPHTH VIS SCI, V50, P4460, DOI 10.1167/iovs.09-3402; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Han Y, 2005, NEUROSCI RES, V53, P216, DOI 10.1016/j.neures.2005.07.002; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Janel N, 2012, J MOL NEUROSCI, DOI [10.1007/s12031-12012-19835-12030, DOI 10.1007/S12031-12012-19835-12030]; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P488, DOI 10.1016/0005-2744(70)90255-X; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P501; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; KRAUS J, 1978, J BIOL CHEM, V253, P6523; KRAUS JP, 1983, ARCH BIOCHEM BIOPHYS, V222, P44, DOI 10.1016/0003-9861(83)90500-3; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Regnier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029056; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shao C, 2012, RADIAT RES, DOI [10.1667/RR2967.1661, DOI 10.1667/RR2967.1661]; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Talaei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022568; Tyagi SC, 2012, MOL CELL BIOCHEM, DOI [10.1007/s11010-11012-11425-11015, DOI 10.1007/S11010-11012-11425-11015]; Wang HY, 2012, CELL RES, DOI [10.1038/cr.2012.1135, DOI 10.1038/CR.2012.1135]; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhong WX, 2012, J BIOL CHEM, V287, P34189, DOI 10.1074/jbc.M112.383646; Zhou Xiao-hong, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P199	43	13	14	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2013	51	1					57	67		10.1007/s12031-012-9948-5			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	211PJ	WOS:000323921000007	23315129				2021-06-18	
J	Wondrusch, C; Schuster-Amft, C				Wondrusch, C.; Schuster-Amft, C.			A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						motor imagery introduction program (MIIP); CNS lesion; sensorimotor impairments; mental practice; stroke; multiple sclerosis; Parkinson's disease	MENTAL PRACTICE; GAIT REHABILITATION; STROKE; POSTSTROKE; PEOPLE; KNOWLEDGE; EDUCATION; EFFICACY	Background: For patients with central nervous system (CNS) lesions and sensorimotor impairments a solid motor imagery (MI) introduction is crucial to understand and use MI to improve motor performance. The study's aim was to develop and evaluate a standardized MI group introduction program (MIIP) for patients after stroke, multiple sclerosis (MS), Parkinson's disease (PD), and traumatic brain injury (TBI). Methods: Phase 1: Based on literature a MIIP was developed comprising MI theory (definition, type, mode, perspective, planning) and MI practice (performance, control). Phase 2: Development of a 27-item self-administered MIIP evaluation questionnaire, assessing MI knowledge self-evaluation of the ability to perform MI and patient satisfaction with the MIIP. Phase 3: Evaluation of MIIP and MI questionnaire by 2 independent MI experts based on predefined criteria and 2 patients using semi-structured interviews. Phase 4: Case series with a pre-post design to evaluate MIIP (3 x 30 min) using the MI questionnaire, Imaprax, Kinaesthetic and Visual Imagery Questionnaire, and Mental Chronometry. The paired t-test and the Wilcoxon signed-rank test were used to determine significant changes. Results: Data of eleven patients were analysed (5 females; age 62.3 +/- 14.1 years). Declarative MI knowledge improved significantly from 5.4 +/- 2.2 to 8.8 +/- 2.9 (p = 0.010). Patients demonstrated good satisfaction with MIIP (mean satisfaction score: 83.2 +/- 11.4%). MI ability remained on a high level but showed no significant change, except a significant decrease in the Kinaesthetic and Visual Imagery Questionnaire score. Conclusion: The presented MIIP seems to be valid and feasible for patients with CNS lesions and sensorimotor impairments resulting in improved MI knowledge. MIIP sessions can be held in groups of four or less. MI ability and Mental Chronometry remained unchanged after 3 training sessions.	[Wondrusch, C.] Zurich Univ Appl Sci, Inst Physiotherapy, Sch Hlth Profess, Winterthur, Switzerland; [Schuster-Amft, C.] Reha Rheinfelden, Res Dept, CH-4310 Rheinfelden, Switzerland; [Schuster-Amft, C.] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Dept Engn & Informat Technol, Burgdorf, Switzerland	Schuster-Amft, C (corresponding author), Reha Rheinfelden, Res Dept, Salinenstr 98, CH-4310 Rheinfelden, Switzerland.	c.schuster@reha-rhf.ch	Schuster, Corina/B-6939-2008	Schuster-Amft, Corina/0000-0003-1120-4423			Annett J, 1996, COGNITIVE BRAIN RES, V3, P65, DOI 10.1016/0926-6410(95)00030-5; Barclay-Goddard RE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005950.pub4; Bovend'Eerdt TJ, 2010, ARCH PHYS MED REHAB, V91, P939, DOI 10.1016/j.apmr.2010.03.008; Bovend'Eerdt TJH, 2012, DISABIL REHABIL, V34, P2192, DOI 10.3109/09638288.2012.676703; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P137, DOI 10.1177/0269215508097298; Braun S, 2008, CLIN REHABIL, V22, P579, DOI 10.1177/0269215508090066; Braun SM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2010.07.009; Buhner M., 2006, EINFUHRUNGIN TEST FR; Casby A, 1998, IRISH J PSYCHOL, V19, P525, DOI 10.1080/03033910.1998.10558212; CLARK LV, 1960, RES QUART, V31, P560, DOI 10.1080/10671188.1960.10613109; Clasen H., 2010, MESSUNG LERNERFOLG G; Crosbie JH, 2004, CLIN REHABIL, V18, P60, DOI 10.1191/0269215504cr702oa; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Dunsky A, 2006, INT J REHABIL RES, V29, P351, DOI 10.1097/MRR.0b013e328010f559; Edelmann W., 2012, LERNPSYCHOLOGIE; Etnier JL, 1996, SPORT PSYCHOL, V10, P48, DOI 10.1123/tsp.10.1.48; Foltran FA, 2012, REV BRAS FISIOTER, V16, P128, DOI 10.1590/S1413-35552012005000023; Fournier JF, 2000, PERCEPT MOTOR SKILL, V90, P367, DOI 10.2466/PMS.90.2.367-370; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2010, J SPORT SCI, V28, P291, DOI 10.1080/02640410903473828; Hemayattalab R, 2010, RES DEV DISABIL, V31, P81, DOI 10.1016/j.ridd.2009.07.022; Heremans E, 2012, NEUROREHAB NEURAL RE, V26, P27, DOI 10.1177/1545968311411055; Holmes PS, 2001, J APPL SPORT PSYCHOL, V13, P60, DOI 10.1080/10413200109339004; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Immenroth M, 2007, ANN SURG, V245, P385, DOI 10.1097/01.sla.0000251575.95171.b3; Klauer K. J., 2012, LEHREN LERNEN; Klauer K. J., 2012, LEHREN LERNEN EINFUH; Kornspan AS., 2004, J MENTAL IMAG, V28, P59; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Liu KPY, 2004, BRAIN INJURY, V18, P1163, DOI 10.1080/02699050410001671883; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Madan CR, 2012, COGN PROCESS, V13, P211, DOI 10.1007/s10339-012-0438-z; Malouin F, 2008, NEUROREHAB NEURAL RE, V22, P330, DOI 10.1177/1545968307313499; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Malouin F, 2008, ARCH PHYS MED REHAB, V89, P311, DOI 10.1016/j.apmr.2007.11.006; Malouin F, 2009, J NEUROL PHYS THER, V33, P195, DOI 10.1097/NPT.0b013e3181c2112b; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Marzano R. J., 1988, DIMENSIONS THINKING, P13; Meng K, 2009, REHABILITATION, V48, P335, DOI 10.1055/s-0029-1239575; Nickols F., 2000, KNOWLEDGE MANAGEMENT, P12; Reiser M., 2005, Z SPORTPSYCHOL, V12, P11; SCHMIDT J, 1989, PSYCHOTHER PSYCH MED, V39, P248; Schuster C, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-106; Schuster C, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/503190; Schuster C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-11; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Shambrook CJ, 1996, J APPL SPORT PSYCHOL, V8, P27, DOI 10.1080/10413209608406306; Sidaway B, 2005, PHYS THER, V85, P1053, DOI 10.1093/ptj/85.10.1053; Smith D., 2001, Journal of Sport Behavior, V24, P408; SONNENSCHEIN I, 1990, PSYCHOL ERZ UNTERR, V37, P232; Sorrell JT, 2009, J DENT EDUC, V73, P1293; START KB, 1964, RES QUART, V35, P316, DOI 10.1080/10671188.1964.10613316; VANGYN GH, 1990, J SPORT EXERCISE PSY, V12, P366, DOI 10.1123/jsep.12.4.366; WARNER L, 1988, PHYS THER, V68, P516, DOI 10.1093/ptj/68.4.516; Wuthrich-Schneider E., 2000, SCHWEIZERISCHE ARZTE, V81, P1116; Yoo EY, 2006, CLIN REHABIL, V20, P388, DOI 10.1191/0269215506cr962oa	58	13	15	1	21	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	AUG 22	2013	7								477	10.3389/fnhum.2013.00477			12	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	204LD	WOS:000323365900001	23986676	DOAJ Gold, Green Published			2021-06-18	
J	Arentsen, TJ; Boone, KB; Lo, TTY; Goldberg, HE; Cottingham, ME; Victor, TL; Ziegler, E; Zeller, MA				Arentsen, Timothy J.; Boone, Kyle Brauer; Lo, Tracy T. Y.; Goldberg, Hope E.; Cottingham, Maria E.; Victor, Tara L.; Ziegler, Elizabeth; Zeller, Michelle A.			Effectiveness of the Comalli Stroop Test as a Measure of Negative Response Bias	CLINICAL NEUROPSYCHOLOGIST			English	Article						Stroop; Malingering; Symptom validity testing; Forensic neuropsychology	RECOGNITION TRIAL; HEAD-INJURY; SENSITIVITY; SCORES; SPECIFICITY; PERFORMANCE; DYSFUNCTION; IQ	Practice guidelines recommend the use of multiple performance validity tests (PVTs) to detect noncredible performance during neuropsychological evaluations, and PVTs embedded in standard cognitive tests achieve this goal most efficiently. The present study examined the utility of the Comalli version of the Stroop Test as a measure of response bias in a large sample of real world noncredible patients (n = 129) as compared with credible neuropsychology clinic patients (n=233). The credible group performed significantly better than the noncredible group on all trials, but particularly on word-reading (Stroop A) and color-naming (Stroop B); cut-scores for Stroop A and Stroop B trials were associated with moderate sensitivity (49-53%) as compared to the low sensitivity found for the color interference trial (29%). Some types of diagnoses (including learning disability, severe traumatic brain injury, psychosis, and depression), very advanced age (80), and lowered IQ were associated with increased rates of false positive identifications, suggesting the need for some adjustments to cut-offs in these subgroups. Despite some previous reports of an inverted Stroop effect (i.e., color-naming worse than color interference) in noncredible subjects, individual Stroop word reading and color naming trials were much more effective in identifying response bias.	[Arentsen, Timothy J.] Fuller Grad Sch Psychol, Pasadena, CA USA; [Boone, Kyle Brauer] Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA USA; [Lo, Tracy T. Y.] City Hope Med Ctr, Duarte, CA USA; [Goldberg, Hope E.] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA; [Victor, Tara L.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA; [Ziegler, Elizabeth] VA Med Ctr Spokane, Spokane, WA USA; [Zeller, Michelle A.] West Los Angeles VA, Los Angeles, CA USA	Arentsen, TJ (corresponding author), Fuller Grad Sch Psychol, 135 N Oakland Ave, Pasadena, CA USA.	TimArentsen@fuller.edu	Victor, Tara/K-6581-2019				Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Boone K., 2002, DOT COUNTING TEST; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone K. B., 2002, B TEST; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Buckley TC, 2003, J TRAUMA STRESS, V16, P59, DOI 10.1023/A:1022063412056; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cannon BJ, 2003, PERCEPT MOTOR SKILL, V96, P827, DOI 10.2466/PMS.96.3.827-834; Chafetz MD, 2004, ARCH CLIN NEUROPSYCH, V19, P555, DOI 10.1016/j.acn.2003.08.004; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Giger P, 2010, J FORENSIC PSYCHOL P, V10, P440, DOI 10.1080/15228932.2010.489875; Golden C., 1978, STROOP COLOR WORD TE; Golden ZL, 2002, PSYCHOL SCHOOLS, V39, P489, DOI 10.1002/pits.10047; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Mitrushina M., 2005, HDB NORMATIVE DATA N; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Rosselli M, 2002, J INT NEUROPSYCH SOC, V8, P819, DOI 10.1017/S1355617702860106; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet J.J., 2007, ASSESSMENT FEIGNED C; Thomas TA, 2009, J FORENSIC PSYCHI PS, V20, P936, DOI 10.1080/14789940903174162; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Willcutt EG, 2001, J ABNORM PSYCHOL, V110, P157, DOI 10.1037//0021-843X.1001.1.157	45	13	13	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 1	2013	27	6					1060	1076		10.1080/13854046.2013.803603			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	197RA	WOS:000322867100011	23742292				2021-06-18	
J	Greiner, MV; Berger, RP; Thackeray, JD; Lindberg, DM				Greiner, Mary V.; Berger, Rachel P.; Thackeray, Jonathan D.; Lindberg, Daniel M.		Examining Siblings Recognize Abuse	Dedicated Retinal Examination in Children Evaluated for Physical Abuse without Radiographically Identified Traumatic Brain Injury	JOURNAL OF PEDIATRICS			English	Article							HEPATIC TRANSAMINASES; SKELETAL SURVEYS; HEMORRHAGES; PREVALENCE; UTILITY	Objective To determine the rate of retinal hemorrhages in children evaluated for physical abuse without traumatic brain injury (TBI) by diagnostic imaging. Study design This study was a prospectively planned, secondary analysis of the Examining Siblings to Recognize Abuse (ExSTRA) research network, and included only index children who presented with concerns for abuse. Subjects were eligible for the parent study if they were less than 10 years old and evaluated by a Child Abuse Physician for concerns of physical abuse. Child Abuse Physicians recorded results of all screening testing and determination of the likelihood of abuse in each case. For this analysis, we examined the results of dedicated retinal examinations for children with neuroimaging that showed no TBI. Isolated skull fractures were not considered to be TBI. Results The original ExSTRA sample included 2890 index children evaluated for physical abuse. Of this group, 1692 underwent neuroimaging and 1122 had no TBI. Of these 1122 children, 352 had a dedicated retinal examination. Retinal hemorrhages were identified in 2 (0.6%) children. In both cases, there were few (defined as 3-10) hemorrhages isolated to the posterior poles; neither was diagnosed with physical abuse. The presence of facial bruising, altered mental status, or complex skull fractures was neither sensitive nor specific for retinal hemorrhage identification. Conclusions Forensically significant retinal hemorrhages are unlikely to be found in children evaluated for physical abuse without TBI on neuroimaging, and such children may not require routine dedicated retinal examination.	[Greiner, Mary V.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Berger, Rachel P.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Thackeray, Jonathan D.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Lindberg, Daniel M.] Boston Childrens Hosp, Brigham & Womens Hosp, Dept Emergency Med, Boston, MA USA	Greiner, MV (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,ML 3008, Cincinnati, OH 45229 USA.	mary.greiner@cchmc.org			Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program [H34MC19346-01-02]; Harvard Medical School	Supported by the Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program (H34MC19346-01-02). D. L. is funded in part by an Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School. J.T. and D. L. have provided paid expert witness testimony, for both the prosecution and defense, in cases of alleged child abuse. The other authors declare no conflicts of interest.	Agrawal S, 2012, PEDIATRICS, V129, pE1388, DOI 10.1542/peds.2011-2772; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Levin AV, 2010, PEDIATRICS, V126, P376, DOI 10.1542/peds.2010-1397; Li SM, 2011, ARCH PEDIAT ADOL MED, V165, P913, DOI 10.1001/archpediatrics.2011.150; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Lindberg DM, 2013, PEDIATRICS, V131, P268, DOI 10.1542/peds.2012-1952; Lindberg DM, 2012, PEDIATRICS, V130, P193, DOI 10.1542/peds.2012-0085; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Offiah A, 2009, PEDIATR RADIOL, V39, P461, DOI 10.1007/s00247-009-1157-1; Pitetti RD, 2002, PEDIATRICS, V110, P557, DOI 10.1542/peds.110.3.557; Reece RM, 2009, CHILD ABUSE MED DIAG; Thackeray JD, 2010, PEDIATRICS, V125, pE1066, DOI 10.1542/peds.2009-2184; Ziemssen R, 2010, PEDIATRICS	23	13	13	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2013	163	2					527	+		10.1016/j.jpeds.2013.01.063			6	Pediatrics	Pediatrics	198YG	WOS:000322959500045	23498157				2021-06-18	
J	Miller, KL; Kontos, PC				Miller, Karen-Lee; Kontos, Pia C.			The intraprofessional and interprofessional relations of neurorehabilitation nurses: a negotiated order perspective	JOURNAL OF ADVANCED NURSING			English	Article						allied health; collaboration; interprofessional practice; intraprofessional practice; negotiated order theory; nursing; traumatic brain injury	GENERAL INTERNAL-MEDICINE; HEALTH-CARE; REHABILITATION; QUALITY; COLLABORATION; PROFESSIONS; ASSISTANTS; BOUNDARY; POLITICS	AimsTo report a study of the negotiation practices of neurorehabilitation nurses with one another and with allied health professionals to understand nursing relations. BackgroundNegotiated order theory offers a promising theoretical lens with which to explore negotiation between nurses and other professionals. This study is the first to apply the perspective to nurse-nurse and nurse-allied health professional relations. DesignThe study is a secondary analysis of findings from a multi-site arts-based intervention to improve patient-centred neurorehabilitation practice. MethodsInterviews and ethnographic observations were conducted (2008-2011) in two neurorehabilitation units in Ontario, Canada. Participants (n=31) included registered and practical nurses, nurse leaders, and allied health professionals from physical, occupational, and recreational therapy, speech language pathology, and social work. FindingsNeurorehabilitation nursing is characterized by heavy workload, high patient acuity, and poor interprofessional collaboration. This practice context was negotiated by nurses through two strategies: (1) intraprofessional collegialism, accomplished through tactics including task and knowledge sharing, emotional support, coercive threats, and suppression of dissension; and (2) vying for an autonomous essential nursing role in interprofessional practice, accomplished by claiming unique nursing knowledge based on 24/7 nursing proximity, the expansion of the division of professional labour with allied health professionals and modifying physical therapy care plans. ConclusionThe intraprofessional context and negotiations therein were linked in significant ways to interprofessional negotiations. Understanding this complexity has important implications for improving patient safety and interprofessional practice interventions.	[Miller, Karen-Lee; Kontos, Pia C.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Miller, Karen-Lee] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Miller, KL (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.	karen-lee.miller@uhn.ca		Miller, Karen-Lee/0000-0001-7583-6724; Kontos, Pia/0000-0002-8893-2544	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP - 86624, MSH - 87726]; Toronto Rehabilitation InstituteUniversity of Toronto; Ministry of Health and Long-Term Care in OntarioMinistry of Health and Long-Term Care, Ontario	The authors disclosed receipt of the following financial support for the research and/or authorship of this article: Canadian Institutes of Health Research Operating Grant (2008-2011, MOP - 86624); Pia Kontos holds a Canadian Institutes of Health Research New Investigator Award (2009 -2014, MSH - 87726). The authors acknowledge the support of Toronto Rehabilitation Institute that receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario. The views expressed do not necessarily reflect those of our supporters or funders.	Allen D, 1997, SOCIOL HEALTH ILL, V19, P498; Balogun JA, 2006, J ADV NURS, V56, P532, DOI 10.1111/j.1365-2648.2006.04045.x; Barker P, 2000, INT J NURS STUD, V37, P329, DOI 10.1016/S0020-7489(00)00012-2; Bowen G. A., 2006, INT J QUAL METHODS, V5, P12, DOI [10.1177/160940690600500304, DOI 10.1177/160940690600500304]; Briskin L., 2011, NURSING INQUIRY, DOI 10.1111/j.1440-1800.2011.00585.x; Cohen H.A., 1981, NURSES QUEST PROFESS; Colantonio A., 2008, J CONTIN EDUC HEALTH, V28, P1; Colyer HM, 2004, J ADV NURS, V48, P406, DOI 10.1111/j.1365-2648.2004.03209.x; Conn LG, 2009, QUAL HEALTH RES, V19, P943, DOI 10.1177/1049732309338282; Daykin N, 2000, SOCIOL HEALTH ILL, V22, P349, DOI 10.1111/1467-9566.00208; Embree JL, 2010, NURS FORUM, V45, P166, DOI 10.1111/j.1744-6198.2010.00185.x; Evans T, 2007, QUALITATIVE SOCIAL W, V6, DOI [10.1177/1473325007077254, DOI 10.1177/1473325007077254]; Geva E., 2000, DEV FRAMEWORK INTERP, P1; Gladstone BM, 2007, J BEHAV HEALTH SER R, V34, P431, DOI 10.1007/s11414-007-9079-x; Gold R., 1997, QUALITATIVE INQUIRY, V3, P387, DOI DOI 10.1177/107780049700300401; Green J., 2004, QUALITATIVE METHODS; Hall LM, 2003, MED CARE, V41, P1096; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huynh T., 2011, NURSING RES PRACTICE, V2011, P1, DOI [10. 1155/2011/501790, DOI 10.1155/2011/501790]; Kenaszchuk C, 2010, CAN J NURS RES, V42, P120; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; LECOMPTE MD, 1993, ETHNOGRAPHIC QUALITA; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V289, P289, DOI DOI 10.1016/0147-1767(85)90062-8; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCallin Antoinette, 2007, J Nurs Manag, V15, P386, DOI 10.1111/j.1365-2834.2007.00711.x; McKenna BG, 2003, J ADV NURS, V42, P90, DOI 10.1046/j.1365-2648.2003.02583.x; MCPHERSON KM, 1996, BEDSIDE MATTERS TRAN; Medjedovic I., 2007, FORUM QUALITATIVE SO, V6; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller KL, 2008, J ADV NURS, V64, P332, DOI 10.1111/j.1365-2648.2008.04768.x; Miyata H., 2009, INT J QUAL METHODS, V8, P64, DOI [DOI 10.1177/160940690900800106, 10.1177/160940690900800106]; Norris P, 2001, SOCIOL HEALTH ILL, V23, P24, DOI 10.1111/1467-9566.00239; Nugus P, 2010, SOC SCI MED, V71, P898, DOI 10.1016/j.socscimed.2010.05.029; Patton MQ., 1990, QUALITATIVE EVALUATI; Peter Elizabeth, 2004, Nurs Inq, V11, P218, DOI 10.1111/j.1440-1800.2004.00236.x; Pryor J., 2007, COLLEGIAN, V14, P26; Pryor J, 2010, J ADV NURS, V66, P978, DOI 10.1111/j.1365-2648.2009.05237.x; Reeves S, 2008, NURS INQ, V15, P1, DOI 10.1111/j.1440-1800.2008.00396.x; Reeves S, 2009, J INTERPROF CARE, V23, P633, DOI 10.3109/13561820902886295; Rheaume A, 2003, J ADV NURS, V41, P435, DOI 10.1046/j.1365-2648.2003.02550.x; Salhan D, 2009, SOC SCI MED, V68, P1221, DOI 10.1016/j.socscimed.2009.01.041; SANDS RG, 1990, SOC WORK HEALTH CARE, V14, P55, DOI 10.1300/J010v14n03_04; Schatzman L., 1963, HOSP MODERN SOC, P147; Sinclair LB, 2009, ARCH PHYS MED REHAB, V90, P1196, DOI 10.1016/j.apmr.2009.01.021; Spano R, 2005, SOC SCI RES, V34, P591, DOI 10.1016/j.ssresearch.2004.05.003; STEIN LI, 1967, ARCH GEN PSYCHIAT, V16, P699; Strauss A., 1966, STRUCTURE IDEOLOGY A, P60; Strauss A. L., 1978, NEGOTIATION VARIETIE; STRAUSS A. L., 1993, CONTINUAL PERMUTATIO; Svensson R, 1996, SOCIOL HEALTH ILL, V18, P379, DOI 10.1111/1467-9566.ep10934735; Takhashi Y, 2011, INT C REHAB ROBOT; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; WITZ A, 1990, SOCIOLOGY, V24, P675, DOI 10.1177/0038038590024004007	53	13	13	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	AUG	2013	69	8					1797	1807		10.1111/jan.12041			11	Nursing	Nursing	262YE	WOS:000327773000013	23157380				2021-06-18	
J	Russell, KL; Berman, NEJ; Levant, B				Russell, Kristin L.; Berman, Nancy E. J.; Levant, Beth			Low brain DHA content worsens sensorimotor outcomes after TBI and decreases TBI-induced Timp1 expression in juvenile rats	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Traumatic brain injury; Juvenile; Sensorimotor; Docosahexaenoic acid; TIMP-1; Matrix metalloproteinase	POLYUNSATURATED FATTY-ACIDS; CENTRAL-NERVOUS-SYSTEM; DOCOSAHEXAENOIC ACID; TISSUE INHIBITOR; SPINAL-CORD; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; UNIQUE FEATURES; CORTICAL IMPACT; PEDIATRIC SKULL	The effects of dietary modulation of brain DHA content on outcomes after TBI were examined in a juvenile rat model. Long-Evans rats with normal or diet-induced decreases in brain DHA were subjected to a controlled cortical impact or sham surgery on postnatal day 17. Rats with the greatest decreases in brain DHA had the poorest sensorimotor outcomes after TBI. Ccl2, Gfap, and Mmp 9 mRNA levels, and MMP-2 and -9 enzymatic activities were increased after TBI regardless of brain DHA level. Lesion volume was not affected by brain DHA level. In contrast, TBI-induced Timp1 expression was lower in rats on the Deficient diet and correlated with brain DHA level. These data suggest that decreased brain DHA content contributes to poorer sensorimotor outcomes after TBI through a mechanism involving modulation of Timp1 expression. (C) 2013 Elsevier Ltd. All rights reserved.	[Russell, Kristin L.; Levant, Beth] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	krussell@kumc.edu; nberman@kumc.edu; blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 HD059939, P30 HD02528, P20 GM103418, T32 ES007079, T32 HD007523]; University of Kansas Medical Center Biomedical Research Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD059939, T32HD007523] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER	The authors thank Andrew Ralya, Ph.D. and Patrick Gregg for technical assistance. Supported by NIH R03 HD059939 (B.L.), P30 HD02528 (B.L., N.E.J.B.), P20 GM103418 (B.L.), T32 ES007079 (K.L.R.), T32 HD007523 (K.L.R.), and the University of Kansas Medical Center Biomedical Research Training Program (K.L.R.).	Abr`amoff M.D., 2005, BIOPHOTONICS INT, V11, P36, DOI [10.1117/1.3589100, DOI 10.1117/1.3589100]; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Favreliere S, 1998, LIPIDS, V33, P401, DOI 10.1007/s11745-998-0221-y; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; GALLI C, 1971, BIOCHIM BIOPHYS ACTA, V248, P449, DOI 10.1016/0005-2760(71)90233-5; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Javierre C, 2006, J PHYSIOL BIOCHEM, V62, P271, DOI 10.1007/BF03165756; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jourquin J, 2005, EUR J NEUROSCI, V22, P2569, DOI 10.1111/j.1460-9568.2005.04426.x; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Levant B, 2004, BEHAV BRAIN RES, V152, P49, DOI 10.1016/j.bbr.2003.09.029; Levant B, 2008, PSYCHONEUROENDOCRINO, V33, P1279, DOI 10.1016/j.psyneuen.2008.06.012; Levant B, 2006, PHYSIOL BEHAV, V89, P196, DOI 10.1016/j.physbeh.2006.06.007; Levant B, 2006, LIPIDS, V41, P407, DOI 10.1007/s11745-006-5114-6; Levant B, 2006, J NUTR, V136, P2236; Levant B, 2010, PHYSIOL BEHAV, V101, P176, DOI 10.1016/j.physbeh.2010.04.038; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Orr SK., 2012, PROSTAGLANDINS LEUKO; Ozias MK, 2007, J NUTR, V137, P125; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rasband W. S, 2012, IMAGEJ; REEVES PG, 1993, J NUTR, V123, P1939; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shaikh SR, 2012, J NUTR BIOCHEM, V23, P101, DOI 10.1016/j.jnutbio.2011.07.001; Sherwood N.M., 1970, STEREOTAXIC ATLAS DE; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; SINCLAIR AJ, 1975, P NUTR SOC, V34, P287, DOI 10.1079/PNS19750051; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vancassel S, 2007, BEHAV BRAIN RES, V180, P119, DOI 10.1016/j.bbr.2007.02.032; Wainwright PE, 1998, J NUTR, V128, P661; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whishaw I. Q., 2005, BEHAV LAB RAT HDB TE; WRIGHT LL, 1977, DEV PSYCHOBIOL, V10, P331, DOI 10.1002/dev.420100407; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Yang DY, 2007, NEUROTOXICOLOGY, V28, P1220, DOI 10.1016/j.neuro.2007.08.003; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	74	13	13	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	AUG	2013	89	2-3					97	105		10.1016/j.plefa.2013.05.004			9	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	198RH	WOS:000322939500006	23796971	Green Accepted			2021-06-18	
J	Tanoue, K; Aida, N; Matsui, K				Tanoue, Koji; Aida, Noriko; Matsui, Kiyoshi			Apparent diffusion coefficient values predict outcomes of abusive head trauma	ACTA PAEDIATRICA			English	Article						Abusive head trauma; Apparent diffusion coefficient; Inflicted traumatic brain injury; Outcome; Shaken baby syndrome	SHAKEN BABY SYNDROME; BRAIN-INJURY; PERINATAL ASPHYXIA; YOUNG-CHILDREN; IMPACT SYNDROME; INFANTS	Aim To evaluate the apparent diffusion coefficient (ADC) values for predicting the long-term neurodevelopmental outcomes of patients with abusive head trauma (AHT). Methods Apparent diffusion coefficient maps were retrospectively reviewed for 14 patients who presented with AHT at a mean age of 6.7months (range 1-18months), and the clinical outcomes of the survivors were based on the Glasgow Outcome Score. Results One of 14 infants died, and two were severely disabled. One had mild impairment and four had moderate disability. In the 4days after admission, the ADC values in all brain regions were strongly associated with a poor neurodevelopmental outcome (p<0.05): basal ganglia, thalamus, brain stem, corpus callosum, frontal white matter, central white matter, parietal white matter, frontal grey matter, parietal grey matter, cerebellar vermis, cerebellar cortex and mean total brain. Conclusion Apparent diffusion coefficient values during the acute phase of AHT were significantly associated with poor long-term neurodevelopmental outcomes.	[Tanoue, Koji; Matsui, Kiyoshi] Kanagawa Childrens Med Ctr, Dept Gen Med, Yokohama, Kanagawa 2328555, Japan; [Aida, Noriko] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa 2328555, Japan	Tanoue, K (corresponding author), Kanagawa Childrens Med Ctr, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	ktanoue@kcmc.jp					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Barkovich AJ, 2001, AM J NEURORADIOL, V22, P1786; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Brissaud O, 2010, AM J NEURORADIOL, V31, P282, DOI 10.3174/ajnr.A1805; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Forbes KPN, 2000, AM J NEURORADIOL, V21, P1490; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Hunt RW, 2004, PEDIATRICS, V114, P999, DOI 10.1542/peds.2003-0935-L; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Tanoue K, 2012, ACTA PAEDIATR, V101, P614, DOI 10.1111/j.1651-2227.2012.02635.x; Wolf RL, 2001, RADIOLOGY, V218, P825, DOI 10.1148/radiology.218.3.r01fe47825; Zarifi MK, 2002, RADIOLOGY, V225, P859, DOI 10.1148/radiol.2253011797	27	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	AUG	2013	102	8					805	808		10.1111/apa.12281			4	Pediatrics	Pediatrics	169KA	WOS:000320777700020	23631484				2021-06-18	
J	Wang, B; Dawson, H; Wang, HC; Kernagis, D; Kolls, BJ; Yao, L; Laskowitz, DT				Wang, Bo; Dawson, Hana; Wang, Haichen; Kernagis, Dawn; Kolls, Brad J.; Yao, Lucy; Laskowitz, Daniel T.			Lacosamide Improves Outcome in a Murine Model of Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Lacosamide; Neuroprotection; Inflammation; Microglial activation	CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; SUBARACHNOID HEMORRHAGE; ANTICONVULSANT PROPHYLAXIS; FUNCTIONAL RECOVERY; SODIUM-CHANNELS; ONSET SEIZURES; PHENYTOIN; PRESSURE; LEVETIRACETAM	Use of antiepileptic drugs (AED's) is common in the neurocritical care setting. However, there remains a great deal of controversy regarding the optimal agent. Studies associating the prophylactic use of AED's with poor outcomes are heavily biased by the prevalent use of phenytoin, an agent highly associated with deleterious effects. In the current study, we evaluate lacosamide for neuroprotective properties in a murine model of closed head injury. Mice were subjected to moderate closed head injury using a pneumatic impactor, and then treated with either low-dose (6 mg/kg) or high-dose (30 mg/kg) lacosamide or vehicle at 30 min post-injury, and twice daily for 3 days after injury. Motor and cognitive functional assessments were performed following injury using rotarod and Morris Water Maze, respectively. Neuronal injury and microglial activation were measured by flourojade-B, NeuN, and F4/80 staining at 1 and 7 days post-injury. Timm's staining was also performed to assess lacosamide effects on mossy fiber axonal sprouting. To evaluate possible mechanisms of lacosamide effects on the inflammatory response to injury, an RNA expression array was used to evaluate for alterations in differential gene expression patterns in injured mice following lacosamide or vehicle treatments. High-dose lacosamide was associated with improved functional outcome on both the rotarod and Morris Water Maze. High-dose lacosamide was also associated with a reduction of neuronal injury at 24 h post-injury. However, the reduction in neuronal loss observed early did not result in greater neuronal density at 31 days post-injury based on unbiased stereology of NeuN staining. High-dose lacosamide was also associated with a significant reduction in microglial activation at 7 days post-injury. The therapeutic effects of lacosamide are associated with a delay in injury-related changes in RNA expression of a subset of inflammatory mediator genes typically seen at 24 h post-injury. Administration of lacosamide improves functional performance, and reduces histological evidence of acute neuronal injury and neuroinflammation in a murine model of closed head injury. Lacosamide effects appear to be mediated via a reduction or delay in the acute inflammatory response to injury. Prior clinical and animal studies have found antiepileptic treatment following injury to be detrimental, though these studies are biased by the common use of older medications such as phenytoin. Our current results as well as prior work on levetiracetam suggest the newer AED's may be beneficial in the setting of acute brain injury.	[Wang, Bo] Shandong Univ, Shandong Prov Hosp, Dept Anesthesiol, Jinan 250021, Shandong, Peoples R China; [Wang, Bo; Dawson, Hana; Wang, Haichen; Kernagis, Dawn; Kolls, Brad J.; Yao, Lucy; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Brain Injury Translat Res Ctr, Durham, NC 27710 USA; [Wang, Bo; Dawson, Hana; Wang, Haichen; Kolls, Brad J.; Yao, Lucy; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [Kernagis, Dawn] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Laskowitz, DT (corresponding author), Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA.	danl@neuro.duke.edu	Kolls, Brad/R-9154-2019	Kolls, Brad/0000-0002-8704-8749			BAKER CJ, 1995, NEUROSURGERY, V37, P863, DOI 10.1227/00006123-199511000-00003; Baker CJ, 1995, NEUROSURGERY, V37, P870; Beydoun A, 2009, EXPERT REV NEUROTHER, V9, P33, DOI 10.1586/14737175.9.1.33; Biton V, 2012, EXPERT REV NEUROTHER, V12, P645, DOI [10.1586/ERN.12.50, 10.1586/ern.12.50]; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; DANSCHER G, 1978, HISTOCHEMISTRY, V55, P27, DOI 10.1007/BF00496691; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Edwards HB, 2012, ACTA NEUROL SCAND, V125, P228, DOI 10.1111/j.1600-0404.2011.01619.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FOY PM, 1981, ACTA NEUROCHIR, V55, P253, DOI 10.1007/BF01808441; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Guekht Alla, 2012, Handb Clin Neurol, V108, P569, DOI 10.1016/B978-0-444-52899-5.00016-2; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; HASAN D, 1993, ANN NEUROL, V33, P286; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Lanzino G, 2011, NEUROCRIT CARE, V15, P247, DOI 10.1007/s12028-011-9584-x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; McNamara B, 2003, BRIT J ANAESTH, V90, P39, DOI 10.1093/bja/aeg008; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; Pinder C, 2011, BRAIN INJURY, V25, P634, DOI 10.3109/02699052.2011.572946; Pineda JA, 2001, J NEUROTRAUM, V18, P625, DOI 10.1089/089771501750291864; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Slapo Geir D, 2006, Expert Rev Neurother, V6, P1801, DOI 10.1586/14737175.6.12.1801; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Vezzani Annamaria, 2012, Handb Clin Neurol, V107, P163, DOI 10.1016/B978-0-444-52898-8.00010-0; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001	52	13	13	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					125	134		10.1007/s12028-012-9808-8			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000020	23269559				2021-06-18	
J	Yuan, QJ; Su, HX; Chiu, K; Wu, WT; Lin, ZX				Yuan, Qiuju; Su, Huanxing; Chiu, Kin; Wu, Wutian; Lin, Zhi-Xiu			Contrasting neuropathology and functional recovery after spinal cord injury in developing and adult rats	NEUROSCIENCE BULLETIN			English	Article						neonatal; spinal cord injury; regeneration; functional recovery; rat	NEONATAL RAT; CORTICOSPINAL AXONS; TRAUMATIC INJURY; DEVELOPING BRAIN; LESION SITE; REGENERATION; TRANSECTION; REGROWTH; DEGENERATION; NEURONS	Conflicting findings exist regarding the link between functional recovery and the regrowth of spinal tracts across the lesion leading to the restoration of functional contacts. In the present study, we investigated whether functional locomotor recovery was attributable to anatomical regeneration at postnatal day 1 (PN1), PN7, PN14 and in adult rats two months after transection injury at the tenth thoracic segment of the spinal cord. The Basso, Beattie, and Bresnahan scores showed that transection led to a failure of hindlimb locomotor function in PN14 and adult rats. However, PN1 and PN7 rats showed a significant level of stepping function after complete spinal cord transection. Unexpectedly, unlike the transected PN14 and adult rats in which the spinal cord underwent limited secondary degeneration and showed a scar at the lesion site, the rats transected at PN1 and PN7 showed massive secondary degeneration both anterograde and retrograde, leaving a > 5-mm gap between the two stumps. Furthermore, retrograde tracing with fluorogold (FG) also showed that FG did not cross the transection site in PN1 and PN7 rats as in PN14 and adult rats, and re-transection of the cord caused no apparent loss in locomotor performance in the rats transected at PN1. Thus, these three lines of evidence strongly indicated that the functional recovery after transection in neonatal rats is independent of regrowth of spinal tracts across the lesion site. Our results support the notion that the recovery of locomotor function in developing rats may be due to intrinsic adaptations in the spinal circuitry below the lesion that control hindlimb locomotor activity rather than the regrowth of spinal tracts across the lesion. The difference in secondary degeneration between neonatal and adult rats remains to be explored.	[Yuan, Qiuju; Chiu, Kin; Wu, Wutian] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Yuan, Qiuju; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Sch Chinese Med, Fac Sci, Shatin, Hong Kong, Peoples R China; [Su, Huanxing] Univ Macau, State Key Lab Qual Res Chinese Med, Macao, Macao, Peoples R China; [Su, Huanxing] Univ Macau, Inst Chinese Med Sci, Macao, Macao, Peoples R China; [Wu, Wutian] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Res Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China	Wu, WT (corresponding author), Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	wtwu@hkucc.hku.hk; linzx@cuhk.edu.hk	Chiu, Kin/ABI-7938-2020; Lin, Zhi-Xiu/H-2807-2016; Su, Huanxing/X-3954-2019; Su, Huanxing/X-3980-2019; Yuan, Qiuju/AAJ-3101-2020	Chiu, Kin/0000-0001-6581-9007; Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; 	Hong Kong SCI Fund; National Basic Research Development Program (973 program) of ChinaNational Basic Research Program of China [2011CB504402]	This work was supported by the Hong Kong SCI Fund and the National Basic Research Development Program (973 program) of China (2011CB504402).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BERNSTEIN DR, 1981, NEUROSCI LETT, V26, P55, DOI 10.1016/0304-3940(81)90425-0; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; BRYZGORNIA WF, 1986, EXP NEUROL, V93, P195, DOI 10.1016/0014-4886(86)90159-7; CUMMINGS JP, 1981, EXP NEUROL, V74, P615, DOI 10.1016/0014-4886(81)90196-5; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Guzen FP, 2012, RESTOR NEUROL NEUROS, V30, P265, DOI 10.3233/RNN-2012-110184; Hase T, 2002, J NEUROTRAUM, V19, P267, DOI 10.1089/08977150252807009; Hase T, 2002, EUR J NEUROSCI, V15, P969, DOI 10.1046/j.1460-9568.2002.01932.x; KALIL K, 1982, J COMP NEUROL, V211, P265, DOI 10.1002/cne.902110305; Lee YS, 2004, J NEUROPATH EXP NEUR, V63, P233, DOI 10.1093/jnen/63.3.223-a; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042813; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; SCHREYER DJ, 1983, NEUROSCIENCE, V9, P31, DOI 10.1016/0306-4522(83)90044-1; Schwab ME, 1996, PHYSIOL REV, V76, P319; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; TOLBERT DL, 1987, J COMP NEUROL, V260, P299, DOI 10.1002/cne.902600210; Wakabayashi Y, 2001, SPINE, V26, P1215, DOI 10.1097/00007632-200106010-00009; Yuan QJ, 2006, BRAIN RES, V1113, P45, DOI 10.1016/j.brainres.2006.07.052; Yuan QJ, 2006, NEUROREPORT, V17, P711, DOI 10.1097/01.wnr.0000214390.35480.1a; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072	24	13	13	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067			NEUROSCI BULL	Neurosci. Bull.	AUG	2013	29	4			SI		509	516		10.1007/s12264-013-1356-5			8	Neurosciences	Neurosciences & Neurology	191DU	WOS:000322393600013	23846597	Green Published			2021-06-18	
J	Zhou, SZ; Zhang, X; Ma, HL				Zhou, Shuangzhen; Zhang, Xiong; Ma, Honglei			NUMERICAL SIMULATION OF HUMAN HEAD IMPACT USING THE MATERIAL POINT METHOD	INTERNATIONAL JOURNAL OF COMPUTATIONAL METHODS			English	Article						Human head impact; material point model; injury	SKULL	In this paper, a three-dimensional material point human head model is constructed from the computed tomography (CT) scanned images of an adult male volunteer, and used to study the dynamic response of human head under the impact of a three-dimensional cylindrical lead projectile with a speed of 6.4m/s. The model consists of skull bone, brain tissue and membrane of human head, which is close to the real one. The skull and membrane are modeled by an elastic constitutive model, and the brain tissue is modeled by an anisotropic viscoelastic constitutive model. These constitutive models have been implemented in our three-dimensional explicit material point method code, MPM3D, and is verified by comparing its numerical results for a ball impact problem with those obtained by LS-DYNA. The simulation results help illustrate the response of skull bone, membrane and brain tissues subjected to impact, which contributes to the understanding of the biomechanics and mechanisms of head injury.	[Zhou, Shuangzhen; Zhang, Xiong] Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China; [Zhou, Shuangzhen; Ma, Honglei] China Astronaut Res & Training Ctr, Beijing 100094, Peoples R China	Zhou, SZ (corresponding author), Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China.	xzhang@tsinghua.edu.cn	Zhang, Xiong/B-6733-2012	Zhang, Xiong/0000-0001-9905-281X	National Basic Research Program of ChinaNational Basic Research Program of China [2010CB832701]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [10872107, 60971094]	This work was supported by the National Basic Research Program of China (2010CB832701) and National Natural Science Foundation of China (10872107, 60971094)	Aomura S, 2003, JSME INT J C-MECH SY, V46, P583, DOI 10.1299/jsmec.46.583; Charalambopoulos A, 1998, MATH COMPUT MODEL, V27, P81, DOI 10.1016/S0895-7177(97)00261-6; Faleh H, 2011, ADV STRUCT ENG, V14, P777, DOI 10.1260/1369-4332.14.5.777; Gan Y, 2011, CMES-COMP MODEL ENG, V73, P45; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gong SW, 2008, IEEE T BIO-MED ENG, V55, P1226, DOI 10.1109/TBME.2007.912431; Guilkey JE, 2006, J BIOMECH, V39, P2074, DOI 10.1016/j.jbiomech.2005.06.017; Hallquist, 2006, LS DYNA THEORY MANUA; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; HERTZ E, 1993, 37 ANN P ASS ADV AUT, P303; Hosey R. R., 1980, P INT C FIN EL BIOM, P851; Kang HS, 1997, P 41 STAPP CAR CRASH, P329; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Lankarani H. M., 1997, 971457 SAE; Lian YP, 2011, INT J IMPACT ENG, V38, P238, DOI 10.1016/j.ijimpeng.2010.10.031; Ma S., 2007, COMPUT MECH, P156; Ma S, 2009, CMES-COMP MODEL ENG, V39, P101; SULSKY D, 1994, COMPUT METHOD APPL M, V118, P179, DOI 10.1016/0045-7825(94)00033-6; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Zhang X., 2007, COMPUTATIONAL DYNAMI; Zhao Wei, 2011, Chinese Journal of Biomedical Engineering, V30, P110, DOI 10.3969/j.issn.0258-8021.2011.01.019	21	13	14	2	26	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-8762			INT J COMP METH-SING	Int. J. Comput. Methods	AUG	2013	10	4							1350014	10.1142/S021987621350014X			14	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Engineering; Mathematics	137MO	WOS:000318440200004					2021-06-18	
J	Al-Habib, A; A-shail, A; Alaqeel, A; Zamakhshary, M; Al-Bedah, K; AlQunai, M; Al-enazi, S				Al-Habib, Amro; A-shail, Abdulaziz; Alaqeel, Ahmed; Zamakhshary, Mohammed; Al-bedah, Khalid; AlQunai, Mansur; Al-enazi, Saleem			Causes and patterns of adult traumatic head injuries in Saudi Arabia: implications for injury prevention	ANNALS OF SAUDI MEDICINE			English	Article							BRAIN-INJURY; UNITED-STATES; HELMET USE; EPIDEMIOLOGY; DEATHS	BACKGROUND AND OBJECTIVES: Data on the epidemiology of traumatic head injuries (THI) is essential for any organized prevention program. Such data are few in the developing world. Our primary goal was to study the causes, descriptive features, and outcomes of THI in adults in Saudi Arabia. DESIGN AND SETTINGS: The present study is a retrospective review. METHODS: This retrospective review included all consecutive cases of adults with THI (>18 years) who were admitted to a major trauma centre in Riyadh, Saudi Arabia, from May 2001 to July 2010. Patients were identified through a trauma database, which includes cases that required hospital admission or died in the emergency department. RESULTS: A total of 1870 patients met the inclusion criteria with a mean age of 32.6 years and a male predominance (91.2%). Most injuries were secondary to motor vehicle collisions (MVC; 69.4%). Pedestrian injuries were second (16.8%) and had 40% risk of mortality (odds ratio 0.62, 95% CI 0.48-0.8). Most patients (56.7%) had a severe THI (Glasgow coma score, GCS < 8). The overall mortality rate was 30%. Mortality was significantly associated with older age (P=.0001), lower GCS (P=.0001), and a higher injury severity score (ISS; P=.0001). CONCLUSION: The most common causes of hospital admission following injury were MVC and pedestrian injuries. Both were also the most common causes for injury-related deaths. Safety on the roads should be the primary target for any organized injury prevention programs to be successful.	[Al-Habib, Amro; A-shail, Abdulaziz; Alaqeel, Ahmed; Al-enazi, Saleem] King Saud Univ, Coll Med, Dept Surg, Div Neurosurg, Riyadh 11323, Saudi Arabia; [Zamakhshary, Mohammed; Al-bedah, Khalid] King Abdul Aziz Med City, Dept Surg, Riyadh, Saudi Arabia; [AlQunai, Mansur] Aljouf Univ, Dept Surg, Aljouf, Saudi Arabia	Alaqeel, A (corresponding author), King Saud Univ, Coll Med, Dept Surg, Div Neurosurg, Riyadh 11323, Saudi Arabia.	ahmedalaqeel@hotmail.com	Alhabib, Amro F/F-1778-2018	Zamakhshary, Mohammed/0000-0001-8870-8684			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Al-Habib A, 2012, J TRAUMA ACUTE CARE, V72, P1356, DOI 10.1097/TA.0b013e318250b537; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Alaranta H, 2000, Wien Med Wochenschr, V150, P444; Arregui-Dalmases C, 2010, ACCIDENT ANAL PREV, V42, P1164, DOI 10.1016/j.aap.2010.01.005; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Chakravarthy B, 2007, PEDIATR EMERG CARE, V23, P738, DOI 10.1097/PEC.0b013e318156acea; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Committee EEV-s, 1998, IMPR TEST METH EV PE, P17; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crankson SJ, 2006, PEDIATR SURG INT, V22, P641, DOI 10.1007/s00383-006-1715-7; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Hefny AF, 2012, ACCIDENT ANAL PREV, V49, P245, DOI 10.1016/j.aap.2011.05.003; Hillier SL, 1997, BRAIN INJURY, V11, P649; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; National Institute for Health and Clinical Excellence, 2007, HEAT INJ TRIAG ASS I; Nogueira LD, 2009, REV LAT-AM ENFERM, V17, P1037, DOI 10.1590/S0104-11692009000600017; Peden M., 2002, INJURY LEADING CAUSE; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SERVADEI F, 1989, Neurosurgical Review, V12, P429, DOI 10.1007/BF01790686; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; United States. Central Intelligence Agency, WORLD FACTB WASH	30	13	13	0	2	K FAISAL SPEC HOSP RES CENTRE	RIYADH	PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA	0256-4947	1319-9226		ANN SAUDI MED	Ann. Saudi Med.	JUL-AUG	2013	33	4					351	355		10.5144/0256-4947.2013.351			5	Medicine, General & Internal	General & Internal Medicine	AA3PB	WOS:000331003700005	24060713	DOAJ Gold, Green Published			2021-06-18	
J	Brandner, S; Thaler, C; Buchfelder, M; Kleindienst, A				Brandner, Sebastian; Thaler, Christian; Buchfelder, Michael; Kleindienst, Andrea			Brain-Derived Protein Concentrations in the Cerebrospinal Fluid: Contribution of Trauma Resulting from Ventricular Drain Insertion	JOURNAL OF NEUROTRAUMA			English	Article						Beta-Trace; biomarker; neuroproteins; neurotrauma; NSE; S100B; ventricular drain	NEURON-SPECIFIC ENOLASE; BETA-TRACE PROTEIN; S-100 PROTEIN; SUBARACHNOID HEMORRHAGE; POTENTIAL MARKER; S100B; SERUM; DYNAMICS; DAMAGE	In recent years, the measurement of biomarkers following neurotrauma assisted in improving outcome prediction and guiding therapy. The use of neuroproteins as diagnostic parameters requires a detailed knowledge of their dynamics in biological fluids for an appropriate interpretation. S100B is the most widely studied neuromarker, and its concentration in serum and cerebrospinal fluid (CSF) reflects the extent of brain damage. Neuron-specific enolase (NSE) is considered reflecting neuronal damage, while Beta-Trace is a lepto-meningeal protein used to diagnose CSF leakage. In five patients treated with an external ventricular drain (EVD) because of aneurysmal subarachnoid hemorrhage (SAH, n = 3) or postinfectious hydrocephalus (n = 2), an EVD exchange was performed 8 to 12 days after initial insertion. S100B and NSE were measured with the Cobas e411 (R) electrochemiluminescence assay (Roche Diagnostics, Mannheim, Germany) and Beta-Trace with the BN Pro Spec (R) nephelometer (Dade Behring/Siemens, Germany) 1 h before EVD exchange, upon the insertion of the new drain, and 1, 3, 6, 12, 18, 24 and 48 h after EVD exchange. Before EVD exchange, S100B CSF concentrations were within the normal range in all patients (1.48 +/- 0.37 mu g/L), while NSE CSF concentrations were normal in four of five patients (6.51 +/- 2.98 mu g/L). Following EVD exchange, S100B and NSE CSF levels peaked significantly at 3 h after insertion of the new drain (S100B 39.02 +/- 9.17 mu g/L; NSE 54.80 +/- 43.34 mu g/L). S100B serum levels were slightly increased 6 to 24 h after EVD exchange. Beta-Trace concentrations in the CSF were not altered by EVD insertion. Our data demonstrate that EVD insertion results in a distinct increase of S100B and NSE concentrations in the CSF. Thus, the tampering of brain-derived protein concentrations in the CSF by diagnostic or therapeutic procedures has to be considered in the interpretation of neuromarker levels.	[Brandner, Sebastian; Thaler, Christian; Buchfelder, Michael; Kleindienst, Andrea] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany	Kleindienst, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, D-91054 Erlangen, Germany.	andrea.kleindienst@uk-erlangen.de	Kleindienst, Andrea/F-1674-2014; Brandner, Sebastian/J-4562-2014	Kleindienst, Andrea/0000-0003-4758-0324; Brandner, Sebastian/0000-0002-9821-0342	Kuratorium ZNS-Hannelore Kohl Stiftung	This work was partially supported by the Kuratorium ZNS-Hannelore Kohl Stiftung.	[Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brandner S, 2012, Acta Neurochir Suppl, V114, P217, DOI 10.1007/978-3-7091-0956-4_42; HARDEMARK HG, 1989, ACTA NEUROCHIR, V99, P135, DOI 10.1007/BF01402322; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; JACOBI C, 1988, CLIN CHIM ACTA, V177, P49, DOI 10.1016/0009-8981(88)90306-3; Kirchhoff C, 2008, EUR J MED RES, V13, P511; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1997, CLIN CHEM, V43, P541; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; Reiber H, 2003, ACTA NEUROL SCAND, V108, P359, DOI 10.1034/j.1600-0404.2003.00173.x; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Woertgen C, 2004, NEUROSURG REV, V27, P178, DOI 10.1007/s10143-004-0341-x	26	13	15	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1205	1210		10.1089/neu.2012.2621			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400012	23390981				2021-06-18	
J	Kernic, MA; Rivara, FP; Zatzick, DF; Bell, MJ; Wainwright, MS; Groner, JI; Giza, CC; Mink, RB; Ellenbogen, RG; Boyle, L; Mitchell, PH; Kannan, N; Vavilala, MS				Kernic, Mary A.; Rivara, Frederick P.; Zatzick, Douglas F.; Bell, Michael J.; Wainwright, Mark S.; Groner, Jonathan I.; Giza, Christopher C.; Mink, Richard B.; Ellenbogen, Richard G.; Boyle, Linda; Mitchell, Pamela H.; Kannan, Nithya; Vavilala, Monica S.		PEGASUS Pediat Guideline Adh	Triage of Children with Moderate and Severe Traumatic Brain Injury to Trauma Centers	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; pediatrics; trauma; trauma center	PEDIATRIC TRAUMA; CENTER DESIGNATION; CARE; VALIDATION; CALIFORNIA; SURGEONS; SYSTEM; IMPACT	Outcomes after pediatric traumatic brain injury (TBI) are related to pre-treatment factors including age, injury severity, and mechanism of injury, and may be positively affected by treatment at trauma centers relative to non-trauma centers. This study estimated the proportion of children with moderate to severe TBI who receive care at trauma centers, and examined factors associated with receipt of care at adult (ATC), pediatric (PTC), and adult/pediatric trauma centers (APTC), compared with care at non-trauma centers (NTC) using a nationally representative database. The Kids' Inpatient Database was used to identify hospitalizations for moderate to severe pediatric TBI. Pediatric inpatients ages 0 to 17 years with at least one diagnosis of TBI and a maximum head Abbreviated Injury Scale score of 3 were studied. Multinomial logistic regression was performed to examine factors predictive of the level and type of facility where care was received. A total of 16.7% of patients were hospitalized at NTC, 44.2% at Level I or II ATC, 17.9% at Level I or II PTC, and 21.2% at Level I or II APTC. Multiple regression analyses showed receipt of care at a trauma center was associated with age and polytrauma. We concluded that almost 84% of children with moderate to severe TBI currently receive care at a Level I or Level II trauma center. Children with trauma to multiple body regions in addition to more severe TBI are more likely to receive care a trauma center relative to a NTC.	[Kernic, Mary A.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98104 USA; [Boyle, Linda] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98104 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98104 USA; [Kannan, Nithya] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Pediat Neurol, Los Angeles, CA USA; [Mink, Richard B.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA	Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Groner, Jonathan/0000-0002-0998-593X	Dr. Vavilala's National Institutes of Health R01 award "Pediatric Guideline Adherence and Outcomes Project'' [R01 NS072308-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	We would like to respectfully acknowledge the contributors to the Healthcare Cost and Utilization Project data partners who contributed to the Kids' Inpatient Database. A list of contributing partners is found at www.hcup-us.ahrq.gov/hcupdatapartners.jsp. Funding for this study came from Dr. Vavilala's National Institutes of Health R01 award "Pediatric Guideline Adherence and Outcomes Project'' R01 NS072308-01.	Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; [Anonymous], 1999, RES OPT CAR INJ PAT; [Anonymous], 2010, INT CLASS DIS 9 REV; BENSARD DD, 1994, J PEDIATR SURG, V29, P11, DOI 10.1016/0022-3468(94)90514-2; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; DAMELIO LF, 1995, AM SURGEON, V61, P968; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FORTUNE JB, 1992, J TRAUMA, V33, P130, DOI 10.1097/00005373-199207000-00024; Haas B, 2009, J AM COLL SURGEONS, V208, P28, DOI 10.1016/j.jamcollsurg.2008.09.004; Hahn D.R, 2009, ICDPIC STATA MODULE; Healthcare Cost and Utilization Project, 2006, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project, 2005, CALC KIDS INP DAT KI; Healthcare Cost and Utilization Project, 2008, KID DESCR DAT EL; Hsia RY, 2010, J TRAUMA, V68, P217, DOI 10.1097/TA.0b013e3181a0e66d; Ingram Deborah D, 2012, Vital Health Stat 2, P1; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; KNUDSON MM, 1992, J TRAUMA, V32, P729, DOI 10.1097/00005373-199206000-00009; Long JS, 2006, REGRESSION MODELS CA; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 1986, P AAAM, V30, P135; NAKAYAMA DK, 1992, J PEDIATR SURG, V27, P427, DOI 10.1016/0022-3468(92)90328-5; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; Stata Corp, 2009, STAT STAT SOFTW REL; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Wang NE, 2008, ANN EMERG MED, V52, P607, DOI 10.1016/j.annemergmed.2008.05.011	33	13	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1129	1136		10.1089/neu.2012.2716			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400004	23343131	Green Published			2021-06-18	
J	Plurad, DS; Kim, D; Bricker, S; Lemesurier, L; Neville, A; Bongard, F; Putnam, B				Plurad, David S.; Kim, Dennis; Bricker, Scott; Lemesurier, Louis; Neville, Angela; Bongard, Frederic; Putnam, Brant			Ventilator-associated pneumonia in severe traumatic brain injury: the clinical significance of admission chest computed tomography findings	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Ventilator-associated pneumonia; Computed tomography; Enterobacter; Morbidity	PULMONARY INFECTION SCORE; DIAGNOSIS; SCAN	Background: Ventilator-associated pneumonia (VAP) in severe traumatic brain injury (STBI) is a significant morbidity. Bilateral dependent consolidation (BDC) can be seen on admission chest computed tomography (CCT) in STBI. We hypothesize that this finding may be associated with VAP. Materials and methods: We retrospectively studied patients who sustained STBI after blunt injury and survived >48 h, who were admitted over a 40-mo period. We defined STBI as an admission Glasgow Coma Scale Score <= 8. We identified VAP by an elevated white blood cell count, a new infiltrate on chest x-ray, and a positive respiratory culture in a ventilated patient. Variables included demographics, injury, admission CCT, and culture data. We compared BDC-positive and BDC-negative patients. Results: There were 33 cases of VAP in 94 study patients (35.1%), in whom the incidence of intracranial pressure (ICP) monitoring (66.7% versus 39.3%; P = 0.011) was significantly increased. Ventilator-associated pneumonia was significantly increased in the 28 patients (29.8%) in the BDC-positive group (16 [57.1%] versus 17 (25.6%); P = 0.004). Bilateral dependent consolidation independently predicted VAP. In the 33 VAP cases, gram-negative organisms were present in 27 patients (81.8%), with a predominance of Enterobacteriaceae (16 patients [48.5%]). Culture results did not significantly differ between the early (<4 d) versus late or BDC-positive versus BDC-negative VAP groups. Conclusions: Ventilator-associated pneumonia is common after STBI, and BDC is independently associated; however, there is no predilection for specific organisms. Admission CCT findings may prove useful in identifying a group of STBI patients at higher risk for VAP. (C) 2013 Elsevier Inc. All rights reserved.	[Plurad, David S.; Kim, Dennis; Bricker, Scott; Lemesurier, Louis; Neville, Angela; Bongard, Frederic; Putnam, Brant] Univ Calif Los Angeles, David Geffen Sch Med, Div Trauma Acute Care Surg & Surg Crit Care, Harbor UCLA Med Ctr, Torrance, CA USA	Plurad, DS (corresponding author), Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, 1000 W Carson St,Box 42, Torrance, CA 91024 USA.	dplurad@dhs.lacounty.gov					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Campbell W, 1999, CRIT CARE MED, V21, P365; Croce MA, 2006, J TRAUMA, V60, P523, DOI 10.1097/01.ta.0000204033.78125.1b; Croce MA, 2001, AM SURGEON, V67, P105; de Moya MA, 2011, J TRAUMA, V71, P1543, DOI 10.1097/TA.0b013e31822c4a8b; Demetriades D, 1998, ARCH SURG-CHICAGO, V133, P1084, DOI 10.1001/archsurg.133.10.1084; Franquet T, 2000, RADIOGRAPHICS, V20, P673, DOI 10.1148/radiographics.20.3.g00ma01673; Hanpeter DE, 2000, J TRAUMA, V49, P689, DOI 10.1097/00005373-200010000-00017; Karaaslan T, 1995, J TRAUMA, V39, P1081, DOI 10.1097/00005373-199512000-00012; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Lauzier F, 2008, J CRIT CARE, V23, P50, DOI 10.1016/j.jcrc.2008.01.006; Liberati A, 2009, COCHRANE DB SYST REV, V4, P22, DOI [10.1002/14651858.CD000022.pub2, DOI 10.1002/14651858]; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; Plurad D, 2007, J TRAUMA, V62, P631, DOI 10.1097/TA.0b013e31802bf009; Plurad D, 2011, J TRAUMA, V71, P1035, DOI 10.1097/TA.0b013e31821282bb; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; RELLO J, 1994, AM J RESP CRIT CARE, V150, P1545, DOI 10.1164/ajrccm.150.6.7952612; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sirgo G, 2002, SEM RESP CRIT CARE M, V23, P435, DOI 10.1055/s-2002-35714; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Zilberberg MD, 2010, CLIN INFECT DIS, V51, pS131, DOI 10.1086/653062; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	23	13	17	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2013	183	1					371	376		10.1016/j.jss.2013.01.036			6	Surgery	Surgery	166ZK	WOS:000320599600054	23434213				2021-06-18	
J	Semyachkina-Glushkovskaya, OV; Lychagov, VV; Bibikova, OA; Semyachkin-Glushkovskiy, IA; Sindeev, SS; Zinchenko, EM; Kassim, MM; Ali, AF; Leith, A; Ulanova, MV; Tuchin, VV				Semyachkina-Glushkovskaya, Oxana V.; Lychagov, Vladislav V.; Bibikova, Olga A.; Semyachkin-Glushkovskiy, Igor A.; Sindeev, Sergey S.; Zinchenko, Ekaterina M.; Kassim, Mohhanad M.; Ali, Al-Fatle Fatema; Leith, Al Hassani; Ulanova, Maria V.; Tuchin, Valery V.			THE EXPERIMENTAL STUDY OF STRESS-RELATED PATHOLOGICAL CHANGES IN CEREBRAL VENOUS BLOOD FLOW IN NEWBORN RATS ASSESSED BY DOCT	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						Doppler optical coherence tomography; stress-related intracranial hemorrhage; cerebral venous blood flow; adrenaline	SYMPTOMATIC INTRACRANIAL HEMORRHAGE; OPTICAL COHERENCE TOMOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURIES; FULL-TERM INFANTS; INTRACEREBRAL HEMORRHAGE; PERFUSION-PRESSURE; RISK-FACTORS; PREMATURE-INFANTS	In experiments on newborn rats with stress-related intracranial hemorrhage (ICH) using Doppler optical coherence tomography (DOCT) we have shown that latent stage of ICH (4 h after stress) is characterized by decrease of venous blood outflow and the loss of sensitivity of sagittal vein to vasoconstrictor effect of adrenaline. The incidence of ICH (24 h after stress) was accompanied by progression of early pathological changes in cerebral venous blood flow (CVBF) and development of venous insufficiency. Taking into consideration of this fact, we suggest that the suppression of CVBF related to the severity to the deleterious effect of stress on the brain hemodynamics in newborn rats. These facts allow us to conclude that the venous insufficiency with the loss of vasoconstrictor response to adrenaline is an informative and sensitive component of pattern of CVBF that can be important diagnostic criteria of risk of ICH development in newborns.	[Semyachkina-Glushkovskaya, Oxana V.; Lychagov, Vladislav V.; Bibikova, Olga A.; Semyachkin-Glushkovskiy, Igor A.; Sindeev, Sergey S.; Zinchenko, Ekaterina M.; Kassim, Mohhanad M.; Ali, Al-Fatle Fatema; Leith, Al Hassani; Ulanova, Maria V.; Tuchin, Valery V.] Saratov NG Chernyshevskii State Univ, Dept Biol, Saratov 410012, Russia; [Kassim, Mohhanad M.; Ali, Al-Fatle Fatema; Leith, Al Hassani] Al Mustansiriya Univ, Dept Biol, Baghdad, Iraq; [Tuchin, Valery V.] Russia Acad Sci, Inst Precise Mech & Control, Saratov, Russia; [Tuchin, Valery V.] Univ Oulu, Optoelect & Measurement Tech Lab, SF-90100 Oulu, Finland	Semyachkina-Glushkovskaya, OV (corresponding author), Saratov NG Chernyshevskii State Univ, Dept Biol, Astrachanskaya Str 83, Saratov 410012, Russia.	glushkovskaya@mail.ru	Glushkovskaya, Oxana V/D-5190-2013; Lychagov, Vladislav/A-3575-2014; Tuchin, Valery V/C-7865-2013; Zinchenko, Ekaterina/F-8069-2015	Glushkovskaya, Oxana V/0000-0001-6753-7513; Tuchin, Valery V/0000-0001-7479-2694; Zinchenko, Ekaterina/0000-0001-7926-1681	RF Governmental contracts [11.519.11.2035, 14.B37.21.0728, 14.B37.21.0563, 14.B37.21.0216]; FiDiPro, Finland; TEKES Program, Finland [40111/11]; SCOPES EC; Uzb/Switz/RF; Swiss NSFSwiss National Science Foundation (SNSF) [IZ74ZO_137423/1]; RF President's grant "Scientific Schools" [1177.2012.2.]; Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [12-02-31204 mol-a, a-11-02-00560]	This work was supported in part by RF Governmental contracts 11.519.11.2035, 14.B37.21.0728, 14.B37.21.0563; 14.B37.21.0216 and grants: FiDiPro, TEKES Program (40111/11), Finland; SCOPES EC, Uzb/Switz/RF, Swiss NSF, IZ74ZO_137423/1; RF President's grant "Scientific Schools", 1177.2012.2., Russian Foundation for Basic Research Grant No. 12-02-31204 mol-a and No. a-11-02-00560.	ADELSON PD, 2003, PEDIATR CRIT CARE ME, V4, P12; Ahlqvist J, 2001, STROKE, V32, P276, DOI 10.1161/01.STR.32.1.275-a; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Annibale DJ, PERIVENTRICULAR HEMO; Ballabh P, 2004, PEDIATR RES, V56, P117, DOI 10.1203/01.PDR.0000130472.30874.FF; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; BARTOLOME JV, 1987, NEUROTOXICOLOGY, V8, P1; Bengel FM, 2009, J AM COLL CARDIOL, V54, P1, DOI 10.1016/j.jacc.2009.02.065; Beslow LA, 2010, STROKE, V41, P313, DOI 10.1161/STROKEAHA.109.568071; Bevan J A, 1981, HDB PHYSL          2, VII, P515; Bhattacharjee M, 2011, J INNOV OPT HEAL SCI, V4, P59, DOI 10.1142/S1793545811001083; BUSIJA DW, 1984, REV PHYSIOL BIOCH P, V101, P161, DOI 10.1007/BFb0027696; CAPLAN L, 1988, NEUROLOGY, V38, P624, DOI 10.1212/WNL.38.4.624; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Cassaglia PA, 2008, AM J PHYSIOL-REG I, V294, pR1255, DOI 10.1152/ajpregu.00332.2007; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Enmi J, 2004, INT CONGR SER, P150, DOI 10.1016/j.ics.2004.04.045; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; GhaziBirry HS, 1997, AM J NEURORADIOL, V18, P219; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Green MA, 2011, SEMIN NEPHROL, V31, P291, DOI 10.1016/j.semnephrol.2011.05.008; Guennadi S., 2012, J INNOV OPT HEAL SCI, V5; Gupta SN, 2009, PEDIATR NEUROL, V40, P1, DOI 10.1016/j.pediatrneurol.2008.09.019; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hanigan WC, 1995, CHILD NERV SYST, V11, P698, DOI 10.1007/BF00262235; Happe HK, 1999, J PHARMACOL EXP THER, V288, P1134; Helmchen F, 2008, METHOD ENZYMOL, V444, P231, DOI 10.1016/S0076-6879(08)02810-3; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Hojberg AS, 1997, DAN MED BULL, V44, P439; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P689, DOI 10.1097/00004647-200206000-00007; Jordan LC, 2009, STROKE, V40, P1666, DOI 10.1161/STROKEAHA.108.541383; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Kiening KL, 1998, ACT NEUR S, V71, P172; Koretsky AP, 2012, NEUROIMAGE, V62, P602, DOI 10.1016/j.neuroimage.2012.01.005; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Lammie GA, 2000, STROKE, V31, P1426, DOI 10.1161/01.STR.31.6.1426; Li XQ, 2011, J INNOV OPT HEAL SCI, V4, P325, DOI 10.1142/S1793545811001599; Li-Ping Y., 2012, J INNOV OPT HEAL SCI, V5; Liem KD, 2010, EARLY HUM DEV, V86, P155, DOI 10.1016/j.earlhumdev.2010.01.029; Lo WD, 2011, J CHILD NEUROL, V26, P1174, DOI 10.1177/0883073811408424; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; MCCALDEN TA, 1981, J AUTON PHARMACOL, V1, P421, DOI 10.1111/j.1474-8673.1981.tb00082.x; MEYER CHA, 1983, NEUROSURGERY, V12, P58, DOI 10.1227/00006123-198301000-00010; MORRIS MJ, 1980, BRAIN RES, V190, P268, DOI 10.1016/0006-8993(80)91178-6; *NAT CTR HLTH STAT, 2002, DEATHS PERC TOT DEAT; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Purves M. J., 1972, PHYSL CEREBRAL CIRCU, P427; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Semyachkina-Glushkovskaya O., 2013, J PHOTON LASERS MED, P1; Semyachkina-Glushkovskaya O., 2012, Patent, Patent No. [RF 072642, 072642]; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Srinivasan VJ, 2010, OPT EXPRESS, V18, P2477, DOI 10.1364/OE.18.002477; The Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, P7; van Amerom JFP, 2009, MAGN RESON IMAGING, V27, P38, DOI 10.1016/j.mri.2008.05.016; Vilensky MA, 2012, QUANTUM ELECTRON+, V42, P489, DOI 10.1070/QE2012v042n06ABEH014887; Volpe JJ., 2008, NEUROLOGY NEWBORN, V5th, P517, DOI [10.1016/B978-1-4160-3995-2.10011-1, DOI 10.1016/B978-1-4160-3995-2.10011-1]; Weber TF, 2011, EUR J RADIOL, V80, P103, DOI 10.1016/j.ejrad.2010.06.045; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wintermark P., 2013, NEUROIMAGE IN PRESS, DOI [10.1016/j.neuroimage.2013.04.072, DOI 10.1016/J.NEUR0IMAGE.2013.04.072]; Yao JJ, 2010, OPT LETT, V35, P1419, DOI 10.1364/OL.35.001419	69	13	13	0	13	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	JUL	2013	6	3							1350023	10.1142/S1793545813500235			10	Optics; Radiology, Nuclear Medicine & Medical Imaging	Optics; Radiology, Nuclear Medicine & Medical Imaging	192XB	WOS:000322519900008		DOAJ Gold			2021-06-18	
J	Soliman, ML; Ohm, JE; Rosenberger, TA				Soliman, Mahmoud L.; Ohm, Joyce E.; Rosenberger, Thad A.			Acetate Reduces PGE(2) Release and Modulates Phospholipase and Cyclooxygenase Levels in Neuroglia Stimulated with Lipopolysaccharide	LIPIDS			English	Article						Phospholipase; Cyclooxygenase; Eicosanoid; Acetate; Histone acetylation	HISTONE DEACETYLASE INHIBITORS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; RAT MODEL; MOUSE MODEL; NUCLEOSOMAL DNA; A(2); ACETYLATION	Acetate supplementation attenuates neuroglial activation, increases histone and non-histone protein acetylation, reduces pro-inflammatory cytokine expression, and increases IL-4 transcription in rat models of neuroinflammation and Lyme's neuroborreliosis. Because eicosanoid signaling is involved in neuroinflammation, we measured the effect acetate treatment had on phospholipase, cyclooxygenase, and prostaglandin E-2 (PGE(2)) levels in BV-2 microglia and primary astrocytes stimulated with lipopolysaccharide (LPS). In BV-2 microglia, we found that LPS increased the phosphorylation-state of cytosolic phospholipase A(2) (cPLA(2)), reduced the levels of phospholipase C (PLC) beta 1, and increased the levels of cyclooxygenase (Cox)-1 and -2. Acetate treatment returned PLC beta 1 and Cox-1 levels to normal, attenuated the increase in Cox-2, but had no effect on cPLA(2) phosphorylation. In primary astrocytes, LPS increased the phosphorylation of cPLA(2) and increased the levels of Cox-1 and Cox-2. Acetate treatment in these cells reduced secretory PLA(2) IIA and PLC beta 1 levels as compared to LPS-treatment groups, reversed the increase in cPLA(2) phosphorylation, and returned Cox-1 levels to normal. Acetate treatment reduced PGE(2) release in astrocytes stimulated with LPS to control levels, but did not alter PGE(2) levels in BV-2 microglia. The amount of acetylated H3K9 bound to the promoter regions of Cox-1, Cox-2, IL-1 beta and NF-kappa B p65 genes, but not IL-4 in were increased in BV-2 microglia treated with acetate. These data suggest that acetate treatment can disrupt eicosanoid signaling in neuroglia that may, in part, be the result of altering gene expression due chromatin remodeling as a result of increasing H3K9 acetylation.	[Soliman, Mahmoud L.; Rosenberger, Thad A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Ohm, Joyce E.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58203 USA	Rosenberger, TA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, 501 North Columbia Rd,Room 3742, Grand Forks, ND 58203 USA.	thad.rosenberger@med.und.edu		Rosenberger, Thad/0000-0001-6360-4977	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P20RR17699, P30GM103329]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES022030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103329] Funding Source: NIH RePORTER	This work was funded by grants from the National Institutes of Health (2P20RR17699 and P30GM103329). We would like to thank Kendra L. Puig and Dr. Colin K. Combs (University of North Dakota School of Medicine and Health Sciences) for providing primary astrocytes and BV-2 microglia.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Adibhatla RM, 2007, BRAIN RES, V1134, P199, DOI 10.1016/j.brainres.2006.11.080; Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Anthonsen MW, 2001, J BIOL CHEM, V276, P30527, DOI 10.1074/jbc.M008481200; Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Balboa MA, 2002, FEBS LETT, V531, P12, DOI 10.1016/S0014-5793(02)03481-6; Bhatt DP, 2013, NEUROCHEM INT, V62, P296, DOI 10.1016/j.neuint.2013.01.004; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Brissette CA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-249; Casolini P, 2002, J NEUROSCI RES, V68, P337, DOI 10.1002/jnr.10192; da Silva PF, 2012, NEUROSCIENCE, V200, P42, DOI 10.1016/j.neuroscience.2011.10.038; Lima IVD, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/946813; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Farooqui AA, 2005, REPROD NUTR DEV, V45, P613, DOI 10.1051/rnd:2005049; Farooqui AA, 1997, J NEUROCHEM, V69, P889; FUJIMORI Y, 1992, J BIOCHEM-TOKYO, V111, P54, DOI 10.1093/oxfordjournals.jbchem.a123718; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Grinberg S, 2009, AM J PATHOL, V175, P2439, DOI 10.2353/ajpath.2009.090290; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Hiller G, 1999, CELL SIGNAL, V11, P863, DOI 10.1016/S0898-6568(99)00058-3; Jupp OJ, 2003, BIOCHEM J, V374, P453, DOI 10.1042/BJ20030705; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; LAURITZEN I, 1994, BRAIN RES, V651, P353, DOI 10.1016/0006-8993(94)90719-6; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Mu Changjun, 2007, Mol Biol (Mosk), V41, P395; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Reisenauer CJ, 2011, J NEUROCHEM, V117, P264, DOI 10.1111/j.1471-4159.2011.07198.x; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soliman ML, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-51; Soliman ML, 2013, J NEUROIMMUNE PHARM, V8, P287, DOI 10.1007/s11481-012-9426-4; Soliman ML, 2012, J NEUROCHEM, V123, P555, DOI 10.1111/j.1471-4159.2012.07955.x; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Yermakova A, 2000, CURR PHARM DESIGN, V6, P1755, DOI 10.2174/1381612003398672; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	58	13	13	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4201	1558-9307		LIPIDS	Lipids	JUL	2013	48	7					651	662		10.1007/s11745-013-3799-x			12	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	170OD	WOS:000320861600001	23709104	Green Accepted			2021-06-18	
J	Calik, M; Abuhandan, M; Aycicek, A; Taskin, A; Selek, S; Iscan, A				Calik, Mustafa; Abuhandan, Mahmut; Aycicek, Ali; Taskin, Abdullah; Selek, Sahabettin; Iscan, Akin			Increased oxidant status in children with breath-holding spells	CHILDS NERVOUS SYSTEM			English	Article						Antioxidants; Breath-holding spells; Infants; Iron-deficiency anemia; Oxidative stress	IRON-DEFICIENCY ANEMIA; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT STATUS; NERVOUS-SYSTEM; SUSCEPTIBILITY; CELLS	Breath-holding spells (BHS) are the most common form of non-epileptic paroxysmal events in infancy. The pathophysiology of BHS is not fully understood. Iron-deficiency anemia (IDA) may be a factor contributing to breath-holding spells. Although numerous reports have shown that elevated oxidative stress is implicated in the pathophysiology of neurodegenerative diseases and neurological conditions, such as epileptic seizures, brain damage, and neurotrauma, there are no data regarding the role of oxidative stress in the development of BHS. This study aimed to investigate oxidative stress in children with BHS. This case-control study was conducted at the Department of Pediatric Neurology, Harran University School of Medicine, Sanliurfa, in Turkey. Blood samples from 31 patients (14 females, 17 males) with BHS which were taken at least 24 h after the BHS attack, and a control group of 35 healthy individuals (13 females, 22 males) were used for the measurement of the plasma total antioxidant capacity, total oxidant status, and oxidative stress index, hemoglobin concentration, serum iron, transferrin saturation and serum ferritin levels. The plasma total antioxidant capacity values were markedly lower and total oxidant status and oxidative stress index values in the BHS group were significantly higher than that in the controls (P a parts per thousand currency signaEuro parts per thousand 0.01). Our data suggest that the value of oxidative stress was significantly higher in patients with BHS than in the controls. Conditions associated with increased oxidative stress such as IDA may be a risk factor for the development of BHS.	[Calik, Mustafa] Harran Univ, Fac Med, Sanliurfa, Turkey; [Calik, Mustafa] Harran Univ, Div Pediat Neurol, Dept Pediat, Fac Med, TR-63100 Yenisehir, Sanliurfa, Turkey; [Abuhandan, Mahmut] Harran Univ, Dept Pediat, Fac Med, Sanliurfa, Turkey; [Aycicek, Ali] Harran Univ, Fac Med, Dept Pediat, Div Pediat Hematol & Oncol, Sanliurfa, Turkey; [Taskin, Abdullah; Selek, Sahabettin] Harran Univ, Dept Biochem & Clin Biochem, Fac Med, Sanliurfa, Turkey; [Iscan, Akin] Bezmialem Vakif Univ, Dept Pediat Neurol, Fac Med, Istanbul, Turkey	Calik, M (corresponding author), Harran Univ, Div Pediat Neurol, Dept Pediat, Fac Med, TR-63100 Yenisehir, Sanliurfa, Turkey.	m.calik80@hotmail.com	Taskin, Abdullah/ABF-5740-2020; Selek, Sahabettin/N-9323-2019; Aycicek, Ali/ABI-3846-2020; CALIK, Mustafa/Q-8105-2019	Selek, Sahabettin/0000-0003-1235-3957; Aycicek, Ali/0000-0001-8951-4750; CALIK, Mustafa/0000-0001-9963-5724; ABUHANDAN, Mahmut/0000-0002-5315-3209			Aslan M, 2011, TURK J HEMATOL, V28, P42, DOI 10.5152/tjh.2011.04; Brugnara C, 2009, NATHAN OSKIS HEMATOL, P456; CORRONS JLV, 1995, EUR J HAEMATOL, V55, P327; Daoud AS, 1997, J PEDIATR-US, V130, P547, DOI 10.1016/S0022-3476(97)70237-3; DiMario FJ, 1997, J PEDIATR-US, V130, P647, DOI 10.1016/S0022-3476(97)70251-8; DiMario FJ, 2001, PEDIATRICS, V107, P265, DOI 10.1542/peds.107.2.265; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Handan U, 2005, PEDIATR HEMAT ONCOL, V22, P711, DOI 10.1080/08880010500278855; Harma M, 2003, SWISS MED WKLY, V133, P563; Isler M, 2002, CROAT MED J, V43, P16; JANSSON LT, 1985, ACTA HAEMATOL-BASEL, V74, P218, DOI 10.1159/000206222; Kumerova Ausma, 1998, Materia Medica Polona, V30, P12; Kurtoglu E, 2003, BIOL TRACE ELEM RES, V96, P117, DOI 10.1385/BTER:96:1-3:117; MACDOUGA.LG, 1972, J PEDIATR-US, V80, P775, DOI 10.1016/S0022-3476(72)80130-6; Mocan H, 1999, ARCH DIS CHILD, V81, P261, DOI 10.1136/adc.81.3.261; Orii KE, 2002, J CHILD NEUROL, V17, P337, DOI 10.1177/088307380201700505; Patel M, 2003, NEUROSCIENCE, V118, P431, DOI 10.1016/S0306-4522(02)00979-X; RAMACHANDRAN M, 1984, EXPERIENTIA, V40, P173, DOI 10.1007/BF01963584; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; Simsek Orhon Filiz, 2006, Turk J Haematol, V23, P15; Tekin D, 2001, PEDIATR INT, V43, P74, DOI 10.1046/j.1442-200x.2001.01329.x; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001	25	13	13	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2013	29	6					1015	1019		10.1007/s00381-012-2001-8			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	148FE	WOS:000319227800019	23250250				2021-06-18	
J	Holschneider, DP; Guo, YM; Wang, Z; Roch, M; Scremin, OU				Holschneider, Daniel P.; Guo, Yumei; Wang, Zhuo; Roch, Margareth; Scremin, Oscar U.			Remote Brain Network Changes after Unilateral Cortical Impact Injury and Their Modulation by Acetylcholinesterase Inhibition	JOURNAL OF NEUROTRAUMA			English	Article						cholinergic; diaschisis; functional brain mapping; functional connectivity; traumatic brain injury	CEREBRAL BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; BASAL GANGLIA; RESTING-STATE; MOTOR CORTEX; PARKINSONS-DISEASE; INDICATOR FRACTIONATION; SPATIAL NORMALIZATION; RECOVERY; RAT	We explored whether cerebral cortical impact injury (CCI) effects extend beyond direct lesion sites to affect remote brain networks, and whether acetylcholinesterase (AChE) inhibition elicits discrete changes in functional activation of motor circuits following CCI. Adult male rats underwent unilateral motor-sensory CCI or sham injury. Physostigmine (AChE inhibitor) or saline were administered subcutaneously continuously via implanted minipumps (1.6 micromoles/kg/day) for 3 weeks, followed by cerebral perfusion mapping during treadmill walking using [C-14]-iodoantipyrine. Quantitative autoradiographs were analyzed by statistical parametric mapping and functional connectivity (FC) analysis. CCI resulted in functional deficits in the ipsilesional basal ganglia, with increased activation contralesionally. Recruitment was also observed, especially contralesionally, of the red nucleus, superior colliculus, pedunculopontine tegmental nucleus, thalamus (ventrolateral n., central medial n.), cerebellum, and sensory cortex. FC decreased significantly within ipsi- and contralesional motor circuits and between hemispheres, but increased between midline cerebellum and select regions of the basal ganglia within each hemisphere. Physostigmine significantly increased functional brain activation in the cerebellar thalamocortical pathway (midline cerebellum -> ventrolateral thalamus -> motor cortex), subthalamic nucleus/zona incerta, and red nucleus and bilateral sensory cortex. In conclusion, CCI resulted in increased functional recruitment of contralesional motor cortex and bilateral subcortical motor regions, as well as recruitment of the cerebellar-thalamocortical circuit and contralesional sensory cortex. This phenomenon, augmented by physostigmine, may partially compensate motor deficits. FC decreased inter-hemispherically and in negative, but not positive, intra-hemispherical FC, and it was not affected by physostigmine. Circuit-based approaches into functional brain reorganization may inform future behavioral or molecular strategies to augment targeted neurorehabilitation.	[Holschneider, Daniel P.; Guo, Yumei; Wang, Zhuo] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.; Guo, Yumei; Wang, Zhuo] Univ So Calif, Keck Sch Med, Dept Behav Sci, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.; Roch, Margareth; Scremin, Oscar U.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Scremin, Oscar U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	Holschneider, DP (corresponding author), Univ So Calif, Dept Psychiat & Behav Sci, 1333 San Pablo St,MCH 51A,MC9151, Los Angeles, CA 90033 USA.	holschne@usc.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARRD)US Department of Veterans Affairs [B5089R]; VARR&D Research Career Scientist award (OUS)	This study was supported by a Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARR&D) #B5089R and a VARR&D Research Career Scientist award (OUS).	Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Aumann T D, 2002, Cerebellum, V1, P69, DOI 10.1080/147342202753203104; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Barrett D, 2003, J NEUROSCI, V23, P5740; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Conti AC, 1998, J NEUROSCI, V18, P5663; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; De Filippi G, 2005, PROG BRAIN RES, V148, P309, DOI 10.1016/S0079-6123(04)48024-8; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054; Esculier JF, 2012, J REHABIL MED, V44, P144, DOI 10.2340/16501977-0922; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fidalgo C, 2011, BRAIN RES, V1368, P143, DOI 10.1016/j.brainres.2010.10.066; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gharbawie OA, 2005, BEHAV BRAIN RES, V156, P125, DOI 10.1016/j.bbr.2004.05.015; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Holschneider DP, 2003, J CEREBR BLOOD F MET, V23, P925, DOI 10.1097/01.WCB.0000072797.66873.6A; Holschneider DP, 2002, AM J PHYSIOL-HEART C, V283, pH1713, DOI 10.1152/ajpheart.00362.2002; HORWITZ B, 1995, BEHAV BRAIN RES, V66, P187, DOI 10.1016/0166-4328(94)00139-7; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Koch G, 2009, NEUROLOGY, V73, P113, DOI 10.1212/WNL.0b013e3181ad5387; Langguth B, 2008, NEUROPHYSIOL CLIN, V38, P289, DOI 10.1016/j.neucli.2008.08.003; Lee JS, 2005, EUR J NUCL MED MOL I, V32, P696, DOI 10.1007/s00259-004-1739-y; Lewis DH, 2006, J NEUROIMAGING, V16, P272, DOI 10.1111/j.1552-6569.2006.00034.x; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Magnuson M, 2010, J MAGN RESON IMAGING, V32, P584, DOI 10.1002/jmri.22295; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; MEDINA L, 1995, BRAIN BEHAV EVOLUT, V46, P235, DOI 10.1159/000113277; Mountz J M, 2007, Eura Medicophys, V43, P221; Na J, 1997, NEUROSCI RES, V28, P77, DOI 10.1016/S0168-0102(97)00031-X; Nair HP, 1999, J NEUROSCI, V19, P8646; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Padilla E, 2011, BRAIN RES, V1387, P71, DOI 10.1016/j.brainres.2011.02.080; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Palmer SJ, 2009, EUR J NEUROSCI, V29, P2187, DOI 10.1111/j.1460-9568.2009.06753.x; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Paxinos G., 2007, RAT BRAIN STEREOTACT; Paxinos G.U.C., 2005, RAT BRAIN STEREOTACT; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Ripolles P, 2012, NEUROIMAGE, V60, P1296, DOI 10.1016/j.neuroimage.2012.01.094; Roby-Brami A, 2003, ACTA NEUROL SCAND, V107, P369, DOI 10.1034/j.1600-0404.2003.00021.x; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; SCREMIN OU, 1990, J NEUROSCI RES, V26, P188, DOI 10.1002/jnr.490260208; Shumake J, 2004, BRAIN RES, V1030, P267, DOI 10.1016/j.brainres.2004.10.015; Smeets WJAJ, 2000, J ANAT, V196, P501, DOI 10.1046/j.1469-7580.2000.19640501.x; SONCRANT TT, 1986, BRAIN RES, V369, P1, DOI 10.1016/0006-8993(86)90507-X; Stumpf WE, 1995, AUTORADIOGRAPHY CORR; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Turner JR, 2011, CEREBELLUM, V10, P748, DOI 10.1007/s12311-011-0285-y; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Von Monakow C., 1969, BRAIN BEHAV, VI, P27; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; WAN XST, 1992, NEUROSCIENCE, V49, P749, DOI 10.1016/0306-4522(92)90353-4; Wang Z, 2012, NEUROIMAGE, V59, P4168, DOI 10.1016/j.neuroimage.2011.11.047; Wang Z, 2011, PAIN, V152, P2746, DOI 10.1016/j.pain.2011.08.022; Warner JJ, 2001, ATLAS NEUROANATOMY S; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yang J, 2007, NEUROIMAGE, V36, P755, DOI 10.1016/j.neuroimage.2007.03.010; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	93	13	13	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					907	919		10.1089/neu.2012.2657			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300002	23343118	Green Published			2021-06-18	
J	Law, AS; Trawley, SL; Brown, LA; Stephens, AN; Logie, RH				Law, Anna S.; Trawley, Steven L.; Brown, Louise A.; Stephens, Amanda N.; Logie, Robert H.			The impact of working memory load on task execution and online plan adjustment during multitasking in a virtual environment	QUARTERLY JOURNAL OF EXPERIMENTAL PSYCHOLOGY			English	Article						Multitasking; Planning; Working memory; Dual task; Executive function	TRAUMATIC BRAIN-INJURY; STRATEGY APPLICATION DISORDER; MULTIPLE ERRANDS TEST; ECOLOGICAL VALIDITY; SIMPLIFIED VERSION; INNER SPEECH; LONDON TASK; CAPACITY; PERFORMANCE; GENERATION	Three experiments investigated the impact of working memory load on online plan adjustment during a test of multitasking in young, nonexpert, adult participants. Multitasking was assessed using the Edinburgh Virtual Errands Test (EVET). Participants were asked to memorize either good or poor plans for performing multiple errands and were assessed both on task completion and on the extent to which they modified their plans during EVET performance. EVET was performed twice, with and without a secondary task loading a component of working memory. In Experiment 1, articulatory suppression was used to load the phonological loop. In Experiment 2, oral random generation was used to load executive functions. In Experiment 3, spatial working memory was loaded with an auditory spatial localization task. EVET performance for both good- and poor-planning groups was disrupted by random generation and sound localization, but not by articulatory suppression. Additionally, people given a poor plan were able to overcome this initial disadvantage by modifying their plans online. It was concluded that, in addition to executive functions, multiple errands performance draws heavily on spatial, but not verbal, working memory resources but can be successfully completed on the basis of modifying plans online, despite a secondary task load.	[Law, Anna S.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Trawley, Steven L.] Natl Univ Ireland Univ Coll Cork, Sch Med, Ctr Gerontol & Rehabil, Cork, Ireland; [Brown, Louise A.] Nottingham Trent Univ, Div Psychol, Nottingham, England; [Stephens, Amanda N.] Natl Univ Ireland Univ Coll Cork, Sch Appl Psychol, Cork, Ireland; [Logie, Robert H.] Univ Edinburgh, Edinburgh, Midlothian, Scotland	Law, AS (corresponding author), Liverpool John Moores Univ, Tom Reilly Bldg,Byrom St, Liverpool L3 3AF, Merseyside, England.	a.law@ljmu.ac.uk	Trawley, Steven/C-3261-2018; Logie, Robert H/C-6965-2009; Stephens, Amanda/C-4857-2018	Trawley, Steven/0000-0002-0917-730X; Stephens, Amanda/0000-0002-4118-4972; Law, Anna/0000-0002-0926-1309; Logie, Robert/0000-0003-4532-9312; Brown Nicholls, Louise A./0000-0003-3520-6175	Leverhulme TrustLeverhulme Trust [F/00 158/W]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K026992/1] Funding Source: researchfish	We are grateful to Matthew Logie for undertaking the programming to create the Edinburgh Virtual Errands Test (EVET) environment. We acknowledge Leverhulme Trust Research Grant F/00 158/W, which supported the research that we report here.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; BADDELEY A, 1984, Q J EXP PSYCHOL-A, V36, P233, DOI 10.1080/14640748408402157; Baddeley A.D., 1999, MODELS WORKING MEMOR, P28, DOI DOI 10.1017/CBO9781139174909.005; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Baumann O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019707; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Cowan N., 2005, WORKING MEMORY CAPAC; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; Crepeau F, 1996, BRAIN COGNITION, V32, P266; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Deyzac E, 2006, BRIT J PSYCHOL, V97, P217, DOI 10.1348/000712605X67484; Emerson MJ, 2003, J MEM LANG, V48, P148, DOI 10.1016/S0749-596X(02)00511-9; EVANS FJ, 1978, B PSYCHONOMIC SOC, V12, P35; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Garden S, 2002, APPL COGNITIVE PSYCH, V16, P35, DOI 10.1002/acp.746; Garden SE, 2001, NEUROPSYCHOLOGY, V15, P472, DOI 10.1037//0894-4105.15.4.472; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; Hambrick DZ, 2010, APPL COGNITIVE PSYCH, V24, P1149, DOI 10.1002/acp.1624; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Law A. S., 2004, THESIS U ABERDEEN AB; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; Law AS, 2004, ACTA PSYCHOL, V116, P285, DOI 10.1016/j.actpsy.2004.04.003; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Logie R. H., 2012, MENTAL IMAGERY SPATI, P77; Logie RH, 1995, VISUOSPATIAL WORKING; Logie RH, 2011, CURR DIR PSYCHOL SCI, V20, P240, DOI 10.1177/0963721411415340; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Logie RH, 2010, PSYCHOL BELG, V50, P309, DOI 10.5334/pb-50-3-4-309; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; Miyake A, 2004, ACTA PSYCHOL, V115, P123, DOI 10.1016/j.actpsy.2003.12.004; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MURRAY DJ, 1965, Q J EXP PSYCHOL, V17, P47, DOI 10.1080/17470216508416407; Phillips LH, 2001, Q J EXP PSYCHOL-A, V54, P579, DOI 10.1080/02724980042000237; Phillips LH, 1999, MEMORY, V7, P209, DOI 10.1080/741944066; Rajendran G, 2011, J AUTISM DEV DISORD, V41, P1445, DOI 10.1007/s10803-010-1151-3; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Saito S, 2008, J MEM LANG, V59, P1, DOI 10.1016/j.jml.2008.01.004; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Towse JN, 1998, BEHAV RES METH INS C, V30, P583, DOI 10.3758/BF03209475; Trawley SL, 2011, Q J EXP PSYCHOL, V64, P2181, DOI 10.1080/17470218.2011.584976; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104	45	13	15	1	31	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1747-0218	1747-0226		Q J EXP PSYCHOL	Q. J. Exp. Psychol.	JUN 1	2013	66	6					1241	1258		10.1080/17470218.2012.748813			18	Psychology, Biological; Physiology; Psychology; Psychology, Experimental	Psychology; Physiology	152SW	WOS:000319552400014	23234420				2021-06-18	
J	Li, XJ; Han, H; Hou, RL; Wei, LY; Wang, GH; Li, CK; Li, DL				Li, Xinjuan; Han, Hua; Hou, Ruanling; Wei, Linyu; Wang, Guohong; Li, Chaokun; Li, Dongliang			Progesterone treatment before experimental hypoxia-ischemia enhances the expression of glucose transporter proteins GLUT1 and GLUT3 in neonatal rats	NEUROSCIENCE BULLETIN			English	Article						hypoxic-ischemic injury; progesterone; GLUT1; GLUT3; stroke	INDUCED DIABETIC-RATS; BLOOD-BRAIN-BARRIER; 17 BETA-ESTRADIOL; GLUCOSE-TRANSPORTER-1 EXPRESSION; CEREBRAL-CORTEX; GROWTH-FACTOR; INSULIN; STROKE; NEURONS; INJURY	Progesterone is an efficient candidate for treating stroke and traumatic brain damage. The current study was designed to investigate the effects of progesterone on glucose transporter proteins (GLUT1 and GLUT3) during hypoxic-ischemic injury in a neonatal rat model. We demonstrated strong staining for GLUT1 in the walls of blood vessels and GLUT3 immunoreactivity in hippocampal neurons after hypoxiaischemia. Hypoxia-ischemia elevated GLUT1 and GLUT3 at both the mRNA and protein levels in the hippocampus, and pre-treatment with progesterone (8 mg/kg) further enhanced their accumulation until 24 h after hypoxic-ischemic injury. These results showed that progesterone treatment induced the accumulation of both GLUT1 and GLUT3 transporters, and an energy-compensation mechanism may be involved in the neuroprotective effect of progesterone during hypoxic-ischemic injury after cerebral ischemic attacks.	[Li, Xinjuan; Han, Hua; Hou, Ruanling; Wei, Linyu; Wang, Guohong; Li, Chaokun; Li, Dongliang] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang 453003, Peoples R China; [Li, Dongliang] Henan Key Lab Biol Psychiat, Xinxiang 453002, Peoples R China; [Han, Hua] Cent Hosp Xinxiang City, Dept Ultrason Diag, Xinxiang 453000, Peoples R China	Li, CK (corresponding author), Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang 453003, Peoples R China.	lichaokun@hotmail.com; xyldl8@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100912]; Science Foundation of Xinxiang Medical University, China [2009-63]; Science and Technology Project of Henan Province, China [092102310098]	This work was supported by the National Natural Science Foundation of China (81100912), the Science Foundation of Xinxiang Medical University, China (CL and ZD 2009-63) and the Science and Technology Project of Henan Province, China (092102310098).	Abdul Muneer P M, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P48; Balietti M, 2010, AGEING RES REV, V9, P273, DOI 10.1016/j.arr.2010.02.003; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Chavez JC, 2002, J NEUROSCI, V22, P8922; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duarte AI, 2005, FREE RADICAL BIO MED, V39, P876, DOI 10.1016/j.freeradbiomed.2005.05.002; Espinoza-Rojo Monica, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P317; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Iwabuchi S, 2011, NEUROCHEM INT, V59, P319, DOI 10.1016/j.neuint.2011.06.006; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Lawrence MS, 1996, J CEREBR BLOOD F MET, V16, P181, DOI 10.1097/00004647-199603000-00001; Li SY, 2010, FREE RADICAL BIO MED, V48, P597, DOI 10.1016/j.freeradbiomed.2009.12.004; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Ordonez P, 2007, EXP PHYSIOL, V92, P241, DOI 10.1113/expphysiol.2006.035006; Shi J, 1997, AM J PHYSIOL-ENDOC M, V272, pE1016; Shi J, 1997, EXP BRAIN RES, V117, P200, DOI 10.1007/s002210050216; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Urabe T, 1996, J NEUROCHEM, V67, P265; VARGADEFTERDAROVIC L, 1992, INT J PEPT PROT RES, V39, P12; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	28	13	15	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067			NEUROSCI BULL	Neurosci. Bull.	JUN	2013	29	3					287	294		10.1007/s12264-013-1298-y			8	Neurosciences	Neurosciences & Neurology	149ZG	WOS:000319359400004	23307114	Green Published			2021-06-18	
J	Seo, JP; Jang, SH				Seo, Jeong Pyo; Jang, Sung Ho			Traumatic thalamic injury demonstrated by diffusion tensor tractography of the spinothalamic pathway	BRAIN INJURY			English	Article						Spinothalamic tract; diffusion tensor imaging; head trauma; traumatic axonal injury	CENTRAL POSTSTROKE PAIN; BRAIN-INJURY; CORTICAL PATHWAY; AXONAL INJURY; HEAD TRAUMA; ABNORMALITIES; FEATURES; STATE	Background: This study reports on a patient with traumatic brain injury (TBI) with a thalamic lesion in the ventroposterolateral nucleus which was demonstrated by diffusion tensor tractography (DTT) for the spinothalamic tract and its thalamocortical pathway (STP). Methods: One patient with TBI and eight normal control subjects were recruited. A 64-year-old woman who had suffered a motor vehicle accident presented with a persisting tingling sensation and pain in her right upper and lower extremities at 3 weeks after onset. The patient showed impaired touch sensation, but normal proprioception. Diffusion tensor imaging was performed at 1 month after onset. Fractional anisotropy (FA) and mean diffusivity were measured using a region of interest method along the STP. Results: DTT showed normal STP integrities as compared with normal controls. However, the FA values of the left STP at the thalamus were more than 2 SD decreased. The diminished FA value of the left STP in the left thalamus seems to indicate injury of the left ventrolateroposterior nucleus. Central pain and impaired touch sensation of right extremities supports the presence of left STP injury at the ventroposterolateral nucleus in this patient. Conclusion: It is believed that DTT for the STP provides a useful means of detecting thalamic injury in TBI.	[Seo, Jeong Pyo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Namku 705717, Taegu, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Namku 705717, Taegu, South Korea.	strokerehab@hanmail.net			National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haines D.E., 2002, FUNDAMENTAL NEUROSCI; Hattori N, 2003, J NUCL MED, V44, P1709; Hong JH, 2011, AM J NEURORADIOL, V32, P1358, DOI 10.3174/ajnr.A2497; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lincoln N. B., 1998, PHYSIOTHERAPY, V84, P358, DOI DOI 10.1016/S0031-9406(05)61454-X; Miller M D, 1993, Fam Pract Res J, V13, P15; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Yamada K, 2010, AM J NEURORADIOL, V31, P732, DOI 10.3174/ajnr.A1870; Yang DS, 2009, NEUROSCI LETT, V459, P19, DOI 10.1016/j.neulet.2009.04.058; Yeo SS, 2012, BRAIN INJURY, V26, P891, DOI 10.3109/02699052.2012.661119	28	13	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					749	753		10.3109/02699052.2013.771794			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500013	23672449				2021-06-18	
J	Scivoletto, G; Farchi, S; Laurenza, L; Tamburella, F; Molinari, M				Scivoletto, Giorgio; Farchi, Sara; Laurenza, Letizia; Tamburella, Federica; Molinari, Marco			Impact of multiple injuries on functional and neurological outcomes of patients with spinal cord injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Spinal cord injury; Multiple injuries; Outcomes	REHABILITATION; POLYTRAUMA; RECOVERY; INDEX	Background: The effects of multiple injuries on the neurological and functional outcomes of patients with traumatic spinal cord injury (SCI) are debated-some groups have shown that subjects with multiple injuries have the same neurological and functional outcomes of those without them, whereas others have found that SCI patients with associated traumatic brain injury have worse functional status at admission and discharge and longer rehabilitation stays than patients without brain injury. Thus, the aim of this study was to compare the outcomes of SCI subjects with or without multiple injuries. Methods: A total of 245 patients with a traumatic SCI during the first rehabilitation stay after the development of the lesion (202 males and 43 females; age 39.8 +/- 17 years; lesion to admission time 51.1 +/- 58 days) were examined on a referral basis. Patients were assessed using the following measures: American Spinal Injury Association standards, Barthel Index, Rivermead Mobility Index, and Walking Index for Spinal Cord Injury. The statistical analysis comprised Poisson regression models with relative risks and 95% confidence intervals, adjusted for the following confounders: age, sex, lesion level, and ASIA impairment scale (AIS) grade. Student's T test was used to compare the outcomes of patients divided by AIS impairment and lesion level. Results: SCI patients with and without multiple injuries differed significantly with regard to the level and completeness of the lesion. Overall, patients with multiple injuries had worse functional status at admission and discharge than monotraumatic subjects. However, when adjusted for neurological features, the populations had comparable functional and neurological status at admission and discharge and similar rates of complications and discharge destinations. The separate analysis per each level of lesion/AIS grade showed that in some groups, patients with multiple injuries had a significant longer length of stay or worse functional status at rehabilitation admission (but not at discharge) than their monotraumatic counterparts. Conclusions: Multiple injuries do not affect the neurological or rehabilitative prognosis of spinal cord injuries. At discharge, patients with spinal cord injuries with and without multiple injuries achieved similar results with regard to neurological and functional improvement. Some groups of patients with multiple injuries had a longer length of stay.	[Scivoletto, Giorgio; Laurenza, Letizia; Tamburella, Federica; Molinari, Marco] IRCCS S Lucia Fdn, Spinal Cord Unit, Rome, Italy; [Scivoletto, Giorgio; Tamburella, Federica] IRCCS S Lucia Fdn, Clin & Res Movement Anal CaRMA Lab, Rome, Italy; [Farchi, Sara] Publ Hlth Agcy Lazio Reg, Rome, Italy	Scivoletto, G (corresponding author), IRCCS S Lucia Fdn, Spinal Cord Unit, Rome, Italy.	g.scivoletto@hsantalucia.it	Scivoletto, Giorgio/J-3030-2018; Molinari, Marco/A-9624-2010; Tamburella, Federica/J-9917-2016	Scivoletto, Giorgio/0000-0001-5766-6952; Molinari, Marco/0000-0001-9808-9688; Tamburella, Federica/0000-0001-9920-1010	Italian Ministry of HealthMinistry of Health, Italy [RC12G]; International Foundation for Research in Paraplegie [P133]	The authors declare no conflict of interest; supported in part by grant RC12G of the Italian Ministry of Health and grant P133 of the International Foundation for Research in Paraplegie to GS.	American Spinal Injury Association, 2000, INT STAND NEUR CLASS; Boerger TO, 2000, J BONE JOINT SURG BR, V82B, P629, DOI 10.1302/0301-620X.82B5.11321; Calancie B, 2005, J SPINAL CORD MED, V28, P92, DOI 10.1080/10790268.2005.11753804; Chafetz RS, 2007, J SPINAL CORD MED, V30, pS178, DOI 10.1080/10790268.2007.11754598; *CO SP CO CL PR GU, 1999, OUTC FOLL TRAUM SPIN, P1999; Collen F M, 1991, Int Disabil Stud, V13, P50; Ditunno JF, 1999, ARCH PHYS MED REHAB, V80, P361, DOI 10.1016/S0003-9993(99)90270-8; Ditunno PL, 2001, SPINAL CORD, V39, P654, DOI 10.1038/sj.sc.3101223; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Lieutaud T, 2010, J NEUROTRAUM, V27, P1101, DOI 10.1089/neu.2009.1197; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Madersbacher H, 1999, INCONTINENCE, P775; MAHONEY F I, 1965, Md State Med J, V14, P61; Pagliacci MC, 2003, SPINAL CORD, V41, P620, DOI 10.1038/sj.sc.3101521; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Putz C, 2011, SPINAL CORD, V49, P721, DOI 10.1038/sc.2010.181; Putz C, 2011, J TRAUMA, V70, P1078, DOI 10.1097/TA.0b013e3181e73fa0; Rahimi-Movaghar V, 2005, J SPINAL CORD MED, V28, P415, DOI 10.1080/10790268.2005.11753841; Reynard JM, 2003, SPINAL CORD, V41, P1, DOI 10.1038/sj.sc.3101378; Scivoletto G, 2011, SPINAL CORD, V49, P391, DOI 10.1038/sc.2010.85; Scivoletto G, 2003, SPINAL CORD, V41, P457, DOI 10.1038/sj.sc.3101489; Shenot PJ, 1998, NEUROUROL URODYNAM, V17, P25, DOI 10.1002/(SICI)1520-6777(1998)17:1<25::AID-NAU5>3.3.CO;2-J; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Sumida M, 2001, ARCH PHYS MED REHAB, V82, P391, DOI 10.1053/apmr.2001.19780	25	13	14	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAY 30	2013	21								42	10.1186/1757-7241-21-42			7	Emergency Medicine	Emergency Medicine	160NB	WOS:000320125300001	23718823	DOAJ Gold, Green Published			2021-06-18	
J	Peck, CP; Schroeder, RW; Heinrichs, RJ; VonDran, EJ; Brockman, CJ; Webster, BK; Baade, LE				Peck, C. P.; Schroeder, R. W.; Heinrichs, R. J.; VonDran, E. J.; Brockman, C. J.; Webster, B. K.; Baade, L. E.			Differences in MMPI-2 FBS and RBS Scores in Brain Injury, Probable Malingering, and Conversion Disorder Groups: A Preliminary Study	CLINICAL NEUROPSYCHOLOGIST			English	Article						Conversion disorder; Malingering; Minnesota Multiphasic Personality Inventory-2; Symptom Validity Scale; Response Bias Scale	FAKE BAD SCALE; VALIDITY SCALES; RESPONSE BIAS; NEUROCOGNITIVE DYSFUNCTION; PERFORMANCE; VALIDATION; SAMPLES; CLAIMS	This study examined differences in raw scores on the Symptom Validity Scale and Response Bias Scale (RBS) from the Minnesota Multiphasic Personality Inventory-2 in three criterion groups: (i) valid traumatic brain injured, (ii) invalid traumatic brain injured, and (iii) psychogenic non-epileptic seizure disorders. Results indicate that a >30 raw score cutoff for the Symptom Validity Scale accurately identified 50% of the invalid traumatic brain injured group, while misclassifying none of the valid traumatic brain injured group and 6% of the psychogenic non-epileptic seizure disorder group. Using a >15 RBS raw cutoff score accurately classified 50% of the invalid traumatic brain injured group and misclassified fewer than 10% of the valid traumatic brain injured and psychogenic non-epileptic seizure disorder groups. These cutoff scores used conjunctively did not misclassify any members of the psychogenic non-epileptic seizure disorder or valid traumatic brain injured groups, while accurately classifying 44% of the invalid traumatic brain injured individuals. Findings from this preliminary study suggest that the conjunctive use of the Symptom Validity Scale and the RBS from the Minnesota Multiphasic Personality Inventory-2 may be useful in differentiating probable malingering from individuals with brain injuries and conversion disorders.	[Peck, C. P.] Univ Florida, Gainesville, FL 32610 USA; [Schroeder, R. W.; Heinrichs, R. J.; VonDran, E. J.; Brockman, C. J.; Webster, B. K.; Baade, L. E.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	Peck, CP (corresponding author), Univ Florida, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	CalebPPeck@Yahoo.com					An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Ben-Porath Y. S., 2008, MINNESOTA MULTIPHASI; Boone K. B., 2007, ASSESSMENT FEIGNED C, P29; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher, 1989, MINNESOTA MULTIPHASI; Denney R. L., 1999, J FORENSIC NEUROPSYC, V1, P5; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Drane DL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P521, DOI 10.1007/978-0-387-76978-3_17; Frederick R.I., 1997, VALIDITY INDICATOR P; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green, 2004, GREENS MED SYMPTOM V; Green P., 2003, GREENS WORLD MEMORY; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hurwitz TA, 2004, CAN J PSYCHIAT, V49, P172, DOI 10.1177/070674370404900304; Johnson AL, 2010, CLIN NEUROPSYCHOL, V24, P220, DOI 10.1080/13854040903266902; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Locke DEC, 2010, EPILEPSY BEHAV, V17, P252, DOI 10.1016/j.yebeh.2009.12.004; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Psychological Corporation, 2009, ADV CLIN SOL WAIS 4; Rogers R, 2011, J PSYCHOPATHOL BEHAV, V33, P355, DOI 10.1007/s10862-011-9222-0; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073	36	13	13	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY 1	2013	27	4					693	707		10.1080/13854046.2013.779032			15	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	163TZ	WOS:000320361100235	23510271				2021-06-18	
J	Pierce, JE; Cotton, S; Perry, A				Pierce, John E.; Cotton, Susan; Perry, Alison			Alternating and sequential motion rates in older adults	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article							TRAUMATIC BRAIN-INJURY; TONGUE STRENGTH; READING RATES; SPEECH; DIADOCHOKINESIS; AGE; ARTICULATION; DISORDERS; SPEAKING	Background Alternating motion rate (AMR) and sequential motion rate (SMR) are tests of articulatory diadochokinesis that are widely used in the evaluation of motor speech. However, there are no quality normative data available for adults aged 65 years and older. Aims There were two aims: (1) to obtain a representative, normative dataset of diadochokinetic rates from adults aged 65 years and older; and (2) to examine the effects of age and gender on those rates. Methods & Procedures Seventy-six healthy adults (6586 years) were recruited; 45 females and 31 males. Participants were divided across two age groups (6574 and 7586 years) and audio-recorded while undertaking AMR (/pa/, /ta/ and /ka/) and SMR (/pataka/). The rate of the first nine syllables for each task was measured using acoustic analysis software, and age and gender effects were examined using a series of generalized linear models. The effect of age on rate variability between groups was also assessed. Outcomes & Results Normative data were obtained for both age groups and across gender. Age was not a significant factor for any task. Males had significantly higher AMR than females (/pa/ p = 0.001, /ta/ p = 0.001, /ka/ p = 0.010). No such gender difference was found for SMR. There was no significant difference in rate variability between the age groups. Conclusions & Implications Normative values for AMR and SMR in both genders and across two older age groups were acquired. Diadochokinetic rates outside such values cannot be attributed to normal ageing, so will merit further clinical investigation.	[Pierce, John E.] Peninsula Hlth, Frankston, Vic, Australia; [Cotton, Susan] Univ Melbourne, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Cotton, Susan] Univ Melbourne, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia; [Perry, Alison] Univ Limerick, Fac Educ & Hlth Sci, Dept Clin Therapies, Limerick, Ireland	Pierce, JE (corresponding author), Peninsula Hlth, Frankston, Vic, Australia.	pierce.john.e@gmail.com		Cotton, Sue/0000-0002-9386-8348; Pierce, John E./0000-0001-5164-5106			Amerman J. D., 1982, J NATL STUDENT SPEEC, V10, P55; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Boersma P., 2010, PRAAT DOING PHONETIC; Bubach A., 1993, LOGOP PHONIATR VOCO, V18, P131; Dash P, 2005, ALZHEIMERS DIS; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828, DOI 10.1044/jshr.2304.828; Gadesmann M, 2008, INT J LANG COMM DIS, V43, P41, DOI 10.1080/13682820701234444; Gress C., 1997, ASHA C BOST MA US; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; Kikutani T, 2009, GERODONTOLOGY, V26, P291, DOI 10.1111/j.1741-2358.2008.00258.x; Kikutani T, 2009, ODONTOLOGY, V97, P38, DOI 10.1007/s10266-008-0094-z; KREUL EJ, 1972, J SPEECH HEAR RES, V15, P72, DOI 10.1044/jshr.1501.72; Lass NJ., 1971, TODAYS SPEECH, V19, P49; Lundeen DJ, 1950, J SPEECH HEAR DISORD, V15, P54, DOI 10.1044/jshd.1501.54; Maslan J, 2011, J VOICE, V25, P709, DOI [10.1016/j.jvoice.2010.10.002, 10.1016/j.jvoicc.2010.10.002]; Maturo S. C., 2011, OTOLARYNGOLOGY HEAD, V145, pP112; Meurer EM, 2004, J VOICE, V18, P369, DOI 10.1016/j.jvoice.2003.02.001; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Neel AT, 2006, J MED SPEECH-LANG PA, V14, P273; Nishio M, 2006, FOLIA PHONIATR LOGO, V58, P114, DOI 10.1159/000089612; Ogar J, 2006, BRAIN LANG, V97, P343, DOI 10.1016/j.bandl.2006.01.008; Ozawa Y., 1996, B HIROSHIMA PREF COL, V2, P39; Padovani M, 2009, ARQ NEURO-PSIQUIAT, V67, P58, DOI 10.1590/S0004-282X2009000100015; PORTNOY RP, 1976, THESIS U MISSOURI CO; PTACEK PH, 1966, J SPEECH HEAR RES, V9, P353, DOI 10.1044/jshr.0903.353; RAMIG LA, 1983, J GERONTOL, V38, P223, DOI 10.1093/geronj/38.2.223; RAMIG LA, 1983, J COMMUN DISORD, V16, P217, DOI 10.1016/0021-9924(83)90035-7; SIGURD B, 1973, LANG SPEECH, V16, P373, DOI 10.1177/002383097301600408; Torre P, 2009, J COMMUN DISORD, V42, P324, DOI 10.1016/j.jcomdis.2009.03.001; Uhlenberg P., 2009, INT HDB POPULATION A, V1; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Wang YT, 2009, FOLIA PHONIATR LOGO, V61, P1, DOI 10.1159/000184539; Westbury JR, 1993, ANN B RES I LOGOPEDI, P13; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208	35	13	14	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822			INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAY-JUN	2013	48	3					257	264		10.1111/1460-6984.12001			8	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	139HF	WOS:000318572000002	23650883				2021-06-18	
J	Rizzo, JA; Burgess, P; Cartie, RJ; Prasad, BM				Rizzo, Julie A.; Burgess, Pamela; Cartie, Richard J.; Prasad, Balakrishna M.			Moderate systemic hypothermia decreases burn depth progression	BURNS			English	Article						Therapeutic hypothermia; Burn progression; Matrix metalloprotease; Inflammation; Microarray	THERAPEUTIC HYPOTHERMIA; THERMAL-INJURY; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; PROFOUND HYPOTHERMIA; CEREBRAL-ISCHEMIA; LETHAL HEMORRHAGE; MILD HYPOTHERMIA; UP-REGULATION; BRAIN-INJURY	Background: Therapeutic hypothermia has been proposed to be beneficial in an array of human pathologies including cardiac arrest, stroke, traumatic brain and spinal cord injury, and hemorrhagic shock. Burn depth progression is multifactorial but inflammation plays a large role. Because hypothermia is known to reduce inflammation, we hypothesized that moderate hypothermia will decrease burn depth progression. Methods: We used a second-degree 15% total body surface area thermal injury model in rats. Burn depth was assessed by histology of biopsy sections. Moderate hypothermia in the range of 31-33 degrees C was applied for 4 h immediately after burn and in a delayed fashion, starting 2 h after burn. In order to gain insight into the beneficial effects of hypothermia, we analyzed global gene expression in the burned skin. Results: Immediate hypothermia decreased burn depth progression at 6 h post injury, and this protective effect was sustained for at least 24 h. Burn depth was 18% lower in rats subjected to immediate hypothermia compared to control rats at both 6 and 24 h post injury. Rats in the delayed hypothermia group did not show any significant decrease in burn depth at 6 h, but had 23% lower burn depth than controls at 24 h. Increased expression of several skin-protective genes such as CCL4, CCL6 and CXCL13 and decreased expression of tissue remodeling genes such as matrix metalloprotease-9 were discovered in the skin biopsy samples of rats subjected to immediate hypothermia. Conclusions: Systemic hypothermia decreases burn depth progression in a rodent model and up-regulation of skin-protective genes and down-regulation of detrimental tissue remodeling genes by hypothermia may contribute to its beneficial effects. Published by Elsevier Ltd and ISBI	[Rizzo, Julie A.; Burgess, Pamela; Cartie, Richard J.; Prasad, Balakrishna M.] Dwight D Eisenhower Army Med Ctr, Ft Gordon, GA USA	Rizzo, JA (corresponding author), MCHF SCL GSS, Ft Gordon, GA 30905 USA.	julie.rizzo@us.army.mil; pamela.burgess@us.army.mil; rcartie@hotmail.com; balakrishna.prasad@us.army.mil					Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; BOYKIN JV, 1981, J SURG RES, V31, P111, DOI 10.1016/0022-4804(81)90038-X; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHOI MY, 1993, AM J PATHOL, V142, P519; COURTICE FC, 1946, J PHYSIOL-LONDON, V104, P321, DOI 10.1113/jphysiol.1946.sp004125; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; DEMLING RH, 1979, J TRAUMA, V19, P56, DOI 10.1097/00005373-197901000-00011; Hamann GF, 2004, STROKE, V35, P764, DOI 10.1161/01.STR.0000116866.60794.21; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Han YP, 2001, J CELL SCI, V114, P131; Iwasaki K, 1997, BRIT J DERMATOL, V137, P647, DOI 10.1111/j.1365-2133.1997.tb03805.x; Jackson DM, 1953, BRIT J SURG, V40, P388; Jonsson A, 1998, J BURN CARE REHABIL, V19, P50; Klein RD, 2000, J BURN CARE REHABIL, V21, P345, DOI 10.1097/00004630-200021040-00010; Kochanek PM, 2009, J NEUROTRAUM, V26, P417, DOI 10.1089/neu.2008.0612; Li Y, 2009, ARCH DERMATOL RES, V301, P205, DOI 10.1007/s00403-008-0881-y; Maier CM, 2001, J NEUROSURG, V94, P90, DOI 10.3171/jns.2001.94.1.0090; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; Morita-Fujimura Y, 2000, J CEREBR BLOOD F MET, V20, P130, DOI 10.1097/00004647-200001000-00017; Nisanci M, 2010, BURNS, V36, P397, DOI 10.1016/j.burns.2009.06.208; Oda J, 2009, J TRAUMA, V66, P1525, DOI 10.1097/TA.0b013e3181a51f35; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; PHAM TN, 2007, TOTAL BURN CARE, P119; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; POOL JL, 1958, J NEUROSURG, V15, P52, DOI 10.3171/jns.1958.15.1.0052; REGAS FC, 1992, J TRAUMA, V32, P557, DOI 10.1097/00005373-199205000-00004; Reiss MJ, 2009, WOUND REPAIR REGEN, V17, P418, DOI 10.1111/j.1524-475X.2009.00476.x; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; Roth N, 2011, ALLERGY, V66, P1477, DOI 10.1111/j.1398-9995.2011.02694.x; Sawada Y, 1997, BURNS, V23, P55, DOI 10.1016/S0305-4179(96)00080-0; Shupp JW, 2010, J BURN CARE RES, V31, P849, DOI 10.1097/BCR.0b013e3181f93571; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; Tang CH, 2008, CARCINOGENESIS, V29, P35, DOI 10.1093/carcin/bgm220; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; ULEVITCH RJ, 1990, J TRAUMA, V30, pS189; Weckroth M, 1996, J INVEST DERMATOL, V106, P1119, DOI 10.1111/1523-1747.ep12340167; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Yoshizaki T, 2009, CLIN EXP IMMUNOL, V157, P71, DOI 10.1111/j.1365-2249.2009.03945.x; YOUNG PK, 1994, J INVEST DERMATOL, V103, P660, DOI 10.1111/1523-1747.ep12398424	43	13	14	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179			BURNS	Burns	MAY	2013	39	3					436	444		10.1016/j.burns.2012.07.022			9	Critical Care Medicine; Dermatology; Surgery	General & Internal Medicine; Dermatology; Surgery	118KX	WOS:000317025500009	23149435				2021-06-18	
J	Tanriverdi, F; Suer, C; Yapislar, H; Kocyigit, I; Selcuklu, A; Unluhizarci, K; Casanueva, FF; Kelestimur, F				Tanriverdi, Fatih; Suer, Cem; Yapislar, Hande; Kocyigit, Ismail; Selcuklu, Ahmet; Unluhizarci, Kursad; Casanueva, Felipe F.; Kelestimur, Fahrettin			Growth hormone deficiency due to sports-related head trauma is associated with impaired cognitive performance in amateur boxers and kickboxers as revealed by P300 auditory event-related potentials	CLINICAL ENDOCRINOLOGY			English	Article							ANTERIOR-PITUITARY FUNCTION; QUALITY-OF-LIFE; BRAIN-INJURY; GH REPLACEMENT; MULTIPLE CONCUSSIONS; ALZHEIMERS-DISEASE; LATENCY; THERAPY; ADULTS; HYPOPITUITARISM	Objectives It has been recently reported that boxing and kickboxing may cause pituitary dysfunction, GH deficiency in particular. The strong link between poor cognitive performance and GH deficiency due to causes other than head trauma and the improvement of cognitive function after GH replacement therapy have been previously shown. P300 auditory event-related potential (ERP) measure is widely used to evaluate cognitive performance. In this study, we investigated the relation between the GH-IGF-I axis and cognitive performance in boxers and kickboxers. Design and patients Forty-one actively competing or retired male boxers (n: 27) and kickboxers (n: 14) with a mean age of 29 center dot 04 +/- 9 center dot 30year and 14age- and education-matched healthy male controls were included in the study. For neuropsychological tests, the mini-mental state examination (MMSE) and Quality of Life Assessment of GH Deficiency in Adults (QoL-AGHDA) questionnaires were administered. Moreover, cognitive performance was evaluated according to P300 ERPs. Results Nine of 41 (21 center dot 9%) athletes had GH deficiency. P300 amplitudes were lower at all electrode sites in the GH-deficient group than in controls, and the differences were statistically significant at Fz and Oz electrode sites (P<0 center dot 05). When GH-deficient athletes were compared with GH-sufficient athletes, the P300 amplitudes were lower at all electrode sites in the GH-deficient group; these differences were statistically significant at Fz, Pz and Cz electrode sites (P<0 center dot 05). In all athletes, there were significant negative correlations between IGF-I levels vs P300 latencies, and there were significant positive correlations between IGF-I levels vs P300 amplitudes (P<0 center dot 05). Conclusion This study provides the first electrophysiological evidence for the close relation between the P300 ERPs and the GH-IGF-I axis in boxers and kickboxers.	[Tanriverdi, Fatih; Unluhizarci, Kursad; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Suer, Cem; Yapislar, Hande] Erciyes Univ, Sch Med, Dept Physiol, TR-38039 Kayseri, Turkey; [Kocyigit, Ismail] Erciyes Univ, Sch Med, Dept Internal Med, TR-38039 Kayseri, Turkey; [Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Casanueva, Felipe F.] Univ Santiago de Compostela, Dept Med, Complejo Hosp Univ Santiago CHUS, Santiago De Compostela, Spain; [Casanueva, Felipe F.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain	Tanriverdi, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fatihtan@erciyes.edu.tr	Yapislar, Hande/X-1407-2018	Suer, Cem/0000-0002-6455-6644; KOCYIGIT, ISMAIL/0000-0002-6654-4727	Scientific and Technical Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [SBAG-3017]	This work was partially supported by the Scientific and Technical Research Council of Turkey (TUBITAK, project no. SBAG-3017).	Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Bennys K, 2007, J CLIN NEUROPHYSIOL, V24, P405, DOI 10.1097/WNP.0b013e31815068d5; Braverman ER, 2003, CLIN ELECTROENCEPHAL, V34, P124, DOI 10.1177/155005940303400306; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghigo E, 2000, J PEDIATR ENDOCR MET, V13, P1493; Golgeli A, 2004, EUR J ENDOCRINOL, V150, P153, DOI 10.1530/eje.0.1500153; Golgeli A, 1999, INT J NEUROSCI, V99, P69; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; HAN VKM, 1995, ACTA PAEDIATR, V84, P3, DOI 10.1111/j.1651-2227.1995.tb13850.x; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Lamberts SWJ, 1998, LANCET, V352, P127; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.1007/BF03350340, 10.3275/7045]; MCKENNA SP, 1994, PHARMACOECONOMICS, V6, P434, DOI 10.2165/00019053-199406050-00005; Naganuma Yoshihiro, 1993, No To Hattatsu, V25, P515; NESHIGE R, 1988, J NEUROL NEUROSUR PS, V51, P1120, DOI 10.1136/jnnp.51.9.1120; Oken Barry S., 1997, P529; ORTIZ AT, 2002, ACTAS ESP PSIQUIATRI, V30, P1; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Powell JW, 2001, J ATHL TRAINING, V36, P307; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tanriverdi Fatih, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P131, DOI 10.1586/14737167.6.2.131; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Walhovd KB, 2008, PSYCHOPHYSIOLOGY, V45, P545, DOI 10.1111/j.1469-8986.2008.00661.x; Wright MJ, 2001, BEHAV GENET, V31, P555, DOI 10.1023/A:1013393327704; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	44	13	13	1	27	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664			CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2013	78	5					730	737		10.1111/cen.12037			8	Endocrinology & Metabolism	Endocrinology & Metabolism	126KX	WOS:000317615300015	22994791				2021-06-18	
J	Tominaga, GT; Schaffer, KB; Dandan, IS; Kraus, JF				Tominaga, Gail T.; Schaffer, Kathryn B.; Dandan, Imad S.; Kraus, Jess F.			Epidemiological and clinical features of an older high-risk population of skateboarders	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Adults; Injury; Epidemiology; Skateboard	INJURIES; CHILDREN	Background: Skateboard injuries have been described in the media and scientific journals as a problem prevalent among children and adolescents. Skateboarding popularity has continued to grow since the 1970s with ridership increasing to include all age groups. Recently, surgeons at one trauma centre at an urban hospital noted an increase in the number of older skateboarders with life-threatening injuries. We hypothesise that the clinical and epidemiological features of skateboard-related injuries from one trauma centre (TC) will be different from injured skateboarders identified in the U. S. National Trauma Data Bank (NTDB). We also sought to identify factors related to poor outcomes in the TC and NTDB patient groups. Methods: Two injured skateboarder patient groups were identified and compared using proportional morbidity odds ratios (PMORs) and multivariable methods to estimate differences among factors common to both groups of patients. Clinical and demographic features were evaluated for hospital admitted patients injured whilst riding a skateboard. Chi-square tests, PMORs and logistic regression were used to determine outcome differences between patients in both groups. Results: Patients in the TC group were on average older, with higher Injury Severity Scores (ISS), more head injuries requiring neurosurgical intervention, longer ICU and hospital stays, and injured more frequently on local streets than patients in the NTDB series. Poor outcomes in the TC group were related to moderate or severe head injuries and presence of a head/face injury. For NTDB patients, a GCS of <13, a head/face injury and an ISS of 25+ were related to poor outcomes. Conclusions: From our Trauma Centre we describe an older injured skateboarding population, clinically and epidemiologically different from injured patients identified in the NTDB as well as those described in the literature. The greater severity of injury, including traumatic brain injury, has direct implications for preventive and educational measures and the planning of emergency surgical response. (C) 2012 Elsevier Ltd. All rights reserved.		Tominaga, GT (corresponding author), Scripps Mem Hosp La Jolla, 9888 Genesee Ave,LJ 601, La Jolla, CA 92037 USA.	Tominaga.gail@scrippshealth.org		SCHAFFER, KATHRYN/0000-0002-3550-1679	N. Paul Whittier Trauma Endowment Fund	This study was funded in part by the N. Paul Whittier Trauma Endowment Fund.	Adams I D, 1979, Nurs Times, V75, P707; ALLUM RL, 1978, INJURY, V10, P152; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; ATIENZA F, 1976, PEDIATRICS, V57, P793; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER SP, 1994, AM J PUBLIC HEALTH, V84, P649, DOI 10.2105/AJPH.84.4.649; Banas M P, 1992, J Orthop Trauma, V6, P301, DOI 10.1097/00005131-199209000-00006; CASS DT, 1990, MED J AUSTRALIA, V153, P140, DOI 10.5694/j.1326-5377.1990.tb136832.x; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; Christian M S, 1980, Br J Sports Med, V14, P102; Everett WW, 2002, J EMERG MED, V23, P269, DOI 10.1016/S0736-4679(02)00528-0; Forsman L, 2001, BRIT J SPORT MED, V35, P325, DOI 10.1136/bjsm.35.5.325; Fountain JL, 1996, SPORTS MED, V22, P360, DOI 10.2165/00007256-199622060-00004; FYFE IS, 1978, INJURY, V10, P149; Greenland S, 1998, MODERN EPIDEMIOLOGY, P214; HAWKINS RW, 1978, AM J DIS CHILD, V132, P751, DOI 10.1001/archpedi.1978.02120330023004; Homser DW, 1989, APPL LOGISTIC REGRES; ILLINGWORTH CM, 1978, CLIN PEDIATR, V17, P781, DOI 10.1177/000992287801701012; JACOBS RA, 1977, PEDIATRICS, V59, P939; KEMM I, 1978, BRIT MED J, V1, P894, DOI 10.1136/bmj.1.6117.894; KIRKPATRICK SML, 1980, CAN MED ASSOC J, V122, P159; Klein A, 2002, SAFETY GEAR SOME PRO, P73; Konkin DE, 2006, AM J SURG, V191, P615, DOI 10.1016/j.amjsurg.2006.02.012; Kyle SB, 2002, J TRAUMA, V53, P686, DOI 10.1097/00005373-200210000-00011; Little R, 2000, ENCY EPIDEMIOLOGIC M, P585; Lustenberger T, 2010, J TRAUMA, V69, P924, DOI 10.1097/TA.0b013e3181b9a05a; Maddox D, 1976, PHYSICIAN SPORTSMED, V4, P24; MAITRA AK, 1979, BRIT J CLIN PRACT, V33, P281; McGeehan J, 2004, PEDIATRICS, V114, P124, DOI 10.1542/peds.114.1.124; Osberg JS, 1998, ARCH PEDIAT ADOL MED, V152, P985; PENDERGRAST RA, 1990, J ADOLESCENT HEALTH, V11, P408, DOI 10.1016/0197-0070(90)90087-I; Rethnam Ulfin, 2008, BMC Res Notes, V1, P59, DOI 10.1186/1756-0500-1-59; RETSKY J, 1991, AM J DIS CHILD, V145, P188, DOI 10.1001/archpedi.1991.02160020080022; Rutherford G, 2004, HAZARD SCREENING REP; SCHIEBER RA, 1994, JAMA-J AM MED ASSOC, V271, P1856, DOI 10.1001/jama.271.23.1856; SCHUMAN SH, 1967, CLIN PEDIATR, V6, P252, DOI 10.1177/000992286700600421; SENTURIA YD, 1993, ACCIDENT ANAL PREV, V25, P473, DOI 10.1016/0001-4575(93)90077-A; SMITH RG, 1979, CAN MED ASSOC J, V121, P510; Sorensen L, 2001, J PAEDIT CHILD HLTH, V3, P567; WIDOME MD, 1989, PEDIATRICS, V83, P1070; WILSON DH, 1977, BRIT MED J, V2, P1349; Zalavras C, 2005, AM J SPORT MED, V33, P568, DOI 10.1177/0363546504269256	42	13	13	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2013	44	5					645	649		10.1016/j.injury.2012.01.022			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	122VE	WOS:000317345400014	22480946				2021-06-18	
J	Whitney, KA				Whitney, Kriscinda A.			Predicting Test of Memory Malingering and Medical Symptom Validity Test Failure within a Veterans Affairs Medical Center: Use of the Response Bias Scale and the HenryHeilbronner Index	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Malingering; symptom validity testing; Forensic neuropsychology; Head injury; Traumatic brain injury	HENRY-HEILBRONNER INDEX; FAKE-BAD-SCALE; PERSONAL-INJURY LITIGANTS; DISABILITY CLAIMANTS; COGNITIVELY INTACT; HIGH SPECIFICITY; MILITARY SAMPLE; NORMATIVE DATA; MMPI-2; TOMM	The ability of the Response Bias Scale (RBS) and the HenryHeilbronner Index (HHI), along with several other MMPI-2 validity scales, to predict performance on two separate stand-alone symptom validity tests, the Test of Memory Malingering (TOMM) and the Medical Symptom Validity Test (MSVT), was examined. Findings from this retrospective data analysis of outpatients seen within a Veterans Affairs medical center (N 194) showed that group differences between those passing and failing the TOMM were largest for the RBS (d 0.79), HHI (d 0.75), and Infrequency (F; d 0.72). The largest group differences for those passing versus failing the MSVT were greatest on the HHI (d 0.83), RBS (d 0.80), and F (d 0.78). Regression analyses showed that the RBS accounted for the most variance in TOMM scores (20), whereas the HHI accounted for the most variance in MSVT scores (26). Nonetheless, due to unacceptably low positive and negative predictive values, caution is warranted in using either one of these indices in isolation to predict performance invalidity.	[Whitney, Kriscinda A.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN USA; [Whitney, Kriscinda A.] Indiana Univ Sch Med, Indianapolis, IN USA	Whitney, KA (corresponding author), Richard L Roudebush Vet Affairs Med Ctr 116P, 1481 W 10th St, Indianapolis, IN 46202 USA.	kamarks@iupui.edu					Allen L., 1997, CARB97 MANUAL FOR TH; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Ben-Porath Y. S., 2008, MINNESOTA MULTIPHASI; Butcher, 1989, MINNESOTA MULTIPHASI; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Devilly G., 2004, EFFECT SIZE GENERATO; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Elhai JD, 2002, J PERS ASSESS, V79, P531, DOI 10.1207/S15327752JPA7903_08; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Graham J. R, 2005, MMPI 2 ASSESSING PER; Graham JR, 1990, MMPI 2 ASSESSING PER; Green P., 2003, GREENS WORD MEMORY T; Green P., 2008, MANUAL FOR THE NONVE; Green P., 2004, GREENS MEDICAL SYMPT; Green P., 1996, THE WORD MEMORY TEST; Green P., 1995, MANUAL FOR THE ORAL; Green P., 2009, THE ADVANCED INTERPR; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Hathaway S. R., 1951, THE MINNESOTA MULTIP; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kaemmer B, 2001, MMPI-2: Manual for Administration and Scoring; Lange RT, 2010, PSYCHIAT RES, V176, P229, DOI 10.1016/j.psychres.2009.03.004; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LIPSEY MW, 1990, DESIGN SENSITIVITY; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MCCAFFREY RJ, 2003, PRACTITIONERS GUIDE; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; SHAW DJ, 1965, J CLIN PSYCHOL, V21, P405, DOI 10.1002/1097-4679(196510)21:4<405::AID-JCLP2270210416>3.0.CO;2-I; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P160, DOI 10.1080/13854046.2011.647084; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T. N., 1996, TOMM TEST OF MEMORY; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tsushima WT, 2011, CLIN NEUROPSYCHOL, V25, P1403, DOI 10.1080/13854046.2011.613854; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P165, DOI 10.1093/arclin/acr013	58	13	13	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2013	28	3					222	235		10.1093/arclin/act012			14	Psychology, Clinical; Psychology	Psychology	138YK	WOS:000318547600003	23493404	Bronze			2021-06-18	
J	Barcelos, GK; Tholance, Y; Grousson, S; Renaud, B; Perret-Liaudet, A; Dailler, F; Zimmer, L				Barcelos, Gleicy K.; Tholance, Yannick; Grousson, Sebastien; Renaud, Bernard; Perret-Liaudet, Armand; Dailler, Frederic; Zimmer, Luc			Outcome of Poor-Grade Subarachnoid Hemorrhage as Determined by Biomarkers of Glucose Cerebral Metabolism	NEUROCRITICAL CARE			English	Article						Cerebral ischemia; Glucose metabolism; Hyperglycolysis; Neurologic outcome; Subarachnoid hemorrhage	HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; SPECIAL WRITING GROUP; VENOUS DIFFERENCES; STROKE-COUNCIL; HEAD-INJURY; LACTATE; OXYGEN; DYSFUNCTION; ISCHEMIA	The aim of this study was to determine if the measurement of blood biomarkers of glucose cerebral metabolism, performed with retrograde jugular catheter, could predict the outcome of poor-grade aneurysmal subarachnoid hemorrhage (aSAH) patients. This study was conducted in 68 poor-grade aSAH patients. A total of 4,024 blood samples obtained from jugular and radial catheters were analyzed for glucose, lactate, and oxygen content every 8 h for 10 +/- A 0.5 days. Metabolic ratio (MR) and lactate-oxygen index (LOI) were obtained by ratios using arterio-jugular differences. Functional outcome was evaluated at 12 months with the Glasgow Outcome Scale. Outcome was unfavorable in 40 patients. In this group of patients, the MR was significantly lower (p < 0.0001) and the LOI was significantly higher (p = 0.0001) than in the group with favorable outcome. The MR cutoff value, below which the patients are likely to have an unfavorable outcome, was determined to be 3.35. More interestingly, the data obtained in this study demonstrated that the patients achieving an unfavorable outcome were distinguished from those with a favorable outcome by having at least three events of MR inferior to 3.35 (sensitivity = 90 %, specificity = 82.1 %). Moreover, in patients who developed cerebral vasospasm, we observed a significant decrease in the MR. Our data provide additional support to the view that the MR is a reliable marker for predicting the outcome of poor-grade aSAH patients. Prospective studies are needed to confirm its value in multimodal monitoring.	[Barcelos, Gleicy K.; Perret-Liaudet, Armand; Zimmer, Luc] Univ Lyon 1, INSERM U1028, CNRS UMR 5292, BioRaN Team,Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Grousson, Sebastien; Dailler, Frederic] Hosp Civils Lyon, Neurol Hosp, Intens Care Unit, Lyon, France; [Barcelos, Gleicy K.] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland; [Barcelos, Gleicy K.; Tholance, Yannick; Renaud, Bernard; Perret-Liaudet, Armand] Hosp Civils Lyon, Neurol Hosp, Dept Biochem, Neurochem Unit, Lyon, France; [Tholance, Yannick] Univ Lyon 1, INSERM U1028, CNRS UMR 5292, WAKING Team,Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Renaud, Bernard] Lyon Neurosci Res Ctr, Lyon, France; [Zimmer, Luc] Hosp Civils Lyon, Neurol Hosp, CERMEP, Lyon, France; [Barcelos, Gleicy K.] Hop Univ Geneve, Dept APSI, CH-1211 Geneva 14, Switzerland	Barcelos, GK (corresponding author), Hop Univ Geneve, Dept APSI, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	gleicy.barcelos@hcuge.ch	ZIMMER, Luc/G-6538-2011; ZIMMER, Luc/AAG-1986-2019	ZIMMER, Luc/0000-0002-2805-7098; ZIMMER, Luc/0000-0002-2805-7098; tholance, yannick/0000-0002-1826-3031			Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Coppadoro A, 2011, MINERVA ANESTESIOL, V77, P74; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; CRUZ J, 1994, CRIT CARE MED, V22, P1465, DOI 10.1097/00003246-199409000-00018; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Erlichman JS, 2008, J NEUROSCI, V28, P4888, DOI 10.1523/JNEUROSCI.5430-07.2008; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gandhi GK, 2009, J NEUROCHEM, V111, P522, DOI 10.1111/j.1471-4159.2009.06333.x; Gibbs EL, 1942, J BIOL CHEM, V144, P325; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lieutaud T, 2007, HBK BEHAV NEUROSCI, V16, P659, DOI 10.1016/S1569-7339(06)16035-X; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Moritz S, 2008, J NEUROSURG ANESTH, V20, P8, DOI 10.1097/ANA.0b013e31814b1459; Naval NS, 2013, J CRIT CARE, V28, P182, DOI 10.1016/j.jcrc.2012.05.008; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oertel MF, 2007, J CLIN NEUROSCI, V14, P948, DOI 10.1016/j.jocn.2006.11.002; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Rabinstein Alejandro A, 2009, Neurocrit Care, V10, P414, DOI 10.1007/s12028-009-9218-8; Risselada R, 2010, EUR J EPIDEMIOL, V25, P261, DOI 10.1007/s10654-010-9432-x; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; Stuart RM, 2011, NEUROCRIT CARE, V15, P146, DOI 10.1007/s12028-009-9264-2; Taylor CJ, 2011, NEUROCRIT CARE, V14, P341, DOI 10.1007/s12028-010-9377-7; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2006, CURR OPIN CRIT CARE, V12, P119, DOI 10.1097/01.ccx.0000216577.57180.bd; Wartenberg KE, 2011, CURR OPIN CRIT CARE, V17, P85, DOI 10.1097/MCC.0b013e328342f83d; White H, 2002, CAN J ANAESTH, V49, P623, DOI 10.1007/BF03017393; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	41	13	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2013	18	2					234	244		10.1007/s12028-012-9810-1			11	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	105PR	WOS:000316084700011	23292767				2021-06-18	
J	Chen, X; Yin, J; Wu, XN; Li, R; Fang, JQ; Chen, R; Zhang, B; Zhang, WG				Chen, Xiao; Yin, Jun; Wu, Xiaoning; Li, Ran; Fang, Jingqin; Chen, Rong; Zhang, Bo; Zhang, Weiguo			Effects of magnetically labeled exogenous endothelial progenitor cells on cerebral blood perfusion and microvasculature alterations after traumatic brain injury in rat model	ACTA RADIOLOGICA			English	Article						Traumatic brain injury; endothelial progenitor cells; computed tomography perfusion imaging; microvascular density; superparamagnetic iron oxide	MARROW STROMAL CELLS; HEAD-INJURY; ANGIOGENESIS; GROWTH; NEUROGENESIS; INCREASES; MICE; CT	Background: Increasing evidence suggests that endothelial progenitor cells (EPCs), a subgroup of bone marrow hematopoietic stromal cells, play a critical role in neovascularization and tissue repair. Purpose: To explore the effect of exogenous EPCs on the cerebral blood perfusion and microvessels in the injured region in rat model with traumatic brain injury (TBI). Material and Methods: EPCs were collected from the spleens of healthy Sprague-Dawley rats. Fifty-four Sprague-Dawley rats were randomly divided into six groups. The controlled cortical impact TBI was performed. Spleen-derived exogenous EPCs labeled with super-paramagnetic iron oxide (SPIO) (SPIO-EPCs) were transplanted into the blood by tail vein of rats at 6 and 12 h after TBI, respectively. Magnetic resonance imaging (MRI) and computed tomography perfusion imaging were performed at various time points. Microvascular density was determined by immunohistochemistry. Results: In SPIO-EPCs group, patchlike hypointensities were detected in the injured region at 24 h after transplantation, and the range of hypointensities tended to expand gradually over time on MRI, which was confirmed by Prussian blue staining. Computed tomography perfusion imaging parameters were gradually developed from hyperperfusion to normal, while, microvascular density was gradually increased during 72 to 168 h after injury. The values of these indices in SPIO-EPCs group were significantly lower than those in SPIO-alone group at the same time point, but no significant differences were found in different time groups. Conclusion: The intravenously transplanted EPCs diminish the brain injury through restoring cerebral blood perfusion and increasing the cerebral microvasculature in the injured region in rat model with TBI.	[Chen, Xiao; Wu, Xiaoning; Li, Ran; Fang, Jingqin; Chen, Rong; Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China; [Yin, Jun] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Med Engn, Chongqing, Peoples R China; [Zhang, Bo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 4, Chongqing, Peoples R China; [Zhang, Bo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Zhang, WG (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China.	wguo.zhang@gmail.com			National Key Basic Research and Development Plan of ChinaNational Basic Research Program of China [2011CB964701]; Scientific Foundation of Third Military Medical University [2009XHG14]; Initiation Foundation for Returned Overseas Researchers by Ministry of Education [2010-1561]	This study was supported by the Grant of National Key Basic Research and Development Plan of China (2011CB964701), the Scientific Foundation of Third Military Medical University (2009XHG14), the Initiation Foundation for Returned Overseas Researchers by Ministry of Education (2010-1561).	Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; de Lussanet QG, 2005, RADIOLOGY, V235, P65, DOI 10.1148/radiol.2351040411; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Fang JQ, 2011, ACAD RADIOL, V18, P892, DOI 10.1016/j.acra.2011.02.017; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Jain R, 2008, AM J NEURORADIOL, V29, P694, DOI 10.3174/ajnr.A0899; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Wang SA, 2011, J NEURO-ONCOL, V105, P67, DOI 10.1007/s11060-011-0569-6; Wintermark M, 2008, J NEURORADIOLOGY, V35, P253, DOI 10.1016/j.neurad.2008.03.005; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046	28	13	14	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	APR	2013	54	3					313	323		10.1258/ar.2012.120605			11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	190EN	WOS:000322321900012	23528570				2021-06-18	
J	Shi, C; Flanagan, SR; Samadani, U				Shi, Chen; Flanagan, Steven R.; Samadani, Uzma			Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial	NEUROLOGICAL RESEARCH			English	Article						Clinical trial; Epilepsy; Minimally conscious state; Traumatic brain injury; Vagus nerve stimulation; Vegetative states	QUALITY-OF-LIFE; DELTA-FOSB IMMUNOREACTIVITY; DORSAL MOTOR NUCLEUS; BLOOD-FLOW CHANGES; LONG-TERM; REFRACTORY EPILEPSY; VAGAL-STIMULATION; VEGETATIVE STATE; HEAD-INJURY; BARRIER DISRUPTION	Objectives: Traumatic brain injury (TBI) has high morbidity and mortality in both civilian and military populations. Blast and other mechanisms of TBI damage the brain by causing neurons to disconnect and atrophy. Such traumatic axonal injury can lead to persistent vegetative and minimally conscious states (VS and MCS), for which limited treatment options exist, including physical, occupational, speech, and cognitive therapies. More than 60 000 patients have received vagus nerve stimulation (VNS) for epilepsy and depression. In addition to decreased seizure frequency and severity, patients report enhanced mood, reduced daytime sleepiness independent of seizure control, increased slow wave sleep, and improved cognition, memory, and quality of life. Early stimulation of the vagus nerve accelerates the rate and extent of behavioral and cognitive recovery after fluid percussion brain injury in rats. Methods: We recently obtained Food and Drug Administration (FDA) approval for a pilot prospective randomized crossover trial to demonstrate objective improvement in clinical outcome by placement of a vagus nerve stimulator in patients who are recovering from severe TBI. Our hypothesis is that stimulation of the vagus nerve results in increased cerebral blood flow and metabolism in the forebrain, thalamus, and reticular formation, which promotes arousal and improved consciousness, thereby improving outcome after TBI resulting in MCS or VS. Discussion: If this study demonstrates that VNS can safely and positively impact outcome, then a larger randomized prospective crossover trial will be proposed.	[Shi, Chen; Samadani, Uzma] NYU, Dept Neurosurg, Sch Med, New York, NY 10016 USA; [Shi, Chen; Flanagan, Steven R.; Samadani, Uzma] NYU Langone Med Ctr, New York, NY USA; [Flanagan, Steven R.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Samadani, Uzma] New York Harbor Healthcare Syst, Div Neurosurg, Dept Vet Affairs, New York, NY USA	Samadani, U (corresponding author), New York Harbor Healthcare Syst Manhattan Vet Hos, Div Neurosurg, 4168N,MC 112 423 East 23rd St, New York, NY 10010 USA.	uzma.samadani@med.nyu.edu		Flanagan, Steven/0000-0001-9005-5897	Department of Veterans Affairs, Veterans Health Administration Office of Research and Development Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1I01RX000319-01]; AOA Carolyn L. Kuckein Medical Student Summer Research Fellowship; Veterans AffairsUS Department of Veterans Affairs [I01RX000319] Funding Source: NIH RePORTER	This material is based on work supported by the Department of Veterans Affairs, Veterans Health Administration Office of Research and Development Rehabilitation Research and Development Service (1I01RX000319-01). CS was supported by the AOA Carolyn L. Kuckein Medical Student Summer Research Fellowship.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Ammori JB, 2008, SURGERY, V144, P159, DOI 10.1016/j.surg.2008.03.008; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; [Anonymous], 2002, PHYS MAN NEUR PROSTH; Ardesch JJ, 2007, SEIZURE-EUR J EPILEP, V16, P579, DOI 10.1016/j.seizure.2007.04.005; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bailey P, 1938, J NEUROPHYSIOL, V1, P405; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Benbadis SR, 2001, SEIZURE-EUR J EPILEP, V10, P512, DOI 10.1053/seiz.2001.0540; Benbadis SR, 2000, NEUROLOGY, V55, P1780, DOI 10.1212/WNL.55.12.1780; BENMENACHEM E, 1995, EPILEPSY RES, V20, P221, DOI 10.1016/0920-1211(94)00083-9; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bohning DE, 2001, INVEST RADIOL, V36, P470, DOI 10.1097/00004424-200108000-00006; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2011, CURR OPIN NEUROL, V24, P394, DOI 10.1097/WCO.0b013e328347da94; Borovikova LV, 2000, NATURE, V405, P458; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chae JH, 2003, J PSYCHIATR RES, V37, P443, DOI 10.1016/S0022-3956(03)00074-8; CHASE MICHAEL H., 1967, BRAIN RES, V5, P236, DOI 10.1016/0006-8993(67)90089-3; Clark KB, 1999, NAT NEUROSCI, V2, P94; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Conway CR, 2006, PSYCHIAT RES-NEUROIM, V146, P179, DOI 10.1016/j.pscychresns.2005.12.007; Cunningham JT, 2008, NEUROPSYCHOPHARMACOL, V33, P1884, DOI 10.1038/sj.npp.1301570; De Herdt V, 2009, J NEUROIMMUNOL, V214, P104, DOI 10.1016/j.jneuroim.2009.06.008; Dedeurwaerdere S, 2005, EPILEPSY RES, V67, P133, DOI 10.1016/j.eplepsyres.2005.09.008; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Dodrill CB, 2001, EPILEPSY BEHAV, V2, P46, DOI 10.1006/ebeh.2000.0148; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Furmaga H, 2012, J PHARMACOL EXP THER, V341, P317, DOI 10.1124/jpet.111.188953; Ghacibeh GA, 2006, COGN BEHAV NEUROL, V19, P119, DOI 10.1097/01.wnn.0000213908.34278.7d; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giorgi FS, 2008, NEUROBIOL DIS, V30, P388, DOI 10.1016/j.nbd.2008.02.008; Giorgi FS, 2004, NEUROSCI BIOBEHAV R, V28, P507, DOI 10.1016/j.neubiorev.2004.06.008; Goldfine AM, 2011, NEUROL CLIN, V29, P723, DOI 10.1016/j.ncl.2011.08.001; Gorny KR, 2010, J MAGN RESON IMAGING, V31, P475, DOI 10.1002/jmri.22037; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Grill MF, 2010, SEMIN PEDIATR NEUROL, V17, P54, DOI 10.1016/j.spen.2010.02.009; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Groves DA, 2005, NEUROSCI LETT, V379, P174, DOI 10.1016/j.neulet.2004.12.055; Hallbook T, 2005, EUR J PAEDIATR NEURO, V9, P399, DOI 10.1016/j.ejpn.2005.08.004; Hallbook T, 2005, SEIZURE-EUR J EPILEP, V14, P527, DOI 10.1016/j.seizure.2005.07.004; Hallbook T, 2005, SEIZURE-EUR J EPILEP, V14, P504, DOI 10.1016/j.seizure.2005.08.007; HAMMOND EJ, 1990, EPILEPSIA, V31, pS51, DOI 10.1111/j.1528-1157.1990.tb05850.x; Hassert DL, 2004, BEHAV NEUROSCI, V118, P79, DOI 10.1037/0735-7044.118.1.79; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Helmers SL, 2012, EUR J PAEDIATR NEURO, V16, P449, DOI 10.1016/j.ejpn.2012.01.001; Helmers SL, 2001, J CHILD NEUROL, V16, P843, DOI 10.1177/08830738010160111101; Henry TR, 2004, EPILEPSIA, V45, P1064, DOI 10.1111/j.0013-9580.2004.03104.x; Henry TR, 1998, EPILEPSIA, V39, P983, DOI 10.1111/j.1528-1157.1998.tb01448.x; Henry TR, 1999, NEUROLOGY, V52, P1166, DOI 10.1212/WNL.52.6.1166; Jaseja H, 2008, CLIN NEUROL NEUROSUR, V110, P755, DOI 10.1016/j.clineuro.2008.05.005; Jaseja H, 2010, MED HYPOTHESES, V74, P855, DOI 10.1016/j.mehy.2009.11.031; Klinkenberg S, 2012, CLIN NEUROL NEUROSUR, V114, P336, DOI 10.1016/j.clineuro.2011.11.016; Klinkenberg S, 2012, DEV MED CHILD NEUROL, V54, P855, DOI 10.1111/j.1469-8749.2012.04305.x; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P434, DOI 10.1097/00004691-200109000-00008; Kosel M, 2011, PSYCHIAT RES-NEUROIM, V191, P153, DOI 10.1016/j.pscychresns.2010.11.004; Krahl SE, 2001, EPILEPSIA, V42, P586, DOI 10.1046/j.1528-1157.2001.09700.x; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Kuba R, 2002, EPILEPSIA, V43, P1181, DOI 10.1046/j.1528-1157.2002.08202.x; Kuba R, 2010, SEIZURE-EUR J EPILEP, V19, P352, DOI 10.1016/j.seizure.2010.05.009; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; LOCKARD JS, 1990, EPILEPSIA, V31, pS20, DOI 10.1111/j.1528-1157.1990.tb05844.x; Lomarev M, 2002, J PSYCHIATR RES, V36, P219, DOI 10.1016/S0022-3956(02)00013-4; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Majoie HJM, 2011, NEUROIMMUNOMODULAT, V18, P52, DOI 10.1159/000315530; Malow BA, 2000, NEUROLOGY, V55, P1450, DOI 10.1212/WNL.55.10.1450; Malow BA, 2001, NEUROLOGY, V57, P879, DOI 10.1212/WNL.57.5.879; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; Marrosu F, 2003, EPILEPSY RES, V55, P59, DOI 10.1016/S0920-1211(03)00107-4; Marzec M, 2003, EPILEPSIA, V44, P930, DOI 10.1046/j.1528-1157.2003.56202.x; Merrill CA, 2006, J CLIN PSYCHIAT, V67, P1171, DOI 10.4088/JCP.v67n0801; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mu QW, 2004, BIOL PSYCHIAT, V55, P816, DOI 10.1016/j.biopsych.2003.12.004; Narayanan JT, 2002, EPILEPSIA, V43, P1509, DOI 10.1046/j.1528-1157.2002.16102.x; NARITOKU DK, 1995, EPILEPSY RES, V22, P53, DOI 10.1016/0920-1211(95)00035-9; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Nichols JA, 2011, NEUROSCIENCE, V189, P207, DOI 10.1016/j.neuroscience.2011.05.024; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patel NC, 2004, PEDIATR INFECT DIS J, V23, P681, DOI 10.1097/01.inf.0000131632.25375.c7; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; PENRY JK, 1990, EPILEPSIA, V31, pS40, DOI 10.1111/j.1528-1157.1990.tb05848.x; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; RANDALL WC, 1985, AM J PHYSIOL, V249, pH133; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; REID SA, 1990, EPILEPSIA, V31, pS38, DOI 10.1111/j.1528-1157.1990.tb05847.x; Revesz D, 2008, EXP NEUROL, V214, P259, DOI 10.1016/j.expneurol.2008.08.012; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Roosevelt RW, 2006, BRAIN RES, V1119, P124, DOI 10.1016/j.brainres.2006.08.048; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ruffoli R, 2011, J CHEM NEUROANAT, V42, P288, DOI 10.1016/j.jchemneu.2010.12.002; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Santiago-Rodriguez E, 2006, SEIZURE-EUR J EPILEP, V15, P615, DOI 10.1016/j.seizure.2006.09.006; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2007, CURR OPIN NEUROL, V20, P638, DOI 10.1097/WCO.0b013e3282f1c6e4; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shaw GY, 2006, ANN OTO RHINOL LARYN, V115, P260, DOI 10.1177/000348940611500403; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Sirven JI, 2000, NEUROLOGY, V54, P1179, DOI 10.1212/WNL.54.5.1179; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Spanaki MV, 2004, SEIZURE-EUR J EPILEP, V13, P587, DOI 10.1016/j.seizure.2004.01.009; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sucholeiki R, 2002, SEIZURE-EUR J EPILEP, V11, P157, DOI 10.1053/seiz.2001.0601; Tatum WO, 2004, EPILEPSY BEHAV, V5, P411, DOI 10.1016/j.yebeh.2004.02.009; Tatum WO, 1999, NEUROLOGY, V52, P1267, DOI 10.1212/WNL.52.6.1267; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; UTHMAN BM, 1990, EPILEPSIA, V31, pS44, DOI 10.1111/j.1528-1157.1990.tb05849.x; Uthman BM, 2004, NEUROLOGY, V63, P1124, DOI 10.1212/01.WNL.0000138499.87068.C0; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Van Laere K, 2002, J NUCL MED, V43, P733; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2012, NEUROPHARMACOLOGY; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vonck K, 2001, J CLIN NEUROPHYSIOL, V18, P394, DOI 10.1097/00004691-200109000-00002; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HY, 2009, J NEUROL SCI, V284, P96, DOI 10.1016/j.jns.2009.04.012; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; WOODBURY JW, 1991, PACE, V14, P94, DOI 10.1111/j.1540-8159.1991.tb04053.x; Xiong J, 2009, MED HYPOTHESES, V73, P938, DOI 10.1016/j.mehy.2009.06.033; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; ZABARA J, 1988, PHARMACOL TOXICOL, V63, P70, DOI 10.1111/j.1600-0773.1988.tb00913.x; Zamponi N, 2011, EUR J PAEDIATR NEURO, V15, P8, DOI 10.1016/j.ejpn.2010.09.003; Zhang WZ, 2004, J PHYSIOL-LONDON, V559, P729, DOI 10.1113/jphysiol.2004.064121	169	13	19	1	29	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					263	276		10.1179/1743132813Y.0000000167			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	104QW	WOS:000316010700007	23485054	Green Accepted			2021-06-18	
J	Casoli, T; Balietti, M; Giorgetti, B; Solazzi, M; Scarpino, O; Fattoretti, P				Casoli, Tiziana; Balietti, Marta; Giorgetti, Belinda; Solazzi, Moreno; Scarpino, Osvaldo; Fattoretti, Patrizia			Platelets in Alzheimer's Disease-Associated Cellular Senescence and Inflammation	CURRENT PHARMACEUTICAL DESIGN			English	Article						Alzheimer's disease; platelets; inflammation; senescence; amyloid; therapeutic targets; aging	BETA-AMYLOID PEPTIDE; LYMPHOCYTE SUBSET PATTERNS; TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; A-BETA; SUBVENTRICULAR ZONE; ENDOTHELIAL-CELLS; TELOMERES SHORTEN; T-LYMPHOCYTES; FREE-RADICALS	Alzheimer's disease (AD) is a complex degenerative disorder of the brain, associated with a progressive cognitive decline. Age is the main risk factor with almost half of the population above 90 years affected by this pathology. AD and brain aging share common molecular changes, so it has been hypothesized that AD could be a form of accelerated brain aging. In this context, senescence-associated mechanisms could be a valuable target of investigation both to analyze the causes of this disease and to define therapeutic strategies. Senescent phenotypes of glia and neurons, as well as of peripheral cells, have been described in AD. Much evidence indicate that vascular impairment is a fundamental contributor to AD pathology and platelets are generally considered a key element because they represent the link between amyloid-beta (A beta) deposition, peripheral inflammation and endothelial senescence. Both activated and senescent platelets are a source of A beta, in addition activated platelets secrete many proinflammatory mediators that could contribute to increased peripheral inflammation and endothelial senescence. Treatments aimed to target peripheral endothelial senescence include antioxidants and some substances, such as aspirin, that modulate platelet aggregation and inflammatory response. Heparin has been proposed as a treatment for senile dementia and exhibits anti-inflammatory action as well as inhibitory effects on A beta assembly. Identifying peripheral targets for AD treatments could also result advantageous as it would be possible to monitor directly their efficacy. Nevertheless more research is needed to clarify all the different aspects and interactions of blood cells, vascular cells and their secretory products.	[Casoli, Tiziana; Balietti, Marta; Giorgetti, Belinda; Solazzi, Moreno; Fattoretti, Patrizia] INRCA Ancona, Neurobiol Aging Ctr, I-60121 Ancona, Italy; [Balietti, Marta; Solazzi, Moreno; Fattoretti, Patrizia] INRCA Ancona, Cellular Bioenerget Lab, Sci Technol Area, I-60121 Ancona, Italy; [Scarpino, Osvaldo] INRCA Ancona, Geriatr Hosp, Neurol Unit, I-60127 Ancona, Italy	Casoli, T (corresponding author), INRCA Sci Technol Area, Neurobiol Aging Ctr, Via Birarelli 8, I-60121 Ancona, Italy.	t.casoli@inrca.it	Balietti, Marta/AAD-9098-2020; Casoli, Tiziana/AAC-2787-2019	Balietti, Marta/0000-0002-3123-7903; Fattoretti, Patrizia/0000-0003-1998-0080; Casoli, Tiziana/0000-0002-0512-2934	Italian Ministry of HealthMinistry of Health, Italy [RF-INR-2006-346774]	The present study was supported by Italian Ministry of Health, grant RF-INR-2006-346774.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; ADIBZADEH M, 1995, MECH AGEING DEV, V83, P171, DOI 10.1016/0047-6374(95)01625-A; Afanas'ev I, 2009, FRONT BIOSCI-LANDMRK, V14, P3899, DOI 10.2735/3499; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Allain H, 2003, FUND CLIN PHARMACOL, V17, P419, DOI 10.1046/j.1472-8206.2003.00153.x; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bergamaschini L, 2002, NEUROBIOL AGING, V23, P531, DOI 10.1016/S0197-4580(02)00003-9; Bermejo P, 2008, IMMUNOL LETT, V117, P198, DOI 10.1016/j.imlet.2008.02.002; BERRY IJ, 1994, MOL CARCINOGEN, V9, P134, DOI 10.1002/mc.2940090305; BERTONIFREDDARI C, 1990, BRAIN RES, V517, P69, DOI 10.1016/0006-8993(90)91009-6; BERTONIFREDDARI C, 1993, BRAIN RES, V628, P193, DOI 10.1016/0006-8993(93)90955-M; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Blasko I, 1999, FASEB J, V13, P63; Bode-Boger SM, 2005, BIOCHEM BIOPH RES CO, V334, P1226, DOI 10.1016/j.bbrc.2005.07.014; Borenstein, 2004, NEUROEPIDEMIOLOGY PR; Brodsky SV, 2004, CIRC RES, V94, P377, DOI 10.1161/01.RES.0000111802.09964.EF; Buoso E, 2010, PHARMACOL RES, V62, P308, DOI 10.1016/j.phrs.2010.05.002; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Casadesus G, 2004, CNS NEUROL DISORD-DR, V3, P281, DOI 10.2174/1568007043337265; Casoli T, 2008, MECH AGEING DEV, V129, P154, DOI 10.1016/j.mad.2007.11.004; Casoli T, 2010, BIOGERONTOLOGY, V11, P627, DOI 10.1007/s10522-010-9281-8; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617; de Magalhaes JP, 2004, EXP GERONTOL, V39, P1379, DOI 10.1016/j.exger.2004.06.004; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; EFFROS RB, 1994, J GERONTOL, V49, pB65, DOI 10.1093/geronj/49.2.B65; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Esmon CT, 2002, J EXP MED, V196, P561, DOI 10.1084/jem.20021088; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fernandez M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-87; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894; Flanary BE, 2004, GLIA, V45, P75, DOI 10.1002/glia.10301; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Galluzzi L, 2008, CURR MOL MED, V8, P78; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772; Giulian D, 1996, J NEUROSCI, V16, P6021; Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Halliday G, 2000, CLIN EXP PHARMACOL P, V27, P1, DOI 10.1046/j.1440-1681.2000.03200.x; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hartley PS, 2007, CLIN LAB, V53, P157; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Helmbold H, 2006, ONCOGENE, V25, P5257, DOI 10.1038/sj.onc.1209613; Herholz K, 2003, ANN NUCL MED, V17, P79, DOI 10.1007/BF02988444; Hochstrasser T, 2012, EXP GERONTOL, V47, P160, DOI 10.1016/j.exger.2011.11.012; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huguenin S, 2004, PROSTATE, V61, P132, DOI 10.1002/pros.20081; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075; Kokjohn TA, 2011, BBA-MOL BASIS DIS, V1812, P1508, DOI 10.1016/j.bbadis.2011.07.004; KOROTZER AR, 1993, BRAIN RES, V624, P121, DOI 10.1016/0006-8993(93)90068-X; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; LANDFIELD PW, 1981, NEUROBIOL AGING, V2, P265, DOI 10.1016/0197-4580(81)90034-8; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li QX, 1998, LAB INVEST, V78, P461; Liu JP, 1999, FASEB J, V13, P2091; Lo D, 2011, EXPERT REV NEUROTHER, V11, P1359, DOI [10.1586/ERN.11.132, 10.1586/ern.11.132]; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Ma Q, 2007, CURR PHARM DESIGN, V13, P1607, DOI 10.2174/138161207780765918; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Matsushima H, 1995, ALZ DIS ASSOC DIS, V9, P213; McDonald DR, 1997, J NEUROSCI, V17, P2284; McGinn MJ, 2012, J NEUROSCI RES, V90, P1159, DOI 10.1002/jnr.23012; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2004, CURR VASC PHARMACOL, V2, P141, DOI 10.2174/1570161043476393; Moller P, 2010, FREE RADICAL BIO MED, V48, P1275, DOI 10.1016/j.freeradbiomed.2010.02.003; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Padovani A, 2001, MECH AGEING DEV, V122, P1997, DOI 10.1016/S0047-6374(01)00315-3; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Pera MF, 2000, J CELL SCI, V113, P5; Pereira J, 2002, THROMB HAEMOSTASIS, V87, P905; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; PERLMUTTER LS, 1994, MOL NEUROBIOL, V9, P33, DOI 10.1007/BF02816103; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PILETZ JE, 1991, NEUROBIOL AGING, V12, P401, DOI 10.1016/0197-4580(91)90064-Q; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Poon HF, 2004, CLIN GERIATR MED, V20, P329, DOI 10.1016/j.cger.2004.02.005; Porchet R, 2003, PROTEOMICS, V3, P1476, DOI 10.1002/pmic.200300456; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Rand ML, 2004, J THROMB HAEMOST, V2, P651, DOI 10.1111/j.1538-7836.2004.00670.x; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sevush S, 1998, ARCH NEUROL-CHICAGO, V55, P530, DOI 10.1001/archneur.55.4.530; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Song DK, 2001, J NEUROCHEM, V76, P1326, DOI 10.1046/j.1471-4159.2001.00121.x; Sortino MA, 2004, NEUROPHARMACOLOGY, V47, P1198, DOI 10.1016/j.neuropharm.2004.08.011; Speciale L, 2007, NEUROBIOL AGING, V28, P1163, DOI 10.1016/j.neurobiolaging.2006.05.020; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; STURROCK RR, 1987, J HIRNFORSCH, V28, P505; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Ueberham U, 2005, CNS NEUROL DISORD-DR, V4, P293, DOI 10.2174/1568007054038175; van Heemst D, 2007, EUR J CANCER, V43, P2144, DOI 10.1016/j.ejca.2007.07.011; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; VANNOSTRAND WE, 1991, ANN NY ACAD SCI, V640, P140; Vaziri H, 1999, ONCOGENE, V18, P7676, DOI 10.1038/sj.onc.1203016; Wang BB, 2008, J NEUROL SCI, V268, P172, DOI 10.1016/j.jns.2007.12.006; Webber KM, 2006, CURR PHARM DESIGN, V12, P691, DOI 10.2174/138161206775474305; Webber KM, 2005, MECH AGEING DEV, V126, P1019, DOI 10.1016/j.mad.2005.03.024; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1; WISNIEWSKI HM, 1994, ACTA NEUROPATHOL, V87, P233; Wisniewski HM, 2000, ANN NY ACAD SCI, V903, P6, DOI 10.1111/j.1749-6632.2000.tb06344.x; WOJCICKI J, 1991, ATHEROSCLEROSIS, V87, P9, DOI 10.1016/0021-9150(91)90227-T; Wolozin B, 2006, NEUROL RES, V28, P630, DOI 10.1179/016164106X130515; Woo DH, 2004, LIFE SCI, V75, P2439, DOI 10.1016/j.lfs.2004.04.042; Xue SR, 2009, CHINESE MED J-PEKING, V122, P1469, DOI 10.3760/cma.j.issn.0366-6999.2009.12.022; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yew DT, 1999, EXP GERONTOL, V34, P117, DOI 10.1016/S0531-5565(98)00017-5; Yi TN, 2009, CHINESE MED J-PEKING, V122, P3055, DOI 10.3760/cma.j.issn.0366-6999.2009.24.027; Young NT, 2002, TRENDS IMMUNOL, V23, P71, DOI 10.1016/S1471-4906(01)02113-5; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang ZH, 2004, WORLD J GASTROENTERO, V10, P2954; Zhu XW, 2000, NEUROBIOL AGING, V21, P807, DOI 10.1016/S0197-4580(00)00217-7	167	13	15	0	19	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design	MAR	2013	19	9					1727	1738					12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	110OF	WOS:000316453200020	23061730				2021-06-18	
J	Li, W; Liu, HD; You, WC; Zhou, ML; Ling, HP; Shen, W; Zhu, L; Hang, CH				Li, Wei; Liu, Huan-Dong; You, Wan-Chun; Zhou, Meng-Liang; Ling, Hai-Ping; Shen, Wei; Zhu, Lin; Hang, Chun-Hua			Enhanced cortical expression of myeloid differentiation primary response protein 88 (Myd88) in patients with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Myd88; TBI; Human; Inflammatory response; NF-kappa B	FACTOR-KAPPA-B; SIGNALING PATHWAY; CEREBRAL-CORTEX; CONTUSION; RATS; INVOLVEMENT; ACTIVATION; REPERFUSION; CYTOKINES; ISCHEMIA	Background: Inflammatory response has been proven to play a crucial role in the pathophysilogical process after traumatic brain injury (TBI). Myeloid differentiation primary response protein 88 (Myd88) is considered as a vital factor for inflammation and immunity. Therefore, it is essential to know the detailed expression of Myd88 after TBI. However, the expression patterns of Myd88 in patients with TBI remain obscure. Hence, the aim of present study was to investigate the cortical expression of Myd88 in human contused brain. Methods: Nineteen contused brain tissue biopsies were obtained from 19 patients undergoing surgery for brain contusions 3 h-17 d after trauma, and samples of control group were from three patients in the pathway during surgical removal of deep benign tumors. The expression of Myd88 was assessed by quantitative real-time polymerase chain reaction, Western blotting, immunohistochemistry and double immunofluorescent staining, and the messenger RNA (mRNA) levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin 1beta (IL-1 beta) were measured by quantitative real-time polymerase chain reaction. Results: The progressively elevated mRNA and protein levels of Myd88 were detected after trauma, with the maximum after 72 h post-injury, and the distribution of Myd88 was found in neurons, astrocytes, and microglia. TNF-alpha and IL-1 beta mRNA levels ascended significantly within 12 h, and then descended gradually until after 72 h post-injury. Interestingly, there was a positive relationship between the expression of Myd88 and the proinflammatory cytokine TNF-alpha. Conclusions: These findings indicated that Myd88 might play an important role in the inflammatory response after human TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Li, Wei; You, Wan-Chun; Zhou, Meng-Liang; Zhu, Lin; Hang, Chun-Hua] Jinling Hosp, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Liu, Huan-Dong; Zhou, Meng-Liang; Ling, Hai-Ping; Shen, Wei; Zhu, Lin; Hang, Chun-Hua] So Med Univ Guangzhou, Dept Neurosurg, Sch Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China	Hang, CH (corresponding author), Jinling Hosp, Dept Neurosurg, Jinling Hosp, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170, 8100053, 81271377]; Nature Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	The authors acknowledge support for this study by grants from National Natural Science Foundation, China (no. 81171170 to C.-H. H., no. 8100053 to M.-L. Z., and no. 81271377 to L. Z.) and Nature Science Foundation of Jiangsu Province, China (BK2010459).	Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Gao Y, 2009, BIOMED PHARMACOTHER, V63, P442, DOI 10.1016/j.biopha.2008.06.028; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hua F, 2009, BIOCHEM BIOPH RES CO, V390, P678, DOI 10.1016/j.bbrc.2009.10.027; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li W, 2012, NEUROL SCI; Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Sette Claudio, 2007, J Leukoc Biol, V82, P811; Victoni T, 2010, MED MICROBIOL IMMUN, V199, P35, DOI 10.1007/s00430-009-0134-5; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	25	13	15	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2013	180	1					133	139		10.1016/j.jss.2012.10.928			7	Surgery	Surgery	089LQ	WOS:000314912400028	23186691				2021-06-18	
J	Zou, XT; Wu, N; Tian, Y; Zhang, Y; Fitek, J; Maffeo, M; Niezrecki, C; Chen, J; Wang, XW				Zou, Xiaotian; Wu, Nan; Tian, Ye; Zhang, Yang; Fitek, John; Maffeo, Michael; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			Ultrafast Fabry-Perot fiber-optic pressure sensors for multimedia blast event measurements	APPLIED OPTICS			English	Article							SHOCK-WAVE	A shock wave (SW) is characterized as a large pressure fluctuation that typically lasts only a few milliseconds. On the battlefield, SWs pose a serious threat to soldiers who are exposed to explosions, which may lead to blast-induced traumatic brain injuries. SWs can also be used beneficially and have been applied to a variety of medical treatments due to their unique interaction with tissues and cells. Consequently, it is important to have sensors that can quantify SW dynamics in order to better understand the physical interaction between body tissue and the incident acoustic wave. In this paper, the ultrafast fiber-optic sensor based on the Fabry-Perot interferometric principle was designed and four such sensors were fabricated to quantify a blast event within different media, simultaneously. The compact design of the fiber-optic sensor allows for a high degree of spatial resolution when capturing the wavefront of the traveling SW. Several blast event experiments were conducted within different media (e. g., air, rubber membrane, and water) to evaluate the sensor's performance. This research revealed valuable knowledge for further study of SW behavior and SW-related applications. (C) 2013 Optical Society of America	[Zou, Xiaotian; Wang, Xingwei] Univ Massachusetts Lowell, Dept Biomed Engn & Biotechnol, Lowell, MA 01854 USA; [Wu, Nan; Tian, Ye; Zhang, Yang; Wang, Xingwei] Univ Massachusetts Lowell, Dept Elect & Comp Engn, Lowell, MA 01854 USA; [Fitek, John; Maffeo, Michael] USA, Natick Soldier Res Dev & Engn Ctr, Natick, MA 01760 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts Lowell, Dept Mech Engn, Lowell, MA 01854 USA	Wang, XW (corresponding author), Univ Massachusetts Lowell, Dept Biomed Engn & Biotechnol, 1 Univ Ave, Lowell, MA 01854 USA.	xingwei_wang@uml.edu	Zou, Xiaotian/J-8657-2013; Tian, Ye/A-1090-2014	Tian, Ye/0000-0002-0785-1145	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Natick Soldier Research, Development and Engineering Center for sharing the shock tube and the reference pressure sensors. The authors also appreciate the Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Award Number W911NF-07-2-0081).	CHAUSSY C, 1980, LANCET, V2, P1265; Delius M., 1994, Shock Waves, V4, P55, DOI 10.1007/BF01418569; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eaton WP, 1997, SMART MATER STRUCT, V6, P530, DOI 10.1088/0964-1726/6/5/004; Ikeda K, 1999, J TRAUMA, V47, P946, DOI 10.1097/00005373-199911000-00024; Liang SM, 2009, J MECH, V25, P313, DOI 10.1017/S172771910000277X; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; MERZKIRCH W, 1974, APPL PHYS, V4, P363, DOI 10.1007/BF00928393; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; RIDAH S, 1988, J APPL PHYS, V64, P152, DOI 10.1063/1.341448; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wu N, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/5/055102; Wu N, 2011, OPT EXPRESS, V19, P10797, DOI 10.1364/OE.19.010797; Zou X., 2011, P SOC PHOTO-OPT INS, V8028; Zou XT, 2013, OPT LASER ENG, V51, P134, DOI 10.1016/j.optlaseng.2012.09.001; Zou XT, 2012, MEASUREMENT, V45, P1077, DOI 10.1016/j.measurement.2012.01.034	20	13	14	1	38	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 20	2013	52	6					1248	1254		10.1364/AO.52.001248			7	Optics	Optics	094TM	WOS:000315286700018	23434996				2021-06-18	
J	Hawkins, BE; Cowart, JC; Parsley, MA; Capra, BA; Eidson, KA; Hellmich, HL; DeWitt, DS; Prough, DS				Hawkins, Bridget E.; Cowart, Jeremy C.; Parsley, Margaret A.; Capra, Bridget A.; Eidson, Kristine A.; Hellmich, Helen L.; DeWitt, Douglas S.; Prough, Donald S.			Effects of trauma, hemorrhage and resuscitation in aged rats	BRAIN RESEARCH			English	Article						Age; Cerebral blood flow; Hemorrhage; Neuron cell death; Traumatic brain injury; Fluid percussion injury	CEREBRAL-BLOOD-FLOW; PERCUSSION BRAIN-INJURY; HEAD-INJURY; AUTO-REGULATION; CEREBROVASCULAR RESPONSES; FLUORO-JADE; ISCHEMIA; HYPOTENSION; HYPERTENSION; PRESSURE	Traumatic brain injury (TBI) is a leading cause of death in the elderly and the incidence of mortality and morbidity increases with age. This study tested the hypothesis that, after TBI followed by hemorrhagic hypotension (HH) and resuscitation, cerebral blood flow (CBF) would decrease more in aged compared with young rats. Young adult (4-6 months) and aged (20-24 months) male Sprague-Dawley rats were anesthetized with isoflurane, prepared for parasagittal fluid percussion injury (FPI) and randomly assigned to receive either moderate FPI (2.0 atm) only, moderate FPI+severe HH (40 mm Hg for 45 min) followed by return of shed blood, or sham FPI. Intracranial pressure (ICP), CBF, and mean arterial pressure (MAP) were measured and, after twenty-four hours survival, the rats were euthanized and their brains were sectioned and stained with Fluoro-Jade (FJ), a dye that stains injured neurons. After moderate FPI, severe HH and reinfusion of shed blood, MAP and CBF were significantly reduced in the aged group, compared to the young group. Both FPI and FPI+HH groups significantly increased the numbers of FJ-positive neurons in hippocampal cell layers CA1, CA2 and CA3 (p<0.05 vs Sham) in young and aged rats. Despite differences in post-resuscitation MAP and CBF, there were no differences in the numbers of FJ-positive neurons in aged compared to young rats after FPI, HH and blood resuscitation. Although cerebral hypoperfusion in the aged rats was not associated with increased hippocampal cell injury, the trauma-induced reductions in CBF and post-resuscitation blood pressure may have resulted in damage to brain regions that were not examined or neurological or behavioral impairments that were not assessed in this study. Therefore, the maintenance of normal blood pressure and cerebral perfusion would be advisable in the treatment of elderly patients after TBI. (c) 2013 Elsevier B.V. All rights reserved.	[Hawkins, Bridget E.; Cowart, Jeremy C.; Parsley, Margaret A.; Capra, Bridget A.; Eidson, Kristine A.; Hellmich, Helen L.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA	Hawkins, BE (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	behawkin@utmb.edu; jccowart@live.com; maparsle@utmb.edu; bacapra@utmb.edu; kristyeidson@yahoo.com; hhellmic@utmb.edu; ddewitt@utmb.edu; dsprough@utmb.edu	Hawkins, Bridget/H-4933-2015; Prough, Donald S/G-5793-2013	Hawkins, Bridget/0000-0002-1887-3657; Prough, Donald S/0000-0001-7994-532X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS19355]; UTMB Sealy Center on Aging; Moody Center for Traumatic Brain and Spinal Cord Injury Research/Mission Connect; NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [5T32ES007254-17]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER	This study was supported in part by grants from the National Institutes of Health (NS19355 to DSD), UTMB Sealy Center on Aging (DSP) and Moody Center for Traumatic Brain and Spinal Cord Injury Research/Mission Connect (to DSD). Bridget E. Hawkins' work was supported by a predoctoral fellowship under NIEHS Grant no. 5T32ES007254-17 ("Molecular Mechanisms for Environmental Injury," Dr. Mary Moslen, PI). We thank Tatsuo Uchida for his help performing the post-hoc power analysis.	Armstead WM, 2002, J NEUROTRAUM, V19, P1193, DOI 10.1089/08977150260337994; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Castillo-Ruiz MM, 2007, EXP GERONTOL, V42, P343, DOI 10.1016/j.exger.2006.10.008; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; GOZES I, 1981, J NEUROCHEM, V36, P1311, DOI 10.1111/j.1471-4159.1981.tb01738.x; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hawkins BE, 2012, BRAIN RES, V1432, P28, DOI 10.1016/j.brainres.2011.11.009; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; HOFFMAN WE, 1981, BRAIN RES, V214, P196, DOI 10.1016/0006-8993(81)90454-6; HONGO K, 1988, STROKE, V19, P892, DOI 10.1161/01.STR.19.7.892; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Ley EJ, 2012, J SURG RES, V177, P326, DOI 10.1016/j.jss.2012.05.019; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1138; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; SMEDA JS, 1992, CAN J PHYSIOL PHARM, V70, P552, DOI 10.1139/y92-070; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wasserman JK, 2008, EUR J NEUROSCI, V28, P1316, DOI 10.1111/j.1460-9568.2008.06442.x; ZHU CZ, 1995, J CEREBR BLOOD F MET, V15, P980, DOI 10.1038/jcbfm.1995.124	44	13	13	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 16	2013	1496						28	35		10.1016/j.brainres.2012.12.027			8	Neurosciences	Neurosciences & Neurology	090WN	WOS:000315010800003	23274538	Green Accepted			2021-06-18	
J	Dagher, JH; Richard-Denis, A; Lamoureux, J; de Guise, E; Feyz, M				Dagher, Jehane H.; Richard-Denis, Andreane; Lamoureux, Julie; de Guise, Elaine; Feyz, Mitra			Acute global outcome in patients with mild uncomplicated and complicated traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; acute care; outcome	GLASGOW COMA SCALE; HEAD-INJURY; PREDICTION; ALCOHOL; INTOXICATION; PROGNOSIS; RECOVERY; TIME	Primary objective: This study assesses the influence of socio-demographic, psychosocial, clinical and radiological variables on the outcome of patients with mild traumatic brain injury (MTBI) in an acute care inpatient setting. Research design: Retrospective cohort study. Methods and procedure: A total of 2127 inpatients with MTBI were included. Outcomes measured were Extended Glasgow Outcome Scale (GOS-E), the FIM (R) instrument, length of stay (LOS) and discharge destination. Main outcomes and results: Fifty-four per cent of patients with MTBI with a median GOS-E of 2 were discharged home with no need for further follow-up. Age, LOS, lower Glasgow score (GCS) at admission, insurance coverage and positive CT scans were associated with rehabilitation referrals on discharge. Age, LOS, alcohol and drug abuse, motor vehicle collision and lower GCS at admission were associated with greater physical disabilities and functional impairment at discharge. FIM (R) cognitive functional scores were higher in women, younger patients and patients without psychiatric disorders. Brain lesions were correlated with longer LOS. CT scan findings in patients with MTBI may help clinicians predict the final outcome and resources required for patient care during their hospitalization and on discharge. Conclusion: This study can help healthcare professionals in treating and planning future care of patients with MTBI.	[Dagher, Jehane H.] McGill Univ, Ctr Hlth, Phys Med & Rehabil Dept, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane H.; Richard-Denis, Andreane] Inst Readaptat Lindsay Gingras Montreal, Phys Med & Rehabil Dept, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [de Guise, Elaine; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	Dagher, JH (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.			Lamoureux, Julie/0000-0002-4986-2504			Agence de la sante et des services sociaux de Montreal, 2011, PROJ ORG SERV INT MO, P23; Alban RF, 2010, AM SURGEON, V76, P1108; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Caplain S., 2008, J REHABILITATION M S, V22, P528; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2007, HEADS FACTS PHYS MIL; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	37	13	13	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					189	199		10.3109/02699052.2012.729288			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500007	23384216				2021-06-18	
J	Li, YJ; Wang, ZH; Zhang, B; Zhe, X; Wang, MJ; Bai, J; Lin, T; Zhang, SJ				Li, Yajun; Wang, Zhenghai; Zhang, Bei; Zhe, Xiao; Wang, Mingjue; Bai, Jing; Lin, Tao; Zhang, Shijun			Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure	EPILEPSY RESEARCH			English	Article						Ubiquitin; UCH-L1; Biomarker; Cerebrospinal fluid; Epilepsy	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SERUM-LEVELS; ENOLASE; BIOMARKER; PROTEIN; PROLACTIN	Background: Ubiquitin carboxy-terminal hydrolase (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage after acute neurologic insults such as ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury. The effects of seizures on UCH-L1 levels in cerebrospinal fluid (CSF) has not been investigated in epileptic patients. The aim of the present study was to evaluate whether CSF UCH-L1 levels are a reliable marker of brain damage from epileptic seizures. Methods: Thirty-three patients with epilepsy (mean age 45 years) participated. Twenty-five patients had generalized seizures and eight had partial seizures. CSF was sampled by lumbar puncture. The control samples were obtained from 23 adult patients on whom lumbar puncture was performed to exclude neurological disease. CSF UCH-L1 levels were determined using an enzyme-linked immunosorbent assay (ELISA) kit. Results: Patients with epilepsy had significantly elevated CSF levels of UCH-L1 after seizures compared with controls (p < 0.001). CSF UCH-L1 levels were significantly higher in patients with generalized seizures than in patients with partial seizures and controls (p < 0.001). Moreover, patients with repetitive generalized tonic clonic (GTC) seizures had higher CSF UCH-L1 levels than those with a single GTC seizure (p < 0.001). CSF UCH-L1 levels in seizure patients showed strong correlation with severity of seizures (r = 0.56) and seizure duration (r = 0.77). Conversely, CSF UCH-L1 levels in seizure patients did not correlate with the age of patients, duration of epilepsy, age of first seizure, time from last seizure or number of seizures. Conclusions: Our results suggest that UCH-L1 may serve as a novel biomarker for neuronal damage after epileptic seizure. (c) 2012 Elsevier B.V. All rights reserved.	[Li, Yajun; Zhang, Bei; Zhe, Xiao; Wang, Mingjue; Bai, Jing; Lin, Tao; Zhang, Shijun] Xian Med Univ, Affiliated Hosp, Dept Neurol, Xian 710077, Shaanxi Provinc, Peoples R China; [Li, Yajun; Zhang, Bei; Wang, Mingjue; Bai, Jing] Xian Med Univ, Inst Neurosci, Xian 710077, Shaanxi Provinc, Peoples R China; [Wang, Zhenghai] Ningxia Med Univ, Gen Hosp, Dept Neurol, Ningxia, Peoples R China	Li, YJ (corresponding author), Xian Med Univ, Affiliated Hosp, Dept Neurol, 48 West Fenghao Rd, Xian 710077, Shaanxi Provinc, Peoples R China.	liyajun9@hotmail.com			Natural Science Foundation of Shaanxi ProvinceNatural Science Foundation of Shaanxi Province [2009JM4035]; Science and technology plan projects of Xi'an [YF07168]	This work was supported by grants from Natural Science Foundation of Shaanxi Province (No. 2009JM4035) and from Science and technology plan projects of Xi'an (No. YF07168). We thank Dr. Austin Cape for careful reading of the manuscript.	BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Buttner T, 1999, J NEUROL, V246, P459, DOI 10.1007/s004150050383; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Duncan JS, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.9_suppl_5.S15; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Lee SY, 2010, J NEUROL, V257, P1708, DOI 10.1007/s00415-010-5608-2; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu RSN, 2005, EPILEPSIA, V46, P1482, DOI 10.1111/j.1528-1167.2005.51603.x; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; ODonoghue MF, 1996, EPILEPSIA, V37, P563, DOI 10.1111/j.1528-1157.1996.tb00610.x; Palmio J, 2008, EPILEPSY RES, V81, P155, DOI 10.1016/j.eplepsyres.2008.05.006; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rejdak K, 2012, EPILEPSIA, V53, P922, DOI 10.1111/j.1528-1167.2012.03459.x; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Tumani H, 1999, EPILEPSIA, V40, P713, DOI 10.1111/j.1528-1157.1999.tb00768.x; Wang ES, 2010, ACTA NEUROL SCAND, V122, P350, DOI 10.1111/j.1600-0404.2009.01318.x; Wang L, 2010, CLIN CHIM ACTA, V411, P581, DOI 10.1016/j.cca.2010.01.022; Willert C, 2004, ACTA NEUROL SCAND, V109, P318, DOI 10.1046/j.1600-0404.2003.00232.x; Young G Bryan, 2006, Adv Neurol, V97, P217	28	13	15	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	FEB	2013	103	2-3					205	210		10.1016/j.eplepsyres.2012.08.001			6	Clinical Neurology	Neurosciences & Neurology	095ZD	WOS:000315372600009	22920679				2021-06-18	
J	Wang, KW; Chen, HJ; Lu, K; Liliang, PC; Huang, CK; Tang, PL; Tsai, YD; Wang, HK; Liang, CL				Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Huang, Chun-Kai; Tang, Pi-Lien; Tsai, Yu-Duan; Wang, Hao-Kuang; Liang, Cheng-Loong			Pneumonia in patients with severe head injury: incidence, risk factors, and outcomes	JOURNAL OF NEUROSURGERY			English	Article						severe head injury; pneumonia incidence; risk factor; traumatic brain injury	INTENSIVE-CARE; PULMONARY COMPLICATIONS; NOSOCOMIAL PNEUMONIA; TRACT-INFECTION; SEVERE TRAUMA; STROKE; DYSPHAGIA; FAILURE; VICTIMS; TRIAL	Object. The reported incidence of hospital-acquired bacterial pneumonia in critically ill trauma patients varies from as low as 4% to as high as 87%, with fatality rates varying from 6% to 59%. Clinical studies have identified the risk factors for pneumonia. The authors undertook this retrospective study to evaluate the incidence, risk factors, and outcomes of hospital-acquired bacterial pneumonia in a group of patients with severe head injuries. Methods. This was a retrospective review of consecutive adult patients admitted to the neurosurgical ICU in the authors' hospital because of severe head injury (Glasgow Coma Scale scores <= 8) between January 2008 and December 2010. Results. During the study period, 290 patients were admitted to the neurosurgical ICU. Multivariate Cox regression analysis showed that age (HR 1.01, 95% CI 1.001-1.02), nasogastric tube insertion (BR 4.56, 95% CI 1.11-18.64), and hemiplegia or hemiparesis (BR 3.79, 95% CI 2.01-7.17) were significantly associated with the development of pneumonia. Conclusions. The authors identified 3 risk factors (age, nasogastric tube insertion, and hemiplegia or hemiparesis) associated with the development of pneumonia in patients with severe head injury. This finding constituted the basis for developing a simple screening tool that can be used to assess the risk of occurrence of pneumonia in such patients. (http://thejns.org/doi/abs/10.3171/2012.10.JNS127)	[Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Tsai, Yu-Duan; Wang, Hao-Kuang; Liang, Cheng-Loong] I Shou Univ, Dept Neurosurg, E Da Hosp, Kaohsiung 824, Taiwan; [Huang, Chun-Kai] I Shou Univ, Dept Infect, E Da Hosp, Kaohsiung 824, Taiwan; [Tang, Pi-Lien] Fooyin Univ Hosp, Dept Nursing, Kaohsiung, Taiwan	Liang, CL (corresponding author), I Shou Univ, Dept Neurosurg, E Da Hosp, 1 E Da Rd, Kaohsiung 824, Taiwan.	ed100183@edah.org.tw					Andermahr J, 2002, INFLAMM RES, V51, P265, DOI 10.1007/PL00000303; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRAUN SR, 1986, CRIT CARE MED, V14, P198, DOI 10.1097/00003246-198603000-00006; CRAIG CP, 1984, AM J INFECT CONTROL, V12, P233, DOI 10.1016/0196-6553(84)90114-7; CROSS AS, 1981, AM J MED, V70, P681, DOI 10.1016/0002-9343(81)90596-9; ESPERSEN F, 1981, J INFECT DIS, V144, P19, DOI 10.1093/infdis/144.1.19; FAIST E, 1992, SURGERY, V112, P562; FINK MP, 1990, CHEST, V97, P132, DOI 10.1378/chest.97.1.132; FULTON RL, 1975, SURG GYNECOL OBSTET, V140, P179; HALEY RW, 1981, AM J MED, V70, P51, DOI 10.1016/0002-9343(81)90411-3; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kostadima E, 2005, EUR RESPIR J, V26, P106, DOI 10.1183/09031936.05.00096104; LAFORCE FM, 1981, AM J MED, V70, P664, DOI 10.1016/0002-9343(81)90593-3; LANGER M, 1989, AM REV RESPIR DIS, V140, P302, DOI 10.1164/ajrccm/140.2.302; LANGER M, 1987, INTENS CARE MED, V13, P342; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; MILLER EH, 1984, SURG GYNECOL OBSTET, V159, P153; Richards Guy, 2011, J Intensive Care Med, V26, P34, DOI 10.1177/0885066610383949; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; SCHIMPFF SC, 1974, ANN SURG, V179, P352, DOI 10.1097/00000658-197403000-00017; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Walker WE, 1985, ANN SURG, V201, P705; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; Wong WP, 2000, PHYS THER, V80, P662, DOI 10.1093/ptj/80.7.662	32	13	16	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	2013	118	2					358	363		10.3171/2012.10.JNS127			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	076DY	WOS:000313937900020	23157183				2021-06-18	
J	Wang, MM; Xi, GH; Keep, RF				Wang, Michael M.; Xi, Guohua; Keep, Richard F.			Should the STAIR Criteria Be Modified for Preconditioning Studies?	TRANSLATIONAL STROKE RESEARCH			English	Article						Translational research; Preconditioning; Ischemic tolerance; STAIR; Remote ischemic preconditioning	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN; SUBARACHNOID HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; INDUCED NEUROPROTECTION; EXPERIMENTAL STROKE; FOREBRAIN ISCHEMIA; RAPID TOLERANCE; PROTEIN-KINASE	Diverse preconditioning (PC) stimuli protect against a wide variety of neuronal insults in animal models, engendering enthusiasm that PC could be used to protect the brain clinically. Candidate clinical applications include cardiac and vascular surgery, after subarachnoid hemorrhage, and prior to conditions in which acute neuronal injury is anticipated. However, disappointments in clinical validation of multiple neuroprotectants suggest potential problems translating animal data into successful human therapies. Thus, despite strong promise of preclinical PC studies, caution should be maintained in translating these findings into clinical applications. The Stroke Therapy Academic Industry Roundtable working group and the National institute of Neurological Diseases and Stroke proposed working guidelines to improve the utility of preclinical studies that form the foundation of therapies for neurological disease. Here, we review the applicability of these consensus criteria to preconditioning studies and discuss additional considerations for PC studies. We propose that special attention should be paid to several areas, including (1) safety and dosage of PC treatments, (2) meticulously matching preclinical modeling to the human condition to be tested, and (3) timing of both the initiation and discontinuation of the PC stimulus relative to injury ictus.	[Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.; Keep, Richard F.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Xi, Guohua; Keep, Richard F.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Wang, Michael M.] VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA	Wang, MM (corresponding author), Univ Michigan, Dept Neurol, 1137 Catherine St,Box 5622, Ann Arbor, MI 48109 USA.	micwang@med.umich.edu		Keep, Richard/0000-0001-6441-5334	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS054724, NS039866, NS34709]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062816, R01NS034709, R01NS039866, K02NS054724] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants NS054724 (MMW), NS039866 (GX), and NS34709 (RFK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abe H, 2004, J CEREBR BLOOD F MET, V24, P84, DOI 10.1097/01.WCB.0000098607.42140.4B; Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Bilgin-Freiert A, 2012, TRANSL STROKE RES, V3, P266, DOI 10.1007/s12975-012-0153-1; Blanck TJJ, 2000, ANESTHESIOLOGY, V93, P1285, DOI 10.1097/00000542-200011000-00023; Brambrink AM, 2006, ANESTHESIOLOGY, V104, P1208, DOI 10.1097/00000542-200606000-00016; Chan MTV, 2005, ACTA NEUROCHIR SUPPL, V95, P93; Chang CZ, 2010, ACTA NEUROCHIR, V152, P1399, DOI 10.1007/s00701-010-0652-3; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Clarkson AN, 2007, LIFE SCI, V80, P1157, DOI 10.1016/j.lfs.2006.12.022; Codaccioni JL, 2009, ANESTHESIOLOGY, V110, P1271, DOI 10.1097/ALN.0b013e3181a1fe68; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dowden J, 1999, STROKE, V30, P1240, DOI 10.1161/01.STR.30.6.1240; Fairbanks SL, 2010, BEST PRACT RES-CLIN, V24, P521, DOI 10.1016/j.bpa.2010.10.004; Faries PL, 2008, VASCULAR, V16, P1, DOI 10.2310/6670.2008.00012; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Feuerstein GZ, 2008, J CEREBR BLOOD F MET, V28, P217, DOI 10.1038/sj.jcbfm.9600516; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fisher M, 2012, TRANSL STROKE RES, V3, pS39, DOI 10.1007/s12975-012-0185-6; Geng XK, 2012, NEUROL RES, V34, P143, DOI 10.1179/1743132811Y.0000000073; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gidday JM, 2010, TRANSL STROKE RES, V1, P19, DOI 10.1007/s12975-010-0011-y; Gigante PR, 2011, ACTA NEUROCHIR SUPPL, V111, P141, DOI 10.1007/978-3-7091-0693-8_23; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Gonzalez NR, 2011, STROKE, V42, pE553, DOI 10.1161/STROKEAHA.111.622464; Green AR, 2008, BRIT J PHARMACOL, V153, pS325, DOI 10.1038/sj.bjp.0707594; Hahn CD, 2011, STROKE, V42, P2960, DOI 10.1161/STROKEAHA.111.622340; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; He YD, 2012, TRANSL STROKE RES, V3, pS180, DOI 10.1007/s12975-012-0171-z; He Z, 2005, CURR NEUROVASC RES, V2, P365, DOI 10.2174/156720205774962674; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hu S, 2010, J NEUROSURG ANESTH, V22, P46, DOI 10.1097/ANA.0b013e3181c572bd; Hua Y, 2005, NEUROL RES, V27, P261, DOI 10.1179/016164105X25270; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Keep RF, 2010, TRANSL STROKE RES, V1, P4, DOI 10.1007/s12975-009-0007-7; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Kim SH, 2008, CURR NEUROVASC RES, V5, P28; Kirino T, 1996, ADV NEUROL, V71, P505; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1377, DOI 10.1038/sj.jcbfm.9600444; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Koerner IP, 2007, ANESTHESIOLOGY, V106, P538, DOI 10.1097/00000542-200703000-00019; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Li LL, 2008, EUR J PHARMACOL, V586, P106, DOI 10.1016/j.ejphar.2008.02.073; Li Y, 2011, J CARDIOTHOR VASC AN, V25, P908, DOI 10.1053/j.jvca.2011.06.017; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2005, J CEREBR BLOOD F MET, V25, P713, DOI 10.1038/sj.jcbfm.9600064; Malhotra S, 2011, BRAIN RES, V1386, P184, DOI 10.1016/j.brainres.2011.02.032; Matchett GA, 2009, NEUROL RES, V31, P114, DOI 10.1179/174313209X389857; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nasu I, 2006, ANESTH ANALG, V103, P413, DOI 10.1213/01.ane.0000223686.50202.38; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Payne RS, 2005, BRAIN RES, V1034, P147, DOI 10.1016/j.brainres.2004.12.006; Pera J, 2004, J NEUROSCI RES, V78, P132, DOI 10.1002/jnr.20232; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Petcu EB, 2008, CURR NEUROVASC RES, V5, P214, DOI 10.2174/156720208786413424; Przyklenk K, 2011, DRUG AGING, V28, P331, DOI 10.2165/11587190-000000000-00000; Puisieux F, 2000, EUR J PHARMACOL, V389, P71, DOI 10.1016/S0014-2999(99)00893-6; Purcell JE, 2003, NEUROSCI LETT, V339, P151, DOI 10.1016/S0304-3940(02)01476-3; Qin Zhiyong, 2007, Neurosurg Focus, V22, pE13, DOI 10.3171/foc.2007.22.5.14; Rehni AK, 2007, INDIAN J EXP BIOL, V45, P247; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Sack MN, 2011, J CARDIOVASC PHARM T, V16, P267, DOI 10.1177/1074248411408313; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Saxena P, 2009, PERFUSION-UK, V24, P207, DOI 10.1177/0267659109346902; Schaller BJ, 2007, EXP NEUROL, V205, P9, DOI 10.1016/j.expneurol.2006.01.017; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Steiger HJ, 2007, ACTA NEUROCHIR, V149, P1, DOI 10.1007/s00701-006-1057-1; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tymianski M, 2010, STROKE, V41, pS87, DOI 10.1161/STROKEAHA.110.595496; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Vellimana AK, 2011, STROKE, V42, P776, DOI 10.1161/STROKEAHA.110.607200; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P434, DOI 10.1177/1538574410369709; Wang L, 2008, CURR OPIN PHARMACOL, V8, P104, DOI 10.1016/j.coph.2007.09.005; Wang Q, 2005, NEUROSCI LETT, V381, P158, DOI 10.1016/j.neulet.2005.02.019; Wang Q, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-24; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wegener S, 2004, STROKE, V35, P616, DOI 10.1161/01.STR.0000115767.17923.6A; Wei DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030892; Xi G, 2000, ACTA NEUROCHIR SUPPL, V76, P501; Xiong L, 2003, CHINESE MED J-PEKING, V116, P108; Xu T, 2011, MED SCI MONITOR, V17, pBR299, DOI 10.12659/MSM.882038; Yamashita S, 2009, BRAIN RES, V1301, P171, DOI 10.1016/j.brainres.2009.08.096; Yeh CH, 2004, J THORAC CARDIOV SUR, V128, P203, DOI 10.1016/j.jtcvs.2003.12.010; Yu Qiong, 2011, Front Biosci (Elite Ed), V3, P978; Yung LM, 2012, STROKE, V43, P199, DOI 10.1161/STROKEAHA.111.626911; Zhang HP, 2010, ANESTH ANALG, V111, P506, DOI 10.1213/ANE.0b013e3181e45519; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172	104	13	15	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	FEB	2013	4	1					3	14		10.1007/s12975-012-0219-0			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	109WG	WOS:000316399900002	23458885	Green Accepted			2021-06-18	
J	Balci, BD; Akdal, G; Yaka, E; Angin, S				Balci, Birgul Donmez; Akdal, Gulden; Yaka, Erdem; Angin, Salih			Vestibular rehabilitation in acute central vestibulopathy: A randomized controlled trial	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article						Acute stroke; posterior circulation; vestibular rehabilitation; balance	TRAUMATIC BRAIN-INJURY; PHYSICAL-THERAPY; VISUAL FEEDBACK; BALANCE; STROKE; HANDICAP; RECOVERY; ADAPTATION; DISORDERS; DIZZINESS	OBJECTIVE: To investigate the effects of two different rehabilitation programs in acute central vestibulopathy secondary to posterior circulation stroke. METHOD: A prospective randomized controlled study was conducted on 25 patients with posterior circulation stroke. Patients were instructed in routine balance and mobility exercises during the acute hospitalization period. At discharge, patients were assigned to either a rehabilitation or home exercise group. The home exercise group was instructed to perform the same exercise program provided in the course of hospitalization period. The rehabilitation group was randomized into the visual feedback posturography training or vestibular rehabilitation group. The balance and gait performance were assessed with clinical and objective measurements before and after 6 weeks of training. RESULTS: The balance and gait scores were significantly improved in both rehabilitation groups and in the home exercise group (p < 0.05), but no significant difference was found between the groups in terms of post-treatment values (p > 0.05). CONCLUSION: The improvements of balance and gait function in rehabilitation groups did not differ from the home exercise group. Rehabilitation programs were equally effective to improve the recovery in acute central vestibulopathy.	[Balci, Birgul Donmez; Angin, Salih] Dokuz Eylul Univ, Sch Physiotherapy & Rehabil, Izmir, Turkey; [Akdal, Gulden; Yaka, Erdem] Dokuz Eylul Univ, Dept Neurol, Fac Med, Izmir, Turkey	Balci, BD (corresponding author), Dokuz Eylul Univ, Sch Physiotherapy & Rehabil, Izmir, Turkey.	birgul.donmez@deu.edu.tr	Akdal, Gulden/AAG-4782-2019; BALCI, BIRGUL/AAA-2293-2020	Akdal, Gulden/0000-0002-2486-4490; BALCI, BIRGUL/0000-0002-0873-0900			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Badaracco C, 2007, OTOL NEUROTOL, V28, P809, DOI 10.1097/MAO.0b013e3180cab73f; Bamiou DE, 2000, SCAND AUDIOL, V29, P238, DOI 10.1080/010503900750022862; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Cheng PT, 2004, CLIN REHABIL, V18, P747, DOI 10.1191/0269215504cr778oa; Cohen HS, 2002, ACTA OTO-LARYNGOL, V122, P841, DOI 10.1080/003655402/000028039; Davies P.M., 1985, GUIDE TREATMENT ADUL; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Gill-Body K.M., 2011, CURRENT CONCEPTS MAN, P1; GillBody KM, 1997, PHYS THER, V77, P534, DOI 10.1093/ptj/77.5.534; Godbout A, 1997, BRAIN INJURY, V11, P629, DOI 10.1080/026990597123188; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Hall CD, 2009, OTOLARYNG CLIN N AM, V42, P161, DOI 10.1016/j.otc.2008.09.006; Hansson EE, 2005, SCAND J PRIM HEALTH, V23, P215, DOI 10.1080/02813430500287299; HERDMAN S J, 1989, Ear Nose and Throat Journal, V68, P961; Herdman S.J., 2007, VESTIBULAR REHABILIT, P322; HERDMAN SJ, 1995, OTOLARYNG HEAD NECK, V113, P77, DOI 10.1016/S0194-5998(95)70148-6; Herdman SJ, 1998, OTOLARYNG HEAD NECK, V119, P49, DOI 10.1016/S0194-5998(98)70195-0; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KREBS DE, 1993, OTOLARYNG HEAD NECK, V109, P735, DOI 10.1177/019459989310900417; Kruger E, 2007, TOP STROKE REHABIL, V14, P56, DOI 10.1310/tsr1405-56; Maeshima S, 2002, AM J PHYS MED REHAB, V81, P626, DOI 10.1097/00002060-200208000-00012; Marioni G, 2013, EUR ARCH OTO-RHINO-L, V270, P425, DOI 10.1007/s00405-012-1944-4; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Meli A, 2007, J PSYCHOSOM RES, V63, P185, DOI 10.1016/j.jpsychores.2007.02.007; MRUZEK M, 1995, LARYNGOSCOPE, V105, P686, DOI 10.1288/00005537-199507000-00004; Murray K, 2001, Physiother Res Int, V6, P251, DOI 10.1002/pri.232; SHEPARD NT, 1993, ANN OTO RHINOL LARYN, V102, P198, DOI 10.1177/000348949310200306; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Strupp M, 1998, NEUROLOGY, V51, P838, DOI 10.1212/WNL.51.3.838; Suarez H, 2003, ACTA OTO-LARYNGOL, V123, P143, DOI 10.1080/0036554021000028109; Susan B, 2006, PHYS REHABILITATION; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P1013, DOI 10.1053/apmr.2002.33102; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99; Whitney SL, 2011, NEUROREHABILITATION, V29, P157, DOI 10.3233/NRE-2011-0690	41	13	15	2	23	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2013	23	4-5					259	267		10.3233/VES-130491			9	Neurosciences; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	262VX	WOS:000327767100009	24284606				2021-06-18	
J	Dulla, CG; Tani, H; Brill, J; Reimer, RJ; Huguenard, JR				Dulla, C. G.; Tani, H.; Brill, J.; Reimer, R. J.; Huguenard, J. R.			Glutamate biosensor imaging reveals dysregulation of glutamatergic pathways in a model of developmental cortical malformation	NEUROBIOLOGY OF DISEASE			English	Article						Epilepsy; Cortex; Astrocyte; Glutamate; Imaging; Malformation	TRAUMATIC BRAIN-INJURY; FREEZE-LESION MODEL; EPILEPTIFORM ACTIVITY; RAT MODEL; IN-VIVO; POSTSYNAPTIC CURRENTS; REACTIVE ASTROCYTES; EXPRESSION; EPILEPSY; DYSPLASIA	Cortical malformations can cause intractable epilepsy, but the underlying epileptogenic mechanisms are poorly understood. We used high-speed glutamate biosensor imaging to ask how glutamatergic signaling is altered in cortical malformations induced by neonatal freeze-lesions (FL). In non-lesion neocortical slices from 2 to 8 week old rats, evoked glutamate signals were symmetrical in the medio-lateral axis and monotonic, correlating with simple, brief (approximate to 50 ms) local field potentials (LFPs). By contrast, in FL cortex glutamate signals were prolonged, increased in amplitude, and polyphasic, which paralleled a prolongation of the LFP. Using glutamate biosensor imaging, we found that glutamate signals propagated throughout large areas of FL cortex and were asymmetric (skewed toward the lesion). Laminar analysis demonstrated a shift in the region of maximal glutamate release toward superficial layers in FL cortex. The ability to remove exogenous glutamate was increased within the FL itself but was decreased in immediately adjacent regions. There were corresponding alterations in astrocyte density, with an increase within the lesion and a decrease in deep cortical layers surrounding the lesion. These findings demonstrate both network connectivity and glutamate metabolism are altered in this cortical malformation model and suggests that the regional ability of astrocytes to remove released glutamate may be inversely related to local excitability. (C) 2012 Elsevier Inc. All rights reserved.	[Dulla, C. G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Dulla, C. G.; Tani, H.; Brill, J.; Reimer, R. J.; Huguenard, J. R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Dulla, CG (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Chris.Dulla@tufts.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Dulla, Chris/0000-0002-6560-6535	American Epilepsy Society/Epilepsy Foundation of America [NS12151]; Dana Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS006477, P50NS012151, P01NS012151, R01NS034774, R01NS076885] Funding Source: NIH RePORTER	Funding for this article was provided by NS12151, American Epilepsy Society/Epilepsy Foundation of America, and the Dana Foundation.	Albertson A.J., 2011, J NEUROPHYS; Beschorner R, 2007, HISTOL HISTOPATHOL, V22, P515, DOI 10.14670/HH-22.515; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bordey A, 2001, J NEUROPHYSIOL, V85, P1719; Brill J, 2010, CEREB CORTEX, V20, P2926, DOI 10.1093/cercor/bhq040; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell S, 2005, EPILEPSIA, V46, P129, DOI 10.1111/j.1528-1167.2005.01020.x; Campbell S.L., 2008, NEUROBIOL DIS; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Crino PB, 2005, J CHILD NEUROL, V20, P330, DOI 10.1177/08830738050200041101; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Crino PB, 1999, NEUROLOGY, V53, P1384, DOI 10.1212/WNL.53.7.1384; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Dulla C, 2008, J NEUROSCI METH, V168, P306, DOI 10.1016/j.jneumeth.2007.10.017; DVORAK K, 1978, ACTA NEUROPATHOL, V44, P121; Furuta A, 1997, J NEUROSCI, V17, P8363; Gonzalez-Martinez JA, 2011, J NEUROSURG, V114, P1195, DOI 10.3171/2010.10.JNS10715; Hablitz JJ, 2000, EPILEPSIA, V41, pS82, DOI 10.1111/j.1528-1157.2000.tb01562.x; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Isaeva E, 2010, EUR J NEUROSCI, V31, P1446, DOI 10.1111/j.1460-9568.2010.07179.x; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Jacobs KM, 2005, J NEUROPHYSIOL, V93, P687, DOI 10.1152/jn.00288.2004; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Jacobs KM, 1999, J NEUROPHYSIOL, V81, P159; Jacobs KM, 1999, CEREB CORTEX, V9, P733, DOI 10.1093/cercor/9.7.733; Kakita A, 2005, J CHILD NEUROL, V20, P341, DOI 10.1177/08830738050200041301; Leventer RJ, 2010, BRAIN, V133, P1415, DOI 10.1093/brain/awq078; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Namiki S, 2007, EUR J NEUROSCI, V25, P2249, DOI 10.1111/j.1460-9568.2007.05511.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Okubo Y, 2010, P NATL ACAD SCI USA, V107, P6526, DOI 10.1073/pnas.0913154107; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Patrick SL, 2006, EPILEPSY RES, V70, P161, DOI 10.1016/j.eplepsyres.2006.04.001; Redecker C, 2000, J NEUROSCI, V20, P5045; Redecker C, 2005, EXP NEUROL, V192, P288, DOI 10.1016/j.expneurol.2004.11.018; Rosen GD, 2000, J COMP NEUROL, V418, P423; Rosen GD, 1998, CEREB CORTEX, V8, P753, DOI 10.1093/cercor/8.8.753; Rosen GD, 2001, NEUROSCIENCE, V103, P931, DOI 10.1016/S0306-4522(01)00044-6; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Schmidt S, 2006, EXP NEUROL, V201, P270, DOI 10.1016/j.expneurol.2006.03.027; Schwartzkroin PA, 2000, MENT RETARD DEV D R, V6, P268, DOI 10.1002/1098-2779(2000)6:4<268::AID-MRDD6>3.0.CO;2-B; Shimizu-Okabe C, 2007, NEUROSCI RES, V59, P288, DOI 10.1016/j.neures.2007.07.010; Takahashi DK, 2010, NEUROBIOL DIS, V40, P573, DOI 10.1016/j.nbd.2010.07.018; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tani H, 2010, J NEUROSCI, V30, P1288, DOI 10.1523/JNEUROSCI.0106-09.2010; Telfeian AE, 1998, EPILEPSIA, V39, P700, DOI 10.1111/j.1528-1157.1998.tb01154.x; Thomas CG, 2011, J NEUROSCI, V31, P4743, DOI 10.1523/JNEUROSCI.5953-10.2011; Ullensvang K, 1997, EUR J NEUROSCI, V9, P1646, DOI 10.1111/j.1460-9568.1997.tb01522.x; Ulu MO, 2010, ACTA NEUROCHIR, V152, P845, DOI 10.1007/s00701-009-0548-2; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zsombok A, 2007, J NEUROPHYSIOL, V98, P178, DOI 10.1152/jn.00106.2007	55	13	13	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961			NEUROBIOL DIS	Neurobiol. Dis.	JAN	2013	49						232	246		10.1016/j.nbd.2012.09.001			15	Neurosciences	Neurosciences & Neurology	044BO	WOS:000311594600025	22982711	Green Accepted			2021-06-18	
J	Gonzalez, MMC; Blaya, MO; Alonso, OF; Bramlett, HM; Hentall, ID				Gonzalez, Melissa M. Carballosa; Blaya, Meghan O.; Alonso, Ofelia F.; Bramlett, Helen M.; Hentall, Ian D.			Midbrain Raphe Stimulation Improves Behavioral and Anatomical Recovery from Fluid-Percussion Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cAMP; deep brain stimulation; forebrain trauma; forelimb reaching; neuroanatomical volume; water maze	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; PHA-L ANALYSIS; ELECTRICAL-STIMULATION; HIPPOCAMPAL-THETA; SEROTONIN RELEASE; MEDULLARY RAPHE; RAT; NUCLEUS; PROJECTIONS	The midbrain median raphe (MR) and dorsal raphe (DR) nuclei were tested for their capacity to regulate recovery from traumatic brain injury (TBI). An implanted, wireless self-powered stimulator delivered intermittent 8-Hz pulse trains for 7 days to the rat's MR or DR, beginning 4-6 h after a moderate parasagittal (right) fluid-percussion injury. MR stimulation was also examined with a higher frequency (24 Hz) or a delayed start (7 days after injury). Controls had sham injuries, inactive stimulators, or both. The stimulation caused no apparent acute responses or adverse long-term changes. In water-maze trials conducted 5 weeks post-injury, early 8-Hz MR and DR stimulation restored the rate of acquisition of reference memory for a hidden platform of fixed location. Short-term spatial working memory, for a variably located hidden platform, was restored only by early 8-Hz MR stimulation. All stimulation protocols reversed injury-induced asymmetry of spontaneous forelimb reaching movements tested 6 weeks post-injury. Post-mortem histological measurement at 8 weeks post-injury revealed volume losses in parietal-occipital cortex and decussating white matter (corpus callosum plus external capsule), but not hippocampus. The cortical losses were significantly reversed by early 8-Hz MR and DR stimulation, the white matter losses by all forms of MR stimulation. The generally most effective protocol, 8-Hz MR stimulation, was tested 3 days post-injury for its acute effect on forebrain cyclic adenosine monophosphate (cAMP), a key trophic signaling molecule. This procedure reversed injury-induced declines of cAMP levels in both cortex and hippocampus. In conclusion, midbrain raphe nuclei can enduringly enhance recovery from early disseminated TBI, possibly in part through increased signaling by cAMP in efferent targets. A neurosurgical treatment for TBI using interim electrical stimulation in raphe repair centers is suggested.	[Gonzalez, Melissa M. Carballosa; Blaya, Meghan O.; Alonso, Ofelia F.; Bramlett, Helen M.; Hentall, Ian D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33101 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA	Hentall, ID (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, R-48,POB 016960, Miami, FL 33101 USA.	ihentall@med.miami.edu		Hentall, Ian/0000-0002-9937-2546	Department of Defense (CDMPRP) [W81XWH-08-1-0288]; State of Florida	The work described in this article was supported by the Department of Defense (CDMPRP grant W81XWH-08-1-0288) and State of Florida funding. We thank Jessie S. Truettner, William J. Moreno, Scott S. Burns, Allison Irvine, Clayton Jackson, and Lizbeth Manoah for technical assistance.	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P405, DOI 10.1038/jcbfm.1986.73; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hentall ID, 2006, NEUROSCIENCE, V142, P893, DOI 10.1016/j.neuroscience.2006.06.038; Hentall ID, 2012, NEUROREHAB NEURAL RE, V26, P374, DOI 10.1177/1545968311425178; Hentall ID, 2009, J REHABIL RES DEV, V46, P109, DOI 10.1682/JRRD.2008.04.0054; HENTALL ID, 1984, J NEUROPHYSIOL, V51, P968; Hobson SA, 2010, EXPERIENTIA SUPPL, V102, P25, DOI 10.1007/978-3-0346-0228-0_3; Hokfelt T, 1998, ANN NY ACAD SCI, V863, P252, DOI 10.1111/j.1749-6632.1998.tb10700.x; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Jackson J, 2008, J NEUROPHYSIOL, V99, P3009, DOI 10.1152/jn.00065.2008; JACOBS BL, 1992, PHYSIOL REV, V72, P165; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kanjhan R, 1999, J COMP NEUROL, V407, P11; Kitson SL, 2007, CURR PHARM DESIGN, V13, P2621, DOI 10.2174/138161207781663000; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Langhans W, 2007, P NUTR SOC, V66, P321, DOI 10.1017/S0029665107005587; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meyer-Bernstein EL, 1999, NEUROSCIENCE, V92, P267, DOI 10.1016/S0306-4522(98)00733-7; Mokler DJ, 2009, BRAIN RES BULL, V78, P132, DOI 10.1016/j.brainresbull.2008.09.017; MOLLIVER ME, 1987, J CLIN PSYCHOPHARM, V7, pS3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakamura K, 2001, NEUROSCIENCE, V103, P763, DOI 10.1016/S0306-4522(01)00027-6; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Garcia AS, 2011, J INVEST ALLERG CLIN, V21, P1; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Shannon R V, 1997, IEEE Trans Rehabil Eng, V5, P70, DOI 10.1109/86.559351; Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x; SUTHERLAND RJ, 1989, BEHAV NEURAL BIOL, V52, P331, DOI 10.1016/S0163-1047(89)90457-3; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Turlejski K, 1996, ACTA NEUROBIOL EXP, V56, P619; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; Vazey EM, 2006, EXP NEUROL, V199, P384, DOI 10.1016/j.expneurol.2006.01.034; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; VERTES RP, 1994, J COMP NEUROL, V340, P11, DOI 10.1002/cne.903400103; Wagner AK, 2012, PATHOPHYSIOLOGY; WHISHAW IQ, 1984, BEHAV BRAIN RES, V11, P123, DOI 10.1016/0166-4328(84)90135-9; Williams JM, 2003, HIPPOCAMPUS, V13, P109, DOI 10.1002/hipo.10082; Xiong Y, 2010, DISCOV MED, V10, P434; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	61	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	2					119	130		10.1089/neu.2012.2499			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	069NT	WOS:000313444000007	22963112	Green Published			2021-06-18	
J	Kholod, H; Jamil, A; Katz-Leurer, M				Kholod, Hajuj; Jamil, Andrawes; Katz-Leurer, Michal			The associations between motor ability, walking activity and heart rate and heart rate variability parameters among children with cerebral palsy and typically developed controls	NEUROREHABILITATION			English	Article						Cerebral palsy; heart rate variability; motor performance; walking	TRAUMATIC BRAIN-INJURY; RELIABILITY; PREDICTION; SYSTEM	AIMS: To measure heart rate (HR) and heart rate variability (HRV) at rest, during and after walking among children with cerebral palsy (CP) as compared to age matched typically developed (TD) controls. The second aim was to describe the association between HRV and motor performance in children with CP. METHODS: Twenty six children with CP (age 8-14 years) and sixteen TD children matched for age assessed during rest, walking and after walking. HR and HRV parameters include: time domain parameters: standard deviation of the R-R interval (SDNN), square root of the mean squared differences of successive R-R differences (RMSSD). RESULTS: Children with CP demonstrated higher mean HR values at rest; 98.4 +/- 13.9 bpm vs 83.0 +/- 11.5 bpm in controls, (p < 0.05) and significantly lower time domain measures of HRV; RMSSD was 52.0 +/- 19.1 ms and 87.0 +/- 39.8 ms respectively (p < 0.05). Significant interaction effects were noted for HR and time domain HRV parameters. HR increased and SDNN and RMSSD decreased when children change their activity level from rest to walking and HR decreased and SDNN and RMSSD increased again after walking for TD children but not for children with CP (p < 0.05). No association was noted between HRV and motor performance in children with CP. INTERPRETATION: The findings of this study suggest that among children with CP, the cardiac autonomic mechanism is less efficient at rest and less adaptive to exercise and activity as compared to TD children.	[Kholod, Hajuj; Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Jamil, Andrawes] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Child Dev Ctr, San Vincent Hosp Nazareth,Pediat Dept, IL-32000 Haifa, Israel	Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Bjelakovic B, 2010, EARLY HUM DEV, V86, P77, DOI 10.1016/j.earlhumdev.2010.01.022; DoussardRoosevelt JA, 1997, CHILD DEV, V68, P173, DOI 10.1111/j.1467-8624.1997.tb01934.x; El-Sayed HL, 2007, ACTA NEUROL SCAND, V115, P377, DOI 10.1111/j.1600-0404.2006.00792.x; Ferreira MC, 2011, J ORAL PATHOL MED, V40, P576, DOI 10.1111/j.1600-0714.2011.01008.x; FOX NA, 1985, CHILD DEV, V56, P28, DOI 10.2307/1130170; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Hadley DM, 2008, MED SCI SPORT EXER, V40, P1072, DOI 10.1249/MSS.0b013e318167665a; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Korpelainen JT, 1999, CLIN AUTON RES, V9, P325, DOI 10.1007/BF02318379; Maestri R, 2010, CLIN SCI, V118, P195, DOI 10.1042/CS20090183; Maher CA, 2008, INT J REHABIL RES, V31, P185, DOI 10.1097/MRR.0b013e32830150f9; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Park ES, 2002, YONSEI MED J, V43, P65, DOI 10.3349/ymj.2002.43.1.65; Pastore CA, 2011, J ELECTROCARDIOL, V44, P138, DOI 10.1016/j.jelectrocard.2011.01.002; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Schreiber Joe, 2004, Pediatr Phys Ther, V16, P173, DOI 10.1097/01.PEP.0000136007.39269.17; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Vos-Vromans DCW, 2005, DISABIL REHABIL, V27, P1245, DOI 10.1080/09638280500076178; Yang TF, 2002, AM J PHYS MED REHAB, V81, P350, DOI 10.1097/00002060-200205000-00005; Zamuner AR, 2011, RES DEV DISABIL, V32, P217, DOI 10.1016/j.ridd.2010.09.020	26	13	13	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	1					113	119		10.3233/NRE-130934			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	216DA	WOS:000324260400014	23949027				2021-06-18	
J	Ling, HP; Li, W; Zhou, ML; Tang, Y; Chen, ZR; Hang, CH				Ling, Hai-Ping; Li, Wei; Zhou, Meng-Liang; Tang, Yong; Chen, Zhen-Rui; Hang, Chun-Hua			Expression of intestinal myeloid differentiation primary response protein 88 (Myd88) following experimental traumatic brain injury in a mouse model	JOURNAL OF SURGICAL RESEARCH			English	Article						TBI; Myd88; Intestinal inflammation; NF-kappa B; Pro-inflammatory cytokines	NF-KAPPA-B; TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; TNF-ALPHA; INFLAMMATION; GUT; ISCHEMIA; RATS; ISCHEMIA/REPERFUSION; REPERFUSION	Background: Traumatic brain injury (TBI) can cause gastrointestinal dysfunction and increase intestinal permeability. Nuclear factor kappa B (NF-kappa B) has been shown to be associated with these intestinal events, but it is not well known how NF-kappa B is activated in the intestine after TBI. Based on previous studies, we hypothesize that myeloid differentiation primary response protein 88 (Myd88) may have an important role in NF-kappa B activation in the intestine, which mediates the inflammation and ultimately results in acute intestinal mucosal injury. Methods: We randomly divided adult male C57BL/6 mice into control groups and TBI groups at different time points. We induced a closed head injury model by weight drop (a 333-g metal rod dropping from a 2.5-cm height). We detected Myd88 protein level and NF-kappa B binding activity in ileum tissue by Western blot and electrophoretic mobility shift assay, respectively. Meanwhile, we detected the mRNA levels of Myd88, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and intercellular adhesion molecule-1 by real-time polymerase chain reaction. Results: The Myd88 protein and mRNA levels, as well as NF-kappa B binding activity in the ileum tissue, significantly increased at 6 h after TBI, peaked at 3 d, and remained elevated by 5 d post-injury. The levels of TNF-alpha, IL-1 beta, and intercellular adhesion molecule-1 also remarkably increased after TBI. There was a positive relationship between the expression of Myd88 and that of NF-kappa B, TNF-alpha, and IL-1 beta. Conclusions: Traumatic brain injury induced a rapid and persistent up-regulation of Myd88, NF-kappa B, and proinflammatory cytokines in the intestine. This up-regulation which might have an important role in the pathogenesis of acute intestinal mucosal injury. (C) 2013 Elsevier Inc. All rights reserved.	[Ling, Hai-Ping; Zhou, Meng-Liang; Chen, Zhen-Rui; Hang, Chun-Hua] So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Li, Wei; Zhou, Meng-Liang; Tang, Yong; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Hang, CH (corresponding author), So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171170, 8100053]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	The authors appreciate the excellent technical assistance of Dr. Gen-bao Feng. This work was supported by grants from the National Natural Science Foundation of China (No. 81171170 for C. H. Hang and No. 8100053 for M. L. Zhou) and the Natural Science Foundation of Jiangsu Province, China (No. BK2010459).	Akhtar Suhail, 2011, Recent Pat Antiinfect Drug Discov, V6, P206; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Buchholz BM, 2010, AM J PHYSIOL-GASTR L, V299, pG531, DOI 10.1152/ajpgi.00060.2010; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kessel A, 2008, CLIN EXP IMMUNOL, V151, P341, DOI 10.1111/j.1365-2249.2007.03571.x; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Matharu KS, 2009, GASTROENTEROLOGY, V137, P1380, DOI 10.1053/j.gastro.2009.07.004; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Moses T, 2009, J LEUKOCYTE BIOL, V86, P971, DOI 10.1189/jlb.0708396; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Suzuki T, 2008, J SURG RES, V149, P69, DOI 10.1016/j.jss.2008.01.020; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Victoni T, 2010, MED MICROBIOL IMMUN, V199, P35, DOI 10.1007/s00430-009-0134-5; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	35	13	16	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2013	179	1					E227	E234		10.1016/j.jss.2012.03.030			8	Surgery	Surgery	051LW	WOS:000312129700029	22498027				2021-06-18	
J	Moore, TL; Pessina, MA; Finklestein, SP; Kramer, BC; Killiany, RJ; Rosene, DL				Moore, Tara L.; Pessina, Monica A.; Finklestein, Seth P.; Kramer, Brian C.; Killiany, Ronald J.; Rosene, Douglas L.			Recovery of fine motor performance after ischemic damage to motor cortex is facilitated by cell therapy in the rhesus monkey	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Monkey; stroke	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; GROWTH-ASSOCIATED GENE; INTRACEREBRAL HEMORRHAGE; MOLECULAR-MECHANISMS; NEURAL REPAIR; STEM-CELLS; STROKE; BLOOD; EXPRESSION	We investigated the efficacy on recovery of function following controlled cortical ischemia in the monkey of the investigational cell drug product, CNTO 0007. This drug contains a cellular component, human umbilical tissue-derived cells, in a proprietary thaw and inject formulation. Results demonstrate significantly better recovery of motor function in the treatment group with no difference between groups in the volume or surface area of ischemic damage, suggesting that the cells stimulated plasticity.	[Moore, Tara L.; Pessina, Monica A.; Killiany, Ronald J.; Rosene, Douglas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Moore, Tara L.; Killiany, Ronald J.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Finklestein, Seth P.] Biotrofix Inc, Waltham, MA USA; [Kramer, Brian C.] Janssen Serv LLC, Horsham, PA USA; [Rosene, Douglas L.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Moore, TL (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 700 Albany St, Boston, MA 02118 USA.	tlmoore@bu.edu	Killiany, Ronald/Y-7251-2019; Rosene, Douglas L/G-1973-2015	Killiany, Ronald/0000-0003-4740-2181; Rosene, Douglas/0000-0001-8719-1441; Moore, Tara/0000-0003-3869-3837	Advanced Technologies and Regenerative Medicine, LLC (ATRM), RR [101115-PR]	This study was supported by a contract from Advanced Technologies and Regenerative Medicine, LLC (ATRM), RR# 101115-PR, who funded the study and provided CNTO 0007 and a vehicle control.	Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhasin A, 2011, CEREBROVASC DIS EXTR, V1, P93, DOI 10.1159/000333381; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Broxmeyer H E, 1996, Cancer Treat Res, V84, P139; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2008, ACTA NEUROCHIR SUPPL, V105, P79; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GRABOWSKI M, 1993, ANN NEUROL, V34, P362, DOI 10.1002/ana.410340310; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Hess DC, 2002, TRENDS MOL MED, V8, P452, DOI 10.1016/S1471-4914(02)02404-8; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kluver H, 1935, J PSYCHOL, V1, P1; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li HY, 2013, J CELL BIOCHEM, V114, P650, DOI 10.1002/jcb.24407; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lin SZ, 2010, CELL TRANSPLANT, V19, P1451, DOI 10.3727/096368910X514198; Liu HA, 2010, J CLIN BIOCHEM NUTR, V47, P174, DOI 10.3164/jcbn.10-47; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Moore TL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.005; Moore TL, 2010, SOMATOSENS MOT RES, V27, P121, DOI 10.3109/08990220.2010.485963; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Nieda M, 1997, BRIT J HAEMATOL, V98, P775, DOI 10.1046/j.1365-2141.1997.2583074.x; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Qu ZB, 2007, ONKOLOGIE, V30, P256, DOI 10.1159/000101010; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; ROSENE DL, 1986, J HISTOCHEM CYTOCHEM, V34, P1301, DOI 10.1177/34.10.3745909; Rosenkranz K, 2011, ANN ANAT, V193, P371, DOI 10.1016/j.aanat.2011.03.005; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Savitz SI, 2002, ANN NEUROL, V52, P266, DOI 10.1002/ana.60000; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Seyfried DM, 2010, J NEUROSURG, V112, P329, DOI 10.3171/2009.2.JNS08907; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Sng J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/521343; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Yang DM, 2012, BRAIN RES, V1444, P1, DOI 10.1016/j.brainres.2012.01.024; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	67	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0899-0220	1369-1651		SOMATOSENS MOT RES	Somatosens. Mot. Res.		2013	30	4					185	196		10.3109/08990220.2013.790806			12	Neurosciences	Neurosciences & Neurology	255OJ	WOS:000327249400004	23758412	Green Accepted			2021-06-18	
J	O'Neil, RL; Skeel, RL; Ustinova, KI				O'Neil, Rochelle L.; Skeel, Reid L.; Ustinova, Ksenia I.			Cognitive ability predicts motor learning on a virtual reality game in patients with TBI	NEUROREHABILITATION			English	Article						Cognitive ability; virtual reality; traumatic brain injury	REHABILITATION; ENVIRONMENTS; RELIABILITY; SEVERITY; SKILL; TASK	BACKGROUND: Virtual reality games and simulations have been utilized successfully for motor rehabilitation of individuals with traumatic brain injury (TBI). Little is known, however, how TBI-related cognitive decline affects learning of motor tasks in virtual environments. OBJECTIVE: To fill this gap, we examined learning within a virtual reality game involving various reaching motions in 14 patients with TBI and 15 healthy individuals with different cognitive abilities. METHODS: All participants practiced ten 90-second gaming trials to assess various aspects of motor learning. Cognitive abilities were assessed with a battery of tests including measures of memory, executive functioning, and visuospatial ability. RESULTS: Overall, participants with TBI showed both reduced performance and a slower learning rate in the virtual reality game compared to healthy individuals. Numerous correlations between overall performance and several of the cognitive ability domains were revealed for both the patient and control groups, with the best predictor being overall cognitive ability. CONCLUSIONS: The results may provide a starting point for rehabilitation programs regarding which cognitive domains interact with motor learning.	[O'Neil, Rochelle L.; Skeel, Reid L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; [Ustinova, Ksenia I.] Cent Michigan Univ, Dept Phys Therapy, Mt Pleasant, MI 48859 USA	O'Neil, RL (corresponding author), Cent Michigan Univ, Dept Psychol, Sloan Hall 101, Mt Pleasant, MI 48859 USA.	ONeil1rl@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	US Department of DefenseUnited States Department of Defense	The study was supported by the US Department of Defense.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Batson CD, 2011, EXP BRAIN RES, V209, P515, DOI 10.1007/s00221-011-2574-6; Benton A., 1976, MULTILINGUAL APHASIA; BERG K, 1989, Physiotherapy Canada, V41, P304; Boyd LA, 2007, NEUROREHAB NEURAL RE, V21, P444, DOI 10.1177/1545968307300438; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cherniack EP, 2011, DISABIL REHABIL-ASSI, V6, P283, DOI 10.3109/17483107.2010.542570; Cirstea MC, 2003, EXP BRAIN RES, V152, P476, DOI 10.1007/s00221-003-1568-4; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Colarusso R., 2003, MOTOR FREE VISUAL PE, V3rd edn; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Halstead WC, 1947, BRAIN INTELLIGENCE; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Kerr R., 1982, PSYCHOMOTOR LEARNING; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; KlOve H, 1963, MED CLIN N AM; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Magill R.A., 2004, MOTOR LEARNING CONTR; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Meyers J., 1995, REY COMPLEX FIGURE T; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Pearson Assessment, 2009, ADV CLIN SOL WAIS 4; Rand D, 2005, ANN REV CYBERTHERAPY, V3, P193; ROBINSONRIEGLER G, 2004, COGNITIVE PSYCHOL AP; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Schmidt RA., 2004, MOTOR LEARNING PERFO, V3; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Smith A., 1991, SYMBOL DIGIT MODALIT; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Suarez Hamlet, 2006, Int Tinnitus J, V12, P41; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Winstein CJ, 1999, NEUROPSYCHOLOGIA, V37, P975, DOI 10.1016/S0028-3932(98)00145-6; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wulf G, 2010, MED EDUC, V44, P75, DOI 10.1111/j.1365-2923.2009.03421.x; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	44	13	13	1	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	4					667	680		10.3233/NRE-130985			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	275QA	WOS:000328690700017	24018367				2021-06-18	
J	Olson, K; Jacobson, KK; Van Oot, P				Olson, Katie; Jacobson, Kristin K.; Van Oot, Peter			Ecological Validity of Pediatric Neuropsychological Measures: Current State and Future Directions	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						child/clinical/pediatric; memory; rural/urban; teaching; tests	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; MEMORY QUESTIONNAIRE; EVERYDAY MEMORY; REAL-WORLD; TESTS; PREDICT; ATTENTION; CHILDREN; SKILLS	Neuropsychologists are increasingly requested to identify specific deficits in cognitive abilities and determine the ways in which these deficits will affect a client's everyday functioning. The demand for prescriptive diagnostic endeavors that provide recommendations for rehabilitation has drawn attention to the necessity of considering the ecological validity of instruments. Most of the current knowledge regarding the ecological validity of neuropsychological measures is the result of studies examining adult and older adult populations. The relationship of test performance and everyday functioning in children has been less examined and is, therefore, less understood. The purpose of this article is to provide a brief history of ecological validity in neuropsychology, discuss why this is an important consideration when working with child populations, and provide suggestions for continued research in this field.	[Olson, Katie; Jacobson, Kristin K.; Van Oot, Peter] John F Kennedy Univ, Coll Grad & Profess Studies, Pleasant Hill, CA 94523 USA	Olson, K (corresponding author), John F Kennedy Univ, Coll Grad & Profess Studies, 100 Ellinwood Way, Pleasant Hill, CA 94523 USA.	kolson2@jfku.edu					BENNETTLEVY J, 1980, BRIT J SOC CLIN PSYC, V19, P177, DOI 10.1111/j.2044-8260.1980.tb00946.x; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Drysdale K, 2004, CHILD NEUROPSYCHOL, V10, P67, DOI 10.1080/09297040490911087; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; FAUST D, 1991, Neuropsychology Review, V2, P205, DOI 10.1007/BF01109045; Franzen M. D., 1996, ECOLOGICAL VALIDITY, P75; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia D, 2009, QUAL HEALTH RES, V19, P1495, DOI 10.1177/1049732309348500; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; HARTLAGE LC, 1996, ECOLOGICAL VALIDITY, P301; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Kingstone A, 2003, CURR DIR PSYCHOL SCI, V12, P176, DOI 10.1111/1467-8721.01255; Kingstone Alan, 2005, MEASURING MIND SPEED, P341; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Poletti M, 2010, NEUROPSYCHOLOGICAL T, V7, P7; Price KJ, 2003, CLIN NEUROPSYCHOL, V17, P170, DOI 10.1076/clin.17.2.170.16506; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; SBORDONE RJ, 1996, ECOLOGICAL VALIDITY, P91; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; STROOP JR, 1935, J EXP PSYCHOL, V18, P642; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Williams JM, 1996, ECOLOGICAL VALIDITY, P129; Wilson B. A., 1991, RIVERMEAD BEHAV MEMO; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, BEHAV ASSESSMENT DYS	37	13	13	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2013	2	1					17	23		10.1080/21622965.2012.686330			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	AD0SV	WOS:000332945300004	23427773				2021-06-18	
J	Schimizze, B; Son, SF; Goel, R; Vechart, AP; Young, L				Schimizze, Benjamin; Son, Steven F.; Goel, Rahul; Vechart, Andrew P.; Young, Laurence			An experimental and numerical study of blast induced shock wave mitigation in sandwich structures	APPLIED ACOUSTICS			English	Article						Shock waves; Finite elements; Inhomogeneous material; Acoustics; Blast mitigation	ATTENUATION; AFGHANISTAN; IRAQ	The liners of US military helmets are typically made using common soft foams. In order to better protect troops from Traumatic Brain Injury resulting from Improvised Explosive Devices, it is necessary to better understand the material properties involved in air blast mitigation. In this work, mitigation properties are studied using sandwich samples made from a vinyl-nitrile foam shell filled with materials which were selected to span a range of material properties. These materials-water, glycerin, glass beads, Aerogel (R), CAB-O-SIL (R), tuff volcanic rock, and expanding foam-were compared to both uniform vinyl-nitrile foam and a US Army helmet pad. Possible modes of shock attenuation include inertial effects based on density and acoustic impedance, dispersion based on porosity, and thermal effects. Since no standard test exists, we developed two experimental configurations to evaluate performance. The results were additionally used to verify a numerical model made using ABAQUS (R) software. Both the numerical model and the experimental results were consistent in showing that most materials attenuate the peak blast pressure while Aerogel (R) actually enhances the blast. Density and acoustic impedance mismatch are shown to be of primary importance while porosity is shown to have an effect as well. Furthermore, a differentiation is made between reflective and absorptive shock mitigation. (C) 2012 Elsevier Ltd. All rights reserved.	[Schimizze, Benjamin] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Son, Steven F.] Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA; [Goel, Rahul] MIT, Sch Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Vechart, Andrew P.] MIT, Computat Design & Optimizat Program, Cambridge, MA 02139 USA; [Young, Laurence] MIT, Dept Biomed Engn, Cambridge, MA 02139 USA	Schimizze, B (corresponding author), 4220 Bramble Ave,Apt 3, Cincinnati, OH 45227 USA.	bschimizze@gmail.com; sson@purdue.edu; rahulg@mit.edu; avechart@mit.edu; lry@mit.edu	Goel, Rahul/C-4480-2016	Goel, Rahul/0000-0002-3516-6938; Son, Steven/0000-0001-7498-2922	Office of Naval ResearchOffice of Naval Research [N00014-08-1-0261]; Deshpande Center at MIT	Authors are thankful to the financial support provided by Office of Naval Research (#N00014-08-1-0261) and Deshpande Center at MIT.	Allen RM, 2003, AIP C P; Calogne R, 1998, US Patent, Patent No. 5815846; Gel'fand BE, 2001, COMBUST EXPLO SHOCK+, V37, P607, DOI 10.1023/A:1012309623934; Gerber U, 1987, US Patent, Patent No. 4665794; Gooding ER, 1983, US Patent, Patent No. 4375108; Groves TK, 1992, US Patent, Patent No. 5087516; Hartman W. F., 2006, SAND20060533 SAND NA; Holt MC, 1974, US Patent, Patent No. 3849801; Hosaka, 1992, US Patent, Patent No. 5148950; Li QM, 2002, INT J IMPACT ENG, V27, P1049, DOI 10.1016/S0734-743X(02)00016-7; Mendoza ID, 2003, US Patent, Patent No. 6560787; Morgan G.E., 1971, US Patent, Patent No. 3609764; Nesterenko V. F., 2003, MATER RES SOC S P, P759; Ponomarev V., 2006, US Patent, Patent No. 7017705; Resnyansky AD, 2006, DSTOTR1944 WEAP SYST; Rhoades L. J., 2004, Patent US, Patent No. [6,701,529, 6701529]; Schardin H, 1950, WORLD WAR 2, P1207; Stewart D, 2008, THESIS UCD DUBLIN; Stuhmiller JH, 2008, US Patent, Patent No. 250548; Villari FK, 1976, US Patent, Patent No. 3994021; Wakabayashi TH, 2007, SHOCK COMPRESS CONDE; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhuang SM, 2003, J MECH PHYS SOLIDS, V51, P245, DOI 10.1016/S0022-5096(02)00100-X	25	13	15	4	78	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0003-682X			APPL ACOUST	Appl. Acoust.	JAN	2013	74	1					1	9		10.1016/j.apacoust.2012.05.011			9	Acoustics	Acoustics	018EH	WOS:000309642400001					2021-06-18	
J	Shin, DD; Ozyurt, IB; Liu, TT				Shin, David D.; Ozyurt, I. Burak; Liu, Thomas T.			The Cerebral Blood Flow Biomedical Informatics Research Network (CBFBIRN) database and analysis pipeline for arterial spin labeling MRI data	FRONTIERS IN NEUROINFORMATICS			English	Article						database; data sharing; arterial spin labeling; cerebral blood flow; perfusion imaging; group analysis; magnetic resonance imaging		Arterial spin labeling (ASL) is a magnetic resonance imaging technique that provides a non-invasive and quantitative measure of cerebral blood flow (CBF). After more than a decade of active research, ASL is now emerging as a robust and reliable CBF measurement technique with increased availability and ease of use. There is a growing number of research and clinical sites using ASL for neuroscience research and clinical care. In this paper, we present an online CBF Database and Analysis Pipeline, collectively called the Cerebral Blood Flow Biomedical Informatics Research Network (CBFBIRN) that allows researchers to upload and share ASL and clinical data. In addition to serving the role as a central data repository, the CBFBIRN provides a streamlined data processing infrastructure for CBF quantification and group analysis, which has the potential to accelerate the discovery of new scientific and clinical knowledge. All capabilities and features built into the CBFBIRN are accessed online using a web browser through a secure login. In this work, we begin with a general description of the CBFBIRN system data model and its architecture, then devote the remainder of the paper to the CBFBIRN capabilities. The latter part of our work is divided into two processing modules: (1) Data Upload and CBF Quantification Module; (2) Group Analysis Module that supports three types of analysis commonly used in neuroscience research. To date, the CBFBIRN hosts CBF maps and associated clinical data from more than 1,300 individual subjects. The data have been contributed by more than 20 different research studies, investigating the effect of various conditions on CBF including Alzheimer's, schizophrenia, bipolar disorder, depression, traumatic brain injury, HIV, caffeine usage, and methamphetamine abuse. Several example results, generated by the CBFBIRN processing modules, are presented. We conclude with the lessons learned during implementation and deployment of the CBFBIRN and our experience in promoting data sharing.	[Shin, David D.; Liu, Thomas T.] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Ozyurt, I. Burak] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Shin, DD (corresponding author), Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, 9500 Gilman Dr 0677, La Jolla, CA 92093 USA.	ddshin@ucsd.edu; ttliu@ucsd.edu		Liu, Thomas/0000-0002-1978-7486	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH084796]	This work was supported by a grant from the National Institutes of Health (R01MH084796). The authors thank Peter Wong, Eman Ghobrial, and Valur Olafsson at the UCSD Center for Functional MRI and Jerod Rasmussen at the University of California Irvine for their assistance to this project. The authors also would like to acknowledge the FBIRN collaborators (U24-PR021992) for their generous contribution of clinical and ASL data to the CBFBIRN.	Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Anhoj J, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.4.e27; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Ford JM, 2009, SCHIZOPHRENIA BULL, V35, P58, DOI 10.1093/schbul/sbn140; Funai AK, 2008, IEEE T MED IMAGING, V27, P1484, DOI 10.1109/TMI.2008.923956; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Ho T.C., 2012, P AM AC CHILD AD PSY; Ho TC, 2013, J AM ACAD CHILD PSY, V52, P1076, DOI 10.1016/j.jaac.2013.07.008; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; Keator David B, 2009, Front Neuroinform, V3, P30, DOI 10.3389/neuro.11.030.2009; Kim SG, 1997, MAGNET RESON MED, V37, P425, DOI 10.1002/mrm.1910370321; Liu T. T., 2008, P INT SOC MAGN RES M; Marenco L, 2003, J AM MED INFORM ASSN, V10, P444, DOI 10.1197/jamia.M1303; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; Ozyurt IB, 2010, NEUROINFORMATICS, V8, P231, DOI 10.1007/s12021-010-9078-6; Poline JB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00009; Pollock JM, 2009, MAGN RESON IMAGING C, V17, P315, DOI 10.1016/j.mric.2009.01.008; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P15, DOI 10.1093/schbul/sbn159; Rasmussen J. M., 2010, P INT SOC MAGN RES M; Shin D.D., 2013, P INT SOC MAGN RES M; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Van Horn JD, 2009, NEUROIMAGE, V47, P1720, DOI 10.1016/j.neuroimage.2009.03.086; Wierenga CE, 2012, J CEREBR BLOOD F MET, V32, P1589, DOI 10.1038/jcbfm.2012.58; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	30	13	13	0	6	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5196			FRONT NEUROINFORM	Front. Neuroinformatics		2013	7								UNSP 21	10.3389/fninf.2013.00021			17	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	V36JA	WOS:000209207300020	24151465	DOAJ Gold, Green Published			2021-06-18	
J	Slattery, M; Dugger, MT; Lamb, TA; Williams, L				Slattery, Michelle; Dugger, Mallory Tascha; Lamb, Theodore A.; Williams, Laura			Catch, Treat, and Release: Veteran Treatment Courts Address the Challenges of Returning Home	SUBSTANCE USE & MISUSE			English	Article						Veteran Treatment Court; substance use; PTSD; TBI; employment; housing; US military; OEF/OIF; justice; SAMHSA	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; SUBSTANCE USE; AFGHANISTAN; IRAQ	After a decade of war, there is a great need for treatment and alternatives to incarceration for justice-involved veterans. U. S. military service members are returning from combat with substantial mental health challenges, which increase the potential for justice involvement. Veteran Treatment Courts are starting across the nation to meet this need for therapeutic justice. These problem solving courts provide access to treatment and motivation for engagement. Preliminary evidence from a Substance Abuse and Mental Health Services Administration-funded evaluation suggests that significant improvements in posttraumatic stress disorder and substance use are just a few of the positive outcomes that these courts may help veterans achieve.	[Slattery, Michelle; Dugger, Mallory Tascha] UCCS, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80918 USA; [Slattery, Michelle; Lamb, Theodore A.] Peak Res LLC, Colorado Springs, CO USA; [Williams, Laura] Colorado Dept Human Serv, Off Behav Hlth, Denver, CO USA	Slattery, M (corresponding author), UCCS, Trauma Hlth & Hazards Ctr, 1420 Austin Bluffs Pkwy, Colorado Springs, CO 80918 USA.	peakresearch@usa.net			Substance Abuse and Mental Health Services AdministrationUnited States Department of Health & Human Services [SM58806]	Funding support for the study was provided by the Jail Diversion and Trauma Recovery-Priority to Veterans Grant awarded to the Colorado Department of Human Services, Division of Behavioral Health from the Substance Abuse and Mental Health Services Administration, Grant #SM58806.	American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; [Anonymous], 2011, BUR LAB STAT REP EMP; [Anonymous], 2010, ARMY TIMES; [Anonymous], 2012, ARMY GOLD BOOK; *ARM SUIC PREV TAS, 2010, ARM HLTH PROM RISK R; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Drug Policy Alliance, 2009, HEAL BROK SYST VET B; Erickson SK, 2008, PSYCHIAT SERV, V59, P178, DOI 10.1176/ps.2008.59.2.178; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Foa E.B., 1995, POSTTRAUMATIC STRESS; Friedman MJ, 2004, NEW ENGL J MED, V351, P75, DOI 10.1056/NEJMe048129; GAO, 2008, GAO08276; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook J. G., 2011, 1125 WID LAW SCH; Idiculla T., 2005, BASIS 24 COMP GROUP; Institute of Medicine, 2012, SUBST US IDS US ARM; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; MSMR, 2010, MED SURVEILLANCE MON, V17, P2; Mumola C. J., 2000, 178888 NCJ; National Association of Drug Court Professionals (NADCP), 2010, VET TREATM COURTS SE; National Association of Drug Court Professionals (NADCP), 2012, VET TREATM COURT STU; National Center for PTSD, 2010, RET WAR ZON GUID MIL; Noonan M. E., 2004, VETERANS STATE FEDER; Ouimette PC, 1998, ADDICT BEHAV, V23, P785, DOI 10.1016/S0306-4603(98)00064-1; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Reynolds M, 2005, DRUG ALCOHOL DEPEN, V77, P251, DOI 10.1016/j.drugalcdep.2004.08.017; Russell R., 2009, NEW ENG J CRIM CIV C, V35, P357; Russell Robert T., 2009, VETERANS TREATMENT C; Saxon AJ, 2001, PSYCHIATR SERV, V52, P959, DOI 10.1176/appi.ps.52.7.959; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Substance Abuse and Mental Health Service Administration (SAMHSA), 2008, JAIL DIV TRAUM REC P; Substance Abuse and Mental Health Services Administration, 2012, HHS PUBL; Substance Abuse and Mental Health Services Administration (SAMHSA), 2012, BRIEF, V7; Tanielian T, 2008, INVISIBLE WOUNDS WAR; United States Census Bureau, 2010, HIST VET QUEST INSTR; United States Department of Veterans Affairs National Center for PTSD, FACT SHEET EP FACTS; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wilson J.P., 1983, BEHAV SCI LAW, V1, P69, DOI DOI 10.1002/BSL.2370010308	48	13	13	0	22	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2013	48	10					922	932		10.3109/10826084.2013.797468			11	Substance Abuse; Psychiatry; Psychology	Substance Abuse; Psychiatry; Psychology	186ES	WOS:000322025400011	23869463				2021-06-18	
J	Shao, JB; Zhu, HP; Yao, HY; Stallones, L; Yeates, K; Wheeler, K; Xiang, HY				Shao, Jianbo; Zhu, Huiping; Yao, Hongyan; Stallones, Lorann; Yeates, Keith; Wheeler, Krista; Xiang, Huiyun			Characteristics and Trends of Pediatric Traumatic Brain Injuries Treated at a Large Pediatric Medical Center in China, 2002-2011	PLOS ONE			English	Article							COMMON OUTCOME MEASURES; UNIQUE FEATURES; YOUNG-CHILDREN; UNITED-STATES; HEAD TRAUMA; EPIDEMIOLOGY; HOSPITALIZATION; RECOMMENDATIONS; COMPLICATIONS; MECHANISMS	Background: Pediatric traumatic brain injuries (TBIs) have not been well studied in China. This study investigated characteristics and trends of hospitalized TBIs sustained by Chinese children. Methods and Findings: We analyzed 2002-2011 hospitalized TBI patients (0-17 years of age) treated at a large pediatric medical center in China. TBIs were defined using the International Classification of Diseases, Tenth Revision (ICD-10) codes. We examined age patterns across external causes of TBIs. We reported the trend of traffic-related TBIs for each year from 2002 to 2011. Of 4,230 TBI patients, 67.1% (95% CI: 65.4%-68.8%) were city residents and 28.8% (95% CI: 26.3%-31.3%) came from rural villages. Males had disproportionately more TBIs than females (65.2% vs. 34.8%). Falls, struck by/against objects, and traffic collisions were the top three external causes of TBIs for all age groups. Falls were the leading cause of TBI for all ages but peaked at 2 years of age. There were 125 TBIs in 0-2 year olds (5.9% of all TBIs in this age group) that were caused by suspected child abuse. Suspected child abuse was significantly more likely to occur in 0-1 year olds. The proportion of traffic -related TBIs increased significantly from 12.99% in 2002 to 19.68% in 2008 but dropped each subsequent year until it reached a level of 8.91% in 2011. Conclusions: Our study confirms that falls, struck by/against objects and traffic collisions are the top external causes of TBIs in Chinese children. When compared with national data from the developed countries, gender patterns are similar, but the ranking of external causes is different. This is the first study to highlight the important role of suspected child abuse in causing TBIs in infants in China. TBIs caused by child abuse warrant further research and government attention as a social and medical problem in China.	[Shao, Jianbo] Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China; [Zhu, Huiping] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Yao, Hongyan] Chinese Ctr Dis Control & Prevent, Off Epidemiol, Beijing, Peoples R China; [Stallones, Lorann] Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA; [Yeates, Keith] Ohio State Univ, Ctr Biobehav Hlth, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA; [Yeates, Keith; Wheeler, Krista; Xiang, Huiyun] Ohio State Univ, Ctr Injury Res & Policy, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA	Shao, JB (corresponding author), Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China.	jbshao2005@yahoo.com.cn; huiyun.xiang@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Xiang, Huiyun/E-4335-2011; Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X; Wheeler, Krista/0000-0003-3728-8928; Yeates, Keith/0000-0001-7680-2892	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007257] Funding Source: NIH RePORTER	Drs. Stallones and Xiang were supported by the USA-China Agricultural Injury Research Training Project, funded by the National Institutes of Health Fogarty International Center (PIs: L Stallones and H Xiang; Grant #: 1D43TW007257-01A2). The views expressed here are those of the authors and do not necessarily reflect the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; Bo Liu, 2005, J NEURO NEUROREHABIL, V2, P179; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Deb S, 1999, AM J PSYCHIAT, V156, P374; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Harrison J E, 2012, BRAIN INJ, P1; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kuang JG, 2011, JIANGXI MED J, V46, P299; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sun Y, 2006, INJURY, V37, P416, DOI 10.1016/j.injury.2005.12.002; Tieves Kelly S, 2005, WMJ, V104, P22; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2006, NEUR DIS PUBL HLTH C; World Health Organization (WHO), 1994, INT CLASS DIS REL HL; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang SZ, 2002, CHIN J CLIN NEUROSCI, V10, P155; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zhao YD, 2001, WORLD J SURG, V25, P1202	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51634	10.1371/journal.pone.0051634			7	Multidisciplinary Sciences	Science & Technology - Other Topics	066QV	WOS:000313236200151	23251600	DOAJ Gold, Green Published			2021-06-18	
J	Matsuoka, K; Kotani, I; Yamasato, M				Matsuoka, Keiko; Kotani, Izumi; Yamasato, Michihiko			Correct information unit analysis for determining the characteristics of narrative discourse in individuals with chronic traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; discourse; executive function; working memory	CLOSED-HEAD-INJURY; ADULTS; COMMUNICATION; CHILDREN; PERFORMANCE; ADOLESCENTS; ABILITIES; LANGUAGE; DEFICITS; APHASIA	Primary objective: To investigate differences between individuals with traumatic brain injury (TBI) and a control group regarding quantitative characteristics of narrative discourse including correct information units (CIUs). The secondary objective was to explore cognitive correlations with narrative discourse measurements. Research design: Case-control study. Methods: Twenty-six individuals with TBI and 24 age-, gender- and education-matched subjects without brain injury were examined. Four-frame comic strips were used for elicitation of narrative discourse. Six variables of discourse measurements (total time, total number of units and CIUs, units per time, CIUs per time and CIUs per unit) were calculated. The relationships between the 6 discourse measurements and results of standard cognitive tests were also examined, including logical memory, working memory and executive functions. Main outcomes and results: The time efficiency for narrative discourse (i.e. total time, units per time and CIUs per time) was significantly decreased in the TBI group. Moreover, time efficiency was significantly related to measurements of working memory and executive function. The TBI group did not differ from the control group with regard to total number of units and CIUs and CIUs per unit. Conclusion: Decreased time efficiency is the most critical characteristic of narrative discourse in individuals with TBI.	[Matsuoka, Keiko] Kamata TERAKOYA, Ota Ku, Tokyo 1460095, Japan; [Yamasato, Michihiko] Tsukuba Mem Hosp, Tsukuba, Ibaraki, Japan	Matsuoka, K (corresponding author), Kamata TERAKOYA, Ota Ku, Tamagawa 1-21-21, Tokyo 1460095, Japan.	keiko_matsuoka@nifty.ne.jp			 [19905015]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19905015] Funding Source: KAKEN	This study was financially supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Encouragement of Scientists, No. 19905015.	Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; BODY R, 1999, BRAIN DAM B, P81; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1999, BRAIN DAM B, P55; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Honda R, 1999, APHASIOLOGY, V13, P475, DOI 10.1080/026870399402037; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; KASHIMA H, 2003, JAPANESE VERSION BEH; Kertesz A., 1982, W APHASIA BATTERY WA; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Nihon-Koujinou-Kinou-Syougai-Gakkai, 1999, SUPPL TESTS STAND LA; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; SUGISHITA M, 2001, JAPANESE VERSION WEC; Sugishita M., 1986, JAPANESE VERSION W A; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D., 1987, MANUAL WECHSLER MEMO; Wilson, 1991, NATL ADULT READING T; Wilson BA, 1996, BEHAV ASSESSMENT DYS; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Youse KM, 2005, APHASIOLOGY, V19, P297, DOI 10.1080/02687030444000769	38	13	14	0	17	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1723	1730		10.3109/02699052.2012.698789			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700018	22794783				2021-06-18	
J	Pruthi, N; Ashok, M; Kumar, VS; Jhavar, K; Sampath, S; Devi, BI				Pruthi, Nupur; Ashok, M.; Kumar, Shiva, V; Jhavar, Ketaki; Sampath, S.; Devi, B. Indira			Magnitude of pedestrian head injuries & fatalities in Bangalore, south India: A retrospective study from an apex neurotrauma center	INDIAN JOURNAL OF MEDICAL RESEARCH			English	Article						Head injuries; mortality; pedestrian trauma; postmortem; traffic injuries		Background & objectives: Pedestrians contribute to 30-40 per cent of all road traffic injuries in India. However, there is a paucity of literature on pedestrian head injury as compared to two wheeler trauma. The purpose of the present study was to study the pattern of pedestrian injuries and their outcome with a special focus on head injuries. Methods: The study was conducted in two parts in the Trauma Center at National Institute of Mental Health & Neuro Sciences, Bangalore. A retrospective study was conducted at the casualty services of the hospital in which 529 consecutive pedestrians who sustained injury in a road traffic accident were studied from June to September 2009. In the second part, records from the hospital mortuary were retrospectively analyzed from 2007 to 2009. An analysis of 326 patients who died as a pedestrian in road accidents during this period was performed. Results: Patients in both paediatric and elderly age groups constituted 47.6 per cent (252/529) of all casualty admissions. Majority of the pedestrian injuries (41.7%, 221/529) occurred between 1600 2100 h; 87.1 per cent of all patients received some primary care before admission. The most common offending vehicle was a two wheeler (49.1%, 260/529). At the time of admission, 55.2 per cent (292/529) patients had sustained a moderate or severe head injury (GCS 3-13), and 40.5 per cent (214/529) had an abnormal CT scan. In addition, 90.4 per cent (478/529) patients had also sustained associated injuries. Major thoracoabdominal trauma was seen in 4 per cent and spine injury in 2.3 per cent of the patients. The mortality rate was 6.6 per cent. In the postmortem group, pedestrian deaths constituted 26.2 per cent of all the postmortems conducted. Two wheelers were the offending vehicle in the majority of the fatal crashes (39.9%). Interpretation & conclusions: Pedestrian injuries form a major part of the workload of a neurotrauma emergency. Majority of them sustained moderate to severe head injury. More attention, infrastructure and strict implementation of rules may help reduce this burden.	[Pruthi, Nupur; Ashok, M.; Kumar, Shiva, V; Jhavar, Ketaki; Sampath, S.; Devi, B. Indira] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India	Pruthi, N (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore 560029, Karnataka, India.	pruthi_nupur@yahoo.co.in					Baldwin A, 2008, EMERG MED J, V25, P843, DOI 10.1136/emj.2007.057596; Dandona R, 2011, INJURY, V42, P97, DOI 10.1016/j.injury.2009.10.048; Gururaj G, 2006, ROAD TRAFFIC INJURY; Hotz G, 2009, J TRAUMA, V66, P1492, DOI 10.1097/TA.0b013e31819d9c9b; Martin ND, 2010, J SURG RES, V163, P323, DOI 10.1016/j.jss.2010.03.073; Ministry of Urban Development, 2008, STUD TRAFF TRANSP PO; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; National Crime Records Bureau, 2007, ACC DEATHS SUIC IND; Peden M., 2004, WORLD REPORT ROAD TR; Pruthi N, 2010, INDIAN J NEUROTRAUM, V7, P123, DOI 10.1016/S0973-0508(10)80026-7; Tokdemir M, 2009, MED SCI MONIT, V15, pPI1; Umaru H, 2007, Niger J Med, V16, P169	12	13	15	0	2	INDIAN COUNCIL MEDICAL RES	NEW DELHI	PO BOX 4911 ANSARI NAGAR, NEW DELHI 110029, INDIA	0971-5916			INDIAN J MED RES	Indian J. Med. Res.	DEC	2012	136						1039	1043					5	Immunology; Medicine, General & Internal; Medicine, Research & Experimental	Immunology; General & Internal Medicine; Research & Experimental Medicine	V30YV	WOS:000208852200019	23391802	DOAJ Gold			2021-06-18	
J	Smith, B; Harms, WD; Burres, S; Korda, H; Rosen, H; Davis, J				Smith, Brad; Harms, William D.; Burres, Stephanie; Korda, Holly; Rosen, Howard; Davis, Jamie			Enhancing behavioral health treatment and crisis management through mobile ecological momentary assessment and SMS messaging	HEALTH INFORMATICS JOURNAL			English	Article						Mental health; mHealth; SMS messaging; pilot study	POSTTRAUMATIC-STRESS-DISORDER; MEMORY; INTERVENTION; VETERANS; DEFICITS; RELAPSE; PHONE	Many veterans returning from service in Afghanistan or Iraq suffer from post-traumatic stress disorder or mild traumatic brain injury. Treating these conditions can be challenging because of high rates of relapse and associated memory impairments. We report on a pilot study that assessed the utility of mobile health (mHealth) technologies, including personal digital assistant-based ecological momentary assessment and two-way interactive text (SMS) messaging, for providing treatment feedback to clinicians, encouraging and motivating veterans throughout treatment, and monitoring participants for relapse after treatment discharge. The results of the pilot suggest that mHealth technologies are feasible adjuncts to traditional mental treatment in the veteran population. Additional work is needed to establish the degree of clinical and economic value.	[Smith, Brad] Altarum Inst, San Antonio, TX 78216 USA; [Harms, William D.] Life WIRE Grp, Washington, DC USA; [Burres, Stephanie] Altarum Inst, Washington, DC USA; [Korda, Holly] Altarum Inst, Portland, ME USA; [Rosen, Howard] Life WIRE Grp, Toronto, ON, Canada; [Davis, Jamie] VA Maryland Hlth Care Syst, Baltimore, MD USA	Smith, B (corresponding author), Altarum Inst, 10001 Reunion Pl,Suite 200, San Antonio, TX 78216 USA.	brad.smith@altarum.org					Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Daly R, 2009, PSYCHIAT NEWS; Davidson J, 2001, AM J PSYCHIAT, V158, P1974, DOI 10.1176/appi.ajp.158.12.1974; Department of Veterans Affairs, 2010, WHIT HOUS SEEKS 125; Franklin VL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.962; Gerber BS, 2009, HEALTH INFORM J, V15, P17, DOI 10.1177/1460458208099865; Hareva DH, 2009, ACTA MED OKAYAMA, V63, P113; Lockwood A, 2009, ANN PHARMACOTHER, V43, P1227, DOI 10.1345/aph.1M017; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Mirza Farhaan, 2008, Health Informatics J, V14, P309, DOI 10.1177/1460458208096559; National Council on Disability, 2009, INV WOUNDS SERV SERV; Norris AC, 2009, HEALTH INFORM J, V15, P244, DOI 10.1177/1460458209337445; NORRIS T, 2008, J INFORM TECHNOLOGY, V6, P326; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Rosen CS, 2000, ASSESSMENT, V7, P103, DOI 10.1177/107319110000700201; Shiffman S, 2002, J ABNORM PSYCHOL, V111, P531, DOI 10.1037/0021-843X.111.4.531; Skulimowski A. M. J., 2004, 81 IPTS, P3; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100108-02, 10.3928/02793695-20100107-01]; Stockdale R, 2008, 19 AUSTR C INF SYST; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; Tanelian T., 2008, INVISIBLE WOUNDS WAR; Velez Olivia, 2011, DESIGN USABILITY TES; Waller Annalu, 2006, Health Informatics J, V12, P304, DOI 10.1177/1460458206070023; Wegner KE, 2002, INT J EAT DISORDER, V32, P352, DOI 10.1002/eat.10086	28	13	13	0	35	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1460-4582	1741-2811		HEALTH INFORM J	Health Inform. J.	DEC	2012	18	4					294	308		10.1177/1460458212445349			15	Health Care Sciences & Services; Medical Informatics	Health Care Sciences & Services; Medical Informatics	057HU	WOS:000312554600005	23257059				2021-06-18	
J	Urban, JE; Whitlow, CT; Edgerton, CA; Powers, AK; Maldjian, JA; Stitzel, JD				Urban, Jillian E.; Whitlow, Christopher T.; Edgerton, Colston A.; Powers, Alexander K.; Maldjian, Joseph A.; Stitzel, Joel D.			Motor Vehicle Crash-Related Subdural Hematoma from Real-World Head Impact Data	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; CIREN; head trauma; radiology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MIDLINE SHIFT; SEVERITY; RISK; MASS; CONSCIOUSNESS; HEMORRHAGE; MORTALITY; CHILDREN	Approximately 1,700,000 people sustain a traumatic brain injury (TBI) each year and motor vehicle crashes (MVCs) are a leading cause of hospitalization from TBI. Acute subdural hematoma (SDH) is a common intracranial injury that occurs in MVCs associated with high mortality and morbidity rates. In this study, SDH volume and midline shift have been analyzed in order to better understand occupant injury by correlating them to crash and occupant parameters. Fifty-seven head computed tomography (CT) scans were selected from the Crash Injury Research Engineering Network (CIREN) with Abbreviated Injury Scale (AIS) level 3 + SDH. Semi-automated methods were used to isolate the intracranial volume. SDH and additional occupant intracranial injuries were segmented across axial CT images, providing a total SDH injury volume. SDH volume was correlated to crash parameters and occupant characteristics. Results show a positive correlation between SDH volume and crash severity in near-side and frontal crashes. Additionally, the location of the resulting hemorrhage varied by crash type. Those with greater SDH volumes had significantly lower Glasgow Coma Scale (GCS) scores at the crash site in near-side crashes. Age and fracture type were found to be significant contributors to SDH volume. This study is a volumetric analysis of real world brain injuries and known MVC impacts. The results of this study demonstrate a relationship among SDH volume, crash mechanics, and occupant characteristics that provide a better understanding of the injury mechanisms of MVC-associated TBI.	[Urban, Jillian E.; Whitlow, Christopher T.; Edgerton, Colston A.; Powers, Alexander K.; Maldjian, Joseph A.; Stitzel, Joel D.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27101 USA; [Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Univ, Ctr Injury Biomech, Virginia Tech, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Whitlow, Christopher T.; Maldjian, Joseph A.] Wake Forest Univ, Dept Radiol Neuroradiol, Winston Salem, NC 27101 USA; [Whitlow, Christopher T.] Wake Forest Univ, Translat Sci Inst, Winston Salem, NC 27101 USA	Stitzel, JD (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Biotech Pl Bldg,575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	jdstitzel@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Maldjian, Joseph/0000-0002-6384-1072	National Highway Traffic Safety Administration [DTNH22-09-H-00265, DTNH22-10-H-00294]; Toyota Motor North America Inc [DTNH22-05-H-61001]; Medical Student Research Program (MSRP); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T35DK007400-32]; Wake Forest Division of Surgical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK007400] Funding Source: NIH RePORTER	Work was performed for the CIREN Project at Wake Forest University School of Medicine in cooperation with the United States Department of Transportation/National Highway Traffic Safety Administration (USDOT/NHTSA). Funding has been provided by National Highway Traffic Safety Administration under Cooperative Agreement Numbers DTNH22-09-H-00265 and DTNH22-10-H-00294. Views expressed are those of the authors and do not represent the views of NHTSA. Previous funding of the Wake Forest University CIREN center has been provided by Toyota Motor North America Inc under Cooperative Agreement Number DTNH22-05-H-61001.; Support for Colston A. Edgerton was provided through the Medical Student Research Program (MSRP) funded by National Institutes of Health (NIH Short-term Training Grant 5T35DK007400-32 and the Wake Forest Division of Surgical Sciences.	Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 U; Bohman K, 2011, TRAFFIC INJ PREV, V12, P62, DOI 10.1080/15389588.2010.526159; Bruce DA, 2000, CHILD NERV SYST, V16, P755, DOI 10.1007/PL00013720; Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; Divani AA, 2011, STROKE, V42, P1569, DOI 10.1161/STROKEAHA.110.607861; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Loftis Kathryn L, 2011, Ann Adv Automot Med, V55, P81; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; McCartt Anne T, 2007, Traffic Inj Prev, V8, P162, DOI 10.1080/15389580601173875; Nance ML, 2010, TRAFFIC INJ PREV, V11, P600, DOI 10.1080/15389588.2010.513072; National Highway Traffic Safety Administration, 2010, CRASH INJ RES ENG NE; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Ryb GE, 2008, J TRAUMA, V64, P406, DOI 10.1097/TA.0b013e31802beff9; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Strik HM, 2005, NEURORADIOLOGY, V47, P417, DOI 10.1007/s00234-005-1373-9; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Takhounts E. G., 2011, 22 ENH SAF VEH C P; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P597, DOI [10.1089/neu.2000.17.597, DOI 10.1089/NEU.2000.17.597]; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Weninger P, 2007, RESUSCITATION, V75, P35, DOI 10.1016/j.resuscitation.2007.03.011; Westhoff J., 2001, J TRAUMA, V51, P10; Yoganandan Narayan, 2011, Ann Adv Automot Med, V55, P267; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017	44	13	13	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2774	2781		10.1089/neu.2012.2373			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800006	22928543	Green Published			2021-06-18	
J	Cohen-Adad, J; Buchbinder, B; Oaklander, AL				Cohen-Adad, Julien; Buchbinder, Bradley; Oaklander, Anne Louise			Cervical spinal cord injection of epidural corticosteroids: Comprehensive longitudinal study including multiparametric magnetic resonance imaging	PAIN			English	Article						Adverse event; Spinal cord injury; Wallerian degeneration; Diffusion tensor imaging; Magnetization transfer; Central motor conduction time	MULTIPLE-SCLEROSIS; WALLERIAN DEGENERATION; WHITE-MATTER; AXONAL INJURY; CLINICAL-APPLICATIONS; STEROID INJECTIONS; MOUSE MODEL; BRAIN; MYELIN; NERVE	Despite widespread use, the efficacy of epidural corticosteroid injections (ESI) for osteoarthritis-associated neck or radicular pain remains uncertain, so even rare serious complications enter into discussions about use. However, various factors impede investigation and publication of serious adverse events. To that end, we developed new magnetic resonance imaging (MRI) techniques for spinal cord white matter quantification and used the best available physiological tests to characterize a cervical spinal cord lesion caused by inadvertent intramedullary injection of Depo-Medrol. A 29-year-old woman with mild cervical osteoarthritis had 2 years of headache and neck pain (concussion and whiplash) after 2 minor motor vehicle accidents. During C5-6 ESI, she developed new left-sided motor and sensory symptoms, and MRI demonstrated a new left dorsal spinal cord cavity. Mild left-sided motor and sensory symptoms have persisted for more than 2.5 years, during which time we performed serial neurological examinations, standard electrodiagnostics, somatosensory evoked potentials, and transcranial measurement of cortico-spinal central motor conduction time (CMCT). We used 3-Tesla MRI with a 32-channel coil developed for high-resolution cervical spinal cord structural imaging, diffusion tensor imaging (DTI), and magnetization transfer (MT). T-2(*)-weighted signal and DTI and MT metrics showed delayed spread of the lesion across 4 vertebral levels rostrally, consistent with Wallerian degeneration within the ascending left dorsal columns. However, only CMCT metrics detected objective correlates of her left hemiparesis and bilateral hyperreflexia. DTI and MT metrics may better distinguish between post-traumatic demyelination and axonal degeneration than conventional MRI. These tests should be considered to better characterize similar spinal cord injuries. (C) 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	[Cohen-Adad, Julien] Ecole Polytech, Dept Elect Engn, Montreal, PQ H3T 1J4, Canada; [Cohen-Adad, Julien] Massachusetts Gen Hosp, Dept Radiol, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Cohen-Adad, Julien; Buchbinder, Bradley; Oaklander, Anne Louise] Harvard Univ, Sch Med, Boston, MA USA; [Buchbinder, Bradley] Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02114 USA; [Oaklander, Anne Louise] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Oaklander, Anne Louise] Massachusetts Gen Hosp, Dept Neuropathol, Boston, MA 02114 USA	Cohen-Adad, J (corresponding author), Ecole Polytech, Dept Elect Engn, 2900 Edouard Montpetit Bld, Montreal, PQ H3T 1J4, Canada.	jcohen@polymtl.ca			Public Health ServiceUnited States Department of Health & Human ServicesUnited States Public Health Service; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [FG 1892A1/1];  [NIH-P41RR14075];  [NIH-K24NS59892];  [NIH-1S10OD010364];  [NIH-U01MH093765]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH093765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K24NS059892] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD010364] Funding Source: NIH RePORTER	Funded in part by the Public Health Service; NIH-P41RR14075, NIH-K24NS59892, NIH-1S10OD010364, NIH-U01MH093765 National Multiple Sclerosis Society (FG 1892A1/1). Presented in abstract form at the 2011 meeting of the International Society for Magnetic Resonance in Medicine. We thank Dr. Lawrence Wald for helping with MRI acquisition.	Abbasi A, 2007, SPINE, V32, P2144, DOI 10.1097/BRS.0b013e318145a360; Benzon HT, 2007, ANESTHESIOLOGY, V106, P331, DOI 10.1097/00000542-200702000-00022; BENZON HT, 1987, ANESTH ANALG, V66, P553; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Cohen-Adad J, 2011, MAGN RESON MED, V66, P1198, DOI 10.1002/mrm.22906; Cohen-Adad J, 2011, NEUROIMAGE, V57, P1068, DOI 10.1016/j.neuroimage.2011.04.068; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cohen-Adad J, 2010, NEUROIMAGE, V50, P1074, DOI 10.1016/j.neuroimage.2009.12.122; Cohen-Adad J, NEUROLOGY IN PRESS; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Derby Richard, 2004, Pain Physician, V7, P445; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; DVORAK J, 1990, SPINE, V15, P1013, DOI 10.1097/00007632-199015100-00006; FEASBY TE, 1983, NEW ENGL J MED, V308, P966; Goel A, 2006, SPINE, V31, P1576, DOI 10.1097/01.brs.0000222020.45794.ac; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; HAHN AF, 1983, NEUROLOGY, V33, P1032, DOI 10.1212/WNL.33.8.1032; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hodges SD, 1998, SPINE, V23, P2137, DOI 10.1097/00007632-199810010-00020; Hodges SD, 1998, SPINE, V23, P2141; Huang RC, 2004, SPINE, V29, pE7, DOI 10.1097/01.BRS.0000106764.40001.84; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kashani H, 2010, J COMPUT ASSIST TOMO, V34, P251, DOI 10.1097/RCT.0b013e3181c34626; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Lee JH, 2008, REGION ANESTH PAIN M, V33, P377, DOI 10.1016/j.rapm.2007.12.006; Lo YL, 2004, SPINE, V29, P1137, DOI 10.1097/00007632-200405150-00017; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MACKINNON SE, 1982, PLAST RECONSTR SURG, V69, P482, DOI 10.1097/00006534-198203000-00014; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Neema M, 2007, NEUROTHERAPEUTICS, V4, P602, DOI 10.1016/j.nurt.2007.08.001; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pike GB, 2000, RADIOLOGY, V215, P824, DOI 10.1148/radiology.215.3.r00jn02824; Reich DS, 2007, NEUROIMAGE, V38, P271, DOI 10.1016/j.neuroimage.2007.07.049; Reitman CA, 2002, SPINE, V27, pE174, DOI 10.1097/00007632-200203150-00022; Rijsdijk M, 2012, ANESTHESIOLOGY, V116, P170, DOI 10.1097/ALN.0b013e31823cf035; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Smith SA, 2005, MAGN RESON MED, V54, P201, DOI 10.1002/mrm.20553; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Trentman TL, 2009, PAIN PRACT, V9, P59, DOI 10.1111/j.1533-2500.2008.00242.x; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; WALDMAN SD, 1989, REGION ANESTH, V14, P149; WALDMAN SD, 1991, ANESTH ANALG, V72, P717; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	55	13	15	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959			PAIN	Pain	NOV	2012	153	11					2292	2299		10.1016/j.pain.2012.07.028			8	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	033CZ	WOS:000310772400021	22964435	Green Accepted, Green Published			2021-06-18	
J	Crystal, JD				Crystal, Jonathon D.			Prospective cognition in rats	LEARNING AND MOTIVATION			English	Article						Prospective cognition; Prospective memory; Comparative cognition; Animal model; Episodic memory; Mental time travel	EPISODIC-LIKE MEMORY; MENTAL TIME-TRAVEL; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; TASK INTERFERENCE; TRANSGENIC MICE; FUTURE EVENTS; RADIAL MAZE; SCRUB-JAYS; IMPAIRMENT	Efforts to develop animal models of memory are critical for understanding the neural substrate of memory. Memory is essential for daily life and enables information to be stored and retrieved after seconds to years. The ability to remember episodes from the past is thought to be related to the ability to plan for the future. Here we focus on a particular aspect of prospective cognition, namely the ability to remember to take action when a future scenario occurs. This review focuses on a recently developed method to evaluate prospective memory in the rat. Available evidence suggests that rats remember to take action in the future, but little is known about the temporal specificity of such memories or about the flexibility and limitations of prospective memories. Recent studies that suggest that rats remember a specific past episode are reviewed to underscore potential approaches that may be used to explore the range and limits of prospective cognition. The review highlights some directions to explore, including the temporal specificity of prospective cognition, the range of flexibility or creativity within prospective cognition, and the constraints imposed by multiple motivational systems. (C) 2012 Elsevier Inc. All rights reserved.	Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Crystal, JD (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jcrystal@indiana.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080052] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH080052] Funding Source: Medline		Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; Babb SJ, 2005, LEARN MOTIV, V36, P177, DOI 10.1016/j.lmot.2005.02.009; Babb SJ, 2006, CURR BIOL, V16, P1317, DOI 10.1016/j.cub.2006.05.025; Beran MJ, 2012, LEARN MOTIV, V43, P192, DOI 10.1016/j.lmot.2012.05.002; Bird LR, 2003, J COMP PSYCHOL, V117, P176, DOI 10.1037/0735-7036.117.2.176; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cheke LG, 2012, BIOL LETTERS, V8, P171, DOI 10.1098/rsbl.2011.0909; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; Craik F.I.M., 1986, HUMAN MEMORY COGNITI, P409; Crystal J. D., 2012, OXFORD HDB COMP EVOL, P261; Crystal Jonathon D, 2011, Int J Comp Psychol, V24, P412; Crystal JD, 2010, BEHAV BRAIN RES, V215, P235, DOI 10.1016/j.bbr.2010.03.005; Crystal JD, 2009, BEHAV PROCESS, V80, P269, DOI 10.1016/j.beproc.2008.09.009; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; Eacott MJ, 2012, LEARN MOTIV, V43, P200, DOI 10.1016/j.lmot.2012.05.012; Eacott MJ, 2005, LEARN MEMORY, V12, P221, DOI 10.1101/lm.92505; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Hwang DY, 2004, EXP NEUROL, V186, P20, DOI 10.1016/j.expneurol.2003.09.021; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Keri RA, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P2673; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Marsh RL, 2006, MEM COGNITION, V34, P1037, DOI 10.3758/BF03193250; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; Maxwell MM, 2009, CURR PHARM DESIGN, V15, P3977, DOI 10.2174/138161209789649295; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M. A., 2007, PROSPECTIVE MEMORY O; Naqshbandi M, 2007, BEHAV PROCESS, V74, P217, DOI 10.1016/j.beproc.2006.10.010; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Pizzo MJ, 2004, LEARN BEHAV, V32, P240; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Roberts WA, 2002, J GEN PSYCHOL, V129, P415, DOI 10.1080/00221300209602105; Roberts WA, 2008, SCIENCE, V320, P113, DOI 10.1126/science.1152709; Roberts WA, 2012, LEARN MOTIV, V43, P169, DOI 10.1016/j.lmot.2012.05.005; Roberts WA, 2009, TRENDS COGN SCI, V13, P271, DOI 10.1016/j.tics.2009.03.003; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Ueberham U, 2006, INT J DEV NEUROSCI, V24, P177, DOI 10.1016/j.ijdevneu.2005.11.007; Wenyi Z., 2012, CURR BIOL, V22, P1149; Wilson AG, 2012, ANIM COGN, V15, P349, DOI 10.1007/s10071-011-0459-5; Zentall TR, 2010, LEARN MOTIV, V41, P225, DOI 10.1016/j.lmot.2010.08.001; Zentall TR, 2006, BEHAV PROCESS, V72, P173, DOI 10.1016/j.beproc.2006.01.009; Zentall TR, 2005, LEARN MOTIV, V36, P208, DOI 10.1016/j.lmot.2005.03.001; Zhou WY, 2011, ANIM COGN, V14, P325, DOI 10.1007/s10071-010-0367-0; Zhou WY, 2009, P NATL ACAD SCI USA, V106, P9525, DOI 10.1073/pnas.0904360106	66	13	13	1	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0023-9690			LEARN MOTIV	Learn. Motiv.	NOV	2012	43	4			SI		181	191		10.1016/j.lmot.2012.05.006			11	Psychology, Biological; Psychology, Experimental	Psychology	024ND	WOS:000310115000003	23180886	Green Accepted			2021-06-18	
J	LaBella, CR; Mjaanes, J				LaBella, Cynthia R.; Mjaanes, Jeffrey			Cheerleading Injuries: Epidemiology and Recommendations for Prevention	PEDIATRICS			English	Article						cheer; athletes; sports; adolescents; females	HIGH-SCHOOL; UNITED-STATES; NORTH-CAROLINA; RISK-FACTORS; CONCUSSION; FREQUENCY	Over the last 30 years, cheerleading has increased dramatically in popularity and has evolved from leading the crowd in cheers at sporting events into a competitive, year-round sport involving complex acrobatic stunts and tumbling. Consequently, cheerleading injuries have steadily increased over the years in both number and severity. Sprains and strains to the lower extremities are the most common injuries. Although the overall injury rate remains relatively low, cheerleading has accounted for approximately 66% of all catastrophic injuries in high school girl athletes over the past 25 years. Risk factors for injuries in cheerleading include higher BMI, previous injury, cheering on harder surfaces, performing stunts, and supervision by a coach with low level of training and experience. This policy statement describes the epidemiology of cheerleading injuries and provides recommendations for injury prevention. Pediatrics 2012;130:966-971								American Association of Cheerleading Coaches and Administrators, 2011 2012 SCH CHEERL; American Sports Data Inc, 2004, SUP SPORTS PART, VII; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Fort GG, 1999, AM J EMERG MED, V17, P432, DOI 10.1016/S0735-6757(99)90107-9; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2005, BRIT J SPORT MED, V39, P237, DOI 10.1136/bjsm.2004.014605; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; Julka B., 2009, HIGH SCH TODAY  0930; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mueller FO, 2009, CATASTROPHIC SPORTS; National Federation of State High School Associations, 2012 2013 SPIR RUL B; National Injury Information Clearinghouse, 2008, CHEERL INJ 1980 2007; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P595, DOI 10.4085/1062-6050-44.6.595; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567	21	13	13	0	38	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2012	130	5					966	971		10.1542/peds.2012-2480			6	Pediatrics	Pediatrics	029OT	WOS:000310505900067	23090348	Bronze			2021-06-18	
J	Price, J; Malliaras, P; Hudson, Z				Price, Jo; Malliaras, Peter; Hudson, Zoe			Current practices in determining return to play following head injury in professional football in the UK	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Objective To investigate the awareness of English football team doctors of the 'Consensus in Sport' (CIS) guidelines for the assessment and management of concussion, and to identify adherence to these internationally accepted recommendations. Method A questionnaire was sent to Club Medical Officers of all the 92 English Football league teams. Results The majority (55.6%) of teams in the English Football Association (FA) do not routinely follow the CIS guidelines. Only 21% of teams routinely record an approved preseason cognitive score and only 42% complete a recommended postconcussion assessment. One-third are still using outdated fixed periods of abstinence following a concussion. Conclusions FA players are not being treated according to the guidelines recommended by International sporting organisations. The endorsement of the CIS guidelines by the English FA would ensure that all medical teams have a sound and safe protocol for managing concussed players and making return to play decisions.	[Price, Jo; Malliaras, Peter; Hudson, Zoe] Queen Mary Univ, Ctr Sports & Exercise Med, Mile End Hosp, London E1 4DG, England	Hudson, Z (corresponding author), Queen Mary Univ, Ctr Sports & Exercise Med, Mile End Hosp, Bancroft Rd, London E1 4DG, England.	z.Hudson@qmul.ac.uk		Malliaras, Peter/0000-0001-5879-4139				0	13	13	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	NOV	2012	46	14					1000	1003		10.1136/bjsports-2011-090687			4	Sport Sciences	Sport Sciences	027MX	WOS:000310357900009	22926934				2021-06-18	
J	Puggina, ACG; da Silva, MJP; Schnakers, C; Laureys, S				Giesbrecht Puggina, Ana Claudia; Paes da Silva, Maria Julia; Schnakers, Caroline; Laureys, Steven			Nursing Care of Patients With Disorders of Consciousness	JOURNAL OF NEUROSCIENCE NURSING			English	Article						coma; consciousness disorders; nursing care; persistent vegetative state	PERSISTENT VEGETATIVE STATE; LOCKED-IN SYNDROME; CONTEMPORARY MOTION-PICTURES; TRAUMATIC COMA PATIENTS; SEVERE HEAD-INJURY; INTENSIVE-CARE; VERBAL COMMUNICATION; FAMILY-MEMBERS; BRAIN; SCALE	Management of severely brain-injured patients constitutes a social, economical, and ethical dilemma as well as a real challenge for the medical staff, as it requires specific expertise. The aim of this article is to explore the aspects of nursing care in patients recovering from coma such as difficulty of diagnosis, residual perception, clinical assessment, care and management, and communication with the patient and the family. The nursing care of patients with disorder of consciousness must be particular and specific for various reasons such as the difficult diagnosis, the problem of unconsciousness or lack of demonstration of consciousness, extremely complex clinical assessment, daily management with total dependence, communication with patients that requires special attention and training by health professionals, and communication with the family of these patients that requires more sensitivity and full involvement by the team.	[Paes da Silva, Maria Julia] Univ Sao Paulo EE USP, Sch Nursing, Sao Paulo, Brazil; [Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium		claudiapuggina@usp.br	Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; PUGGINA, ANA CLAUDIA/B-5396-2014	Laureys, Steven/0000-0002-3096-3807; PUGGINA, ANA CLAUDIA/0000-0001-8095-6560	Belgian Fund for Scientific ResearchFonds de la Recherche Scientifique - FNRS; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC-06/11-340]; Fondation Medicale Reine Elisabeth; University of LiegeUniversity of Liege; CNRS/FNRS-CGRICentre National de la Recherche Scientifique (CNRS)Fonds de la Recherche Scientifique - FNRS; University of Sao Paulo and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	The Coma Science Group research is funded by the Belgian Fund for Scientific Research, European Commission, James McDonnell Foundation, Mind Science Foundation, French Speaking Community Concerted Research Action (ARC-06/11-340), Fondation Medicale Reine Elisabeth, University of Liege and the CNRS/FNRS-CGRI collaboration funds. The School of Nursing is funded by University of Sao Paulo and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo collaboration funds.	*AM ASS NEUR NURS, 2008, AANN CLIN PRACT GUID; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baker C, 1996, J CLIN NURS, V5, P185, DOI 10.1111/j.1365-2702.1996.tb00248.x; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Cardim M. G., 2004, ENFERMAGEM BRASIL, V3, P131; Carpenito-Moyet L. J, 2006, MANUAL DIAGNOSTICOS; Casarett D., 2005, BRIT MED J, V331, P24; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Demertzi A, 2009, PROG BRAIN RES, V177, P329, DOI 10.1016/S0079-6123(09)17722-1; Demertzi Athena, 2008, Expert Rev Neurother, V8, P1719, DOI 10.1586/14737175.8.11.1719; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Elliott R, 1999, J ADV NURS, V29, P1412, DOI 10.1046/j.1365-2648.1999.01028.x; Ferreira M. I. P. R, 2000, THESIS U FEDERAL SAN; Fife C, 2001, CRIT CARE MED, V29, P283, DOI 10.1097/00003246-200102000-00011; Finch H, 2005, NEUROPSYCHOL REHABIL, V15, P537, DOI 10.1080/09602010443000542; Fins JJ, 2007, NEUROLOGY, V68, P79, DOI 10.1212/01.wnl.0000253019.00880.72; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2009, ENCY NEUROSCI, V2, P1133; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; *N AM NURS DIAGN A, 2006, DIAGN ENF NANDA DEF; Owen AM, 2009, PROG BRAIN RES, V177, P399, DOI 10.1016/S0079-6123(09)17728-2; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Plum F, 1977, DIAGNOSTICO ESTUPOR; Rosenberg RN, 2009, JAMA-J AM MED ASSOC, V301, P1172, DOI 10.1001/jama.2009.224; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, J NEUROL, V255, P323, DOI 10.1007/s00415-008-0544-0; Schnakers C, 2007, CURR OPIN NEUROL, V20, P620, DOI 10.1097/WCO.0b013e3282f169d9; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; SMELTZER SC, 2002, TRATADO ENFERMAGEM M; TEASDALE G, 1974, LANCET, V2, P81; Vanhaudenhuyse A, 2008, NEUROLOGY, V71, P1374, DOI 10.1212/01.wnl.0000320110.70134.60; Verhaeghe STL, 2007, J CLIN NURS, V16, P1488, DOI 10.1111/j.1365-2702.2006.01807.x; Verhaeghe STL, 2007, QUAL HEALTH RES, V17, P730, DOI 10.1177/1049732307303242; Wijdicks EFM, 2006, NEUROLOGY, V66, P1300, DOI 10.1212/01.wnl.0000210497.62202.e9; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; WILD K, 2007, EUR J TRAUMA EMERG S, V33, P268	48	13	14	3	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2012	44	5					260	270		10.1097/JNN.0b013e3182666407			11	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	004GQ	WOS:000308669400006	22955240				2021-06-18	
J	Paredes-Andrade, E; Solid, CA; Rockswold, SB; Odland, RM; Rockswold, GL				Paredes-Andrade, Eduardo; Solid, Craig A.; Rockswold, Sarah B.; Odland, Rick M.; Rockswold, Gaylan L.			Hypertonic Saline Reduces Intracranial Hypertension in the Presence of High Serum and Cerebrospinal Fluid Osmolalities	NEUROCRITICAL CARE			English	Article						Cerebrospinal fluid osmolality; Hypertonic saline; Intracranial pressure; Osmotherapy; Serum osmolality; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SODIUM-CHLORIDE; CEREBRAL EDEMA; CELL-VOLUME; PRESSURE; MANNITOL; MANAGEMENT; OSMOTHERAPY; TRIAL	Osmotherapy has been the cornerstone in the management of patients with elevated intracranial pressure (ICP) following traumatic brain injury (TBI). Several studies have demonstrated that hypertonic saline (HTS) is a safe and effective osmotherapy agent. This study evaluated the effectiveness of HTS in reducing intracranial hypertension in the presence of a wide range of serum and cerebrospinal fluid (CSF) osmolalities. Forty-two doses of 23.4% saline boluses for treatment of refractory intracranial hypertension were reviewed retrospectively. Thirty milliliters of 23.4% NaCl was infused over 15 min for intracranial hypertension, defined as ICP > 20 mmHg. The CSF and serum osmolalities from frozen stored samples were measured with an osmometer. The values of serum sodium, hourly ICP, blood urea nitrogen (BUN), and creatinine were obtained directly from the medical records. The serum and CSF osmolalities correlated very closely to serum sodium (r > 0.9, P < 0.0001). The reduction in ICP from the baseline (measured from either the mean ICP or the lowest ICP measurement in the first 6 h after bolus HTS treatment) was statistically significant regardless of serum osmolality. The mean reduction from baseline to follow-up values was 8.8 mm Hg (P < 0.0001). The decrease in ICP was as evident with serum osmolalities > 320 as it was at a parts per thousand currency sign320. This study demonstrates that 23.4% HTS bolus is effective for the reduction of elevated ICP in patients with severe TBI even in the presence of high serum and CSF osmolalities.	[Paredes-Andrade, Eduardo; Rockswold, Sarah B.; Rockswold, Gaylan L.] Hennepin Cty Med Ctr, Dept Surg, Div Neurosurg, Minneapolis, MN 55415 USA; [Solid, Craig A.] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Analyt Serv, Minneapolis, MN USA; [Rockswold, Sarah B.] Hennepin Cty Med Ctr, Dept Phys Med & Rehabil, Minneapolis, MN 55415 USA; [Odland, Rick M.] Hennepin Cty Med Ctr, Dept Otolaryngol, Minneapolis, MN 55415 USA; [Odland, Rick M.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA; [Rockswold, Gaylan L.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Rockswold, Sarah B.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA	Rockswold, GL (corresponding author), Hennepin Cty Med Ctr, Dept Surg, Div Neurosurg, 701 Pk Ave, Minneapolis, MN 55415 USA.	gaylan.rockswold@hcmed.org					Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Becker DP, 1972, INTRACRANIAL PRESSUR, P309; Berger S., 2005, TRANSFUS ALTERN TRAN, V6, P59; Bhardwaj A, 2007, CURR NEUROL NEUROSCI, V7, P513, DOI 10.1007/s11910-007-0079-2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; FISHMAN RA, 1959, J CLIN INVEST, V38, P1698, DOI 10.1172/JCI103948; FISHMAN RA, 1992, CEREBROSPINAL FLUID, P43; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Johanson C., 2008, NEUROSCIENCE MED, P173; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Nau R, 1997, EUR J CLIN PHARMACOL, V53, P271, DOI 10.1007/s002280050375; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Palma L, 2006, J Neurosurg Sci, V50, P63; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Polderman KH, 2003, CRIT CARE MED, V31, P584, DOI 10.1097/01.CCM.0000050287.68977.84; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Swanson PD, 1976, HDB CLIN NEUROLOGY, V28, P443; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	36	13	13	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2012	17	2					204	210		10.1007/s12028-011-9574-z			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	002QU	WOS:000308548800008	21725694				2021-06-18	
J	Atkins, CM; Kang, Y; Furones, C; Truettner, JS; Alonso, OF; Dietrich, WD				Atkins, C. M.; Kang, Y.; Furones, C.; Truettner, J. S.; Alonso, O. F.; Dietrich, W. D.			Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						blood-brain barrier; cAMP; cerebral blood flow; cytokine; phosphodiesterase	TUMOR-NECROSIS-FACTOR; PHOSPHODIESTERASE TYPE-IV; CEREBRAL-BLOOD-FLOW; SPINAL-CORD-INJURY; TNF-ALPHA PRODUCTION; INHIBITOR ROLIPRAM; NEURONAL DAMAGE; HEAD-INJURY; DIFFERENTIAL REGULATION; FUNCTIONAL RECOVERY	The pathology caused by traumatic brain injury (TBI) is exacerbated by the inflammatory response of the injured brain. Two proinflammatory cytokines that contribute to inflammation after TBI are tumor necrosis factor-a (TNF-a) and interleukin-1 beta (IL-1 beta). From previous studies using the parasagittal fluid-percussion brain injury model, we reported that the anti-inflammatory drug rolipram, a phosphodiesterase 4 inhibitor, reduced TNF-a and IL-1 beta levels and improved histopathological outcome when administered 30 min prior to injury. We now report that treatment with (+/-)-rolipram given 30 min after injury significantly reduced TNF-a levels in the cortex and hippocampus. However, postinjury administration of (+/-)-rolipram significantly increased cortical contusion volume and increased atrophy of the cortex compared with vehicle-treated animals at 10 days postinjury. Thus, despite the reduction in proinflammatory cytokine levels, histopathological outcome was worsened with post-TBI (+/-)-rolipram treatment. Further histological analysis of (+/-)-rolipram-treated TBI animals revealed significant hemorrhage in the contused brain. Given the well-known role of (+/-)-rolipram of increasing vasodilation, it is likely that (+/-)-rolipram worsened outcome after fluid-percussion brain injury by causing increased bleeding. (c) 2012 Wiley Periodicals, Inc.	[Atkins, C. M.] Univ Miami, Miller Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis,Dept Neurol Surg, Miami, FL 33136 USA	Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis,Dept Neurol Surg, 1095 NW 14 Terrace,3-17, Miami, FL 33136 USA.	catkins@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS056072, NS069721]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS069721, R01NS056072] Funding Source: NIH RePORTER	Contract grant sponsor: National Institute of Neurological Disorders and Stroke; Contract grant number: NS056072; Contract grant number: NS069721.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Barnette MS, 1996, BIOCHEM PHARMACOL, V51, P949; Beaumont E, 2009, NEUROSCIENCE, V163, P985, DOI 10.1016/j.neuroscience.2009.07.039; Birk S, 2004, EUR J PHARMACOL, V489, P93, DOI 10.1016/j.ejphar.2004.02.038; Block F, 2001, NEUROREPORT, V12, P1507, DOI 10.1097/00001756-200105250-00041; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Chang YC, 2008, PEDIATR RES, V64, P234, DOI 10.1203/PDR.0b013e31817cfc87; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Dlaboga D, 2006, BRAIN RES, V1096, P104, DOI 10.1016/j.brainres.2006.04.032; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Foey AD, 2003, ARTHRITIS RES THER, V5, pR317, DOI 10.1186/ar999; Giorgi M, 2004, BEHAV BRAIN RES, V154, P99, DOI 10.1016/j.bbr.2004.01.024; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hosseini-Sharifabad A, 2012, PHARMACOL BIOCHEM BE, V101, P311, DOI 10.1016/j.pbb.2012.01.017; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/bj20021698; Hu W, 2011, PSYCHOPHARMACOLOGY, V218, P331, DOI 10.1007/s00213-011-2290-8; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jacobitz S, 1996, MOL PHARMACOL, V50, P891; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Lee HT, 2004, ANN NEUROL, V56, P611, DOI 10.1002/ana.20259; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Losco PE, 2004, TOXICOL PATHOL, V32, P295, DOI 10.1080/01926230490431493; Maeda T, 2005, J NEUROTRAUM, V22, P763, DOI 10.1089/neu.2005.22.763; Mecklenburg L, 2006, TOXICOL LETT, V163, P54, DOI 10.1016/j.toxlet.2005.09.037; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; MERRILL JE, 1991, DEV NEUROSCI-BASEL, V13, P130, DOI 10.1159/000112150; Miwa T, 2009, EUR J PHARMACOL, V602, P112, DOI 10.1016/j.ejphar.2008.10.060; Nagakura A, 2002, BRIT J PHARMACOL, V135, P1783, DOI 10.1038/sj.bjp.0704629; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; PRABHAKAR U, 1994, INT J IMMUNOPHARMACO, V16, P805, DOI 10.1016/0192-0561(94)90054-X; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; Santos-Silva AJ, 2008, EUR J PHARMACOL, V582, P102, DOI 10.1016/j.ejphar.2007.12.017; SCHNEIDER HH, 1986, EUR J PHARMACOL, V127, P105, DOI 10.1016/0014-2999(86)90210-4; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Si QS, 1998, BRAIN RES, V812, P97, DOI 10.1016/S0006-8993(98)00954-8; Silvestre JS, 1999, J PSYCHOPHARMACOL, V13, P274, DOI 10.1177/026988119901300309; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; Suzumura A, 1999, BRAIN RES, V837, P203, DOI 10.1016/S0006-8993(99)01666-2; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tilley DG, 2002, MOL PHARMACOL, V62, P497, DOI 10.1124/mol.62.3.497; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Ueda Y, 2004, STROKE, V35, P601, DOI 10.1161/01.STR.0000113693.56783.73; VERGHESE MW, 1995, J PHARMACOL EXP THER, V272, P1313; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; Willette RN, 1997, J CEREBR BLOOD F MET, V17, P210, DOI 10.1097/00004647-199702000-00011; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1191/135245899678847194; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Zhang J, 2008, TOXICOL PATHOL, V36, P827, DOI 10.1177/0192623308322308; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao Y, 2003, J PHARMACOL EXP THER, V305, P565, DOI 10.1124/jpet.102.47407; Zhu B, 2004, BIOCHEM PHARMACOL, V68, P479, DOI 10.1016/j.bcp.2004.03.039; Zhu WH, 1998, LIFE SCI, V63, P265, DOI 10.1016/S0024-3205(98)00270-7; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	13	14	1	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	SEP	2012	90	9					1861	1871		10.1002/jnr.23069			11	Neurosciences	Neurosciences & Neurology	972IZ	WOS:000306272100020	22535545	Green Accepted			2021-06-18	
J	Davidson, PL; Taylor, MC; Wilson, SJ; Walsh, KAJ; Kieser, JA				Davidson, Peter L.; Taylor, Michael C.; Wilson, Suzanne J.; Walsh, Kevan A. J.; Kieser, Jules A.			Physical Components of Soft-Tissue Ballistic Wounding and Their Involvement in the Generation of Blood Backspatter	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; bloodstain pattern analysis; blood backspatter; projectile wound mechanics; impact biomechanics; phenomenological model	ENDOTHELIAL-CELL INJURY; CLOSE-RANGE SHOTS; GUNSHOT WOUNDS; PENETRATION; MECHANISMS; CAVITY; ENTRY; BRAIN; HEAD; SKIN	Gunshot backspatter comprises biological material expelled backward through bullet entry holes. Crime scene investigators analyze backspatter patterns to infer wounding circumstances. An understanding of the mechanism of backspatter generation, and the relationship between spatter patterns and bullet and tissue characteristics, would enhance the predictive value of such analysis. We examined soft-tissue ballistic wounding responses to determine the underlying components and how these might be relevant to the generation of backspatter. We identified five mechanistic components to ballistic wounding (elastic, viscous, crushing, cutting, and thermal), each related to mechanical disciplines (respectively, solid mechanics, fluid mechanics, fracture mechanics, rheology, and thermodynamics). We identified potential roles for these five components in backspatter formation and provide a scenario whereby a sequence of events incorporating these components could lead to backspatter generation and expulsion. This research provides a framework for the mathematical representation, and subsequent computational predictive modeling, of backspatter generation and pattern formation.	[Davidson, Peter L.; Wilson, Suzanne J.] Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [Taylor, Michael C.] Inst Environm Sci & Res Ltd ESR, Christchurch Sci Ctr, Christchurch, New Zealand; [Walsh, Kevan A. J.] Inst Environm Sci & Res Ltd ESR, Auckland Sci Ctr, Auckland, New Zealand; [Kieser, Jules A.] Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dunedin 9054, New Zealand	Davidson, PL (corresponding author), Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, POB 56, Dunedin 9054, New Zealand.	peter.davidson@otago.ac.nz			Crown Research Institute Capability Fund, Institute of Environmental Science and Research Ltd (ESR), New Zealand	Supported by a Crown Research Institute Capability Fund Grant from the Institute of Environmental Science and Research Ltd (ESR), New Zealand.	ATKINS PW, 1984, 2 LAW; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; COOPER GJ, 1990, BRIT J SURG, V77, P606, DOI 10.1002/bjs.1800770604; Di Maio V. J. M., 1999, GUNSHOT WOUNDS PRACT; Fackler ML, 1996, ANN EMERG MED, V28, P194, DOI 10.1016/S0196-0644(96)70062-8; FACKLER ML, 1985, J TRAUMA, V25, P522, DOI 10.1097/00005373-198506000-00009; Fung Y., 1993, BIOMECHANICS MECH PR; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Jussila J, 2005, INJURY, V36, P282, DOI 10.1016/j.injury.2004.09.010; Jussila J., 2005, THESIS U HELSINKI HE; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 1997, INT J LEGAL MED, V110, P27; Karger B, 2008, FORENSIC PATHOL REV, V5, P139, DOI 10.1007/978-1-59745-110-9_9; Lew E., 2005, FORENSIC PATHOLOGY P, P163; Maiden N, 2009, FORENSIC SCI MED PAT, V5, P85, DOI 10.1007/s12024-009-9090-z; MARTY W, 1994, AM J FOREN MED PATH, V15, P1, DOI 10.1097/00000433-199403000-00001; Peters CE, 1996, J TRAUMA, V40, pS16, DOI 10.1097/00005373-199603001-00003; PEX JO, 1987, J FORENSIC SCI, V32, P1587; Sellier KG., 1994, WOUND BALLISTICS SCI; Shergold OA, 2005, J BIOMECH ENG-T ASME, V127, P838, DOI 10.1115/1.1992528; Shi HH, 2000, J FLUID ENG-T ASME, V122, P806, DOI 10.1115/1.1310575; Shkrum MJ, 2007, FORENSIC PATHOLOGY T; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Sonden A, 2002, LASER SURG MED, V31, P233, DOI 10.1002/lsm.10093; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; SWGSTAIN, 2009, FORENSIC SCI COMM, V11; Taylor MC, 2011, INT J LEGAL MED, V125, P617, DOI 10.1007/s00414-010-0462-4; Volgas DA, 2005, INJURY, V36, P373, DOI 10.1016/j.injury.2004.08.037; Young F. R., 1999, CAVITATION; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	30	13	13	0	46	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2012	57	5					1339	1342		10.1111/j.1556-4029.2012.02143.x			4	Medicine, Legal	Legal Medicine	000MX	WOS:000308391500030	22494340				2021-06-18	
J	Dethier, M; Blairy, S				Dethier, Marie; Blairy, Sylvie			Capacity for Cognitive and Emotional Empathy in Alcohol-Dependent Patients	PSYCHOLOGY OF ADDICTIVE BEHAVIORS			English	Article						alcohol-dependence; alcoholism typology; empathy; emotional facial expressions; social relationship satisfaction	FACIAL EXPRESSION RECOGNITION; INTIMATE PARTNER VIOLENCE; HIGH-FUNCTIONING AUTISM; TRAUMATIC BRAIN-INJURY; LONG-TERM ABSTINENCE; INTERPERSONAL PROBLEMS; ANTISOCIAL PERSONALITY; MARITAL ADJUSTMENT; GENDER-DIFFERENCES; ASPERGER-SYNDROME	This study assessed two previously unexplored facets of empathy in alcohol-dependent patients (ADS) divided into two groups according to Cloninger's alcoholism typology: the attribution of intentions according to emotional facial expressions (EFEs) and emotional contagion in reaction to EFEs. Twenty-three male Type-I ADs, 21 male Type-II ADs, and 24 male control participants were compared in two computerized tasks. First, participants rated the extent to which an adjective descriptive of personality weighted on interpersonal dimensions (of rejection, aggressiveness, dominance, and affiliation) corresponded with a video of a neutral EFE that changed to an intense EFE. Second, participants evaluated their own emotional states after watching a series of videos that depicted EFEs while their own face was being filmed. The results showed that Type-I ADs attributed more rejection intentions and fewer affiliation intentions to EFEs compared with controls; however, depression might better explain this biased attribution. Furthermore, AD subtypes showed a different pattern of intention attribution according to the emotions that were portrayed and the sex of the stimulus. In addition, angry EFE mimicry was stronger in Type-II ADs than other participants. Finally, ADs expressed fewer positive emotions and more negative emotions than controls when watching EFEs. These findings emphasize the importance of differentiating alcoholism subtypes and contribute to the understanding of AD interpersonal behaviors.	[Dethier, Marie; Blairy, Sylvie] Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, B-4000 Liege, Belgium	Dethier, M (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, Blvd Rectorat 3,B33, B-4000 Liege, Belgium.	marie.dethier@ulg.ac.be					Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bartek J K, 1999, Nurs Diagn, V10, P158; Beck A. T., 1996, BECK DEPRESSION INVE; Benton A. L., 1983, FACIAL RECOGNITION S; Bjork JM, 2004, ALCOHOL, V34, P133, DOI 10.1016/j.alcohol.2004.06.012; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Blanchard J. J., 1998, HDB SOCIAL FUNCTIONI; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brozgold A Z, 1998, Appl Neuropsychol, V5, P15, DOI 10.1207/s15324826an0501_2; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Caetano R, 2008, J FAM VIOLENCE, V23, P37, DOI 10.1007/s10896-007-9127-6; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Cloninger CR, 1996, ALCOHOL HEALTH RES W, V20, P18; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Combs DR, 2007, SCHIZOPHR RES, V91, P112, DOI 10.1016/j.schres.2006.12.010; Darwin C., 1872, EXPRESSION EMOTIONS, DOI [10.1037/10001-000, DOI 10.1037/10001-000]; Davis M.H., 1994, EMPATHY SOCIAL PSYCH; Dethier M., 2010, REV FRANCOPHONE CLIN, V15, P1; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Douilliez C., 2008, REV FRANCOPHONE CLIN, V13, P1; Driessen M, 1998, ALCOHOL CLIN EXP RES, V22, P77, DOI 10.1097/00000374-199802000-00009; DUBERSTEIN PR, 1993, J NERV MENT DIS, V181, P80, DOI 10.1097/00005053-199302000-00002; Epstein EE, 1997, ALCOHOL CLIN EXP RES, V21, P547; ERIKSEN L, 1986, ADDICT BEHAV, V11, P309, DOI 10.1016/0306-4603(86)90058-4; EVANS CM, 1980, BRIT J ALCOHOL ALCOH, V15, P104; Fals-Stewart W, 2005, J CONSULT CLIN PSYCH, V73, P239, DOI 10.1037/0022-006X.73.2.239; Feldman R.S., 1991, FUNDAMENTALS NONVERB, P329, DOI DOI 10.1037/A0036052; Floyd FJ, 2006, J ABNORM PSYCHOL, V115, P121, DOI 10.1037/0021-843X.115.1.121; Foisy ML, 2007, ALCOHOL CLIN EXP RES, V31, P404, DOI 10.1111/j.1530-0277.2006.00321.x; Foisy ML, 2005, J STUD ALCOHOL, V66, P673, DOI 10.15288/jsa.2005.66.673; Fridlund A., 1997, PSYCHOL FACIAL EXPRE, P103, DOI DOI 10.1017/CBO9780511659911.007; Fridlund A. J., 1994, HUMAN FACIAL EXPRESS; Frigerio E, 2002, PSYCHIAT RES, V113, P161, DOI 10.1016/S0165-1781(02)00244-5; Frommann N, 2003, PSYCHIAT RES, V117, P281, DOI 10.1016/S0165-1781(03)00039-8; Gendre F., 2007, PRAT PSYCHOL, V13, P255, DOI [10.1016/j.prps.2007.01.004, DOI 10.1016/J.PRPS.2007.01.004]; Gendre F., 2002, PSYCHOL PSYCHOMETRIE, V23, P101; Gilman SE, 2001, DRUG ALCOHOL DEPEN, V63, P277, DOI 10.1016/S0376-8716(00)00216-7; Glick P, 1997, PERS SOC PSYCHOL B, V23, P1323, DOI 10.1177/01461672972312009; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Halberstadt AG, 2011, J NONVERBAL BEHAV, V35, P35, DOI 10.1007/s10919-010-0099-5; Hale WW, 1998, PSYCHIAT RES, V80, P265, DOI 10.1016/S0165-1781(98)00070-5; Hallman J, 1996, J STUD ALCOHOL, V57, P155, DOI 10.15288/jsa.1996.57.155; Hatfield E., 1992, EMOTION SOCIAL BEHAV, P151, DOI DOI 10.1017/CBO9781139174138; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Hess U, 2005, COGNITION EMOTION, V19, P515, DOI 10.1080/02699930441000364; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; HOROWITZ LM, 1988, J CONSULT CLIN PSYCH, V56, P885, DOI 10.1037/0022-006X.56.6.885; Ichiyama MA, 1996, J CONSULT CLIN PSYCH, V64, P1245, DOI 10.1037/0022-006X.64.6.1245; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Karno MP, 2004, J STUD ALCOHOL, V65, P501, DOI 10.15288/jsa.2004.65.501; Knutson B, 1996, J NONVERBAL BEHAV, V20, P165, DOI 10.1007/BF02281954; Kornreich C, 2003, PSYCHIAT RES, V119, P251, DOI 10.1016/S0165-1781(03)00130-6; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; Kornreich C, 2001, PSYCHIAT RES, V102, P235, DOI 10.1016/S0165-1781(01)00261-X; Kornreich C, 2001, J STUD ALCOHOL, V62, P533, DOI 10.15288/jsa.2001.62.533; Lipps T., 1907, PSYCHOL UNTERSUCHUNG, VVol. 1, P694; Lynskey MT, 1998, DRUG ALCOHOL DEPEN, V52, P201, DOI 10.1016/S0376-8716(98)00095-7; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V61, P13, DOI 10.2466/pms.1985.61.1.13; Marlatt GA, 1996, ADDICTION, V91, pS37, DOI 10.1111/j.1360-0443.1996.tb02326.x; Marshal Michael P, 2003, Clin Psychol Rev, V23, P959, DOI 10.1016/j.cpr.2003.09.002; Martinotti G, 2009, AM J ADDICTION, V18, P157, DOI 10.1080/10550490802544391; Matsumoto D., 1988, JAPANESE CAUCASIAN F; Matyassy A, 2006, ALCOHOL ALCOHOLISM, V41, P512, DOI 10.1093/alcalc/agl045; Maurage P, 2009, ALCOHOL ALCOHOLISM, V44, P476, DOI 10.1093/alcalc/agp037; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McIntosh D. N., 2006, POLISH PSYCHOL B, V37, P31, DOI DOI 10.3389/FPSYG.2016.00458; McNally AM, 2003, ADDICT BEHAV, V28, P1115, DOI 10.1016/S0306-4603(02)00224-1; MILLER WR, 1998, TREATING ADDICTIVE B, P203; Modestin J, 1997, EUR PSYCHIAT, V12, P335, DOI 10.1016/S0924-9338(97)80002-8; Mueller SE, 2009, INT J ENV RES PUB HE, V6, P3010, DOI 10.3390/ijerph6123010; Murphy CM, 2001, J CONSULT CLIN PSYCH, V69, P528, DOI 10.1037//0022-006X.69.3.528; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; NIXON SJ, 1992, ALCOHOL CLIN EXP RES, V16, P684, DOI 10.1111/j.1530-0277.1992.tb00661.x; Patock-Peckham JA, 2010, J STUD ALCOHOL DRUGS, V71, P95, DOI 10.15288/jsad.2010.71.95; Pekala RJ, 2009, ALCOHOL TREAT Q, V27, P94, DOI 10.1080/07347320802587005; Philippot P, 2005, CLAR SYMP, P17; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Philippot P, 2003, NONVERBAL BEHAV CLIN, P209; Pombo S, 2009, ALCOHOL ALCOHOLISM, V44, P46, DOI 10.1093/alcalc/agn080; Raes F, 2006, J NERV MENT DIS, V194, P796, DOI 10.1097/01.nmd.0000240187.80270.bb; REILLY PM, 1994, J PSYCHOACTIVE DRUGS, V26, P401, DOI 10.1080/02791072.1994.10472460; Roper L, 2010, COGNITIVE THER RES, V34, P207, DOI 10.1007/s10608-009-9252-z; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; RYCHTARIK RG, 1989, J STUD ALCOHOL, V50, P24, DOI 10.15288/jsa.1989.50.24; Schachner DA, 2005, J NONVERBAL BEHAV, V29, P141, DOI 10.1007/s10919-005-4847-x; SCHIFFENBAUER A, 1974, J PERS SOC PSYCHOL, V30, P31, DOI 10.1037/h0036643; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; SHER KJ, 1991, J ABNORM PSYCHOL, V100, P427, DOI 10.1037/0021-843X.100.4.427; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; StatSoft, 2011, STATISTICA VERS 10 S; STOCKWELL T, 1979, BRIT J ADDICT, V74, P79; Tivis LJ, 1998, ALCOHOL CLIN EXP RES, V22, P902, DOI 10.1097/00000374-199806000-00021; Uekermann J, 2008, ADDICTION, V103, P726, DOI 10.1111/j.1360-0443.2008.02157.x; VONKNORRING AL, 1985, ACTA PSYCHIAT SCAND, V72, P51; VONKNORRING L, 1987, J STUD ALCOHOL, V48, P523, DOI 10.15288/jsa.1987.48.523; Windle M, 1999, DEV PSYCHOPATHOL, V11, P823, DOI 10.1017/S0954579499002345; Witkiewitz K, 2009, J CONSULT CLIN PSYCH, V77, P633, DOI 10.1037/a0015647; Young JE., 1994, COGNITIVE THERAPY PE; ZWEBEN A, 1986, J STUD ALCOHOL, V47, P167, DOI 10.15288/jsa.1986.47.167	100	13	14	0	23	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0893-164X	1939-1501		PSYCHOL ADDICT BEHAV	Psychol. Addict. Behav.	SEP	2012	26	3					371	383		10.1037/a0028673			13	Substance Abuse; Psychology, Multidisciplinary	Substance Abuse; Psychology	005XZ	WOS:000308784700001	22642862				2021-06-18	
J	Gazzellini, S; Strazzer, S; Stortini, M; Veredice, C; Beretta, E; Lispi, ML; Petacchi, ME; Menna, M; Cipriani, P; Zampolini, M; Castelli, E				Gazzellini, S.; Strazzer, S.; Stortini, M.; Veredice, C.; Beretta, E.; Lispi, M. L.; Petacchi, M. E.; Menna, M.; Cipriani, P.; Zampolini, M.; Castelli, E.			Pediatric rehabilitation of severe acquired brain injury: a multicenter survey	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Rehabilitation; Neuropsychology; Child	DISABILITY RATING-SCALE; QUALITY-OF-LIFE; HEAD-INJURY; EPIDEMIOLOGY; CHILDREN; PATHOPHYSIOLOGY; OUTCOMES; COMA; AGE	Background. Epidemiological and descriptive data concerning the clinical and socio-demographic characteristics of severe acquired brain injuries (TBI) in pediatric age are meager. In particular, in Italy we only find data concerning traumatic brain injury (TBI) in adults. Earlier data show that the most prevalent etiology in ABI is traumatic and that greater clinical impairments are reported for patients with non-traumatic etiologies. Aim. The main aims of the GISCAR (Gruppo Italiano per lo Studio delle Gravi Cerebrolesioni Acquisite e Riabilitazione) study are: 1) to define the clinical features of pediatric patients with severe neurological disabilities; 2) to determine the etiology and onset modality of the cerebral lesions; and 3) to analyse the characteristics of the rehabilitation processes and patient outcome in terms of disability, strategies for treatment and clinical picture. Design. Quasi-epidemiologic. Setting. In-patient. Population. 184 pediatric patients with severe ABI were recruited. Methods. Data collection was done by means of an assessment protocol created and used by a group of Italian neurorehabilitation centers. Traumatic and non traumatic aetiologies (NTBI) have been treated separately. Results. Traumatic etiology of ABI is the most prevalent (51.6%, N. 95) and about twice as many males as females are involved. Of these cases, 70.5% (N. 67) are the result of a car accident, either as a pedestrian or as a passenger, representing a crucial area for preventive action by the public health services. Eighty-six (46.7%) patients were in the acute state, 19 (10.3%) in subacute state and 76 (42.9%) in chronic condition. The results show that the positive trend for the TBI group was steeper than for NTBIs. Neuropsychological data are also discussed. Conclusions and clinical rehabilitation impact. We report the first Italian descriptive study on pediatric patients affected by ABI of traumatic or non traumatic etiology. The main points concerning rehabilitation are that major differences between aetiologies must be taken into account and that ABI of any severity in the acute phase may lead to long term disability, confirming the high social and economic impact of this pathology. Our study demonstrates the great importance of providing specialised rehabilitation centers for pediatric patients, and increases awareness of the importance of ABI prevention.	[Gazzellini, S.] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, I-00050 Rome, Italy; [Strazzer, S.; Beretta, E.] La Nostra Famiglia, Eugenio Medea Sci Inst, Bosisio Parini, Lecco, Italy; [Petacchi, M. E.] La Nostra Famiglia, Eugenio Medea Sci Inst, Treviso, Italy; [Menna, M.] Assisi, Ist Seraf, Perugia, Italy; [Cipriani, P.] Stella Maris Sci Inst, Pisa, Italy; [Zampolini, M.] ASL 3 Umbria, Perugia, Italy	Gazzellini, S (corresponding author), Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, Via Torre di Palidoro, I-00050 Rome, Italy.	simone.gazzellini@opbg.net	Castelli, Enrico/J-1887-2012; Strazzer, Sandra/AAH-5712-2019; Zampolini, Mauro/B-7749-2009; Gazzellini, Simone/AAC-2721-2019; Beretta, Elena/AAH-5369-2019	Strazzer, Sandra/0000-0001-8414-6565; Beretta, Elena/0000-0002-8036-7624			Ashwal S, 2004, NEUROREHABILITATION, V19, P349; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Baddeley A. D., 1986, WORKING MEMORY; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Boldrini P, 2004, NEUROL SCI, V25, pS255; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V6, P1; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; JENNETT B, 1975, LANCET, V1, P480; Johnson P, 2006, BRAIN COGNITION, V60, P205; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mazaux JM, 2001, J REHABIL MED, V33, P99; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Meyer P, 2006, ARCH PEDIATRIE, V13, P737, DOI 10.1016/j.arcped.2006.03.023; Piras F, 2011, EUR J PHYS REHAB MED, V47, P149; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sans A, 2009, Rev Neurol, V48 Suppl 2, pS23; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193; Zampolini M., 2003, GIORNALE ITALIANO ME, V17, P15; Zampolini M., 2008, EUR MED PHYS, V44, P1	33	13	13	0	16	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	SEP	2012	48	3					423	431					9	Rehabilitation	Rehabilitation	024EY	WOS:000310093000010	22522434				2021-06-18	
J	Lee, SY; Kim, SS; Kim, CH; Park, SW; Park, JH; Yeo, M				Lee, Seo-Young; Kim, Sam Soo; Kim, Choong-Hyo; Park, Seung-Woo; Park, Jae Hyo; Yeo, Minjoo			Prediction of Outcome after Traumatic Brain Injury Using Clinical and Neuroimaging Variables	JOURNAL OF CLINICAL NEUROLOGY			English	Article						traumatic brain injury; outcome; magnetic resonance imaging	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; PROGNOSTIC VALUE; MODERATE; LESIONS; IMPACT; MR	Background and Purpose The functional outcome of traumatic brain injury (TBI) varies widely. The aim of this study was to identify the factors predicting outcome following TBI. Methods We prospectively enrolled acute TBI patients, and assessed them clinically and radio-logically using brain magnetic resonance imaging (MRI). Functional outcome was measured using the Glasgow Outcome Scale (GOS) at 3 months after TBI. A GOS score of <= 4 was regarded as an unfavorable outcome. We performed multivariate analysis to investigate the association between clinicoradiological variables and outcome. Results Forty-two patients completed the clinical evaluation in the acute phase and outcome measurement at 3 months. Motorcycle accident was associated with unfavorable outcome [odds ratio (OR)=38.3,p=0.022]. If the patients were the victims of the accident, they were more likely to have an unfavorable outcome (OR=21.3, p=0.037). All seven patients with a low Glasgow Coma Scale (GCS) score (i.e., <= 8) at 24 or 48 h after TBI were also found to have an unfavorable outcome. The presence of diffuse axonal injury (DAI) was a significant predicting factor of an unfavorable outcome (OR=8.48,p=0.042). Conclusions Motorcycle accident, being an accident victim, and a lower GCS score at 24 hours or more after the accident were found to be unfavorable prognostic variables. DAI was the only radiologic variable predicting an unfavorable outcome. Thus, it is important to identify DAI by applying MRI in the acute phase. J Clin Neurol 2012;8:224-229	[Kim, Choong-Hyo; Park, Seung-Woo] Kangwon Natl Univ Hosp, Dept Neurosurg, Chunchon 200722, South Korea; [Lee, Seo-Young; Yeo, Minjoo] Kangwon Natl Univ Hosp, Dept Neurol, Chunchon 200722, South Korea; [Kim, Sam Soo] Kangwon Natl Univ Hosp, Dept Radiol, Chunchon 200722, South Korea; [Park, Jae Hyo] Dongguk Univ, Ilsan Hosp, Dept Neurosurg, Goyang, South Korea	Kim, CH (corresponding author), Kangwon Natl Univ Hosp, Dept Neurosurg, 156 Baengnyeong Ro, Chunchon 200722, South Korea.	jeuel@kangwon.ac.kr; mdmju@naver.com			Kangwon National University Hospital	This study was supported by a 2008 Kangwon National University Hospital Grant.	Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	22	13	14	0	6	KOREAN NEUROLOGICAL ASSOC	SEOUL	1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA	1738-6586	2005-5013		J CLIN NEUROL	J. Clin. Neurol.	SEP	2012	8	3					224	229		10.3988/jcn.2012.8.3.224			6	Clinical Neurology	Neurosciences & Neurology	016BG	WOS:000309491700010	23091533	Green Published			2021-06-18	
J	Patzkowski, JC; Blair, JA; Schoenfeld, AJ; Lehman, RA; Hsu, JR				Patzkowski, Jeanne C.; Blair, James A.; Schoenfeld, Andrew J.; Lehman, Ronald A.; Hsu, Joseph R.		Skeletal Trauma Res Consortium STR	Multiple associated injuries are common with spine fractures during war	SPINE JOURNAL			English	Article						Spine trauma; Combat trauma; Associated injuries; Polytrauma	OPERATION ENDURING FREEDOM; IRAQI FREEDOM; TRAUMA; WOUNDS	BACKGROUND CONTEXT: The nature of concomitant injuries associated with spine fractures in American military personnel engaged in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) has been poorly documented in the literature. PURPOSE: To characterize the incidence and epidemiology of associated injuries (AIs) in American military personnel with spine fractures sustained during OEF and OIF from 2001 to 2009. STUDY DESIGN: Retrospective study. PATIENT SAMPLE: American military personnel who were injured in a combat zone and whose medical data were abstracted in the Joint Theater Trauma Registry (JTTR). OUTCOME MEASURES: Not applicable. METHODS: The JTTR was queried using International Statistical Classification of Disease, Ninth Revision codes to identify all individuals who sustained spine injuries in OEF or OIF from October 2001 to December 2009. Medical records of all identified service members were abstracted to ensure accuracy and avoid duplication. Demographic information, including sex, age, and military rank, were obtained for all patients. Information regarding fracture type, spine region, mechanism of injury, and the presence of AIs was collected for all patients. RESULTS: Seventy-eight percent of patients with a spine fracture sustained at least one AI, with an average of 3.4 AIs per patient. Musculoskeletal injuries were most common, followed by chest, abdomen, and traumatic brain injuries. Most patients were injured by an explosive mechanism (62%). Head and face traumas were more common with cervical fractures, chest with thoracic injuries, and abdominopelvic injuries with lumbosacral fractures. Pelvis and acetabulum fractures were common after helicopter crashes, tibia/fibula injuries after explosions, thoracoabdominal injuries after gunshot wounds, and traumatic brain injuries after falls. Most patients (76%) sustained multiple spine fractures. CONCLUSION: Spine fractures sustained in OEF and OIF have high rates of AIs. Musculoskeletal AIs are the most common, but visceral injuries adjacent to the spine fracture frequently occur. Multiple spine injuries are more prevalent after military trauma. Published by Elsevier Inc.	[Patzkowski, Jeanne C.; Blair, James A.] San Antonio Mil Med Ctr, Dept Orthopaed & Rehabil, Ft Sam Houston, TX 78234 USA; [Schoenfeld, Andrew J.] William Beaumont Army Med Ctr, Dept Orthoped, El Paso, TX 79920 USA; [Lehman, Ronald A.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed & Rehabil, Bethesda, MD 20889 USA; [Hsu, Joseph R.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA	Patzkowski, JC (corresponding author), San Antonio Mil Med Ctr, Dept Orthopaed & Rehabil, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	jeanne.patzkowski2@amedd.army.mil	Patzkowski, Jeanne/AAO-2102-2020	Schoenfeld, Andrew/0000-0002-3691-1215	DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); DMRDP; Geneva Foundation	JCP: Nothing to disclose. JAB: Nothing to disclose. AJS: Nothing to disclose. RAL: Grants: DARPA (I, Paid directly to institution/employer), DMRDP (H, Paid directly to institution/employer). JRH: Grants: Geneva Foundation (D, Paid direction to institution/employer).	Bagg Mark R, 2006, J Am Acad Orthop Surg, V14, pS7; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Chen Rigao, 2009, Orthopedics, V32, P322; Chu D, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-137; Cross Jessica D, 2011, J Surg Orthop Adv, V20, P56; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1, DOI 10.5435/00124635-201102001-00002; Hannon M, 2009, J TRAUMA, V67, P1384, DOI 10.1097/TA.0b013e31819ea3e0; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Helgeson MD, 2011, SPINE, V36, pE469, DOI 10.1097/BRS.0b013e3182077fd7; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Laurer H, 2007, EUR J TRAUMA EMERG S, V33, P476, DOI 10.1007/s00068-007-7124-3; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Ragel Brian T, 2009, Spine (Phila Pa 1976), V34, P2400, DOI 10.1097/BRS.0b013e3181b7e585; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; Schoenfeld AJ, 2012, SPINE J, V12, P771, DOI 10.1016/j.spinee.2010.05.004; Vives MJ, 2008, J SPINAL DISORD TECH, V21, P281, DOI 10.1097/BSD.0b013e3181370703	18	13	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430			SPINE J	Spine Journal	SEP	2012	12	9			SI		791	797		10.1016/j.spinee.2011.10.001			7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	016OF	WOS:000309527900012	22054909				2021-06-18	
J	Firsching, R; Piek, J; Skalej, M; Rohde, V; Schmidt, U; Striggow, F				Firsching, Raimund; Piek, Juergen; Skalej, Martin; Rohde, Veit; Schmidt, Uwe; Striggow, Frank		KN38-7271 Study Grp	Early Survival of Comatose Patients after Severe Traumatic Brain Injury with the Dual Cannabinoid CB1/CB2 Receptor Agonist KN38-7271: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						traumatic brain injury; severe head trauma; cannabinoids; cannabinoid receptor agonist	FOCAL CEREBRAL-ISCHEMIA; SEVERE HEAD-INJURY; ENDOCANNABINOID SYSTEM; DEXANABINOL HU-211; PREDICTIVE-VALUE; CLINICAL-TRIAL; STEM LESIONS; BAY 38-7271; CLASSIFICATION; EFFICACY	Background and Study Object Despite many drug trials, no substance has yet been identified that improves the outcome of severe head injury. The dual cannabinoid CB1/CB2 receptor agonist KN38-7271 mediates potent neuroprotection in animal models. We describe here the first randomized, double-blind, prospective, placebo-controlled clinical phase IIa proof-of-concept trial to investigate the safety, pharmacokinetics, and potential efficacy of a cannabinoid receptor agonist in humans. Patients and Methods Out of the 439, 97 comatose patients at 14 European neurosurgical centers met the inclusion criteria. KN38-7271 was administered within 4.5 hours of the injury, and the patients received 1000, 500 mu g, or placebo. The primary analysis was pharmacokinetic; efficacy was measured by survival and by neurological improvement or deterioration 7 and 14 days and 1, 3, and 6 months after the injury. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) were analyzed from start of treatment to end of day 7. Results Survival rates within 1 month of the injury were significantly better in the treatment groups than in the placebo group (high-dose, Kaplan-Meier difference on day 30 + 0.12 with p = 0.043; low-dose, difference +0.15 with p = 0.011) but this effect was not seen after 6 months. Critical ICP and CPP were less extreme and less frequent in the treatment group. There were no severe and no serious adverse effects that could be attributed to KN38-7271. Conclusions KN38-7271 appeared beneficial in the acute early phase of the comatose patient after a head injury. Its use was safe and well tolerated by patients. These results may provide the basis for further phase II/III trials in larger study populations.	[Firsching, Raimund] Univ Magdeburg, Univ Klinikum, Klin Neurochirurg, D-39120 Magdeburg, Germany; [Piek, Juergen] Chirurg Univ Klin Rostock, Abt Neurochirurg, Rostock, Germany; [Skalej, Martin] Univ Magdeburg, Univ Klinikum, Inst Neuroradiol, Zentrum Radiol, D-39120 Magdeburg, Germany; [Rohde, Veit] Univ Gottingen, Klin & Poliklin Neurochirurg, D-37073 Gottingen, Germany; [Schmidt, Uwe] StatConsult Gesell Klin & Versorgungsforsch mbH, Biometrie, Magdeburg, Germany; [Striggow, Frank] KeyNeurotek Pharmaceut Ag, Magdeburg, Germany; [Striggow, Frank] DZNE, Arbeitsgrp Neurodegenerat & Intervent Strategien, Magdeburg, Germany	Firsching, R (corresponding author), Univ Magdeburg, Univ Klinikum, Klin Neurochirurg, Leipziger Str 44, D-39120 Magdeburg, Germany.	raimund.firsching@med.ovgu.de	Skalej, Martin/G-2122-2013	Skalej, Martin/0000-0001-9506-619X	KeyNeurotek Pharmaceuticals AG, Magdeburg, Germany	This study was sponsored by KeyNeurotek Pharmaceuticals AG, Magdeburg, Germany. The authors would like to thank all patients and their involved relatives for their agreement to participate in this study. We greatly acknowledge the contribution and commitment of our colleagues in the KN38-7271 study group, and of H. Riethmuller-Winzen, O. Mielke, K. Barnitzke, M. Hartleb, H. Koppitz, H. Kurzidim, and A. Platz. Special thanks go to Prof. G. Murray for advising us on the optimization of study endpoint criteria and Prof. H. E. von der Leyen, who provided consultation as Medical Expert in the study.	[Anonymous], 2007, DTSCH GES NEUR LEITL; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bedell EA, 2002, CRIT CARE MED, V30, P710, DOI 10.1097/00003246-200203000-00041; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; Brewster ME, 1997, INT J CLIN PHARM TH, V35, P361; BRIHAYE J, 1978, ACTA NEUROCHIR, V40, P181, DOI 10.1007/BF01773126; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2008, ACTA NEUROCHIR SUPPL, V102, P237, DOI 10.1007/978-3-211-85578-2_45; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mauler F, 2003, CNS DRUG REV, V9, P343; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; MECHOULAM R, 1988, EXPERIENTIA, V44, P762, DOI 10.1007/BF01959156; Miller JD, 1986, ADV NEUROTRAUMATOLOG, V1, P230; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Nagayama T, 1999, J NEUROSCI, V19, P2987; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Wolf SA, 2008, CURR PHARM DESIGN, V14, P2266, DOI 10.2174/138161208785740090	35	13	14	0	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	AUG	2012	73	4					204	216		10.1055/s-0032-1304815			13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	175UV	WOS:000321260000003	22696266				2021-06-18	
J	Phelan, HA; Eastman, AL; Madden, CJ; Aldy, K; Berne, JD; Norwood, SH; Scott, WW; Bernstein, IH; Pruitt, J; Butler, G; Rogers, L; Minei, JP				Phelan, Herb A.; Eastman, Alexander L.; Madden, Christopher J.; Aldy, Kim; Berne, John D.; Norwood, Scott H.; Scott, William W.; Bernstein, Ira H.; Pruitt, Jeffrey; Butler, Gordon; Rogers, Lowery; Minei, Joseph P.			TBI risk stratification at presentation: A prospective study of the incidence and timing of radiographic worsening in the Parkland Protocol	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Advanced Technology Applications for Combat Casualty Care Conference (ATACCC)	AUG 15-18, 2011	Fort Lauderdale, FL			Traumatic brain injury; venous thromboembolism; progression; prophylaxis	MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM PROPHYLAXIS; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; ENOXAPARIN PROPHYLAXIS; SAFETY; HEAD	BACKGROUND: We have created a theoretical algorithm for venous thromboembolism prophylaxis after traumatic brain injury (TBI) known as the Parkland Protocol, which stratifies patients into low-, medium-, and high-risk categories for spontaneous progression of hemorrhage. This prospective study characterizes the incidence and timing of radiographic progression of the TBI patterns in these categories. METHODS: Inclusion criterion was presentation with intracranial blood between February 2010 and March 2011; exclusion was receipt of only one computed tomographic scan of the head during the inpatient stay or preinjury warfarin. At admission, all patients were preliminarily categorized per the Parkland Protocol as follows: low risk (LR), patients meeting the modified Berne-Norwood criteria; moderate risk(MR), injuries larger than the modified Berne-Norwood criteria without requiring a neurosurgical procedure; high risk (HR), any patient with a craniotomy/monitor. RESULTS: A total of 245 patients with intracranial hemorrhage were enrolled during the 13-month study period. Of patients preliminarily classified as LR at admission (n = 136), progression was seen in 25.0%. Spontaneous worsening was seen in 7.4% of LR patients at 24 hours after injury, and no LR patients progressed at 72 hours after injury. In patients initially classified as MR at admission (n = 42), progression was seen in 42.9%, with 91.5% of patients demonstrating stable computed tomographic head scans at 72 hours after injury. In patients initially classified as HR (n = 67), 64.2% demonstrated spontaneous progression of their TBI patterns, with 10.5% continuing to progress at 72 hours after injury. Most repeat scans were performed as routinely scheduled studies (81-91%). CONCLUSION: Increases in the incidence of spontaneous worsening were seen as severities of injury progressed from the Parkland Protocol's LR to MR to HR arms. The time frames for these spontaneous worsenings seem to be such that the protocol's theoretical recommendations for venous thromboembolism prophylaxis are worth pursuing as future points of investigation. (J Trauma Acute Care Surg. 2012; 73: S122-S127. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Phelan, Herb A.] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Surg, Div Burns Trauma Crit Care, Dallas, TX 75390 USA; [Madden, Christopher J.; Scott, William W.] Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Div Burns Trauma Crit Care & Neurol Surg, Dallas, TX USA; [Berne, John D.] E Texas Med Ctr, Dept Surg, Tyler, TX USA; [Norwood, Scott H.] Univ S Florida, Med Ctr, Dept Surg, Hudson, FL USA; [Bernstein, Ira H.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci Biostat, Dallas, TX USA; [Pruitt, Jeffrey; Butler, Gordon; Rogers, Lowery] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX USA	Phelan, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Parkland Mem Hosp, Dept Surg, Div Burns Trauma Crit Care, 5323 Harry Hines Blvd,E5-508A, Dallas, TX 75390 USA.	herb.phelan@utsouthwestern.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 KL2 RR024983-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024983] Funding Source: NIH RePORTER		Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS32, DOI DOI 10.1089/NEU.2007.9991; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Depew AJ, 2008, AM SURGEON, V74, P906; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d	13	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73			1			S122	S127		10.1097/TA.0b013e3182606327			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	992VP	WOS:000307808500022	22847081				2021-06-18	
J	Samanta, S; Ghoshal, A; Bhattacharya, K; Saha, B; Walden, P; Mandal, C				Samanta, Sajal; Ghoshal, Angana; Bhattacharya, Kaushik; Saha, Bibhuti; Walden, Peter; Mandal, Chitra			Sialoglycosylation of RBC in Visceral Leishmaniasis Leads to Enhanced Oxidative Stress, Calpain-Induced Fragmentation of Spectrin and Hemolysis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACETYLATED SIALIC ACIDS; TRAUMATIC BRAIN-INJURY; ERYTHROCYTE-MEMBRANE; BINDING LECTIN; PHOSPHATIDYLSERINE EXTERNALIZATION; 9-O-ACETYLATED SIALOGLYCOPROTEINS; DIFFERENTIAL EXPRESSION; DONOVANI PROMASTIGOTES; MEDIATED HEMOLYSIS	Visceral leishmaniasis (VL) caused by the intracellular parasite Leishmania donovani accounts for an estimated 12 million cases of human infection. It is almost always associated with anemia, which severely complicates the disease course. However, the pathological processes leading to anemia in VL have thus far not been adequately characterized to date. In studying the glycosylation patterns of peripheral blood cells we found that the red blood cells (RBC) of VL patients (RBCVL) express eight 9-O-acetylated sialoglycoproteins (9-O-AcSGPs) that are not detected in the RBC of healthy individuals (RBCN). At the same time, the patients had high titers of anti-9-O-AcSGP IgG antibodies in their sera. These two conditions appear to be linked and related to the anemic state of the patients, as exposure of RBCVL but not RBCN to anti-9-O-AcSGPs antibodies purified from patient sera triggered a series of responses. These included calcium influx via the P/Q-type but not L-type channels, activation of calpain I, proteolysis of spectrin, enhanced oxidative stress, lipid peroxidation, externalization of phosphatidyl serine with enhanced erythrophagocytosis, enhanced membrane fragility and, finally, hemolysis. Taken together, this study suggests that the enhanced hemolysis is linked to an impairment of membrane integrity in RBCVL which is mediated by ligand-specific interaction of surface 9-O-AcSGPs. This affords a potential explanation for the structural and functional features of RBCVL which are involved in the hemolysis related to the anemia which develops in VL patients.	[Samanta, Sajal; Ghoshal, Angana; Bhattacharya, Kaushik; Mandal, Chitra] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India; [Saha, Bibhuti] Sch Trop Med, Dept Trop Med, Kolkata, India; [Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, Berlin, Germany	Samanta, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India.	chitra_mandal@yahoo.com			CSIR-IICB; Department of Biotechnology [GAP235]; Indian Council of Medical Research, New DelhiIndian Council of Medical Research (ICMR) [GAP266]; J.C. Bose FellowshipDepartment of Science & Technology (India); Department of Science and Technology, Govt. of IndiaDepartment of Science & Technology (India) [P90807]	This work received financial support from the CSIR-IICB, Department of Biotechnology (GAP235) (http://dbtindia.nic.in/index.asp), Indian Council of Medical Research (GAP266) (http://www.icmr.nic.in/), New Delhi, J.C. Bose Fellowship, Department of Science and Technology (P90807) (http://www.dst.gov.in/), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED H, 1989, J BIOL CHEM, V264, P18673; Ansar W, 2009, GLYCOCONJUGATE J, V26, P1151, DOI 10.1007/s10719-009-9236-y; Bandyopadhyay S, 2004, GLYCOCONJUGATE J, V20, P531; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bennett V, 2001, PHYSIOL REV, V81, P1353; BLUMENFELD N, 1991, BLOOD, V77, P849; BORENSTAINBENYASHAR V, 1993, AM J HEMATOL, V44, P63; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chatterjee M, 1998, GLYCOCONJUGATE J, V15, P1141, DOI 10.1023/A:1006963806318; Chava AK, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P71; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; Chava AK, 2002, J IMMUNOL METHODS, V270, P1, DOI 10.1016/S0022-1759(02)00216-8; CROALL DE, 1986, BIOCHIM BIOPHYS ACTA, V882, P287, DOI 10.1016/0304-4165(86)90250-3; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; de Jong K, 2001, BLOOD, V98, P860, DOI 10.1182/blood.V98.3.860; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Ghosh S, 2005, ANN HEMATOL, V84, P76, DOI 10.1007/s00277-004-0933-0; Ghosh S, 2007, GLYCOCONJUGATE J, V24, P17, DOI 10.1007/s10719-006-9007-y; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Ghoshal A, 2011, GLYCOCONJ J, V26, P675; Ghoshal A, 2008, MINI-REV MED CHEM, V8, P358, DOI 10.2174/138955708783955980; Ghoshal A, 2009, CLIN VACCINE IMMUNOL, V16, P889, DOI 10.1128/CVI.00453-08; GLASER T, 1994, P NATL ACAD SCI USA, V91, P7879, DOI 10.1073/pnas.91.17.7879; HU RJ, 1991, J BIOL CHEM, V266, P18200; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Lee JC, 2006, NEUROCHEM RES, V31, P989, DOI 10.1007/s11064-006-9104-0; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lijnen P, 1998, AM J HYPERTENS, V11, P81, DOI 10.1016/S0895-7061(97)00368-3; Mahajan V, 2007, J TROP PEDIATRICS, V53, P284, DOI 10.1093/tropej/fmm018; Malorni W, 2000, FEBS LETT, V468, P125, DOI 10.1016/S0014-5793(00)01187-X; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Mandal D, 2002, FEBS LETT, V513, P184, DOI 10.1016/S0014-5793(02)02294-9; MORTENSEN AM, 1991, TOXICOL APPL PHARM, V110, P435, DOI 10.1016/0041-008X(91)90045-G; Mukherjee K, 2007, BIOCHEM BIOPH RES CO, V362, P651, DOI 10.1016/j.bbrc.2007.08.048; Pal S, 2000, GLYCOBIOLOGY, V10, P539, DOI 10.1093/glycob/10.6.539; Pal S, 2004, GLYCOBIOLOGY, V14, P859, DOI 10.1093/glycob/cwh111; Pal S, 2004, INT J CANCER, V111, P270, DOI 10.1002/ijc.20246; PANT HC, 1983, BIOCHEM BIOPH RES CO, V117, P372, DOI 10.1016/0006-291X(83)91210-X; PRADHAN D, 1994, MOL MEMBR BIOL, V11, P181, DOI 10.3109/09687689409162237; Resmi H, 2001, CLIN EXP MED, V1, P187, DOI 10.1007/s102380100002; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Sen G, 2001, ANN HEMATOL, V80, P32, DOI 10.1007/s002770000240; SEN GT, 1995, CARBOHYD RES, V268, P115, DOI 10.1016/0008-6215(94)00311-3; Sharma V, 1998, AM J TROP MED HYG, V58, P551, DOI 10.4269/ajtmh.1998.58.551; Sharma V, 2000, GLYCOCONJUGATE J, V17, P887, DOI 10.1023/A:1010925414222; Shukla M, 2006, NEUROCHEM INT, V48, P108, DOI 10.1016/j.neuint.2005.09.001; Siebert HC, 1996, GLYCOBIOLOGY, V6, P561, DOI 10.1093/glycob/6.6.561-b; Sinha D, 2000, TRENDS GLYCOSCI GLYC, V12, P17, DOI 10.4052/tigg.12.17; Starodubtseva MN, 2008, B EXP BIOL MED+, V145, P99, DOI 10.1007/s10517-008-0036-3; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WILSON MJ, 1993, BIOCHEMISTRY-US, V32, P11302, DOI 10.1021/bi00093a006; WOODRUFF AW, 1972, BRIT J HAEMATOL, V22, P319, DOI 10.1111/j.1365-2141.1972.tb05678.x; World Health Organization, 2010, TECH REP SER, V949, P186; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	61	13	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42361	10.1371/journal.pone.0042361			13	Multidisciplinary Sciences	Science & Technology - Other Topics	982LS	WOS:000307045600094	22860118	DOAJ Gold, Green Published			2021-06-18	
J	Joseph, MS; Ying, Z; Zhuang, YM; Zhong, H; Wu, AG; Bhatia, HS; Cruz, R; Tillakaratne, NJK; Roy, RR; Edgerton, VR; Gomez-Pinilla, F				Joseph, M. Selvan; Ying, Zhe; Zhuang, Yumei; Zhong, Hui; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando			Effects of Diet and/or Exercise in Enhancing Spinal Cord Sensorimotor Learning	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SATURATED-FAT DIET; DOCOSAHEXAENOIC ACID; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; IN-VIVO; MEMBRANE HOMEOSTASIS; PROTEIN-SYNTHESIS; DENTATE GYRUS	Given that the spinal cord is capable of learning sensorimotor tasks and that dietary interventions can influence learning involving supraspinal centers, we asked whether the presence of omega-3 fatty acid docosahexaenoic acid (DHA) and the curry spice curcumin (Cur) by themselves or in combination with voluntary exercise could affect spinal cord learning in adult spinal mice. Using an instrumental learning paradigm to assess spinal learning we observed that mice fed a diet containing DHA/Cur performed better in the spinal learning paradigm than mice fed a diet deficient in DHA/Cur. The enhanced performance was accompanied by increases in the mRNA levels of molecular markers of learning, i.e., BDNF, CREB, CaMKII, and syntaxin 3. Concurrent exposure to exercise was complementary to the dietary treatment effects on spinal learning. The diet containing DHA/Cur resulted in higher levels of DHA and lower levels of omega-6 fatty acid arachidonic acid (AA) in the spinal cord than the diet deficient in DHA/Cur. The level of spinal learning was inversely related to the ratio of AA: DHA. These results emphasize the capacity of select dietary factors and exercise to foster spinal cord learning. Given the non-invasiveness and safety of the modulation of diet and exercise, these interventions should be considered in light of their potential to enhance relearning of sensorimotor tasks during rehabilitative training paradigms after a spinal cord injury.	[Joseph, M. Selvan; Ying, Zhe; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Zhuang, Yumei; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Zhong, Hui; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	Joseph, MS (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Bhatia, Harsharan singh/AAR-4628-2021	Joseph, Michael Selvan/0000-0002-0620-9249; Bhatia, Harsharan Singh/0000-0001-9912-8263	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS056413, NS056413, R01 NS050465]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health R01 NS056413, Diversity Supplement NS056413, and R01 NS050465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Alberini CM, 1999, J EXP BIOL, V202, P2887; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; ARAUJO DM, 1989, BRAIN RES, V484, P130, DOI 10.1016/0006-8993(89)90355-7; Baumbauer KM, 2009, J NEUROSCI, V29, P14383, DOI 10.1523/JNEUROSCI.3583-09.2009; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Chung WL, 2008, J NUTR, V138, P1165; Chytrova G, 2009, BRAIN RES; Cole Greg M., 2006, Nutrition and Health (Bicester), V18, P249; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; DELEON R, 1994, BRAIN RES, V654, P241, DOI 10.1016/0006-8993(94)90485-5; Edgerton VE, 2009, ENCY NEUROSCIENCE, P629; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2010, NEUROSCIENCE, V168, P130, DOI 10.1016/j.neuroscience.2010.02.070; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2011, PREV MED, V52, pS75, DOI 10.1016/j.ypmed.2011.01.023; Grau James W, 2006, Behav Cogn Neurosci Rev, V5, P191, DOI 10.1177/1534582306289738; Grau JW, 1998, BEHAV NEUROSCI, V112, P1366, DOI 10.1037/0735-7044.112.6.1366; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; Harkema S. J., 2011, ARCH PHYS MED REHABI; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797; Hashimoto M, 2006, CLIN EXP PHARMACOL P, V33, P934, DOI 10.1111/j.1440-1681.2006.04467.x; HORRIDGE GA, 1962, NATURE, V193, P899, DOI 10.1038/193899a0; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Igarashi M, 2011, J NEUROCHEM; Igarashi M., 2011, BIOCH BIOPHYS ACTA; Jindrich DL, 2009, J NEUROSCI METH, V182, P250, DOI 10.1016/j.jneumeth.2009.06.001; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lim SY, 2001, J NUTR, V131, P319; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma DX, 2010, BRAIN RES, V1330, P1, DOI 10.1016/j.brainres.2010.03.002; Maher P, 2010, NEUROBIOL AGING, V31, P706, DOI 10.1016/j.neurobiolaging.2008.05.020; Marini AM, 2008, CNS NEUROL DISORD-DR, V7, P382, DOI 10.2174/187152708786441849; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Rodger J, 1998, J NEUROCHEM, V71, P666; Rongo C, 2002, BIOESSAYS, V24, P223, DOI 10.1002/bies.10057; ROY RR, 1992, LAB ANIM SCI, V42, P335; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shah PK, 2012, EUR J NEUROSCI; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Teague WE, 2002, CELL MOL BIOL LETT, V7, P262; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Yamashima T, 2008, PROG NEUROBIOL, V84, P105, DOI 10.1016/j.pneurobio.2007.11.002; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	87	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41288	10.1371/journal.pone.0041288			10	Multidisciplinary Sciences	Science & Technology - Other Topics	977GL	WOS:000306644600067	22911773	DOAJ Gold, Green Published			2021-06-18	
J	Fries, R; Schrohe, K; Lotz, F; Arndt, G				Fries, R.; Schrohe, K.; Lotz, F.; Arndt, G.			Application of captive bolt to cattle stunning - a survey of stunner placement under practical conditions	ANIMAL			English	Article						stunning; cattle; shot precision; captive bolt; animal welfare	SLAUGHTER PLANTS; CONCUSSION	In two cattle head deboning plants, a total of 8879 cattle skulls were investigated for number and precision of shots. Deviation from the ideal position on the forehead and the direction of the shot were measured, results were then attributed to three classes of precision. In all, 64.7% of the skulls in plant 1 and 65.3% in plant 2 were shot from the ideal position and in the ideal direction. A medium precision was observed in 31.3% and 31.5% of cases, 4.0% and 3.1%, respectively, of the skulls indicated a poor precision. In both plants, skulls with more than one shot hole were observed. Shot holes may indicate the precision of a shot, and thus the risk of suffering during the sensitive time of stunning. In addition to observations at the time of stunning, the observation of shot holes on skulls at random or in total after a day's slaughter can reflect the shooting precision.	[Fries, R.; Schrohe, K.] Free Univ Berlin, Fac Vet Med, Inst Meat Hyg & Technol, D-14195 Berlin, Germany; [Lotz, F.; Arndt, G.] Free Univ Berlin, Fac Vet Med, Inst Biometr & Data Proc, D-14163 Berlin, Germany	Fries, R (corresponding author), Free Univ Berlin, Fac Vet Med, Inst Meat Hyg & Technol, Brummerstr 10, D-14195 Berlin, Germany.	fries.reinhard@vetmed.fu-berlin.de					EFSA Panel on Animal Health and Welfare (AHAW), 2004, EFSA J, V45, P1; EU, 2004, AHAW04027 EU EFSA; FAO, 2004, GOOD PRACT MEAT IND, p[9, 14]; FINNIE JW, 1995, NEW ZEAL VET J, V43, P183, DOI 10.1080/00480169.1995.35886; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Grandin T, 1998, J AM VET MED ASSOC, V212, P36; Grandin T, 2002, J AM VET MED ASSOC, V221, P1258, DOI 10.2460/javma.2002.221.1258; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Hagen U, 2002, P ARB ARB LEB DVG GA, P109; Ilgert H, 1985, THESIS MED VET BERLI; Kaegi B, 1988, THESIS MED VET ZURIC; PALMER AC, 1982, VET REC, V111, P575; Schrohe K, THESIS MED VET BERLI	13	13	13	0	21	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1751-7311			ANIMAL	Animal	JUL	2012	6	7					1124	1128		10.1017/S1751731111002667			5	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	949VA	WOS:000304602900012	23031473	Other Gold			2021-06-18	
J	Hall, A; Grohn, B; Nalder, E; Worrall, L; Fleming, J				Hall, Alexandra; Grohn, Brooke; Nalder, Emily; Worrall, Linda; Fleming, Jennifer			A Mixed Methods Study of the Experience of Transition to the Community of Working-Aged People with Non-Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Aneurysm; stroke; psychosocial integration; qualitative	QUALITY-OF-LIFE; STROKE SURVIVORS; FAMILY CAREGIVERS; HOME; RECOVERY; REHABILITATION; SUPPORT; NEEDS	Background and aims: The 'transition' phase from hospital to home following brain injury is well established as a critical period of adjustment for individuals and their families. There is, however, a lack of knowledge about the experience of transition following nontraumatic brain injury (e.g., stroke, aneurysm) for individuals of working age. The purpose of this study was to explore the transition experiences of individuals with nontraumatic brain injury using mixed methods approach. Methods: Six individuals with nontraumatic brain injury were recruited from a larger study using maximum variation sampling criteria. Individuals participated in semistructured interviews at 6-months postdischarge and completed quantitative measures of psychosocial outcomes predischarge and at 6-months postdischarge. Results: Qualitative content analysis of interviews identified three themes: (1) changes in role performance, (2) support and services and (3) coping with life after brain injury. The transition experience was characterised by loss of valued roles including driving and work, identified as major barriers to regaining independence postdischarge. Informal support provided by family and friends were relied on, while formal supports were accessed infrequently. Life post-injury presented a number of challenges including adjusting to changes in physical and cognitive abilities and a fear of reinjury. Qualitative data were supported by an overall trend of improved functioning on the quantitative measures over the 6 months. Conclusions: Key life circumstances of working age adults with nontraumatic brain injury influence the transition experience. Clinically, the findings support the need for individualised, structured transition services pre- and postdischarge for this group.	[Worrall, Linda] Univ Queensland, NHMRC CCRE Aphasia Rehabil, St Lucia, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Brisbane, Qld, Australia; [Fleming, Jennifer] Ctr Functioning & Hlth Res, Brisbane, Qld, Australia	Worrall, L (corresponding author), Univ Queensland, NHMRC CCRE Aphasia Rehabil, St Lucia, Qld 4072, Australia.	l.worrall@uq.edu.au	Worrall, Linda/D-2579-2010	Worrall, Linda/0000-0002-3283-7038; Ryan, Brooke/0000-0002-6053-7614	National Stroke Foundation; ARCAustralian Research Council [LP0776294]	The authors would like to thank the staff, patients and their families in the brain injury rehabilitation unit and acute neurosciences unit and our partner organisations, Department of Communities (Disability Services) and the Acquired Brain Injury Outreach Service for the larger research project. This study was supported by a National Stroke Foundation Honours Grant awarded to A. Hall and an ARC Linkage Grant (LP0776294) awarded to J. Fleming and L. Worall.	Australian Institute of Health Welfare, 2006, AUSTR HLTH 2006; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Burton CR, 2000, J ADV NURS, V32, P301, DOI 10.1046/j.1365-2648.2000.01477.x; Cameron JI, 2008, PATIENT EDUC COUNS, V70, P305, DOI 10.1016/j.pec.2007.10.020; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; Creswell J. W., 2017, DESIGNING CONDUCTING; Dolan P, 2002, MED CARE, V40, P442, DOI 10.1097/00005650-200205000-00009; Ellis-Hill C, 2009, DISABIL REHABIL, V31, P61, DOI 10.1080/09638280701775289; GLASS TA, 1992, SOC SCI MED, V34, P1249, DOI 10.1016/0277-9536(92)90317-J; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kirkevold M, 2002, DISABIL REHABIL, V24, P887, DOI 10.1080/09638280210142239; Kvigne Kari, 2004, Health Care Women Int, V25, P370, DOI 10.1080/07399330490278376; Kwok T, 2006, ARCH PHYS MED REHAB, V87, P1177, DOI 10.1016/j.apmr.2006.05.015; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Lawrence Maggie, 2010, Br J Nurs, V19, P241; LEWINTER M, 1995, DISABIL REHABIL, V17, P3, DOI 10.3109/09638289509166621; Lister R., 1999, BRIT J OCCUPATIONAL, V62, P514; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Malec J. F., 2003, MANUAL MAYO PORTLAND; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Michels N, 1988, Home Health Care Serv Q, V9, P29, DOI 10.1300/J027v09n01_03; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Nalder E., BRAIN INJUR IN PRESS; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; National Stroke Foundation, 2010, FACTS FIG STAT; National Stroke Foundation, 2007, WALK OUR SHOES STROK; National Stroke Foundation, 2010, CLIN GUID STROK MAN; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; O'Connell B, 2001, J Qual Clin Pract, V21, P120, DOI 10.1046/j.1440-1762.2001.00426.x; Olofsson A, 2005, CLIN REHABIL, V19, P433, DOI 10.1191/0269215505cr788oa; Patomella AH, 2009, DISABIL REHABIL, V31, P726, DOI 10.1080/09638280802306539; Pound P, 1998, CLIN REHABIL, V12, P338, DOI 10.1191/026921598677661555; POUND P, 1995, BMJ-BRIT MED J, V311, P18, DOI 10.1136/bmj.311.6996.18; Rittman M, 2004, J REHABIL RES DEV, V41, P259, DOI 10.1682/JRRD.2003.06.0099; Rittman M, 2007, TOP STROKE REHABIL, V14, P21, DOI 10.1310/tsr1402-21; Roding J, 2003, DISABIL REHABIL, V25, P867, DOI 10.1080/0963828031000122276; Schlossberg NK, 1984, COUNSELING ADULTS TR; SECREST J, 2000, REHABILITATION NURSI, V25, P93, DOI DOI 10.1002/J.2048-7940.2000.TB01877.X; Smith LN, 2004, J ADV NURS, V46, P235, DOI 10.1111/j.1365-2648.2004.02983.x; Stone SD, 2005, DISABIL REHABIL, V27, P293, DOI 10.1080/09638280400008990; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Townend W, 2001, J NEUROL NEUROSUR PS, V70, P267; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Wiles R, 2002, DISABIL REHABIL, V24, P841, DOI 10.1080/09638280210142158; Wissel J., J STROKE CE IN PRESS	46	13	13	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646			BRAIN IMPAIR	Brain Impair.	JUL	2012	13	1			SI		85	98		10.1017/BrImp.2012.7			14	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	964VQ	WOS:000305725200008					2021-06-18	
J	Jourdan, C; Brugel, D; Hubeaux, K; Toure, H; Laurent-Vannier, A; Chevignard, M				Jourdan, Claire; Brugel, Dominique; Hubeaux, Katelyne; Toure, Hanna; Laurent-Vannier, Anne; Chevignard, Mathilde			Weight gain after childhood traumatic brain injury: a matter of concern	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							PITUITARY-FUNCTION; FOOD-INTAKE; OBESITY; CRANIOPHARYNGIOMA; HYPOPITUITARISM; CHILDREN	Aim The aim of the study was to assess weight changes after traumatic brain injury (TBI) in children and the factors influencing them. Method We conducted a longitudinal observational study of children with TBI of mixed severity who were consecutively admitted to one rehabilitation department (39 children; 23 males, 16 females; median age 8y 7mo; 25th to 75th centiles 3y 7mo11y 6mo). Weight and height before TBI were obtained from the childrens records and were measured monthly for 1 year after TBI. Body mass index (BMI) and BMI z-scores were calculated, and pre-TBI values were compared with the final values using paired tests. Linear mixed-effect interaction models were used to assess the effect of various factors on z-score evolution. Results Z-score curves revealed early weight loss followed by a rapid increase in weight. The mean BMI gain over the period under study was 0.9kg/m(2) (p < 0.001) and the mean z-score gain was 0.4 (p = 0.006). Six children had become overweight by the time of final assessment. Factors associated with a greater rate of increase in the post-TBI z-score were mobility restriction, male sex, and older age. Global pre- to post-TBI weight gain was significantly higher in males (z-score 0.7). Pituitary hormonal testing was available for 17 children at 3 months and for 27 at 1 year. Growth hormone deficiency was detected in one child. Interpretation Weight gain of children during the first year after TBI was rapid and excessive. Male sex was a risk factor for excessive weight gain.	[Jourdan, Claire] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Dept Phys Med & Rehabil, F-92380 Garches, France; [Jourdan, Claire] Univ Versailles St Quentin, UFR Med, Guyancourt, France; [Brugel, Dominique; Toure, Hanna; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Neurol Injuries, St Maurice, France; [Hubeaux, Katelyne] Hop Morvan, Dept Phys Med & Rehabil, Brest, France	Jourdan, C (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France.	claire.jourdan@rpc.aphp.fr					Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Ahmet A, 2006, J PEDIATR ENDOCR MET, V19, P121; [Anonymous], 2002, REC HAUT AUT SANT PR; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dolberg OT, 2005, PSYCHOPHARMACOLOGY, V179, P838, DOI 10.1007/s00213-004-2117-y; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hamchaoui S, 2010, CLIN NUTR, V5, P58; Harz KJ, 2003, J CLIN ENDOCR METAB, V88, P5227, DOI 10.1210/jc.2002-021797; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lek N, 2009, ARCH DIS CHILD, V94, P702, DOI 10.1136/adc.2008.147165; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lustig RH, 2001, PEDIATR CLIN N AM, V48, P909, DOI 10.1016/S0031-3955(05)70348-5; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Muller HL, 2001, KLIN PADIATR, V213, P244, DOI 10.1055/s-2001-16855; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Patradoon-Ho P, 2005, Pediatr Rehabil, V8, P303, DOI 10.1080/13638490500049578; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Sharples PM, 1998, INJURY YOUNG, P151; World Health Organization (WHO), 2009, ANTHROPLUS PERS COMP	28	13	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUL	2012	54	7					624	628		10.1111/j.1469-8749.2012.04291.x			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	958KK	WOS:000305235200015	22524689				2021-06-18	
J	Luo, JM; Liu, B; Xie, ZY; Ding, S; Zhuang, ZR; Lin, L; Guo, YC; Chen, H; Yu, XJ				Luo, JianMing; Liu, Bin; Xie, ZeYu; Ding, Shan; Zhuang, ZeRui; Lin, Lan; Guo, YanChun; Chen, Hui; Yu, Xiaojun			Comparison of manually shaped and computer-shaped titanium mesh for repairing large frontotemporoparietal skull defects after traumatic brain injury	NEUROSURGICAL FOCUS			English	Article						cranioplasty; titanium mesh; skull defect; frontotemporoparietal	CRANIOPLASTY; RECONSTRUCTION; IMPLANTS	Object. The object of this study was to compare the effects and complications of manual and computer-aided shaping of titanium meshes for repairing large frontotemporoparietal skull defects following traumatic brain injury. Methods. From March 2005 to June 2011, 161 patients with frontotemporoparietal skull defects were observed. Patients were divided into 2 groups according to the repair materials used for cranioplasty: 83 cases used computer-aided shaping for the titanium mesh, whereas the remaining 78 cases used a manually shaped titanium mesh. The advantages and disadvantages of the 2 methods were compared. Results. No case of titanium mesh loosening occurred in either group. Subcutaneous fluid collection, titanium mesh tilt, and temporal muscle pain were the most common complications. In the manually shaped group, there were 14 cases of effusion, 10 cases of titanium mesh tilt, and 15 cases of temporal muscle pain. In the computer-aided group, there were 6 cases of effusion, 3 cases of titanium mesh tilt, and 6 cases of temporal muscle pain. The differences were significant between the 2 groups (p < 0.05). Other common complications were scalp infection, exposure of titanium mesh, epidural hematoma, and seizures. In the computer-aided group, the operative time decreased (p < 0.01), the number of screws used was reduced (p < 0.01), and the satisfaction of patients was significantly increased (p < 0.05). Conclusions. Computer-aided shaping of titanium mesh for repairing large frontotemporoparietal skull defects decreases postoperative complications and the operative duration, reduces the number of screws used, increases the satisfaction of patients, and restores the appearance of the patient's head, making it an ideal choice for cranioplasty. (http://thejns.org/doi/abs/10.3171/2012.2.FOCUS129)	[Yu, Xiaojun] Shantou Univ Med Coll, Dept Forens Med, Shantou City 515031, Guangdong, Peoples R China; [Luo, JianMing; Liu, Bin; Xie, ZeYu; Ding, Shan; Zhuang, ZeRui; Lin, Lan; Guo, YanChun; Chen, Hui] Shantou Univ Med Coll, Affiliated Hosp 2, Dept Neurosurg, Shantou City 515031, Guangdong, Peoples R China	Yu, XJ (corresponding author), Shantou Univ Med Coll, Dept Forens Med, Xinling Rd 22, Shantou City 515031, Guangdong, Peoples R China.	cnxjyu@yahoo.com.cn			National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458]	This work was supported by a grant from the National Natural Science Foundation Council of China (no. 30772458).	BLAIR GAS, 1976, BRIT MED J, V2, P907, DOI 10.1136/bmj.2.6041.907; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chiarini L, 2004, J CRANIO MAXILL SURG, V32, P5, DOI 10.1016/j.jcms.2003.08.005; D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Durand J L, 1997, Ann Chir Plast Esthet, V42, P75; EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7; GLADSTONE HB, 1995, OTOLARYNG CLIN N AM, V28, P381; GORDON DS, 1974, BRIT MED J, V2, P478, DOI 10.1136/bmj.2.5917.478; Heissler E, 1998, INT J ORAL MAX SURG, V27, P334, DOI 10.1016/S0901-5027(98)80060-X; Joffe JM, 1999, INT J ORAL MAX SURG, V28, P309; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Pou Anna M, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P240, DOI 10.1097/00020840-200308000-00004; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026	17	13	13	1	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUL	2012	33	1							E13	10.3171/2012.2.FOCUS129			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	968PX	WOS:000305997400014	22746230				2021-06-18	
J	Sharma, D; Brown, MJ; Curry, P; Noda, S; Chesnut, RM; Vavilala, MS				Sharma, Deepak; Brown, Michelle J.; Curry, Parichat; Noda, Sakura; Chesnut, Randall M.; Vavilala, Monica S.			Prevalence and Risk Factors for Intraoperative Hypotension During Craniotomy for Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intraoperative hypotension; traumatic brain injury; craniotomy	VENTRICULAR DIASTOLIC FUNCTION; BLOOD-PRESSURE; PROPOFOL; SEVOFLURANE; ANESTHESIA; HYPOTHERMIA; ISOFLURANE; HEMATOMA; CHILDREN; HUMANS	Background: Hypotension after traumatic brain injury (TBI) is associated with poor outcomes. However, data on intraoperative hypotension (IH) are scarce and the effect of anesthetic agents on IH is unknown. We examined the prevalence and risk factors for IH, including the effect of anesthetic agents during emergent craniotomy for isolated TBI. Methods: This is a retrospective cohort study of patients 18 years and above, who underwent emergent craniotomy for TBI at Harborview Medical Center (level 1 trauma center) between October 2007 and January 2010. Demographic, clinical, and radiographic characteristics and hemodynamic and anesthetic data were abstracted from medical and electronic anesthesia records. Hypotension was defined as systolic blood pressure <90 mm Hg. Univariate analyses were performed to compare the clinical characteristics of patients with and without IH, and multiple logistic regression analysis was used to determine independent risk factors for IH. Results: Data abstracted from 113 eligible patients aged 48 +/- 19 years were analyzed. IH was common (n = 73, 65%) but not affected by the choice of anesthetic agent. Independent risk factors for IH were multiple computed tomographic (CT) lesions [adjusted odds ratios (AOR) 19.1; 95% confidence interval (CI), 2.08-175.99; P = 0.009], subdural hematoma (AOR 17.9; 95% CI, 2.97-108.10; P = 0.002), maximum CT lesion thickness (AOR 1.1; 95% CI, 1.01-1.13; P = 0.016), and anesthesia duration (AOR 1.1; 95% CI, 1.01-1.30; P = 0.009). Conclusions: IH was common in adult patients with isolated TBI undergoing emergent craniotomy. The presence of multiple CT lesions, subdural hematoma, maximum thickness of CT lesion, and longer duration of anesthesia increase the risk for IH.	[Sharma, Deepak; Brown, Michelle J.; Curry, Parichat; Noda, Sakura; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Sharma, Deepak; Chesnut, Randall M.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98104 USA	Sharma, D (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Box 359724,325 9th Ave, Seattle, WA 98104 USA.	dsharma@uw.edu		Chesnut, Randall/0000-0001-6377-3666; Noda, Sakura/0000-0002-8341-5740	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-02, R01 NS072308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER		Bhagat H, 2009, ANN CARD ANAESTH, V12, P149, DOI 10.4103/0971-9784.53446; Bolliger D, 2010, BRIT J ANAESTH, V104, P547, DOI 10.1093/bja/aeq066; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Conti A, 2006, BRIT J ANAESTH, V97, P333, DOI 10.1093/bja/ael169; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Filipovic M, 2005, BRIT J ANAESTH, V94, P186, DOI 10.1093/bja/aei028; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kadoi Y, 2009, ANAESTH INTENS CARE, V37, P598, DOI 10.1177/0310057X0903700412; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kawano Y, 2004, J NEUROSURG ANESTH, V16, P6, DOI 10.1097/00008506-200401000-00002; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; MARTIN C, 1994, ACTA ANAESTH SCAND, V38, P223, DOI 10.1111/j.1399-6576.1994.tb03878.x; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Pecha T, 2011, ANESTH ANALG, V30, P1; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Uchida M, 1982, CRIT CARE MED, V19, P5; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	25	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2012	24	3					178	184		10.1097/ANA.0b013e318254fb70			7	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	958WT	WOS:000305272400002	22504924	Green Accepted			2021-06-18	
J	Waljas, M; Iverson, GL; Hartikainen, KM; Liimatainen, S; Dastidar, P; Soimakallio, S; Jehkonen, M; Ohman, J				Waljas, Minna; Iverson, Grant L.; Hartikainen, Kaisa M.; Liimatainen, Suvi; Dastidar, Prasun; Soimakallio, Seppo; Jehkonen, Mervi; Ohman, Juha			Reliability, validity and clinical usefulness of the BNI fatigue scale in mild traumatic brain injury	BRAIN INJURY			English	Article						Fatigue; measurement; mild traumatic brain injury	HEAD-INJURY; DEPRESSION; SYMPTOMS; IMPACT; VALIDATION; COMPLAINTS; RECOVERY	Objectives: The purpose of this study was to examine the reliability, validity and clinical usefulness of the Barrow Neurological Institute Fatigue Scale (BNI-FS) in patients with mild traumatic brain injuries (MTBI). Methods and procedure: Participants were 125 patients enrolled from the Emergency Department (ED) of Tampere University Hospital, Finland who had sustained an MTBI. The average number of days from injury to the interview and questionnaires was 24.1 (SD = 5.4, Range = 8-38). The patients were compared to a healthy control sample. Patients completed the Barrow Neurological Institute Fatigue Scale, Fatigue Impact Scale (FIS), Beck Depression Inventory-Second Edition (BDI-II), Rivermead Post-concussion Symptom Questionnaire (RPSQ) and the health assessment measure EuroQol five Dimension (EQ-5D) Visual Analogue Scale (VAS). Results: The MTBI group had significantly greater total scores on the BNI-FS than the control group (p < 0.005, Cohen's d = 0.40). The internal consistency reliability for the BNI-FS, as measured by Cronbach's alpha, was 0.96 for the MTBI group and 0.87 for the control group. The 10 items were submitted to an exploratory principal components factor analysis with varimax rotation in the MTBI group. A one-factor solution, accounting for 73.3% of the total variance, appropriately summarized the data. The correlation between the BNI-FS and other measures was rs = 0.68 (p < 0.001) for the BDI-II, rs = 0.68 (p < 0.001) for the RPSQ, rs = -0.39 (p < 0.001) for the EQ-5D VAS and rs = 0.84 (p < 0.001) for the FIS. Fatigue ratings correlated positively with number of days post-injury before returning to work (rs = 0.27, p < 0.006). Conclusion: The BNI-FS is a relatively new, brief and highly reliable measure of fatigue.	[Waljas, Minna; Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, FIN-33521 Tampere, Finland; [Waljas, Minna; Hartikainen, Kaisa M.; Dastidar, Prasun; Soimakallio, Seppo; Ohman, Juha] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hartikainen, Kaisa M.; Liimatainen, Suvi] Tampere Univ Hosp, Dept Neurosci & Rehabil, FIN-33521 Tampere, Finland; [Liimatainen, Suvi] Tampere Univ Hosp, Emergency Dept Acuta, FIN-33521 Tampere, Finland; [Dastidar, Prasun; Soimakallio, Seppo] Pirkanmaa Hosp Dist, Med Imaging Ctr, Tampere, Finland; [Jehkonen, Mervi] Univ Tampere, Dept Psychol, FIN-33101 Tampere, Finland	Waljas, M (corresponding author), Tampere Univ Hosp, Dept Neurosurg, POB 2000, FIN-33521 Tampere, Finland.	minna.waljas@pshp.fi	Jehkonen, Mervi/AAI-4596-2020	Iverson, Grant/0000-0001-7348-9570; Hartikainen, Kaisa/0000-0001-7278-9635; Ohman, Juha/0000-0002-6592-1367			Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Beck AT., 1996, BECK DEPRESSION INVE, V2; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Chwastiak LA, 2005, J PSYCHOSOM RES, V59, P291, DOI 10.1016/j.jpsychores.2005.06.001; Elovic EP, 2005, ISS CLIN COGN NEUROP, P89; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fisk JD, 2002, QUAL LIFE RES, V11, P263, DOI 10.1023/A:1015295106602; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	31	13	13	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					972	978		10.3109/02699052.2012.660511			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100008	22571230				2021-06-18	
J	Hong, MY; Gao, JL; Cui, JZ; Wang, KJ; Tian, YX; Li, R; Wang, HT; Wang, H				Hong Ming-yan; Gao Jun-ling; Cui Jian-zhong; Wang Kai-jie; Tian Yan-xia; Li Ran; Wang Hai-tao; Wang Huan			Effect of c-Jun NH2-terminal kinase-mediated p53 expression on neuron autophagy following traumatic brain injury in rats	CHINESE MEDICAL JOURNAL			English	Article						brain injuries; autophagy; c-Jun NH2-terminal kinase; p53; damage-regulated autophagy modulator	CEREBRAL-ISCHEMIA; HIPPOCAMPAL CA1; DEATH; ACTIVATION; APOPTOSIS; PATHWAYS; JNK; PHOSPHORYLATION; MECHANISMS; INHIBITOR	Background Activation of c-Jun NH2-terminal kinase (JNK) has been implicated in neuron apoptosis as well as autophagy in response to various stressors after traumatic brain injury (TBI). However, the underlying molecular pathway remains unclear. Our study assessed whether JNK-mediated p53 phosphorylation might be an important mechanism for enhancing neuron autophagy in response to TBI. Methods A total of 186 male Sprague-Dawley (SD) rats (300-350 g) were used in this study. By randomized block method rats were randomly divided into four groups: sham-operated (n=46), TBI (n=60), TBI + dimethyl sulfoxide (DMSO) (n=40), and TBI + SP600125 (n=40). JNK was treated with SP600125, a specific JNK inhibitor. JNK, p-P53, Beclin-1, damage-regulated autophagy modulator (DRAM) and p-bcl-2 were evaluated by Western blotting analysis. The cellular localization and expression of Beclin-1 and DRAM was observed by immunofluorescence and immunohistochemistry, and the expression of Beclin-1-Bcl-2/Bcl-xL complexes was evaluated by immunoprecipitation. Multiple-group comparisons were conducted using analysis of variance (ANOVA). P values of less than 0.05 were considered statistically significant. Results It was observed that the expression of JNK, p-P53, Beclin-1, DRAM and p-bcl-2 was increasing after TBI, and the expression of Beclin-1 and DRAM was mainly located in the cytoplasm of neurons. But these were significantly inhibited in SP600125 group compared with sham group and TBI+SP600125 group (P <0.05). The expression of Beclin-1-Bcl-2/Bcl-xL complexes was reduced after TBI. Conclusion JNK-mediated p53 phosphorylation might be an important mechanism for enhancing neuron autophagy in response to TBI. Chin Med J 2012;125(11):2019-2024	[Hong Ming-yan; Cui Jian-zhong] Hebei Med Univ, Dept Surg, Shijiazhuang 050017, Hebei, Peoples R China; [Gao Jun-ling; Tian Yan-xia; Li Ran; Wang Hai-tao; Wang Huan] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China; [Wang Kai-jie] Workers Hosp, Tangshan 063000, Hebei, Peoples R China	Cui, JZ (corresponding author), Hebei Med Univ, Dept Surg, Shijiazhuang 050017, Hebei, Peoples R China.	jzhcui01@hotmail.com			Hebei Province Natural Science FoundationNatural Science Foundation of Hebei Province [C2009001247]	This work was supported by a grant from Hebei Province Natural Science Foundation (No. C2009001247).	Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Fan SM, 2012, FREE RADICAL RES, V46, P310, DOI 10.3109/10715762.2012.655244; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Guan QH, 2005, BRAIN RES, V1035, P51, DOI 10.1016/j.brainres.2004.11.050; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Malik SA, 2011, AUTOPHAGY, V7, P914, DOI 10.4161/auto.7.8.15785; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NEELY N, 1974, BIOCHEM BIOPH RES CO, V59, P680; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang QG, 2005, J NEUROCHEM, V95, P784, DOI 10.1111/j.1471-4159.2005.03435.x	28	13	15	0	10	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUN 5	2012	125	11					2019	2024		10.3760/cma.j.issn.0366-6999.2012.11.032			6	Medicine, General & Internal	General & Internal Medicine	958RZ	WOS:000305259700033	22884071	DOAJ Gold			2021-06-18	
J	Ashwell, Z; Mckay, MP; Brubacher, JR; Gareau, A				Ashwell, Zachary; Mckay, Mary Pat; Brubacher, Jeffery R.; Gareau, Annie			The Epidemiology of Mountain Bike Park Injuries at the Whistler Bike Park, British Columbia (BC), Canada	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						mountain biking; epidemiology; injury	BIKING INJURIES	Objective.-To describe the epidemiology of injuries sustained during the 2009 season at Whistler Mountain Bike Park. Methods.-A retrospective chart review was performed of injured bike park cyclists presenting to the Whistler Health Clinic between May 16 and October 12, 2009. Results.-Of 898 cases, 86% were male (median age, 26 years), 68.7% were Canadian, 19.4% required transport by the Whistler Bike Patrol, and 8.4% arrived by emergency medical services. Identification of 1759 specific injury diagnoses was made, including 420 fractures in 382 patients (42.5%). Upper extremity fractures predominated (75.4%), 11.2% had a traumatic brain injury, and 8.5% were transferred to a higher level of care: 7 by helicopter, 62 by ground, and 5 by personal vehicle. Two patients refused transfer. Conclusions.-Mountain bikers incurred many injuries with significant morbidity while riding in the Whistler Mountain Bike Park in 2009. Although exposure information is unavailable, these findings demonstrate serious risks associated with this sport and highlight the need for continued research into appropriate safety equipment and risk avoidance measures.	[Ashwell, Zachary] George Washington Univ, Sch Med, Washington, DC USA; [Mckay, Mary Pat] George Washington Univ, Dept Emergency Med, Washington, DC USA; [Brubacher, Jeffery R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Gareau, Annie] Whistler Hlth Care Ctr, Whistler, BC, Canada	Mckay, MP (corresponding author), 2150 Pennsylvania Ave,Suite 2B, Washington, DC 20037 USA.	mpmckay@gmail.com		Brubacher, Jeffrey/0000-0002-4866-4231			[Anonymous], AL BIK; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Carmont MR, 2008, BRIT MED BULL, V85, P101, DOI 10.1093/bmb/ldn009; CHOW TK, 1993, WESTERN J MED, V159, P145; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Deer Valley expanded biking and hiking trail access now open, SKI CHANNEL NEWS; Dodwell ER, 2010, AM J SPORT MED, V38, P1647, DOI 10.1177/0363546510365532; Kim PTW, 2006, J TRAUMA, V60, P312, DOI 10.1097/01.ta.0000202714.31780.5f; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; Outdoor Foundation, OUTD RECR PART REP 2; Wikipedia, LIFT ACC MOUNT BIK	13	13	13	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	SUM	2012	23	2					140	145		10.1016/j.wem.2012.02.002			6	Public, Environmental & Occupational Health; Sport Sciences	Public, Environmental & Occupational Health; Sport Sciences	956OD	WOS:000305098100009	22656660	Bronze			2021-06-18	
J	Caracuel, A; Verdejo-Garcia, A; Fernandez-Serrano, MJ; Moreno-Lopez, L; Santago-Ramajo, S; Salinas-Sanchez, I; Perez-Garcia, M				Caracuel, Alfonso; Verdejo-Garcia, Antonio; Jose Fernandez-Serrano, Maria; Moreno-Lopez, Laura; Santago-Ramajo, Sandra; Salinas-Sanchez, Ignacio; Perez-Garcia, Miguel			Preliminary validation of the Spanish version of the Frontal Systems Behavior Scale (FrSBe) using Rasch analysis	BRAIN INJURY			English	Article						FrSBe; Rasch analysis; prefrontal cortex systems; apathy; disinhibition; executive dysfunction; frontal behaviours; traumatic brain injury; stroke	EXECUTIVE DYSFUNCTION; SELF-AWARENESS; BRAIN-INJURY; DRUG-USE; SUBCORTICAL CIRCUITS; EMOTIONAL SYMPTOMS; MEASUREMENT MODEL; RATING-SCALES; NEUROPSYCHOLOGY; CONSEQUENCES	Primary objective: To explore the construct validity of the Spanish version of the Frontal Systems Behavioral Scale (FrSBe) using Rasch modelling. Methods: Item responses of 245 Spanish subjects were analysed using Rasch analysis: self-rating of 65 participants with TBI or stroke (sample A), family-rating of the same 65 participants (sample B) and self-rating of 115 healthy individuals (sample C). Results: After removing or grouping several problematic items, the Apathy and the Executive Dysfunction sub-scales were found to be valid measures for samples A and B and the Disinhibition sub-scale was valid for samples B and C. Person Separation Index of reliability of sub-scales was greater than 0.83 for sample B and similar to 0.72 for A and C. All items showed disordered threshold categories in samples A and B and five items were ordered in sample C. Conclusions: With a few modifications, the sub-scales of the FrSBe-Spanish version are adequate measures for the assessment of the behavioural syndromes derived from frontal systems dysfunction in persons with brain injury. The family-rating form is preferable to the self-rating form. Only the Disinhibition scale is a valid measure for the behavioural assessment of the normal population. A reduction of response categories is suggested.	[Caracuel, Alfonso] Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, E-18071 Granada, Spain; [Caracuel, Alfonso; Verdejo-Garcia, Antonio; Perez-Garcia, Miguel] Univ Granada, Inst Neurosci F Oloriz, E-18071 Granada, Spain; [Salinas-Sanchez, Ignacio] Virgen de las Nieves Hosp, Granada, Spain	Caracuel, A (corresponding author), Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, Campus Cartuja, E-18071 Granada, Spain.	acaracuel@ugr.es	Moreno-Lopez, Laura/K-9568-2015; Caracuel, Alfonso/V-3695-2019; Serrano, M Josefa Fernandez/V-3124-2019; Garcia, Miguel Perez/F-9630-2010; Santiago-Ramajo, Sandra/H-6801-2015	Moreno-Lopez, Laura/0000-0003-3687-7237; Caracuel, Alfonso/0000-0002-9738-8456; Serrano, M Josefa Fernandez/0000-0002-6158-237X; Garcia, Miguel Perez/0000-0003-4775-7556; Santiago-Ramajo, Sandra/0000-0002-6358-6155; Verdejo-Garcia, Antonio/0000-0001-8874-9339			Andrich D., 2003, RUMM2020; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P920, DOI 10.1080/13803390801888733; Batistuzzo MC, 2009, NEUROCASE, V15, P157, DOI 10.1080/13554790802709047; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bond T.G., 2007, APPL RASCH MODEL FUN; Caracuel A, 2008, ARCH CLIN NEUROPSYCH, V23, P447, DOI 10.1016/j.acn.2008.03.004; Caracuel A, J HEAD TRAUMA REHABI; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Decruynaere C, 2007, EUR J PAIN, V11, P469, DOI 10.1016/j.ejpain.2006.07.001; Denheyer M, 2009, NEUROPSYCHOLOGIA, V47, P3203, DOI 10.1016/j.neuropsychologia.2009.07.022; Fox CM, 1998, J COUNS PSYCHOL, V45, P30; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Kawada R, 2009, PROG NEURO-PSYCHOPH, V33, P1255, DOI 10.1016/j.pnpbp.2009.07.014; Kersten P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-26; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lawton G, 2006, SPINAL CORD, V44, P746, DOI 10.1038/sj.sc.3101895; Linacre J.M., 2000, RASCH MEAS T, V14, P768; Linacre John M, 2002, J Appl Meas, V3, P85; Lyvers M, 2010, PERS INDIV DIFFER, V48, P332, DOI 10.1016/j.paid.2009.10.030; Lyvers M, 2009, ADDICT RES THEORY, V17, P668, DOI 10.3109/16066350802404158; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Malloy P, 2007, ALZHEIMERS DEMENT, V3, P200, DOI 10.1016/j.jalz.2007.04.374; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; Marsh L, 2009, MOVEMENT DISORD, V24, P277, DOI 10.1002/mds.22307; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Rasch G., 1980, PROBABILISTIC MODELS; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Ross SR, 2007, J PERS DISORD, V21, P384, DOI 10.1521/pedi.2007.21.4.384; Spinella M, 2005, BIOL PSYCHOL, V70, P175, DOI 10.1016/j.biopsycho.2004.01.005; Spinella M, 2004, INT J NEUROSCI, V114, P1323, DOI 10.1080/00207450490476011; Spinella M, 2004, INT J NEUROSCI, V114, P83, DOI 10.1080/00207450490249356; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Spinella M, 2008, J SOCIO-ECON, V37, P1785; Spinella M, 2007, J GEN PSYCHOL, V134, P101, DOI 10.3200/GENP.134.1.101-111; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tesio L, 2007, Eura Medicophys, V43, P515; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Verdejo-Garcia A, 2008, PSYCHIAT RES, V158, P172, DOI 10.1016/j.psychres.2006.08.001; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003; Wilson M., 2005, CONSTRUCTING MEASURE; Yoshizumi M, 2008, PSYCHIAT CLIN NEUROS, V62, P669, DOI 10.1111/j.1440-1819.2008.01866.x	54	13	14	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2012	26	6					844	852		10.3109/02699052.2012.655365			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500006	22583175				2021-06-18	
J	Caterino, JM; Raubenolt, A				Caterino, Jeffrey M.; Raubenolt, Amy			The prehospital simplified motor score is as accurate as the prehospital Glasgow coma scale: analysis of a statewide trauma registry	EMERGENCY MEDICINE JOURNAL			English	Article							BRAIN-INJURY OUTCOMES; EMERGENCY-DEPARTMENT; RELIABILITY; PREDICTION	Objectives The simplified motor score (SMS) is a three-point measure of traumatic brain injury (TBI) severity, which is easier to calculate than the 15-point Glasgow coma scale (GCS). Using a state trauma registry, the accuracy of the emergency medical services (EMS)obtained SMS was compared with the GCS for predicting neurological outcomes and mortality. Methods A retrospective, observational analysis was performed of patients aged 16 years and older in the 2002-7 Ohio Trauma Registry. Those not initially transported by EMS or with incomplete EMS GCS scores were excluded. Outcomes included inhospital mortality, TBI, neurosurgical intervention, any emergency intubation and emergency department intubation. Discriminatory ability was compared using area under the receiver-operating characteristic curves (AUC). Sensitivity and specificity for each outcome were calculated at a SMS cutoff of one or less (any abnormal SMS) and a GCS cutoff of 13 or less. Results 52 412 patients were identified. Sensitivity, specificity and AUC were similar between the SMS and GCS for all outcomes. Sensitivity for mortality was 72.2% for SMS and 74.6% for GCS. Sensitivity for TBI was 40.8% for SMS and 45.4% for GCS. Sensitivity for neurosurgical intervention was 52.9% for SMS and 60.0% for GCS. Sensitivity for any intubation was 72.7% for SMS and 75.5% for GCS. Specificity was less than 2% different for all outcomes. Discriminatory ability was similar with the difference in AUC between SMS and GCS no greater than 6% for any outcome. Conclusions In a state trauma registry including both trauma and non-trauma centres, the EMS-obtained SMS performs as well as the 15-point GCS.	[Caterino, Jeffrey M.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Caterino, Jeffrey M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Raubenolt, Amy] Michigan State Univ, Dept Emergency Med, Kalamazoo, MI USA	Caterino, JM (corresponding author), 146 Means Hall,1654 Upham Dr, Columbus, OH 43210 USA.	jeffrey.caterino@osumc.edu	Caterino, Jeffrey/E-2859-2011		Ohio Department of Public Safety	This study was supported by a Trauma Grant from the Ohio Department of Public Safety. The sponsoring agency had no role in or control over the design, methods, subject recruitment, data collection, analysis, or paper preparation.	[Anonymous], 1999, STATA TECHNICAL B ST, V52, P19; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Limmer Daniel, 2002, Emerg Med Serv, V31, P54; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Nirula R, 2006, J TRAUMA, V61, P268, DOI 10.1097/01.ta.0000230305.36456.4e; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009	16	13	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	JUN	2012	29	6					492	496		10.1136/emj.2010.110437			5	Emergency Medicine	Emergency Medicine	964KN	WOS:000305693500012	21795294				2021-06-18	
J	Chabok, SY; Kapourchali, SR; Leili, EK; Saberi, A; Mohtasham-Amiri, Z				Chabok, Shahrokh Yousefzadeh; Kapourchali, Sara Ramezani; Leili, Ehsan Kazemnezhad; Saberi, Alia; Mohtasham-Amiri, Zahra			Effective factors on linguistic disorder during acute phase following traumatic brain injury in adults	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Post-traumatic language disorder; Post-traumatic cognitive deficit; Acute phase	EXECUTIVE DYSFUNCTION; WORKING-MEMORY; DEFICITS; DISCOURSE; APHASIA	Traumatic brain injury (TBI) has been known to be the leading cause of breakdown and long-term disability in people under 45 years of age. This study highlights the effective factors on post-traumatic (PT) linguistic disorder and relations between linguistic and cognitive function after trauma in adults with acute TBI. A cross-sectional design was employed to study 60 post-TBI hospitalized adults aged 18-65 years. Post-traumatic (PT) linguistic disorder and cognitive deficit after TBI were respectively diagnosed using the Persian Aphasia Test (PAT) and Persian version of Mini-Mental State Examination (MMSE) at discharge. Primary post-resuscitation consciousness level was determined using the Glasgow Coma Scale (GCS). Paracilinical data was obtained by CT scan technique. Multiple logistic regression analysis illustrated that brain injury severity was the first powerful significant predictor of PT linguistic disorder after TBI and frontotemporal lesion was the second. It was also revealed that cognitive function score was significantly correlated with score of each language skill except repetition. Subsequences of TBI are more commonly language dysfunctions that demand cognitive flexibility. Moderate, severe and frontotemporal lesion can increase the risk of processing deficit in linguistic macrostructure production and comprehension. The dissociation risk of cortical and subcortical pathways related to cognitive-linguistic processing due to intracranial lesions can augment possibility of lexical-semantic processing deficit in acute phase which probably contributes to later cognitive-communication disorder. (C) 2012 Elsevier Ltd. All rights reserved.	[Kapourchali, Sara Ramezani; Saberi, Alia] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Dept Neurol, Rasht 4193713194, Guilan Province, Iran; [Mohtasham-Amiri, Zahra] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Dept Social Med, Rasht 4193713194, Guilan Province, Iran	Kapourchali, SR (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Dept Neurol, Rasht 4193713194, Guilan Province, Iran.	s.ramezanislp@gmail.com	Ramezani, Sara/E-6926-2012; Mohtasham-Amiri, Zahra/C-4469-2012; Saberi, Alia/X-4857-2018	Ramezani, Sara/0000-0001-6096-7975; Mohtasham-Amiri, Zahra/0000-0002-4896-6248; Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015	Road Trauma Research Center, Guilan University of Medical Sciences	We offer our special thanks to Road Trauma Research Center, Guilan University of Medical Sciences for supporting us, the staff of Neurosurgery Ward in Poorsina Teaching Hospital, who helped us in sampling procedure and Ms. Fatemeh Javadi for editing the manuscript.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Baldo JV, 2010, BRAIN LANG, V113, P59, DOI 10.1016/j.bandl.2010.01.004; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bear MF., 2007, NEUROSCIENCE EXPLORI, V3; Bhatnagar S. C., 2002, NEUROSCIENCE STUDY C; Bourgeois M. S., 2009, DEMENTIA DIAGNOSIS M; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chapey R., 2008, LANGUAGE INTERVENTIO, P33; Chua S. E., 2005, HONG KONG J PSYCHIAT, V15, P77; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Cohen N. J., 2003, NEUROPSYCHOLOGY NEUR, P322; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Foroughan M, 2008, ADV COGNITIVE SCI, V10, P29, DOI 10.1080/09084282.2010.499773; Hanlon RE, 1999, J NEUROL NEUROSUR PS, V66, P365, DOI 10.1136/jnnp.66.3.365; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Helm-Estabrooks N, 2002, J COMMUN DISORD, V35, P171, DOI 10.1016/S0021-9924(02)00063-1; Hemmati H., 2009, Acta Medica Iranica, V47, P403; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; HJELMQUIST EKE, 1989, SCAND J PSYCHOL, V30, P243, DOI 10.1111/j.1467-9450.1989.tb01087.x; Jonides J., 1995, INVITATION COGNITIVE, V3, P215; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Martin N., 2004, BRAIN LANG, V89, P243; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mitrushina M. N., 2000, HDB NORMATIVE DATA N; Nilipour R, 1993, PERSIAN APHASIA TEST; Paradis M., 1989, BILINGUAL APHASIA TE; Rengachary S. S., 2005, PRINCIPLE NEUROSURGE; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Saygin AP, 2004, NEUROPSYCHOLOGIA, V42, P1788, DOI 10.1016/j.neuropsychologia.2004.04.016; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Spreen O, 2003, ASSESSMENT APHASIA; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P691, DOI 10.1076/jcen.25.5.691.14573; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thothathiri M, 2010, BRAIN LANG, V113, P28, DOI 10.1016/j.bandl.2010.01.002; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vukovic M, 1998, TRAUMATIC APHASIA; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wong GKC, 2010, J NEUROL SCI, V299, P5, DOI 10.1016/j.jns.2010.08.059; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; Yousefzadeh Ch. Sh., 2007, J GUILAN U MED SCI, V16, P112; Yousefzadeh Ch. Sh., 2010, NEUROSURG QUART, V20, P65	59	13	16	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUN	2012	50	7					1444	1450		10.1016/j.neuropsychologia.2012.02.029			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	966RQ	WOS:000305855500023	22410412				2021-06-18	
J	Goodman, MJ; Durkin, M; Forlenza, J; Ye, XY; Brixner, DI				Goodman, Michael J.; Durkin, Michael; Forlenza, Jamie; Ye, Xiangyang; Brixner, Diana I.			Assessing adherence-based quality measures in epilepsy	INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE			English	Article						quality management; quality indicators; measurement of quality; epilepsy; quality of care	ANTIEPILEPTIC DRUGS; NONADHERENCE; SEIZURES; RISK	To examine the relationship of three alternative measures of adherence with seven negative outcomes associated with epilepsy for development of a quality measure in epilepsy. Retrospective cohort analysis. PharMetrics national claims database. Patients in the PharMetrics database for the years 200408 taking antiepileptic drugs. None. For each definition of adherence, the odds ratios (ORs) comparing non-adherent with adherent groups were assessed for consistency and direction for the number of hospital admissions, emergency room (ER) visits, head injuries including traumatic brain injuries, falls, motor vehicle accidents (MVAs), fractures and a oseizure' outcome defined as hospital admissions or ER visits with a primary diagnosis of epilepsy or convulsions. The inclusion criteria were met by 31 635 individuals. In the multivariate analysis, the adherent group had lower odds of hospital admissions with ORs for the eight specifications ranging from 0.729 to 0.872 and ER visits where ORs for the eight specifications ranged from 0.750 to 0.893. The eight ORs for head injuries ranged from 0.647 to 0.888. For fractures, the ORs ranged from 0.407 to 0.841. Our proxy for seizure was inconsistently associated with adherence status. All the adherence measures defined non-adherent groups that were associated with negative outcomes in epilepsy.	[Goodman, Michael J.; Ye, Xiangyang; Brixner, Diana I.] Univ Utah, Outcomes Res Ctr, Dept Pharmacotherapy, Salt Lake City, UT 84108 USA; [Durkin, Michael; Forlenza, Jamie] Ortho McNeil Janssen Pharmaceut Inc, Raritan, NJ USA	Goodman, MJ (corresponding author), Univ Utah, Outcomes Res Ctr, Dept Pharmacotherapy, 421 Wakara Way,Suite 208, Salt Lake City, UT 84108 USA.	michael.goodman@pharm.utah.edu		Ye, Xiangyang/0000-0003-2722-3653	Ortho-McNeil Janssen Pharmaceuticals Inc.	This research was funded by Ortho-McNeil Janssen Pharmaceuticals Inc.	Cramer JA, 2002, EPILEPSY BEHAV, V3, P338, DOI 10.1016/S1525-5050(02)00037-9; Davis KL, 2008, EPILEPSIA, V49, P446, DOI 10.1111/j.1528-1167.2007.01414.x; Davis KL, 2007, AC MAN CAR PHARM 19; Ettinger AB, 2009, EPILEPSY BEHAV, V14, P324, DOI 10.1016/j.yebeh.2008.10.021; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jones RM, 2006, SEIZURE-EUR J EPILEP, V15, P504, DOI 10.1016/j.seizure.2006.06.003; Karve S, 2008, MED CARE, V46, P1125, DOI 10.1097/MLR.0b013e31817924d2; Manjunath R, 2009, EPILEPSY BEHAV, V14, P372, DOI 10.1016/j.yebeh.2008.12.006; Martin BC, 2009, ANN PHARMACOTHER, V43, P36, DOI 10.1345/aph.1K671; National Epilepsy Foundation, EP SEIZ STAT; Pharmacy Quality Alliance, 2010, PQA APPR MEAS; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; Vanderpoel DR, 2004, CLIN THER, V26, P2066, DOI 10.1016/j.clinthera.2004.12.018; Vink NM, 2009, PHARMACOEPIDEM DR S, V18, P159, DOI 10.1002/pds.1698; Weiden PJ, 2004, PSYCHIAT SERV, V55, P886, DOI 10.1176/appi.ps.55.8.886	18	13	13	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1353-4505			INT J QUAL HEALTH C	Int. J. Qual. Health Care	JUN	2012	24	3					293	300		10.1093/intqhc/mzs017			8	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	944KA	WOS:000304198700013	22507847	Bronze			2021-06-18	
J	Greiner, MV; Lawrence, AP; Horn, P; Newmeyer, AJ; Makoroff, KL				Greiner, Mary V.; Lawrence, Alice P.; Horn, Paul; Newmeyer, Amy J.; Makoroff, Kathi L.			Early clinical indicators of developmental outcome in abusive head trauma	CHILDS NERVOUS SYSTEM			English	Article						Abuse; Developmental outcome; Head trauma; Intensive care; Seizure	AUDITORY MILESTONE SCALE; GLASGOW COMA SCALE; YOUNG-CHILDREN; BRAIN-INJURIES; BAYLEY SCALES; CAT/CLAMS; INFANTS; PREDICT; DEMOGRAPHICS; VALIDITY	The purpose of the study was to determine the developmental prognostic significance of early clinical indicators in abusive head trauma. Seventy-one children were diagnosed with abusive head trauma and followed in a post-injury growth and development clinic. A retrospective chart review was completed to gather clinical features at the time of injury, including presence or absence of early post-traumatic seizures, presence or absence of intubation, and presence or absence of pediatric intensive care unit admission. Children then underwent developmental testing with use of the Capute Scales of the Cognitive Adaptive Test (CAT) and the Clinical Linguistic and Auditory Milestone Scale (CLAMS) during follow-up clinic visits. Clinical features at initial injury were compared to developmental outcome. Thirty-four of 71 patients with seizures during their admission hospitalization scored significantly lower on follow-up developmental testing than patients who did not have seizures. Twenty-one of 71 patients who required intubation scored lower on developmental testing than patients who did not require intubation. Thirty-five of 71 patients who required pediatric intensive care unit admission scored lower on developmental testing than patients who did not require pediatric intensive care unit admission. This study demonstrates that clinical factors at the time of injury, such as early post-traumatic seizures and intubation requirement, are associated with poorer developmental outcome. This study also suggests that close developmental follow-up should be obtained for all children with abusive head trauma, regardless of whether or not the child was admitted to the PICU.	[Greiner, Mary V.; Horn, Paul; Makoroff, Kathi L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Lawrence, Alice P.] Childrens Hosp Vanderbilt, Dept Pediat, Nashville, TN USA; [Newmeyer, Amy J.] Childrens Hosp Kings Daughter, Dept Pediat, Norfolk, VA USA	Greiner, MV (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,ML 3008, Cincinnati, OH 45229 USA.	mary.greiner@cchmc.org					Accardo P., 2008, CAPUTE ACCARDOS NEUR, V3rd ed; Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; Capute A J, 1996, Curr Probl Pediatr, V26, P279; Capute A J, 1996, Curr Probl Pediatr, V26, P238, DOI 10.1016/S0045-9380(06)80061-7; Chang Y C, 1998, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V39, P306; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Hoon Jr AH, 1993, J PEDIAT, V123; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Kube DA, 2000, PEDIATR NEUROL, V23, P208, DOI 10.1016/S0887-8994(00)00191-0; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Macias MM, 1998, J DEV BEHAV PEDIATR, V19, P155, DOI 10.1097/00004703-199806000-00002; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Myers SE, 2007, AM J MED GENET A, V143A, P443, DOI 10.1002/ajmg.a.31468; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Pittock ST, 2002, CLIN PEDIATR, V41, P397, DOI 10.1177/000992280204100604; ROSSMAN MJ, 1994, CLIN PEDIATR, V33, P404, DOI 10.1177/000992289403300705; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Vanprapar Nirun, 2005, J Med Assoc Thai, V88 Suppl 8, pS211; Vincer MJ, 2005, PEDIATRICS, V116, pE864, DOI 10.1542/peds.2005-0447; Visintainer PF, 2004, J CHILD NEUROL, V19, P967, DOI 10.1177/08830738040190121101; Voigt RG, 2003, CLIN PEDIATR, V42, P427, DOI 10.1177/000992280304200507; WACHTEL RC, 1994, CLIN PEDIATR, V33, P410, DOI 10.1177/000992289403300706; Wang LW, 2005, J DEV BEHAV PEDIATR, V26, P412, DOI 10.1097/00004703-200512000-00004; Wickremasinghe AC, 2011, CHILD CARE HLTH DEV	37	13	13	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2012	28	6					889	896		10.1007/s00381-012-1714-z			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	949DO	WOS:000304556600012	22367916				2021-06-18	
J	Hussain, ZM; Fitting, S; Watanabe, H; Usynin, I; Yakovleva, T; Knapp, PE; Scheff, SW; Hauser, KF; Bakalkin, G				Hussain, Zubair Muhammad; Fitting, Sylvia; Watanabe, Hiroyuki; Usynin, Ivan; Yakovleva, Tatjana; Knapp, Pamela E.; Scheff, Stephen W.; Hauser, Kurt F.; Bakalkin, Georgy			Lateralized Response of Dynorphin A Peptide Levels after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dynorphins; lateralization; neurodegeneration; neuronal networks; traumatic brain injury	SPINAL-CORD-INJURY; CONTROLLED CORTICAL IMPACT; POSTURAL ASYMMETRY; HEAD-INJURY; RAT; MICE; RECEPTOR; DEFICITS; MECHANISMS; OPIOIDS	Traumatic brain injury (TBI) induces a cascade of primary and secondary events resulting in impairment of neuronal networks that eventually determines clinical outcome. The dynorphins, endogenous opioid peptides, have been implicated in secondary injury and neurodegeneration in rodent and human brain. To gain insight into the role of dynorphins in the brain's response to trauma, we analyzed short-term (1-day) and long-term (7-day) changes in dynorphin A (Dyn A) levels in the frontal cortex, hippocampus, and striatum, induced by unilateral left-side or right-side cortical TBI in mice. The effects of TBI were significantly different from those of sham surgery (Sham), while the sham surgery also produced noticeable effects. Both sham and TBI induced short-term changes and long-term changes in all three regions. Two types of responses were generally observed. In the hippocampus, Dyn A levels were predominantly altered ipsilateral to the injury. In the striatum and frontal cortex, injury to the right (R) hemisphere affected Dyn A levels to a greater extent than that seen in the left (L) hemisphere. The R-TBI but not L-TBI produced Dyn A changes in the striatum and frontal cortex at 7 days after injury. Effects of the R-side injury were similar in the two hemispheres. In naive animals, Dyn A was symmetrically distributed between the two hemispheres. Thus, trauma may reveal a lateralization in the mechanism mediating the response of Dyn A-expressing neuronal networks in the brain. These networks may differentially mediate effects of left and right brain injury on lateralized brain functions.	[Hussain, Zubair Muhammad; Watanabe, Hiroyuki; Yakovleva, Tatjana; Bakalkin, Georgy] Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden; [Fitting, Sylvia; Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA; [Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Usynin, Ivan] Russian Acad Med Sci, Inst Biochem, Siberian Div, Novosibirsk, Russia; [Scheff, Stephen W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	Bakalkin, G (corresponding author), Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, Box 591, S-75124 Uppsala, Sweden.	Georgy.Bakalkin@farmbio.uu.se	Usynin, Ivan F/A-4945-2017; Evgeny, Usynin/D-1505-2012; Polyakov, Lev Mikhailovith/R-7853-2016; Hauser, Kurt/AAX-8361-2020	Evgeny, Usynin/0000-0001-7127-0188; Bakalkin, Georgy/0000-0002-8074-9833; Usynin, Ivan/0000-0003-1752-9034; Hauser, Kurt/0000-0001-7886-0332; Fitting, Sylvia/0000-0002-8906-3133	Swedish Science Research Council [DA015097]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS39828]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K02DA027374, R01DA015097] Funding Source: NIH RePORTER	This work was supported by grants from the Swedish Science Research Council to G. B., DA015097 to P. E. K., and from the NIH NS39828 to S.W.S.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adjan VV, 2007, NEUROSCIENCE, V148, P724, DOI 10.1016/j.neuroscience.2007.05.053; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1989, INT J NEUROSCI, V47, P217, DOI 10.3109/00207458908987436; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; BAKSHI R, 1992, BRAIN RES, V580, P255, DOI 10.1016/0006-8993(92)90952-6; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Banghart MR, 2012, NEURON, V73, P249, DOI 10.1016/j.neuron.2011.11.016; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Duggan AW, 2000, PROG BRAIN RES, V125, P369; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Gao HM, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-57; Gieryk A, 2010, PSYCHOPHARMACOLOGY, V208, P291, DOI 10.1007/s00213-009-1730-1; Goody RJ, 2003, NEUROSCIENCE, V116, P807, DOI 10.1016/S0306-4522(02)00563-8; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; Hu WH, 1996, NEUROSCI LETT, V203, P13, DOI 10.1016/0304-3940(95)12246-X; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; KHACHATURIAN H, 1985, TRENDS NEUROSCI, V8, P111, DOI 10.1016/0166-2236(85)90048-7; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; Murphy M, 2004, FRONT BIOSCI-LANDMRK, V9, P40, DOI 10.2741/1203; Neveu PJ, 2003, STRESS, V6, P5, DOI 10.1080/1025389031000087472; Pavlovskaya M, 2007, BRAIN COGNITION, V64, P21, DOI 10.1016/j.bandc.2006.10.003; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock JT, 1999, ACT NEUR S, V73, P15; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Soares HD, 1995, J NEUROSCI, V15, P8223; Sullivan RM, 2012, NEUROSCIENCE, V202, P192, DOI 10.1016/j.neuroscience.2011.12.001; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; VINK R, 1990, J NEUROSCI, V10, P3524; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Woods AS, 2006, J PROTEOME RES, V5, P1017, DOI 10.1021/pr060016+	68	13	14	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2012	29	9					1785	1793		10.1089/neu.2011.2286			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	954CN	WOS:000304924000008	22468884	Green Published			2021-06-18	
J	Stergiou-Kita, M; Dawson, D; Rappolt, S				Stergiou-Kita, Mary; Dawson, Deirdre; Rappolt, Susan			Inter-Professional Clinical Practice Guideline for Vocational Evaluation Following Traumatic Brain Injury: A Systematic and Evidence-Based Approach	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Brain injuries; Rehabilitation vocational; Work assessment; Employment; Practice guidelines	COMMUNITY INTEGRATION; NEUROPSYCHOLOGICAL ASSESSMENT; EMPLOYMENT OUTCOMES; ACUTE PREDICTORS; PRODUCTIVE WORK; RETURN; TBI; REHABILITATION; MODERATE; PERSPECTIVES	Introduction This paper introduces an inter-professional clinical practice guideline for vocational evaluation following traumatic brain injury. This guideline aims to explicate the processes and factors relevant to vocational evaluation to assist evaluators (i.e. health care teams, individuals and employers) in collaboratively determining if clients are able to work and to make recommendations for work entry, re-entry or vocational planning. Methods Methods in the Canadian Medical Association's (CMA) Handbook on Clinical Practice Guideline and the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument were utilized to ensure rigour. Steps in the CMA handbook were followed and included: (1) identifying the guideline's objective and questions; (2) systematic literature review; (3) study selection and quality appraisal; (4) development of clear recommendations by key stakeholders; (5) guideline pilot testing and endorsement. Results The resulting guideline includes 17 key recommendations within the seven domains: (1) evaluation purpose and rationale; (2) initial intake process; (3) assessment of the personal domain; (4) assessment of the environment; (5) assessment of occupational/job requirements; (6) analysis and synthesis; (7) evaluation recommendations. Conclusions The guideline may be useful to individually practicing clinicians, health care teams, employers and individuals with TBI. Future research will formally examine the success of the guideline's implementation.	[Stergiou-Kita, Mary; Dawson, Deirdre; Rappolt, Susan] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre; Rappolt, Susan] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre] Baycrest, Rotman Res Inst, Toronto, ON, Canada	Stergiou-Kita, M (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	mary.kita@utoronto.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121			[Anonymous], 2006, TRAUM BRAIN INJ DIAG; [Anonymous], 2011, DIAB EMPL; [Anonymous], WORK LOSS DATA I GUI; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, J HEAD TRAUMA REHAB, V22, P73, DOI 10.1097/01.HTR.0000265094.98940.e0; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Archer-Heese G, 2002, OTNOW, V4, P4; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Askham, 1998, HEALTH TECHNOL ASSES, V2, DOI [10.3310/hta2030, DOI 10.3310/hta2030]; Barisa MT, 2001, NEUROREHABILITATION, V16, P289; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Black N, 1999, J Health Serv Res Policy, V4, P236; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bootes Kylie, 2002, Work, V19, P255; Brand C, 2006, INTERN MED J, V36, P170, DOI 10.1111/j.1445-5994.2006.01018.x; Canadian Medical Association, 2007, CAN MED ASS HDB CLIN; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chappell Irene, 2003, Can J Occup Ther, V70, P163; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Cook D, 1999, JAMA-J AM MED ASSOC, V281, P1950, DOI 10.1001/jama.281.20.1950; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85; Dartnell Jonathan, 2008, Evid Based Nurs, V11, P6, DOI 10.1136/ebn.11.1.6; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Detsky AS, 2006, CAN MED ASSOC J, V175, P1033, DOI 10.1503/cmaj.061181; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Ellingsen G, 2003, INFORMATION ORG, V13, P203, DOI DOI 10.1016/S1471-7727(03)00011-3; Escorpizo R, 2011, J OCCUP REHABIL, V21, P134, DOI 10.1007/s10926-011-9290-8; Escorpizo R, 2011, J OCCUP REHABIL, V21, P147, DOI 10.1007/s10926-010-9276-y; Escorpizo R, 2010, J OCCUP REHABIL, V20, P502, DOI 10.1007/s10926-010-9241-9; Field M, 1991, CLIN PRACTICE GUIDEL; Finger ME, 2011, J OCCUP REHABIL, V21, P156, DOI 10.1007/s10926-011-9308-2; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Fraser RT, 2003, J HEAD TRAUMA REHAB, V6, P46; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Giaquinto S, 2007, DISABIL REHABIL, V29, P1313, DOI 10.1080/09638280701415282; Green S, 2003, AUST J PHYSIOTHER, V49, P3, DOI 10.1016/S0004-9514(14)60182-3; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Higgins J, 2009, COCHRANE HDB SYSTEMA; Hirsh A, 1996, J VOCAT REHABIL, V7, P217; Holtzberg E, 2001, WORK, V16, P246; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hurwitz B, 1999, BRIT MED J, V318, P661, DOI 10.1136/bmj.318.7184.661; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P172, DOI 10.1258/135581906777641659; Innes E, 1998, Work, V11, P191, DOI 10.3233/WOR-1998-11209; Innes E, 1998, Work, V11, P183, DOI 10.3233/WOR-1998-11208; Innes E, 1998, Work, V11, P207, DOI 10.3233/WOR-1998-11210; Innes Ev, 2002, Work, V18, P51; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kaskutus V, OCCUPATIONAL THERAPY; KENDALL E, 2003, J VOCAT REHABIL, V19, P31; Kent B, 2007, WORLDV EVID-BASED NU, V2, P106; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kirschner KL, 2009, PM&R, V1, P674, DOI 10.1016/j.pmrj.2009.05.016; Kirsh B, 2009, WORK, V32, P391, DOI 10.3233/WOR-2009-0851; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lysaght R, 2005, AM J OCCUP THER, V59, P209, DOI 10.5014/ajot.59.2.209; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McMahon Brian T, 2005, Work, V25, P67; Michie S, 2004, BRIT MED J, V328, P343, DOI 10.1136/bmj.328.7435.343; Michie S, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-29; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Moreira T, 2006, J CLIN EPIDEMIOL, V59, P1199, DOI 10.1016/j.jclinepi.2005.08.021; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; National Institute of Clinical Excellence, 2001, NAT I CLIN EXC GUID; National Institute of Clinical Excellence Guideline Manuals, 2001, NAT I CLIN EXC GUID; National Stroke Foundation, 2010, NAT STROK FDN CLIN G; New Zealand Guideline Group, 2001, NZ GUID GROUP HDB PR; NHS Plus Evidence Based Guideline Project, 2006, OCC ASP MAN CHRON FA; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; North South Wales Faculty of Australasian College of Emergency Medicine, 2008, MILD TRAUM BRIAN INJ; NYU Langone Medical Centre, NYU LANG MED CTR DEF; O'Brien L, 2007, BRAIN INJURY, V21, P465, DOI 10.1080/02699050701315134; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pagliari C, 2002, J EVAL CLIN PRACT, V8, P145, DOI 10.1046/j.1365-2753.2002.00333.x; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Royal College of Physicians, 2004, ROYAL COLL PHYS INT; Rubenson C, 2006, SCAND J OCCUP THER, V14, P205; Rycroft-Malone J, 2001, QUAL HEALTH CARE, V10, P238, DOI 10.1136/qhc.0100238..; Sale P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, 10.1097/00001199-199109000-00004.]; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249; Stergiou-Kita M, 2006, OCCUP THER NOW, V8, P5; Stergiou-Kita M, DISABIL REH IN PRESS; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stergiou-Kita M, 2009, CAN J OCCUP THER, V76, P276, DOI 10.1177/000841740907600406; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; The AGREE Collaboration, 2001, AGREE COLL APPR GUID; Thomas DF, 1996, J VOCATIONAL REHABIL, V7, P243; Thompson SB, 2011, NEUROLOGY, V2; Travis J., 2002, WORK, V19, P269; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; University of Sydney, 2006, U SYDN CLIN PRACT GU; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Walters C, 1996, J VOC REHABIL, V7, P139; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2007, J HEAD TRAUMA REHAB, V22, P95, DOI 10.1097/01.HTR.0000265097.44683.22; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; Wollersheim H, 2005, NETH J MED, V63, P188; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010	129	13	13	0	16	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	JUN	2012	22	2					166	181		10.1007/s10926-011-9332-2			16	Rehabilitation; Social Issues	Rehabilitation; Social Issues	926DS	WOS:000302812100003	21968612				2021-06-18	
J	Fujita, M; Wei, EP; Povlishock, JT				Fujita, Motoki; Wei, Enoch P.; Povlishock, John T.			Effects of Hypothermia on Cerebral Autoregulatory Vascular Responses in Two Rodent Models of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal models of injury; pial vessels; therapeutic intervention; vascular reactivity	SEVERE HEAD-INJURY; BLOOD-FLOW; POSTTRAUMATIC HYPOTHERMIA; CEREBROVASCULAR RESPONSES; PRESSURE AUTOREGULATION; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; AUTO-REGULATION; RAT; HYPOTENSION	Traumatic brain injury (TBI) can trigger disturbances of cerebral pressure autoregulation that can translate into the generation of secondary insults and increased morbidity/mortality. Few therapies have been developed to attenuate the damaging consequences of disturbed autoregulatory control, although some suggest that hypothermia may exert such protection. Here we reexamine this issue of traumatically induced autoregulatory disturbances and their modulation by hypothermic intervention, examining these phenomena in two different models of TBI. Adult rats were subjected to either impact acceleration injury (IAI) or lateral fluid percussion injury (LFPI) followed by the insertion of cranial windows to assess the pial arteriolar cerebral autoregulatory vascular response to the post-traumatic induction of sequential reductions of arterial blood pressure. The potential for continued pial vasodilation in response to declining blood pressure was directly measured post-injury and compared with that in injured groups subjected to 33 degrees C of hypothermia of 1-2 h duration initiated 1 h post-injury. We observed that the TBI resulted in either impaired or abolished cerebral vascular dilation in response to the sequential declines in blood pressure. Following IAI there was a 50% reduction in the vasculature's ability to dilate in response to the induced hypotension. In contrast, following LFPI, the vascular response to hypotension was abolished both ipsilateral and contralateral to the LFPI. In animals sustaining IAI, the use of 1 h post-traumatic hypothermia preserved vascular dilation in response to declines in blood pressure in contrast to the LFPI in which the use of the same strategy afforded no improvement. However, with LFPI, the use of 2 h of hypothermia provided partial vascular protection. These results clearly illustrate that TBI can alter the cerebral autoregulatory vascular response to sequentially induced hypotensive insult, whereas the use of post-traumatic hypothermia provides benefit. Collectively, these studies also demonstrate that different animal models of TBI can evoke different biological responses to injury.	[Fujita, Motoki; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Fujita, Motoki] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan	Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055813, NS047463]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463] Funding Source: NIH RePORTER	We thank Susan Walker and Lynn Davis for their excellent technical assistance. This study is supported by NIH grants HD055813 and NS047463.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Consonni F, 2009, NEUROCRIT CARE, V10, P232, DOI 10.1007/s12028-008-9151-2; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371; LASSEN NA, 1959, PHYSIOL REV, V39, P183; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Ueda Y, 2004, STROKE, V35, P601, DOI 10.1161/01.STR.0000113693.56783.73; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	37	13	14	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1491	1498		10.1089/neu.2011.2278			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600021	22364620	Green Published			2021-06-18	
J	Leon-Carrion, J; Dominguez-Morales, MR; Martin, JMBY; Leon-Dominguez, U				Leon-Carrion, Jose; Rosario Dominguez-Morales, Maria; Barroso y Martin, Juan Manuel; Leon-Dominguez, Umberto			RECOVERY OF COGNITIVE FUNCTION DURING COMPREHENSIVE REHABILITATION AFTER SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article; Proceedings Paper	Workshop on Consciousness and the Vegetative State - Today/2nd Conference on Consciousness and Coma	JUL 06, 2010	Salerno, ITALY			cognitive functions; neuropsychological rehabilitation; neurorehabilitation; traumatic brain injury		Objective: To explore the course and timing of functional recovery in patients who have emerged from coma after undergoing severe traumatic brain injury. Methods: An observational study involving 19 patients with traumatic brain injury recovered from coma who underwent holistic, intensive and multidisciplinary neurorehabilitation. Daily performance in each cognitive function (long-term memory, short-term memory, orientation, calculation, attention; mental control, automation, and planning) was clinically scored and compared at admission and discharge. Results: The course of cognitive recovery after post-traumatic coma is not uniform, offering a curve with many ups, downs and plateaus. To achieve a good response and outcome nearing normalcy, a patient needs over 300 h of intensive rehabilitation. Conclusion: The consolidation of functional recovery in patients with traumatic brain injury requires time and adequate training, and discharge is not recommended until cognitive improvement is established.	[Leon-Carrion, Jose; Rosario Dominguez-Morales, Maria; Leon-Dominguez, Umberto] Univ Seville, Ctr Brain Injury Rehabil CRE CER, ES-41002 Seville, Spain; [Leon-Carrion, Jose; Barroso y Martin, Juan Manuel] Univ Seville, Dept Expt Psychol, ES-41002 Seville, Spain	Leon-Carrion, J (corresponding author), Univ Seville, Ctr Brain Injury Rehabil CRE CER, C Torneo 23, ES-41002 Seville, Spain.	leoncarrion@us.es	Barroso y Martin, Juan Manuel/AAB-9758-2020	Leon-Dominguez, Umberto/0000-0001-5170-2553			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; FUSTER JM, 2003, CORTEX MIND UNIFYING; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; Leon-Carrion J., 2010, COMPUTERIZED SEVILLA; Leon-Carrion J., 1998, BRAIN INJURY SOURCES, V3, P16; Leon-Carrion J., 1997, NEUROPSYCHOL REHABIL, P371; Leon-Carrion J., 1999, REV ESPANOLA NEUROPS, V1, P49; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P385; Leon-Carrion J, 2010, BEHAV BRAIN RES, V208, P502, DOI 10.1016/j.bbr.2009.12.026; Lezack MD., 1995, NEUROPSYCHOLOGICAL A; Lincoln N, 1999, COGNITIVE NEUROREHAB, P203; Machuca F., 1997, NEUROPSYCHOL REHABIL, p453 ; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Miller EH, 2007, ARCH DIS CHILD, V92, pA3; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; Prigatano GP., 1999, J HEAD TRAUMA REHAB, P322; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; YU J, 1976, ARCH PHYS MED REHAB, V57, P38	20	13	13	0	18	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2012	44	6			SI		505	511		10.2340/16501977-0982			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	956TW	WOS:000305113000006	22661001	DOAJ Gold			2021-06-18	
J	Saadat, S; Akbari, H; Khorramirouz, R; Mofid, R; Rahimi-Movaghar, V				Saadat, Soheil; Akbari, Hesam; Khorramirouz, Reza; Mofid, Roza; Rahimi-Movaghar, Vafa			Determinants of mortality in patients with traumatic brain injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Mortality; outcome; prognosis; traumatic brain injury	PROGNOSTIC VALUE; HEAD-INJURY; ALCOHOL; IMPACT; RISK; AGE	BACKGROUND We aimed to determine factors associated with mortality rates in patients with traumatic brain injury (TBI). METHODS Registered data of a national trauma project conducted in eight major cities in Iran during a five-year period were used. Patients with a TBI were identified and both univariate and multivariate analyses were performed. RESULTS 2274 brain-injured patients including 1794 males (78.9%) were identified. The mean age of the patients was 30.1 +/- 19.11 years. The age of 345 patients was less than 12, while 137 patients were older than 65. 383 patients (16.9%) died as a result of their injury. Univariate analysis showed a significant association between mortality and the following factors: age, sex, Glasgow Coma Scale (GCS), Injury Severity Score (ISS), systolic, diastolic and mean arterial blood pressure (BP), and respiratory rate (RR) (p<0.05). The logistic regression analysis revealed a statistically significant association between death and age (odds ratio [OR]=1.04), GCS (OR=0.59), ISS (OR=1.03), mean arterial BP (OR=0.71), and RR (OR=0.82) one-half hour after hospital arrival. CONCLUSION Our results demonstrated that age, GCS, ISS, BP, and RR as prognostic factors in patients with TBI indicate those that need special care during the initial management in the emergency department.	[Saadat, Soheil; Akbari, Hesam; Khorramirouz, Reza; Mofid, Roza; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, SSRC, Tehran, Iran	Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Sina Hosp, Hassan Abad Sq,Imam Khomeini Ave, Tehran 113653876, Iran.	v_rahimi@sina.tums.ac.ir	Rahimi-Movaghar, Vafa/L-6339-2019; Saadat, Soheil/J-1595-2014	Saadat, Soheil/0000-0002-2744-7983; Khorramirouz, Reza/0000-0003-2143-6068; adibzadeh, amir/0000-0002-5703-0759			Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Farace E, 2000, NEUROSURG FOCUS, V8, P6; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P149, DOI 10.5505/tjtes.2011.26043; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	23	13	13	0	4	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2012	18	3					219	224		10.5505/tjtes.2012.03453			6	Emergency Medicine	Emergency Medicine	958VM	WOS:000305269000005	22864713	Bronze			2021-06-18	
J	Weber, M; Edwards, MG				Weber, Mareen; Edwards, Martin Gareth			Sport Concussion Knowledge in the UK General Public	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Rehabilitation; Assessment	TRAUMATIC BRAIN-INJURY; MISCONCEPTIONS; STATEMENT	This is the first study to assess sport concussion knowledge and the effect of sport concussion self-report on knowledge in the UK general public. In the online survey, participants (n 227) stated personal sport concussion history, injury indicators, and rated 26 injury statements for truthfulness using definite (true, false) or non-definite (probably true, probably false) response options. As anticipated, knowledge was limited. Few statement ratings were definite, and misconceptions prevailed. The injurys seriousness was systematically underestimated, suggesting that knowledge may not be sufficient for injury self-diagnosis and self-recovery measures. Sport concussion self-report was associated with more definite than non-definite statement ratings. However, response accuracy did not differ. This suggested that personal injury experience may yield a false sense of security. The use of accessible, easy-to-use tools needs to be promoted to improve sport practice safety.	[Weber, Mareen] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02478 USA; [Weber, Mareen; Edwards, Martin Gareth] Univ Birmingham, Coll Life & Environm Sci, Sch Sport & Exercise Sci, Birmingham, W Midlands, England; [Edwards, Martin Gareth] Catholic Univ Louvain, Inst Rech Sci Psychol, B-1348 Louvain, Belgium	Weber, M (corresponding author), Harvard Univ, McLean Hosp, Sch Med, 115 Mill St, Belmont, MA 02478 USA.	mweber@mclean.harvard.edu		Edwards, Martin/0000-0003-4532-2436	University of Birmingham	This work was supported by a University of Birmingham PhD scholarship.	Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; De Beaumont L., 2009, BRAIN, V1, P1; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; O'Jile J. R., 1997, INT J REHABILITATION, V3, P61, DOI DOI 10.1007/BF02766798; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110	17	13	13	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2012	27	3					355	361		10.1093/arclin/acs029			7	Psychology, Clinical; Psychology	Psychology	930SA	WOS:000303158400011	22377909	Bronze			2021-06-18	
J	Bukur, M; Mosheni, S; Ley, E; Salim, A; Margulies, D; Talving, P; Demetriades, D; Inaba, K				Bukur, Marko; Mosheni, Shahin; Ley, Eric; Salim, Ali; Margulies, Daniel; Talving, Peep; Demetriades, Demetrios; Inaba, Kenji			Efficacy of beta-blockade after isolated blunt head injury: Does race matter?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	63rd Annual Meeting of the Southwestern-Surgical-Congress	APR 03-08, 2011	HI	SW Surg Congress		Trauma; head injury; beta-blocker; ethnicity; mortality	TRAUMATIC BRAIN-INJURY; ADULT BURN PATIENTS; IMPROVED OUTCOMES; FUNCTIONAL OUTCOMES; CEREBRAL PERFUSION; ORGAN DYSFUNCTION; MYOCARDIAL DAMAGE; IMPROVED SURVIVAL; EPIDEMIOLOGY; PROPRANOLOL	BACKGROUND: Several retrospective clinical studies and recent prospective animal models demonstrate improved outcomes with beta-blocker administration after isolated blunt head injury. However, no investigations to date have examined the influence of race on the potential therapeutic effectiveness of these medications. Our hypothesis was that mortality benefits associated with beta-blocker exposure after isolated blunt head injury varies based on ethnicity. METHODS: The trauma registry and the surgical intensive care unit (ICU) databases of an academic Level I trauma center were used to identify all patients sustaining blunt head injury requiring ICU admission from July 1998 to December 2009. Patients sustaining major associated extracranial injuries (Abbreviated Injury Scale [AIS] score >= 3 in any body region) were excluded. Patient demographics, injury profile, Injury Severity Score, and beta-blocker exposure were abstracted. The primary outcome evaluated was in-hospital mortality stratified by ethnicity. RESULTS: During the 11-year study period, 3,750 patients were admitted to the Los Angeles County + University of Southern California Medical Center trauma ICU because of blunt trauma. Of these, 65% (n = 2,446) had an "isolated" head injury. When stratified by race, most patients were Hispanics (60%), followed by Whites (21%), Asians (11%), and African Americans (8%). After adjusting for confounding variables with multivariate regression, only those of Asian and Hispanic descent demonstrated significantly improved outcomes associated with beta-blocker administration. CONCLUSIONS: Our results indicate that beta-blockade after traumatic brain injury may not benefit all races equally. Further prospective research is necessary to assess this discrepancy in treatment benefit and explore other possible therapeutic interventions. (J Trauma. 2012;72:1013-1018. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Bukur, Marko; Ley, Eric; Salim, Ali; Margulies, Daniel] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA; [Mosheni, Shahin; Talving, Peep; Demetriades, Demetrios; Inaba, Kenji] Univ So Calif, Los Angeles Cty Med Ctr, Dept Acute Care Surg, Los Angeles, CA 90033 USA	Bukur, M (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, 8635 W 3rd St,Suite 650, Los Angeles, CA 90048 USA.	bukurm@cshs.org	Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015; INABA, KENJI/AAC-8532-2020	Talving, Peep/0000-0002-9741-2073; Bukur, Marko/0000-0002-1850-7147			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; COLGAN FJ, 1983, CRIT CARE MED, V11, P368, DOI 10.1097/00003246-198305000-00010; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; CONNOR RCR, 1969, AM HEART J, V78, P145, DOI 10.1016/0002-8703(69)90001-5; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Enderson BL, 2007, J TRAUMA, V62, P33; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; GILLUM RF, 1979, HYPERTENSION, V1, P468, DOI 10.1161/01.HYP.1.5.468; Girasek DC, 2010, TRAFFIC INJ PREV, V11, P151, DOI 10.1080/15389580903531598; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HAWKINS WE, 1971, CARDIOVASC RES, V5, P524, DOI 10.1093/cvr/5.4.524; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kemp CD, 2008, AM SURGEON, V74, P866; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lipsky RH, 2003, ANN NY ACAD SCI, V1003, P22, DOI 10.1196/annals.1300.003; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; MEYER JS, 1976, STROKE, V7, P158, DOI 10.1161/01.STR.7.2.158; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Pryor JP, 2007, J TRAUMA, V62, P61; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Simon RJ, 2004, J TRAUMA, V56, P269; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Stallion A, 2007, J TRAUMA, V62, P1262; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Voas RB, 2009, ACCIDENT ANAL PREV, V41, P522, DOI 10.1016/j.aap.2009.02.004; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Yancy CW, 2003, AM HEART J, V146, P203, DOI 10.1016/S0002-8703(03)00241-2; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	58	13	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					1013	1018		10.1097/TA.0b013e318241bc5b			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	925TO	WOS:000302784600046	22491619				2021-06-18	
J	Cohen, ML; Heaton, SC; Ginn, N; Eyberg, SM				Cohen, Matthew L.; Heaton, Shelley C.; Ginn, Nicole; Eyberg, Sheila M.			Parent-Child Interaction Therapy as a Family-Oriented Approach to Behavioral Management Following Pediatric Traumatic Brain Injury: A Case Report	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						behavior problems; case study; parent-child interaction therapy; pediatric traumatic brain injury; traumatic brain injury	CLOSED-HEAD-INJURY; SHORT-TERM; PSYCHIATRIC-DISORDERS; DISRUPTIVE BEHAVIOR; OUTCOMES; ADOLESCENTS; MAINTENANCE; EFFICACY; INTERVENTION; FEASIBILITY	Objective To present a case study illustrating the application of parent-child interaction therapy (PCIT) for management of a child's externalizing behaviors related to a severe traumatic brain injury (TBI). Methods An 11-year-old boy's history and injury are described, followed by a description of PCIT and the course of therapy. Results After 9 sessions of PCIT, the child displayed fewer negative behaviors, and his mother's distress was reduced. Conclusions This case demonstrates the feasibility of using PCIT with a child older than the recommended age range to address behavior problems associated with TBI.	[Cohen, Matthew L.] Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA	Cohen, ML (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, POB 100165, Gainesville, FL 32610 USA.	mlcohen@phhp.ufl.edu	Cohen, Mathew/W-3982-2019	Cohen, Matthew/0000-0001-9609-2461			Anderson V., 2010, PEDIAT TRAUMATIC BRA, P179; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bagner DM, 2007, J CLIN CHILD ADOLESC, V36, P418, DOI 10.1080/15374410701448448; Bagner DM, 2010, J DEV BEHAV PEDIATR, V31, P209, DOI 10.1097/DBP.0b013e3181d5a294; Bagner DM, 2004, J CLIN PSYCHOL MED S, V11, P1, DOI 10.1023/B:JOCS.0000016264.02407.fd; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Chaffin M, 2004, J CONSULT CLIN PSYCH, V72, P500, DOI 10.1037/0022-006X.72.3.500; EISENSTADT TH, 1993, J CLIN CHILD PSYCHOL, V22, P42, DOI 10.1207/s15374424jccp2201_4; EISENSTADT TH, 1994, CHILD FAM BEHAV THER, V16, P21, DOI 10.1300/J019v16n01_02; Eyberg S., 1999, EYBERG CHILD BEHAV I; Eyberg S., 2011, PARENT CHILD INTERAC; Eyberg S. M., 2004, MANUAL DYADIC PARENT; Eyberg SM, 2008, J CLIN CHILD ADOLESC, V37, P215, DOI 10.1080/15374410701820117; Eyberg SM, 2010, CLINICAL HANDBOOK OF ASSESSING AND TREATING CONDUCT PROBLEMS IN YOUTH, P139, DOI 10.1007/978-1-4419-6297-3_6; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Funderburk B. W., 2003, EARLY EDUC DEV, V14, P67, DOI [DOI 10.1207/s15566935eed1401_5, 10.1207/s15566935-ed1401_5]; Funderburk BW, 1998, CHILD FAM BEHAV THER, V20, P17, DOI 10.1300/J019v20n02_02; Gioia G.A., 2000, BEHAV RATING INVENTO; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Hood KK, 2003, J CLIN CHILD ADOLESC, V32, P419, DOI 10.1207/S15374424JCCP3203_10; Jacobson N. S., J CONSULTING CLIN PS, V59, P12; JENNETT B, 1975, LANCET, V1, P480; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; MCNEIL CB, 1991, J CLIN CHILD PSYCHOL, V20, P140, DOI 10.1207/s15374424jccp2002_5; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.0.CO;2-1; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor H. G., 2010, PEDIAT TRAUMATIC BRA, P145; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; WAALAND PK, 1998, TRAUMATIC BRAIN INJU, P345; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WADE SL, 2006, TREATING NEURODEVELO, P170; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI DOI 10.1375/BRIM.7.3.246; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zisser A., 2010, EVIDENCE BASED PSYCH, P179, DOI DOI 10.1111/J.1467-8624.2010.01548.X	54	13	13	0	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693			J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2012	37	3					251	261		10.1093/jpepsy/jsr086			11	Psychology, Developmental	Psychology	915IJ	WOS:000302017400001	22004884	Bronze			2021-06-18	
J	Li, Z; Cui, G; Wang, JX; Yu, ZH; Zhao, L; Lv, ZW				Li, Zhen; Cui, Gang; Wang, Junxiang; Yu, Zhihua; Zhao, Li; Lv, ZhengWen			Nemo-like Kinase (NLK) Involves in Neuronal Apoptosis after Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; NLK; PC12 cell; Glutamate; Apoptosis	DEATH; CASPASE-3; PATHWAY; CATENIN; MICE; RECEPTORS; BCL-2	Traumatic brain injury (TBI) consists of two phases: an immediate phase in which damage is caused as a direct result of the mechanical impact: and a late phase of altered biochemical events that results in delayed tissue damage and is therefore amenable to therapeutic treatment. Because the molecular mechanisms of delayed post-traumatic neuronal cell death are still poorly understood, we investigated whether nemo-like kinase (NLK), an evolutionarily conserved serine/threonine kinase involved in neuronal apoptosis following TBI. In the model of TBI, western blot analysis, double immunofluorescent staining and immunohistochemistry were used to analyze the role of NLK in the process. The results showed a significant down-regulation of NLK and a concomitant up-regulation of caspase-3 during the early stage of TBI. In the model of glutamate inducing PC12 apoptosis, we analyzed the effect of over-expression of NLK on the neuronal cell line PC12 apoptosis by cck-8, western blot and TUNEL assays. Together with previous reports. We hypothesize NLK was related to the down-regulation of caspase-3 expression after TBI, and such an event may be associated with neuronal apoptosis.	[Li, Zhen; Zhao, Li; Lv, ZhengWen] Cent Hosp TaiAN, Tai An 27100, Shandong, Peoples R China; [Cui, Gang; Wang, Junxiang; Yu, Zhihua] Suzhou Univ, Affiliated Hosp 1, Suzhou 215104, Peoples R China	Lv, ZW (corresponding author), Cent Hosp TaiAN, Tai An 27100, Shandong, Peoples R China.	lizhen840320@163.com; lvzhengwen1388@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2006547]	The plasmid was kindly given by laboratory of genetics, FuDAN. This study was supported by the National Natural Science Foundation of China (No. 30770488 and No. 30870320); Natural Science Foundation of Jiangsu province (No. BK2006547).	Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden H, 2002, PEDIATR INFECT DIS J, V21, P791, DOI 10.1097/00006454-200208000-00020; Frantseva M, 2002, PROG BRAIN RES, V137, P171; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Yakovlev AG, 2001, J NEUROSCI, V21, P7439	26	13	15	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2012	32	3					381	389		10.1007/s10571-011-9766-2			9	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	934AE	WOS:000303409700007	22127415				2021-06-18	
J	Nemati, F; Kolb, B				Nemati, Farshad; Kolb, Bryan			Recovery from medial prefrontal cortex injury during adolescence: Implications for age-dependent plasticity	BEHAVIOURAL BRAIN RESEARCH			English	Article						Adolescence; Dendritic reorganization; Functional recovery; Medial prefrontal cortex injury; Neuroplasticity	EARLY-ONSET SCHIZOPHRENIA; TRAUMATIC BRAIN-INJURY; CORTICAL ATROPHY; FEMALE RATS; ADULT RATS; LESIONS; ASYMMETRY; VOLUME; MOTOR; MATURATION	Focal cortical injuries generate various behavioral deficits associated with different morphological changes. The age and the area of the injury determine the nature and extent of recovery represented by the level of performance in various behavioral tasks. Previously, we have shown that motor cortex injury in early (but not late) adolescence leads to behavioral deficits that do not recover spontaneously with time. Considering the fact that the pace of brain maturation differs in different brain areas, we undertook to examine the pattern of spontaneous recovery following medial prefrontal cortex (mPFC) lesion in early or late adolescence. A battery of motor tasks (postural asymmetry, skilled reaching, sunflower seed manipulation, forepaw inhibition in swimming) was used to investigate the pattern of behavioral recovery following mPFC lesions. Golgi-Cox analysis was used to examine dendritic reorganization of the relevant brain areas. The results indicated that rats perform poorly when receiving mPFC injuries in late adolescence in contrast to when they receive the lesion in early adolescence. Almost opposite pattern of recovery following motor cortex and medial prefrontal injuries in early and late adolescence will be discussed as an age-area dependent model for prognosis of brain injury during adolescence. (C) 2012 Elsevier B.V. All rights reserved.	[Nemati, Farshad; Kolb, Bryan] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	Nemati, F (corresponding author), Univ Lethbridge, Dept Neurosci, 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	farshad.nemati@uleth.ca		Nemati, Farshad/0000-0002-4989-889X	Alberta Heritage Foundation for Medical Research/Hotchkiss Brain InstituteAlberta Heritage Foundation for Medical Research; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	This research was supported by an Alberta Heritage Foundation for Medical Research/Hotchkiss Brain Institute postdoctoral fellowship to FN and a Canadian Institutes for Health Research grant to BK. We thank Sharon Mustard, Ayuno Nakahashi, Serah Raza, Rayan Rota, and Saif Zahir for their technical assistance.	Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; ANDREASEN NC, 1982, AM J PSYCHIAT, V139, P297; Brenhouse HC, 2011, NEUROSCI BIOBEHAV R, V35, P1687, DOI 10.1016/j.neubiorev.2011.04.013; Collinson SL, 2003, BRIT J PSYCHIAT, V183, P114, DOI 10.1192/bjp.183.2.114; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; DeVito EE, 2005, EUR J ANAESTH, V22, P23; Ferrari MCL, 2006, ARQ NEURO-PSIQUIAT, V64, P741, DOI 10.1590/S0004-282X2006000500008; Gaser C, 2004, AM J PSYCHIAT, V161, P154, DOI 10.1176/appi.ajp.161.1.154; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Highley JR, 1998, SCHIZOPHR RES, V34, P13, DOI 10.1016/S0920-9964(98)00077-2; HOFFMAN RE, 1989, SCHIZOPHRENIA BULL, V15, P477, DOI 10.1093/schbul/15.3.477; Janssen J, 2008, J AM ACAD CHILD PSY, V47, P1311, DOI 10.1097/CHI.0b013e318184ff48; John JP, 2009, SCHIZOPHR RES, V109, P148, DOI 10.1016/j.schres.2008.12.019; Kellogg CK, 1998, PERSPECT DEV NEUROBI, V5, P219; Kolb B, 1996, BEHAV BRAIN RES, V79, P1, DOI 10.1016/0166-4328(95)00254-5; KOLB B, 1981, NEUROPSYCHOLOGIA, V19, P491, DOI 10.1016/0028-3932(81)90016-6; KOLB B, 1982, EXP NEUROL, V78, P348, DOI 10.1016/0014-4886(82)90053-X; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Kolb B, 2000, RESTOR NEUROL NEUROS, V17, P61; KOLB B, 1976, SCIENCE, V193, P335, DOI 10.1126/science.935872; KOLB B, 1995, BEHAV NEUROSCI, V109, P285, DOI 10.1037/0735-7044.109.2.285; KOLB B, 1978, BRAIN RES, V151, P135, DOI 10.1016/0006-8993(78)90956-3; Kolb B., 1995, BRAIN PLASTICITY BEH; MASSMAN PJ, 1986, INT J NEUROSCI, V30, P87, DOI 10.3109/00207458608985659; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Meduri M, 2010, PSYCHIAT RES-NEUROIM, V183, P52, DOI 10.1016/j.pscychresns.2010.01.014; Meehan SK, 2011, HUM BRAIN MAPP, V32, P290, DOI 10.1002/hbm.21019; Metz GA., 2005, BEHAV LAB RAT HDB TE; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nemati F, 2010, BEHAV NEUROSCI, V124, P612, DOI 10.1037/a0020911; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; NONNEMAN AJ, 1981, J COMP PHYSIOL PSYCH, V95, P588, DOI 10.1037/h0077800; Owler BK, 2004, J CEREBR BLOOD F MET, V24, P17, DOI 10.1097/01.WCB.0000093326.88757.49; PAXINOS G, 1997, RAT BRAIN STEREOTAXI; Pienaar IS, 2007, RESTOR NEUROL NEUROS, V25, P513; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert T, 1997, ADV NEUROL, V73, P229; Sholl DA, 1956, ORG CEREBRAL CORTEX; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2010, BRAIN COGNITION, V72, P160, DOI 10.1016/j.bandc.2009.11.003; STEWART J, 1988, BEHAV NEURAL BIOL, V49, P344, DOI 10.1016/S0163-1047(88)90354-8; VANEDEN CG, 1990, PROG BRAIN RES, V85, P169; Whishaw IQ, 1998, BEHAV BRAIN RES, V96, P79, DOI 10.1016/S0166-4328(97)00200-3; Whishaw IQ, 2004, J NEUROTRAUM, V21, P1584, DOI 10.1089/neu.2004.21.1584; Zilles K., 1985, CORTEX RAT STEREOTAX	51	13	13	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR 1	2012	229	1					168	175		10.1016/j.bbr.2012.01.002			8	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	915SL	WOS:000302047600021	22261018				2021-06-18	
J	Piper, GL; Kaplan, LJ				Piper, Greta L.; Kaplan, Lewis J.			Fluid and Electrolyte Management for the Surgical Patient	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Fluid balance; Electrolyte balance; Acid-base assessment; Plasma volume; Hyperchloremic metabolic acidosis	SPONTANEOUS BACTERIAL PERITONITIS; DAMAGE CONTROL RESUSCITATION; SEVERE HEMORRHAGIC-SHOCK; TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; ALBUMIN; MORTALITY; PLASMA; PARACENTESIS; EXPANSION	For surgical patients, appropriate selection and administration of fluids can mitigate against organ failure, whereas improper dosing can exacerbate already injured systems. Fluid and electrolyte goals and deficiencies must be defined for individual patients to provide the appropriate combination of resuscitation and maintenance fluids. Specific electrolyte abnormalities should be anticipated, identified, and corrected to optimize organ functions. Using the strong-ion approach to acid-base assessment, delivered fluids that contain calculated amounts of electrolytes will interact with the patient's plasma charge and influence the patient's pH, allowing the clinician to achieve a more precise end point.	[Piper, Greta L.; Kaplan, Lewis J.] Yale Univ, Sch Med, Sect Trauma Surg Crit Care & Surg Emergencies, Dept Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Trauma Surg Crit Care & Surg Emergencies, Dept Surg, New Haven, CT 06520 USA	Kaplan, LJ (corresponding author), Yale Univ, Sch Med, Sect Trauma Surg Crit Care & Surg Emergencies, Dept Surg, 330 Cedar St,BB 310, New Haven, CT 06520 USA.	Lewis.Kaplan@yale.edu					Alderson P, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001208.pub3, 10.1002/14651858.CD001208.pub4]; Bavir H, 2003, CRIT CARE MED S1, V31, pS112; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Byrnes MC, 2011, CURR OPIN CLIN NUTR, V14, P186, DOI 10.1097/MCO.0b013e328341ed93; Choi CH, 2005, J GASTROEN HEPATOL, V20, P1215, DOI 10.1111/j.1440-1746.2005.03861.x; Cohn SM, 2007, J TRAUMA, V62, P44, DOI 10.1097/TA.0b013e31802eb817; Crookes BA, 2005, J TRAUMA, V58, P806, DOI 10.1097/01.TA.0000158269.68409.1C; Davidson IJ, 2006, EUR J ANAESTH, V23, P721, DOI 10.1017/S0265021506000639; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Duchesne JC, 2011, AM SURGEON, V77, P201; Fallon W F, 1993, Curr Opin Gen Surg, P40; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Fuentebella J, 2009, PEDIATR CLIN N AM, V56, P1201, DOI 10.1016/j.pcl.2009.06.006; Hai S. A., 2004, JPMA Journal of the Pakistan Medical Association, V54, P434; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Kaplan LJ, 2008, SHOCK, V29, P662, DOI 10.1097/shk.0b013e3181618946; Kaplan LJ, 2006, J TRAUMA, V61, P90, DOI 10.1097/01.ta.0000222578.85413.4e; Kaplan LJ, 2010, CURR OPIN CRIT CARE, V16, P323, DOI 10.1097/MCC.0b013e32833c0957; Kaplan LJ, 2009, J TRAUMA, V66, P1045, DOI 10.1097/TA.0b013e31819a04be; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; KRAUSZ MM, 1995, SHOCK, V3, P69, DOI 10.1097/00024382-199503010-00012; LEE JA, 1981, ANAESTHESIA, V36, P1115, DOI 10.1111/j.1365-2044.1981.tb08698.x; Moore B, 1911, BIOCHEM J, V5, pib3, DOI [10.1042/bj005000i, DOI 10.1042/BJ005000I]; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; Narula N, 2011, CAN J GASTROENTEROL, V25, P373, DOI 10.1155/2011/586702; Ragaller MJR, 2001, J AM SOC NEPHROL, V12, P533; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roche AM, 2006, ANESTH ANALG, V102, P1274, DOI 10.1213/01.ane.0000197694.48429.94; SILVA MRF, 1987, AM J PHYSIOL, V253, pH751; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Umgelter A, 2008, CRIT CARE, V12, DOI 10.1186/cc6765; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	38	13	13	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	APR	2012	92	2					189	+		10.1016/j.suc.2012.01.004			18	Surgery	Surgery	926LH	WOS:000302832000003	22414407				2021-06-18	
J	Schmidt, J; Fleming, J; Ownsworth, T; Lannin, N; Khan, A				Schmidt, Julia; Fleming, Jennifer; Ownsworth, Tamara; Lannin, Natasha; Khan, Asad			Feedback interventions for improving self-awareness after brain injury: A protocol for a pragmatic randomised controlled trial	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						feedback; rehabilitation; traumatic brain injury	ANXIETY STRESS SCALES; STATISTICS NOTES; TREATMENT ALLOCATION; VALIDITY; SAMPLE	Background: Occupational therapists working in brain injury rehabilitation use functional tasks as a means of providing feedback to improve self-awareness of people who have a brain injury and ultimately improve their occupational performance. Purpose: To compare the effectiveness of video, verbal and experiential feedback for improving self-awareness in people with traumatic brain injury. Methods: A randomised controlled trial will be conducted to compare the efficacy of video and verbal feedback during occupational therapy. Fifty-four participants with traumatic brain injury will be randomly allocated into three intervention groups: (i) video plus verbal feedback, (ii) verbal feedback and (iii) experiential feedback (control condition). Participants will receive the allocated intervention based on performance of a meal preparation task. The intervention sessions will occur four times during a two-week period. Blinded assessment will occur at baseline, post-intervention, and two months follow up. The primary outcome will be a measure of on-line self-awareness (number of self-corrected and therapist corrected errors). Secondary outcomes to be assessed include levels of intellectual self-awareness, emotional distress, and acceptance of disability. Data will be analysed using an intention to treat approach. Linear mixed effects models will be used to investigate the intervention effects. Findings and Implications: Results will contribute to evidence-based guidelines to support therapists to choose the most effective form of feedback for people with decreased self-awareness after traumatic brain injury.	[Schmidt, Julia] Royal Rehabil Ctr Sydney, Ryde, NSW 1680, Australia; [Schmidt, Julia; Fleming, Jennifer; Khan, Asad] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Fleming, Jennifer; Khan, Asad] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Lannin, Natasha] Univ Sydney, Rehabil Studies Unit, Sydney Med Sch, Sydney, NSW 2006, Australia	Schmidt, J (corresponding author), Royal Rehabil Ctr Sydney, POB 6, Ryde, NSW 1680, Australia.	julia.schmidt@royalrehab.com.au	Lannin, Natasha A/A-4195-2013; Khan, Asad/R-8484-2016; Khan, Asaduzzaman/F-8739-2010; Khan, Asad/N-7481-2019	Lannin, Natasha A/0000-0002-2066-8345; Khan, Asad/0000-0003-4188-2065; Khan, Asaduzzaman/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Schmidt, Julia/0000-0003-2004-4871; Ownsworth, Tamara/0000-0003-1835-7094			Altman DG, 1999, BRIT MED J, V318, P1209; Altman DG, 2001, BRIT MED J, V323, P446, DOI 10.1136/bmj.323.7310.446; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Barco P.P., 1991, COGNITIVE REHABILITA, P129; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming J, 2009, INTERNATIONAL HANDBOOK OF OCCUPATIONAL THERAPY INTERVENTIONS, P225, DOI 10.1007/978-0-387-75424-6_20; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Langer K.G., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [https://doi.org/10.1080/09602019208401395, DOI 10.1080/09602019208401395]; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T., 2009, 6 S NEUR REH TALL ES; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Prescott R, 2006, APPL MIXED MODELS ME; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M., 2004, The Awareness Questionnaire. The center for outcome measurement in brain injury; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tango T, 2009, STAT PROBABIL LETT, V79, P466, DOI 10.1016/j.spl.2008.09.016; Tham K, 1997, ARCH PHYS MED REHAB, V78, P410, DOI 10.1016/S0003-9993(97)90234-3; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Wechsler D., 2002, WAIS 3 WMS 3 TECHNIC; Wilson BA, 1996, BEHAV ASSESSMENT DYS	35	13	13	0	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	APR	2012	59	2					138	146		10.1111/j.1440-1630.2012.00998.x			9	Rehabilitation	Rehabilitation	914BH	WOS:000301923200005	22448994				2021-06-18	
J	Tanguy, M; Seguin, P; Laviolle, B; Bleichner, JP; Morandi, X; Malledant, Y				Tanguy, Michele; Seguin, Philippe; Laviolle, Bruno; Bleichner, Jean-Paul; Morandi, Xavier; Malledant, Yannick			Cerebral Microdialysis Effects of Propofol versus Midazolam in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						lactate:pyruvate ratio; microdialysis; sedative agents; trauma brain injury	OXIDATIVE STRESS; CULTURED ASTROCYTES; METABOLIC CRISIS; HEAD-INJURY; RATS; TOMOGRAPHY; PROTECTION; GLUTAMATE; ISCHEMIA; CELLS	Propofol, an anesthetic agent acting as an analogue of vitamin E, has been advocated to be an ideal neuroprotective agent both in animal models and in clinical practice, due to its positive effects on oxidative stress. Nevertheless, no studies have compared this agent to another sedative agent used for sedation after traumatic brain injury (TBI). The objective was to compare the effects of propofol to midazolam on cerebral biomarkers at the acute phase of severe TBI patients. Thirty patients aged 35 +/- 18 years were prospectively randomized to receive propofol or midazolam and 29 were analyzed (n = 15 for propofol, and n = 14 for midazolam). A cerebral microdialysis catheter was used to measure the lactate: pyruvate (L:P) ratio, glutamate, glycerol, and glucose for 72 h. No difference between groups was observed for the L:P ratio (time effect p = 0.201, treatment effect p = 0.401, time x treatment interaction p = 0.101). Similarly, no difference was observed for glutamate (time effect p = 0.930, treatment effect p = 0.651, time x treatment interaction p = 0.353), glycerol (time effect p = 0.223, treatment effect p = 0.922, time x treatment interaction p = 0.308), or glucose (time effect p = 0.116, treatment effect p = 0.088, time x treatment interaction p = 0.235). These results do not support a difference between propofol and midazolam for sedation for the cerebral metabolic profile in severe TBI.	[Tanguy, Michele; Seguin, Philippe; Bleichner, Jean-Paul; Malledant, Yannick] Univ Rennes 1, Dept Anesthesie Reanimat 1, INSERM, Serv Reanimat Chirurg,U991, F-35014 Rennes, France; [Laviolle, Bruno] Univ Rennes 1, Serv Pharmacol, INSERM, Serv Reanimat Chirurg,U991, F-35014 Rennes, France; [Laviolle, Bruno] Univ Rennes 1, Ctr Invest Clin, INSERM, Serv Reanimat Chirurg,U991, F-35014 Rennes, France; [Morandi, Xavier] Hop Pontchaillou, Serv Neurochirurg, Rennes 9, France	Seguin, P (corresponding author), Hop Pontchaillou, Serv Anesthesie Reanimat 1, 2 Rue Henri Le Guilloux, Rennes 9, France.	philippe.seguin@chu-rennes.fr	MORANDI, Xavier/ABC-5851-2020; Seguin, Philippe/P-9487-2019	MORANDI, Xavier/0000-0002-8031-7221; Seguin, Philippe/0000-0002-7774-4257; Malledant, yannick/0000-0001-6680-5184	Programme Hospitalier de Recherche Clinique (PHRC) of Rennes [R0903]	The study was supported by a grant from Programme Hospitalier de Recherche Clinique (PHRC) of Rennes, October 2005 (R0903).	Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Clausen F., 2011, J NEUROTRAUMA; DEROUESNE C, 1993, INT J GERIATR PSYCH, V8, P599, DOI 10.1002/gps.930080712; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Kobayashi K, 2008, ANESTHESIOLOGY, V109, P426, DOI 10.1097/ALN.0b013e318182a903; Li X, 2003, BIOCHEM BIOPH RES CO, V305, P656, DOI 10.1016/S0006-291X(03)00836-2; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nakahata K, 2008, ANESTHESIOLOGY, V108, P269, DOI 10.1097/01.anes.0000299830.13203.60; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sarnowska A, 2009, NEUROCHEM INT, V55, P164, DOI 10.1016/j.neuint.2009.01.024; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sitar SM, 1999, ANESTHESIOLOGY, V90, P1446, DOI 10.1097/00000542-199905000-00030; Smith H, 2009, NEUROCRIT CARE, V10, P166, DOI 10.1007/s12028-008-9163-y; Tanabe K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-68; Tsuchiya M, 2002, AM J RESP CRIT CARE, V165, P54, DOI 10.1164/ajrccm.165.1.2010134; Tsuchiya M, 2001, AM J RESP CRIT CARE, V163, P26, DOI 10.1164/ajrccm.163.1.9911120; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D	32	13	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1105	1110		10.1089/neu.2011.1817			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100010	22182405				2021-06-18	
J	Hinton-Bayre, AD				Hinton-Bayre, Anton D.			Choice of Reliable Change Model Can Alter Decisions Regarding Neuropsychological Impairment After Sports-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; neuropsychology; reilable change; return to play	CHANGE INDEXES; SCORES	Objective: Impaired neuropsychological test performance after concussion has been used to guide restraint from play, in particular using reliable change indices (RCI). It remains unclear which of the RCI is most appropriate. Design: Athletes were assessed prospectively before and after cerebral concussion and compared with control athletes. Setting: Athletes were assessed in a clinical office environment after referral from a Sports Physician. Participants: One hundred ninety-four Australian rugby league athletes were assessed preseason (time 1). Interventions: Twenty-seven concussed athletes were assessed 2 days after trauma (time 2) and compared with 26 distribution-matched volunteer uninjured controls. Main Outcome Measures: Cognitive performance was assessed on 5 neuropsychological measures of speed of information processing, psychomotor speed, and response inhibition. Four previously reported RCI models used in sports concussion were contrasted, as described by Barr and McCrea (2001) and Maassen et al (2006). Results: Reliable change index models were marginally comparable in classifying the control sample. In the concussed sample, no one model seemed to be consistently more or less sensitive. Moreover, the same model could be most sensitive for one individual and least sensitive for another, even on the same test. Conclusions: Reliable change index models can yield different outcomes regarding whether an athlete has experienced cognitive impairment after concussion. Reliable change index model sensitivity to impairment depends on multiple test and situational factors, including test-retest reliability, differences in test and retest variances, and the individual's relative position on initial testing. In the absence of consensus, the clinician must use highly reliable measures with suitably matched controls if using an RCI.	[Hinton-Bayre, Anton D.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Hinton-Bayre, AD (corresponding author), Royal Perth Hosp, Dept Otolaryngol Head & Neck Surg, Wellington Rd, Perth, WA 6001, Australia.	anton.hb@hotmail.com					Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Chelune GJ, 2003, NEUROPSYCHOLOGY, V7, P41; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hinton-Bayre A, 2005, BRIT J SPORT MED, V39, P488; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Maassen GH, 2006, BRIT J SPORT MED, V40, P829, DOI 10.1136/bjsm.2005.023713; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Maassen GH, 2005, BRIT J SPORT MED, V39, P483, DOI 10.1136/bjsm.2004.015594; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCSWEENY AJ, 1993, CLIN NEUROPSYCHOL, V7, P460; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876	18	13	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2012	22	2					105	108		10.1097/JSM.0b013e318248a526			4	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	908RG	WOS:000301507200006	22343968				2021-06-18	
J	Shin, SS; Bray, ER; Dixon, CE				Shin, Samuel S.; Bray, Eric R.; Dixon, C. Edward			Effects of Nicotine Administration on Striatal Dopamine Signaling after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; nicotine; striatum; TBI	CONTROLLED CORTICAL IMPACT; TYROSINE-HYDROXYLASE GENE; MORRIS WATER MAZE; CATECHOLAMINE SYNTHESIS; CHROMAFFIN CELLS; FRONTAL-CORTEX; PHOSPHORYLATION; ACTIVATION; EXPRESSION; DARPP-32	Previous studies on the therapeutic potential of agents affecting the dopamine system in traumatic brain injury (TBI) suggest that dopamine dysregulation may have a major role in behavioral deficit after TBI. We have previously identified that TBI reduces striatal dopamine synthesis and release at 7 days post-injury. In order to reverse deficits in the activity of tyrosine hydroxylase and dopamine release following TBI, we administered nicotine by intraperitoneal injection into rats for 7 days. Tyrosine hydroxylase activity assay demonstrated recovery of activity with nicotine treatment in injured animals. Microdialysis experiments using potassium stimulation to induce dopamine release showed recovery of dopamine release in injured animals receiving nicotine treatment. There was no effect of nicotine injection on extracellular dopamine metabolite levels, indicating the specificity of nicotine's effect on dopamine synthesis and release. Also, the activation of downstream postsynaptic molecule dopamine and cAMP regulated phosphoprotein 32 (DARPP-32) was assessed by Western blots for DARPP-32 phosphorylated at threonine 34 (pDARPP-32-T34). Injury reduced pDARPP-32-T34 levels, but nicotine treatment of injured animals did not alter pDARPP-32-T34 levels, indicating that postsynaptic dopamine signaling is complex, and the recovery of dopamine release may not be sufficient for the recovery of DARPP-32 activity.	[Shin, Samuel S.; Bray, Eric R.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bray, Eric R.; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA	Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F30NS067731-01, 5R01NS060672-02]; Veterans AdministrationUS Department of Veterans Affairs [B6761R]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060672, F30NS067731] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health grants 1F30NS067731-01 and 5R01NS060672-02, and Veterans Administration Rehabilitation Research and Development grant B6761R.	Bales J.W., 2011, EXP NEUROL; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; BLOCK F, 1993, NEUROSCI LETT, V149, P126, DOI 10.1016/0304-3940(93)90752-7; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Brown GP, 2000, J NEUROSCI, V20, P7880; BUSTOS G, 1980, J NEUROCHEM, V35, P47, DOI 10.1111/j.1471-4159.1980.tb12488.x; CARR LA, 1989, NEUROCHEM RES, V14, P511, DOI 10.1007/BF00964911; CHOI DW, 1987, J NEUROSCI, V7, P369; CRAVISO GL, 1992, J NEUROCHEM, V59, P2285; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; ERINOFF L, 1979, BRAIN RES, V164, P195, DOI 10.1016/0006-8993(79)90015-5; FAIRBROTHER IS, 1990, J NEUROCHEM, V54, P1844, DOI 10.1111/j.1471-4159.1990.tb04881.x; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAYCOCK JW, 1993, NEUROCHEM RES, V18, P15, DOI 10.1007/BF00966919; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; HIREMAGALUR B, 1993, J BIOL CHEM, V268, P23704; KING MM, 1984, J BIOL CHEM, V259, P8847; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; LEVIN ED, 1990, BEHAV NEURAL BIOL, V53, P269, DOI 10.1016/0163-1047(90)90509-5; Levin ED, 1996, PSYCHOPHARMACOLOGY, V127, P25, DOI 10.1007/BF02805971; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Marshall DL, 1997, J NEUROCHEM, V68, P1511; Martinez-Sanchez M, 2004, NEUROSCIENCE, V128, P729, DOI 10.1016/j.neuroscience.2004.06.074; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishi A, 1997, J NEUROSCI, V17, P8147; Osterhout CA, 2005, J NEUROCHEM, V94, P731, DOI 10.1111/j.1471-4159.2005.03222.x; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Rahman S, 2007, NEUROPHARMACOLOGY, V52, P755, DOI 10.1016/j.neuropharm.2006.09.012; Sabban EL, 2002, ANN NY ACAD SCI, V971, P39, DOI 10.1111/j.1749-6632.2002.tb04430.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sgambato V, 1998, J NEUROSCI, V18, P8814; Shiflett MW, 2011, BEHAV BRAIN RES, V218, P240, DOI 10.1016/j.bbr.2010.12.010; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Smith AM, 2010, BIOCHEM PHARMACOL, V80, P402, DOI 10.1016/j.bcp.2010.03.018; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Tang KC, 1997, J CLIN INVEST, V100, P1180, DOI 10.1172/JCI119630; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009	57	13	13	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					843	850		10.1089/neu.2011.1966			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900012	21815786	Green Published			2021-06-18	
J	Xing, GQ; Ren, M; O'Neill, JT; Verma, A; Watson, WD				Xing, Guoqiang; Ren, Ming; O'Neill, J. Timothy; Verma, Ajay; Watson, William D.			Controlled cortical impact injury and craniotomy result in divergent alterations of pyruvate metabolizing enzymes in rat brain	EXPERIMENTAL NEUROLOGY			English	Article						Head injury; Pyruvate dehydrogenase; Kinase; Phosphatase; mRNA; Protein; In situ hybridization; Real-time PCR; Western blotting; Rat	CEREBRAL GLUCOSE-UTILIZATION; DEHYDROGENASE KINASE; DECOMPRESSIVE HEMICRANIECTOMY; FUNCTIONAL CONNECTIVITY; SPREADING DEPRESSION; MICRODIALYSIS; EXPRESSION; PHOSPHATASE; RECOVERY; COMPLEX	Dysregulated glucose metabolism and energy deficit is a characteristic of severe traumatic brain injury (TBI) but its mechanism remains to be fully elucidated. Phosphorylation of pyruvate dehydrogenase (PDH) is the rate-limiting mitochondria enzyme reaction coupling glycolysis to the tricarboxylic acid cycle. Phosphorylation of PDHE1 alpha 1 subunit catalyzed by PDH kinase (PDK) inhibits PDH activity, effectively decoupling aerobic glycolysis whereas dephosphorylation of phosphorylated PDHE1 alpha 1 by PDH phosphatase (PDP) restores PDH activity. We recently reported altered expression and phosphorylation of pyruvate dehydrogenase (PDH) following TBI. However, little is known about PDK and PDP involvement. We determined PDK (PDK1-4) and PDP isoenzyme (PDP1-2) mRNA and protein expression in rat brain using immunohistochemistry and in situ hybridization techniques. We also quantified PDK and PDP mRNA and protein levels in rat brain following TBI using quantitative real-time PCR and Western blot, respectively. Controlled cortical impact-induced TB! (CCI-TBI) and craniotomy significantly enhanced PDK1-2 isoenzyme mRNA expression level but significantly suppressed PDP1 and PDK4 mRNA expression after the injury (4 h to 7 days). CCI-TBI and craniotomy also significantly increased PDK1-4 isoenzyme protein expression but suppressed PDP1-2 protein expression in rat brain. In summary, the divergent changes between PDK and PDP expression indicate imbalance between PDK and PDP activities that would favor increased PDHE1 alpha 1 phosphorylation and enzyme inhibition contributing to impaired oxidative glucose metabolism in TBI as well as craniotomy. (C) 2011 Elsevier Inc. All rights reserved.	[Xing, Guoqiang; Ren, Ming; Verma, Ajay; Watson, William D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Xing, Guoqiang] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [O'Neill, J. Timothy] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Xing, Guoqiang] Friends Res Inst, Baltimore, MD 21201 USA	Xing, GQ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	gxing99@yahoo.com	Xing, Guoqiang/ABA-8450-2020		GEMI; Henry Jackson Foundation TRP	This work was supported, in part, by GEMI Fund and Henry Jackson Foundation TRP grant.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13442, DOI 10.1021/bi0494875; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Chowdhury GMI, 2003, NEUROSCI RES, V45, P149, DOI 10.1016/S0168-0102(02)00207-9; Cole J.T., 2010, ANN M SOC NEUR SAN D; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Hattori N, 2003, J NUCL MED, V44, P1709; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 2008, CRIT CARE MED, V36, P2952, DOI 10.1097/CCM.0b013e3181872178; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lim Y, 2007, BRAIN RES REV, V53, P17, DOI 10.1016/j.brainresrev.2006.06.004; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Mitelman SA, 2006, BRAIN RES, V1114, P125, DOI 10.1016/j.brainres.2006.07.043; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Schaller B, 2004, BRAIN RES PROTOC, V12, P125, DOI 10.1016/j.brainresprot.2003.09.003; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sokoloff L, 2008, COGN NEURODYNAMICS, V2, P1, DOI 10.1007/s11571-007-9033-x; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xing GQ, 1997, MOL BRAIN RES, V47, P251, DOI 10.1016/S0169-328X(97)00056-9; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	43	13	13	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAR	2012	234	1					31	38		10.1016/j.expneurol.2011.12.007			8	Neurosciences	Neurosciences & Neurology	910DN	WOS:000301617500005	22193111				2021-06-18	
J	Li, CY; Wu, PM; Wu, ZZ; Ahn, CH; LeDoux, D; Shutter, LA; Hartings, JA; Narayan, RK				Li, Chunyan; Wu, Pei-Ming; Wu, Zhizhen; Ahn, Chong H.; LeDoux, David; Shutter, Lori A.; Hartings, Jed A.; Narayan, Raj K.			Brain temperature measurement: A study of in vitro accuracy and stability of smart catheter temperature sensors	BIOMEDICAL MICRODEVICES			English	Article						Temperature microsensor; Smart catheter; Accuracy; Drift; Hypothermia; Traumatic brain injury	HEAD-INJURED PATIENTS; HYPOTHERMIA; MANAGEMENT; TUBE	The injured brain is vulnerable to increases in temperature after severe head injury. Therefore, accurate and reliable measurement of brain temperature is important to optimize patient outcome. In this work, we have fabricated, optimized and characterized temperature sensors for use with a micromachined smart catheter for multimodal intracranial monitoring. Developed temperature sensors have resistance of 100.79 +/- 1.19 Omega and sensitivity of 67.95 mV/A degrees C in the operating range from15-50A degrees C, and time constant of 180 ms. Under the optimized excitation current of 500 mu A, adequate signal-to-noise ratio was achieved without causing self-heating, and changes in immersion depth did not introduce clinically significant errors of measurements (< 0.01A degrees C). We evaluated the accuracy and long-term drift (5 days) of twenty temperature sensors in comparison to two types of commercial temperature probes (USB Reference Thermometer, NIST-traceable bulk probe with 0.05A degrees C accuracy; and IT-21, type T type clinical microprobe with guaranteed 0.1A degrees C accuracy) under controlled laboratory conditions. These in vitro experimental data showed that the temperature measurement performance of our sensors was accurate and reliable over the course of 5 days. The smart catheter temperature sensors provided accuracy and long-term stability comparable to those of commercial tissue-implantable microprobes, and therefore provide a means for temperature measurement in a microfabricated, multimodal cerebral monitoring device.	[Li, Chunyan; Wu, Pei-Ming; Narayan, Raj K.] N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Wu, Zhizhen; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA; [LeDoux, David] N Shore Univ Hosp, Neurosurg Intens Care Unit, Manhasset, NY 11030 USA; [Shutter, Lori A.; Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Inst Neurosci, Cincinnati, OH 45219 USA; [Narayan, Raj K.] N Shore Univ Hosp, Dept Neurosurg, Harvey Cushing Inst Neurosci, Manhasset, NY 11030 USA	Li, CY (corresponding author), N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA.	cli11@nshs.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628; Hartings, Jed/0000-0001-8583-3471	US Department of DefenseUnited States Department of Defense [PT090526P4 (W81XWH-10-1-0978)]	This work was supported by the US Department of Defense under project No. PT090526P4 (W81XWH-10-1-0978). The authors gratefully acknowledge Mr. Joseph A. Green at the North Shore University Hospital for performing polyethylene gas sterilization and Dr. Nadeen Chahine and Ms. Neena Rajan at the Feinstein Institute for Medical Research for their valuable discussion.	Axelrod YK, 2008, NEUROL CLIN, V26, P585, DOI 10.1016/j.ncl.2008.02.005; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Deyne C.S.D., 2010, CURR OPIN ANESTHESIO, V23, P258; Duck FA, 1990, PHYS PROPERTIES TISS; Fountas KN, 2004, NEUROCRIT CARE, V1, P195, DOI 10.1385/NCC:1:2:195; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Kurth CD, 2000, ANESTHESIOLOGY, V93, P598, DOI 10.1097/00000542-200009000-00006; Kurth CD, 1997, CIRCULATION, V96, P358; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2007, BIOSENS BIOELECTRON, V22, P1988, DOI 10.1016/j.bios.2006.08.043; Li CY, 2010, LAB CHIP, V10, P1476, DOI 10.1039/c000897d; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Liptak B.G., 1995, PROCESS MEASUREMENT, P690; Liu P, 2009, SENSORS-BASEL, V9, P9533, DOI 10.3390/s91209533; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; MM Elizabeth, 2011, INT J CARE IN PRESS; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Seymour JP, 2009, BIOMATERIALS, V30, P6158, DOI 10.1016/j.biomaterials.2009.07.061; Thomas J.L., 1948, NBS CIRCULAR, V470, P13; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; VERLOOY J, 1995, ACTA NEUROCHIR, V134, P76, DOI 10.1007/BF01428508	23	13	13	0	11	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176			BIOMED MICRODEVICES	Biomed. Microdevices	FEB	2012	14	1					109	118		10.1007/s10544-011-9589-4			10	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	899YC	WOS:000300851600010	21952982				2021-06-18	
J	Morgan, M; Lockwood, A; Steinke, D; Schleenbaker, R; Botts, S				Morgan, Meghan; Lockwood, Anna; Steinke, Doug; Schleenbaker, Randal; Botts, Sheila			Pharmacotherapy Regimens Among Patients With Posttraumatic Stress Disorder and Mild Traumatic Brain Injury	PSYCHIATRIC SERVICES			English	Article							ADHERENCE	Objective: The purpose of this study was to determine if veterans with posttraumatic stress disorder (PTSD) and mild traumatic brain injury (TBI) are treated differently pharmacologically than patients with PTSD alone. Methods: A retrospective evaluation of PTSD pharmacotherapy of Operation Enduring Freedom/Operation Iraqi Freedom veterans with PTSD (N=707) was conducted between April 1, 2007, and March 31, 2009. A total of 45 veterans had suffered a mild TBI. Results: Compared with the patients with PTSD alone, the patients with PTSD and TBI were more likely to be prescribed an antidepressant (p<.001), a sedative-hypnotic (p<.001), or an antipsychotic (p=.024). The patients with TBI were also significantly more likely to receive psychotropic polypharmacy (p=.001) and to receive higher doses of psychiatric medications (p=.03). Conclusions: The differences in drug therapy found in this study may indicate that patients with TBI and PTSD respond differently to treatment than patients with PTSD alone.	[Morgan, Meghan] US Dept Vet Affairs VA Gulf Coast Vet Healthcare, Dept Pharm, Biloxi, MS 39531 USA; [Lockwood, Anna; Steinke, Doug; Botts, Sheila] Lexington VA Med Ctr, Dept Pharm, Lexington, KY USA; [Morgan, Meghan; Steinke, Doug; Botts, Sheila] Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA; [Schleenbaker, Randal] Lexington VA Med Ctr, Dept Med, Lexington, KY USA; [Schleenbaker, Randal] Univ Kentucky, Coll Med, Lexington, KY 40506 USA	Morgan, M (corresponding author), US Dept Vet Affairs VA Gulf Coast Vet Healthcare, Dept Pharm, 400 Vet Ave, Biloxi, MS 39531 USA.	meghan.mor-gan@va.gov					[Anonymous], 2009, EV BAS SYNTH PROGR A; [Anonymous], 1995, J NEUROLOGY NEUROSUR, V58, P753; [Anonymous], 2011, ATC DDD IND 2011; [Anonymous], 2011, EV VAS TRAUM BRAIN I; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Hertz RP, 2005, CLIN THER, V27, P1064, DOI 10.1016/j.clinthera.2005.07.009; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Lew HL, 2009, J REHABILITATION RES, V45, pxi; Management of Concussion-Mild Traumatic Brain Injury, 2009, MAN CONC MILD TRAUM; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spoont M, 2005, J NERV MENT DIS, V193, P515, DOI 10.1097/01.nmd.0000172474.86877.2b; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604	13	13	16	0	5	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	FEB	2012	63	2					182	185		10.1176/appi.ps.201000531			4	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	255WD	WOS:000327269900017	22302339				2021-06-18	
J	Carrasco, CE; Godinho, M; Barros, MBD; Rizoli, S; Fraga, GP				Carrasco, Carlos Eduardo; Godinho, Mauricio; de Azevedo Barros, Marilisa Berti; Rizoli, Sandro; Fraga, Gustavo Pereira			Fatal motorcycle crashes: a serious public health problem in Brazil	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article								Introduction: The numbers of two-wheel vehicles are growing across the world. In comparison to other vehicles, motorcycles are cheaper and thus represent a significant part of the automobile market. Both the mobility and speed are attractive factors to those who want to use them for work or leisure. Crashes involving motorcyclists have become an important issue, especially fatal ones. Specific severe injuries are responsible for the deaths. Defining them is necessary in order to offer better prevention and a more suitable medical approach. Methods: All fatal motorcycle crashes between January 2001 and December 2009 in Campinas, Brazil, were analyzed in this study. Official data have been collected from police incident reports, hospitals' registers and autopsies. Both incidents and casualties were analyzed according to relevant variables. The Injury Severity Score (ISS) was calculated, describing the most potentially fatal injuries. Results: There were 479 deaths; 90.8% were male; the mean age was 27.8 (range 0-73); 86.4% were conductors of the vehicles; blood alcohol was positive in 42.3%; 49.7% died at a hospital; 32.6% died at the scene; 26.1% of the accidents occurred at night, 69.1% were urban and 30.9% occurred on highways. The main causes of injury were collisions (63%) and falls (14%). The mean ISS was 38.5 (range 9-75). With regard to injuries, head trauma (67%) and thoracic trauma (40%) were the most common, followed by abdominal trauma (35%). Traumatic brain injury (67%) and hypovolemic shock (38%) were the most frequent causes of death. Conclusions: Alcohol was a significant factor in relation to the accidents. Head trauma was the most frequent and severe injury. Half of the victims died before receiving adequate medical attention, suggesting that prevention programs and laws should be implemented and applied in order to save future lives.	[Carrasco, Carlos Eduardo] Univ Campinas FCM UNICAMP, Fac Med Sci, Campinas, SP, Brazil; [Godinho, Mauricio; Fraga, Gustavo Pereira] Univ Campinas FCM UNICAMP, Div Trauma Surg, Dept Surg, Fac Med Sci, Campinas, SP, Brazil; [de Azevedo Barros, Marilisa Berti] Univ Campinas FCM UNICAMP, Dept Publ Hlth, Fac Med Sci, Campinas, SP, Brazil; [Rizoli, Sandro] Univ Toronto, Dept Surg, Sunnybrook Hlth Sci Ctr, Toronto, ON M5S 1A1, Canada; [Rizoli, Sandro] Univ Toronto, Dept Crit Care Med, Sunnybrook Hlth Sci Ctr, Toronto, ON M5S 1A1, Canada	Fraga, GP (corresponding author), Univ Campinas FCM UNICAMP, Div Trauma Surg, Dept Surg, Fac Med Sci, Campinas, SP, Brazil.	fragagp2008@gmail.com			Foundation of Support to the Research of the State of Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	This study has been financed by the Foundation of Support to the Research of the State of Sao Paulo (FAPESP).	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; [Anonymous], 2004, Epidemiol Bull, V25, P2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barros Aluísio J. D., 2003, Cad. Saúde Pública, V19, P979, DOI 10.1590/S0102-311X2003000400021; Empresa Municipal para o Desenvolvimento de Campinas, 2010, AC TRANS CAMP 2009; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P212, DOI 10.1590/S1415-790X2002000200008; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; Ledesma RD, 2008, REV SAUDE PUBL, V42, P143, DOI 10.1590/S0034-89102008000100019; Leong QM, 2009, WORLD J SURG, V33, P870, DOI 10.1007/s00268-008-9915-z; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Marin-Leon L, 2012, CAD SAUDE PUBLICA, V28, P39, DOI 10.1590/S0102-311X2012000100005; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; Montilla M., 2011, REV SAUDE PUBL, V45, P1; Nunn S, 2011, J FORENSIC SCI, P1; O'Keeffe T, 2007, J TRAUMA, V63, P1006, DOI 10.1097/TA.0b013e31815644cd; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Savolainen P, 2007, ACCIDENT ANAL PREV, V39, P955, DOI 10.1016/j.aap.2006.12.016; Scalassara MB, 1998, REV SAUDE PUBL, V32, P125, DOI 10.1590/S0034-89101998000200004; Zargar M., 2006, Eastern Mediterranean Health Journal, V12, P81	20	13	15	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.		2012	7			1					S5	10.1186/1749-7922-7-S1-S5			6	Emergency Medicine; Surgery	Emergency Medicine; Surgery	V41OM	WOS:000209555500005	23531421	DOAJ Gold, Green Published			2021-06-18	
J	Dikranian, K; Kim, J; Stewart, FR; Levy, MA; Holtzman, DM				Dikranian, Krikor; Kim, Jungsu; Stewart, Floy R.; Levy, Marilyn A.; Holtzman, David M.			Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Alzheimer's disease; electron microscopy; amyloid precursor protein; presenilin 1; ApoE	AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MOUSE MODELS; TRAUMATIC AXONAL INJURY; FIBRILLAR PLAQUE-FORMATION; APOLIPOPROTEIN-E GENE; SYNAPTIC PATHOLOGY; A-BETA; MUTANT PRESENILIN-1; MICROGLIAL CELLS; TAU	Alzheimer's disease is characterized in part by extracellular aggregation of the amyloid-beta peptide in the form of diffuse and fibrillar plaques in the brain. Electron microscopy (EM) has made an important contribution in understanding of the structure of amyloid plaques in humans. Classical EM studies have revealed the architecture of the fibrillar core, characterized the progression of neuritic changes, and have identified the neurofibrillary tangles formed by paired helical filaments (PHF) in degenerating neurons. Clinical data has strongly correlated cognitive impairment in AD with the substantial synapse loss observed in these early ultrastructural studies. Animal models of AD-type brain amyloidosis have provided excellent opportunities to study amyloid and neuritic pathology in detail and establish the role of neurons and glia in plaque formation. Transgenic mice overexpressing mutant amyloid precursor protein (APP) alone with or without mutant presenilin 1 (PS1), have shown that brain amyloid plaque development and structure grossly recapitulate classical findings in humans. Transgenic APP/PS1 mice expressing human apolioprotein E isoforms also develop amyloid plaque deposition. However no ultrastructural data has been reported for these animals. Here we show results from detailed EM analysis of amyloid plaques in APP/PS1 mice expressing human isoforms of ApoE and compare these findings with EM data in other transgenic models and in human AD. Our results show that similar to other transgenic animals, APP/PS1 mice expressing human ApoE isoforms share all major cellular and subcellular degenerative features and highlight the identity of the cellular elements involved in A beta deposition and neuronal degeneration.	[Dikranian, Krikor] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA; [Kim, Jungsu; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO USA; [Levy, Marilyn A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA; [Kim, Jungsu; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO USA; [Kim, Jungsu; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Knight Alzheimers Dis Res Ctr, St Louis, MO USA	Dikranian, K (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660S Euclid Ave, St Louis, MO 63130 USA.	kdikrani@pcg.wustl.edu	Kim, Jungsu/F-2457-2012	Kim, Jungsu/0000-0002-6931-8581	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG13956]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG013956, R01AG013956] Funding Source: NIH RePORTER	Supported by NIH grant AG13956 (DMH).	Bertram L, 2007, NAT GENET       0527, V39, P7; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260; Boutajangout A, 2004, NEUROBIOL DIS, V15, P47, DOI 10.1016/j.nbd.2003.09.007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Crews L, 2010, BRAIN STRUCT FUNCT, V214, P111, DOI 10.1007/s00429-009-0232-6; Cruts M, 1998, ANN MED, V30, P560, DOI 10.3109/07853899809002605; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; GALLOWAY PG, 1987, BRAIN RES, V403, P337, DOI 10.1016/0006-8993(87)90071-0; GOLDMAN JE, 1983, J NEUROPATH EXP NEUR, V42, P146, DOI 10.1097/00005072-198303000-00004; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; IKEDA K, 1990, J NEUROL, V237, P88, DOI 10.1007/BF00314668; Janus C, 2000, BBA-MOL BASIS DIS, V1502, P63, DOI 10.1016/S0925-4439(00)00033-8; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Kurt MA, 1999, EXP NEUROL, V158, P221, DOI 10.1006/exnr.1999.7096; Kurt MA, 2001, EXP NEUROL, V171, P59, DOI 10.1006/exnr.2001.7717; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lin WL, 2005, J NEUROCYTOL, V34, P397, DOI 10.1007/s11068-006-8726-0; Lin WL, 2003, J NEUROCYTOL, V32, P1091, DOI 10.1023/B:NEUR.0000021904.61387.95; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; Masliah E, 1996, J NEUROSCI, V16, P5795; Masliah E, 2001, J NEUROPATH EXP NEUR, V60, P357, DOI 10.1093/jnen/60.4.357; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pastor Pau, 2004, Curr Psychiatry Rep, V6, P125, DOI 10.1007/s11920-004-0052-6; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Phinney AL, 1999, J NEUROSCI, V19, P8552; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; Samura E, 2006, BRAIN RES, V1094, P192, DOI 10.1016/j.brainres.2005.12.134; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; TERRY RD, 1964, AM J PATHOL, V44, P269; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; TSUKITA S, 1980, J CELL BIOL, V84, P513, DOI 10.1083/jcb.84.3.513; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Wegiel J, 2004, BRAIN RES, V1022, P19, DOI 10.1016/j.brainres.2004.06.058; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; Wirths O, 2006, ACTA NEUROPATHOL, V111, P312, DOI 10.1007/s00401-006-0041-4; Wisniewski H, 1973, PROGR NEUROPATHOLOGY, V2, P26; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; Yamaguchi H, 1989, Prog Clin Biol Res, V317, P467; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176	79	13	16	0	7	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2012	5	6					482	495					14	Oncology; Pathology	Oncology; Pathology	000BF	WOS:000308360800001	22949930				2021-06-18	
J	Gomez, D; Haas, B; Al-Ali, K; Monneuse, O; Nathens, AB; Ahmed, N				Gomez, David; Haas, Barbara; Al-Ali, Kaes; Monneuse, Olivier; Nathens, Avery B.; Ahmed, Najma			Controversies in the management of splenic trauma	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Splenic trauma; Non-operative management	NONOPERATIVE MANAGEMENT; ASSOCIATION; ULTRASOUND; INJURIES; ADULTS	Background: The technologic innovations of the last three decades, coupled with a deeper understanding of the immunologic role of the spleen, have significantly shifted the management of splenic injuries towards non-operative approaches. However, there continuous to be a wide range of practice patterns related to the non-operative management of splenic injuries, from which the authors infer a gap between the best available evidence and its translation into practice. We sought to explore ongoing areas of controversy in the non-operative management of splenic trauma with the aim of further elucidating why these controversies continue to exist. Methods: We explored areas of ongoing controversy in the management of splenic injury though a series of iterative surveys. We invited 70 experts in trauma care from ten countries around the world to participate. Areas of controversy explored included: indications and frequency for in-hospital and follow-up imaging, definitions of failure of non-operative management, indications for angioembolisation and non-operative management in special populations (i.e. elderly, concomitant traumatic brain injury, penetrating trauma). Results: A 49% response rate was obtained. Even though a wide range of practice patterns were identified, no controversies were identified in areas that do not involve the adoption of new technologies. In areas where practice pattern variation was observed, the strong influence of the local environment was constantly identified as an impediment to changes in practice. Conclusions: We have identified that barriers present within local practice environments are the major driving forces behind controversies in the non-operative management of splenic injuries. (C) 2010 Elsevier Ltd. All rights reserved.	[Gomez, David; Haas, Barbara; Al-Ali, Kaes; Nathens, Avery B.; Ahmed, Najma] Univ Toronto, St Michaels Hosp, Dept Surg, Div Trauma, Toronto, ON M5S 1A1, Canada; [Gomez, David; Haas, Barbara; Al-Ali, Kaes; Nathens, Avery B.; Ahmed, Najma] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5S 1A1, Canada; [Monneuse, Olivier] Hosp Civils, Hop Edouard Herriot, Lyon, France	Gomez, D (corresponding author), 30 Bond St,Queen Wing 3-076, Toronto, ON M5B 1W8, Canada.	GomezJaramiD@smh.ca		Gomez, David/0000-0002-0926-2547			AGREE Collaboration, 2001, MONOGRAPH INTERNET; Alonso MBC, 2003, E ASS SURG TRAUMA; [Anonymous], 2005, J GASTROINTEST SURG, V9, P453, DOI 10.1016/j.gassur.2004.05.003; Archer LP, 1996, ARCH SURG-CHICAGO, V131, P309; Branney SW, 1997, J TRAUMA, V42, P1086, DOI 10.1097/00005373-199706000-00017; BRANNEY SW, 1995, J TRAUMA, V39, P375, DOI 10.1097/00005373-199508000-00032; COBURN MC, 1995, ARCH SURG-CHICAGO, V130, P332; COGBILL TH, 1989, J TRAUMA, V29, P1312, DOI 10.1097/00005373-198910000-00002; Fata P, 2005, J TRAUMA, V59, P836, DOI 10.1097/01.ta.0000187652.55405.73; FEDERLE MP, 1981, RADIOLOGY, V138, P637, DOI 10.1148/radiology.138.3.6450962; Fishman EK, 1996, RADIOGRAPHICS, V16, P943, DOI 10.1148/radiographics.16.4.8835983; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Graham ID, 2002, JOGNN-J OBST GYN NEO, V31, P599, DOI 10.1111/j.1552-6909.2002.tb00086.x; Grol R, 2001, MED CARE, V39, pII46; KOURY HI, 1991, INJURY, V22, P349, DOI 10.1016/0020-1383(91)90091-R; MILLIKAN JS, 1982, AM J SURG, V144, P711, DOI 10.1016/0002-9610(82)90556-6; Moore FA, 2008, J TRAUMA, V65, P1007, DOI 10.1097/TA.0b013e31818a93bf; O'Neill P, 2005, J TRAUMA, V59, P841; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; SCLAFANI SJA, 1995, J TRAUMA, V39, P818, DOI 10.1097/00005373-199511000-00004; SHACKFORD SR, 1981, J TRAUMA, V21, P538, DOI 10.1097/00005373-198107000-00006	22	13	13	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2012	43	1					55	61		10.1016/j.injury.2010.09.007			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	879BZ	WOS:000299306000011	20970799				2021-06-18	
J	Halldorsson, JG; Flekkoy, KM; Arnkelsson, GB; Tomasson, K; Magnadottir, HB; Arnarson, EO				Halldorsson, Jonas G.; Flekkoy, Kjell M.; Arnkelsson, Gudmundur B.; Tomasson, Kristinn; Magnadottir, Hulda Bra; Arnarson, Eirikur Orn			The scope of early traumatic brain injury as a long-term health concern in two nationwide samples: Prevalence and prognostic factors	BRAIN INJURY			English	Article						Adolescents; children; disability; health concern; long-term; nationwide; paediatric; prevalence; prospective; traumatic brain injury; young adults	MILD HEAD-INJURY; UNITED-STATES; EARLY-CHILDHOOD; BIRTH COHORT; CLINICAL MANAGEMENT; ACADEMIC OUTCOMES; YOUNG-ADULTS; CHILDREN; POPULATION; EPIDEMIOLOGY	Primary objectives: To examine the scope of paediatric traumatic brain injury (TBI) as a health concern and to identify prognostic factors for TBI-related sequelae. Methods and procedures: The study was prospective and nationwide. A questionnaire was sent to a study group (SG) of all 0-19 years old in Iceland, diagnosed similar to 16 years earlier with TBI during a 1-year period, 1992-1993 (n = 550) and to a control group (CG) (n = 1232), selected from the National Register. Main outcomes and results: In the CG 49.5% reported having sustained TBI and 7.0% reported long-term disability. In the group with TBI, force of impact to the head, more than one incident of TBI and the injury severity by gender interaction predicted late symptoms. TBI severity had substantially less effect than force of impact and was close to non-existent for females. Conclusions: Based on two independent nationwide samples, the scope of TBI as a health concern in adolescence and young adulthood is greater than previously documented. The findings suggest that TBI event-related factors, especially force of impact, have greater predictive value than clinical symptoms of severity at the acute stage, females being more sensitive to the effects of mild TBI than males.	[Halldorsson, Jonas G.; Arnarson, Eirikur Orn] Landspitali Univ Hosp, Psychol Serv, IS-108 Reykjavik, Iceland; [Halldorsson, Jonas G.; Arnarson, Eirikur Orn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Flekkoy, Kjell M.] Univ Oslo, Oslo, Norway; [Arnkelsson, Gudmundur B.] Univ Iceland, Dept Psychol, Reykjavik, Iceland; [Tomasson, Kristinn] Adm Occupat Safety & Hlth, Reykjavik, Iceland	Halldorsson, JG (corresponding author), Landspitali Univ Hosp, Psychol Serv, IS-108 Reykjavik, Iceland.	jonasgh@landspitali.is	Arnarson, Eirikur O/N-7731-2014; Arnarson, Eirikur Orn/AAE-4476-2021	Arnarson, Eirikur O/0000-0002-6816-148X; 	Statistics Iceland; Icelandic Directorate of Health; Landspitali University Hospital; University of Iceland; Margret Bjorgolfsdottir memorial fund; Olafia Jonsdottir memorial fund; Helga Jonsdottir and Sigurlidi Kristjansson memorial fund; Alcan in Iceland community	The authors are grateful for support, assistance and information provided by Statistics Iceland, the Icelandic Directorate of Health, Landspitali University Hospital and other state hospitals, emergency departments and healthcare centres. The study was funded in part with grants from the University of Iceland doctoral fund, the Landspitali University Hospital science fund, the Margret Bjorgolfsdottir memorial fund, the Olafia Jonsdottir memorial fund, the Helga Jonsdottir and Sigurlidi Kristjansson memorial fund and the Alcan in Iceland community fund.	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BERNARDI B, 1993, TOP MAGN RESON IMAG, V5, P161; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cordon IM, 2004, DEV REV, V24, P101, DOI 10.1016/j.dr.2003.09.003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; *DAN NAT BOARD IND, 2004, MENT; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dillman D., 2006, MAIL INTERNET SURVEY; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Halldorsson Jonas G, 2008, Neuropsychiatr Dis Treat, V4, P405; Halldorsson Jonas G, 2007, Neuropsychiatr Dis Treat, V3, P935; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENNETT B, 1975, LANCET, V1, P480; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine SC, 2005, BRAIN COGNITION, V59, P114, DOI 10.1016/j.bandc.2005.05.008; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Locker D, 2007, DENT TRAUMATOL, V23, P291, DOI 10.1111/j.1600-9657.2006.00457.x; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Peterson C, 2005, LAW HUMAN BEHAV, V29, P527, DOI 10.1007/s10979-005-6833-6; Peterson C, 1999, DEV PSYCHOL, V35, P1493, DOI 10.1037/0012-1649.35.6.1493; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; R Development Core Team, 2010, R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sosin DM, 1996, BRAIN INJURY, V10, P47; *SPSS INC, 2006, SPSS WIND 15 0 0; *STAT IC, 2001, IC CAUS DEATH REG; *STAT IC, 2008, NAT ACC PUBL FIN; Stefansdottir A, 1997, SCAND J PRIM HEALTH, V15, P30, DOI 10.3109/02813439709043426; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; VANE DW, 1995, J TRAUMA, V38, P867, DOI 10.1097/00005373-199506000-00006; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	82	13	13	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					1	13		10.3109/02699052.2011.635359			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900001	22149441				2021-06-18	
B	Howe, LLS		Reynolds, CR; Horton, AM		Howe, Laura L. S.			Distinguishing Genuine from Malingered Posttraumatic Stress Disorder in Head Injury Litigation	DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION			English	Article; Book Chapter							FAKE-BAD SCALE; MMPI-2 VALIDITY SCALES; TRAUMATIC BRAIN-INJURY; MILLER-FORENSIC ASSESSMENT; PERSONALITY-ASSESSMENT INVENTORY; COMPENSATION SEEKING STATUS; COMBAT VETERANS; RESPONSE BIAS; SYMPTOM INVENTORY; MENTAL-DISORDERS		VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Howe, LLS (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	lauralshowe@yahoo.com					Alwes YR, 2008, J CLIN EXP NEUROPSYC, V30, P133, DOI 10.1080/13803390701260363; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1992, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2006, LOY L REV, V52, P525; Arbisi P. A., 2006, SYMBOL DIGITS MODALI, V3, P249; Arbisi PA, 2004, ARCH CLIN NEUROPSYCH, V19, P341, DOI 10.1016/j.acn.2003.12.003; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Bagby, 1994, Assessment, V1, P31, DOI 10.1177/1073191194001001005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Berry D. T. R., 2007, ASSESSMENT MALINGERE, P226; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Blanchard EB, 2003, BEHAV RES THER, V41, P79, DOI 10.1016/S0005-7967(01)00131-0; Blanchard EB, 2001, CURR OPIN PSYCHIATR, V14, P143, DOI 10.1097/00001504-200103000-00008; BLANCHARD EB, 1997, CRASH ASSESSMENT TRE; BOWEN C, 2006, INT J FORENSIC PSYCH, V1, P22, DOI DOI 10.1207/S15327752JPA7103_3; Bowman M., 2004, POSTTRAUMATIC STRESS, P15, DOI [10.1002/9780470713570.ch2, DOI 10.1002/9780470713570.CH2, DOI 10.1002/9780470713570]; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Braverman M., 1978, ANN NY ACAD SCI, V444, P502; Breed A., 2009, POW CLAIMANTS EXCEED; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Breslau N., 1991, ARCH GEN PSYCHIAT, V156, P908; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Briere J., 1995, TRAUMA SYMPTOM INVEN; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; BURKETT BG, 1998, STOLEN VALOR VIETNAM; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J. N., 1989, MMPI 2 MANUAL ADM SC; Butcher JN, 2008, PSYCHOL INJ LAW, V1, P191, DOI 10.1007/s12207-007-9002-z; Butcher JN, 2003, ARCH CLIN NEUROPSYCH, V18, P473, DOI 10.1016/S0887-6177(02)00142-7; Calhoun PS, 2000, J PERS ASSESS, V75, P338, DOI 10.1207/S15327752JPA7502_11; Carmody DP, 2005, J FORENSIC PSYCHI PS, V16, P477, DOI 10.1080/14789940500034462; Carone D. A., 2008, APPL NEUROPSYCHOL, V16, P309; CHARNEY DS, 1998, CNS SPECTRUMS S2, V3, P7; Crawford EF, 2006, J PERS ASSESS, V86, P217, DOI 10.1207/s15327752jpa8602_11; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; DALTON JE, 1989, PSYCHOL ASSESSMENT, V1, P56, DOI DOI 10.1037/1040-3590.1.1.56; Davidson HA, 1950, B MENNINGER CLIN, V14, P157; Davidson J., 1993, AM PSYCHIAT PRESS RE; deCarteret J C, 1994, AAOHN J, V42, P494; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Derogatis L.R, 1994, SYMPTOM CHECKLIST 90; Dickens S. E., 1992, STRUCTURED INTERVIEW; Eakin D. E., 2004, THESIS AUBURN U AUBU; Eakin DE, 2006, J PSYCHOPATHOL BEHAV, V28, P145, DOI 10.1007/s10862-005-9006-5; Edens JF, 1998, J PERS ASSESS, V71, P379, DOI 10.1207/s15327752jpa7103_7; Efendov AA, 2008, PSYCHOL ASSESSMENT, V20, P317, DOI 10.1037/a0013870; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Elhai J, 2005, ASSESSMENT, V12, P210, DOI 10.1177/1073191105275456; Elhai JD, 2000, J PERS ASSESS, V75, P449, DOI 10.1207/S15327752JPA7503_06; Elhai JD, 2004, ASSESSMENT, V11, P139, DOI 10.1177/1073191104264965; Elhai JD, 2003, J CLIN PSYCHOL, V59, P385, DOI 10.1002/jclp.10135; Elhai JD, 2002, J PERS ASSESS, V79, P531, DOI 10.1207/S15327752JPA7903_08; Elhai JD, 2001, ASSESSMENT, V8, P221, DOI 10.1177/107319110100800210; Elhai JD, 2000, J NERV MENT DIS, V188, P708, DOI 10.1097/00005053-200010000-00010; Elhai JD, 2007, J PERS ASSESS, V88, P328, DOI 10.1080/00223890701332136; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Faust D, 1998, CRIT ISS NE, P1; Fecteau G., 1999, BEHAV COGN PSYCHOTH, V27, P201; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; Foa E. B., 1995, POSTTRAUMATIC DIAGNO; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 1996, J TRAUMA STRESS, V9, P427, DOI 10.1002/jts.2490090303; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Garner B.A., 2005, BLACKS LAW DICT; Geraerts E., 2006, J FORENSIC PSYCHIATR, V20, P278; Geraerts E, 2006, LAW HUMAN BEHAV, V30, P621, DOI 10.1007/s10979-006-9043-y; GERARDI RJ, 1989, BEHAV THER, V20, P229, DOI 10.1016/S0005-7894(89)80071-1; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gold PB, 1999, J NERV MENT DIS, V187, P680, DOI 10.1097/00005053-199911000-00005; Goldberg H. E., 2007, ASSESSMENT FEIGNED C, P281; Green, 2004, GREENS MED SYMPTOM V; Green B. L., 2003, POSTTRAUMATIC STRESS, P19; Green P., 2003, GREENS WORD MEMORY T; Green P., 1995, MANUAL ORAL WORD MEM; Greene, 2000, MMPI 2 INTERPRETIVE; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P337, DOI 10.1016/j.acn.2003.12.005; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guriel J., 2004, J FORENSIC PSYCHOL P, V4, P37, DOI DOI 10.1300/J158V04N02_02; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Guriel-Tennant J, 2006, J FORENSIC PSYCHI PS, V17, P577, DOI 10.1080/14789940600895838; Guy LS, 2006, BEHAV SCI LAW, V24, P687, DOI 10.1002/bsl.706; Guy LS, 2004, CRIM JUSTICE BEHAV, V31, P695, DOI 10.1177/0093854804268754; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; HATHAWAY S. R., 1951, MMPI MANUAL; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hertzberg M A, 2000, Ann Clin Psychiatry, V12, P101, DOI 10.1023/A:1009076231175; Hickling E. J., 1999, INT HDB ROAD TRAFFIC, P305; Hickling E. J., 2002, J FORENSIC PSYCHOL P, V2, P33, DOI DOI 10.1300/J158V02N01_; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Howe LLS, 2010, CLIN NEUROPSYCHOL, V24, P518, DOI 10.1080/13854041003775347; HYER L, 1987, J CLIN PSYCHOL, V43, P79, DOI 10.1002/1097-4679(198701)43:1<79::AID-JCLP2270430110>3.0.CO;2-P; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Iverson G. L., 1996, J COGNITIVE REHABILI, P10; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Jackson RL, 2005, LAW HUMAN BEHAV, V29, P199, DOI 10.1007/s10979-005-2193-5; Johnson DR, 1996, AM J PSYCHIAT, V153, P771; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; KEANE TM, 1984, J CONSULT CLIN PSYCH, V52, P888, DOI 10.1037/0022-006X.52.5.888; KEANE TM, 1995, POSTTRAUMATIC STRESS, P99; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kremen WS, 2007, ARCH GEN PSYCHIAT, V64, P361, DOI 10.1001/archpsyc.64.3.361; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; Lamb DG, 1994, PSYCHOL ASSESSMENT, V6, P8; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Lees-Haley P. R., 1986, TRIAL DIPLOMACY J, V9, P17; Lees-Haley PR, 2004, ARCH CLIN NEUROPSYCH, V19, P333, DOI 10.1016/j.acn.2003.12.004; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; LEESHALEY PR, 2001, J FORENSIC NEUROPSYC, V2, P45, DOI DOI 10.1300/J151V02N02_04; LEESHALEY PR, 1990, J TRAUMA STRESS, V3, P315; Lewis JL, 2002, PSYCHOL ASSESSMENT, V14, P170, DOI 10.1037//1040-3590.14.2.170; Liljequist L, 1998, J PERS ASSESS, V71, P322, DOI 10.1207/s15327752jpa7103_3; LYONS JA, 1994, J TRAUMA STRESS, V7, P1; Marino SE, 2009, EPILEPSY BEHAV, V14, P459, DOI 10.1016/j.yebeh.2008.12.007; Marshall MB, 2006, ASSESSMENT, V13, P417, DOI 10.1177/1073191106290842; McCaffrey RJ, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P287, DOI 10.1007/978-1-4614-0442-2_10; McCrea M, 2008, MILD TRAUMATIC BRAIN; McNally RJ, 2006, ANN NY ACAD SCI, V1071, P267, DOI 10.1196/annals.1364.021; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Merten Th, 2006, Versicherungsmedizin, V58, P19; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Messer JM, 2007, J FORENSIC PSYCHOL P, V7, P33, DOI 10.1300/J158v07n03_02; Miller HA., 2001, M FAST MILLER FORENS; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore SA, 2009, CURR OPIN PSYCHIATR, V22, P19, DOI 10.1097/YCO.0b013e328314e3bb; Morel K. R., 2008, GERMAN J PSYCHIAT, V11, P128; Morel K. R., 1995, ANXIETY DISORDERS PR, V2, P55; Morel KR, 2008, J FORENSIC PSYCHI PS, V19, P52, DOI 10.1080/14789940701594645; Morel KR, 1998, J PERS ASSESS, V70, P299, DOI 10.1207/s15327752jpa7002_8; Morey L. C., 1991, PERSONALITY ASSESSME; Morey L.C., 2004, COMPREHENSIVE HDB PS, V2, P15; Moyer D. M., 2002, AM J FORENSIC PSYCH, V20, P81; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; O'Bryant SE, 2007, J PSYCHOPATHOL BEHAV, V29, P111, DOI 10.1007/s10862-006-9034-9; Olsen W. K, 1991, LITIGATION EXPLOSION; ORR SP, 1993, BIOL PSYCHIAT, V33, P127, DOI 10.1016/0006-3223(93)90312-2; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Peterson DI, 1998, NEUROLOGIST, V4, P131, DOI 10.1097/00127893-199805000-00004; Poythress NG, 2001, LAW HUMAN BEHAV, V25, P567, DOI 10.1023/A:1012702223004; Price K. P., 1994, DEF LAW J, V43, P113; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Resnick P, 2008, CLIN ASSESSMENT MALI, P109; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; ROGERS R, 1992, J CLIN PSYCHOL, V48, P643; Rogers R., 2008, CLIN ASSESSMENT MALI, P14; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rogers R, 2009, J PERS ASSESS, V91, P429, DOI 10.1080/00223890903087745; Rogers R, 2009, LAW HUMAN BEHAV, V33, P213, DOI 10.1007/s10979-008-9145-9; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Rosen G. M., 2004, POSTTRAUMATIC STRESS, P85, DOI 10.1002/9780470713570.ch5.; Rosen GM, 2007, J ANXIETY DISORD, V21, P201, DOI 10.1016/j.janxdis.2006.09.011; Rosen GM, 2006, J ANXIETY DISORD, V20, P530, DOI 10.1016/j.janxdis.2005.03.004; Rosen GM, 2006, J PERS ASSESS, V86, P329, DOI 10.1207/s15327752jpa8603_08; Rosen GM, 2004, PERS INDIV DIFFER, V36, P1291, DOI 10.1016/S0191-8869(03)00216-2; Rosen GM, 1996, B AM ACAD PSYCH LAW, V24, P267; ROSEN GM, 1995, PROF PSYCHOL-RES PR, V26, P82, DOI 10.1037/0735-7028.26.1.82; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Sachinvala N, 2000, J NERV MENT DIS, V188, P818, DOI 10.1097/00005053-200012000-00005; Samuel R. Z., 2005, PRIMARY PSYCHIAT, V12, P60; Sayer NA, 2008, J TRAUMA STRESS, V21, P40, DOI 10.1002/jts.20309; Scheibe S, 2001, PSYCHOL ASSESSMENT, V13, P369, DOI 10.1037/1040-3590.13.3.369; Scragg P, 2000, CLIN PSYCHOL PSYCHOT, V7, P155, DOI 10.1002/(SICI)1099-0879(200005)7:2<155::AID-CPP237>3.0.CO;2-Z; Sellers S, 2006, PSYCHIAT PSYCHOL LAW, V13, P91; Shapinsky A, 2005, ASSESSMENT, V12, P220, DOI 10.1177/1073191104273130; Skodol AE, 1996, BRIT J PSYCHIAT, V169, P717, DOI 10.1192/bjp.169.6.717; SLOVENKO R, 1994, PSYCHIAT CLIN N AM, V17, P439; Smith G. P., 2008, CLIN ASSESSMENT MALI, P323; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Stone A A, 1993, Bull Am Acad Psychiatry Law, V21, P23; Tombaugh TN, 1996, TEST MEMORY MALINGER; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wetter, 1994, Assessment, V1, P199, DOI 10.1177/1073191194001002010; Wetter M. W., 1993, PSYCHOL ASSESSMENT, V5, P317; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Widows M. R., 2005, STRUCTURED INVENTORY; Williams CL, 2009, PSYCHOL INJ LAW, V2, P182, DOI 10.1007/s12207-009-9046-3; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Yanez YT, 2006, ARCH CLIN NEUROPSYCH, V21, P161, DOI 10.1016/j.acn.2005.07.009	212	13	13	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4614-0441-5				2012							301	331		10.1007/978-1-4614-0442-2_11	10.1007/978-1-4614-0442-2		31	Psychology, Clinical; Neurosciences	Psychology; Neurosciences & Neurology	BAD69	WOS:000303852000011					2021-06-18	
J	Kool, B; Raj, N; Wainiqolo, I; Kafoa, B; McCaig, E; Ameratunga, S				Kool, Bridget; Raj, Naina; Wainiqolo, Iris; Kafoa, Berlin; McCaig, Eddie; Ameratunga, Shanthi			Hospitalised and Fatal Head Injuries in Viti Levu, Fiji: Findings from an Island-Wide Trauma Registry (TRIP 4)	NEUROEPIDEMIOLOGY			English	Article						Head injuries; Epidemiology; Traumatic brain injury; Surveillance; Fiji	BRAIN-INJURY; NEW-ZEALAND; EPIDEMIOLOGY; MANAGEMENT; ADMISSIONS; MORTALITY; CHILDREN; DEATHS; TRENDS; IMPACT	Background: Globally, head injury is a substantial cause of mortality and morbidity. A disproportionately greater burden is borne by low-and middle-income countries. The incidence and characteristics of fatal and hospitalised head injuries in Fiji are unknown. Methods: Using prospective data from the Fiji Injury Surveillance in Hospital system, the epidemiology of fatal and hospitalised head injuries was investigated (2004-2005). Results: In total, 226 hospital admissions and 50 fatalities (66% died prior to admission) with a principal diagnosis of head injury were identified (crude annual rates of 34.7 and 7.7/100,000, respectively). Males were more likely to die and be hospitalised as a result of head injury than females. The highest fatality rate was among those in the 30-44-year age group. Road traffic crashes were the leading causes of injuries resulting in death (70%), followed by 'hit by person or object' and falls (14% each). Among people admitted to hospital, road traffic crashes (34.5%) and falls (33.2%) were the leading causes of injury. The leading cause of head injuries in children was falls, in 15-29-year-olds road traffic crashes, and in adults aged 30-44 years or 45 years and older 'hit by person or object'. Among the two major ethnic groups, Fijians had higher rates of falls and 'hit by person or object' and Indians higher rates for road traffic crashes. There were no statistically significant differences between the overall rates of head injuries or the fatal and nonfatal rates among Fijians or Indians by gender following age standardisation to the total Fijian national population. Conclusion: Despite underestimating the overall burden, this study identified head injury to be a major cause of death and hospitalisation in Fiji. The predominance of males and road traffic-related injuries is consistent with studies on head injuries conducted in other low-and middle-income countries. The high fatality rate among those aged 30-44 years in this study has not been noted previously. The high case fatality rate prior to admission to the hospital requires urgent attention. Copyright (C) 2012 S. Karger AG, Basel	[Kool, Bridget; Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1142, New Zealand; [Raj, Naina] Auckland Reg Publ Hlth Serv, Environm Hlth Protect Team, Auckland, New Zealand; [Wainiqolo, Iris; Kafoa, Berlin; McCaig, Eddie] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji	Kool, B (corresponding author), Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Private Bag 92019, Auckland 1142, New Zealand.	b.kool@auckland.ac.nz		Ameratunga, Shanthi/0000-0001-8042-2251	Wellcome Trust (UK)Wellcome Trust; New Zealand Health Research CouncilHealth Research Council of New Zealand; Fiji Ministry of Health; Fiji School of Medicine	This study was funded by an international collaborative research grant from the Wellcome Trust (UK) and the New Zealand Health Research Council. The authors gratefully acknowledge the support of the Permanent Secretary of Health, Dr. Lepani Waqatakirewa, and the Fiji Ministry of Health staff at national, divisional, and subdivisional levels, the doctors and nurses in the surveillance hospitals, and the final-year medical students of 2005-2006 at the Fiji School of Medicine.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Fiji Bureau of Statistics, 2007 CENS DAT; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Holder Y, 2001, INJURY SURVEILLANCE, P80; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jat Afzal Ali, 2004, Asian J Surg, V27, P58, DOI 10.1016/S1015-9584(09)60247-5; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Matthew PK, 1996, AUST NZ J SURG, V66, P659, DOI 10.1111/j.1445-2197.1996.tb00712.x; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mukhida K, 2006, CHILD NERV SYST, V22, P352, DOI 10.1007/s00381-005-1235-0; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; ROY PD, 1987, CAN J SURG, V30, P17; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SINHA SN, 1981, PAPUA NEW GUINEA MED, V24, P222; SINHA SN, 1989, ACCIDENT ANAL PREV, V21, P297, DOI 10.1016/0001-4575(89)90021-3; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Wainiqolo I, 2011, INJURY; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Zhao YD, 2001, WORLD J SURG, V25, P1202	34	13	13	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2012	38	3					179	185		10.1159/000337261			7	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	941TP	WOS:000303989000008	22472517	Green Published, Bronze			2021-06-18	
J	Martelli, MF; Zasler, ND; Tiernan, P				Martelli, Michael F.; Zasler, Nathan D.; Tiernan, Patricia			Community based rehabilitation: Special issues	NEUROREHABILITATION			English	Article						Post-acute rehabilitation; community care; brain injury; biopsychosocial; community based rehabilitation; community reintegration	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; INDUCED MOVEMENT THERAPY; VOCATIONAL-REHABILITATION; MENTORING PROGRAM; VANISHING CUES; MEMORY; PSYCHOTHERAPY; INDIVIDUALS; EXERCISE	The primary goal in the developing field of community based rehabilitation (CBR) for individuals with TBI/ABI is community participation and integration. At present, CBR is less than clearly defined and is represented by a set of interventions with varied types, degrees of clinical support and models of intervention that are conducted for a diverse and complex set of individuals, situations, deficits and settings. Nonetheless, holistic neurorehabilitation programs should be considered both evidence based and a practice standard. This paper attempts to address some of the significant issues relevant to optimizing long term adaptation for persons receiving CBR. The article also addresses the current need for definitions, models, program classifications and comparisons, as well as programmatic methodologies by attempting to integrate some of the best scientifically supported methodologies within an eclectic holistic rehabilitation model that is easily understood and teachable to persons with TBI, families and rehabilitation professionals. This model and associated methodologies are intended to inform best practices while offering a framework for hypothesis generation, clinical decision-making, evaluation of treatment outcomes and direction of future research.	[Martelli, Michael F.; Zasler, Nathan D.; Tiernan, Patricia] Tree Life Serv Inc, Richmond, VA USA; [Martelli, Michael F.; Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA	Zasler, ND (corresponding author), 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA.	nzasler@cccv-ltd.com					Agel J., 1971, RADICAL THERAPIST RA; Andrews S.S., 2004, TRAUMATIC BRAIN INJU; [Anonymous], 1999, TRAUMATIC BRAIN INJU; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P1, DOI 10.1201/9781439849828; Ben-Yishay Y., 2000, INT HDB NEUROPSYCHOL, P127, DOI [10.1007/978-1-4757-5569-5_8, DOI 10.1007/978-1-4757-5569-5_8]; Bender M. C., 2003, WILL TRAUM BRAIN INJ; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; Bergin A.E., 1994, HDB PSYCHOTHERAPY BE; Broach E, 2000, FACILITATION TECHNIQ; Buffington ALH, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199710000-00002; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Childress JF., 2001, PRINCIPLES BIOMEDICA; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Condeluci A., 1996, DIFFERENCE; Condeluci A., 2004, ADVOCACY CHANGE MANU; Condeluci A., 2008, ESSENCE INTERDEPENDE; Dahlberg C.A., 2005, HEAD TRAUMA REHABIL, V20, P62; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; Division of Acute Care Rehabilitation Research and DisabiIlity Prevention. National Center for Injury Prevention and Control Centers for Disease Control and Prevention. U.S. Department of Health and Human Services, 1999, TRAUM BRAIN INJ US R; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Englander J., 2007, BRAIN INJURY MED PRI; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feeney T.J., 2010, J HEAD TRAUMA REHAB, V25, P1; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Fenech A.M., BRAIN INJURY MED PRI; Finkenflugel H, 2005, INT J REHABIL RES, V28, P187, DOI 10.1097/00004356-200509000-00001; Finkenflugel H, 2008, DISABIL REHABIL, V30, P348, DOI 10.1080/09638280701257288; Frank J.D., 1993, PERSUASION HEALING C; FRANK JD, 1974, J NERV MENT DIS, V159, P325, DOI 10.1097/00005053-197411000-00003; FRANK JD, 1983, BEHAV BRAIN SCI, V6, P291, DOI 10.1017/S0140525X00015958; FRANK JD, 1982, PSYCHOTHERAPY RES BE, P9; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; Goldstein K., 1939, ORGANISM HOLISTIC AP; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Greenwood R, 2001, BRIT MED J, V323, P1082, DOI 10.1136/bmj.323.7321.1082; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hanson S., 2004, TRAUMATIC BRAIN INJU; Hanson S.L., 2000, HDB REHABILITATION P; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; Helander E., 1989, TRAINING COMMUNITY P; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hubble M. A., 1999, HEART SOUL CHANGE WH; Hutchinson SL, 2003, LEISURE SCI, V25, P143, DOI 10.1080/01490400306566; JACOBS HE, 1993, BEHAV ANAL GUIDELINE; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; Jonassen D.H., 1999, TASK ANAL METHODS IN; Judd T, 2009, NEUROPSYCHOL REHABIL, V19, P841, DOI 10.1080/09602010903024943; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kern RS, 2002, AM J PSYCHIAT, V159, P1921, DOI 10.1176/appi.ajp.159.11.1921; Kern RS, 2005, AM J PSYCHIAT, V162, P513, DOI 10.1176/appi.ajp.162.3.513; Kern RS, 2003, PSYCHOL MED, V33, P433, DOI 10.1017/S0033291702007298; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kiser L, 2009, NEUROREHABILITATION, V25, P219, DOI 10.3233/NRE-2009-0518; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Klonoff P., 2003, COMMUNITY REHABILITA, P213; Klonoff PS, 2000, INT HDB NEUROPSYCHOL, P195; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; LENG NRC, 1991, BEHAV PSYCHOTHER, V19, P173, DOI 10.1017/S0141347300012209; Mackelprang RW, 2009, J SOC WORK DISABIL R, V8, P205, DOI 10.1080/15367100903202771; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Martelli M.F., 1999, ARCH CLIN NEUROPSYCH, V14; Martelli M. F., 2007, BRAIN INJURY MED PRI; Martelli MF, 2005, BRAIN INJURY PROFESS, V2, P10; MARTELLI MF, 2002, 21 ANN S BRAIN INJ A; MARTELLI MF, 2003, ANN M COAL CLIN PRAC; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; Martins S, 2006, NEUROPSYCHOLOGIA, V44, P2792, DOI 10.1016/j.neuropsychologia.2006.05.022; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MASTERS JC, 1987, BEHAV THERAPY TECHNI; Masters RSW, 2004, REHABIL PSYCHOL, V49, P79, DOI 10.1037/0090-5550.49.1.79; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NORDAL KC, 2009, MONITOR PSYCHOL, V40, P43; Ormrod J.E., 1999, HUMAN LEARNING; PATTERSON CH, 1989, PSYCHOTHERAPY, V26, P427, DOI 10.1037/h0085461; Pitel AL, 2006, BRAIN INJURY, V20, P1099, DOI 10.1080/02699050600909961; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; RIM DC, 1979, BEHAV THERAPY TECHNI; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander A.M., 2006, CONT FOR BRAIN INJ C; Sander A.M., 2007, BRAIN INJURY MED PRI; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sbordone R.J., 1990, PSYCHOTHERAPY PRIVAT, V8, P129; SCHACTER D, 1996, SEARCHING MEMORY; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schutz LE, 2007, BRAIN INJURY, V21, P545, DOI 10.1080/02699050701426923; SELIGMAN MEP, 2000, ENCY STRESS; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Spiegler M. D, 2003, CONT BEHAV THERAPY; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; The Cornell Institute for Translational Research on Aging (CITRA), 2007, SOC IS STRAT CONN EN; Todd D.D., 1999, COGNIPHOBIA SCALE C; TRIESCHMANN RB, 1984, REHABIL LIT, V45, P345; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; VERFAELLIE M, 1990, BRAIN COGNITION, V13, P178, DOI 10.1016/0278-2626(90)90049-T; Wampold B. E., 2001, GREAT PSYCHOTHERAPY; WEHMAN P, 1993, COMMUNITY BASED EMPL; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201; Weintraub A., 2004, TRAUMATIC BRAIN INJU; Wheeler SD, 2007, OTJR-OCCUP PART HEAL, V27, P13, DOI 10.1177/153944920702700103; Whiteneck G.G., 2007, ARCH PHYS MED REHAB, V88, P1561; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638; Zasler N.D., 2005, TXB TRAUMATIC BRAIN, P419; Zasler ND, 2010, CHALLENGE, V3, P1825; Zasler ND, 2012, BRAIN INJURY MED PRI	121	13	13	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					3	18		10.3233/NRE-2012-0770			16	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900002	22523014				2021-06-18	
S	Morris, DC; Zhang, ZG; Zhang, J; Xiong, Y; Zhang, L; Chopp, M		Goldstein, AL; Garaci, E		Morris, Daniel C.; Zhang, Zheng G.; Zhang, Jing; Xiong, Ye; Zhang, Li; Chopp, Michael			Treatment of neurological injury with thymosin beta 4	THYMOSINS IN HEALTH AND DISEASE I	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	3rd International Symposium on Thymosins in Health and Disease	MAR 14-16, 2012	Washington, DC	George Washington Univ, Ist Superiore Sanita (ISS), Univ Rome Tor Vergata		thymosin beta 4; stroke; multiple sclerosis; traumatic brain injury; rat	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; RAT MODEL; STROKE; REMYELINATION; NEUROGENESIS; PRECURSORS; ISCHEMIA; RECOVERY	Neurorestorative therapy targets multiple types of parenchymal cells in the intact tissue of injured brain tissue to increase neurogenesis, angiogenesis, oligodendrogenesis, and axonal remodeling during recovery from neurological injury. In our laboratory, we tested thymosin beta 4 (T beta 4) as a neurorestorative agent to treat models of neurological injury. This review discusses our results demonstrating that T beta 4 improves neurological functional outcome in a rat model of embolic stroke, a mouse model of multiple sclerosis, and a rat model of traumatic brain injury. T beta 4 is a pleiotropic peptide exhibiting many actions in several different types of tissues. One mechanism associated with improvement of neurological improvement from T beta 4 treatment is oligodendrogenesis involving the differentiation of oligodendrocyte progenitor cells to mature myelin-secreting oligodendrocytes. Moreover, our preclinical data provide a basis for movement of T beta 4 into clinical trials for treatment of these devastating neurological diseases and injuries.	[Morris, Daniel C.] Henry Ford Hlth Sci Ctr, Dept Emergency Med, Detroit, MI USA; [Zhang, Zheng G.; Zhang, Jing; Zhang, Li; Chopp, Michael] Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI USA; [Xiong, Ye] Henry Ford Hlth Sci Ctr, Dept Neurosurg, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Morris, DC (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 W Grand Blvd,CFP 2, Detroit, MI 48202 USA.	Dmorris4@hfhs.org		Xiong, Ye/0000-0001-9770-6031	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [PO1 NS23393, RO1 NS062832, R01 NS075156, R01 AG038648]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062832, R01NS075156, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG038648] Funding Source: NIH RePORTER	This research was supported in part by NINDS and NIA Grants PO1 NS23393, RO1 NS062832, R01 NS075156, and R01 AG038648. T beta 4 was supplied by RegeneRx Biopharmaceuticals Inc. under a Material Transfer Agreement. A U.S. Provisional Patent 61/163,556 has been filed for use of T beta 4 in neurological disease.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuchs VR, 2008, NEW ENGL J MED, V359, P1749, DOI 10.1056/NEJMp0807432; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1038/nrneurol.2011.2; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; Sharma JC, 1999, CEREBROVASC DIS, V9, P2, DOI 10.1159/000015889; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	27	13	16	0	9	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923		978-1-57331-871-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2012	1269						110	116		10.1111/j.1749-6632.2012.06651.x			7	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Multidisciplinary Sciences	Biochemistry & Molecular Biology; Research & Experimental Medicine; Science & Technology - Other Topics	BDB67	WOS:000312491500016	23045978	Green Accepted			2021-06-18	
J	Soeker, MS; Van Rensburg, V; Travill, A				Soeker, Mogammad Shaheed; Van Rensburg, Viki; Travill, Andre			Are rehabilitation programmes enabling clients to return to work? Return to work perspectives of individuals with mild to moderate brain injury in South Africa	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Vocational rehabilitation; traumatic brain injury; qualitative research; enablers and barriers	EMPLOYMENT; PERCEPTIONS	Objective: To describe the perceptions and experiences of individuals with brain injury with regard to return to work rehabilitation programmes. Participants: Nine males and one female who were diagnosed with a moderate to mild brain injury participated in the study. Methods: In-depth interviews were conducted and data were analyzed using a qualitative approach to explicate patterns and themes. Results: Two themes emerged that reflected the lived experiences of individuals with brain injury regarding intervention programmes that influenced their ability to return to work after the brain injury: 1) Enablers of return to work programmes, 2) Barriers related to return to work programmes. Conclusions: Occupational therapy practitioners as well as rehabilitation personnel should identify and eliminate the barriers that impact on return to work intervention programmes, incorporate the enablers identified in this study when designing return to work programmes.	[Soeker, Mogammad Shaheed; Van Rensburg, Viki; Travill, Andre] Univ Western Cape, Dept Occupat Therapy, ZA-7535 Bellville, South Africa	Soeker, MS (corresponding author), Univ Western Cape, Dept Occupat Therapy, Private Bag X17, ZA-7535 Bellville, South Africa.	msoeker@uwc.ac.za					Abreu BC, 1996, AM J OCCUP THER, V50, P417, DOI 10.5014/ajot.50.6.417; [Anonymous], 2005, TYG HOSP BRAIN INJ S; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; Cook JA, 2002, BEHAV SCI LAW, V20, P541, DOI 10.1002/bsl.515; Creswell J., 2003, RES DESIGN QUALITATI, V2nd edn; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; DUFFY ME, 1993, PRACTICAL RES PLANNI; Fontana A., 1994, HDB QUALITATIVE RES; Friesen MN., 2001, WORK, V17, P11; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; HOLZBERG E, 2001, WORK, V16, P245; Jansen P, 1994, S AFRICAN J OCCUPATI, V24, P20; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; Law M., 2005, OCCUPATIONAL THERAPY, V3rd; MCGEE RA, 1989, J COUNS PSYCHOL, V36, P345, DOI 10.1037/0022-0167.36.3.345; Morse J. M., 1996, NURSING RES APPL QUA; Murdoch BE., 2001, TRAUMATIC BRAIN INJU; Philpott S, 1997, DISABILITY S AFRICAN; Pierce L L, 1988, Rehabil Nurs, V13, P189; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sanders M, 2008, OCCUPATIONAL THERAPY; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schultz-Krohn W, 2005, PEDRETTIS OCCUPATION; Statistics South Africa, 2005, S AFR MORT RAT DEATH; Sumsion T, 1999, CLIENT CTR PRACTISE; Townsend L, 1992, NATIONAL, V9, P8; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	30	13	14	0	19	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815			WORK	Work		2012	43	2					171	182		10.3233/WOR-2012-1413			12	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	012CX	WOS:000309214100007	22927624				2021-06-18	
J	Staniloiu, A; Markowitsch, HJ				Staniloiu, Angelica; Markowitsch, Hans J.			Towards solving the riddle of forgetting in functional amnesia: recent advances and current opinions	FRONTIERS IN PSYCHOLOGY			English	Article						dissociative amnesia; psychogenic amnesia; head injury; psychosocial stress; mnestic block syndrome	TRAUMATIC BRAIN-INJURY; PERSISTENT ANTEROGRADE AMNESIA; POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; RETROGRADE-AMNESIA; AUTOBIOGRAPHICAL MEMORY; DISSOCIATIVE DISORDERS; PSYCHOGENIC AMNESIA; AUTONOETIC CONSCIOUSNESS; ALZHEIMERS-DISEASE	Remembering the past is a core feature of human beings, enabling them to maintain a sense of wholeness and identity and preparing them for the demands of the future. Forgetting operates in a dynamic neural connection with remembering, allowing the elimination of unnecessary or irrelevant information overload and decreasing interference. Stress and traumatic experiences could affect this connection, resulting in memory disturbances, such as functional amnesia. An overview of clinical, epidemiological, neuropsychological, and neurobiological aspects of functional amnesia is presented, by preponderantly resorting to own data from patients with functional amnesia. Patients were investigated medically, neuropsychologically, and neuroradiologically. A detailed report of a new case is included to illustrate the challenges posed by making an accurate differential diagnosis of functional amnesia, a condition that may encroach on the boundaries between psychiatry and neurology. Several mechanisms may play a role in "forgetting" in functional amnesia, such as retrieval impairments, consolidating defects, motivated forgetting, deficits in binding and reassembling details of the past, deficits in establishing a first person autonoetic connection with personal events, and loss of information. In a substantial number of patients, we observed a synchronization abnormality between a frontal lobe system, important for autonoetic consciousness, and a temporo-amygdalar system, important for evaluation and emotions, which provides empirical support for an underlying mechanism of dissociation (a failure of integration between cognition and emotion). This observation suggests a mnestic blockade in functional amnesia that is triggered by psychological or environmental stress and is underpinned by a stress hormone mediated synchronization abnormality during retrieval between processing of affect-laden events and fact-processing.	[Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Hanse Inst Adv Study, Delmenhorst, Germany	Staniloiu, A (corresponding author), Univ Bielefeld, POB 100131, D-33501 Bielefeld, Germany.	astaniloiu@uni-bielefeld.de					Abe N, 2007, NEUROPSYCHOLOGIA, V45, P2902, DOI 10.1016/j.neuropsychologia.2007.06.003; Abeles M, 1935, ARCH NEURO PSYCHIATR, V34, P587, DOI 10.1001/archneurpsyc.1935.02250210108008; Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Admon R., 2012, CEREB CORTEX, DOI [10.1093/cer-cor/bhr369, DOI 10.1093/CER-COR/BHR369]; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; [Anonymous], 1992, CLASS MENT BEH DIS C; Arzy S, 2011, EUR J NEUROL, V18, P1422, DOI 10.1111/j.1468-1331.2011.03423.x; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; Barnabe A, 2012, HIPPOCAMPUS, V22, P1809, DOI 10.1002/hipo.22015; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bass C, 2007, J ROY SOC MED, V100, P81, DOI 10.1258/jrsm.100.2.81; Beck AT, 1995, BECK DEPRESSIONS INV; Becker-Blease KA, 2004, J CHILD PSYCHOL PSYC, V45, P522, DOI 10.1111/j.1469-7610.2004.00242.x; Bell V, 2011, J NEUROL NEUROSUR PS, V82, P332, DOI 10.1136/jnnp.2009.199158; Black DN, 2004, J NEUROPSYCH CLIN N, V16, P245, DOI 10.1176/appi.neuropsych.16.3.245; Bogousslavsky J, 2011, FRONT NEUROL NEUROSC, V29, P1; Boone, 2007, ASSESSMENT FEIGNED C; Borsutzky S, 2008, NEUROPSYCHOLOGIA, V46, P3133, DOI 10.1016/j.neuropsychologia.2008.07.005; Borsutzky S, 2010, NEUROPSYCHOLOGIA, V48, P2811, DOI 10.1016/j.neuropsychologia.2010.05.023; Bowers D., 1991, FLORIDA AFFECT BATTE; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brandt J, 2006, SEMIN NEUROL, V26, P331, DOI 10.1055/s-2006-945519; Briquet P., 1859, ANTHOLOGY FRENCH LAN, P131; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Burnham WH, 1903, AM J PSYCHOL, V14, P382; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Calabrese P, 2001, FORTSCHR NEUROL PSYC, V69, P42, DOI 10.1055/s-2001-10467; Calabrese P., 2000, DEMTECT; Carter RB, 1853, PATHOLOGY TREATMENT; Casey E., 2000, REMEMBERING PHENOMEN; Charney E, 2012, BEHAV BRAIN IN PRESS; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Coons PM, 1992, DISSOCIATION, V5, P73; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Croft KE, 2010, NEUROPSYCHOLOGIA, V48, P1789, DOI 10.1016/j.neuropsychologia.2010.03.001; Dahl G., 1972, WIP REDUZIERTER WECH; Dalenberg CJ, 2012, PSYCHOL BULL, V138, P550, DOI 10.1037/a0027447; Dalfen AK, 2000, BRAIN INJURY, V14, P1101; Davis N, 2008, MEMORY, V16, P465, DOI 10.1080/09658210802077082; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; Donaldson W., 1972, ORG MEMORY, P381, DOI [DOI 10.1016/B978-0-12-809324-5.21037-7, DOI 10.1017/S0140525X00047257]; Dorahy M., 2007, TRAUMATIC DISSOCIATI, P3; Draijer N, 1999, AM J PSYCHIAT, V156, P379; Duff MC, 2008, APHASIOLOGY, V22, P866, DOI 10.1080/02687030701844196; During EH, 2011, CAN J PSYCHIAT, V56, P235, DOI 10.1177/070674371105600407; Dwyer J, 2004, LANCET, V364, P471, DOI 10.1016/S0140-6736(04)16772-X; Eco U., 1999, CONVERSATIONS END TI; Eich E, 2009, NEUROPSYCHOLOGIA, V47, P2239, DOI 10.1016/j.neuropsychologia.2009.02.019; Enzi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008429; Erdelyi MH, 2006, BEHAV BRAIN SCI, V29, P499, DOI 10.1017/S0140525X06009113; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Fast K, 2001, Neurocase, V7, P269, DOI 10.1093/neucas/7.4.269; Fast K., 2012, ERWEITERTES AUTOBIOG; Fink GR, 1996, J NEUROSCI, V16, P4275; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Fujii Y, 1998, PSYCHIAT CLIN NEUROS, V52, P299, DOI 10.1046/j.1440-1819.1998.00394.x; Fujiwara E., 2004, THESIS U BIELEFELD B; Fujiwara E., 2006, BINDING HUMAN MEMORY, P379; Fujiwara E, 2003, TRAUMA PSYCHISCHE ER, P19; Fujiwara E, 2008, CORTEX, V44, P29, DOI 10.1016/j.cortex.2005.09.001; Fulton D, 2006, J NEUROSCI, V26, P10935, DOI 10.1523/JNEUROSCI.3694-06.2006; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Ganser S. J., 1904, ARCH PSYCHIAT NERVEN, V38, P34; Ganser SJ, 1898, ARCH PSYCHIATRIE NER, V30:, P633; Glisky EL, 2004, NEUROPSYCHOLOGIA, V42, P1132, DOI 10.1016/j.neuropsychologia.2003.08.016; Goldsmith RE, 2009, J TRAUMA DISSOCIATIO, V10, P237, DOI 10.1080/15299730902956572; Hacking I., 1995, REWRITING SOUL MULTI; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Harpaz-Rotem I, 2005, MEMORY, V13, P51, DOI 10.1080/09658210344000567; Harting C., 2000, WECHSLER MEMORY SCAL; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Hinton DE, 2008, TRANSCULT PSYCHIATRY, V45, P142, DOI 10.1177/1363461508089763; HOFF H, 1938, DTSCH Z NERVENHEILK, V145, P150; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; James W., 1984, PSYCHOL BRIEFER COUR; Janet P, 2001, HIST PSYCHIATR, V12, P481, DOI 10.1177/0957154X0101204806; JANET P, 2007, MAJOR SYMPTOMS HYSTE; Janet Pierre, 1892, ARCH NEUROLOGIE, V24, P29; Jenkins KG, 2009, CURR OPIN NEUROL, V22, P601, DOI 10.1097/WCO.0b013e32833299bb; Johnson JG, 2006, J PSYCHIAT RES, V40, P131, DOI 10.1016/j.jpsychires.2005.03.003; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kanaan RA, 2012, J NEUROL NEUROSUR PS, V83, P248, DOI 10.1136/jnnp-2011-300992; Kanzer M, 1939, AM J PSYCHIAT, V96, P711, DOI 10.1176/ajp.96.3.711; Kessler J, 1997, J CLIN EXP NEUROPSYC, V19, P604, DOI 10.1080/01688639708403746; KIERSCH TA, 1962, AM J PSYCHIAT, V119, P57, DOI 10.1176/ajp.119.1.57; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Krahn LE, 2008, PSYCHOSOMATICS, V49, P277, DOI 10.1176/appi.psy.49.4.277; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; Kumar S, 2007, PSYCHIAT CLIN NEUROS, V61, P583, DOI 10.1111/j.1440-1819.2007.01735.x; Kundera Milan, 1984, UNBEARABLE LIGHTNESS; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Ladowsky-Brooks RL, 2003, J CLIN EXP NEUROPSYC, V25, P761, DOI 10.1076/jcen.25.6.761.16473; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Lennox WG, 1943, AM J PSYCHIAT, V99, P732, DOI 10.1176/ajp.99.5.732; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2009, NEUROPSYCHOLOGIA, V47, P2188, DOI 10.1016/j.neuropsychologia.2008.12.026; Lewis A., 1963, MED AFFECTIONS MIND; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Linden SC, 2012, EUR ARCH PSY CLIN N, V262, P253, DOI 10.1007/s00406-011-0272-9; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loewenstein R, 1991, ANN REV PSYCHIAT, P189; Lundholm H, 1931, J ABNORM SOC PSYCH, V26, P355; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Luria A. R., 1987, MIND MNEMONIST LITTL; Lynn SJ, 2012, CURR DIR PSYCHOL SCI, V21, P48, DOI 10.1177/0963721411429457; Magnin E, 2012, NEUROCASE; Maldonado J.R., 2008, AM PSYCHIAT PUBLISHI, P665; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch HJ, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 2: H-O, P131; Markowitsch H. J., 2003, BEHAV NEUROLOGY NEUR, P431; Markowitsch H.J., 1992, INTELLECTUAL FUNCTIO; Markowitsch H. J., 2006, ORBITOFRONTAL CORTEX, P285, DOI DOI 10.1093/ACPR0F:0S0/9780198565741.003.0011; Markowitsch H. J., 2012, CORTEX; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Markowitsch HJ, 2011, CONSCIOUS COGN, V20, P16, DOI 10.1016/j.concog.2010.09.005; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; Markowitsch Hans J., 1995, P765; MARKOWITSCH HJ, 1985, INT J NEUROSCI, V27, P191, DOI 10.3109/00207458509149767; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 1999, NEUROCASE, V5, P189, DOI 10.1093/neucas/5.3.189; MARKOWITSCH HJ, 1988, BRAIN RES REV, V13, P351, DOI 10.1016/0165-0173(88)90012-4; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1994, NEUROREPORT, V5, P1349, DOI 10.1097/00001756-199406270-00013; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; Markowitsch HJ, 2000, BEHAV NEUROL, V12, P181, DOI 10.1155/2000/303651; Markowitsch HJ, 1999, MEMORY, V7, P561, DOI 10.1080/096582199387751; Markowitsch HJ, 1999, CURR OPIN PSYCHIATR, V12, P331, DOI 10.1097/00001504-199905000-00014; MARKOWITSCH HJ, 2005, ENDOPHYSICS TIME QUA, P131; Marsh R, 2009, ARCH GEN PSYCHIAT, V66, P51, DOI 10.1001/archgenpsychiatry.2008.504; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McKay GCM, 2009, ADV PSYCHIAT TREAT, V15, P152, DOI DOI 10.1192/APT.BP.105.001586; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Miller P, 1997, J AM ACAD CHILD PSY, V36, P112, DOI 10.1097/00004583-199701000-00024; Mishkin M., 1984, NE UR OPS YCHOL MEMO, P287; Mitchell S. A., 1995, FREUD HIST MODERN PS; Nadel L, 2012, NEUROSCI BIOBEHAV R, V36, P1640, DOI 10.1016/j.neubiorev.2012.03.001; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; NARDI TJ, 1977, AM J PSYCHIAT, V134, P453; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Newcombe V., 2012, BRAIN INJURY, V26, P323; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22356, DOI 10.1073/pnas.1016823108; Ortega A, 2012, ARCH CLIN NEUROPSYCH, V27, P453, DOI 10.1093/arclin/acs038; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Peigneux P, 2010, CURR ISS MEM, P165; Picard L, 2009, CONSCIOUS COGN, V18, P864, DOI 10.1016/j.concog.2009.07.008; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Pommerenke K, 2012, NEUROL REHAB, V18, P106; Pope HG, 2007, PSYCHOL MED, V37, P225, DOI 10.1017/S0033291706009500; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Post RM, 1995, ANN NY ACAD SCI, V771, P677, DOI 10.1111/j.1749-6632.1995.tb44720.x; Putnam F.W., 1997, DISSOCIATION CHILDRE; Reinhold N, 2006, CURR MED IMAGING, V2, P35, DOI 10.2174/157340506775541668; Reinhold N, 2007, J NEUROPSYCHOL, V1, P53, DOI 10.1348/174866407X180819; Reinhold N, 2009, NEUROPSYCHOLOGIA, V47, P2197, DOI 10.1016/j.neuropsychologia.2009.01.037; Ribot T., 1882, DIS MEMORY; Rinne T., 2007, TRAUMATIC DISSOCIATI, P139; Rosenbaum RS, 2009, NEUROPSYCHOLOGIA, V47, P2181, DOI 10.1016/j.neuropsychologia.2008.11.028; SCHACTER DL, 1982, NEUROPSYCHOLOGIA, V20, P523, DOI 10.1016/0028-3932(82)90026-4; Schmidtke K, 1999, Z NEUROPSYCHOL, V10, P13, DOI DOI 10.1024//1016-264X.10.1.13; Schneider K, 1912, Z GESAMTE NEUROL PSY, V8, P553, DOI 10.1007/BF02866053; Schneider K., 1928, HDB GEISTESKRANKHEIT, V1, P508; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Schultz IH, 1924, Z GESAMTE NEUROL PSY, V89, P107, DOI 10.1007/BF02885806; Sehm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026538; Seligman R, 2008, CULT MED PSYCHIAT, V32, P31, DOI 10.1007/s11013-007-9077-8; Semon R., 1904, MNEME ALS ERHALTENDE; Serra L, 2007, BEHAV NEUROL, V18, P53, DOI 10.1155/2007/193140; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; Simeon D, 2007, BIOL PSYCHIAT, V61, P966, DOI 10.1016/j.biopsych.2006.07.030; SLATER ETO, 1965, J PSYCHOSOM RES, V9, P9, DOI 10.1016/0022-3999(65)90004-8; Smith CN, 2010, NEUROPSYCHOLOGIA, V39, P2823; Sollier P., 1892, GENESE NATURE HYSTER; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Souques A., 1892, REV MED, V13, P367; SPIEGEL D, 1991, J ABNORM PSYCHOL, V100, P366, DOI 10.1037/0021-843X.100.3.366; Spiegel D, 2011, DEPRESS ANXIETY, V28, P824, DOI 10.1002/da.20874; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Staniloiu A, 2010, J GEN MED, V22, P41; Staniloiu A., 2010, ASCS09, P316; STANILOIU A, 2010, J PSYCHOL, V218, P96, DOI DOI 10.1027/0044-3409/A000017; Staniloiu A, 2010, CONSCIOUS COGN, V19, P778, DOI 10.1016/j.concog.2010.06.024; Staniloiu Angelica, 2009, Cogn Neuropsychiatry, V14, P180, DOI 10.1080/13546800902931036; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; Stone J, 2006, BRIT J PSYCHIAT, V188, P204, DOI 10.1192/bjp.188.3.204; Stone J, 2009, NEUROL NEUROSURG PSY, V9, P179, DOI 10.1136/jnnp.2009.177204; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; SULLIVAN HS, 1972, PERSONAL PSYCHOPATHO; Takahashi Y., 1991, DISSOCIATION, V3, P57; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Thom DA, 1920, AM J INSANITY, V76, P437, DOI 10.1176/ajp.76.4.437; Thomas-Anterion C, 2010, J NEUROL NEUROSUR PS, V81, P468, DOI 10.1136/jnnp.2008.163808; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Tulving E, 1983, ELEMENTS EPISODIC ME; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [DOI 10.1093/ACPROF:OSO/9780195161564.003.0001, 10.1093/acprof:oso/9780195161564.003.0001]; Tulving Endel, 1995, P839; van Huijzen, 2008, HUMAN CENTRAL NERVOU; VANDERKOLK BA, 1989, AM J PSYCHIAT, V146, P1530; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Venugopal S., 2012, BRAIN INJURY, V26, P474; Vits S, 2011, PHILOS T R SOC B, V366, P1799, DOI 10.1098/rstb.2010.0392; von Cramon D. Yves, 2000, P380; VONCRAMON DY, 1993, NEUROPSYCHOLOGIA, V31, P1159, DOI 10.1016/0028-3932(93)90065-8; Vrij A., 2000, DETECTING LIES DECEI; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Wang Q, 2008, COGNITION, V108, P117, DOI 10.1016/j.cognition.2008.02.002; Weinrich Harald, 1997, LETHE KUNST KRITIK V; Welzer H, 2005, MEMORY, V13, P63, DOI 10.1080/09658210344000576; Willoughby KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00053; WILSON FAW, 1990, EXP BRAIN RES, V80, P104; WILSON G, 1950, AM J PSYCHIAT, V106, P481, DOI 10.1176/ajp.106.7.481; Wilson RS, 2007, J NEUROL NEUROSUR PS, V78, P30, DOI 10.1136/jnnp.2006.099721; Wood H, 2003, NAT REV NEUROSCI, V4, P774; Xiao ZP, 2006, AM J PSYCHIAT, V163, P1388, DOI 10.1176/appi.ajp.163.8.1388; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Ziehen T., 1908, GEDACHTNIS	248	13	13	1	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.		2012	3								403	10.3389/fpsyg.2012.00403			23	Psychology, Multidisciplinary	Psychology	V31DJ	WOS:000208864000119	23125838	DOAJ Gold, Green Published			2021-06-18	
S	Starkstein, SE; Tranel, D		Schlaepfer, TE; Nemeroff, CB		Starkstein, Sergio E.; Tranel, Daniel			Neurological and psychiatric aspects of emotion	NEUROBIOLOGY OF PSYCHIATRIC DISORDERS	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PROVISIONAL DIAGNOSTIC-CRITERIA; POSTSTROKE DEPRESSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SELF-AWARENESS; NEUROPSYCHIATRIC-SYMPTOMS; FUNCTIONAL RECOVERY; MAJOR DEPRESSION; DOUBLE-BLIND		[Starkstein, Sergio E.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Tranel, Daniel] Univ Iowa, Coll Med, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA; [Tranel, Daniel] Univ Iowa, Dept Psychol, Coll Med, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA	Starkstein, SE (corresponding author), Fremantle Hosp T 7, Fremantle, WA 6959, Australia.	ses@meddent.-uwa.edu.au		Tranel, Daniel/0000-0002-1338-1389	NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA022549] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS19632] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA022549] Funding Source: NIH RePORTER		Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Aalten P, 2005, INT J GERIATR PSYCH, V20, P523, DOI 10.1002/gps.1316; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2004, PRINCIPLES PRACTICE, P457; Adolphs Ralph, 2000, AMYGDALA FUNCTIONAL, P587; Aggleton J.P., 2000, AMYGDALA FUNCTIONAL; AGGLETON JP, 1992, AMYGDALA NEUROBIOLOG; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMARAL D G, 1992, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Babinski J, 1918, REV NEUROL, V31, P365; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bennet M. R., 2003, PHILOS FDN NEUROSCIE; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOLLAWILSON K, 1989, AM J PSYCHIAT, V146, P627; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Borod JC, 1997, NEUROPSYCHOL REV, V7, P41, DOI 10.1007/BF02876972; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bowers D., 1993, NEUROPSYCHOLOGY, V7, P433, DOI DOI 10.1037/0894-4105.7.4.433; Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173; Brothers L., 1990, CONCEPT NEUROSCI, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Buchanan TW, 2009, HUMAN AMYGDALA, P289; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; BURNS A, 1990, BRIT J PSYCHIAT, V157, P81, DOI 10.1192/bjp.157.1.81; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P320, DOI 10.1192/bjp.166.3.320; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CANCELLIERE AEB, 1990, BRAIN COGNITION, V13, P133, DOI 10.1016/0278-2626(90)90046-Q; Canli T, 1999, NEUROSCIENTIST, V5, P201, DOI 10.1177/107385849900500409; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chemerinski E, 2001, J NERV MENT DIS, V189, P421, DOI 10.1097/00005053-200107000-00002; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Chung J. C. C., 2002, COCHRANE DB SYST REV, V4, P1, DOI DOI 10.1002/14651858; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P177, DOI 10.1348/014466504323088042; Cohen CI, 2003, AM J PSYCHIAT, V160, P2012, DOI 10.1176/appi.ajp.160.11.2012; Cummings JL, 2001, J GERIATR PSYCH NEUR, V14, P101, DOI 10.1177/089198870101400211; CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443; CUTTING J, 1978, J NEUROL NEUROSUR PS, V41, P548, DOI 10.1136/jnnp.41.6.548; Czernecki V, 2008, MOVEMENT DISORD, V23, P964, DOI 10.1002/mds.21949; Dam~asio A., 1999, FEELING WHAT HAPPENS; Damasio A., 1994, DESCARTESERROR EMOTI; Damasio A. R., 2011, CLIN NEUROPSYCHOLOGY, P417; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davidson Richard J., 1992, BRAIN COGNITION, V6, P245; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Dobkin Roseanne DeFronzo, 2008, Expert Rev Neurother, V8, P27, DOI 10.1586/14737175.8.1.27; DOWNHILL JE, 1994, J NERV MENT DIS, V182, P425, DOI 10.1097/00005053-199408000-00001; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Dujardin K, 2007, MOVEMENT DISORD, V22, P778, DOI 10.1002/mds.21316; Fall PA, 1999, J NEURAL TRANSM, V106, P737, DOI 10.1007/s007020050194; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Feinberg TE, 2000, J NEUROL NEUROSUR PS, V68, P511, DOI 10.1136/jnnp.68.4.511; Figiel G, 2008, CURR MED RES OPIN, V24, P157, DOI 10.1185/030079908X260961; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gainotti G, 1997, J CLIN EXP NEUROPSYC, V19, P340, DOI 10.1080/01688639708403863; GAINOTTI G, 2000, NEUROPSYCHOLOGY EMOT; Gallegos DR, 2005, BRAIN LANG, V93, P338, DOI 10.1016/j.bandl.2004.11.001; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallo JJ, 1997, J AM GERIATR SOC, V45, P570, DOI 10.1111/j.1532-5415.1997.tb03089.x; Galynker I, 1997, J NERV MENT DIS, V185, P616, DOI 10.1097/00005053-199710000-00004; Garre-Olmo J, 2003, ALZ DIS ASSOC DIS, V17, P77, DOI 10.1097/00002093-200304000-00005; Gialanella B, 2005, STROKE, V36, P2687, DOI 10.1161/01.STR.0000189627.27562.c0; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; GRAY JM, 1994, CLIN REHABIL, V8, P188, DOI DOI 10.1080/09602010902949207; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hackett ML, 2004, COCHRANE DB SYST REV, V4; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hare RD., 1970, PSYCHOPATHY THEORY R; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Heilman KM, 2003, CLIN NEUROPSYCHOLOGY, P447; Herrmann N, 2005, AM J GERIAT PSYCHIAT, V13, P527, DOI 10.1176/appi.ajgp.13.6.527; Herrmann N, 2008, J CLIN PSYCHOPHARM, V28, P296, DOI 10.1097/JCP.0b013e318172b479; Holmes C, 2006, INT PSYCHOGERIATR, V18, P623, DOI 10.1017/S1041610206003887; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; JACOBS DH, 1995, NEUROLOGY, V45, P1217, DOI 10.1212/WNL.45.6.1217; Jansari A, 2000, COGNITION EMOTION, V14, P341, DOI 10.1080/026999300378860; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kawasaki H, 2001, NAT NEUROSCI, V4, P15; Kimura M, 2000, STROKE, V31, P1482, DOI 10.1161/01.STR.31.7.1482; Koscik T, 2010, NEUROPSYCHOPHARMACOL, V35, P340, DOI 10.1038/npp.2009.122; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Landes AM, 2005, J NEUROPSYCH CLIN N, V17, P342, DOI 10.1176/appi.neuropsych.17.3.342; Lane-Brown A, 2009, COCHRANE DB SYST REV, V2; LeDoux J., 1996, EMOTIONAL BRAIN; Lee HCB, 2003, BIOL PSYCHIAT, V54, P353, DOI 10.1016/S0006-3223(03)00543-2; Leentjens AFG, 2003, INT J GERIATR PSYCH, V18, P552, DOI 10.1002/gps.865; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; LIPSEY JR, 1986, AM J PSYCHIAT, V143, P527; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P1686, DOI 10.1176/appi.ajp.157.10.1686; Magai C, 2000, AM J GERIAT PSYCHIAT, V8, P66, DOI 10.1097/00019442-200002000-00009; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh L, 2006, MOVEMENT DISORD, V21, P148, DOI 10.1002/mds.20723; Menza M, 2009, NEUROLOGY, V72, P886, DOI 10.1212/01.wnl.0000336340.89821.b3; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P129, DOI 10.1176/appi.ajgp.10.2.129; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Palhagen SE, 2008, ACTA NEUROL SCAND, V117, P295, DOI 10.1111/j.1600-0404.2007.00986.x; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Pedersen KF, 2010, J NEUROL, V257, P217, DOI 10.1007/s00415-009-5297-x; Pedersen KF, 2009, PARKINSONISM RELAT D, V15, P295, DOI 10.1016/j.parkreldis.2008.07.006; Piccinelli M, 1999, J PSYCHOSOM RES, V46, P455, DOI 10.1016/S0022-3999(98)00126-3; Pohjasvaara T, 2001, EUR J NEUROL, V8, P315, DOI 10.1046/j.1468-1331.2001.00182.x; Prigatano G., 2010, STUDY ANOSOGNOSIA, P229; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Robert PH, 2006, CLIN NEUROL NEUROSUR, V108, P733, DOI 10.1016/j.clineuro.2006.02.003; ROBERTS RC, 1988, PHILOS REV, V97, P183, DOI 10.2307/2185261; Robinson R, 2006, CLIN NEUROPSYCHIATRY; ROBINSON RG, 1987, STROKE, V18, P837, DOI 10.1161/01.STR.18.5.837; Robinson RG, 2008, J NEUROL NEUROSUR PS, V21, P144; Robinson RG, 2008, JAMA-J AM MED ASSOC, V299, P2391, DOI 10.1001/jama.299.20.2391; Rolls ET, 1999, NEUROCASE, V5, P301, DOI 10.1080/13554799908411984; Royet JP, 2000, J NEUROSCI, V20, P7752; Santa N, 2008, INT J REHABIL RES, V31, P321, DOI 10.1097/MRR.0b013e3282fc0f0e; Santangelo G, 2009, J NEUROL, V256, P632, DOI 10.1007/s00415-009-0146-5; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1997, P ROY SOC B-BIOL SCI, V264, P1767, DOI 10.1098/rspb.1997.0245; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; Starkstein SE, 2007, EUR J NEUROL, V14, P455, DOI 10.1111/j.1468-1331.2007.01745.x; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; STARKSTEIN SE, 1988, ARCH GEN PSYCHIAT, V45, P247; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; STARKSTEIN SE, 1995, ARCH NEUROL-CHICAGO, V52, P415, DOI 10.1001/archneur.1995.00540280105024; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Starkstein SE, 2005, AM J PSYCHIAT, V162, P2086, DOI 10.1176/appi.ajp.162.11.2086; Starkstein SE, 2005, AM J GERIAT PSYCHIAT, V13, P802, DOI 10.1176/appi.ajgp.13.9.802; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Starkstein SE, 1998, MOVEMENT DISORD, V13, P29, DOI 10.1002/mds.870130109; STARKSTEIN SE, 1990, J NERV MENT DIS, V178, P27, DOI 10.1097/00005053-199001000-00005; STARKSTEIN SE, 1991, EUR NEUROL, V31, P352, DOI 10.1159/000116692; STARKSTEIN SE, 1992, J NEUROL NEUROSUR PS, V55, P377, DOI 10.1136/jnnp.55.5.377; Starkstein SE, 1997, BRIT J PSYCHIAT, V171, P47, DOI 10.1192/bjp.171.1.47; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.6.872; STARKSTEIN SE, 1992, NEUROPSY NEUROPSY BE, V5, P114; Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Starkstein SE, 2010, J NEUROPSYCH CLIN N, V22, P378, DOI 10.1176/appi.neuropsych.22.4.378; Starkstein SE, 2009, MOVEMENT DISORD, V24, P1211, DOI 10.1002/mds.22577; Steinberg M, 2004, INT J GERIATR PSYCH, V19, P144, DOI 10.1002/gps.1048; Strauss ME, 2002, NEUROPSY NEUROPSY BE, V15, P176, DOI 10.1097/01.WNN.0000020010.79870.C3; Tatsch MF, 2006, AM J GERIAT PSYCHIAT, V14, P438, DOI 10.1097/01.JGP.0000218218.47279.db; Teng E, 2008, AM J GERIAT PSYCHIAT, V16, P469, DOI 10.1097/JGP.0b013e318165dbae; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Thompson S, 2007, CAN J PSYCHIAT, V52, P248, DOI 10.1177/070674370705200407; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; TRANEL D, 1990, ARCH NEUROL-CHICAGO, V47, P349, DOI 10.1001/archneur.1990.00530030131029; TRANEL D, 2000, NEW COGNITIVE NEUROS, P1047; Tranel D, 2009, NEUROCASE, V15, P217, DOI 10.1080/13554790902775492; Turro-Garriga O, 2009, REV NEUROLOGIA, V48, P7, DOI 10.33588/rn.4801.2008565; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; VANLANCKER D, 1992, J SPEECH HEAR RES, V35, P963, DOI 10.1044/jshr.3505.963; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Vilalta-Franch J, 2006, AM J GERIAT PSYCHIAT, V14, P589, DOI 10.1097/01.JGP.0000209396.15788.9d; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whyte EM, 2008, CEREBROVASC DIS, V26, P317, DOI 10.1159/000149580; Williams LS, 2007, STROKE, V38, P998, DOI 10.1161/01.STR.0000257319.14023.61; World Health Organization, 1992, ICD 10 INT STAT CLAS; Zawacki TM, 2002, J NEUROPSYCH CLIN N, V14, P296, DOI 10.1176/appi.neuropsych.14.3.296	218	13	13	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-453500-9; 978-0-44-452002-9	HAND CLINIC			2012	106						53	74					22	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	BCQ82	WOS:000311042100006	22608615				2021-06-18	
J	Gray, H; Van Waerebeek, K				Gray, Howard; Van Waerebeek, Koen			Postural instability and akinesia in a pantropical spotted dolphin, Stenella attenuata, in proximity to operating airguns of a geophysical seismic vessel	JOURNAL FOR NATURE CONSERVATION			English	Article						Acoustic distress; Behaviour; Catatonia; Injury; Liberia; Myopathy; Stress; Seismic survey	CETACEANS; RESPONSES; CONJUNCTION; HEALTH; SOUND; GAS	Aberrant behaviour including erratic locomotion was observed in a pantropical spotted dolphin 600 m ahead of an airgun array during 3D seismic explorations off Liberia in March 2009. The dolphin, presumably in acoustic distress, lifted its head and cervical region above the surface in an oblique, strikingly rigid posture during 5 min. Turbulent white-water evidenced a major propulsory thrust. Incremental postural instability and apparent exhaustion progressed to a catatonic-like state of akinesia as the dolphin rolled over onto one side, then its back before sinking virtually motionless close to the airgun array. Unless it recovered full locomotory control, asphyxiation was inevitable. Potential internal injury is discussed, both acoustic-mediated and from extreme exertion (exertional myopathy, rhabdomyolysis and myoglobinuric nephrosis). As behaviour was spatially and temporally closely associated with firing seismic airguns, we suggest a cause-effect relationship. Differential diagnoses of pre-existing morbidity, senescence, or intoxication are considered possible but unlikely. (C) 2011 Elsevier GmbH. All rights reserved.	[Gray, Howard] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Van Waerebeek, Koen] Museo Delfines, Ctr Peruano Estudios Cetol CEPEC, Cetacean Conservat Med Grp, Lima 20, Peru	Gray, H (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	howard_gray@btinternet.com					Bain DE, 2006, SC58E35 INT WHAL COM; Bargu S, 2002, MAR ECOL PROG SER, V237, P209, DOI 10.3354/meps237209; BATESON M, 2007, INT J COMP PSYCHOL, V20, P169; BOWLES AE, 1994, J ACOUST SOC AM, V96, P2469, DOI 10.1121/1.410120; Calambokidis J., 1998, MARINE MAMMAL RES MI; COE JM, 1980, FISH B-NOAA, V78, P535; Curry B, 1999, NOAATMNMFSSWFSC261; Di Guardo G, 2010, VET PATHOL, V47, P245, DOI 10.1177/0300985809358036; DOMINGO M, 1995, VET MICROBIOL, V44, P229, DOI 10.1016/0378-1135(95)00016-4; Edwards E.F., 2007, INT J COMP PSYCHOL, V20, P217; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Fernandez A., 2004, NATURE, V10, P1038; Goold JC, 1998, J ACOUST SOC AM, V103, P2177, DOI 10.1121/1.421363; Goold JC, 1996, J MAR BIOL ASSOC UK, V76, P811, DOI 10.1017/S0025315400031477; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Greenfield JG, 1939, BRAIN, V62, P129, DOI 10.1093/brain/62.2.129; Herman LM., 1980, COMMUNICATION SYSTEM, P149; Hernandez-Mora G, 2008, EMERG INFECT DIS, V14, P1430, DOI 10.3201/eid1409.071056; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Jefferson T. A., 2008, MARINE MAMMALS WORLD; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Ketten DR, 1993, J ACOUST SOC AM, V94, P1849, DOI DOI 10.1121/1.407688; Konrad H. R, 1990, CLIN METHODS HIST PH, P604; Madsen C. J., 1980, CETACEAN BEHAV MECH, P101; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Oelschlager H. H. A., 2002, ENCY MARINE MAMMALS, P133; Olendorf D., 2006, GALE ENCY MED; Oliveros E. S., 2002, LJ0236C NMFS SW FIS; Perrin William F., 2001, Mammalian Species, V683, P1, DOI 10.1644/1545-1410(2001)683<0001:SA>2.0.CO;2; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P819; Popov V. V., 2008, Doklady Akademii Nauk, V419, P842; Popper A. N., 1980, CETACEAN BEHAV MECH, P1; Richardson W. J., 1999, J ACOUST SOC AM, V106, P2281, DOI DOI 10.1121/1.427801; Richardson W. J., 1995, MARINE MAMMALS NOISE; Richardson WJ, 1997, MAR FRESHW BEHAV PHY, V29, P183, DOI 10.1080/10236249709379006; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI 10.1139/F04-055; SHEPHARD RH, 1956, BRAIN, V79, P282, DOI 10.1093/brain/79.2.282; Slijper E. J., 1979, WHALES, P511; Southall B.L., 2007, AQUAT MAMM, V33, P411, DOI [10.1578/am.33.4.2007.411, DOI 10.1578/AM.33.4.2007.411]; Stone C. J, 2003, 232 JOINT NAT CONS C; Stone Carolyn J., 2006, Journal of Cetacean Research and Management, V8, P255; Van Bressem Marie-Francoise, 2007, Latin American Journal of Aquatic Mammals, V6, P7; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Weilgart L.S., 2007, INT J COMP PSYCHOL, V20, P159, DOI DOI 10.3354/MEPS07117; Weir Caroline R., 2008, Aquatic Mammals, V34, P71, DOI 10.1578/AM.34.1.2008.71; Williams Elizabeth S., 1996, P181; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298	47	13	13	0	18	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	1617-1381	1618-1093		J NAT CONSERV	J. Nat. Conserv.	DEC	2011	19	6					363	367		10.1016/j.jnc.2011.06.005			5	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	849VR	WOS:000297153900006					2021-06-18	
J	Kimbler, DE; Murphy, M; Dhandapani, KM				Kimbler, Donald E.; Murphy, Marguerite; Dhandapani, Krishnan M.			Concussion and the Adolescent Athlete	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; NCAA CONCUSSION; MANAGEMENT; RECOVERY	Traumatic brain injury (TBI) is a complex and debilitating neurological injury that places a significant financial and emotional burden on both families and medical providers. Accumulating evidence suggests that mild TBI or concussion remains grossly underdiagnosed, as compared with more severe TBI, due to a poor understanding of the clinical signs and symptoms involved with a head injury. Notably, pediatric head injury may be associated with the subsequent development of serious, long-term neurological consequences, emphasizing the need for improved diagnosis and acute medical intervention. The purpose of this minireview is to summarize the association between participation in youth athletics and the occurrence of concussions, a primary source of mild TBI in the adolescent population, with the goal of increasing awareness within the nursing profession for this clinically important yet underdiagnosed form of brain injury.	[Kimbler, Donald E.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Murphy, Marguerite] Georgia Hlth Sci Univ, Sch Nursing, Augusta, GA USA	Kimbler, DE (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA.	dkimbler@georgiahealth.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS065172]; Uniformed Services University of the Health Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065172] Funding Source: NIH RePORTER	This project is sponsored, in part, by grants from the National Institutes of Health (R01NS065172) and from the TriService Nursing Research Program, Uniformed Services University of the Health Sciences. The information, content, and conclusions do not necessarily represent the official position or policy of, nor should any official endorsement be inferred by the TriService Nursing Research Program, the Uniformed Services University of the Health Sciences, the Department of Defense, or the U. S. Government.	BINDER S, 2005, REHABILITATION, V20, pY195; BRADSHAW BD, 2008, REPORT SURGEON GEN T; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; KUSINSKI P, 2011, MED EXAMINER; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Management of Concussion/mTBI Working Group, 2009, J REHABILITATION RES, V46; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Schwarz A, 2010, NY TIMES; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; STREETER J, 2011, INNOVATING DIAGNOSTI; Tanielian T, 2008, INVISIBLE WOUNDS WAR; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR, P1; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599; 2011, NEUROLOGY, V48	32	13	13	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2011	43	6					286	290		10.1097/JNN.0b013e31823858a6			5	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	850PL	WOS:000297207700002	22045196	Green Accepted			2021-06-18	
J	Moeller, JJ; Tu, B; Bazil, CW				Moeller, Jeremy J.; Tu, Bin; Bazil, Carl W.			Quantitative and Qualitative Analysis of Ambulatory Electroencephalography During Mild Traumatic Brain Injury	ARCHIVES OF NEUROLOGY			English	Article							EEG; CONCUSSION	Objectives: To characterize the neurophysiological changes in a patient with mild traumatic brain injury (mTBI) and to compare these changes with a small cohort of patients with neurocardiogenic syncope, an analogous cause of transient neurological dysfunction. Design: Case report and quantitative analysis of a small electroencephalography (EEG) cohort. Setting: University-affiliated teaching hospital. Patients: A 64-year-old man with mTBI recorded on ambulatory EEG. The comparison group was 4 patients with spontaneous neurocardiogenic syncope during continuous video EEG recording. Intervention: Quantitative and qualitative analysis of EEG. Main Outcome Measures: Changes in quantitative EEG measurements between the patient with mTBI and the comparison group. Results: In the patient with mTBI, there was an abrupt decrease in high-frequency (beta) power and alpha-delta ratio immediately after the injury and a corresponding increase in lower-frequency (alpha, theta, delta) power. The change in beta power resolved within 5 minutes of the injury, but the increases in low-frequency power persisted up to 20 minutes after the injury before resolving. Similar but smaller changes were seen in the patients with syncope, but these changes resolved within 5 minutes, with no intermediate or long-term changes. Conclusions: The quantitative EEG changes in mTBI are initially similar to those in syncope, suggesting acute transient cortical dysfunction. However, there are longer-lasting increases in low-frequency power during mTBI, suggesting ongoing disruption of cortical-thalamic circuits. Arch Neurol. 2011; 68(12):1595-1598	[Moeller, Jeremy J.; Tu, Bin; Bazil, Carl W.] Columbia Univ, Med Ctr, New York, NY USA	Bazil, CW (corresponding author), Columbia Comprehens Epilepsy Ctr, 7th Floor,710 W 168th St, New York, NY 10032 USA.	cwb11@columbia.edu	Moeller, Jeremy/AAE-6153-2020				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Brenner RP, 1997, J CLIN NEUROPHYSIOL, V14, P197, DOI 10.1097/00004691-199705000-00004; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; KAPLAN HA, 1954, JAMA-J AM MED ASSOC, V156, P1138, DOI 10.1001/jama.1954.02950120012004; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Olejniczak P, 2006, J CLIN NEUROPHYSIOL, V23, P186, DOI 10.1097/01.wnp.0000220079.61973.6c; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107	12	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	DEC	2011	68	12					1595	1598		10.1001/archneurol.2011.1080			4	Clinical Neurology	Neurosciences & Neurology	861BJ	WOS:000297993500016	22159059	Bronze			2021-06-18	
J	Jiang, L; Yin, XH; Yin, C; Zhou, SA; Dan, W; Sun, XC				Jiang, Li; Yin, Xiaohong; Yin, Cheng; Zhou, Shuai; Dan, Wei; Sun, Xiaochuan			Different quantitative EEG alterations induced by TBI among patients with different APOE genotypes	NEUROSCIENCE LETTERS			English	Article						TBI; QEEG; APOE polymorphism; Brain electrical activity	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; EARLY-STAGE; ASSOCIATION; PROMOTER	Although several studies have revealed the EEG alterations in AD and TBI patients, the influence of APOE (apolipoprotein E) genotype in EEG at the early stage of TBI has not been reported yet. We have previously studied EEG alterations caused by TBI among different APOE genotype carriers. In this study, we firstly investigated the relationship between APOE polymorphisms and quantitative EEG (QEEG) changes after TBI. A total of 118 consecutive TBI patients with a Glasgow Coma Scale (GCS) of 9 or higher were recruited, and 40 normal adults were also included as a control group. APOE genotype was determined by PCR-RFLP for each subject, and QEEG recordings were performed in rest, relaxed, awake and with eyes closed in normal subjects and TBI patients during 1-3 days after TBI. In the normal control group, both APOE epsilon 4 carriers and non-carriers had normal EEG, and no significant difference of QEEG data was found between APOE epsilon 4 carriers and non-carriers. But in the TBI group, APOE epsilon 4 carriers had more focal or global irregular slow wave activities than APOE epsilon 4 non-carriers. APOE gene did not influence brain electrical activity under normal conditions, but TBI can induce different alterations among different APOE gene carriers, and APOE epsilon 4 allele enhances the EEG abnormalities at the early stage of TBI. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Jiang, Li; Yin, Cheng; Zhou, Shuai; Dan, Wei; Sun, Xiaochuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Yin, Xiaohong] N Sichuan Med Coll, Affiliated Hosp, Dept Neurosurg, Chengtu, Peoples R China	Sun, XC (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1st Youyi Rd, Chongqing 400016, Peoples R China.	sunxch1445@gmail.com		Jiang, Li/0000-0002-2407-3672; sun, xiao chuan/0000-0001-6992-332X	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973087]	The study was supported by National Science Foundation of China (approval number: 30973087).	Babiloni C, 2006, ANN NEUROL, V59, P323, DOI 10.1002/ana.20724; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; COURJON J, 1972, TRAUMATIC DISORDERS, V14, P1; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Jelic V, 1997, J NEUROL NEUROSUR PS, V63, P59, DOI 10.1136/jnnp.63.1.59; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Lehtovirta M, 1996, NEUROBIOL AGING, V17, P523; Lin B, 2011, ACTA NEUROCHIR SUPPL, V110, P39, DOI 10.1007/978-3-7091-0353-1_7; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; PONOMAREVA NV, 2008, NEUROBIOLOGY, V81, P9; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HT, 2010, BRAIN RES, V1362, P112, DOI 10.1016/j.brainres.2010.09.013	17	13	17	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 14	2011	505	2					160	164		10.1016/j.neulet.2011.10.011			5	Neurosciences	Neurosciences & Neurology	856CO	WOS:000297614600021	22015765				2021-06-18	
J	Bulger, EM; Tower, CM; Warner, KJ; Garland, T; Cuschieri, J; Rizoli, S; Rhind, S; Junger, WG				Bulger, Eileen M.; Tower, Cindy M.; Warner, Keir J.; Garland, Tara; Cuschieri, Joseph; Rizoli, Sandro; Rhind, Shawn; Junger, Wolfgang G.			INCREASED NEUTROPHIL ADENOSINE A3 RECEPTOR EXPRESSION IS ASSOCIATED WITH HEMORRHAGIC SHOCK AND INJURY SEVERITY IN TRAUMA PATIENTS	SHOCK			English	Article						Adenosine A3 receptor; hypovolemic shock; neutrophil activation; hypertonic saline	HYPERTONIC SALINE RESUSCITATION; ORGAN DYSFUNCTION; LUNG INJURY; ACTIVATION; RELEASE; SEPSIS	Hypertonic saline (HS) has been investigated as an immune modulator following hemorrhagic shock and sepsis. The polymorphonuclear neutrophil (PMN) response to HS is regulated by the release of ATP, which is converted to adenosine and activates adenosine receptors. Binding to A3 adenosine receptors promotes PMN activation, and inhibition of A3 receptors improves the efficacy of HS resuscitation. A3 receptor expression of PMNs has not been previously evaluated in injured patients. Whole blood was obtained from 10 healthy volunteers and 60 injured patients within 2 h of injury. Inclusion criteria were blunt or penetrating injury with evidence of hypovolemic shock (systolic blood pressure [SBP] <= 90 mmHg and base deficit >= 6 mEq/L or need for blood transfusion) or evidence of severe traumatic brain injury including initial Glasgow Coma Scale score of 8 or less or evidence of traumatic brain injury on head computed tomography scan (head Abbreviated Injury Score >= 3) or intubation in the field or emergency department. A3 receptor expression was assessed by flow cytometry. Polymorphonuclear neutrophils were also exposed to fMLP or HS (20-40 mM) in vitro. Clinical data were collected including admission physiology, injury severity (Injury Severity Score [ISS]), development of multiple organ failure, and survival. In normal volunteers, less than 1% of PMNs expressed A3 receptors on the cell surface. A3 receptor expression was significantly higher in injured patients, and the level of expression correlated with the severity of injury (ISS >= 25: A3 positive PMN 36.6% vs. ISS <25: 16.2%; P = 0.019) and degree of hypovolemic shock (SBP <= 90 mmHg: A3 positive PMN 43.8% vs. SBP>90 mmHg: 20.6%; P = 0.008). Stimulation with fMLP or HS increased A3 expression in normal volunteers, but only in patients with ISS of less than 25 or without hypovolemic shock. A3 receptor expression on the surface of PMNs is upregulated by injury, and increased expression levels are associated with greater injury severity and hypovolemic shock. Hypertonic saline increases A3 expression of PMNs from healthy volunteers and less severely injured patients.	[Bulger, Eileen M.; Tower, Cindy M.; Warner, Keir J.; Garland, Tara; Cuschieri, Joseph] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Rizoli, Sandro] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Rhind, Shawn] Def Res & Dev Canada Toronto, Toronto, ON, Canada; [Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA	Bulger, EM (corresponding author), Box 359796 Harborview Med Ctr,325 9th Ave, Seattle, WA 98104 USA.	ebulger@u.washington.edu		Rhind, Shawn/0000-0003-2300-0620	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1R01GM76101-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM076101] Funding Source: NIH RePORTER	This study was supported by National Institute of General Medical Sciences (1R01GM76101-01).	Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Chen Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1051, DOI 10.1152/ajpcell.00216.2005; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Curry N, 2011, CRIT CARE, V15, DOI 10.1186/cc10096; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Grassi F, 2010, J MOL CELL BIOL, V2, P176, DOI 10.1093/jmcb/mjq014; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; Inoue Y, 2011, SHOCK, V35, P178, DOI 10.1097/SHK.0b013e3181f221fb; Junger WG, 2008, CELL MOL LIFE SCI, V65, P2528, DOI 10.1007/s00018-008-8095-1; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218	21	13	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2011	36	5					435	439		10.1097/SHK.0b013e318231ee2e			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	837TX	WOS:000296227600002	21841534	Green Accepted			2021-06-18	
J	Gross, T; Amsler, F				Gross, Thomas; Amsler, Felix			Prevalence and incidence of longer term pain in survivors of polytrauma	SURGERY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; MULTIPLE INJURIES; HEALTH-STATUS; MAJOR TRAUMA; RECOMMENDATIONS; DISABILITY; DETERMINANTS; POPULATION; INSTRUMENT	Background. Little is known about the longer term status of pain or the factors associated with pain-related outcome in patients after polytrauma. The current study evaluated the prevalence and severity of pain at least 2 years after injury compared with preinjury status using several pain scores in a Swiss cohort of survivors of blunt poly trauma. Methods. Pearson correlation testing was used for the comparison of different measures of pain. Uni and multivariate analyses of patient, trauma, and treatment characteristics, as well as parameters. of self-reported, health-related quality of life and functional outcome, were undertaken to determine associations with pain after polytrauma. Results. Depending on the measure used, 46% to 85% of polytrauma survivors indicated the presence of pain. at longer term follow-up. Both the prevalence and the severity of pain were increased compared with the preinjury status (P < .001) and varied importantly depending on scoring. The Trauma Outcome Profile was the most sensitive pain measure and showed the greatest correlation with objective, longer term outcomes (R = .5). Pain measured by the SF-36 was found to have the best internal criterion validity among the scores investigated (R = .6-.8). Patients' longer term pain status had greater associations with health-related quality-of-life scores (R = .6-.8) than with capacity to work or income (R = .4-.5). Conclusion. Our study shows a high rate of longer term pain in survivors of polytrauma and important differences in the type and sensitivity of the standard pain measures investigated. Given the potential impact of these findings, international guidelines for the assessment of pain in polytraumatized patients are needed. (Surgery 2011;150:985-95.)	[Gross, Thomas; Amsler, Felix] Univ Basel Hosp, Dept Comp Assisted Radiol & Suigely Switzerland C, CH-4031 Basel, Switzerland; [Amsler, Felix] Amsler Consulting, Basel, Switzerland	Gross, T (corresponding author), Kantonsspital Aarau, Dept Traumatol, Tellstr, CH-5003 Aarau, Switzerland.	Thomas.Gross@ksa.ch		Amsler, Felix/0000-0003-4259-7004	Scientific Foundation of the Swiss Accident Insurance Fund (SUVA); Voluntary Academic Society (FAG) Basel; Swiss Intervention; Swiss National Information Center For Accident Prevention (BFU)	Supported by the Scientific Foundation of the Swiss Accident Insurance Fund (SUVA), the Voluntary Academic Society (FAG) Basel, Swiss Intervention, and the Swiss National Information Center For Accident Prevention (BFU).	Attenberger C, 2011, INJURY; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouamra O, 2006, J TRAUMA, V38, P185; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Bouillon B, 1998, LANGENBECK ARCH SURG, V383, P228, DOI 10.1007/s004230050123; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Carstensen TBW, 2008, PAIN, V139, P248, DOI 10.1016/j.pain.2008.04.008; Casey CY, 2008, PAIN, V134, P69, DOI 10.1016/j.pain.2007.03.032; Castillo RC, 2006, PAIN, V124, P321, DOI 10.1016/j.pain.2006.04.020; Chien LC, 2007, J TRAUMA, V62, P928, DOI 10.1097/01.ta.0000215411.92950.72; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Committee on Trauma American College of Surgeons, 1997, ADV TRAUM LIF SUPP P; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Eastman AB, 2008, ARCH SURG-CHICAGO, V143, P288, DOI 10.1001/archsurg.2007.63; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Engelberg R, 1996, J ORTHOPAED RES, V14, P182, DOI 10.1002/jor.1100140204; FALCONE RE, 1993, WORLD J SURG, V17, P575, DOI 10.1007/BF01659111; Fuglistaler-Montali I, 2009, WORLD J SURG, V33, P2477, DOI 10.1007/s00268-009-0193-1; Gennarelli T, 1990, ASS ADVANCEMENT AUTO; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gross T, 2010, J AM COLL SURGEONS, V211, P81, DOI 10.1016/j.jamcollsurg.2010.02.042; Harris I, 2008, J TRAUMA, V64, P696; HETHERINGTON H, 1995, INJURY, V26, P97, DOI 10.1016/0020-1383(95)92185-D; Hinrichs-Rocker A, 2009, EUR J PAIN, V13, P719, DOI 10.1016/j.ejpain.2008.07.015; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; JENNETT B, 1975, LANCET, V1, P480; Kappesser J, 2010, PAIN, V148, P184, DOI 10.1016/j.pain.2009.10.007; Konig HH, 2005, GESUNDHEITSWESEN, V67, P173, DOI 10.1055/s-2005-857991; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Martin DP, 1996, J ORTHOP RES, V14, P173, DOI 10.1002/jor.1100140203; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Neugebauer E, 2006, EUROPEAN J TRAUMA, V32, P44, DOI [10.1007/s00068-006-0150-8, DOI 10.1007/S00068-006-0150-8]; Nijboer JMM, 2007, J TRAUMA, V63, P670, DOI 10.1097/01.ta.0000228890.65522.53; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rivara FP, 2008, ARCH SURG-CHICAGO, V143, P282, DOI 10.1001/archsurg.2007.61; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; SALOVEY P, 1993, APS J, V2, P184, DOI 10.1016/S1058-9139(05)80087-7; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; SMITH WB, 1993, PAIN, V55, P355, DOI 10.1016/0304-3959(93)90011-D; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Spertus IL, 1999, PAIN, V82, P97, DOI 10.1016/S0304-3959(99)00040-8; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Szende A, 2004, EUROQOL GROUPS INT T; TEASDALE G, 1974, LANCET, V2, P81; THIAGARAJAN J, 1994, ANAESTHESIA, V49, P211; Turchin DC, 1999, J ORTHOP TRAUMA, V13, P1, DOI 10.1097/00005131-199901000-00001; Ulvik A, 2008, ACTA ANAESTH SCAND, V52, P195, DOI 10.1111/j.1399-6576.2007.01533.x; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Vranceanu AM, 2009, J BONE JOINT SURG AM, V91A, P2014, DOI 10.2106/JBJS.H.01512; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	59	13	13	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2011	150	5					985	995		10.1016/j.surg.2011.04.003			11	Surgery	Surgery	845NC	WOS:000296828600014	21676423				2021-06-18	
J	Kwaan, HC				Kwaan, Hau C.			Microvascular Thrombosis: A Serious and Deadly Pathologic Process in Multiple Diseases	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						Thrombosis; disseminated intravascular coagulation; inflammation; hypercoagulable state; sepsis	TRAUMATIC BRAIN-INJURY; SICKLE-CELL-DISEASE; HEMOLYTIC-UREMIC SYNDROME; DISSEMINATED INTRAVASCULAR COAGULATION; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-C; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; ANEURYSMAL SUBARACHNOID HEMORRHAGE; POSTVARICELLA-PURPURA-FULMINANS; TISSUE FACTOR EXPRESSION	Much of our understanding of the pathogenesis of thrombosis has long been based on observations made on large blood vessels. Nevertheless, there has been a recent shift in our attention to the microvasculature and to how microcirculatory occlusion affects function of various organs in diseases. This article provides an overview of microthrombosis in small blood vessels, with discussion of the progressive stages of its development. The initial event is triggered by a variety of diseases, followed by a second phase when multiple contributory factors amplify the process with the final phase of microvascular occlusion and microvascular thrombosis. The outcome is either recovery or injury to the affected organ. If the process is generalized, it is often associated with catastrophic or fatal outcomes. Our current knowledge of the major role of contributory factors leads to a new paradigm. A therapeutic approach limited to a single target of the underlying pathogenic factor, such as the use of anticoagulants, is insufficient and too often unsuccessful. Simultaneous management of all the contributory factors should therefore be considered.	Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Kwaan, HC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 710 Fairbanks Court,Room 8258, Chicago, IL 60611 USA.	h-kwaan@northwestern.edu					Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Asherson RA, 1998, MEDICINE, V77, P195, DOI 10.1097/00005792-199805000-00005; Asherson RA, 2001, MEDICINE, V80, P355, DOI 10.1097/00005792-200111000-00002; Ashjian P, 2007, ANN PLAS SURG, V59, P36, DOI 10.1097/01.sap.0000264837.15110.2f; ASTEDT B, 1974, EXPERIENTIA, V30, P1466; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Azizzadeh Babak, 2003, Arch Facial Plast Surg, V5, P31; Bajzar L, 2004, CRIT CARE MED, V32, pS320, DOI 10.1097/01.CCM.0000126361.00450.B1; Barie Philip S, 2007, Surg Infect (Larchmt), V8, P491, DOI 10.1089/sur.2007.9980; Barie Philip S, 2008, Curr Infect Dis Rep, V10, P368, DOI 10.1007/s11908-008-0060-5; Baronzio G, 2003, SEMIN THROMB HEMOST, V29, P489; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Beek AM, 2010, INT J CARDIOVAS IMAG, V26, P49, DOI 10.1007/s10554-009-9499-1; Bekkers SCAM, 2010, J AM COLL CARDIOL, V55, P1649, DOI 10.1016/j.jacc.2009.12.037; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1993, THROMB HAEMOSTASIS, V70, P152; Bhavsar J, 2010, CLIN HEMORHEOL MICRO, V44, P193, DOI 10.3233/CH-2010-1274; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Blum W, 2007, SEMIN THROMB HEMOST, V33, P350, DOI 10.1055/s-2007-976170; Brands MT, 2010, INT J ORAL MAX SURG, V39, P101, DOI 10.1016/j.ijom.2009.11.020; BRANDTZAEG P, 1989, THROMB RES, V55, P459, DOI 10.1016/0049-3848(89)90054-6; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Bucciarelli S, 2009, CLIN REV ALLERG IMMU, V36, P80, DOI 10.1007/s12016-008-8107-9; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Busuttil DP, 2000, BRIT J HAEMATOL, V110, P1012, DOI 10.1046/j.1365-2141.2000.02270-9.x; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Cervera R, 2009, ANN RHEUM DIS, V68, P1428, DOI 10.1136/ard.2008.093179; Cervera R, 2006, PATHOPHYSIOL HAEMO T, V35, P181, DOI 10.1159/000093565; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Chinen K, 2010, PATHOL RES PRACT, V206, P682, DOI 10.1016/j.prp.2010.05.002; Chwajol M, 2008, NEUROCRIT CARE, V8, P418, DOI 10.1007/s12028-008-9088-5; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Costa Vania, 2007, BMC Anesthesiol, V7, P5, DOI 10.1186/1471-2253-7-5; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; CREUTZIG U, 1987, CANCER-AM CANCER SOC, V60, P3071, DOI 10.1002/1097-0142(19871215)60:12<3071::AID-CNCR2820601235>3.0.CO;2-Y; CROMPTON MR, 1964, BRAIN, V87, P491, DOI 10.1093/brain/87.3.491; CUTTNER J, 1980, AM J MED, V69, P555, DOI 10.1016/0002-9343(80)90467-2; DAHLBACK B, 1995, THROMB HAEMOSTASIS, V74, P139; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Dhainaut JF, 2001, CRIT CARE MED, V29, pS42, DOI 10.1097/00003246-200107001-00016; DIETRICH WD, 1994, ANN NY ACAD SCI, V723, P15, DOI 10.1111/j.1749-6632.1994.tb36713.x; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dragon-Durey MA, 2010, J AM SOC NEPHROL, V21, P2180, DOI 10.1681/ASN.2010030315; Dropcho EJ, 2010, NEUROL CLIN, V28, P217, DOI 10.1016/j.ncl.2009.09.008; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Elliott MA, 2010, EUR J HAEMATOL, V85, P43, DOI 10.1111/j.1600-0609.2010.01448.x; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Esmon CT, 1999, HAEMATOLOGICA, V84, P254; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Espinosa G, 2010, NAT REV RHEUMATOL, V6, P296, DOI 10.1038/nrrheum.2010.47; Fluri S, 2010, PEDIATR EMERG CARE, V26, P932, DOI 10.1097/PEC.0b013e3181fe91cd; FRANCIS RB, 1991, BLOOD COAGUL FIBRIN, V2, P341, DOI 10.1097/00001721-199104000-00018; FRANCIS RB, 1990, SEMIN THROMB HEMOST, V16, P310, DOI 10.1055/s-2007-1002684; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Galindo M, 2009, RHEUMATOLOGY, V48, P1003, DOI 10.1093/rheumatology/kep152; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Garcia F, 1999, J INFECT DIS, V179, P475, DOI 10.1086/314598; Giller CA, 1998, NEUROSURGERY, V42, P490, DOI 10.1097/00006123-199803000-00010; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2007, HAEMATOLOGICA, V93, P1, DOI 10.3324/haematol.12318; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Gordeuk VR, 2009, BLOOD, V114, P4639, DOI 10.1182/blood-2009-04-218040; Gordon LI, 1997, SEMIN HEMATOL, V34, P140; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Hallahan D, 1995, BIOCHEM BIOPH RES CO, V217, P784, DOI 10.1006/bbrc.1995.2841; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; ISHII H, 1986, BLOOD, V67, P362; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jahroudi N, 1996, BLOOD, V88, P3801, DOI 10.1182/blood.V88.10.3801.bloodjournal88103801; Josephson C, 2001, PEDIATR RES, V50, P345, DOI 10.1203/00006450-200109000-00009; Karpman D, 2010, SEMIN THROMB HEMOST, V36, P575, DOI 10.1055/s-0030-1262879; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Kelton JG, 2008, BLOOD, V112, P2607, DOI 10.1182/blood-2008-02-078014; Key NS, 2010, SEMIN THROMB HEMOST, V36, P805, DOI 10.1055/s-0030-1267033; Key NS, 1998, BLOOD, V91, P4216, DOI 10.1182/blood.V91.11.4216.411k15_4216_4223; KHOURI RK, 1992, CLIN PLAST SURG, V19, P757; KIEHL R, 1987, THROMB RES, V45, P191, DOI 10.1016/0049-3848(87)90173-3; Klintman D, 2004, CLIN DIAGN LAB IMMUN, V11, P56, DOI 10.1128/CDLI.11.1.56-62.2004; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Kojima M, 1983, Bibl Haematol, P95; KURANTSINMILLS J, 1992, BRIT J HAEMATOL, V81, P539, DOI 10.1111/j.1365-2141.1992.tb02989.x; KURANTSINMILLS J, 1994, BRIT J HAEMATOL, V87, P580, DOI 10.1111/j.1365-2141.1994.tb08316.x; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kwaan HC, 2010, SEMIN THROMB HEMOST, V36, P917, DOI 10.1055/s-0030-1267045; Kwaan HC, 2010, SEMIN THROMB HEMOST, V36, P286, DOI 10.1055/s-0030-1253451; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P23; Kwaan HC, 2005, SEMIN THROMB HEMOST, V31, P615, DOI 10.1055/s-2005-925467; Kwaan HC, 2005, SEMIN THROMB HEMOST, V31, P673, DOI 10.1055/s-2005-925473; Kwaan HC, 2003, SEMIN THROMB HEMOST, V29, P451; KWAAN HC, 1987, SEMIN HEMATOL, V24, P141; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P199, DOI 10.1055/s-2007-994921; Kwaan HC, 2001, ACTA HAEMATOL-BASEL, V106, P52, DOI 10.1159/000046589; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Laurence J, 1997, SEMIN HEMATOL, V34, P98; Le Quintrec M, 2010, SEMIN THROMB HEMOST, V36, P641, DOI 10.1055/s-0030-1262886; Lecoq JP, 2006, ACTA CHIR BELG, V106, P158; Lee CC, 2001, ANN EMERG MED, V38, P170, DOI 10.1067/mem.2001.114313; Leitner JM, 2006, CLIN PHARMACOL THER, V79, P23, DOI 10.1016/j.clpt.2005.10.003; Leung LLK, 2008, ADV EXP MED BIOL, V632, P61, DOI 10.1007/978-0-387-78952-1_5; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2010, HAMOSTASEOLOGIE, V30, P10; Levi M, 2007, AM J RESP CRIT CARE, V176, P483, DOI 10.1164/rccm.200612-1803OC; Levi M, 2010, SEMIN THROMB HEMOST, V36, P550, DOI 10.1055/s-0030-1255449; Levi M, 2010, SEMIN THROMB HEMOST, V36, P367, DOI 10.1055/s-0030-1254046; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P378, DOI 10.1055/s-0030-1254047; Lippi G, 2009, SEMIN THROMB HEMOST, V35, P597, DOI 10.1055/s-0029-1242713; Lippi G, 2008, SEMIN THROMB HEMOST, V34, P747, DOI 10.1055/s-0029-1145257; LOUISE CB, 1994, MICROVASC RES, V47, P377, DOI 10.1006/mvre.1994.1030; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Lyons A, 2008, BRIT J ORAL MAX SURG, V46, P653, DOI 10.1016/j.bjoms.2008.04.006; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Madrid C, 2010, ORAL ONCOL, V46, P471, DOI 10.1016/j.oraloncology.2010.03.017; Maeda T, 1997, ACT NEUR S, V70, P102; MancoJohnson MJ, 1996, J PEDIATR-US, V128, P319, DOI 10.1016/S0022-3476(96)70274-3; MCEVER RP, 1991, J CELL BIOCHEM, V45, P156, DOI 10.1002/jcb.240450206; MCGEHEE WG, 1984, ANN INTERN MED, V101, P59, DOI 10.7326/0003-4819-101-1-59; Mehdi Ali A, 2011, Semin Thromb Hemost, V37, P49, DOI 10.1055/s-0030-1270071; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Milner DA, 2010, CURR OPIN INFECT DIS, V23, P456, DOI 10.1097/QCO.0b013e32833c3dbe; Mitra D, 1997, BLOOD, V89, P1224, DOI 10.1182/blood.V89.4.1224; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; MYHREJENSEN O, 1972, ACTA PATH MICRO IM A, VA 80, P403; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Newton CRJC, 1996, PEDIATR NEUROL, V15, P41, DOI 10.1016/0887-8994(96)00115-4; Nsiri B, 1996, HEMATOL CELL THER, V38, P279, DOI 10.1007/s00282-996-0279-2; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; Ott I, 2000, ARTERIOSCL THROM VAS, V20, P874, DOI 10.1161/01.ATV.20.3.874; PABINGER I, 1986, BLUT, V52, P365, DOI 10.1007/BF00320783; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Patel B, 2010, PHARMACOL THERAPEUT, V127, P131, DOI 10.1016/j.pharmthera.2010.04.014; PETERS M, 1994, THROMB HAEMOSTASIS, V71, P169; Porcu P, 1997, BRIT J HAEMATOL, V98, P433, DOI 10.1046/j.1365-2141.1997.1943011.x; Pries A. R., 2006, V176, P1; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Romano JG, 2002, NEUROSURGERY, V50, P1026, DOI 10.1097/00006123-200205000-00016; Roos Y, 2000, NEUROLOGY, V54, P77, DOI 10.1212/WNL.54.1.77; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; ROSE VL, 1986, AM J CLIN PATHOL, V86, P653, DOI 10.1093/ajcp/86.5.653; ROSE VL, 1985, AM J HEMATOL, V19, P419, DOI 10.1002/ajh.2830190413; RUBIN DB, 1991, INT J RADIAT BIOL, V60, P29, DOI 10.1080/09553009114551461; Ruch J, 2009, AM J HEMATOL, V84, P120, DOI 10.1002/ajh.21330; Sallah S, 1998, HAEMOSTASIS, V28, P25; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; SCOTT CS, 1988, BRIT J HAEMATOL, V69, P247, DOI 10.1111/j.1365-2141.1988.tb07629.x; Sharma V K, 2010, J Indian Med Assoc, V108, P529; Shih HM, 2011, AM J EMERG MED, V29, DOI 10.1016/j.ajem.2010.03.004; SHIMAMURA K, 1983, ARCH PATHOL LAB MED, V107, P543; Soriano AO, 2005, CRIT CARE MED, V33, P2540, DOI 10.1097/01.CCM.0000186414.86162.03; Starke RM, 2008, STROKE, V39, P2617, DOI 10.1161/STROKEAHA.107.506097; Stegmayr BG, 2001, THER APHER, V5, P123, DOI 10.1046/j.1526-0968.2001.005002123.x; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; Stucki A, 2001, BLOOD, V97, P2121, DOI 10.1182/blood.V97.7.2121; Tehrani M, 2008, BRAIN PATHOL, V18, P164, DOI 10.1111/j.1750-3639.2007.00108.x; ten Cate H, 1999, THROMB HAEMOSTASIS, V82, P713; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; VANDERPOLL T, 1991, J EXP MED, V174, P729, DOI 10.1084/jem.174.3.729; VAUGHAN WP, 1981, CANCER TREAT REP, V65, P1007; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; VERHEIJ M, 1995, THROMB HAEMOSTASIS, V73, P894; Virchow R., 1856, GESAMMELTE ABH, P458; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Wang J, 2001, BRIT J HAEMATOL, V115, P382, DOI 10.1046/j.1365-2141.2001.03095.x; Ward PA, 2008, J LEUKOCYTE BIOL, V83, P467, DOI 10.1189/jlb.0607376; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Welty-Wolf KE, 2002, THROMB HAEMOSTASIS, V88, P17; Wurm G, 2004, CLIN NEUROL NEUROSUR, V106, P97, DOI 10.1016/j.clineuro.2004.01.006; Zakarija Anaadriana, 2009, V148, P115, DOI 10.1007/978-0-387-79962-9_8; Zipfel PF, 2010, CURR OPIN NEPHROL HY, V19, P372, DOI 10.1097/MNH.0b013e32833aff4a	195	13	15	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	NOV	2011	37	8					960	976		10.1055/s-0031-1297375			17	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	866TS	WOS:000298407500013	22198861				2021-06-18	
J	Mao, HJ; Guan, FJ; Han, X; Yang, KH				Mao, Haojie; Guan, Fengjiao; Han, Xu; Yang, King H.			Strain-Based Regional Traumatic Brain Injury Intensity in Controlled Cortical Impact: A Systematic Numerical Analysis	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; finite element; rat brain model; regional injury; response surface methodology; strain	CONTUSION INJURY; SERUM-LEVELS; CELL-DEATH; RAT; DEFICITS; DAMAGE; EDEMA; BIOMECHANICS; HIPPOCAMPUS; ANTIOXIDANT	Regional strain-based brain injury intensity during controlled cortical impact (CCI) was studied using a three-dimensional numerical rat brain model. A full factorial design of CCI computer experiments was performed using two typical impactor shapes (flat or hemispherical) at a fixed impact velocity of 4 m/s with various impact depths (1, 1.5, 1.6, 2, 2.5, 2.7, and 3mm) and various impactor diameters (4, 5, 6, 8, and 9.5 mm). In total, 70 CCI cases were simulated numerically. Two injury assessment measures, the cumulative strain damage measure (CSDM), which accounts for the volume of brain tissue with elevated strains, and cumulative strain damage percentage measure (CSDPM), which is a strain-based estimate of the neuronal cell loss percentage, were used to evaluate the risk of brain injury. Results demonstrated positive nonlinear relationships between impact depth and these injury assessment measures in six regions of interest: ipsilateral cortex, ipsilateral corpus callosum, ipsilateral hippocampus, ipsilateral thalamus, cerebellum, and brainstem. However, the impactor diameter was not always positively correlated with regional tissue strains. For the flat impactor group, the 5mm diameter impactor induced more tissue strain in the corpus callosum/hippocampus, and a smaller impactor induced more strain in the thalamus. For the hemispherical impactor group, a larger impactor tended to induce more tissue strain in subcortical regions, with the exception of the 6mm diameter impactor. This study systematically predicts regional intensity of primary brain injury according to tissue strain distributions in the hope that strain distribution maps may become a common platform to compare CCI severities with different configurations.	[Mao, Haojie; Yang, King H.] Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA; [Guan, Fengjiao; Han, Xu] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China	Yang, KH (corresponding author), Wayne State Univ, Ctr Bioengn, 818 W Hancock, Detroit, MI 48201 USA.	king.yang@wayne.edu	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	Injury Control Research Center at the University of Alabama in Birmingham; Bioengineering Center, Wayne State University; State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body of Hunan University; China Scholarship CouncilChina Scholarship Council	We thank Christina D. Wagner for proofreading the manuscript. The development of the finite element rat brain model is financially supported by the Injury Control Research Center at the University of Alabama in Birmingham. The project is partially supported by the Bioengineering Center, Wayne State University, and State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body of Hunan University. We thank LSTC for providing LS-Dyna and Esteco for providing modeFrontier. Financial support of Fengjiao Guan is provided by the China Scholarship Council.	Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; Bain A.C., 1999, 43 STAPP CAR CRASH C; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bandak F.A, 1994, STAPP CAR CRASH C SO, P145; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bates RA, 1996, J ROY STAT SOC B MET, V58, P77; Billings SA, 1998, NEURAL NETWORKS, V11, P479, DOI 10.1016/S0893-6080(97)00132-9; Boyd JP, 2009, APPL MATH COMPUT, V215, P2215, DOI 10.1016/j.amc.2009.08.037; Buhmann M. D., 2003, C MO AP C M, DOI 10.1017/CBO9780511543241; Carlson S, 2009, J NEUROTRAUM, V26, pA50; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cowper MR, 2002, SIGNAL PROCESS, V82, P775, DOI 10.1016/S0165-1684(02)00155-X; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Kawamata T, 1997, ACT NEUR S, V70, P191; Kim K.B., 2000, INF SCI, V130, P163; Kochanek PM, 2005, J CEREBR BLOOD F MET, V25, P1596, DOI 10.1038/sj.jcbfm.9600154; Koehler J.R., 1996, HDB STAT, V13, P261; Lapeer RJ, 2010, COMPUT BIOL MED, V40, P1, DOI 10.1016/j.compbiomed.2009.10.002; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Pena A, 2005, ACT NEUR S, V95, P333; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Portella G, 2000, ACT NEUR S, V76, P273; Povlishock JT, 2008, J NEUROTRAUM, V25, P717, DOI 10.1089/neu.2008.9964; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SACKS J, 1989, TECHNOMETRICS, V31, P41, DOI 10.2307/1270363; Sacks J., 1989, STAT SCI, V4, P409, DOI DOI 10.1214/SS/1177012413; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sheta AF, 2001, INFORM SCIENCES, V133, P221, DOI 10.1016/S0020-0255(01)00086-X; SHREIBER DI, 1997, 41 STAPP CAR CRASH C; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Takhounts EG, 2008, STAPP CAR C, V52, P1; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Woertgen C, 2002, ACT NEUR S, V81, P205; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; Yang RJ, 2005, J MECH DESIGN, V127, P1014, DOI 10.1115/1.1906264	63	13	13	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2263	2276		10.1089/neu.2010.1600			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600006	21488718				2021-06-18	
J	Matsukawa, H; Shinoda, M; Fujii, M; Takahashi, O; Yamamoto, D; Murakata, A; Ishikawa, R				Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Takahashi, Osamu; Yamamoto, Daisuke; Murakata, Atsushi; Ishikawa, Ryoichi			Genu of corpus callosum as a prognostic factor in diffuse axonal injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						corpus callosum; diffuse axonal injury; genu of corpus callosum; outcome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MODERATE	Object. Previous studies have shown a relationship between a patient's stage of diffuse axonal injury (DAI) and outcome. However, few studies have assessed whether a specific lesion or type of corpus callosum injury (CCI) influences outcome in patients with DAI. The authors investigated the effect of various DAIs and CCIs on outcome in patients with traumatic brain injury (TBI). Methods. The authors retrospectively reviewed 78 consecutive patients with DAI who were seen between May 2004 and March 2010. Outcome was evaluated using the Extended Glasgow Outcome Scale (EGOS) 1 year after TBI. Patients with single DAIs had only 1 of the 3 lesions (lobar, CC, or brainstem). Patients with dual DAIs had 2 of these lesions, and those with triple DAIs had all of these lesions. Furthermore, the authors defined single, dual, and triple CCIs by using 3 lesions (genu, body, splenium) in the same way among patients with single (CC) DAIs. Univariate and multivariate logistic regression analyses were performed to evaluate the relationships between these lesions and outcome in patients with DAI. Results. Fifty patients had single DAIs: 34 in the lobar area, 11 in the CC, and 5 in the brainstem. Twenty had dual DAIs, and 8 had triple DAIs. Of the 11 CCIs, 9 were single and 2 were dual CCIs. Among these lesions, only those in the genu were related to disability. The authors dichotomized patients into those with and without genu lesions, regardless of other injuries. Multinomial logistic regression analysis showed that a genu lesion (OR 18, 95% CI 2.2-32; p = 0.0021) and a pupillary abnormality (OR 14, 95% CI 1.6-24; p = 0.0068) were associated with disability (EGOS <= 6) in patients with DAI. Conclusions. Regardless of the number of lesions, the existence of a genu lesion suggested disability 1 year after TBI in patients with DAI. (DOI: 10.3171/2011.6.JNS11513)	[Matsukawa, Hidetoshi] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Div Gen Internal Med, Dept Med, Tokyo 1048560, Japan	Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan	This study was supported by a medical research grant on traffic accidents from the General Insurance Association of Japan in 2010. The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper.	Aglioti S, 1998, NEUROPSYCHOLOGIA, V36, P1015, DOI 10.1016/S0028-3932(98)00055-4; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Caille S, 2005, NEUROSURGERY, V57, P50, DOI 10.1227/01.NEU.0000163089.31657.08; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; GODERSKY JC, 1990, ACT NEUR S, V51, P311; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Ryberg C, 2007, NEUROBIOL AGING, V28, P955, DOI 10.1016/j.neurobiolaging.2006.04.008; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	27	13	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2011	115	5					1019	1024		10.3171/2011.6.JNS11513			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	839OR	WOS:000296377800027	21780860				2021-06-18	
J	Mattei, TA; Bond, BJ; Hafner, JW; Morris, MJ; Travis, J; Hannah, G; Webster, J; Lin, JJ				Mattei, Tobias A.; Bond, Brandon J.; Hafner, John W., Jr.; Morris, Martin J.; Travis, Jennifer; Hannah, Greg; Webster, Jim; Lin, Julian J.			Definition and measurement of rider-intrinsic physical attributes influencing all-terrain vehicle safety	NEUROSURGICAL FOCUS			English	Article						all-terrain vehicle; safety legislation; wingspan; pediatric traumatic brain injury	INJURIES; CRASHES	Object. All-terrain vehicle (ATV) usage has grown tremendously over the years, reaching 9.5 million vehicles in use in 2007. Accompanying this growth has been a concomitant increase in rider morbidity (including traumatic brain and spine injuries) and death, especially in children. The purpose of this study was to define and measure, through field testing, those physical attributes intrinsic to riders, such as height, weight, and wingspan, which may have implications for ATV riders' safety. Methods. Three field tests (J-hook, brake, and bump) were developed and performed to allow direct measurement of the lateral, longitudinal, and vertical dynamics in 5 riders of varying heights, weights, and wingspans. Two ATVs, a utility and a sport model, were tested for further comparisons. Data were acquired using a comprehensive data acquisition system attached to the ATVs. Assignment of individual rider/ATV test safety ratings and a rider/ATV Total Safety Rating were made from the results of these field tests. Results. The J-hook test results demonstrated that larger rider wingspans positively influence ATV rider safety and mitigate against lateral instability. From the brake test it was determined that a 10-in (25.4-cm) longitudinal displacement, such as that experienced during a sharp deceleration, for a rider of any height or weight, breached the level of defined safety. As rider weight increased, displacement decreased. The bump test provided evidence that increased rider weight also mitigates against vertical displacement. Conclusions. Individuals with light weights and small wingspans, such as those in the pediatric population, are under considerable risk of injury when operating an ATV due to lateral, longitudinal, and vertical operational instability. (DOI: 10.3171/2011.9.FOCUS11176)	[Mattei, Tobias A.; Lin, Julian J.] Illinois Neurol Inst, Dept Neurosurg, Peoria, IL 61637 USA; [Bond, Brandon J.; Hafner, John W., Jr.; Lin, Julian J.] Univ Illinois, Coll Med, Peoria, IL 61656 USA; [Hafner, John W., Jr.] OSF St Francis Med Ctr, Dept Emergency Med, Peoria, IL USA; [Morris, Martin J.; Travis, Jennifer; Hannah, Greg; Webster, Jim] Bradley Univ, Dept Mech Engn, Peoria, IL 61625 USA	Mattei, TA (corresponding author), Illinois Neurol Inst, Dept Neurosurg, 530 NE Glen Oak, Peoria, IL 61637 USA.	tobiasmattei@yahoo.com	Mattei, Tobias A./U-7166-2019; Hafner, John W/A-2586-2008				Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Finn MA, 2010, NEUROSURGERY, V67, P993, DOI 10.1227/NEU.0b013e3181f209db; *GOV ACC OFF, 2010, GAO10418; Hafner JW, 2010, J RURAL HEALTH, V26, P67, DOI 10.1111/j.1748-0361.2009.00267.x; Haney P., 2003, RACING HIGH PERFORMA; Humphries RL, 2006, PEDIATR EMERG CARE, V22, P491, DOI 10.1097/01.pec.0000227383.69014.36; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Levenson MS., 2003, ALL TERRAIN VEHICLE; Long G, 2011, PEDIATR EMERG CARE, V27, P409, DOI 10.1097/PEC.0b013e31821d86ea; MAYERCIK VA, 2011, INJURY; McBride AS, 2011, PEDIATR EMERG CARE, V27, P97, DOI 10.1097/PEC.0b013e31820942f8; Merrigan TL, 2011, TRAFFIC INJ PREV, V12, P251, DOI 10.1080/15389588.2011.561455; Milliken WF., 1995, RACE CAR VEHICLE DYN; Murphy N, 2004, J TRAUMA, V56, P1185, DOI 10.1097/01.TA.0000123038.94864.E2; Myers ML, 2009, J AGROMEDICINE, V14, P312, DOI 10.1080/10599240903041885; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; Sawyer JR, 2011, J AM ACAD ORTHOP SUR, V19, P219, DOI 10.5435/00124635-201104000-00006; Scott A, 2011, ANZ J SURG, V81, P172, DOI 10.1111/j.1445-2197.2010.05484.x; Shults RA, 2005, PEDIATRICS, V116, pE608, DOI 10.1542/peds.2005-0937; Smith LM, 2005, J TRAUMA, V58, P783, DOI 10.1097/01.TA.0000158252.11002.6E; Streeter RA, 2008, 2007 ANN REPORT ATV; *US CONS PROD SAF, AN ATV REL FAT DAT C	24	13	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E6	10.3171/2011.9.FOCUS11176			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300007	22044105				2021-06-18	
J	Salter, K; McClure, JA; Foley, NC; Teasell, R				Salter, Katherine; McClure, J. Andrew; Foley, Norine C.; Teasell, Robert			Community integration following TBI: An examination of community integration measures within the ICF framework	BRAIN INJURY			English	Article						Community integration; measurement; traumatic brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NORMAL LIVING INDEX; INTERNATIONAL-CLASSIFICATION; HEALTH ICF; PSYCHOMETRIC PROPERTIES; DISABILITY; PARTICIPATION; REINTEGRATION; REHABILITATION	Purpose: The objectives of the present study are ( 1) to examine whether the content of existing community integration measures used following traumatic brain injury (TBI) is represented in the International Classification of Functioning, Disability and Health (ICF) and ( 2) to determine if the ICF provides a reasonable framework within which such measurement tools may be compared. Method: Five commonly-used assessment instruments were selected for inclusion. Independent raters mapped identified measurement concepts to the ICF using established linking rules. Results: One hundred and eighty-five concepts were identified from 85 items in five scales. Of these more than 75%% could be linked to the ICF. The majority of linked concepts were assigned to 64 categories within the activities and participation component of the ICF; however, the focus of assessment within each instrument varied considerably. Conclusion: Through a standardized process of item mapping to the ICF, one may examine operationalizations of community integration. This may help inform selection of a method of assessment appropriate to both the subject population and clinical or research purpose. However, this process allows comparison of only the objective content of measurement tools. Subjective evaluations may also be necessary to provide comprehensive assessment of community integration.	[Salter, Katherine; McClure, J. Andrew; Foley, Norine C.; Teasell, Robert] Lawson Hlth Res Inst, Aging Rehabil & Geriatr Care Program, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, Dept Phys Med & Rehabil, Schulich Sch Med, London, ON, Canada	Salter, K (corresponding author), Ctr Aging Rehabil & Geriatr Res, Room B-3019-C,Parkwood Hosp,801 Commissioners Rd, London, ON N6C 5J1, Canada.	katherine.salter@sjhc.london.on.ca		McClure, Andrew/0000-0001-5595-730X			Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Bluvol A, 2004, J ADV NURS, V48, P322, DOI 10.1111/j.1365-2648.2004.03004.x; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Geyh S, 2007, QUAL LIFE RES, V16, P833, DOI 10.1007/s11136-007-9174-8; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hemmingsson H, 2005, AM J OCCUP THER, V59, P569, DOI 10.5014/ajot.59.5.569; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Stark SL, 2005, ARCH PHYS MED REHAB, V86, P344, DOI 10.1016/j.apmr.2004.03.020; Steiner A, 1996, GERONTOLOGIST, V36, P54, DOI 10.1093/geront/36.1.54; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Teasell R, 2010, COMMUNITY REINTEGRAT; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; World Health Organization, 2001, INT CLASS FUNCT DIS	35	13	13	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1147	1154		10.3109/02699052.2011.613088			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200001	21961571				2021-06-18	
J	Asgari, S; Vespa, P; Bergsneider, M; Hu, X				Asgari, Shadnaz; Vespa, Paul; Bergsneider, Marvin; Hu, Xiao			Lack of consistent intracranial pressure pulse morphological changes during episodes of microdialysis lactate/pyruvate ratio increase	PHYSIOLOGICAL MEASUREMENT			English	Article						intracranial pressure; hemodynamic signal; microdialysis; lactate/pyruvate ratio; waveform morphology	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; CEREBROSPINAL-FLUID; SIGNALS; WAVE; HYPOGLYCEMIA; RECOGNITION; CHEMISTRY; ELEVATION; ISCHEMIA	Lactate/pyruvate ratio (LPR) from microdialysis is a well-established marker of cerebral metabolic crisis. For brain injury patients, abnormally high LPR could indicate cerebral ischemia or failure of O-2 uptake. However, there is a debate on the primary factor responsible for LPR increase. Exploiting the potential of using the morphology of a high temporal resolution signal such as intracranial pulse (ICP) to characterize cerebrovascular changes, a data analysis experiment is taken to test whether consistent changes in ICP pulse morphological metrics accompany the LPR increase. We studied 3517 h of LPR and continuous ICP data from 19 severe traumatic brain injury patients. Our morphological clustering and analysis of intracranial pressure (MOCAIP) algorithm was applied to ICP pulses, which were matched in time to the LPR measurements, and 128 pulse morphological metrics were extracted. We automatically identified the episodes of LPR increases using a moving time window of 10-20 h. We then studied the trending patterns of each of the 128 ICP MOCAIP metrics within these identified periods and determined them to be one of the following three types: increasing, decreasing or no trend. A binomial test was employed to investigate whether any MOCAIP metrics show a consistent trend among all episodes of LPR increase per patient. Regardless of the selected values for different parameters of the proposed method, for the majority of the subjects in the study (78%), none of the ICP metrics show any consistent trend during the episodes of LPR increase. Even for the few subjects who have at least one ICP metric with a consistent trend during the LPR increase episodes, the number of such metrics is small and varies from subject to subject. Given the fact that ICP pulse morphology is influenced by the cerebral vasculature, our results suggest that a dominant cerebral vascular cause may be behind the changes in LPR when LPR trends correlate with ICP pulse morphological changes. However, the incidence of such correlation seems to be low.	[Asgari, Shadnaz; Vespa, Paul; Bergsneider, Marvin; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Neural Syst & Dynam Lab, Dept Neurosurg, Los Angeles, CA 90095 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Neurocrit Care Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Bergsneider, Marvin] Univ Calif Los Angeles, Biomed Engn Grad Program, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA USA	Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Neural Syst & Dynam Lab, Dept Neurosurg, Los Angeles, CA 90095 USA.	xhu@mednet.ucla.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS059797, NS054881, NS066008]; UC Brain Injury Research Center (BIRC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS059797, R01NS066008, R01NS054881] Funding Source: NIH RePORTER	This work was partially supported by NINDS awards (NS059797, NS054881 and NS066008) and UC Brain Injury Research Center (BIRC).	ADOLPH RJ, 1967, AM J PHYSIOL, V212, P840; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Asgari S, 2010, IEEE T INF TECHNOL B, V14, P166, DOI 10.1109/TITB.2009.2034845; Asgari S, 2009, PHYSIOL MEAS, V30, P1211, DOI 10.1088/0967-3334/30/11/006; Bjerring PN, 2010, J HEPATOL, V53, P1054, DOI 10.1016/j.jhep.2010.05.032; CARDOSO ER, 1988, J NEUROSURG, V69, P712, DOI 10.3171/jns.1988.69.5.0712; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Ellis T, 2007, IEEE T BIO-MED ENG, V54, P1552, DOI 10.1109/TBME.2007.892918; HADI AS, 1993, J AM STAT ASSOC, V88, P1264, DOI 10.2307/2291266; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kawai Nobuyuki, 2010, No Shinkei Geka, V38, P795; Kennan R P, 2005, J CEREB BLOOD FLOW M, V25, P527; LAITINEN L, 1968, ACTA NEUROL SCAND, V44, P168, DOI 10.1111/j.1600-0404.1968.tb05563.x; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Scalzo F, 2009, MED BIOL ENG COMPUT, V47, P967, DOI 10.1007/s11517-009-0505-5; Sotheim O, 2008, SEIZURE-EUR J EPILEP, V17, P740, DOI 10.1016/j.seizure.2008.05.006; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F	35	13	14	0	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	OCT	2011	32	10					1639	1651		10.1088/0967-3334/32/10/011			13	Biophysics; Engineering, Biomedical; Physiology	Biophysics; Engineering; Physiology	823VT	WOS:000295155400011	21904021	Green Accepted			2021-06-18	
J	Engstrom, A; Soderberg, S				Engstrom, Asa; Soderberg, Siv			Transition as Experienced by Close Relatives of People With Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article							CHRONIC ILLNESS; CONSEQUENCES; ADJUSTMENT; DIGNITY	When someone is afflicted by a traumatic brain injury (TBI), it entails a sudden change in the lives of their close relatives. Relatives provide the primary support system for the person with TBI, and new living patterns have to be developed by the family to achieve balance in the new situation. There is an absence of studies focusing on the process of transition for people living close to a person with TBI, especially in a long-term relationship. The aim of this study, therefore, was to describe such transitions experienced by the close relatives of people with TBI. Five close relatives, all women, who lived with or close to a person with TBI in the northern part of Sweden, were interviewed. The data were analyzed in accordance with the qualitative interpretive method and performed in a series of steps to arrive at a description of the transition. The findings of the analysis are presented in 4 categories: the starting point of the transitions, transitions in pattern of daily life, transitions in relationship, and transitions in social life. The transitions of daily life for close relatives began suddenly as the person with TBI was injured unexpectedly. The relatives could feel lonely as former friends were gone or avoided them. How the person with TBI was met by other people strongly affected how the close relatives felt. Although they struggled to lessen the dependence of the person with TBI on them, they also felt anxious about how things would be if close relatives were no longer there for that person. The findings are discussed with reference to works by the philosophers Buber, Levinas, and Logstrup and theories of transition.	[Engstrom, Asa; Soderberg, Siv] Lulea Univ Technol, Dept Hlth Sci, Div Nursing, S-95187 Lulea, Sweden	Engstrom, A (corresponding author), Lulea Univ Technol, Dept Hlth Sci, Div Nursing, S-95187 Lulea, Sweden.	asa.engstrom@ltu.se					Bond A Elaine, 2003, Crit Care Nurse, V23, P63; BUBER M, 1957, PSYCHIATR, V20, P97; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; DeMarle DJ, 2001, J LOSS TRAUMA, V6, P29, DOI 10.1080/108114401753197459; DONOGHUE PJ, 1992, SICK TIRED FEELING S; ENGSTROM A, 2008, THESIS LULEA U TECHN; Engstrom Asa, 2004, Intensive Crit Care Nurs, V20, P299; Fumiyo I, 2009, J NEUROSCI NURS, V41, P277, DOI 10.1097/JNN.0b013e3181b2c73c; Gallagher A, 2004, NURS ETHICS, V11, P587, DOI 10.1191/0969733004ne744oa; Hammer K, 2009, SCAND J CARING SCI, V23, P549, DOI 10.1111/j.1471-6712.2008.00635.x; Johnson L H, 1996, J Neurosci Nurs, V28, P259; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kralik D, 2002, J ADV NURS, V39, P146, DOI 10.1046/j.1365-2648.2000.02254.x; Kuyper MB, 1998, QUAL HEALTH RES, V8, P237, DOI 10.1177/104973239800800207; Kvale S., 2009, KVALITATIVA FORSKNIN, V2nd edn.; Levinas E., 1990, ETIK OANDLIGHET SAMT; Levinas E., 2003, HUMANISM OTHER; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Logstrup K., 1994, ETISKA KRAVET; LUSKIN BD, 2009, CHRONIC ILLNESS IMPA, P85; Meleis A.I., 1986, NURSING RES METHODOL, P237; Meleis AI, 2000, ADV NURS SCI, V23, P12, DOI 10.1097/00012272-200009000-00006; MELEIS AI, 1994, NURS OUTLOOK, V42, P255, DOI 10.1016/0029-6554(94)90045-0; MELEIS AI, 1991, THEORETICAL NURSING; Minnes P, 2000, BRAIN INJURY, V14, P737; Morse J., 1991, QUALITATIVE NURSING; Ohman M, 2004, QUAL HEALTH RES, V14, P396, DOI 10.1177/1049732303261692; POLIT DF, 2008, NURSING RES GENER AT; Schumacher K L, 1994, Image J Nurs Sch, V26, P119; Shotton L, 1998, NURS ETHICS, V5, P246, DOI 10.1177/096973309800500308; Soderberg S, 2001, Health Care Women Int, V22, P617, DOI 10.1080/07399330127169; Soderberg S, 2003, J ADV NURS, V42, P143, DOI 10.1046/j.1365-2648.2003.02597.x; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne SE, 2008, INTERPRETIVE DESCRIP; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020	38	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2011	43	5					253	260		10.1097/JNN.0b013e318227ef9b			8	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	821SR	WOS:000294995200005	21926520				2021-06-18	
J	Vazquez-Valls, E; Flores-Soto, ME; Chaparro-Huerta, V; Torres-Mendoza, BM; Gudino-Cabrera, G; Rivera-Cervantes, MC; Pallas, M; Camins, A; Armendariz-Borunda, J; Beas-Zarate, C				Vazquez-Valls, E.; Flores-Soto, M. E.; Chaparro-Huerta, V.; Torres-Mendoza, B. M.; Gudino-Cabrera, G.; Rivera-Cervantes, M. C.; Pallas, M.; Camins, A.; Armendariz-Borunda, J.; Beas-Zarate, C.			HIF-1 alpha expression in the hippocampus and peripheral macrophages after glutamate-induced excitotoxicity	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Hippocampus; Macrophages; HIF-1 alpha; VEGF; EPO; Excitotoxicity	ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; TRAUMATIC BRAIN-INJURY; NEURONAL DEATH; NEONATAL-RATS; NEURODEGENERATIVE DISEASES; GENE-EXPRESSION; CEREBRAL-CORTEX; NITRIC-OXIDE; SPINAL-CORD	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master transcription factor that regulates the response to hypoxia and ischemia and induces the expression of various genes, including vascular endothelial growth factor (VEGF) and erythropoietin (EPO). This study shows the systemic response of increased HIF-1 alpha, EPO, and VEGF mRNA and protein. In addition, VEGF expression was increased in neurons and over-expressed in glial cells in a model of neuroexcitotoxicity in the hippocampus, in which rats were neonatally exposed to high glutamate concentrations. Simultaneous increases in HIF-1 alpha, EPO and VEGF mRNA in peritoneal macrophages were also observed. Our study is consistent with the hypothesis that these genes exert a protective effect in response to neurotoxicity. (C) 2011 Elsevier B.V. All rights reserved.	[Vazquez-Valls, E.] Hosp Especialidades Ctr Med La Raza, Unidad Invest Med Epidemiol Clin, UMAE, CMNO,IMSS, Mexico City, DF, Mexico; [Flores-Soto, M. E.; Chaparro-Huerta, V.; Torres-Mendoza, B. M.; Beas-Zarate, C.] IMSS, CIBO, Lab Neurobiol Celular & Mol, Div Neurociencias, Guadalajara 44340, Jalisco, Mexico; [Torres-Mendoza, B. M.] CUCS, Inst Patol Infecciosa & Expt, Mexico City, DF, Mexico; [Gudino-Cabrera, G.; Beas-Zarate, C.] CUCBA, Lab Regenerac & Desarrollo Neural, Inst Neurobiol, Dept Biol Celular & Mol, Mexico City, DF, Mexico; [Rivera-Cervantes, M. C.] CUCBA, Lab Neurobiol Celular & Mol, Mexico City, DF, Mexico; [Pallas, M.; Camins, A.] Univ Barcelona, Unitat Farmacol & Farmacognosia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Farm, E-08028 Barcelona, Spain; [Pallas, M.; Camins, A.] Univ Barcelona, Inst Biomed IBUB, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Farm, E-08028 Barcelona, Spain; [Armendariz-Borunda, J.] CUCS, Inst Biol Mol & Terapia Gen, Guadalajara, Jalisco, Mexico	Beas-Zarate, C (corresponding author), IMSS, CIBO, Lab Mol & Cell Neurobiol, Div Neurosci, Sierra Mojada 800, Guadalajara 44340, Jalisco, Mexico.	carlosbeas55@gmail.com	de Guadalupe Torres Mendoza, Blanca Miriam/ABC-3523-2020; Camins, Antonio/J-5126-2019; Torres-Mendoza, Blanca Miriam/O-5793-2019; Pallas, Merce/H-3129-2016	Camins, Antonio/0000-0002-1229-5956; Pallas, Merce/0000-0003-3095-4254; GUDINO CABRERA, GRACIELA/0000-0002-4247-9246; Flores Soto, Eduardo/0000-0001-9409-4690; Gudino Cabrera, Graciela/0000-0003-3170-6535; Torres-Mendoza, Blanca Miriam/0000-0003-2233-571X; Vazquez-Valls, Eduardo/0000-0002-9639-5339; Chaparro-Huerta, Veronica/0000-0001-8647-5071; Cervantes, Rivera/0000-0002-7601-6944	Spain's "Ministerio de Educacion y Ciencia"Spanish Government [SAF2009-13093]; Fondo de Investigacion SanitariaInstituto de Salud Carlos III; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI080400, PS09/01789]; Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED) [610RT0405]; Generalitat de CatalunyaGeneralitat de Catalunya [2009/SGR00853]; Fundacio la Marato TV3 [063230]	This study was supported by grants from Spain's "Ministerio de Educacion y Ciencia" SAF2009-13093, the "Fondo de Investigacion Sanitaria", and the "Instituto de Salud Carlos III" PI080400 and PS09/01789 (FEDER FOUNDS). 610RT0405 from Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED). We would like to thank the "Generalitat de Catalunya" for supporting the research groups (2009/SGR00853) and the "Fundacio la Marato TV3" (063230). We wish to thank the Language Assessment Service of the University of Barcelona for revising the manuscript.	Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Beas-Zarate C, 2007, INT J DEV NEUROSCI, V25, P53, DOI 10.1016/j.ijdevneu.2006.10.001; Bogaert E, 2010, NEUROBIOL AGING, V31, P2185, DOI 10.1016/j.neurobiolaging.2008.12.007; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Castellani RJ, 2008, J NEUROPATH EXP NEUR, V67, P523, DOI 10.1097/NEN.0b013e318177eaf4; Chaparro-Huerta V, 2008, INT J DEV NEUROSCI, V26, P487, DOI 10.1016/j.ijdevneu.2008.02.008; Chaparro-Huerta V, 2005, J NEUROIMMUNOL, V165, P53, DOI 10.1016/j.jneuroim.2005.04.025; Chaparro-Huerta V, 2002, NEUROSCI LETT, V333, P95, DOI 10.1016/S0304-3940(02)01006-6; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Ernens I, 2010, BIOCHEM BIOPH RES CO, V392, P351, DOI 10.1016/j.bbrc.2010.01.023; Fujiki M, 2010, EXP NEUROL, V225, P377, DOI 10.1016/j.expneurol.2010.07.010; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Gras G, 2006, J LEUKOCYTE BIOL, V80, P1067, DOI 10.1189/jlb.0306153; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Khan Haseeb Ahmad, 2004, Inflammopharmacology, V12, P81, DOI 10.1163/156856004773121392; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; Lemus-Varela ML, 2010, CLIN BIOCHEM, V43, P234, DOI 10.1016/j.clinbiochem.2009.09.022; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunn JS, 2009, DEV NEUROBIOL, V69, P871, DOI 10.1002/dneu.20747; Manoonkitiwongsa PS, 2011, CNS NEUROL DISORD-DR, V10, P215; Martinez-Contreras A, 2002, J NEUROSCI RES, V67, P200, DOI 10.1002/jnr.10093; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Nicoletti JN, 2010, EPILEPSY BEHAV, V19, P272, DOI 10.1016/j.yebeh.2010.07.011; Pacheco R, 2007, J NEUROIMMUNOL, V185, P9, DOI 10.1016/j.jneuroim.2007.01.003; Porcheray F, 2006, AM J PHYSIOL-CELL PH, V291, pC618, DOI 10.1152/ajpcell.00021.2006; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Seta KA, 2004, J APPL PHYSIOL, V96, P765, DOI 10.1152/japplphysiol.00836.2003; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Tian You-yong, 2006, Zhonghua Yi Xue Za Zhi, V86, P2054; Tolosa L, 2008, J NEUROCHEM, V105, P1080, DOI 10.1111/j.1471-4159.2007.05206.x; Toyooka K, 2009, CURR OPIN NEUROL, V22, P475, DOI 10.1097/WCO.0b013e32832fbc52; Vezzani Annamaria, 2008, Epilepsy Curr, V8, P135, DOI 10.1111/j.1535-7511.2008.00269.x; Wang Yong-Quan, 2007, Sheng Li Ke Xue Jin Zhan, V38, P202; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Zhang B, 2004, NEUROSCIENCE, V126, P433, DOI 10.1016/j.neuroscience.2004.03.057; Zhao H, 2011, HUM GENE THER, V22, P207, DOI 10.1089/hum.2010.111; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	47	13	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	SEP 15	2011	238	1-2					12	18		10.1016/j.jneuroim.2011.06.001			7	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	831CK	WOS:000295706100002	21807419				2021-06-18	
J	Burov, S; Leko, M; Dorosh, M; Dobrodumov, A; Veselkina, O				Burov, Sergey; Leko, Maria; Dorosh, Marina; Dobrodumov, Anatoliy; Veselkina, Olga			Creatinyl amino acids - new hybrid compounds with neuroprotective activity	JOURNAL OF PEPTIDE SCIENCE			English	Article						creatinyl amino acids; sarcosine guanidinylation; creatine p-toluenesulfonate; brain stroke; neuroprotective activity	MODEL	Prolonged oral creatine administration resulted in remarkable neuroprotection in experimental models of brain stroke. However, because of its polar nature creatine has poor ability to penetrate the blood-brain barrier (BBB) without specific creatine transporter (CRT). Thus, synthesis of hydrophobic derivatives capable of crossing the BBB by alternative pathway is of great importance for the treatment of acute and chronic neurological diseases including stroke, traumatic brain injury and hereditary CRT deficiency. Here we describe synthesis of new hybrid compounds - creatinyl amino acids, their neuroprotective activity in vivo and stability to degradation in different media. The title compounds were synthesized by guanidinylation of corresponding sarcosyl peptides or direct creatine attachment using isobutyl chloroformate method. Addition of lipophilic counterion (p-toluenesulfonate) ensures efficient creatine dissolution in DMF with simultaneous protection of guanidino group towards intramolecular cyclization. It excludes the application of expensive guanidinylating reagents, permits to simplify synthetic procedure and adapt it to large-scale production. The biological activity of creatinyl amino acids was tested in vivo on ischemic stroke and NaNO2-induced hypoxia models. One of the most effective compounds - creatinyl-glycine ethyl ester increases life span of experimental animals more than two times in hypoxia model and has neuroprotective action in brain stroke model when applied both before and after ischemia. These data evidenced that creatinyl amino acids can represent promising candidates for the development of new drugs useful in stroke treatment. Copyright (C) 2011 European Peptide Society and John Wiley & Sons, Ltd.	[Burov, Sergey] Russian Acad Sci, Inst Macromol Cpds, VO, St Petersburg 199004, Russia; [Veselkina, Olga] Closed Joint Stock Co Vertex, St Petersburg 199026, Russia	Burov, S (corresponding author), Russian Acad Sci, Inst Macromol Cpds, VO, Bolshoi Pr 31, St Petersburg 199004, Russia.	burov@hq.macro.ru	Burov, Sergey V/P-7225-2015; Dobrodumov, Anatoliy V/I-9151-2017	Burov, Sergey V/0000-0003-3607-5680; Dobrodumov, Anatoliy V/0000-0002-4554-6002			AN L, 1999, Patent No. 99118985; Andrushchenko VV, 2007, J PEPT SCI, V13, P37, DOI 10.1002/psc.793; Belayev L, 1999, BRAIN RES, V833, P181, DOI 10.1016/S0006-8993(99)01528-0; BUROV SV, 2007, Patent No. 2354645; Christie David L., 2007, V46, P99; CRIADO M, 1980, ANAL BIOCHEM, V103, P289, DOI 10.1016/0003-2697(80)90612-0; GIBSON GE, 1981, J NEUROCHEM, V37, P192, DOI 10.1111/j.1471-4159.1981.tb05308.x; Giese MW, 2009, INT J SPORTS MED, V30, P766, DOI 10.1055/s-0029-1231045; Giese MW, 2009, BIOCHEM BIOPH RES CO, V388, P252, DOI 10.1016/j.bbrc.2009.07.151; HOFMANN E, 1958, NATURWISSENSCHAFTEN, V45, P338, DOI 10.1007/BF00640225; KATRITZKY AR, 1995, SYNTHETIC COMMUN, V25, P1173, DOI 10.1080/00397919508012681; Klein Autumn M., 2007, V46, P205; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Koizumi J., 1986, NOSOTCHU, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kristensen CA, 1999, BRIT J CANCER, V79, P278, DOI 10.1038/sj.bjc.6690045; Li FH, 1997, J CEREBR BLOOD F MET, V17, P1132, DOI 10.1097/00004647-199710000-00016; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lunardi G, 2006, NEUROSCIENCE, V142, P991, DOI 10.1016/j.neuroscience.2006.06.058; Matthews RT, 1998, J NEUROSCI, V18, P156; Musiol HJ, 2001, ORG LETT, V3, P3859, DOI 10.1021/ol010191q; Prass K, 2007, J CEREBR BLOOD F MET, V27, P1290, DOI 10.1038/sj.jcbfm.9600442; VENNERSTROM JL, 2002, Patent No. 2002022135; WEISS S, 1995, Patent No. 0754679; Zhu S, 2004, J NEUROSCI, V24, P5909, DOI 10.1523/JNEUROSCI.1278-04.2004	24	13	14	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	SEP	2011	17	9					620	626		10.1002/psc.1379			7	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	814JF	WOS:000294444100004	21644247				2021-06-18	
J	Keenan, MA				Keenan, Mary Ann			The Management of Spastic Equinovarus Deformity Following Stroke and Head Injury	FOOT AND ANKLE CLINICS			English	Article						Equinovarus deformity; Split anterior tibialis tendon transfer (SPLATT); Foot deformity	TIBIAL-TENDON TRANSFER; GAIT ANALYSIS; TOE FLEXORS; EQUINUS; ADULT; FOOT; HEMIPLEGIA; SCALE	Spastic equinovarus foot deformity is common in patients with upper motor neuron syndrome following stroke and traumatic brain injury. Equinovarus posture of the foot causes significant problems with shoe wear, standing, transfers, and walking. The deformity often cannot be managed with nonsurgical treatments such as chemodenervation, orthoses, and physical therapy. In fact, these modalities may be more costly and less effective than surgical treatment This article describes evaluation and surgical techniques of combined multitendon transfers and lengthenings for correction of spastic equinovarus deformity. These tendon transfers reliably result in improvement in quality of life.	Univ Penn, Dept Orthopaed Surg, Sch Med, Philadelphia, PA 19104 USA	Keenan, MA (corresponding author), Univ Penn, Dept Orthopaed Surg, Sch Med, 3400 Spruce St,2 Silverstien Pavill, Philadelphia, PA 19104 USA.	MaryAnn.Keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				ASHWORTH B, 1964, PRACTITIONER, V192, P540; BANKS HH, 1977, CLIN ORTHOP RELAT R, P70; BARNES MJ, 1991, J BONE JOINT SURG AM, V73A, P734, DOI 10.2106/00004623-199173050-00012; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; DiGiovanni CW, 2002, J BONE JOINT SURG AM, V84A, P962, DOI 10.2106/00004623-200206000-00010; Dunkerley D R, 1985, Int Rehabil Med, V7, P39; EDWARDS P, 1993, FOOT ANKLE, V14, P335, DOI 10.1177/107110079301400605; Fuller DA, 2004, ORTHOPEDICS, V27, P372; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; HOFFER MM, 1974, ORTHOP CLIN N AM, V5, P31; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Hosalkar H, 2008, CLIN ORTHOP RELAT R, V466, P2500, DOI 10.1007/s11999-008-0395-0; JORDAN C, 1988, CLIN ORTHOP RELAT R, P102; Keenan M A, 1988, Orthop Rev, V17, P1185; KEENAN MA, 1984, CLIN ORTHOP RELAT R, P165; Keenan MA, 1999, NEUROREHABILITATION, V12, P119; KEENAN MA, 1984, FOOT ANKLE, V5, P35, DOI 10.1177/107110078400500105; KEENAN MAE, 1987, FOOT ANKLE, V7, P333, DOI 10.1177/107110078700700604; Keenan MAE, 1999, J HEAD TRAUMA REHAB, V14, P163, DOI 10.1097/00001199-199904000-00006; KEENAN MAE, 2001, CHAPMANS OPERATIVE O, P3201; LAWRENCE SJ, 1994, FOOT ANKLE INT, V15, P340, DOI 10.1177/107110079401500610; Lee K.-C., 1989, J NEUROL REHABIL, V3, P205, DOI DOI 10.1177/136140968900300406; LEMPERG R, 1969, ACTA ORTHOP SCAND, V40, P507, DOI 10.3109/17453676909046536; Mayer NH, 2008, SPASTICITY OTHER FOR, P11; Namdari S, 2009, FOOT ANKLE INT, V30, P923, DOI 10.3113/FAI.2009.0923; ONO K, 1980, INT ORTHOP, V4, P225, DOI 10.1007/BF00268160; PERRY J, 1987, CLIN ORTHOP RELAT R, P8; Perry J, 1978, CLIN ORTHOP RELAT R, V131, P4753; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; Reddy S, 2008, CLIN ORTHOP RELAT R, V466, P1683, DOI 10.1007/s11999-008-0250-3; ROPER BA, 1978, J BONE JOINT SURG BR, V60, P533; Silfverskiold N, 1924, ACTACHIRSCAND, V56, P315; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016; Walshe FMR, 1923, BRAIN, V46, P1, DOI 10.1093/brain/46.1.1; WATERS RL, 1982, J BONE JOINT SURG AM, V64, P284, DOI 10.2106/00004623-198264020-00022	35	13	13	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1083-7515	1558-1934		FOOT ANKLE CLIN	Foot Ankle Clin.	SEP	2011	16	3					499	514		10.1016/j.fcl.2011.07.002			16	Orthopedics	Orthopedics	837NF	WOS:000296209800011	21925364				2021-06-18	
J	Que, HP; Liu, Y; Jia, YF; Liu, SJ				Que, Haiping; Liu, Yong; Jia, Yufeng; Liu, Shaojun			Establishment and assessment of a simple and easily reproducible incision model of spinal cord neuron cells in vitro	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						In vitro studies; Models of injury; Neural injury; Traumatic spinal cord injury	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SCIATIC-NERVE; FOS PROTEIN; RAT; EXPRESSION; TRANSECTION; IMMUNOREACTIVITY; INDUCTION; APOPTOSIS	A growing number of in vitro models have been introduced to study the mechanisms of spinal cord injury. A potential drawback of these models is that they are difficult to reproduce. In this study, an in vitro incision model was established using primary cultured neuronal cells from fetal rat spinal cords. The neurons were subjected to incision in a simple and reproducible way. To assess whether this model could simulate the responses of spinal cord neuron cells in vivo after a spinal cord transection, apoptosis, and the expression of immediate early genes were detected in the neurons at various time points after injury. The results indicated that: (1) significantly more terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells were observed at 1, 3, and 7 d following injury and (2) the expression of both c-Jun and c-Fos was induced 10 min after incision and had markedly higher levels 2 h post-injury. These results suggested that our model can partially imitate the responses of in vivo neuronal cells after a spinal cord transection and such models may facilitate further understanding of biochemical and cellular events associated with spinal cord injury.	[Que, Haiping; Liu, Yong; Jia, Yufeng; Liu, Shaojun] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Prote, Dept Neurobiol, Beijing 100730, Peoples R China	Liu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Prote, Dept Neurobiol, Beijing 100730, Peoples R China.	liuyongxiao1225@yahoo.com.cn; liusj@nic.bmi.ac.cn			Chinese National Basic Research ProgramNational Basic Research Program of China [2009CB918301]; State Key Laboratory of Proteomics [SKLP2010yx-004]	This work was supported by grants from Chinese National Basic Research Program (grant no. 2009CB918301) and Open Project Program of the State Key Laboratory of Proteomics (SKLP2010yx-004).	Akhtar AZ, 2008, REV NEUROSCIENCE, V19, P47; BALENTINE JD, 1988, LAB INVEST, V58, P93; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Buchanan K M, 2001, Axone, V22, P16; Campagnolo D I, 2000, J Spinal Cord Med, V23, P121; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Casanovas A, 2001, J NEUROSCI RES, V63, P469, DOI 10.1002/jnr.1041; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; CHI SI, 1993, BRAIN RES, V617, P220, DOI 10.1016/0006-8993(93)91089-B; Del-Bel EA, 2000, BRAZ J MED BIOL RES, V33, P521, DOI 10.1590/S0100-879X2000000500006; Dias MS, 2004, PEDIATR CLIN N AM, V51, P271, DOI 10.1016/S0031-3955(03)00211-6; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; GROSS GW, 1983, J NEUROSCI, V3, P1979; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Hirata Y, 1998, J NEUROCHEM, V71, P1607; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Ikeda S, 1998, BRAIN RES, V792, P164, DOI 10.1016/S0006-8993(98)00213-3; Kajander KC, 1996, NEUROSCI LETT, V206, P9, DOI 10.1016/0304-3940(96)12447-2; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliveira ALR, 2002, J COMP NEUROL, V447, P381, DOI 10.1002/cne.10248; Pan WH, 2008, CURR PHARM DESIGN, V14, P1620, DOI 10.2174/138161208784705450; Ribotta MGY, 1996, BRAIN RES, V707, P245, DOI 10.1016/0006-8993(95)01266-4; Ruggiero DA, 1997, BRAIN RES, V763, P21, DOI 10.1016/S0006-8993(97)00356-9; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410	35	13	13	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	SEP	2011	47	8					558	564		10.1007/s11626-011-9443-2			7	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	864HS	WOS:000298229800009	21792724				2021-06-18	
J	Zafonte, R				Zafonte, Ross			Diagnosis and Management of Sports-Related Concussion A 15-Year-Old Athlete With a Concussion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC-BRAIN-INJURY; PROFESSIONAL FOOTBALL PLAYERS; MILD HEAD-INJURY; HIGH-SCHOOL; RECURRENT CONCUSSION; NEUROCOGNITIVE PERFORMANCE; POSTTRAUMATIC MIGRAINE; INTELLECTUAL ABILITY; MAGNETIC-RESONANCE; POSTURAL STABILITY	Concussion in youth athletes is a growing problem worldwide. During the past decade, significant progress has been made in standardization of the assessment of young athletes, and a growing appreciation of metabolic vulnerability, activity, and cognitive challenges has led to guidelines and suggestions for rest from the field as well as cognitive rest from school. Outcome data have begun to establish groups linked to symptom class, genetics, and sex who are at risk of worse outcomes from concussions. Decisions regarding return to activity are now based on at-rest symptoms, graded increases in activity, and neuropsychological testing. Using the case of Ms X, a 15-year-old otherwise healthy high school student who fell while skiing, evaluation, prognosis, and management of concussion are discussed.	[Zafonte, Ross] Spaulding Rehabil Hosp Network, Boston, MA 02114 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA	Zafonte, R (corresponding author), Spaulding Rehabil Hosp Network, 125 Nashua St, Boston, MA 02114 USA.	rzafonte@partners.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Disability and Rehabilitation Research; Department of DefenseUnited States Department of Defense; US Food and Drug Administration	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Zafonte reports receiving research funding from the National Institutes of Health, the National Institute on Disability and Rehabilitation Research, and the Department of Defense. He is principal investigator on a study funded by the US Food and Drug Administration orphan drug program in collaboration with Neurohealing. He is a member of Neurohealing's scientific advisory board but receives no compensation.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Barth JT, 2009, PM&R, V1, P769, DOI 10.1016/j.pmrj.2009.07.001; Bey T, 2009, WEST J EMERG MED, V10, P6; Bouma G J, 1995, New Horiz, V3, P384; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Centers for Disease Control and Prevention, WHAT SHOULD I DO IF; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins M. W., 2007, BRAIN INJURY MED PRI, P407; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hagel B, 2005, MED SPORT SCI, V48, P74, DOI 10.1159/000084284; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mathew NT, 1997, NEUROL CLIN, V15, P167, DOI 10.1016/S0733-8619(05)70302-9; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Runkle D, 2010, NCAA COMMITTEE COMPE; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SHEFTELL FD, 1994, HEADACHE, V34, P67, DOI 10.1111/j.1526-4610.1994.hed3402067.x; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Weir Dr, 2009, NATL FOOTBALL LEAGUE; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x	81	13	13	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					79	86		10.1001/jama.2011.819			8	Medicine, General & Internal	General & Internal Medicine	787LV	WOS:000292378700023	21632470				2021-06-18	
J	Akin, FW; Murnane, OD; Pearson, A; Byrd, S; Kelly, JK				Akin, Faith W.; Murnane, Owen D.; Pearson, Amber; Byrd, Stephanie; Kelly, J. Kip			Normative Data for the Subjective Visual Vertical Test during Centrifugation	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						Saccule and utricle; subjective visual vertical; vestibular function tests	UNILATERAL LOSS; TILT	Background: The otoliths act as gravito-inertial force sensors and contribute to the perception of spatial orientation. The perception of gravitational vertical can be assessed by asking a subject to adjust a light bar to the vertical. Prior to clinical use of the SVV (subjective visual vertical) test, normative data and test-retest reliability must be established. Purpose: To obtain normative data and determine the test-retest reliability for the SVV test performed in static and dynamic test conditions. Research Design: A descriptive design was used to obtain normative data. Study Sample: Twenty-four young adults with no history of neurological disease, middle-ear pathology, open or closed head injury, cervical injury, or audiovestibular disorder participated in the study. Data Collection and Analysis: The SVV angle was measured in the static position and in three dynamic conditions: (1) on-axis clockwise (CW) rotation, (2) off-axis CW rotation of right ear, and (3) off-axis CW rotation of left ear. Results: In young healthy individuals, the SVV was <2 degrees for static and on-axis rotation, and shifted up to 11 degrees during unilateral centrifugation. Test-retest reliability of the SVV was good for all test conditions. Conclusions: The normative data obtained in this study may be useful in identifying patients with chronic utricular dysfunction. We recommend the use of difference angles (on-axis SVV - off-axis SVV) to remove baseline bias and decrease the variability of the SVV angles for the off-axis conditions.	[Akin, Faith W.; Murnane, Owen D.; Pearson, Amber; Byrd, Stephanie; Kelly, J. Kip] James H Quillen VA Med Ctr, Mountain Home, TN USA; [Akin, Faith W.; Murnane, Owen D.] E Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN 37614 USA	Akin, FW (corresponding author), VAMC, Mountain Home, TN 37684 USA.	Faith.akin@va.gov			Auditory and Vestibular Dysfunction Research Enhancement Award Program; Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C.US Department of Veterans Affairs;  [C6241R]	Support for this study was provided by a Merit Review (C6241R) and the Auditory and Vestibular Dysfunction Research Enhancement Award Program sponsored by the Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C.	Bohmer A, 1995, J Vestib Res, V5, P35; Bohmer A, 1996, BRAIN RES BULL, V40, P423, DOI 10.1016/0361-9230(96)00137-2; Bohmer A, 1999, J VESTIBUL RES-EQUIL, V9, P413; Chang CM, 2010, OTOLARYNG HEAD NECK, V143, P418, DOI 10.1016/j.otohns.2010.04.269; Clarke AH, 2001, ACTA OTO-LARYNGOL, P84; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; GLOSTER J, 1953, T OPHTHAL SOC UK, V73, P421; Gomez Garcia A., 2003, ENT-EAR NOSE THROAT, V82, P442, DOI DOI 10.1177/014556130308200614; Goto F, 2003, AURIS NASUS LARYNX, V30, P29, DOI 10.1016/S0385-8146(02)00110-4; HALMAGYI G, 2007, VESTIBULAR REHABILIT, P144; Helling K, 2006, ACTA OTO-LARYNGOL, V126, P587, DOI 10.1080/00016480500450008; Kobayashi H, 2002, AURIS NASUS LARYNX, V29, P325, DOI 10.1016/S0385-8146(02)00058-5; Merchant SN, 2000, ANN OTO RHINOL LARYN, V109, P3; Min KK, 2007, OTOL NEUROTOL, V28, P520, DOI 10.1097/01.mao.0000271674.41307.f2; Mossman S, 1997, NEUROLOGY, V49, P491, DOI 10.1212/WNL.49.2.491; Neal E, 1926, AM J PSYCHOL, V37, P287, DOI 10.2307/1413700; Nowe V, 2003, J VESTIBUL RES-EQUIL, V13, P17; Paige G D, 1992, J Vestib Res, V2, P133; Su HC, 2004, OTOL NEUROTOL, V25, P977, DOI 10.1097/00129492-200411000-00019; Tian JR, 2002, EXP BRAIN RES, V145, P142, DOI 10.1007/s00221-002-1111-z; Tribukait A, 1996, BRAIN RES BULL, V40, P375, DOI 10.1016/0361-9230(96)00130-X; Vibert D, 1999, J VESTIBUL RES-EQUIL, V9, P145; Welgampola MS, 2001, CLIN NEUROPHYSIOL, V112, P1971, DOI 10.1016/S1388-2457(01)00645-9; WETZIG J, 1990, ACTA ASTRONAUT, V21, P519, DOI 10.1016/0094-5765(90)90070-2; WITKIN HA, 1948, J EXP PSYCHOL, V38, P603, DOI 10.1037/h0055372	26	13	14	0	7	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	JUL-AUG	2011	22	7			SI		460	468		10.3766/jaaa.22.7.6			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Audiology & Speech-Language Pathology; Otorhinolaryngology	831DD	WOS:000295708000006	21993051				2021-06-18	
J	Carlesimo, GA; Costa, A; Serra, L; Bozzali, M; Fadda, L; Caltagirone, C				Carlesimo, G. A.; Costa, A.; Serra, L.; Bozzali, M.; Fadda, L.; Caltagirone, C.			Prospective memory in thalamic amnesia	NEUROPSYCHOLOGIA			English	Article						Prospective memory; Thalamus; Amnesia; Executive functions	MILD COGNITIVE IMPAIRMENT; CLOSED-HEAD INJURY; PARKINSONS-DISEASE; BRAIN-INJURY; NEUROPSYCHOLOGY; TRACTOGRAPHY; INTENTIONS; DEFICITS; TASK	The contribution of the thalamus to the functioning of prospective memory (PM) is currently unknown. Here we report an experimental investigation of the performance of two patients with bilateral infarcts in the anterior-mesial regions of the thalami on an event-based PM paradigm. One patient, G.P., had a pervasive declarative memory impairment but no significant executive deficit. The other patient, R.F., had a memory deficit limited to verbal material with associated behavioral abnormalities (inertia and apathy); she performed poorly on tests of executive functions. Although both patients performed poorly on the PM task, a qualitative analysis of performance revealed different mechanisms at the base of their impaired PM. G.P. had reduced declarative memory for target words compared with normal controls; but, unforgotten words were normally able to elicit his recall of the prospective intention. Conversely, R.F.'s declarative memory for target words was as accurate as that of normal controls, but she presented a dramatically reduced ratio between the number of target words she recalled and the number of times she activated the prospective intention on the PM task, suggesting that her deficit consisted of difficulty in activating the intention despite normal declarative memory for the target events. In conclusion, results of the present study demonstrate that thalamic structures have an important role in PM processes. They also document that damage to the anterior-mesial regions of the thalami affects PM abilities by two different mechanisms, respectively based on the relative disruption of declarative memory or executive processes functioning, which, in turn, is related to the specific intrathalamic structures involved by the lesions. Indeed, while G.P.'s pervasive declarative memory deficit was underlain by bilateral involvement of the mammillo-thalamic tract, R.F.'s executive and behavioral abnormalities were likely related to bilateral damage of the midline, intralaminar, and medio-dorsal nuclei. (C) 2010 Elsevier Ltd. All rights reserved.	[Carlesimo, G. A.; Fadda, L.; Caltagirone, C.] Tor Vergata Univ, Neurol Clin, Rome, Italy; [Carlesimo, G. A.; Costa, A.; Fadda, L.; Caltagirone, C.] IRCCS, Santa Lucia Fdn, Unit Clin & Behav Neurol, Rome, Italy; [Serra, L.; Bozzali, M.] IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy	Carlesimo, GA (corresponding author), IRCCS S Lucia, V Ardeatina 306, I-00179 Rome, Italy.	memolab@hsantalucia.it	Costa, Alberto/AAA-7038-2019; Serra, Laura/K-5637-2016; Caltagirone, Carlo/B-4930-2013	Serra, Laura/0000-0002-2717-1286; Bozzali, Marco/0000-0002-0568-2026; COSTA, Alberto/0000-0002-4784-5524; Fadda, Lucia/0000-0003-0659-9416			Adda CC, 2008, NEUROPSYCHOLOGIA, V46, P1954, DOI 10.1016/j.neuropsychologia.2008.01.016; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BORTOLINI V, 1971, LESSICO FREQUENZE LI; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carlesimo GA, 2007, NEUROPSYCHOLOGIA, V45, P2467, DOI 10.1016/j.neuropsychologia.2007.03.025; Carlesimo G.A., 2002, NUOVA RIV NEUROLOGIA, V12, P1, DOI DOI 10.1080/17408989.2016.1268591; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Carlesimo GA, 2009, BEHAV NEUROL, V22, P101, DOI [10.3233/ben-2009-0251, 10.3233/BEN-2009-0251]; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; Cipolotti L, 2008, NEUROPSYCHOLOGIA, V46, P2745, DOI 10.1016/j.neuropsychologia.2008.05.009; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Einstein G., 1996, PROSPECTIVE MEMORY T, P115; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Ellis JA., 1996, PROSPECTIVE MEMORY T, P1; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kazui H, 2005, DEMENT GERIATR COGN, V19, P331, DOI 10.1159/000084559; Kliegel M, 2005, J NEUROL NEUROSUR PS, V76, P1501, DOI 10.1136/jnnp.2004.051268; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Mai J.K., 2004, ATLAS HUMAN BRAIN; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; MAURI M, 1997, ARCH PSICOLOGIA NEUR, V5, P621; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Nocentini U., 2002, NUOVA RIV NEUROLOGIA, V12, P13; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Steriade M, 1997, THALAMUS ORG FUNCTIO; Tognoni, 1987, ITALIAN J NEUROLOGIC, V8, P35; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Warrington EK, 1996, CAMDEN MEMORY TEST	47	13	17	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	JUL	2011	49	8			SI		2199	2208		10.1016/j.neuropsychologia.2010.11.013			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	793FL	WOS:000292805700007	21115022				2021-06-18	
J	Niemeier, JP; Kreutzer, JS; Marwitz, JH; Gary, KW; Ketchum, JM				Niemeier, Janet P.; Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Gary, Kelli W.; Ketchum, Jessica M.			Efficacy of a brief acute neurobehavioural intervention following traumatic brain injury: A preliminary investigation	BRAIN INJURY			English	Article						Neurobehavioural; intervention; rehabilitation; efficacy	RANDOMIZED CONTROLLED-TRIAL; CLOSED-HEAD-INJURY; MINI-MENTAL-STATE; RATING-SCALE; COGNITIVE REHABILITATION; INPATIENT REHABILITATION; MULTICENTER ANALYSIS; LIFE SCALE; SATISFACTION; RELIABILITY	Primary objective: To evaluate the effectiveness of a brief acute neurobehavioural intervention, the First Steps Acute Neurobehavioural and Cognitive Intervention (FANCI), with persons who have traumatic brain injury (TBI). Research design: Prospective, controlled, repeated measures design. Methods and procedures: Seventy-two patients in acute TBI rehabilitation participated either as FANCI subjects or as control participants who watched videos to control for time and attention. Outcome measures included the Neurobehavioural Rating Scale-Revised (NRS-R), Functional Independence Measure (FIM (TM)), a FANCI Learning Assessment (LA) and the Satisfaction with Life Scale (SWLS). Main outcomes and results: In comparison with controls, FANCI participants had significantly greater neurobehavioural (cognitive, emotional and behavioural) as well as FIM motor improvements. Significantly greater learning occurred and persisted over time for FANCI subjects as compared to controls. Pre-treatment cognitive and neurobehavioural status, length of coma and number of sessions completed were moderating variables for functional and cognitive outcomes. Conclusions: Persons with TBI can benefit from comprehensive, manualized neurobehavioural interventions, over and above standard rehabilitation care, even during the acute phase of recovery.	[Niemeier, Janet P.; Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Gary, Kelli W.; Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Niemeier, JP (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980542, Richmond, VA 23298 USA.	jhmarwit@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Dept. of Education, Washington, D.C. [H133A020516, H133A070036]	This work was supported by Grants # H133A020516 and H133A070036 from the National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Dept. of Education, Washington, D.C.	BASSETT SF, 2003, PHYSIOTHERAPY, V31, P60; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC8; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; KEYSER L, 1995, NEUROREHABILITATION, V5, P255, DOI 10.3233/NRE-1995-5308; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; Kolb B., 1995, BRAIN PLASTICITY BEH; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; Niemeier J., 2004, 1 STEPS NEUROBEHAVIO; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; NIEMEIER JP, 2001, 1 STEPS RECOVERY BRA; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pavot L, 1993, PSYCHOL ASSESSMENTS, V5, P164; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Prescott R, 2006, APPL MIXED MODELS ME; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; SAS Institute Inc, 2008, SAS 9 2; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Thies S, 2008, REHABILITATION, V47, P308, DOI 10.1055/s-2008-1076709; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1053/apmr.2000.4436; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams GC, 1996, J PERS SOC PSYCHOL, V70, P115, DOI 10.1037/0022-3514.70.1.115; Williams GC, 1998, HEALTH PSYCHOL, V17, P269, DOI 10.1037/0278-6133.17.3.269; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644	59	13	13	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					680	690		10.3109/02699052.2011.573520			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600004	21604926				2021-06-18	
J	Shim, DJ; Yang, L; Reed, JG; Noebels, JL; Chiao, PJ; Zheng, H				Shim, David J.; Yang, Li; Reed, J. Graham; Noebels, Jeffrey L.; Chiao, Paul J.; Zheng, Hui			Disruption of the NF-kappa B/I kappa B alpha Autoinhibitory Loop Improves Cognitive Performance and Promotes Hyperexcitability of Hippocampal Neurons	MOLECULAR NEURODEGENERATION			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; GLIAL TNF-ALPHA; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; MEMORY FORMATION; C-REL; ACTIVATION	Background: Though originally discovered in the immune system as an important mediator of inflammation, NF-kappa B has recently been shown to play key roles in the central nervous system, such as synaptogenesis, synaptic plasticity, and cognition. NF-kappa B activity is normally tightly regulated by its primary inhibitor, I kappa B alpha, through a unique autoinhibitory loop. In this study, we tested the hypothesis that the I kappa B alpha autoinhibitory loop ensures optimal levels of NF-kappa B activity to promote proper brain development and function. To do so, we utilized knock-in mice which possess mutations in the I kappa B alpha promoter to disrupt the autoinhibitory loop (I kappa B alpha(M/M) KI mice). Results: Here, we show that these mutations delay I kappa B alpha resynthesis and enhance NF-kappa B activation in neurons following acute activating stimuli. This leads to improved cognitive ability on tests of hippocampal-dependent learning and memory but no change in hippocampal synaptic plasticity. Instead, hippocampal neurons from I kappa B alpha(M/M) KI mice form more excitatory and less inhibitory synapses in dissociated cultures and are hyperexcitable. This leads to increased burst firing of action potentials and the development of abnormal hypersynchronous discharges in vivo. Conclusions: These results demonstrate that the I kappa B alpha autoinhibitory loop is critical for titrating appropriate levels of endogenous NF-kappa B activity to maintain proper neuronal function.	[Shim, David J.; Yang, Li; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Shim, David J.; Noebels, Jeffrey L.; Zheng, Hui] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shim, David J.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Noebels, Jeffrey L.; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Reed, J. Graham; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Chiao, Paul J.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol Res, Houston, TX 77030 USA	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	huiz@bcm.edu		Noebels, Jeffrey/0000-0002-2887-0839	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG20670, AG32051, AG33467, NS614283]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA097159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS061428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG032051, R01AG020670, R01AG033467] Funding Source: NIH RePORTER	We are grateful to N. Aithmitti and X. Chen for expert technical support, Z. Wang and B. Peng for assistance with initial breeding and characterization of the mice, and N. Justice and members of the Zheng laboratory for constructive discussions and help with the manuscript. We thank C. Spencer and the Baylor College of Medicine IDDRC Administrative, Mouse Neurobehavior, and Mouse Physiology cores (HD24064) for their assistance. This work was supported by grants from NIH (AG20670, AG32051, and AG33467 to HZ; NS614283 to DS).	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Albensi BC, 2000, SYNAPSE, V35, P151; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Barkmeier DT, 2009, CLIN EEG NEUROSCI, V40, P234, DOI 10.1177/155005940904000405; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Begni S, 2003, BIOL PSYCHIAT, V53, P617, DOI 10.1016/S0006-3223(02)01783-3; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kassed CA, 2002, EXP NEUROL, V176, P277, DOI 10.1006/exnr.2002.7967; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; O'Sullivan NC, 2010, BRAIN RES BULL, V81, P385, DOI 10.1016/j.brainresbull.2009.11.001; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Wang J, 2010, J NEUROSCI, V30, P11104, DOI 10.1523/JNEUROSCI.2118-10.2010; Yu ZF, 2002, NEUROBIOL DIS, V11, P199, DOI 10.1006/nbdi.2002.0530; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	56	13	13	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	JUN 10	2011	6								42	10.1186/1750-1326-6-42			14	Neurosciences	Neurosciences & Neurology	795HQ	WOS:000292965700001	21663635	DOAJ Gold, Green Published			2021-06-18	
J	Formica, V; Del Monte, G; Giacchetti, I; Grenga, I; Giaquinto, S; Fini, M; Roselli, M				Formica, Vincenzo; Del Monte, Girolamo; Giacchetti, Ilaria; Grenga, Italia; Giaquinto, Salvatore; Fini, Massimo; Roselli, Mario			Rehabilitation in Neuro-Oncology: A Meta-Analysis of Published Data and a Mono-Institutional Experience	INTEGRATIVE CANCER THERAPIES			English	Article						neuro-oncology rehabilitation; meta-analysis; Functional Independence Motricity scale; Barthel Index	SPINAL-CORD COMPRESSION; TRAUMATIC BRAIN-INJURY; LOW-GRADE GLIOMAS; INPATIENT REHABILITATION; FUNCTIONAL OUTCOMES; ACUTE STROKE; TUMORS; SURVIVAL; SURGERY; RESECTION	Rehabilitation for cancer patients with central nervous system (CNS) involvement is rarely considered and data on its use are limited. The purpose of the present study is to collect all available published data on neuro-oncology rehabilitation and perform a meta-analysis where results were presented in a comparable manner. Moreover, the authors report results on cancer patients with neurological disabilities undergoing rehabilitation at their unit. Study design. A PubMed search was performed to identify studies regarding cancer patients with CNS involvement undergoing inpatient physical rehabilitation. Studies with a complete functional evaluation at admission and discharge were selected. As the most common evaluation scales were Functional Independence Measure (FIM) and Barthel Index (BI), only articles with complete FIM and/or BI data were selected for the meta-analysis. Moreover, 23 cancer patients suffering from diverse neurological disabilities underwent standard rehabilitation program between April 2005 and December 2007 at the San Raffaele Pisana Rehabilitation Center. Patient demographics and relevant clinical data were collected. Motricity Index, Trunk Control Test score, and BI were monitored during rehabilitation to assess patient progresses. BI results of patients in this study were included in the meta-analysis. Results. The meta-analysis included results of a total of 994 patients. A statistically significant (P < .05) improvement of both BI and FIM scores was demonstrated after rehabilitation (standardized mean difference = 0.60 and 0.75, respectively). Functional status determined by either FIM or BI improved on average by 36%. Conclusion. Published data demonstrate that patients with brain tumors undergoing inpatient rehabilitation appear to make functional gains in line with those seen in similar patients with nonneoplastic conditions.	[Formica, Vincenzo] Univ Rome, Med Oncol Unit, Tor Vergata Clin Ctr, I-00133 Rome, Italy; [Formica, Vincenzo; Giacchetti, Ilaria; Giaquinto, Salvatore; Fini, Massimo; Roselli, Mario] IRCCS San Raffaele Pisana, I-00133 Rome, Italy; [Del Monte, Girolamo] San Raffaele Rocca di Papa Clin Ctr, Rome, Italy	Formica, V (corresponding author), Univ Rome, Med Oncol Unit, Tor Vergata Clin Ctr, Viale Oxford 81, I-00133 Rome, Italy.	v.formica@fastwebnet.it	Roselli, Mario/AAJ-5481-2020; Fini, Massimo/AAA-9948-2021	Roselli, Mario/0000-0002-2431-6689	Italian Ministry of HealthMinistry of Health, Italy [RO 2006]	The present research has been partially funded by the Italian Ministry of Health as a part of the national project RO 2006 titled "Quality of Life in Oncological Frail Patients. The Role of Oncological Rehabilitation: From Care to Take Care.	Boake C, 1993, ARCH PHYS MED REHAB, V74, P1247; Chaichana KL, 2010, J NEUROSURG, V112, P10, DOI 10.3171/2008.10.JNS08608; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Eriks IE, 2004, SPINAL CORD, V42, P235, DOI 10.1038/sj.sc.3101555; Franceschini M, 2009, AM J PHYS MED REHAB, V88, P679, DOI 10.1097/PHM.0b013e3181b20a4d; Geler-Kulcu D, 2009, J CLIN NEUROSCI, V16, P74, DOI 10.1016/j.jocn.2008.04.014; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Greenberg E, 2006, AM J PHYS MED REHAB, V85, P568, DOI 10.1097/01.phm.0000223218.38152.53; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Kilic T, 2002, J CLIN NEUROSCI, V9, P549, DOI 10.1054/jocn.2002.1136; Kirshblum S, 2001, CANCER, V92, P1029, DOI 10.1002/1097-0142(20010815)92:4+<1029::AID-CNCR1416>3.0.CO;2-P; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1253, DOI 10.1016/S0003-9993(99)90025-4; McKinley WO, 2000, AM J PHYS MED REHAB, V79, P138, DOI 10.1097/00002060-200003000-00005; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; Pouratian N, 2007, NAT CLIN PRACT NEURO, V3, P628, DOI 10.1038/ncpneuro0634; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Tang V, 2007, SPINAL CORD, V45, P671, DOI 10.1038/sj.sc.3102024; Tang V, 2008, J NEUROL, V255, P820, DOI 10.1007/s00415-008-0695-z; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; YOSHIOKA H, 1994, AM J PHYS MED REHAB, V73, P199, DOI 10.1097/00002060-199406000-00009	28	13	13	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-7354	1552-695X		INTEGR CANCER THER	Integr. Cancer Ther.	JUN	2011	10	2					119	126		10.1177/1534735410392575			8	Oncology; Integrative & Complementary Medicine	Oncology; Integrative & Complementary Medicine	784OD	WOS:000292165700001	21196433	DOAJ Gold			2021-06-18	
J	Rivara, FP; Koepsell, TD; Wang, J; Durbin, D; Jaffe, KM; Vavilala, M; Dorsch, A; Roper-Caldbeck, M; Houseknecht, E; Temkin, N				Rivara, Frederick P.; Koepsell, Thomas D.; Wang, Jin; Durbin, Dennis; Jaffe, Kenneth M.; Vavilala, Monica; Dorsch, Andrea; Roper-Caldbeck, Maria; Houseknecht, Eileen; Temkin, Nancy			Comparison of Telephone with World Wide Web-Based Responses by Parents and Teens to a Follow-Up Survey after Injury	HEALTH SERVICES RESEARCH			English	Article						Injuries; surveys; Internet; telephone; children	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; DIGITAL DIVIDE; ALCOHOL-USE; RELIABILITY; MODE; NONRESPONSE; VALIDITY; DESIGN; INCOME	Objective To identify sociodemographic factors associated with completing a follow-up survey about health status on the web versus by telephone, and to examine differences in reported health-related quality of life by method of response. Data Sources/Study Settings Survey about child health status of 896 parents of children aged 0-17 years treated in a hospital emergency department or admitted for a traumatic brain injury or arm injury, and 227 injured adolescents aged 14-17 years. Study Design The main outcomes were characteristics of those who completed a follow-up survey on the web versus by telephone and health-related quality of life by method of response. Principal Findings Email addresses were provided by 76.9 percent of parents and 56.5 percent of adolescents at baseline. The survey was completed on the web by 64.9 percent of parents and 40.2 percent of adolescents through email. Parents with email access who were Blacks, Hispanics, had lower incomes, and those who were not working were less likely to choose the web mode for completing the survey. Unlike adolescents, the amount of time for parents to complete the survey online was significantly shorter than completion by telephone. Differences by survey mode were small but statistically significant in some of the six functional outcome measures examined. Conclusions Survey mode was associated with several sociodemographic characteristics. Sole use of web surveys could provide biased data.	[Rivara, Frederick P.; Koepsell, Thomas D.; Wang, Jin; Jaffe, Kenneth M.; Vavilala, Monica; Dorsch, Andrea; Roper-Caldbeck, Maria] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Rivara, Frederick P.; Wang, Jin; Jaffe, Kenneth M.; Vavilala, Monica] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Koepsell, Thomas D.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Vavilala, Monica] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Dorsch, Andrea] Seattle Childrens Hosp, Seattle, WA USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Dept Pediat, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	Rivara, FP (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	fpr@uw.edu			National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE 001021]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025014] Funding Source: NIH RePORTER	This study was funded by a grant (grant number R49 CE 001021) from the National Center for Injury Prevention and Control and Centers for Disease Control and Prevention. The study sponsor had no role in the review or approval of the manuscript.	AQUILINO WS, 1994, PUBLIC OPIN QUART, V58, P210, DOI 10.1086/269419; Atkinson NL, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1035; Beckjord EB, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e20; Bedell G., 2006, BRAIN INJ PROF, V3, P14; Chakraborty J, 2005, PROF GEOGR, V57, P395, DOI 10.1111/j.0033-0124.2005.00486.x; *COMM F C, 2010, HIGH SPEED SERV INT; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; de Leeuw Edith D., 1988, TELEPHONE SURVEY MET, P273; Dillman DA, 2007, AM J PREV MED, V32, pS90, DOI 10.1016/j.amepre.2007.03.008; Fahimi Mansour, 2008, Prev Chronic Dis, V5, pA80; Fairlie Robert W, 2007, Electronic Commerce Research, V7, P265, DOI 10.1007/s10660-007-9006-5; Fricker S, 2005, PUBLIC OPIN QUART, V69, P370, DOI 10.1093/poq/nfi027; Galesic M, 2006, AM J PREV MED, V31, P437, DOI 10.1016/j.amepre.2006.07.023; Graham AL, 2006, NICOTINE TOB RES, V8, pS49, DOI 10.1080/14622200601045367; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.987; Hargittai E., 2008, SOCIAL STRATIFICATIO, P936; Harrison P., 2003, ADAPTIVE BEHAV ASSES; JELLINEK MS, 1988, AM J DIS CHILD, V142, P1153, DOI 10.1001/archpedi.1988.02150110031013; LENJNIEKS C, 2009, GENERATION UNPLUGGED; Link MW, 2005, EPIDEMIOLOGY, V16, P701, DOI 10.1097/01.ede.0000172138.67080.7f; Link MW, 2005, J STUD ALCOHOL, V66, P239, DOI 10.15288/jsa.2005.66.239; Martin SP, 2007, SOC PROBL, V54, P1, DOI 10.1525/sp.2007.54.1.1; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McMorris BJ, 2009, EVALUATION REV, V33, P138, DOI 10.1177/0193841X08326463; Parks KA, 2006, J STUD ALCOHOL, V67, P318, DOI 10.15288/jsa.2006.67.318; Pena-Purcell N, 2008, J MED LIBR ASSOC, V96, P101, DOI 10.3163/1536-5050.96.2.101; Rankin KM, 2008, CANCER EPIDEM BIOMAR, V17, P2639, DOI 10.1158/1055-9965.EPI-08-0304; Santuzzi Nicole R, 2009, Qual Manag Health Care, V18, P3, DOI 10.1097/01.QMH.0000344589.61971.41; Simon G, 2009, PSYCHIAT SERV, V60, P67, DOI 10.1176/appi.ps.60.1.67; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; Tourangeau R, 2004, ANNU REV PSYCHOL, V55, P775, DOI 10.1146/annurev.psych.55.090902.142040; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wilson KR, 2003, SOC SCI COMPUT REV, V21, P133, DOI [10.1177/0894439303021002001, 10.1177/0894439303251554]	34	13	13	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0017-9124			HEALTH SERV RES	Health Serv. Res.	JUN	2011	46	3					964	981		10.1111/j.1475-6773.2010.01236.x			18	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	758NN	WOS:000290171600016	21275989	Green Published			2021-06-18	
J	Zhang, LY; Gurao, M; Yang, KH; King, AI				Zhang, Liying; Gurao, Manish; Yang, King H.; King, Albert I.			Material characterization and computer model simulation of low density polyurethane foam used in a rodent traumatic brain injury model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Rodent head impact acceleration device; Traumatic brain injury; Low density polyurethane foam; Compression test; Rate dependency; Finite element modeling	AXONAL INJURY; DIFFUSE; IMPAIRMENT; ENERGY; RATS	Computer models of the head can be used to simulate the events associated with traumatic brain injury (TBI) and quantify biomechanical response within the brain. Marmarou's impact acceleration rodent model is a widely used experimental model of TBI mirroring axonal pathology in humans. The mechanical properties of the low density polyurethane (PU) foam, an essential piece of energy management used in Marmarou's impact device, has not been fully characterized. The foam used in Marmarou's device was tested at seven strain rates ranging from quasi-static to dynamic (0.014-42.86 s(-1)) to quantify the stress-strain relationships in compression. Recovery rate of the foam after cyclic compression was also determined through the periods of recovery up to three weeks. The experimentally determined stress-strain curves were incorporated into a material model in an explicit Finite Element (FE) solver to validate the strain rate dependency of the FE foam model. Compression test results have shown that the foam used in the rodent impact acceleration model is strain rate dependent. The foam has been found to be reusable for multiple impacts. However the stress resistance of used foam is reduced to 70% of the new foam. The FU_CHANG_FOAM material model in an FE solver has been found to be adequate to simulate this rate sensitive foam. (C) 2011 Elsevier B.V. All rights reserved.	[Zhang, Liying; Gurao, Manish; Yang, King H.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA	Zhang, LY (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.	lzhang@wayne.edu			National Highway Transportation Safety Administration (NHTSA) through the UAB Southern Consortium of Injury Biomechanics; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EB006508]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB006508] Funding Source: NIH RePORTER	The study was funded in part by the National Highway Transportation Safety Administration (NHTSA) through the UAB Southern Consortium of Injury Biomechanics (AIK) and NIH R01 EB006508 (LYZ).	Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chang FS, 1998, J ENG MATER-T ASME, V120, P212, DOI 10.1115/1.2812345; Davies OL, 1999, CELL POLYM, V18, P117; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2; Hager S.L., 1992, THE J, V28, P284, DOI [10.1177/0021955X9202800305, DOI 10.1177/0021955X9202800305]; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HOSFORD WF, 1993, METAL FORMING MECH M, P80; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kim JS, 2002, INT J MECH SCI, V44, P2285, DOI 10.1016/S0020-7403(02)00176-5; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mills NJ, 2002, CELL POLYM, V21, P343, DOI 10.1177/026248930202100502; Mills NJ, 2000, CELL POLYM, V19, P389; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; REHKOPF JD, 1994, P INT C EXP; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Sengul G, 2008, J CLIN NEUROSCI, V15, P1125, DOI 10.1016/j.jocn.2007.11.005; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Suresh S., 1991, FATIGUE MAT; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; VORSPOHL K, 1994, J CELL PLAST, V30, P361, DOI 10.1177/0021955X9403000410; Youssef S, 2005, ACTA MATER, V53, P719, DOI 10.1016/j.actamat.2004.10.024; ZHANG L, 2006, P ASME BIOENG C; ZHANG L, 2010, J NEUROTRAUM, V26, P42	28	13	13	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAY 15	2011	198	1					93	98		10.1016/j.jneumeth.2011.03.024			6	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	771FM	WOS:000291142600013	21459114	Green Accepted			2021-06-18	
J	Moon, Y; Kim, JY; Choi, SY; Kim, K; Kim, H; Sun, W				Moon, Younghye; Kim, Joo Yeon; Choi, So Yoen; Kim, Kyungjin; Kim, Hyun; Sun, Woong			Induction of ezrin-radixin-moesin molecules after cryogenic traumatic brain injury of the mouse cortex	NEUROREPORT			English	Article						ezrin-radixin-moesin; macrophage; microglia; traumatic brain injury	ADULT SUBVENTRICULAR ZONE; ROSTRAL MIGRATORY STREAM; ERM PROTEINS; EXPRESSION; CELLS	Traumatic brain injury promotes rapid induction of microglial cells and infiltration of peripheral macrophages to the injury sites. Such inflammatory responses are mediated by the activation and migration of immune cells, which are influenced by the actin cytoskeleton remodeling. In this study, we observed that the phosphorylation and expressions of ezrin-radixin-moesin (ERM) proteins, which are linkers for cell surface with actin cytoskeleton, are induced in the activated microglia/macrophages, whereas ERM molecules are only marginally expressed in quiescent microglia in the normal brain. These results suggest that ERM activation in the injury penumbra is implicated in the inflammatory immune responses after traumatic brain injury. NeuroReport 22:304-308 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Kim, Joo Yeon; Choi, So Yoen; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Joo Yeon; Choi, So Yoen; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Coll Nat Sci, Brain & Neuroendocrine Lab, Sch Biol Sci, Seoul 151742, South Korea	Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Choi, So Yoen/AAV-1947-2020	Moon, Younghye/0000-0002-3737-0043	Korean Ministry of Education, Science, and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010K000803]; National Research Foundation of KoreaNational Research Foundation of Korea [20100020237]	This work is supported by Grants from the Korean Ministry of Education, Science, and Technology by Brain Research Center of the twenty-first century Frontier Program in Neuroscience (2010K000803) and the National Research Foundation of Korea (20100020237).	BERRYMAN M, 1993, J CELL SCI, V105, P1025; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Cleary MA, 2006, NEUROSCIENCE, V143, P851, DOI 10.1016/j.neuroscience.2006.08.028; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Soares HD, 1995, J NEUROSCI, V15, P8223	16	13	15	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 20	2011	22	6					304	308		10.1097/WNR.0b013e3283460265			5	Neurosciences	Neurosciences & Neurology	743AQ	WOS:000288987800009	21451358				2021-06-18	
J	Tate, DF; Neeley, ES; Norton, MC; Tschanz, JT; Miller, MJ; Wolfson, L; Hulette, C; Leslie, C; Welsh-Bohmer, KA; Plassman, B; Bigler, ED				Tate, D. F.; Neeley, E. S.; Norton, M. C.; Tschanz, J. T.; Miller, M. J.; Wolfson, L.; Hulette, C.; Leslie, C.; Welsh-Bohmer, K. A.; Plassman, B.; Bigler, Erin D.			Intracranial volume and dementia: Some evidence in support of the cerebral reserve hypothesis	BRAIN RESEARCH			English	Article						Alzheimer's disease; Intracranial volume; Cognitive or brain reserve; APOE; Dementia	APOLIPOPROTEIN-E GENOTYPE; TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; HEAD CIRCUMFERENCE; CACHE-COUNTY; COGNITIVE RESERVE; SIZE; ASSOCIATION; CHILDREN; INTELLIGENCE	The brain reserve hypothesis has been posited as being one important mediating factor for developing dementia, especially Alzheimer's disease (AD). Evidence for this hypothesis is mixed though different methodologies have made these findings difficult to interpret. We examined imaging data from a large cohort (N=194) of mixed dementia patients and controls, 65 years old and older from the Cache County, Utah Study of Memory and Aging for evidence of the brain reserve hypothesis using total intracranial volume (TICV) as a quantitative measure of pre-morbid brain size and a vicarious indicator of reserve. A broader spectrum of non-demented elderly control subjects from previous studies was also included for comparison (N=423). In addition, non-parametric Classification and Regression Tree (CART) analyses were performed to model group heterogeneity and identify any subgroups of patients where TICV might be an important predictor of dementia. Parametrically, no main effect was found for TICV when predicting a dementia diagnosis; however, the CART analysis did reveal important TICV subgroups, including a sex differential wherein epsilon 4 APOE allele presence in males and low TICV predicted AD classification. TICV, APOE, and other potential mediator/moderator variables are discussed in the context of the brain reserve hypothesis. (C) 2010 Published by Elsevier B.V.	[Tate, D. F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Imaging, Boston, MA 02115 USA; [Tate, D. F.] Boston Univ, Med Ctr, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Neeley, E. S.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Norton, M. C.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA; [Norton, M. C.; Tschanz, J. T.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Miller, M. J.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Miller, M. J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Wolfson, L.] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland; [Hulette, C.; Leslie, C.; Welsh-Bohmer, K. A.; Plassman, B.] Duke Univ, Med Ctr, Durham, NC USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA	Tate, DF (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Imaging, 221 Longwood Ave, Boston, MA 02115 USA.	dtate1@partners.org; sneeley@stat.byu.edu; maria.norton@usu.edu; joann.tschanz@usu.edu; wolfsonl@who.int; kwe@duke.edu; brenda.plassman@duke.edu; erin_bigler@byu.edu	Tate, David/G-5166-2011; Wolfson, Lara/AAC-1400-2019; Tate, David F/I-3963-2013; Plassman, Brenda L/K-2620-2015; Welsh-Bohmer, Kathleen/AAA-3178-2020; Norton, Maria C/E-6994-2013; Tschanz, JoAnn T./E-5986-2010	Tate, David/0000-0003-0213-1920; Wolfson, Lara/0000-0002-6454-3368; Tate, David F/0000-0003-0213-1920; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG-1380]; Ira Fulton Foundation; Radiology Department at Logan Regional Medical Center Logan, Utah; John C.S. Breitner, M.D.; Boston University Alzheimer's Disease Core Center [RO1-AG11380, RO1-AG21136, K23MH073416, P30-AG013486]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH073416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021136, R01AG011380] Funding Source: NIH RePORTER	Supported in part by the National Institutes of Health Grant AG-1380 and the Ira Fulton Foundation. The support from the Radiology Department at Logan Regional Medical Center Logan, Utah, where the imaging studies were performed, is gratefully acknowledged, along with the support of John C.S. Breitner, M.D. and other investigators of the Cache County Memory in Aging Project. We would like to acknowledge the following funding sources as being instrumental in the completion of this project: RO1-AG11380 (K.W.B.), RO1-AG21136 (J.T.T.), K23MH073416 (D.F.T.), and P30-AG013486 (Boston University Alzheimer's Disease Core Center).	Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; ARMSTRONG E, 1982, PRIMATE BRAIN EVOLUT; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Bigler ED, 2002, J INT NEUROPSYCH SOC, V8, P925, DOI 10.1017/S1355617702870072; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2001, ARCH NEUROL-CHICAGO, V58, P831, DOI 10.1001/archneur.58.5.831; Bigler ED, 2001, INVEST RADIOL, V36, P539, DOI 10.1097/00004424-200109000-00006; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Breiman L., 1983, CLASSIFICATION REGRE; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Coffey CE, 1999, NEUROLOGY, V53, P189, DOI 10.1212/WNL.53.1.189; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; Daly E, 2000, ARCH NEUROL-CHICAGO, V57, P675, DOI 10.1001/archneur.57.5.675; DAVIS PJM, 1977, NEUROPATH APPL NEURO, V3, P341, DOI 10.1111/j.1365-2990.1977.tb00595.x; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; DeMeyer W., 1994, PEDIAT NEUROLOGY PRI, P205; DIAMOND MC, 1986, BIOL SUBSTRATES ALZH, P55; Drachman DA, 2002, NEUROLOGY, V59, P156, DOI 10.1212/WNL.59.2.156; Edland SD, 2002, NEUROLOGY, V59, P272, DOI 10.1212/WNL.59.2.272; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Espinosa PS, 2006, J ALZHEIMERS DIS, V9, P77; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Frisk V, 2002, DEV NEUROPSYCHOL, V22, P565, DOI 10.1207/S15326942DN2203_2; Ganguli M, 2000, NEUROLOGY, V54, P1109, DOI 10.1212/WNL.54.5.1109; GLASSMAN RB, 1987, NEUROSCI BIOBEHAV R, V11, P275, DOI 10.1016/S0149-7634(87)80014-3; GOSCH A, 1997, DEV MED CHILD NEUROL, V39, P295; Graves AB, 1996, BRIT J PSYCHIAT, V169, P86, DOI 10.1192/bjp.169.1.86; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P761, DOI 10.1001/archpsyc.57.8.761; Hall KS, 2000, NEUROLOGY, V54, P95, DOI 10.1212/WNL.54.1.95; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Jenkins R, 2000, ARCH NEUROL-CHICAGO, V57, P220, DOI 10.1001/archneur.57.2.220; Jerison H.J., 1987, ENCY NEUROSCIENCE, V1, P168; JOHNSON FP, 1991, BRIT J ORAL MAX SURG, V29, P282, DOI 10.1016/0266-4356(91)90200-O; Jorm AF, 1997, PERS INDIV DIFFER, V23, P371; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; KATZMAN R, 1993, NEUROLOGY, V43, P12; Kim KR, 2008, AM J GERIAT PSYCHIAT, V16, P819, DOI 10.1097/JGP.0b013e3181800551; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Martyn CN, 1996, BRIT MED J, V312, P1393; Moore W. J., 1974, GROWTH FACIAL SKELET; Mori E, 1997, AM J PSYCHIAT, V154, P18, DOI 10.1176/ajp.154.1.18; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; PAGEL MD, 1988, AM NAT, V132, P344, DOI 10.1086/284857; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; RANLY D, 1980, SYNOPSIS CRANIOFACIA; Reddick WE, 1998, MAGN RESON IMAGING, V16, P413, DOI 10.1016/S0730-725X(98)00014-9; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Reynolds MD, 1999, NEUROLOGY, V53, P228, DOI 10.1212/WNL.53.1.228; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P108, DOI 10.1001/archneurol.2007.11; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SCHEIBEL A, 1990, BRAIN COGNITION, V12, P85, DOI 10.1016/0278-2626(90)90006-A; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SCHOFIELD PW, 1995, ARCH NEUROL-CHICAGO, V52, P95, DOI 10.1001/archneur.1995.00540250103019; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Sperber G.H., 2001, CRANIOFACIAL DEV; Stathis SL, 1999, DEV MED CHILD NEUROL, V41, P375, DOI 10.1017/S0012162299000833; Steffens DC, 2000, ARCH GEN PSYCHIAT, V57, P601, DOI 10.1001/archpsyc.57.6.601; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2007, COGNITIVE RESERVE TH; Tate DF, 2007, NEUROPEDIATRICS, V38, P18, DOI 10.1055/s-2007-981450; Tschanz JT, 2006, NEUROLOGY, V67, P229, DOI 10.1212/01.wnl.0000224748.48011.84; Tschanz JT, 2000, NEUROLOGY, V54, P1290, DOI 10.1212/WNL.54.6.1290; Van der Flier WM, 2008, DEMENT GERIATR COGN, V25, P433, DOI 10.1159/000124750; Vernon P. A., 2000, HDB INTELLIGENCE, P245, DOI DOI 10.1017/CBO9780511807947.013; WILLERMAN L, 1991, INTELLIGENCE, V15, P223, DOI 10.1016/0160-2896(91)90031-8; Zhang H, 1999, RECURSIVE PARTITIONI; ZHANG H, 1998, ENCY BIOSTATISTICS	86	13	13	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	APR 18	2011	1385						151	162		10.1016/j.brainres.2010.12.038			12	Neurosciences	Neurosciences & Neurology	753WL	WOS:000289810800017	21172323	Green Accepted			2021-06-18	
J	Boudreau, D; Costanza-Smith, A				Boudreau, Donna; Costanza-Smith, Amy			Assessment and Treatment of Working Memory Deficits in School-Age Children: The Role of the Speech-Language Pathologist	LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS			English	Article						working memory; language impairment; language assessment; language intervention; phonological memory	COMPLEX SENTENCE COMPREHENSION; TRAUMATIC BRAIN-INJURY; LESS SKILLED READERS; SHORT-TERM-MEMORY; NONWORD REPETITION; PHONOLOGICAL MEMORY; INDIVIDUAL-DIFFERENCES; READING DISABILITIES; VOCABULARY ACQUISITION; LEARNING-DISABILITIES	Purpose: To review research addressing the relationship of working memory (WM) to language development and academic functioning and to consider the role of the speech-language pathologist (SLP) in assessment and intervention of WM difficulties in school-age children. Method: Aspects of WM critical to language acquisition and academic success are defined, and the importance of WM to language development and learning is discussed. Subsequently, strategies for assessing WM skills in children are presented. Following a discussion regarding the assessment of WM demands in the classroom, intervention strategies are provided. Results: Children with poor WM skills are likely to experience significant difficulty in academic settings. Evidence-based strategies for both reducing WM demands and improving functional WM skills are reviewed. Conclusion: Research to date has documented that children with language impairments frequently have poor WM skills. SLPs can support poor WM skills by considering both modifications to the environment and child-enacted knowledge and skills, which may serve to reduce the impact of poor WM skills on learning and academic success.	[Boudreau, Donna] Univ No Colorado, Greeley, CO 80639 USA; [Costanza-Smith, Amy] Oregon Hlth & Sci Univ, Portland, OR USA	Boudreau, D (corresponding author), Univ No Colorado, Greeley, CO 80639 USA.	donna.boudreau@unco.edu					Adams A.M., 2001, WORKING MEMORY PERSP, P79; ADAMS AM, 1995, J SPEECH HEAR RES, V38, P403, DOI 10.1044/jshr.3802.403; Adams AM, 1999, INT J PSYCHOL, V34, P364, DOI 10.1080/002075999399701; Alloway TP, 2005, BRIT J DEV PSYCHOL, V23, P417, DOI 10.1348/026151005X26804; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Alloway TP, 2009, LEARN INDIVID DIFFER, V19, P242, DOI 10.1016/j.lindif.2008.10.003; Alloway TP, 2009, EUR J PSYCHOL ASSESS, V25, P92, DOI 10.1027/1015-5759.25.2.92; Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Avons SE, 1998, APPL PSYCHOLINGUIST, V19, P583, DOI 10.1017/S0142716400010377; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Baddeley A., 1990, NEUROPSYCHOLOGICAL I, P54; Baddeley AD, 2000, J EXP CHILD PSYCHOL, V77, P128, DOI 10.1006/jecp.2000.2592; Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Berninger VW, 2008, READ WRIT, V21, P95, DOI 10.1007/s11145-007-9066-x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Botting N, 2001, INT J LANG COMM DIS, V36, P421, DOI 10.1080/13682820110074971; Boudreau D., 2007, LANGUAGE DISORDERS D, P331; Brocki KC, 2008, J CLIN EXP NEUROPSYC, V30, P749, DOI 10.1080/13803390701754720; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Campbell T, 1997, J SPEECH LANG HEAR R, V40, P519, DOI 10.1044/jslhr.4003.519; Carretti B, 2009, LEARN INDIVID DIFFER, V19, P246, DOI 10.1016/j.lindif.2008.10.002; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Conti-Ramsden G, 2007, J CHILD PSYCHOL PSYC, V48, P147, DOI 10.1111/j.1469-7610.2006.01703.x; Cowan N., 1998, TOP LANG DISORD, V17, P1; DANCY MLW, 1997, TOP LANG DISORD, V18, P32; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; Duff SC, 2001, Q J EXP PSYCHOL-A, V54, P31, DOI 10.1080/02724980042000011; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Engel PMJ, 2008, J SPEECH LANG HEAR R, V51, P1580, DOI 10.1044/1092-4388(2008/07-0210); Engle RW, 2001, SCI CON SER, P297, DOI 10.1037/10394-016; Fazio BB, 1996, TOP LANG DISORD, V17, P58, DOI 10.1097/00011363-199611000-00007; GALE R, 2003, STANFORD BINET INTEL; Gathercole S. E., 2008, APPL COGNITIVE RES K, P17; Gathercole S.E., 1996, CHILDRENS TEST NONWO; Gathercole S. E., 1993, WORKING MEMORY LANGU; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; GATHERCOLE SE, 1995, MEM COGNITION, V23, P83, DOI 10.3758/BF03210559; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; GATHERCOLE SE, 1993, EUR J PSYCHOL EDUC, V8, P259, DOI 10.1007/BF03174081; GATHERCOLE SE, 2004, WORKING MEMORY ED, P219; Gathercole SE, 2008, PSYCHOLOGIST, V21, P382; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Georgiou GK, 2008, J EDUC PSYCHOL, V100, P566, DOI 10.1037/0022-0663.100.3.566; Gill CB, 2003, CHILD LANG TEACH THE, V19, P85, DOI DOI 10.1191/0265659003CT245OA; Gillam RB, 1997, TOP LANG DISORD, V18, P72, DOI 10.1097/00011363-199711000-00008; Gillam RB, 2002, TOP LANG DISORD, V22, P30, DOI 10.1097/00011363-200205000-00005; Gillam RB, 1996, TOP LANG DISORD, V17, P72, DOI 10.1097/00011363-199611000-00008; Gilliver ML, 2009, READ WRIT, V22, P637, DOI 10.1007/s11145-008-9155-5; GLENBERG AM, 2005, IMPROVING READ UNPUB; Glenberg AM, 2007, CONTEMP EDUC PSYCHOL, V32, P389, DOI 10.1016/j.cedpsych.2006.03.001; Gupta P, 2009, J MEM LANG, V61, P481, DOI 10.1016/j.jml.2009.08.001; HITCH GJ, 2001, J EXP PSYCHOL, V130, P194; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Hood Jane, 2005, Pediatr Rehabil, V8, P272, DOI 10.1080/13638490400022303; Horohov JE, 2004, APPL PSYCHOLINGUIST, V25, P43, DOI 10.1017/S0142716404001031; Hutchinson J, 1997, TOP LANG DISORD, V18, P45, DOI 10.1097/00011363-199711000-00006; Imbo I, 2007, J EXP CHILD PSYCHOL, V96, P284, DOI 10.1016/j.jecp.2006.09.001; Isaki E, 2008, J COMMUN DISORD, V41, P512, DOI 10.1016/j.jcomdis.2008.03.006; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; JARROLD C, 2001, WORKING MEMORY PERSP, P126; Jones G, 2007, DEVELOPMENTAL SCI, V10, P853, DOI 10.1111/j.1467-7687.2007.00638.x; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kail R., 1990, DEV MEMORY CHILDREN; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; KLINGBERG T, 2001, COGNITIVE MEMORY TRA; Klingner J.K., 2007, TEACHING READING COM; Lahey M, 1994, LANGUAGE LEARNING DI, P354; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); LINDBLOM B, 1989, BRAIN READING, P27; Maridaki-Kassotaki K, 2002, EUR J PSYCHOL EDUC, V17, P63, DOI 10.1007/BF03173205; Marton K, 2008, INT J LANG COMM DIS, V43, P181, DOI 10.1080/16066350701340719; Marton K, 2007, PSYCHOLOGIA, V50, P110, DOI 10.2117/psysoc.2007.110; McCabe A., 2003, PATTERNS NARRATIVE D; Minear M., 2006, WORKING MEMORY ED, P273; Montgomery JW, 2008, J PSYCHOLINGUIST RES, V37, P331, DOI 10.1007/s10936-008-9077-z; Montgomery JW, 2010, AM J SPEECH-LANG PAT, V19, P78, DOI 10.1044/1058-0360(2009/09-0028); Montgomery JW, 2009, APPL PSYCHOLINGUIST, V30, P485, DOI 10.1017/S0142716409090249; Montgomery JW, 2009, J SPEECH LANG HEAR R, V52, P269, DOI 10.1044/1092-4388(2008/07-0116); Montgomery JW, 2000, APPL PSYCHOLINGUIST, V21, P117, DOI 10.1017/S0142716400001065; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; Montgomery JW, 2002, AM J SPEECH-LANG PAT, V11, P77, DOI 10.1044/1058-0360(2002/009); MONTGOMERY JW, 1995, J SPEECH HEAR RES, V38, P187, DOI 10.1044/jshr.3801.187; Nation K, 1999, J EXP CHILD PSYCHOL, V73, P139, DOI 10.1006/jecp.1999.2498; O'Shaughnessy TE, 2000, J LEARN DISABIL-US, V33, P257, DOI 10.1177/002221940003300304; O'Shaughnessy TE, 1998, LEARN DISABILITY Q, V21, P123, DOI 10.2307/1511341; Oetting JB, 2006, CLIN LINGUIST PHONET, V20, P553, DOI 10.1080/02699200500266455; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Parente R, 1999, NEUROREHABILITATION, V13, P13; Passolunghi MC, 2004, J EXP CHILD PSYCHOL, V88, P348, DOI 10.1016/j.jecp.2004.04.002; Pickering S. J., 2003, ED CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Pickering S.J., 2001, WORKING MEMORY TEST; Quail M, 2009, INT J SPEECH-LANG PA, V11, P220, DOI 10.1080/17549500802495581; Rankin Peter M, 2005, Pediatr Rehabil, V8, P283, DOI 10.1080/13638490400022436; Riccio CA, 2007, APPL NEUROPSYCHOL, V14, P255, DOI 10.1080/09084280701719203; Ricks TR, 2009, J MEM LANG, V61, P519, DOI 10.1016/j.jml.2009.07.007; Rodekohr RK, 2001, J COMMUN DISORD, V34, P255, DOI 10.1016/S0021-9924(01)00050-8; SALTHOUSE R, 1989, J EXPT PSYCHOL LEARN, V15, P507; Seigneuric A, 2000, READ WRIT, V13, P81, DOI 10.1023/A:1008088230941; Seigneuric A., 2005, READING AND WRITING, V18, DOI [10.1007/s11145-005-2038-0, DOI 10.1007/S11145-005-2038-0]; Semel E., 2003, CLIN EVALUATION LANG; Snyder LE, 2002, TOP LANG DISORD, V22, P1, DOI 10.1097/00011363-200205000-00003; SOHLBERG MM, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; St Clair-Thompson H, 2010, EDUC PSYCHOL-UK, V30, P203, DOI 10.1080/01443410903509259; Swanson HL, 2007, J EXP CHILD PSYCHOL, V96, P249, DOI 10.1016/j.jecp.2006.12.004; Swanson HL, 2010, J LEARN DISABIL-US, V43, P24, DOI 10.1177/0022219409338743; Swanson HL, 2004, J EDUC PSYCHOL, V96, P471, DOI 10.1037/0022-0663.96.3.471; SWANSON HL, 1989, J ABNORM CHILD PSYCH, V17, P145, DOI 10.1007/BF00913790; SWANSON HL, 1995, INTELLIGENCE, V21, P83, DOI 10.1016/0160-2896(95)90040-3; Thordardottir E, 2008, J SPEECH LANG HEAR R, V51, P922, DOI 10.1044/1092-4388(2008/068); Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Tompkins C.A., 1995, RIGHT HEMISPHERE COM; Torppa M, 2006, DEV PSYCHOL, V42, P1128, DOI 10.1037/0012-1649.42.6.1128; Turley-Ames KJ, 2003, J MEM LANG, V49, P446, DOI 10.1016/S0749-596X(03)00095-0; Vallat C, 2005, BRAIN INJURY, V19, P1157, DOI 10.1080/02699050500110595; van Kleeck A, 1998, AM J SPEECH-LANG PAT, V7, P65, DOI 10.1044/1058-0360.0703.65; Vanderberg R, 2007, READ WRIT, V20, P721, DOI 10.1007/s11145-006-9046-6; Vukovic R. K., 2010, LEARNING DISABILITIE, V25, P25, DOI [10.1111/j.1540-5826.2009.00298.x, DOI 10.1111/J.1540-5826.2009.00298.X]; Wagner RK., 1999, COMPREHENSIVE TEST P; Wechsler D., 2004, WECHSLER INTELLIGENC; Weismer SE, 1999, J SPEECH LANG HEAR R, V42, P1249, DOI 10.1044/jslhr.4205.1249; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865; Weismer SE, 2005, J SPEECH LANG HEAR R, V48, P405, DOI 10.1044/1092-4388(2005/028); Weismer SE, 1996, J SPEECH HEAR RES, V39, P177, DOI 10.1044/jshr.3901.177; Weismer SE, 2002, TOP LANG DISORD, V22, P15, DOI 10.1097/00011363-200205000-00004; Weismer SE, 2006, APPL PSYCHOLINGUIST, V27, P556, DOI 10.1017/S0142716406240396; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; YUILL N, 1989, BRIT J PSYCHOL, V80, P351, DOI 10.1111/j.2044-8295.1989.tb02325.x	137	13	13	1	39	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	0161-1461	1558-9129		LANG SPEECH HEAR SER	Lang. Speech Hear. Serv. Sch.	APR 1	2011	42	2					152	166		10.1044/0161-1461(2010/09-0088)			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	744AE	WOS:000289062800004	21173396				2021-06-18	
J	Donovan, NJ; Heaton, SC; Kimberg, CI; Wen, PS; Waid-Ebbs, JK; Coster, W; Singletary, F; Velozo, CA				Donovan, Neila J.; Heaton, Shelley C.; Kimberg, Cara I.; Wen, Pey-Shan; Waid-Ebbs, J. Kay; Coster, Wendy; Singletary, Floris; Velozo, Craig A.			Conceptualizing functional cognition in traumatic brain injury rehabilitation	BRAIN INJURY			English	Article						Brain injury; cognition; cognition disorders; outcomes research; function	PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; ECOLOGICAL VALIDITY; SELF-AWARENESS; NEUROPSYCHOLOGICAL TESTS; HEALTH OUTCOMES; ERROR-AWARENESS; WORKING-MEMORY; HEAD-INJURY; ITEM BANKS	Primary objective: To conceptualize functional cognitive constructs across the continuum of traumatic brain injury (TBI) recovery, to form the foundation for the Computer Adaptive Measure of Functional Cognition for TBI (CAMFC-TBI). Background: TBI often has a profound impact on a survivor's ability to return to previous level of functioning and significantly reduces the overall quality of life for survivors and caregivers. Few assessments are designed to evaluate TBI's impact on cognitive functioning in everyday life. Neuropsychological tests are time consuming and may have questionable ecological validity for predicting functional outcomes. Global functional assessments contain few cognitive items and may lack psychometric rigour. Presently there is a lack of efficient, precise, ecologically valid functional cognitive measures. Main outcome and results: Studies that used neuropsychological and global functional assessments were reviewed to direct conceptualization of functional cognitive constructs across TBI recovery stages. An advisory panel reviewed study methodology and functional cognitive constructs development. They validated the need for the CAMFC-TBI and the six functional cognitive constructs: attention, memory, processing speed, executive functioning, social communication and emotional management. Conclusion: Conceptualizing functional cognitive constructs is the first step in CAMFC-TBI development. Future project stages include item pool development, qualitative testing, field-testing, psychometric analysis and computerized adaptive test programming.	[Donovan, Neila J.] Louisiana State Univ, Dept Commun Sci & Disorders, Baton Rouge, LA 70803 USA; [Donovan, Neila J.; Velozo, Craig A.] Univ Florida, N Florida S Georgia Vet Hlth Syst Rehabil Outcome, Gainesville, FL USA; [Donovan, Neila J.; Waid-Ebbs, J. Kay; Velozo, Craig A.] Univ Florida, Brain Rehabil Res Ctr, Gainesville, FL USA; [Heaton, Shelley C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Kimberg, Cara I.] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA; [Wen, Pey-Shan; Velozo, Craig A.] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Coster, Wendy] Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA; [Singletary, Floris] Brooks Ctr Rehabil Studies, Jacksonville, FL USA	Donovan, NJ (corresponding author), Louisiana State Univ, Dept Commun Sci & Disorders, 72 Hatcher Hall, Baton Rouge, LA 70803 USA.	ndonovan@lsu.edu		Wen, Pey-Shan/0000-0002-8921-8801	National Institute of Health National Center for Medical Rehabilitation Research [5R21HD045869-03]; Office of Veterans Affairs Rehabilitation Research and Development at the VA RR&D/HSR&D Rehabilitation Outcomes Research Center at the North Florida/South Georgia Veterans Medical Center in Gainesville, Florida [04296H]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD045869] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This study was supported by a grant from the National Institute of Health National Center for Medical Rehabilitation Research # 5R21HD045869-03. Dr Donovan's work was funded in part by the Office of Veterans Affairs Rehabilitation Research and Development Associate Investigator Award #04296H at the VA RR&D/HSR&D Rehabilitation Outcomes Research Center at the North Florida/South Georgia Veterans Medical Center in Gainesville, Florida.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arpinelli F, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-85; Arthanat S, 2004, DISABIL REHABIL, V26, P235, DOI 10.1080/09638280310001644889; Bergeson AG, 2004, CLIN NEUROPSYCHOL, V18, P509, DOI 10.1080/1385404049052414; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Cantagallo A, 2006, BRAIN INJURY, V20, P913, DOI 10.1080/02699050600832742; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; COLLINS JG, 1993, VITAL HLTH STAT, V2, P1; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Cook KF, 2007, QUAL LIFE RES, V16, P121, DOI 10.1007/s11136-007-9177-5; Cook KF, 2005, HEALTH SERV RES, V40, P1694, DOI 10.1111/j.1475-6773.2005.00446.x; Coster WJ, 2004, ARCH PHYS MED REHAB, V85, P2030, DOI 10.1016/j.apmr.2004.05.002; Coyne KS, 2006, UROLOGY, V68, P9, DOI 10.1016/j.urology.2006.05.042; D'Zurilla T. J., 1999, PROBLEM SOLVING THER; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; DeLisa JA, 2004, ARCH PHYS MED REHAB, V85, P531, DOI 10.1016/j.apmr.2003.12.003; Demir SO, 2006, BRAIN INJURY, V20, P1383, DOI 10.1080/02699050601081844; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Doward LC, 2004, VALUE HEALTH, V7, P4; DZurilla T. J., 2002, SOCIAL PROBLEM SOLVI; Elliott D, 2006, J CLIN EPIDEMIOL, V59, P153, DOI 10.1016/j.jclinepi.2005.06.010; *FED DRUG ADM, 2009, GUID IND PAT REP OUT, P37; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Fries JF, 2006, ANN RHEUM DIS, V65, P16, DOI 10.1136/ard.2006.059279; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 1996, BEHAV RATING INVENTO; GOLEMAN D, 1998, HARVARD BUSINESS NOV, P93; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Hahn EA, 2006, MED CARE, V44, pS189, DOI 10.1097/01.mlr.0000245145.21869.5b; Haley SM, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000103520.43902.6c; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; JENNETT B, 1975, LANCET, V1, P480; Jette AM, 2003, J REHABIL MED, V35, P145, DOI 10.1080/16501970310010501; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Luria A. R., 1966, HIGHER CORTICAL FUNC; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McHorney CA, 1997, ANN INTERN MED, V127, P743, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00061; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MOSCOVITCH M, 1979, HDB BEHAV NEUROBIOLO, V2; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Revicki DA, 2007, QUAL LIFE RES, V16, P717, DOI 10.1007/s11136-006-9153-5; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SBORDONE R, 1997, NEUROPSYCHOLOGY HDB, P365; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Silverberg ND, 2007, J INT NEUROPSYCH SOC, V13, P898, DOI 10.1017/S1355617707071135; Sneeuw KCA, 2002, J CLIN EPIDEMIOL, V55, P1130, DOI 10.1016/S0895-4356(02)00479-1; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; State University of New York at Buffalo, 1993, GUID US UN DAT SET M; Stuss D.T., 1986, FRONTAL LOBES; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Townend W, 2001, J NEUROL NEUROSUR PS, V70, P267; Tupper DE, 1990, NEUROPSYCHOLOGY EVER, P3, DOI DOI 10.1007/978-1-4613-1503-2_1; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Velozo CA, 1999, AM J OCCUP THER, V53, P83, DOI 10.5014/ajot.53.1.83; *WHO, 2001, INT CLASS FUNCT DISA; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014	96	13	13	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2011	25	4					348	364		10.3109/02699052.2011.556105			17	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600004	21323413				2021-06-18	
J	Gamache, PL; Lavalliere, M; Tremblay, M; Simoneau, M; Teasdale, N				Gamache, Pierre-Luc; Lavalliere, Martin; Tremblay, Mathieu; Simoneau, Martin; Teasdale, Normand			In-simulator training of driving abilities in a person with a traumatic brain injury	BRAIN INJURY			English	Article						Driving rehabilitation; traumatic brain injury; training; learning	REHABILITATION; STROKE	Aim: This study reports the case of a 23-year-old woman (MC) who sustained a severe traumatic brain injury in 2004. After her accident, her driving license was revoked. Despite recovering normal neuropsychological functions in the following years, MC was unable to renew her license, failing four on-road evaluations assessing her fitness to drive. Method: In hope of an eventual license renewal, MC went through an in-simulator training programme in the laboratory in 2009. The training programme aimed at improving features of MC's driving behaviour that were identified as being problematic in prior on-road evaluations. To do so, proper driving behaviour was reinforced via driving-specific feedback provided during the training sessions. Results: After 25 sessions in the simulator (over a period of 4 months), MC significantly improved various components of her driving. Notably, compared to early sessions, later ones were associated with a reduced cognitive load, less jerky speed profiles when stopping at intersections and better vehicle control and positioning. A 1-year retention test showed most of these improvements were consistent. Conclusions: The learning principles underlying well conducted simulator-based education programmes have a strong scientific basis. A simulator training programme like this one represents a promising avenue for driving rehabilitation. It allows individuals without a driving license to practice and improve their skills in a safe and realistic environment.	[Gamache, Pierre-Luc; Lavalliere, Martin; Tremblay, Mathieu; Simoneau, Martin; Teasdale, Normand] Univ Laval, Fac Med, GRAME, PEPS, Quebec City, PQ G1V 0A6, Canada; [Gamache, Pierre-Luc; Lavalliere, Martin; Simoneau, Martin; Teasdale, Normand] CHA, Ctr Rech FRSQ, Ctr Excellence Vieillissement Quebec, Quebec City, PQ, Canada	Gamache, PL (corresponding author), Univ Laval, CHA Hop St Sacrement,Fac Med, Ctr Excellence Vieillissement Quebec,Div Kinesiol, Ctr Rech FRSQ,Grp Rech Anal Mouvement & Ergon, 2300 Rue Terrasse, Quebec City, PQ G1V 0A6, Canada.	pierre-luc.gamache@psy.ulaval.ca	Simoneau, Martin/AAE-3727-2020	Simoneau, Martin/0000-0003-3207-1973			ALM H, 1994, ACCIDENT ANAL PREV, V26, P441, DOI 10.1016/0001-4575(94)90035-3; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Brenner LA, 2008, REHABIL PSYCHOL, V53, P18, DOI 10.1037/0090-5550.53.1.18; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; CALVANIO R, 1993, NEUROL CLIN, V11, P25; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; De Waard D, 1997, TRAFFIC TRANSPORT PS; de Waard D., 1996, THESIS U GRONINGEN G; Fisher D. L., 2003, INJURY INSIGHTS, V1, P2; Gamache PL, 2010, CURR DIR PSYCHOL SCI, V19, P370, DOI 10.1177/0963721410388641; HANCOCK PA, 1990, ACCIDENT ANAL PREV, V22, P281, DOI 10.1016/0001-4575(90)90019-H; Kantak SS, 2010, NAT NEUROSCI, V13, P923, DOI 10.1038/nn.2596; Kendall F, 1983, MUSCLE TESTING FUNCT; Lavalliere M., 2009, 5 INT DRIV S HUM FAC; LAVALLIERE M, 2011, TRAFFIC INJ IN PRESS; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Michon J.A., 1985, HUMAN BEHAV TRAFFIC; MICHON JA, 1979, WORKSH TRAFF RES CTR; Osterrieth P. A, 1944, ARCH PSYCHOL, V30, P286; ROSOMER M, 2009, HUM FACTORS, V51, P652; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4, 89-122; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; TEASDALE N, 2004, ADV TRANSPORTATION S, P29; The Psychological Corporation, 1997, WAIS 3 WMS 2 TECHN M; Tombaugh T. N., 1998, COMPENDIUM NEUROPSYC; Tulving E, 1983, ELEMENTS EPISODIC ME; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	27	13	14	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2011	25	4					416	425		10.3109/02699052.2011.558039			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600012	21355675				2021-06-18	
J	Luton, LM; Reed-Knight, B; Loiselle, K; O'Toole, K; Blount, R				Luton, Lindsay M.; Reed-Knight, Bonney; Loiselle, Kristin; O'Toole, Kathleen; Blount, Ronald			A pilot study evaluating an abbreviated version of the cognitive remediation programme for youth with neurocognitive deficits	BRAIN INJURY			English	Article						Cognitive remediation; attention; children; intervention	TRAUMATIC BRAIN-INJURY; ATTENTION; CHILDHOOD; CHILDREN	Primary objective: To determine the effectiveness of an abbreviated version of an established cognitive remediation programme for children with neurological disorders and attention problems in an outpatient setting. Methods and procedures: Eighteen 6-15-year-old children diagnosed with neurological and attention difficulties completed a six-module training programme aimed at improving attention. This programme was a shorter version of the Cognitive Remediation Programme (CRP), which has been successfully implemented with children with neurocognitive deficits. Parents completed measures of their children's attention and children completed neuropsychological measures of attention. Main outcomes and results: The programme was associated with improvement in several aspects of parent-reported attention and children's performance on tasks measuring attention. Conclusions: The shortened version of the CRP shows promise as a brief treatment for attention problems in outpatient neurological populations. Future research should assess programme effectiveness using a control group, longer-term follow-up and teacher reports.	[Luton, Lindsay M.; O'Toole, Kathleen] Childrens Healthcare Atlanta, Atlanta, GA USA; [Reed-Knight, Bonney; Loiselle, Kristin; Blount, Ronald] Univ Georgia, Athens, GA 30602 USA	Luton, LM (corresponding author), Dept Neuropsychol, 5455 Meridian Mark Rd,Suite 180, Atlanta, GA 30342 USA.	lindsay.luton@choa.org		Reed, Bonney/0000-0003-1808-6132			Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, pXXI; Duncan CC, 2008, INT J PSYCHOPHYSIOL, V69, P207, DOI 10.1016/j.ijpsycho.2008.05.011; FRISK V, 1994, DEV NEUROPSYCHOL, V10, P313, DOI 10.1080/87565649409540586; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia G.A., 2000, BEHAV RATING INVENTO; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Loss N, 1998, CHILD NEUROPSYCHOL, V4, P7, DOI 10.1076/chin.4.1.7.3192; Manly T., 1998, TEST EVERYDAY ATTENT; Pfiffner L.J., 2006, ATTENTION DEFICIT HY, P547; Pruitt DW, 2009, PHYS MED REH CLIN N, V20, P455, DOI 10.1016/j.pmr.2009.06.002; Sohlberg M., 1999, ATTENTION PROCESS TR; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED	16	13	13	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2011	25	4					409	415		10.3109/02699052.2011.558044			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600011	21355674				2021-06-18	
J	Armstead, WM; Kreipke, CW				Armstead, William M.; Kreipke, Christian W.			Endothelin-1 is upregulated after traumatic brain injury: a cross-species, cross-model analysis	NEUROLOGICAL RESEARCH			English	Article						Endothelin; Microcirculation; Rat; Porcine	CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION MODEL; AXONAL INJURY; HEAD-INJURY; RAT; MICROCIRCULATION	Objectives: This work was designed to compare levels of endothelin-1 following brain injury in both rat and porcine models of head injury. In a broader sense, this work also determines the feasibility of testing traumatic brain injury-related phenomenology across species and models. Methods: Male Sprague-Dawley rats (400-450 g) were subjected to traumatic brain injury using a weight acceleration impact injury device (n=5 per group). Following impact, cerebrospinal fluid was collected for enzyme-linked immunosorbent assay analysis of endothelin-1 concentration using a standard endothelin-1 detection kit at 4 hours, 24 hours, 48 hours, and 7 days post-traumatic brain injury. Sham operated animals (n=5) were used as controls. In another set of experiments, traumatic brain injury was induced in newborn and juvenile pigs (n=6 per group) using a lateral fluid percussion model of brain injury. Cerebrospinal fluid was collected at 4 hours, 8 hours, 72 hours, and 7 days post-injury and endothelin-1 levels were measured using a radiolabeled kit. Results: Endothelin-1 levels rapidly increased from similar to 35 in sham operated animals to over 200 pg/g tissue 4 hours post-impact in both rat cortex and hippocampus. This elevation was sustained through 48 hours post-impact. By 7 days post-injury, endothelin-1 levels returned to normal, control concentrations. This trend was consistent with the porcine model, being more pronounced in newborn versus juvenile pigs. Conclusion: These results show that endothelin-1 peptide concentration elevation is a consistent finding between rat and pig and between weight acceleration and fluid percussion models of traumatic brain injury. This suggests that endothelin-1 elevation is not only a conserved phenomenon in different models of traumatic brain injury, but that it is a likely target for understanding the observed enhanced vascular response to traumatic brain injury and ultimately developing strategies to improve outcome following traumatic brain injury.	[Kreipke, Christian W.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Armstead, William M.] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Kreipke, Christian W.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA	Kreipke, CW (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	ckreipke@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS064976, NS34932]; VA Rehabilitation Research & Development Merit Award [RX000224]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034932, R01NS064976] Funding Source: NIH RePORTER	This work was supported by grants from National Institutes of Health (C. W. Kreipke: NINDS NS064976; W. Armstead: NS34932) and a VA Rehabilitation Research & Development Merit Award (C. W. Kreipke: RX000224).	BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hayes R L, 1987, Brain Inj, V1, P1, DOI 10.3109/02699058709034437; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	28	13	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					133	136		10.1179/016164111X12881719352174			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	723OM	WOS:000287516600004	21801588				2021-06-18	
J	Clausen, F; Hillered, L; Gustafsson, J				Clausen, Fredrik; Hillered, Lars; Gustafsson, Jan			Cerebral glucose metabolism after traumatic brain injury in the rat studied by C-13-glucose and microdialysis	ACTA NEUROCHIRURGICA			English	Article						Microdialysis; Traumatic brain injury; Metabolism; In vivo studies	MEMBRANE PHOSPHOLIPID DEGRADATION; COMPRESSION CONTUSION TRAUMA; INTERSTITIAL GLYCEROL; ENERGY-METABOLISM; ISOFLURANE; OXYGEN; ANESTHESIA; ISCHEMIA; MARKER; DAMAGE	Following traumatic brain injury (TBI), a disturbed cerebral glucose metabolism contributes to secondary brain damage. To study local cerebral glucose metabolism after TBI, we delivered C-13-labeled glucose into brain tissue by microdialysis (MD). MD probes were inserted bilaterally into the parietal cortex of rat brain, one probe in the shear stress zone of the injury and the other at the corresponding contralateral coordinates. A moderately severe controlled cortical contusion was used to model TBI. Dialysate concentrations of glucose, pyruvate, lactate, and glycerol were measured, and following derivatization, C-13 enrichments of the compounds were determined by gas chromatography-mass spectrometry. We found that C-13-labeled glucose was rapidly converted into C-13-lactate and C-13-glycerol. In the hours following TBI, concentrations and C-13 enrichments of lactate and glycerol increased. The findings confirm the occurrence of anaerobic local glucose metabolism early after TBI. Only a small fraction of the glycerol was newly synthesized, suggesting that the hypothesis that most of the released glycerol after TBI comes from degradation of membrane phospholipids still holds. We conclude that the combination of microdialysis and stable isotope technique is a useful tool for investigating local glucose metabolism following brain injury.	[Clausen, Fredrik; Hillered, Lars] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden; [Gustafsson, Jan] Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden	Clausen, F (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, Entrance 85,2nd Floor, S-75185 Uppsala, Sweden.	fredrik.clausen@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417; Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Uppsala University Hospital; Selander Foundation; Gillberg Foundation; Ahlen Foundation	The authors would like to thank Elisabet Soderberg and Inger Stahl-Myllyaho for skillful technical assistance. This study was supported by the Swedish Research Council, the Swedish Brain Foundation, Uppsala University Hospital, the Selander Foundation, The Gillberg Foundation, and the Ahlen Foundation.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; ARCHER DP, 1990, J CEREBR BLOOD F MET, V10, P624, DOI 10.1038/jcbfm.1990.114; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Gustafsson J, 2007, SCAND J CLIN LAB INV, V67, P155, DOI 10.1080/00365510600995259; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Nguyen NHT, 2007, J NEUROCHEM, V101, P1694, DOI 10.1111/j.1471-4159.2006.04433.x; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; ORI C, 1986, ANESTHESIOLOGY, V65, P152, DOI 10.1097/00000542-198608000-00004; Pfeuffer J, 1999, MAGNET RESON MED, V41, P1077, DOI 10.1002/(SICI)1522-2594(199906)41:6<1077::AID-MRM1>3.0.CO;2-#; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	27	13	14	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2011	153	3					653	658		10.1007/s00701-010-0871-7			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	723HN	WOS:000287497500033	21103896				2021-06-18	
J	Kahraman, S; Hu, P; Stein, DM; Stansbury, LG; Dutton, RP; Xiao, Y; Hess, JR; Scalea, TM				Kahraman, Sibel; Hu, Peter; Stein, Deborah M.; Stansbury, Lynn G.; Dutton, Richard P.; Xiao, Yan; Hess, John R.; Scalea, Thomas M.			Dynamic Three-Dimensional Scoring of Cerebral Perfusion Pressure and Intracranial Pressure Provides a Brain Trauma Index That Predicts Outcome in Patients With Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-25, 2010	Boston, MA	Amer Assoc Surg Trauma (AAST)		ICP; CPP; TBI; Electronic monitoring; Automated vital signs	HYPERTENSION; SYSTEMS	Background: Data on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) guide therapy in severe traumatic brain injury (TBI), but current linear analytic methods are insufficiently sensitive and specific for prognosis in dynamic situations over time. Methods: We have developed algorithms incorporating continuous, automated, digital ICP and CPP monitoring data into a pressure times time "dose" function. In this study, we calculated cumulative doses using thresholds of ICP > 20 mm Hg and CPP < 60 mm Hg and graphed these as a Brain Trauma Index (BTI or CPP/ICP). Using receiver operator characteristics analysis, we examined BTI < 3 and BTI < 2 and various threshold levels of pressure times time doses of ICP and CPP as predictors of 30-day mortality and Extended Glasgow Outcome Scale (GOSE) < 5 at 6 months and 12 months. Using the data processing and analysis tools underlying this work, we are also piloting a real-time bedside and telemetric display system as a means of indentifying and monitoring critical changes in physiologic metrics, including BTI, CPP, and ICP. Results: Sixty subjects yielded 8678.1 hours of data (5,206,860 data points). BTI < 2 was better than CPP < 60 mm Hg in predicting unfavorable Extended Glasgow Outcome Scale at 6 months (p < 0.05). An example of linear and graphically processed BTI, CPP, and ICP data from a representative TBI patient is provided. Conclusion: Calculation of a BTI from continuous digital data predicts outcome in severe TBI and has potential for the design of real-time bedside early warning systems.	[Kahraman, Sibel; Hu, Peter; Stein, Deborah M.; Stansbury, Lynn G.; Dutton, Richard P.; Xiao, Yan; Hess, John R.; Scalea, Thomas M.] Shock Trauma & Anesthesia Res Ctr, R Adams Cowley Shock Truma Ctr, Baltimore, MD 21201 USA	Stansbury, LG (corresponding author), Shock Trauma & Anesthesia Res Ctr, R Adams Cowley Shock Truma Ctr, 419 W Redwood St, Baltimore, MD 21201 USA.	Istansbury@STAPA.umm.edu	Xiao, Yan/A-7506-2009	Xiao, Yan/0000-0003-2805-0619; Stein, Deborah/0000-0003-3683-3963			Box GE, 2015, TIME SERIES ANAL FOR, V5th; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Duda RO, 2000, PATTERN CLASSIFICATI; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; GERSHENFELD N, 2000, NATURE MATH MODELING; Heldt Thomas, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P350; Hravnak M, 2008, ARCH INTERN MED, V168, P1300, DOI 10.1001/archinte.168.12.1300; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Subbe CP, 2007, INTENS CARE MED, V33, P619, DOI 10.1007/s00134-006-0516-8; Tarassenko L, 2006, BRIT J ANAESTH, V97, P64, DOI 10.1093/bja/ael113; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; 2007, J NEUROTRAUMA, V24, pS1	14	13	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2011	70	3					547	552		10.1097/TA.0b013e31820c768a			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	732PU	WOS:000288201200011	21610341				2021-06-18	
J	Lemoyne, R; Mastroianni, T; Kale, H; Luna, J; Stewart, J; Elliot, S; Bryan, F; Coroian, C; Grundfest, W				Lemoyne, Robert; Mastroianni, Timothy; Kale, Halo; Luna, Jorge; Stewart, Joshua; Elliot, Stephen; Bryan, Filip; Coroian, Cristian; Grundfest, Warren			FOURTH GENERATION WIRELESS REFLEX QUANTIFICATION SYSTEM FOR ACQUIRING TENDON REFLEX RESPONSE AND LATENCY	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Reflex quantification; wireless accelerometers; accelerometers; neurorehabilitation; traumatic brain injury	QUANTITATIVE-EVALUATION; HOFFMANN REFLEX; RELIABILITY; PATELLAR; ELECTROMYOGRAPHY; REQUESTS; DEVICE; GAIT	An intrinsic aspect of the standard neurological examination is the deep tendon reflex. A clinician is tasked with qualitatively evaluating reflex parameters, such as reflex response and latency. The tendon reflex is capable of providing preliminary insight with respect to dysfunction of the central and peripheral nervous systems. The qualitative assessment of the tendon reflex can be classified through the implementation of an ordinal scale, such as the NINDS scale which spans five ordinal components from 0 to 4. The reliability and accuracy of the ordinal-scale method for classifying reflex characteristics have been demonstrated to be an issue of controversy. Ordinal scales lack the capacity to properly classify the temporal features of the tendon reflex. Electrodiagnostic testing traditionally provides higher fidelity evaluation of peripheral neuropathy; however, a study by Cocito et al., has discovered 28% of the prescriptions were inappropriate. The fourth-generation wireless reflex quantification system provides a less resource intensive, highly accurate, reliable, and reproducible alternative. The patellar tendon reflex is evoked through a predetermined potential energy derived swing arm attached to a standard reflex hammer. Tandem wireless 3D MEMS accelerometers quantify reflex response and latency. The reflex response maximum and minimum are acquired from the wireless 3D MEMS accelerometer positioned above the ankle joint. The latencies derived from the maximum and minimum of the reflex responses are derived from the temporal disparity relative to the acceleration waveforms of the reflex response and swing arm evoking the tendon reflex. The fourth-generation wireless reflex quantification system has been evolved with a more user-convenient wirelessly activated datalogger mode, which is subsequently downloaded to a local PC wirelessly. The wireless datalogger mode enables sampling at a greater rate relative to the real-time streaming data mode. An automated MATLAB software program is implemented for acquiring reflex parameters. Enclosed is the longitudinal study of the fourth-generation wireless reflex quantification system that demonstrates considerable precision for accuracy, reliability, and reproducibility. As a supplement to the research, a brief reflex modulation study is amended to the longitudinal study.	[Lemoyne, Robert; Grundfest, Warren] Univ Calif Los Angeles, Biomed Engn IDP, Los Angeles, CA 90095 USA; [Mastroianni, Timothy] Cognit Engn, Pittsburgh, PA USA; [Kale, Halo; Luna, Jorge; Stewart, Joshua; Elliot, Stephen; Bryan, Filip] Glendale Coll, Glendale, AZ USA; [Coroian, Cristian] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn IDP, 5121 Engn V,Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			Bickley LS, 2003, BATES GUIDE PHYS EXA; CHUNGW, 2008, P 30 ANN INT C IEEE, P1120; Cocito D, 2006, NEUROL SCI, V26, P419, DOI 10.1007/s10072-006-0525-y; Cozens JA, 2000, J NEUROL NEUROSUR PS, V68, P581, DOI 10.1136/jnnp.68.5.581; ENGLUND C, 2004, THESIS ROYAL I TECHN; Faist M, 1999, BRAIN, V122, P567, DOI 10.1093/brain/122.3.567; Frijns CJM, 1997, CLIN NEUROL NEUROSUR, V99, P31, DOI 10.1016/S0303-8467(96)00593-8; HOFFMAN MA, 1995, BRAIN RES, V700, P303, DOI 10.1016/0006-8993(95)01082-7; KAMEN G, 1989, NEUROBIOL AGING, V10, P311, DOI 10.1016/0197-4580(89)90041-9; KAMEYAMA O, 1989, AM J PHYS MED REHAB, V68, P277, DOI 10.1097/00002060-198912000-00004; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; KOCEJA DM, 1988, MED SCI SPORT EXER, V20, P172, DOI 10.1249/00005768-198820020-00012; KURUOGLU HR, 1994, MUSCLE NERVE, V17, P145, DOI 10.1002/mus.880170203; Lebiedowska MK, 2003, ARCH PHYS MED REHAB, V84, P828, DOI 10.1016/S0003-9993(02)04946-8; LeMoyne R, 2009, ICME INT C IEEE COMP, P1, DOI DOI 10.1109/ICCME.2009.4906657; LEMOYNE R, 2005, UCLA COMMUNICATION N; LEMOYNE R, 2005, 35 SOC NEUR ANN M WA; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; Lemoyne R, 2008, J MECH MED BIOL, V8, P491, DOI 10.1142/S0219519408002772; Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969; Mamizuka N, 2007, J BIOMECH, V40, P2107, DOI 10.1016/j.jbiomech.2006.10.003; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; MASTROIANNI T, 2003, COMPUTATIONAL ANAL I; Mitchell T.M, 1997, MACHINE LEARNING MCG; Mondelli M, 1998, ITAL J NEUROL SCI, V19, P195, DOI 10.1007/BF02427600; Pagliaro P, 1999, J ELECTROMYOGR KINES, V9, P141, DOI 10.1016/S1050-6411(98)00045-5; Podnar S, 2005, EUR J NEUROL, V12, P150, DOI 10.1111/j.1468-1331.2004.00979.x; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; Seeley RR, 2003, ANATOMY PHYSL; STAM J, 1990, J NEUROL, V237, P427, DOI 10.1007/BF00314735; van Dijk GW, 1999, NEUROLOGY, V53, P1573, DOI 10.1212/WNL.53.7.1573; VandeCrommert HWAA, 1996, BRAIN RES, V734, P341, DOI 10.1016/0006-8993(96)00885-2; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600; Zhang LQ, 2000, ARCH PHYS MED REHAB, V81, P901, DOI 10.1053/apmr.2000.5582	35	13	13	0	3	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	MAR	2011	11	1					31	54		10.1142/S0219519410003654			24	Biophysics; Engineering, Biomedical	Biophysics; Engineering	764MD	WOS:000290632700003					2021-06-18	
J	Rubovitch, V; Shachar, A; Werner, H; Pick, CG				Rubovitch, Vardit; Shachar, Adi; Werner, Haim; Pick, Chaim G.			Does IGF-1 administration after a mild traumatic brain injury in mice activate the adaptive arm of ER stress?	NEUROCHEMISTRY INTERNATIONAL			English	Article						Brain-trauma; Cell death mechanisms; Cognitive impairments; Neuroprotection	UNFOLDED PROTEIN RESPONSE; DEATH; ATF6	Mild traumatic brain injury (mTBI) induces along with cognitive impairments, both cell death and survival pathways. Previously, IGF-1 (Insulin like growth factor 1) administration prevented TBI-induced damage. This study was aimed at testing the effect of mTBI on ER (endoplasmic reticulum) stress activation and looking for a possible interaction between IGF-1 and ER stress pathways. Mice were subjected to a weight drop closed head injury. Western blot analysis revealed that mTBI induced activation of ATF6 (activating transcription factor 6), but not of CHOP or grp78. IGF-1 administration following mTBI did not change ATF6 or grp78 levels, but significantly elevated CHOP. These results suggest that IGF-1 may exert its neuroprotection via PERK/CHOP, the adaptive arm of the unfolded protein response. (C) 2011 Elsevier Ltd. All rights reserved.	[Rubovitch, Vardit; Shachar, Adi; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Werner, Haim] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rubovitch, V (corresponding author), Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	rubovitc@post.tau.ac.il					Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Benjamin IJ, 2006, CIRC RES, V98, P1120, DOI 10.1161/01.RES.0000223522.47948.16; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160	15	13	15	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186			NEUROCHEM INT	Neurochem. Int.	MAR	2011	58	4					443	446		10.1016/j.neuint.2011.01.009			4	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	740EQ	WOS:000288774800001	21219958				2021-06-18	
J	Arellano-Orden, V; Leal-Noval, SR; Cayuela, A; Munoz-Gomez, M; Ferrandiz-Millon, C; Garcia-Alfaro, C; Marin-Caballos, A; Dominguez-Roldan, JM; Murillo-Cabezas, F				Arellano-Orden, Victoria; Leal-Noval, Santiago R.; Cayuela, Aurelio; Munoz-Gomez, Manuel; Ferrandiz-Millon, Carmen; Garcia-Alfaro, Claudio; Marin-Caballos, Antonio; Ma. Dominguez-Roldan, Jose; Murillo-Cabezas, Francisco			Gender Influences Cerebral Oxygenation After Red Blood Cell Transfusion in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Brain tissue oxygen pressure; Cerebral oxygenation; Gender; Severe traumatic brain injury and transfusion	PROGESTERONE; RATS; MORTALITY; ESTROGEN; LESIONS; CORTEX; WORSE; AGE	Important differences with respect to gender exist in the prognosis and mortality of traumatic brain injury (TBI) patients. The objective of this study was to assess the role of gender as an independent factor in cerebral oxygenation variations following red blood cell transfusion (RBCT). This retrospective analysis of a prospective study was conducted on patients with severe TBI. Hemoglobin levels were measured at baseline and 6 h after transfusion. Brain tissue oxygen pressure (PbrO(2)), cerebral perfusion pressure (CPP), intracranial pressure (ICP), and mean arterial pressure (MAP) were measured at baseline, at the end of RBCT and at 1, 2, 3, 4, 5, and 6 h after transfusion. After the patients were stratified into two groups according to gender, the effect of RBCT on PbrO(2) (cerebral oxygenation) was analyzed using a multivariate analysis of variance with repeated measures (MANOVA). The MANOVA was repeated after adjusting for all covariables with baseline differences between groups. At baseline, we found differences in age (P = 0.01), weight (P = 0.03), MAP (P = 0.01), ISS (P = 0.05), and CCP (P = 0.01) between the groups. After adjusting for these co-variables, we observed that gender and age were related to the increase in PbrO(2) (P = 0.05 and P = 0.04, respectively). Our results suggest that the effect of RBCT on cerebral oxygenation, as measured by PbrO(2), is greater in women than in men.	[Leal-Noval, Santiago R.] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Serv Cuidados Crit & Urgencias, Seville 41013, Spain; [Munoz-Gomez, Manuel] Univ Malaga, Sch Med, Malaga, Spain; [Cayuela, Aurelio] Hosp Virgen del Rocio, Div Stat, Seville, Spain; [Arellano-Orden, Victoria; Leal-Noval, Santiago R.; Ferrandiz-Millon, Carmen; Garcia-Alfaro, Claudio; Marin-Caballos, Antonio; Ma. Dominguez-Roldan, Jose; Murillo-Cabezas, Francisco] Hosp Virgen del Rocio, Neuro Crit Care Div, Seville, Spain	Leal-Noval, SR (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Serv Cuidados Crit & Urgencias, Avda Manuel Siurot S-N, Seville 41013, Spain.	srleal@telefonica.net	Cayuela, Aurelio/AAZ-1294-2020; Cayuela, Aurelio/C-6698-2012; IBIS, NEUROCRITICOS/C-1805-2016; Noval, Santiago/K-4515-2019; Murillo-Cabezas, Francisco/AAO-3348-2021; Dominguez-Roldan, Jose-Maria/M-1728-2016	Cayuela, Aurelio/0000-0002-4936-9402; Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478	Spanish Government funds (Fondo de Investigacion Sanitaria-FIS-Proyecto de Investigacion) [PI 081069]; Consejeria de Salud de la Junta de Andalucia (Proyecto de Investigacion)Junta de Andalucia [PI 0157/2006]; Fundacion MAP-FRE	This study is supported by Spanish Government funds (Fondo de Investigacion Sanitaria-FIS-Proyecto de Investigacion: PI 081069), by Consejeria de Salud de la Junta de Andalucia (Proyecto de Investigacion: PI 0157/2006) and by Fundacion MAP-FRE 2008.	Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; DEEGAN BM, 31 ANN INT C IEEE EM; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Herrmann MJ, 2006, NEUROBIOL AGING, V27, P888, DOI 10.1016/j.neurobiolaging.2005.04.013; Juraska JM, 1990, CEREBRAL CORTEX RAT, P483; Kaldi I, 2004, EUR J OPHTHALMOL, V14, P306, DOI 10.5301/EJO.2008.1363; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kolb B, 1996, BEHAV NEUROSCI, V110, P1271, DOI 10.1037/0735-7044.110.6.1271; KOLB B, 1995, BEHAV NEUROSCI, V109, P285, DOI 10.1037/0735-7044.109.2.285; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	26	13	14	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2011	14	1					18	23		10.1007/s12028-010-9441-3			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	708WF	WOS:000286394300004	20838931				2021-06-18	
J	de Andrade, AF; Paiva, WS; de Amorim, RLO; Figueiredo, EG; de Almeida, AN; Brock, RS; Bor-Seng-Shu, E; Teixeira, MJ				de Andrade, Almir Ferreira; Paiva, Wellingson Silva; Oliveira de Amorim, Robson Luis; Figueiredo, Eberval Gadelha; de Almeida, Antonio Nogueira; Brock, Roger Schmidt; Bor-Seng-Shu, Edson; Teixeira, Manoel Jacobsen			Continuous ventricular cerebrospinal fluid drainage with intracranial pressure monitoring for management of posttraumatic diffuse brain swelling	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						decompressive craniectomy; intracranial pressure monitoring; head injury; brain swelling	INJURY; INFECTION; EDEMA; RISK; EXPERIENCE; RESOLUTION; DURATION	Background: Ventricular drainage has played an important role in the management of traumatic brain-injured patients. The aim of the present study was describe outcomes in a series of 57 patients with diffuse brain swelling underwent to intracranial pressure (ICP) monitoring. Method: Fifty-eight patients with diffuse posttraumatic brain swelling, were evaluated prospectively. The Glasgow Coma Scale (GCS) scores of patients varied from 4 to 12. Patients groups divided according to GCS and age. Patient neurological assessment was classified as favorable, unfavorable, and death. Results: Mechanisms of injury were vehicle accidents in 72.4% and falls in 15.6%. 54% of patients had GCS scores between 6 and 8. There were no statistical differences, regarding outcome, between groups separated by age. In the adults group (n=47), 44.7% evolved favorably. Conclusion: Our results indicate a poor prognosis in patients with brain swelling. We believe that continuous ventricular CSF drainage with ICP monitoring is a simple method as an adjunct in the management of these patients.	[de Andrade, Almir Ferreira; Paiva, Wellingson Silva; Oliveira de Amorim, Robson Luis; Figueiredo, Eberval Gadelha; de Almeida, Antonio Nogueira; Brock, Roger Schmidt; Bor-Seng-Shu, Edson; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Fac Med, Clin Hosp, Dept Neurol & Neurosurg, Sao Paulo, Brazil	Paiva, WS (corresponding author), Rua Teodoro Sampaio 498-66, BR-05406000 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Almeida, Antonio/O-5506-2019; Amorim, Robson/AAK-1368-2021; Teixeira, Manoel J/E-3110-2012; de Almeida, Antonio Nogueira/A-2957-2016; BOR-SENG-SHU, EDSON/H-7784-2013; BOR-SENG-SHU, EDSON/AAC-9762-2019; Figueiredo, Eberval Gadelha/H-3488-2012; Paiva, Wellingson S/G-5517-2013; Figueiredo, Eberval G/E-2071-2016	Almeida, Antonio/0000-0002-0796-7025; Amorim, Robson/0000-0003-2391-7519; de Almeida, Antonio Nogueira/0000-0002-0796-7025; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Paiva, Wellingson S/0000-0002-5165-7040; 			*AM COLL SURG, 2007, ATLS STUD MAN; ANDRADE AF, 2000, J NEUROTRAUM, V19, P1381; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; CAO MH, 1984, J NEUROSURG, V61, P707, DOI 10.3171/jns.1984.61.4.0707; Caruselli G, 1992, J Neurosurg Sci, V36, P219; CHESNUT RM, 1993, HEAD INJURY, P225; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; de Andrade AF, 2001, WORLD J SURG, V25, P1186; FELDMAN Z, 1993, HEAD INJURY, P247; Flibotte JJ, 2004, NEUROCRIT CARE, V1, P61, DOI 10.1385/NCC:1:1:61; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Kanter M J, 1991, Neurosurg Clin N Am, V2, P257; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; LUERSSEN TG, 1991, INTRACRANIAL PRESSUR, V8, P42; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; REULEN HJ, 1978, J NEUROSURG, V48, P754, DOI 10.3171/jns.1978.48.5.0754; Shore PM, 2004, J NEUROTRAUM, V21, P1113; SHU EBS, 2006, J NEUROSURG, V104, P93; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; WINFIELD JA, 1993, NEUROSURGERY, V33, P424	33	13	20	0	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	FEB	2011	69	1					79	84		10.1590/S0004-282X2011000100016			6	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	727OB	WOS:000287809600016	21359428	DOAJ Gold			2021-06-18	
J	Amantini, A; Carrai, R; Fossi, S; Pinto, F; Grippo, A				Amantini, Aldo; Carrai, Riccardo; Fossi, Selvaggia; Pinto, Francesco; Grippo, Antonello			The role of early electroclinical assessment in improving the evaluation of patients with disorders of consciousness	FUNCTIONAL NEUROLOGY			English	Article						coma; EEG; ERP; minimally conscious state; SEP; vegetative state	SOMATOSENSORY-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; ANOXIC-ISCHEMIC COMA; VEGETATIVE STATE; CARDIAC-ARREST; PROGNOSTIC VALUE; CARDIOPULMONARY-RESUSCITATION; MISMATCH NEGATIVITY; PREDICTS RECOVERY	We all share the need to optimise the evaluation of patients with disorders of consciousness (DOC), given the high rate of misdiagnosis of vegetative state based on clinical examination. We believe that one way to do this is to optimise assessment from the early stages, in order to reduce discontinuity between the hospital and rehabilitation phases. While clinical observation remains the "gold standard" for the diagnostic assessment of patients with DOC, neurophysiological investigations (electroencephalography, short latency evoked potentials and event-related potentials) could help to further understanding of the pathophysiology underlying the state of unresponsiveness, differentiate coma from other apparently similar conditions (i.e., locked-in and locked-in-like syndromes), and potentially integrate prognostic evaluation with monitoring of the evolution of the clinical state. Moreover, these techniques have the considerable advantage of being available at the bedside. Discontinuity between the hospital and rehabilitation phases is rightly considered to be one of the critical points in the assessment of patients with DOC. In our view, a continuum of expert neurological assessment that begins with monitoring of the acute phase (focusing on evolution of primary brain damage and secondary complications) and follows through to the patient's discharge from the intensive care unit (focusing on the pathophysiology of brain damage and prognostication based on clinical, neuroimaging and neurophysiological tests) could help to: i) optimise the rehabilitation programme according to the expectations of recovery; ii) provide a basis for comparison with subsequent periodic re-evaluations; iii) ensure uniformity of assessment regardless of the heterogeneity of care facilities; and iv) characterise a subset of patients who, showing discrepancies between neurophysiological tests and clinical status, are more likely to undergo unexpected recovery.	[Amantini, Aldo; Carrai, Riccardo; Fossi, Selvaggia; Pinto, Francesco; Grippo, Antonello] Careggi Univ Hosp, Dept Neurosci, Florence, Italy; [Carrai, Riccardo; Grippo, Antonello] IRCCS Don Carlo Gnocchi Fdn, UOF Neurol, Florence, Italy	Amantini, A (corresponding author), AOUC Careggi, Dip Sci Neurol, Largo Brambilla 3, I-50134 Florence, Italy.	amantini@unifi.it	grippo, antonello/AAP-6926-2020	Grippo, Antonello/0000-0002-9997-8564			Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Attia J, 1998, CRIT CARE CLIN, V14, P497, DOI 10.1016/S0749-0704(05)70013-0; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Bouwes A, 2009, NEUROLOGY, V73, P1457, DOI 10.1212/WNL.0b013e3181bf98f4; Carrai R, 2009, NEUROPHYSIOL CLIN, V39, P95, DOI 10.1016/j.neucli.2008.11.003; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Fins JJ, 2007, CURR OPIN NEUROL, V20, P650, DOI 10.1097/WCO.0b013e3282f11f6d; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Geocadin RG, 2008, CURR OPIN CRIT CARE, V14, P261, DOI 10.1097/MCC.0b013e3282fd68ea; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giugni E, 2010, FUNCT NEUROL, V25, P189; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; GUERIT JM, 2008, INTRAOPERATIVE MONIT, V8, P829; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kottenberg-Assenmacher E, 2003, ANESTHESIOLOGY, V98, P1112, DOI 10.1097/00000542-200305000-00013; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Lee YC, 2010, NEUROLOGY, V74, P572, DOI 10.1212/WNL.0b013e3181cff761; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Owen AM, 2007, CURR OPIN NEUROL, V20, P632, DOI 10.1097/WCO.0b013e3282f15669; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Tiainen M, 2005, CRIT CARE MED, V33, P1736, DOI 10.1097/01.CCM.0000171536.63641.D9; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	52	13	15	0	5	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264			FUNCT NEUROL	Funct. Neurol.	JAN-MAR	2011	26	1					7	14					8	Clinical Neurology	Neurosciences & Neurology	789OJ	WOS:000292524900002	21693083				2021-06-18	
J	Boehncke, S; Ackermann, H; Badenhoop, K; Sitzer, M				Boehncke, Sandra; Ackermann, Hanns; Badenhoop, Klaus; Sitzer, Matthias			Pituitary Function and IGF-I Levels following Ischemic Stroke	CEREBROVASCULAR DISEASES			English	Article						Ischemic stroke; IGF-I; Pituitary dysfunction; NIHSS; Stroke outcome	GROWTH-FACTOR-I; ANEURYSMAL SUBARACHNOID HEMORRHAGE; BASE-LINE; SCALE; RISK; DYSFUNCTION; DEPRESSION	Background: Pituitary dysfunction is a known complication of traumatic brain injury and subarachnoidal hemorrhage but there are few data about pituitary dysfunction as a complication of ischemic stroke. Methods: We prospectively studied patients 66-274 days after an ischemic stroke, evaluating the prevalence of pituitary dysfunction (by combined releasing hormone testing: GHRH, CRH), stroke severity, outcome and incidence of anxiety and depression. Results: Thirty-two patients (82%) presented with some degree of pituitary dysfunction with predominantly impaired growth hormone response (79.5%) and secondary adrenal failure (14.6%). Abnormal anxiety and/or depression was found in 28.3 and 32.7% of the patients. NIHSS (National Institute of Health Stroke Scale) varied between 1 and 15. Improvement in neurological deficit (Delta NIHSS) correlated significantly with NIHSS at baseline (p < 0.001) but not with pituitary function. Conclusions: Patients with ischemic stroke may suffer from pituitary dysfunction with predominantly impaired growth hormone response and secondary adrenal failure. We suggest that patients who suffer from stroke should undergo pituitary testing. Copyright (C) 2010 S. Karger AG, Basel	[Boehncke, Sandra; Badenhoop, Klaus] Goethe Univ Frankfurt, Dept Internal Med 1, Div Endocrinol Diabet & Metab, DE-60590 Frankfurt, Germany; [Ackermann, Hanns] Goethe Univ Frankfurt, Dept Biostat, DE-60590 Frankfurt, Germany; [Sitzer, Matthias] Goethe Univ Frankfurt, Stroke Unit, Dept Neurol, DE-60590 Frankfurt, Germany	Boehncke, S (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 1, Div Endocrinol Diabet & Metab, Theodor Stern Kai 7, DE-60590 Frankfurt, Germany.	Sandra.Boehncke@kgu.de			Novo Nordisk Corp., Mainz, Germany	This project was partially supported by a research grant from Novo Nordisk Corp., Mainz, Germany, to S. B. The sponsors had no role in the design of the study, in the collection, analyses and interpretation of data, in the writing of the report and in the decision to submit the article for publication. The researchers are independent from the sponsors. All authors had full access to all of the data in the study. Parts of this study were reported at the 10th European Congress of Endocrinology in Berlin, Germany, May 3-7, 2008.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Allolio B, 1996, PRAKTISCHE ENDOKRINO, P219; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; Arwert LI, 2005, HORM BEHAV, V47, P343, DOI 10.1016/j.yhbeh.2004.11.015; ASTROM M, 1993, STROKE, V24, P52, DOI 10.1161/01.STR.24.1.52; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Denti L, 2004, AM J MED, V117, P312, DOI 10.1016/j.amjmed.2004.02.049; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Johansson A, 1997, J NEUROL SCI, V147, P43; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; MAHONEY F I, 1965, Md State Med J, V14, P61; Reschke K, 2003, INTERNIST, V44, P98, DOI 10.1007/s00108-002-0783-6; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van Rijn MJE, 2006, J NEUROL NEUROSUR PS, V77, P24, DOI 10.1136/jnnp.2005.067447; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; Weber-Hamann B, 2009, PHARMACOPSYCHIATRY, V42, P23, DOI 10.1055/s-0028-1085442; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	24	13	14	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.		2011	31	2					163	169		10.1159/000321738			7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	779XK	WOS:000291815300008	21135552				2021-06-18	
J	Alves, TCDF; Scazufca, M; Squarzoni, P; Duran, FLD; Tamashiro-Duran, JH; Vallada, HP; Andrei, A; Wajngarten, M; Menezes, PR; Busatto, GF				de Toledo Ferraz Alves, Tania Correa; Scazufca, Marcia; Squarzoni, Paula; de Souza Duran, Fabio Luiz; Tamashiro-Duran, Jaqueline Hatsuko; Vallada, Homero P.; Andrei, Anna; Wajngarten, Mauricio; Menezes, Paulo R.; Busatto, Geraldo F.			Subtle Gray Matter Changes in Temporo-Parietal Cortex Associated with Cardiovascular Risk Factors	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; elderly; MRI; population-based; vascular risk factors	CORONARY-HEART-DISEASE; VASCULAR COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; TRAUMATIC BRAIN-INJURY; MIDLIFE BLOOD-PRESSURE; ALZHEIMERS-DISEASE; WHITE-MATTER; METABOLIC SYNDROME; APOE GENOTYPE; CEREBRAL HYPOPERFUSION	Vascular risk factors may play an important role in the pathophysiology of Alzheimer's disease (AD). While there is consistent evidence of gray matter (GM) abnormalities in earlier stages of AD, the presence of more subtle GM changes associated with vascular risk factors in the absence of clinically significant vascular events has been scarcely investigated. This study aimed to examine GM changes in elderly subjects with cardiovascular risk factors. We predicted that the presence of cardiovascular risk would be associated with GM abnormalities involving the temporal-parietal cortices and limbic structures. We recruited 248 dementia-free subjects, age range 66-75 years, from the population-based "Sao Paulo Ageing and Health Study", classified in accordance to their Framingham Coronary Heart Disease Risk (FCHDR) score to undergo an MRI scan. We performed an overall analysis of covariance, controlled to total GM and APOE4 status, to investigate the presence of regional GM abnormalities in association with FCHDR subgroups (high-risk, medium-risk, and low-risk), and followed by post hoc t-test. We also applied a co-relational design in order to investigate the presence of linear progression of the GM vulnerability in association with cardiovascular risk factor. Voxel-based morphometry showed that the presence of cardiovascular risk factors were associated with regional GM loss involving the temporal cortices bilaterally. Those results retained statistical significance after including APOE4 as a covariate of interest. We also observed that there was a negative correlation between FCHDR scores and rGM distribution in the parietal cortex. Subclinical cerebrovascular abnormalities involving GM loss may provide an important link between cardiovascular risk factors and AD.	[de Toledo Ferraz Alves, Tania Correa; Scazufca, Marcia; Squarzoni, Paula; de Souza Duran, Fabio Luiz; Tamashiro-Duran, Jaqueline Hatsuko; Vallada, Homero P.; Busatto, Geraldo F.] Univ Sao Paulo, Sch Med, Dept Psychiat, BR-05508 Sao Paulo, Brazil; [de Toledo Ferraz Alves, Tania Correa] ABC Reg Med Sch, Sao Paulo, SP, Brazil; [Wajngarten, Mauricio; Menezes, Paulo R.] Univ Sao Paulo, Sch Med, Cardiol Inst, Gen Hosp, BR-05508 Sao Paulo, Brazil; [Menezes, Paulo R.] Univ Sao Paulo, Dept Prevent Med, BR-05508 Sao Paulo, Brazil	Alves, TCDF (corresponding author), Ctr Med Nucl, 3 Andar,LIM-21,Rua Dr,Ovidio Pires Campos S-N, Sao Paulo, Brazil.	tania_alves@hotmail.com	Menezes, Paulo R/C-9985-2010; Wajngarten, Mauricio/G-3702-2012; Alves, Tania/ABF-5712-2020; Alves, Tania CTF/B-6571-2008; Busatto, Geraldo F/D-4431-2009; Menezes, Paulo/AAM-3529-2021; Scazufca, Marcia/K-7418-2012; Tamashiro-Duran, Jaqueline Hatsuko/B-1023-2013; Duran, Fabio L S/A-9744-2013; Vallada, Homero/D-1333-2014; Alves, Tania CTF/H-3416-2013; Squarzoni, Paula S/M-6155-2014; Squarzoni, Paula/B-1214-2013; Duran, Fabio L S/I-5704-2012; Souza-Duran, Fabio Luis/L-1371-2013	Menezes, Paulo R/0000-0001-6330-3314; Alves, Tania/0000-0003-3402-9656; Alves, Tania CTF/0000-0003-3402-9656; Busatto, Geraldo F/0000-0003-4749-4602; Menezes, Paulo/0000-0001-6330-3314; Tamashiro-Duran, Jaqueline Hatsuko/0000-0002-5448-8158; Duran, Fabio L S/0000-0002-7603-6152; Vallada, Homero/0000-0001-5123-8295; Alves, Tania CTF/0000-0003-3402-9656; Squarzoni, Paula S/0000-0002-5483-759X; Duran, Fabio L S/0000-0003-2494-7250; Souza-Duran, Fabio Luis/0000-0002-7603-6152	Wellcome Trust, UKWellcome Trust [GR066133MA]; FAPESP, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15336-5, 2004/12694-8]; CNPQ-BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	This research was funded by the Wellcome Trust, UK(GR066133MA) and by FAPESP (04/15336-5 and 2004/12694-8), Brazil. G. F. B., M. S. PRM and HPV were supported by CNPQ-Brazil during the development of this work.	Almeida JRC, 2005, BRAZ J MED BIOL RES, V38, P431, DOI 10.1590/S0100-879X2005000300014; Almeida OP, 2008, AM J GERIAT PSYCHIAT, V16, P92, DOI 10.1097/JGP.0b013e318157cad2; ALVES TCD, J ALZHEIMERS DIS, V20, P749; Alves TCTF, 2005, J NEUROIMAGING, V15, P150, DOI 10.1177/1051228404272880; Biessels GJ, 2006, J NEUROL NEUROSUR PS, V77, P304, DOI 10.1136/jnnp.2005.069583; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743; Chamorro A, 1996, STROKE, V27, P388, DOI 10.1161/01.STR.27.3.388; Chen XH, 2006, PSYCHIAT RES-NEUROIM, V147, P105, DOI 10.1016/j.pscychresns.2006.01.009; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Curiati PK, 2009, AM J NEURORADIOL, V30, P1850, DOI 10.3174/ajnr.A1727; De Jong GI, 1999, NEUROSCIENCE, V91, P203, DOI 10.1016/S0306-4522(98)00659-9; de la Torre JC, 2008, NEURODEGENER DIS, V5, P126, DOI 10.1159/000113681; de la Torre JC, 2009, INT REV NEUROBIOL, V84, P35, DOI 10.1016/S0074-7742(09)00403-6; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; de la Torre JC, 2000, NEUROBIOL AGING, V21, P331, DOI 10.1016/S0197-4580(00)00111-1; Alves TCDF, 2006, NEUROL RES, V28, P579, DOI 10.1179/016164106X130416; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; DeJong GI, 1997, ANN NY ACAD SCI, V826, P56; DELATORRE JC, 1992, BRAIN RES, V582, P186, DOI 10.1016/0006-8993(92)90132-S; den Heijer T, 2003, DIABETOLOGIA, V46, P1604, DOI 10.1007/s00125-003-1235-0; Elias MF, 1997, EXP AGING RES, V23, P201, DOI 10.1080/03610739708254281; Eriksson SH, 2009, HUM BRAIN MAPP, V30, P3351, DOI 10.1002/hbm.20757; Erkinjuntti Timo, 2009, V24, P79, DOI 10.1159/000197886; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Espeseth T, 2008, NEUROBIOL AGING, V29, P329, DOI 10.1016/j.neurobiolaging.2006.10.030; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Garrido GEJ, 2002, J NEUROL NEUROSUR PS, V73, P508, DOI 10.1136/jnnp.73.5.508; Giannakopoulos P, 2009, STROKE, V40, P983, DOI 10.1161/STROKEAHA.108.530337; Giele JLP, 2004, STROKE, V35, P742, DOI 10.1161/01.STR.0000117572.56058.2A; Glatt SJ, 2007, BIOL PSYCHIAT, V62, P282, DOI 10.1016/j.biopsych.2006.09.015; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; Gudbjornsdottir S, 2009, DIABETIC MED, V26, P53, DOI 10.1111/j.1464-5491.2008.02633.x; Henskens LH, 2009, J HYPERTENS, V27, P1446, DOI 10.1097/HJH.0b013e32832b5204; Hiekikanen H, 2007, BRAIN INJURY, V21, P1307, DOI 10.1080/02699050701739549; Honea RA, 2010, NEUROLOGY, V74, P113, DOI 10.1212/WNL.0b013e3181c918cb; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Inoue Kazuo, 2007, J Stroke Cerebrovasc Dis, V16, P14, DOI 10.1016/j.jstrokecerebrovasdis.2006.08.001; Inoue T, 1996, DIABETES RES CLIN PR, V31, P81, DOI 10.1016/0168-8227(96)01196-5; Irie F, 2008, ARCH NEUROL-CHICAGO, V65, P89, DOI 10.1001/archneurol.2007.29; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Ito Hirono, 2008, J Stroke Cerebrovasc Dis, V17, P35, DOI 10.1016/j.jstrokecerebrovasdis.2007.11.002; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kannel WB, 1997, ADV INTERNAL MED, V42, P39; Kappagoda CT, 2009, J CARDIOPULM REHABIL, V29, P207, DOI 10.1097/HCR.0b013e3181af6be5; Kim SH, 2006, J AM COLL CARDIOL, V48, P293, DOI 10.1016/j.jacc.2006.03.043; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Knopman DS, 2005, NEUROLOGY, V65, P876, DOI 10.1212/01.wnl.0000176074.09733.a8; Koga H, 2009, J STROKE CEREBROVASC, V18, P32, DOI 10.1016/j.jstrokecerebrovasdis.2008.07.010; Korf ESC, 2007, DIABETIC MED, V24, P166, DOI 10.1111/j.1464-5491.2007.02049.x; Korf ESC, 2004, HYPERTENSION, V44, P29, DOI 10.1161/01.HYP.0000132475.32317.bb; Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243; Kuczynski B, 2009, NEUROLOGY, V72, P738, DOI 10.1212/01.wnl.0000343005.35498.e5; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Kumar A, 2008, J MAGN RESON IMAGING, V27, P14, DOI 10.1002/jmri.21224; Kwon HM, 2006, STROKE, V37, P466, DOI 10.1161/01.STR.0000199081.17935.81; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; Launer LJ, 2009, STROKE, V40, pS53, DOI 10.1161/STROKEAHA.108.533075; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Massaro JM, 2004, STAT MED, V23, P351, DOI 10.1002/sim.1743; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Mercuro Giuseppe, 2003, Ital Heart J, V4, P363; Meyer JS, 2000, ANN NY ACAD SCI, V903, P411, DOI 10.1111/j.1749-6632.2000.tb06393.x; Miura K, 2009, CIRCULATION, V119, P1892, DOI 10.1161/CIRCULATIONAHA.108.823112; Mosconi L, 2007, EXP GERONTOL, V42, P129, DOI 10.1016/j.exger.2006.05.016; Mosconi Lisa, 2004, Expert Rev Neurother, V4, P831, DOI 10.1586/14737175.4.5.831; Mueller SG, 2008, NEUROIMAGE, V42, P42, DOI 10.1016/j.neuroimage.2008.04.174; Prince M, 2004, INT J GERIATR PSYCH, V19, P178, DOI 10.1002/gps.1059; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rafnsson SB, 2009, VASC MED, V14, P51, DOI 10.1177/1358863X08095027; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Raz N, 2007, ANN NY ACAD SCI, V1097, P84, DOI 10.1196/annals.1379.018; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Reiman EM, 2007, ANN NY ACAD SCI, V1097, P94, DOI 10.1196/annals.1379.011; Riello R, 2005, AGING CLIN EXP RES, V17, P329; Rimajova M, 2008, J ALZHEIMERS DIS, V13, P137; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; Roquer J, 2009, CEREBROVASC DIS, V27, P25, DOI 10.1159/000200439; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Sawada H, 2000, J NEUROL NEUROSUR PS, V68, P653, DOI 10.1136/jnnp.68.5.653; SCAZUFCA M, 2007, INT PSYCHOGERIATR, V17, P1; Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125; Scazufca M, 2008, INT J EPIDEMIOL, V37, P721, DOI 10.1093/ije/dym154; Scazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Seshadri S, 2004, NEUROLOGY, V63, P1591, DOI 10.1212/01.WNL.0000142968.22691.70; Seshadri S, 2006, INT REV PSYCHIATR, V18, P409, DOI 10.1080/09540260600935413; Sethi Ankur, 2008, Exp Clin Cardiol, V13, P113; Shintani S, 1998, J NEUROL SCI, V160, P82, DOI 10.1016/S0022-510X(98)00182-8; Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579; Stuerenburg HJ, 2005, NEUROENDOCRINOL LETT, V26, P261; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Teipel SJ, 2009, J ALZHEIMERS DIS, V17, P571, DOI 10.3233/JAD-2009-1077; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Tiehuis AM, 2008, STROKE, V39, P1600, DOI 10.1161/STROKEAHA.107.506089; Tonstad S, 2003, J CARDIOVASC RISK, V10, P129, DOI 10.1097/00043798-200304000-00008; Uehara T, 1999, STROKE, V30, P378, DOI 10.1161/01.STR.30.2.378; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254; Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586; Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015; Yang K, 2009, DIABETES EDUCATOR, V35, P770, DOI 10.1177/0145721709338528; Ystad Martin A, 2009, BMC Med Imaging, V9, P17, DOI 10.1186/1471-2342-9-17; Zivadinov R, 2009, NEUROLOGY, V73, P504, DOI 10.1212/WNL.0b013e3181b2a706	127	13	13	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2011	27	3					575	589		10.3233/JAD-2011-110827			15	Neurosciences	Neurosciences & Neurology	859GV	WOS:000297865800012	21841245				2021-06-18	
J	Doig, E; Fleming, J; Cornwell, P; Kuipers, P				Doig, Emmah; Fleming, Jennifer; Cornwell, Petrea; Kuipers, Pim			Comparing the experience of outpatient therapy in home and day hospital settings after traumatic brain injury: patient, significant other and therapist perspectives	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; occupational therapy; environment	REHABILITATION; STROKE; ENVIRONMENT; OUTCOMES	Purpose. To explore how therapy in a home and day hospital setting impacts on rehabilitation processes and outcomes from the perspective of the patients, their significant others and their treating occupational therapists. Method. Fourteen participants with severe traumatic brain injury received a one-to-one, goal-directed, client-centred outpatient occupational therapy programme (a) in their home for 6 weeks and (b) in a day hospital clinic for 6 weeks. The experience of rehabilitation in both settings was explored using semi-structured interviews with the participants, their significant others and their treating occupational therapists. Results. Participants and their significant others described the two environments as disparate with home-based therapy perceived as more relaxing, normal, satisfying and effective. The approach to therapy at home was commonly described as 'real-life' whereas the therapy approach in day hospital was characterised as 'simulation of real life tasks' and 'remedial exercises'. Participants' experience of therapy relationships at home was characterised as 'friendship', in which the therapist was a 'visitor', whereas in the hospital, participants were characterised as 'patients' and therapists as 'bosses' and 'teachers'. Conclusion. The experience of home-based therapy was perceived as more convenient, positive and preferred by patients and their family members. Therapists described more therapeutic benefits and the ability to work more effectively on activity and participation level goals in the client's real-life environment.	[Doig, Emmah; Fleming, Jennifer; Cornwell, Petrea] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer; Cornwell, Petrea] Princess Alexandra Hosp, Brisbane, Qld 4072, Australia; [Kuipers, Pim] Griffith Univ, Griffith Hlth Inst, Ctr Functioning & Hlth Res, Meadowbrook, Qld 4131, Australia	Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	emmah.doig@optusnet.com.au	Doig, Emmah/AAG-6674-2021; Cornwell, Petrea/AAE-5547-2019	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286	Princess Alexandra Hospital Foundation; Queensland Health Community Rehabilitation Research Scheme; University of QueenslandUniversity of Queensland	We wish to thank the participants, their significant others and the treating therapists for their participation. We thank the Princess Alexandra Hospital Foundation and the Queensland Health Community Rehabilitation Research Scheme for providing grants to undertake this research.; The principal researcher was in receipt of a University of Queensland Postgraduate Research Scholarship whilst conducting this research.	*AIHW, 2003, ICF AUSTR US GUID DI; Bairstow P J, 1997, Aust Health Rev, V20, P55; Bjorkdahl A, 2006, CLIN REHABIL, V20, P1038, DOI 10.1177/0269215506071230; Bottari C, 2006, AUST OCCUP THER J, V53, P98, DOI DOI 10.1111/J.1440-1630.2006.00547.X; *CRAIG HOSP RES DE, 2001, CRAIG HOSP INV UNPUB; DOIG EJ, J HEAD TRAUMA UNPUB; DOIG EJ, DISABIL REH IN PRESS; DOIG EJ, 2010, AM J OCCUP THER, V64, P1; Graneheim U, 2002, NURS EDUC TODAY, V24, P105, DOI DOI 10.1016/J.NEDT.2003.10.001; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Law M, 1998, CANADIAN OCCUPATIONA; Law M., 1996, CANADIAN J OCCUPATIO, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Malec J. F., 2003, MANUAL MAYO PORTLAND; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; Pace GM, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199602000-00004; Patton M.Q., 2002, QUALITATIVE RES EVAL; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Rogers JC, 1997, AM J OCCUP THER, V51, P410, DOI 10.5014/ajot.51.6.410; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TURNERSTOKES L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Wottrich AW, 2007, PHYS THER, V87, P778, DOI 10.2522/ptj.20060152	26	13	13	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2011	33	13-14					1203	1214		10.3109/09638288.2010.525286			12	Rehabilitation	Rehabilitation	768QH	WOS:000290950400014	20977391				2021-06-18	
S	Keller, E; Froehlich, J; Muroi, C; Sikorski, C; Muser, M		Feng, H; Mao, Y; Zhang, JH		Keller, E.; Froehlich, J.; Muroi, C.; Sikorski, C.; Muser, M.			Neuromonitoring in Intensive Care: A New Brain Tissue Probe for Combined Monitoring of Intracranial Pressure (ICP) Cerebral Blood Flow (CBF) and Oxygenation	EARLY BRAIN INJURY OR CEREBRAL VASOSPASM, VOL 2: CLINICAL MANAGEMENT	Acta Neurochirurgica Supplementum		English	Article; Book Chapter						Subarachnoid haemorrhage; Traumatic brain injury; Cerebral blood flow; Brain tissue probe; Intracranial pressure	NEAR-INFRARED SPECTROSCOPY; OPTICAL SPECTROSCOPY; VOLUME	Background: The benefits of monitoring cerebral blood flow (CBF) in stroke patients are apparent. New techniques combining near infrared spectroscopy (NIRS) and indocyanine green (ICG) dye dilution to estimate cerebral hemodynamics are available. However, with transcutaneous NIRS and optodes applied over the skin, the signal is contaminated by extracerebral tissues. The objective is to develop a new brain tissue probe for combined monitoring of intracranial pressure (ICP), CBF and cerebral blood volume (CBV). Methods: Conventional intraparenchymal probes for ICP monitoring are supplied with optical fibers. The light is coupled into the brain tissue and collected after absorption and scattering with a light detector. Venous injections of 0.2 mg/kgbw ICG are performed. The mean transit time of ICG (mttICG), CBF and CBV are calculated. Results: With a prototype of the probe in a first patient with subarachnoid hemorrhage 6 pairs of repetitive measurements were performed. Mean values were for mttICG 5.6 +/- 0.2 s, CBF 22.3 +/- 2.8 ml/100 g/min and CBV 2.1 +/- 0.3 ml/100 g. Conclusions: NIR spectroscopy allows the synchronous determination of multiple parameters with one single device. By measurements in parallel with the NeMo Probe and NIRS optodes placed over the skin, new algorithms can be developed to subtract the extracerebral contamination from the NIRS signal.	[Keller, E.; Muroi, C.; Sikorski, C.] Univ Zurich Hosp, Neurocrit Care Unit, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Froehlich, J.] ETH, Lab Electromagnet Fields & Microwave Elect, Zurich, Switzerland; [Muser, M.] NeMoDevices, Zurich, Switzerland	Keller, E (corresponding author), Univ Zurich Hosp, Neurocrit Care Unit, Dept Neurosurg, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	emanuela.keller@usz.ch	Keller, Emanuela/M-2917-2015	Keller, Emanuela/0000-0001-7892-8261; /0000-0001-9999-3345; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574			AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Colacino J M, 1981, Neurol Res, V3, P17; Germon TJ, 1997, J NEUROL NEUROSUR PS, V63, P660, DOI 10.1136/jnnp.63.5.660; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Hopton P, 1999, J APPL PHYSIOL, V87, P1981; Keller E, 2003, ACTA NEUROCHIR, V145, P1111, DOI 10.1007/s00701-003-0102-6; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Keller E, 2000, CRIT CARE MED, V28, P511, DOI 10.1097/00003246-200002000-00037; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; MCCORMICK PW, 1991, CRIT CARE MED, V19, P89, DOI 10.1097/00003246-199101000-00020; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; ROBERTS I, 1993, LANCET, V342, P1425, DOI 10.1016/0140-6736(93)92786-S; Rossi S, 1998, ACT NEUR S, V71, P91; Schwarz G, 1996, J NEUROSURG ANESTH, V8, P189, DOI 10.1097/00008506-199607000-00001; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; VAJLOCZY P, 2003, J NEUROSURG, V98, P1227	19	13	14	0	8	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, A-1201 VIENNA, AUSTRIA	0065-1419	2197-8395	978-3-7091-0355-5	ACTA NEUROCHIR SUPPL	Acta Neurochir. Suppl.		2011	110		2				217	220		10.1007/978-3-7091-0356-2_39	10.1007/978-3-7091-0356-2		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	BTE37	WOS:000286639100039	21125474	Green Accepted			2021-06-18	
J	Liu, Q; Cui, XR; Abbod, MF; Huang, SJ; Han, YY; Shieh, JS				Liu, Quan; Cui, Xingran; Abbod, Maysam F.; Huang, Sheng-Jean; Han, Yin-Yi; Shieh, Jiann-Shing			Brain death prediction based on ensembled artificial neural networks in neurosurgical intensive care unit	JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS			English	Article						Brain death prediction; Ensembled artificial neural networks; Sensitivity analysis; ROC curve analysis	SENSITIVITY; MANAGEMENT	A novel ensembled artificial neural networks (EANN) model was used for brain death prediction in this study. The experimental material for this study focused on the severe head injury patients with different level of Glasgow Coma Scale (GCS) in neurosurgical and traumatic intensive care unit (ICU) of National Taiwan University Hospital (NTUH) in Taipei. Two prediction models were established, i.e., the first has 11 input variables while the second has 14 input variables. The root mean square error (RMSE) and the receiver operating characteristic (ROC) curve analysis were applied to examine the performance of the prediction models. Regression analysis was developed to compare the prediction results with EANN model. Besides, sensitivity analysis was carried out to evaluate the significance ranking of the input variables. For the 11 input variables models, the topologies of 11-5-1, 11-6-1, 11-20-1, 11-22-1, 11-11-10-1 and 11-20-10-1 gave similar results, which had the best performance with the value of area under curve (AUC) (0.96) and accuracy (0.9167), while the topology of 11-5-1 presented the smallest RMSE (0.2023 for test data). For the 14 input variables models, all of the topologies performed very well with all the parameters in ROC curve analysis were 1.0; however the 14-14-5-1 topology when choosing the best networks in ensemble model showed the best performance (RMSE for test data was 0.0423), which are much better than the results of regression analysis (RMSE for test data was 0.38 for 11 variables and 0.171 for 14 variables). With the help of sensitivity analysis, the significance ranking results for the 11 and 14 input variables in this study were presented. In conclusion, the successful results of RMSE and ROC curve analysis confirm that EANN model is useful to be applied to predict such a complicated issue as brain death. (C) 2010 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.	[Shieh, Jiann-Shing] Yuan Ze Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Liu, Quan; Cui, Xingran] Wuhan Univ Technol, Dept Informat Engn, Wuhan 430070, Peoples R China; [Abbod, Maysam F.] Brunel Univ, Sch Engn & Design, London, England; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Han, Yin-Yi] Natl Taiwan Univ Hosp, Dept Trauma, Taipei, Taiwan	Shieh, JS (corresponding author), Yuan Ze Univ, Dept Mech Engn, Tao Yuan, Taiwan.	jsshieh@saturn.yzu.edu.tw		HAN, YIN-YI/0000-0001-8831-7835	National Science Council (NSC) of TaiwanMinistry of Science and Technology, Taiwan [NSC97-2915-I-155-001]; Yuan Ze University in Taiwan; Wuhan University of Technology (WUT) in China; WUT	The authors wish to thank the National Science Council (NSC) of Taiwan (Grant Number: NSC97-2915-I-155-001) for supporting this research. The authors also wish to thank the exchange PhD student program of Yuan Ze University in Taiwan and Wuhan University of Technology (WUT) in China for supporting this research. This paper is also financially supported by self-determined and innovative research funds of WUT.	AHMET Y, 2009, APPL SOFT COMPUT, V9, P1029; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ANDREW H, 2000, COMPUT METH PROG BIO, V62, P11; Ashwal S, 2001, BRAIN DEATH, P91; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Bugge JF, 2009, ACTA ANAESTH SCAND, V53, P1239, DOI 10.1111/j.1399-6576.2009.02064.x; CHATFIELD C, 1993, J BUS ECON STAT, V11, P121, DOI 10.2307/1391361; Corder GW, 2009, NONPARAMETRIC STAT N; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Cuende N, 2002, ORGANS TISSUES, V5, P109; Delen D, 2006, ACCIDENT ANAL PREV, V38, P434, DOI 10.1016/j.aap.2005.06.024; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Fahlman Scott E., 1988, P 1988 CONN MOD SUMM, P38; Fish K.E., 2003, J TARGET MEAS ANAL M, V11, P244, DOI DOI 10.1057/PALGRAVE.JT.5740081; Fish KE, 2004, KYBERNETES, V33, P1127, DOI 10.1108/03684920410534461; Freeman J.A., 1991, NEURAL NETWORKS ALGO; GERALD FF, 2003, J CLIN DENSITOM, V6, P231; GULER I, 2005, P EMBS SHANG CHIN; Guler I, 2007, IEEE T INF TECHNOL B, V11, P117, DOI 10.1109/TITB.2006.879600; Guler I, 2009, EXPERT SYST APPL, V36, P10424, DOI 10.1016/j.eswa.2009.01.036; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hong Y, 2009, PATTERN RECOGN LETT, V30, P298, DOI 10.1016/j.patrec.2008.10.007; JEAN JSN, 1994, IEEE T NEURAL NETWOR, V5, P752, DOI 10.1109/72.317727; Kennedy J., 1997, P IEEE INT C COMP CY; KENNETH JO, 2001, J CLIN EPIDEMIOL, V54, P1159; KONNO Y, 2007, IEEE DEST, P547; Kung SY, 1998, P IEEE, V86, P1244, DOI 10.1109/5.687838; Lazzus JA, 2009, J TAIWAN INST CHEM E, V40, P213, DOI 10.1016/j.jtice.2008.08.001; LEK S, 2000, APPL ECOLOGY EVOLUTI; Lin C. T., 1999, NEURAL FUZZY SYSTEMS; Mizraji R, 2009, TRANSPL P, V41, P3489, DOI 10.1016/j.transproceed.2009.09.008; Nathan HM, 2003, AM J TRANSPLANT, V3, P29, DOI 10.1034/j.1600-6143.3.s4.4.x; Nathan S., 2006, SEMIN ANESTH PERIO M, V25, P225, DOI [10.1053/j.sane.2006.09.005, DOI 10.1053/j.sane.2006.09.005]; NORMAN GA, 1999, ANESTHESIOLOGY, V91, P275; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Ottenbacher KJ, 2004, ANN EPIDEMIOL, V14, P551, DOI 10.1016/j.annepidem.2003.10.005; Park YS, 2007, ECOL MODEL, V204, P427, DOI 10.1016/j.ecolmodel.2007.01.021; Popovic D, 1998, IEE P-GENER TRANSM D, V145, P355, DOI 10.1049/ip-gtd:19981977; Poularas J, 2006, TRANSPL P, V38, P1213, DOI 10.1016/j.transproceed.2006.02.127; RECKNAGEL F, 2003, UNDERSTANDING ECOLOG; Rizk ML, 2009, J TAIWAN INST CHEM E, V40, P595, DOI 10.1016/j.jtice.2009.05.003; Rosendale JD, 2003, TRANSPLANTATION, V75, P482, DOI 10.1097/01.TP.0000045683.85282.93; SHIEH JS, 2009, HARD SOFT COMPUTING; Sinha RK, 2007, MED ENG PHYS, V29, P120, DOI 10.1016/j.medengphy.2006.01.011; STALENHOEF PA, 2002, J CLIN EPIDEMIOL; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; Vuk M, 2006, METODOLOSKI ZVEZKI, V3, P89; Wijdicks EFM, 2006, NEUROLOGY, V66, P460, DOI 10.1212/01.wnl.0000209204.87339.ef; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Wu B, 2010, EXPERT SYST APPL, V37, P4058, DOI 10.1016/j.eswa.2009.11.051; Yang ACC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108103; Yang S, 2004, EXPERT SYST, V21, P279, DOI 10.1111/j.1468-0394.2004.00285.x; Yu HL, 2010, MATH COMPUT MODEL, V51, P1375, DOI 10.1016/j.mcm.2009.10.028; Zhou ZH, 2003, LECT NOTES ARTIF INT, V2639, P476; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X	56	13	13	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1876-1070	1876-1089		J TAIWAN INST CHEM E	J. Taiwan Inst. Chem. Eng.	JAN	2011	42	1					97	107		10.1016/j.jtice.2010.05.006			11	Engineering, Chemical	Engineering	714YL	WOS:000286847500014					2021-06-18	
J	McDonald, S; Saad, A; James, C				McDonald, Skye; Saad, Abdul; James, Charlotte			Social dysdecorum following severe traumatic brain injury: Loss of implicit social knowledge or loss of control?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Implicit cognition; Explicit cognition; Executive functioning; Implicit association test	ASSOCIATION TEST; EMOTION PERCEPTION; HUMAN AMYGDALA; HEAD-INJURY; COGNITION; BEHAVIOR; DEFICITS; DAMAGE; RELIABILITY; NEUROBIOLOGY	The purpose of the present study was to investigate two theoretical frameworks for understanding acquired deficits in social behavior in individuals with severe traumatic brain injury (TBI). Recent research has found that brain injury can lead to impairments in implicit processes including social cognition. Impairments in implicit social cognition have been recently advanced as an explanation for acquired social deficits, as implicit social cognition is hypothesized to mediate the processing and understanding of often subtle, nonverbal cues in social interactions. In contrast, the executive dysfunction account posits that deficits in higher order cognitive functions, such as attention, planning ability, and mental flexibility, are the locus for acquired deficits in social cognition and behavior. To test these two theories, 22 participants with severe TBI and 25 matched controls were administered a measure of implicit social cognition (Implicit Association Test, IAT), as well as two measure of explicit social attitudes and a range of executive functioning measures. The TBI participants were found to perform normally on the IAT and explicit measures of gender stereotyping but demonstrated executive deficits. Performance on the IAT and executive functions were correlated. Performance in general did not fit well with the implicit social cognition explanation for social dysdecorum following TBI. More evidence was found to support the executive account.	[McDonald, Skye; Saad, Abdul; James, Charlotte] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	S.McDonald@psy.unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094	Australian Research CouncilAustralian Research Council	This research was funded by the Australian Research Council. We would also like to extend many thanks to the research participants with traumatic brain injuries as well as our control participants who gave so freely of their time and showed genuine interest in the project. We wish to thank clinicians from the Royal Rehabilitation Centre Brain Injury Unit and the Liverpool Brain Injury Unit who assisted with recruitment.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; [Anonymous], 2003, INQ 2 0 COMP SOFTW; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Barker LA, 2006, NEUROPSYCHOLOGIA, V44, P1413, DOI 10.1016/j.neuropsychologia.2005.12.005; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beldarrain MG, 1999, NEUROLOGY, V52, P1853, DOI 10.1212/WNL.52.9.1853; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blanton H, 2006, J EXP SOC PSYCHOL, V42, P192, DOI 10.1016/j.jesp.2005.07.003; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Codispoti M, 2009, PSYCHOPHYSIOLOGY, V46, P731, DOI 10.1111/j.1469-8986.2009.00804.x; Conrey FR, 2005, J PERS SOC PSYCHOL, V89, P469, DOI 10.1037/0022-3514.89.4.469; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAUGHERTY CG, 1986, EDUC PSYCHOL MEAS, V46, P449, DOI 10.1177/001316448604600221; De Houwer J, 2006, LEARN MOTIV, V37, P176, DOI 10.1016/j.lmot.2005.12.002; de Sousa A., CORTEX IN PRESS; Eslinger PJ, 2008, NEUROPSYCHOLOGICAL RESEARCH: A REVIEW, P379; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Glick P., 1996, J PERS SOC PSYCHOL, V69, P1013; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hummert ML, 2002, PSYCHOL AGING, V17, P482, DOI 10.1037//0882-7974.17.3.482; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Klauer KC, 2007, J PERS SOC PSYCHOL, V93, P353, DOI 10.1037/0022-3514.93.3.353; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McFarland SG, 2002, SOC COGNITION, V20, P483, DOI 10.1521/soco.20.6.483.22977; Messner C, 2010, J MARKETING RES, V47, P374, DOI 10.1509/jmkr.47.2.374; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reitan R. M, 1992, TRAIL MAKING TEST; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shallice, 1997, HAYLING BRIXTON TEST; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spence J. T., 1972, JSAS CATALOG SELECTE, V2, P66; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; von Stulpnagel R, 2010, Z PSYCHOL, V218, P51, DOI 10.1027/0044-3409/a000008; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whalen PJ, 1998, J NEUROSCI, V18, P411; YODER JD, 1982, SEX ROLES, V8, P651, DOI 10.1007/BF00289898	74	13	14	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	6					619	630		10.1080/13803395.2011.553586			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882GA	WOS:000299550100002	21480024				2021-06-18	
J	Nelson, JA				Nelson, James A.			Local Skull Trephination Before Transfer Is Associated With Favorable Outcomes in Cerebral Herniation from Epidural Hematoma	ACADEMIC EMERGENCY MEDICINE			English	Article							TRAUMATIC EXTRADURAL HEMATOMA; BURR HOLE; DECOMPRESSIVE SURGERY; SUBDURAL HEMATOMAS; HEAD-INJURIES; BRAIN-INJURY; EMERGENCY; MANAGEMENT; NEUROSURGERY; PROGNOSIS	P>Objectives: The patient with epidural hematoma and cerebral herniation has a good prognosis with immediate drainage, but a poor prognosis with delay to decompression. Such patients who present to nonneurosurgical hospitals are commonly transferred without drainage to the nearest neurosurgical center. This practice has never been demonstrated to be the safest approach to treating these patients. A significant minority of emergency physicians (EPs) have advised and taught bedside burr hole drainage or skull trephination before transfer for herniating patients. The objective of this study was to assess the effect of nonneurosurgeon drainage on neurologic outcome in patients with cerebral herniation from epidural hematoma. Methods: A structured literature review was performed using EMBASE, the Cochrane Library, and the Emergency Medicine Abstracts database. Results: No evidence meeting methodologic criteria was found describing outcomes in patients transferred without decompressive procedures. For patients receiving local drainage before transfer, 100% had favorable outcomes. Conclusions: Although the total number of patients is small and the population highly selected, the natural history of cerebral herniation from epidural hematoma and the best available evidence suggests that herniating patients have improved outcomes with drainage procedures before transport.	[Nelson, James A.] Pioneers Mem Hosp, Emergency Dept, Brawley, CA 92227 USA; [Nelson, James A.] Univ Calif San Diego, Emergency Dept, San Diego, CA 92103 USA	Nelson, JA (corresponding author), Pioneers Mem Hosp, Emergency Dept, Brawley, CA 92227 USA.	jamesnelsonmd@gmail.com					[Anonymous], 2003, SURG CAR DISTR HOSP; BATTERSBY RDE, 1990, BRIT J HOSP MED, V44, P276; Biros MH, 2009, ROSENS EMERGENCY MED; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Brock M, 1994, Zentralbl Neurochir, V55, P204; Bulters D, 2009, ANAESTHESIA, V64, P277, DOI 10.1111/j.1365-2044.2008.05779.x; Burton C, 1965, J Trauma, V5, P643, DOI 10.1097/00005373-196509000-00008; Caird J, 1999, IRISH MED J, V92, P270; Caird JD, 2003, BRIT J NEUROSURG, V17, P509, DOI 10.1080/02688690310001627722; Campana Bruce A, 2004, CMAJ, V171, P444, DOI 10.1503/cmaj.1040006; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Deverill J, 2007, EMERG MED AUSTRALAS, V19, P325, DOI 10.1111/J.1742-6723.2007.00969.x; GHANDI Y, 2004, EMERGENCY MED PROCED, P881; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JENNETT B, 1975, LANCET, V1, P480; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Latronico N, 2003, Minerva Anestesiol, V69, P159; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Liu JT, 2006, ACTA NEUROCHIR, V148, P313, DOI 10.1007/s00701-005-0723-z; MAHONEY BD, 1981, NEUROSURGERY, V8, P551, DOI 10.1227/00006123-198105000-00006; Marion DW, 2006, NEUROSURGERY, V58, P655; MCLELLAN K, 1998, CAN J RURAL MED, V3, P223; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; O'SULLIVAN M G, 1990, British Journal of Neurosurgery, V4, P473, DOI 10.3109/02688699008993795; Offner PJ, 2006, AM J SURG, V192, P801, DOI 10.1016/j.amjsurg.2006.08.047; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; Posner J. B., 2007, PLUM POSNERS DIAGNOS, P95; REYNA TM, 1981, MIL MED, V146, P504; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Rottger J, 1997, J Telemed Telecare, V3, P59, DOI 10.1258/1357633971930210; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Smith SW, 2010, J EMERG MED, V39, P377, DOI 10.1016/j.jemermed.2009.04.062; SPRINGER MFB, 1988, AM J EMERG MED, V6, P640, DOI 10.1016/0735-6757(88)90110-6; Tallon JM, 2008, CAN J SURG, V51, P339; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Valadka AB, 2006, J AM COLL SURGEONS, V203, P962, DOI 10.1016/j.jamcollsurg.2006.08.014; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023; WOODRUFF M, 2008, ESSENTIAL EMERGENCY, P153; WRAY AA, 2002, EMERGENCY PROCEDURES, P186; 2009, BBC NEWS        0520; 1998, BBC NEWS        0713; 1998, BBC NEWS        0904	52	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2011	18	1					78	85		10.1111/j.1553-2712.2010.00949.x			8	Emergency Medicine	Emergency Medicine	704LE	WOS:000286053700012	21414061	Bronze			2021-06-18	
J	O'Connor, MK; Mueller, L; Van Ormer, A; Drake, R; Penk, W; Rosenheck, R; Semiatin, A; Drebing, CE				O'Connor, Maureen K.; Mueller, Lisa; Van Ormer, Alice; Drake, Robert; Penk, Walter; Rosenheck, Robert; Semiatin, Alicia; Drebing, Charles E.			Cognitive impairment as barrier to engagement in vocational services among veterans with severe mental illness	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cognitive functioning; cognitive impairment; integrated services; pathways-to-care; return to work; severe mental illness; supported employment; treatment entry; vocational disability; vocational services	RANDOMIZED CONTROLLED-TRIAL; EUTHYMIC BIPOLAR PATIENTS; TRAUMATIC BRAIN-INJURY; SUPPORTED EMPLOYMENT; NEUROPSYCHOLOGICAL PERFORMANCE; SELF-AWARENESS; VISUAL-SEARCH; PART-B; SCHIZOPHRENIA; REHABILITATION	Vocational services (VS), particularly supported employment models, have clear advantages for assisting adults with severe mental illness (SMI) in returning to the workplace, but a majority of eligible individuals with SMI do not receive any type of VS. The reasons for nonparticipation in VS remain poorly understood, and the potential contribution of cognitive impairment as a barrier to entry has not been explored. The present study uses a pathways-to-care design to examine the specific contribution of cognitive functioning to entry into VS among veterans with SMI. We examined 179 veterans with both SMI and un- or underemployment who completed a work history, the Pathways To Care Inventory, and the Trail-Making Test, Part B. Analysis revealed that veterans with SMI and moderate to severe cognitive impairment took significantly longer to progress through pathways-to-care than those with SMI and mild or no cognitive impairment. These results suggest that identifying veterans with SMI and cognitive impairment early and providing them with integrated and adjunct services may help them navigate VS.	[O'Connor, Maureen K.; Mueller, Lisa; Van Ormer, Alice; Penk, Walter; Semiatin, Alicia; Drebing, Charles E.] Bedford Dept Vet Affairs VA Med Ctr, Bedford, MA USA; [O'Connor, Maureen K.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Drake, Robert] Dartmouth Med Sch, Hanover, NH USA; [Rosenheck, Robert] VA Connecticut Healthcare Syst, West Haven, CT USA; [Rosenheck, Robert] Yale Univ, Sch Med, New Haven, CT USA	O'Connor, MK (corresponding author), Bedford VAMC, Dept Psychol, 200 Springs Rd, Bedford, MA 01730 USA.	maureen.oconnor@va.gov	Drake, Robert/AAS-3310-2020		VHA Office of Rehabilitation Research and Development [F3436R]	This material was based on work supported by the VHA Office of Rehabilitation Research and Development (grant F3436R).	Addington J, 2002, ACTA PSYCHIAT SCAND, V106, P358, DOI 10.1034/j.1600-0447.2002.02004.x; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bell M, 2003, ACTA PSYCHIAT SCAND, V108, P101, DOI 10.1034/j.1600-0447.2003.00090.x; Bell M, 2007, J REHABIL RES DEV, V44, P761, DOI 10.1682/JRRD.2007.02.0032; BLACK B, 1988, WORK MENTAL ILLNESS; Blankertz L, 1996, PSYCHIATR SERV, V47, P1216; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Bond GR, 1991, J VOCATIONAL REHABIL, V1, P9; Bryson G, 1998, J NERV MENT DIS, V186, P610, DOI 10.1097/00005053-199810000-00004; Burns T, 2009, SCHIZOPHRENIA BULL, V35, P949, DOI 10.1093/schbul/sbn024; Casper ES, 2006, PSYCHIAT SERV, V57, P1430, DOI 10.1176/appi.ps.57.10.1430; Cook J A, 1992, J Ment Health Adm, V19, P158, DOI 10.1007/BF02521316; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.0.CO;2-K; Crowther R. E., 2001, J MENTAL HLTH, V10, P373, DOI DOI 10.1080/09638230120041137; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Drebing CE, 2003, REHABIL COUNS BULL, V47, P15, DOI 10.1177/00343552030470010301; DREBING CE, 2000, P ANN CONV AM PSYCH; Drebing Charles, 2004, Am J Alzheimers Dis Other Demen, V19, P187, DOI 10.1177/153331750401900306; Drebing CE, 1994, NEUROPSYCHOLOGY, V8, P31, DOI 10.1037/0894-4105.8.1.31; Dunn EC, 2008, PSYCHIATR REHABIL J, V32, P59, DOI 10.2975/32.1.2008.59.62; EHRENSTEIN WH, 1982, ARCH PSYCHIAT NERVEN, V231, P333, DOI 10.1007/BF00345589; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FABIAN E, 1989, PSYCHOSOC REHABIL, V2, P53, DOI DOI 10.1037/H0099503; Field A. P, 2009, DISCOVERING STAT USI; First M. B., 1996, USERS GUIDE STRUCTUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Galderisi S, 2009, SCHIZOPHR RES, V115, P104, DOI 10.1016/j.schres.2009.09.022; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Gervey R., 1994, PSYCHOL ASSESSMENT T, P139; Goldberg D, 1980, MENTAL ILLNESS COMMU; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Jablensky A, 1999, PEOPLE LIVING PSYCHO; KEEFE R, 2008, BEST PRACT MENT HLTH, V4, P123; Keefe RSE, 2007, SCHIZOPHRENIA BULL, V33, P912, DOI 10.1093/schbul/sbm046; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Krabbendam L, 2005, SCHIZOPHR RES, V80, P137, DOI 10.1016/j.schres.2005.08.004; Kurtz MM, 2004, SCHIZOPHR RES, V68, P95, DOI 10.1016/S0920-9964(03)00179-8; Larsen TK, 1998, BRIT J PSYCHIAT, V172, P45, DOI 10.1192/S0007125000297651; Lindenmayer JP, 2008, PSYCHIAT SERV, V59, P241, DOI 10.1176/appi.ps.59.3.241; MacDonald-Wilson K. L., 1991, J VOCATIONAL REHABIL, V1, P30; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Martinez-Aran A, 2002, NEUROPSYCHOBIOLOGY, V46, P16, DOI 10.1159/000068016; Marwaha S, 2004, SOC PSYCH PSYCH EPID, V39, P337, DOI 10.1007/s00127-004-0762-4; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; McGurk SR, 2000, SCHIZOPHR RES, V45, P175, DOI 10.1016/S0920-9964(99)00198-X; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; McGurk SR, 2004, SCHIZOPHR RES, V70, P147, DOI 10.1016/j.schres.2004.01.009; McGurk SR, 2008, PSYCHIATR REHABIL J, V31, P350, DOI 10.2975/31.4.2008.350.359; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; MOWBRAY CT, 1994, COMMUNITY MENT HLT J, V30, P347, DOI 10.1007/BF02207488; Mueser KT, 2001, SCHIZOPHRENIA BULL, V27, P281, DOI 10.1093/oxfordjournals.schbul.a006874; Osuji IJ, 2005, PSYCHIAT CLIN N AM, V28, P427, DOI 10.1016/j.psc.2005.02.005; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resnick SG, 2009, PSYCHIAT SERV, V60, P682, DOI 10.1176/appi.ps.60.5.682; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; STRAUSS ME, 1993, SCHIZOPHRENIA BULL, V19, P215, DOI 10.1093/schbul/19.2.215; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tsang H, 2000, INT J SOC PSYCHIATR, V46, P306, DOI 10.1177/002076400004600407; van Gorp WG, 1998, ARCH GEN PSYCHIAT, V55, P41, DOI 10.1001/archpsyc.55.1.41; vandenBosch RJ, 1997, COMPR PSYCHIAT, V38, P341, DOI 10.1016/S0010-440X(97)90930-5; VOLGRATH M, 1994, J CLIN PSYCHOL, V50, P727; Wexler BE, 2005, SCHIZOPHRENIA BULL, V31, P931, DOI 10.1093/schbul/sbi038; Wilder-Willis KE, 2002, SCHIZOPHR RES, V55, P259, DOI 10.1016/S0920-9964(01)00211-0; Woodruff G. R., 1995, ARCH CLIN NEUROPSYCH, V10, P408	71	13	13	0	13	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	5					597	607		10.1682/JRRD.2010.06.0117			11	Rehabilitation	Rehabilitation	783GJ	WOS:000292069200014	21674409	Bronze			2021-06-18	
J	Pielmaier, L; Maercker, A				Pielmaier, Laura; Maercker, Andreas			Psychological adaptation to life-threatening injury in dyads: the role of dysfunctional disclosure of trauma	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						disclosure of trauma; communication; dyads; significant other; posttraumatic stress disorder; medical trauma; traumatic brain injury; accident	POSTTRAUMATIC-STRESS-DISORDER; SHORT SCREENING SCALE; BRAIN-INJURY; SOCIAL ACKNOWLEDGMENT; SYMPTOMS; PREDICTORS; RISK; VETERANS; SUPPORT; POLICE	Background: Certain modes of trauma disclosure have been found to be associated with more severe symptoms of posttraumatic stress (PTS) in different trauma populations: the reluctance to disclose trauma-related thoughts and feelings, a strong urge to talk about it, and physical as well as emotional reactions during disclosure. Although social-contextual influences gain more and more interest in trauma research, no study has yet investigated these "dysfunctional disclosure tendencies" and their association with PTS from an interpersonal perspective. Objective: (1) To replicate previous findings on dysfunctional disclosure tendencies in patients with life-threatening injury and their significant others and (2) to study interpersonal associations between dysfunctional disclosure style and PTS at a dyadic level. Method: PTS symptom severity and self-reports on dysfunctional disclosure tendencies were assessed in N = 70 dyads comprising one individual with severe traumatic brain injury and a significant other ("proxy") 3 months after injury. Results: Regression analyses predicting PTS symptom severity revealed dysfunctional disclosure tendencies to have incremental validity above and beyond sex, age, and trauma severity within the individual (both patient and proxy), with moderate effect sizes. The interaction between patient's and proxy's disclosure style explained additional portions of the variance in patients' PTS symptom severity. Conclusions: Findings suggest that dysfunctional disclosure tendencies are related to poorer psychological adaptation to severe traumatic brain injury. This intrapersonal association may be exacerbated by dysfunctional disclosure tendencies on the part of a significant other. Although the results require replication in other trauma samples without brain injury to further generalize the findings beyond the observed population, the study contributes to the expanding literature on the crucial role of interpersonal relationships in trauma recovery.	[Pielmaier, Laura; Maercker, Andreas] Univ Zurich, Dept Psychol Psychopathol & Clin Intervent, Zurich, Switzerland	Pielmaier, L (corresponding author), Univ Zurich, Dept Psychol Psychopathol & Clin Intervent, Zurich, Switzerland.	l.pielmaier@psychologie.uzh.ch	Maercker, Andreas/D-2814-2017	Maercker, Andreas/0000-0001-6925-3266			Aiken L.S., 1991, MULTIPLE REGRESSION; American Association for the Advancement for Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Belsher BE, 2012, PSYCHOL TRAUMA-US, V4, P386, DOI 10.1037/a0024362; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Bolton EE, 2003, J TRAUMA STRESS, V16, P203, DOI 10.1023/A:1023754820991; Bootzin RR, 1997, PSYCHOL SCI, V8, P167, DOI 10.1111/j.1467-9280.1997.tb00404.x; Bowen A, 2010, ANXIETY STRESS COPIN, V23, P449, DOI 10.1080/10615800903414315; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Davidson AC, 2008, J LANG SOC PSYCHOL, V27, P51, DOI 10.1177/0261927X07309511; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehring T, 2008, COGNITIVE THER RES, V32, P488, DOI 10.1007/s10608-006-9089-7; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Goff BSN, 2005, J MARITAL FAM THER, V31, P145, DOI 10.1111/j.1752-0606.2005.tb01552.x; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hoyt T, 2010, INT J STRESS MANAGE, V17, P78, DOI 10.1037/a0017453; Institute of Medicine (IOM), 2008, TREATM POSTTR STRESS; Jacques-Tiura AJ, 2010, J TRAUMA DISSOCIATIO, V11, P174, DOI 10.1080/15299730903502938; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Leibowitz RQ, 2008, GEN HOSP PSYCHIAT, V30, P100, DOI 10.1016/j.genhosppsych.2007.11.004; Lepore S. J., 2001, PSYCHOSOC INTERV, P99, DOI [DOI 10.1037/10402-006, 10.1037/10402-006]; Lepore SJ, 1996, J PERS SOC PSYCHOL, V70, P271, DOI 10.1037/0022-3514.70.2.271; Lepore SJ, 2007, SOC PERSONAL PSYCHOL, V1, P313, DOI 10.1111/j.1751-9004.2007.00013.x; Maercker A, 1998, DIAGNOSTICA, V44, P130; Maercker A., 2011, SOCIOINTERPERS UNPUB; Maercker A, 2009, EUR PSYCHOL, V14, P249, DOI 10.1027/1016-9040.14.3.249; McAdam JL, 2009, AM J CRIT CARE, V18, P200, DOI 10.4037/ajcc2009252; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ern.11.94, 10.1586/ERN.11.94]; Monson C. M., 2010, INTERPERSONAL PROCES, P178; Monson CM, 2009, J TRAUMA STRESS, V22, P276, DOI 10.1002/jts.20432; Monson CM, 2005, PTSD RES Q, V16, P1, DOI DOI 10.1016/J.CPR.2009.09.002; Mueller J, 2008, CAN J PSYCHIAT, V53, P160; Mueller J, 2009, CAN J PSYCHIAT, V54, P547, DOI 10.1177/070674370905400807; Muller J, 2006, Z KL PSYCH PSYCHOTH, V35, P49, DOI 10.1026/1616-3443.35.1.49; Muller J., 2000, Z FUER POLITISCHE PS, V4, P413; Mundy E, 2004, CURR OPIN PSYCHIATR, V17, P123, DOI 10.1097/00001504-200403000-00009; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; PENNEBAKER JW, 1986, J ABNORM PSYCHOL, V95, P274, DOI 10.1037/0021-843X.95.3.274; Pennebaker JW, 2001, CURR DIR PSYCHOL SCI, V10, P90, DOI 10.1111/1467-8721.00123; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Renshaw KD, 2008, J FAM PSYCHOL, V22, P586, DOI 10.1037/0893-3200.22.3.586; Siegrist P, 2010, TRAUMA GEWALT, V3, P208; Stephens C, 1999, ANXIETY STRESS COPIN, V12, P247, DOI 10.1080/10615809908250477; Taku K, 2009, J SOC CLIN PSYCHOL, V28, P1226, DOI 10.1521/jscp.2009.28.10.1226; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P603; Ullman Sarah E, 2003, J Child Sex Abus, V12, P89, DOI 10.1300/J070v12n01_05; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Weiss DS, 1996, IMPACT EVENTS SCALE, P399; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zetsche U, 2009, J BEHAV THER EXP PSY, V40, P499, DOI 10.1016/j.jbtep.2009.07.001	58	13	13	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2011	2								8749	10.3402/ejpt.v2i0.8749			12	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	V31EX	WOS:000208868000025	22893822	DOAJ Gold, Green Accepted, Green Published			2021-06-18	
J	Scheibel, RS; Newsome, MR; Wilde, EA; McClelland, MM; Hanten, G; Krawczyk, DC; Cook, LG; Chu, ZD; Vasquez, AC; Yallampalli, R; Lin, XD; Hunter, JV; Levin, HS				Scheibel, Randall S.; Newsome, Mary R.; Wilde, Elisabeth A.; McClelland, Michelle M.; Hanten, Gerri; Krawczyk, Daniel C.; Cook, Lori G.; Chu, Zili D.; Vasquez, Ana C.; Yallampalli, Ragini; Lin, Xiaodi; Hunter, Jill V.; Levin, Harvey S.			Brain activation during a social attribution task in adolescents with moderate to severe traumatic brain injury	SOCIAL NEUROSCIENCE			English	Article						Traumatic brain injury; fMRI; Social cognition; Adolescents; Diffusion tensor imaging	WORKING-MEMORY; EMOTION RECOGNITION; MIND; CHILDREN; CHILDHOOD; COGNITION; OUTCOMES; IMPACT; FMRI; REORGANIZATION	The ability to make accurate judgments about the mental states of others, sometimes referred to as theory of mind (ToM), is often impaired following traumatic brain injury (TBI), and this deficit may contribute to problems with interpersonal relationships. The present study used an animated social attribution task (SAT) with functional magnetic resonance imaging (fMRI) to examine structures mediating ToM in adolescents with moderate to severe TBI. The study design also included a comparison group of matched, typically developing (TD) adolescents. The TD group exhibited activation within a number of areas that are thought to be relevant to ToM, including the medial prefrontal and anterior cingulate cortex, fusiform gyrus, and posterior temporal and parietal areas. The TBI subjects had significant activation within many of these same areas, but their activation was generally more intense and excluded the medial prefrontal cortex. Exploratory regression analyses indicated a negative relation between ToM-related activation and measures of white matter integrity derived from diffusion tensor imaging, while there was also a positive relation between activation and lesion volume. These findings are consistent with alterations in the level and pattern of brain activation that may be due to the combined influence of diffuse axonal injury and focal lesions.	[Scheibel, Randall S.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Scheibel, Randall S.; Newsome, Mary R.; Wilde, Elisabeth A.; Yallampalli, Ragini; Lin, Xiaodi; Levin, Harvey S.] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Chu, Zili D.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McClelland, Michelle M.; Krawczyk, Daniel C.; Cook, Lori G.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [McClelland, Michelle M.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Krawczyk, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Chu, Zili D.; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA	Scheibel, RS (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	scheibel@bcm.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health grant NS021889. We thank the adolescents and their families for their participation, Xiaoqi Li for statistical assistance, and Dr Sandra Chapman for advice regarding the design of this study. Recruitment and imaging of the subjects were facilitated by the General Clinical Research Center at Texas Children's Hospital and Ben Taub General Hospital in Houston, as well as the Children's Medical Center and Our Children's House at the Baylor Medical Center in Dallas and the Advanced Imaging Center at the University of Texas Southwestern Medical Center. The South Central Mental Illness Research, Education, and Clinical Center (MIRECC) and the Michael E. DeBakey Veteran's Affairs Medical Center provided access to laboratory facilities used for the analysis of the image data.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Aldrich NJ, 2011, BRIT J DEV PSYCHOL, V29, P86, DOI 10.1348/026151010X533238; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chevallier C, 2011, NEUROPSYCHOLOGIA, V49, P507, DOI 10.1016/j.neuropsychologia.2010.11.042; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes C., 2010, J EXPT CHILD PSYCHOL, V108, P96; Hynes C. A., 2011, SOCIAL NEUROSCIENCE, VXX, pXXX; Jacobs DM, 2000, PERCEPT PSYCHOPHYS, V62, P1332, DOI 10.3758/BF03212135; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; LaBar KS, 2001, NEUROREPORT, V12, P3461, DOI 10.1097/00001756-200111160-00017; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Moriguchi Y, 2007, PSYCHIAT CLIN NEUROS, V61, P355, DOI 10.1111/j.1440-1819.2007.01687.x; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Stocks EL, 2011, J APPL SOC PSYCHOL, V41, P1, DOI 10.1111/j.1559-1816.2010.00699.x; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 2011, WECHLSER ABBREVIATED; Weiderholt JL., 2001, GRAY ORAL READING TE, V4th; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	70	13	14	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2011	6	5-6			SI		582	598		10.1080/17470919.2011.588844			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	882NL	WOS:000299570500013	21777109	Green Accepted			2021-06-18	
J	van Rijn, CM; Perescis, MFJ; Vinogradova, L; van Luijtelaar, G				van Rijn, Clementine M.; Perescis, Martin F. J.; Vinogradova, Lyudmila; van Luijtelaar, Gilles			Endocannabinoid system protects against cryptogenic seizures	PHARMACOLOGICAL REPORTS			English	Article						cannabis; rimonabant; endocannabinoid system; epilepsy; cryptogenic seizures	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL-NEURONS; EPILEPSY; EXCITOTOXICITY; ANTAGONISTS; DAMAGE; TESTS; MODEL	Effects of the cannabinoid antagonist rimonabant on the EEG were investigated in healthy, non-epileptic rats. The drug was administered orally at 30 mg/kg/day for 3 weeks. The EEG was recorded continuously. In 3 out of 13 rats, limbic convulsive seizures, which were not related to the time of drug administration, were observed after 5-8 days. We hypothesize that an accumulation of micro-injuries in the brain is responsible for these "spontaneous" seizures.	[van Rijn, Clementine M.; Perescis, Martin F. J.; Vinogradova, Lyudmila; van Luijtelaar, Gilles] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands	van Rijn, CM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, POB 9104, NL-6500 HE Nijmegen, Netherlands.	t.vanrijn@donders.ru.nl	Vinogradova, Ljudmila/F-9578-2017; van Luijtelaar, Gilles/D-2290-2010; van Rijn, Clementina/D-5828-2012	Vinogradova, Lyudmila/0000-0003-0336-606X			Alger BE, 2006, NEURON, V51, P393, DOI 10.1016/j.neuron.2006.08.003; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; CORCORAN ME, 1978, EPILEPSIA, V19, P47; COURT A, 1996, EPILEPSIA, V37, P141; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hansen HH, 2002, J NEUROCHEM, V82, P154, DOI 10.1046/j.1471-4159.2002.00961.x; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Jetter GM, 2008, SEMIN NEUROL, V28, P336, DOI 10.1055/s-2008-1079338; Karanian DA, 2007, J PHARMACOL EXP THER, V322, P1059, DOI 10.1124/jpet.107.120147; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Leppik IE, 2006, EPILEPSIA, V47, P65, DOI 10.1111/j.1528-1167.2006.00664.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; MEHTA CR, 1993, AM STAT, V47, P91, DOI 10.2307/2685184; Nagayama T, 1999, J NEUROSCI, V19, P2987; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; Patrylo PR, 2007, EPILEPSIA, V48, P1964, DOI 10.1111/j.1528-1167.2007.01139.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rohmel J, 1999, BIOMETRICAL J, V41, P149; Shen MX, 1998, MOL PHARMACOL, V54, P459; Solbrig MV, 2005, EXP NEUROL, V194, P355, DOI 10.1016/j.expneurol.2005.02.017; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06	28	13	13	0	2	POLISH ACAD SCIENCES INST PHARMACOLOGY	KRAKOW	SMETNA 12, 31-343 KRAKOW, POLAND	1734-1140			PHARMACOL REP	Pharmacol. Rep.	JAN-FEB	2011	63	1					165	168					4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	750ZZ	WOS:000289588400019	21441624				2021-06-18	
J	Croce, A; Moretti, A; Vitullo, F; Castriotta, A; De Rosa, M; Citraro, L				Croce, A.; Moretti, A.; Vitullo, F.; Castriotta, A.; De Rosa, M.; Citraro, L.			Transparotid approach for mandibular condylar neck and subcondylar fractures	ACTA OTORHINOLARYNGOLOGICA ITALICA			English	Article						Mandible; Condylar neck fractures; Subcondylar fractures; Facial nerve	OPEN REDUCTION; INTERNAL-FIXATION; SURGICAL-TREATMENT; OSTEOSYNTHESIS; OSTEOTOMY; REPAIR	Mandibular condylar neck fractures and subcondylar fractures represent, respectively, 19-29% and 62-70% of all mandibular fractures; treatment involves some problems, common to both, concerning the choice of an adequate approach. Herewith, personal experience is reported related to the surgical treatment of some cases of mandibular condylar neck and subcondylar fractures by transparotid approaches with partial parotidectomy, removing the salivary tissue overlying the condylar neck and/or the subcondylar region. Over the last 5 years, we observed 22 fractures of the condylar neck and 10 fractures of the subcondylar region. In 13 patients (11 male, 2 female, age range 10-68 years, mean 33 years), 10 of whom had other mandibular and/or other maxillo-facial and skeleton fractures -50% of these with dislocated condylar heads -and the other 3 for their free choice, regarding the different treatments, 18 transparotid approaches with partial parotidectomy (bilateral in 5 cases), were performed reducing and fixing 12 condylar neck fractures and 5 subcondylar region fractures with appropriate plates (2.0 mm) and screws. After surgery, no intermaxillary fixation was performed. Complications included 4 salivary fistulae (bilateral in 1 patient), which closed spontaneously after 4 or 5 weeks with a dressing, 1 case of Frey's syndrome, which healed after 2 treatments with botulin and 6 cases of transient facial palsy lasting 4-8 weeks (1 case bilateral) affecting zygomatic, buccal and marginal mandibular nerves. During follow-up, functional parameters considered were: restoration of original pre-injury occlusion; vertical, lateral and protrusion mandibular movements. All patients re-acquired the original pre-injury occlusion; the maximal post-operative intrinsical distance was at least 40 mm after a variable period of rehabilitation and lateral and protrusion movements also led to satisfactory final results. All patients were free of pain and had no deflection or clicking upon opening or chewing. None suffered from haematoma, miniplate fractures, bone resorption or condylar necrosis. In our experience, the Transparotid approaches with partial parotidectomy permits very good anatomical repositioning of the displaced condylar or subcondylar osseous segments in all cases, since isolation of the facial nerve branches and removal of a limited part of the parotid gland tissue overlying the lesion allow perfect exposure of the fracture site. The wide operation field allows the facial nerve to be preserved and permits easy internal rigid fixation with plates, as the drill, screws and screwdriver can be positioned exactly perpendicular to the bone surface instead of obliquely, as occurs with many different approaches.	[Croce, A.; Moretti, A.; Vitullo, F.; Castriotta, A.; De Rosa, M.; Citraro, L.] G DAnnunzio Univ Chieti Pescara, Dept Surg Sci, Otorhinolaryngol Unit, Chieti, Italy	Croce, A (corresponding author), Univ G dAnnunzio, Clin Otorinolaringoiatr, Osped Clin SS Annunziata, Via Vestini, I-66013 Chieti, Scalo, Italy.	acroce@unich.it					Anastassov GE, 1997, J CRANIO MAXILL SURG, V25, P9, DOI 10.1016/S1010-5182(97)80018-2; BOYNE PJ, 1989, J ORAL MAXIL SURG, V47, P228, DOI 10.1016/0278-2391(89)90223-1; Chen CT, 1999, PLAST RECONSTR SURG, V103, P60, DOI 10.1097/00006534-199901000-00011; Choi BH, 1999, ORAL SURG ORAL MED O, V88, P292, DOI 10.1016/S1079-2104(99)70030-2; Choung PH, 1998, J ORAL MAXIL SURG, V56, P563, DOI 10.1016/S0278-2391(98)90452-9; Devlin MF, 2002, BRIT J ORAL MAX SURG, V40, P23, DOI 10.1054/bjom.2001.0748; Downie JJ, 2009, BRIT J ORAL MAX SURG, V47, P370, DOI 10.1016/j.bjoms.2008.11.002; Dunaway DJ, 1996, BRIT J PLAST SURG, V49, P79; Ellis E, 2000, J ORAL MAXIL SURG, V58, P27, DOI 10.1016/S0278-2391(00)80010-5; ELLIS E, 1989, ORAL SURG ORAL MED O, V68, P369, DOI 10.1016/0030-4220(89)90130-8; Guerrissi JO, 2002, J CRANIOFAC SURG, V13, P568; Hammer B, 1997, BRIT J ORAL MAX SURG, V35, P288, DOI 10.1016/S0266-4356(97)90050-4; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; Haug RH, 2001, PARAMETERS PATHWAYS, P1; HAYWARD JR, 1993, J ORAL MAXIL SURG, V51, P57, DOI 10.1016/S0278-2391(10)80391-X; Hyde N, 2002, BRIT J ORAL MAX SURG, V40, P19, DOI 10.1054/bjom.2001.0734; KENT JN, 1990, ORAL MAXILLOFAC SURG, V2, P69; Killey HC, 1974, FRACTURES MANDIBLE; KONSTANTINOVIC VS, 1992, J ORAL MAXIL SURG, V50, P349, DOI 10.1016/0278-2391(92)90395-G; LASKIN DM, 1991, J ORAL MAXIL SURG, V49, P1141, DOI 10.1016/0278-2391(91)90403-9; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; MACLENNAN W D, 1969, British Journal of Oral Surgery, V7, P31, DOI 10.1016/S0007-117X(69)80058-2; MIKKONEN P, 1989, INT J ORAL MAX SURG, V18, P267, DOI 10.1016/S0901-5027(89)80092-X; Miloro M, 2003, ORAL SURG ORAL MED O, V96, P387, DOI 10.1016/j.tripleo.2003.07.004; Newman L, 1998, BRIT J ORAL MAX SURG, V36, P176, DOI 10.1016/S0266-4356(98)90492-2; Oezmen Y, 1998, INT J ORAL MAX SURG, V27, P33, DOI 10.1016/S0901-5027(98)80092-1; Palmieri C, 1999, J ORAL MAXIL SURG, V57, P764, DOI 10.1016/S0278-2391(99)90810-8; Sawazaki R, 2010, J ORAL MAXIL SURG, V68, P1252, DOI 10.1016/j.joms.2009.03.064; Schon R, 2003, J ORAL MAXIL SURG, V61, P49, DOI 10.1053/joms.2003.50009; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; Smets LMH, 2003, J CRANIO MAXILL SURG, V31, P162, DOI 10.1016/S1010-5182(03)00025-8; SOREL B, 1998, ORAL MAXILLOFAC SURG, V10, P541; TAKENOSHITA Y, 1990, J ORAL MAXIL SURG, V48, P1191, DOI 10.1016/0278-2391(90)90535-A; VELAVER A, 2005, J CRANIOMAXILLOFAC S, V33, P169; Vogt A, 2005, ORAL MAXILLOFAC SURG, V9, P246, DOI 10.1007/s10006-005-0621-9; Wilson AW, 2005, BRIT J ORAL MAX SURG, V43, P57, DOI 10.1016/j.bjoms.2004.09.011; XIEN Z, 1991, J ORAL MAXIL SURG, V49, P1181, DOI 10.1016/0278-2391(91)90414-H; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854; ZIDE MF, 1983, J ORAL MAXIL SURG, V41, P89, DOI 10.1016/0278-2391(83)90214-8; ZIDE MF, 1989, CLIN PLAST SURG, V16, P69	40	13	14	0	2	PACINI EDITORE	PISA	VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY	0392-100X	1827-675X		ACTA OTORHINOLARYNGO	Acta Otorhinolaryngol. Ital.	DEC	2010	30	6					303	309					7	Otorhinolaryngology	Otorhinolaryngology	742SY	WOS:000288966000007	21808452				2021-06-18	
J	Isaradisaikul, S; Navacharoen, N; Hanprasertpong, C; Kangsanarak, J; Panyathong, R				Isaradisaikul, Suwicha; Navacharoen, Niramon; Hanprasertpong, Charuk; Kangsanarak, Jaran; Panyathong, Rapeepun			Causes and time-course of vertigo in an ear, nose, and throat clinic	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Vertigo; Vestibular disorder; Outpatient clinic	EXPERIENCE; DIZZINESS	The purpose of this study is to review etiologies and identify the time-course of vertigo presenting in an ear, nose, and throat clinic, and serve as a reference guide for other clinics. The study includes retrospective chart review in a tertiary care, university hospital. The patient data with reported ICD-10 codes as causes of vertigo between April 2005 and December 2007 were extracted from the database. At each visit, the main diagnosis as to etiology, characteristics of the vertigo, its time-course, and patient demographic data were recorded. Of 547 cases, 17 diagnoses were made in 73.9%. Diagnostic categories included peripheral vertigo 72.9%, central vertigo 0.8%, psychogenic cause 0.2%, and unknown 26.1%. Common causes of vertigo were benign paroxysmal positional vertigo (BPPV) 52.5%, Meniere's disease 14.6%, and sudden idiopathic hearing loss 2.9%. Less common diagnoses were benign paroxysmal vertigo of childhood 0.7%, labyrinthitis 0.7%, and vestibular schwannoma 0.3%. Rare conditions were delayed endolymphatic hydrops, Ramsey Hunt syndrome, otosyphilis, vestibular neuritis, temporal bone fracture, post-concussion syndrome, cerebellar infarction, epilepsy, cervical vertigo, Streptococcus suis meningitis, and psychogenic vertigo. Ninety-nine cases who reported remission of vertigo during the study period had median onset of the remission at 4 weeks. In the ear, nose, and throat clinic at Chiang Mai University, a tertiary university hospital, peripheral vestibular disorders were the main etiology of vertigo. The three most common causes were BPPV, Meniere's disease, and sudden idiopathic hearing loss. Half of the cases who returned for follow up had remitted symptoms within 4 weeks.	[Isaradisaikul, Suwicha; Navacharoen, Niramon; Hanprasertpong, Charuk; Kangsanarak, Jaran; Panyathong, Rapeepun] Chiang Mai Univ, Dept Otolaryngol, Fac Med, Chiang Mai 50200, Thailand	Isaradisaikul, S (corresponding author), Chiang Mai Univ, Dept Otolaryngol, Fac Med, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.	sisaradi@mail.med.cmu.ac.th; nnavacha@mail.med.cmu.ac.th; jrukhan@yahoo.com; jarank@mail.med.cmu.ac.th; rapee_rapee@hotmail.com		Isaradisaikul Kaewsiri, Suwicha/0000-0003-1332-9940	Faculty of Medicine, Chiang Mai University	Grant support for this project was provided by the Faculty of Medicine, Chiang Mai University. The authors would like to thank Prof. Herman A. Jenkins for proof read the manuscript.	Asawavichianginda S., 2007, EAR VERTIGO HEARING, P47; BANGPOOPHAMORN K, 2007, 11 AS OC ORL HEAD NE; Bath AP, 2000, AM J OTOL, V21, P92, DOI 10.1016/S0196-0709(00)80081-2; Guilemany JM, 2004, ACTA OTO-LARYNGOL, V124, P49, DOI 10.1080/00016480310002122; Hannaford PC, 2005, FAM PRACT, V22, P227, DOI 10.1093/fampra/cmi004; Heaton JM, 1999, J LARYNGOL OTOL, V113, P19, DOI 10.1017/S0022215100143063; KATSARKAS A, 1994, OTOLARYNG HEAD NECK, V110, P296, DOI 10.1016/S0194-5998(94)70772-3; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Navacharoen N, 2009, J LARYNGOL OTOL, V123, P857, DOI 10.1017/S0022215109004939; Navacharoen N, 1995, VERTIGO, P67; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432	11	13	20	0	32	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477			EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	DEC	2010	267	12					1837	1841		10.1007/s00405-010-1309-9			5	Otorhinolaryngology	Otorhinolaryngology	673NQ	WOS:000283670600003	20567978				2021-06-18	
J	Jagoda, AS				Jagoda, Andy S.			Mild Traumatic Brain Injury: Key Decisions in Acute Management	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Mild traumatic brain injury; postconcussive disorders; Rehabilitation; Neurobehavioral; Sequelae	MINOR HEAD-INJURY; EMERGENCY-DEPARTMENT DISCHARGE; COMPUTED-TOMOGRAPHY; RELIABILITY; IMPACT; RULE	The definition of a mild traumatic brain injury (TBI) has come under close scrutiny and is changing as a result of refined diagnostic testing Although up to 15% of patients with a mild TBI will have an acute intracranial lesion identified on head computed tomography (CT), less than 1% of these patients will have a lesion requiring a neurosurgical intervention Evidence-based guideline methodology has assisted in generating recommendations to facilitate clinical decision making however no set of guidelines is 100% sensitive and specific Evidence supports the safety of discharging patients with mild TBI who have a negative CT However though patients with a negative CT are at almost no risk of deteriorating from a neurosurgical lesion, a key intervention is to provide these patients at discharge from the emergency department with counseling regarding postconcussive symptoms when to return to work school, or sports, and when to seek additional medical care	Mt Sinai Sch Med, Dept Emergency Med, New York, NY 10029 USA	Jagoda, AS (corresponding author), Mt Sinai Sch Med, Dept Emergency Med, 1 Gustave L Levy Pl,Box 1620, New York, NY 10029 USA.						af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bergman DA, 1999, PEDIATRICS, V104, P1407; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention Division of Laboratory Science, 2003, CLIA METH, P1; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kelly JP, 1997, NEUROLOGY, V48, P581; LEVITT MA, 1994, AM J EMERG MED, V12, P172, DOI 10.1016/0735-6757(94)90240-2; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAUNDERS CE, 1986, ANN EMERG MED, V15, P160, DOI 10.1016/S0196-0644(86)80012-9; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214	34	13	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					797	+		10.1016/j.psc.2010.09.004			12	Psychiatry	Psychiatry	694TA	WOS:000285320700005	21093679				2021-06-18	
J	Truelle, JL; Fayol, P; Montreuil, M; Chevignard, M				Truelle, Jean-Luc; Fayol, Patrick; Montreuil, Michele; Chevignard, Mathilde			Community integration after severe traumatic brain injury in adults	CURRENT OPINION IN NEUROLOGY			English	Article						community integration; health-related quality of life; long-term outcome; rehabilitation programs; traumatic brain injury	QUALITY-OF-LIFE; VOCATIONAL-REHABILITATION; INDIVIDUALS; WORK; PHARMACOTHERAPY; DISABILITY; HEALTH	Purpose of review Despite being the main cause of death and disability in young adults, traumatic brain injury (TBI) is a rather neglected epidemic. Community integration of persons with TBI was, until recently, insufficiently informed by clinical research. Recent findings To bridge the gap between rehabilitation and community re-entry, the first task is to assess the person, using TBI-specific outcome measures. The second task is to provide re-entry programs, the effectiveness of which is assessed by those measures, using well designed studies. There are very few such studies. However, there are some effective comprehensive programs and others which are specifically targeted dealing mainly with return to work, behavior, and family issues. The complex psychological and environmental components of the disability require individualized and often long-term care. Summary For persons with severe TBI trying to achieve the best possible community integration a new semiology is required, not just limited to medical care, but also involving social and psychological care that is tailored to the needs of each individual and family, living within his/her environment. Currently, only a minority benefit from well validated programs.	[Truelle, Jean-Luc] Raymond Poincare Univ Hosp, Dept Neurol Rehabil, F-92380 Garches, France; [Fayol, Patrick] Ctr Hosp Esquirol, Serv Psychorehabil, Limoges, France; [Montreuil, Michele] Univ Paris 08, Lab Psychopathol & Neuropsychol, St Denis, France; [Chevignard, Mathilde] Hop Natl St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France; [Chevignard, Mathilde] Univ Paris 06, Paris 10, France	Truelle, JL (corresponding author), Raymond Poincare Univ Hosp, Dept Neurol Rehabil, F-92380 Garches, France.	jean-luc.truelle@wanadoo.fr					ALTMAN IM, 2010, BRAIN IMPAIR, V11, P199; *BABICM, 2010, BRIT ASS BRAIN INJ C; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; BROOKS DN, 1994, HEAD INJURY EVALUATI, P1; *C BRAIN INJ TASK, 2009, CLIN PSYCHOL, V8, P1283; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; *COMM ACCR REH FAC, 2005, MED REH STAND MAN; COPE ND, 2009, J WORKERS COMPENSATI, V18, P17; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; FRENCH LM, 2010, MILITARY NEUROPSYCHO, P101; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Hoffman SW, 2010, NEUROREHABILITATION, V26, P257, DOI 10.3233/NRE-2010-0561; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Johnson C, 2006, BRAIN INJURY, V20, P687, DOI 10.1080/02699050600744137; Johnstone B, 2009, BRAIN INJURY, V23, P411, DOI 10.1080/02699050902788501; KNEIPP S, 2007, BRAIN INJURY MED, P1091; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Malec J., 2008, MANUAL MAYO PORTLAND; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; Newby G, 2010, NEUROPSYCHOL REHABIL, V20, P264, DOI 10.1080/09602010903175034; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Prigatano GP, 2009, CURR OPIN NEUROL, V22, P606, DOI 10.1097/WCO.0b013e328332a1e7; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; SULLIVAN K, 2007, BRAIN INJURY MED, P929; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Truelle J-L, 2010, Asian J Neurosurg, V5, P24; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Tsiouris JA, 2010, J INTELL DISABIL RES, V54, P1, DOI 10.1111/j.1365-2788.2009.01232.x; Uprichard S, 2009, BRAIN INJURY, V23, P278, DOI 10.1080/02699050902788444; VANSON AW, 2009, J REHABIL MED, V41, P521; WEED R, 2007, BRAIN INJURY MED, P1223; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; West SL, 2009, ALCOHOL TREAT Q, V27, P280, DOI 10.1080/07347320903008166; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	13	16	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2010	23	6					688	694		10.1097/WCO.0b013e3283404258			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	675SJ	WOS:000283852400022	20962638				2021-06-18	
J	Begonia, MT; Prabhu, R; Liao, J; Horstemeyer, MF; Williams, LN				Begonia, Mark T.; Prabhu, Raj; Liao, Jun; Horstemeyer, Mark F.; Williams, Lakiesha N.			The Influence of Strain Rate Dependency on the Structure-Property Relations of Porcine Brain	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Strain rate dependence; Confocal microscopy; Area fraction	INJURY; TISSUE; BIOMECHANICS; BEHAVIOR; IMPACT; STATE; STEM	This study examines the internal microstructure evolution of porcine brain during mechanical deformation. Strain rate dependency of porcine brain was investigated under quasi-static compression for strain rates of 0.00625, 0.025, and 0.10 s(-1). Confocal microscopy was employed at 15, 30, and 40% strain to quantify microstructural changes, and image analysis was implemented to calculate the area fraction of neurons and glial cells. The nonlinear stress-strain behavior exhibited a viscoelastic response from the strain rate sensitivity observed, and image analysis revealed that the mean area fraction of neurons and glial cells increased according to the applied strain level and strain rate. The area fraction for the undamaged state was 7.85 +/- 0.07%, but at 40% strain the values were 11.55 +/- 0.35%, 13.30 +/- 0.28%, and 19.50 +/- 0.14% for respective strain rates of 0.00625, 0.025, and 0.10 s(-1). The increased area fractions were a function of the applied strain rate and were attributed to the compaction of neural constituents and the stiffening tissue response. The microstructural variations in the tissue were linked to mechanical properties at progressive levels of compression in order to generate structure-property relationships useful for refining current FE material models.	[Begonia, Mark T.; Liao, Jun; Williams, Lakiesha N.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Prabhu, Raj; Horstemeyer, Mark F.] Ctr Adv Vehicular Syst, Starkville, MS 39759 USA	Williams, LN (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, 130 Creelman St, Mississippi State, MS 39762 USA.	lwilliams@abe.msstate.edu	Prabhu, Raj/M-7188-2017	Prabhu, Raj/0000-0002-6073-4802; Liao, Jun/0000-0003-1049-5783; Horstemeyer, Mark/0000-0003-4230-0063	U.S. Army TACOM Life Cycle Command [W56HZV-08-C-0236]	This research was supported by the U.S. Army TACOM Life Cycle Command under Contract No. W56HZV-08-C-0236 through a subcontract with Mississippi State University and was performed for the Simulation Based Reliability and Safety (SimBRS) research program. The authors also recognize the Center for Advanced Vehicular Systems (CAVS) and the Department of Agricultural and Biological Engineering at Mississippi State University for their ongoing support of this research. Further acknowledgment must be given to Sansing Meat Services in Maben, MS for their assistance in providing porcine brain tissue specimens as well as Amanda Lawrence and Bill Monroe of the Mississippi State University Electron Microscopy Center for their assistance with the histological processing and operation of the con-focal laser scanning microscope, respectively. In addition, the authors recognize Dr. Jim Cooley for his assistance in the extraction procedure at the Mississippi State College of Veterinary Medicine. UNCLASSIFIED: Dist A. Approved for public release.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; ARBOGAST KB, 1997, 41 STAPP CAR CRASH C; BRANDS DWA, 2000, P 44 STAPP CAR CRASH; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; DEWEESE RL, 2004, EVALUATION HEAD INJU; Dickerson J. W. T., 1966, Proceedings of the Royal Society, V166B, P384; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; ESTES MS, 1970, 70BHF13 ASME; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller N., 2000, J REAL ESTATE PORTFO, V6, P167; *NAT DISS CTR CHIL, 2006, FACTSH TRAUM BRAIN I; *NAT I NEUR DIS ST, 2006, TRAUM BRAIN INJ HOP; NOLTE J, 2002, HUMAN BRAIN INTRO IT; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Prange M.T., 1998, ADV BIOENGINEERI BED, V39, P151; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; TAKHOUNTS EG, 1999, INJURY BIOMECHANICS, V11, P141; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Versace J., 1971, STAPP CAR CRASH C P; WIDMAIER EP, 2006, VANDERS HUMAN PHYSL, P191; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	46	13	14	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2010	38	10					3043	3057		10.1007/s10439-010-0072-9			15	Engineering, Biomedical	Engineering	650ZX	WOS:000281895500001	20505994				2021-06-18	
J	Turkoglu, OF; Eroglu, H; Gurcan, O; Bodur, E; Sargon, MF; Oner, L; Beskonakli, E				Turkoglu, Omer Farltk; Eroglu, Hakan; Gurcan, Oktay; Bodur, Ebru; Sargon, Mustafa F.; Oner, Levent; Beskonakli, Etem			Local administration of chitosan microspheres after traumatic brain injury in rats: a new challenge for cyclosporine - a delivery	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cyclosporine-A; traumatic brain injury; chitosan; microsphere	INDUCED AXONAL DAMAGE; SPINAL-CORD-INJURY; MITOCHONDRIAL DYSFUNCTION; ULTRASTRUCTURAL-CHANGES; ALBUMIN MICROSPHERES; LIPID-PEROXIDATION; DOSE-RESPONSE; PERMEABILITY; FORMULATION; MECHANISMS	The major aim of this study was to evaluate the efficiency of chitosan microspheres containing cyclosporine-A (Cs-A) on mitochondrial damage in traumatic brain injury (TBI) animal model. Trauma was introduced to male Sprague-Dawley (SD) rats similar to that of modified Feeney Method. Briefly, after craniectomy in the left parietal region (5 mm). Trauma was performed by dropping 24 g metal sterile rods through a teflon guide tube (9.3 cm) on a foot plate placed over the duramater. Just after the trauma, 20 mg/kg Cs-A (Sandimmune (R) has been administered to the traumatised SD rats intraperitoneally (i.p.). On the other hand, only chitosan microspheres containing 10 mg/kg was implanted at the craniectomy area locally after trauma in Group E. A small piece of surgicell was placed over the craniectomy hole and the scalp incision was sutured. 24 h after injury and the brain tissues were removed intact. The results were evaluated through lipid peroxidation ratio and ultrastructural grading system. The statistical comparisons were evaluated by using Mann Whitney U test at the significance level p = 0.05. The lipid peroxidation ratios of sham (78.4 +/- 6.0 nmol/g tissue) and vehicle (80.2 +/- 10.6 nmol/g tissue) were significantly increased 24 h after TBI. However, for treatment groups (i.p. Cs-A; 20 mg/kg) and (10 mg/kg Cs-A in microspheres), statistically significant lower lipid peroxidation ratios were determined as 53.5 +/- 9.7 and 47.9 +/- 8.1 nmol/g tissue, respectively (p < 0.05). The mitochondrial damage scores of the treatment groups were recorded as 21.7 +/- 2.6 and 19.4 +/- 3.9 for Group D and Group E, respectively. Both of these scores of the treatment groups were found as significantly different from the sham and vehicle groups' scores individually. The implantation of microsphere formulation has provided a better efficiency in keeping the uniformity of mitochondrial structure in this complex cascade of events after TBI.	[Turkoglu, Omer Farltk; Beskonakli, Etem] Ankara Ataturk Res & Educ Hosp, Dept Neurosurg, TR-06800 Ankara, Turkey; [Eroglu, Hakan; Oner, Levent] Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, TR-06100 Ankara, Turkey; [Gurcan, Oktay] Ankara Numune Training & Res Hosp, Dept Neurosurg, TR-06100 Ankara, Turkey; [Bodur, Ebru] Hacettepe Univ, Dept Biochem, Fac Med, TR-06100 Ankara, Turkey; [Sargon, Mustafa F.] Hacettepe Univ, Dept Anat, Fac Med, TR-06100 Ankara, Turkey	Turkoglu, OF (corresponding author), Tevfik Saglam Cd Aral Sk 2-4 Etlik, Ankara, Turkey.	ofturkoglu@yahoo.com	BODUR, EBRU/I-8382-2013; ONER, LEVENT/J-1032-2013; EROGLU, HAKAN/J-1040-2013; BODUR, EBRU/AAR-8545-2020	BODUR, EBRU/0000-0001-5829-5487; ONER, LEVENT/0000-0002-6510-7680; BODUR, EBRU/0000-0001-5829-5487; Sargon, Mustafa Fevzi/0000-0001-6360-6008; Eroglu, Hakan/0000-0001-6361-0074			Almond BA, 2003, J CONTROL RELEASE, V91, P147, DOI 10.1016/S0168-3659(03)00214-1; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bejugam NK, 2008, J MICROENCAPSUL, V25, P577, DOI 10.1080/02652040802476187 ; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; HUGHES RL, 1990, NEW ENGL J MED, V323, P420; Ibarra A, 2006, CURR MED CHEM, V13, P2703, DOI 10.2174/092986706778201503; Jameela SR, 1996, J PHARM PHARMACOL, V48, P685, DOI 10.1111/j.2042-7158.1996.tb03951.x; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Petit PX, 1997, MOL CELL BIOCHEM, V174, P185, DOI 10.1023/A:1006848205880; Povlishock JT, 1996, ACT NEUR S, V66, P81; REECE DE, 1991, BONE MARROW TRANSPL, V8, P393; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinder AF, 1996, J NEUROSCI, V16, P6125; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Siwale RC, 2009, J MICROENCAPSUL, V26, P411, DOI 10.1080/02652040802420409; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Solaroglu I, 2004, BIOL NEONATE, V85, P221, DOI 10.1159/000075835; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun Y, 2009, DRUG DEV IND PHARM, V35, P379, DOI [10.1080/03639040802395185, 10.1080/03639040802395185 ]; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Wang HM, 2008, CHINESE J INORG CHEM, V24, P1; Yildirim E, 2004, J HEART LUNG TRANSPL, V23, P1423, DOI 10.1016/j.healun.2003.10.006; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	40	13	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2010	24	5					578	583		10.3109/02688697.2010.487126			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	670HV	WOS:000283412700013	20868245				2021-06-18	
J	Fabbri, A; Servadei, F; Marchesini, G; Negro, A; Vandelli, A				Fabbri, Andrea; Servadei, Franco; Marchesini, Giulio; Negro, Antonella; Vandelli, Alberto			The changing face of mild head injury: Temporal trends and patterns in adolescents and adults from 1997 to 2008	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Epidemiology; Mild head injury; Outcome; Temporal trends	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; IMPACT; POPULATION; COMMUNITY; PEOPLE	Objective: To explore the temporal trend of incidence, causes of injury and main characteristics of adolescent and adult subjects with mild head injury (MHI). Design: This study had a retrospective design. Setting: The study was conducted in a longitudinal database of an Italian Emergency Department (ED). Participants: The study comprised 19 124 consecutive subjects who visited and were managed within 24 h from the event, according to a predefined protocol for MHI from 1997 to 2008. Main outcome measures: Incidence, demography, cause of injury and characteristics of any post-traumatic intracranial lesion within 7 days from MHI. Results: The number of subjects with MHI decreased from 2019 per year (1997-1999) to 1232 per year (2006-2008; P for linear trend < 0.001), without differences in the total number of subjects visited in the ED. The decrease was observed in all age-decades, in particular, in subjects in the age ranges of 20-29 and 30-39 years. Over time, the age of subjects with MHI lost a bimodal distribution, and the mean age increased from 43 (25-69) years (median (interquartile range)) in 1997-1999 to 56 (33-78) years in 2006-2008 (P < 0.001). The prevalence of falls increased from 36.5% to 55.0%, whereas crashes fell from 53.2% to 31.9%. The incidence of subdural haematoma (SDH) and epidural haematoma (EDH) did not change over time, whereas traumatic subarachnoid haemorrhage (t-SAH) and intra-cerebral haematoma/brain contusion (ICH) increased (from 0.7% to 1.9% and from 2.5% to 3.2%; P for trend: < 0.001 for both. Conclusions: The incidence and the clinical characteristics of MHI subjects are rapidly changing in our setting. These data need to be considered in defining the effectiveness of preventive measures and deciding resource allocation. (C) 2010 Elsevier Ltd. All rights reserved.	[Fabbri, Andrea; Vandelli, Alberto] Presidio Osped Morgagni Pierantoni, Dipartimento Emergenza, Azienda USL Forli, I-47100 Forli, Italy; [Servadei, Franco] Univ Parma, Azienda Osped, Unita Operat Neurochirurg, I-43100 Parma, Italy; [Marchesini, Giulio] Univ Bologna, Bologna, Italy; [Negro, Antonella] Agenzia Sanit & Sociale Reg, Bologna, Italy	Fabbri, A (corresponding author), Presidio Osped Morgagni Pierantoni, Dipartimento Emergenza, Azienda USL Forli, Via Forlanini 34, I-47100 Forli, Italy.	dr.andrea.fabbri@gmail.com	Fabbri, Andrea/K-9994-2016	Marchesini, Giulio/0000-0003-2407-9860; Fabbri, Andrea/0000-0002-9837-4638; Servadei, Franco/0000-0002-3595-3464	U.O. Unita Operativa di Neurochirurgia, Azienda Ospedaliero-Universitaria di Parma, Italy	We are grateful to the Dr. Fernanda Tagliaferri U.O. Unita Operativa di Neurochirurgia, Azienda Ospedaliero-Universitaria di Parma, Italy for helpful support and critical review of the manuscript.	Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; GIANNOUDIS PV, 2009, J TRAUMA; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133	26	13	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					913	917		10.1016/j.injury.2010.03.002			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500007	20362983				2021-06-18	
J	Koeberle, PD; Schlichter, LC				Koeberle, Paulo D.; Schlichter, Lyanne C.			Targeting K-V channels rescues retinal ganglion cells in vivo directly and by reducing inflammation	CHANNELS			English	Article						neurotrauma; axotomy; optic nerve transection; microglial activation; apoptosis; K(V)1.1; K(V)1.3; siRNA in vivo; agitoxin-2; margatoxin	GROWTH-FACTOR-BETA; OPTIC-NERVE; SURVIVAL; DEATH; APOPTOSIS; PHOSPHORYLATION; INTERLEUKIN-1; DEGENERATION; TRANSECTION; ACTIVATION	Retinal ganglion cell (RGC) degeneration is an important cause of visual impairment, and results in part from microglia-mediated inflammation. Numerous experimental studies have focused on identifying drug targets to rescue these neurons. We recently showed that K(V)1.1 and K(V)1.3 channels are expressed in adult rat RGCs and that siRNA-mediated knockdown of either channel reduces RGC death after optic nerve transection. Earlier we found that K(V)1.3 channels also contribute to microglial activation and neurotoxicity; raising the possibility that these channels contribute to neurodegeneration through direct roles in RGCs and through inflammatory mechanisms. Here, RGC survival was increased by combined siRNA-mediated knockdown of K(V)1.1 and K(V)1.3 in RGCs, but survival was much greater when knockdown of either channel was combined with intraocular injection of a K(V)1.3 channel blocker (agitoxin-2 or margatoxin). After axotomy, increased expression of several inflammation-related molecules preceded RGC loss and, consistent with a dual mechanism, their expression was differentially affected when channel knockdown in RGCs was combined with K(V)1.3 blocker injection. K(V)1.3 blockers reduced activation of retinal microglia and their tight apposition along RGC axon fascicles after axotomy, but did not prevent their migration from the inner plexiform to the damaged ganglion cell layer. Expression of several growth factors increased after axotomy; and again, there were differences following blocker injection compared with RGC-selective channel knockdown. These results provide evidence that K(V)1.3 channels play important roles in apoptotic degeneration of adult RGCs through cell-autonomous mechanisms mediated by channels in the neurons, and non-autonomous mechanisms mediated by microglia and inflammation.	[Koeberle, Paulo D.; Schlichter, Lyanne C.] Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Koeberle, Paulo D.; Schlichter, Lyanne C.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Koeberle, Paulo D.] Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada	Schlichter, LC (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	schlicht@uhnres.utoronto.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [MT-13657]; Heart and Stroke Foundation, Ontario chapter HSFOHeart & Stroke Foundation of Canada [T5546]; Krembil Scientific Development Seed Fund; HSF Canada	We are grateful to Drs. Yimin Wang and Xiaoping Zhu for performing real-time RT-PCR analysis. This work was supported by operating grants to Lyanne C. Schlichter from the Canadian Institutes for Health Research (MT-13657), the Heart and Stroke Foundation, Ontario chapter (HSFO T5546) and the Krembil Scientific Development Seed Fund. Paulo D. Koeberle was supported by a postdoctoral fellowship from HSF Canada.	Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Beier M, 2006, NEUROSCI RES, V56, P193, DOI 10.1016/j.neures.2006.07.002; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Diem R, 2001, J NEUROSCI, V21, P2058, DOI 10.1523/JNEUROSCI.21-06-02058.2001; Emch GS, 2001, AM J PHYSIOL-REG I, V281, pR1394; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Garcia-Valenzuela E, 2005, MOL VIS, V11, P225; Germain F, 2003, EUR J NEUROSCI, V18, P1103, DOI 10.1046/j.1460-9568.2003.02842.x; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Koeberle PD, 2010, CELL DEATH DIFFER, V17, P134, DOI 10.1038/cdd.2009.113; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Koeberle PD, 1999, EXP NEUROL, V158, P366, DOI 10.1006/exnr.1999.7113; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Levin LA, 1999, EUR J OPHTHALMOL, V9, pS12, DOI 10.1177/112067219900901S08; Missel PJ, 2002, ANN BIOMED ENG, V30, P1128, DOI 10.1114/1.1521417; Schuetz E, 2004, CURR DRUG TARGETS, V5, P619, DOI 10.2174/1389450043345164; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Watanabe M, 1997, CLIN NEUROSCI, V4, P233; Weishaupt JH, 2001, RESTOR NEUROL NEUROS, V19, P19; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yang JJ, 2000, CURR EYE RES, V21, P981, DOI 10.1076/ceyr.21.6.981.6991; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zhang X, 2004, EXP EYE RES, V78, P849, DOI 10.1016/j.exer.2003.10.018	31	13	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6950	1933-6969		CHANNELS	Channels	SEP-OCT	2010	4	5					337	346		10.4161/chan.4.5.12790			10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	663GB	WOS:000282870100002	20699649	Bronze, Green Published			2021-06-18	
J	Ley, EJ; Berry, C; Mirocha, J; Salim, A				Ley, Eric J.; Berry, Cherisse; Mirocha, James; Salim, Ali			Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	5th Annual Academic-Surgical Congress	JAN-FEB -, 2010	San Antonio, TX			traumatic brain injury; heart rate; beta-blockers; outcome; mortality	BETA-BLOCKER EXPOSURE; NONCARDIAC SURGERY; CEREBRAL PERFUSION; PROPRANOLOL; METAANALYSIS; SURVIVAL	Background. Increasing data indicate treatment with beta blockers might improve survival after traumatic brain injury (TBI); the optimal heart rate (HR) range for these patients is unknown. To guide treatment, admission HR in moderate to severe TBI patients was analyzed to determine if a specific range is associated with decreased mortality. Methods. The Los Angeles County Trauma System Database, consisting of five Level I and 8 Level II trauma centers, was queried for all injured patients admitted between 1998 and 2005 (n = 147,788). Isolated moderate to severe TBI patients (head abbreviated injury score >= 3) were then identified. Demographics and outcomes were compared at various admission HR subgroups ( < 50, 50-59, 60-69, 70-79, 80-89, 90-99, 100-109, >= 110). Logistic regression was then performed to determine predictors of mortality. Results. After exclusions, a total of 11,977 isolated moderate to severe isolated TBI patients were analyzed, overall mortality was 11.5% with a trend toward lowest mortality at HR 80 to 89 (7.3%). Each HR subgroup had a significantly increased unadjusted odds ratio for mortality compared with HR 80 to 89, except HR 90 to 99 (OR 1.2, CI 1.0-1.5) and HR 100 to 109 (OR 1.2, CI 1.0-1.5). In multivariable logistic regression analysis, HR < 50, 50-59, 60-69, and >= 110 were independent predictors for increased mortality compared with HR 80-89. Conclusion. After isolated moderate to severe TBI, HR <50, 50-59, 60-69, and >= 110 were independent predictors of increased mortality. HR outside the range 70-109 could serve as a marker for aggressive resuscitation. As mortality increased significantly with HR: <50 (AOR 4.70), 50-59 (AOR 2.21), and 60-69 (AOR 1.63), our findings recommend avoiding HR < 70 in patients with moderate to severe TBI. (C) 2010 Elsevier Inc. All rights reserved.	[Ley, Eric J.; Berry, Cherisse; Mirocha, James; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA	Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fleisher LA, 2006, CIRCULATION, V113, P2662, DOI 10.1161/CIRCULATIONAHA.106.176009; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; HERNDON DN, 1988, ANN SURG, V208, P484, DOI 10.1097/00000658-198810000-00010; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kaafarani HMA, 2008, ARCH SURG-CHICAGO, V143, P940, DOI 10.1001/archsurg.143.10.940; KAUFMAN TM, 1993, J SURG RES, V55, P516, DOI 10.1006/jsre.1993.1177; KRAUS J, 1985, J NEUROSURG, V63, P537, DOI 10.3171/jns.1985.63.4.0537; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Talati R, 2009, ANN PHARMACOTHER, V43, P1181, DOI 10.1345/aph.1L706; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	24	13	13	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2010	163	1					142	145		10.1016/j.jss.2010.04.046			4	Surgery	Surgery	640TT	WOS:000281076300023	20599219				2021-06-18	
J	Sonna, LA; Kuhlmeier, MM; Khatri, P; Chen, D; Lilly, CM				Sonna, Larry A.; Kuhlmeier, Matthew M.; Khatri, Purvesh; Chen, Dechang; Lilly, Craig M.			A microarray analysis of the effects of moderate hypothermia and rewarming on gene expression by human hepatocytes (HepG2)	CELL STRESS & CHAPERONES			English	Article						Cold stress; Cell stress response; DNA microarray; Heat shock proteins	TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; THERAPEUTIC HYPOTHERMIA; DNA MICROARRAY; CARDIAC-ARREST; COLD-EXPOSURE; ONTO-EXPRESS; RAT-BRAIN; STRESS; CELLS	The gene expression changes produced by moderate hypothermia are not fully known, but appear to differ in important ways from those produced by heat shock. We examined the gene expression changes produced by moderate hypothermia and tested the hypothesis that rewarming after hypothermia approximates a heat-shock response. Six sets of human HepG2 hepatocytes were subjected to moderate hypothermia (31A degrees C for 16 h), a conventional in vitro heat shock (43A degrees C for 30 min) or control conditions (37A degrees C), then harvested immediately or allowed to recover for 3 h at 37A degrees C. Expression analysis was performed with Affymetrix U133A gene chips, using analysis of variance-based techniques. Moderate hypothermia led to distinct time-dependent expression changes, as did heat shock. Hypothermia initially caused statistically significant, greater than or equal to twofold changes in expression (relative to controls) of 409 sequences (143 increased and 266 decreased), whereas heat shock affected 71 (35 increased and 36 decreased). After 3 h of recovery, 192 sequences (83 increased, 109 decreased) were affected by hypothermia and 231 (146 increased, 85 decreased) by heat shock. Expression of many heat shock proteins was decreased by hypothermia but significantly increased after rewarming. A comparison of sequences affected by thermal stress without regard to the magnitude of change revealed that the overlap between heat and cold stress was greater after 3 h of recovery than immediately following thermal stress. Thus, while some overlap occurs (particularly after rewarming), moderate hypothermia produces extensive, time-dependent gene expression changes in HepG2 cells that differ in important ways from those induced by heat shock.	[Sonna, Larry A.] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Sonna, Larry A.; Kuhlmeier, Matthew M.] USA, Environm Med Res Inst, Thermal & Mt Med Div, Natick, MA 01760 USA; [Khatri, Purvesh] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Chen, Dechang] Uniformed Serv Univ Hlth Sci, Div Epidemiol & Biostat, Bethesda, MD 20814 USA; [Lilly, Craig M.] Univ Massachusetts, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Worcester, MA 01655 USA	Sonna, LA (corresponding author), Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA.	larry_sonna@yahoo.com			US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-64104, HL-072114]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064104, R01HL072114] Funding Source: NIH RePORTER	Funding was provided by the US Army Medical Research and Materiel Command (USAMRMC). National Heart, Lung, and Blood Institute Grants HL-64104 and HL-072114 also supported this work.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boss O, 1997, FEBS LETT, V412, P111, DOI 10.1016/S0014-5793(97)00755-2; Cotto JJ, 1999, BIOCHEM SOC SYMP, P105; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Denjean F, 1999, FEBS LETT, V444, P181, DOI 10.1016/S0014-5793(99)00056-3; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; FARRELL RE, 1998, DETERMINATION NUCL A, P94; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Fuller BJ, 2003, CRYOLETTERS, V24, P95; Ganta CK, 2006, AM J PHYSIOL-REG I, V291, pR558, DOI 10.1152/ajpregu.00846.2005; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; KHATRI P, 2006, 0705 USARIEM TR; Kobayashi MS, 2008, BRAIN RES REV, V58, P171, DOI 10.1016/j.brainresrev.2008.03.001; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859; Niemann CU, 2010, J SURG RES, V158, P43, DOI 10.1016/j.jss.2008.08.030; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Remick DG, 2006, FRONT BIOSCI-LANDMRK, V11, P1006, DOI 10.2741/1858; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Sonna LA, 2003, PHYSIOL GENOMICS, V12, P195, DOI 10.1152/physiolgenomics.00104.2002; Sonna LA, 2002, J APPL PHYSIOL, V92, P2208, DOI 10.1152/japplphysiol.01002.2001; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Sonna LA, 2006, PHYSIOL GENOMICS, V26, P91, DOI 10.1152/physiolgenomics.00296.2005; Wood RJ, 2004, PHYSIOL GENOMICS, V17, P122, DOI 10.1152/physiolgenomics.00002.2003; Yamashita H, 1999, FEBS LETT, V458, P157, DOI 10.1016/S0014-5793(99)01143-6; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	33	13	13	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	SEP	2010	15	5					687	702		10.1007/s12192-010-0181-2			16	Cell Biology	Cell Biology	636YQ	WOS:000280781800021	20526826	Green Published			2021-06-18	
J	Hill, J; Zhao, J; Dash, PK				Hill, Julia; Zhao, Jing; Dash, Pramod K.			High Blood Glucose Does Not Adversely Affect Outcome in Moderately Brain-Injured Rodents	JOURNAL OF NEUROTRAUMA			English	Article						cerebral edema; diabetes; hyperglycemia; metabolic distress; secondary brain injury	CLOSED-HEAD-INJURY; INTENSIVE INSULIN THERAPY; HYPERGLYCEMIC RATS; COGNITIVE DEFICITS; CEREBRAL-ISCHEMIA; CONTUSION VOLUME; MOTOR DEFICITS; DIABETIC RATS; IMMATURE RAT; METABOLISM	In a number of clinical studies researchers have reported that acute hyperglycemia is associated with increased mortality and worsened neurological outcome in patients with traumatic brain injury (TBI). In contrast, it has been demonstrated that intensive insulin therapy to lower blood glucose can lead to an increased frequency of hypoglycemic episodes and poor outcome. Consistent with this, experimental and clinical studies have shown that TBI causes a "metabolic crisis'' in the injured brain, suggesting that a reduction in glucose availability may exacerbate brain damage. We therefore examined the consequences of hyperglycemia on cognitive and pathological measures. Using a rodent model of TBI, we find that when acute hyperglycemia is induced in animals prior to injury, there is little to no change in motor and cognitive performance, contusion volume, or cerebral edema. To examine the consequences of persistent hyperglycemia (as seen in diabetic patients), animals were treated with streptozotocin (STZ) to induce type 1 diabetes. We find that the presence of persistent STZ-induced hyperglycemia results in a reduction of brain edema. Insulin therapy to reduce blood glucose reverses this beneficial effect of hyperglycemia. Taken together, our results indicate that an acute increase in blood glucose levels may not be harmful, and that intervention with insulin therapy to lower blood glucose levels in TBI patients may increase secondary brain damage.	[Hill, Julia; Zhao, Jing; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Dept Neurosurg, Houston, TX 77225 USA	Dash, PK (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Dept Neurosurg, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Hill, Julia/0000-0003-4744-0532; Dash, Pramod/0000-0001-6746-1002	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The authors would like to thank Anthony Moore and Sara Orsi for their technical assistance and critical reading of the manuscript. This work was supported by grants from the NIH.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Griesdale DE, 2009, NEUROCRIT CARE; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; KADOWAKI T, 1984, J BIOL CHEM, V259, P4208; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MCNEILL JH, 1999, STREPTOZOTOCIN INDUC; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PLASCHKE K, 1993, INT J DEV NEUROSCI, V11, P477, DOI 10.1016/0736-5748(93)90021-5; PULSINELLI WA, 1982, ANN NEUROL, V11, P499, DOI 10.1002/ana.410110510; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Shram NF, 1997, NEUROREPORT, V8, P1109, DOI 10.1097/00001756-199703240-00009; SIEMKOWICZ E, 1978, ACTA NEUROL SCAND, V58, P1; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; XU Y, 2009, J CEREB BLOOD FLOW M, V30, P883, DOI DOI 10.1038/JCBFM.2009.263; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P332, DOI 10.1016/S0891-5849(97)00267-0	50	13	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2010	27	8					1439	1448		10.1089/neu.2010.1328			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	639OU	WOS:000280984900008	20504157	Green Published			2021-06-18	
J	Schaller, B; Evangelopoulos, DS; Muller, C; Martinolli, L; Pouljadoff, MP; Zimmermann, H; Exadaktylos, AK				Schaller, Benoit; Evangelopoulos, Dimitrios Stergios; Mueller, Christian; Martinolli, Luca; Pouljadoff, Marie Pierre; Zimmermann, Heinz; Exadaktylos, Aristomenis K.			Do we really need 24-h observation for patients with minimal brain injury and small intracranial bleeding? The Bernese Trauma Unit Protocol	EMERGENCY MEDICINE JOURNAL			English	Article							MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; PROPOSAL	Background Traumatic brain injury is one of the most common reasons for admission to hospital emergency departments. However, optimal diagnosis and treatment protocols remain controversial. The aim of this study is to assess whether a specific group of patients can be discharged from the hospital without 24-h neurological observation. Methods Retrospective analysis was performed for 1078 patients with a minor isolated head injury admitted to the authors' Emergency Department for 24-h observation. Exclusion criteria included intracranial bleeds with maximum diameter above 5 mm or multiple (>1) bleeds, a history of inherited coagulopathy or anticoagulant therapy, platelet aggregation inhibitor therapy, intoxication or multiple associated injuries. Furthermore, patients who had no-one to observe them at home or who lived more than 1 h away were excluded from the study. Results 110 patients presented with an isolated small intracranial bleed (<5 mm) with a Glasgow Coma Scale (GCS) of 13-15. Of these patients, 46% exhibited small intracerebral haematomas, 23% traumatic subarachnoid haematomas, 9% epidural haematomas and 7% subdural haematomas. Nine patients presented with a GCS of 13/15, 30 patients with a GCS 14/15 and 71 patients with a GCS 15/15. 85% of all patients regained GCS 15/15 within 1 h after admission and 15% within 2 h after admission. All patients maintained their GCS 15/15 over the 24-h period. Conclusions Standard 24-h observation may not be required for adult patients with single intracranial bleeds with maximum diameter less than 5 mm, without a history of inherited coagulopathy or anticoagulant therapy, platelet aggregation inhibitor therapy, intoxication or multiple associated injuries. The decision for discharging patients may be made from the clinical picture. This might help to spare hospital resources and reduce unnecessary hospitalisations.	[Schaller, Benoit; Evangelopoulos, Dimitrios Stergios; Mueller, Christian; Martinolli, Luca; Pouljadoff, Marie Pierre; Zimmermann, Heinz; Exadaktylos, Aristomenis K.] Inselspital Bern, Dept Emergency Med, CH-3010 Bern, Switzerland	Evangelopoulos, DS (corresponding author), Inselspital Bern, Dept Orthopaed, CH-3010 Bern, Switzerland.	ds.evangelopoulos@gmail.com		Schaller, Benoit/0000-0002-6861-2340			Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Fabbri A, 2004, EUR J EMERG MED, V11, P65, DOI 10.1097/00063110-200404000-00002; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; WALLING AD, IS CT SCANNING INDIC	13	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2010	27	7					537	539		10.1136/emj.2009.073031			3	Emergency Medicine	Emergency Medicine	616UK	WOS:000279235500015	20360489				2021-06-18	
J	Dolezal, DN; Kurtz, PF				Dolezal, Danielle N.; Kurtz, Patricia F.			EVALUATION OF COMBINED-ANTECEDENT VARIABLES ON FUNCTIONAL ANALYSIS RESULTS AND TREATMENT OF PROBLEM BEHAVIOR IN A SCHOOL SETTING	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						combined-antecedent variables; functional communication training; motivating operations; problem behavior; structured descriptive assessment	ESCAPE	Call, Wacker, Ringdahl, and Boelter (2005) conducted an analysis in which a single-antecedent condition was compared to a multiple-antecedent condition. The present study extended Call et al. by conducting a structured descriptive assessment (SDA) to identify the antecedent variables most associated with problem behavior in a student with traumatic brain injury and intellectual disabilities. Results indicated that the SDA was effective in identifying relevant antecedent variables that led to the development of an effective intervention in the classroom.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Dolezal, DN (corresponding author), Seattle Childrens Hosp, Dept Psychiat & Behav Hlth, W-3636 Child Psychiat,4800 Sand Point Way NE, Seattle, WA 98105 USA.	danielle.dolezal@seattlechildrens.org					Anderson CM, 2002, J APPL BEHAV ANAL, V35, P137, DOI 10.1901/jaba.2002.35-137; Call NA, 2005, J APPL BEHAV ANAL, V38, P385, DOI 10.1901/jaba.2005.51-04; Golonka Z, 2000, J APPL BEHAV ANAL, V33, P243, DOI 10.1901/jaba.2000.33-243; Lang R, 2009, J APPL BEHAV ANAL, V42, P393, DOI 10.1901/jaba.2009.42-393; Mueller MM, 2005, SCHOOL PSYCHOL REV, V34, P425; Zarcone JR, 1996, J APPL BEHAV ANAL, V29, P247, DOI 10.1901/jaba.1996.29-247	6	13	13	1	7	JOURNAL APPL BEHAV ANAL	LAWRENCE	DEPT HUMAN DEVELOPMENT, UNIV KANSAS, LAWRENCE, KS 66045 USA	0021-8855			J APPL BEHAV ANAL	J. Appl. Behav. Anal.	SUM	2010	43	2					309	314		10.1901/jaba.2010.43-309			6	Psychology, Clinical	Psychology	610YI	WOS:000278776300013	21119906	Bronze, Green Published			2021-06-18	
J	Harbrecht, BG; Smith, JW; Franklin, GA; Miller, FB; Richardson, JD				Harbrecht, Brian G.; Smith, Jason W.; Franklin, Glen A.; Miller, Frank B.; Richardson, J. David			Decreasing Regional Neurosurgical Workforce-A Blueprint for Disaster	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	68th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST)	OCT 01-03, 2009	Pittsburgh, PA	Amer Assoc Surg Trauma (AAST)		Head injury; Workforce; Trauma systems; Traumatic brain injury	ACUTE-CARE SURGERY; OPERATIVE MORTALITY; HOSPITAL VOLUME; TRAUMA CENTERS; BRAIN-INJURIES; CRANIOTOMY; EXPERIENCE; SYSTEM; TRENDS; IMPACT	Background: Traumatic brain injuries are a frequent cause of death and a substantial source of morbidity. Neurosurgeons ( NS) are commonly involved in the management of patients with moderate and severe traumatic brain injuries to minimize morbidity from both primary and secondary brain injuries. However, NS willing to care for injured patients have become increasingly scarce. Although many institutions have been individually affected by shortages of NS providing care to injured patients, data on regional changes in NS availability and the effect on patient care are limited. Methods: We queried a state discharge database for all traumatic intracranial hemorrhages ( ICH) and skull fractures from 2004 to 2007 by International Classification of Diseases - 9th Rev. - Clinical Modification codes. Institutions were categorized as those that admitted >30 or <30 ICH patients per year. The state medical society provided the number of NS practicing in the state per year. Results: The total number of patients with significant head injuries increased over the study period. The number of NS decreased over the same time period. A greater proportion of patients were managed in centers admitting >30 ICH per year, and the number of facilities admitting <30 ICH per year decreased. Conclusion: In this state, increasing numbers of patients with ICH are being concentrated in a small number of centers, while the number of NS available to care for them has decreased. Shortages in neurosurgical workforce for patients with traumatic ICH have the potential for catastrophic consequences on a regional basis if effective solutions to this manpower issue are not created.	[Harbrecht, Brian G.; Smith, Jason W.; Franklin, Glen A.; Miller, Frank B.; Richardson, J. David] Univ Louisville, Dept Surg, Louisville, KY 40292 USA	Harbrecht, BG (corresponding author), Univ Louisville, Dept Surg, 550 S Jackson St, Louisville, KY 40292 USA.	briang.harbrecht@louisville.edu					American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; [Anonymous], 2006, HOSP BAS EM CAR BREA; Barker DE, 2006, AM SURGEON, V72, P1166; Barker FG, 2004, NEUROSURGERY, V55, P506, DOI 10.1227/01.NEU.0000134284.47965.71; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Ciesla DJ, 2006, AM J SURG, V192, P732, DOI 10.1016/j.amjsurg.2006.08.035; Cohn SM, 2007, J TRAUMA, V62, P951, DOI 10.1097/01.ta.0000260131.79063.50; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Earley AS, 2006, ANN SURG, V244, P498, DOI 10.1097/01.sla.0000237756.86181.50; Esposito TJ, 2000, J TRAUMA, V49, P686; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Glance LG, 2004, J TRAUMA, V56, P682, DOI 10.1097/01.TA.0000053469.92142.40; Harbrecht BG, 2009, AM SURGEON, V75, P725; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Ho V, 2003, ANN SURG, V237, P509, DOI 10.1097/00000658-200304000-00012; Ho V, 2007, HEALTH ECON POLICY L, V2, P51, DOI 10.1017/S1744133106006256; Ho V, 2006, ANN SURG ONCOL, V13, P851, DOI 10.1245/ASO.2006.07.021; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; Huynh T, 2006, AM SURGEON, V72, P1162; Lucas CE, 1997, J TRAUMA, V42, P818, DOI 10.1097/00005373-199705000-00011; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Moore EE, 2006, J AM COLL SURGEONS, V202, P698, DOI 10.1016/j.jamcollsurg.2005.12.007; Moore EE, 1998, J TRAUMA, V44, P271; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Pasquale MD, 2001, J TRAUMA, V50, P465, DOI 10.1097/00005373-200103000-00010; Pitts LH, 1998, J TRAUMA, V44, P989; Richardson JD, 1998, J TRAUMA, V44, P266, DOI 10.1097/00005373-199802000-00004; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Tepas JJ, 1998, J TRAUMA, V44, P827, DOI 10.1097/00005373-199805000-00014; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004	36	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1367	1372		10.1097/TA.0b013e3181d990da			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	610ES	WOS:000278714600020	20539182				2021-06-18	
J	Hoh, DJ; Liu, CY; Wang, MY				Hoh, Daniel J.; Liu, Charles Y.; Wang, Michael Y.			A radiographic computed tomography-based study to determine the ideal entry point, trajectory, and length for safe fixation using C-2 pars interarticularis screws Clinical article	JOURNAL OF NEUROSURGERY-SPINE			English	Article						axis; C-2; pars interarticularis; instrumentation; vertebral artery; transverse foramen	ATLANTOAXIAL TRANSARTICULAR SCREW; TRAUMATIC BRAIN-INJURY; VERTEBRAL ARTERY INJURY; ANATOMICAL EVALUATION; PEDICLE; C2; AXIS; COMPLEX; STABILIZATION; ARTHRODESIS	Object. Effective methods for fixation of the axis include C1-2 transarticular and C-2 pedicle screw placement. Both techniques pose a risk of vertebral artery (VA) injury in patients with narrow pedicles or an enlarged, high-riding VA. Pars screws at C-2 avoid the pedicle, but can cause VA injury with excessively long screws. Therefore, the authors evaluated various entry points and trajectories to determine ideal pars screw lengths that avoid breaching the transverse foramen. Methods. Both pars were studied on 50 CT scans (100 total). Various pars lengths were assessed using 2 entry points and 3 trajectories (6 measurements). Entry point A was the superior one-fourth of the lateral mass. Entry point B was 3-mm rostral to the inferior aspect of the lateral mass. Using entry points A and B, Trajectory 1 was the minimum distance to the transverse foramen; Trajectory 2 was the maximum distance to the transverse foramen; and Trajectory 3 was the steepest angle to the pars/C-2 superior facet junction without transverse foramen breach. Results. The mean patient age was 46 17 years, and 84% of the CT scans reviewed were obtained in men. There was no significant difference in right or left measurements. Entry point B demonstrated greater pars lengths for each trajectory compared with entry point A (p < 0.0001). For both entry points, Trajectory 3 provided the greatest pars length. Using Trajectory 3 with entry point B, 84, 95, and 99% had a pars length that measured 18, 16, and 14 mm, respectively. Using Trajectory 3 with Entry point A, only 41, 64, and 87% had a pars length that measured 18, 16, and 14 mm, respectively. Conclusions. Using an entry point 3-mm rostral to the inferior edge of the lateral mass and a trajectory directed toward the superior facet/pars junction, 99% of partes interarticularis in this study would tolerate a 14-mm screw without breach of the transverse foramen. (DOI: 10.3171/2009.12.SPINE09543)	[Hoh, Daniel J.; Liu, Charles Y.] Univ So Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90033 USA; [Wang, Michael Y.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Coral Gables, FL 33124 USA	Hoh, DJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurol Surg, 1200 N State St,Suite 5046, Los Angeles, CA 90033 USA.	dhoh@usc.edu					AbouMadawi A, 1997, J BONE JOINT SURG BR, V79B, P820; Aryan HE, 2008, J NEUROSURG-SPINE, V8, P222, DOI 10.3171/SPI/2008/8/3/222; Benzel EC, 1996, SPINE, V21, P2301, DOI 10.1097/00007632-199610010-00028; Cacciola F, 2004, NEUROL INDIA, V52, P178; Chen JF, 2005, J NEUROSURG-SPINE, V2, P386, DOI 10.3171/spi.2005.2.3.0386; Dickman CA, 1998, NEUROSURGERY, V43, P275, DOI 10.1097/00006123-199808000-00056; Ebraheim N, 1996, SPINE, V21, P691, DOI 10.1097/00007632-199603150-00005; Ebraheim NA, 1998, J SPINAL DISORD, V11, P521; Ebraheim NA, 2001, SPINE, V26, P34; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; GEORGE B, 1987, VERTEBRAL ARTERY PAT, P6; Gluf WM, 2005, J NEUROSURG-SPINE, V2, P155, DOI 10.3171/spi.2005.2.2.0155; Goel A, 2002, NEUROSURGERY, V51, P1351, DOI 10.1097/00006123-200212000-00004; GROB D, 1992, SPINE, V17, P480, DOI 10.1097/00007632-199205000-00003; Haid RW, 2001, NEUROSURGERY, V49, P65, DOI 10.1097/00006123-200107000-00010; Haid RW, 2001, NEUROSURGERY, V49, P71, DOI 10.1097/00006123-200107000-00011; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Hedequist D, 2009, J PEDIATR ORTHOPED, V29, P21, DOI 10.1097/BPO.0b013e3181924367; Henriques T, 2000, SPINE, V25, P2877, DOI 10.1097/00007632-200011150-00007; Hott JS, 2005, J NEUROSURG-SPINE, V2, P175, DOI 10.3171/spi.2005.2.2.0175; Kazan S, 2000, CLIN ANAT, V13, P237, DOI 10.1002/1098-2353(2000)13:4<237::AID-CA2>3.0.CO;2-K; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Liu MF, 2005, AM J TRANSPLANT, V5, P434; Madawi AA, 1997, J NEUROSURG, V86, P961, DOI 10.3171/jns.1997.86.6.0961; Magerl F., 1985, CERVICAL SPINE, P322; Mandel IM, 2000, SPINE, V25, P1542, DOI 10.1097/00007632-200006150-00014; Menendez JA, 2007, NEUROSURGERY, V60, P103, DOI 10.1227/01.NEU.0000249220.50085.E4; Mitchell TC, 1999, J ORTHOP TRAUMA, V13, P483, DOI 10.1097/00005131-199909000-00004; Mummaneni PV, 2005, NEUROL INDIA, V53, P408, DOI 10.4103/0028-3886.22606; Naderi S, 2004, J NEUROSURG-SPINE, V1, P306, DOI 10.3171/spi.2004.1.3.0306; Neo M, 2003, SPINE, V28, P666, DOI 10.1097/00007632-200304010-00009; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ondra SL, 2006, SPINE, V31, pE263, DOI 10.1097/01.brs.0000214882.34674.be; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Paramore CG, 1996, J NEUROSURG, V85, P221, DOI 10.3171/jns.1996.85.2.0221; Resnick DK, 2002, SPINE, V27, P1494, DOI 10.1097/00007632-200207150-00003; STARNES MJ, 2008, J EMERG MED; Wright NM, 1998, J NEUROSURG, V88, P634, DOI 10.3171/jns.1998.88.4.0634; XU RM, 1995, SPINE, V20, P259, DOI 10.1097/00007632-199502000-00001; Yoshida M, 2006, SPINE, V31, pE513, DOI 10.1097/01.brs.0000224516.29747.52	41	13	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654			J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUN	2010	12	6					602	612		10.3171/2009.12.SPINE09543			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	600YG	WOS:000278024300003	20515344				2021-06-18	
J	Ceranoglu, TA				Ceranoglu, Tolga Atilla			Star Wars in Psychotherapy: Video Games in the Office	ACADEMIC PSYCHIATRY			English	Article							DISTRACTION; CHILDREN; CANCER; MEDIA	Objective: Video games are used in medical practice during psycho-education in chronic disease management, physical therapy, rehabilitation following traumatic brain injury, and as an adjunct in pain management during medical procedures or cancer chemotherapy. In psychiatric practice, video games aid in social skills training of children with developmental delays and in cognitive behavioral therapy (CBT). This most popular children's toy may prove a useful tool in dynamic psychotherapy of youth. Methods: The author provides a framework for using video games in psychotherapy by considering the characteristics of video games and describes the ways their use has facilitated various stages of therapeutic process. Results: Just as other play techniques build a relationship and encourage sharing of emotional themes, sitting together in front of a console and screen facilitates a relationship and allows a safe path for the patient's conflict to emerge. Conclusion: During video game play, the therapist may observe thought processes, impulsivity, temperament, decision-making, and sharing, among other aspects of a child's clinical presentation. Several features inherent to video games require a thoughtful approach as resistance and transference in therapy may be elaborated differently in comparison to more traditional toys. Familiarity with the video game content and its dynamics benefits child mental health clinicians in their efforts to help children and their families.	Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Ceranoglu, TA (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St, Boston, MA 02114 USA.	aceranoglu@partners.org					Brezinka V, 2008, STUD HEALTH TECHNOL, V136, P71; Das Debashish A, 2005, BMC Pediatr, V5, P1, DOI 10.1186/1471-2431-5-1; *ENT SOFTW RAT BOA, 2005, GAM RAT DESCR GUID; FREUD S, 1908, JOKES THEIR RELATION; Gold JI, 2006, CYBERPSYCHOL BEHAV, V9, P207, DOI 10.1089/cpb.2006.9.207; Jannink MJA, 2008, CYBERPSYCHOL BEHAV, V11, P27, DOI 10.1089/cpb.2007.0014; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; Klein M, 1955, WRITINGS M KLEIN, V3, P122; Koch-Mohr R, 1998, PRAX KINDERPSYCHOL K, V47, P416; Kutner LA, 2008, J ADOLESCENT RES, V23, P76, DOI 10.1177/0743558407310721; Lenhart A., 2008, TEENS VIDEO GAMES CI; Lionhead Studios, 2004, FABL; Mineo BA, 2009, J AUTISM DEV DISORD, V39, P172, DOI 10.1007/s10803-008-0616-0; Olson CK, 2004, ACAD PSYCHIATR, V28, P144, DOI 10.1176/appi.ap.28.2.144; REDD WH, 1987, J CONSULT CLIN PSYCH, V55, P391, DOI 10.1037/0022-006X.55.3.391; *SON, 2001, IC; *TRAV TAL, 2000, LEG STAR WARS 2 LUC; Winnicott D.W., 2005, PLAYING REALITY; Yoon Saunjoo L, 2007, Pediatr Nurs, V33, P60; Zelnick L., 2005, J INFANT CHILD ADOLE, V4, P209	20	13	13	0	22	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1042-9670			ACAD PSYCHIATR	Acad. Psych.	MAY-JUN	2010	34	3					233	236					4	Education & Educational Research; Psychiatry	Education & Educational Research; Psychiatry	589UP	WOS:000277180000014	20431107				2021-06-18	
J	Ozen, LJ; Skinner, EI; Fernandes, MA				Ozen, Lana J.; Skinner, Erin I.; Fernandes, Myra A.			Rejecting familiar distracters during recognition in young adults with traumatic brain injury and in healthy older adults	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Brain concussion; Aging; Memory disorders; Frontal lobe; Neuropsychological tests	CLOSED-HEAD-INJURY; DEPRESSION FOLLOWING MILD; AGE-RELATED DIFFERENCES; FALSE MEMORIES; WORKING-MEMORY; COGNITIVE IMPAIRMENT; EXPLICIT MEMORY; TEMPORAL-ORDER; LONG; PERFORMANCE	The most common cognitive complaint reported by healthy older adults and young adults with traumatic brain injury (TB!) is memory difficulties. We investigated the effects of normal aging and the long-term effects of TBI in young adults on the susceptibility to incorrectly endorse distracter information on a memory test. Prior to a study phase, participants viewed a "pre-exposure" list containing distracter words, presented once or three times, and half of the target study words. Subsequently, during the study phase, all target words were presented such that, across lists, study words were viewed either once or three times. On the recognition test. TBI and older adult participants were more likely to falsely endorse "pre-exposed" distracter words viewed three times as being from the target study list, compared to non-head-injured young controls. Normal aging and head injury in young may similarly compromise one's ability to reject highly familiar, but distracting, information during recognition. Older adult and TBI participants were also slower to complete the Trail Making task and had poorer output on a Digit Span task, suggesting these two populations share a deficit in executive function and working memory. Similar changes in frontal lobe function may underlie these shared cognitive deficits. (JINS, 2010, 16, 556-565.)	[Ozen, Lana J.; Skinner, Erin I.; Fernandes, Myra A.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	Ozen, LJ (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	lozen@uwaterloo.ca			National Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by a discovery grant from the National Sciences and Engineering Research Council of Canada (NSERC) awarded to ME and post-graduate scholarships from NSERC awarded to LO and to ES.	Alves W., 1992, PHYS MED REHABILITAT, V6, P21; Baayen R. H., 1995, The CELEX lexical database. Linguistic data consortium; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; BARTLETT JC, 1991, MEM COGNITION, V19, P177, DOI 10.3758/BF03197115; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Bopp KL, 2007, J GERONTOL B-PSYCHOL, V62, pP239, DOI 10.1093/geronb/62.5.P239; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; BURKE DM, 1981, PSYCHOL BULL, V90, P513, DOI 10.1037/0033-2909.90.3.513; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COHEN G, 1989, PSYCHOL AGING, V4, P10, DOI 10.1037/0882-7974.4.1.10; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; CRAIK FIM, 1990, PSYCHOL AGING, V5, P148, DOI 10.1037/0882-7974.5.1.148; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dobbins IG, 1998, J MEM LANG, V38, P381, DOI 10.1006/jmla.1997.2554; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HASHTROUDI S, 1989, PSYCHOL AGING, V4, P106, DOI 10.1037/0882-7974.4.1.106; Jacoby LL, 1999, J EXP PSYCHOL LEARN, V25, P3, DOI 10.1037/0278-7393.25.1.3; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kensinger EA, 1999, COGNITIVE NEUROPSYCH, V16, P399, DOI 10.1080/026432999380852; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; LIGHT LL, 1987, J EXP PSYCHOL LEARN, V13, P531, DOI 10.1037/0278-7393.13.4.531; Luo L, 2007, PSYCHOL AGING, V22, P269, DOI 10.1037/0882-7974.22.2.269; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; PARK DC, 1985, J GERONTOL, V40, P198, DOI 10.1093/geronj/40.2.198; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Prull M. W., 2000, HDB AGING COGNITION, P91; *PSYCH SOFTW TOOLS, 2002, E PRIM VERS 1 2; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reitan RM., 1985, HALSTEAD REITAN NEUR; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Tun PA, 1998, PSYCHOL AGING, V13, P230, DOI 10.1037/0882-7974.13.2.230; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2003, J CLIN EXP NEUROPSYC, V25, P274, DOI 10.1076/jcen.25.2.274.13637; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vakil E, 1997, J Int Neuropsychol Soc, V3, P327; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Watson JM, 2001, NEUROPSYCHOLOGY, V15, P254, DOI 10.1037//0894-4105.15.2.254; Watson JM, 2004, MEM COGNITION, V32, P135, DOI 10.3758/BF03195826; Wechsler D, 1997, WAIS 3 ADM SCORING M; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	71	13	14	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2010	16	3					556	565		10.1017/S1355617710000202			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	594ZA	WOS:000277579000016	20211048				2021-06-18	
J	Palmer, HS; Garzon, B; Xu, J; Berntsen, EM; Skandsen, T; Haberg, AK				Palmer, Helen S.; Garzon, Benjamin; Xu, Jian; Berntsen, Erik M.; Skandsen, Toril; Haberg, Asta K.			Reduced Fractional Anisotropy Does Not Change the Shape of the Hemodynamic Response in Survivors of Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood oxygenation level-dependent signal; diffuse axonal injury; diffusion tensor imaging; functional magnetic resonance imaging; visual stimuli	WHITE-MATTER PATHWAYS; PROCESSING SPEED; VISUAL-CORTEX; DIFFUSION ANISOTROPY; WORKING-MEMORY; OPTIC NEURITIS; BOLD-RESPONSE; ADULT CAT; FMRI; RECOVERY	The hemodynamic response (HDR) function is the basis for standard functional magnetic resonance imaging (fMRI) analysis. HDR is influenced by white matter inflammation. Traumatic brain injury (TBI) is frequently accompanied by diffuse white matter injury, but the effect of this on the HDR has not been investigated. The aims of the present study were to describe the HDR in visual cortex and examine its relationship with the microstructure of the optic radiation in severe TBI survivors and controls. Ten severe TBI survivors without visual impairments, but with known diffuse axonal injury, and 9 matched controls underwent diffusion tensor imaging (DTI) and fMRI. From the fMRI time series obtained during brief randomized visual stimuli, blood oxygenation level-dependent (BOLD) signal changes for each subject were estimated in V1, and group HDR curves were produced. Standard between-group analysis of BOLD activation in V1+V2 was performed. For each individual the optic radiations were identified and fractional anisotropy (FA) plus mean apparent diffusion coefficient (ADC(mean)) values for these tracts were calculated. Group HDR curves from the visual cortex were fully transposable between TBI survivors and controls, despite a significant reduction in FA in the optic radiation in TBI survivors. A significant correlation between BOLD signal in the visual cortex and FA values in the optical tract was present in controls, but not in TBI survivors. Between-group comparisons showed that TBI survivors had increased areas of activation in V1 and V2. The HDR appears to be intact in traumatic white matter damage, supporting the validity of using standard fMRI methodology to study neuroplasticity in TBI.	[Skandsen, Toril; Haberg, Asta K.] Norwegian Univ Sci & Technol, Dept Neuromed, N-7034 Trondheim, Norway; [Palmer, Helen S.; Garzon, Benjamin; Xu, Jian; Berntsen, Erik M.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Skandsen, Toril] St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Xu, Jian; Berntsen, Erik M.; Haberg, Asta K.] St Olavs Hosp, Dept Med Imaging, Trondheim, Norway	Haberg, AK (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neuromed, N-7489 Trondheim, Norway.	asta.haberg@ntnu.no	Skandsen, Toril/P-6767-2014; Berntsen, Erik Magnus/AAM-7134-2020	Skandsen, Toril/0000-0001-5495-9338; Garzon, Benjamin/0000-0002-4647-7280			Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Barth AL, 2002, PHYSIOL BEHAV, V77, P545, DOI 10.1016/S0031-9384(02)00932-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Boynton GM, 2004, CURR BIOL, V14, pR523, DOI 10.1016/j.cub.2004.06.044; Butler PD, 2005, ARCH GEN PSYCHIAT, V62, P495, DOI 10.1001/archpsyc.62.5.495; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Friedman L, 2008, NEUROIMAGE, V40, P1181, DOI 10.1016/j.neuroimage.2007.12.040; Friston KJ, 2006, STAT PARAMETRIC MAPP; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V14, P823; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jensen U, 2008, CEREBROVASC DIS, V26, P231, DOI 10.1159/000147449; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Krainik A, 2005, STROKE, V36, P1146, DOI 10.1161/01.STR.0000166178.40973.a7; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langkilde AR, 2002, EUR J NEUROL, V9, P277, DOI 10.1046/j.1468-1331.2002.00399.x; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu YL, 2006, NEUROIMAGE, V32, P238, DOI 10.1016/j.neuroimage.2005.11.040; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Roc AC, 2006, STROKE, V37, P382, DOI 10.1161/01.STR.0000198807.31299.43; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rombouts SARB, 1998, NEUROLOGY, V50, P1896, DOI 10.1212/WNL.50.6.1896; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; SCHROETER ML, 2009, NEUROPSYCHOLOGIA; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SKANDSEN T, 2009, J NEUROSURG; Skare S, 2001, MAGN RESON IMAGING, V19, P1125, DOI 10.1016/S0730-725X(01)00415-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stufflebeam SM, 2008, NEUROIMAGE, V42, P710, DOI 10.1016/j.neuroimage.2008.04.264; TEASDALE G, 1974, LANCET, V2, P81; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Werring DJ, 2000, J NEUROL NEUROSUR PS, V68, P441, DOI 10.1136/jnnp.68.4.441; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	62	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2010	27	5					853	862		10.1089/neu.2009.1225			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	599LX	WOS:000277915400007	20199173				2021-06-18	
J	Williams, GP; Schache, AG				Williams, Gavin P.; Schache, Anthony G.			Evaluation of a Conceptual Framework for Retraining High-Level Mobility Following Traumatic Brain Injury: Two Case Reports	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						high-level mobility assessment tool; quantitative gait analysis; rehabilitation; running; traumatic brain injury	ASSESSMENT-TOOL HIMAT; BOTULINUM-TOXIN; CHRONIC STROKE; EXERCISE; GAIT; WALKING; PHYSIOTHERAPISTS; BIOMECHANICS; INDIVIDUALS; HEMIPARESIS	Traumatic brain injury (TBI) is the primary cause of death and disability for 18- to 45-year-olds. High-level mobility is important for many of the social, leisure, sporting, and employment roles of young adults. The aim of these case reports was to evaluate a conceptual framework for retraining high-level mobility after TBI. The progression of 2 patients who had sustained a severe TBI but had contrasting clinical presentations was monitored over 6 months. Patient 1 presented with left hemiplegia following a TBI 10 years earlier, whereas patient 2 presented with ataxia 2 months following a TBI. Quantitative gait analysis and clinical measures of mobility were used to evaluate outcomes of a 6-month intervention phase. Intervention strategies were based on a conceptual framework comprising 2 main elements: (1) the hierarchical ordering of high-level mobility tasks and (2) the key biomechanical features of able-bodied running. Both patients achieved the ability to run by the end of the intervention phase. Patient 1 displayed improved gait symmetry associated with improved high-level mobility, despite the long-standing duration of his injury. Patient 2 demonstrated improved postural control and stability in gait that resulted in an ability to run, skip, hop, and jump. Findings of these case reports provide evidence supporting "proof of concept" that clinical interventions can lead to improvement in high-level mobility following severe TBI.	[Williams, Gavin P.] Epworth Med Fdn, Physiotherapy Dept, Richmond, Vic, Australia; [Williams, Gavin P.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Sch Physiotherapy, Melbourne, Vic 3010, Australia; [Schache, Anthony G.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic 3010, Australia	Williams, GP (corresponding author), Epworth Med Fdn, Physiotherapy Dept, Melbourne, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Williams, Gavin/0000-0003-2758-7473			Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Collen F M, 1991, Int Disabil Stud, V13, P50; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Kahn JH, 2009, PHYS THER, V89, P474, DOI 10.2522/ptj.20080237; Levy CE, 2007, AM J PHYS MED REHAB, V86, P696, DOI 10.1097/PHM.0b013e31813e2b4d; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; MANN RA, 1980, AM J SPORT MED, V8, P345, DOI 10.1177/036354658000800510; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Molteni F, 1995, EUR J NEUROL, V2, P61; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Olney SJ, 2006, STROKE, V37, P476, DOI 10.1161/01.STR.0000199061.85897.b7; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Quinn B, 2000, BRAIN INJURY, V14, P1063; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; SIMONDSON J, 1998, MOBILITY SCALE ACUTE; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Toro B, 2003, ARCH PHYS MED REHAB, V84, P1878, DOI 10.1016/S0003-9993(03)00482-9; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2009, INT J THER REHABIL, V16, P188, DOI 10.12968/ijtr.2009.16.4.41186; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson DJ, 1997, BRAIN INJURY, V11, P157, DOI 10.1080/026990597123610; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762	34	13	13	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2010	25	3					164	172		10.1097/HTR.0b013e3181dc120b			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	606KG	WOS:000278423300003	20473090				2021-06-18	
J	Chien, LC; Cheng, HM; Chen, WC; Tsai, MC				Chien, Li-Chien; Cheng, Hon-Mei; Chen, Weng-Chau; Tsai, Ming-Che			Pelvic Fracture and Risk Factors for Mortality: A Population-Based Study in Taiwan	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Pelvic injury; Resource utilization; Incidence; Risk factor; Mortality	RETROSPECTIVE ANALYSIS; TRAUMA ADMISSIONS; SACRAL FRACTURES; INJURIES; OSTEOPOROSIS; BURDEN; RING; EPIDEMIOLOGY; AUSTRALIA; WEATHER	Objective: To study the incidence, demographics, distribution of fracture sites, associated injuries, and risk factors for the outcomes of pelvic fracture on a population basis. Methods: An annual claim dataset from 2001 to 2003 was retrieved from the Bureau of National Health Insurance (BNHI) trauma database with any International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) coded as pelvic fracture. Statistical analyses were conducted to discover the association between variables such as age, gender, month of injury, injury mechanisms, associated injuries, and outcome. Results: Pelvic fracture was diagnosed in 10,109 patients (4,693 males, 46.4%) and 384 patients (3.8%) died. The incidence was 14.97/100,000 person-years. The mean length of stay was 9.3 days (females, 8.8 days; males, 9.9 days; p < 0.01) and the average cost per patient was US$1,475. Both were affected by age, gender, and hospital accreditation level and ownership. There were more female cases in the age groups over 44 years old. Head injury (excluding concussion), associated chest and abdominal injuries, open pelvic fracture, and the transfusion of more than four units of blood significantly increased the risk of mortality. Conclusions: The incidence rate of pelvic fracture was higher in females over 44 years of age, but the average medical resource use was higher in males. Associated injuries were stronger positive factors for the risk of mortality than gender, fracture sites, injury mechanisms, and the characteristics of the treating hospitals.	[Chien, Li-Chien; Chen, Weng-Chau; Tsai, Ming-Che] Natl Cheng Kung Univ Hosp, Dept Emergency Med, Tainan 70004, Taiwan; [Cheng, Hon-Mei] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Tsai, MC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Emergency Med, 138 Sheng Li Rd, Tainan 70004, Taiwan.	t2195@mail.ncku.edu.tw					Atherton WG, 2005, INJURY, V36, P40, DOI 10.1016/j.injury.2003.10.027; Bassam D, 1998, AM SURGEON, V64, P862; Boufous S, 2005, INJURY, V36, P1323, DOI 10.1016/j.injury.2005.02.008; Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113; DENIS F, 1988, CLIN ORTHOP RELAT R, P67; FLINT L, 1990, ANN SURG, V211, P703, DOI 10.1097/00000658-199006000-00008; Graham CA, 2005, INJURY, V36, P1040, DOI 10.1016/j.injury.2004.09.011; Guggenbuhl P, 2005, JOINT BONE SPINE, V72, P372, DOI 10.1016/j.jbspin.2004.04.002; Han TH, 2005, BURNS, V31, P465, DOI 10.1016/j.burns.2004.11.014; Hauschild O, 2008, J TRAUMA, V64, P449, DOI 10.1097/TA.0b013e31815982b1; Inaba K, 2004, INJURY, V35, P759, DOI 10.1016/S0020-1383(03)00308-5; Kido A, 2008, J ORTHOP SCI, V13, P21, DOI 10.1007/s00776-007-1190-6; MELTON LJ, 1981, CLIN ORTHOP RELAT R, P43; Muir L, 1996, INJURY, V27, P199, DOI 10.1016/0020-1383(95)00195-6; Pocock NA, 1999, MED J AUSTRALIA, V170, P486, DOI 10.5694/j.1326-5377.1999.tb127851.x; RICHARDSON JD, 1982, J TRAUMA, V22, P533, DOI 10.1097/00005373-198207000-00002; RIEMER BL, 1993, J TRAUMA, V35, P671, DOI 10.1097/00005373-199311000-00003; Rising WR, 2006, J TRAUMA, V60, P1096, DOI 10.1097/01.ta.0000197435.82141.27; Rittmeister M, 2001, ARCH ORTHOP TRAUM SU, V121, P43, DOI 10.1007/s004020000179; Rowe SA, 2004, SURGERY, V136, P842, DOI 10.1016/j.surg.2004.07.003; Sanders KM, 1999, MED J AUSTRALIA, V170, P467, DOI 10.5694/j.1326-5377.1999.tb127845.x; Smith W, 2007, J ORTHOP TRAUMA, V21, P31, DOI 10.1097/BOT.0b013e31802ea951; Starr AJ, 2002, J ORTHOP TRAUMA, V16, P553, DOI 10.1097/00005131-200209000-00003; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; Toro K, 2005, FORENSIC SCI INT, V151, P151, DOI 10.1016/j.forsciint.2005.01.014; Totterman A, 2006, SPINE, V31, pE628	26	13	15	1	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2010	36	2					131	137		10.1007/s00068-009-9094-0			7	Emergency Medicine	Emergency Medicine	587JR	WOS:000276988300008	26815687				2021-06-18	
J	Hokari, M; Kuroda, S; Iwasaki, Y				Hokari, Masaaki; Kuroda, Satoshi; Iwasaki, Yoshinobu			Pretreatment with the ciclosporin derivative NIM811 reduces delayed neuronal death in the hippocampus after transient forebrain ischaemia	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						delayed neuronal death; hippocampus; NIM811; reduced mitochondrial permeability transition; transient forebrain ischaemia	MITOCHONDRIAL PERMEABILITY TRANSITION; INTERMEMBRANE JUNCTIONAL COMPLEXES; BRAIN-DAMAGE; FOCAL ISCHEMIA; PORE; INVOLVEMENT; INHIBITION; MEMBRANE; IMMUNOSUPPRESSANT; POSTTREATMENT	Objectives There have been several previous studies showing that ciclosporin, a ligand for cyclophilin D (CypD), reduces mitochondrial permeability transition (mPT) and ameliorates delayed neuronal death. NIM811 is a non-immunosuppressive ciclosporin derivative that also inhibits mPT, but has significantly less cytotoxicity than ciclosporin. Actually, in animal experiments, several investigators have reported that NIM811 ameliorates central nervous system disorders, such as traumatic brain injury, transient focal cerebral ischaemia and spinal cord injury. Therefore, we evaluated whether the ciclosporin derivative, NIM811 reduces mPT and ameliorates delayed neuronal death in the hippocampal CA1 sectors in mice when subjected to transient forebrain ischaemia. Methods Male C57BL/6 mice were treated with 50 mg/kg ciclosporin, 10,50 or 100 mg/kg NIM811 or phosphate-buffered saline. At 30 min post-injection, all mice were subjected to 20 min bilateral common carotid artery occlusion (BCCAO). To estimate delayed neuronal death, the sections were prepared for HE staining and terminal deoxynucleotidyl transferase-mediated dUTP end-labelling (TUNEL) staining at 72 h after 20 min BCCAO. Furthermore, using 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine iodide (JC-1) staining technique, we evaluated whether NIM811 (1, 10, 100 or 1000 pm) inhibited mPT in the neurons exposed to 100 pm glutamate. Results Both delayed neuronal injury and apoptosis in the hippocampal CA1 sectors were significantly ameliorated at 72 h after transient forebrain ischaemia in the mice treated with 100 mg/kg NIM811 or 50 mg/kg ciclosporin. The treatments with 100 pm and 1000 pm NIM811 significantly inhibited the reduction of mitochondrial membrane potential in the neurons exposed to 100 pm glutamate. Conclusions These findings strongly suggest that NIM811 inhibits mPT and ameliorates delayed neuronal death in mice subjected to transient forebrain ischaemia.	[Hokari, Masaaki] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokari, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	karimasa@med.hokudai.ac.jp	Hokari, Masaaki/G-5395-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17390389, 18390387, 19390371]	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No.17390389, No.18390387 and No.19390371).	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; ATKINSON K, 1984, TRANSPLANTATION, V38, P34, DOI 10.1097/00007890-198407000-00009; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Friberg H, 1998, J NEUROSCI, V18, P5151; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Kikuchi S, 2002, J NEUROSCI RES, V69, P373, DOI 10.1002/jnr.10298; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; KUNZENDORF U, 1988, LANCET, V1, P1223; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; OGAWA N, 1993, NEUROSCI LETT, V152, P173, DOI 10.1016/0304-3940(93)90511-I; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Yamaguchi T, 2006, J PHARMACOL SCI, V100, P73, DOI 10.1254/jphs.FP0050799; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	44	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	APR	2010	62	4					485	490		10.1211/jpp.62.04.0011			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	588VJ	WOS:000277102200011	20604838				2021-06-18	
J	Saito, S; Kobayashi, T; Osawa, T; Kato, S				Saito, Shinnosuke; Kobayashi, Toshiyuki; Osawa, Takuro; Kato, Satoshi			Effectiveness of Japanese herbal medicine yokukansan for alleviating psychiatric symptoms after traumatic brain injury	PSYCHOGERIATRICS			English	Article						traumatic brain injury; yokukansan (Yi-Gan San)	YI-GAN-SAN; PSYCHOLOGICAL SYMPTOMS; LEWY BODIES; DEMENTIA	The Japanese herbal medicine, yokukansan, has been reported to improve behavioral and psychological symptoms of dementia and activities of daily living in patients with dementia. In the present case report, the authors report the effectiveness of yokukansan in treating psychiatric symptoms after traumatic brain injury. An 85-year-old man, who underwent surgery for hepatic portal cholangiocarcinoma, sustained traumatic brain injury after falling from bed as the result of postoperative delirium. He subsequently presented with psychiatric symptoms, showing markedly impulsive and aggressive behavior. Neuroleptics did not alleviate the symptoms. Ultimately, we succeeded in controlling the symptoms, without adverse effects, by giving the patient yokukansan. Yokukansan shows the potential for reducing aggressive and impulsive behavior in dementia as well as in other psychiatric diseases.	[Saito, Shinnosuke; Kobayashi, Toshiyuki; Osawa, Takuro; Kato, Satoshi] Jichi Med Univ, Dept Psychiat, Shimotsuke, Tochigi 3290498, Japan	Saito, S (corresponding author), Jichi Med Univ, Dept Psychiat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	saitoshinnosuke@gmail.com		Kobayashi, Toshiyuki/0000-0002-0237-3623			Egashira N, 2008, PROG NEURO-PSYCHOPH, V32, P1516, DOI 10.1016/j.pnpbp.2008.05.010; Igarashi Y., 2008, GERIAT MED, V46, P255; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P1612, DOI 10.4088/JCP.v66n1219a; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P150, DOI 10.1016/j.pnpbp.2007.07.026; MIZUKAMI K, 2009, NT J NEUROPSYCHOPHAR, V12, P191; Monji A, 2009, PROG NEURO-PSYCHOPH, V33, P308, DOI 10.1016/j.pnpbp.2008.12.008; MUKAI N, 2008, HOKKAIDO GERKA ZASSH, V53, P90; RAO V, 2008, PSYCHIAT ASPECTS NEU, P84; Sekiguchi K, 2009, PHYTOTHER RES, V23, P1175, DOI 10.1002/ptr.2777; Shinno H, 2008, PROG NEURO-PSYCHOPH, V32, P881, DOI 10.1016/j.pnpbp.2007.12.027; Shinno H, 2007, PROG NEURO-PSYCHOPH, V31, P1543, DOI 10.1016/j.pnpbp.2007.07.002; SUDARSANAN BS, 2006, MED J ARMED FORCES I, V62, P259; Tateno M, 2008, PROG NEURO-PSYCHOPH, V32, P1704, DOI 10.1016/j.pnpbp.2008.07.006	15	13	13	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1346-3500			PSYCHOGERIATRICS	Psychogeriatrics	MAR	2010	10	1					45	48		10.1111/j.1479-8301.2010.00313.x			4	Geriatrics & Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	615XJ	WOS:000279171600008	20594286	Bronze			2021-06-18	
J	Sharp, NCC				Sharp, N. C. Craig			The Human Genome and Sport, Including Epigenetics, Gene Doping, and Athleticogenomics	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Athleticogenomics; Epigenetics; Gene doping; Genome sport	TRAUMATIC BRAIN-INJURY; CHRONIC-FATIGUE; ACTN3 GENOTYPE; EXPRESSION; EXERCISE	Hugh Montgomery's discovery of the first of more than 239 fitness genes together with rapid advances in human gene therapy have created a prospect of using genes, genetic elements, and cells that have the capacity to enhance athletic performance (to paraphrase the World Anti-Doping Agency's definition of gene doping). This brief overview covers the main areas of interface between genetics and sport, attempts to provide a context against which gene doping may be viewed, and predicts a futuristic legitimate use of genomic (and possibly epigenetic) information in sport.	Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, West London, England	Sharp, NCC (corresponding author), Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, West London, England.	c.sharp90@btinternet.com					Abbott A, 2006, NATURE, V443, P488, DOI 10.1038/443488a; [Anonymous], BBC; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Brenner S, 2007, NATURE, V446, P725, DOI 10.1038/446725a; Budgett R, 2000, BRIT J SPORT MED, V34, P67, DOI 10.1136/bjsm.34.1.67; Check E, 2007, NATURE, V448, P11; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; COX JC, 2006, NATURE, V444, P9; CULVER KW, 1991, HUM GENE THER, V2, P107, DOI 10.1089/hum.1991.2.2-107; DELACHAPELLE A, 1993, LANCET, V341, P82, DOI 10.1016/0140-6736(93)92558-B; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Hooper R, 2005, NEW SCI, V187, P9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KODADEK T, 2007, NATURE, V446, P472; LAVITRANO M, 2006, P NATL ACAD SCI USA, V103, P17672; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Lyon Mary F., 2007, Biologist (London), V54, P94; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; MACARTHUR DG, 2007, E AFRICAN RUNNING CR, P217; Miah A., 2004, GENETICALLY MODIFIED; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Noakes TD, 2004, BRIT J SPORT MED, V38, P511, DOI 10.1136/bjsm.2003.009860; PANDO OJ, 2007, CELL, V128, P655; PARISOTTO R, 2006, ITS GENES BLOOD SPOR, P207; Puri BK, 2007, J CLIN PATHOL, V60, P122, DOI 10.1136/jcp.2006.042424; RIDLEY M, 2000, GENOME; RIGGS AD, 1996, EPIGENETICS MECH GEN, P34; RMCNEILL A, 1992, HUMAN MACHINE, P74; Santiago C, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.039172; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shadan S, 2007, NATURE, V447, P275, DOI 10.1038/447275b; Sharp C, 1999, NATURE, V398, P675; Sharp NCC, 2008, J SPORT SCI, V26, P1127, DOI 10.1080/02640410801912117; SHARP NCC, 2007, E AFRICAN RUNNING CR, P1; SHARP NCC, 2006, PEAK PERFORMANCE, V230, P8; SHARP NCC, 2004, PHYSL NEWS, V57, P15; SLOT O, 2006, RAISING BAR CHEATING; SPURWAY N, 2006, INTRO MOL EXERCISE P, P61; Sweeney HL, 2004, SCI AM, V291, P62, DOI 10.1038/scientificamerican0704-62; TAMBURRINE C, 2005, GENETIC TECHNOLOGY S; Wackerhage H, 2009, J SPORT SCI, V27, P1109, DOI 10.1080/02640410903114364; WAGNER R, 1990, NATURE, V391, P744; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	56	13	13	0	42	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	MAR	2010	39	1					201	+		10.1016/j.ecl.2009.10.010			16	Endocrinology & Metabolism	Endocrinology & Metabolism	627JR	WOS:000280035800017	20122459				2021-06-18	
J	Xue, T; Mao, Z; Lin, L; Hou, Y; Wei, X; Fu, X; Zhang, J; Yu, C				Xue, T.; Mao, Z.; Lin, L.; Hou, Y.; Wei, X.; Fu, X.; Zhang, J.; Yu, C.			Non-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats	GENE THERAPY			English	Article						siRNA; Runx2; Smad4; non-virus; heterotopic ossification	TOTAL HIP-ARTHROPLASTY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE MORPHOGENETIC PROTEIN-2; TRAUMATIC BRAIN-INJURY; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; ECTOPIC OSSIFICATION; ENHANCED OSTEOGENESIS; GENE-EXPRESSION; RISK-FACTORS	Heterotopic ossification of muscles, tendons and ligaments are a common problem affecting patient with trauma or received elective surgery. But the existing preventive or therapeutic methods all have disadvantages. Runt-related protein 2 (Runx2) and Smad4 are two regulators that have important roles in the differentiation of osteoblast. In this study, we attempted to examine the effect of Runx2 and Smad4 on the development of heterotopic ossification in vitro. We constructed non-virus-containing small interference RNAs (siRNAs) against Runx2 and Smad4 and tested it with reverse transcriptase-PCR and western blot. We then analyzed the independent effect of Runx2- and Smad4-specific siRNAs and their cooperative effect on the formation of heterotopic ossification induced by trauma in rats. The effects were measured with computed tomography scanning, hematoxylin and eosin staining and immunohistochemistry. We found that the Runx2 and Smad4-specific siRNAs inhibited the expression of Runx2 and Smad4 at the level of messenger RNA and protein. Runx2 and Smad4 independently inhibited the formation of heterotopic ossification. Moreover, their co-expression significantly enhanced the inhibition of heterotopic ossification compared with the independent effect. We suggest that gene therapy to inhibit Runx2 and Smad4 by RNAi could be a powerful approach to prevent or treat heterotopic ossification. Gene Therapy (2010) 17, 370-379; doi:10.1038/gt.2009.154; published online 26 November 2009	[Xue, T.; Lin, L.; Hou, Y.; Fu, X.; Zhang, J.; Yu, C.] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China; [Mao, Z.] Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Wei, X.] Tianjin Hosp, Dept Orthoped Surg, Tianjin, Peoples R China	Yu, C (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, 49 N Garden Rd, Beijing 100191, Peoples R China.	YCL123@vip.sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [ZR09-1-01]	This research was supported by the program of Gene Therapy on Sports Injury sponsored by National Natural Science Foundation of China (Grant Number: ZR09-1-01).	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; ALTMAN RD, 1995, J ORTHOP TRAUMA, V9, P392, DOI 10.1097/00005131-199505000-00006; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BONARIGO BC, 1967, RADIOLOGY, V88, P889, DOI 10.1148/88.5.889; BRADY LW, 1979, SKELETAL RADIOL, V4, P72, DOI 10.1007/BF00349330; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629; BRUMBACK RJ, 1990, J BONE JOINT SURG AM, V72A, P1067, DOI 10.2106/00004623-199072070-00017; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76; Crawford C M, 1986, J Burn Care Rehabil, V7, P323, DOI 10.1097/00004630-198607000-00005; DELEE J, 1976, CLIN ORTHOP RELAT R, P53; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dimar JR, 1996, SPINE, V21, P1870, DOI 10.1097/00007632-199608150-00006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FAHRER H, 1988, BRIT J RHEUMATOL, V27, P187; GREEN DP, 1979, J BONE JOINT SURG AM, V61, P1092, DOI 10.2106/00004623-197961070-00021; Haque S, 1996, ARCH PATHOL LAB MED, V120, P666; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Igarashi M, 2004, J MOL HISTOL, V35, P3, DOI 10.1023/B:HIJO.0000020883.33256.fe; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lin L, 2006, BIOCHEM BIOPH RES CO, V349, P564, DOI 10.1016/j.bbrc.2006.08.089; LOVELOCK JE, 1990, SKELETAL RADIOL, V19, P31; MCCLURE J, 1983, J PATHOL, V139, P419, DOI 10.1002/path.1711390403; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naraghi FF, 1996, ORTHOPEDICS, V19, P145; ORZEL JA, 1985, J NUCL MED, V26, P125; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269; QUINLAN JG, 1995, MUSCLE NERVE, V18, P201, DOI 10.1002/mus.880180209; Richards AM, 1997, BURNS, V23, P64, DOI 10.1016/S0305-4179(96)00074-5; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; SHAMBERGER R, 1985, RECENT RESULTS CANC, V98, P17; SOBALLE K, 1988, CLIN ORTHOP RELAT R, P57; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Viola RW, 2000, CLIN ORTHOP RELAT R, P65; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	47	13	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	MAR	2010	17	3					370	379		10.1038/gt.2009.154			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	566SE	WOS:000275392600008	19940863	Bronze			2021-06-18	
J	Bauss, O; Schafer, W; Sadat-Khonsari, R; Knosel, M				Bauss, Oskar; Schaefer, Winfried; Sadat-Khonsari, Reza; Knoesel, Michael			Influence of Orthodontic Extrusion on Pulpal Vitality of Traumatized Maxillary Incisors	JOURNAL OF ENDODONTICS			English	Article						Dental trauma; orthodontic treatment; pulp necrosis	EXPERIMENTAL TOOTH INTRUSION; PERMANENT INCISORS; BLOOD-FLOW; ROOT RESORPTION; DENTAL-PULP; REPLANTED TEETH; ANTERIOR TEETH; MOVEMENT; FORCE; INJURIES	Introduction: The aim of this retrospective study was to examine the effect of orthodontic extrusion on the pulpal vitality of maxillary incisors with a history of trauma. Methods: Pulpal condition was examined clinically (rating of crown color and sensitivity testing with a cryogenic spray) and radiologically (periapical and panoramic radiographs) after orthodontic extrusion of previously traumatized (Orthodontics/Trauma group, n = 77) and nontraumatized teeth (Orthodontics group, n = 400) and after previous dental trauma without subsequent orthodontic treatment (Trauma group, n = 193). Dental traumata were divided into hard tissue injuries (fracture of enamel and enamel chipping, fracture of enamel-dentin without pulpal involvement, fracture of enamel-dentin with pulpal involvement, root fracture, crown-root fracture) and periodontal injuries (concussion, subluxation, intrusion, extrusion, lateral luxation, and avulsion). Results: Teeth in the Orthodontics/Trauma group showed a significantly higher frequency of pulp necrosis than teeth in the Orthodontics group (P <.001) or teeth in the Trauma group (P <.009). In addition, teeth in the Orthodontics/Trauma group with periodontal injuries showed a significantly higher rate of pulp necrosis than teeth in the Orthodontics group (P <.001) or the corresponding teeth in the Trauma group (P =.004). No significant differences were observed between teeth in the Orthodontics/Trauma group with previous hard tissue injuries and teeth in the Orthodontics group or the corresponding teeth in the Trauma group. In addition, no statistically significant differences were determined between central and lateral incisors. Conclusions: The results indicated that maxillary incisors with a history of severe periodontal injury have a higher susceptibility to pulp necrosis during orthodontic extrusion than nontraumatized teeth. (J Endod 2010;36:203-207)	[Bauss, Oskar] Hannover Med Sch, D-3000 Hannover, Germany; [Sadat-Khonsari, Reza; Knoesel, Michael] Univ Gottingen, Dept Orthodont, Gottingen, Germany	Bauss, O (corresponding author), Luisenstr 10-11, D-30159 Hannover, Germany.	o.bauss@praxisbauss.de					ANDREASEN FM, 1989, ENDOD DENT TRAUMATOL, V5, P111; Andreasen FM, 2007, TXB COLOR ATLAS TRAU, P255; Andreasen JO, 1981, TRAUMATIC INJURIES T, P19; Barwick PJ, 1996, AM J ORTHOD DENTOFAC, V110, P273, DOI 10.1016/S0889-5406(96)80011-4; Bauss O, 2004, DENT TRAUMATOL, V20, P61, DOI 10.1111/j.1600-4469.2004.00230.x; Bauss O, 2008, AM J ORTHOD DENTOFAC, V134, P12, DOI 10.1016/j.ajodo.2006.07.033; Bauss O, 2008, J ENDODONT, V34, P417, DOI 10.1016/j.joen.2008.01.006; Bauss O, 2008, J OROFAC ORTHOP, V69, P402, DOI 10.1007/s00056-008-8805-1; Bauss O, 2009, ANGLE ORTHOD, V79, P166, DOI 10.2319/010708-7.1; BRIN I, 1991, European Journal of Orthodontics, V13, P372; BURNSIDE RR, 1974, ANGLE ORTHOD, V44, P213; Cohenca N, 2003, DENT TRAUMATOL, V19, P289, DOI 10.1034/j.1600-9657.2003.t01-1-00191.x; Cvek, 2007, TXB COLOR ATLAS TRAU, P598, DOI DOI 10.1016/J.JOEN.2014.09.0062007; Cwyk F, 1984, J DENT RES, V63; de Souza RS, 2006, J ENDODONT, V32, P115, DOI 10.1016/j.joen.2005.10.025; DELLINGE.EL, 1967, AMER J ORTHODONTICS, V53, P325, DOI 10.1016/0002-9416(67)90100-5; Derringer KA, 1996, J DENT RES, V75, P1761, DOI 10.1177/00220345960750100901; Esteves T, 2007, J ENDODONT, V33, P119, DOI 10.1016/j.joen.2006.09.007; GORDON NS, 1972, AMER J ORTHODONTICS, V62, P544, DOI 10.1016/0002-9416(72)90036-X; GRAUPPER JG, 1972, AMER J ORTHODONTICS, V62, P544, DOI 10.1016/0002-9416(72)90037-1; GUEVARA MJ, 1980, ANGLE ORTHOD, V50, P129; HINES FB, 1979, AM J ORTHOD DENTOFAC, V75, P1, DOI 10.1016/0002-9416(79)90135-0; JACOBSEN I, 1977, SCAND J DENT RES, V85, P588; JARVINEN S, 1979, ACTA ODONTOL SCAND, V37, P335, DOI 10.3109/00016357909004705; KVINNSLAND S, 1989, EUR J ORTHODONT, V11, P200, DOI 10.1093/oxfordjournals.ejo.a035986; LINGE BO, 1983, EUR J ORTHODONT, V5, P173, DOI 10.1093/ejo/5.3.173; MALMGREN O, 1982, AM J ORTHOD DENTOFAC, V82, P487, DOI 10.1016/0002-9416(82)90317-7; MCDONALD F, 1994, EUR J ORTHODONT, V16, P1; MOSTAFA YA, 1991, AM J ORTHOD DENTOFAC, V99, P30, DOI 10.1016/S0889-5406(05)81677-4; NIXON CE, 1993, J ENDODONT, V19, P13, DOI 10.1016/S0099-2399(06)81034-4; Petersson K, 1999, ENDOD DENT TRAUMATOL, V15, P127; Phillips JR, 1955, ANGLE ORTHOD, V25, P1; POPP TW, 1992, AM J ORTHOD DENTOFAC, V101, P228, DOI 10.1016/0889-5406(92)70091-N; Raiden G, 1998, Acta Odontol Latinoam, V11, P49; REITAN K, 1967, AMER J ORTHODONTICS, V53, P721, DOI 10.1016/0002-9416(67)90118-2; RICKETTS RM, 1976, AM J ORTHOD DENTOFAC, V70, P241, DOI 10.1016/0002-9416(76)90332-8; Robertson A, 1996, J ENDODONT, V22, P557, DOI 10.1016/S0099-2399(96)80018-5; Ronnerman A, 1973, Sven Tandlak Tidskr, V66, P527; Sano Y, 2002, EUR J ORTHODONT, V24, P159, DOI 10.1093/ejo/24.2.159; Spector J K, 1974, N Y State Dent J, V40, P30; STENVIK A, 1971, ORAL SURG ORAL MED O, V32, P639, DOI 10.1016/0030-4220(71)90331-8; STENVIK A, 1970, AMER J ORTHODONTICS, V57, P370, DOI 10.1016/S0002-9416(70)90219-8; VANDEVSKARADUNOVIC V, 1994, EUR J ORTHODONT, V16, P361, DOI 10.1093/ejo/16.5.361	43	13	15	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399			J ENDODONT	J. Endod.	FEB	2010	36	2					203	207		10.1016/j.joen.2009.10.025			5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	617KK	WOS:000279279400003	20113775				2021-06-18	
J	Shen, HY; Zhao, Y; Chen, XY; Xiong, RP; Lu, JL; Chen, JF; Chen, LY; Zhou, YG				Shen, Hai-Ying; Zhao, Yan; Chen, Xing-Yun; Xiong, Ren-Ping; Lu, Jin-Li; Chen, Jiang-Fan; Chen, Li-Yong; Zhou, Yuan-Guo			Differential Alteration of Heat Shock Protein 90 in Mice Modifies Glucocorticoid Receptor Function and Susceptibility to Trauma	JOURNAL OF NEUROTRAUMA			English	Article						geldanamycin; glucocorticoid receptor; heat shock protein; traumatic susceptibility; whole-body blast injury	NEUROGENIC PULMONARY-EDEMA; BRAIN-INJURY; HSP90; EXPRESSION; STRESS; GELDANAMYCIN; BINDING; RESISTANCE	Heat shock protein 90 (Hsp90), encoded by the murine hsp84 and hsp86 genes in mice, is a pivotal regulator of glucocorticoid receptor (GR) function in the hypothalamus-pituitary-adrenal axis and affords stress protection. To explore the underlying molecular mechanisms of strain susceptibility to traumatic stress, we investigated the alteration by Hsp90 of the function of the glucocorticoid-glucocorticoid receptor (GC-GR) pathway in attenuating stress responses in C57BL/6 and BALB/c mice using the whole-body blast injury (WBBI) model. We found that C57BL/6 mice had a lower WBBI-induced mortality, higher nuclear GR level, and higher glucocorticoid-response element (GRE) binding activity than BALB/c mice. This study is the first report identifying four genetic variations of the murine hsp84 gene: 226A>C, 996G>C, 1483G>C, and 2000G>T. These nucleotide changes occur in the functional domains associated with the nuclear/cytosolic translocation of GR, GR-Hsp90 interaction, ATP binding, and self-dimerization of Hsp90, respectively. Further, we used a specific Hsp90 inhibitor, geldanamycin (GA), to assess the role of Hsp90 in the discriminative traumatic response in C57BL/6 mice. Pretreatment with GA reduced nuclear GR levels and GRE binding activity, and enhanced WBBI-induced mortality. These findings suggest that Hsp90 may underlie the strain-selective (C57BL/6 versus BALB/c) susceptibility to WBBI by mediating the nuclear translocation of GRs and GRE binding. Thus, pharmacological manipulation of Hsp90 may represent a therapeutic strategy to modify the function of the GC-GR pathway and traumatic stress response.	[Zhou, Yuan-Guo] Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Ctr Mol Biol, Chongqing 400042, Peoples R China; [Chen, Li-Yong] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Chen, Li-Yong] Third Mil Med Univ, Dept Anesthesiol, Inst Surg Res, Chongqing 400042, Peoples R China; [Shen, Hai-Ying; Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Zhou, YG (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Ctr Mol Biol, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	ygzhou@cta.cq.cn		Shen, Hai-Ying/0000-0001-8430-2978; Chen, Xingyun/0000-0001-7699-4425	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30871170, 30470988]; Foundation for the Author of National Excellent Doctoral Dissertation of P. R. ChinaFoundation for the Author of National Excellent Doctoral Dissertation of China [200156]; National Basic Research Program of ChinaNational Basic Research Program of China [2005CB522602]	This work was supported by grants from National Natural Science Foundation of China (to H. Y. S., no. 30871170; and to Y. G. Z., no. 30470988), the Foundation for the Author of National Excellent Doctoral Dissertation of P. R. China (no. 200156), and National Basic Research Program of China (No. 2005CB522602).	Bahloul M, 2006, AM J CRIT CARE, V15, P462; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DeKloet ER, 1996, ANN NY ACAD SCI, V794, P179; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Hashiguchi N, 2001, J TRAUMA, V50, P102, DOI 10.1097/00005373-200101000-00018; Jibard N, 1999, EXP CELL RES, V247, P461, DOI 10.1006/excr.1998.4375; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Li XM, 2001, HEREDITY, V86, P668, DOI 10.1046/j.1365-2540.2001.00879.x; Liu DH, 2002, BURNS, V28, P315, DOI 10.1016/S0305-4179(02)00011-6; Liu JM, 1999, MOL ENDOCRINOL, V13, P355, DOI 10.1210/me.13.3.355; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; MOORE SK, 1987, GENE, V56, P29, DOI 10.1016/0378-1119(87)90155-7; Murphy EK, 2002, ENDOCRINOLOGY, V143, P1362, DOI 10.1210/en.143.4.1362; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; RADOJICIC C, 1990, J TRAUMA, V30, P211; Ramaglia V, 2004, J EXP BIOL, V207, P3775, DOI 10.1242/jeb.01211; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Wang Z G, 1989, Zhonghua Yi Xue Za Zhi, V69, P7; WANG ZG, 1989, ZHONGHUA YI XUE ZHI, V69, P12; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Yan P, 1999, J NEUROSCI, V19, P9355; Zhao Xiao-hui, 2007, Zhonghua Shao Shang Za Zhi, V23, P265	38	13	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2010	27	2					373	381		10.1089/neu.2009.0926			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	557JG	WOS:000274664800010	19845467				2021-06-18	
J	Breshears, RE; Brenner, LA; Harwood, JEF; Gutierrez, PM				Breshears, Ryan E.; Brenner, Lisa A.; Harwood, Jeri E. F.; Gutierrez, Peter M.			Predicting Suicidal Behavior in Veterans With Traumatic Brain Injury: The Utility of the Personality Assessment Inventory	JOURNAL OF PERSONALITY ASSESSMENT			English	Article							PSYCHIATRIC-PATIENTS; MMPI-2 PROFILES; HEAD-INJURY; POPULATION; IRAQ; TBI; AFGHANISTAN; DEPRESSION; RISK	In this study, we investigated the Personality Assessment Inventory's (PAI; Morey, 1991, 2007) Suicide Potential Index (SPI) and Suicide Ideation scale (SUI) as predictors of suicidal behavior (SB) in military Veterans with traumatic brain injury (TBI; N = 154). We analyzed electronic medical records were searched for SB in the 2 years post-PAI administration and data via logistic regressions. We obtained statistical support for the SPI and SUI as predictors of SB. Analyses we performed using receiver operating characteristics suggested an optimal SPI cutoff of epsilon 15 for this sample. Findings suggest that SPI and SUI scores may assist in assessing suicide risk in those with TBI, particularly when population-based cutoffs are considered.	[Breshears, Ryan E.; Brenner, Lisa A.; Harwood, Jeri E. F.; Gutierrez, Peter M.] Denver VA Med Ctr, VA VISN MIRECC 19, Denver, CO USA; [Brenner, Lisa A.; Gutierrez, Peter M.] Univ Colorado, Denver Sch Med, Dept Psychiat, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Denver Sch Med, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Denver Sch Med, Dept Neurol, Boulder, CO 80309 USA; [Harwood, Jeri E. F.] Univ Colorado, Denver Sch Med, Dept Pediat, Boulder, CO 80309 USA	Breshears, RE (corresponding author), WellStar Hlth Syst, 2000 S Pk Pl, Atlanta, GA 30339 USA.	ryan.breshears@wellstar.org	Gutierrez, Peter/K-8905-2019; Brenner, Lisa A./AAG-2442-2019	Gutierrez, Peter/0000-0001-8981-8404; 			ANTSEY KJ, 2004, J CLIN EPIDEMIOL, V57, P1202; Arbisi PA, 1999, NEUROREHABILITATION, V13, P117; Belter RW, 2001, J CLIN PSYCHOL, V57, P717, DOI 10.1002/jclp.1044; BRENNER LA, 2010, 2010 DOD VA SUIC PRE; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; BUTCHER JN, 2001, MINNESOTA MULTIPHASI, V2; *CDCP, 2009, WISQAR WEBS FAT INJ; *CDCP, 2006, TRAUM BRAIN INJ US R; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; *DEP VET AFF, 2004, VETEESA138 SP; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Fleischmann A, 2005, AM J ORTHOPSYCHIAT, V75, P676, DOI 10.1037/0002-9432.75.4.676; Foley J, 2006, INT J NEUROSCI, V116, P1377, DOI 10.1080/00207450500514334; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Martin J., 2009, J MENT HEALTH, V31, P101, DOI DOI 10.17744/MEHC.31.2.A6338384R2770383; MILLER MC, 1999, HARVARD MED SCH GUID, P463; Morey L, 1996, INTERPRETIVE GUIDE P; Morey L. C., 1991, PERSONALITY ASSESSME; Morey LC., 2007, PERSONALITY ASSESSME; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Rudd MD, 1996, J ABNORM PSYCHOL, V105, P541, DOI 10.1037/0021-843X.105.4.541; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; STANLEY B, 2008, SAFETY PLAN TR UNPUB; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wicklund AH, 2008, CLIN NEUROPSYCHOL, V22, P98, DOI 10.1080/13825580601025924; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	43	13	13	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0022-3891			J PERS ASSESS	J. Pers. Assess.		2010	92	4					349	355	PII 923051207	10.1080/00223891.2010.482011			7	Psychology, Clinical; Psychology, Social	Psychology	611EL	WOS:000278794000007	20552509				2021-06-18	
J	Clarke, SE; Chafetz, RS; Kozin, SH				Clarke, Sylvan E.; Chafetz, Ross S.; Kozin, Scott H.			Ossification of the Proximal Humerus in Children With Residual Brachial Plexus Birth Palsy: A Magnetic Resonance Imaging Study	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						shoulder; anatomy; brachial plexus injury; obstetrical palsy; ossification	GLENOHUMERAL DEFORMITY SECONDARY; INTERNAL-ROTATION CONTRACTURES; SHOULDER DEFORMITIES; TENDON TRANSFERS; CLOSED REDUCTION; BONE-MARROW; DISLOCATION; PARALYSIS; MANAGEMENT; GROWTH	Background: Children with residual brachial plexus birth palsy may develop deformities of the humeral head and the glenoid. Surgical treatment has been described to maximize function and to lessen deformity by means of glenohumeral remodeling. The timing and technique of surgical intervention have not been resolved. The timing of the appearance on magnetic resonance imaging of the ossific nuclei in patients with brachial plexus birth palsy has not been described. We examined the timing of ossification about the proximal humerus. Our hypothesis was that the timing of ossification of the proximal humerus differs between the side involved in brachial plexus palsy and the uninvolved side. Methods: A retrospective study was performed of 117 children with residual brachial plexus birth palsy (aged 5mo to 10y) who had magnetic resonance imaging scans of the bilateral shoulders performed at our institution between 2000 and 2007. All axial slices were reviewed by a single observer for evidence of ossification of the humeral head epiphysis, the greater tuberosity, and the lesser tuberosity, as well as for evidence that the 3 were coalesced. Statistical analysis was performed to compare the involved and uninvolved sides. Results: The appearance of the greater tuberosity ossific nucleus on the involved side was significantly delayed. There was a trend towards delay in the appearance of the lesser tuberosity ossific nucleus and the coalescence of the 3 ossific nuclei on the involved side. The duration during which ossification of the involved brachial plexus side occurred was generally shorter compared with the uninvolved side. Conclusion: There is delay in the ossification of the involved side in brachial plexus birth palsy, and a shorter duration of ossification.	[Clarke, Sylvan E.] Temple Univ, Dept Orthopaed Surg, Sch Med, Shriners Hosp Children,Albert Einstein Med Ctr, Philadelphia, PA 19140 USA; [Chafetz, Ross S.] Temple Univ, Shriners Hosp Children, Dept Clin Res, Sch Med, Philadelphia, PA 19140 USA	Kozin, SH (corresponding author), Temple Univ, Dept Orthopaed Surg, Sch Med, Shriners Hosp Children,Albert Einstein Med Ctr, 3551 N Broad St, Philadelphia, PA 19140 USA.	clarkes@alumni.upenn.edu; skozin@shrinenet.org					BABBITT DP, 1968, J BONE JOINT SURG AM, VA 50, P1447, DOI 10.2106/00004623-196850070-00015; Bahm J, 2007, J PEDIATR ORTHOP B, V16, P243, DOI 10.1097/BPB.0b013e3280925681; BAXTER MP, 1986, J BONE JOINT SURG BR, V68, P570; BROWNER BD, 1998, SKELETAL TRAUMA FRAC, P2; Doyle JR, 2003, SURG ANATOMY HAND UP, P721; DUNKERTON MC, 1989, J BONE JOINT SURG BR, V71, P764; GREEN NE, 1998, SKELETAL TRAUMA CHIL, P608; GUDINCHET F, 1992, SKELETAL RADIOL, V21, P19; Gudinchet F, 1995, PEDIATR RADIOL, V25, pS125; HERNANDEZ RJ, 1988, PEDIATR RADIOL, V18, P333, DOI 10.1007/BF02389004; Hoeksma AF, 2003, J BONE JOINT SURG AM, V85A, P316, DOI 10.2106/00004623-200302000-00020; Hui JHP, 2003, J PEDIATR ORTHOPED, V23, P109, DOI 10.1097/00004694-200301000-00022; JARAMILLO D, 1991, RADIOLOGY, V180, P809, DOI 10.1148/radiology.180.3.1871298; Kambhampati SBS, 2006, J BONE JOINT SURG BR, V88B, P213, DOI 10.1302/0301-620X.88B2.17185; KATTAN K R, 1968, Radiology, V91, P462; KERET D, 1991, J BONE JOINT SURG AM, V73A, P410, DOI 10.2106/00004623-199173030-00012; Kim HM, 2009, J BONE JOINT SURG AM, V91A, P879, DOI 10.2106/JBJS.H.00088; Kon DS, 2004, RADIOLOGY, V231, P791, DOI 10.1148/radiol.2313021057; Kozin SH, 2006, J SHOULDER ELB SURG, V15, P554, DOI 10.1016/j.jse.2005.11.004; Kozin SH, 2004, J PEDIATR ORTHOPED, V24, P189, DOI 10.1097/01241398-200403000-00011; LIEBOLT FL, 1953, J BONE JOINT SURG AM, V35-A, P227, DOI 10.2106/00004623-195335010-00024; Lucas JC, 2004, J PEDIATR ORTHOPED, V24, P249, DOI 10.1097/01241398-200405000-00002; MALVITZ TA, 1994, J BONE JOINT SURG AM, V76A, P1777, DOI 10.2106/00004623-199412000-00004; OGDEN JA, 1990, SKELETAL INJURY CHIL, P930; Pearl ML, 1998, J BONE JOINT SURG AM, V80A, P659, DOI 10.2106/00004623-199805000-00006; Pearl ML, 2006, J BONE JOINT SURG AM, V88A, P564, DOI 10.2106/JBJS.D.02872; Pearl ML, 2003, J BONE JOINT SURG AM, V85A, P890, DOI 10.2106/00004623-200305000-00018; POLLOCK AN, 1989, SKELETAL RADIOL, V18, P295, DOI 10.1007/BF00361211; Poyhia TH, 2005, PEDIATR RADIOL, V35, P402, DOI 10.1007/s00247-004-1377-3; PRICE AE, 1995, HAND CLIN, V11, P607; ROCKWOOD CA, 2006, ROCKWOOD WILKINS FRA, P1200; Saifuddin A, 2002, J BONE JOINT SURG BR, V84B, P100, DOI 10.1302/0301-620X.84B1.11813; Sanchez-Sotelo Joaquin, 2002, J Am Acad Orthop Surg, V10, P321; Soldado F, 2005, J PEDIATR ORTHOPED, V25, P666, DOI 10.1097/01.bpo.0000164873.41485.19; TACCONE A, 1995, PEDIATR RADIOL, V25, P596, DOI 10.1007/BF02011826; Terzis JK, 2003, J PEDIATR ORTHOPED, V23, P254, DOI 10.1097/00004694-200303000-00023; van der Sluijs J A, 2004, Neurosurg Focus, V16, pE9; van der Sluijs JA, 2003, J PEDIATR ORTHOP B, V12, P211, DOI 10.1097/00009957-200305000-00008; van der Sluijs JA, 2001, J BONE JOINT SURG BR, V83B, P551, DOI 10.1302/0301-620X.83B4.11205; Vitale M G, 2001, J Am Acad Orthop Surg, V9, P401; Waters PM, 2008, J BONE JOINT SURG AM, V90A, P2171, DOI 10.2106/JBJS.G.01517; Waters PM, 2005, J PEDIATR ORTHOP B, V14, P233, DOI 10.1097/01202412-200507000-00001; Waters PM, 2005, J PEDIATR ORTHOPED, V25, P116, DOI 10.1097/00004694-200501000-00025; Waters PM, 1998, J BONE JOINT SURG AM, V80A, P668, DOI 10.2106/00004623-199805000-00007; ZAWIN JK, 1993, RADIOLOGY, V188, P159, DOI 10.1148/radiology.188.1.8511291; Zouari O, 2004, REV CHIR ORTHOP, V90, P132	46	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN-FEB	2010	30	1					60	66		10.1097/BPO.0b013e3181c6c344			7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	538QF	WOS:000273198300011	20032744				2021-06-18	
J	Cottingham, ME; Boone, KB				Cottingham, Maria E.; Boone, Kyle B.			[image omitted] Non-credible language deficits following mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; Somatoform disorder; Feigned language; Aphasia; Dysarthria	FOREIGN ACCENT SYNDROME; SUSPECT EFFORT; DIFFERENTIAL-DIAGNOSIS; HEAD-INJURY; VERBAL FLUENCY; NORMATIVE DATA; ADULT ONSET; MEMORY; DISORDER; TESTS	Identification of non-credible memory and other cognitive symptoms has received widespread attention within the past two decades. However, minimal information is available regarding patterns of non-credible language symptoms. We present the case of a 36-year-old female civil litigant who displayed delayed onset, severe, relatively focal speech and language symptoms, including difficulties with articulation, dysfluent speech, expressive language impairments with minor receptive difficulties, and lack of prosody, subsequent to a minor head trauma. On neuropsychological evaluation 3 years post injury, the patient presented with the same speech/language characteristics, but additionally exhibited a vague oforeign accent.o Cognitive scores generally were normal with the exception of poor performance on many language tasks and processing/motor speed. The patient showed passing performance on most measures of response bias, but she failed effort indicators requiring rapid letter discrimination (b Test), rapid verbal repetition (timed forward digit span), and sensory function (finger agnosia errors) while passing effort indicators falling within the domains of memory, math/number skills, visuo-constructional ability, and attention. Thus, the type of failed effort indicators predicted the categories of standard cognitive tests on which she underperformed. Personality testing revealed patterns generally consistent with hysterical personality orientation. Given her long-standing history of multiple unexplained medical symptoms, the patient was diagnosed with a somatization disorder, as well as a current conversion disorder involving language symptoms. However, given her compensation-seeking status, the possibility of additional conscious feigning of symptoms could not be ruled out. The need for validation of additional measures to detect feigned language impairment is recommended.	[Cottingham, Maria E.] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; [Boone, Kyle B.] Alliant Int Univ, Calif Sch Forens Studies, Torrance, CA USA	Cottingham, ME (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA.	mecottingham@gmail.com					Abudarham S, 2001, INT J LANG COMM DIS, V36, P58, DOI 10.3109/13682820109177859; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BAUMGARTNER JM, 1999, STUTTERING RELATED D, P269; BEESON PM, 2008, CLIN NEUROPSYCHOLOGY, P436; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A, 1989, MULTILINGUAL APHASIA; Bloodstein O., 2008, HDB STUTTERING; Blumenfeld H, 2002, NEUROANATOMY CLIN CA; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO; Boone K., 2002, B TEST MANUAL; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K. B., 2007, ASSESSMENT FEIGNED C, P29; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Christoph DH, 2004, EUR NEUROL, V52, P198, DOI 10.1159/000082035; Coughlan T, 2004, J ROY SOC MED, V97, P242, DOI 10.1258/jrsm.97.5.242; Croot Karen, 2002, Seminars in Speech and Language, V23, P267, DOI 10.1055/s-2002-35800; Demick J., 1997, ROLE COGNITIVE STYLE; Duffy JR, 2019, MOTOR SPEECH DISORDE; Edwards RJ, 2005, EUR NEUROL, V53, P87, DOI 10.1159/000085503; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Goodglass H, 1997, CLIN NEUROSCI, V4, P51; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, P157; HEINLY MT, 2008, DISS ABSTR INT B, V68, P534; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; JOHNSON AF, 1998, MED SPEECH LANGUAGE, P337; KALLEN D, 1986, BRIT J DISORD COMMUN, V21, P377; Katz WF, 2008, CLIN LINGUIST PHONET, V22, P537, DOI 10.1080/02699200802106284; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; Kwon M, 2006, EUR NEUROL, V56, P249, DOI 10.1159/000096674; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GL, 2004, 32 ANN M INT NEUR SO; Laures-Gore J, 2006, CLIN LINGUIST PHONET, V20, P781, DOI 10.1080/02699200500391105; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lippert-Gruener M, 2005, BRAIN INJURY, V19, P955, DOI 10.1080/02699050500109506; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MAHR G, 1992, J SPEECH HEAR RES, V35, P283, DOI 10.1044/jshr.3502.283; Marien P, 2006, CLIN NEUROL NEUROSUR, V108, P518, DOI 10.1016/j.clineuro.2005.06.006; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mitrushina M., 2005, HDB NORMATIVE DATA N; Munson Patrick D, 2005, S D J Med, V58, P187; Naidoo R, 2008, CAN J NEUROL SCI, V35, P360, DOI 10.1017/S0317167100008970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Osmon DC, 2006, CLIN NEUROPSYCHOL, V20, P315, DOI 10.1080/13854040590947434; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reeves RR, 2007, J NEUROPSYCH CLIN N, V19, P70, DOI 10.1176/appi.neuropsych.19.1.70; Reeves RR, 2001, NEUROPSY NEUROPSY BE, V14, P135; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; ROTH CR, 1989, J SPEECH HEAR DISORD, V54, P634, DOI 10.1044/jshd.5404.634; Ryalls J, 2006, CLIN LINGUIST PHONET, V20, P157, DOI 10.1080/02699200400026900; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Seery CH, 2005, AM J SPEECH-LANG PAT, V14, P284, DOI 10.1044/1058-0360(2005/028); SELIGER GM, 1992, STROKE, V23, P1655, DOI 10.1161/01.STR.23.11.1655; SEVUSH S, 1983, PSYCHOSOMATICS, V24, P847, DOI 10.1016/S0033-3182(83)73158-0; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Tsuruga Koji, 2008, Seishin Shinkeigaku Zasshi, V110, P79; Van Borsel J, 2005, J COMMUN DISORD, V38, P421, DOI 10.1016/j.jcomdis.2005.03.004; Verhoeven J, 2005, BEHAV NEUROL, V16, P225, DOI 10.1155/2005/989602; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; WEPMAN JM, 1957, AUDITORY DISCRIMINAT; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C, P346; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	87	13	13	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	6					1006	1025	PII 923893079	10.1080/13854046.2010.481636			20	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	636WE	WOS:000280773600004	20614387				2021-06-18	
J	DeFina, PA; Fellus, J; Thompson, JWG; Eller, M; Moser, RS; Frisina, PG; Schatz, P; DeLuca, J; Zigarelli-McNish, M; Prestigiacomo, CJ				DeFina, Philip A.; Fellus, Jonathan; Thompson, James W. G.; Eller, Monika; Moser, Rosemarie Scolaro; Frisina, Pasquale G.; Schatz, Philip; DeLuca, John; Zigarelli-McNish, Maria; Prestigiacomo, Charles J.			Improving outcomes of severe disorders of consciousness	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article							PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; DBS THERAPY; HEAD-INJURY; COMA; ZOLPIDEM; RECOVERY; MODEL; SCALE	Purpose: To evaluate the efficacy of an Advanced Care Protocol (ACP) in improving rates of clinical progression and emergence in patients with Severe Disorders of Consciousness (SDOC). Methods: Forty-one patients with SDOC were assigned to groups: Vegetative State (VS) traumatic etiology (VS-TBI), VS non-traumatic etiology (VS-NTBI), Minimally Conscious State (MCS-TBI), MCS non-traumatic etiology (MCS-NTBI). Design was a within-subjects retrospective case series measuring pre-post ACP intervention data. The ACP was administered sequentially over 12 weeks, incorporating traditional therapies (occupational, physical, speech), pharmaceuticals, median nerve stimulation, and neutraceuticals. Main Outcome Measures were: Pre- and post-treatment Disability Rating Scale (DRS), Functional Independence Measure (FIM), Glasgow Coma Scale (GCS), and Coma Recovery Scale-Revised (CRS-R); clinical diagnosis (VS, MCS, emerged) using criteria from the American Academy of Neurology and Mohonk Report. Results: Patients significantly improved across all outcome measures, from baseline to discharge. Clinical improvement of 100% of MCS patients and 78-86% of VS patients was observed following ACP treatment. Significant differences between ACP vs. the published "standard of care" rates, in favor of the ACP, based on DRS scores and on clinical status at discharge. Conclusions: These strikingly positive results of a novel multimodal intervention are a valuable contribution to this frontier of investigation.	[DeFina, Philip A.; Thompson, James W. G.; Moser, Rosemarie Scolaro] Int Brain Res Fdn Inc, Edison, NJ 08837 USA; [Fellus, Jonathan; Eller, Monika; Frisina, Pasquale G.; DeLuca, John; Zigarelli-McNish, Maria] Kessler Inst Rehabil, W Orange, NJ USA; [Moser, Rosemarie Scolaro] RSM Psychol Ctr LLC, Lawrenceville, NJ USA; [Frisina, Pasquale G.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, Cerebrovasc Ctr, Newark, NJ 07103 USA	DeFina, PA (corresponding author), Int Brain Res Fdn Inc, 100 Menlo Pk,Suite 412, Edison, NJ 08837 USA.	pdefina@ibrfinc.org	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378; Schatz, Philip/0000-0002-6222-6545	International Brain Research Foundation, Inc. (IBRF), Edison NJ	Private funding for this study was provided by the International Brain Research Foundation, Inc. (IBRF), Edison NJ.	*AM MED ASS, 2009, CURR PROC TERM; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Coleman MR, 2009, PROG BRAIN RES, V177, P231, DOI 10.1016/S0079-6123(09)17716-6; COOPER E, 2006, RIGHT MEDIAN NERVE S; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, pR7, DOI 10.1097/00001199-199708000-00001; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Kidd PM, 2009, ALTERN MED REV, V14, P14; Kuznetsova AY, 2008, J COMPUT NEUROSCI, V24, P314, DOI 10.1007/s10827-007-0057-3; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; *MOH NY, 2006, MOH REP REP C IMPR O; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Shepperd S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000086; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Sosin DM, 1996, BRAIN INJURY, V10, P47; TEASDALE G, 1974, LANCET, V2, P81; UEMURA Y, 1991, STROKE, V22, P1548, DOI 10.1161/01.STR.22.12.1548; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J., 1999, REHABILITATION ADULT, P435; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15	46	13	14	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2010	28	6					769	780		10.3233/RNN-2010-0548			12	Neurosciences	Neurosciences & Neurology	692GM	WOS:000285141300006	21209492				2021-06-18	
J	Huang, SJ; Ho, HL; Yang, CC				Huang, Sheng-Jean; Ho, Hsueh-Lin; Yang, Chi-Cheng			Longitudinal outcomes of patients with traumatic brain injury: A preliminary study	BRAIN INJURY			English	Article						Traumatic brain injury; outcome measures; longitudinal; GOSE	QUALITY-OF-LIFE; MILD HEAD-INJURY; SCALE; DISABILITY; MODERATE; RETURN; WORK; DISORDERS; SYMPTOMS; COHORT	Primary objective: To examine the long-term global clinical outcomes of TBI patients from 1 week to 10 years post-injury. Research design: A retrospective study was conducted at a level I trauma centre. Methods and procedures: A total of 327 TBI patients were recruited retrospectively in this longitudinal study and the score of Glasgow Outcome Scale Extended (GOSE) was then documented as an indicator of the clinical outcomes. Main outcomes and results: The results presented that less than one-in-three patients recovered well within 2 weeks after trauma. Around 40% of patients were evaluated as favourable outcomes within 6 months post-injury. Less than 30% of TBI patients could gain favourable outcomes at 3 years post-injury and over half of patients still could not recover well at 6 years. Five patients' outcomes were continuously followed until 10 years and the results indicated that they started to have good outcomes after 3 years post-injury. Conclusions: This study might be the first one to longitudinally evaluate the outcomes of patients from 1 week to 10 years post-injury and revealed that patients still may have difficulties in social interactions and family relationships until 6 years post-injury, even though they could live and work independently. Hence, professionals should pay attention to the underlying factors causing their difficulties within the long-term recovery process.	[Yang, Chi-Cheng] Chang Gung Univ, Dept Occupat Therapy, Kwei Shan, Tao Yuan County, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Ho, Hsueh-Lin] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan	Yang, CC (corresponding author), Chang Gung Univ, Dept Occupat Therapy, 259,Wen Hwa 1st Rd, Tao Yuan, Taiwan.	ccyang@mail.cgu.edu.tw					Alderman N, 2004, SCI PRACT NEUROPSYCH, P269; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; GRANACHER RP, 2003, TRAUMATIC BRAIN INJU, P49; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2007, BRAIN INJURY MED PRI, P333; JENNETT B, 1975, LANCET, V1, P480; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Possl O, 2001, BRAIN INJURY, V15, P15; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2001, BRAIN DAM B, P3; Yang CC, 2005, ARCH CLIN PSYCHOL, V2, P49; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779	52	13	13	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	13-14					1606	1615		10.3109/02699052.2010.523056			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800010	20973628				2021-06-18	
J	Kirsch, NL; de Leon, MB; Maio, RF; Millis, SR; Tan-Schriner, CU; Frederiksen, S				Kirsch, Ned L.; de Leon, Marita B.; Maio, Ronald F.; Millis, Scott R.; Tan-Schriner, Cheribeth U.; Frederiksen, Shirley			Characteristics of a Mild Head Injury Subgroup With Extreme, Persisting Distress on the Rivermead Postconcussion Symptoms Questionnaire	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; WHITE-MATTER INJURY; QUALITY-OF-LIFE; SOCIAL SUPPORT; FOLLOW-UP; RECOVERY; PREDICTORS; SEVERITY; DEPRESSION	Kirsch NL, de Leon MB, Maio RF, Millis SR, Tan-Schriner CU, Frederiksen S. Characteristics of a mild head injury subgroup with extreme, persisting distress on the Rivermead Postconcussion Symptoms Questionnaire. Arch Phys Med Rehabil 2010;91:35-42. Objective: To examine baseline variables and identify characteristics of participants with extremely high reports of symptoms (ie, outliers) 12 months after mild head injury (MHI). Design: A prospective cohort study of MHI with and without loss of consciousness (LOC) and/or posttraumatic amnesia (PTA) recruited from and interviewed at the emergency department (ED), with a follow-up telephone interview at 12 months. Setting: Level II community hospital ED. Participants: Participants (n=58) with MHI and LOC less than or equal to 30 minutes and/or PTA less than 24 hours and participants (n=173) with MHI but no PTA/LOC. Inclusion criteria: age greater than or equal to I 8 years, less than or equal to 24 hours after injury, Glasgow Coma Scale score greater than or equal to 13, and discharge from the ED. Fourteen (6%) participants had extremely high scores on the Rivermead Postconcussion Symptoms Questionnaire (RPQ). Main Outcome Measures: RPQ and questions on health services use and litigation. Results: Characterizing the outlier cases are prior head injury, preinjury disability, history of substance use, unemployment, and elevated somatic symptoms at the ED. At 12 months, outliers had higher use of health services and litigation. Conclusions: The existence of a subgroup with a distinctive pattern of baseline characteristics in combination with elevated somatic symptoms at the time of presentation to the ED suggests that further taxonomic distinctions may be warrented for the MHI population, each requiring appropriately targeted interventions for addressing symptomatic complaints.	[Kirsch, Ned L.; de Leon, Marita B.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Maio, Ronald F.; Frederiksen, Shirley] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Maio, Ronald F.] Univ Michigan, Injury Res Ctr, Ann Arbor, MI 48109 USA; [Millis, Scott R.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Tan-Schriner, Cheribeth U.] Michigan Publ Hlth Inst, Okemos, MI USA	Kirsch, NL (corresponding author), Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, 355 Briarwood Circle, Ann Arbor, MI 48109 USA.	nlkirsch@umich.edu			Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR523223-01]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Center for Medical Rehabilitation Research [5-T32-HD007422-17]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER	Supported by the Centers for Disease Control (grant no. R49/CCR523223-01), the National Institutes of Health, the National Institute of Child Health and Human Development, and the National Center for Medical Rehabilitation Research (grant no. 5-T32-HD007422-17).	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Hoffman R. G., 1999, J FORENSIC NEUROPSYC, V1, P3, DOI DOI 10.1300/J151V01N02_02; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McLean SA, 2004, MED HYPOTHESES, V63, P653, DOI 10.1016/j.mehy.2004.03.022; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ocana M, 2000, BRAIN COGNITION, V44, P83, DOI 10.1006/brcg.1999.1211; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; SPINOS PC, 2007, EUR J NEUROL S1, V14, P165; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Uomoto JM, 2004, REHABIL PSYCHOL, V49, P334, DOI 10.1037/0090-5550.49.4.334; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Whiteneck G, 2001, COLORADO TRAUMATIC B; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	67	13	13	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2010	91	1					35	42		10.1016/j.apmr.2009.09.019			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	592YG	WOS:000277417300006	20103394				2021-06-18	
J	Lange, RT; Iverson, GL; Brubacher, JR; Franzen, MD				Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.; Franzen, Michael D.			Effect of blood alcohol level on Glasgow Coma Scale scores following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; alcohol; Glasgow Coma Scale score	HEAD-INJURY; INTOXICATION; TOLERANCE; SEVERITY; ABUSE	Objective: It is a common clinical perception that alcohol intoxication systematically lowers Glasgow Coma Scale (GCS) scores when evaluating traumatic brain injury (TBI). However, the research findings in this area do not uniformly support this notion. The purpose of this study is to examine the effects of blood alcohol level (BAL) on GCS scores following TBI. Method: Participants were 475 patients (64% male) who presented to a Level 1 trauma centre following a TBI. Patients were selected if they were injured in a motor vehicle accident and had an available day-of-injury GCS, BAL and Computed Tomography (CT) brain scan. Results: Overall, acute alcohol intoxication did not significantly affect GCS scores, even in patients with BALs of 200 mg dl(-1) or higher. When controlling for the effects of injury severity, acute alcohol intoxication affected GCS scores only in those patients with BALs greater than 200 mg dl(-1) who also had intracranial abnormalities detected on CT scan. Conclusions: These findings suggest that GCS scores can be interpreted at face value in the vast majority of patients who are intoxicated. However, GCS scores will likely over-estimate the severity of brain injury in patients with abnormal head CT scans and BALs greater than 200 mg dl(-1).	[Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Lange, Rael T.; Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Franzen, Michael D.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA	Lange, RT (corresponding author), Mental Hlth & Addict Serv, PHSA Res & Networks, Suite 201,601 W Broadway St, Vancouver, BC V5Z 4C2, Canada.	rael.lange@gmail.com		Iverson, Grant/0000-0001-7348-9570; Brubacher, Jeffrey/0000-0002-4866-4231			Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Christensen M A, 2001, J Neurosci Nurs, V33, P184; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Hall D, 2005, SCOT MED J, V50, P24, DOI 10.1177/003693300505000110; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Lieber C S, 1991, Drug Alcohol Rev, V10, P175, DOI 10.1080/09595239100185231; MCCUSKER CG, 1990, J STUD ALCOHOL, V51, P494, DOI 10.15288/jsa.1990.51.494; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; NEWLIN DB, 1991, ALCOHOL CLIN EXP RES, V15, P399, DOI 10.1111/j.1530-0277.1991.tb00537.x; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; SDAOJARVIE K, 1992, J STUD ALCOHOL, V53, P533, DOI 10.15288/jsa.1992.53.533; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Smith-Seemiller L, 1996, Appl Neuropsychol, V3, P41, DOI 10.1207/s15324826an0301_6; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TEASDALE G, 1974, LANCET, V2, P81	25	13	14	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					919	927		10.3109/02699052.2010.489794			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000001	20545447				2021-06-18	
J	Howard, AW; Macarthur, C; Rothman, L; Willan, A; Macpherson, AK				Howard, Andrew W.; Macarthur, Colin; Rothman, Linda; Willan, Andrew; Macpherson, Alison K.			School Playground Surfacing and Arm Fractures in Children: A Cluster Randomized Trial Comparing Sand to Wood Chip Surfaces	PLOS MEDICINE			English	Article							SURVEILLANCE SYSTEM; PLAY EQUIPMENT; INJURY RATES; RISK-FACTORS; FALLS; SAFETY; LIMB	Background: The risk of playground injuries, especially fractures, is prevalent in children, and can result in emergency room treatment and hospital admissions. Fall height and surface area are major determinants of playground fall injury risk. The primary objective was to determine if there was a difference in playground upper extremity fracture rates in school playgrounds with wood fibre surfacing versus granite sand surfacing. Secondary objectives were to determine if there were differences in overall playground injury rates or in head injury rates in school playgrounds with wood fibre surfacing compared to school playgrounds with granite sand surfacing. Methods and Findings: The cluster randomized trial comprised 37 elementary schools in the Toronto District School Board in Toronto, Canada with a total of 15,074 students. Each school received qualified funding for installation of new playground equipment and surfacing. The risk of arm fracture from playground falls onto granitic sand versus onto engineered wood fibre surfaces was compared, with an outcome measure of estimated arm fracture rate per 100,000 student-months. Schools were randomly assigned by computer generated list to receive either a granitic sand or an engineered wood fibre playground surface (Fibar), and were not blinded. Schools were visited to ascertain details of the playground and surface actually installed and to observe the exposure to play and to periodically monitor the depth of the surfacing material. Injury data, including details of circumstance and diagnosis, were collected at each school by a prospective surveillance system with confirmation of injury details through a validated telephone interview with parents and also through collection (with consent) of medical reports regarding treated injuries. All schools were recruited together at the beginning of the trial, which is now closed after 2.5 years of injury data collection. Compliant schools included 12 schools randomized to Fibar that installed Fibar and seven schools randomized to sand that installed sand. Noncompliant schools were added to the analysis to complete a cohort type analysis by treatment received (two schools that were randomized to Fibar but installed sand and seven schools that were randomized to sand but installed Fibar). Among compliant schools, an arm fracture rate of 1.9 (95% confidence interval [CI] 0.04-6.9) per 100,000 student-months was observed for falls into sand, compared with an arm fracture rate of 9.4 (95% CI 3.7-21.4) for falls onto Fibar surfaces (p <= 0.04905). Among all schools, the arm fracture rate was 4.5 (95% CI 0.26-15.9) per 100,000 student-months for falls into sand compared with 12.9 (95% CI 5.1-30.1) for falls onto Fibar surfaces. No serious head injuries and no fatalities were observed in either group. Conclusions: Granitic sand playground surfaces reduce the risk of arm fractures from playground falls when compared with engineered wood fibre surfaces. Upgrading playground surfacing standards to reflect this information will prevent arm fractures.	[Howard, Andrew W.] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Macarthur, Colin] Bloorview Kids Rehab, Toronto, ON, Canada; [Macpherson, Alison K.] York Univ, Dept Kinesiol, Toronto, ON M3J 2R7, Canada	Howard, AW (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca	Howard, Andrew/C-7163-2009	Howard, Andrew/0000-0001-7226-6471	Canadian Institutes for Health Research MCTCanadian Institutes of Health Research (CIHR) [70318]	The trial was funded by the Canadian Institutes for Health Research MCT 70318. The funders had no input into the collection, analysis or interpretation of data nor into the decision to publish or preparation of the manuscript. Playground installations were paid for by the Toronto District School board.	*ASTM, 2003, F148701E1 ASTM; *BRIT STAND, 1998, 71881998 BS; *CAN STAND ASS, 1998, GUID CHILDR PLAYSP E; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Chesney D A, 1996, IEEE Trans Rehabil Eng, V4, P182, DOI 10.1109/86.536773; Fiissel D, 2005, INJURY PREV, V11, P337, DOI 10.1136/ip.2005.009167; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Howard AW, 2005, CAN MED ASSOC J, V172, P1443, DOI 10.1503/cmaj.1041096; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Macarthur C, 1999, AM J EPIDEMIOL, V149, P586; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; Macarthur C, 1999, Inj Prev, V5, P214; Macarthur C, 1997, AM J EPIDEMIOL, V145, P834; Mitchell Rebecca, 2007, Health Promot J Austr, V18, P98; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Mowat D L, 1998, Inj Prev, V4, P39; Norton C, 2004, ARCH DIS CHILD, V89, P152, DOI 10.1136/adc.2002.024364; Rubie-Davies CM, 2007, J SCHOOL HEALTH, V77, P36, DOI 10.1111/j.1746-1561.2007.00160.x; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker Shauna, 2005, Int J Inj Contr Saf Promot, V12, P63, DOI 10.1080/17457300512331339184; SOSIN DM, 1993, AM J PUBLIC HEALTH, V83, P733, DOI 10.2105/AJPH.83.5.733; *STAND ASS AUSTR, 1981, AUSTR STAND PLAYGR E; *STAND ASS NZ, 1986, NZ STAND SPEC PLAYGR; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898; YAMAMOTO L G, 1991, Pediatric Emergency Care, V7, P267, DOI 10.1097/00006565-199110000-00002	26	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1549-1277			PLOS MED	PLos Med.	DEC	2009	6	12							e1000195	10.1371/journal.pmed.1000195			9	Medicine, General & Internal	General & Internal Medicine	536RD	WOS:000273060600010	20016688	DOAJ Gold, Green Published			2021-06-18	
J	Sloan, S; Callaway, L; Winkler, D; McKinley, K; Ziino, C; Anson, K				Sloan, Sue; Callaway, Libby; Winkler, Dianne; McKinley, Kirsten; Ziino, Carlo; Anson, Katie			The Community Approach to Participation: Outcomes Following Acquired Brain Injury Intervention	BRAIN IMPAIRMENT			English	Article						community rehabilitation; occupational therapy; outcome measurement	CLOSED HEAD-INJURY; INTEGRATION QUESTIONNAIRE; LIFE SATISFACTION; SOCIAL SUPPORT; REHABILITATION; QUALITY; PEOPLE; MODEL; POSTDISCHARGE; INDIVIDUALS	Objective: To investigate the participation outcomes of individuals with severe acquired brain injury (ABI) who were provided with up to 12 months of intervention based on the Community Approach to Participation (CAP). Method: A case series study design was undertaken with a total of 85 participants from two private practices specialising in community-based, CAP rehabilitation for people with severe ABI. Inclusion criteria were the person had sustained an acquired brain injury, was aged over 18 years and had received up to 12 consecutive months of CAP input from one of the two practices within a three-year period between January 2004 and January 2007 Twenty-six of the 85 participants were an average of 343 days post injury (Early group) and 59 of the participants were an average of 10.2 years post injury (Late group). They were living in a range of community environments and residential facilities. Initial participants were identified for the study in January 2005. Data were gathered using the Functional Independence Measure (FIM (TM)), Community Integration Questionnaire (CIQ), and Role Checklist (RC Part 1) at two time points: prior to intervention (baseline), and after a 12-month period or at discharge (TI). Within the intervention period, all participants received a customised community occupational therapy (OT) rehabilitation program based on the key principles of the CAP. Intervention focused on participation goals of the individual, and development of the associated skills that underpinned valued role performance. Results: Participants each received an average of 51.01 hours of CAP OT during the 12-month period of intervention. Considerable improvement was seen in functional independence, community integration, and role participation after intervention in both the Early and Late groups. A statistically significant increase in FIM (TM) and CIQ total scores was found for all participants from Baseline to T1. The number of roles in which participants engaged increased on average by almost one role per participant following intervention, from a mean of 3.06 to 3.99. Increased participation in volunteer, home maintainer, participant in organisations and hobbyist roles were most common. Conclusion: Increased functional independence, community integration, and participation in both the Early and Late groups over a 12 month period demonstrates the potential for improved participation outcomes for people with complex needs following ABI, even many years post injury.	[Sloan, Sue; McKinley, Kirsten; Ziino, Carlo; Anson, Katie] Osborn Sloan & Associates Pty Ltd, Melbourne, Vic, Australia; [Callaway, Libby] Monash Univ, Dept Occupat Therapy, Clayton, Vic 3800, Australia; [Winkler, Dianne] Summer Fdn Ltd, Melbourne, Vic, Australia	Sloan, S (corresponding author), Osborn Sloan & Associates Pty Ltd, 97 Princess St, Kew, Vic 3101, Australia.	sue@osbornsloan.com.au		Winkler, Di/0000-0003-3899-6248			Aron E., 1994, STAT PSYCHOL; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Beckley MN, 2007, AUST OCCUP THER J, V54, P215, DOI 10.1111/j.1440-1630.2007.00643.x; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; JACOBS HE, 1990, J HEAD TRAUMA REHAB, V5, P1; Jennett B, 1981, MANAGEMENT HEAD INJU; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; PONSFORD J, 2003, 26 ANN BRAIN IMP C S; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Refinetti R, 1996, TEACH PSYCHOL, V23, P51, DOI 10.1207/s15328023top2301_14; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; Sloan S., 2004, BRAIN IMPAIR, V5, P12, DOI DOI 10.1375/BRIM.5.1.12.35399; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; UDS Data Management Service, 1990, GUID US UN DAT SET M; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [10.1375/brim.4.1.1.27031, DOI 10.1375/brim.4.1.1.27031]	52	13	13	0	11	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2009	10	3					282	294		10.1375/brim.10.3.282			13	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	548OG	WOS:000273972400002					2021-06-18	
J	Walilko, T; North, C; Young, LA; Lux, WE; Warden, DL; Jaffee, MS; Moore, DF				Walilko, Timothy; North, Carol; Young, Lee Ann; Lux, Warren E.; Warden, Deborah L.; Jaffee, Michael S.; Moore, David F.			Head Injury as a PTSD Predictor Among Oklahoma City Bombing Survivors	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Posttraumatic stress disorder; Head injury; Injury correlation	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY	Background: The aim of the Oklahoma City (OKC) bombing retrospective review was to investigate the relationship between physical injury, environmental contributors, and psychiatric disorders such as posttraumatic stress disorder (PTSD) in an event-based, matched design study focused on injury. Methods: The 182 selected participants were a random subset of the 1,092 direct survivors from the OKC bombing. Only 124 of these 182 cases had a full complement of medical/clinical data in the OKC database. These 124 cases were assessed to explore relationships among PTSD diagnoses, levels of blast exposure, and physical injuries. Associations among variables were statistically tested using contingency analysis and logistic regression. Results: Comparison of the PTSD cases to symptoms/diagnoses reported in the medical records reveals a statistically significant association between PTSD and head/brain injuries associated with head acceleration. PTSD was not highly correlated with other injuries. Although blast pressure and impulse were highly correlated with head injuries, the correlation with PTSD was not statistically significant. Thus, a correlation between blast pressure and PTSD may exist, but higher fidelity pressure calculations are required to elucidate this potential relationship. Conclusions: This study provides clear evidence that head injury is associated with subsequent PTSD, giving caregivers' information on what physical injuries may suggest the development of psychologic disorders to aid them in developing a profile for the identification of future survivors of terrorist attacks and Warfighters with brain injuries and potential PTSD.	[Warden, Deborah L.; Jaffee, Michael S.; Moore, David F.] Walter Reed Army Med Ctr, DVBIC, HQ, Washington, DC 20012 USA; [Walilko, Timothy; Young, Lee Ann] Appl Res Associates, San Antonio, TX USA; [North, Carol] VA N Texas Hlth Care Syst, Dept Psychiat, Dallas, TX USA; [North, Carol] Univ Texas SW Med Ctr Dallas, Div Emergency Med, Dept Psychiat & Surg, Dallas, TX 75390 USA; [Lux, Warren E.] US EPA, Washington, DC 20460 USA	Moore, DF (corresponding author), Walter Reed Army Med Ctr, DVBIC, HQ, Room B207,Bldg 1,6900 Georgia Ave NW, Washington, DC 20012 USA.	david.f.moore@amedd.army.mil			Henry M. Jackson Foundation [0000104862]	Supported by the Henry M. Jackson Foundation contract No. 0000104862 for the Defense and Veterans Brain Injury Center.	*AP ASS, 1987, DSM 3 R DIAGN STAT M, P247; BRITT J, 1994, 405942 SAIC; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; CREPEAU JE, 2003, SHAMRC 2 ORDER HYDRO; *DIR FEMAM, 1996, OKL CIT BOMB IMPR BU; DOOLITTLE C, 2002, OKLAHOMA CITY MURRAH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; MERBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P1; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; PERRY S, 1992, AM J PSYCHIAT, V155, P625; PITMAN RK, 1989, AM J PSYCHIAT, V146, P667; SHALEV AY, 1992, J NERV MENT DIS, V180, P505, DOI 10.1097/00005053-199208000-00005; STUHMILLER J, 2001, CONVENTIONAL WARFARE; Ursano RJ, 1999, AM J PSYCHIAT, V156, P1808; Ursano RJ, 2007, PROG BRAIN RES, V167, P203, DOI 10.1016/S0079-6123(07)67014-9	19	13	13	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2009	67	6					1311	1319		10.1097/TA.0b013e31819adc36			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	531IL	WOS:000272658100038	20009683				2021-06-18	
J	Oria, RB; Costa, CMC; Lima, AAM; Patrick, PD; Guerrant, RL				Oria, Reinaldo B.; Costa, Carlos Mauricio C.; Lima, Aldo A. M.; Patrick, Peter D.; Guerrant, Richard L.			Semantic fluency: A sensitive marker for cognitive impairment in children with heavy diarrhea burdens?	MEDICAL HYPOTHESES			English	Article							EARLY-CHILDHOOD DIARRHEA; TRICHURIS-TRICHIURA INFECTION; ISCHEMIC VASCULAR DEMENTIA; JAMAICAN SCHOOL-CHILDREN; TRAUMATIC BRAIN-INJURY; FOCAL FRONTAL LESIONS; ALZHEIMERS-DISEASE; VERBAL FLUENCY; EXECUTIVE CONTROL; TAU HYPERPHOSPHORYLATION	One of the most affected cognitive impairments in children who experienced heavy burdens of diarrhea is semantic fluency, the same impairment that is most affected in Alzheimer's dementia. These findings are leading us into provocative genetic studies that may elucidate the evolution of such genetic polymorphisms as the APOE alleles. Alternatively, diarrhea could launch the cognitive deficits that might later progress in neurodegenerative diseases. In addition, they suggest that semantic fluency could provide a simple mean to assess cognitive impairment in impoverished settings so as to determine preventive measures. (C) 2009 Elsevier Ltd. All rights reserved.	[Oria, Reinaldo B.; Costa, Carlos Mauricio C.] Univ Fed Ceara, Inst Biomed Semiarid, Fortaleza, Ceara, Brazil; [Oria, Reinaldo B.] Univ Fed Ceara, Dept Morphol, Fortaleza, Ceara, Brazil; [Costa, Carlos Mauricio C.] Univ Fed Ceara, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Oria, Reinaldo B.; Lima, Aldo A. M.; Guerrant, Richard L.] Univ Virginia, Sch Med, Ctr Global Hlth, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA; [Patrick, Peter D.] Univ Virginia, Dept Pediat, Kluge Childrens Rehabil Ctr, Div Neuropsychol, Charlottesville, VA 22908 USA	Oria, RB (corresponding author), Univ Fed Ceara, Inst Biomed Semiarid, Fortaleza, Ceara, Brazil.	rbo5u@virginia.edu	Lima, Aldo AM/D-8251-2018; Oria, Reinaldo B/D-6440-2014	Lima, Aldo AM/0000-0002-0299-1747; Oria, Reinaldo/0000-0002-6914-5481	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R21TW03-007, 5R01HD053131]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH Office of Dietary Supplements (ODS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053131] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW006713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U01AI026512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK067629] Funding Source: NIH RePORTER	This project was supported by NIH Research Grants #5R21TW03-007 and 5R01HD053131 funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the NIH Office of Dietary Supplements (ODS).	Abbott RD, 1998, PEDIATRICS, V102, P602, DOI 10.1542/peds.102.3.602; Barr A, 1996, J CLIN EXP NEUROPSYC, V18, P810, DOI 10.1080/01688639608408304; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Booth JR, 2003, NEUROIMAGE, V20, P737, DOI 10.1016/S1053-8119(03)00404-X; Bronzino JD, 1997, EXP NEUROL, V148, P317, DOI 10.1006/exnr.1997.6653; Chan AS, 1997, NEUROPSYCHOLOGIA, V35, P241, DOI 10.1016/S0028-3932(96)00067-X; CHANDLER AMK, 1995, J NUTR, V125, P894; Ciaroni S, 2002, NEUROSCI RES, V44, P369, DOI 10.1016/S0168-0102(02)00157-8; Dillingham R, 2004, LANCET, V363, P94, DOI 10.1016/S0140-6736(03)15307-X; DO JV, 1998, NEUROPSYCHOLOGY, V12, P259; Duke LM, 2000, NEUROPSYCHOL REV, V10, P75, DOI 10.1023/A:1009096603879; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Fama R, 2000, NEUROPSYCHOLOGY, V14, P29, DOI 10.1037/0894-4105.14.1.29; Fukuda MTH, 2002, BEHAV BRAIN RES, V133, P271, DOI 10.1016/S0166-4328(02)00010-4; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gardner JM, 1996, ANN TROP MED PARASIT, V90, P55, DOI 10.1080/00034983.1996.11813026; Gleissner U, 2001, CORTEX, V37, P55, DOI 10.1016/S0010-9452(08)70557-4; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2002, ARCH MED RES, V33, P351, DOI 10.1016/S0188-4409(02)00379-X; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kim MJ, 2001, NEUROSCI LETT, V302, P109, DOI 10.1016/S0304-3940(01)01684-6; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608; Laatu S, 2003, ACTA NEUROL SCAND, V108, P82, DOI 10.1034/j.1600-0404.2003.00097.x; Lafosse JM, 1997, NEUROPSYCHOLOGY, V11, P514, DOI 10.1037/0894-4105.11.4.514; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVITSKY DA, 1995, J NUTR, V125, pS2212, DOI 10.1093/jn/125.suppl_8.2212S; Lima AAM, 2000, J INFECT DIS, V181, P1643, DOI 10.1086/315423; Lukoyanov NV, 2000, BEHAV BRAIN RES, V112, P85, DOI 10.1016/S0166-4328(00)00164-9; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Moore SR, 2001, INT J EPIDEMIOL, V30, P1457, DOI 10.1093/ije/30.6.1457; Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590; NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Ralph MAL, 2001, J NEUROL NEUROSUR PS, V70, P149, DOI 10.1136/jnnp.70.2.149; Ribaut-Barassin C, 2003, NEUROSCIENCE, V120, P405, DOI 10.1016/S0306-4522(03)00332-4; Ricci PT, 1999, NEUROIMAGE, V9, P88, DOI 10.1006/nimg.1998.0386; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Rohrer D, 1999, NEUROPSYCHOLOGY, V13, P381, DOI 10.1037/0894-4105.13.3.381; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; SIMEON DT, 1995, PARASITOLOGY, V110, P457, DOI 10.1017/S0031182000064799; Simeon DT, 1998, AM J CLIN NUTR, V67, p790S; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Tierney MC, 2001, ARCH NEUROL-CHICAGO, V58, P1654, DOI 10.1001/archneur.58.10.1654; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Watson JM, 2001, NEUROPSYCHOLOGY, V15, P254, DOI 10.1037//0894-4105.15.2.254; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5	56	13	13	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2009	73	5					682	686		10.1016/j.mehy.2009.05.013			5	Medicine, Research & Experimental	Research & Experimental Medicine	516QS	WOS:000271558000012	19520520	Green Accepted			2021-06-18	
J	Park, SA; Yang, CY; Kim, CG; Shin, YI; Oh, GJ; Lee, M				Park, Soon-Ah; Yang, Chung-Yong; Kim, Chang-Guhn; Shin, Yong-Il; Oh, Gyung-Jae; Lee, Moonyoung			Patterns of Three-Phase Bone Scintigraphy According to the Time Course of Complex Regional Pain Syndrome Type I After a Stroke or Traumatic Brain Injury	CLINICAL NUCLEAR MEDICINE			English	Article						pain; complex regional pain syndrome; three-phase bone scintigraphy	REFLEX SYMPATHETIC DYSTROPHY; QUANTITATIVE-EVALUATION; EXTREMITIES; MECHANISMS; HEMIPLEGIA; DIAGNOSIS; CRITERIA	We have proposed to evaluate different patterns represented on 3-phase bone scintigraphy (TPBS) according to the time course of complex regional pain syndrome (CRPS) type I (CRPS-I) after a stroke or traumatic brain injury. TPBS was performed in 50 consecutive patients for the evaluation of CRPS. We divided the patients into CRPS and non-CPRS groups based on the use of International Association for the Study of Pain criteria. We evaluated the changes on TPBS according to clinical stages based on time course. In the early acute stage within 6 weeks, minimal uptake on all TPBS phases was observed in the 90% of the patients in the CRPS-I group and in 75% of the patients in the non-CRPS group. In the acute stage of CRPS in the range of 2 to 20 weeks, moderately increased uptake was seen for 78%, 83%, and 83% of the patients in the CRPS group for the 3 phases, respectively. However, only 16% of the patients in the non-CRPS group had moderately increased uptake as seen on all TPBS phases. In the late stage of more than 21 weeks, there was no distinct difference in uptake between the 2 groups. A sequential change during the time course for the CPRS-I group was statistically significant (P < 0.05). Therefore, performance of follow-tip TPBS may be useful to diagnose CPRS-I in uncertain cases of the early acute stage after a stroke or traumatic brain injury.	[Park, Soon-Ah; Kim, Chang-Guhn] Wonkwang Univ, Coll Med, Dept Nucl Med, Iksan 570749, Jeollabuk Do, South Korea; [Park, Soon-Ah; Oh, Gyung-Jae; Lee, Moonyoung] Inst Wonkwang Med Sci, Iksan, South Korea; [Yang, Chung-Yong; Shin, Yong-Il] Wonkwang Univ, Coll Med, Dept Phys Med & Rehabil, Iksan 570749, Jeollabuk Do, South Korea	Park, SA (corresponding author), Wonkwang Univ, Coll Med, Dept Nucl Med, 344-2 Shinyong Dong, Iksan 570749, Jeollabuk Do, South Korea.	nmbach@wonkwang.ac.kr			Wonkwang University	Supported by Wonkwang University in 2007.	Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Daviet JC, 2002, AM J PHYS MED REHAB, V81, P34, DOI 10.1097/00002060-200201000-00006; DAVIS SW, 1977, ARCH PHYS MED REHAB, V58, P353; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; GIBBONS JJ, 1992, CLIN J PAIN, V8, P260, DOI 10.1097/00002508-199209000-00012; Gokkaya NKO, 2006, INT J REHABIL RES, V29, P275; Harden RN, 2006, CLIN J PAIN, V22, P420; Harvey R., 2007, PHYS MED REHABILITAT, P1175; HOLDER LE, 1984, RADIOLOGY, V152, P517, DOI 10.1148/radiology.152.2.6739825; INTENZO C, 1989, CLIN NUCL MED, V14, P657, DOI 10.1097/00003072-198909000-00004; Intenzo CM, 2005, CLIN NUCL MED, V30, P400, DOI 10.1097/01.rlu.0000162605.14734.11; LEE GW, 1995, J HAND SURG-AM, V20A, P458, DOI 10.1016/S0363-5023(05)80107-8; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed., P40; ODONOGHUE JP, 1993, CLIN NUCL MED, V18, P829, DOI 10.1097/00003072-199310000-00002; Park SG, 2007, NUCL MED COMMUN, V28, P766, DOI 10.1097/MNM.0b013e32828e513f; SCHWARTZMAN RJ, 1987, ARCH NEUROL-CHICAGO, V44, P555, DOI 10.1001/archneur.1987.00520170081028; van de Vusse AC, 2003, EUR J PAIN, V7, P259, DOI 10.1016/S1090-3801(02)00123-4; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wasner G, 2003, SPINAL CORD, V41, P61, DOI 10.1038/sj.sc.3101404; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; WEISS L, 1993, ARCH PHYS MED REHAB, V74, P716, DOI 10.1016/0003-9993(93)90032-6; Zyluk A, 1999, NUCL MED COMMUN, V20, P327, DOI 10.1097/00006231-199904000-00008	22	13	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	NOV	2009	34	11					773	776		10.1097/RLU.0b013e3181b7d980			4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	515UU	WOS:000271499200007	19851172				2021-06-18	
J	Strote, J; Roth, R; Cone, DC; Wang, HE				Strote, Jared; Roth, Ronald; Cone, David C.; Wang, Henry E.			Prehospital endotracheal intubation: the controversy continues (Conference Proceedings)	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; NEUROMUSCULAR BLOCKING-AGENTS; EMERGENCY MEDICAL TECHNICIANS; SEVERE HEAD-INJURY; TRACHEAL INTUBATION; INAPPROPRIATE CARE; PREVENTABLE DEATH; SERVICES SYSTEM; RURAL STATE		[Strote, Jared] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA; [Roth, Ronald] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Cone, David C.] Yale Univ, Sch Med, Sect Emergency Med, New Haven, CT 06519 USA; [Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, AL 35249 USA	Strote, J (corresponding author), Univ Washington, Div Emergency Med, Box 356123, Seattle, WA 98195 USA.	strote@u.washington.edu		Cone, David/0000-0002-7437-959X			Abo BN, 2007, RESUSCITATION, V72, P234, DOI 10.1016/j.resuscitation.2006.06.028; *ACCR COUNC GRAD M, EM MED GUID PROC RES; Baker CC, 2005, J TRAUMA, V58, P723; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bozeman WP, 2006, PREHOSP EMERG CARE, V10, P8, DOI 10.1080/10903120500366854; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bulger EM, 2002, J EMERG MED, V23, P183, DOI 10.1016/S0736-4679(02)00490-0; Bushby Nathan, 2005, Emerg Med Australas, V17, P443, DOI 10.1111/j.1742-6723.2005.00775.x; Bushra JS, 2004, ACAD EMERG MED, V11, P66, DOI 10.1197/S1069-6563(03)00586-4; Charuluxananan Somrat, 2001, Journal of the Medical Association of Thailand, V84, pS251; Christensen EF, 2003, BRIT MED J, V327, P533, DOI 10.1136/bmj.327.7414.533; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; *COUNC ACCR NURS A, 2004, STAND ACCR NURS AN E; CUMMINS RO, 1986, ANN EMERG MED, V15, P1187, DOI 10.1016/S0196-0644(86)80863-0; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DELEO BC, 1977, HEART LUNG, V6, P851; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; ELLING R, 1983, ANN EMERG MED, V12, P765, DOI 10.1016/S0196-0644(83)80254-6; Esposito TJ, 2003, J TRAUMA, V54, P663, DOI 10.1097/01.TA.0000058124.78958.6B; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Gabrielli Andrea, 2002, Curr Opin Crit Care, V8, P199, DOI 10.1097/00075198-200206000-00002; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; GUSS DA, 1984, AM J EMERG MED, V2, P399, DOI 10.1016/0735-6757(84)90041-X; Hagberg C, 2006, ANESTH ANALG, V102, P621, DOI 10.1213/01.ane.0000189101.26403.06; Hall RE, 2005, ACAD EMERG MED, V12, P850, DOI 10.1197/j.aem.2005.04.007; HESS D, 1985, AM J EMERG MED, V3, P292, DOI 10.1016/0735-6757(85)90049-X; JACOBS LM, 1983, JAMA-J AM MED ASSOC, V250, P2175, DOI 10.1001/jama.250.16.2175; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Johnston BD, 2006, ACAD EMERG MED, V13, P1051, DOI 10.1197/j.aem.2006.06.031; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Konrad C, 1998, ANESTH ANALG, V86, P635; LEVITAN RM, 2004, AIRWAY CAM GUIDE INT; Lockey D, 2001, BRIT MED J, V323, P141, DOI 10.1136/bmj.323.7305.141; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; National Highway Traffic Safety Administration, EM MED TECHN PAR NAT; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Ochs M, 2000, Prehosp Emerg Care, V4, P333, DOI 10.1080/10903120090941065; Rinker CF, 2003, J TRAUMA, V54, P669; Shy Bradley D, 2004, Prehosp Emerg Care, V8, P394, DOI 10.1016/j.prehos.2004.06.013; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Suominen P, 2000, Eur J Emerg Med, V7, P3; Tiamfook-Morgan TO, 2006, PREHOSP EMERG CARE, V10, P363, DOI 10.1080/10903120600725835; Tracy S, 2006, J TRAUMA, V61, P1162, DOI 10.1097/01.ta.0000243887.90697.06; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1111/j.1553-2712.2003.tb00065.x; Wang Henry E, 2005, Prehosp Emerg Care, V9, P145; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	67	13	13	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2009	27	9					1142	1147		10.1016/j.ajem.2008.08.011			6	Emergency Medicine	Emergency Medicine	527XB	WOS:000272403400019	19931764				2021-06-18	
J	Vickery, CD; Evans, CC; Lee, JE; Sepehri, A; Jabeen, LN				Vickery, Chad D.; Evans, Clea C.; Lee, Jae Eun; Sepehri, Arash; Jabeen, Linsa N.			Multilevel Modeling of Self-Esteem Change During Acute Inpatient Stroke Rehabilitation	REHABILITATION PSYCHOLOGY			English	Article						stroke; self-esteem; rehabilitation; multilevel modeling	TRAUMATIC BRAIN-INJURY; POSTSTROKE DEPRESSION; PHYSICAL REHABILITATION; LESION LOCATION; LATE-LIFE; SYMPTOMS; MOOD; VALIDATION; DISABILITY; PHASE	Objective: To explore self-esteem change during inpatient stroke rehabilitation and moderators of change. Research Method: One hundred twenty survivors of stroke serially completed the State Self-Esteem Scale (SSES) during inpatient rehabilitation, as well as measures of mood and perceived recovery as potential moderators of change. Age, gender, prior stroke, prestroke depression, stroke laterality, and admission Functional Independence Measure (FIM) self-care, mobility, and cognitive scores were also included as moderators. Results: Multilevel modeling of the repeated administrations of the SSES indicated that self-esteem significantly improved during rehabilitation. Female gender, left hemisphere stroke, prior stroke, and lower admission FIM cognitive scores were associated with lower self-esteem ratings at admission, but only age and admission FIM self-care and mobility scores were associated with self-esteem change. Older individuals showed less self-esteem improvement than younger individuals, and higher self-care and mobility scores at admission were associated with greater self-esteem improvement. While mood change significantly covaried with self-esteem, the rate of mood change did not appear to influence rate of self-esteem change. Greater improvement in self-esteem over time was related to lower levels of perceived recovery, but this was likely because of the relationship between perceived recovery and self-esteem at rehabilitation admission. Implications: These results suggest that self-esteem improves during inpatient rehabilitation, and this change may be partially dependent on functional status. Implications for facilitating self-esteem change by the clinician are discussed, as well as future research directions.	[Vickery, Chad D.; Evans, Clea C.; Sepehri, Arash; Jabeen, Linsa N.] Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS 39216 USA; [Vickery, Chad D.; Evans, Clea C.; Lee, Jae Eun] Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA; [Lee, Jae Eun] Jackson State Univ, SRCMI Tranlsat Res Network, Jackson, MS USA	Vickery, CD (corresponding author), Methodist Rehabil Ctr, Dept Neuropsychol, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	chadvickery@hotmail.com					ANDERSEN G, 1995, ACTA PSYCHIAT SCAND, V92, P193, DOI 10.1111/j.1600-0447.1995.tb09567.x; Balloun JL, 1997, QUAL QUANT, V31, P317, DOI 10.1023/A:1004254515556; Barbisoni P, 1996, ARCH PHYS MED REHAB, V77, P346, DOI 10.1016/S0003-9993(96)90082-9; Bennett HE, 2006, BRIT J CLIN PSYCHOL, V45, P367, DOI 10.1348/014466505X58277; Berg A, 2001, CEREBROVASC DIS, V12, P14, DOI 10.1159/000047675; Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Chang AM, 1999, J CLIN NURS, V8, P477, DOI 10.1046/j.1365-2702.1999.0196a.x; Chang AM, 1998, STROKE, V29, P2325, DOI 10.1161/01.STR.29.11.2325; Fung LCL, 2006, J CLIN NURS, V15, P505, DOI 10.1111/j.1365-2702.2006.01328.x; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; HARRIS RE, 1988, J AM GERIATR SOC, V36, P890, DOI 10.1111/j.1532-5415.1988.tb05781.x; Hastie T.J., 1990, GEN ADDITIVE MODELS; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lieberman D, 1999, INT J GERIATR PSYCH, V14, P549, DOI 10.1002/(SICI)1099-1166(199907)14:7<549::AID-GPS960>3.0.CO;2-4; Mruk CJ, 2006, SELF ESTEEM ISSUES A, P164; Narushima K, 2003, J NEUROPSYCH CLIN N, V15, P422, DOI 10.1176/appi.neuropsych.15.4.422; Nezlek JB, 2001, PERS SOC PSYCHOL B, V27, P201, DOI 10.1177/0146167201272006; Oosterwegel A, 2001, J PERS, V69, P689, DOI 10.1111/1467-6494.695160; Paolucci S, 1998, CEREBROVASC DIS, V8, P228, DOI 10.1159/000015856; Paolucci S, 2001, CEREBROVASC DIS, V12, P264, DOI 10.1159/000047714; Paolucci S, 1999, ARCH PHYS MED REHAB, V80, P985, DOI 10.1016/S0003-9993(99)90048-5; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Robins RW, 2005, CURR DIR PSYCHOL SCI, V14, P158, DOI 10.1111/j.0963-7214.2005.00353.x; SCHUBERT DSP, 1992, GEN HOSP PSYCHIAT, V14, P135, DOI 10.1016/0163-8343(92)90039-D; SCHULZ R, 1994, J SOC BEHAV PERS, V9, P139; SCHWARTZ JA, 1993, BIOL PSYCHIAT, V33, P694, DOI 10.1016/0006-3223(93)90118-W; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Stern R. A., 1997, VISUAL ANALOG MOOD S; *UB FDN ACT, 1996, UN DAT SET MED REH V; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Vickery CD, 2008, CLIN REHABIL, V22, P179, DOI 10.1177/0269215507080142; Vickery CD, 2008, REHABIL PSYCHOL, V53, P101, DOI 10.1037/0090-5550.53.1.101; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Vickery CD, 2009, REHABIL PSYCHOL, V54, P432, DOI 10.1037/a0017752; Vickery CD, 2009, REHABIL PSYCHOL, V54, P332, DOI 10.1037/a0016434; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Zalewski Christine, 1994, Clinical Gerontologist, V14, P62	40	13	14	0	12	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2009	54	4					372	380		10.1037/a0017854			9	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	526YF	WOS:000272331600003	19929118				2021-06-18	
J	Zhang, SR; Carroll, LJ; Cassidy, JD; Paniak, C				Zhang, Sharon; Carroll, Linda J.; Cassidy, J. David; Paniak, Chris			FACTORS INFLUENCING SELF-RATED HEALTH IN TRAFFIC-RELATED MILD TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; self-rated health; health-related quality of life	QUALITY-OF-LIFE; HEAD-INJURY; GENERAL-POPULATION; RATING-SCALES; NECK PAIN; SYMPTOMS; COMPENSATION; INDIVIDUALS; DEPRESSION; COMMUNITY	Objective: To report self-rated health and factors influencing health after traffic-related mild traumatic brain injury. Design: Population-based, cross-sectional study of traffic-related mild traumatic brain injury occurring between 1 December 1997 and 31 November 1999 in Saskatchewan, Canada. Subjects: Subjects were 929 adults making a personal injury claim after a traffic collision. Inclusion criteria were a head blow with certain or possible loss of consciousness or post-traumatic amnesia, or a possible head blow with certain loss of consciousness/post-traumatic amnesia. Excluded were those with loss of consciousness >30 min and those hospitalized longer than 2 days. Methods: Data were self-reported through insurance application forms completed within 6 weeks of the injury. Multi-variable multinomial logistic regression was applied to identity, factors associated with self-reported general health. Results. In contrast to the 74.5%, of subjects reporting excellent or very good health prior to injury, 70.8% reported having poor/fair health after the injury. Post-crash depressive symptoms, sleep problems, greater neck/low back pain and low expectations for recovery were associated with poorer post-injury health. Conclusion: Those with traffic-related mild traumatic brain injury reported a decline in self-perceived general health. We identified potentially modifiable factors associated with poor post-injury health and suggested that these factors should be considered during early clinical intervention.	[Zhang, Sharon] Alberta Childrens Prov Gen Hosp, Decis Support Res Team, Alberta Hlth Serv, Calgary, AB T3B 6A8, Canada; [Zhang, Sharon] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Carroll, Linda J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2M7, Canada; [Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cassidy, J. David] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	Zhang, SR (corresponding author), Alberta Childrens Prov Gen Hosp, Decis Support Res Team, Alberta Hlth Serv, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	sharon.zhang@albertahealthservices.ca		Carroll, Linda/0000-0003-0876-2336			Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Breivik EK, 2000, CLIN J PAIN, V16, P22, DOI 10.1097/00002508-200003000-00005; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2003, J CLIN EPIDEMIOL, V56, P651, DOI 10.1016/S0895-4356(03)00118-5; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Cote P, 2000, SPINE, V25, P1109; Cote P, 2000, ACCIDENT ANAL PREV, V32, P151, DOI 10.1016/S0001-4575(99)00117-7; *DEP HIGHW TRANSP, 2002, SASK HIGHW TRANSP OP; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eriksson I, 2001, INT J EPIDEMIOL, V30, P326, DOI 10.1093/ije/30.2.326; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; JAROSZYNSKI G, 1996, DEV VALIDATION COMOR; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MacKenzie E J, 1989, Md Med J, V38, P725; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mercado AC, 2000, HEALTH PSYCHOL, V19, P333, DOI 10.1037/0278-6133.19.4.333; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; REVICKI DA, 1989, J FAM PRACTICE, V29, P377; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P120; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Ware JE., 1993, SF 36 HLTH SURVEY MA	35	13	15	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2009	41	13					1062	1067		10.2340/16501977-0462			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	527VZ	WOS:000272399000008	19894002	DOAJ Gold			2021-06-18	
J	Ampo, KI; Suzuki, A; Konishi, H; Kiyama, H				Ampo, Kei-Ichi; Suzuki, Akinobu; Konishi, Hiroyuki; Kiyama, Hiroshi			Induction of Pancreatitis-Associated Protein (PAP) Family Members in Neurons after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						inflammation; rat; Reg-2; Reg-III gamma; weight drop brain injury	INFLAMMATORY-BOWEL-DISEASE; NEUROTROPHIC FACTOR; NERVE INJURY; REG-2 EXPRESSION; GENE-EXPRESSION; MOTOR-NEURONS; HEAD-INJURY; CELL-DEATH; RAT-BRAIN; REGENERATION	The pancreatitis-associated protein (PAP) family is a group of 16-kDa secretory proteins initially identified in the pancreas in rats with acute pancreatitis. Although induction of PAP family genes was reported in peripheral nerve injury models, the expression in the central nervous system after traumatic injury has not been examined. In the present study, we examined the expression of PAP family members (PAP-I, PAP-II, and PAP-III) in the rat brain following traumatic brain injury (TBI) induced by weight drop. There was a significant upregulation of PAPI and PAP-III mRNA in the injured cortex beginning at 1 day after TBI. Immunohistochemical double-staining indicated that PAP-I and PAP-III staining was localized in a subpopulation of neurons in the peri-injured region. Expression of both PAP-I and PAP-III mRNA was observed following a transient increase in inflammatory cytokines, including TNF-alpha, IL-6, and IL-1 beta mRNA. The results of the present study suggest that expression of PAP family members in response to traumatic and inflammatory stimuli are not restricted to the pancreas, intestine, and peripheral nervous system, and are likely a more general cellular response, including the central nervous system in the rat. Thus, PAP family members may have an anti-inflammatory role, and this may contribute to the protection of injured neurons.	[Ampo, Kei-Ichi; Suzuki, Akinobu; Konishi, Hiroyuki; Kiyama, Hiroshi] Osaka City Univ, Dept Anat & Neurobiol, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	Kiyama, H (corresponding author), Osaka City Univ, Dept Anat & Neurobiol, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kiyama@med.osaka-cu.ac.jp	KONISHI, Hiroyuki/M-8871-2014; Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	Ministry of Education, Culture, Sports, and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry of Health, Labor, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan	We are grateful to C. Kadono for excellent technical assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, and Technology (MEXT), and the Ministry of Health, Labor, and Welfare of Japan.	Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Averill S, 2008, NEUROSCIENCE, V155, P1227, DOI 10.1016/j.neuroscience.2008.06.049; Averill S, 2002, J NEUROSCI, V22, P7493; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Closa D, 2007, WORLD J GASTROENTERO, V13, P170, DOI 10.3748/wjg.v13.i2.170; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; DUSETTI NJ, 1995, J BIOL CHEM, V270, P22417, DOI 10.1074/jbc.270.38.22417; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fiedler F, 1998, CRIT CARE MED, V26, P887, DOI 10.1097/00003246-199805000-00024; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; FRIGERIO JM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P329, DOI 10.1016/0167-4781(93)90167-C; FRIGERIO JM, 1993, BIOCHEMISTRY-US, V32, P9236, DOI 10.1021/bi00086a032; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Graf R, 2002, J SURG RES, V105, P136, DOI 10.1006/jsre.2002.6387; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Heller A, 1999, ANESTHESIOLOGY, V91, P1408, DOI 10.1097/00000542-199911000-00034; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Honma M, 2002, J NEUROCHEM, V82, P961, DOI 10.1046/j.1471-4159.2002.01043.x; IOVANNA JL, 1993, AM J PHYSIOL, V265, pG611; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; MASCIOTRA L, 1995, DIGEST DIS SCI, V40, P519, DOI 10.1007/BF02064359; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nishimune H, 2000, NAT CELL BIOL, V2, P906; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Okamotoa T, 2004, MOL BRAIN RES, V131, P119, DOI 10.1016/j.molbrainres.2004.08.015; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Takahara Y, 2008, J UROLOGY, V179, P1603, DOI 10.1016/j.juro.2007.11.034; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Yakovlev AG, 2001, J NEUROSCI, V21, P7439; Zhang H, 2004, SCAND J GASTROENTERO, V39, P870, DOI 10.1080/00365520410006477	48	13	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2009	26	10					1683	1693		10.1089/neu.2008.0847			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	507CT	WOS:000270829200007	19351265				2021-06-18	
J	Fu, YK; Chang, CJ; Chen, KY; Hwang, LC; Wu, KH; Chang, KW; Jan, ML; Chen, CC; Chang, CH				Fu, Ying-Kai; Chang, Chia-Jung; Chen, Kuan-Yin; Hwang, Li-Chung; Wu, Kuo-Hung; Chang, Kang-Wei; Jan, Meei-Ling; Chen, Chia-Chieh; Chang, Chih-Hsien			Imaging of regional metabolic activity by F-18-FDG/PET in rats with transient cerebral ischemia	APPLIED RADIATION AND ISOTOPES			English	Article						F-18-FDG; MicroPET; Rat ischemia model	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; OCCLUSION; RECOVERY; PET	Changes in regional metabolic activities induced by middle cerebral artery occlusion (MCAO) can influence patient outcome. Our aim was to demonstrate in a rat model that F-18-FDG with positron emission tomography (PET) imaging is a quantitative, reproducible approach for identifying acute and sub-acute metabolic variations in infarct regions. We found that imaging with F-18-FDG/PET enabled detection and quantification of ischemia-induced metabolic deficits and provided a sensitive and reliable means of assessing cerebral ischemic lesions compared with conventional neurological scoring systems in rodents. (C) 2009 Elsevier Ltd. All rights reserved,	[Fu, Ying-Kai] Inst Nucl Energy Res, Atom Energy Council, Tao Yuan 32546, Taiwan; [Fu, Ying-Kai] Chung Yuan Christian Univ, Dept Chem, Chungli 32023, Taiwan	Fu, YK (corresponding author), Inst Nucl Energy Res, Atom Energy Council, Execut Yuan 1000,Wunhua Rd, Tao Yuan 32546, Taiwan.	fufrank@iner.gov.tw			National Science CouncilMinistry of Science and Technology, Taiwan; Institute of Nuclear Energy Research, Taiwan, ROC	This research was supported by the National Science Council and the Institute of Nuclear Energy Research, Taiwan, ROC. The authors are grateful to Dr. Wuu-Jyh Lin for providing <SUP>18</SUP>F-FDG, to Mr. Kuo-Wei Chen for his help with image data reconstruction to Professor Yui-whei Chen-Yang, Chung Yuan Christian University, for her knowledgeable discussion on the manuscript, and to Ms. Hsueh-Hsuan Liu for her supervision on animal experiments.	Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Chatziioannou AF, 2002, EUR J NUCL MED, V29, P98, DOI 10.1007/s00259-001-0683-3; GINSBERG MD, 1977, NEUROLOGY, V27, P1042, DOI 10.1212/WNL.27.11.1042; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Kornblum HI, 2000, NAT BIOTECHNOL, V18, P655, DOI 10.1038/76509; Kudo T, 2002, CIRCULATION, V106, P118, DOI 10.1161/01.CIR.0000020221.28996.78; Liu HG, 2003, CLIN NUCL MED, V28, P241, DOI 10.1097/00003072-200303000-00021; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Mirrione MM, 2006, SYNAPSE, V59, P119, DOI 10.1002/syn.20216; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Mountz JM, 2003, SEMIN NUCL MED, V33, P56, DOI 10.1053/snuc.2003.127293; Sakai N, 1996, BEHAV BRAIN RES, V77, P181, DOI 10.1016/0166-4328(95)00232-4; vanderStaay FJ, 1996, BRAIN RES, V715, P180, DOI 10.1016/0006-8993(95)01581-7; Yang Y.R., 2000, J PHYS THER, V25, P223	15	13	15	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	OCT	2009	67	10					1743	1747		10.1016/j.apradiso.2009.03.002			5	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	504TV	WOS:000270641500001	19372040				2021-06-18	
J	Ivancevic, VG				Ivancevic, Vladimir G.			New mechanics of traumatic brain injury	COGNITIVE NEURODYNAMICS			English	Article						Traumatic brain injuries; Coupled loading-rate hypothesis; Euclidean jolt; Coupled Newton-Euler dynamics; Brain's dislocations and disclinations	FINITE-ELEMENT-ANALYSIS; CEREBROSPINAL-FLUID MOTION; ROTATIONAL ACCELERATION; PROFESSIONAL FOOTBALL; COMPACT-BONE; MODEL; STRAIN; BIOMECHANICS; DEFORMATION; IMPACT	The prediction and prevention of traumatic brain injury is a very important aspect of preventive medical science. This paper proposes a new coupled loading-rate hypothesis for the traumatic brain injury (TBI), which states that the main cause of the TBI is an external Euclidean jolt, or SE(3)-jolt, an impulsive loading that strikes the head in several coupled degrees-of-freedom simultaneously. To show this, based on the previously defined covariant force law, we formulate the coupled Newton-Euler dynamics of brain's micro-motions within the cerebrospinal fluid and derive from it the coupled SE(3)-jolt dynamics. The SE(3)-jolt is a cause of the TBI in two forms of brain's rapid discontinuous deformations: translational dislocations and rotational disclinations. Brain's dislocations and disclinations, caused by the SE(3)-jolt, are described using the Cosserat multipolar viscoelastic continuum brain model.	Def Sci & Technol Org, Land Operat Div, Adelaide, SA, Australia	Ivancevic, VG (corresponding author), Def Sci & Technol Org, Land Operat Div, Adelaide, SA, Australia.	Vladimir.Ivancevic@dsto.defence.gov.au					[Anonymous], 2002, NIH PUBL, V01-4913; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Bilby BA., 1968, FRACTURE, P99; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Chen Z, 2008, COGN NEURODYNAMICS, V2, P257, DOI 10.1007/s11571-008-9047-z; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Cosserat E., 1909, THEORIE CORPS DEFORM; Cosserat E, 1898, CR HEBD ACAD SCI, V126, P1089; EDELEN DGB, 1980, INT J ENG SCI, V18, P1095, DOI 10.1016/0020-7225(80)90112-3; Eringen A.C., 2002, NONLOCAL CONTINUUM F; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guan Y, 2006, BIOMED SCI INSTRUM, V42, P199; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Ivancevic V, 2004, SIAM REV, V46, P455, DOI 10.1137/S003614450341313X; IVANCEVIC V, 2007, NEUROFUZZY ASS MACHI; IVANCEVIC V, 2006, NATURAL BIODYNAMICS; IVANCEVIC V, 2006, HUMAN LIKE BIOMECHAN; Ivancevic VG, 2007, STUD COMPUT INTELL, V60, P1, DOI 10.1007/978-3-540-71561-0; Ivancevic V.G., 2007, APPL DIFFERENTIAL GE; Ivancevic V. G., 2007, HIGH DIMENSIONAL CHA; Ivancevic VG, 2006, GEOMETRICAL DYNAMICS; Ivancevic Vladamir G., 2007, COMPLEX DYNAMICS ADV; Ivancevic V, 2006, INT J HUM ROBOT, V3, P205, DOI 10.1142/S0219843606000680; Ivancevic V, 2007, PHYSICA A, V382, P616, DOI 10.1016/j.physa.2007.04.025; Ivancevic VG, 2008, UNDERST COMPLEX SYST, P1; JIAN G, 1995, APPL MATH MECH, V16, P493; Kadic A., 1983, GAUGE THEORY DISLOCA; KRABBEL G, 1995, J NEUROTRAUM, V12, P735, DOI 10.1089/neu.1995.12.735; LAKES RS, 1985, J APPL MECH-T ASME, V52, P234, DOI 10.1115/1.3169009; Lamb H., 1932, HYDRODYNAMICS; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leonard NE, 1997, AUTOMATICA, V33, P331, DOI 10.1016/S0005-1098(96)00176-8; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; MAIER SE, 1994, RADIOLOGY, V193, P477, DOI 10.1148/radiology.193.2.7972766; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MASON M, 2007, DISCOVER MAGAZI 0223; Mindlin RD., 1965, INT J SOLIDS STRUCTU, V1, P265, DOI [DOI 10.1016/0020-7683(65)90033-8, 10.1016/0020-7683(65)90033-8]; MISRA JC, 1985, MATH MODELLING, V6, P83, DOI 10.1016/0270-0255(85)90001-6; MISRA JC, 1984, J BIOMECH, V17, P459, DOI 10.1016/0021-9290(84)90014-9; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; PARK HC, 1986, J BIOMECH, V19, P385, DOI 10.1016/0021-9290(86)90015-1; Park J, 2005, IEEE T ROBOT, V21, P850, DOI 10.1109/TRO.2005.852253; Pena A, 2005, ACT NEUR S, V95, P333; Rapp PE, 2007, COGN NEURODYNAMICS, V1, P287, DOI 10.1007/s11571-007-9027-8; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Sokoloff L, 2008, COGN NEURODYNAMICS, V2, P1, DOI 10.1007/s11571-007-9033-x; TAKAHASHI T, 2007, P 29 ANN INT C IEEE; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; VOO K, 2006, MED BIOL ENG COMPUT, V34, P375; Wolfson DR, 2005, P I MECH ENG H, V219, P63, DOI 10.1243/095441105X9237; YANG JFC, 1981, J BIOMECH ENG-T ASME, V103, P275, DOI 10.1115/1.3138292; YANG JFC, 1982, J BIOMECH, V15, P91, DOI 10.1016/0021-9290(82)90040-9; Yang W, 2001, J MECH PHYS SOLIDS, V49, P2431, DOI 10.1016/S0022-5096(01)00046-1; Yoganandan N, 2008, ANN BIOMED ENG, V36, P406, DOI 10.1007/s10439-007-9422-7; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	71	13	13	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	SEP	2009	3	3					281	293		10.1007/s11571-008-9070-0			13	Neurosciences	Neurosciences & Neurology	483VX	WOS:000269000200009	19031012	Green Published			2021-06-18	
J	Ciccia, AH; Meulenbroek, P; Turkstra, LS				Ciccia, Angela Hein; Meulenbroek, Peter; Turkstra, Lyn S.			Adolescent Brain and Cognitive Developments Implications for Clinical Assessment in Traumatic Brain Injury	TOPICS IN LANGUAGE DISORDERS			English	Article						adolescence; brain-behavior relationships; cognitive development	CLOSED-HEAD INJURY; WHITE-MATTER; WORKING-MEMORY; EXECUTIVE FUNCTIONS; CORPUS-CALLOSUM; FUNCTIONAL MRI; CHILDHOOD; CHILDREN; LANGUAGE; MATURATION	Adolescence is a time of significant physical, social, and emotional developments, accompanied by changes in cognitive and language skills. Underlying these are significant developments in brain structures and functions including changes in cortical and subcortical gray matter and white matter tracts. Among the brain regions that develop during adolescence are areas that are commonly damaged as a result of a traumatic brain injury (TBI). This paper summarizes major brain changes during adolescence and evidence linking maturation of these cognitive and language functions to brain development, placing consideration of both areas of development in the context of rehabilitation for adolescents with TBI.	[Meulenbroek, Peter; Turkstra, Lyn S.] Univ Wisconsin, Dept Communicat Disorders, Madison, WI 53706 USA; [Ciccia, Angela Hein] Case Western Reserve Univ, Dept Commun Sci, Cleveland, OH 44106 USA	Turkstra, LS (corresponding author), Univ Wisconsin, Dept Communicat Disorders, 1975 Goodnight Hall, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Ciccia, Angela/J-5967-2019	Meulenbroek, Peter/0000-0003-4233-9910	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K23DC000163] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K23 DC000163] Funding Source: Medline		Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anokhin AP, 2000, DEV PSYCHOBIOL, V36, P9, DOI 10.1002/(SICI)1098-2302(200001)36:1<9::AID-DEV2>3.3.CO;2-X; ARNETT JJ, 1994, J YOUTH ADOLESCENCE, V23, P517, DOI 10.1007/BF01537734; Asato MR, 2006, NEUROPSYCHOLOGIA, V44, P2259, DOI 10.1016/j.neuropsychologia.2006.05.010; BARKLEY JM, 2007, BRAIN INJURY MED PRI, P129; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bhatnagar S. C., 2008, NEUROSCIENCE STUDY C; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Bosacki SL, 2003, J YOUTH ADOLESCENCE, V32, P141, DOI 10.1023/A:1021861902463; Bosacki SL, 2000, J EDUC PSYCHOL, V92, P709, DOI 10.1037//0022-0663.92.4.709; Brothers L., 1990, CONCEPT NEUROSCI, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; BROWN BB, 1993, CHILD DEV, V64, P467, DOI 10.1111/j.1467-8624.1993.tb02922.x; Cameron JL, 2001, DEV COGN NEUROSCI, P59; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Ciccia AH, 2002, ADV SPEECH LANGUAGE, V4, P1, DOI DOI 10.1080/14417040210001669181; Crone EA, 2008, COGN AFFECT BEHAV NE, V8, P165, DOI 10.3758/CABN.8.2.165; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Donders J, 1997, Pediatr Rehabil, V1, P179; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; EYRE JA, 1991, J PHYSIOL-LONDON, V434, P441, DOI 10.1113/jphysiol.1991.sp018479; Felser Claudia., 2003, LANG ACQUIS, V11, P127, DOI [DOI 10.1207/s15327817la1103_1, DOI 10.1207/S15327817LA1103_1]; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Grumbach MM, 2002, HORM RES, V57, P2, DOI 10.1159/000058094; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kail RV, 2007, CHILD DEV, V78, P1760, DOI 10.1111/j.1467-8624.2007.01088.x; KAMHI H, 2007, CLIN DECISION MAKING; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; KLAHR D, 2001, TIME MATTERS COGNITI; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; Matthews PM, 2004, RESTOR NEUROL NEUROS, V22, P245; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; Moran CA, 2006, BRAIN INJURY, V20, P417, DOI 10.1080/02699050500488223; Muneoka KT, 2002, BRAIN RES, V956, P332, DOI 10.1016/S0006-8993(02)03567-9; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Nippold M., 1998, LATER LANGUAGE DEV S; Nippold M. A., 1988, LATER LANGUAGE DEV A; Nippold MA, 2000, TOP LANG DISORD, V20, P15, DOI 10.1097/00011363-200020020-00004; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Peters M, 1998, BRAIN COGNITION, V37, P254, DOI 10.1006/brcg.1998.0983; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Proctor A, 2000, BRAIN INJURY, V14, P633; RABINOWICZ T, 1979, HUMAN GROWTH, V3, P97; Raymer AM, 2008, J SPEECH LANG HEAR R, V51, pS259, DOI 10.1044/1092-4388(2008/020); RICKER J, 2007, BRAIN INJURY MED PRI, P149; SCHULKIN Jay, 2000, ROOTS SOCIAL SENSIBI; Scott C. M., 1988, LATER LANGUAGE DEV A, P49; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Singh PP, 2007, AM J TROP MED HYG, V77, P98; Snow PC, 2000, BRAIN INJURY, V14, P397; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005; Steinberg L., 1999, ADOLESCENCE; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Tatcher R.W, 1997, DEV PREFRONTAL CORTE, P85; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Williams SE, 2005, BRAIN INJURY, V19, P549, DOI 10.1080/02699050400013576; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6	96	13	13	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2009	29	3					249	265		10.1097/TLD.0b013e3181b53211			17	Linguistics; Rehabilitation	Linguistics; Rehabilitation	488HT	WOS:000269340700006	30220763	Green Accepted			2021-06-18	
J	Olson, DM; Thoyre, SM; Bennett, SN; Stoner, JB; Graffagnino, C				Olson, DaiWai M.; Thoyre, Suzanne M.; Bennett, Stacey N.; Stoner, Joanna B.; Graffagnino, Carmelo			EFFECT OF MECHANICAL CHEST PERCUSSION ON INTRACRANIAL PRESSURE: A PILOT STUDY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; PREVENTION; MANAGEMENT	Background Treatment of brain injury is often focused on minimizing intracranial pressure, which, when elevated, can lead to secondary brain injury. Chest percussion is a common practice used to treat and prevent pneumonia. Conflicting and limited anecdotal evidence indicates that physical stimulation increases intracranial pressure and should be avoided in patients at risk of intracranial hypertension. Objectives To explore the safety of performing chest percussion for patients at high risk for intracranial hypertension. Methods A total of 28 patients with at least 1 documented episode of intracranial hypertension who were having intracranial pressure monitored were studied in a prospective randomized control trial. Patients were randomly assigned to either the control group (no chest percussion) or the intervention group (10 minutes of chest percussion at noon). Intracranial pressure was recorded once a minute before, during, and after the intervention. Results Mean intracranial pressures for the control group before, during, and after the study period (14.4, 15.0, and 15.9 mm Hg, respectively) did not differ significantly from pressures in the intervention group (13.6, 13.7, and 14.2 mm Hg, respectively). Conclusions Mechanical chest percussion may be a safe intervention for nurses to use on neurologically injured patients who are at risk for intracranial hypertension. (American Journal of Critical Care. 2009; 18: 330-335)	[Olson, DaiWai M.; Bennett, Stacey N.; Stoner, Joanna B.; Graffagnino, Carmelo] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Thoyre, Suzanne M.] Univ N Carolina, Chapel Hill, NC USA	Olson, DM (corresponding author), Duke Univ, Med Ctr, Box 2900,Bryan Res Bldg, Durham, NC 27710 USA.	Olson006@mc.duke.edu		Olson, DaiWai/0000-0002-9280-078X	Interventions to Prevent and Manage Chronic Illness [T32 NR07091]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007091] Funding Source: NIH RePORTER	This research was supported by T32 NR07091 Interventions to Prevent and Manage Chronic Illness.	Arbour R, 1998, Crit Care Nurse, V18, P30; Bader M K, 2000, Crit Care Nurs Clin North Am, V12, P413; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Brain Injury Association of America, BRAIN INJ; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; Cody R. P., 2006, APPL STAT SAS PROGRA; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Grap Mary Jo, 2004, Crit Care Nurs Clin North Am, V16, P349, DOI 10.1016/j.ccell.2004.03.005; Greenberg MS, 2001, HDB NEUROSURGERY; HAMMON WE, 1993, CHEST, V103, P1409, DOI 10.1378/chest.103.5.1409; Kleinbaum D., 1998, APPL REGRESSION ANAL; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; MAHANES D, 2004, CRIT CARE NURS CLIN, V16, pR9; Mahanes Dea, 2004, Crit Care Nurs Clin North Am, V16, P387, DOI 10.1016/j.ccell.2004.03.007; March K, 2000, Crit Care Nurs Clin North Am, V12, P429; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marik PE, 2002, CRIT CARE MED, V30, P2146, DOI 10.1097/00003246-200209000-00035; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Munro BH, 2005, STAT METHODS HLTH CA; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; Olson DM, 2007, NEUROCRIT CARE, V6, P100, DOI 10.1007/s12028-007-0015-y; Quenot JP, 2007, CRIT CARE MED, V35, P2031, DOI 10.1097/01.ccm.0000282733.83089.4d; Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Wijdicks EFM, 1998, NEUROLOGY, V50, P11, DOI 10.1212/WNL.50.1.11; Wong F W, 2000, Crit Care Nurse, V20, P18; Yanko J R, 2001, Crit Care Nurs Q, V23, P1; Yilmazlar S, 2005, NEUROL RES, V27, P653, DOI 10.1179/016164105X35657; 2007, J NEUROTRAUMA S1, V24, pS45	31	13	15	0	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	JUL 1	2009	18	4					330	335		10.4037/ajcc2009523			6	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	465UW	WOS:000267614900006	19304565				2021-06-18	
J	Afinowi, R; Tisdall, M; Keir, G; Smith, M; Kitchen, N; Petzold, A				Afinowi, R.; Tisdall, M.; Keir, G.; Smith, M.; Kitchen, N.; Petzold, A.			Improving the recovery of S100B protein in cerebral microdialysis: Implications for multimodal monitoring in neurocritical care	JOURNAL OF NEUROSCIENCE METHODS			English	Article						S100B; Protein; Microdialysis; Brain injury; Intensive care; Monitoring	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; SERUM S100B; IN-VITRO; METHODOLOGY; PERFORMANCE; FUTURE	Introduction: Cerebral microdialysis is an established research too] that is used by an increasing number of neurocritical care units as a component of bedside multimodality monitoring. Body fluid biomarkers are an emerging tool for the assessment of brain injury. The correct interpretation of body fluid biomarker levels depends on the degree of recovery, i.e. relative recovery and the accuracy of the analytical technique. Methods: In vitro recovery experiments were performed on 100 mL volumes of cerebrospinal fluid and solutions of S100B, glucose, lactate and pyruvate comparing relative recoveries using commercially available 20 kDa (CMA70) and 100 kDa (CMA71) microdialysis catheters. We also compared the CMA 600 microdialysis analyzer with a YSI 2003 STAT Plus (TM) analyzer for glucose and lactate to determine its reliability. Results: Significantly, we demonstrate the improved recovery of the protein S100B using a larger molecular weight (MW) cut-off catheter (20 kDa range: 0.1-9%; 100 kDa range: 1.7-18.3%) while maintaining comparable performance for the conventional markers glucose, lactate and pyruvate. Additionally we found that the CMA 600 analyzer may be prone to overestimation of lactate readings at higher concentration with implications for clinical decision-making. Conclusion: Our data demonstrates that the 100 kDa MW cut-off catheter allows for the improved recovery of macromolecules in cerebral microdialysis research while maintaining the value of existing MD data for routine clinical use. (C) 2009 Published by Elsevier B.V.	[Afinowi, R.; Tisdall, M.; Keir, G.; Kitchen, N.] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London WC1N 3BG, England; [Afinowi, R.; Petzold, A.] UCL Inst Neurol, Dept Neuroimmunol, London WC1N 3BG, England; [Tisdall, M.; Smith, M.; Petzold, A.] Natl Hosp Neurol & Neurosurg, Dept Neuroanaesthesia, London WC1N 3BG, England	Afinowi, R (corresponding author), Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Box 31, London WC1N 3BG, England.	R.Afinowi@ion.ucl.ac.uk	Petzold, Axel/C-1090-2009; Smith, Martin/B-2616-2009	Petzold, Axel/0000-0002-0344-9749; Tisdall, Martin/0000-0001-8880-8386	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701458] Funding Source: Medline		Abrahamsson P, 2005, J PHARMACEUT BIOMED, V39, P730, DOI 10.1016/j.jpba.2005.04.036; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; *CMA MICR, 2004, 2 CMA MICR; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; GREEN AJ, 1999, BRAIN SPECIFIC PROTE; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; HILLMAN J, 2006, ACTA NEUROCHIR WIEN, V19, P19; Hutchinson PJ, 2006, NEUROCRIT CARE, V5, P202, DOI 10.1385/NCC:5:3:202; Hutchinson PJ, 2005, ACTA NEUROCHIR SUPPL, V95, P441; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; KEHR J, 1993, J NEUROSCI METH, V48, P251, DOI 10.1016/0165-0270(93)90096-A; Larsen FS, 2006, NEUROCRIT CARE, V5, P173, DOI 10.1385/NCC:5:3:173; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Maurer Martin H, 2003, Proteome Sci, V1, P7, DOI 10.1186/1477-5956-1-7; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosenbloom AJ, 2006, J IMMUNOL METHODS, V309, P55, DOI 10.1016/j.jim.2005.11.013; Rosenbloom AJ, 2005, J NEUROSCI METH, V148, P147, DOI 10.1016/j.jneumeth.2005.04.018; Sakowitz OW, 2002, ACT NEUR S, V81, P351; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; Sen J, 2005, ACTA NEUROCHIR, V147, P897, DOI 10.1007/s00701-005-0526-2; TISDALL MM, 2006, BRIT J ANAESTH, V12, P12; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Waelgaard L, 2006, SCAND J IMMUNOL, V64, P345, DOI 10.1111/j.1365-3083.2006.01826.x; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X	36	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUN 30	2009	181	1					95	99		10.1016/j.jneumeth.2009.02.021			5	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	463RT	WOS:000267450300013	19467712				2021-06-18	
J	Barklin, A; Tonnesen, E; Ingerslev, J; Sorensen, B; Fenger-Eriksen, C				Barklin, Anne; Tonnesen, Else; Ingerslev, Jorgen; Sorensen, Benny; Fenger-Eriksen, Christian			Coagulopathy during Induced Severe Intracranial Hypertension in a Porcine Donor Model	ANESTHESIOLOGY			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; BRAIN-DEATH; TISSUE FACTOR; HEAD-INJURY; INFLAMMATORY RESPONSE; PROFILES; PLASMA	Background: Development of coagulopathy is a serious complication arising from isolated traumatic brain injury, and it predicts poor outcome. The underlying mechanism has not yet been established, although coagulopathy arising from brain tissue injury and the release of tissue factor may represent the pathophysiology. The authors investigated dynamic whole-blood clot formation (ROTEM(R)) in a recently developed porcine model of induced severe intracranial hypertension. Methods: In this prospective, randomized experimental study, 17 pigs were designated for severe intracranial hypertension or sham operation. Intracranial hypertension was induced by inflation of an intracranial balloon. Whole-blood clot formation was assessed by clot initiation, and clot propagation and clot strength through thrombelastometry. The authors also assessed thrombin generation and prothrombin time, which were obtained at baseline, immediately after intervention, and 5 h after intervention. Results: A dramatic shortening in time to clot initiation and an increase in clot propagation were observed after induction of intracranial hypertension as compared to the control group. These results were further substantiated by a pronounced increase in thrombin generation and a significantly shortened prothrombin time in the intervention group. No difference in clot strength was detected between the groups. Conclusions: In a porcine model, induction of increased intracranial pressure causing severe intracranial hypertension was associated with a pronounced activation of the coagulation system. Taken together, the various results indicate that tissue factor probably represents the main trigger of hypercoagulopathy found in these pigs.	[Fenger-Eriksen, Christian] Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Anesthesiol, DK-8200 Aarhus N, Denmark; [Fenger-Eriksen, Christian] Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Anesthesiol, Skejby, Denmark; [Ingerslev, Jorgen; Sorensen, Benny; Fenger-Eriksen, Christian] Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Clin Biochem, Skejby, Denmark; [Sorensen, Benny] Guys & St Thomas Hosp, Ctr Haemostasis & Thrombosis, London SE1 9RT, England	Fenger-Eriksen, C (corresponding author), Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Anesthesiol, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	chfen@dadlnet.dk		Fenger-Eriksen, Christian/0000-0003-0536-560X	Aarhus University [100301]; Faculty of Health Science, Institute of Clinical Medicine, Denmark	Received from the Department of Anesthesiology, Aarhus University Hospital, Aarhus, Denmark. Submitted for publication October 7, 2008. Accepted for publication January 28, 2009, Supported by all Unrestricted grant (project number 100301) from Aarhus University, Faculty of Health Science, Institute of Clinical Medicine, Denmark.	Barklin A, 2008, ACTA ANAESTH SCAND, V52, P628, DOI 10.1111/j.1399-6576.2008.01606.x; Barklin A, 2008, ACTA ANAESTH SCAND, V52, P621, DOI 10.1111/j.1399-6576.2008.01607.x; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; Clark R, 1997, VET ECON, V38, P41; Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028; Fenger-Eriksen C, 2005, BRIT J ANAESTH, V94, P324, DOI 10.1093/bja/aei052; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kozek-Langenecker SA, 2005, ANESTHESIOLOGY, V103, P654, DOI 10.1097/00000542-200509000-00031; Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19; Larsen OH, 2007, ANN HEMATOL, V86, P217, DOI 10.1007/s00277-006-0223-0; Lwaleed BA, 2007, BIOL RES NURS, V9, P97, DOI 10.1177/1099800407305733; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; O'Donnell J, 2004, BLOOD COAGUL FIBRIN, V15, P207, DOI 10.1097/00001721-200404000-00002; Papa M. L., 2007, Experimental Oncology, V29, P111; Pasternak JJ, 2008, J NEUROSURG ANESTH, V20, P15, DOI 10.1097/ANA.0b013e318155b1c4; PFENNINGER J, 1982, Z KINDERCHIR, V37, P53; Poulsen LH, 2006, SCAND J CLIN LAB INV, V66, P329, DOI 10.1080/00365510600672783; Pratschke J, 2005, TRANSPLANT INT, V18, P15, DOI 10.1111/j.1432-2277.2004.00018.x; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Roelsgaard K, 1996, HEPATOLOGY, V24, P871; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Sorensen B, 2005, HAEMOPHILIA, V11, P1, DOI 10.1111/j.1365-2516.2005.01156.x; Sorensen B, 2004, SEMIN HEMATOL, V41, P140, DOI 10.1053/j.seminhematol.2003.11.024; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003	31	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JUN	2009	110	6					1287	1292		10.1097/ALN.0b013e3181a10352			6	Anesthesiology	Anesthesiology	450ET	WOS:000266384500015	19417611	Bronze			2021-06-18	
J	Rhodes, J; Sharke, J; Andrews, P; Stahel, PF; Flierl, MA; Smith, WR				Rhodes, Jonathan; Sharke, John; Andrews, Peter; Stahel, Philip F.; Flierl, Michael A.; Smith, Wade R.			Serum IL-8 and MCP-1 Concentration Do Not Identify Patients With Enlarging Contusions After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cerebral contusion; IL-8; MCP-1; Outcome; TBI	CLOSED-HEAD INJURY; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; RAT-BRAIN; INFLAMMATORY RESPONSE; INTERLEUKIN-8; CHEMOKINES; DAMAGE; PLASMA; ACCUMULATION	Background. Cerebral contusions contain numerous leukocytes, and a temporal relationship exists among cerebral chemokine expression, leukocyte recruitment, and contusion enlargement. This would suggest a role for chemokines in contusion development However, it has not been established if serum concentrations of chemokines such as interleukin-8 (IL-8) or monocyte chemoattractant protein-1 (MCP-1) change with contusion enlargement. Methods. Eighteen adult patients with severe contusional traumatic brain injury, on computerized tomography, were identired. Patients with diffuse injuries or extradural and subdural hematomas associated with mass effect were not included in the study. Daily serum samples were taken for the measurement of EL-8 and MCP-I concentrations for up to 11 days postinjury. Results. In the patients who died while in intensive care, IL-8 and MCP-1 were significantly greater than in those patients discharged (18 [0-202] vs. 0 [0-156] pg/mL and 498 [339-1,063] vs. 368 [86-11,289] pg/mL for IL-8 and MCP-I, respectively). No difference was seen in serum chemokine levels in patients who deteriorated with contusion enlargement compared with those that did not. The IL-8 and MCP-1 concentrations did not change significantly over time either in the group as a whole or in the subgroup of patients who deteriorated. Conclusions: These inflammatory mediators may be predictive of a poor outcome in patients with traumatic brain injury in which contusions are the predominant abnormality. However, they do not distinguish those patients who will deteriorate because of contusion enlargement.	[Rhodes, Jonathan] Univ Edinburgh, Intens Care Unit, Western Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Sharke, John] Univ Dundee, Ninewells Hosp & Med Sch, Sch Life & Sci Res, Dundee DD1 9SY, Scotland; [Stahel, Philip F.; Flierl, Michael A.; Smith, Wade R.] Univ Colorado, Sch Med, Dept Orthopaed Surg, Denver Hlth Med Ctr, Denver, CO USA	Rhodes, J (corresponding author), Univ Edinburgh, Intens Care Unit, Western Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	j.k.j.rhodes@sms.ed.ac.uk		Sharkey, John/0000-0001-8288-1857			Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Castellanos M, 2002, STROKE, V33, P982, DOI 10.1161/hs0402.105339; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CSUKA E, 1997, SHOCK S, V8, P6; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; FREVERT CW, 1995, INFLAMMATION, V19, P133, DOI 10.1007/BF01534386; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Losy J, 2001, STROKE, V32, P2695, DOI 10.1161/hs1101.097380; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; Muller M, 2001, Eur J Ultrasound, V12, P203, DOI 10.1016/S0929-8266(00)00118-X; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Soares HD, 1995, J NEUROSCI, V15, P8223; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	35	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2009	66	6					1591	1598		10.1097/TA.0b013e31819a0344			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	457PN	WOS:000266944500012	19509619				2021-06-18	
J	Bahloul, M; Ben Hamida, C; Chelly, H; Chaari, A; Kallel, H; Dammak, H; Rekik, N; Bahloul, K; Ben Mahfoudh, K; Hachicha, M; Bouaziz, M				Bahloul, Mabrouk; Ben Hamida, Chokri; Chelly, Hedi; Chaari, Adel; Kallel, Hatem; Dammak, Hassen; Rekik, Noureddine; Bahloul, Kamel; Ben Mahfoudh, Kheireddine; Hachicha, Mongia; Bouaziz, Mounir			Severe head injury among children: Prognostic factors and outcome	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Acute head injury; Children; Intensive care unit; Motor vehicle accident	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; PEDIATRIC TRAUMA; INTENSIVE-CARE; SCORE; PREDICTORS; SCALE; CLASSIFICATION; HYPERGLYCEMIA; DEFINITIONS	Aim: To determine predictive factors of mortality among children after traumatic brain injury. Methods: A retrospective study over 8 years of 222 children with severe head injury (Glasgow Coma Scale score <= 8) admitted to a university hospital (Sfax, Tunisia). Basic demographic, clinical, biological and radiological data were recorded on admission and during intensive care unit stay. Results: The study included 163 boys (73.4%) and 59 girls, with mean age 7.54 +/- 3.8 years. The main cause of trauma was road traffic accident (75.7%). Mean Glasgow Coma Scale score was 6 +/- 1.5, mean Injury Severity Score (ISS) was 28.2 +/- 6.9, mean Paediatric Trauma Score (PTS) was 3.7 +/- 2.1 and mean Paediatric Risk of Mortality (PRISM) was 14.3 +/- 8.5; 54 children (24.3%) died. Univariate analysis showed that low PTS on admission, high ISS or PRISM, presence of shock or meningeal haemorrhage or bilateral mydriasis, and serum glucose > 10 mmol l(-1) were associated with mortality rate. Multivariate analysis showed that factors associated with a poor prognosis were PRISM > 20 and bilateral mydriasis on admission. Conclusions: In Tunisia, head injury is a frequent cause of hospital admission and is most often due to road traffic accidents. Short-term prognosis is poor, with a high mortality rate (24.3%), and is influenced by demographic, clinical, radiological and biological factors. (C) 2008 Elsevier Ltd. All rights reserved.	[Bahloul, Mabrouk; Ben Hamida, Chokri; Chelly, Hedi; Chaari, Adel; Kallel, Hatem; Dammak, Hassen; Rekik, Noureddine; Bouaziz, Mounir] Habib Bourguiba Univ Hosp, Dept Intens Care, Sfax, Tunisia; [Bahloul, Kamel] Habib Bourguiba Univ Hosp, Dept Neurosurg, Sfax, Tunisia; [Ben Mahfoudh, Kheireddine] Habib Bourguiba Univ Hosp, Dept Radiol, Sfax, Tunisia; [Hachicha, Mongia] Hedi Chaker Univ Hosp, Dept Paediat, Sfax, Tunisia	Bahloul, M (corresponding author), Hop Habib Bourguiba, Serv Reanimat Med, Route Ain Km 1, Sfax 3029, Tunisia.	bahloulmab@yahoo.fr	Solebo, Colette N/B-6615-2008	Solebo, Colette N/0000-0001-9764-2541; Bahloul, Mabrouk/0000-0002-6488-8294			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Castello FV, 1999, CRIT CARE MED, V27, P985, DOI 10.1097/00003246-199905000-00041; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FUKUDAT T, 1996, SHINKEI GEKA, V24, P723; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Granry JC, 2002, ANN FR ANESTH, V21, P148, DOI 10.1016/S0750-7658(01)00521-4; GREGER NG, 1986, AM J DIS CHILD, V140, P551, DOI 10.1001/archpedi.1986.02140200061028; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hill DA, 1997, J TRAUMA, V42, P62, DOI 10.1097/00005373-199701000-00011; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JAMSHID G, 2000, LANCET, V356, P923; JENNETT B, 1975, LANCET, V1, P480; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Kumaraswamy N, 2002, J CLIN NEUROSCI, V9, P251, DOI 10.1054/jocn.2001.1047; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARQUETTE CH, 1993, AM REV RESPIR DIS, V148, P138, DOI 10.1164/ajrccm/148.1.138; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SIMPSON D, 1982, LANCET, V2, P450; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; *US DEP HHS, 1994, AHCPR PUBL, P12; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	51	13	14	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2009	40	5					535	540		10.1016/j.injury.2008.04.018			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	450UV	WOS:000266427500013	18703191				2021-06-18	
J	Chen, YF; Tzeng, IH; Li, YH; Lo, YC; Lin, WC; Chiang, HJ; Chen, RF; Shen, WC				Chen, Yung-Fang; Tzeng, Iuan-Hong; Li, Ying-Hsuan; Lo, Yu-Chien; Lin, Wei-Ching; Chiang, Hsein-Jar; Chen, Ruey-Fen; Shen, Wu-Chung			Transcatheter Arterial Embolization in the Treatment of Maxillofacial Trauma Induced Life-Threatening Hemorrhages	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Maxillofacial trauma; Hemorrhage; Transcatheter arterial embolization; Facial fractures; Le Fort fractures	THERAPEUTIC EMBOLIZATION; INTRACTABLE EPISTAXIS	Background: Life-threatening hemorrhages with hemodynamic instability are uncommon in patients with sustained maxillofacial trauma, but when they occur, require immediate surgical intervention if conservative treatment fails. This study assessed the effects of transcatheter arterial embolization (TAE) in the treatment of maxillofacial trauma-induced life-threatening hemorrhages. Methods: From January 2004 to January 2007, eight ambulatory patients admitted for maxillofacial injuries with life-threatening hemorrhaging and hemodynamic instability (systolic blood pressure <= 90 mm Hg) caused primarily by intractable oronasal bleeding who subsequently underwent TAE were included in this study. Results: Maxillofacial trauma was caused by motorcycle traffic injuries (6 cases), motor vehicle injury (1 case), and fall injury (1 case). All patients exhibited documented Le Fort III fractures. The average Glasgow Coma Scale score was 4.7. TAE was successfully performed and hemorrhaging arrested in all patients. Three deaths occurred (38%) from severe traumatic brain injury. The other five patients (62%) survived without development of systemic or neurologic complications post-TAE. Conclusions: Conservative treatment consisting of packing of the nares, compression, and blood transfusion should always precede TAE as the primary protocol. When conservative treatment fails, as shown either by the need for continued blood product replacement exceeding 1,500 mL and a systolic blood pressure <= 90 mm Hg, TAE intervention should immediately be considered as an alternative recourse before other surgical interventions.	[Chen, Yung-Fang; Tzeng, Iuan-Hong; Li, Ying-Hsuan; Lo, Yu-Chien; Lin, Wei-Ching; Chen, Ruey-Fen; Shen, Wu-Chung] China Med Univ Hosp, Dept Radiol, Taichung 40447, Taiwan; [Chiang, Hsein-Jar] Nantou Christian Hosp, Dept Radiol, Nantou, Taiwan	Chen, YF (corresponding author), China Med Univ Hosp, Dept Radiol, Yue Deh Rd 2, Taichung 40447, Taiwan.	cyfmagic@yahoo.com.tw					Bynoe RP, 2003, J TRAUMA, V55, P74, DOI 10.1097/01.TA.0000026494.22774.A0; ELAHI MM, 1995, ARCH OTOLARYNGOL, V121, P65; Hagiwara A, 2004, J TRAUMA, V57, P271, DOI 10.1097/01.TA.0000131198.79153.3C; KENDALL B, 1977, J NEUROL NEUROSUR PS, V40, P937, DOI 10.1136/jnnp.40.10.937; Komiyama M, 1998, J TRAUMA, V44, P330, DOI 10.1097/00005373-199802000-00017; Smith TP, 2006, J VASC INTERV RADIOL, V17, P1897, DOI 10.1097/01.RVI.0000247301.64269.27; SOKOLOFF J, 1974, RADIOLOGY, V111, P285, DOI 10.1148/111.2.285; STRUTZ J, 1990, ARCH OTOLARYNGOL, V116, P697	8	13	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2009	66	5					1425	1430		10.1097/TA.0b013e3181842046			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	445AJ	WOS:000266021700030	19430249				2021-06-18	
J	Staal, JA; Dickson, TC; Chung, RS; Vickers, JC				Staal, Jerome A.; Dickson, Tracey C.; Chung, Roger S.; Vickers, James C.			Disruption of the Ubiquitin Proteasome System following Axonal Stretch Injury Accelerates Progression to Secondary Axotomy	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; axonal swellings; cytoskeleton; lactacystin; MG132; neurofilament; ubiquitin	TRAUMATIC BRAIN-INJURY; SPINAL-CORD TRAUMA; WALLERIAN DEGENERATION; IN-VITRO; NEURODEGENERATIVE DISEASES; ISCHEMIC TOLERANCE; CEREBRAL-CORTEX; LACTACYSTIN; EXPRESSION; PROTEIN	The ubiquitin proteasome system (UPS) plays a vital role in the regulation of protein degradation. Ubiquitination of proteins has been implicated in the pathological cascade associated with neuronal degeneration in both neurodegenerative disease and following acquired central nervous system (CNS) injury. In the present study, we have investigated the role of the UPS following mild to moderate in vitro axonal stretch injury to mature primary cortical neurons, a model of the evolving axonal pathology characteristic of diffuse axonal injury following brain trauma. Transient axonal stretch injury in this model does not involve primary axotomy. However, delayed accumulation of ubiquitin in neuritic swellings at 48 h post-injury (PI) was present in axonal bundles, followed by approximately 60% of axonal bundles progressing to secondary axotomy at 72 h PI. This delayed accumulation of ubiquitin was temporally and spatially associated with cytoskeletal damage. Pharmacological inhibition of the UPS with both MG132 and lactacystin prior to axonal injury resulted in a significant (p < 0.05) increase in the number of axonal bundles progressing to secondary axotomy at 48 and 72 h PI. These results demonstrate that, following mild to moderate transient axonal stretch injury, UPS activity may assist structural reorganization within axons, potentially impeding secondary axotomy. Protein ubiquitination in the axon may therefore have a protective role relative to the diffuse axonal changes that follow traumatic brain injury.	[Staal, Jerome A.; Dickson, Tracey C.; Chung, Roger S.; Vickers, James C.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas 7001, Australia	Vickers, JC (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Bag 29, Hobart, Tas 7001, Australia.	James.Vickers@utas.edu.au	Chung, Roger/ABF-8395-2020; Vickers, James C/J-7464-2014	Vickers, James C/0000-0001-5671-4879; Chung, Roger/0000-0002-9286-947X; Dickson, Tracey/0000-0002-9196-1661	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Royal Hobart Hospital Research Foundation; Tasmanian Masonic Centenary Medical Research Foundation	This research was supported by the National Health and Medical Research Council; the Royal Hobart Hospital Research Foundation; and the Tasmanian Masonic Centenary Medical Research Foundation ( fellowship to Dr. Jerome Andrew Staal).	Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; BIZZI A, 1991, BRAIN RES, V548, P292, DOI 10.1016/0006-8993(91)91135-N; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Du YL, 2008, EXP BIOL MED, V233, P881, DOI 10.3181/0712-RM-329; Ehlers MD, 2004, TRENDS NEUROSCI, V27, P3, DOI 10.1016/j.tins.2003.10.015; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Korhonen L, 2004, J CELL BIOL, V165, P27, DOI 10.1083/jcb.200311091; Li GL, 1996, ACTA NEUROPATHOL, V91, P155, DOI 10.1007/s004010050407; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; MARTIN JE, 1990, BRAIN, V113, P1553, DOI 10.1093/brain/113.5.1553; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pan TH, 2008, BRAIN RES, V1222, P222, DOI 10.1016/j.brainres.2008.05.022; Peng ZF, 2008, NITRIC OXIDE-BIOL CH, V18, P136, DOI 10.1016/j.niox.2007.11.002; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Yew EHJ, 2005, J NEUROCHEM, V94, P943, DOI 10.1111/j.1471-4159.2005.03220.x; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang PY, 2008, ACTA PHYS-CHIM SIN, V24, P143, DOI 10.3866/PKU.WHXB20080125; Zhu W, 2008, J NEUROCHEM, V105, P1970, DOI 10.1111/j.1471-4159.2008.05330.x	45	13	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2009	26	5					781	788		10.1089/neu.2008.0669			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	452XM	WOS:000266574500012	19416018				2021-06-18	
J	Tingberg, B; Falk, AC; Flodmark, O; Ygge, BM				Tingberg, Bjorn; Falk, Ann-Charlotte; Flodmark, Olof; Ygge, Britt-Marie			Evaluation of documentation in potential abusive head injury of infants in a Paediatric Emergency Department	ACTA PAEDIATRICA			English	Article						Abusive head injury; Child abuse; Shaken baby syndrome	TRAUMATIC BRAIN-INJURY; SHAKEN IMPACT SYNDROME; YOUNG-CHILDREN; BABY SYNDROME; VICTIMS	Aim: The aim is to evaluate medical record documentation regarding potential abusive head injury (AHI) in infants presenting to a Paediatric Emergency Department (ED) with certain primary complaints known to be associated with AHI. Methods: A database search was performed to find all medical records over a period of one year relating to those children who had one AHI-related primary complaint and who had had a CT head-scan performed in conjunction with admission. Each medical record was reviewed, in order to assess whether potential abuse had been investigated and documented. Each CT-scan image was re-evaluated for missed indications of potential injuries attributable to AHI. Results: Forty-seven such medical records were found. Of these, 87% showed the diagnosis to be head injuries. The largest group of children was in the age group 0-3 months (38%). Of the children admitted to the Paediatric ED due to a head injury, 54% had a history deemed to raise suspicions of abuse but only five of them had had a documented investigation of child abuse. The re-evaluation of the CT-scans showed no missed cases. Conclusion: In this study we found that among children with known risk factors for AHI, only a few had documentation regarding potential child abuse. The use of a standardized protocol could be helpful in the important work to help staff discover potential AHI.	[Tingberg, Bjorn] Astrid Lindgren Childrens Hosp, MIO Grp, Child Protect Team, Karolinska Inst,Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Falk, Ann-Charlotte] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Flodmark, Olof] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden	Tingberg, B (corresponding author), Astrid Lindgren Childrens Hosp, MIO Grp, Child Protect Team, Karolinska Inst,Dept Woman & Child Hlth, S-17176 Stockholm, Sweden.	bjorn.tingberg@karolinska.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894	Stockholm County CouncilStockholm County Council; Karolinska InstituteKarolinska Institutet; SAllskapet Barnavard	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institute, and SAllskapet Barnavard. The authors are grateful to Doris Tomlinson for her language assistance.	Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Chiocca E, 1998, Nursing, V28, P33; Chiocca E M, 1995, Pediatr Nurs, V21, P33; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; FLODMARK O, 2002, VARD, V1, P23; Fulton D R, 2000, Crit Care Nurs Q, V23, P43; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Lewis Kristine, 2002, Pediatr Nurs, V28, P508; Minns RA, 2005, SHAKING OTHER NONACC; Munro E, 1999, CHILD ABUSE NEGLECT, V23, P745, DOI 10.1016/S0145-2134(99)00053-8; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; *SOC, 2001, CHILD AB PREV PROT, P72; *SOC, 2004, STAT AVS VALD MOT BA; STARLING SP, 1995, PEDIATRICS, V95, P259; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Wallis W H, 2000, Crit Care Nurs Clin North Am, V12, P489	25	13	13	0	6	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.	MAY	2009	98	5					777	781		10.1111/j.1651-2227.2009.01241.x			5	Pediatrics	Pediatrics	428UY	WOS:000264878100005	19389121				2021-06-18	
J	Lahoud-Rahme, MS; Stezoski, J; Kochanek, PM; Melick, J; Tisherman, SA; Drabek, T				Lahoud-Rahme, Manuella S.; Stezoski, Jason; Kochanek, Patrick M.; Melick, John; Tisherman, Samuel A.; Drabek, Tomas			Blood-brain barrier integrity in a rat model of emergency preservation and resuscitation	RESUSCITATION			English	Article						Cardiopulmonary bypass; Deep hypothermic circulatory arrest; Cardiac arrest; Traumatic brain injury; Hemorrhage	PROLONGED CARDIAC-ARREST; HYPOTHERMIC CIRCULATORY ARREST; CARDIOPULMONARY BYPASS; DELAYED RESUSCITATION; SUSPENDED ANIMATION; PERMEABILITY; INJURY; ACCUMULATION; DYSFUNCTION; EXPRESSION	Emergency Preservation and Resuscitation (EPR) represents a novel approach to treat exsanguination cardiac arrest (CA) Victims, using an aortic flush to induce hypothermia during circulatory arrest, followed by delayed resuscitation with cardiopulmonary bypass (CPB). The status of the blood-brain barrier (BBB) integrity after prolonged hypothermic CA is unclear. The objective of this study was to assess BBB permeability in two EPR models in rats, associated with poor outcome. Rats subjected to traumatic brain injury (TBI) and naive rats served as positive and negative controls, respectively. Hypothesis: The BBB will be disrupted after TBI, but intact after prolonged hypothermic CA. Methods: Four groups were studied: (1) EPR-IC (ice cold)-75 min CA at 15 degrees C; (2) EPR-RT (room temperature)-20 min CA at 28 degrees C; (3) TBI; (4) sham. Rats in EPR groups were subjected to rapid hemorrhage, followed by CA. Rats in the TBI group had a controlled cortical impact to the left hemisphere. Naives were subjected to the same anesthesia and surgery. I h after insult, rats were injected with Evans Blue (EB), a marker of BBB permeability for albumin. Rats were sacrificed after 5 h and EB absorbance was quantified in brain samples. Results: TBI produced an approximately 10-fold increase in EB absorbance in the left (injured) hemisphere vs. left hemisphere for all other groups (p = 0.001). In contrast, EB absorbance in either EPR group did not differ from sham. Conclusion: BBB integrity to albumin is not disrupted early after resuscitation from prolonged CA treated with EPR. Neuroprotective adjuncts to hypothermia in this setting should focus on agents that penetrate the BBB. These findings also have implications for deep hypothermic circulatory arrest. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Lahoud-Rahme, Manuella S.; Stezoski, Jason; Kochanek, Patrick M.; Melick, John; Tisherman, Samuel A.; Drabek, Tomas] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Lahoud-Rahme, Manuella S.; Kochanek, Patrick M.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Drabek, Tomas] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Stezoski, Jason; Kochanek, Patrick M.; Melick, John; Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA	Drabek, T (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	tomasdrabek@hotmail.com	Kochanek, Patrick M/D-2371-2015; Drabek, Tomas/AAJ-1595-2021; Tisherman, Samuel A./AAK-9377-2020	Kochanek, Patrick M/0000-0002-2627-913X; Drabek, Tomas/0000-0002-5702-4498; Tisherman, Samuel A./0000-0003-3810-3729	Department of Anesthesiology, University of PittsburghUniversity of Pittsburgh; Laerdal Foundation for Acute Medicine; Society of Cardiovascular Anesthesiologists; American Heart AssociationAmerican Heart Association	This work was supported by a Seed Grant from the Department of Anesthesiology, University of Pittsburgh (TD), the Laerdal Foundation for Acute Medicine (TD), and the Society of Cardiovascular Anesthesiologists (TD). This paper was presented at the 2008 Fellows Research Day of the American Heart Association, Pennsylvania-Delaware Affiliate on February 22, 2008. Based on the abstract of this work, Dr. Manuella-Lahoud Rahme received a Young Investigator Award at the 6th Resuscitation Science Symposium, organized by the American Heart Association in New Orleans in November 2008.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; ARAI T, 1981, CRIT CARE MED, V9, P444; Behringer W, 2002, J CEREBR BLOOD F MET, V22, P105, DOI 10.1097/00004647-200201000-00013; Bellamy R, 1996, CRIT CARE MED, V24, pS24; BEUKE L, 2008, ANESTH ANALG, pSCA39; BREGMAN D, 1980, AM J CARDIOL, V46, P261, DOI 10.1016/0002-9149(80)90067-3; Cavaglia M, 2004, ANN THORAC SURG, V78, P1418, DOI 10.1016/j.athoracsur.2004.04.036; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; DOBBIN J, 1989, J CEREBR BLOOD F MET, V9, P71, DOI 10.1038/jcbfm.1989.10; Drabeck T, 2007, CRIT CARE MED, V35, pA91; DRABEK T, 2007, ANESTHESIOLOGY, V107, pA1574; Drabek T, 2007, RESUSCITATION, V75, P114, DOI 10.1016/j.resuscitation.2007.03.012; GILLINOV AM, 1992, J THORAC CARDIOV SUR, V104, P1110; GRIFFIN MP, 1990, CIRC SHOCK, V31, P343; Han F, 2008, RESUSCITATION, V79, P301, DOI 10.1016/j.resuscitation.2008.06.004; HARRIS DN, 1993, LANCET, V342, P586, DOI 10.1016/0140-6736(93)91412-F; Harris DNF, 1998, ANESTHESIOLOGY, V88, P340, DOI 10.1097/00000542-199802000-00011; Kapuscinski A, 1996, FOLIA NEUROPATHOL, V34, P72; KAPUSCINSKI A, 1995, FOLIA NEUROPATHOL, V33, P1; Kozler P, 2003, PHYSIOL RES, V52, P607; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; Laursen H, 1989, Eur J Cardiothorac Surg, V3, P539, DOI 10.1016/1010-7940(89)90115-2; LAURSEN H, 1986, SCAND J THORAC CARD, V20, P161, DOI 10.3109/14017438609106495; Leach L, 2002, J ANAT, V200, P539, DOI 10.1046/j.1469-7580.2002.00067.x; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P483; Mazzini GS, 2005, LIFE SCI, V77, P882, DOI 10.1016/j.lfs.2004.12.035; MEYER J, 1993, CRIT CARE MED, V21, P84, DOI 10.1097/00003246-199301000-00017; Mizushima H, 1999, LIFE SCI, V65, P2127, DOI 10.1016/S0024-3205(99)00477-4; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Pluta R, 2003, ACT NEUR S, V86, P117; Pokela M, 2000, SCAND CARDIOVASC J, V34, P570; PONT F, 1995, NEUROSCI LETT, V184, P52, DOI 10.1016/0304-3940(94)11166-G; ROGERS FB, 1993, J TRAUMA, V34, P142, DOI 10.1097/00005373-199301000-00027; Safar P, 2000, CRIT CARE MED, V28, pN214, DOI 10.1097/00003246-200011001-00012; Safar Peter J, 2002, Curr Opin Anaesthesiol, V15, P203, DOI 10.1097/00001503-200204000-00010; SCHLEIEN CL, 1990, STROKE, V21, P1185, DOI 10.1161/01.STR.21.8.1185; SCHLEIEN CL, 1991, STROKE, V22, P477, DOI 10.1161/01.STR.22.4.477; Statler KD, 2003, CRIT CARE MED, V31, P1134, DOI 10.1097/01.CCM.0000054864.43122.52; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Suzuki T, 2005, CRIT CARE MED, V33, P2294, DOI 10.1097/01.CCM.0000182796.11329.3B; WAABEN J, 1994, EUR J CARDIO-THORAC, V8, P91, DOI 10.1016/1010-7940(94)90099-X; WAABEN J, 1994, J THORAC CARDIOV SUR, V107, P1030, DOI 10.1016/S0022-5223(94)70377-9; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204	47	13	14	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2009	80	4					484	488		10.1016/j.resuscitation.2009.01.007			5	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	429UZ	WOS:000264946900018	19203824				2021-06-18	
J	Wang, SM; Tsai, HP; Huang, JJ; Huang, HC; Lin, JL; Liu, PH				Wang, Shang-Ming; Tsai, Hui-Ping; Huang, Jiun-Jen; Huang, Hsuan-Chi; Lin, Jia-Li; Liu, Pei-Hsin			Inhibition of nitric oxide synthase promotes facial axonal regeneration following neurorrhaphy	EXPERIMENTAL NEUROLOGY			English	Article						Axotomy; Facial motoneuron; NO; NOS; Oxidative stress; Electromyography; Peripheral nerve repair; Axonal regeneration; NOS inhibitor; Neuromuscular junction	TRAUMATIC BRAIN-INJURY; SPINAL ROOT AVULSION; MICROTUBULE-ASSOCIATED PROTEIN-2; IN-VITRO; ENDOTHELIAL-CELLS; OXIDATIVE DAMAGE; MOTONEURON DEATH; MOUSE MODEL; ADULT RATS; NERVE	Reconnection of interrupted peripheral nerve by microsurgical suture is a common clinical practice. However, the extent to which peripheral neurorrhaphy improves nerve regeneration and functional recovery remains unsatisfactory. Here, we used anatomical and electrophysiological techniques to investigate the temporal correlation between the expressions of oxidative stress-related biomarkers such as neuronal nitric oxide synthase (nNOS) and the facial axonal regeneration after an immediate facial nerve repair in adult rats since peripheral nerve lesion is well known to induce a dramatic increase of NOS expression in the affected neuronal cell bodies. We found that compared to nerve cut without suture, facial nerve repair not only caused the facial axonal regeneration but also consistently prevented the fluctuations of expressions of oxidative stress-related biomakers in 10 weeks postlesion. To further elucidate the role of nitric oxide (NO) in the axonal degeneration/regeneration, four different NOS inhibitors were applied to additional rats after facial nerve Cut or repair. Both of facial nerve cut + NOS inhibition and facial nerve repair + NOS inhibition were seen to prevent the alterations of expressions of the biomakers, no matter which NOS inhibitor was used. Moreover, we found that facial nerve repair + NOS inhibition promoted earlier and better axonal regeneration than facial nerve repair, demonstrated by labeling of neuromuscular junctions, retrograde tracing, and electromyography. These results provide direct evidence that peripheral nerve Suture and/or treatment of NOS inhibitors can maintain the homeostasis of oxidative stress-related biomarkers, especially nNOS in neuronal cell bodies. These actions may thus facilitate the axonal regeneration. (C) 2009 Elsevier Inc. All rights reserved.	[Huang, Hsuan-Chi; Liu, Pei-Hsin] Tzu Chi Univ, Inst Physiol & Anat Med, Hualien 97004, Taiwan; [Wang, Shang-Ming; Tsai, Hui-Ping; Huang, Jiun-Jen; Lin, Jia-Li] Tzu Chi Univ, Inst Neurosci, Hualien, Taiwan	Liu, PH (corresponding author), Tzu Chi Univ, Inst Physiol & Anat Med, 701,Sect 3,Chung Yang Rd, Hualien 97004, Taiwan.	peihsin@mail.tcu.edu.tw		Liu, Pei-Hsin/0000-0002-1398-7006	Tzu Chi University [TCMRC94017]	The study was supported by research grants from the Tzu Chi University to Pei-Hsin Liu (TCMRC94017).	Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Cappelletti G, 2004, FEBS LETT, V562, P35, DOI 10.1016/S0014-5793(04)00173-5; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Frankfurt OS, 1996, EXP CELL RES, V226, P387, DOI 10.1006/excr.1996.0240; FU SY, 1995, J NEUROSCI, V15, P3876; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; Garthwaite G, 2002, NEUROSCIENCE, V109, P145, DOI 10.1016/S0306-4522(01)00447-X; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GuntinasLichius O, 1997, J COMP NEUROL, V387, P234, DOI 10.1002/(SICI)1096-9861(19971020)387:2<234::AID-CNE5>3.0.CO;2-1; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; He Y, 2002, J NEUROSCI, V22, P5982; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; Landino LM, 2007, CHEM RES TOXICOL, V20, P1693, DOI 10.1021/tx7001492; Landino LM, 2004, J BIOL CHEM, V279, P35101, DOI 10.1074/jbc.M405471200; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu PH, 2006, J NEUROTRAUM, V23, P1857, DOI 10.1089/neu.2006.23.1857; Liu PH, 2004, ANAT EMBRYOL, V207, P439, DOI 10.1007/s00429-003-0361-2; Marino J, 2003, J NEUROSCI, V23, P4299; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; NATHAN C, 1992, FASEB J, V6, P3051; Obal I, 2006, J COMP NEUROL, V499, P17, DOI 10.1002/cne.21041; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Raivich G, 1998, J NEUROSCI, V18, P5804; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Rothe F, 2002, NITRIC OXIDE-BIOL CH, V6, P9, DOI 10.1006/niox.2001.0390; RUAN RS, 1995, BRAIN RES, V698, P163, DOI 10.1016/0006-8993(95)00887-V; Shrager P, 1998, J NEUROPHYSIOL, V79, P529; Stenger S, 1995, EUR J PHARMACOL, V294, P703, DOI 10.1016/0014-2999(95)00618-4; Stoll G, 1999, BRAIN PATHOL, V9, P313; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; Varathan V, 2001, J NEUROSCI RES, V66, P428, DOI 10.1002/jnr.1235; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wu WT, 2004, J NEUROTRAUM, V21, P1050, DOI 10.1089/0897715041651006; Wu WT, 2003, J NEUROTRAUM, V20, P603, DOI 10.1089/089771503767168528; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; ZEMBOWICZ A, 1991, P NATL ACAD SCI USA, V88, P11172, DOI 10.1073/pnas.88.24.11172	51	13	16	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2009	216	2					499	510		10.1016/j.expneurol.2009.01.006			12	Neurosciences	Neurosciences & Neurology	424ZK	WOS:000264606600032	19320008				2021-06-18	
J	Bailey, CM; Barth, JT; Bender, SD				Bailey, Christopher M.; Barth, Jeffrey T.; Bender, Scott D.			SLAM on the Stand: How the Sports-Related Concussion Literature Can Inform the Expert Witness	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; forensic neuropsychology; sports	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; HIGH-SCHOOL; POSTCONCUSSION-SYNDROME; ACCIDENT NEUROSIS; FOOTBALL PLAYERS; SYMPTOM REPORT; CHRONIC PAIN; RECOVERY; PERFORMANCE	Mild head injury is a controversial topic because patients may have subtle deficits and widely varied outcomes. Accordingly, neuropsychologists are frequently asked to provide expert testimony about the nature of mild head injury. This article discusses how the sports-related concussion literature, including the concept of baseline assessment, can inform expert witnesses who are asked to provide such testimony. We first provide a review of several of the controversies surrounding mild head injury, both within and outside of the forensic context. This is followed by a review of the sports as a laboratory assessment model literature, which demonstrates consistent and meaningful evidence of cognitive sequelae following mild head injury. We conclude with a description of how the sports as a laboratory assessment model literature may be utilized in a forensic neuropsychology context to address some of the identified controversies. We end with a call for more research that will further inform the forensic neuropsychologist about mild head injury and those factors that may result in poor recovery.	[Bailey, Christopher M.; Barth, Jeffrey T.; Bender, Scott D.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA	Bailey, CM (corresponding author), Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, POB 800203, Charlottesville, VA 22908 USA.						Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BARTH JT, 2002, ENCY HUMAN BRAIN, V3, P81; Barth JT., 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER RL, 1991, AM J PSYCHIAT, V148, P1073; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; ECHEMENDIA RJ, 1997, M NAT AC NEUR LAS VE; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FRANZEN MD, 2006, CLIN NEUROPSYCHOLOGY, P102; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVY A, 1992, Brain Injury, V6, P401, DOI 10.3109/02699059209008136; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P405; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Ruff RM, 1999, BRAIN INJURY, V13, P943; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214	65	13	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2009	24	2					123	130		10.1097/HTR.0b013e31819c1caa			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	427WF	WOS:000264809100006	19333067				2021-06-18	
J	Formisano, R; Cicinelli, P; Buzzi, MG; Brunelli, S; Zafonte, R; Vinicola, V; Gabrielli, A; Sabatini, U				Formisano, Rita; Cicinelli, Paola; Buzzi, Maria Gabriella; Brunelli, Stefano; Zafonte, Ross; Vinicola, Vincenzo; Gabrielli, Andrea; Sabatini, Umberto			Blink reflex changes in parkinsonism following severe traumatic brain injury correlates with diffuse axonal injury	MEDICAL SCIENCE MONITOR			English	Article						post-traumatic parkinsonism; severe traumatic brain injury; coma; blink reflex habituation; diffuse axonal injury	PERSISTENT VEGETATIVE STATE; RECOVERY; BLEPHAROSPASM; DEFINITION; LEVODOPA; LESIONS	Background: Survivors Of severe traumatic brain injury (TBI) may show transient or persistent extrapyramidal symptoms such as rigidity, akinesia and parkinsonian posture, associated with hypomimia, not estinguishable glabellar tap reflex, seborrhea and hypersalivation. The Blink Reflex (BR), all electrically-induced reflex, is abnormal in Parkinson's disease (PD) and in some parkinsonisms. The aim of the study was to investigate BR habituation and its recovery cycle in survivors of severe TBI suffering from parkinsonian syndrome and the possible correlation with neuroimaging findings. Material/Methods: Twenty-three patients (18 males, 5 females; mean age 23.7 years, range 13-35), who sustained a severe TBI, (Glasgow Coma Scale or GCS, lower than 8 in the first. 48 hours), and followed by coma for a duration equal or longer than 15 days, Were studied during the post-acute or chronic phase. Enrollement criteria include the presence of at least 3 extrapyramidal symptoms. BR was elicited by electrical stimulation of the supraorbital nerve and responses Were recorded With surface electrodes from the orbicularis oculi muscle ipsilateral to the stimulation. A repeated series of 10 electrical stimuli was applied at. the frequencies of stimulation of 0.3, 0.5, 0.7, 1.0, 1.5, 2.0 and 3.0 Hz, respectively. Values between 0.5 and 1 Hz were considered as normal, according to the international literature, Cerebral Magnetic Resonance (C-MRI), with fist sequences was performed within 3 months after brain injury. Ten healthy subjects, age and sex matched, served as controls and underwent. the same procedure. Results: Nineteen of the twenty-three patients (82.6%) showed a significantly reduced BR habituation in comparison with controls. This findings highly correlated with C-MRI diagnosis of Diffuse Axonal Injury (DAI). A normal BR habituation was found in only 4 out of 23 patients (17%). in these subjects, C-MRI revealed focal lesions rather than DAI. Conclusions: BR changes correlate with parkinsonian signs and neuroimaging findings. BR may have a role as a diagnostic tool in post-traumatic parkinsonism and as a prognostic tool to evaluate the effect Of therapeutic options.	[Formisano, Rita; Cicinelli, Paola; Buzzi, Maria Gabriella; Brunelli, Stefano; Vinicola, Vincenzo; Sabatini, Umberto] Rehabil Hosp, Santa Lucia Fdn, Post Coma Unit, I-00179 Rome, Italy; [Zafonte, Ross] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Gabrielli, Andrea] Univ Florida, Div Crit Care Med, Jacksonville, FL USA	Formisano, R (corresponding author), Rehabil Hosp, Santa Lucia Fdn, Post Coma Unit, Via Ardeatina 354, I-00179 Rome, Italy.	r.formisano@hsantalucia.it	Sabatini, Umberto/A-8484-2010; Sabatini, Umberto/K-4659-2016; Buzzi, Maria Gabriella/K-5468-2016; Brunelli, Stefano/D-4967-2014	Sabatini, Umberto/0000-0001-5321-8626; Buzzi, Maria Gabriella/0000-0003-1307-8707; 			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams R. D., 1976, PRINCIPLES NEUROLOGY; [Anonymous], 2003, Clin Med (Lond), V3, P249; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Basso MA, 1996, J NEUROSCI, V16, P7318; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Chia LG, 1997, NEUROLOGY, V49, P874, DOI 10.1212/WNL.49.3.874; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; Eekhof JLA, 1996, MUSCLE NERVE, V19, P10, DOI 10.1002/(SICI)1097-4598(199601)19:1<10::AID-MUS2>3.0.CO;2-B; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; Formisano R, 2005, ACT NEUR S, V93, P201; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Jellinger K, 1966, Wien Z Nervenheilkd Grenzgeb, V23, P40; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P1082; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KARSON CN, 1982, ANN NEUROL, V12, P580, DOI 10.1002/ana.410120614; KIMURA J, 1973, BRAIN, V96, P87, DOI 10.1093/brain/96.1.87; Lees AJ, 1997, REV NEUROL-FRANCE, V153, P541; LINDENBERG R, 1964, Dtsch Z Nervenheilkd, V185, P637; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MATSUMOTO H, 1992, J NEUROL SCI, V107, P155, DOI 10.1016/0022-510X(92)90283-Q; MATSUMURA, 1993, RECENT ADV NEUROTRAU, P192; Morsier G, 1960, PSYCHIAT NEUROL, V139, P60; Napolitano A, 1997, EUR NEUROL, V38, P119, DOI 10.1159/000113174; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; RUMPL E, 1982, ELECTROEN CLIN NEURO, V54, P406, DOI 10.1016/0013-4694(82)90204-8; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; TEASDALE G, 1974, LANCET, V2, P81; Zijlmans JCM, 2004, MOVEMENT DISORD, V19, P630, DOI 10.1002/mds.20083	38	13	13	0	4	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR	2009	15	3					CR101	CR106					6	Medicine, Research & Experimental	Research & Experimental Medicine	434MY	WOS:000265280000008	19247239				2021-06-18	
J	Kochanek, PM; Drabek, T; Tisherman, SA				Kochanek, Patrick M.; Drabek, Tomas; Tisherman, Samuel A.			Therapeutic Hypothermia: The Safar Vision	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	2nd International Brain Hypothermia Symposium	OCT, 2007	Miami Beach, FL			cerebrospinal fluid; clinical trial; glia cell response to injury; human studies; hypothermia; pediatric brain injury; regeneration; stem cells; therapeutic approaches for the treatment of CNS injury; traumatic brain injury; traumatic spinal cord injury	GLOBAL BRAIN ISCHEMIA; CARDIAC-ARREST; HEMORRHAGIC-SHOCK; MILD HYPOTHERMIA; EMERGENCY PRESERVATION; CEREBRAL RESUSCITATION; SYSTEMIC HYPOTHERMIA; PROFOUND HYPOTHERMIA; CIRCULATORY ARREST; FLUID PRESSURE	At the 2(nd) International Brain Hypothermia conference, in Miami, the late Dr. Peter Safar was honored for his many contributions to the field of therapeutic hypothermia. Therapeutic hypothermia played a central role in his overall vision for optimized resuscitation and neurointensive care, across a large number of potential insults. The successful use of therapeutic hypothermia in comatose patients after cardiac arrest, for example, was already included in the historic first "ABCs'' of resuscitation, published by Safar in 1964. This review addresses key historical events in the development and implementation of therapeutic hypothermia across a number of central nervous system insults. A discussion of future potential uses of this therapy in a variety of applications as part of the Safar vision is also presented.	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Drabek, Tomas] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Tisherman, Samuel A./AAK-9377-2020; Drabek, Tomas/AAJ-1595-2021	Kochanek, Patrick M/0000-0002-2627-913X; Tisherman, Samuel A./0000-0003-3810-3729; Drabek, Tomas/0000-0002-5702-4498	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38087, NS 30318, R01 NS038087-01A1, P01 NS030318, R01 NS038087-09, R01 NS038087, P01 NS030318-160010] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, R01NS038087, P50NS030318, P20NS030318] Funding Source: NIH RePORTER		Albin M S, 1965, Surg Forum, V16, P423; Behringer W, 2003, CRIT CARE MED, V31, P1523, DOI 10.1097/01.CCM.0000063450.73967.40; Behringer W, 2000, ANESTHESIOLOGY, V93, P1491, DOI 10.1097/00000542-200012000-00022; CONN AW, 1979, PEDIATR CLIN N AM, V26, P691; CRIPPEN D, 1991, RESUSCITATION, V21, P271, DOI 10.1016/0300-9572(91)90052-Z; Drabek T, 2007, CRIT CARE MED, V35, P532, DOI 10.1097/01.CCM.0000253398.61666.0D; GISVOLD SE, 1984, STROKE, V15, P803, DOI 10.1161/01.STR.15.5.803; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; LARREY DJ, 1814, MEMOIRS MILITARY SUR, V1; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Nozari A, 2004, CRIT CARE MED, V32, P2110, DOI 10.1097/01.CCM.0000142700.19377.AE; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; PHELPS C, 1897, CLASSICS NEUROLOGY N, P223; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; REICH H, 1990, ANN EMERG MED, V19, P887, DOI 10.1016/S0196-0644(05)81562-8; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19; ROSOMOFF HL, 1965, RESP THERAPY, P244; SAFAR P, 1978, CRIT CARE MED, V6, P215, DOI 10.1097/00003246-197807000-00003; Safar P, 2003, ANN EMERG MED, V41, P887, DOI 10.1067/mem.2003.215; SAFAR P, 1964, J Iowa Med Soc, V54, P629; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; TISHERMAN SA, 1990, J TRAUMA, V30, P836, DOI 10.1097/00005373-199007000-00014; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; Tortorici MA, 2006, CRIT CARE MED, V34, P785, DOI 10.1097/01.CCM.0000201899.52739.4F; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Wu XR, 2008, J CEREBR BLOOD F MET, V28, P302, DOI 10.1038/sj.jcbfm.9600524; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204; Wu XR, 2002, J TRAUMA, V53, P654, DOI 10.1097/00005373-200210000-00006; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085	37	13	19	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2009	26	3					417	420		10.1089/neu.2008.0612			4	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	420ZO	WOS:000264327900016	19271966	Green Accepted, Green Published			2021-06-18	
J	Seckin, H; Ates, O; Bauer, AM; Baskaya, MK				Seckin, Hakan; Ates, Oezkan; Bauer, Andrew M.; Baskaya, Mustafa K.			Microsurgical anatomy of the posterior spinal artery via a far-lateral transcondylar approach	JOURNAL OF NEUROSURGERY-SPINE			English	Article						far-lateral approach; posterior inferior cerebellar artery; posterior spinal artery; spinal cord; vertebral artery	INFERIOR CEREBELLAR ARTERY; FORAMEN-MAGNUM; PARACONDYLAR EXTENSIONS; VERTEBRAL ARTERY; TECHNICAL NOTE; LESIONS; CORD; SUPRACONDYLAR; INFARCTION; VARIANTS	Object. The posterior spinal artery (PSA) is a clinically significant vessel that may frequently be encountered during the far-lateral transcondylar approach. There have been a limited number of reports on the specific origin of the PSA in the literature. The aim of this study was to demonstrate the origin of the PSA. Methods. Thirteen cadaveric heads (26 sides) were injected with colored silicon. A bilateral far-lateral transcondylar approach was performed on each side. In every specimen the site of the origin of the PSAs, as well as their course, branching pattern and anastomoses, external diameters, and neighboring vascular and nervous structures were recorded. Microanatomical dissections were performed using the surgical microscope. In addition, 8 surgical cases in which the far-lateral approach was used were collected prospectively to record the course and origin of the PSA. Altogether, a total of 34 sides were analyzed for their PSA origin and course. Results. In the cadaveric specimens, the PSA was found to originate from the vertebral artery (VA) in 25 sides (96%). In 13 specimens (50%) the PSA originated from the V-4 segment of the VA intradurally. In 12 specimens (46%) the PSA originated from the V-3 segment of the VA extradurally. In 1 specimen (4%), in whom the posterior inferior cerebellar artery (PICA) had an early origin from the VA extradurally at the C-I level, the PSA originated from the PICA. Of the 8 surgical cases, 2 patients had extradural origin of the PSA from the V, segment of the VA, whereas 6 patients had intradural origin of the PSA from the V-4 segment. Conclusions. Although the usual origin of the PSA is from the VA either intra- or extradurally, its origin is closely related to the origin of the PICA. The PSA originates from the PICA in cases in which the PICA originates extradurally from the VA. In the far-lateral transcondylar approach, the dura is opened in close proximity to the VA. Knowledge of the origin and course of the PSA is critically important when executing the far-lateral approach to avoid its injury. (DOI: 10.3171/2008.12.SPINE08289)	[Seckin, Hakan; Ates, Oezkan; Bauer, Andrew M.; Baskaya, Mustafa K.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA	Baskaya, MK (corresponding author), Univ Wisconsin Hosp & Clin, Dept Neurol Surg, 600 Highland Ave,UWHC Neurosurg F4-315,CSC-8660, Madison, WI 53792 USA.	m.baskaya@neurosurg.wisc.edu		Bauer, Andrew/0000-0001-9458-6951			Bergqvist CAG, 1997, NEUROLOGY, V48, P1112, DOI 10.1212/WNL.48.4.1112; Bruneau M, 2008, NEUROSURG REV, V31, P19, DOI 10.1007/s10143-007-0097-1; DEOLIVEIRA E, 1985, SURG NEUROL, V24, P293, DOI 10.1016/0090-3019(85)90042-4; Fine AD, 1999, J NEUROSURG, V91, P645, DOI 10.3171/jns.1999.91.4.0645; GEORGE B, 1995, SKULL BASE SURG, V5, P9, DOI 10.1055/s-2008-1058945; GEORGE B, 1988, SURG NEUROL, V29, P484, DOI 10.1016/0090-3019(88)90145-0; HEROS RC, 1986, J NEUROSURG, V64, P559, DOI 10.3171/jns.1986.64.4.0559; Huber P., 1982, CEREBRAL ANGIOGRAPHY; Ito S, 2005, J NEUROL, V252, P850, DOI 10.1007/s00415-005-0758-3; KANEKI M, 1994, J NEUROL NEUROSUR PS, V57, P629, DOI 10.1136/jnnp.57.5.629; Kawashima M, 2003, NEUROSURGERY, V53, P662, DOI 10.1227/01.NEU.0000080070.16099.BB; LASJAUNIAS P, 1985, J NEUROSURG, V63, P235, DOI 10.3171/jns.1985.63.2.0235; LASJAUNIAS P, 2001, SURG NEUROANGIOGRAPH, V1, P135; LISTER JR, 1982, NEUROSURGERY, V10, P170; Macchi V, 2004, SURG RADIOL ANAT, V26, P60, DOI 10.1007/s00276-003-0190-2; MAILLOT C, 1970, C R ASSOC ANAT, V149, P837; MARGOLIS MT, 1974, RADIOLOGY SKULL BRAI, V2, P1710; Mascalchi M, 1998, AM J NEURORADIOL, V19, P361; Nanda A, 2002, J NEUROSURG, V96, P302, DOI 10.3171/jns.2002.96.2.0302; Newton TH., 1974, RADIOLOGY SKULL BRAI, P1659; Osborn AG, 1999, DIAGNOSTIC CEREBRAL; Rhoton AL, 2000, NEUROSURGERY, V47, pS195, DOI 10.1097/00006123-200009001-00020; Rhoton AL., 2003, CRANIAL ANATOMY SURG; Sanan A, 1999, NEUROSURGERY, V45, P1267, DOI 10.1097/00006123-199911000-00058; SCHECHTER MM, 1966, ACTA RADIOL DIAGN, V5, P1124, DOI 10.1177/02841851660050P256; Siclari F, 2007, AM J NEURORADIOL, V28, P1185, DOI 10.3174/ajnr.A0498; Stopford JSB, 1916, J ANAT PHYSIOL, V50, P131; Wen HT, 1997, J NEUROSURG, V87, P555, DOI 10.3171/jns.1997.87.4.0555; WILLIAMS P, 1985, GRAYS ANATOMY, P751; YASARGIL MG, 1984, MICRONEUROSURGERY, V1, P130	30	13	15	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAR	2009	10	3					228	233		10.3171/2008.12.SPINE08289			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	414MN	WOS:000263868200009	19320582				2021-06-18	
J	Furlan, JC; Fehlings, MG				Furlan, Julio C.; Fehlings, Michael G.			Attitudes toward the Elderly with CNS Trauma: A Cross-Sectional Study of Neuroscientists, Clinicians, and Allied-Health Professionals	JOURNAL OF NEUROTRAUMA			English	Article						ageism; aging; cross-sectional study; elderly	SPINAL-CORD-INJURY; BRAIN-INJURY; PROGESTERONE TREATMENT; OLD-PEOPLE; AGED MICE; HIPPOCAMPUS; OUTCOMES; YOUNG; RELIABILITY; SECONDARY	Despite the potential impact of ageist attitudes on outcomes of central nervous system (CNS)-injured patients, little has been reported on this issue. Given this, we sought to conduct a questionnaire-based survey to assess the attitudes toward the elderly among basic and clinical neuroscientists, clinicians, and allied-health professionals whose research or medical practice is focused on neurotrauma. We also reviewed all abstracts presented in the National Neurotrauma Symposia from 1984 to 2007 and identified previous studies on the potential effects of age/aging on outcomes. The Kogan's Old People (KOP) scale was used to assess attitudes toward elderly individuals among all members of the National Neurotrauma Society (NNS). Of the 504 registered members, 137 subjects completed the survey that was re-mailed for non-respondents 4 weeks apart. There were no significant differences between respondents of the first and second mailings regarding their demographic and professional profiles or regarding their responses. These results support the validity of our findings in spite of the relatively low mail survey response rate (27.2%). Female gender was significantly associated with more positive attitudes toward old people compared to males. Clinicians showed significantly fewer negative attitudes toward old people in comparison with basic and clinical neuroscientists. Of the 4,194 abstracts reviewed, we identified only 44 studies (1.05%) that were explicitly focused on the effects of aging/old age on neurotrauma. In conclusion, our questionnaire-based survey, which appears to be representative of the population of interest, recognized significant differences in the attitudes toward old people among various professional groups and between male and female professionals. These findings may reflect a lack of knowledge and misconceptions regarding the impact of aging and old age on outcomes after CNS trauma. Further research on the impact of aging on outcomes after neurotrauma is required. Moreover, knowledge translation and mobilization appears required to positively influence attitudes among neuroscience research and clinical professionals regarding the issues of neurotrauma and the elderly.	[Furlan, Julio C.; Fehlings, Michael G.] Univ Hlth Network, Div Genet & Dev, Toronto Western Res Inst, Toronto, ON M5T S8, Canada; [Fehlings, Michael G.] Univ Hlth Network, Spinal Program, Krembil Neurosci Ctr, Toronto Western Hosp, Toronto, ON M5T S8, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada	Furlan, JC (corresponding author), Univ Hlth Network, Div Genet & Dev, Toronto Western Res Inst, 399 Bathurst St,McL 12-407, Toronto, ON M5T S8, Canada.	jfurlan@gmail.com	Furlan, Julio/Q-8290-2018	Furlan, Julio/0000-0002-2038-0018; Fehlings, Michael/0000-0002-5722-6364	National Neurotrauma Society; The Toronto General and Western Hospital Foundation; Henry A. Beatty Scholarship; Krembil Chair in Neural Repair and Regeneration	We gratefully acknowledge Professor Kogan for kindly permitting us to use his outcome measure instrument. We also thank Linda Garcia for secretarial assistance and all members of the National Neurotrauma Society who completed the questionnaire-based survey. This work was supported by a Lawson Neurology Fellowship from The Toronto General and Western Hospital Foundation (J.C.F.), the Henry A. Beatty Scholarship (J.C.F.) and the Krembil Chair in Neural Repair and Regeneration (M. G. F.).	Adkins RH, 2004, NEUROREHABILITATION, V19, P3; BACKMAN C, 1995, J NEUROTRAUM, V12, P981; Bugeja G, 1997, BRIT MED J, V315, P1059, DOI 10.1136/bmj.315.7115.1059; Cekic M, 2007, J NEUROTRAUM, V24, P1262; Chaovipoch P, 2005, J NEUROTRAUM, V22, P1241; Colello RJ, 2003, J NEUROTRAUM, V20, P1124; Coleman WP, 2003, J NEUROTRAUM, V20, P1063; Cutler S, 2006, J NEUROTRAUM, V23, P996; Dobriansky PJ, 2007, WHY POPULATION AGING, P1; FEHLINGS MG, 2002, J NEUROTRAUM, V19, P1388; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Foroughi A., 2000, Journal of Neurotrauma, V17, P970; Fowler F. J., 1993, SURVEY RES METHODS; FOWLER JH, 1999, J NEUROTRAUM, V16, P1001; Fugaccia I, 2003, J NEUROTRAUM, V20, P1086; Furlan JC, 2005, J NEUROTRAUM, V22, P1215; Furlan JC, 2004, J NEUROTRAUM, V21, P1321; Furlan J, 2007, J NEUROTRAUM, V24, P1257; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Gallagher S., 2006, INT J NURS PRACT, V12, P273, DOI DOI 10.1111/J.1440-172X.2006.00582.X; Geisler FH, 2004, J NEUROTRAUM, V21, P1341; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; Gilmer LK, 2006, J NEUROTRAUM, V23, P1004; GOLDSTEIN FC, 1994, J NEUROTRAUM, V12, P119; GORMAN LK, 1995, J NEUROTRAUM, V12, P971; Gorrie CA, 2004, J NEUROTRAUM, V21, P1314; GWAK YS, 2002, J NEUROTRAUM, V19, P1388; HAIGHT BK, 1994, J ADV NURS, V20, P382, DOI 10.1046/j.1365-2648.1994.20020382.x; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hawkins BE, 2005, J NEUROTRAUM, V22, P1181; HESSE KA, 1984, J AM GERIATR SOC, V32, P747, DOI 10.1111/j.1532-5415.1984.tb04174.x; Hikmet N, 2003, INT J MED INFORM, V72, P29, DOI 10.1016/j.ijmedinf.2003.09.002; HORSBURGH K, 1995, J NEUROTRAUM, V12, P972; Hurley SD, 2005, J NEUROTRAUM, V22, P1206; HURLEY SD, 2001, J NEUROTRAUM, V18, P1142; Kearney N, 2000, ANN ONCOL, V11, P599, DOI 10.1023/A:1008327129699; KOGAN N, 1961, J ABNORM SOC PSYCH, V62, P44, DOI 10.1037/h0048053; KUMEKICK J, 1994, J NEUROTRAUM, V12, P128; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LASLEY LA, 2002, J NEUROTRAUM, V19, P1328; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; LIFSHITZ J, 2002, J NEUROTRAUM, V19, P1359; Lim PAC, 2007, ANN ACAD MED SINGAP, V36, P49; MacDowell N M, 1999, J Allied Health, V28, P212; Marklund N, 2005, J NEUROTRAUM, V22, P1229; McArthur DL, 2004, J NEUROTRAUM, V21, P1293; McKinley W, 2003, NEUROREHABILITATION, V18, P83; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; NICHOLS JS, 1995, J NEUROTRAUM, V12, P133; *NNS, 2008, MISS STAT NAT NEUR S; Onyszchuk G, 2007, J NEUROTRAUM, V24, P1269; Onyszchuk G, 2006, J NEUROTRAUM, V23, P999; Palmore Erdman B, 2004, J Cross Cult Gerontol, V19, P41, DOI 10.1023/B:JCCG.0000015098.62691.ab; Panizzon K, 2007, J NEUROTRAUM, V24, P1253; Penson RT, 2004, ONCOLOGIST, V9, P343, DOI 10.1634/theoncologist.9-3-343; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; PIERCE JES, 1995, J NEUROTRAUM, V12, P964; ROZZINE R, 2003, AGE AGEING, V32, P517; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sadler J, 2005, CRIT CARE, V9, P314, DOI 10.1186/cc3785; Sandhir R, 2007, J NEUROTRAUM, V24, P1237; SCHEFF SW, 2002, J NEUROTRAUM, V19, P1340; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shah SA, 2004, J NEUROTRAUM, V21, P1299; SHEPHERD MD, 1983, AM J PHARM EDUC, V47, P35; Soderhamn O, 2000, SCAND J CARING SCI, V14, P211, DOI 10.1080/028393100300006799; Soderhamn O, 2001, NURS EDUC TODAY, V21, P225, DOI 10.1054/nedt.2000.0546; SOIZA RL, 2003, AGE AGEING, V32, P413; Stulemeijer M, 2006, J NEUROTRAUM, V23, P997; Swan A, 2007, J NEUROTRAUM, V24, P1238; Tasaki O, 2005, J NEUROTRAUM, V22, P1247; THIBEAULT SL, 1994, J NEUROTRAUM, V11, P129; Tokutomi T, 2005, J NEUROTRAUM, V22, P1200; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; *US BUR CENS, 2003, NAT POP EST CHAR; Whiteneck GG, 2001, AM J PHYS MED REHAB, V80, P305, DOI 10.1097/00002060-200104000-00017; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	77	13	14	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					209	225		10.1089/neu.2008.0663			17	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100004	19196075				2021-06-18	
J	Wan, JJ; Cohen, MJ; Rosenthal, G; Haitsma, IK; Morabito, DJ; Derugin, N; Knudson, MM; Manley, GT				Wan, Jennifer J.; Cohen, Mitchell J.; Rosenthal, Guy; Haitsma, Iain K.; Morabito, Diane J.; Derugin, Nikita; Knudson, M. Margaret; Manley, Geoffrey T.			Refining Resuscitation Strategies Using Tissue Oxygen and Perfusion Monitoring in Critical Organ Beds	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	38th Annual Meeting of the Western-Trauma-Association	FEB 24-MAR 01, 2008	Squaw Creek, CA	Western Trauma Assoc			HEMORRHAGIC-SHOCK; PRESSURE; PROTOCOL; TENSION	Background: Muscle tissue oxygen monitoring (Pmo(2)) holds promise as a continuous guide to resuscitation after hemorrhagic shock, but the relationship of muscle tissue oxygen to perfusion has not been described previously. On the other hand, brain tissue oxygen PbrO(2), and perfusion as measured by cerebral blood flow (CBF) are already used clinically, especially as guides to vasopressor use in cerebral perfusion targeted therapy in patients with traumatic brain injury. This laboratory study was undertaken to describe the relative contributions of muscle perfusion and arterial oxygen tension (Pao(2)) to muscle tissue oxygen (Pmo(2)) levels. Second, we wanted to compare the relationship between muscle oxygen and muscle blood flow (MBF) with simultaneously measured brain tissue oxygen and perfusion during the administration of a vasopressor and during experimental hemorrhagic shock. We hypothesized that muscle perfusion would be an important contributor to Pmo(2) thus underscoring the need for optimal fluid resuscitation after shock. We further hypothesized that Pmo(2) would decrease even as Pbro(2), increased when vasopressor therapy was used. Methods: Eight pigs were anesthetized, intubated, underwent splenectomies, and were instrumented to monitor Pmo(2) MBF, Pbro(2), and CBF. Oxygen challenges were performed by increasing Pao(2), from 100 to 500 mm Hg during three different experimental phases: baseline, vasopressor administration, and hemorrhage. Mean Pmo(2) and MBF were compared at the beginning and end of each experimental phase and correlations between Pmo(2) MBF, Pbro(2) CBF, and traditional endpoints of resuscitation were investigated. Results: During oxygen challenges in all phases, Pmo(2) increased (31.2 +/- 16.6 mm Hg to 56.6 +/- 34.1 mm Hg; p < 0.01), whereas MBF did not change significantly (16.4 +/- 11.3 mL/100 g/min to 15.4 +/- 11.9 mL/100 g/min). On administration of vasopressors, MBF decreased (18 +/- 8.8 mL/100 g/min to 5.3 +/- 3 mL/100 g/min; p = 0.03), but no change in Pmo(2), was detected. During hemorrhage, both Pmo(2) and MBF declined (Pmo(2): 40 +/- 8.8 mm Hg to 7.7 +/- 9.6 mm Hg; p = 0.002; MBF: 9.8 +/- 5.8 mL/100 g/min to 3.3 +/- 2.4 mL/100 g/min; p = 0.046). Both Pmo(2) and MBF showed strong relationships with measurements of resuscitation, base deficit (Pmo(2) and MBF: p < 0.01), and mean arterial pressure (Pmo(2): P < 0.01, MBF: p = 0.02). Like Pmo(2) and MBF, Pbro(2), and CBF decreased uniformly during hemorrhage. However, on vasopressor administration, CBF and Pbro(2) increased significantly, whereas MBF decreased. Conclusion: Pmo(2) and MBF can be monitored simultaneously and continuously and correlate well with measurements of resuscitation. Pmo(2) values reflect both local perfusion and arterial oxygen tension. The clinical application of Pmo(2) as a continuous endpoint of resuscitation and its relationship to muscle perfusion warrants further study in critically injured patients and these investigations may help to refine resuscitation strategies.	[Wan, Jennifer J.; Cohen, Mitchell J.; Morabito, Diane J.; Knudson, M. Margaret] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Rosenthal, Guy; Haitsma, Iain K.; Derugin, Nikita; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; San Francisco Injury Ctr Res & Prevent, San Francisco, CA USA	Knudson, MM (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A, 1001 Potrero Ave, San Francisco, CA 94110 USA.	pknudson@sfghsurg.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008258] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM08258] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR90369] Funding Source: Medline		*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BUCKMAN RF, 1994, J TRAUMA, V36, P856; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; Knudson MM, 1997, J TRAUMA, V42, P608, DOI 10.1097/00005373-199704000-00005; Knudson MM, 2003, J TRAUMA, V54, P242, DOI 10.1097/01.TA.0000037776.28201.75; Lee SK, 2002, ACAD EMERG MED, V9, P969; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; McKinley BA, 1998, J TRAUMA, V44, P119, DOI 10.1097/00005373-199801000-00015; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sims C, 2001, J TRAUMA, V51, P1137, DOI 10.1097/00005373-200112000-00020; WAXMAN K, 1994, J TRAUMA, V36, P852, DOI 10.1097/00005373-199406000-00016	16	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2009	66	2					353	357		10.1097/TA.0b013e318195e222			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	408NX	WOS:000263442800009	19204507				2021-06-18	
J	Anderson, JW; Schmitter-Edgecombe, M				Anderson, Jonathan W.; Schmitter-Edgecombe, Maureen			Predictions of episodic memory following moderate to severe traumatic brain injury during inpatient rehabilitation	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Memory awareness; Memory monitoring; Metamemory; Metacognition	CLOSED-HEAD-INJURY; SELF-AWARENESS; FRONTAL-LOBE; POSTTRAUMATIC AMNESIA; TEMPORAL-LOBE; METAMEMORY; PERFORMANCE; RETRIEVAL; ACCURACY; DEFICITS	We examined memory self-awareness and memory self-monitoring abilities during inpatient rehabilitation in participants with moderate to severe traumatic brain injury (TBI). A total of 29 participants with moderate to severe TBI and 29 controls matched on age, gender, and education completed a performance prediction paradigm. To assess memory self-awareness, participants predicted the amount of information they would remember before completing list-learning tasks and visual-spatial memory tasks. Memory self-monitoring was assessed by participants' ability to increase accuracy of their predictions after experience with the tests. Although the TBI participants performed more poorly than controls on both episodic memory tasks, no significant group differences emerged in memory self-awareness or memory self-monitoring. The TBI participants predicted that their memory performances would be poorer than that of controls, accurately adjusted their predictions in accordance with the demands of the tasks, and successfully modified their predictions following experience with the tasks. The results indicate that moderate to severe TBI individuals in the early stages of recovery can competently assess the demands of externally driven metamemorial situations and utilize experience with task to accurately update their knowledge of memory abilities.	[Anderson, Jonathan W.] Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Pullman, WA 99164 USA	Anderson, JW (corresponding author), Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA.	janderson@mail.ewu.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was partially supported by Grant R01 NS47690 from the National Institute of Neurological Disorders and Stroke (NINDS). We would like to thank Randi McDonald, Shital Pavawalla, Jennifer McWilliams, Michelle Nuegen, Matthew Wright, and Ellen Woo for their support in coordinating data collection. We would also like to thank the traumatic brain injury participants and the members of the Head Injury Research Team for their help in collecting and scoring the data.	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1994, MULTILINGUAL APHASIA; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bunnell JK, 1999, NEW ZEAL J PSYCHOL, V28, P23; Cohen J, 1983, APPL MULTIPLE REGRES, P56; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Fleming JM, 1996, BRAIN INJURY, V10, P1; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GERMAN DJ, 1990, NATL COLL ED TEST AD; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Hertzog C., 1994, Aging & Cognition, V1, P203, DOI DOI 10.1080/13825589408256577; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; Koriat A., 2000, OXFORD HDB MEMORY, P333; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Leckey GS, 2002, J INT NEUROPSYCH SOC, V8, P48, DOI 10.1017/S1355617701020057; Lee GP, 1997, CLIN NEUROPSYCHOL, V11, P59, DOI 10.1080/13854049708407030; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Myers JL., 2003, RES DESIGN STAT ANAL; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Smith A., 1991, SYMBOL DIGIT MODALIT; Tabachnick B. G., 2001, COMPUTERASSISTED RES; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vilkki J, 1999, NEUROPSYCHOLOGY, V13, P298, DOI 10.1037/0894-4105.13.2.298; Wechsler D., 1997, MANUAL WECHSLER ADUL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zachary R.A., 1991, SHIPLEY I LIVING SCA	48	13	14	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	4					425	438	PII 901418785	10.1080/13803390802232667			14	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	435HH	WOS:000265334200005	18686113	Green Accepted			2021-06-18	
J	Corral, L; Herrero, JI; Monfort, JL; Ventura, JL; Javierre, CF; Juncadella, M; Garcia-Huete, L; Bartolome, C; Gabarros, A				Corral, Luisa; Ignacio Herrero, Jose; Luis Monfort, Jose; Luis Ventura, Jose; Javierre, Casimiro F.; Juncadella, Montserrat; Garcia-Huete, Lucia; Bartolome, Carlos; Gabarros, Andreu			First CT findings and improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury	BRAIN INJURY			English	Article						Severe traumatic brain injury; Glasgow Outcome Scale; Glasgow Coma Scale; computerized tomography; prognosis	SEVERE HEAD-INJURY; GLASGOW-OUTCOME-SCALE; EARLY COMPUTED-TOMOGRAPHY; DECISION-TREE ANALYSIS; TERM FOLLOW-UP; COMA DATA-BANK; INTRAVENTRICULAR HEMORRHAGE; STRUCTURED INTERVIEWS; MULTICENTER TRIAL; RATING-SCALE	Primary objective: To analyse the association between individual initial computerized tomography (CT) scan characteristics and Glasgow Outcome Scale (GOS) and Extended Glasgow Outcome Scale (GOSE) improvement between 6 months and 1 year. Methods and procedures: Two hundred and twenty-four adult patients with severe traumatic brain injury and Glasgow Coma Scale (GCS) score of 8 or less who were admitted to an intensive care unit were studied. GOS and GOSE scores were obtained 6 and 12 months after injury in 203 subjects. Patients were predominantly male (84%) and median age was 35 years. Main outcomes and results: Traumatic Coma Data Bank (TCDB) CT classification was associated with GOS/GOSE improvement between 6 months and 1 year, with diffuse injury type I, type II and evacuated mass improving more than diffuse injury type III, type IV and non-evacuated mass; for GOS 43/155 (28%) vs 3/48 (6%) (2 = 9.66, p 0.01) and for GOSE 71/155 (46%) vs 7/48 (15%) (2 = 15.1, p 0.01). CT individual abnormalities were not associated with GOS/GOSE improvement, with the exception of subarachnoid haemorrhage, which showed a negative association with GOSE improvement (2 = 4.08, p 0.05). Conclusions: TCDB CT scan classification and subarachnoid haemorrhage were associated with GOS/GOSE improvement from 6-12 months, but individual CT abnormalities were not associated.	[Corral, Luisa; Ignacio Herrero, Jose; Luis Ventura, Jose] Bellvitge Univ Hosp, Intens Care Unit, Barcelona 08907, Spain; [Luis Monfort, Jose] Bellvitge Univ Hosp, Dept Neuroradiol, Barcelona 08907, Spain; [Javierre, Casimiro F.] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain; [Juncadella, Montserrat] Bellvitge Univ Hosp, Dept Neuropsychol, Barcelona 08907, Spain; [Garcia-Huete, Lucia; Bartolome, Carlos] Bellvitge Univ Hosp, Dept Anaesthesiol, Barcelona 08907, Spain; [Gabarros, Andreu] Bellvitge Univ Hosp, Dept Neurosurg, Barcelona 08907, Spain	Corral, L (corresponding author), Bellvitge Univ Hosp, Intens Care Unit, Feixa Llarga S-N, Barcelona 08907, Spain.	lcorral@bellvitgehospital.cat		Corral, Luisa/0000-0002-2888-7833			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CHESTNUT RM, 2000, GUIDELINES MANAGEMEN; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; EIDE PK, 1992, ACTA NEUROL SCAND, V86, P194, DOI 10.1111/j.1600-0404.1992.tb05065.x; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GENARELLI TA, 1982, J NEUROSURG, V56, P26; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MAHONEY F I, 1965, Md State Med J, V14, P61; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2000, NEUROSURGERY, V46, P70; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Woischneck D, 1998, ACT NEUR S, V71, P138	44	13	13	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	5					403	410	PII 909709429	10.1080/02699050902788477			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	439NL	WOS:000265633700004	19301165				2021-06-18	
J	Han, SD; Suzuki, H; Drake, AI; Jak, AJ; Houston, WS; Bondi, MW				Han, S. Duke; Suzuki, Hideo; Drake, Angela I.; Jak, Amy J.; Houston, Wes S.; Bondi, Mark W.			Clinical, Cognitive, and Genetic Predictors of Change in Job Status Following Traumatic Brain Injury in a Military Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						apolipoprotein E; military; neurocognition; optimal data analysis; traumatic brain injury	APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; GENOTYPE; ASSOCIATION; DEPOSITION; EPSILON-4; PROTEIN; ALLELE	Objective: Traumatic brain injury (TBI) is a risk associated with military duty, and residual effects from TBI may adversely affect a service member's ability to complete duties. It is, therefore, important to identify factors associated with a change in job status following TBI in an active military population. On the basis of previous research, we predicted that apolipoprotein E (APOE) genotype may be 1 factor. Design: Cohort study of military personnel who sustained a mild to moderate TBI. Setting: Military medical clinics. Patients or Other Participants: Fifty-two military participants were recruited through the Defense and Veterans Brain Injury Center, affiliated with Naval Medical Center San Diego and the Defense and Veterans Brain Injury Center Concussion Clinic located at the First Marine Division at Camp Pendleton. Intervention(s): A multivariate statistical classification approach called optimal data analysis allowed for consideration of APOE genotype alongside cognitive, emotional, psychosocial, and physical functioning. Main Outcome Measure(s): APOE genotype, neuropsychological, psychosocial, and clinical outcomes. Results: We identified a model of factors that was associated with a change in job status among military personnel who experienced a mild or moderate TBI. Conclusions: Factors associated with a change in job status are different when APOE genotype is considered. We conclude that APOE genotype may be an important genetic factor in recovery from mild to moderate head injury.	[Han, S. Duke; Suzuki, Hideo] Loyola Univ, Dept Psychol, Chicago, IL 60626 USA; [Han, S. Duke] Loyola Univ, Med Ctr, Dept Neurol, Maywood, IL 60153 USA; [Han, S. Duke] Loyola Univ, Med Ctr, Inst Neurosci, Maywood, IL 60153 USA; [Jak, Amy J.; Bondi, Mark W.] Univ Calif San Diego, Dept Psychiat, San Diego Sch Med, San Diego, CA 92103 USA; [Jak, Amy J.; Bondi, Mark W.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Drake, Angela I.] USN, Dept Neurosci, Def & Vet Brain Injury Ctr, Med Ctr, San Diego, CA 92152 USA; [Houston, Wes S.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Houston, Wes S.] VA Cincinnati Healthcare Syst, Cincinnati, OH USA	Han, SD (corresponding author), Loyola Univ, Dept Psychol, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	dhan2@luc.edu	Han/N-1246-2019		Medical Research Service of the Department of Veterans AffairsUS Department of Veterans Affairs; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG026431] Funding Source: NIH RePORTER	This work was supported by a merit review research program from the Medical Research Service of the Department of Veterans Affairs and by the Defense and Veterans Brain Injury Center; resources and use of facilities were also provided by the Naval Medical Center San Diego. The authors gratefully acknowledge the staff, patients, and volunteers at Naval Medical Center San Diego and US Marine Corps Base Camp Pendleton for their assistance with this study.	Arendt T, 1997, J NEUROSCI, V17, P516; BELANGER HG, J INT NEURO IN PRESS; BLOSS CS, NEUROBIOL A IN PRESS; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS D N, 1975, Cortex, V11, P329; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Graham DI, 1999, CELL MOL NEUROBIOL, V19, P19, DOI 10.1023/A:1006937205905; GRONWALL D, 1975, LANCET, V2, P995; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KELTIKANGASJARVINEN L, 1993, PSYCHOSOM MED, V55, P155, DOI 10.1097/00006842-199303000-00004; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249; SOLTYSIK RC, 1993, ODA 1 0 OPTIMAL DATA; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yarnold P. R., 2005, OPTIMAL DATA ANAL GU; Yarnold PR, 1997, STAT MED, V16, P1451, DOI 10.1002/(SICI)1097-0258(19970715)16:13&lt;1451::AID-SIM571&gt;3.0.CO;2-F	36	13	13	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					57	64		10.1097/HTR.0b013e3181957055			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500009	19158597	Green Accepted			2021-06-18	
J	Mascialino, G; Hirshson, C; Egan, M; Cantor, J; Ashman, T; Tsaousides, T; Spielman, L				Mascialino, Guido; Hirshson, Chari; Egan, Mathew; Cantor, Joshua; Ashman, Teresa; Tsaousides, Theodore; Spielman, Lisa			Objective and subjective assessment of long-term community integration in minority groups following traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; community integration; minorities; minority status	QUALITY-OF-LIFE; FUNCTIONAL OUTCOMES; RACIAL DISPARITIES; SATISFACTION; REHABILITATION; IMPACT; PARTICIPATION; PERSPECTIVE; MODERATE; HEALTH	Previous studies that used objective measures of community integration found that in the first year after injury, minority groups with traumatic brain injury (TBI) exhibit lower levels of community integration than White participants. The objective of this study was to determine if this discrepancy persists beyond one year post injury, and if assessing subjective components of community integration helps understand these differences. Participants were 360 community dwelling adults with TBI including 29% from minority backgrounds. Mean time post injury was 8.66 years (SD = 9.94). Main outcome measure utilized was the Participation Objective Participation Subjective (POPS). Multiple regression indicated that minority status predicted levels of transportation use (p < 0.01), with white participants reporting less use, after controlling for demographic and injury variables. When looking at subjective indicators, minority status predicted levels of dissatisfaction with community, civic, life and leisure participation (p < 0.01), and total levels of participation (p < 0.0125), with White participants reporting significantly less dissatisfaction. Findings indicate that differences between minorities and white participants in objective aspects of community integration after one year post-injury are only evident in levels of transportation use. However, when looking at subjective indicators differences between groups are present in other areas. These findings underscore the importance of considering the consumer's subjective experience when providing services to minorities in a rehabilitation setting.	[Mascialino, Guido; Hirshson, Chari; Egan, Mathew; Cantor, Joshua; Ashman, Teresa; Tsaousides, Theodore; Spielman, Lisa] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	Mascialino, G (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	Guido.Mascialino@mountsinai.org	Ashman, Teresa/B-1621-2013	MASCIALINO, GUIDO/0000-0001-7408-6546			Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 2006, PARTICIPATION OBJECT; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Burnett DM, 2000, BRAIN INJURY, V14, P713; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; COOPER KD, 1983, NEUROEPIDEMIOLOGY, V2, P70; *CORM AM, 1993, J HEAD TRAUMA REHAB, V8, P86; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; HOLM S, 1979, SCANDINAVIAN J STAT, V6; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Minnes P, 2001, NEUROREHABILITATION, V16, P3; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Ruff RM, 1999, BRAIN INJURY, V13, P943; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009	34	13	13	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	1					29	36		10.3233/NRE-2009-0451			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	412DS	WOS:000263704400004	19208955				2021-06-18	
J	Kirchhoff, C; Buhmann, S; Braunstein, V; Leidel, BA; Vogel, T; Kreimeier, U; Mutschler, W; Biberthaler, P				Kirchhoff, C.; Buhmann, S.; Braunstein, V.; Leidel, B. A.; Vogel, T.; Kreimeier, U.; Mutschler, W.; Biberthaler, P.			CEREBROSPINAL S100-B: A POTENTIAL MARKER FOR PROGRESSIVE INTRACRANIAL HEMORRHAGE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article						S100-B; traumatic brain injury; blood brain barrier; cerebrospinal fluid	SEVERE HEAD-INJURY; HIGH-RISK PATIENTS; COMPUTED-TOMOGRAPHY; S-100 PROTEIN; DAMAGE; BLOOD; SERUM; FLUID; IDENTIFICATION; BARRIER	Objective: Traumatic brain injury (TBI) is associated with cerebrovascular dysfunction and changes of the blood-brain barrier (131313) function. Although knowledge about the function of the 131313 would be of high interest, non-invasive neurodiagnostic tools are still lacking. In this context it has been shown, that the astrocytic protein S100-B is a significant parameter for neuronal damage. However, there is only poor knowledge about the dynamics of S100-B in cerebrospinal fluid (CSF) and serum of patients with severe TBI. Therefore, the aim of this study was to analyze intrathecal and systemic concentrations of S100-B in patients with severe TBI in correlation to the development of progressive intracranial hemorrhage (PIH) as well as to the CSF/serum albumin ratio (Q(alb)), as functional parameter of the BBB. Patients and Methods: In patients, suffering from severe TBI (GCS <= 8pts) and respectively healthy control patients, albumin for calculating the CSF/serum albumin ratio (Q(alb)) as well as S100-B protein were analyzed in CSF and serum. Samples were collected immediately after placement of a ventricular catheter and 12h, 24h, 48h and 72h after TBI. S100-B was quantified using Elecsys S-100 (R) assay (Roche (R) Diagnostics; Mannheim, Germany). Volume measurements of focal mass lesions based on CT images taken during the first 72 h after TBI were obtained according to the Cavalieri's Direct Estimator method. Results: 21 TBI-patients and respectively 10 health controls were enrolled. In patients exhibiting a mean ICP > 15mmHg (n = 15) CSF levels of S100-B were significantly increased on admission (819 +/- 78 pg/ml) compared to patients with ICP <= 15mmHg (n = 6, 175 +/- 12 pg/ml) as well as to the control group (n = 10, 0.8 +/- 0.09 pg/ml). In the group with ICP > 15mmHg 8 patients developed PIH A positive correlation was found between CSF S100-B and ICP (r(2) = 0.925, p<0.001). Furthermore a positive correlation between serum S100-B and Q(alb) was found for each sampling point (r(2) = 0.793, p<0.001). Conclusions: The cerebrospinal and serum concentration of S100-B in patients with severe TBI was evaluated. Monitoring cerebrospinal S100-B might help to prospectively identify patients with P.M.	[Kirchhoff, C.] Tech Univ Munich, Abt Sportorthopadie, Klinikum Rechts Isar, D-80809 Munich, Germany; [Buhmann, S.] Univ Munich, Inst Klin Radiol, D-80539 Munich, Germany; [Braunstein, V.; Leidel, B. A.; Mutschler, W.; Biberthaler, P.] Univ Munich, Chirurg Klin Innenstadt, D-80539 Munich, Germany; [Kreimeier, U.] Univ Munich, Klin Anaesthesiol, D-80539 Munich, Germany; [Vogel, T.] Klinikum Ruhr Univ Bochum, Klin Orthopadie & Unfallchirurg, Bochum, Germany	Kirchhoff, C (corresponding author), Tech Univ Munich, Abt Sportorthopadie, Klinikum Rechts Isar, Conollystr 32, D-80809 Munich, Germany.	Chlodwig.Kirchhoff@med.uni-muenchen.de		LEIDEL, Bernd A./0000-0002-5149-8764			Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2002, EUR J MED RES, V7, P164; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Farin A, 2004, ACT NEUR S, V89, P101; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Krotz M, 2004, EUR RADIOL, V14, P227, DOI 10.1007/s00330-003-2134-y; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Otto M, 1997, J NEUROL, V244, P566, DOI 10.1007/s004150050145; Otto VI, 2000, J NEUROSCI RES, V60, P733, DOI 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; The Brain Trauma Foundation The American Association of Neurological Surgeons The Joint Section on Neurotrauma and Critical Care, 2000, J NEUROTRAUM, V17, P497; Ucar T, 2004, J TRAUMA, V57, P95, DOI 10.1097/01.TA.0000071352.95491.75	30	13	15	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0949-2321	2047-783X		EUR J MED RES	Eur. J. Med. Res.	NOV 24	2008	13	11					511	516					6	Medicine, Research & Experimental	Research & Experimental Medicine	384HK	WOS:000261735700005	19073387				2021-06-18	
J	Bhalla, K; Shahraz, S; Naghavi, M; Lozano, R; Murray, C				Bhalla, Kavi; Shahraz, Saeid; Naghavi, Mohsen; Lozano, Rafael; Murray, Christopher			Estimating the distribution of external causes in hospital data from injury diagnosis	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Injury surveillance; Hospital discharge; Missing data; Non-fatal injuries; Bayesian inference; ICD		Hospital discharge datasets area key source for estimating the incidence of non-fatal injuries. While hospital records usually document injury diagnosis (e.g. traumatic brain injury, femur fracture, etc.) accurately, they often contain poor quality information on external causes (e.g. road traffic crashes, falls, fires, etc.). if such data is recorded at all. However, estimating incidence by external causes is essential for designing effective prevention strategies. Thus, we developed a method for estimating the number of hospital admissions due to each external cause based on injury diagnosis. We start with a prior probability distribution of external causes for each case (based on victim age and sex) and use Bayesian inference to update the probabilities based on the victim's injury diagnoses. We validate the method on a trial dataset in which both external causes and injury diagnoses are known and demonstrate application to two problems: redistribution of cases classified to ill-defined external causes in one hospital data system; and, estimation of external causes in another hospital data system that only records nature of injuries. In comparison with age-sex proportional distribution (the method usually employed), we found the Bayesian method to be a significant improvement for generating estimates of incidence for many external causes (e.g. fires, drownings, poisonings). But the method, performed poorly in distinguishing between falls and road traffic injuries, both of which are characterized by similar injury codes in our datasets. While such stop gap methods can help derive additional information, hospitals need to incorporate accurate external cause coding in routine record keeping. (C) 2008 Elsevier Ltd. All rights reserved.	[Bhalla, Kavi; Shahraz, Saeid] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; [Naghavi, Mohsen; Lozano, Rafael; Murray, Christopher] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA; [Lozano, Rafael] Mexico Minist Hlth, Cuauhtemoc 06600, DF, Mexico	Bhalla, K (corresponding author), Harvard Univ, Initiat Global Hlth, 104 Mt Auburn St, Cambridge, MA 02138 USA.	kavi_bhalla@harvard.edu	Lozano, Rafael/T-5352-2018	Lozano, Rafael/0000-0002-7356-8823			ABELLERA J, 2004, STATES ARE COLLECTIN; ALEXANDRESCU R, 2008, TRAUMA AUDIT RES NET, V8, P80; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; ANNEST JL, 2008, MORBIDITY MORTALITY, V28, P57; Bergen GS, 2008, INJURY US 2007 CHART; BHALLA K, 2008, ROAD TRAFFIC INJURIE; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Conner KR, 2003, AM J PUBLIC HEALTH, V93, P1128, DOI 10.2105/AJPH.93.7.1128; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Finkelstein EA., 2006, INCIDENCE EC BURDEN; LANGLOIS JA, 1995, AM J PUBLIC HEALTH, V85, P1261, DOI 10.2105/AJPH.85.9.1261; Lawrence BA, 2007, ACCIDENT ANAL PREV, V39, P319, DOI 10.1016/j.aap.2006.08.001; MARGANITT B, 1990, AM J PUBLIC HEALTH, V80, P1463, DOI 10.2105/AJPH.80.12.1463; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Tepas Joseph J 3rd, 2004, Semin Pediatr Surg, V13, P126, DOI 10.1053/j.sempedsurg.2004.01.009; Welander G, 1999, ACCIDENT ANAL PREV, V31, P13, DOI 10.1016/S0001-4575(98)00040-2; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277	18	13	14	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2008	40	6					1822	1829		10.1016/j.aap.2008.07.002			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	378UN	WOS:000261349800004	19068282				2021-06-18	
J	Josie, KL; Peterson, CC; Burant, C; Drotar, D; Stancin, T; Wade, SL; Yeates, K; Taylor, HG				Josie, Katherine Leigh; Peterson, Catherine Cant; Burant, Christopher; Drotar, Dennis; Stancin, Terry; Wade, Shari L.; Yeates, Keith; Taylor, H. Gerry			Predicting Family Burden Following Childhood Traumatic Brain Injury: A Cumulative Risk Approach	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						childhood traumatic brain injury; cumulative risk index; family burden of injury	ENVIRONMENTAL RISK; SHORT-TERM; BEHAVIOR; CHILDREN; OUTCOMES; INTELLIGENCE; RELIABILITY; CAREGIVER	Objective: To examine the utility of a cumulative risk index (CRI) in predicting the family burden of injury (FBI) over time in families of children with traumatic brain injury (TBI). Participants: One hundred eight children with severe or moderate TBI and their families participated in the study. Measures: The measures used in the study include the Socioeconomic Composite Index, Life Stressors and Social Resources Inventory-Adult Form, Vineland Adaptive Behavior Scales, Child Behavior Checklist, Children's Depression Inventory, McMaster Family Assessment Device, Brief Symptom Inventory, and Family Burden of Injury Interview. In addition, information on injury-related risk was obtained via medical charts. Methods: Participants were assessed immediately, 6, and 12 months postinjury and at a 4-year extended follow-up. Results: Risk variables were dichotomized (ie, high- or low-risk) and summed to create a CRI for each child. The CRI predicted the FBI at all assessments, even after accounting for autocorrelations across repeated assessments. Path coefficients between the outcome measures at each time point were significant, as were all path coefficients from the CRI to family burden at each time point. In addition, all fit indices were above the recommended guidelines, and the X-2 statistic indicated a good fit to the data. Conclusions: The current study provides initial support for the utility of a CRI (ie, an index of accumulated risk factors) in predicting family outcomes over time for children with TBI. The time period immediately after injury best predicts the future levels of FBI; however, cumulative risk continues to influence the change across successive postinjury assessments. These results suggest that clinical interventions could be proactive or preventive by intervening with identified "at-risk" subgroups immediately following injury.	[Josie, Katherine Leigh; Peterson, Catherine Cant] Case Western Reserve Univ, Sch Med, Dept Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Burant, Christopher] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Dept Pediat, Metro Hlth Med Ctr, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Behav Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Drotar, Dennis; Wade, Shari L.] Univ Cincinnati, Med Ctr, Coll Med, Dept Pediat,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA; [Yeates, Keith] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith] Columbus Childrens Res Inst, Ctr Biobehav Hlth, Columbus, OH USA	Josie, KL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Behav Pediat & Psychol, 11100 Euclid Ave, Cleveland, OH 44106 USA.	Katherine.Josie@uhhospitals.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR008084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32-HD041923-05, T32 HD041923] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36335] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD041923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER		Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; Atzaba-Poria N, 2004, J CHILD PSYCHOL PSYC, V45, P707, DOI 10.1111/j.1469-7610.2004.00265.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX, p[xv, 330]; Browne M.W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Burchinal MR, 2000, DEV PSYCHOL, V36, P793, DOI 10.1037//0012-1649.36.6.793; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Curran PJ, 2001, DECADE BEHAV, P107, DOI 10.1037/10409-004; DEROGATIS L, BRIEF SYMPTON INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Gerard JM, 2004, CHILD DEV, V75, P1832, DOI 10.1111/j.1467-8624.2004.00820.x; Greenberg MT, 2001, DEV PSYCHOPATHOL, V13, P255, DOI 10.1017/S0954579401002048; Griffin K W, 2000, Prev Sci, V1, P199, DOI 10.1023/A:1026599112279; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Hooper SR, 1998, J APPL DEV PSYCHOL, V19, P85, DOI 10.1016/S0193-3973(99)80029-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kerr MA, 2000, CHILD ABUSE NEGLECT, V24, P587, DOI 10.1016/S0145-2134(00)00126-5; KLINE RB, 2004, PRINCIPLES PRACTICE, P1; Kovacs M., 1992, CHILDRENS DEPRESSION; Kraus J., 1995, TRAUMATIC HEAD INJUR, P117; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS R, 1988, LIFE STRESSORS SOCIA; Moos RH, 1988, J SUBSTANCE ABUSE, V1, P135, DOI DOI 10.1016/S0899-3289(88)80017-8; Perkins DF, 2002, J ADOLESCENT RES, V17, P3, DOI 10.1177/0743558402171001; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Rolf J. E., 1979, PRIMARY PREVENTION P, V3, P49, DOI DOI 10.1016/1054-139X(93)90196-V; Rutter M, 1970, ED HLTH BEHAV; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; SAMEROFF AJ, 1993, CHILD DEV, V64, P80, DOI 10.2307/1131438; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sparrow S., 1984, VINELAND ADAPTIVE BE; *SPSS INC SMALLW C, 2005, AM SOFTW PROGR VERS; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor HG, 1998, J DEV BEHAV PEDIATR, V19, P235; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; WADE SL, 1997, CHILDHOOD TRAUMATIC, P115; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	54	13	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					357	368		10.1097/01.HTR.0000341431.29133.a8			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300001	19033828	Green Accepted			2021-06-18	
J	Ben Salem, D; Walker, PM; Bejot, Y; Aho, SL; Vernier, BTA; Rouaud, O; Ricolfi, F; Brunotte, F				Ben Salem, Douraied; Walker, Paul M.; Bejot, Yannick; Aho, Serge L.; Vernier, Beatrice T. A.; Rouaud, Olivier; Ricolfi, Frederic; Brunotte, Francois			N-Acetylaspartate/Creatine and Choline/Creatine Ratios in the Thalami, Insular Cortex and White Matter as Markers of Hypertension and Cognitive Impairment in the Elderly	HYPERTENSION RESEARCH			English	Article						hypertension; proton magnetic resonance spectroscopy; Trail Making Test; elderly	MAGNETIC-RESONANCE SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; LONGITUDINAL CHANGES; SUBCORTICAL LESIONS; VASCULAR DEMENTIA; STROKE PATIENTS; NORMATIVE DATA; BASE-LINE; TRAIL	Our objective was to investigate the influence of hypertension on N-acetylaspartate (NAA) and choline (Cho) ratios in brain tissues in a community-dwelling elderly population. Brain flexibility was also evaluated with regard to the same metabolite ratios. Proton magnetic resonance spectroscopy (MRS) and the Trail Making Test (TMT) were performed in 80 subjects (75.7 +/- 4 years old) from the Three-City Study. Fifty-eight participants had hypertension. The NAA/creatine (Cr) and Cho/Cr ratios were obtained in the insular cortex, the thalami and the deep periventricular white matter. In addition, the B-A score of the TMT was evaluated. Uniand multi-variate analyses were performed in order to examine the relationships among these data. In the insula and the thalami of the hypertensive group, NAA/Cr ratios were significantly lower (1.39 +/- 0.23 and 1.52 +/- 0.23, respectively; p=0.01) than those in the normotensive control goup (1.52 +/- 0.25 and 1.70 +/- 0.19, respectively; p < 0.0001), whereas no such reduction was observed in the periventricular white matter of older hypertensive brains. Moreover, the NAA or Cho ratios were significantly correlated with the TMT B-A scores at the level of the thalami, insula and periventricular white matter. These statistical results were confirmed by the multivariate analysis. In an elderly population, hypertension leads to a reduction in NAA/Cr ratios in the insula and the thalami, possibly due to a decrease in blood flow through small perforating and cortical arteries. The TMT B-A test appears to be relevant not only for the frontal areas but also for more remote areas such as the thalami, the insula and the deep periventricular white matter. (Hypertens Res 2008; 31: 1851-1857)	[Ben Salem, Douraied; Ricolfi, Frederic] Univ Hosp Dijon, Dept Neuroradiol, F-21033 Dijon, France; [Aho, Serge L.] Univ Hosp Dijon, Epidemiol Unit, F-21033 Dijon, France; [Walker, Paul M.; Brunotte, Francois] Univ Burgundy, CNRS, UMR 5158, Le2i, Dijon, France; [Bejot, Yannick; Rouaud, Olivier] Univ Burgundy, CEP EA 4184, Dijon, France; [Vernier, Beatrice T. A.] Dijon Three City Ctr, Dijon, France	Ben Salem, D (corresponding author), Univ Hosp Dijon, Dept Neuroradiol, 3 Rue Fg Raines, F-21033 Dijon, France.	douraied.bensalem@chu-dijon.fr	AHO, ludwig/AAR-5753-2021; Serge, Aho Glele Ludwig/AAP-8863-2021; Bejot, Yannick/D-3942-2019; BEJOT, Yannick/E-6088-2010; Salem, Douraied Ben/AAF-4698-2020	Serge, Aho Glele Ludwig/0000-0001-7590-8644; Bejot, Yannick/0000-0001-7848-7072; BEN SALEM, DOURAIED/0000-0001-5532-2208	Faculty of Medicine of Dijon; Fondation pour la Recherche MedicaleFondation pour la Recherche Medicale; Sanofi-Synthelabo Company	The spectroscopic part of this study was supported by a research grant from the Faculty of Medicine of Dijon. The Three-City study is supported by the Fondation pour la Recherche Medicale and the Sanofi-Synthelabo Company.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Beason-Held LL, 2007, STROKE, V38, P1766, DOI 10.1161/STROKEAHA.106.477109; Charlton RA, 2007, BRAIN RES, V1164, P108, DOI 10.1016/j.brainres.2007.06.027; Cook IA, 2002, ARCH NEUROL-CHICAGO, V59, P1612, DOI 10.1001/archneur.59.10.1612; Firbank MJ, 2007, J NEUROL, V254, P713, DOI 10.1007/s00415-006-0238-4; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fujishima M, 1995, Hypertens Res, V18, P111, DOI 10.1291/hypres.18.111; Gianaros PJ, 2006, NEUROIMAGE, V31, P754, DOI 10.1016/j.neuroimage.2006.01.003; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Goldstein IB, 1998, STROKE, V29, P765, DOI 10.1161/01.STR.29.4.765; Guenot M, 2004, ADV TECH STAND NEUR, V29, P265; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; Inzitari M, 2007, J NEUROL SCI, V257, P166, DOI 10.1016/j.jns.2007.01.026; KAWAMURA J, 1991, STROKE, V22, P609, DOI 10.1161/01.STR.22.5.609; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; Marshall GA, 2006, INT J GERIATR PSYCH, V21, P32, DOI 10.1002/gps.1419; MENTIS MJ, 1994, STROKE, V25, P601, DOI 10.1161/01.STR.25.3.601; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Miller SP, 2000, NEUROLOGY, V54, P1465, DOI 10.1212/WNL.54.7.1465; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; O'Sullivan M, 2005, NEUROLOGY, V65, P1584, DOI 10.1212/01.wnl.0000184480.07394.fb; Ohmine T, 2008, HYPERTENS RES, V31, P75, DOI 10.1291/hypres.31.75; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ross AJ, 2006, J GERONTOL A-BIOL, V61, P291, DOI 10.1093/gerona/61.3.291; SANDER D, 1994, STROKE, V25, P1730, DOI 10.1161/01.STR.25.9.1730; Sijens PE, 2003, RADIOLOGY, V226, P889, DOI 10.1148/radiol.2263011937; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; SULTZER DL, 1995, ARCH NEUROL-CHICAGO, V52, P773, DOI 10.1001/archneur.1995.00540320049012; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Twisk JWR., 2003, APPL LONGITUDINAL DA; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Walker PM, 2006, J NEUROL NEUROSUR PS, V77, P596, DOI 10.1136/jnnp.2005.078238; Walker PM, 2004, J NEUROL SCI, V220, P23, DOI 10.1016/j.jns.2004.01.012; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	42	13	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636			HYPERTENS RES	Hypertens. Res.	OCT	2008	31	10					1851	1857		10.1291/hypres.31.1851			7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	394QE	WOS:000262461400004	19015591	Bronze			2021-06-18	
J	Dudkiewicz, M; Harpaul, TA; Proctor, KG				Dudkiewicz, Michael; Harpaul, Tracey A.; Proctor, Kenneth G.			Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score=27-41)	CRITICAL CARE MEDICINE			English	Article						hemoglobin-based oxygen carrying compound; blood substitute; traumatic brain injury; cerebral perfusion pressure; blast; swine; combat casualty care	CROSS-LINKED HEMOGLOBIN; HUMAN POLYMERIZED HEMOGLOBIN; TRAUMATIC HEMORRHAGIC-SHOCK; CEREBRAL PERFUSION-PRESSURE; SMALL-VOLUME RESUSCITATION; BLOOD SUBSTITUTES; BRAIN-INJURY; HBOC-201; SWINE; TRIAL	Objective: A prehospital trial in trauma patients has been proposed to evaluate Hemopure (hemoglobin glutamer-250 [bovine], hemoglobin-based oxygen carrying compound [HBOC]-201, Biopure). We tested the hypothesis that HBOC-201 would improve cerebrovascular resuscitation in a unique polytrauma model. Design: Prospective, randomized, blinded animal study. Subjects: Thirty-two anesthetized swine (42 +/- 1 kg). Interventions: Blunt trauma to the head, right chest, and bilateral femurs (injury Severity Score = 27-41) with captive bolt guns was followed by hypoventilation. Resuscitation was divided into phases to simulate conventional treatment in the prehospital, emergency room, and early intensive care unit. For 30-60 mins postinjury, 500 mL of either normal saline (control, n = 14) or HBOC-201 (n = 14) was administered. All received similar care thereafter. For 60-120 mins, normal saline maintained systolic arterial pressure > 100 mm Hg and heart rate < 100 beats/min plus mannitol (250 mg/kg) for intracranial hypertension. For 120-480 mins, phenylephrine, normal saline, and dextrose were administered to maintain cerebral perfusion pressure >70 mm Hg, filling pressure >12 mm Hg, and plasma glucose >60 mg%, respectively. Two formulations of HBOC-201 (average MW = 250 kDa) were tested: one with < 3% 65 kDa tetramers (n = 7) and the other with <0.3% 65 kDa tetramers (n = 7). Measurements and Main Results: Injury severity is reflected by the death of 2 of 32 swine within 30 mins. In survivors (n = 30), systolic arterial pressure was 83 +/- 6 mm Hg, heart rate was 115 +/- 5 beats/min, and lactate was 5.8 +/- 0.4 mM. Intracranial pressure rose from 8 +/- 1 to 18 +/- 1 mm Hg and brain tissue Po-2 fell from 17 +/- 1 to 2 +/- 1 mm Hg. Without immediate resuscitation, death occurred within 60 mins (n = 2). With normal saline resuscitation (n = 14), systemic hemodynamics, mixed venous oxygen, renal oxygen, portal oxygen, and muscle oxygen corrected but there were four deaths (two at 45 mins, one at 100 mins, and one at 200 mins). Cerebral perfusion pressure was not restored until mannitol and pressor therapy were initiated at 120 mins. In contrast, with HBOC-201 at 30 mins (n = 14), systolic arterial pressure and cerebral perfusion pressure corrected immediately (both p < 0.05) and there were no deaths (p = 0.0978). After 8 hrs, in both groups, cerebral perfusion pressure, systolic arterial pressure, and heart rate were stable; peripheral oxygen saturations were near normal; lactate was cleared; urine output was adequate. However, with HBOC-201, pressor and fluid requirements were reduced by half, which improved intracranial pressure and brain tissue Po-2 (all p < 0.05 vs. control). Reducing tetramer content had no significant effect on the actions of HBOC-201. Conclusions: 1) A single bolus of HBOC-201 at initial resuscitation rapidly restored cerebral perfusion pressure and stabilized hemodynamics with improved intracranial pressure and brain oxygen for the first 8 hrs; and 2) HBOC-201 could be an effective salvage therapy after severe neurotrauma or as a temporizing measure during prolonged transport of a polytrauma patient.	[Dudkiewicz, Michael] Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA; Univ Miami, Div Surg Crit Care, Miami, FL 33136 USA	Dudkiewicz, M (corresponding author), Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA.	kproctor@miami.edu	Viani, Rafael/V-1196-2018		Naval Medical Research Center [N140610670]	Supported, in part, by grant N140610670 from the Office of Naval Research and by a grant from the Naval Medical Research Center.	Alam HB, 2000, J SURG RES, V94, P145, DOI 10.1006/jsre.2000.6011; Ayuste EC, 2006, J TRAUMA, V60, P52, DOI 10.1097/01.ta.0000200156.05397.0b; Bloomfield EL, 2004, MIL MED, V169, P546, DOI 10.7205/MILMED.169.7.546; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Deltch EA, 2003, J TRAUMA, V54, P139; DeWitt DS, 2000, CRIT CARE MED, V28, P3933, DOI 10.1097/00003246-200012000-00036; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; GEORGE I, 2001, AM J PHYSIOL-HEART C, V291, pH1126; Gould SA, 1998, J AM COLL SURGEONS, V187, P113, DOI 10.1016/S1072-7515(98)00095-7; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Gould SA, 1998, J AM COLL SURGEONS, V187, P121; Gould SA, 2002, J AM COLL SURGEONS, V195, P52, DOI DOI 10.1016/S1072-7515(02)01335-2; Hess J R, 1989, Prog Clin Biol Res, V319, P351; Hess J.R., 1989, PROG CLIN BIOL RES, V319, P358; Huynh T, 2006, J TRAUMA, V61, P97; Johnson JL, 2001, J TRAUMA, V50, P449, DOI 10.1097/00005373-200103000-00008; Johnson JL, 2003, J TRAUMA, V54, P133, DOI 10.1097/00005373-200301000-00016; Johnson T, 2006, CRIT CARE MED, V34, P1464, DOI 10.1097/01.CCM.0000215824.85190.89; Kaplan LJ, 2006, J TRAUMA, V61, P90, DOI 10.1097/01.ta.0000222578.85413.4e; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Kerner T, 2003, INTENS CARE MED, V29, P378, DOI 10.1007/s00134-002-1622-x; King DR, 2005, J TRAUMA, V59, P853, DOI 10.1097/01.ta.0000187656.26849.39; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Koustova E, 2002, J TRAUMA, V52, P872, DOI 10.1097/00005373-200205000-00009; Lee SK, 2002, ACAD EMERG MED, V9, P969; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Manley GT, 2003, ADV EXP MED BIOL, V530, P311; Maxwell RA, 2000, J TRAUMA, V49, P200, DOI 10.1097/00005373-200008000-00005; Moore EE, 2003, J AM COLL SURGEONS, V196, P1, DOI 10.1016/S1072-7515(02)01704-0; Moore EE, 2006, WORLD J SURG, V30, P1247, DOI 10.1007/s00268-005-0499-6; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Proctor KG, 2003, J TRAUMA, V54, pS106, DOI 10.1097/01.TA.0000047222.96258.0D; Przybelski R J, 1999, Prehosp Disaster Med, V14, P251; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rice J, 2008, J TRAUMA, V64, P1240, DOI 10.1097/TA.0b013e318058245e; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schubert A, 2003, ANESTH ANALG, V97, P323, DOI 10.1213/01.ANE.0000068888.02977.DA; Schubert A, 2002, ARTIF CELL BLOOD SUB, V30, P259, DOI 10.1081/BIO-120006118; Shackford SR, 2005, J TRAUMA, V59, P560; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sloan EP, 2002, J TRAUMA, V52, P887, DOI 10.1097/00005373-200205000-00011; Stanton K, 2003, J TRAUMA, V54, P1065, DOI 10.1097/01.TA.0000058123.05571.9E; *US FDA, GUID IND CRIT SAF EF; WINSLOW RM, 1966, J BIOL CHEM, V241, P1144; Winslow RM, 2000, VOX SANG, V79, P1; SAFETY EFFICACY POLY	52	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2008	36	10					2838	2848		10.1097/CCM.0b013e318186f6b3			11	Critical Care Medicine	General & Internal Medicine	356GF	WOS:000259766000018	18766094				2021-06-18	
J	Figaji, AA; Zwane, E; Fieggen, AG; Peter, JC; LeRoux, PD				Figaji, Anthony A.; Zwane, Eugene; Fieggen, A. Graham; Peter, Jonathan C.; LeRoux, Peter D.			Acute clinical grading in pediatric severe traumatic brain injury and its association with subsequent intracranial pressure, cerebral perfusion pressure, and brain oxygenation	NEUROSURGICAL FOCUS			English	Article						brain oxygenation; cerebral perfusion pressure; clinical assessment; Glasgow Coma Scale; secondary insult; traumatic brain injury	SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC FACTORS; CHILDREN; HYPOTENSION; MORTALITY; CARE; EXPERIENCE; HYPOXIA; SCALE	Object. The goal of this paper was to examine the relationship between methods of acute clinical assessment and measures of secondary cerebral insults in severe traumatic brain injury in children. Methods. Patients who underwent intracranial pressure (ICP), cerebral perfusion pressure (CPP), and brain oxygenation (PbtO(2)) monitoring and who had an initial Glasgow Coma Scale score, Pediatric Trauma Score, Pediatric Index of Mortality 2 score, and CT classification were evaluated. The relationship between these acute clinical scores and secondary cerebral insult measures, including ICP, CPP, PbtO(2), and systemic hypoxia were evaluated using univariate and multivariate analysis. Results. The authors found significant associations between individual acute clinical scores and select physiological markers of secondary injury. However, there was a large amount of variability in these results, and none of the scores evaluated predicted each and every insult. Furthermore, a number of physiological measures were not predicted by any of the scores. Conclusions. Although they may guide initial treatment, grading systems used to classify initial injury severity appear to have a limited value in predicting who is at risk for secondary cerebral insults.	[Figaji, Anthony A.; Fieggen, A. Graham; Peter, Jonathan C.] Univ Cape Town, Red Cross Childrens Hosp, Inst Child Hlth, Sch Child & Adolescent Hlth,Div Neurosurg, ZA-7925 Cape Town, South Africa; [Figaji, Anthony A.; Fieggen, A. Graham] Univ Cape Town, Red Cross Childrens Hosp, Inst Child Hlth, Sch Child & Adolescent Hlth,Div Pediat Neurosci, ZA-7925 Cape Town, South Africa; [Zwane, Eugene] Univ Cape Town, Sch Publ Hlth & Family Med, Infect Dis Epidemiol Unit Biostat, ZA-7700 Rondebosch, South Africa; [LeRoux, Peter D.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Figaji, AA (corresponding author), Red Cross War Mem Childrens Hosp, Inst Child Hlth 617, Klipfontein Rd, ZA-7700 Rondebosch, Cape Town, South Africa.	Anthony.Figaji@uct.ac.za		Fieggen, Graham/0000-0001-6541-8377; Figaji, Anthony/0000-0002-3357-6490	Integra Foundation	Anthony Figaji and Peter LeRoux have received a grant for the study of perfusion pressure thresholds in pediatric traumatic brain injury from the Integra Foundation.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Ananda A, 1999, ACTA NEUROCHIR SUPPL, V73, P99; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Grinkeviciute DE, 2007, MEDICINA-LITHUANIA, V43, P861, DOI 10.3390/medicina43110111; JENNETT B, 1975, LANCET, V1, P480; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	31	13	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2008	25	4							E4	10.3171/FOC.2008.25.10.E4			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	355HX	WOS:000259701100004	18828702	Bronze			2021-06-18	
J	Cengiz, P; Zemlan, F; Ellenbogen, R; Hawkins, D; Zimmerman, JJ				Cengiz, Pelin; Zemlan, Frank; Ellenbogen, Richard; Hawkins, Douglas; Zimmerman, Jerry J.			Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hydrocephalus; cleaved-tau protein; 9-hydroxyoctadecadienoic acid; cerebrospinal fluid; neurological injury; neuronal injury; lipid peroxidation	TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION PROCESSES; CHILDHOOD HYDROCEPHALUS; INTRACRANIAL-PRESSURE; BACTERIAL-MENINGITIS; NEURONAL DAMAGE; LINOLEIC-ACID; FATTY-ACID; RAT-BRAIN; C-TAU	Objective: To ascertain if cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid, reflecting potential biomarkers of overall neuronal injury and lipid peroxidation, respectively, are elevated in hydrocephalus patients compared with controls, and if cleaved-tau and 9-hydroxyoctadecadienoic acid levels correlate with each other. Design: Prospective clinical observational study. Setting: Tertiary-care children's hospital. Patients: Children younger than or equal to 18 yrs who underwent ventriculoperitoneal shunt placement or revision surgery for intrinsic hydrocephalus. Measurements and Main Results: During the study period 12 patients with intrinsic hydrocephalus required ventriculoperitoneal shunt placement or revision. Cerebrospinal fluid cleaved-tau levels were significantly elevated in patients with hydrocephalus (44.7 +/- 9.6 ng/mL, n = 11) compared with control patients (0.0 +/- 0.0 ng/mL, n = 9; p < 0.0001). Cleaved-tau levels correlated with patient age (r = .609, p = 0.047) and duration of symptoms (r = .755, p = 0.007). No significant difference in cerebrospinal fluid 9-hydroxyoctadecadienoic acid levels between patients with hydrocephalus (24.6 +/- 5.7, n = 8) and control patients (24.9 +/- 9.3 ng/mL, n = 7) was detected (p = 0.25). There was also no statistically significant correlation between 9-hydroxyoctadecadienoic acid levels and duration of symptoms (r = .668, p = 0.07), nor was there a significant correlation between 9-hydroxyoctadecadienoic acid levels and patient age (r = -.011, p > 0.10). There was no significant relationship between 9-hydroxyoctadecadienoic acid levels and signs of elevated intracranial pressure, nor was there a correlation between 9-hydroxyoctadecadienoic acid levels and cleaved-tau levels. Conclusion: Children with hydrocephalus who have clinical signs of increased intracranial pressure and require ventriculoperitoneal shunt placement or revision exhibit markedly elevated cerebrospinal fluid cleaved-tau levels, suggesting evidence of axonal damage. However, this axonal injury does not seem to be associated with significant lipid peroxidation, at least as assessed by quantifying cerebrospinal fluid 9-hydroxyoctadecadienoic acid at a single, concurrent time point. The significant relationship between age and cerebrospinal fluid cleaved-tau levels suggest that brain injury associated with hydrocephalus may be more pronounced in older children. (Pediatr Crit Care Med 2008; 9:524-529)	[Cengiz, Pelin] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Cengiz, Pelin] Univ Wisconsin, Childrens Hosp, Dept Pediat, Madison, WI USA; [Zemlan, Frank] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA; [Ellenbogen, Richard] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hawkins, Douglas; Zimmerman, Jerry J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Cengiz, P (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	cengiz@pediatrics.wisc.edu					Balasubramaniam J, 2002, EXP NEUROL, V173, P105, DOI 10.1006/exnr.2001.7831; Barnes NP, 2002, ARCH DIS CHILD, V87, P198, DOI 10.1136/adc.87.3.198; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Beems T, 2003, ACTA NEUROCHIR, V145, P37, DOI 10.1007/s00701-002-1019-1; CAMACHO M, 1995, J BIOL CHEM, V270, P17279, DOI 10.1074/jbc.270.29.17279; CANER H, 1993, ACTA NEUROCHIR, V121, P68, DOI 10.1007/BF01405185; COBBS CS, 1995, CANCER RES, V55, P727; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P355, DOI 10.1210/jc.86.1.355; Del Bigio MR, 2004, BRAIN PATHOL, V14, P317; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Felderhoff-Mueser U, 2001, ARCH DIS CHILD, V84, P369, DOI 10.1136/adc.84.4.369; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GOH D, 1995, CHILD NERV SYST, V11, P392, DOI 10.1007/BF00717403; HENRICKS PAJ, 1991, PROSTAGLANDINS, V41, P21, DOI 10.1016/0090-6980(91)90101-K; Hochhaus F, 2001, BMC Pediatr, V1, P2, DOI 10.1186/1471-2431-1-2; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; ILLINGWORTH DR, 1971, J NEUROCHEM, V18, P769, DOI 10.1111/j.1471-4159.1971.tb12006.x; Inouye M, 1999, BBA-MOL CELL BIOL L, V1438, P204, DOI 10.1016/S1388-1981(99)00052-9; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; Irazuzta JE, 2002, CRIT CARE MED, V30, P2553, DOI 10.1097/00003246-200211000-00025; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Iskandar BJ, 1998, PEDIATRICS, V101, P1031, DOI 10.1542/peds.101.6.1031; Koehne P, 2002, CHILD NERV SYST, V18, P137, DOI 10.1007/s00381-002-0567-2; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Kreil P, 1998, Z NATURFORSCH C, V53, P876; KU G, 1992, J BIOL CHEM, V267, P14183; Kudo T, 2000, PSYCHIAT CLIN NEUROS, V54, P199, DOI 10.1046/j.1440-1819.2000.00658.x; Li WG, 2003, FREE RADICAL BIO MED, V34, P937, DOI 10.1016/S0891-5849(03)00032-7; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; METZGER K, 1995, FREE RADICAL BIO MED, V18, P185, DOI 10.1016/0891-5849(94)00108-V; Nussinovitch M, 2001, ACTA PAEDIATR, V90, P972; ONODERA Y, 1977, CHILD BRAIN, V3, P101; ONODERA Y, 1982, CHILD BRAIN, V9, P95; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Radwanska-Wala B, 2002, PATHOL RES PRACT, V198, P421, DOI 10.1078/0344-0338-00275; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Spindler SA, 1996, BIOCHEM BIOPH RES CO, V218, P187, DOI 10.1006/bbrc.1996.0033; Spiteller G, 2003, MED HYPOTHESES, V60, P69, DOI 10.1016/S0306-9877(02)00333-X; STOLL LL, 1994, AM J PHYSIOL, V266, pC990; Straiko MMW, 2006, J NEUROSCI RES, V84, P1116, DOI 10.1002/jnr.21002; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TICHY J, 1979, J CHROMATOGR, V162, P185, DOI 10.1016/S0378-4347(00)81912-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Yoshida Y, 2006, NUTRITION, V22, P303, DOI 10.1016/j.nut.2005.07.020; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2003, NEUROSCIENCE, V121, P399, DOI 10.1016/S0306-4522(03)00459-7; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	51	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535			PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2008	9	5					524	529		10.1097/PCC.0b013e3181849dc9			6	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	360NK	WOS:000260064000011	18679140				2021-06-18	
J	Faleiro, RM; Faleiro, LCM; Caetano, E; Gomide, I; Pita, C; Coelho, G; Bras, E; Carvalho, B; Gusmao, SNS				Faleiro, Rodrigo Moreira; Faleiro, Luiz Carlos Mendes; Caetano, Elisa; Gomide, Isabella; Pita, Cristina; Coelho, Gustavo; Bras, Ellen; Carvalho, Bruna; Silva Gusmao, Sebastiao Nataniel			Decompressive craniotomy - Prognostic factors and complications in 89 patients	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						head injury; intracranial hypertension; decompressive craniotomy	SEVERE HEAD-INJURY; MASS LESIONS; CRANIOPLASTY; CRANIECTOMY; MANAGEMENT; REDUCTION; CHILDREN	Decompressive craniotomy (DC) is applied to treat post-traumatic intracranial hypertension (ICH). The purpose of this study is to identify prognostic factors and complications of unilateral DC. Eighty-nine patients submited to unilateral DC were retrospectively analyzed over a period of 30 months. Qui square independent test and Fisher test were used to identify prognostic factors. The majority of patients were male (87%). Traffic accidents had occurred in 47% of the cases. 64% of the patients had suffered severe head injury, while pupillary abnormalities were already present in 34%. Brain swelling plus acute subdural hematoma were the most common tomographic findings (64%). Complications occurred in 34.8% of the patients: subdural effusions in 10 (11.2%), hydrocephalus in 7 (7.9%) and infection in 14 (15.7%). The admittance Glasgow coma scale was a statistically significant predictor of outcome (p=0.0309).	Hosp Pronto Socorro Joao XXIII FHEMIG, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Felicio Rocho & HPS J23, Belo Horizonte, MG, Brazil; FCMMG, Sch Med Sci Minas Gerais, Belo Horizonte, MG, Brazil; [Silva Gusmao, Sebastiao Nataniel] Hosp Clin UFMG, Belo Horizonte, MG, Brazil	Faleiro, RM (corresponding author), Rua Caraca 518-201, BR-30220260 Belo Horizonte, MG, Brazil.	rfaleiro@brfree.com.br					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper P R, 1976, Surg Neurol, V5, P25; DOSS K, 2005, ANNS ORG LIB; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; IWAMA T, 2002, NEUROSURGERY, V52, P501; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT WB, 1960, J NEUROSURG, V17, P598, DOI 10.3171/jns.1960.17.4.0598; MARMAROU A, 1989, INTRACRANIAL PRESSUR, P549; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Missori P, 2003, ACTA NEUROCHIR, V145, P899, DOI 10.1007/s00701-003-0118-y; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; PEREIRA WC, 1977, ARQ NEURO-PSIQUIAT, V35, P99, DOI 10.1590/S0004-282X1977000200002; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SILVA JA, 1976, ARQ NEURO-PSIQUIAT, V34, P232; WHITFIELD P, 1995, STROKE, V26, P1125; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Woolf JI, 1945, INT ABSTR SURG, V81, P1; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	30	13	14	0	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2008	66	2B					369	373		10.1590/S0004-282X2008000300017			5	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	327WV	WOS:000257760100017	18641874	DOAJ Gold			2021-06-18	
J	Suma, T; Koshinaga, M; Fukushima, M; Kano, T; Katayama, Y				Suma, Takeshi; Koshinaga, Morimichi; Fukushima, Masamichi; Kano, Tsuneo; Katayama, Yoichi			Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article; Proceedings Paper	American-Heart-Association International Stroke Conference 2008	FEB 20-22, 2008	New Orleans, LA			astroglial swelling; excitatory amino acid; microglial reaction; traumatic brain injury; traumatic depolarization	SPREADING DEPRESSION; EXTRACELLULAR POTASSIUM; GLUCOSE-UTILIZATION; CORTICAL CONTUSION; CEREBRAL-CORTEX; SPINAL-CORD; ASTROCYTES; GLUTAMATE; RELEASE; CELLS	Objective: Both microglia and astrocytes respond immediately to traumatic brain injury (TBI). The present study was undertaken to examine whether or not excitatory amino acid (EAA) antagonists could attenuate such glial responses. Methods: EAA antagonists, including the broad spectrum EAA antagonist, kynurenic acid (KYN), specific N-methyl-D-aspartate (NMDA) receptor blocker, 2-amino-5-phosphonovalerate (AP-5), and AMPA-KA receptor blocker, 6,7-dinitroquinoxaline-2,3-dione (DNQX), as well as the voltage-dependent ion channel blocker, tetrodotoxin (TTX), were administered into the unilateral hippocampus of rats through a dialysis probe for 30 minutes before the induction of unilateral controlled cortical impact injury. The rats were killed 10 minutes after injury and their brains were processed immunohistochemically for OX42 (marker for microglia) and glial fibrillary acidic protein (GFAP; marker for astrocytes). Objective: Ten minutes after injury, microglial activation with increased OX42 immunoreactivity was evident in the entire hemisphere including the hippocampus ipsilateral to the injury side. Similarly, swollen astrocytes with increased GFAP expression could be detected exclusively on the injury side. When KYN was administered in situ before injury, both the rapid microglial and astroglial responses in the hippocampus were significantly attenuated. However, AP-5, DNQX and TTX, the voltage-dependent ion channel blocker, at doses which can inhibit each channel activation, failed to attenuate these glial reactions. Discussion: These findings indicate that massive ionic fluxes and/or concomitantly occurring EAA release may be closely related to the initiation of microglial and astroglial responses following TBI.	[Koshinaga, Morimichi] Nihon Univ, Sch Med, Dept Anat, Itabashi Ku, Tokyo 1738610, Japan; [Suma, Takeshi; Koshinaga, Morimichi; Fukushima, Masamichi; Kano, Tsuneo; Katayama, Yoichi] Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, Tokyo 1738610, Japan	Koshinaga, M (corresponding author), Nihon Univ, Sch Med, Dept Anat, Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	koshimo@med.nihon-u.ac.jp					Abe K, 2000, BIOL PHARM BULL, V23, P1051; Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; AQUINO DA, 1988, J NEUROCHEM, V51, P1085, DOI 10.1111/j.1471-4159.1988.tb03072.x; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BENVENISTE EN, 1997, IMMUNOLOGY NERVOUS S, P419; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Caggiano AO, 1996, J COMP NEUROL, V369, P93, DOI 10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F; Chang RCC, 2000, NEUROSCIENCE, V97, P757, DOI 10.1016/S0306-4522(00)00059-2; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chung S, 1998, NEUROSCI LETT, V242, P73, DOI 10.1016/S0304-3940(98)00029-9; Del Rio-Hortega R., 1965, CYTOLOGY CELLULAR PA, P483; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dombro RS, 2000, INT J DEV NEUROSCI, V18, P161, DOI 10.1016/S0736-5748(99)00084-2; Duchen L. W, 1984, GREENFIELDS NEUROPAT, P1; Eder C, 1999, EUR J NEUROSCI, V11, P4251, DOI 10.1046/j.1460-9568.1999.00852.x; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; HAMBERGER A, 1979, BRAIN RES, V168, P531, DOI 10.1016/0006-8993(79)90307-X; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P8, DOI 10.1098/rspb.1967.0010; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; KETTENMANN H, 1993, GLIA, V7, P93, DOI 10.1002/glia.440070115; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kraig Richard P., 1995, P964; KRAIG RP, 1991, J NEUROSCI, V11, P2187; KREUTZBERG GW, 1987, ENCY NEUROSCIENCE, P661; Maeda T, 1997, ACT NEUR S, V70, P102; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; Miele M, 1996, J PHYSIOL-LONDON, V497, P745, DOI 10.1113/jphysiol.1996.sp021805; MURPHY S, 1987, NEUROSCIENCE, V22, P381, DOI 10.1016/0306-4522(87)90342-3; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6; NORENBERG MD, 1982, J NEUROPATH EXP NEUR, V41, P347, DOI 10.1097/00005072-198205000-00026; OCHS S, 1971, J NEUROCHEM, V18, P107, DOI 10.1111/j.1471-4159.1971.tb00172.x; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; PUEL JL, 1994, J COMP NEUROL, V341, P241, DOI 10.1002/cne.903410209; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SHIMOHAMA S, 1989, MOL BRAIN RES, V5, P271, DOI 10.1016/0169-328X(89)90061-2; Sperlagh B, 1998, NEUROSCIENCE, V86, P1195, DOI 10.1016/S0306-4522(98)00026-8; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; SUGAYA E, 1975, J NEUROPHYSIOL, V38, P822; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Vernadakis A, 1996, PROG NEUROBIOL, V49, P185, DOI 10.1016/S0301-0082(96)00012-3; WALZ W, 1989, PROG NEUROBIOL, V33, P309, DOI 10.1016/0301-0082(89)90005-1; WALZ W, 1993, J NEUROSCI, V13, P4403; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0	57	13	15	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2008	30	4					420	429		10.1179/016164107X251745			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	314VR	WOS:000256837800019	18248696				2021-06-18	
J	Yap, SGM; Chua, KSG				Yap, Samantha G. M.; Chua, Karen S. G.			Rehabilitation outcomes in elderly patients with traumatic brain injury in Singapore	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability; elderly; head injury; neurorehabilitation; outcomes	OLDER PATIENTS; UNITED-STATES; HEAD-INJURY; MORTALITY; RECOVERY; ADULTS; WORSE; AGE	Objective: To identify and characterize injury variables and outcomes in persons with traumatic brain injury (TBI) 55 years and older admitted to a tertiary rehabilitation unit. Design: Retrospective study of 52 individuals with TBI covering a 4-year period. Outcome measures: Admission and discharge Modified Barthel Index scores; total acute and rehabilitation length of stay; Glasgow Coma Scale (GCS); duration of posttraumatic amnesia (PTA); Glasgow Outcome Scale at discharge and at 6 months postinjury; Ranchos Los Amigos Scale; and discharge disposition. Results: Most common mechanism of injury was falls (61.5%), and predominant computed tomographic scan finding was lobar contusion (44%). Thirty-one percent had GCS score less than 9, but 90% had PTA duration of more than I week. Mean length of stay in acute and rehabilitation facilities was 26.4 (SD = 15.9) days and 29.8 (SD = 14.4) days, respectively. Difference between admission and discharge Modified Barthel Index was significant (P < .001), and 90% were discharged home. There was improvement in Glasgow Outcome Scale score at 6 months. Conclusions: Most patients in this cohort had severe brain injury, which may be due to a higher incidence of intracerebral hematoma. The GCS score underestimates the severity of brain injury in elderly persons with TBI; PTA duration was more representative of severity. Older patients with TBI do benefit from rehabilitation with significant functional gains and a high rate of return to home and to community.	[Yap, Samantha G. M.; Chua, Karen S. G.] Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore	Yap, SGM (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mokio Ave 9, Singapore 569766, Singapore.	samantha_yap@ttsh.com.sg					Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GOODMAN H, 1992, PHYS MED REH CLIN N, V3, P441; HORN LJ, 1992, PHYS MED REHAB CLIN, V3, P475; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1995, EPIDEMIOLOGY BRAIN I; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; MCKISSOCK W, 1960, LANCET, V1, P1365; MILLER J D, 1989, Neurosurgical Review, V12, P441; *MIN HLTH, 2006, HLTH FACTS SING; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; PERMINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; *SING DEP STAT, KEY IND POP; *SING DEP STAT, 2006, SING RES AG GROUP ET; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 2001, HEAD TRAUMA, P327; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traynelis V C, 1991, Clin Geriatr Med, V7, P583; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	31	13	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2008	23	3					158	163		10.1097/01.HTR.0000319932.15085.fe			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	309XN	WOS:000256493600004	18520428				2021-06-18	
J	McDonald, A; Lindell, M; Dunger, DB; Acerini, CL				McDonald, Anna; Lindell, Margaretha; Dunger, David B.; Acerini, Carlo L.			Traumatic brain injury is a rarely reported cause of growth hormone deficiency	JOURNAL OF PEDIATRICS			English	Article							ANTERIOR-PITUITARY DYSFUNCTION; OF-THE-LITERATURE; HEAD-INJURY; LONG-TERM; HYPOPITUITARISM; CHILDREN; ABNORMALITIES; PREVALENCE; TBI	We determined the frequency of traumatic brain injury (TBI)-related growth hormone deficiency (GHD) from a large registry of growth hormone-deficient subjects and compared these subjects' clinical characteristics with those of children with idiopathic growth hormone deficiency (IGHD). A surprisingly small number of subjects with TBI-induced GHD (n = 141) were registered compared with those with IGHD (n = 23,722). At onset of treatment, the subjects with TBI-induced GHD were older (P = .045), had lower height velocity (P < .001), had a greater number of other pituitary hormone deficiencies (P < .001) and, after a year of recombinant human GH treatment, demonstrated a greater change in height velocity (P = .016). We speculate that TBI-induced GHD may be a neglected phenomenon in childhood, and recommend prospective longitudinal studies to explore its natural history and frequency.	[McDonald, Anna; Dunger, David B.; Acerini, Carlo L.] Univ Cambridge, Dept Pediat, Cambridge, England; [Lindell, Margaretha] Pfizer Inc, KIGS, Stockholm, Sweden	Acerini, CL (corresponding author), Addenbrookes Hosp, Dept Pediat, Level 8,Box 116, Cambridge CB2 2OO, England.	cla22@cam.ac.uk		Dunger, Professor David/0000-0002-2566-9304; Acerini, Carlo/0000-0003-2121-5871			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Dogru O, 2005, NEUROENDOCRINOL LETT, V26, P311; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lehnung M, 2001, CHILD NEUROPSYCHOL, V7, P59, DOI 10.1076/chin.7.2.59.3129; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Verger K, 2000, BRAIN INJURY, V14, P495	21	13	13	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2008	152	4					590	593		10.1016/j.jpeds.2007.12.046			4	Pediatrics	Pediatrics	282BS	WOS:000254543200040	18346522				2021-06-18	
J	Lemoyne, R; Dabiri, F; Jafari, R				Lemoyne, Robert; Dabiri, Foad; Jafari, Roozbeh			Quantified deep tendon reflex device, second generation	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article; Proceedings Paper	15th Biennial International Conference on Mechanics in Medicine and Biology	DEC 05-08, 2006	HI	Nanyang Technol Univ, Pacific Cent ThermalFluids Engn		reflex quantification; accelerometers; neurorehabilitation; traumatic brain injury	QUANTITATIVE-EVALUATION; STRETCH REFLEX; SPASTICITY	The deep tendon reflex is a fundamental aspect of neurological examinations. The severity of and degree of recovery from a traumatic brain injury can be assessed by the myotatic stretch reflex. A hyperactive reflex response is correlated with spasticity, which can also be correlated with the degree of damage to the supraspinal input, in essence assessing the severity of traumatic brain injury. The myotatic stretch reflex is clinically evaluated by the National Institute of Neurological Disorders and Stroke (NINDS) reflex scale (0-4); however, this scale lacks temporal data and may also vary in interpretation. The solution is a fully quantified evaluation system of the myotatic stretch reflex, whereby a patellar hammer's force input is based on original potential energy and a microelectromechanical system (MEMS) accelerometer quantifies the output. The MEMS accelerometer is attached to a set anchor point near the ankle. The reflex amplitude is based on the maximum acceleration of the reflex response. The quantified data collected from MEMS accelerometers are transmitted by a portable computer (i.e. a Pocket PC). This paper describes a device that quantitatively evaluates the reflex response using accelerometers and that demonstrates precision for reproducibility.	[Lemoyne, Robert] Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90095 USA; [Dabiri, Foad; Jafari, Roozbeh] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA	Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, 5121 Engn 5,Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			Cozens JA, 2000, J NEUROL NEUROSUR PS, V68, P581, DOI 10.1136/jnnp.68.5.581; Faist M, 1999, BRAIN, V122, P567, DOI 10.1093/brain/122.3.567; JAFARI R, 2005, 2 ACM IEEE INT C MOB; Lebiedowska MK, 2003, ARCH PHYS MED REHAB, V84, P828, DOI 10.1016/S0003-9993(02)04946-8; LEMOYNE R, 2005, UCLA COMMUNICATION N; LEMOYNE R, 2006, 15 INT C MECH MED BI; LEMOYNE R, 2005, 35 SOC NEUR ANN M WA; LEMOYNE R, 2006, 36 SOC NEUR ANN M; Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; Pagliaro P, 1999, J ELECTROMYOGR KINES, V9, P141, DOI 10.1016/S1050-6411(98)00045-5; VandeCrommert HWAA, 1996, BRAIN RES, V734, P341, DOI 10.1016/0006-8993(96)00885-2; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	13	13	13	0	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194			J MECH MED BIOL	J. Mech. Med. Biol.	MAR	2008	8	1					75	85		10.1142/S0219519408002462			11	Biophysics; Engineering, Biomedical	Biophysics; Engineering	321GC	WOS:000257291700008					2021-06-18	
J	Makulski, DD; Taber, KH; Chiou-Tan, FY				Makulski, Darlene D.; Taber, Katherine H.; Chiou-Tan, Faye Y.			Neuroimaging in posttraumatic hypopituitarism	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						posttraumatic hypopituitarism; traumatic brain injury; diabetes insipidus	TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; PITUITARY-GLAND; ACUTE-PHASE; MR-IMAGES; PREVALENCE; LESIONS; ENHANCEMENT	Posttraumatic hypopituitarism is the failure of the hypothalamic-pituitary axis secondary to traumatic brain injury. It can clinically present as decreased muscle mass, concentration, libido, and fertility. It can also present as increased fatigue, depression, and cognitive deficits. In addition, electrolyte abnormalities such as hyponatremia can occur in hypopituitarism. As a result of heightened awareness of posttraumatic hypopituitarism, it is a phenomenon that is becoming more commonly diagnosed. Posttraumatic hypopituitarism is a diagnosis based on clinical evaluation, laboratory testing, and neuroimaging. Of the radiological techniques, magnetic resonance imaging is the preferred technique to image the pituitary gland. This article contains coronal and sagittal magnetic resonance imaging of the posterior fossa, illustrating the normal hypothalamus and pituitary gland as well as adjacent structures. The sequential enhancement pattern of the normal pituitary gland is consistent with its vascular supply. A colored illustration was created to display the vascular supply to the hypothalamus, pituitary stalk, and pituitary gland.	[Taber, Katherine H.; Chiou-Tan, Faye Y.] Harris Cty Hosp Dist, Quentin Mease Hosp, Ctr Trauma Rehabil Res, Dept Phys Med & Rehabil, Houston, TX 77004 USA; [Makulski, Darlene D.; Chiou-Tan, Faye Y.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Taber, Katherine H.] WG Bill Hefner Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Taber, Katherine H.] Virginia Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA	Chiou-Tan, FY (corresponding author), Harris Cty Hosp Dist, Quentin Mease Hosp, Ctr Trauma Rehabil Res, Dept Phys Med & Rehabil, 3601 N MacGregor,Suite 240, Houston, TX 77004 USA.		Taber, Katherine H/B-8260-2011	Taber, Katherine H/0000-0001-7382-6151			Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; BENVEGA S, 2000, J CLIN ENDOCR METAB, V85, P675; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Ceballos R, 1966, Ala J Med Sci, V3, P185; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; COLOMBO N, 1987, RADIOLOGY, V165, P481, DOI 10.1148/radiology.165.2.3659370; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DENGHUANG S, 2005, J FORMOS MED ASSOC, V104, P463; Grossman RI., 2003, NEURORADIOLOGY REQUI, V2nd ed.; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; JAKUBOWSKI J, 1995, BRIT J NEUROSURG, V9, P331, DOI 10.1080/02688699550041340; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LUIGI M, 1997, CLIN IMAG, V21, P311; Ma L, 1996, CHINESE MED J-PEKING, V109, P724; Mai J.K., 2004, ATLAS HUMAN BRAIN; MARK AS, 1992, RADIOLOGY, V182, P49, DOI 10.1148/radiology.182.1.1727308; MIKI Y, 1990, RADIOLOGY, V178, P441; NOLTE J, 2002, HIONAN BRAIN INTRO I; Nussey, 2001, ENDOCRINOLOGY INTEGR; Pisaneschi M, 2005, NEUROIMAG CLIN N AM, V15, P203, DOI 10.1016/j.nic.2005.02.007; Saleem SN, 2007, RADIOGRAPHICS, V27, P1087, DOI 10.1148/rg.274065123; SATO N, 1993, RADIOLOGY, V186, P357, DOI 10.1148/radiology.186.2.8421734; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; TIEN R, 1991, AM J NEURORADIOL, V12, P533; TIEN RD, 1992, AM J ROENTGENOL, V158, P651, DOI 10.2214/ajr.158.3.1739013; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; YUH WTC, 1994, AM J NEURORADIOL, V15, P101	33	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAR-APR	2008	32	2					324	328		10.1097/RCT.0b013e3181636ed4			5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	284CS	WOS:000254683500031	18379326				2021-06-18	
J	Shafi, NI; Andresen, J; Marrelli, SP; Bryan, RM				Shafi, Nadeem I.; Andresen, Jon; Marrelli, Sean P.; Bryan, Robert M., Jr.			Erythropoietin potentiates EDHF-Mediated dilations in rat middle cerebral arteries	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; EDHF; erythropoietin; therapeutic approaches for the treatment of CNS injury; vascular reactivity	RECOMBINANT-HUMAN-ERYTHROPOIETIN; NITRIC-OXIDE SYNTHASE; CORTICAL IMPACT INJURY; TRAUMATIC BRAIN-INJURY; HYPERPOLARIZING FACTOR; IN-VITRO; SUBARACHNOID HEMORRHAGE; VASCULAR PROTECTION; BLOOD-FLOW; RECEPTOR	The neuroprotective effects of exogenous erythropoietin ( EPO) in animals and humans after brain injury may be afforded, in part, by the influence of EPO on cerebral arteries. We tested ( 1) if EPO itself is vasoactive and ( 2) if EPO enhances endothelium-mediated dilations, specifically those mediated by endothelium-derived hyperpolarizing factor ( EDHF). Immunoblotting and reverse transcriptase - polymerase chain reaction ( RT-PCR) were used to detect EPO receptor. Rat middle cerebral arteries ( MCAs) were isolated, pressurized, and perfused in vitro. EPO was directly applied to MCAs to test its vasoactivity. Endothelium-mediated dilations were elicited by UTP, whereas EDHF-mediated dilations were elicited by UTP after inhibition of endothelial nitric oxide synthase and cyclooxygenase. mRNA and protein for EPO receptor was found in rat MCA. Abluminal application of 0.001 - 10 U/mL EPO, which is selective for vascular smooth muscle, did not alter vessel diameter. In contrast, luminal application of EPO, which is selective for endothelium, resulted in concentration-dependent dilations of up to 39 +/- 16% at 10 U/mL ( p = 0.0018), though responses were variable. A single dose of EPO ( 1,000 U/kg) administered to rats 24 h prior to examining vascular function potentiated dilations to UTP 2.6-fold ( p < 0.0001). EDHF-mediated dilations were potentiated 2.1-fold following in vivo EPO treatment ( p = 0.0034). This study demonstrates that EPO can directly dilate rat MCAs via the endothelium, though not all vessels are responsive. Additionally, pre-treatment with EPO for 24 h in vivo potentiates endothelium-mediated dilations, specifically those mediated by EDHF. Thus, enhanced endothelium-mediated dilations may partially underlie the neuroprotective effects of EPO after brain injury.	[Andresen, Jon; Marrelli, Sean P.; Bryan, Robert M., Jr.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; [Shafi, Nadeem I.] Baylor Coll Med, Sect Pediat Crit Care Med, Houston, TX 77030 USA	Bryan, RM (corresponding author), Baylor Coll Med, Dept Anesthesiol, 1 Baylor Plaza,Suite 434-D, Houston, TX 77030 USA.	rbryan@bcm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007939, F32HL080916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046666] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL07939-01A2, F32HL080916] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS46666] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [P01NSO38660] Funding Source: Medline		Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bryan RM, 2005, ANESTHESIOLOGY, V102, P1261, DOI 10.1097/00000542-200506000-00028; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; Bryan RM, 2006, AM J PHYSIOL-HEART C, V291, pH770, DOI 10.1152/ajpheart.01377.2005; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Golding EM, 2001, J NEUROTRAUM, V18, P691, DOI 10.1089/089771501750357636; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; HEIDENREICH S, 1991, KIDNEY INT, V39, P259, DOI 10.1038/ki.1991.31; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Juul SE, 1999, PEDIATR RES, V46, P543, DOI 10.1203/00006450-199911000-00009; Juul SE, 1999, PEDIATR DEVEL PATHOL, V2, P148, DOI 10.1007/s100249900103; KIRKPATRICK PJ, 2005, ERYTHROPOIETIN THERA; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; MASUDA S, 1993, J BIOL CHEM, V268, P11208; MAYEUX P, 1991, J BIOL CHEM, V266, P23380; Monge A, 2006, LARYNGOSCOPE, V116, P312, DOI 10.1097/01.mlg.0000199400.08550.3f; Morakkabati N, 1996, EXP HEMATOL, V24, P392; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Resch BE, 2003, AM J OBSTET GYNECOL, V188, P993, DOI 10.1067/mob.2003.211; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; ROBERTSON CS, 2006, EFFECTS ERYTHROPOIET; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2006, AM J PHYSIOL-HEART C, V291, pH781, DOI 10.1152/ajpheart.00045.2006; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Sun Y, 2004, J CEREBR BLOOD F MET, V24, P259, DOI 10.1097/01.WCB.0000110049.43905.AC; TAKAHASHI S, 1995, NEPHROL DIAL TRANSPL, V10, P815; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; You JP, 1997, AM J PHYSIOL-HEART C, V273, pH1472; You JP, 1999, STROKE, V30, P1125, DOI 10.1161/01.STR.30.5.1125; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223	42	13	13	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2008	25	3					257	265		10.1089/neu.2007.0347			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	282PJ	WOS:000254579400009	18352839				2021-06-18	
J	Jussen, D; Papaioannou, C; Heimann, A; Kempski, O; Alessandri, B				Jussen, Daniel; Papaioannou, Chrysostomos; Heimann, Axel; Kempski, Oliver; Alessandri, Beat			Effects of hypertonic/hyperoncotic treatment and surgical evacuation after acute subdural hematoma in rats	CRITICAL CARE MEDICINE			English	Article						rats; acute subdural hematoma; hypertonic hyperoncotic treatment; neurologic deficit; surgical evacuation; intracranial pressure	CEREBRAL-BLOOD-FLOW; INCREASED INTRACRANIAL-PRESSURE; SALINE HYDROXYETHYL STARCH; SMALL-VOLUME RESUSCITATION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; CLINICAL-TRIAL; DAMAGE; REDUCTION; ISCHEMIA	Objective. The treatment of acute subdural hematoma (ASDH) consists mainly of surgical evacuation of the hematoma. It is conceivable that early preoperative neuroprotection with hypertonic/hyperoncotic treatment (HHT) can improve survival rates. The present study investigated the benefit of treatment with hypertonic/hyperoncotic solution on functional and histologic outcome as supportive therapy accompanying surgical intervention. Design: Laboratory experiment. Setting: University laboratory. Subjects: Male Sprague-Dawley rats weighing 296-350 g (n = 56). Interventions: ASDH was induced through subdural infusion of 400 ILL of autologous venous blood. Thirty minutes after subdural blood infusion, the rats received either HyperHAES (7.2% saline/6% hydroxyethyl starch) or vehicle (NaCI 0.9%) intravenously, followed by surgical evacuation of the hematoma 1 hr after ASDH induction in those rats scheduled for surgical treatment. The experiment was divided into two parts: an acute study, which explored acute effects of HHT on blood variables, ASDH-induced changes of intracranial pressure (ICP), and cerebral perfusion pressure (CPP), and a chronic study, which investigated the chronic effects of HHT, surgical blood clot evacuation, and the combination of both on the functional and histologic outcome following ASDH (12 days). Measurements and Main Results: In the acute study, HHT expectedly raised the serum sodium concentration and lowered hematocrit. ASDH increased ICP and decreased CPP in all groups. HHT improved CPP by reducing ICP. In the chronic study, all treated groups showed a better recovery with respect to neurologic function and neuronal cell death compared with the vehicle-treated ASDH group. HHT with surgical evacuation or HHT alone improved functional and histologic outcome slightly more than surgical evacuation alone. Conclusions: In this rat model, HHT led to a decrease of ICP after ASDH. This significantly improved functional and histologic outcome, which was comparable to the effects after blood evacuation alone. The combination of evacuation of subdural blood and early HHT improved histologic outcome further but not significantly, which was due to the strong effects of single treatments and a ceiling effect of the combined treatment in this model.	[Jussen, Daniel; Papaioannou, Chrysostomos; Heimann, Axel; Kempski, Oliver; Alessandri, Beat] Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany	Jussen, D (corresponding author), Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany.	beat.alessandri@uni-mainz.de		Heimann, Axel/0000-0003-2510-3228			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alessandri B, 2006, J NEUROTRAUM, V23, P800; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Bentsen G, 2004, ACTA ANAESTH SCAND, V48, P1089, DOI 10.1111/j.1399-6576.2004.00497.x; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bullock MR, 2006, NEUROSURGERY, V58, P16, DOI [10.1227/01.NEU.0000210364.29290.C9, DOI 10.1227/01.NEU.0000210364.29290.C9]; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Eijkenboom M, 2000, NEUROPHARMACOLOGY, V39, P817, DOI 10.1016/S0028-3908(00)00002-2; Fischer M, 1996, RESUSCITATION, V32, P227, DOI 10.1016/0300-9572(96)00953-7; FUJISAWA H, 1994, ACT NEUR S, V60, P193; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Hartl R, 1997, ACT NEUR S, V70, P126; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Heimann A, 2003, CRIT CARE MED, V31, P2495, DOI 10.1097/01.CCM.0000084893.44650.CB; INGLIS FM, 1990, ACT NEUR S, V51, P277; JUVELA S, 1991, J NEUROSURG, V74, P386, DOI 10.3171/jns.1991.74.3.0386; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kempski O, 1996, ACT NEUR S, V66, P114; KRAUS GE, 1991, SURG NEUROL, V35, P20, DOI 10.1016/0090-3019(91)90197-H; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; Lepeintre JF, 2004, NEUROCHIRURGIE, V50, P83; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Munch E, 2000, NEUROSURGERY, V47, P315; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Noppens RR, 2006, CRIT CARE MED, V34, P2194, DOI 10.1097/01.CCM.0000228915.94169.B1; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Patel TR, 1999, J NEUROTRAUM, V16, P1049, DOI 10.1089/neu.1999.16.1049; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sehba FA, 2000, J CEREBR BLOOD F MET, V20, P604, DOI 10.1097/00004647-200003000-00018; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Thomas D, 2004, IEEE SOFTWARE, V21, P12, DOI 10.1109/MS.2004.49; Tsuchida E, 1997, J NEUROTRAUM, V14, P409, DOI 10.1089/neu.1997.14.409; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE	56	13	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2008	36	2					543	549		10.1097/01.CCM.0B013E3181620A0F			7	Critical Care Medicine	General & Internal Medicine	257JB	WOS:000252794000024	18091536				2021-06-18	
J	Chavira, DA; Garrido, H; Bagnarello, M; Azzoin, A; Reus, VI; Mathews, CA				Chavira, Denise A.; Garrido, Helena; Bagnarello, Monica; Azzoin, Anun; Reus, Victor I.; Mathews, Carol A.			A comparative study of obsessive-compulsive disorder in Costa Rica and the United States	DEPRESSION AND ANXIETY			English	Article						obsessions; compulsions; obsessive-compulsive disorder; culture; Hispanic; Latino	BECK DEPRESSION INVENTORY; COMPLEX SEGREGATION ANALYSIS; TRAUMATIC BRAIN-INJURY; AGE-CHILDREN-PRESENT; K-SADS-PL; SPANISH VERSION; PSYCHOMETRIC PROPERTIES; TOURETTES-SYNDROME; ANXIETY DISORDERS; MATERNAL SMOKING	This study compares the presentation and expression of obsessive-compulsive symptoms between a Latin-American and North American sample. In Costa Rica (CR) and the United States (US), respectively, 26 and 52 affected individuals with early-onset obsessive-compulsive disorder (OCD) were recruited. The Yale Brown Obsessive Compulsive Scale (YBOCS), a semi-structured psychiatric interview, and self-report questionnaires were administered. Age of onset and the distribution of OCD across men and women were similar across groups. Both CR and US participants reported obsessions and compulsions, with similar frequencies of symptoms, and contamination, symmetry, and boarding as the most common symptom subtypes. The US sample had higher YBOCS total severity scores than the Costa Rican group. Similarly, there were significant ethnicity effects for YBOCS compulsion [F(1, 70) = 17.88, P<.001] and obsession severity IF(1, 70) = S. 78, P <. 0011, with Caucasians having higher scores than Costa Ricans on both subscales. Comorbidity rates were higher for US Caucasians than Costa Ricans for all disorders; differences were significant mood disorders [64.7% versus 34.6%] alcohol use [21.3%, vervus 3.8%], cannabis use disorders [19.1% versus 0%], and other substance use disorders [39.4% versus 0%]. Regression analyses revealed that ethnicity, trait anxiety, and proband status were the on, significant predictors of total YBOCS severity. Findings suggest that the core phenotype of OCD is the same in both CR and the US, and perhaps biologically driven. However some features of OCD, such as impairment, may be culturally influenced, leading to differences in prevalence rates and treatment utilization.	[Chavira, Denise A.; Azzoin, Anun; Reus, Victor I.; Mathews, Carol A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; [Garrido, Helena; Bagnarello, Monica] Hosp CIMA, San Jose, Costa Rica	Chavira, DA (corresponding author), Univ Calif San Diego, Dept Psychiat, 8950 Villa La Jolla Dr,Ste B218, La Jolla, CA 92037 USA.	dchavira@ucsd.edu	reus, victor i/I-7923-2015; Mathews, Carol A A/M-8922-2017	reus, victor i/0000-0002-8193-5697; Mathews, Carol A A/0000-0003-2208-7058; Azzam, Amin/0000-0002-7024-7450	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K23 RR15533] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH07295-01A1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K23RR015533] Funding Source: NIH RePORTER		AKHTAR S, 1978, INT J SOC PSYCHIATR, V24, P164, DOI 10.1177/002076407802400303; Bebbington PE, 1998, BRIT J PSYCHIAT, V173, P2, DOI 10.1192/S0007125000297833; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63; Bonicatto S, 1998, PSYCHIAT RES, V79, P277, DOI 10.1016/S0165-1781(98)00047-X; Borges G, 2006, AM J PSYCHIAT, V163, P1371, DOI 10.1176/appi.ajp.163.8.1371; Button TMM, 2005, BRIT J PSYCHIAT, V187, P155, DOI 10.1192/bjp.187.2.155; CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727; Caraveo-Anduaga JJ, 1999, SALUD MENT, V22, P62; Cavallini MC, 1999, AM J MED GENET, V88, P38, DOI 10.1002/(SICI)1096-8628(19990205)88:1<38::AID-AJMG7>3.0.CO;2-#; Coetzer BR, 2004, INT J PSYCHIAT MED, V34, P363, DOI 10.2190/XENN-NNWT-7N2K-R26A; do Rosario-Campos MC, 2005, AM J MED GENET B, V136B, P92, DOI 10.1002/ajmg.b.30149; Evans DW, 1999, CHILD PSYCHIAT HUM D, V29, P261, DOI 10.1023/A:1021392931450; Fireman B, 2001, AM J PSYCHIAT, V158, P1904, DOI 10.1176/appi.ajp.158.11.1904; Fontenelle LF, 2004, J PSYCHIATR RES, V38, P403, DOI 10.1016/j.jpsychires.2003.12.004; Franzblau S H, 1997, Cult Divers Ment Health, V3, P259; GARRALDA ME, 1988, BRIT J PSYCHIAT, V153, P81, DOI 10.1192/bjp.153.1.81; Geller DA, 2001, INT J NEUROPSYCHOPH, V4, P169, DOI 10.1017/S1461145701002395; Goodman WK, 1999, J CLIN PSYCHIAT, V60, P27; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Grados MA, 2003, INT REV PSYCHIATR, V15, P350, DOI 10.1080/09540260310001606737; HANTOUCHE EG, 1995, ENCEPHALE, V21, P571; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Heyman I, 2001, BRIT J PSYCHIAT, V179, P324, DOI 10.1192/bjp.179.4.324; HOLLANDER E, 1998, CNS SPECTRUMS S1, V3, P10, DOI DOI 10.1017/S1092852900007148; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; KARNO M, 1989, J NERV MENT DIS, V177, P202, DOI 10.1097/00005053-198904000-00003; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; LEONARD HL, 1990, J AM ACAD CHILD PSY, V29, P17, DOI 10.1097/00004583-199001000-00004; Mathews CA, 2006, AM J PSYCHIAT, V163, P1066, DOI 10.1176/appi.ajp.163.6.1066; Mathews CA, 2001, J AM ACAD CHILD PSY, V40, P456, DOI 10.1097/00004583-200104000-00015; Mell LK, 2005, PEDIATRICS, V116, P56, DOI 10.1542/peds.2004-2058; Neal-Barnett A. M., 1997, CULTURAL ISSUES TREA; Nestadt G, 2000, AM J HUM GENET, V67, P1611, DOI 10.1086/316898; NESTADT G, 1994, ACTA PSYCHIAT SCAND, V89, P219, DOI 10.1111/j.1600-0447.1994.tb01504.x; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; Ng CH, 1997, AUST NZ J PSYCHIAT, V31, P382, DOI 10.3109/00048679709073848; Nicolini H, 1993, Arch Med Res, V24, P193; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; OKASHA A, 1994, COMPR PSYCHIAT, V35, P191, DOI 10.1016/0010-440X(94)90191-0; Palacio Carlos Alberto, 2004, Biomédica, V24, P56; Paula D, 1999, AM J HUM GENET, V65, P1428; Pauls DL, 1999, CHILD ADOL PSYCH CL, V8, P481; Quintana JM, 2003, ACTA PSYCHIAT SCAND, V107, P216, DOI 10.1034/j.1600-0447.2003.00062.x; RASMUSSEN SA, 1984, J CLIN PSYCHIAT, V45, P450; RASMUSSEN SA, 1986, AM J PSYCHIAT, V143, P317; Spielberger C, 2005, ACTAS ESP PSIQUIATRI, V33, P374; SPIELBERGER CD, 1986, MANUAL STAI; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Steketee G, 1998, J ANXIETY DISORD, V12, P525, DOI 10.1016/S0887-6185(98)00030-9; SuarezMendoza AA, 1997, ARTHRIT CARE RES, V10, P194, DOI 10.1002/art.1790100307; TAKEUCHI DT, 1993, J HEALTH SOC BEHAV, V34, P153, DOI 10.2307/2137241; Ulloa RE, 2006, ACTAS ESP PSIQUIATRI, V34, P36; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5; Weissman MM, 1998, CNS SPECTRUMS, V3, P6; Woodward L, 1997, J CHILD PSYCHOL PSYC, V38, P479, DOI 10.1111/j.1469-7610.1997.tb01533.x; Zahner GEP, 1997, AM J PUBLIC HEALTH, V87, P1440, DOI 10.2105/AJPH.87.9.1440; Zohar AH, 2001, J ABNORM CHILD PSYCH, V29, P121, DOI 10.1023/A:1005231912747; Zohar AH, 1997, J CHILD PSYCHOL PSYC, V38, P993, DOI 10.1111/j.1469-7610.1997.tb01616.x	66	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety		2008	25	7					609	619		10.1002/da.20357			11	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	335GV	WOS:000258279700007	17823962				2021-06-18	
J	Kristman, VL; Cote, P; Van Eerd, D; Vidmar, M; Rezai, M; Hogg-Johnson, S; Wennberg, RA; Cassidy, JD				Kristman, Vicki L.; Cote, Pierre; Van Eerd, Dwayne; Vidmar, Marjan; Rezai, Mana; Hogg-Johnson, Sheilah; Wennberg, Richard A.; Cassidy, J. David			Prevalence of lost-time claims for mild traumatic brain injury in the working population: Improving estimates using workers compensation databases	BRAIN INJURY			English	Article						administrative database; bias; diagnosis; measurement; mild traumatic brain injury; workers' compensation; occupational injury; prevalence; stratified estimates; whiplash	BACK; NECK; PAIN	Primary objective: To test the usefulness of a method to improve the measurement of prevalent mild traumatic brain injury (MTBI) among injured workers with a workers compensation claim. Methods: Database codes were selected to identify MTBI cases in the Ontario workers compensation lost-time claims database. A random sample of 210 claims was selected, classified as MTBI or not, and used to calculate proportions with MTBI among code groups. The annual prevalence of MTBI in 1997 and 1998 was calculated by weighting the numerators with the appropriate proportions of MTBI within each code group. Results: Four code groups were created: the head region, cranial region, concussion code group and the brain region. The proportion of MTBI in each group was 29%, 19%, 92% and 32%, respectively. The 1997 prevalence depended on the codes used, from 39/10 000 (95% confidence interval (CI): 35-44) for a weighted version of the 'concussion' code to 58/10 000 (95% CI: 50-65) for inclusion of all identified MTBI codes. Conclusions: Restricting the enumeration of MTBI to specific 'concussion' codes can lead to under-estimation of the prevalence of MTBI in epidemiological studies using workers compensation data. Approximately six out of every 1000 lost-time claims are associated with MTBI. Given lost-time estimates of disability under-estimate the prevalence of this mild injury, MTBI, is an important workplace injury.	[Kristman, Vicki L.; Cote, Pierre; Cassidy, J. David] Toronto Western Hosp, Univ Hlth Network, CREIDO, Toronto, ON M5T 2S8, Canada; [Kristman, Vicki L.; Cote, Pierre; Rezai, Mana; Hogg-Johnson, Sheilah; Cassidy, J. David] Univ Toronto, Fac Med, Dept Publ Hlth Sci, Toronto, ON, Canada; [Kristman, Vicki L.; Cote, Pierre; Van Eerd, Dwayne; Vidmar, Marjan; Rezai, Mana; Hogg-Johnson, Sheilah] Inst Work & Hlth, Toronto, ON, Canada; [Hogg-Johnson, Sheilah; Cassidy, J. David] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Wennberg, Richard A.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada	Kristman, VL (corresponding author), Toronto Western Hosp, Univ Hlth Network, CREIDO, 399 Bathurst St,Fell Pavil 4-132, Toronto, ON M5T 2S8, Canada.	vicki.kristman@uhnresearch.ca	Kristman, Vicki/G-8317-2011; Cote, Pierre/AAG-5358-2021	Cote, Pierre/0000-0002-6986-6676; Kristman, Vicki/0000-0001-5508-0552			Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; *ASS WORK COMP BOA, 1999, NAT WORK INJ DIS FAT; Azaroff LS, 2002, AM J PUBLIC HEALTH, V92, P1421, DOI 10.2105/AJPH.92.9.1421; BEATON DE, 1995, THESIS U TORONTO TOR; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Johnson WG, 1999, J RISK INSUR, V66, P185, DOI 10.2307/253608; ROOS LL, 1991, J CLIN EPIDEMIOL, V44, P881, DOI 10.1016/0895-4356(91)90050-J; SAS Institute, 1990, SAS STAT US GUID VER; Silverstein B, 2002, AM J IND MED, V41, P149, DOI 10.1002/ajim.10054; Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193; Van Eerd D, 2006, AM J IND MED, V49, P557, DOI 10.1002/ajim.20329; Wasiak R, 2003, SPINE, V28, P2283, DOI 10.1097/01.BRS.0000085032.00663.83; *WSIB, 2005, COV DIS PAP; Zakaria D, 2003, AM J IND MED, V43, P507, DOI 10.1002/ajim.10217	17	13	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	1					51	59		10.1080/02699050701849991			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400007	18183509				2021-06-18	
J	Nayak, CD; Nayak, DM; Raja, A; Ra, A				Nayak, Chandrika D.; Nayak, Dinesh M.; Raja, Annaswamy; Ra, Anjali			Erythrocyte indicators of oxidative changes in patients with graded traumatic head injury	NEUROLOGY INDIA			English	Article						erythrocytes; glutathione. head injury; lipid peroxidation; superoxide dismutase	TIME-LEVEL RELATIONSHIP; CENTRAL NERVOUS-SYSTEM; GLASGOW COMA SCALE; LIPID-PEROXIDATION; BRAIN-INJURY; FREE-RADICALS; SUPEROXIDE-DISMUTASE; STRESS; MECHANISMS; GLUTATHIONE	Context: Acute oxidative stress following a traumatic head injury (HI) has been implicated in inducing severe secondary brain damage and influencing the clinical outcome of HI patients. Aims: This study was performed to evaluate and compare the oxidative changes in patients with varying severity of HI in the early posttraumatic period using erythrocyte indicators. Settings and Design: Head injury patients were divided into two groups based on their Glasgow Coma Scale (GCS) scores recorded at admission to the hospital on the day of trauma itself. Accordingly, the study included 30 severe HI (SHI, GCS scores 8 or less) and 25 Mild HI (MHI, GCS scores more than 8) patients. Thirty age and sex-matched healthy individuals were included in this comparative study as controls. Materials and Methods: Blood samples were obtained from controls and HI patients (within 24 h of trauma onset). Erythrocyte oxidative changes were studied by estimating thiobarbituric acid reactive substances (TBARS), glutathione (GSH), superoxide dismutase (SOD) and glutathione reductase (GR). Results: Erythrocyte TBARS levels were significantly higher and GSH levels were significantly lower in SHI and MHI patients as compared to controls. The SOD activity was significantly increased only in SHI patients and remained unchanged in MHI patients as compared to controls. As compared to MHI patients, erythrocyte TBARS levels were significantly higher, GSH levels were significantly lower and SOD activity was markedly elevated in SHI patients. Erythrocyte GR activity did not show significant changes in both groups of patients as compared to controls. Conclusion: Oxidative stress is evident in both SHI and MHI patients in the early posttraumatic period as reflected by their erythrocyte indicators, but the severity of oxidative stress has varied relatively with the severity of head injury. The present findings provide indications that early oxidative changes could influence the neurological recovery of HI patients.	[Nayak, Chandrika D.] Manipal Univ, Melaka Manipal Med Coll, Dept Biochem, Manipal 576104, Karnataka, India; [Nayak, Dinesh M.] Kasturba Med Coll & Hosp, Dept Pediat, Manipal, Karnataka, India; [Raja, Annaswamy] Kasturba Med Coll & Hosp, Dept Neurosurg, Manipal, Karnataka, India; [Ra, Anjali] Kasturba Med Coll & Hosp, Dept Biochem, Manipal, Karnataka, India	Nayak, CD (corresponding author), Manipal Univ, Melaka Manipal Med Coll, Dept Biochem, Manipal Campus, Manipal 576104, Karnataka, India.	chandrikadinesh@yahoo.com		Nayak, Chandrika D/0000-0002-4674-7359; Nayak, Dinesh M/0000-0001-7384-8916; Rao, Anjali/0000-0002-2676-2762			Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CADET JL, 1988, INT J NEUROSCI, V40, P13, DOI 10.3109/00207458808985722; Chen J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-10; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Giustarini D, 2003, CLIN CHEM, V49, P327, DOI 10.1373/49.2.327; Hall E. D, 1996, NEUROSURGERY, P505; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Horn H.D., 1978, METHODS ENZYMATIC AN, P875; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LYNCH RE, 1978, J BIOL CHEM, V253, P1838; MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nayak C, 2006, CLIN CHEM LAB MED, V44, P460, DOI 10.1515/CCLM.2006.068; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nayak Chandrika D, 2007, Indian J Med Sci, V61, P381; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; REITER RJ, 1995, FASEB J, V9, P526; Sagara Y, 1998, FREE RADICAL BIO MED, V24, P1375, DOI 10.1016/S0891-5849(97)00457-7; SELMBERT D, 2001, J NEUROSCI, V21, P7455; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Siems WG, 2000, CLIN NEPHROL, V53, pS9; SUDHA K, 1998, THESIS MANIPAL ACAD; Tentori L, 1981, Methods Enzymol, V76, P707, DOI 10.1016/0076-6879(81)76152-4; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Yamamoto T, 1999, ACT NEUR S, V75, P17	41	13	15	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JAN-MAR	2008	56	1					31	35		10.4103/0028-3886.39309			5	Neurosciences	Neurosciences & Neurology	283YA	WOS:000254671200007	18310834				2021-06-18	
J	Roebuck-Spencer, TM; Reeves, DL; Bleiberg, J; Cernich, AN; Schwab, K; Ivins, B; Salazar, A; Harvey, S; Brown, F; Warden, D				Roebuck-Spencer, T. M.; Reeves, D. L.; Bleiberg, J.; Cernich, A. N.; Schwab, K.; Ivins, B.; Salazar, A.; Harvey, S.; Brown, F.; Warden, D.			Influence of demographics on computerized cognitive testing in a military sample	MILITARY PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL ASSESSMENT; GENDER-DIFFERENCES; EPISODIC MEMORY; NORMATIVE DATA; PERFORMANCE; AGE; ARMY; IQ	Computerized cognitive testing with software programs such as the Automated Neuropsychological Assessment Metrics (ANAM) have long been used to assess cognition in military samples. This study describes demographic influences on computerized testing performance in a large active duty military sample (n = 2366). Performance differences between men and women were minimal on most ANAM subtests, but there was a clear speed/accuracy trade-off, with men favoring speed and women favoring accuracy on the Continuous Performance Test (CPT) subtest. As expected, reaction time increased with age on most subtests, with the exception of Mathematical Processing Test (MTH). Higher education resulted in significant but minimal performance increases on Code Substitution (CDS), Matching to Sample (MSP), and Memory Search (STN) subtests. In contrast, substantial performance differences were seen between education groups on the MTH subtest. These data reveal that it is important to consider demographic factors, particularly age, when using ANAM to draw conclusions about military samples. These results also point to the importance of exploring demographic influences for all reaction time-based computerized assessment batteries.	[Roebuck-Spencer, T. M.; Bleiberg, J.; Cernich, A. N.] Natl Rehabil Hosp, Ctr Cognit Neurosci, Washington, DC USA; [Reeves, D. L.] ClinVest Inc, Springfield, MO USA; [Schwab, K.; Ivins, B.; Warden, D.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Brown, F.] Womack Army Med Ctr, Ft Bragg, NC USA	Bleiberg, J (corresponding author), Bethesda Neuropsychol LLC, 9515 Linden Ave, Bethesda, MD 20814 USA.	jb454@georgetown.edu					Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P231, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT231; Beatty WW, 2003, J CLIN EXP NEUROPSYC, V25, P1065, DOI 10.1076/jcen.25.8.1065.16732; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Buffery A., 1972, GENDER DIFFERENCES T, P123; CERNICH AN, 2004, AM PSYCH ASS C HON H; CERNICH AN, 2004, 2004 INT NEUR SOC M; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; GASTALDO E, 1997, ANAM DATA USMC 1995; Gestaldo E, 2001, ARCH CLIN NEUROPSYCH, V16, P825; Harris WC, 2005, MIL PSYCHOL, V17, P115, DOI 10.1207/s15327876mp1702_4; Heaton RK., 1996, NEUROPSYCHOL ASSESS, V2, P141; Herlitz A, 2002, J CLIN EXP NEUROPSYC, V24, P107, DOI 10.1076/jcen.24.1.107.970; Herlitz A, 1997, MEM COGNITION, V25, P801, DOI 10.3758/BF03211324; Herlitz A, 1999, NEUROPSYCHOLOGY, V13, P590, DOI 10.1037/0894-4105.13.4.590; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; KABAT MH, 2000, J INT NEUROPSYCH SOC, V6, P146; Kimura D, 2003, PSYCHOL REP, V93, P263, DOI 10.2466/PR0.93.5.263-264; Kramer JH, 2003, J INT NEUROPSYCH SOC, V9, P97, DOI 10.1017/S1355617703910113; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Lewin C, 2001, NEUROPSYCHOLOGY, V15, P165, DOI 10.1037//0894-4105.15.2.165; Maccoby EE., 1974, PSYCHOL SEX DIFFEREN; MCCARROLL JE, 1990, NEUROEPIDEMIOLOGY, V9, P296, DOI 10.1159/000110792; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V8, P48, DOI 10.1159/000110165; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; REEVES DL, 1991, SR911 NAMRL OFF MIL; REEVES DL, 1996, EFFECTS HEAT STRESS, V1; REYNOLDS CR, 1987, J SCHOOL PSYCHOL, V25, P323, DOI 10.1016/0022-4405(87)90035-5; VONKLUGE S, 1992, PERCEPT MOTOR SKILL, V75, P651, DOI 10.2466/pms.1992.75.2.651; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	36	13	13	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.		2008	20	3					187	203		10.1080/08995600802118825			17	Psychology, Multidisciplinary	Psychology	334LO	WOS:000258223500004					2021-06-18	
J	Crawford, FC; Wood, M; Ferguson, S; Mathura, VS; Faza, B; Wilson, S; Fan, T; O'Steen, B; Ait-Ghezala, G; Hayes, R; Mullan, MJ				Crawford, Fiona C.; Wood, Marcie; Ferguson, Scott; Mathura, Venkatarajan S.; Faza, Brandon; Wilson, Sarah; Fan, Tao; O'Steen, Barbara; Ait-Ghezala, Ghania; Hayes, Ronald; Mullan, Michael J.			Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease(APPsw)	BRAIN RESEARCH			English; Estonian	Article						traumatic brain injury; Alzheimer's; amyloid; inflammation; genomic	CLOSED-HEAD INJURY; A-BETA DEPOSITION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; ALTERED EXPRESSION; GENE-EXPRESSION; CELL-CYCLE; HIPPOCAMPUS	Numerous studies have shown that the beta-amyloid peptide (A beta) or beta-amyloid deposits impact many processes that can contribute to neurodegeneration, ranging from immune and inflammatory processes to cell death and apoptosis, processes characteristic of both Alzheimer's disease and head injury. Human and animal studies of traumatic brain injury (TBI) have shown that A production is increased acutely following injury, and there is evidence for increased amyloid deposition and risk for Alzheimer's disease following TBI. Given the poorer outcome after injury observed both in transgenic mice overproducing A beta, as well as in humans subjected to repetitive head injury, one may conclude that the presence of elevated brain levels of A beta, whether endogenous or as a consequence of previous injury, exacerbates many of the deleterious processes triggered by TBI. We sought to test this hypothesis by examining the genomic response to injury in wild-type mice and in transgenic mice (APPsw) overexpressing and accumulating cerebral A beta/beta-amyloid. Gene expression was investigated by microarray 24 h after controlled cortical impact (CCI) injury or sham injury in aged APPsw transgenic mice and wild-type controls. Stringent statistical analysis revealed differential expression of a total of 129 genes in the transgenic TBI vs. sham comparison and 119 genes in the wild-type TBI vs. sham comparison. Of these, only 28 genes were common to both comparisons, suggesting considerable differences in response to injury in the Alzheimer models compared to wild-type mice. We focused our analyses by creating a "genotype-dependent" data set of response to injury which contained the genes that were uniquely altered in response to injury in either wild-type or APPsw mice, as well as those which were significantly differently modulated following TBI in one genotype compared to the other. The cellular functions predicted to be influenced by these changes in gene expression thus indicate the adverse pathways triggered by increased levels of A beta, and the potentially favorable (recovery) pathways which are activated in wild-type mice but suppressed when A beta levels are high. The results show that the cellular functions most influenced by the cerebral A beta levels following TBI include inflammation, immune response, and cell death, which suggest a particular vulnerability to head injury in the Alzheimer brain. (C) 2007 Elsevier B.V. All rights reserved.	[Crawford, Fiona C.; Wood, Marcie; Ferguson, Scott; Mathura, Venkatarajan S.; Faza, Brandon; Wilson, Sarah; Ait-Ghezala, Ghania; Mullan, Michael J.] Roskamp Inst, Sarasota, FL 34243 USA; [Crawford, Fiona C.; Wood, Marcie; Ferguson, Scott; Mathura, Venkatarajan S.; Faza, Brandon; Wilson, Sarah; Mullan, Michael J.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Fan, Tao; O'Steen, Barbara; Hayes, Ronald] Univ Florida, Ctr Traumat Brain Injury Studies, Evelyn F & William L McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA	Crawford, FC (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	fcrawford@rfdn.org		Ait-Ghezala, Ghania/0000-0002-9836-8617; Mullan, Michael/0000-0002-1473-7527			ALLSOP D, 1990, AM J PATHOL, V136, P255; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Cousar JL, 2006, DEV NEUROSCI-BASEL, V28, P342, DOI 10.1159/000094160; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI 10.1172/JCI0216143; Decourt B, 2005, DEV BRAIN RES, V159, P36, DOI 10.1016/j.devbrainres.2005.06.013; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; GHIMIKAR RS, 1996, J NEUROSCI RES, V46, P727; Grosjean MB, 2007, HISTOL HISTOPATHOL, V22, P235, DOI 10.14670/HH-22.235; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; MORRIS JC, 1987, J GERONTOL, V42, P412, DOI 10.1093/geronj/42.4.412; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; Nilsson CL, 2001, PEPTIDES, V22, P2105, DOI 10.1016/S0196-9781(01)00571-X; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomas T, 1997, J SUBMICR CYTOL PATH, V29, P293; Ueberham U, 2005, CNS NEUROL DISORD-DR, V4, P293, DOI 10.2174/1568007054038175; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	43	13	13	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 14	2007	1185						45	58		10.1016/j.brainres.2007.09.042			14	Neurosciences	Neurosciences & Neurology	247FY	WOS:000252064400005	17961517				2021-06-18	
J	McCarter, RJ; Walton, NH; Moore, C; Ward, A; Nelson, I				McCarter, R. J.; Walton, N. H.; Moore, C.; Ward, A.; Nelson, I.			PTA testing, the westmead post traumatic amnesia scale and opiate analgesia: A cautionary note	BRAIN INJURY			English	Article						post-traumatic amnesia; Westmead PTA scale; opiates	CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; RECOVERY; MEMORY; PSYCHOMOTOR; COGNITION; DURATION; SEDATION; PROPOFOL; MORPHINE	Objective: To assess the validity of the Westmead PTA scale in patients treated with opiate analgesia. Method: Seventeen non-head injured, non-traumatic, electively hospitalized orthopaedic patients treated with opiate analgesia were tested on the Westmead PTA scale for a minimum of 2 consecutive days (n = 17) to a maximum of 4 consecutive days (n = 10). Results: Only 20% of participants tested over 4 days reached criteria of three consecutive 12/12 scores on the Westmead PTA scale. Daily failure rates on the 12 item scale ranged from 36-70%. All failures were on the 'new learning' items, orientation items were never failed. Conclusions: The low pass rate of non-head injured patients treated with opiate analgesics indicates that the Westmead PTA scale is non-specific to traumatic brain injury and is probably an invalid measure of post-traumatic amnesia in patients actively treated with opiates. Implications for the measurement and accurate classification of traumatic brain injury patients are discussed.	[McCarter, R. J.; Walton, N. H.; Moore, C.] Frenchay Hosp, Dept Neuropsychol, Bristol BS16 1LE, Avon, England; [Ward, A.; Nelson, I.] Frenchay Hosp, Dept Orthopaed, Bristol BS16 1LE, Avon, England	McCarter, RJ (corresponding author), Ashover House,133 Long Ashton Rd, Bristol BS41 9JQ, Avon, England.	rjmccarter@npsych.co.uk					Ahmed S, 2000, BRAIN INJURY, V14, P765; Andrade J, 1996, ANESTH ANALG, V83, P1279, DOI 10.1097/00000539-199612000-00026; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BELL DS, 1992, MEDICOLEGAL ASSESSME; BOYLE CA, 1988, PSYCHOPHARMACOLOGY S, V6, P146; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Curran HV, 1998, PSYCHOPHARMACOLOGY, V135, P27, DOI 10.1007/s002130050482; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Jennett B, 1981, MANAGEMENT HEAD INJU; Jones C, 2000, MEMORY, V8, P81; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; KRAUS JF, 1989, MILD HEAD INJURY, P8; LARABEE GL, 2005, FORENSIC NEUROPSYCHO, P209; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; Sarasin DS, 1996, J ORAL MAXIL SURG, V54, P1187, DOI 10.1016/S0278-2391(96)90348-1; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M., 2005, FORENSIC NEUROPSYCHO, P237; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Walker DJ, 1998, PSYCHOPHARMACOLOGY, V140, P191, DOI 10.1007/s002130050757; Whittington MA, 1998, P NATL ACAD SCI USA, V95, P5807, DOI 10.1073/pnas.95.10.5807; Whitty CW, 1966, AMNESIA; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412	33	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2007	21	13-14					1393	1397		10.1080/02699050701793793			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	253AA	WOS:000252488200007	18066941				2021-06-18	
J	Oertel, MF; Schwedler, M; Stein, M; Wachter, D; Scharbrodt, W; Schmidinger, A; Boker, DK				Oertel, Matthias F.; Schwedler, Madlen; Stein, Marco; Wachter, Dorothee; Scharbrodt, Wolfram; Schmidinger, Andrea; Boeker, Dieter-Karsten			Cerebral energy failure after subarachnoid hemorrhage: The role of relative hyperglycolysis	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						subarachnoid hemorrhage; hyperglycolysis; glucose metabolism; oxygen metabolism; energy crises; outcome	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ACUTE STAGE; EMISSION TOMOGRAPHY; CLINICAL-TRIAL; BLOOD-FLOW; METABOLISM; MICRODIALYSIS; DYSFUNCTION; VASOSPASM	After subarachnoid hemorrhage (SAH) cerebral metabolism is significantly impaired. Hyperglycolysis describes the reduction of oxidative metabolism followed by a relative increase of anaerobic glycolysis to maintain energy supply. This phenomenon is known in head injury but has not as yet been shown after SAH. This Study was conducted to test the hypothesis that hyperglycolysis is present ill SAH patients and is associated with vasospasm. A total of 105 measurements were conducted on 21 SAH patients (age 49 +/- 15 years, median World Federation of Neurosurgical Societies Grade 4) over the first 5 days following admission. Arteriovenous differences were calculated for oxygen (avDO(2)) and glucose (avDGlc). Relative hyperglycolysis was defined as metabolic ratio (MR = avDO(2)[mmol/L]/avDGlc[mmol/L]) < 3.44. Juaular-venous saturation for oxygen (SjvO(2)), mean arterial blood pressure (MAP), intracranial pressure (ICP), cerebral perfusion pressure (CPP) were monitored. Relative hyperglycolyis was recorded in 34% of studies after SAH. In hyperglycolytic studies both jugular-venous lactate and SjvO, were significantly elevated (jugular-venous lactate 14.9 +/- 9.9 us. 11.8 +/- 5.5 mg/dL, p = 0.04; SjvO(2): 70.0 +/- 18% us. 81.7 +/- 9%, p = 0.002). Relative hyperglycolysis is associated with outcome after SAH. In patients who died after SAH almost 50% of Studies showed hyperglycolysis, whereas patients who survived without neurological deficit had no hyperglycolytic events. Relative hyperglycolysis is a common event after SAH. It may be associated with relative hyperemia but most importantly with outcome. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Hosp, Dept Neurosurg, D-35385 Giessen, Germany	Oertel, MF (corresponding author), Univ Hosp, Dept Neurosurg, Klinikstrasse 29, D-35385 Giessen, Germany.	matthias.oertel@neuro.med.uni-giessen.de					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; ATKINS DL, 1998, DEV TRANSMEMBRANE AC; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frykholm P, 2004, ACTA NEUROL SCAND, V109, P25, DOI 10.1034/j.1600-0404.2003.00174.x; GAAB MR, 1990, ACT NEUR S, V51, P320; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hayashi T, 2000, J NEUROSURG, V93, P1014, DOI 10.3171/jns.2000.93.6.1014; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HOVDA DA, 1990, ACT NEUR S, V51, P331; JENNETT B, 1975, LANCET, V7905, P480; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; KAWAMURA S, 1992, ACTA NEUROCHIR, V114, P12, DOI 10.1007/BF01401107; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; King W A, 1994, Neurosurg Clin N Am, V5, P767; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Oertel M, 2002, ACT NEUR S, V81, P69; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pickard JD, 2005, ACT NEUR S, V95, P459; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; SEITZ HD, 1977, ACTA NEUROCHIR, V38, P211, DOI 10.1007/BF01401092; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Wu GJ, 2005, ANN NY ACAD SCI, V1042, P168, DOI 10.1196/annals.1338.019	32	13	14	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2007	14	10					948	954		10.1016/j.jocn.2006.11.002			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	217HE	WOS:000249938200006	17669657				2021-06-18	
J	Dehail, P; Petit, H; Joseph, PA; Vuadens, P; Mazaux, JM				Dehail, Patrick; Petit, Herve; Joseph, Pierre-Alain; Vuadens, Philippe; Mazaux, Jean-Michel			Assessment of postural instability in patients with traumatic brain injury upon enrolment in a vocational adjustment programme	JOURNAL OF REHABILITATION MEDICINE			English	Article						balance impairment; posturography; traumatic brain; injury; return to work	BALANCE DEFICITS; HEAD-INJURY; REHABILITATION; ADMISSION; MODERATE; OUTCOMES; SWAY	Objective: To assess postural instability in patients with traumatic brain injury upon enrolment to vocational adjustment. Design: A cross-sectional study. Patients and methods: Sixty-eight patients at the time of admission to a vocational adjustment programme and 52 healthy age-matched controls were evaluated. Complaints of dizziness, or balance impairment and data from a clinical examination were recorded. Postural characteristics during quiet upright standing were assessed using a static posturographic platform. Results: Twenty-six patients complained of dizziness or instability and 36 had evidence of neurological impairment. Centre of pressure displacement and area were significantly increased in the traumatic brain injury group as a whole, compared with controls, even among 23 patients who had no complaint or clinical abnormality. Conclusion: In spite of a high variability in time since injury, significant posturographic abnormalities were found in patients with traumatic brain injury, including those who had no complaints or evidence of neurological impairment. Posturography may help in understanding how a traumatic brain injury impairs the human balance, and may provide helpful information for patients participating in vocational adjustment programmes, especially when jobs require a long standing posture or balance.	Hop Pellegrin, CHU Bordeaux, Serv Med Phys Readaptat, F-33076 Bordeaux, France; Univ Victor Segalen, Ctr Hosp Univ Bordeaux, EA Handicap Syst Nerveux, Rehabil Unit,UEROS Aquitaine Network, Bordeaux, France; Clin Romande Readaptat, Sion, Switzerland	Dehail, P (corresponding author), Hop Pellegrin, CHU Bordeaux, Serv Med Phys Readaptat, F-33076 Bordeaux, France.	patrick.dehail@chu-bordeaux.fr	Dehail, Patrick/T-5081-2019				Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; BROOKS N, 1994, EUROPEAN HEAD INJURY; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; RAVEN JC, 1976, MANUAL RAVENS PROGRE; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wechsler, 1981, WAIS R MANUAL; Wechsler D, 1974, WECHSLER MEMORY SCAL; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	18	13	13	0	4	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	SEP	2007	39	7					531	536		10.2340/16501977-0096			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	213IS	WOS:000249660700005	17724552	DOAJ Gold			2021-06-18	
J	Zhou, H; Gupta, A; Zou, T; Zhou, JH				Zhou, Hong; Gupta, Anju; Zou, Tie; Zhou, Jianhua			Photoresist derived carbon for growth and differentiation of neuronal cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cell adhesion; carbon; nerve growth factor; nerve regeneration; scanning electron microscope	NERVE REGENERATION; LAMININ	Apoptosis or necrosis of neurons in the central nervous system (CNS) is the hallmark of many neurodegenerative diseases and Traumatic Brain Injury (TBI). The inability to regenerate in CNS offers little hope for naturally repairing the damaged neurons. However, with the rapid development of new technologies, regenerative medicine offers great promises to patients with these disorders. Among many events for further advancement of regenerative medicine, extracellular matrix (ECM) plays a critical role for cellular migration and differentiation. To develop a biocompatible and electrically conductive substrate that can be potentially used to promote growth and regeneration of neurons and to record intracellular and multisite signals from brain as a probe, a polymeric precursor - SPR 220.7 was fabricated by pyrolysis at temperatures higher than 700 degrees C. Human Neuroblastoma cells - SK-N-MC, SY5Y, mouse teratocarcinoma cells P-19 and rat PC12 cells were found to attach and proliferate on photoresist derived carbon film. Significantly, neuronal differentiation of PC12 cells induced by NGF was demonstrated by observing cell shape and size, and measuring the length of neurites under SEM. Our results indicated that fabricated carbon could potentially be explored in regenerative medicine for promoting neuronal growth and differentiation in CNS with neurodegeneration.	[Zhou, Hong; Gupta, Anju] Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA; [Zou, Tie; Zhou, Jianhua] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Zhou, H (corresponding author), Worcester Polytech Inst, Dept Chem Engn, 100 Inst Rd, Worcester, MA 01609 USA.	szhou@wpi.edu	Zhou, Hong Susan/AAP-6521-2020	Zhou, Hong Susan/0000-0002-6659-6965			BOKROS JC, 1983, MATERIALS SCI MONOGR, V17, P199; Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Fromherz P, 2002, CHEMPHYSCHEM, V3, P276, DOI 10.1002/1439-7641(20020315)3:3<276::AID-CPHC276>3.0.CO;2-A; HAYAT MA, 1978, INTRO BIOL SCANNING, P131; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Jenkins G. M., 1980, CLIN PHYS PHYSL MEAS, V1, P171; Kim J, 1998, J ELECTROCHEM SOC, V145, P2314, DOI 10.1149/1.1838636; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; MASSIA SP, 1993, J BIOL CHEM, V268, P8053; Singh A, 2002, J ELECTROCHEM SOC, V149, pE78, DOI 10.1149/1.1436085; Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009; Yao CJ, 2005, J ALTERN COMPLEM MED, V11, P903, DOI 10.1089/acm.2005.11.903; Zhang X, 2005, SENSOR ACTUAT B-CHEM, V106, P843, DOI 10.1016/j.snb.2004.10.039	14	13	13	0	6	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	AUG	2007	8	8					884	893		10.3390/i8080884			10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	204PR	WOS:000249057000011		DOAJ Gold, Green Published			2021-06-18	
J	Kuo, LT; Groves, MJ; Scaravilli, F; Sugden, D; An, SF				Kuo, L.-T.; Groves, M. J.; Scaravilli, F.; Sugden, D.; An, S. F.			Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy	NEUROSCIENCE			English	Article						real-time quantitative PCIR; neurogenesis; immunohistochemistry; in situ hybridization; micro-osmotic pump	NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; RETROGRADE AXONAL-TRANSPORT; TRAUMATIC BRAIN-INJURY; PERIPHERAL-NERVE; SCIATIC-NERVE; ADULT-RAT; DIFFERENTIAL EXPRESSION; FUNCTIONAL INTERACTIONS; PERICELLULAR BASKETS	In the months following transection of adult rat peripheral nerve some sensory neurons undergo apoptosis. Two weeks after sciatic nerve transection some neurons in the L4 and L5 dorsal root ganglia begin to show immunoreactivity for nestin, a filament protein expressed by neuronal precursors and immature neurons, which is stimulated by neurotrophin-3 (NT-3) administration. The aim of this study was to examine whether NT-3 administration could be compensating for decreased production of neurotrophins or their receptors after axotomy, and to determine the effect on nestin synthesis. The levels of mRNA in the ipsilateral and contralateral L4 and L5 dorsal root ganglia were analyzed using real-time polymerase chain reaction, 1 day, 1, 2 and 4 weeks after unilateral sciatic nerve transection and NT-3 or vehicle administration via s.c. micro-osmotic pumps. In situ hybridization was used to identify which cells and neurons expressed mRNAs of interest, and the expression of full-length trkC and p75(NTR) protein was investigated using immunohistochemistry. Systemic NT-3 treatment increased the expression of brain-derived neurotrophic factor, nestin, trkA, trkB and trkC mRNA in ipsilateral ganglia compared with vehicle-treated animals. Some satellite cells surrounding neurons expressed trkA and trkC mRNA and trkC immunoreactivity. NT-3 administration did not affect neurotrophin mRNA levels in the contralateral ganglia, but decreased the expression of trkA mRNA and increased the expression of trkB mRNA and p75(NTR) mRNA and protein. These data suggest that systemically administered NT-3 may counteract the decrease, or even increase, neurotrophin responsiveness in both ipsi- and contralateral ganglia after nerve injury. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	UCL, Dept Mol Neurosci, Div Neuropathol, London WC1N 3BG, England; Kings Coll London, Sch Biomed & Hlth Sci, Div Reprod & Endocrinol, London SE1 1UL, England	Groves, MJ (corresponding author), UCL, Dept Mol Neurosci, Div Neuropathol, Queen Sq, London WC1N 3BG, England.	m.groves@ion.ucl.ac.uk		Kuo, Lu-Ting/0000-0002-1405-8700			Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200; ARVIDSSON J, 1986, BRAIN RES, V373, P15, DOI 10.1016/0006-8993(86)90310-0; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Benn B, 1998, J COMP NEUROL, V401, P47, DOI 10.1002/(SICI)1096-9861(19981109)401:1<47::AID-CNE4>3.0.CO;2-C; Bergman E, 1999, J COMP NEUROL, V410, P368, DOI 10.1002/(SICI)1096-9861(19990802)410:3<368::AID-CNE2>3.0.CO;2-I; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brannvall K, 2006, NEUROREPORT, V17, P623; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Ciaroni S, 2000, NEUROSCI LETT, V281, P69, DOI 10.1016/S0304-3940(00)00785-0; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; Corti S, 2002, J NEUROSCI RES, V70, P721, DOI 10.1002/jnr.10455; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Deng LLYS, 2000, NEUROSCI RES, V38, P183; Edsjo A, 2001, CELL GROWTH DIFFER, V12, P39; Edstrom A, 1996, NEUROSCIENCE, V75, P1165, DOI 10.1016/0306-4522(96)00324-7; ElShamy WM, 1998, NEURON, V21, P1003, DOI 10.1016/S0896-6273(00)80619-4; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1993, BRAIN RES MOL BRAIN, V17, P217; Fanarraga ML, 1999, EUR J NEUROSCI, V11, P517; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; FRIEDE RL, 1967, ACTA NEUROPATHOL, V7, P218, DOI 10.1007/BF00686373; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Geuna S, 2002, INT J DEV NEUROSCI, V20, P475, DOI 10.1016/S0736-5748(02)00059-X; Gratto KA, 2003, EUR J NEUROSCI, V18, P1535, DOI 10.1046/j.1460-9568.2003.02881.x; Groves MJ, 1997, J NEUROCYTOL, V26, P615, DOI 10.1023/A:1018541726460; Groves MJ, 1999, EXP NEUROL, V155, P284, DOI 10.1006/exnr.1998.6985; Groves MJ, 2003, J NEUROCYTOL, V32, P113, DOI 10.1023/B:NEUR.0000005596.88385.ec; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Helgren ME, 1997, J NEUROSCI, V17, P372; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; JACOBS JM, 1976, J NEUROL SCI, V29, P95, DOI 10.1016/0022-510X(76)90083-6; Karchewski LA, 2002, EUR J NEUROSCI, V16, P1449, DOI 10.1046/j.1460-9568.2002.02205.x; Kato T, 1999, NEUROREPORT, V10, P2769, DOI 10.1097/00001756-199909090-00013; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Krekoski CA, 1996, J NEUROSCI RES, V43, P1, DOI 10.1002/jnr.490430102; Kruttgen A, 1998, P NATL ACAD SCI USA, V95, P9614, DOI 10.1073/pnas.95.16.9614; Kuo LT, 2005, J COMP NEUROL, V482, P320, DOI 10.1002/cne.20400; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LAWSON SN, 2005, PERIPHERAL NEUROPATH, V1, P163; Leclere P, 1998, NEUROSCIENCE, V82, P545; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li L, 2001, J COMP NEUROL, V439, P259, DOI 10.1002/cne.1349; Ljungberg C, 1999, NEUROSCI LETT, V262, P29, DOI 10.1016/S0304-3940(99)00040-3; LU X, 1991, J NEUROSCI, V11, P972; Macdonald R, 2001, MOL BRAIN RES, V90, P48, DOI 10.1016/S0169-328X(01)00086-9; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; McKay Hart A., 2002, EXP BRAIN RES, V142, P308; McLachlan EM, 1998, NEUROSCIENCE, V84, P961, DOI 10.1016/S0306-4522(97)00680-5; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Mizisin AP, 1997, J NEUROPATH EXP NEUR, V56, P1290, DOI 10.1097/00005072-199712000-00004; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Munson JB, 1997, J NEUROSCI, V17, P470; Namaka MP, 2001, EXP NEUROL, V172, P60, DOI 10.1006/exnr.2001.7761; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pannese E, 2002, J NEUROCYTOL, V31, P755, DOI 10.1023/A:1025708132119; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; RICH KM, 1989, J NEUROCYTOL, V18, P569, DOI 10.1007/BF01187077; Romero MI, 2001, J NEUROSCI, V21, P8408; SCHMALBRUCH H, 1987, ANAT REC, V219, P323, DOI 10.1002/ar.1092190314; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; Shen H, 1999, EXP BRAIN RES, V127, P141, DOI 10.1007/s002210050783; Shubayev VI, 2005, J PERIPHER NERV SYST, V10, P86; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TRIA MA, 1994, EXP NEUROL, V127, P178, DOI 10.1006/exnr.1994.1093; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Xu B, 2002, NEUROSCIENCE, V115, P1295, DOI 10.1016/S0306-4522(02)00384-6; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhou XF, 1999, EUR J NEUROSCI, V11, P1711, DOI 10.1046/j.1460-9568.1999.00589.x; Zhou XF, 1996, J NEUROSCI, V16, P2901	83	13	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 29	2007	147	2					491	507		10.1016/j.neuroscience.2007.04.023			17	Neurosciences	Neurosciences & Neurology	187NA	WOS:000247853400021	17532148				2021-06-18	
J	Johnson, JB; Malone, SD				Johnson, Jeffrey B.; Malone, Stephen D.			Ground-coupled acoustic airwaves from Mount St. Helens provide constraints on the May 18, 1980 eruption	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						acoustic airwaves; ground-coupled seismicity; Mount St. Helens	WAVES; PROPAGATION; INFRASOUND; ATMOSPHERE; SATELLITE; VOLCANO; MIDDLE; WINDS; MODEL	The May 18, 1980 Mount St. Helens eruption perturbed the atmosphere and generated atmosphere-to-ground coupled airwaves, which were recorded on at least 35 seismometers operated by the Pacific Northwest Seismograph Network (PNSN). From 102 distinct travel time picks we identify coherent airwaves crossing Washington State primarily to the north and east of the volcano. The travel time curves provide evidence for both stratospheric refractions (at 200 to 300 kin from the volcano) as well as probable thermospheric refractions (at 100 to 350 kin). The very few first-hand reports of audible volcano sounds within about 80 kin of the volcano coincide with a general absence of ground-coupled acoustic arrivals registered within about 100 kin and are attributed to upward refraction of sound waves. From the coherent refracted airwave arrivals, we identify at least four distinct sources which we infer to originate 10 s, 114 s, similar to 180 s and 319 s after the onset of an 8:32: 11 PDT landslide. The first of these sources is attributed to resultant depressurization and explosion of the cryptodome. Most of the subsequent arrivals also appear to be coincident with a source located at or near the presumed volcanic conduit, but at least one of the later arrivals suggests an epicenter displaced about 9 km to the northwest of the vent. This dislocation is compatible with the direction of the sector collapse and lateral blast. We speculate that this concussion corresponds to a northern explosion event associated with hot cryptodome entering the Toutle River Valley. (C) 2007 Elsevier B.V. All rights reserved.	New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Johnson, JB (corresponding author), New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA.	jeff.johnson@unh.edu; steve@ess.washington.edu					Aki K, 1980, QUANTITATIVE SEISMOL, V1st; Baker WE., 1973, EXPLOSIONS AIR; BANISTER JR, 1984, J GEOPHYS RES-ATMOS, V89, P4895, DOI 10.1029/JD089iD03p04895; BATH M, 1982, EOS T AGU, V63, P193; Bolt B. A., 1981, EOS Transactions of the American Geophysical Union, V62, P529; Brodsky EE, 1999, J GEOPHYS RES-SOL EA, V104, P29387, DOI 10.1029/1999JB900308; DONN WL, 1981, SCIENCE, V213, P539, DOI 10.1126/science.213.4507.539; Drob DP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003307; FAIRFIELD C, 1980, OREGON GEOL, V42, P200; FLEMING EL, 1988, 100697 NAT AER SPAC; Ford RD, 1970, INTRO ACOUSTICS; Garces M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020696; Garces MA, 1998, GEOPHYS RES LETT, V25, P2293, DOI 10.1029/98GL01511; GEORGES TM, 1977, J ACOUST SOC AM, V61, P28, DOI 10.1121/1.381263; GEORGES TM, 1971, 212WPL16 NAT OC ATM; HEDIN AE, 1987, J GEOPHYS RES, V92, P4649, DOI 10.1029/JA092iA05p04649; HEDIN AE, 1991, J GEOPHYS RES, V96, P7657, DOI 10.1029/91JA00251; HEDIN AE, 1991, J GEOPHYS RES, V96, P1159, DOI 10.1029/90JA02125; Hoblitt RP, 2000, PHILOS T ROY SOC A, V358, P1639, DOI 10.1098/rsta.2000.0608; HOLASEK RE, 1995, J GEOPHYS RES-SOL EA, V100, P8469, DOI 10.1029/94JB03137; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; KANAMORI H, 1984, J GEOPHYS RES, V89; Kitov IO, 1997, B SEISMOL SOC AM, V87, P1553; Le Pichon A, 2002, J ACOUST SOC AM, V111, P629, DOI 10.1121/1.1404434; Lipman P.W., 1981, 1980 ERUPTIONS MOUNT; MALONE SD, 1981, US GEOL SURV PROF PA, V1250, P803; MOORE JG, 1984, CHRONOLOGY CHARACTER, P133; POWER J, 1993, ALASKA VOLCANO OBSER, V5, P14; Raspet R, 1998, HANDBOOK OF ACOUSTICS, P293; REED JW, 1987, J GEOPHYS RES-ATMOS, V92, P11979, DOI 10.1029/JD092iD10p11979; REES DE, 1986, ADV SPACE RES, V8; RITSEMA AR, 1980, EOS T AGU, V61, P1201; ROSENBAUM JG, 1981, US GEOLOGICAL SURVEY, V1250, P53; Rowe CA, 2000, J VOLCANOL GEOTH RES, V101, P105, DOI 10.1016/S0377-0273(00)00170-0; SCOTT E, 2003, EOS T AGU S, V84; SPARKS RSJ, 1986, J VOLCANOL GEOTH RES, V28, P257, DOI 10.1016/0377-0273(86)90026-0; Sutherland LC, 2004, J ACOUST SOC AM, V115, P1012, DOI 10.1121/1.1631937; SYMONS G, 1988, ERUPTION KRAKATAU SU; Tahira M, 1996, FIRE AND MUD, P601; VOIGHT B, 1981, US GEOL SURV PROF PA, V1250, P69	40	13	13	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	JUN 15	2007	258	1-2					16	31		10.1016/j.epsl.2007.03.001			16	Geochemistry & Geophysics	Geochemistry & Geophysics	187DR	WOS:000247828000002					2021-06-18	
J	Canter, HI; Kayikcioglu, A; Aksu, M; Mavili, ME				Canter, Halil Ibrahim; Kayikcioglu, Aycan; Aksu, Muge; Mavili, Mehmet Emin			Botulinum toxin in closed treatment of mandibular condylar fracture	ANNALS OF PLASTIC SURGERY			English	Article						botulinum toxin; closed treatment; condylar fracture	TEMPOROMANDIBULAR-JOINT; SPASM; AGE	Background: The topic of condylar injury in adults has generated more discussion and controversy than any other in the field of maxillofacial trauma. The treatment of condylar fractures in adults is still a highly debated theme. Methods: Patients with unilateral subcondylar or condylar neck fractures of the mandibula without any significant angulation of the condylar head were managed with closed-treatment protocol. Closed treatment was applied through the injection of 100 units of botulinum toxin A, diluted to a concentration of 20 IU/mL, into the muscles of mastication of the fractured side. Masseter and anterior fibers of temporalis muscles were reached through percutaneous extraoral route and 30 IU of the toxin was injected to each muscle. Additional 40 IU of the toxin was injected around the fractured bone fragments through transmucosal intraoral route to paralyze medial and lateral pterygoid muscles as much as possible. An asymmetric occlusal splint was applied for maxillomandibular fixation to restore the vertical height for 10 days. Functional therapy with intermaxillary guiding elastics was advocated for 2 months. Results: There were no complications related to either toxin injections or splint application procedures. The toxin was effective on all occasions. Fractured condylar process and ramus of the mandibula were in good approximation and remained in reduced positions. None of the patients had any occlusal disturbance, mandibular asymmetry, or joint dysfunction in the follow-up period. Conclusions: We believe that modification of treatment options concerning the clinical situation of the patients is the best method for condylar injury. The purpose of this study is to present and discuss the results achieved in closed treatment of a selected group of patients with mandibular condylar fractures to whom botulinum toxin A was injected to relieve the spasm of muscles of mastication, along with special splint application.	Hacettepe Univ, Fac Med, Dept Plast & Reconstruct Surg, Ankara, Turkey; Hacettepe Univ, Fac Dent, Dept Orthodont, Ankara, Turkey		hicanter@gmail.com					Albanese A, 1995, ALIMENT PHARM THERAP, V9, P599; Bos RRM, 1999, BRIT J ORAL MAX SURG, V37, P87; Brandt MT, 2003, J ORAL MAXIL SURG, V61, P1324, DOI 10.1016/S0278-2391(03)00735-3; Brisinda G, 1999, NEW ENGL J MED, V341, P65, DOI 10.1056/NEJM199907083410201; Carruthers J, 2004, PLAST RECONSTR SURG, V114, p1S, DOI 10.1097/01.PRS.0000144795.76040.D3; CARRUTHERS J, 1987, CAN J NEUROL SCI, V14, P42; CLARK RP, 1989, PLAST RECONSTR SURG, V84, P353, DOI 10.1097/00006534-198908000-00027; da Silveira Eduardo B V, 2002, Am J Ther, V9, P157, DOI 10.1097/00045391-200203000-00010; Ellis E, 2005, J ORAL MAXIL SURG, V63, P115, DOI 10.1016/j.joms.2004.02.019; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Freitag FG, 2003, CNS DRUGS, V17, P373, DOI 10.2165/00023210-200317060-00001; Glogau RG, 2002, CLIN J PAIN, V18, pS191, DOI 10.1097/00002508-200211001-00012; Karacalar A, 2005, J CRANIOFAC SURG, V16, P476, DOI 10.1097/04.SCS.0000157263.73768.64; Kayikcioglu A, 2003, PLAST RECONSTR SURG, V111, P341, DOI 10.1097/01.PRS.0000037870.07434.D0; Koman L Andrew, 2003, Paediatr Drugs, V5, P11, DOI 10.2165/00128072-200305010-00002; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; Miloro M, 2004, ARCH OTOLARYNGOL, V130, P1231, DOI 10.1001/archotol.130.10.1231; O'Brien CF, 2002, CLIN J PAIN, V18, pS182, DOI 10.1097/00002508-200211001-00011; PITANGUY I, 1981, PLAST RECONSTR SURG, V67, P157, DOI 10.1097/00006534-198167020-00005; Porta M, 2000, PAIN, V85, P101, DOI 10.1016/S0304-3959(99)00264-X; SATKO CR, 1986, J ORAL MAXIL SURG, V44, P871, DOI 10.1016/0278-2391(86)90224-7; SCOTT AB, 1980, OPHTHALMOLOGY, V87, P1044; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Talwar RM, 1998, J ORAL MAXIL SURG, V56, P430, DOI 10.1016/S0278-2391(98)90707-8; TASANEN A, 1976, Journal of Maxillofacial Surgery, V4, P200, DOI 10.1016/S0301-0503(76)80036-7; Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010; Vural E, 2004, ARCH OTOLARYNGOL, V130, P1228, DOI 10.1001/archotol.130.10.1228	27	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	MAY	2007	58	5					474	478		10.1097/01.sap.0000244987.68092.6e			5	Surgery	Surgery	161RK	WOS:000246033000002	17452828				2021-06-18	
J	Beal, AL; Deuser, WE; Beilman, GJ				Beal, Alan L.; Deuser, William E.; Beilman, Greg J.			A role for epinephrine in post-traumatic hypokalemia	SHOCK			English	Article						wounds and injuries complications; catecholamines; resuscitation; electrolytes; stress response; Injury Severity Score (ISS); Glasgow Coma Score (GCS)	SYMPATHETIC NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; POTASSIUM CONCENTRATIONS; PLASMA-CATECHOLAMINES; BETA-ADRENOCEPTORS; ADRENERGIC CONTROL; SERUM POTASSIUM; INSULIN; STIMULATION	We have previously described a high incidence of admission hypokalemia in trauma patients at our institution. We subsequently performed a prospective study of 112 trauma patients to examine the possible etiologies of post-traumatic hypokalemia. Trauma patients >= 5 years old were evaluated within 6 h of injury with a variety of studies including catecholamines, cortisol, and insulin levels, with studies repeated 24 to 36 h after admission. No potassium replacement was given during this time. Demographic factors such as age, types of injury, and severity of injuries were collected. We found that the mean age of those with post-traumatic hypokalemia (<= 3.5 mEq/L) was significantly younger (29 vs. 37 years old; P = 0.004) and epinephrine levels were significantly higher (863 vs. 406 pg/mL; P = 0.01) when compared with normokalemic patients on admission. At 24 to 36 h, the hypokalemia group compared with the normokalemic patients showed a significant rise in the mean potassium levels (17.2% vs. 4.1%; P < 0.001), a significant fall in mean epinephrine levels (-86.6% vs. -81.4%; P < 0.001), and a significant rise in insulin levels (161% vs. 24%; P < 0.005). Finally, because our previous study had shown that post-traumatic hypokalemia was predictive of injury severity score, 4 trauma admission groups were compared with regard to potassium levels and injury severity score. Those trauma patients with both high injury severity and hypokalemia had significantly higher admission epinephrine levels (1222 vs. 290 pg/mL; P = 0.005), glucose levels (174 vs. 126 mg/dL; P = 0.001), and lower carbon dioxide levels (21.3 vs. 24.6 mEq/L; P < 0.03) than those trauma patients with less severe injury and normokalemia. We conclude that post-traumatic hypokalemia seems to be related to a rise in epinephrine levels, that this rise in epinephrine levels seems to be blunted in older patients, and that post-traumatic hypokalemia is rapidly reversible without specific therapy.	N Mem Hlth Care, Robbinsdale, MN 55422 USA; Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	Beal, AL (corresponding author), N Mem Hlth Care, 3300 Oakdale Ave N, Robbinsdale, MN 55422 USA.	ALAN.BEAL@NORTHMEMORIAL.COM		Beilman, Gregory/0000-0001-5036-3027			Beal AL, 2002, SHOCK, V18, P107, DOI 10.1097/00024382-200208000-00002; BROWN MJ, 1985, AM J CARDIOL, V56, pD3, DOI 10.1016/0002-9149(85)91107-5; CLAUSEN T, 1983, ACTA MED SCAND, P111; DAVIES CL, 1984, J TRAUMA, V24, P99, DOI 10.1097/00005373-198402000-00002; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; FRANCIS GS, 1990, AM J CARDIOL, V65, pE24, DOI 10.1016/0002-9149(90)90248-Y; Gabow PA, 1992, RENAL ELECTROLYTE DI, P231; Grace G T, 1988, Curr Surg, V45, P463; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HANSEN O, 1990, ANGIOLOGY, V41, P175, DOI 10.1177/000331979004100302; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; JAATTELA A, 1975, BRIT J SURG, V62, P177, DOI 10.1002/bjs.1800620303; Kolloch RE, 1996, J LAB CLIN MED, V127, P50, DOI 10.1016/S0022-2143(96)90165-1; Lakatua D J, 1987, Prog Clin Biol Res, V227B, P31; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; LUNDBORG P, 1983, ACTA MED SCAND, P121; Meguid M M, 1973, Surg Forum, V24, P97; MEGUID MM, 1978, J SURG RES, V25, P389, DOI 10.1016/S0022-4804(78)80002-X; MORATINOS J, 1993, FUNDAM CLIN PHARM, V7, P143, DOI 10.1111/j.1472-8206.1993.tb00228.x; MORGAN DB, 1982, LANCET, V2, P1283; Nicolau G Y, 1985, Endocrinologie, V23, P189; NORDREHAUG JE, 1985, AM HEART J, V110, P944, DOI 10.1016/0002-8703(85)90189-9; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; REID JL, 1986, AM J CARDIOL, V57, pF23, DOI 10.1016/0002-9149(86)90884-2; ROSA RM, 1980, NEW ENGL J MED, V302, P431, DOI 10.1056/NEJM198002213020803; SHIN B, 1986, ANESTHESIOLOGY, V65, P90, DOI 10.1097/00000542-198607000-00018; SMITH JS, 1978, SURG GYNECOL OBSTET, V147, P18; STRUTHERS AD, 1984, CLIN ENDOCRINOL, V20, P409; VANEK VW, 1994, SOUTHERN MED J, V87, P41, DOI 10.1097/00007611-199401000-00010; VITEK V, 1979, AM SURGEON, V45, P228; VITEK V, 1979, CLIN CHIM ACTA, V95, P93, DOI 10.1016/0009-8981(79)90341-3; WILLIAMS ME, 1985, NEW ENGL J MED, V312, P823, DOI 10.1056/NEJM198503283121304; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	35	13	17	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	APR	2007	27	4					358	363		10.1097/01.shk.0000245029.47106.db			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	152NI	WOS:000245368300004	17414416				2021-06-18	
J	Ang, BT; Wong, J; Lee, KK; Wang, E; Ng, I				Ang, B. T.; Wong, J.; Lee, K. K.; Wang, E.; Ng, I.			Temporal changes in cerebral tissue oxygenation with cerebrovascular pressure reactivity in severe traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SEVERE HEAD-INJURY; BLOOD-FLOW; VASOMOTOR REACTIVITY; PERFUSION-PRESSURE; AUTOREGULATION; MANAGEMENT; METABOLISM	Objective: To investigate the temporal relationship between cerebrovascular pressure reactivity and brain tissue oxygenation in patients with severe head injury. Methods: In 40 patients, brain tissue oxygenation and intracranial pressure were monitored. Time-averaged values for intracranial pressure (ICP), mean arterial pressure (MAP), cerebral perfusion pressure (CPP) and brain tissue oxygenation (PtiO(2)) were computed. The pressure reactivity index (PRx) was calculated. The mean values of the variables were obtained at the 6-h and 72-h post-injury time points, and the difference between the two time points for each of the variables was denoted as delta (delta). Results: Of the 40 patients, 32 were survivors and 8 were non-survivors. Statistically significant differences were present between these two groups with regard to delta MAP (p = 0.013), ICP at 6 h (p = 0.027), CPP at 72 h (p = 0.018), delta CPP (p = 0.033), PRx at 6 h (p = 0.029), PRx at 72 h (p = 0.002), PtiO(2) at 72 h (p < 0.0005) and delta PtiO(2) (p = 0.023) values, reflecting an improvement with time in survivors and a deterioration with time in non-survivors. In non-survivors, the magnitude of change in PtiO(2) and CPP with time correlated in a negative linear fashion (p = 0.042 and 0.029, respectively) with the change in PRx with time, whereas no such relationship was seen in survivors. Conclusion: The severity of brain tissue oxygenation derangement correlates with increasing cerebrovascular dysautoregulation in patients succumbing to severe head injury, supporting the utility of PRx as a monitoring variable and the rationale for a target-driven approach to head injury management.	Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, Singapore 308433, Singapore	Ng, I (corresponding author), Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, 11,Jalan Tan Tock Seng, Singapore 308433, Singapore.	ivan_ng@nni.com.sg					BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Czosnyka M, 1996, CEREBROVAS BRAIN MET, V8, P273; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LASSEN NA, 1959, PHYSIOL REV, V39, P183; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MARMAROU A, 1993, ACTA NEUROCHIR, P18; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	23	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2007	78	3					298	302		10.1136/jnnp.2005.082735			5	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	137EZ	WOS:000244277100017	17028122	Green Published			2021-06-18	
J	Lo, YL; Yang, TC; Liao, CC; Yang, ST				Lo, Yang-Lan; Yang, Tao-Chieh; Liao, Chen-Chih; Yang, Shun-Tai			Diagnosis of traumatic internal carotid artery injury: The role of craniofacial fracture	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						traumatic internal carotid artery injury; computed tomography; craniofacial fracture; course of internal carotid artery	BLUNT CEREBROVASCULAR INJURIES; DISSECTION; OUTCOMES	Optimally, internal carotid artery (ICA) injury associated with craniofacial trauma should be treated soon after diagnosis. However, diagnosis is difficult and often delayed. The typical symptoms and signs for diagnosis of traumatic ICA injuries are sometimes easily neglected. Clinically, some patients were initially diagnosed by craniofacial fracture nearby the course of ICA. This investigation retrospectively reviews clinical experience in patients with traumatic ICA injury with a focus on the importance of craniofacial fracture nearby the course of ICA observed on brain or facial bone computed tomography. Eighteen patients with traumatic ICA injury were diagnosed at Chang Gung Memorial Hospital, Taiwan, from June 1998 to April 2004, including 10 patients with pseudoaneurysm formation, seven patients with occlusion, and one patient with laceration. Brain or facial bone computed tomography was reviewed retrospectively. The sample included 14 (78%) patients with skull base fractures involving the intracranial course of ICA and three (17%) patients with mandibular and cervical spine fractures near the course of extracranial ICA. Only one (5%) patient did not have evident fracture. Fractures involving the carotid canal were rioted in three (17%) patients. Eight patients received interventional treatments. No further interventional treatments for traumatic ICA occlusion were performed as a result of good collateral flow from contralateral ICA or large infarction noted when diagnosed. Three patients with pseudoaneurysm received expectant management. One patient with arterial laceration with extravasation received no further management. Through meticulously evaluating routine brain and facial bone computed tomography, craniofacial fracture involving intracranial or extracranial course of ICA may be an adjuvant indicator of traumatic ICA injury for early diagnosis.	Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan	Yang, ST (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, 5 Fu Shin St, Tao Yuan, Taiwan.	yst0708@adm.cgmh.org.tw					Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Carter DA, 1998, J TRAUMA, V44, P230, DOI 10.1097/00005373-199801000-00039; HABAL MB, 1986, PLAST RECONSTR SURG, V77, P981; Kerwin AJ, 2001, J TRAUMA, V51, P308, DOI 10.1097/00005373-200108000-00013; Lee WW, 2000, J EMERG MED, V19, P35, DOI 10.1016/S0736-4679(00)00190-6; Liu AY, 1999, NEUROSURGERY, V45, P1368, DOI 10.1097/00006123-199912000-00022; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; PERRY MO, 1980, ANN SURG, V192, P74, DOI 10.1097/00000658-198007000-00013; POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; Vishteh AG, 1998, NEUROSURGERY, V43, P761, DOI 10.1097/00006123-199810000-00016; WELLING RE, 1987, J TRAUMA, V27, P1221; Yang ST, 2006, J CLIN NEUROSCI, V13, P123, DOI 10.1016/j.jocn.2005.02.016; Yang WG, 2003, PLAST RECONSTR SURG, V111, P789, DOI 10.1097/01.PRS.0000041541.72469.53; York G, 2005, AM J ROENTGENOL, V184, P1672, DOI 10.2214/ajr.184.5.01841672; ZELENOCK GB, 1982, ARCH SURG-CHICAGO, V117, P425	18	13	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2007	18	2					361	368		10.1097/scs.0b013e318033605f			8	Surgery	Surgery	153IA	WOS:000245424400021	17414287				2021-06-18	
J	O'Sullivan, JC; Yao, XL; Alam, H; McCabe, JT				O'Sullivan, Joseph C.; Yao, Xiang-Lan; Alam, Hasan; McCabe, Joseph T.			Diazoxide, as a postconditioning and delayed preconditioning trigger, increases HSP25 and HSP70 in the central nervous system following combined cerebral stroke and hemorrhagic shock	JOURNAL OF NEUROTRAUMA			English	Article						HSP; ischemia; ischemic preconditioning; postconditioning; shock	K-ATP CHANNELS; TRAUMATIC BRAIN-INJURY; ISCHEMIC TOLERANCE; CELL-DEATH; PROTEINS; EXPRESSION; REPERFUSION; ACTIVATION; CHAPERONES; APOPTOSIS	Combined hemorrhagic shock (Shock) and unilateral common carotid artery occlusion (Stroke) results in a decrease of oxygen availability to peripheral tissues and organs and the central nervous system (CNS). A variety of biochemical processes ensue, including organ failure, cellular apoptosis, and necrosis. The present study used male, Sprague-Dawley rats to assess the impact of cerebral insult. Using heat-shock protein 25 and 70 (HSP25, HSP70) as biomarkers, measured 24 h after injury, we tested the hypothesis that pharmacological induction of preconditioning can offer cytoprotection from combined Stroke and Shock. The compound, diazoxide (DZ), is known to induce preconditioning through its effect as a mitochondrial potassium ATP (mK(ATP)) channel opener and succinate dehydrogenase inhibitor. When administered 24 h prior to Stroke and Shock (delayed preconditioning), DZ increased cerebral cortical and hippocampal levels of HSP25 and HSP70. A more clinically relevant treatment paradigm was tested, where DZ was administered after the induction of Stroke and Shock (postconditioning). When administered 60 min (but not 10 min) after the induction of Stroke and Shock, DZ significantly increased HSP25 and HSP70 expression in the ipsilateral cerebral cortex and hippocampus. Taken together, these results suggest that DZ treatment may be efficacious for CNS injury resulting from blood loss and anoxia from combined cerebral ischemia and hemorrhagic shock. "Postconditioning" triggered by DZ, immediately before resuscitation, is a potentially effective treatment for ischemia-reperfusion injury from combined Stroke and Shock.	Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02115 USA	McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	JMcCabe@usuhs.mil	McCabe, Joseph/J-6293-2014	McCabe, Joseph/0000-0002-1159-7442			Acarin L, 2002, GLIA, V38, P1, DOI 10.1002/glia.10040; Alemzadeh R, 1999, ENDOCRINOLOGY, V140, P3197, DOI 10.1210/en.140.7.3197; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Beere HM, 2000, NAT CELL BIOL, V2, P469; Boeri D, 2003, EUR J CLIN INVEST, V33, P500, DOI 10.1046/j.1365-2362.2003.01157.x; Bruey JM, 2000, NAT CELL BIOL, V2, P645; Brustovetsky T, 2005, J PHYSIOL-LONDON, V568, P47, DOI 10.1113/jphysiol.2005.091199; Carroll R, 2001, CARDIOVASC RES, V51, P691, DOI 10.1016/S0008-6363(01)00330-3; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; Chen MK, 2001, J NEUROSCI, V21, P6512; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Diaz RJ, 2004, CARDIOVASC RES, V62, P4, DOI 10.1016/j.cardiores.2004.01.036; Downey JM, 2005, CIRCULATION, V111, P120, DOI 10.1161/01.CIR.0000153622.49496.10; Dzeja PP, 2003, AM J PHYSIOL-HEART C, V284, pH1048, DOI 10.1152/ajpheart.00847.2002; Fryer RM, 2000, AM J PHYSIOL-HEART C, V278, pH305; GLAZIER SS, 1994, J CEREBR BLOOD F MET, V14, P545, DOI 10.1038/jcbfm.1994.68; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; MIZUMURA T, 1995, CIRCULATION, V92, P1236, DOI 10.1161/01.CIR.92.5.1236; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; PANG CY, 1995, CARDIOVASC RES, V29, P782, DOI 10.1016/S0008-6363(96)88613-5; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Peralta C, 1996, BIOCHEM BIOPH RES CO, V229, P264, DOI 10.1006/bbrc.1996.1790; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Seharaseyon J, 2000, J MOL CELL CARDIOL, V32, P1923, DOI 10.1006/jmcc.2000.1226; Shake JG, 2001, ANN THORAC SURG, V72, P1849, DOI 10.1016/S0003-4975(01)03192-7; Tidwell JL, 2004, CELL STRESS CHAPERON, V9, P88, DOI 10.1379/1466-1268(2004)009<0088:AOHIVI>2.0.CO;2; Wang X, 2004, SHOCK, V22, P23, DOI 10.1097/01.shk.0000129200.30965.57; Wang X, 2003, EUR J CARDIO-THORAC, V24, P967, DOI 10.1016/S1010-7940(03)00438-X; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Zaugg M, 2002, ANESTHESIOLOGY, V97, P4, DOI 10.1097/00000542-200207000-00003; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	45	13	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2007	24	3					532	546		10.1089/neu.2006.0128			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	152RQ	WOS:000245379900009	17402858				2021-06-18	
J	Xilouri, M; Avlonitis, N; Calogeropoulou, T; Papazafiri, P				Xilouri, Maria; Avlonitis, Nicolaos; Calogeropoulou, Theodora; Papazafiri, Panagiota			Neuroprotective effects of steroid analogues on P19-N neurons	NEUROCHEMISTRY INTERNATIONAL			English	Article						synthetic neurosteroids; NMDA cytotoxicity; GABA(A) receptor; cytochrome c; neuroprotection	EMBRYONAL CARCINOMA-CELLS; CYTOCHROME-C RELEASE; GLUTAMATE-INDUCED APOPTOSIS; TRAUMATIC BRAIN-INJURY; NEUROSTEROID ANALOGS; GABA(A) RECEPTOR; NEUROACTIVE STEROIDS; PROTEIN-KINASE; IN-VITRO; DEHYDROEPIANDROSTERONE-SULFATE	Naturally occurring neurosteroids are potent allosteric modulators of gamma-aminobutyric acid(A) receptor and through augmentation of gamma-aminobutyric acid(A) receptor function, can protect neuronal cells against N-methyl-D-aspartate receptor over-activation, ischemia and traumatic brain injury. In this study, mouse P19 cells were induced to differentiate into post-mitotic neurons and were subjected to excitotoxicity in the presence of N-methyl-D-aspartate. Novel synthetic analogues of the endogenous neurosteroids allopregnanolone and dehydroepiandrostrone, inhibited excitotoxic cell death of P19-N neurons, by directly maintaining the activation of PKB/Akt kinase, and interfering with the intrinsic mitochondrial apoptotic pathway, preserving cytochrome c in the mitochondria and Bax in the cytoplasm. The efficiency and the potency of these neurosteroids were similar to those of allopregnanolone and dehydroepiandrostrone. Their effects were gamma-aminobutyric acid(A) receptor mediated, since they were abolished in the presence of bicuculline, an antagonist of receptor's function. In addition, the synthetic compounds retained the ability to alter gamma-aminobutyric acid(A) receptor subunit gene expression, but their effects on transcriptional activity were less pronounced than those of allopregnanolone and dehydroepiandrostrone. These results suggest that synthetic neurosteroids may serve as potent, membrane acting, neuroprotectants against N-methyl-D-aspartate receptor neurotoxicity on neuronal cells. (c) 2007 Elsevier Ltd. All rights reserved.	Univ Athens, Dept Anim & Human Physiol, Sch Biol, Fac Sci, Athens 15784, Greece; Natl Hellen Res Fdn, Inst Organ & Pharmaceut Chem, Athens 11635, Greece	Papazafiri, P (corresponding author), Univ Athens, Dept Anim & Human Physiol, Sch Biol, Fac Sci, Athens 15784, Greece.	ppapaz@biol.uoa.gr	Avlonitis, Nicolaos/A-5161-2009; Avlonitis, Nicolaos/T-6053-2019	Xilouri, Maria/0000-0001-7038-0780			Anderson A, 1997, J MED CHEM, V40, P1668, DOI 10.1021/jm960733n; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bain G, 1998, PERSPECT DEV NEUROBI, V5, P175; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Beal M F, 1992, Curr Opin Neurobiol, V2, P657, DOI 10.1016/0959-4388(92)90035-J; Beekman M, 1998, J PHARMACOL EXP THER, V284, P868; Belelli D, 2006, NEUROSCIENCE, V138, P821, DOI 10.1016/j.neuroscience.2005.07.021; BELELLI D, 2005, NAT REV NEUROSCI; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brussard AB, 2003, ANN NY ACAD SCI, V1007, P29, DOI 10.1196/annals.1286.003; Canzoniero LMT, 1996, J NEUROSCI RES, V45, P226; Cascio C, 2002, J NEUROCHEM, V83, P1358, DOI 10.1046/j.1471-4159.2002.01229.x; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Charalampopoulos L, 2004, P NATL ACAD SCI USA, V101, P8209, DOI 10.1073/pnas.0306631101; Chatman K, 1999, ANAL CHEM, V71, P2358, DOI 10.1021/ac9806411; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chuang DM, 2002, BIPOLAR DISORD, V4, P129, DOI 10.1034/j.1399-5618.2002.01179.x; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Concas A, 1999, EUR J PHARMACOL, V375, P225, DOI 10.1016/S0014-2999(99)00232-0; Covey DF, 2000, J MED CHEM, V43, P3201, DOI 10.1021/jm0002477; CRAIG CR, 1968, ARCH INT PHARMACOD T, V172, P366; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies S, 2001, J CLIN PATHOL-MOL PA, V54, P409; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Finley MFA, 1996, J NEUROSCI, V16, P1056; Follesa P, 2002, NEUROPHARMACOLOGY, V42, P325, DOI 10.1016/S0028-3908(01)00187-3; Follesa P, 2004, EUR J PHARMACOL, V500, P413, DOI 10.1016/j.ejphar.2004.07.041; Follesa P, 2004, MOL BRAIN RES, V120, P130, DOI 10.1016/j.molbrainres.2003.10.011; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Follesa P, 2006, PSYCHOPHARMACOLOGY, V186, P267, DOI 10.1007/s00213-005-0126-0; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gasior M, 1999, TRENDS PHARMACOL SCI, V20, P107, DOI 10.1016/S0165-6147(99)01318-8; GEE KW, 1995, CRIT REV NEUROBIOL, V9, P207; Grobin AC, 1999, BRAIN RES, V827, P1; Grobin AC, 2000, EUR J PHARMACOL, V409, pR1, DOI 10.1016/S0014-2999(00)00797-4; Guillon J, 2001, J PHARM PHARMACOL, V53, P1561, DOI 10.1211/0022357011777945; Hamilton Niall M., 2002, Current Topics in Medicinal Chemistry, V2, P887, DOI 10.2174/1568026023393570; Han MC, 1996, J MED CHEM, V39, P4218, DOI 10.1021/jm960304p; HAN MC, 1995, J MED CHEM, V38, P4548, DOI 10.1021/jm00022a021; HU YF, 1993, J MED CHEM, V36, P3956, DOI 10.1021/jm00076a025; Jiang X, 2003, J MED CHEM, V46, P5334, DOI 10.1021/jm030302m; Jung-Testas I, 1999, J STEROID BIOCHEM, V69, P97, DOI 10.1016/S0960-0760(98)00149-6; Kaasik A, 2001, NEUROSCIENCE, V102, P427, DOI 10.1016/S0306-4522(00)00489-9; Keller J, 2005, NEUROCHEM INT, V46, P293, DOI 10.1016/j.neuint.2004.11.003; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Macdonald RL, 1997, CURR OPIN NEUROL, V10, P121, DOI 10.1097/00019052-199704000-00009; MacPherson PA, 1997, NEUROSCIENCE, V80, P487, DOI 10.1016/S0306-4522(97)00102-4; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marcos J, 2004, STEROIDS, V69, P51, DOI 10.1016/j.steroids.2003.09.013; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MORLEY P, 1995, J NEUROCHEM, V65, P1093; Nakazawa T, 2005, MOL VIS, V11; Nilsson KR, 1998, J MED CHEM, V41, P2604, DOI 10.1021/jm980148h; NORBERG L, 1987, PHARMACOL TOXICOL, V61, P42, DOI 10.1111/j.1600-0773.1987.tb01770.x; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Rupprecht R, 1997, J PSYCHIATR RES, V31, P297, DOI 10.1016/S0022-3956(96)00060-X; Rupprecht R, 1996, J STEROID BIOCHEM, V56, P163, DOI 10.1016/0960-0760(95)00233-2; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Scaglione JB, 2006, J MED CHEM, V49, P4595, DOI 10.1021/jm0602920; Souli C, 2005, J MED CHEM, V48, P5203, DOI 10.1021/jm050271q; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Sunol C, 2006, J MED CHEM, V49, P3225, DOI 10.1021/jm060002f; Tunez I, 2006, NEUROCHEM INT, V48, P367, DOI 10.1016/j.neuint.2005.11.011; TURETSKY DM, 1993, J NEUROBIOL, V24, P1157, DOI 10.1002/neu.480240904; Upasani RB, 1997, J MED CHEM, V40, P73, DOI 10.1021/jm9605344; Vassilopoulos A, 2005, FREE RADICAL RES, V39, P1273, DOI 10.1080/10715760500166685; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Xilouri M, 2006, EUR J NEUROSCI, V23, P43, DOI 10.1111/j.1460-9568.2005.04548.x; Zeng CM, 2005, J MED CHEM, V48, P3051, DOI 10.1021/jm049027+; Zeng CM, 2000, J ORG CHEM, V65, P2264, DOI 10.1021/jo991953m; Zhang L, 2002, MOL BRAIN RES, V98, P58, DOI 10.1016/S0169-328X(01)00315-1; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zorumski C F, 2000, Curr Opin Investig Drugs, V1, P360; Zorumski CF, 1998, SYNAPSE, V29, P162, DOI 10.1002/(SICI)1098-2396(199806)29:2<162::AID-SYN7>3.0.CO;2-5	92	13	13	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2007	50	4					660	670		10.1016/j.neuint.2006.12.010			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	152YA	WOS:000245397000010	17316905				2021-06-18	
J	Robinson, Y; Reinke, M; Heyde, CE; Ertel, W; Oberholzer, A				Robinson, Yohan; Reinke, Marcus; Heyde, Christoph E.; Ertel, Wolfgang; Oberholzer, Andreas			Traumatic proximal tibiofibular joint dislocation treated by open reduction and temporary fixation: a case report	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						proximal tibiofibular dislocation; peroneal head dislocation	SUBLUXATION	Isolated dislocations of the proximal tibiofibular joint are a rare condition. Missed diagnosis can lead to chronic knee pain and disability. Early recognition should be followed by immediate closed reduction or open reduction and joint transfixation. We present a young athlete with this injury which was treated successfully by open reduction.	Klin Unfall Wiederherstellungschirurg, Dept Orthopaed & Trauma Surg, Charite, D-12200 Berlin, Germany	Robinson, Y (corresponding author), Klin Unfall Wiederherstellungschirurg, Dept Orthopaed & Trauma Surg, Charite, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	yohan.robinson@charite.de	Robinson, Yohan/V-8177-2017	Robinson, Yohan/0000-0002-2724-6372			Aladin A, 2002, KNEE, V9, P233, DOI 10.1016/S0968-0160(02)00012-1; Dinkelaker F, 1985, Aktuelle Traumatol, V15, P264; Laing AJ, 2003, BRIT J SPORT MED, V37, P366, DOI 10.1136/bjsm.37.4.366; Miettinen H, 1999, ARCH ORTHOP TRAUM SU, V119, P358, DOI 10.1007/s004020050428; OGDEN JA, 1974, J BONE JOINT SURG AM, VA 56, P145, DOI 10.2106/00004623-197456010-00015; SACHSE J, 2005, EXTREMITATENGELENKE; Sekiya Jon K, 2003, J Am Acad Orthop Surg, V11, P120; SEMONIAN RH, 1995, J ORTHOP SPORT PHYS, V21, P248, DOI 10.2519/jospt.1995.21.5.248; van den Bekerom Michel P J, 2004, Acta Orthop Belg, V70, P604	9	13	15	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0942-2056			KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	FEB	2007	15	2					199	201		10.1007/s00167-006-0147-1			3	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	133QZ	WOS:000244028900015	16858561				2021-06-18	
J	Jaworski, DM; Beem-Miller, M; Lluri, G; Barrantes-Reynolds, R				Jaworski, Diane M.; Beem-Miller, Micah; Lluri, Gentian; Barrantes-Reynolds, Ramiro			Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2	PHYSIOLOGICAL GENOMICS			English	Article						alternative splicing; gene nesting; knockout; differential display clone 8	MESSENGER-RNA EXPRESSION; EFFICIENT ACTIVATION; BINDING PROTEIN; TIMP-2; SEQUENCES; IDENTIFICATION; ANGIOGENESIS; DIFFERENTIATION; DROSOPHILA; DISPLAY	Nested genes are fairly common within the mammalian nervous system, yet few studies have examined whether the guest and host genes might be coordinately regulated. Tissue inhibitors of metalloproteinase (TIMPs) inhibit extracellular matrix proteolysis mediated by metzincin proteases. TIMP-2 is the only TIMP not nested within a synapsin gene. It does, however, serve as a host for differential display clone 8 (DDC8), a testis-specific gene whose expression is upregulated during spermatogenesis. Here, we demonstrate that DDC8 is not testis specific. Furthermore, DDC8 expression in nonneural and neural tissues mimics that of TIMP-2, including its upregulation in response to traumatic brain injury, suggesting a potential regulatory relationship. The most striking observation is that the TIMP-2 knockout mouse brain contains TIMP-2 mRNA encoding exons 2-5, which are downstream of DDC8, but not exon 1, which contains the signal sequence and cysteine residue required for MMP inhibition, indicating a functional knockout. That TIMP-2 transcripts in wild-type brain contain DDC8 sequence suggests alternative splicing between the two genes.	Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	Jaworski, DM (corresponding author), Univ Vermont, Coll Med, Dept Anat & Neurobiol, 149 Beaumont Ave,HSRF 418, Burlington, VT 05405 USA.	diane.jaworski@uvm.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA022435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016462, P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS035874, R01NS045225] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA022435, P30 CA-22435] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR016462, P20 RR-16462, P20 RR16435, P20 RR016435] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29 NS035874-04S1, R29 NS035874-05, NS-045225, R01 NS045225-01A2, R01 NS045225] Funding Source: Medline		Ahuja S, 2006, OPHTHAL RES, V38, P125, DOI 10.1159/000090533; Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Catalano RD, 1997, MOL HUM REPROD, V3, P215, DOI 10.1093/molehr/3.3.215; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; CAWSTON TE, 1990, BIOCHEM J, V269, P183, DOI 10.1042/bj2690183; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CURRY VA, 1992, BIOCHEM J, V285, P143, DOI 10.1042/bj2850143; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; DERRY JMJ, 1992, GENOMICS, V12, P632, DOI 10.1016/0888-7543(92)90286-2; Duenas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8; FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400; Felsenstein J., 2005, PHYLOGENY INFERENCE; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; Grima J, 1996, J ANDROL, V17, P263; Habib AA, 1998, ONCOGENE, V16, P1525, DOI 10.1038/sj.onc.1201683; Hammani K, 1996, J BIOL CHEM, V271, P25498, DOI 10.1074/jbc.271.41.25498; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HENIKOFF S, 1986, CELL, V44, P33, DOI 10.1016/0092-8674(86)90482-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Jaworski DM, 2006, J NEUROCHEM, V98, P234, DOI 10.1111/j.1471-4159.2006.03855.x; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Jaworski DM, 2005, BRAIN RES, V1051, P81, DOI 10.1016/j.brainres.2005.05.057; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEE SC, 1993, J BIOL CHEM, V268, P12164; LENOIR D, 1986, J NEUROSCI, V6, P522; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; Lluri G, 2006, J NEUROBIOL, V66, P1365, DOI 10.1002/neu.20315; Longin J, 2002, MOL CELL ENDOCRINOL, V189, P25, DOI 10.1016/S0303-7207(01)00756-0; Longin J, 2001, J CELL SCI, V114, P2125; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mruk DD, 1999, J BIOL CHEM, V274, P27056, DOI 10.1074/jbc.274.38.27056; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Pohar N, 1999, GENOMICS, V57, P293, DOI 10.1006/geno.1999.5776; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SILVERMAN TA, 1992, J BIOL CHEM, V267, P9738; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Young DA, 2002, BIOCHEM J, V364, P89, DOI 10.1042/bj3640089; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008	60	13	17	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1094-8341	1531-2267		PHYSIOL GENOMICS	Physiol. Genomics	JAN 17	2007	28	2					168	178		10.1152/physiolgenomics.00160.2006			11	Cell Biology; Genetics & Heredity; Physiology	Cell Biology; Genetics & Heredity; Physiology	135RW	WOS:000244171700004	16985004	Green Accepted			2021-06-18	
J	Brenner, LA; Dise-Lewis, JE; Bartles, SK; O'Brien, SE; Godleski, M; Selinger, M				Brenner, Lisa A.; Dise-Lewis, Jeanne E.; Bartles, Sarah K.; O'Brien, Susan E.; Godleski, Matthew; Selinger, Marilyn			The long-term impact and rehabilitation of pediatric traumatic brain injury: A 50-year follow-up case study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						evaluation; intervention; latent; long-term; pediatric; remote; sequelae; traumatic brain injury	CHILDREN; ADOLESCENTS; OUTCOMES; CHILDHOOD; NORMS	Despite significant advances in the understanding of pediatric traumatic brain injury (TBI)-related sequelae, members of the medical community working with adult survivors often do not appreciate the impact of "latent" effects of these injuries. To assess deficits and facilitate intervention, the interactions among the nature of the TBI, the individual's developmental course, and the history of community response must be understood. This case study discusses the lifelong challenges faced by a 56-year-old individual who sustained a TBI at age 5. His case highlights the importance of developmental stage consideration, remote evaluation/intervention, and collaboration with mental health professionals.	MIRECC, Denver, CO 80220 USA; VA ECHCS, Dept Phys Med & Rehabil, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Psychiat, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Rehabil Med, Denver, CO USA	Brenner, LA (corresponding author), MIRECC, VA VISN 19 1055 Clermont St, Denver, CO 80220 USA.		Brenner, Lisa A./AAG-2442-2019	Godleski, Matthew/0000-0002-3592-679X			Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Baker H.J, 1967, DETROIT TESTS LEARNI; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; BIGLER ED, 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Brady K.D., 2001, CHILDREN TRAUMATIC B; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHOW TW, 1999, SCI PRACT NEUROPSYCH, P3; Conners K, 1999, ADHD ADULTS CHILDREN; Dawson G., 1994, HUMAN BEHAV DEV BRAI; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dise-Lewis J. E., 2002, BRAIN STARS BRAIN IN; Erikson EH., 1964, CHILDHOOD SOC, V2d; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Goodglass H., 1972, ASSESSMENT APHASIA R; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Heaton RK, 2004, REVISED COMPREHENSIV; Hendryx P. M., 1995, J COGN REHABIL, V13, P9; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Kaplan E., 1983, BOSTON NAMING TEST; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kohlberg Lawrence., 1981, ESSAYS MORAL DEV, V1; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Morey L. C., 1991, PERSONALITY ASSESSME; PENNINGTON BF, 1991, DIAGNOSING LEARNING; Piaget J., 1936, ORIGINS INTELLIGENCE; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; ROOPER AH, 2005, ADAMS VICTORS PRINCI; Sbordone R. J., 1998, ECOLOGICAL VALIDITY, P15; Schuell H., 1965, MINNESOTA TEST DIFFE; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Silver JM, 2005, TXB TRAUMATIC BRAIN, P609; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stevenson HW, 1972, CHILDRENS LEARNING; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Teeter P.A., 1997, CHILD NEUROPSYCHOLOG; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wilson B., 1987, BEHAV INATTENTION TE; WOLCOTT GF, 1995, ED MANUAL ED NEED KN; Wolfson D., 1993, HALSTEAD REITAN NEUR; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; YLVISAKER M, 1985, HEAD INJURY REHABILI	48	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2007	22	1					56	64		10.1097/00001199-200701000-00007			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	130SX	WOS:000243820400007	17235232				2021-06-18	
J	Frankel, T; Penn, C				Frankel, Tali; Penn, Claire			Perseveration and conversation in TBI: Response to pharmacological intervention	APHASIOLOGY			English	Article							ATTENTION; APHASIA; ORGANIZATION; INHIBITION; DISCOURSE	Background: Perseveration is a frequently encountered characteristic of individuals with organic brain involvement, including individuals with traumatic brain injury (TBI). Current theory implicates disordered executive functioning, particularly deficient inhibitory control, in the manifestation of perseverative phenomena (McNamara & Albert, 2004). To date, no work has been published related to conversational data despite numerous allusions in the literature to the presence of perseveration during conversational discourse. Existing research indicates that pharmacological approaches to reduction of verbal perseveration may be effective, although no full-scale clinical trial of any pharmacological agent targeted specifically at reducing perseveration has been conducted ( McNamara & Albert, 2004). Aims: This study examines conversational correlates of perseveration in TBI, the accompanying executive functioning profiles in relation to Barkley's hybrid model of executive functioning and self-regulation ( 1997) and responses to pharmacotherapy ( Ritalin). Methods & Procedures: Two participants, in chronic stages following TBI with prefrontal and sub-cortical damage, participated in parallel case studies with a quasi-experimental research design. Baseline, active, placebo, and withdrawal phases were included as well as double blind and randomisation precautions. Conversational data were generated using Conversation Analysis. Neuropsychological data were generated following a full battery of tests investigating behavioural inhibition, nonverbal working memory, internalisation of language, regulation of affect, and reconstitution. Outcomes & Results: Conversational data demonstrated disturbed topic management as a result of verbal perseveration. Participant AA demonstrated recurrent perseveration while PB demonstrated stuck-in-set perseveration, which influenced their conversations in highly specific ways. These findings were accompanied by discrete profiles indicating unique disruptions of executive functioning, particularly in relation to behavioural inhibition. Deficits in attention impacted profoundly on self-regulating functions, in particular nonverbal working memory and reconstitution. Improvements were noted during active drug phases related to improved behavioural inhibition and subsequent amelioration of perseverative manifestations with some evidence of improved topic shift and contribution and greater capacity for reconstitution and working memory tasks. Context was found to exert significant effects in relation to perseveration and its conversational manifestations. Conclusions: Perseveration co-exists with marked deficits in behavioural inhibition, which differentially affects executive functioning abilities, resulting in discrete cognitive profiles with corresponding conversational outcomes. Positive responses to pharmacotherapy present optimistic potential for future treatment, while context variables highlight the need for individualised, data-driven intervention programmes with an emphasis on continuous conversational interaction to preserve and improve communicative skills in individuals with chronic TBI.	Univ Witwatersrand, ZA-2050 Johannesburg, South Africa	Frankel, T (corresponding author), Univ Witwatersrand, Private Bag 3, ZA-2050 Johannesburg, South Africa.	tdfranky@absamail.co.za					Adamovich B. B., 1992, SCALES COGNITIVE ABI; ATEN JL, 1994, LANGUAGE INTERVENTIO; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Benton A., 1976, MULTILINGUAL APHASIA; BLANKEN G, 1993, LINGUISTIC DISORDERS; Booth S, 1999, APHASIOLOGY, V13, P283, DOI 10.1080/026870399402109; Bryant Shannon L., 1994, Seminars in Speech and Language, V15, P71, DOI 10.1055/s-2008-1064134; Christman Sarah S., 2004, Seminars in Speech and Language, V25, P295, DOI 10.1055/s-2004-837243; CODE C, 1982, CHARACTERISTICS APHA; Coelho CA, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Cohen L, 1998, BRAIN, V121, P1641, DOI 10.1093/brain/121.9.1641; Eisenson J, 1973, ADULT APHASIA ASSESS; FEENEY DM, 1993, CRIT REV NEURBIOL, V3, P135; FUSTER JM, 1997, PREFRONTAL CORTEX AN; Gathercole S. E., 1993, WORKING MEMORY LANGU; GILES M, 1993, BRAIN INJURY REHABIL; GILLIS R, 1996, TRAUMATIC BRAIN INJU; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Golden J. C., 1978, STROOP COLOR WORD TE; Gotts SJ, 2002, NEUROPSYCHOLOGIA, V40, P1930, DOI 10.1016/S0028-3932(02)00067-2; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; GUALTIERI CG, 1991, RITALIN THEORY PATIE; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; HOLMES VF, 1995, INT J PSYCHIAT MED, V25, P1, DOI 10.2190/2TVT-2LH0-AD5A-CP91; Laakso M, 1999, APHASIOLOGY, V13, P345, DOI 10.1080/026870399402136; LANDAUER TK, 1978, PRACTICAL ASPECTS ME; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lesser R., 1993, LINGUISTICS APHASIA; LESSER R, 1999, COGNITIVE NEUROPSYCH; Levin H. S., 1991, FRONTAL LOBE FUNCTIO; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Lock S, 2001, INT J LANG COMM DIS, V36, P25, DOI 10.3109/13682820109177853; LUBINSKI R, 1991, DEMENTIA COMMUNICATI; LUNDGREN K, 1994, BRAIN LANG, V47, P370; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2nd; McNamara Patrick, 2004, Seminars in Speech and Language, V25, P309, DOI 10.1055/s-2004-837244; McNeil M. R., 1995, AM J SPEECH LANGUAGE, V4, P76; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MILNER B, 1995, EPILEPSY FUNCTIONAL; MILTON S, 1984, CLIN APH C P MINN; MOLLOY R, 1990, DISCOURSE ABILITY BR; MOSES M, 2001, CAMEL CANDLE UNDERST; NELSON L, 1994, NEUROPSYCHOLOGY BEHA; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; NEWCOMBE F, 1997, NEUROLOGICAL REHABIL; Paolo A. M., 1996, ASSESSMENT, V3, P137, DOI [10.1177/107319119600300205, DOI 10.1177/107319119600300205]; PARLOFF MB, 1986, J CONSULT CLIN PSYCH, V54, P79, DOI 10.1037/0022-006X.54.1.79; Pashler H., 1998, ATTENTION; Penn C, 2000, BRAIN LANG, V71, P185, DOI 10.1006/brln.1999.2247; Penn C, 1999, BRAIN LANG, V68, P535, DOI 10.1006/brln.1999.2127; Perkins L, 1999, APHASIOLOGY, V13, P259, DOI 10.1080/026870399402091; Perkins L, 1998, J NEUROLINGUIST, V11, P33, DOI 10.1016/S0911-6044(98)00004-9; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RASKIN SA, 1992, NEUROPSYCHOLOGIA, V30, P95, DOI 10.1016/0028-3932(92)90018-H; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; SANDSON J, 1987, NEUROLOGY, V37, P1736, DOI 10.1212/WNL.37.11.1736; SCHACHAR R, 1995, J ABNORM CHILD PSYCH, V23, P411, DOI 10.1007/BF01447206; SCHEGLOFF EA, 1977, LANGUAGE, V53, P361, DOI 10.2307/413107; SEHAPIRO SR, 1993, MINOR HEAD TRAUMA AS; Spencer JP, 2004, PSYCHOL SCI, V15, P187, DOI 10.1111/j.0956-7976.2004.01503007.x; Spreen O., 1998, COMPENDIUM NEUROPSYC; STUSS DT, 1982, J COMP PHYSIOL PSYCH, V96, P913, DOI 10.1037/0735-7036.96.6.913; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; STUSS DT, 1986, LOCALIZATION NEUROPS; TENHAVE P, 1999, CONVERSATION ANAL; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; VANZOMERAN AH, 1994, CLIN NEUROPSYCHOLOGY; Walker-Batson D, 1998, RESTORATIVE NEUROLOGY, P257; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wilkinson R, 1999, APHASIOLOGY, V13, P251, DOI 10.1080/026870399402082; WYCKOFF LH, 1984, NARRATIVE PROCEDURAL; YLVISAKER M, 1994, LANGUAGE INTERVENTIO	77	13	14	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2007	21	10-11					1039	1078		10.1080/02687030701198395			40	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	218HW	WOS:000250007600008					2021-06-18	
J	Kozlowski, KF; Leddy, JJ; Tomita, M; Bergen, A; Willer, BS				Kozlowski, Karl F.; Leddy, John J.; Tomita, Machiko; Bergen, Anne; Willer, Barry S.			Use of the ICECI and ICD-10 E-Coding structures to evaluate causes of head injury and concussion from sport and recreation participation in a school population	NEUROREHABILITATION			English	Article						concussion; sports; ICECI; ICD-10	AGED CHILDREN SURVEY; HEALTH BEHAVIOR; CANADIAN YOUTH; EPIDEMIOLOGY; ADOLESCENTS; CARE	The purpose of this study was to identify the most common causes of head injury and associated symptoms of concussion in a population of school children (n=1,372,979). Using standardized injury report forms, we identified the mechanisms of head injury associated with various sports/recreation activities and assessed each injury for the presence of concussion symptoms. Head injury reports (n=7,765) were coded using the WHO's ICECI and ICD-10 E-codes. 1,338 Cases reported symptoms of concussion. The majority of head injuries occurred during School Free-Play/Recess (59.8%). Combative Sports and Wheeled Non-Motored Sports were the activities most often associated with concussion symptoms (rate of concussion (RC): 48.3% and 44.4%, respectively, p < 0.001). School Free-Play/Recess and Physical Education Classes were significantly less likely to have head injuries associated with concussion (RC: 16.0%, p < 0.001, and 12.4%, p=0.034, respectively). The most common causes of head injury were (1) Struck by an Object (24.9%) and (2) Falling on the Same Level (22.8%). Falling from a Transport was the only etiological code significantly associated with concussion symptoms after head injury (RC: 28.7%, p <.001). Results were similar when using the two coding structures in combination. Prevention efforts should focus on activities where children are moving at high speeds since these are more likely to cause a concussion when a head injury occurs.	SUNY Buffalo, Dept Exercise & Nutr Sci, Program Athlet Training, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Orthoped, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY 14260 USA; Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA	Kozlowski, KF (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Program Athlet Training, Kimball Tower,Room 214A, Buffalo, NY 14214 USA.	kfk@buffalo.edu	Kozlowski, Karl/H-5253-2019				Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; ANNEST JL, 2000, CDCS SHORT VERSION I; Ardern C, 2001, CAN J PUBLIC HEALTH, V92, P201, DOI 10.1007/BF03404305; BIJUR PE, 1995, ARCH PEDIAT ADOL MED, V149, P1009, DOI 10.1001/archpedi.1995.02170220075010; BLOEMHOFF A, 2000, TESTING ICECI REV FI; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Di Scala C, 1997, J SCHOOL HEALTH, V67, P384; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Evans G D, 1987, J Community Health, V12, P246, DOI 10.1007/BF01324294; Gibson H, 1996, CAN J PUBLIC HEALTH, V87, P106; Hambidge SJ, 2002, PEDIATRICS, V109, P559, DOI 10.1542/peds.109.4.559; HAMMARSTROM A, 1994, SCAND J SOC MED, V22, P120, DOI 10.1177/140349489402200207; HARRISON J, 1999, ORGANIZATION; Hendrick E B, 1964, Clin Neurosurg, V11, P46; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; *ICECI, 2003, ICECI VERS 1 1A; King MA, 1998, CAN J PUBLIC HEALTH, V89, P397, DOI 10.1007/BF03404082; Knight S, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e81; Kohen D E, 2000, Inj Prev, V6, P223, DOI 10.1136/ip.6.3.223; Laforest S, 2000, J EPIDEMIOL COMMUN H, V54, P475, DOI 10.1136/jech.54.6.475; Langley J D, 1999, Inj Prev, V5, P247; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; *STAT CAN, 2003, PROV TERR PROF 2001; Vorko-Jovic A, 2001, CROAT MED J, V42, P58; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017	28	13	13	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	3					191	198					8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	216NM	WOS:000249884800005	17917169				2021-06-18	
J	Maskell, F; Chiarelli, P; Isles, R				Maskell, Fiona; Chiarelli, Pauline; Isles, Rosemary			Dizziness after traumatic brain injury: Results from an interview study	BRAIN INJURY			English	Article						dizziness; traumatic brain injury; functional impact; symptomatology	HEAD-INJURY; QUANTITATIVE-EVALUATION; POSTURAL INSTABILITY; ATTENTIONAL DEMANDS; VISUAL VERTIGO; HANDICAP; BALANCE; INDIVIDUALS; MOTION; ABNORMALITIES	Background: Dizziness is a commonly reported sequel to traumatic brain injury ( TBI). Objective: To better define the nature of the symptomatology and the impact that dizziness has on the TBI survivor. Setting: A community brain injury rehabilitation programme and a community access programme for TBI survivors. Method: Focus groups with TBI survivors and individual interviews with TBI survivors and some of their carers. Results: The data confirmed that dizziness is difficult for TBI survivors to define and describe and it consists of multiple symptoms. Dizziness also appears to be associated with significant functional difficulties. Additionally, many of the participants of this study reported falling. Carers reported a number of observable signs of dizziness and indicated that they believed they were able to tell when the person they cared for was dizzy. Conclusion: The results provide information which will help in the development of more appropriate outcome measurement tools for dizziness after a TBI.	Univ Newcastle, Discipline Physiotherapy, Sch Hlth Sci, Fac Hlth, Callaghan, NSW 2308, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; Hunter Brain Injury Serv, Newcastle, NSW, Australia	Maskell, F (corresponding author), Univ Newcastle, Discipline Physiotherapy, Sch Hlth Sci, Fac Hlth, Univ Dr, Callaghan, NSW 2308, Australia.	fiona.maskell@hnehealth.nsw.gov.au					Allison L., 1999, NEUROLOGY REPORT, V23, P13, DOI DOI 10.1097/01253086-199923010-00010; Andersson G, 1998, AM J OTOL, V19, P632; Asai M, 1997, ACTA OTO-LARYNGOL, P116; ASBURY JE, 1995, QUAL HEALTH RES, V5, P414, DOI 10.1177/104973239500500402; Benvenuti F, 1999, ARCH PHYS MED REHAB, V80, P278, DOI 10.1016/S0003-9993(99)90138-7; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Bronstein AM, 2002, BRIT MED BULL, V63, P213, DOI 10.1093/bmb/63.1.213; BRONSTEIN AM, 1990, BRAIN, V113, P767, DOI 10.1093/brain/113.3.767; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; COHEN H, 1992, OTOLARYNG HEAD NECK, V107, P638, DOI 10.1177/019459989210700505; Cohen HS, 2000, ARCH OTOLARYNGOL, V126, P881, DOI 10.1001/archotol.126.7.881; Cohen HS, 2003, J SAFETY RES, V34, P361, DOI 10.1016/j.jsr.2003.09.009; Cohen HS, 2002, J VESTIBUL RES-EQUIL, V12, P47; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Davies RA, 1997, HDB VESTIBULAR REHAB, P30; El-Kahky AM, 2000, ACTA OTO-LARYNGOL, V120, P508, DOI 10.1080/000164800750046018; Emily A, 2000, VESTIBULAR REHABILIT, P52; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; FITZGERALD DC, 1995, ARCH PHYS MED REHAB, V76, P1017, DOI 10.1016/S0003-9993(95)81041-2; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; FOLCHLYON E, 1981, STUD FAMILY PLANN, V12, P443, DOI 10.2307/1965656; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; HALMAGYI GM, 1996, DISORDERS VESTIBULAR, P171; Herdman SJ, 2000, VESTIBULAR REHABILIT, P424; Herdman SJ, 2000, VESTIBULAR REHABILIT, P451; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; HOFFER ME, 2003, OTOLOGY NEUROLOGY, V34, P633; Honrubia V, 1996, AM J OTOL, V17, P595; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KIRJAVAINEN S, 1968, ACTA OTO-LARYNGOL, V233, P5; Kisilevski V, 2001, Int Tinnitus J, V7, P118; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Lin SI, 2002, J BIOMED SCI, V9, P428; Longridge NS, 2005, OTOL NEUROTOL, V26, P695, DOI 10.1097/01.mao.0000178152.21634.6d; Mactavish JB, 2000, MENT RETARD, V38, P216, DOI 10.1352/0047-6765(2000)038<0216:ICSFMI>2.0.CO;2; MALLINSON AI, 1996, J MUSCULOSKELET PAIN, V4, P105, DOI DOI 10.1300/J094V04N04_10; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mckiernan D, 2001, CLIN OTOLARYNGOL, V26, P1, DOI 10.1046/j.1365-2273.2001.00410.x; Mendel B, 1997, J ADV NURS, V26, P1134, DOI 10.1111/j.1365-2648.1997.tb00805.x; Morgan D., 1988, FOCUS GROUPS QUALITA; *NH MRC, 1999, NAT STAT ETH COND RE; Ocampo S, 1997, OCCUP THER INT, V4, P161; PAGE NGR, 1985, J NEUROL NEUROSUR PS, V48, P729, DOI 10.1136/jnnp.48.8.729; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Peruch P, 2005, COGNITIVE BRAIN RES, V25, P862, DOI 10.1016/j.cogbrainres.2005.09.012; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; SEALE J, 1998, THERAPY RES PROCESSE; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679; Yardley L, 2002, NEUROPSYCHOLOGIA, V40, P373, DOI 10.1016/S0028-3932(01)00113-0; Yardley L, 1999, NEUROPSYCHOLOGIA, V37, P1293, DOI 10.1016/S0028-3932(99)00024-X; YARDLEY L, 1992, CLIN OTOLARYNGOL, V17, P231, DOI 10.1111/j.1365-2273.1992.tb01833.x; YARDLEY L, 1994, SOC SCI MED, V39, P573, DOI 10.1016/0277-9536(94)90100-7; YARDLEY L, 1994, VERTIGO DIZZINESS; Yardley L, 1992, PSYCHOL HEALTH, V6, P85; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	74	13	13	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	7					741	752		10.1080/02699050701472109			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400010	17653948				2021-06-18	
J	Powner, DJ; Hergenroeder, GW; Awili, M; Atik, MA; Robertson, C				Powner, David J.; Hergenroeder, Georgene W.; Awili, Mustafa; Atik, Mustafa A.; Robertson, Claudia			Hyponatremia and comparison of NT-pro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: A pilot study	NEUROCRITICAL CARE			English	Article						brain injuries; trauma; nervous system; natriuretic hormone; natriuretic peptide; brain	NATRIURETIC PEPTIDE LEVELS; CARDIAC DYSFUNCTION; SEPTIC SHOCK; PLASMA-LEVEL; ATRIAL; MARKER	Background Hyponatremia after traumatic brain injury (TBI) may influence neurological function and treatment. A causal relationship between elevated serum concentrations of Type B natriuretic peptide (BNP) and hyponatremia has been implied after subarachnoid hemorrhage and other neurosurgical disorders, although the source of BNP has not been identified. We evaluated if hyponatremia and increased BNP occur after TBI and if BNP is produced/released by the brain within 24 h after injury. Results NT-proBNP was measured in concomitant jugular venous and arterial blood samples within 24 h after TBI. NT-proBNP was elevated in both samples in six patients (24%). One patient (4%) showed an increased jugular NT-proBNP concentration above a normal arterial concentration, suggesting a brain source. In the other 24 patients the difference between jugular and arterial NT-proBNP was not statistically significant. Hyponatremia( <= 136 mEq/l) also occurred in six patients (24%), but only two (8%) had both increased arterial NT-proBNP and hyponatremia. In both the urine sodium was slightly elevated above normal, but not statistically different from other patients. The difference in serum sodium between hypo- and normo-natremic groups was significant, but mean NT-proBNP and jugular: arterial NT-proBNP differences were not. Conclusions In this pilot study BNP is elevated within 24 h after TBI in some patients. However, it does not originate from the brain and increased NT-proBNP concentrations are not consistently associated with hyponatremia or increased urinary sodium loss.	Univ Texas, Hlth Sci Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77225 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Powner, DJ (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Neurosurg, 6431 Fannin St,MSB 7-154, Houston, TX 77030 USA.	david.j.powner@uth.tmc.edu		Hergenroeder, Georgene/0000-0002-6170-2191	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR 02558] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660] Funding Source: Medline		Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Almog Y, 2006, ANESTH ANALG, V102, P1809, DOI 10.1213/01.ane.0000217202.55909.5d; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; Baylis PH, 2003, INT J BIOCHEM CELL B, V35, P1495, DOI 10.1016/S1357-2725(03)00139-0; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Cai Jia-ning, 2003, Chin J Traumatol, V6, P179; Cole CD, 2004, NEUROSURG FOCUS, V16, P1; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; HASAN D, 1990, ANN NEUROL, V27, P106, DOI 10.1002/ana.410270118; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Jason P, 2005, CRIT CARE MED, V33, P2094, DOI 10.1097/01.CCM.0000178351.03327.9F; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; MARUMO F, 1987, BIOCHEM BIOPH RES CO, V143, P813, DOI 10.1016/0006-291X(87)90321-4; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; McLean AS, 2003, CRIT CARE MED, V31, P2611, DOI 10.1097/01.CCM.0000094225.18237.20; Mueller T, 2003, CLIN CHEM, V49, P976, DOI 10.1373/49.6.976; Nakagawa K, 2002, NEUROL RES, V24, P627, DOI 10.1179/016164102101200474; Nogami M, 2001, HISTOCHEM J, V33, P87, DOI 10.1023/A:1017996113871; Obi T, 2002, ACTA NEUROL SCAND, V106, P225, DOI 10.1034/j.1600-0404.2002.01228.x; Palac Robert T, 2003, Prog Transplant, V13, P42; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89; Roch A, 2005, CRIT CARE MED, V33, P1001, DOI 10.1097/01.CCM.0000162561.82012.E9; Rudiger A, 2006, CRIT CARE MED, V34, P2140, DOI 10.1097/01.CCM.0000229144.97624.90; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Sviri GE, 2003, ACTA NEUROCHIR, V145, P851, DOI 10.1007/s00701-003-0101-7; Takami S, 2000, AM J HYPERTENS, V13, P121, DOI 10.1016/S0895-7061(99)00184-3; TOGASHI K, 1991, CLIN CHIM ACTA, V201, P193, DOI 10.1016/0009-8981(91)90370-R; Tung PP, 2005, STROKE, V36, P1567, DOI 10.1161/01.STR.0000170699.59783.d6; Vuolteenaho O, 2005, ADV CLIN CHEM, V40, P1, DOI 10.1016/S0065-2423(05)40001-3; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wiedemann K, 2000, EXP CLIN ENDOCR DIAB, V108, P5; Wittebole X, 2005, J ELECTROCARDIOL, V38, P77, DOI 10.1016/j.jelectrocard.2004.09.004; Witthaut R, 2004, CRIT CARE, V8, P342, DOI 10.1186/cc2890	36	13	16	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	7	2					119	123		10.1007/s12028-007-0079-8			5	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	214MJ	WOS:000249741700004	17690842				2021-06-18	
J	Brady, SL; Darragh, M; Escobar, NG; O'Neil, K; Pape, TLB; Rao, N				Brady, Susan L.; Darragh, Meghan; Escobar, Nelson G.; O'Neil, Kara; Pape, Theresa L. -B.; Rao, Noel			Persons with disorders of consciousness: Are oral feedings safe/effective?	BRAIN INJURY			English	Article						coma; deglutition; dysphagia; outcomes; rehabilitation	TRAUMATIC BRAIN-INJURY; SWALLOWING DISORDERS; RECOVERY	Primary objective: Evaluate the safety and efficacy of providing oral feedings to persons early in coma recovery following a severe brain injury. Research design: Descriptive, retrospective study. Methods and procedures: Medical chart reviews of all patients admitted to a rehabilitation hospital following severe brain injury. Main outcomes and results: Twenty-five patients met the inclusion criteria, 22 had a tracheostomy, and all were NPO. Subjects were divided into two cohorts. Group 1, n = 10, mean age 43.5 years, received oral feedings early in. coma recovery. Group 2, n = 15, mean age 45.2 years, did not. Group 1, 30% returned to an oral diet of three meals daily at discharge from inpatient rehabilitation as compared to 40% in group 2 (X-2 = 0.260, p = 0.610). Average cost of care for group 1 = US$45759 and group 2 = US$41056 (p = 0.634). Conclusion: Safe therapeutic oral feedings, in accordance with findings from instrumental swallowing examinations, are possible for patients with disordered consciousness. The therapeutic oral feedings do not significantly increase the cost of care, but the effectiveness of oral feedings early in coma recovery requires further investigation.	Marianjoy Rehabil Hosp, Wheaton, IL 60187 USA; Hines VA Hosp, Res Serv, Hines, IL USA	Brady, SL (corresponding author), Marianjoy Rehabil Hosp, 26 W 171 Roosevelt Rd, Wheaton, IL 60187 USA.	sbrady@marianjoy.org		Bender Pape, Theresa/0000-0001-7738-5963			*CDCP NAT CTR INJ, 1998, 1994 NAT HOISP DISCH; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; HEGAN C, 1982, COGNITIVE REHABILITA, P131; *INIDRR NAT I DIS, 2001, TRAUM BRAIN INJ FACT, V7, P9; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; O'Neil-Pirozzi TM, 2003, BRAIN INJURY, V17, P389, DOI 10.1080/0269905031000070251; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SASAKI CT, 2004, DYSPHAGIA, V19, P60; Walker WC, 1996, BRAIN INJURY, V10, P65	15	13	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1329	1334		10.1080/02699050601111435			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100002	17378224				2021-06-18	
J	Iverson, GL				Iverson, Grant L.			Sensitivity of computerized neuropsychological screening in depressed university students	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	111th Annual Convention of the American-Psychological-Association	AUG 07-10, 2003	Toronto, CANADA	Amer Psychol Assoc			MAJOR DEPRESSION; EXECUTIVE FUNCTION; NEUROCOGNITIVE IMPAIRMENT; COGNITIVE FUNCTION; TEST-PERFORMANCE; DISORDER; SCHIZOPHRENIA; CONCUSSION; BIPOLAR; DEFICIT	This study examined the sensitivity of a computerized neuropsychological screening (ImPACT) to the cognitive effects of depression in a sample of 20 students with suspected depression and 20 healthy university students matched for gender, age, and education. Students with depression had slower reaction times (p < .02; d=.82, large effect) and processing speeds (p < .03; d = .77, large effect). The brevity and sensitivity of ImPACT to the cognitive effects of depression warrants further research with psychiatric populations.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Riverview Hosp, Vancouver, BC, Canada	Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; Channon S, 1999, J NEUROL NEUROSUR PS, V66, P162, DOI 10.1136/jnnp.66.2.162; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Degl'Innocenti A, 1998, ACTA PSYCHIAT SCAND, V97, P182, DOI 10.1111/j.1600-0447.1998.tb09985.x; Deuschle M, 2004, PHARMACOPSYCHIATRY, V37, P147, DOI 10.1055/s-2004-827168; Di Sclafani V, 2002, DRUG ALCOHOL DEPEN, V66, P161, DOI 10.1016/S0376-8716(01)00197-1; Dorion AA, 2002, NEUROPSYCHOLOGIA, V40, P946, DOI 10.1016/S0028-3932(01)00150-6; Dunkin JJ, 2000, J AFFECT DISORDERS, V60, P13, DOI 10.1016/S0165-0327(99)00157-3; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Honig A, 1999, INT CLIN PSYCHOPHARM, V14, P167, DOI 10.1097/00004850-199905030-00003; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kampf-Sherf O, 2004, J AFFECT DISORDERS, V82, P453, DOI 10.1016/j.jad.2004.02.006; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Kempton S, 1999, PSYCHOL MED, V29, P527, DOI 10.1017/S0033291799008338; Lopez SJ, 2001, PSYCHOL REP, V88, P183, DOI 10.2466/PR0.88.1.183-188; Louis WJ, 1999, J HYPERTENS, V17, P1813, DOI 10.1097/00004872-199917121-00005; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Moore JL, 2002, EPILEPSY BEHAV, V3, P92, DOI 10.1006/ebeh.2001.0313; Neu P, 2005, J PSYCHIAT RES, V39, P129, DOI 10.1016/j.jpsychires.2004.06.004; NEWMAN P, 1992, HDB NEUROPSYCHOLOGIC; Nielen MMA, 2003, PSYCHOL MED, V33, P917, DOI 10.1017/S0033291703007682; Nieuwenstein MR, 2001, J PSYCHIATR RES, V35, P119, DOI 10.1016/S0022-3956(01)00014-0; Politis A, 2004, COMPR PSYCHIAT, V45, P452, DOI 10.1016/j.comppsych.2004.07.007; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; Voruganti LNP, 1997, CAN J PSYCHIAT, V42, P1066, DOI 10.1177/070674379704201008; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	39	13	14	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2006	20	4					695	701		10.1080/138540491005857			7	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	085IE	WOS:000240597000007	16980255				2021-06-18	
J	Jiang, JY; Xu, W; Yang, PF; Ga, GY; Gao, YG; Liang, YM; Yin, XL; Zhu, C				Jiang, Ji-Yao; Xu, Wei; Yang, Peng-Feng; Ga, Guo-Yi; Gao, Yong-Gun; Liang, Yu-Min; Yin, Xiao-Lu; Zhu, Cheng			Marked protection by selective cerebral profound hypothermia after complete cerebral ischemia in primates	JOURNAL OF NEUROTRAUMA			English	Article						cerebral anoxia; cerebral protection; selective brain cooling; subhuman primate	TRAUMATIC BRAIN-INJURY; CIRCULATORY ARREST; THERAPEUTIC HYPOTHERMIA; EXTRACORPOREAL-CIRCULATION; DEEP HYPOTHERMIA; CARDIAC-ARREST; ANEURYSMS; TEMPERATURE; MANAGEMENT; OPERATIONS	Hypothermia has been demonstrated to protect the brain from ischemia or traumatic brain injury. Achieving profound hypothermia has relied on techniques requiring total body cooling, which may result in serious cardiovascular and pulmonary complications. A technique to selectively cool the brain could conceivably exert a marked protection on cerebral structures and provide a relatively bloodless operative surgical field without systemic complications. Accordingly, this approach was tried in 7 rhesus monkeys after induction of general anesthesia. The right internal carotid artery and both internal jugular veins were each occlusively cannulated and connected to a circulation pump. The left internal carotid artery, both external carotid arteries, and both external jugular veins were temporarily clamped to establish severe cerebral ischemia. Using a closed-circuit system, cooled Ringer's lactate liquid (4 degrees C) was infused through right internal carotid artery with outflow draining though both internal jugular veins. Cooled perfusate decreased cerebral temperature to the target temperature of 15 degrees C. Thereafter, pump flow was discontinued, and brains were rewarmed spontaneously, while the temporarily clamped carotid arteries and jugular veins were opened to resume normal cerebral blood circulation. Neurological functions were recorded daily and cerebral histology was examined at the conclusion of the experiment. Magnetic resonance (MR) scans were routinely taken before and 3 weeks after ischemia. In the normothermia control group of five rhesus monkeys, Ringer's solution at 37 degrees C was infused in the same manner as the cold solution with cerebral temperature maintained at 36.7 +/- 0.32 degrees C. Right cerebral temperature decreased from 36.5 +/- 0.49 to 15.5 +/- 2.29 degrees C, and simultaneously the left cerebral temperature decreased from 36.4 +/- 0.38 to 16.3 +/- 2.4 degrees C for 62.8 +/- 9.76 min during selective cerebral cooled Ringer's liquid perfusion. In contrast, rectal temperature was only reduced to 32.4 +/- 0.96 degrees C from a baseline of 37.2 +/- 0.76 degrees C. Internal jugular vein hematocrit was 38.2 +/- 0.31% before perfusion and 2.82 +/- 0.46% at the end of perfusion in profound hypothermia group; hematocrit was 39.7 +/- 0.62% before perfusion and 3.42 +/- 0.38% at the end of perfusion in the normothermia group. In the hypothermic group, neurological functions were normal during 6 months of follow-up, and microscopic examination of brain tissue did not show evidence of pathological changes in hippocampus or medulla. MR scans did not show any cerebral infarction. In contrast, none of the monkeys in normothermia group survived for more than several hours, and microscopic examination of the brain revealed extensive neuronal necrosis within the medulla. Selective cerebral profound hypothermia provides significant histologic and neurologic protection after severe cerebral ischemia. In addition, there were no major complications, and the operative field remained relatively bloodless in the profound hypothermic group.	Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200001, Peoples R China; Kunming Med Coll, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China; Fuzhou Gen Mil Hosp, Dept Neurosurg, Fuzhou, Fujian Province, Peoples R China; Second Mil Med Univ, Changzhen Hosp, Dept Neurosurg, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Pathol, Shanghai 200030, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200001, Peoples R China.	Jiangjyb@online.sh.cn					ALBERTS MJ, 1995, ANN INTERN MED, V122, P622, DOI 10.7326/0003-4819-122-8-199504150-00013; ALTHAUS U, 1982, ANN SURG, V195, P492, DOI 10.1097/00000658-198204000-00018; AVNDAM LD, 1959, NEW ENGL J MED, V261, P546; BACHET J, 1991, J THORAC CARDIOV SUR, V102, P85; BAUMGARTNER WA, 1983, SURGERY, V94, P242; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CONNOLLY JE, 1962, SURGERY, V52, P15; Dietrich WD, 1999, STROKE, V30, P855, DOI 10.1161/01.STR.30.4.855; DRAKE CG, 1964, J NEUROSURG, V21, P575, DOI 10.3171/jns.1964.21.7.0575; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GRIEPP EB, 1992, J CARDIAC SURG, V7, P134, DOI 10.1111/j.1540-8191.1992.tb00790.x; GUEGAN Y, 1985, SURG NEUROL, V24, P441, DOI 10.1016/0090-3019(85)90306-4; Holzer M, 2002, NEW ENGL J MED, V346, P549; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; KIMOTO S, 1956, SURGERY, V39, P592; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MCMURTRY JG, 1974, J NEUROSURG, V40, P486, DOI 10.3171/jns.1974.40.4.0486; MICHENFELDER JD, 1964, ANESTHESIOLOGY, V25, P131, DOI 10.1097/00000542-196403000-00004; MILLER DL, 1989, RADIOLOGY, V172, P1007, DOI 10.1148/172.3.1007; OHTA T, 1992, NEUROSURGERY, V31, P1049, DOI 10.1227/00006123-199212000-00010; OHTA T, 1966, J NEUROSURG, V24, P994; PARKINS WM, 1954, ANN SURG, V140, P284, DOI 10.1097/00000658-195409000-00004; PATTERSON RH, 1962, ANN SURG, V156, P377, DOI 10.1097/00000658-196209000-00005; Richards P G, 1987, Br J Neurosurg, V1, P261, DOI 10.3109/02688698709035310; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Schwartz Arthur E., 1996, Neurosurgery (Baltimore), V39, P577, DOI 10.1097/00006123-199609000-00028; SILVERBERG GD, 1980, NEUROSURGERY, V6, P301; SOLOMON RA, 1991, NEUROSURGERY, V29, P732, DOI 10.1227/00006123-199111000-00015; SPETZLER RF, 1988, J NEUROSURG, V68, P868, DOI 10.3171/jns.1988.68.6.0868; SPETZLER RF, 1980, NEUROSURGERY, V7, P257, DOI 10.1227/00006123-198009000-00009; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; WOODHALL B, 1960, ANN SURG, V152, P37, DOI 10.1097/00000658-196007000-00006; ZARINS CK, 1973, J SURG RES, V14, P97, DOI 10.1016/0022-4804(73)90015-2	36	13	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2006	23	12					1847	1856		10.1089/neu.2006.23.1847			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	120AP	WOS:000243056100011	17184193				2021-06-18	
J	Lebesgue, D; LeBold, DG; Surles, NO; Morales, DM; Etgen, AM; Zukin, RS; Saatman, KE				Lebesgue, Diane; LeBold, David G.; Surles, Nathan O.; Morales, Diego M.; Etgen, Anne M.; Zukin, R. Suzanne; Saatman, Kathryn E.			Effects of estradiol on cognition and hippocampal pathology after lateral fluid percussion brain injury in female rats	JOURNAL OF NEUROTRAUMA			English	Article						gender; in vivo studies; learning and memory; neuronal cell death; traumatic brain injury	TRANSIENT GLOBAL-ISCHEMIA; ESTROGEN-RECEPTOR-ALPHA; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; GENDER-DIFFERENCES; NEURONAL INJURY; CELL-DEATH; PROGESTERONE; MECHANISMS; APOPTOSIS	Studies involving animal models of acute central nervous system (CNS) stroke and trauma strongly indicate that sex and/or hormonal status are important determinants of outcome after brain injury. The present study was undertaken to examine the ability of estradiol to protect hippocampal neurons from lateral fluid percussion brain injury. Sprague-Dawley female rats (211-285 g; n = 119) were ovariectomized, and a subset (it = 66) were implanted with 17 beta-estradiol pellets to provide near physiological levels of estradiol. Animals were subjected to lateral fluid percussion brain injury or sham injury 1 week later. Activation of caspase-3 (n = 26) and TUNEL staining (it = 21) were assessed at 3 and 12 h after injury, respectively, in surviving control and estradiol-treated animals. Memory retention was examined using a Morris water maze test in a separate subset of animals (n = 43) at 8 days after injury. Activated caspase-3 and TUNEL staining were observed in the dentate hilus, granule cell layer, and CA3 regions in all injured rats, indicative of selective hippocampal cell apoptosis in the acute posttraumatic period. Estradiol did not significantly alter the number of hippocampal neurons exhibiting caspase-3 activity or TUNEL staining. Brain injury impaired cognitive ability, assessed at 1 week post-injury (p < 0.001). However, estradiol at physiological levels did not significantly alter injury-induced loss of memory. These data indicate that estradiol at physiological levels does not ameliorate trauma-induced hippocampal injury or cognitive deficits in ovariectomized female rats.	Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B367 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	k.saatman@uky.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045693] Funding Source: NIH RePORTER		Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Bagetta G, 2004, NEUROSCI LETT, V368, P87, DOI 10.1016/j.neulet.2004.06.062; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Bengzon J, 2002, PROG BRAIN RES, V135, P111; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; EMERSON CS, 1992, NEUROREPORT, V3, P957, DOI 10.1097/00001756-199211000-00002; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; He Z, 2002, J NEUROL SCI, V193, P79, DOI 10.1016/S0022-510X(01)00648-7; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Mouihate A, 2003, ENDOCRINOLOGY, V144, P2454, DOI 10.1210/en.2002-0093; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RINK A, 1995, AM J PATHOL, V147, P1575; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Shughrue PJ, 2000, NEUROSCIENCE, V99, P605, DOI 10.1016/S0306-4522(00)00242-6; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stumpf W E, 1975, Adv Biosci, V15, P77; Sunday L, 2006, AM J PHYSIOL-ENDOC M, V291, pE261, DOI 10.1152/ajpendo.00550.2005; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	66	13	13	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2006	23	12					1814	1827		10.1089/neu.2006.23.1814			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	120AP	WOS:000243056100009	17184191				2021-06-18	
J	Martin, CD				Martin, Christopher D.			Ernest Hemingway: A psychological autopsy of a suicide	PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES			English	Article								Much has been written about Ernest Hemingway, including discussion of his well-documented mood disorder, alcoholism, and suicide. However, a thorough biopsychosocial approach capable of integrating the various threads of the author's complex psychiatric picture has yet to be applied. Application of such a psychiatric view to the case of Ernest Hemingway in an effort toward better understanding of the author's experience with illness and the tragic outcome is the aim of this investigation. Thus, Hemingway's life is examined through a review and discussion of biographies, psychiatric literature, personal correspondence, photography, and medical records. Significant evidence exists to support the diagnoses of bipolar disorder, alcohol dependence, traumatic brain injury, and probable borderline and narcissistic personality traits. Late in life, Hemingway also developed symptoms of psychosis likely related to his underlying affective illness and superimposed alcoholism and traumatic brain injury. Hemingway utilized a variety of defense mechanisms, including self-medication with alcohol, a lifestyle of aggressive, risk-taking sportsmanship, and writing, in order to cope with the suffering caused by the complex comorbidity of his interrelated psychiatric disorders. Ultimately, Hemingway's defense mechanisms failed, overwhelmed by the burden of his complex comorbid illness, resulting in his suicide. However, despite suffering from multiple psychiatric disorders, Hemingway was able to live a vibrant life until the age of 61 and within that time contribute immortal works of fiction to the literary canon.	Baylor Coll Med, Menninger Clin, COMPAS Unit, Menninger Dept Psychiat & Behav Sci, Houston, TX 77280 USA	Martin, CD (corresponding author), Baylor Coll Med, Menninger Clin, COMPAS Unit, Menninger Dept Psychiat & Behav Sci, POB 809045,2801 Gessner Dr, Houston, TX 77280 USA.	cmartin@menninger.edu					ALLEN J, 1999, HEMINGWAY BIOGRAPHY; Baker Carlos, 1969, E HEMINGWAY LIFE STO; BURGESS A, 1978, E HEMINGWAY; Hemingway Ernest, 1929, FAREWELL ARMS; Hemingway Ernest, 1952, OLD MAN SEA; Hemingway Ernest, 1964, MOVEABLE FEAST; Hemingway Ernest, 1935, GREEN HILLS AFRICA; Hemingway Ernest, 1981, E HEMINGWAY SELECTED; HOTCHNER AE, 1966, PAPA HEMINGWAY; Jamison K.R., 1993, TOUCHED FIRE MANIC D; Lynn K., 1987, HEMINGWAY; MARANO HE, 1996, PSYCHOL TODAY   0526; Mellow James R, 1992, HEMINGWAY LIFE CONSE; MONNIER AJ, 1957, COMMUNICATION   0318; OHARA J, 1950, NY TIMES        0910, P200; Reynolds M., 1989, HEMINGWAY PARIS YEAR; REYNOLDS M, 1999, HEMINGWAY FINAL YEAR; Reynolds Michael, 1986, YOUNG HEMINGWAY; SCHOENBERG N, 2001, CHICAGO TRIBUNE 1119; YALOM ID, 1971, ARCH GEN PSYCHIAT, V24, P485	20	13	15	0	10	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0033-2747			PSYCHIATRY	Psychiatry-Interpers. Biol. Process.	WIN	2006	69	4					351	361		10.1521/psyc.2006.69.4.351			11	Psychiatry	Psychiatry	133XV	WOS:000244048100010	17326729				2021-06-18	
J	Ross, SR; Putnam, SH; Millis, SR; Adams, KM; Krukowski, RA				Ross, Scott R.; Putnam, Steven H.; Millis, Scott R.; Adams, Kenneth M.; Krukowski, Rebecca A.			Detecting insufficient effort using the seashore rhythm and speech-sounds perception tests in head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							RECOGNITION MEMORY TEST; ADULT INTELLIGENCE SCALE; TRAUMATIC BRAIN-INJURY; FAKE-BAD SCALE; INCOMPLETE EFFORT; MMPI-2; IMPAIRMENT; VALIDATION; CATEGORY; IDENTIFICATION	This study examined the capacity of the Seashore Rhythm Test (SRT) and the Speech-Sounds Perception Test (SSPT) to detect insufficient effort in a clinical sample. Forty-six participants with financially compensable mild head injury who obtained scores indicative of insufficient effort on multiple measures were compared to 49 participants with brain injury who were not involved in litigation. Receiver operating characteristic (ROC) curve analysis indicated that both the SRT (AUC= .84) and SSPT (AUC= .80) were significant (p <.001) predictors of insufficient effort. Maximizing sensitivity and specificity, the optimal cutoff scores were 8 errors on the SRT and 10 errors on the SSPT. Combining both variables into a logistic regression function increased the diagnostic efficiency.	Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Kessler Med Rehabil Res & Educ Corp, Newark, NJ 07103 USA; VAMC, Ann Arbor, MI USA; Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA; Univ Vermont, Burlington, VT USA	Ross, SR (corresponding author), Depauw Univ, Dept Psychol, 7 Larabee St, Greencastle, IN 46135 USA.	srross@depauw.edu	Krukowski, Rebecca/AAS-4304-2020	Krukowski, Rebecca/0000-0001-9193-2783			Axelrod B. N., 1999, J FORENSIC NEUROPSYC, V1, P15; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BORNSTEIN RA, 1983, PERCEPT MOTOR SKILL, V57, P571, DOI 10.2466/pms.1983.57.2.571; BORNSTEIN RA, 1982, PERCEPT MOTOR SKILL, V55, P203, DOI 10.2466/pms.1982.55.1.203; Butcher, 1989, MINNESOTA MULTIPHASI; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; Frederick R.I., 1997, VALIDITY INDICATOR P; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Gfeller JD, 1998, J CLIN PSYCHOL, V54, P431, DOI 10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q; Greenhalgh T, 1997, BRIT MED J, V315, P540, DOI 10.1136/bmj.315.7107.540; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Halstead WC., 1947, BRAIN INTELLIGENCE Q; Hardin J.W., 2001, GEN LINEAR MODELS EX; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; Iverson G.L., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401, DOI 10.1177/107319119400100401]; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Kneebone A C, 1997, J Int Neuropsychol Soc, V3, P159; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Menard S. W., 2002, APPL LOGISTIC REGRES; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Millis Scott R., 1993, Brain Injury, V7, P53, DOI 10.3109/02699059309008156; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Mutchnick M G, 1991, Arch Clin Neuropsychol, V6, P259, DOI 10.1016/0887-6177(91)90003-R; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; REITAN RM, 1990, ARCH CLIN NEUROPSYCH, V5, P70; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; Rogers Richard, 1990, BEHAVIORAL SCI LAW, V8, P85, DOI DOI 10.1002/BSL.2370080110; Rohling ML, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P171; Ross SR, 2003, CLIN NEUROPSYCHOL, V17, P581, DOI 10.1076/clin.17.4.581.27940; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ross SR, 1999, CLIN NEUROPSYCHOL, V13, P112, DOI 10.1076/clin.13.1.112.1973; Sackett D.L., 2000, EVIDENCE BASED MED, V2nd; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P301, DOI 10.1016/S0887-6177(99)00018-9; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; WARRINGTON EK, 1994, RECOGNITION MEMORY T; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]; Wolfson D., 1993, HALSTEAD REITAN NEUR	70	13	13	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2006	20	4					798	815		10.1080/13854040500328477			18	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	085IE	WOS:000240597000015	16980263				2021-06-18	
J	Splavski, B; Radanovic, B; Vrankovic, D; Has, B; Muzevic, D; Janculjak, D; Legcevic, J				Splavski, B.; Radanovic, B.; Vrankovic, D.; Has, B.; Muzevic, D.; Janculjak, D.; Legcevic, J.			Transcranial Doppler ultrasonography as an early outcome forecaster following severe brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						severe head injury; transcranial Doppler; outcome	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; ISCHEMIA; VELOCITY; ULTRASOUND; PATHOPHYSIOLOGY; HYPERTENSION; THRESHOLDS	Knowledge of post-traumatic cerebral haemodynamic disturbances might be beneficial for predicting the management outcome when measuring the basal cerebral arteries blood flow velocity by ultrasonic transcranial Doppler device immediately after severe head injury. Thirty patients who sustained severe brain injury underwent an early blood velocity measuring by transcranial Doppler ultrasonography during a 1-year period of study. The standard technique of measuring the mean blood flow velocity in the middle cerebral artery was applied. The outcome was assessed at 6-month follow-up by the Glasgow Outcome Score. The middle cerebral artery low blood flow velocity, and the increased values of the pulsatility index significantly correlated to an unfavourable outcome. Transcranial Doppler ultrasonography for measuring the middle cerebral artery blood flow velocity has been proved worthy as a possible predictor of severe head injury management outcome. This non-invasive and simple procedure could be engaged in the daily management of severely brain-injured patients.	Osijek Univ Hosp, Div Neurosurg, Osijek 31000, Croatia; Osijek Univ Hosp, Dept Neurol, Osijek, Croatia; Osijek Univ Hosp, Dept Surg, Osijek, Croatia; Osijek Univ, Fac Law, Dept Econ, Osijek, Croatia	Splavski, B (corresponding author), Osijek Univ Hosp, Div Neurosurg, Huttlerova 4, Osijek 31000, Croatia.	splavski.bruno@kbr.hr	Splavski, Bruno/AAM-1579-2020	Splavski, Bruno/0000-0002-4483-9364			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brauer P, 1998, J NEUROSURG ANESTH, V10, P80, DOI 10.1097/00008506-199804000-00003; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burger R, 1993, Aktuelle Traumatol, V23, P14; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHAN KH, 1993, ACTA NEUROCHIR, P81; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GORAJ B, 1994, AM J NEURORADIOL, V15, P1333; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MORENO JA, 2000, NEUROSURG FOCUS, V8; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Steiner LA, 2002, BRIT J NEUROSURG, V16, P429, DOI 10.1080/0268869021000030221; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Visocchi M, 2002, J Neurosurg Sci, V46, P10; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49	31	13	13	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2006	20	6					386	390		10.1080/02688690601048104			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	128MC	WOS:000243660800004	17439090				2021-06-18	
J	Arican, N; Kaya, M; Yorulmaz, C; Kalayci, R; Ince, H; Kucuk, M; Fincanci, SK; Elmas, I				Arican, N.; Kaya, M.; Yorulmaz, C.; Kalayci, R.; Ince, H.; Kucuk, M.; Fincanci, S. K.; Elmas, I.			Effect of hypothermia on blood-brain barrier permeability following traumatic brain injury in chronically ethanol-treated rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						blood-brain barrier; cold exposure; ethanol; Evans blue; traumatic brain injury	CLOSED-HEAD-INJURY; POSTTRAUMATIC HYPOTHERMIA; ACCIDENTAL HYPOTHERMIA; ALCOHOL; EDEMA; DAMAGE; DEATH; MODEL; PATHOPHYSIOLOGY; HYPOTENSION	The objective of this study was to investigate the effect of hypothermia on the blood-brain barrier (BBB) disruption caused by traumatic brain injury (TBI) in chronically ethanol-treated rats. BBB permeability was measured using Evans blue (EB) dye. Arterial blood pressure levels of animals in hypothermic groups decreased significantly. The EB dye extravasation into the brain significantly increased in hypothermia and at 6 and 24 h after TBI. In ethanol-treated rats that were subjected to TBI, hypothermia led to a significant decrease in EB dye content in the brain at 24 h but not at 6 h after TBI when compared with TBI alone.	Istanbul Univ, Istanbul Fac Med, Dept Physiol, TR-34390 Istanbul, Turkey; Istanbul Univ, Istanbul Fac Med, Dept Forens Med, TR-34390 Istanbul, Turkey; Istanbul Univ, Cerrahpasa Fac Med, Dept Forens Med, Istanbul, Turkey; Istanbul Univ, Expt Med Res Inst, Istanbul, Turkey	Kaya, M (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Physiol, TR-34390 Istanbul, Turkey.	mehkaya@istanbul.edu.tr	elmas, imdat/AAD-6054-2020; Kalayci, Rivaze/K-6330-2018; ARICAN, Nadir/G-2778-2012; Fincanci, Sebnem Korur/F-6684-2010	Kalayci, Rivaze/0000-0002-7061-4863; ARICAN, Nadir/0000-0002-9736-0277; Fincanci, Sebnem Korur/0000-0003-4484-4961			Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Elmas I, 2001, FORENSIC SCI INT, V119, P212, DOI 10.1016/S0379-0738(00)00429-1; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Fischer S, 1999, MOL BRAIN RES, V74, P135, DOI 10.1016/S0169-328X(99)00272-7; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; HATTON DC, 1992, J HYPERTENS, V10, P529, DOI 10.1097/00004872-199206000-00005; HONKANEN R, 1993, ADDICTION, V88, P939, DOI 10.1111/j.1360-0443.1993.tb02111.x; HORN M, 1991, ACTA NEUROPATHOL, V81, P443, DOI 10.1007/BF00293466; ISHIKAWA T, 1983, ANESTHESIOLOGY, V59, P526, DOI 10.1097/00000542-198312000-00007; KELLY DF, 1995, NEUROTRAUMA, V2, P883; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; KRANTIS A, 1983, ACTA NEUROPATHOL, V60, P61, DOI 10.1007/BF00685348; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Milovanovic AV, 1999, AM J FOREN MED PATH, V20, P6, DOI 10.1097/00000433-199903000-00002; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; PHILLIPS SC, 1981, J NEUROL SCI, V50, P81, DOI 10.1016/0022-510X(81)90043-5; SAKAMOTO T, 1989, AM J PHYSIOL, V257, pH785; SCHINDELMEISER J, 1987, ACTA NEUROPATHOL, V73, P349, DOI 10.1007/BF00688258; Schwab M, 1998, ACTA NEUROBIOL EXP, V58, P29; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Strachan R D, 1989, Brain Inj, V3, P51, DOI 10.3109/02699058909008073; TANAKA M, 1991, INT J BIOMETEOROL, V34, P242, DOI 10.1007/BF01041837; THOMAS D, 1994, DEMOGRAPHY, V31, P185, DOI 10.2307/2061881; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Yamada Shinichi, 2004, Kurume Medical Journal, V51, P1	38	13	14	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	NOV	2006	116	11					1249	1261		10.1080/00207450600550303			13	Neurosciences	Neurosciences & Neurology	087OC	WOS:000240750700001	17000527				2021-06-18	
J	Leach, K; Kinsella, G; Jackson, M; Matyas, T				Leach, Kathleen; Kinsella, Glynda; Jackson, Martin; Matyas, Tom			Recovery of components of memory in post-traumatic amnesia	BRAIN INJURY			English	Article						post-traumatic amnesia; Westmead PTA scale; traumatic brain injury; recovery of memory	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; POST-COMA DISTURBANCE; WESTMEAD PTA SCALE; NONLINEAR PREDICTORS; REHABILITATION; DISORIENTATION; ORIENTATION	Primary objective: Post-traumatic amnesia by definition indicates significant impairment of new learning ability, however very few studies have, examined the natural history and resolution of memory and new learning during PTA. Those studies which have, tended to examine orientation separately from the memory processes required to achieve orientation. Analysis of the order of recovery of the items of the Westmead PTA scale was used to examine recovery of memory and new learning capacity. Methods: The results of daily assessment of 34 patients with traumatic brain injury (TBI) on the Westmead PTA scale were analysed for order of recovery. Results: The pattern of rank order of item recovery indicated that Date of Birth recovered consistently first. There was variability in the remaining items, however items reflecting long-term memory tended to recover second and items reflecting simple new learning followed. Recall of all three pictures reflecting complex new learning recovered last. Conclusion: The pattern of recovery of memory and new learning during PTA reflects a number of complex, inter-related variables including; the familiarity with the information, amount of rehearsal both before and since the accident and the number of cues available in the environment.	La Trobe Univ, Fac Sci, Sch Psychol Sci Technol & Engn, Melbourne, Vic, Australia	Leach, K (corresponding author), Cedar Court Rehabil Hosp, 888 Toorak Rd, Camberwell, Vic 3124, Australia.	kathleen.leach@cedarcourt.com.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DANIEL WF, 1986, ANN NY ACAD SCI, V462, P293, DOI 10.1111/j.1749-6632.1986.tb51264.x; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Everitt BS., 2011, CLUSTER ANAL, V5, DOI [DOI 10.1201/9781420057492.CH10, 10.1002/9780470977811, DOI 10.1002/9780470977811]; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fleming J, 1999, BRAIN INJURY, V13, P417; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Geffen G., 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Gennarelli TA, 1993, BIOMECHANICS IMPACT, P411; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HORN S, 1991, J CLIN EXP NEUROPSYC, V13, P19; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lunn V, 1949, ACTA PSYCH NEUROL, V24, P33, DOI 10.1111/j.1600-0447.1949.tb04589.x; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MOWBRAY RM, 1959, ACTA PSYCH NEUROL, V34, P330, DOI 10.1111/j.1600-0447.1959.tb07583.x; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J., 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; SHORES A, 1986, MED J AUSTRALIA, V144, P569; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Tate RL., 2000, BRAIN IMPAIR, V1, P116; Wilson B.A., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [10.1080/09602019208401410, DOI 10.1080/09602019208401410]; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	34	13	13	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2006	20	12					1241	1249		10.1080/02699050601049874			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	110DF	WOS:000242357800003	17132547				2021-06-18	
J	Belabed, L; Charrueau, C; Besson, V; Gupta, S; Walrand, S; Marchand-Verrecchia, C; Richon, S; Nafziger, J; Plotkine, M; Chaumeil, JC; Cynober, L; Moinard, C				Belabed, Linda; Charrueau, Christine; Besson, Valerie; Gupta, Severine; Walrand, Stephane; Marchand-Verrecchia, Catherine; Richon, Sophie; Nafziger, Joelle; Plotkine, Michel; Chaumeil, Jean-Claude; Cynober, Luc; Moinard, Christophe			Impairment of lymphocyte function in head-injured rats: Effects of standard and immune-enhancing diets for enteral nutrition	CLINICAL NUTRITION			English	Article; Proceedings Paper	23rd Congress of the Societe-Francophone-de-Nutrition-Enterale-et-Parenterale (SFNEP)	NOV 30-DEC 03, 2003	Ghent, BELGIUM	Soc Francophone Nutr Enterale & Parenterale		head injury; dysimmunity; lymphocytes; CD25 receptor; immune-enhancing diet	TRAUMATIC BRAIN-INJURY; INFECTIOUS COMPLICATIONS; ENDOTOXEMIC RATS; CRITICALLY ILL; IMMUNONUTRITION; TRANSLOCATION; ARGININE; SUPPORT	Background: The metabolic response to head injury (HI) is characterized by a dysimmunity which may be a risk factor of a septic state. The use of immune enhancing diets (IEDs) could be a promising approach to improve immune functions. The aim of the study was to investigate the consequences of HI on lymphocyte function and to determine the effects of an enteral IED comparatively to a standard enteral. nutrition. Method: A rat model of HI by fluid percussion was used. Twenty-five mate Sprague-Dawley rats were randomized into 4 groups: rats receiving standard chow diet ad libitum (AL), rats sustaining HI and receiving standard chow diet and enteral satine (HI), rats receiving the enterat standard diet Sondalis HP((R)) (HIS), and rats receiving the IED Crucial((R)) (HIC). The two enterat diets were infused continuously during 4 days after the HI and were isocaloric, isonitrogenous and isovolumic. Results: HI induced a thymus atrophy (HI vs. AL, P < 0.05), and an impairment in lymphocyte CD25 receptor density responsiveness to stimulation. The IED blunted thymus atrophy and allowed to preserve the stimulation of blood and Peyer patches lymphocytes (HIC: Stimulated vs. Basal, P < 0.05). Conclusion: IED seems more adapted for preserving lymphocyte function than standard diet in HI patients. (c) 2006 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	Univ Paris 05, Fac Pharm, EA2498, Pharm Galen Lab, F-75270 Paris 06, France; Lab Biol Nutr, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Lab Pharmacol Circulat Cerebrale, EA2510, F-75270 Paris 06, France; Human Nutr Lab, F-63000 Clermont Ferrand, France; Univ Paris 05, Fac Pharm, CNRS, FRE 2443,Lab Immunol Tumeurs, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Hematol Lab, F-75270 Paris 06, France	Charrueau, C (corresponding author), Univ Paris 05, Fac Pharm, EA2498, Pharm Galen Lab, 4 Ave Observ, F-75270 Paris 06, France.	christine.charrueau@univ-paris5.fr	MARCHAND-LEROUX, Catherine/L-7453-2017; Cynober, Luc/ABB-2368-2020; BESSON, VALERIE/AAZ-9989-2020; besson, valerie C/L-7388-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; BESSON, VALERIE/0000-0002-1491-2380; besson, valerie C/0000-0002-1491-2380			Abumrad NN, 2004, METABOLIC THERAPEUTI, P595; BARBUL A, 1984, J SURG RES, V36, P620, DOI 10.1016/0022-4804(84)90149-5; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Berger MM, 2003, NES NUTR WS, V8, P99, DOI 10.1159/000072750; Berger MM, 2001, INTENS CARE MED, V27, P91, DOI 10.1007/s001340000757; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Biffl WL, 2002, NUTRITION, V18, P960, DOI 10.1016/S0899-9007(02)00987-5; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; LASNIER E, 1996, CLIN NUTR, V77, P197; Loi C, 2005, NUTRITION, V21, P255, DOI 10.1016/j.nut.2004.05.021; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Porter JM, 1999, AM SURGEON, V65, P478; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Schauder P, 2002, BRIT J NUTR, V87, pS103, DOI 10.1079/BJN2001463; Schlegel L, 1999, CRIT CARE MED, V27, P1511, DOI 10.1097/00003246-199908000-00019; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Suchner U, 2002, BRIT J NUTR, V87, pS121, DOI 10.1079/BJN2001465; Ulusoy H, 2003, J CLIN NEUROSCI, V10, P596, DOI 10.1016/S0967-5868(03)00142-5; Walrand S, 2004, AM J PHYSIOL-CELL PH, V286, pC1474, DOI 10.1152/ajpcell.00563.2002; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25	24	13	14	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614			CLIN NUTR	Clin. Nutr.	OCT	2006	25	5					832	841		10.1016/j.clnu.2006.02.003			10	Nutrition & Dietetics	Nutrition & Dietetics	099SL	WOS:000241615800016	16678308				2021-06-18	
J	Miller, P; Mack, CD; Sammer, M; Rozet, I; Lee, LA; Muangman, S; Wang, M; Hollingworth, W; Lam, AM; Vavilala, MS				Miller, Patrick; Mack, Christopher D.; Sammer, Marla; Rozet, Irene; Lee, Lorri A.; Muangman, Saipin; Wang, Marjorie; Hollingworth, Will; Lam, Arthur M.; Vavilala, Monica S.			The incidence and risk factors for hypotension during emergent decompressive craniotomy in children with traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; SURGICAL EVACUATION; BLOOD-PRESSURE; SURGERY	We conducted a retrospective cohort study in children < 13 yr with traumatic brain injury (TBI) at a Level 1 pediatric trauma center to describe risk factors for intraoperative hypotension (IH) during emergent decompressive craniotomy. Between 1994 and 2004, 108 children underwent emergent decompressive craniotomy for TBI. Overall, 56 (52%) patients had IH. Independent risk factors for IH were each 10 mL estimated blood loss/kg (ARR 1.15 95% CI 1.08-1.22), each mm of computed tomography (CT) midline shift (ARR 1.04 95%CI 1.01-1.07), each 10 mL of CT lesion volume (ARR 1.03 95%CI 1.01-1.05), and emergency department (ED) hypotension (5/5 patients with ED hypotension had IH). CT midline shift >= 4 mm predicted IH (ARR 1.67 95% CI 1.06-2.63), independent of blood loss. IH occurred frequently during emergent decompressive craniotomy in children with TBI. ED hypotension, blood loss, CT lesion volume, and CT midline shift predicted IH. Anesthesiologists can expect children with preoperative CT midline shift >= 4 mm to have IH during this procedure.	Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; Univ Washington, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Dept Radiol, Seattle, WA 98104 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; Harborview Injury Prevent & Res Ctr, Seattle, WA USA	Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9Th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Hollingworth, William/0000-0002-0840-6254	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [K23044632] Funding Source: Medline		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; HAGLUND MM, 1996, ANESTH ANALG, V83, P1014; HORAN M J, 1987, Pediatrics, V79, P1; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; OSTEBEE A, 1995, CALCULUS GRAPHICAL N, V2; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Ransom GH, 2003, CHILD ABUSE NEGLECT, V27, P381, DOI 10.1016/S0145-2134(03)00025-5; UCHIDA M, 1982, CRIT CARE MED, V10, P5, DOI 10.1097/00003246-198201000-00002; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	13	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	OCT	2006	103	4					869	875		10.1213/01.ane.0000237327.12205.dc			7	Anesthesiology	Anesthesiology	087RL	WOS:000240759800014	17000796				2021-06-18	
J	Whiting, MD; Hamm, RJ				Whiting, Mark D.; Hamm, Robert J.			Traumatic brain injury produces delay-dependent memory impairment in rats	JOURNAL OF NEUROTRAUMA			English	Article						memory; memory impairment; non-matching-to-place; rat; traumatic brain injury	CLOSED-HEAD-INJURY; PERIRHINAL CORTEX; WORKING-MEMORY; LONG-TERM; DEFICITS; ACQUISITION; HIPPOCAMPUS; AMNESIA; LESIONS; INTACT	Memory impairment following traumatic brain injury (TBI) is common in both humans and animals. A noteworthy feature of memory dysfunction in human TBI is impaired memory performance that is dependent on the delay between initial learning and recall of information. However, previous studies of TBI-induced memory impairment in animals have failed to control for the initial amount of learning between sham and injured animals. The present study demonstrates that experimental TBI in rats produces delay-dependent memory impairment, even when the initial degree of learning is controlled for. Animals were injured at a moderate level of lateral fluid percussion (LFP) injury (n = 10) or received a sham injury (n = 9), and then trained in a water T-maze version of the delayed-non-matching-to-place (DNMP) task beginning 10 days post-injury. Acquisition training consisted of 15 trials per day on post-injury days 11-15 using a minimal (7-sec) delay between the sample and choice phases of the task. Following acquisition, the delay between the sample and choice phases of the task was progressively increased to 15, 30, and 120 sec. Injured animals acquired the task at the same rate as sham animals and performed equally well at the 15-sec delay (p > 0.05). However, as the delay increased to 30 and 120 sec, the performance of the injured animals deteriorated (p < 0.05). These results indicate that LFP injury produces delay-dependent memory impairments in rats. This is therefore a valid model of an important feature of memory impairment in human TBI, and should be a useful addition to the available methods for assessing memory impairment and the effect of therapeutic interventions after TBI.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA	Whiting, MD (corresponding author), Virginia Commonwealth Univ, Dept Psychol, 808 W Franklin St, Richmond, VA 23284 USA.	whitingmd@vcu.edu					ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; BROOKS D N, 1975, Cortex, V11, P329; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; JENNET WB, 1969, CURRENT PROBLEMS NEU; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1992, J NEUROTRAUM, V9, P359; Liu P, 1998, BEHAV NEUROSCI, V112, P512, DOI 10.1037/0735-7044.112.3.512; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Wiig KA, 1998, BEHAV NEUROSCI, V112, P827, DOI 10.1037/0735-7044.112.4.827; WOOD ER, 1993, BEHAV NEUROSCI, V107, P51, DOI 10.1037/0735-7044.107.1.51; ZOLAMORGAN S, 1992, J NEUROSCI, V12, P2582	21	13	14	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2006	23	10					1529	1534		10.1089/neu.2006.23.1529			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	093XL	WOS:000241203500012	17020487				2021-06-18	
J	Saeki, S; Okazaki, T; Hachisuka, K				Saeki, Satoru; Okazaki, Tetsuya; Hachisuka, Kenji			Concurrent validity of the community integration questionnaire in patients with traumatic brain injury in Japan	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; community integration; validity	QUALITY-OF-LIFE	Objective: To examine the concurrent validity of the Community Integration Questionnaire (CIQ) by comparing actual participation in community activities by individuals with traumatic brain injury. Design: Cross-sectional survey. Subjects: A total of 148 community-dwelling patients in Japan with a medical diagnosis of traumatic brain injury. Methods: A postal questionnaire survey examined the relationships between individual's actual participation in community activities ( working or attending school; undergoing rehabilitation at home or hospital; other) and productive activities evaluated by the CIQ in the community. Results: Responses were received from 115 subjects ( response rate 78%). Total CIQ scores and scores on the 3 subscales of the CIQ significantly differed among the 3 groups based on community participation. Total CIQ scores among individuals in the "working or attending school'' group were significantly higher than for individuals in the "undergoing rehabilitation at home or hospital'' and "other'' groups. In addition, scores on the Productive Activity subscale of the CIQ were significantly higher among the "working or attending school'' group than for the other 2 groups. Conclusion: These results suggest that the CIQ has concurrent validity for patients with traumatic brain injury.	Univ Occupat & Environm Hlth, Dept Rehabil Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Saeki, S (corresponding author), Univ Occupat & Environm Hlth, Dept Rehabil Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	sae@med.uoeh-u.ac.jp					CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; WANGER AK, 2002, ARCH PHYS MED REHAB, V83, P107; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	11	13	13	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2006	38	5					333	335		10.1080/16501970600780245			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	088AC	WOS:000240782900010	16931465	DOAJ Gold			2021-06-18	
J	Baranova, AI; Whiting, MD; Hamm, RJ				Baranova, Anna I.; Whiting, Mark D.; Hamm, Robert J.			Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						aniracetam; brain injury; cognitive recovery; Morris water maze; rat; traumatic brain injury	FOREBRAIN CHOLINE-ACETYLTRANSFERASE; NOREPINEPHRINE TURNOVER; MOTOR RECOVERY; RECEPTOR; CORTEX; IMPAIRMENT; STROKE; MEMORY; PHARMACOTHERAPY; HIPPOCAMPUS	Chronic cognitive impairment is an enduring aspect of traumatic brain injury (TBI) in both humans and animals. Treating cognitive impairment in the post-traumatic stages of injury often involves the delivery of pharmacologic agents aimed at specific neurotransmitter systems. The current investigation examined the effects of the nootropoic drug aniracetam on cognitive recovery following TBI in rats. Three experiments were performed to determine (1) the optimal dose of aniracetam for treating cognitive impairment, (2) the effect of delaying drug treatment for a period of days following TBI, and (3) the effect of terminating drug treatment before cognitive assessment. In experiment 1, rats were administered moderate fluid percussion injury and treated with vehicle, 25, or 50 mg/kg aniracetam for 15 days. Both doses of aniracetam effectively reduced injury-induced deficits in the Morris water maze (MWM) as measured on postinjury days 11-15. In experiment 2, injured rats were treated with 50 mg/kg aniracetam or vehicle beginning on day 11 postinjury and continuing for 15 days. MWM performance, assessed on days 26-30, indicates that aniracetam-treated animals performed as well as sham-injured controls. In experiment 3, animals were injured and treated with aniracetam for 15 days. Drug treatment was terminated during MWM testing on postinjury days 16-20. In this experiment, aniracetam-treated rats did not perform better than vehicle-treated rats. The results of these experiments indicate that aniracetam is an effective treatment for cognitive impairment induced by TBI, even when treatment is delayed for a period of days following injury.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA	Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Dept Psychol, Box 842018,808 W Franklin St, Richmond, VA 23284 USA.	rhamm@vcu.edu					BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1997, J NEUROTRAUM, V14, P159; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; Feeney DM, 1997, ADV NEUROL, V73, P383; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; FUSHIKI S, 1995, NEUROSCI LETT, V199, P171, DOI 10.1016/0304-3940(95)12054-8; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kikuchi K, 2000, BRAIN RES, V860, P130, DOI 10.1016/S0006-8993(00)02034-5; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Lebrun C, 2000, EUR J PHARMACOL, V401, P205, DOI 10.1016/S0014-2999(00)00429-5; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Lu Y, 1997, BRAIN RES, V768, P197, DOI 10.1016/S0006-8993(97)00644-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Nakamura K, 1999, EUR J PHARMACOL, V380, P81, DOI 10.1016/S0014-2999(99)00534-8; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Ouchi Y, 1999, J NEUROL SCI, V164, P7, DOI 10.1016/S0022-510X(99)00036-2; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PIZZI M, 1993, J NEUROCHEM, V61, P683; SATOH M, 1986, NEUROSCI LETT, V68, P216, DOI 10.1016/0304-3940(86)90145-X; Togashi H, 1996, STROKE, V27, P520, DOI 10.1161/01.STR.27.3.520; Togashi H, 2002, NEUROSCI LETT, V320, P109, DOI 10.1016/S0304-3940(01)02436-3; Von Monakow C., 1969, BRAIN BEHAV, VI, P27; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zajaczkowski W, 1997, PHARMACOL BIOCHEM BE, V56, P21, DOI 10.1016/S0091-3057(96)00133-5; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	41	13	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2006	23	8					1233	1240		10.1089/neu.2006.23.1233			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	075CF	WOS:000239859300005	16928181				2021-06-18	
J	Miller, A				Miller, Ariel			Pseudobulbar affect in multiple sclerosis: Toward the development of innovative therapeutic strategies	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	Symposium on Cognitive Decline in Multiple Sclerosis	NOV 11-13, 2004	Taormina, ITALY	European Charcot Fdn		pseudobulbar affect; multiple sclerosis; affect; emotion; crying; laughing	DEXTROMETHORPHAN; LAUGHTER; CITALOPRAM; PREVALENCE; PAROXETINE; QUINIDINE; LABILITY; STROKE; ALS	Pseudobulbar affect (PBA), a condition involving involuntary and uncontrollable episodes of crying and/or laughing, occurs frequently in patients with a variety of neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, traumatic brain injury, dementia including Alzheimer's disease, and multiple sclerosis (MS). Although PBA results in considerable distress for patients and caretakers, it is underrecognized and undertreated. Agents used to treat psychiatric disorders-particularly tricyclic antidepressants and selective serotonin reuptake inhibitors-are useful in alleviating PBA, but act on diffuse neural networks rather than targeting those involved in emotional motor expression. As a result of their nonspecific activity, these agents are associated with a range of unwanted effects that preclude many patients from using them. Dextromethorphan, a common cough suppressant, specifically targets sigma, receptors concentrated in the brainstem and cerebellum, thus providing the possibility of targeting regions implicated in emotional expression. When administered in a fixed combination with quinidine, dextromethorphan is effective in treating PBA in patients with ALS, and preliminary results suggest that this therapy also is effective in treating MS-related PBA. (c) 2006 Elsevier B.V. All rights reserved.	Technion Israel Inst Technol, Ctr Multiple Sclerosis, Dept Neurol, Carmel Med Ctr,Rappaport Fac Med, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Res Inst, IL-32000 Haifa, Israel	Miller, A (corresponding author), Technion Israel Inst Technol, Ctr Multiple Sclerosis, Dept Neurol, Carmel Med Ctr,Rappaport Fac Med, IL-32000 Haifa, Israel.	millera@tx.technion.ac.il					ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; Benedict RHB, 2004, J NEUROIMAGING, V14, p36S, DOI 10.1111/j.1552-6569.2004.tb00277.x; Brooks BR, 2004, NEUROLOGY, V63, P1364; Burns A, 1999, INT J GERIATR PSYCH, V14, P681, DOI 10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO;2-Z; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Darwin C, 1872, EXPRESSION EMOTIONS; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Huffman Jeff C., 2003, Prim Care Companion J Clin Psychiatry, V5, P85; IRONSIDE R, 1956, BRAIN, V79, P589, DOI 10.1093/brain/79.4.589; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; Matthews PM, 2004, CURR OPIN NEUROL, V17, P453, DOI 10.1097/01.wco.0000137537.06986.b0; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; MUSACCHIO JM, 1989, LIFE SCI, V45, P1721, DOI 10.1016/0024-3205(89)90510-9; PANITCH HS, IN PRESS ANN NEUROL, V59; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Poeck K, 1969, Ger Med Mon, V14, P394; Pollock BG, 1998, AM J PSYCHIAT, V155, P1110, DOI 10.1176/ajp.155.8.1110; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; PRATT RTC, 1951, J NEUROL NEUROSUR PS, V14, P326, DOI 10.1136/jnnp.14.4.326; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; Smith RA, 2004, MULT SCLER, V10, P1; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; SURRIDGE D, 1969, BRIT J PSYCHIAT, V115, P749, DOI 10.1192/bjp.115.524.749; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; UDAKA F, 1984, ARCH NEUROL-CHICAGO, V41, P1095, DOI 10.1001/archneur.1984.04050210093023; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; ZHANG Y, 1992, CLIN PHARMACOL THER, V51, P647, DOI 10.1038/clpt.1992.77; Zivadinov R, 2004, J NEUROIMAGING, V14, p27S, DOI 10.1111/j.1552-6569.2004.tb00276.x	38	13	13	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUN 15	2006	245	1-2			SI		153	159		10.1016/j.jns.2005.09.018			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	055PK	WOS:000238462500026	16674978				2021-06-18	
J	Duhem, R; Vinchon, M; Tonnelle, V; Soto-Ares, G; Leclerc, X				Duhem, R.; Vinchon, M.; Tonnelle, V.; Soto-Ares, G.; Leclerc, X.			Main temporal aspects of the MRI signal of subdural hematomas and practical contribution to dating head injury	NEUROCHIRURGIE			French	Article						subdural hematoma; MRI; head injury	CHILD-ABUSE; INTRACRANIAL HEMORRHAGE; INTRACEREBRAL HEMATOMA; DIAGNOSIS; BRAIN; SEQUENCES; INFANTS; TISSUE	Background and purpose. - MRI signal of a subdural hematoma (SDH) is often regarded as similar to that of an intracerebral hematoma but no precise study has analyzed the evolution of the signal of subdural hematomas. Their dating is however significant, in particular in the child, within the context of the diagnosis of child abuse. The objective of this study is to compare with MRI a group of adult patients having a subdural and/or intracerebral, in order to study the evolution of the signals of these two types of hematomas. Material and methods. - This prospective study included patients hospitalized for post-traumatic acute subdural or intracerebral hematoma. The protocol included an emergency brain CT and 4 MRI at fixed times: in emergency (early phase), between the third and the seventh day (early subacute phase), during the third week (late subacute phase), and after four months after the hemorrhage. The protocol included T1-weighted sequences before and after injection of gadolinium, T2-weighted, fluid-attenuated inversion-recovery (FLAIR), gradient echo and diffusion. Results. - Eighteen patients were included and all 72 MRI were interpretable. The time course of the cerebral hematomas was similar to that described in the literature, whereas that of subdural hematomas was different in 1.5 patients. This distinction was significant in the early phase for subdural hematomas, which displayed hypersignal in T2 and FLAIR, whereas cerebral hematomas showed a hyposignal in the same sequences. The variation was also notable in the early subacute period during which subdural hematomas displayed hypersignal in T1, FLAIR and diffusion, and isosignal in T2, whereas cerebral hematomas showed isosignal in T1, and hyposignal in T2, FLAIR and diffusion. Conclusion. - The time course of MRI signal of subdural hematomas is different from that of cerebral hematomas. This difference is significant in T2 sequence and FLAIR, especially in the early subacute period. These radiographic observations in adults can be useful for the MRI dating of subdural hematomas in shaken-baby syndrome.	Ctr Hosp Reg & Univ Lille, Clin Neurochirurg, F-59037 Lille, France; Ctr Hosp Reg & Univ Lille, Serv Neuroradiol, F-59037 Lille, France	Duhem, R (corresponding author), Ctr Hosp Reg & Univ Lille, Clin Neurochirurg, Pl Verdun, F-59037 Lille, France.	rduhem@yahoo.fr		Vinchon, Matthieu/0000-0002-9122-6165			Al-Sarraj S, 2004, CLIN NEUROPATHOL, V23, P62; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BROOKS RA, 1989, MAGNET RESON MED, V12, P241, DOI 10.1002/mrm.1910120210; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; CHIN HY, 1991, NEURORADIOLOGY, V33, P79; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; Gomori J M, 1988, Radiographics, V8, P427; GOMORI JM, 1993, AM J NEURORADIOL, V14, P871; Grossman R I, 1986, Acta Radiol Suppl, V369, P56; JANICK P A, 1991, Magnetic Resonance Quarterly, V7, P57; JENKINS A, 1989, MAGN RESON IMAGING, V7, P395, DOI 10.1016/0730-725X(89)90488-8; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Kuker W, 2000, ACTA RADIOL, V41, P544, DOI 10.1034/j.1600-0455.2000.041006544.x; Leclerc X, 2003, J NEURORADIOLOGY, V30, P303; Nakamura S, 1989, Brain Inj, V3, P129, DOI 10.3109/02699058909004543; Orlin JR, 1997, ACTA RADIOL, V38, P610; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Silvera S, 2005, AM J NEURORADIOL, V26, P236; Soto-Ares G, 2003, J RADIOL, V84, P1757; STROOBANDT G, 1978, NEUROCHIRURGIE, V24, P47; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2003, PEDIATR NEUROSURG, V39, P122, DOI 10.1159/000071648; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216	26	13	14	0	6	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie	JUN	2006	52	2-3	1				93	104		10.1016/S0028-3770(06)71203-6			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	060XY	WOS:000238836500002	16840968				2021-06-18	
J	Kawata, M; Takamoto, S; Kitahori, K; Tsukihara, H; Morota, T; Ono, M; Motomura, N; Murakami, A; Suematsu, Y				Kawata, Mitsuhiro; Takamoto, Shinichi; Kitahori, Kazuo; Tsukihara, Hiroyuki; Morota, Tetsuro; Ono, Minoru; Motomura, Noboru; Murakami, Arata; Suematsu, Yoshihiro			Erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest: An experimental study in a canine model	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							ISCHEMIA	Objective: Current data suggest that erythropoietin protects the brain and the spinal cord from ischemic and traumatic injury. In this study, we determined whether erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest in an experimental canine model. Methods: Ten adult beagle dogs were randomly and intravenously injected with either 5000 U/kg recombinant human erythropoietin or normal saline. Each dog was then subjected to a cardiopulmonary bypass and 120 minutes of deep hypothermic circulatory arrest ( 18 C). The level of tau proteins in the cerebrospinal fluid, a modified marker of neurologic deficit in dogs, and the histopathologic characteristics of the brains and spinal cords were then examined. Results: The level of tau proteins was significantly lower in the erythropoietin-treated group than in the untreated group at 6 hours ( 20 +/- 12 vs 144 +/- 54 pg/mL; P =.036) and 12 hours ( 64 +/- 35 vs 478 +/- 103 pg/mL; P =.01) after the operation. The total Neurologic Deficit Score was 59 +/- 31 ( 0, normal; 500, brain death) in the erythropoietin-treated group, compared with 376 +/- 30 in the untreated group ( P =.0117). Histopathologic examination revealed that ischemic neuronal changes and apoptosis in the hippocampus CA1 were significantly lower in the erythropoietin-treated group ( P <.01 and P =.028, respectively). Conclusions: This study showed that erythropoietin protected the central nervous system during prolonged hypothermic circulatory arrest, partly by preventing both necrosis ( ischemic neuronal changes) and apoptosis.	Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan	Kawata, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mkawata-ths@umin.ac.jp	ac°, a a/AAY-7569-2020; Motomura, Noboru/AAK-6000-2020	ac°, a a/0000-0001-8547-4499; 			Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Castella M, 2005, ANN THORAC SURG, V79, P646, DOI 10.1016/j.athoracsur.2004.07.007; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fiordaliso F, 2005, P NATL ACAD SCI USA, V102, P2046, DOI 10.1073/pnas.0409329102; FROSCH MP, 2005, ROBBINS COTRAN PATHO, P1347; Kongstad L, 2005, ACTA ANAESTH SCAND, V49, P614, DOI 10.1111/j.1399-6576.2005.00680.x; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Romsi P, 2002, J THORAC CARDIOV SUR, V124, P714, DOI 10.1067/mtc.2002.123704; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; WELLER RO, 1990, SYSTEMIC PATHOLOGY, V4, P38; Ye J, 1998, CIRCULATION, V98, pII313; Ye J, 1996, ANN THORAC SURG, V61, P1316	17	13	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	JUN	2006	131	6					1331	1337		10.1016/j.jtcvs.2005.10.035			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	049NM	WOS:000238023300023	16733166	Bronze			2021-06-18	
J	Ang, BT; Xuo, G; Xiao, ZC				Ang, BT; Xuo, G; Xiao, ZC			Therapeutic vaccination for central nervous system repair	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						axonal regeneration; myelin-associated glycoprotein; neurodegeneration; Nogo; tenascin; vaccine	MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; TENASCIN-R; NOGO-A; AXON REGENERATION; NEURODEGENERATIVE DISORDERS; FUNCTIONAL RECOVERY; PROMOTES RECOVERY; MESSENGER-RNA	1. Vaccination against infectious agents has been heralded as a triumph in modern medicine and, more recently, cancer vaccines have risen in prominence. The present review looks towards the use of vaccine therapy to attenuate damage after injury to the central nervous system (CNS). 2. Significant debility is associated with brain injury, most commonly occurring as a result of physical trauma or stroke. This end result reflects the inability of neurons and axons to regenerate following injury to the CNS. This unconducive environment is due, in large part, to the presence of myelin and oligodendrocyte-related inhibitors of neurite outgrowth. 3. We review how a vaccine-based approach has been variably used to circumvent this issue and promote axonal regeneration and repair following traumatic injury and other neurodegenerative disorders. In addition, emerging evidence suggests that the immune response to injury in the CNS may be manipulated so as to reduce cellular damage. Vaccine-directed approaches using this concept are also outlined.	Singapore Gen Hosp, Dept Neurosurg, Natl Inst Neurosci, Singapore 0316, Singapore; Singapore Gen Hosp, Ctr Mol Med, Singapore 0316, Singapore; Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore; Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore	Ang, BT (corresponding author), Natl Inst Neurosci, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	beng_ti_ang@nni.com.sg	xiao, zhicheng/A-1529-2011	xiao, zhicheng/0000-0001-5172-762X			Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Angelov DN, 1998, J NEUROSCI, V18, P6218; Avidan H, 2004, EUR J IMMUNOL, V34, P3434, DOI 10.1002/eji.200424883; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; CADELLI D, 1991, EUR J NEUROSCI, V3, P825, DOI 10.1111/j.1460-9568.1991.tb00093.x; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; During MJ, 2000, SCIENCE, V287, P1453, DOI 10.1126/science.287.5457.1453; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kim GM, 2001, J NEUROSCI, V21, P6617; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Kipnis J, 2002, TRENDS MOL MED, V8, P319, DOI 10.1016/S1471-4914(02)02373-0; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Liao H, 2005, J BIOL CHEM, V280, P8316, DOI 10.1074/jbc.M412730200; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOTAN M, 1994, FASEB J, V8, P1026; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MIKOL DD, 1988, J CELL BIOL, V106, P1273, DOI 10.1083/jcb.106.4.1273; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Pesheva P, 2000, PROG NEUROBIOL, V61, P465, DOI 10.1016/S0301-0082(99)00061-1; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 1999, EUR J NEUROSCI, V11, P1486, DOI 10.1046/j.1460-9568.1999.00560.x; RODRIGUEZ M, 1987, J NEUROPATH EXP NEUR, V46, P84, DOI 10.1097/00005072-198701000-00008; RODRIGUEZ M, 1990, ANN NEUROL, V27, P12, DOI 10.1002/ana.410270104; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schwartz M, 2005, ANN NY ACAD SCI, V1051, P701, DOI 10.1196/annals.1361.114; Schwartz M, 2004, TRENDS PHARMACOL SCI, V25, P407, DOI 10.1016/j.tips.2004.06.010; Schwartz M, 2003, INVEST OPHTH VIS SCI, V44, P1407, DOI 10.1167/iovs.02-0594; Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X; WINTERGERST ES, 1993, EUR J NEUROSCI, V5, P299, DOI 10.1111/j.1460-9568.1993.tb00497.x; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Xu G, 2004, J NEUROCHEM, V91, P1018, DOI 10.1111/j.1471-4159.2004.02803.x; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	65	13	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1870	1440-1681		CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	MAY-JUN	2006	33	5-6					541	545		10.1111/j.1440-1681.2006.04404.x			5	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	040YY	WOS:000237420800020	16700891				2021-06-18	
J	Cruise, CM; Sasson, N; Lee, MHM				Cruise, Cathy M.; Sasson, Nicole; Lee, Mathew H. M.			Rehabilitation outcomes in the older adult	CLINICS IN GERIATRIC MEDICINE			English	Article							BRAIN-INJURY; FRAIL; FALLS; HIP; INPATIENT; EXERCISE; PROGRAM; STROKE; TRIAL; RISK	Numerous studies support the use of rehabilitative interventions in the older adult. Given the many fiscal challenges in health care today, it is of utmost importance that funding for rehabilitation result in fruitful outcomes. Specific rehabilitative interventions have been found to be very effective in the elderly and can be demonstrated through numerous studies. Outcomes for conditions including stroke, traumatic brain injury, spinal cord injury, amputation, hip fracture, and joint replacement are discussed. There is great need for ongoing research to determine optimal rehabilitative interventions in the elderly.	NYU, Sch Med, Rusk Inst Rehabil, New York, NY 10016 USA; Northport Vet Affairs Med Ctr, Phys Med & Rehabil Serv 117, Vet Integrated Serv Network, Northport, NY 11768 USA; New York Harbor Healthcare Syst, Dept Vet Affairs, Phys Med & Rehabil Serv 117, New York, NY 10010 USA	Cruise, CM (corresponding author), NYU, Sch Med, Rusk Inst Rehabil, Suite 600,400 E 34th St, New York, NY 10016 USA.	cmcruise@optonline.net					Ades PA, 1996, ANN INTERN MED, V124, P568, DOI 10.7326/0003-4819-124-6-199603150-00005; *AM HEART ASS, HEART DIS STROK STAT; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Chumbler NR, 2004, TELEMED J E-HEALTH, V10, P129, DOI 10.1089/1530562041641200; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; *DEP VET AFF, 2005, PHYS MED REH; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P1089, DOI 10.1016/j.apmr.2004.11.018; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P373, DOI 10.1016/j.apmr.2004.10.018; KEITH RA, 1995, ARCH PHYS MED REHAB, V76, P495, DOI 10.1016/S0003-9993(95)80501-X; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LEE MHM, 1988, REHABILITATION MED, P393; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; MEYERS AR, 2000, REHABILITATION PEOPL, P13; MOREY MC, 1989, J AM GERIATR SOC, V37, P348, DOI 10.1111/j.1532-5415.1989.tb05503.x; Munin MC, 2005, ARCH PHYS MED REHAB, V86, P367, DOI 10.1016/j.apmr.2004.10.004; MUNIN MC, 1995, AM J PHYS MED REHAB, V74, P294, DOI 10.1097/00002060-199507000-00006; Murray PK, 2005, ARCH PHYS MED REHAB, V86, P876, DOI 10.1016/j.apmr.2004.10.045; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENTLAND W, 1995, PARAPLEGIA, V33, P367, DOI 10.1038/sc.1995.84; SCHERER T, 2000, REHABILITATION PEOPL, P1110; Scivoletto G, 2005, ARCH PHYS MED REHAB, V86, P512, DOI 10.1016/j.apmr.2004.05.021; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P38, DOI 10.1053/apmr.2003.50060; Sullivan DH, 2001, AM J PHYS MED REHAB, V80, P503, DOI 10.1097/00002060-200107000-00007; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806	32	13	13	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0690	1879-8853		CLIN GERIATR MED	Clin. Geriatr. Med.	MAY	2006	22	2					257	+		10.1016/j.cger.2005.12.015			12	Geriatrics & Gerontology	Geriatrics & Gerontology	044VX	WOS:000237702200004	16627077				2021-06-18	
J	Wiese, H; Tonnes, C; de Greiff, A; Nebel, K; Diener, HC; Stude, P				Wiese, Holger; Toennes, Christina; de Greiff, Armin; Nebel, Katharina; Diener, Hans-Christoph; Stude, Philipp			Self-initiated movements in chronic prefrontal traumatic brain injury: An event-related functional MR1 study	NEUROIMAGE			English	Article							EXTERNALLY TRIGGERED MOVEMENTS; SUPPLEMENTARY MOTOR AREA; VOLUNTARY MOVEMENT; POTENTIALS; FMRI; ACTIVATION; CORTEX; LESIONS	Electrophysiological studies found traumatic lesions of the prefrontal cortex (PFC) to affect the preparation of self-initiated movements. However, a precise localization of the observed effects has not been reported yet. Moreover, previous reports did not account for effects of lesion location. Therefore, the present study utilized functional MRI to investigate the influence of predominantly left or right hemispheric PFC lesions on movement preparation in chronic traumatic brain injury (TBI) patients. 18 TBI patients with MRI-defined contusions of the PFC as well as 18 healthy control subjects matched for age and gender were examined. Patients were divided into subgroups of predominantly left or right hemispheric lesions. During functional image acquisition, subjects performed self-initiated abductions of their right index finger. Neuropsychological tests of attention and working memory, which are supposed to modulate preparatory processes, were conducted. Patients with predominantly left contusions demonstrated enhanced activity of the dorsal lateral premotor cortex in comparison to healthy control subjects. In predominantly right lesioned patients, reduced activity within the right caudate head was observed. Compared to predominantly left lesioned patients, neuropsychological tests yielded reduced task performances in the right lesion subgroup. In line with previous electrophysiological research, imaging results of the present study are interpreted to represent altered preparatory networks in chronic prefrontal TBI patients. Since attentional and working memory functions are supposed to modulate preparatory processes, differences between the patient subgroups are suggested to result from the more pronounced cognitive impairments in the right-lesioned group. (c) 2005 Elsevier Inc. All rights reserved.	Univ Duisburg Gesamthsch, Dept Neurol, Essen, Germany; Univ Duisburg Gesamthsch, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	Wiese, H (corresponding author), Univ Jena, Dept Gen Psychol, Steiger 3,Haus 1, D-07743 Jena, Germany.	holger.wiese@uni-jena.de	Diener, Hans-Christoph/AAF-7275-2019; Wiese, Holger/M-5281-2014	Wiese, Holger/0000-0003-4928-0771			Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Hamano T, 1997, EVOKED POTENTIAL, V104, P257, DOI 10.1016/S0168-5597(97)96107-4; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Hopfinger JB, 2000, NEUROIMAGE, V11, P326, DOI 10.1006/nimg.2000.0549; Ikeda A, 1996, ELECTROEN CLIN NEURO, V98, P206, DOI 10.1016/0013-4694(95)00239-1; Jahanshahi M, 2001, NEUROCASE, V7, P495, DOI 10.1093/neucas/7.6.495; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Knight R., 2002, PRINCIPLES FRONTAL L, P573, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Luria A. R, 1973, WORKING BRAIN; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAPA SM, 1991, MOVEMENT DISORD, V6, P217, DOI 10.1002/mds.870060305; PRAAMSTRA P, 2003, BEREITSCHAFTSPOTENTI, P131; REKTOR I, 2003, BEREITSCHAFTSPOTENTI, P61; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rockstroh B, 1989, SLOW BRAIN POTENTIAL; SHALLICE T, 1998, PREFRONTAL CORTEX EX, P22; Shallice T., 2002, PRINCIPLES FRONTAL L, P261, DOI [10.1093/acprof:oso/9780195134971.003.0017, DOI 10.1093/ACPROF:OSO/9780195134971.003.0017]; SINGH J, 1990, BRAIN RES, V531, P45, DOI 10.1016/0006-8993(90)90756-2; SINGH J, 1992, SCHIZOPHR RES, V8, P31, DOI 10.1016/0920-9964(92)90058-D; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; Weilke F, 2001, J NEUROPHYSIOL, V85, P1858; WEINBERGER DR, 1988, TRENDS NEUROSCI, V11, P367, DOI 10.1016/0166-2236(88)90060-4; Westphal K. P., 2003, BEREITSCHAFTSPOTENTI, P155; Wiese H, 2005, NEUROIMAGE, V28, P691, DOI 10.1016/j.neuroimage.2005.06.044; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Wildgruber D, 1997, NEUROSCI LETT, V227, P161, DOI 10.1016/S0304-3940(97)00329-7; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; ZIMMERMANN P, 1994, TEST ATTENTIONAL PER	43	13	14	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 1	2006	30	4					1292	1301		10.1016/j.neuroimage.2005.11.012			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	043LB	WOS:000237601500021	16380271				2021-06-18	
J	Driver, S				Driver, S			Applying physical activity motivation theories to people with brain injuries	ADAPTED PHYSICAL ACTIVITY QUARTERLY			English	Article							SELF-EFFICACY; PERCEPTIONS; PERFORMANCE; COMPETENCE; ESTEEM; PARTICIPATION; INDIVIDUALS; PREDICTORS; AQUATICS; PROGRAM	The purpose of the paper is to provide specialists with theoretical frameworks that can be used to guide the creation of physical activity interventions as well as facilitating participation for people with traumatic brain injuries. Two frameworks for examining the physical activity motivation of people with brain injuries are presented. The theories include Bandura's (1986) self-efficacy theory and Harter's (1987) mediational model of self-worth. The constructs within both theories are explained and then applied to people with brain injuries. Suggestions for practitioners are also provided about how to manipulate the physical activity environment to promote physical activity participation.	Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	Driver, S (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA.	SDriver@coe.unt.edu					American College of Sports Medicine, 2000, ACSM GUID EX TEST PR; ARMSTRONG C, 1991, J REHABIL, V57, P15; Babkes ML, 1999, PEDIATR EXERC SCI, V11, P44, DOI 10.1123/pes.11.1.44; BAKERROTH S, 1995, THERAPEUTIC RECREATI, V25, P316; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; BIDDLE SJ, 1994, PHYS ACTIVITY PROMOT; BOSLEY CM, 1995, EUR RESPIR J, V8, P899; Clark NM, 1999, HEALTH EDUC BEHAV, V26, P72, DOI 10.1177/109019819902600107; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; DILORIO C, 1996, NURS RES, V45, P211, DOI DOI 10.1097/00006199-199607000-00004; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2006, ADAPT PHYS ACT Q, V23, P1; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; DRIVER S, 2003, J PHYS ED RECREATION, V74, P41; DRIVER S, 2003, J COGNITIVE REHABILI, V21, P26; DRIVER S, IN PRESS BRAIN INJUR; DRIVER S, 2005, UNPUB BARRIERS PHYS; Driver S, 2003, J COGNITIVE REHABILI, V21, P22; DUNCAN TE, 1993, J BEHAV MED, V16, P199, DOI 10.1007/BF00844893; Ebbeck V, 1996, PEDIATR EXERC SCI, V8, P368, DOI 10.1123/pes.8.4.368; Ebbeck V, 1998, PEDIATR EXERC SCI, V10, P285, DOI 10.1123/pes.10.3.285; EBBECK V, 1993, PEDIATR EXERC SCI, V5, P253; EWART CK, 1989, MED SCI SPORT EXER, V21, P683, DOI 10.1249/00005768-198912000-00011; FELTZ DL, 1982, J PERS SOC PSYCHOL, V42, P764, DOI 10.1037/0022-3514.42.4.764; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fox K, 1997, BRIT J GEN PRACT, V47, P367; FOX KR, 1989, J SPORT EXERCISE PSY, V11, P408, DOI 10.1123/jsep.11.4.408; GEORGE TR, 1992, J SPORT EXERCISE PSY, V14, P237, DOI 10.1123/jsep.14.3.237; HARTER S, 1978, HUM DEV, V21, P34, DOI 10.1159/000271574; Harter S., 1987, CONT TOPICS DEV PSYC, P219; Harter S., 1999, CONSTRUCTION SELF DE; Heller T, 2001, EXERCISE NUTR ED CUR; HORN T, 2003, DEV SPORT EXERCISE P, P101; Kennedy P, 2000, BRIT J HEALTH PSYCH, V5, P157, DOI 10.1348/135910700168838; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Li FZ, 2001, J AGING PHYS ACTIV, V9, P161, DOI 10.1123/japa.9.2.161; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; Lox CL, 1999, REHABIL PSYCHOL, V44, P1; LOX CL, 2003, PSYCHOL EXERCISE THE; Martin JJ, 2002, SPORT PSYCHOL, V16, P384, DOI 10.1123/tsp.16.4.384; MCAULEY E, 1993, J BEHAV MED, V16, P103, DOI 10.1007/BF00844757; McAuley E, 1999, J GERONTOL B-PSYCHOL, V54, pP283, DOI 10.1093/geronb/54B.5.P283; MCAULEY E, 1993, J GERONTOL, V48, pP218, DOI 10.1093/geronj/48.4.P218; MCAULEY E, 1985, J SPORT PSYCHOL, V7, P283, DOI 10.1123/jsp.7.3.283; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; McAuley E., 2002, ADV SPORT PSYCHOL, P185; McCullagh P, 2002, EXPLORING SPORT EXER, P131; Messent PR, 1998, BRIT J LEARN DISABIL, V26, P17, DOI DOI 10.1111/J.1468-3156.1998.TB00041.X; Nahas M. V., 2003, PHYS EDUC, V60, P42; *NIH, 1999, REH PERS TRAUM BRAIN, V16, P1; PESCATELLO LS, 1993, SPORTS MED, V15, P353, DOI 10.2165/00007256-199315060-00001; Smith AL, 1999, J SPORT EXERCISE PSY, V21, P329, DOI 10.1123/jsep.21.4.329; STANDAGE M, 2003, DEV SPORT EXERCISE P, P101; Treasure DC, 1996, SPORT PSYCHOL, V10, P73, DOI 10.1123/tsp.10.1.73; U.S Department of Health and Human Services, 2000, HLTH PEOPL 2010; *US DEP HHS, 2002, PUBL US DEP HHS; Weiss M., 1991, SPORT PSYCHOL, V5, P335; Weiss M.R., 1996, ENCY SPORTS MED, VVI, P364; Weiss MR, 1997, J SPORT EXERCISE PSY, V19, P52, DOI 10.1123/jsep.19.1.52; Weiss MR, 1998, RES Q EXERCISE SPORT, V69, P380, DOI 10.1080/02701367.1998.10607712; Weiss MR, 2002, ADV SPORT PSYCHOL, P101; WEISS MR, 2003, DEV SPORT EXERCISE P, P101	63	13	13	0	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0736-5829	1543-2777		ADAPT PHYS ACT Q	Adapt. Phys. Act. Q.	APR	2006	23	2					148	162		10.1123/apaq.23.2.148			15	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	032ZD	WOS:000236814500003					2021-06-18	
J	Lagares, A; Ramos, A; Alday, R; Ballenilla, F; Perez-Nunez, A; Arrese, I; Alen, JF; Pascual, B; Kaen, A; Gomez, PA; Lobato, RD				Lagares, A.; Ramos, A.; Alday, R.; Ballenilla, F.; Perez-Nunez, A.; Arrese, I.; Alen, J. F.; Pascual, B.; Kaen, A.; Gomez, P. A.; Lobato, R. D.			Magnetic resonance in moderate and severe head injury: comparative study of CT and MR findings. Characteristics related to the presence and location of diffuse axonal injury in MR	NEUROCIRUGIA			Spanish	Article						traumatic brain injury; head trauma; MR; CT; diffuse axonal injury; imaging methods	TRAUMA	Introduction. Cranial CT has been the most extended evaluation means for patients suffering head trauma. However, it has low sensitivity in the identification of diffuse axonal injury and posterior fossa lesions. Cranial MR is a potentially more sensitive test but difficult to perform in these patients, a fact that has hampered its generalised use. Objective. To compare the identification capability of traumatic intracranial lesions by both diagnostic tests in patients with moderate and severe head injury and to determine which radiological characteristics are associated with the presence of diffuse injury in MR and their clinical severity. Material and methods. 100 patients suffering moderate or severe head injury to whom a MR had been performed in the first 30 days after trauma were included. All clinical variables related to prognosis were registered, as well as the data from the initial CT following Marshall et al., classification. The MR was blindly evaluated by two neuroradiologists that were not aware of the initial CT results or the clinical situation of the patient. All lesions were registered as well as the classification following the classification of lesions related to DAI described by Adams et al. CT and MR findings were compared evaluating the sensitivities of each test. Factors related to the presence of diffuse injury in MR were studied by univariate analysis using chi(2) test and simple correlations. Results. MR is more sensitive than CT for lesions in cerebral white matter, corpus callosum and brainstem. It also detects a greater number of cerebral contusions. The presence of diffuse axonal injury depends on the mechanism of the trauma, being more frequent in higher energy trauma, specially in traffic accidents. Among the radiological characteristics associated to DAI the most clearly related is intraventricular haemorrhage. The presence of a deeper injury and a higher score in the scales of Adams is associated with a lower score in the GCS and motor GCS, and so with a worse level of consciousness and bigger severity of injury, confirming Ommaya's model.	Hosp 12 Octubre, Serv Neurocirugia, E-28041 Madrid, Spain; Hosp 12 Octubre, Serv Neurorradiol, E-28041 Madrid, Spain	Lagares, A (corresponding author), Hosp 12 Octubre, Serv Neurocirugia, Crta Andalucia Km 5-4, E-28041 Madrid, Spain.		ALEN, JOSE A FERNANDEZ/G-4990-2018; kaen, ariel/G-3786-2015; Gomez, Pedro/N-5051-2019; Lagares, Alfonso/B-2969-2011; KAEN, ARIEL/F-1338-2015; Perez-Nunez, Angel/AAG-4422-2020	ALEN, JOSE A FERNANDEZ/0000-0002-3321-983X; Gomez, Pedro/0000-0002-4185-5238; Lagares, Alfonso/0000-0003-3996-0554; Perez-Nunez, Angel/0000-0002-2391-6586			Adams A, 2001, BCS CONF SERIES, P49; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Aguas J, 2005, NEUROCIRUGIA, V16, P14; Boto GR, 2005, NEUROCIRUGIA, V16, P39; Boto GR, 2004, NEUROCIRUGIA, V15, P233; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; SAHUQUILLO J, 1989, ACTA NEUROCHIR WIEN, V101, P762; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; VILALTA J, 1984, REV NEUROLOGIA, V57, P133; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	31	13	15	1	3	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	APR	2006	17	2					105	118					14	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	056YN	WOS:000238561100004	16721477				2021-06-18	
